PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Zhou, XB; Song, H; Hu, M; Li, XL; Cai, Y; Huang, GP; Li, J; Kang, L; Li, J				Zhou, Xiaobo; Song, Hui; Hu, Min; Li, Xiaolin; Cai, Ying; Huang, Guoping; Li, Jun; Kang, Lin; Li, Jing			Risk factors of severity of post-traumatic stress disorder among survivors with physical disabilities one year after the Wenchuan earthquake	PSYCHIATRY RESEARCH			English	Article						Disaster; Trauma; China; Disability	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; GENERAL-POPULATION; ADULT SURVIVORS; PTSD; CHINA; IMPACT; SYMPTOMS; EXPOSURE; ADOLESCENTS	On May 12,2008, a devastating earthquake measuring 8.0 on the Richter scale struck Wenchuan County and surrounding areas in China. This study aimed to assess post-traumatic stress disorder (PTSD) in the aftermath of the earthquake, and to evaluate factors of severity of PTSD symptoms among survivors with physical disabilities. We conducted a population-based cross-sectional survey and recruited 817 survivors with physical disabilities in three stricken areas. Assessment measures included the PTSD Checklist-Civilian Version (PCL-C) and the 12-item General Health Questionnaire (GHQ-12). Our study showed that 27.42% of the survivors with physical disabilities had PTSD symptoms one year after the Wenchuan earthquake. In the regression model, geographic location, female, suffering from paralysis following the earthquake, and going into a coma in the earthquake were associated with severe PTSD symptoms. Our findings suggest that a substantial proportion of physically disabled survivors of a big earthquake may have severe PTSD symptoms. The associated factors of PTSD identified in our study could inform the implementation of preventive programs for this population and give hint on the way to cope with this kind of disaster in the future. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Zhou, Xiaobo; Li, Xiaolin; Cai, Ying; Kang, Lin; Li, Jing] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610041, Sichuan, Peoples R China; [Song, Hui; Huang, Guoping] Third Peoples Hosp Mianyang City, Dept Psychiat, Mianyang City 621000, Sichuan, Peoples R China; [Hu, Min] Fourth Peoples Hosp Chengdu City, Dept Psychiat, Chengdu 610000, Sichuan, Peoples R China; [Li, Jun] Demobilized Vet Hosp Sichuan Prov, Dept Psychiat, Chongzhou City 611200, Sichuan, Peoples R China		Li, J (corresponding author), 28 Dianxinnan St, Chengdu 610041, Sichuan, Peoples R China.	joana028@163.com			863 National Project [2008 AA 022 605]	This work was funded by the 863 National Project (No. 2008 AA 022 605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Agar E, 2006, BEHAV COGN PSYCHOTH, V34, P437, DOI 10.1017/S1352465806002943; Amital D, 2012, ISR MED ASSOC J, V14, P281; [Anonymous], 2008, SOHU NEWS; Bhuvaneswar Chaya G, 2007, Prim Care Companion J Clin Psychiatry, V9, P303; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Broberg AG, 2005, J CHILD PSYCHOL PSYC, V46, P1279, DOI 10.1111/j.1469-7610.2005.01439.x; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Chen ZX, 2009, SEX ROLES, V60, P765, DOI 10.1007/s11199-009-9585-9; Cheng HG, 2012, PSYCHIAT RES, V199, P212, DOI 10.1016/j.psychres.2012.03.019; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096644; China Disabled Person's Federation, 2012, TOT POP DIS PEOPL TY; Chiu KB, 2011, ACAD EMERG MED, V18, P1156, DOI 10.1111/j.1553-2712.2011.01206.x; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Goldberg D., 1992, GEN HLTH QUESTIONNAI; Grubaugh AL, 2007, DEPRESS ANXIETY, V24, P124, DOI 10.1002/da.20226; Hatcher MB, 2009, BRIT J HEALTH PSYCH, V14, P541, DOI 10.1348/135910708X373445; Hussain A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-232; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Jia ZB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-172; Jones R., 2012, SCI SCOPE, V36, P54; Khamis V, 2012, SOC SCI MED, V74, P2005, DOI 10.1016/j.socscimed.2012.02.025; Klein MB, 2007, J BURN CARE RES, V28, P84, DOI 10.1097/BCR.0b013E31802C888E; Koenen KC, 2002, J NERV MENT DIS, V190, P209, DOI 10.1097/00005053-200204000-00001; Koren D, 2006, CNS SPECTRUMS, V11, P616, DOI 10.1017/S1092852900013675; LI A, 1994, CHIN J REHABIL MED, V10, P96; Li Wenxue, 2013, Shanghai Arch Psychiatry, V25, P306, DOI 10.3969/j.issn.1002-0829.2013.05.006; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Liu ZY, 2012, ASIA-PAC J PUBLIC HE, V24, P21, DOI 10.1177/1010539510373945; Niederkrotenthaler T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083038; Ongecha-Owuor F A, 2004, East Afr Med J, V81, P362; Otis Catherine, 2012, Top Spinal Cord Inj Rehabil, V18, P253, DOI 10.1310/sci1803-253; Peng K., 2010, CHINESE HLTH EC, V29, P33; Pevalin DJ, 2000, SOC PSYCH PSYCH EPID, V35, P508, DOI 10.1007/s001270050272; Roberge Marie-Anne, 2010, Can J Cardiol, V26, pe170; Salazar AM, 2013, SOC PSYCH PSYCH EPID, V48, P545, DOI 10.1007/s00127-012-0563-0; Sareen J, 2014, CAN J PSYCHIAT, V59, P460, DOI 10.1177/070674371405900902; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Tian YL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1073; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Wu ZB, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-126; Xu J, 2005, J INTELL DISABIL RES, V49, P745, DOI 10.1111/j.1365-2788.2005.00744.x; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Ying L, 2014, SUICIDE LIFE THREAT; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046449, 10.1371/journal.pone.0029651, 10.1371/journal.pone.0030551]; Zheng QL, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-25; Zhuoying T.B.Z.Y.Q., 2007, CHIN J SPEC ED, V8, P011	55	15	17	0	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	AUG 30	2015	228	3					468	474		10.1016/j.psychres.2015.05.062			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CP9YI	WOS:000360251400035	26163729				2022-02-06	
J	Spitz, G; Downing, MG; McKenzie, D; Ponsford, JL				Spitz, Gershon; Downing, Marina G.; McKenzie, Dean; Ponsford, Jennie L.			Mortality following Traumatic Brain Injury Inpatient Rehabilitation	JOURNAL OF NEUROTRAUMA			English	Article						head injury; mortality; traumatic brain injury	LONG-TERM SURVIVAL; HEAD-INJURY; ADULTS; PREVALENCE; DISABILITY; PEOPLE; TRENDS; RATES; RISK; AGE	The aim of this study was to examine the rate and causes of mortality following mild to severe traumatic brain injury (TBI) rehabilitation and to develop a multivariate prognostic model of mortality. We conducted a cohort study of 3341 individuals with mild to severe TBI followed-up from a post-acute inpatient rehabilitation center. Rate of death and survival between one and 26 years following injury were examined using standardized mortality ratios (SMRs) and prognostic models developed using Cox regression. A mortality rate of 9.3% was observed and an overall SMR of 1.04 (95% confidence interval [CI]=1.04-1.05). A statistically significant elevated SMR of 1.20 (95% CI=1.06-1.37) was observed for males, and both males and females had an elevated risk of death from external causes. Females also were found to have a significantly elevated SMR of 5.02 (95% CI=1.36-12.80) for intentional self-harm. Individuals ages 15-44 had a two-fold increase in mortality, compared with the general population. The multivariate Cox model indicated that increased risk of mortality was associated with older age, being male, being unemployed prior to injury, having a history of stroke, alcohol use, mental health issues, and back injury sustained in the accident. Premorbid lifestyle factors exerted a greater influence on mortality following TBI, compared with injury-related factors. This risk was especially prominent for younger individuals, who died primarily due to external causes. These findings highlight the need for interventions that address premorbid issues, such as substance abuse and mental health issues.	[Spitz, Gershon; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [McKenzie, Dean] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Spitz, Gershon; Downing, Marina G.; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean] Epworth Healthcare, Clin Trials & Res Ctr, Melbourne, Vic, Australia		Spitz, G (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	gershon.spitz@monash.edu	Downing, Marina/AAX-2380-2020; Spitz, Gershon/H-7755-2014	Downing, Marina/0000-0002-3126-6632; Spitz, Gershon/0000-0002-7810-1480	Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This project is funded by the Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research (ISCRR).	Armitage P, 2008, STAT METHODS MED RES; Australian Bureau of Statistics, 1996, DEATHS AUSTR CAT 220; Australian Bureau of Statistics, 2009, DEATHS AUSTR CAT 330; Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns Jr J, EPILEPSIA S10, V44, P2; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Corp. I, 2011, IBM SPSS STAT WIND V; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kraus J. F., 1999, REHABILITATION ADULT, P3; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McMillan T, BRAIN, V130, P2520; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507	34	15	15	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1272	1280		10.1089/neu.2014.3814			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400011	25706104				2022-02-06	
J	Al-Burdeni, S; Abuodeh, Y; Ibrahim, T; Ahmed, G				Al-Burdeni, Salah; Abuodeh, Yousef; Ibrahim, Talal; Ahmed, Ghalib			Open reduction and internal fixation versus radial head arthroplasty in the treatment of adult closed comminuted radial head fractures (modified Mason type III and IV)	INTERNATIONAL ORTHOPAEDICS			English	Article						Radial head fracture; Radial head fixation; Radial head arthroplasty	FOLLOW-UP; EXCISION; ELBOW; REPLACEMENT; PROSTHESIS; KINEMATICS; RESECTION	Background The purpose of our study was to compare the outcome of radial head fractures (modified Mason type III and IV) treated by open reduction and internal fixation (ORIF) versus radial head arthroplasty (RHA). Patients and methods A retrospective review of 36 patients with closed comminuted radial head fractures treated either by ORIF or RHA with an average of 15-months' follow-up was undertaken. The primary outcome was the QuickDASH, the shortened version of the Dissabilities of the Arm, Shouler and Hand score. Other outcomes included regain of functional range of motion (ROM) of the elbow and duration of surgery. Surgical complications were noted. Results Thirty-six patients with a mean age of 36 years were evaluated. Nineteen patients underwent ORIF and 17 RHA. The two treatment groups were comparable with regards to gender, side of injury, Mason type and mechanism of injury. Patients who underwent RHA were slightly older (p < 0.001). At follow-up, the QuickDASH score was similar between groups (p = 0.58). Regain of functional ROM of the elbow (p = 0.13) and complication rate (p = 0.57) were similar. Conclusion The treatment of closed comminuted radial head fracture (modified Mason type III and IV) with ORIF and RHA demonstrates similar findings despite less surgical time for performing RHA.	[Al-Burdeni, Salah; Abuodeh, Yousef; Ibrahim, Talal; Ahmed, Ghalib] Hamad Gen Hosp, Doha, Qatar		Ahmed, G (corresponding author), Hamad Gen Hosp, POB 3050, Doha, Qatar.	ghaliboudah@gmail.com	Ibrahim, Talal/AAK-6433-2020	Ibrahim, Talal/0000-0001-9192-1435; ALHANEEDI, GHALIB/0000-0003-4326-7250; Abuodeh, Yousef/0000-0002-9008-5487			Bain G I, 2005, J Bone Joint Surg Am, V87 Suppl 1, P136, DOI 10.2106/JBJS.D.02710; Beingessner DM, 2004, J BONE JOINT SURG AM, V86A, P1730, DOI 10.2106/00004623-200408000-00018; Chen X, 2011, INT ORTHOP, V35, P1071, DOI 10.1007/s00264-010-1107-4; COLEMAN DA, 1987, J BONE JOINT SURG AM, V69A, P385; ESSER RD, 1995, J ORTHOP TRAUMA, V9, P318, DOI 10.1097/00005131-199509040-00008; GOLDBERG I, 1986, J BONE JOINT SURG AM, V68A, P675, DOI 10.2106/00004623-198668050-00006; Holmenschlager F, 2002, REV CHIR ORTHOP, V88, P387; Ikeda A, 2003, J BONE JOINT SURG BR, V85B, P1040, DOI 10.1302/0301-620X.85B7.13823; Janssen RPA, 1998, J BONE JOINT SURG BR, V80B, P231, DOI 10.1302/0301-620X.80B2.8255; Johnson JA, 2005, J SHOULDER ELB SURG, V14, p195S, DOI 10.1016/j.jse.2004.09.034; King G J, 1991, J Orthop Trauma, V5, P21, DOI 10.1097/00005131-199103000-00004; KNIGHT DJ, 1993, J BONE JOINT SURG BR, V75, P572, DOI 10.1302/0301-620X.75B4.8331111; Leppilahti J, 2000, INT ORTHOP, V24, P160, DOI 10.1007/s002640000134; MANCINI G B, 1989, Italian Journal of Orthopaedics and Traumatology, V15, P295; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; MCARTHUR RA, 1987, CLIN ORTHOP RELAT R, P79; MIKIC ZD, 1983, CLIN ORTHOP RELAT R, P220; Moro JK, 2001, J BONE JOINT SURG AM, V83A, P1201, DOI 10.2106/00004623-200108000-00010; MORREY BF, 1979, J BONE JOINT SURG AM, V61, P63, DOI 10.2106/00004623-197961010-00012; Morrey BF, 2000, ELBOW ITS DISORDERS, P341; Postacchini F, 1992, Ital J Orthop Traumatol, V18, P323; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; Ruan HJ, 2009, INT ORTHOP, V33, P249, DOI 10.1007/s00264-007-0453-3; RYMASZEWSKI LA, 1984, J BONE JOINT SURG BR, V66, P109, DOI 10.1302/0301-620X.66B1.6693467; Schnetzke M, 2014, INT ORTHOP, V38, P2295, DOI 10.1007/s00264-014-2478-8	25	15	17	1	12	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	AUG	2015	39	8					1659	1664		10.1007/s00264-015-2755-1			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	CN4FE	WOS:000358385000029	25823518				2022-02-06	
J	Barbey, AK; Belli, A; Logan, A; Rubin, R; Zamroziewicz, M; Operskalski, JT				Barbey, Aron K.; Belli, Antonio; Logan, Ann; Rubin, Rachael; Zamroziewicz, Marta; Operskalski, Joachim T.			Network topology and dynamics in traumatic brain injury	CURRENT OPINION IN BEHAVIORAL SCIENCES			English	Article							DIRECT-CURRENT STIMULATION; FRONTOPARIETAL CONTROL-SYSTEM; DIFFUSE AXONAL INJURY; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; AEROBIC FITNESS; COGNITIVE FUNCTION; EXECUTIVE FUNCTION; PHYSICAL-ACTIVITY; WORKING-MEMORY	We propose a network approach to clinical translation that defines core behavioral phenotypes of traumatic brain injury (TBI) with respect to damage to specific intrinsic connectivity networks (ICNs). We survey recent approaches to clinical translation from cognitive neuroscience that enhance network function and recovery from brain injury through interventions that deliver targeted (network specific) and global (systemic) effects. A network approach provides insight into the mechanisms of brain injury, linking ICN characteristics to specific profiles of cognitive impairment, providing key neurobiological targets for therapeutic intervention, and motivating new perspectives about the nature of cognitive recovery and rehabilitation in TBI.	[Barbey, Aron K.; Rubin, Rachael; Zamroziewicz, Marta; Operskalski, Joachim T.] Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA; [Barbey, Aron K.; Rubin, Rachael; Zamroziewicz, Marta; Operskalski, Joachim T.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Barbey, Aron K.] Univ Illinois, Dept Internal Med, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Inst Genom Biol, Champaign, IL 61820 USA; [Belli, Antonio; Logan, Ann] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Rubin, Rachael] Carle Fdn Hosp, Carle Neurosci Inst, Urbana, IL USA		Barbey, AK (corresponding author), Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA.	barbey@illinois.edu	Belli, Antonio/I-3799-2015; Barbey, Aron/L-7312-2015	Belli, Antonio/0000-0002-3211-9933; Barbey, Aron/0000-0002-6092-0912; Logan, Ann/0000-0003-3215-5042	Birmingham-Illinois Partnership Discovery, Engagement and Education (BRIDGE) Program	This work was supported by funding from the Birmingham-Illinois Partnership Discovery, Engagement and Education (BRIDGE) Program.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Barbey AK, 2014, BRAIN; Barbey AK, 2014, BRAIN, V137, P2823, DOI 10.1093/brain/awu207; Barbey AK, 2014, BRAIN STRUCT FUNCT, V219, P485, DOI 10.1007/s00429-013-0512-z; Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312; Barbey AK, 2014, SOC COGN AFFECT NEUR, V9, P265, DOI 10.1093/scan/nss124; Barbey AK, 2013, NEUROIMAGE, V82, P547, DOI 10.1016/j.neuroimage.2013.05.087; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barbey AK, 2013, NEUROPSYCHOLOGIA, V51, P1361, DOI 10.1016/j.neuropsychologia.2012.05.017; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Barbey AK, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00162; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Braver T S, 1999, Prog Brain Res, V121, P327; Buckley J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00747, 10.3389/fnhum.2014.00747, 10.3389/fnhum.2014.00584]; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burzynska AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107413; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chaddock L., 2012, KINESIOL REV, V1, P37, DOI [DOI 10.1123/krj.1.1.37, 10.1123/krj.1.1.37]; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock-Heyman L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00072; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Coffman BA, 2012, NEUROPSYCHOLOGIA, V50, P1594, DOI 10.1016/j.neuropsychologia.2012.03.012; Coffman BA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-108; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Datta A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036018; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Dmochowski JP, 2013, NEUROIMAGE, V75, P12, DOI 10.1016/j.neuroimage.2013.02.049; Dmochowski JP, 2012, IEEE ENG MED BIO, P6426, DOI 10.1109/EMBC.2012.6347465; Dmochowski JP, 2012, PHYS MED BIOL, V57, P6459, DOI 10.1088/0031-9155/57/20/6459; Dmochowski JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046011; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hellyer PJ, 2014, J NEUROSCI, V34, P451, DOI 10.1523/JNEUROSCI.1853-13.2014; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hillman CH, 2006, INT J PSYCHOPHYSIOL, V59, P30, DOI 10.1016/j.ijpsycho.2005.04.009; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Kamijo K, 2010, PSYCHOPHYSIOLOGY, V47, P814, DOI 10.1111/j.1469-8986.2010.00992.x; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Leocani L, 2006, NEUROL SCI, V27, pS27, DOI 10.1007/s10072-006-0542-x; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monti JM, 2012, HIPPOCAMPUS, V22, P1876, DOI 10.1002/hipo.22023; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Pontifex MB, 2009, PSYCHOPHYSIOLOGY, V46, P379, DOI 10.1111/j.1469-8986.2008.00782.x; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Simmons WK, 2013, HUM BRAIN MAPP, V34, P2944, DOI 10.1002/hbm.22113; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Themanson JR, 2008, NEUROSCIENCE, V157, P319, DOI 10.1016/j.neuroscience.2008.09.014; Themanson JR, 2006, NEUROBIOL AGING, V27, P1335, DOI 10.1016/j.neurobiolaging.2005.07.002; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Warren DE, 2014, P NATL ACAD SCI USA, V111, P14247, DOI 10.1073/pnas.1322173111; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	118	15	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-1546	2352-1554		CURR OPIN BEHAV SCI	Curr. Opin. Behav. Sci.	AUG	2015	4						92	102		10.1016/j.cobeha.2015.04.002			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Emerging Sources Citation Index (ESCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	V3O5R	WOS:000218444200013					2022-02-06	
J	Griesdale, DE; Sekhon, MS; Menon, DK; Lavinio, A; Donnelly, J; Robba, C; Sekhon, IS; Taylor, A; Henderson, WR; Turgeon, AF; Gupta, AK				Griesdale, Donald E.; Sekhon, Mypinder S.; Menon, David K.; Lavinio, Andrea; Donnelly, Joseph; Robba, Chiara; Sekhon, Indeep S.; Taylor, Andrew; Henderson, William R.; Turgeon, Alexis F.; Gupta, Arun K.			Hemoglobin Area and Time Index Above 90 g/L are Associated with Improved 6-Month Functional Outcomes in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Anemia; Brain injuries; Blood transfusion; Glasgow Outcome Scale; Neurocritical care; Area under curve	BLOOD-CELL TRANSFUSION; CRITICALLY-ILL; CLINICAL-PRACTICE; ANEMIA; INCREASES; MORTALITY; INFECTION; EVENTS	There is conflicting data on the relationship between anemia and outcomes in patients with traumatic brain injuries (TBI). The objective of this study was to determine if the proportion of time and area under the hemoglobin-time curve of a parts per thousand yen90 g/L are independently associated with 6-month functional outcomes. Retrospective cohort study of 116 patients with a severe TBI who underwent invasive neuromonitoring between June 2006 and December 2013. Hemoglobin area (HAI) and time (HTI) indices were calculated by dividing the total area, or time, under the hemoglobin-time curve at 90 g/L or above by the total duration of monitoring. Multivariable log-binomial regression was used to model the association between HAI or HTI and 6 month favorable neurologic outcome (Glasgow Outcome Score 4 or 5). Patients had a mean age of 38 years (SD 16) with a median admission Glasgow Coma Scale of 6 (IQR 4-7). There were 1523 hemoglobin measurements and 523 monitoring days. Patients had a hemoglobin a parts per thousand yen90 g/L for a median of 70 % (IQR 37-100) of the time. Each 10 g/L increase in HAI (RR 1.23, 95 %CI 1.04-1.44, P = 0.011), and 10 % increase in HTI (1.10, 95 %CI 1.04-1.16, P < 0.001) were associated with improved neurologic outcome. Thirty-one patients (27 %) received a transfusion with the median pre-transfusion hemoglobin being 81 g/L (IQR 76-87). In patients with severe TBI, increased area under the curve and percentage of time that the hemoglobin concentration was a parts per thousand yen90 g/L, were associated with improved neurologic outcomes.	[Griesdale, Donald E.; Sekhon, Mypinder S.; Sekhon, Indeep S.; Henderson, William R.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Menon, David K.; Lavinio, Andrea; Donnelly, Joseph; Robba, Chiara; Taylor, Andrew; Gupta, Arun K.] Univ Cambridge, Addenbrookes Hosp, Cambridge Univ Hosp Trust, Neurocrit Care Unit, Cambridge CB2 2QQ, England; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval, CHU Quebec Res Ctr, Populat Hlth & Optimal Hlth Practices Unit, Quebec City, PQ, Canada		Griesdale, DE (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	donald.griesdale@vch.ca	Donnelly, Joseph/N-6803-2019; Robba, Chiara/AAS-7421-2020; Griesdale, Donald/AAT-7762-2021; Lavinio, Andrea/M-1778-2016; Donnelly, Joseph/E-9235-2018	Donnelly, Joseph/0000-0002-6502-8069; Griesdale, Donald/0000-0001-5985-8624; Donnelly, Joseph/0000-0002-6502-8069	VGH & UBC Hospital Foundation Best of Health Fund; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	Dr. Griesdale is funded by the VGH & UBC Hospital Foundation Best of Health Fund.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Claridge JA, 2002, AM SURGEON, V68, P566; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Griesdale DEG, 2015, J CRIT CARE, V30, P111, DOI 10.1016/j.jcrc.2014.07.026; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mackenzie IMJ, 2011, INTENS CARE MED, V37, P435, DOI 10.1007/s00134-010-2103-2; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Roberts DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11489; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sekhon MS, 2011, J CRIT CARE, V26, P357, DOI 10.1016/j.jcrc.2010.12.001; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vogelzang M, 2004, CRIT CARE, V8, pR122, DOI 10.1186/cc2840; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	33	15	15	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2015	23	1					78	84		10.1007/s12028-014-0096-3			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CN8FJ	WOS:000358674600012	25510896				2022-02-06	
J	Ilie, G; Mann, RE; Ialomiteanu, A; Adlaf, EM; Hamilton, H; Wickens, CM; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Mann, Robert E.; Ialomiteanu, Anca; Adlaf, Edward M.; Hamilton, Hayley; Wickens, Christine M.; Asbridge, Mark; Rehm, Juergen; Cusimano, Michael D.			Traumatic brain injury, driver aggression and motor vehicle collisions in Canadian adults	ACCIDENT ANALYSIS AND PREVENTION			English	Article; Proceedings Paper	2nd International Conference on Transportation Information and Safety (ICTIS)	JUN 29-JUL 02, 2013	Wuhan, PEOPLES R CHINA			Traumatic brain injury; Concussions; Driver aggression; Adults; Motor vehicle collision	ILLICIT DRUG-USE; SELF-REPORTED COLLISIONS; ROAD RAGE; REPRESENTATIVE SAMPLE; CANNABIS USE; ALCOHOL-USE; POPULATION; PREVALENCE; IMPACT; PERFORMANCE	Objective: This study examines the associations between lifetime traumatic brain injury (TBI), driver aggression, and motor vehicle collisions among a population sample of adults who reside in the province of Ontario, Canada. Method: A cross-sectional sample of 3993 Ontario adults, aged 18-97 were surveyed by telephone in 2011 and 2012 as part of Center for Addiction and Mental Health's ongoing representative survey of adult mental health and substance use in Canada. TBI was defined as trauma to the head that resulted in loss of consciousness for at least five minutes or overnight hospitalization. Results: An estimated 91% (95% CI: 90.0, 91.9) of individuals in this sample held a valid Ontario driver's license at the time of testing. Among those, 16.7% reported a history of lifetime TB! and 83.3% reported no 'FBI. The prevalence of TBI was higher among men than women. Relative to licensed adults without 'FBI, adults with a history of TBI had significantly higher odds of engaging in serious driver aggression in the past 12 months, such as making threats to hurt another driver, passenger or their vehicle (AOR=4.39). These individuals also reported significantly higher odds (AOR=1.74) of being involved in a motor vehicle collision that resulted in hurting themselves, their passenger(s) or their vehicle. Conclusion: This is the first population-based study to demonstrate a relationship between a history of TBI and higher rates of serious driver aggression and collision involvement. Given the large proportion of adult drivers with a history of 'FBI, these individuals may account for a disproportion burden of all traffic safety problems. Whether the increased road safety risk of adults with a history of TBI is reflective of neurocognitive deficits or is merely evidence of a cluster of unsafe activities produced by a higher risk lifestyles requires further research attention. (C) 2015 Elsevier Ltd. All rights reserved.	[Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Mann, Robert E.; Ialomiteanu, Anca; Adlaf, Edward M.; Hamilton, Hayley; Wickens, Christine M.; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON M5S 2S1, Canada; [Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Wickens, Christine M.; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS B3H 4R2, Canada		Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021; Wickens, Christine M./Q-2014-2017	Wickens, Christine M./0000-0002-9865-850X; Cusimano, Michael/0000-0002-9989-0650	STAIR Team Grant from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR103946]; Ontario Neurotrauma Foundation; AUTO21; Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	This work was financially supported by a STAIR Team Grant (TIR103946) from the Canadian Institutes of Health Research, by the Ontario Neurotrauma Foundation, and by AUTO21, a member of the Networks of Centres of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada. RM, AI, HH, CW and JR also acknowledge funding support from the Ontario Ministry of Health and Long Term Care. The funding agencies had no role in design and conduct of the study, the collection, management, analysis and interpretation of the data, or the preparation, review or approval of the manuscript.	Aday L.A., 1995, DESIGNING CONDUCTING; Adlaf E. M., 2013, CAMH MONITOR 2012 ME; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Asbridge Mark, 2003, Violence Vict, V18, P517, DOI 10.1891/vivi.2003.18.5.517; Asbridge M, 2014, INT J PUBLIC HEALTH, V59, P395, DOI 10.1007/s00038-013-0512-z; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Borkenstein R. F., 1964, ROLE DRINKING DRIVER; Boufous S, 2010, INJURY PREV, V16, P275, DOI 10.1136/ip.2009.024877; Butters JE, 2006, CAN J PUBLIC HEALTH, V97, P96, DOI 10.1007/BF03405323; Butters JE, 2005, DRUG ALCOHOL DEPEN, V80, P169, DOI 10.1016/j.drugalcdep.2005.03.018; Callaghan RC, 2013, ACCIDENT ANAL PREV, V53, P149, DOI 10.1016/j.aap.2013.01.008; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US 2; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Deffenbacher JL, 2003, BEHAV RES THER, V41, P701, DOI 10.1016/S0005-7967(02)00046-3; Deffenbacher JL, 2001, PERS INDIV DIFFER, V31, P1321, DOI 10.1016/S0191-8869(00)00226-9; Eby DW, 2010, JAMA-J AM MED ASSOC, V303, P1642, DOI 10.1001/jama.2010.495; Ellis L., 2009, HDB CRIME CORRELATES; Fierro I, 2011, J STUD ALCOHOL DRUGS, V72, P185, DOI 10.15288/jsad.2011.72.185; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fong G, 2001, SOC PSYCH PSYCH EPID, V36, P277, DOI 10.1007/s001270170045; Galovski T, 2002, BEHAV RES THER, V40, P1157, DOI 10.1016/S0005-7967(01)00083-3; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hemenway D, 2006, ACCIDENT ANAL PREV, V38, P687, DOI 10.1016/j.aap.2005.12.014; Hennessy Dwight A, 2004, Violence Vict, V19, P469, DOI 10.1891/vivi.19.4.469.64169; Ialomiteanu A., 2011, CAMH RES DOCUMENT SE, V35; Ilie G., 2015, J HEAD TRAU IN PRESS; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Joint M., 1995, AGGRESSIVE DRIVING 3; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Li MC, 2012, EPIDEMIOL REV, V34, P65, DOI 10.1093/epirev/mxr017; Mann RE, 2004, J STUD ALCOHOL, V65, P161, DOI 10.15288/jsa.2004.65.161; Mann RE, 2007, J SAFETY RES, V38, P669, DOI 10.1016/j.jsr.2007.09.004; Mann RE, 2007, AM J HEALTH BEHAV, V31, P384, DOI 10.5993/AJHB.31.4.5; Mann RE, 2010, TRAFFIC INJ PREV, V11, P115, DOI 10.1080/15389580903536704; Mann RE, 2010, STRESS HEALTH, V26, P127, DOI 10.1002/smi.1274; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Peden M., 2004, WORLD REPORT ROAD TR; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sagar R, 2013, INT J SOC PSYCHIATR, V59, P407, DOI 10.1177/0020764011431547; Sansone RA, 2010, INT J PSYCHIAT MED, V40, P21, DOI 10.2190/PM.40.1.b; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; Smart Reginald, 2004, Traffic Inj Prev, V5, P343, DOI 10.1080/15389580490509482; Smart RG, 2003, CAN J PUBLIC HEALTH, V94, P247, DOI 10.1007/BF03403543; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Turner C., 1992, SURVEY MEASUREMENT D; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wells-Parker E, 2002, ACCIDENT ANAL PREV, V34, P271, DOI 10.1016/S0001-4575(01)00021-5; Wickens CM, 2013, J AFFECT DISORDERS, V145, P253, DOI 10.1016/j.jad.2012.04.046; Wickens CM, 2012, ACCIDENT ANAL PREV, V45, P10, DOI 10.1016/j.aap.2011.11.013; Wickens CM, 2011, TRANSPORT RES F-TRAF, V14, P400, DOI 10.1016/j.trf.2011.04.007; Yu J, 2004, J CRIM JUST, V32, P421, DOI 10.1016/j.jcrimjus.2004.06.004; [No title captured]	65	15	15	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	AUG	2015	81						1	7		10.1016/j.aap.2015.04.021			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CM2YR	WOS:000357548800001	25935425				2022-02-06	
J	Miller, SC; Whitehead, CR; Otte, CN; Wells, TS; Webb, TS; Gore, RK; Maynard, C				Miller, Shannon C.; Whitehead, Casserly R.; Otte, Clifford N.; Wells, Timothy S.; Webb, Timothy S.; Gore, Russell K.; Maynard, Charles			Risk for broad-spectrum neuropsychiatric disorders after mild traumatic brain injury in a cohort of US Air Force personnel	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; DEPRESSION; IRAQ; SCHIZOPHRENIA; AFGHANISTAN; CONCUSSION; VETERANS; HEALTH	Background Military personnel are at increased risk for traumatic brain injury (TBI) from combat and non-combat exposures. Sequelae of moderate-to-severe TBI are well described, but the literature remains conflicted regarding whether mild TBI (mTBI) results in lasting brain injury and functional impairments. This study assessed risk for a range of neuropsychiatric disorders presenting after mTBI while adjusting for the potential confounds of depression and post-traumatic stress disorder (PTSD). Methods A historical prospective association study was conducted utilising electronic demographic, medical and military-specific data for over 49 000 active duty US Air Force service members (Airmen). This study utilised diagnostic codes considered by an expert panel to be indicative of mTBI to identify cases. Cox proportional hazards modelling calculated HRs for neuropsychiatric outcomes while controlling for varying lengths of follow-up and potentially confounding variables. Results Airmen with mTBI were at increased risk for specific neuropsychiatric disorders compared with a similarly injured non-mTBI control group. HRs for memory loss/amnesia, cognitive disorders, schizophrenia, PTSD, and depression were significantly elevated and remained so for at least 6 months post-mTBI, even after eliminating those with previous neuropsychiatric diagnoses. Conclusions mTBI was positively associated with neuropsychiatric disorders in this population of primarily young adult males; with increased HRs 6 months post-mTBI. The results support that mTBI is distinguished from moderate-to-severe TBI in terms of risk for developing neuropsychiatric disorders. Further, these findings suggest the importance of screening for psychiatric and cognitive disorders post-mTBI in general medical practice.	[Miller, Shannon C.; Wells, Timothy S.; Gore, Russell K.] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA; [Miller, Shannon C.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Addict Sci Div, Cincinnati, OH USA; [Miller, Shannon C.] Air Force Res Lab, Vulnerabil Anal Branch, Wright Patterson AFB, OH USA; [Whitehead, Casserly R.] Infoscitex Corp, Dayton, OH 45431 USA; [Wells, Timothy S.] Def Hlth Program, Res Management Div, Plans & Programs Off, Wright Patterson AFB, OH USA; [Gore, Russell K.] Sports Concuss Inst, Atlanta, GA USA; [Maynard, Charles] Epidemiol Res & Informat Ctr ERIC, Seattle, WA USA		Whitehead, CR (corresponding author), Infoscitex Corp, 4027 Colonel Glenn Highway,Suite 210, Dayton, OH 45431 USA.	Casserly.Whitehead.ctr@US.AF.MIL	Maynard, Charles/N-3906-2015; Otte, Clifford/AAB-9991-2022; Gore, Russell/N-8988-2016	Maynard, Charles/0000-0002-1644-7814; Gore, Russell/0000-0002-8012-1579	Defense Center of Excellence for Psychological Health and Traumatic Brain Injury; Department of Veterans AffairsUS Department of Veterans Affairs	This study was funded by the Defense Center of Excellence for Psychological Health and Traumatic Brain Injury, with work also supported in part by the Department of Veterans Affairs. This study was conducted in accordance with all applicable federal regulations governing the protection of human subjects in research as approved by Air Force Research Laboratory/Wright Site Institutional Review Board (Protocol F-WR-2009-0066-H).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2013, MSMR, V20, P2; Armed Forces Health Surveillance Center, 2013, MED SURVEILL MON REP, V20, P30; Armed Forces Health Surveillance Center, 2007, MED SURVEILL MON REP, V14, P2; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Chew LJ, 2013, DEV NEUROSCI-BASEL, V35, P102, DOI 10.1159/000346157; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fischer H, 2010, RS22452 C RES SERV; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Hoge CW, 2008, AM J EPIDEMIOL, V168, P1095, DOI 10.1093/aje/kwn261; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Practice Management Information Corporation, 2005, INT CLASS DIS 9 REV, V1-3; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schulte PA, 1996, AM J PUBLIC HEALTH, V86, P1281, DOI 10.2105/AJPH.86.9.1281; Singh JA, 2009, PREV CHRONIC DIS, V6; Smeltzer DJ, 1994, PSYCHOTIC DISORDERS, P251; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Whitehead CR, 2014, J SAFETY RES, V48, P43, DOI 10.1016/j.jsr.2013.11.004	40	15	16	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	AUG	2015	72	8					560	566		10.1136/oemed-2014-102646			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CM9IB	WOS:000358020600005	25896331				2022-02-06	
J	Ning, YL; Yang, N; Chen, X; Zhao, ZA; Zhang, XZ; Chen, XY; Li, P; Zhao, Y; Zhou, YG				Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Zhang, Xiu-Zhu; Chen, Xing-Yun; Li, Ping; Zhao, Yan; Zhou, Yuan-Guo			Chronic caffeine exposure attenuates blast-induced memory deficit in mice	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Brain injuries; Caffeine; Memory disorders; Blast injuries		Objective: To investigate the effects of three different ways of chronic caffeine administration on blast-induced memory dysfunction and to explore the underlying mechanisms. Methods: Adult male C57BL/6 mice were used and randomly divided into five groups: control: without blast exposure, con-water: administrated with water continuously before and after blast-induced traumatic brain injury (bTBI), con-caffeine: administrated with caffeine continuously for 1 month before and after bTBI, pre-caffeine: chronically administrated with caffeine for 1 month before bTBI and withdrawal after bTBI, post-caffeine: chronically administrated with caffeine after bTBI. After being subjected to moderate intensity of blast injury, mice were recorded for learning and memory performance using Morris water maze (MWM) paradigms at 1, 4, and 8 weeks post-blast injury. Neurological deficit scoring, glutamate concentration, proinflammatory cytokines production, and neuropathological changes at 24 h, 1, 4, and 8 weeks post-bTBI were examined to evaluate the brain injury in early and prolonged stages. Adenosine A1 receptor expression was detected using qPCR. Results: All of the three ways of chronic caffeine exposure ameliorated blast-induced memory deficit, which is correlated with the neuroprotective effects against excitotoxicity, inflammation, astrogliosis and neuronal loss at different stages of injury. Continuous caffeine treatment played positive roles in both early and prolonged stages of bTBI; pre-bTBI and post-bTBI treatment of caffeine tended to exert neuroprotective effects at early and prolonged stages of bTBI respectively. Up-regulation of adenosine A1 receptor expression might contribute to the favorable effects of chronic caffeine consumption. Conclusion: Since caffeinated beverages are widely consumed in both civilian and military personnel and are convenient to get, the results may provide a promising prophylactic strategy for blast-induced neurotrauma and the consequent cognitive impairment. (C) 2015 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.	[Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Chen, Xing-Yun; Li, Ping; Zhao, Yan; Zhou, Yuan-Guo] Third Mil Med Univ, Mol Biol Ctr, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing, Peoples R China; [Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Zhang, Xiu-Zhu; Chen, Xing-Yun; Li, Ping; Zhao, Yan; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Zhang, Xiu-Zhu] Third Mil Med Univ, Dept 4, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing, Peoples R China		Zhou, YG (corresponding author), Third Mil Med Univ, Mol Biol Ctr, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing, Peoples R China.	yuanguo.zhou@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201461]; Key Project of Medicine and Health of PLA [08G098]; Natural Science Foundation of Chongqing, ChinaNatural Science Foundation of Chongqing [CSTC2012jjA10107]	We gratefully acknowledge Prof. Zhi-Yong Yin, senior engineers Xiao-Yan Li and Xin Ning for their technical support on the BST-I bio-shock tube. We thank Academician Zheng-Guo Wang for critically reading and editing the manuscript. This work was supported by the grants from National Natural Science Foundation of China (No. 81201461), Key Project of Medicine and Health of PLA (No. 08G098) and the Natural Science Foundation of Chongqing, China (No. CSTC2012jjA10107).	Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; BENOWITZ NL, 1990, ANNU REV MED, V41, P277, DOI 10.1146/annurev.me.41.020190.001425; Boison Detlev, 2011, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-13443-2_9; Bura SA, 2008, PAIN, V140, P95, DOI 10.1016/j.pain.2008.07.012; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Cunha RA, 2008, CURR PHARM DESIGN, V14, P1512, DOI 10.2174/138161208784480090; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Espinosa J, 2013, J ALZHEIMERS DIS, V34, P509, DOI 10.3233/JAD-111982; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fredholm Bertil B, 2004, Lakartidningen, V101, P2552; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002; Gui L, 2009, BRAIN RES, V1297, P185, DOI 10.1016/j.brainres.2009.08.050; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Jacobson KA, 1996, TRENDS PHARMACOL SCI, V17, P108, DOI 10.1016/0165-6147(96)10002-X; Johansson B, 1997, BRAIN RES, V762, P153, DOI 10.1016/S0006-8993(97)00378-8; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Liu MD, 2014, CHIN J TRAUMATOL, V17, P317, DOI 10.3760/cma.j.issn.1008-1275.2014.06.003; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001; Vijayanathan V, 2011, BEHAV BRAIN RES, V225, P491, DOI 10.1016/j.bbr.2011.08.006; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Wei CJ, 2011, LEARN MEMORY, V18, P459, DOI 10.1101/lm.2136011; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhou SJ, 2009, BRAIN RES, V1303, P74, DOI 10.1016/j.brainres.2009.09.082	43	15	15	2	3	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2015	18	4					204	211		10.1016/j.cjtee.2015.10.003			8	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1NE	WOS:000442089500004	26764541	gold			2022-02-06	
J	Lorente, L; Martin, MM; Almeida, T; Abreu-Gonzalez, P; Ramos, L; Argueso, M; Riano-Ruiz, M; Sole-Violan, J; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Almeida, Teresa; Abreu-Gonzalez, Pedro; Ramos, Luis; Argueso, Monica; Riano-Ruiz, Marta; Sole-Violan, Jordi; Jimenez, Alejandro			Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury	BMC NEUROLOGY			English	Article						Total antioxidant capacity; Brain trauma; Patients; Mortality; Injury	OXIDATIVE STRESS; HEAD-INJURY; DAMAGE; MELATONIN	Background: Previously, circulating total antioxidant capacity (TAC) in traumatic brain injury (TBI) patients has been scarcely studied and only in studies of small sample size (lower than 55 TBI patients). In one study were found higher serum TAC in non-survivor than in survivor TBI patients; however, an association between circulating TAC and mortality in patients with TBI has not been previously reported. Thus, the objective of this study was to determine whether there is an association between circulating TAC, peroxidation state and mortality in patients with severe TBI. Methods: This was a multicenter, observational and prospective study was carried out in six Spanish Intensive Care Units. We included patients with severe TBI defined as Glasgow Coma Scale (GCS) lower than 9. We excluded patients with Injury Severity Score (ISS) in non-cranial aspects higher than 9. We measured serum TAC on day 1 of TBI. The 30-day mortality was established as endpoint. Results: Non-surviving TBI patients (N = 27) showed higher serum TAC (P < 0.001) than survivor ones (N = 73). Logistic regression analyses showed that serum TAC higher than 2.59 nmol/mL were associated with 30-day mortality controlling for APACHE-II and CT classification (OR = 4.40; 95 % CI = 1.14-16.98; P = 0.03), controlling for GCS and age (OR = 5.88; 95 % CI = 1.57-22.06; P = 0.009), and controlling for CT classification and admission abnormal pupils (OR = 3.89; 95 % CI = 1.30-11.61; P = 0.02). There was an association between serum TAC and malondialdehyde (a biomarker of lipid peroxidation) levels (rho = 0.25; p = 0.01), APACHE-II score (rho = 0.23; p = 0.03) and GCS (rho = -0.21; p = 0.04). Conclusions: To our knowledge, our series is the largest reporting data on circulating TAC in patients with severe TBI. The most relevant and new findings of our study were that there is an association between circulating TAC and peroxidation state and mortality in patients with severe TBI.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife 38320, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife 38320, Spain; [Almeida, Teresa] Univ La Laguna, Inst Enfermedades Trop & Salud Publ Canarias, Unidad Genet, San Cristobal la Laguna 38071, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Phisiol, Santa Cruz De Tenerife 38320, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta 38713, La Palma, Spain; [Argueso, Monica] Univ Valencia, Hosp Clin, Intens Care Unit, Valencia 46004, Spain; [Riano-Ruiz, Marta] Complejo Hosp Univ Insular Materno Infantil, Serv Bioquim Clin, Las Palmas Gran Canaria 35016, Canaria, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Las Palmas Gran Canaria 35010, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna 38320, Santa Cruz DeTe, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain.	lorentemartin@msn.com	Abreu-Gonzalez, Pedro/AAC-7790-2020; Almeida, Teresa A/S-1166-2018	Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Almeida, Teresa A/0000-0002-7644-3436; Argueso, Monica/0000-0001-5917-1056	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	We would like to thank Andreina Leon Carmenatis and Henoc del Rosario Garcia for their technical assistance. This study was supported by fundings from Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain). The fundings have not affected in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chuang CC, 2006, CRIT CARE, V10, DOI 10.1186/cc4826; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kavakli HS, 2010, SCI RES ESSAYS, V5, P2832; Kaya H, 2013, HONG KONG J EMERG ME, V20, P225, DOI 10.1177/102490791302000406; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lorente L, 2015, J CRIT CARE, V30; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; MacKinnon KL, 1999, CLIN BIOCHEM, V32, P263, DOI 10.1016/S0009-9120(98)00109-X; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Sogut O, 2012, TURK J MED SCI, V42, P1010, DOI 10.3906/sag-1109-35; TEASDALE G, 1974, LANCET, V2, P81; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	34	15	15	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUL 25	2015	15								115	10.1186/s12883-015-0378-1			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN5QD	WOS:000358483100001	26205136	Green Published, gold			2022-02-06	
J	Baldwin, VN; Powell, T				Baldwin, Victoria N.; Powell, Theresa			Google Calendar: A single case experimental design study of a man with severe memory problems	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Prospective memory; Single case experimental design; Acquired brain injury; Google Calendar	TRAUMATIC BRAIN-INJURY; DRIVEN TRAINING-PROGRAM; PAGING SYSTEM; POCKET-COMPUTER; EVERYDAY MEMORY; REHABILITATION; PEOPLE; AID; DEFICITS; SCALE	A single case experimental design across behaviours was utilised to explore the effectiveness of Google Calendar text alerts delivered to a mobile phone as a memory aid. The participant was a 43-year-old man (JA) with severe memory problems and executive difficulties caused by a traumatic brain injury (TBI). JA was initially very unwilling to use any memory aid and so a detailed assessment of his beliefs about memory aids, his cognitive difficulties and his social context was performed and a set of specifications for an aid was produced collaboratively. Six weeks of baseline data and six weeks of intervention data were collected for three target memory behaviours and three control memory behaviours. Results were analysed using nonoverlap of all pairs (NAP) analysis which showed a reduction in forgetting in the three target behaviours and no change in two of the three control behaviours. A subjective measure (the revised Everyday Memory Questionnaire) also suggested improvement. This study illustrates that Google Calendar is a highly effective memory aid and emphasises the importance of choosing a memory aid to suit the person's lifestyle and beliefs.	[Baldwin, Victoria N.; Powell, Theresa] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England		Powell, T (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	t.powell@bham.ac.uk		Powell, Theresa/0000-0002-3351-9453			BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Baldwin V. N., 2012, THESIS U BIRMINGHAM; Baldwin VN, 2011, NEUROPSYCHOL REHABIL, V21, P484, DOI 10.1080/09602011.2011.582378; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Electronics Take Back Coalition, 2010, FACTS FIG E WAST REC; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gartland D, 2004, NEUROPSYCHOL REHABIL, V14, P61, DOI 10.1080/09602010343000165; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Hodges S, 2006, LECT NOTES COMPUT SC, V4206, P177; Kapur N, 2004, NEUROPSYCHOL REHABIL, V14, P41, DOI 10.1080/09602010343000138; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Manolov R, 2011, BEHAV THER, V42, P533, DOI 10.1016/j.beth.2010.12.003; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; Morris K., 2010, SPECIAL INTEREST SEC, V20, P1; Ofcom, 2013, MARK CONT UK CMR 201; Pape TLB, 2002, DISABIL REHABIL, V24, P5, DOI 10.1080/09638280110066235; Parker RI, 2009, BEHAV THER, V40, P357, DOI 10.1016/j.beth.2008.10.006; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Savage KR, 2013, CLIN REHABIL, V27, P521, DOI 10.1177/0269215512464230; Scherer M., 2010, EPARENT; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; THONEOTTO AIT, 2003, INT J PSYCHOL, V38, P1, DOI DOI 10.1080/00207590344000169; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Waldron B., 2012, IRISH J PSYCHOL, V33, P29, DOI [10.1080/03033910.2012.659044, DOI 10.1080/03033910.2012.659044]; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	15	15	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 4	2015	25	4					617	636		10.1080/09602011.2014.956764			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CK6QJ	WOS:000356352400006	25263266	Green Published			2022-02-06	
J	Kratz, AL; Chadd, E; Jensen, MP; Kehn, M; Kroll, T				Kratz, Anna L.; Chadd, Edmund; Jensen, Mark P.; Kehn, Matthew; Kroll, Thilo			An examination of the psychometric properties of the community integration questionnaire (CIQ) in spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injury; Community Integration Questionnaire; Factor analysis; Validity; Reliability	CRAIG HANDICAP ASSESSMENT; TRAUMATIC BRAIN-INJURY; REPORTING TECHNIQUE; LIFE SATISFACTION; FIT INDEXES; INDIVIDUALS; PARTICIPATION; RELIABILITY; DISABILITY; VALIDITY	Objective: To examine the psychometric properties of the Community Integration Questionnaire (CIQ) in large samples of individuals with spinal cord injury (SCI). Design: Longitudinal 12-month survey study. Setting: Nation-wide, community dwelling. Participants: Adults with SCI: 627 at Time 1, 494 at Time 2. Interventions: Not applicable. Outcome measures: The CIQ is a 15-item measure developed to measure three domains of community integration in individuals with traumatic brain injury: home integration, social integration, and productive activity. SCI consumer input suggested the need for two additional items assessing socializing at home and internet/email activity. Results: Exploratory factor analyses at Time 1 indicated three factors. Time 2 confirmatory factor analysis did not show a good fit of the 3-factor model. CIQ scores were normally distributed and only the Productive subscale demonstrated problems with high (25%) ceiling effects. Internal reliability was acceptable for the Total and Home scales, but low for the Social and Productive activity scales. Validity of the CIQ is suggested by significant differences by sex, age, and wheelchair use. Conclusions: The factor structure of the CIQ was not stable over time. The CIQ may be most useful for assessing home integration, as this is the subscale with the most scale stability and internal reliability. The CIQ may be improved for use in SCI by including items that reflect higher levels of productive functioning, integration across the life span, and home-and internet-based social functioning.	[Kratz, Anna L.; Chadd, Edmund] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Jensen, Mark P.] Univ Washington, Seattle, WA 98195 USA; [Kehn, Matthew] Math Policy Res, Washington, DC USA; [Kroll, Thilo] Univ Dundee & St Andrews, Social Dimens Hlth Inst, Dundee, Scotland		Kratz, AL (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy,Suite 300, Ann Arbor, MI 48108 USA.	alkratz@umich.edu		Kroll, Thilo/0000-0003-2082-5117	National Institute on Disability and Rehabilitation Research (NIDRR) [H133B031114]; NRH Rehabilitation Research and Training Center on SCI: Promoting Health and Preventing Complications Through Exercise; Department of Education, NIDRR [H133B080024]	This study was funded by National Institute on Disability and Rehabilitation Research (NIDRR) grant H133B031114, the NRH Rehabilitation Research and Training Center on SCI: Promoting Health and Preventing Complications Through Exercise. Manuscript development was also supported by a grant from the Department of Education, NIDRR grant number H133B080024.	Allen K, 1996, JAMA-J AM MED ASSOC, V275, P1001, DOI 10.1001/jama.275.13.1001; BENTLER PM, 1990, MULTIVAR BEHAV RES, V25, P163, DOI 10.1207/s15327906mbr2502_3; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Comas-Herrera A, 2006, AGEING SOC, V26, P285, DOI 10.1017/S0144686X05004289; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M., 1998, TOP SPINAL CORD INJ, V4, P1, DOI DOI 10.1310/BJJA-2018-45KL-0VTL; Drainoni ML, 2004, ARCH PHYS MED REHAB, V85, P1872, DOI 10.1016/j.apmr.2004.07.350; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Hall K., 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Houlihan BV, 2003, DISABIL REHABIL, V25, P422, DOI 10.1080/0963828031000071750; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kroll T, 2012, AM J PHYS MED REHAB, V91, P640, DOI 10.1097/PHM.0b013e31825a12cd; Masedo AI, 2005, AM J PHYS MED REHAB, V84, P167, DOI 10.1097/01.PHM.0000154898.25609.4A; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Noonan VK, 2009, SPINAL CORD, V47, P435, DOI 10.1038/sc.2008.171; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Streiner D.L., 1989, HLTH MEASUREMENT SCA; Tozato F, 2005, TOHOKU J EXP MED, V205, P357, DOI 10.1620/tjem.205.357; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van der Slot WMA, 2007, DISABIL REHABIL, V29, P179, DOI 10.1080/09638280600747686; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whiteneck GG, 1992, GUIDE US CHART CRAIG; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization (WHO), 1997, INT CLASS IMP ACT PA; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	35	15	16	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2015	38	4					446	455		10.1179/2045772313Y.0000000182			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CL4RS	WOS:000356941800007	24621050	Green Published			2022-02-06	
J	Li, Q; Cheng, YM; Bi, MJ; Lin, HY; Chen, YF; Zou, Y; Liu, YY; Kang, H; Guo, YL				Li, Qin; Cheng, Yongmei; Bi, MingJun; Lin, Hongyang; Chen, Yufei; Zou, Yong; Liu, Yuanyuan; Kang, Hai; Guo, Yunliang			Effects of N-butylphthalide on the activation of Keap1/Nrf-2 signal pathway in rats after carbon monoxide poisoning	ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY			English	Article						CO poisoning; N-Butylphthalide; Apoptosis-associated gene; MMP; Keapl; Nrf-2; NQO-1	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NRF2/ARE PATHWAY; NEONATAL-RATS; DISEASE; EXPRESSION; APOPTOSIS; QUINONE; CELLS; HO-1	Carbon monoxide (CO) is the leading cause of death by poisoning all over the world and may result in neuropathologic changes and cognitive and neurologic sequelae, yet little is known regarding its outcomes. The present study aimed to evaluate the neuroprotective effects of N-butylphthalide (NBP) against brain damage after acute CO poisoning. The animal model of CO poisoning was established by exposed to 1000 ppm CO in air for 40 min and then to 3000 ppm for another 20 min. RT-PCR was used to assess the expressions of apoptosis-associated genes Bcl-2 mRNA and Bax mRNA. Mitochondrial membrane potential (MMP) was detected by fluorescent probe JC-1. Immunohistochemistry stain and Western blot assay were used to evaluate the expression levels of Kelch-like ECH-associated protein 1 (Keapl), nuclear factor erythroid 2-related factor 2 (Nrf-2) and NAD(P)H: quinone oxidoreductase 1(NQO-1). CO poisoning could increase the levels of Bcl-2 mRNA and Bax mRNA expressions, and obviously decrease the MMP of cells. NBP treatment could maintain the high MMP, significantly up-regulate Bcl-2 mRNA and down-regulate Bax mRNA expression, and the ratio of Bcl-2 mRNA/Bax mRNA expressions was higher than that in the CO poisoning group (P < 0.05). CO poisoning could start oxidative stress response. The expressions of Keap1, Nrf-2 and NQO-1 proteins significantly increased at 1, 3 and 7 day after NBP administration as compared with the CO poisoning group (P < 0.01). These findings suggest that N-butylphthalide may protect mitochondrial function, balance the expressions of anti-apoptosis genes and pro-apoptosis genes, be in part associated with activation of Keap1-Nrf-2/antioxidant response element (ARE) signaling pathway, and play a neuroprotective role in brain damage after acute CO poisoning. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Qin; Cheng, Yongmei; Bi, MingJun; Lin, Hongyang; Chen, Yufei; Liu, Yuanyuan; Kang, Hai] Qingdao Univ, Coll Med, Yantai Yuhuangding Hosp Affiliated Hosp, Emergency Ctr, Yantai, Yudong, Peoples R China; [Zou, Yong] Qingdao Univ, Coll Med, Yantai Yuhuangding Hosp Affiliated Hosp, Dept Clin Med, Yantai, Yudong, Peoples R China; [Guo, Yunliang] Qingdao Univ, Coll Med, Inst Cerebrovasc Dis, Affiliated Hosp, Qingdao 266071, Jiangsu, Peoples R China		Bi, MJ (corresponding author), Qingdao Univ, Coll Med, Yantai Yuhuangding Hosp Affiliated Hosp, Emergency Ctr, 20 Rd, Yantai, Yudong, Peoples R China.	chengym1967@163.com; bimingjun00@163.com			Yantai Science and Technology Project [2014WS013]; Medical and Health Development Project in Shandong [2014WS0248]	This work was supported by Yantai Science and Technology Project Grants in 2014 (2014WS013) and Medical and Health Development Project in Shandong (2014WS0248).	Biswas C, 2014, J BIOL CHEM, V289, P26882, DOI 10.1074/jbc.M114.567685; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Geraldo AF, 2014, J RADIOL CASE REP, V8, P1, DOI 10.3941/jrcr.v8i5.1721; Ghosh N, 2011, FREE RADICAL RES, V45, P888, DOI 10.3109/10715762.2011.574290; Guratowska Monika, 2010, Przegl Lek, V67, P566; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Han ST, 2007, TOXICOL LETT, V170, P111, DOI 10.1016/j.toxlet.2007.02.006; Hu JY, 2014, CELL BIOCHEM BIOPHYS, V69, P363, DOI 10.1007/s12013-013-9808-0; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069030; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; LI Q, 2014, ENV TOXICOL; Mauriz E, 2013, NUTR HOSP, V28, P2229, DOI [10.3305/nh.2013.28.6.6983, 10.3305/nutr hosp.v28in06.6983]; Milani P, 2013, NEUROBIOL DIS, V60, P51, DOI 10.1016/j.nbd.2013.08.005; Morris G, 2014, METAB BRAIN DIS, V29, P19, DOI 10.1007/s11011-013-9435-x; Muller Aaron J, 2014, Neoreviews, V15, pe177; Neil B., 2009, CRIT CARE MED, V37, P1941; Pangeni R, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/48/485102; Qin L., 2015, ENV TOXICOL PHARM; Qu Y, 2014, NEUROBIOL DIS, V63, P184, DOI 10.1016/j.nbd.2013.11.023; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Shrader WD, 2012, BIOORG MED CHEM LETT, V22, P391, DOI 10.1016/j.bmcl.2011.10.117; Tofighi R, 2006, BRAIN RES, V1098, P1, DOI 10.1016/j.brainres.2006.04.095; Wang XL, 2014, LIFE SCI, V114, P77, DOI 10.1016/j.lfs.2014.08.004; Wang XL, 2014, BRAIN RES, V1560, P18, DOI 10.1016/j.brainres.2014.02.019; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yuan H., 2010, ACTA PHARMACOL SIN, V31, P1421; Zhang B, 2015, ENVIRON TOXICOL PHAR, V39, P237, DOI 10.1016/j.etap.2014.11.013; Zovein A, 2004, AM J PHYSIOL-REG I, V286, pR273, DOI 10.1152/ajpregu.00160.2003	30	15	23	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1382-6689	1872-7077		ENVIRON TOXICOL PHAR	Environ. Toxicol. Pharmacol.	JUL	2015	40	1					22	29		10.1016/j.etap.2015.05.009			8	Environmental Sciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Pharmacology & Pharmacy; Toxicology	CO5BQ	WOS:000359175000004	26056974				2022-02-06	
J	Sandhaug, M; Andelic, N; Langhammer, B; Mygland, A				Sandhaug, Maria; Andelic, Nada; Langhammer, Birgitta; Mygland, Aase			Community integration 2 years after moderate and severe traumatic brain injury	BRAIN INJURY			English	Article						Community integration; rehabilitation; traumatic brain injury	QUALITY-OF-LIFE; LONG-TERM OUTCOMES; REHABILITATION; QUESTIONNAIRE; PARTICIPATION; PERSPECTIVES; PREDICTION; DISABILITY; SWEDEN	Objective: The aim of this study was to examine community integration by the Community Integration Questionnaire (CIQ) 2 years after injury in a divided TBI sample of moderately and severely injured patients. The second aim was to identify social-demographic, injury-related and rehabilitation associated predictors of CIQ Design: A cohort study. Setting: Outpatient follow-up. Participants: Fifty-seven patients with moderate (n = 21) or severe (n = 36) TBI were examined with the Community Integration Questionnaire (CIQ)) at 2 years after injury. Possible predictors were analysed in a regression model using CIQ total score at 2 years as the outcome measure. Main outcome measures: The Community Integration Questionnaire. Results: At 2 years follow-up, there was significant difference between the moderately and severely injured patients in the productivity scores (p < 0.003), while difference in the total CIQ scores approached the significance level (p = 0.074). Significant predictors of a higher CIQ score were living with a spouse, higher Glasgow Coma Scale (GCS) in the acute phase, shorter Post-Traumatic Amnesia (PTA), longer rehabilitation stay (LOS) and use of rehabilitation service. Use of rehabilitation service (B = 7.766) and living with a spouse (B = 4.251) had the largest influence. This means that living with a spouse, better score on the GCS scale, shorter PTA, longer LOS and use of rehabilitation service after discharge equated to better community integration 2 years after TBI Conclusions: Two years after TBI the moderately injured patients have a higher productivity level than the severely injured patients. Marital status, injury severity and rehabilitation after injury were associated with community integration 2 years after TBI.	[Sandhaug, Maria; Langhammer, Birgitta] Oslo & Akershus Univ Coll, Inst Physiotherapy, Oslo, Norway; [Sandhaug, Maria] Statped, Head Off, Oslo, Norway; [Sandhaug, Maria] Statped, Dept Acquired Brain Injury, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Andelic, Nada] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Langhammer, Birgitta] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Mygland, Aase] Sorlandet Hosp, Dept Habilitat, Kristiansand, Norway; [Mygland, Aase] Sorlandet Hosp, Dept Neurol, Kristiansand, Norway; [Mygland, Aase] Univ Bergen, Dept Clin Med, Bergen, Norway		Sandhaug, M (corresponding author), Statped Head Off, Acquired Brain Injury, Postbox 2814, N-0204 Oslo, Norway.	maria.sandhaug@statped.no	Langhammer, Birgitta/P-1765-2019	Langhammer, Birgitta/0000-0002-9639-0570; Andelic, Nada/0000-0002-3719-4406	Norwegian Foundation for Health and Rehabilitation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study has been financed with the aid of EXTRA funds from the Norwegian Foundation for Health and Rehabilitation.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fleming J, 1999, BRAIN INJURY, V13, P417; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Millis S R, 1994, Int J Neurosci, V79, P165; Pallant, 2005, SPSS SURVIVAL MANUAL; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1994, BRAIN INJURY REHABIL, P355; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2007, INT CLASS FUNCT DIS	33	15	15	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					915	920		10.3109/02699052.2015.1022880			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800017	25962927				2022-02-06	
J	To, MJ; O'Brien, K; Palepu, A; Hubley, AM; Farrell, S; Aubry, T; Gogosis, E; Muckle, W; Hwang, SW				To, Matthew J.; O'Brien, Kristen; Palepu, Anita; Hubley, Anita M.; Farrell, Susan; Aubry, Tim; Gogosis, Evie; Muckle, Wendy; Hwang, Stephen W.			Healthcare Utilization, Legal Incidents, and Victimization Following Traumatic Brain Injury in Homeless and Vulnerably Housed Individuals: A Prospective Cohort Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							PSYCHIATRIC-DISORDERS; EMERGENCY; POPULATION; PREVALENCE; CONSEQUENCES; COMMUNITY; BEHAVIOR; PEOPLE; ADULTS; CITY	Objective: To characterize the associations between a history of traumatic brain injury (TBI) and subsequent healthcare utilization, legal involvement, and victimization. Setting: Three major Canadian cities. Participants: A total of 1181 homeless and vulnerably housed adults who were single and 18 years or older. Data for 968 participants (82%) were available at 1-year follow-up. Design: Prospective cohort study. Data were collected using structured, in-person interviews at baseline in 2009 and approximately 1 year after baseline. Main Measures: Self-reported TBI, 12-item Short Form Health Survey, healthcare, and criminal justice use questionnaires. Results: The lifetime prevalence of TBI was 61%. A history of TBI was independently associated with emergency department (ED) use [adjusted odds ratio (AOR) = 1.5, 95% confidence interval (CI): 1.11-1.96], being arrested or incarcerated (AOR = 1.79, 95% CI: 1.3-2.48) and being a victim of physical assault (AOR = 2.81, 95% CI: 1.96-4.03) during the 1-year follow-up period. Conclusions: Homeless and vulnerably housed individuals with a lifetime history of TBI are more likely to be ED users, arrested or incarcerated, and victims of physical assault over a 1-year follow-up period even after adjustment for health status and other confounders. These findings have public health and criminal justice implications and highlight the need for effective screening, treatment, and rehabilitation for TBI in this population.	[To, Matthew J.; O'Brien, Kristen; Gogosis, Evie; Hwang, Stephen W.] St Michaels Hosp, Ctr Res Inner City Hlth, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Palepu, Anita] Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, Div Gen Internal Med, Vancouver, BC V5Z 1M9, Canada; [Hubley, Anita M.] Univ British Columbia, Measurement Evaluat & Res Methodol, Dept Educ & Counselling Psychol & Special Educ, Vancouver, BC V5Z 1M9, Canada; [Farrell, Susan] Univ Ottawa, Royal Ottawa Hlth Care Grp, Ottawa, ON, Canada; [Aubry, Tim] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Aubry, Tim] Univ Ottawa, Ctr Res Educ & Community Serv, Ottawa, ON, Canada; [Muckle, Wendy] Univ Ottawa, Ottawa Inner City Hlth Initiat, Ottawa, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada		Hwang, SW (corresponding author), St Michaels Hosp, Ctr Res Inner City Hlth, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	HwangS@smh.ca	Aubry, Tim/ABB-9932-2021; Hwang, Stephen/D-2297-2011	Aubry, Tim/0000-0002-6204-3773; Hwang, Stephen/0000-0002-1276-1101			Allgulander C, 2000, AM J PSYCHIAT, V157, P244, DOI 10.1176/appi.ajp.157.2.244; Ardilly P, 2001, SURVEY METHODOL, V27, P109; Babor TF, 2001, AUDIT ALCOHOL USE DI; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BAKER DW, 1994, JAMA-J AM MED ASSOC, V271, P1909, DOI 10.1001/jama.271.24.1909; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; French MT, 2001, SUBST USE MISUSE, V36, P927, DOI 10.1081/JA-100104096; HELVIE C, 1999, HOMELESSNESS US EURO; Housing Family and Social Statistics Division, 2002, ETHN DIV SURV QUEST; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2011, INT J PUBLIC HEALTH, V56, P609, DOI 10.1007/s00038-011-0283-3; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Kim E, 2002, NEUROREHABILITATION, V17, P297; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kosinski M., 1995, SF 12 SCORE SF 12 PH; Ku BS, 2010, PUBLIC HEALTH REP, V125, P398, DOI 10.1177/003335491012500308; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; MacReady N, 2009, LANCET NEUROL, V8, P228, DOI 10.1016/S1474-4422(09)70033-X; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; PADGETT DK, 1995, SOC SCI MED, V41, P547, DOI 10.1016/0277-9536(94)00364-Y; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Statistics Canada, 2012, CAN COMM HLTH SURV C; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294	29	15	15	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					270	276		10.1097/HTR.0000000000000044			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JA	WOS:000357944700005	24651000				2022-02-06	
J	Walker, WC; Ketchum, JS; Marwitz, JH; Kolakowsky-Hayner, SA; McClish, DK; Bushnik, T				Walker, William C.; Ketchum, James S., III; Marwitz, Jennifer H.; Kolakowsky-Hayner, Stephanie A.; McClish, Donna K.; Bushnik, Tamara			Global Outcome and Late Seizures After Penetrating Versus Closed Traumatic Brain Injury: A NIDRR TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							POSTTRAUMATIC EPILEPSY; RISK-FACTORS; HEAD-INJURY; RECOVERY; PREDICTION; MULTICENTER; POPULATION; PREVENTION; SCALE; BLUNT	Background: If and how much dural penetration influences long-term outcome after traumatic brain injury (TBI) is understudied, especially within the civilian population. Objectives: Using the large TBI Model Systems cohort, this study assessed and compared penetrating TBI (PTBI) and closed TBI with respect to global outcome and late seizures 2 years after injury. Methods: After performing unadjusted PTBI versus closed TBI comparisons, multivariate regression models were built and analyzed for both outcomes by including the following additional predictors: length of unconsciousness, posttraumatic amnesia duration, hospital length of stay, age, gender, race, marital status, education level, problem substance abuse, and preinjury employment status. Results: The collapsed Glasgow Outcome Scale model (n = 6111) showed significant secondary effects of PTBI with employment status. When employed before injury, individuals with PTBI were 2.62 times more likely (95% confidence interval, 1.92-3.57) to have a lower Glasgow Outcome Scale category. The final model for late seizures (n = 6737) showed a significant main effect for PTBI. Adjusting for other predictors, individuals with PTBI were 2.78 times more likely (95% confidence interval, 1.93-3.99) than those with closed TBI to be rehospitalized for a seizure. Conclusion: This study empirically demonstrates that penetrating injury mechanism has important prognostic implications.	[Walker, William C.; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, James S., III; McClish, Donna K.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Bushnik, Tamara] NYU, Rusk Rehabil, Langone Sch Med, New York, NY USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1223 E Marshall St,4th Fl, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Bushnik, Tamara/0000-0003-3328-257X	US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; TBI Model Systems Centers (VCU) [H133A120031, H133A070038, H133A120100]	The TBI Model Systems National Database is supported by the US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) in collaboration with the TBI Model Systems Centers (VCU, no. H133A120031; Santa Clara, no. H133A070038; and Rusk, no. H133A120100). However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDRR or the US Department of Education.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Black KL, 2002, J HEAD TRAUMA REHAB, V17, P489, DOI 10.1097/00001199-200212000-00001; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; DASILVA AM, 1990, ACT NEUR S, V50, P48; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Konigs M, 2012, J NEUROL NEUROSUR PS, V83, P1048, DOI 10.1136/jnnp-2012-302635; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Perrin PB, 2014, J HEAD TRAUMA REHABI; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1997, BRAIN INJURY, V11, P403	40	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					231	240		10.1097/HTR.0000000000000127			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JA	WOS:000357944700001	25931183				2022-02-06	
J	Wijayatilake, DS; Talati, C; Panchatsharam, S				Wijayatilake, Dhuleep S.; Talati, Chiraag; Panchatsharam, Selvakumar			The Monitoring and Management of Severe Traumatic Brain Injury in the United Kingdom: Is there a Consensus?: A National Survey	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						trauma; head injury; intensive care	INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; INTENSIVE-CARE; PERFUSION	Background: To survey the current practice of monitoring and management of severe traumatic brain injury (TBI) patients in the critical care units across the United Kingdom. Methods: A structured telephone interview was conducted with senior medical or nursing staff of all the adult neurocritical care units. Thirty-one neurocritical care units that managed adult patients with severe TBI were identified from the Risk Adjustment in Neurocritical Care (RAIN) study and the Society of British Neurological Surgeons. Results: Intracranial pressure (ICP) monitoring was used in all the 31 institutions. Cerebral perfusion pressure was used in 30 of the 31 units and a Cerebral perfusion pressure target of 60 to 70mm Hg was the most widely used target (25 of 31 units). Transcranial Doppler was used in 12 units (39%); brain tissue oxygen (PbtO(2)) was used in 8 (26%); cerebral microdialysis was used in 4 (13%); jugular bulb oximetry in 1 unit; and near-infrared spectrometry was not used in any unit. Continuous capnometry was used in 28 (91%) units for mechanically ventilated patients. Mannitol was the most commonly used agent for osmotherapy to treat intracranial hypertension. Conclusions: We identified that there was no clear consensus and considerable variation in practice in the management of TBI patients in UK neurocritical care units. A protocol-based management has been shown to improve outcome in sepsis patients. Given the magnitude of the problem, we conclude that there is an urgent need for international consensus guidelines for management of TBI patients in critical care units.	[Wijayatilake, Dhuleep S.] Barking Havering & Redbridge Hosp NHS Trust, Queens Hosp, Dept Neurocrit Care, Romford RM7 0AG, Essex, England; [Talati, Chiraag] London Chest Hosp, Barts Hlth NHS Trust, Dept Anaesthesia, London E2 9JX, England; [Panchatsharam, Selvakumar] Univ Hosp Leicester NHS Trust, Dept Anaesthesia & Crit Care, Leicester, Leics, England		Wijayatilake, DS (corresponding author), Barking Havering & Redbridge Hosp NHS Trust, Queens Hosp, Dept Neurocrit Care, Romford RM7 0AG, Essex, England.	sanjay.wijayatilake@bhrhospitals.nhs.uk	Wijayatilake, Sanjay/AAQ-2164-2020				Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Bratton S, 2007, J NEUROTRAUM, V24, P7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Dunham CM, 2006, CRIT CARE, V10, DOI 10.1186/cc5097; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Haydel MJ, ASSESSMENT ACUTE TRA; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Kowoll CM, 2014, NEUROCRIT CARE, V20, P176, DOI 10.1007/s12028-013-9893-3; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Lecky F, 2014, HEAD INJURY TRIAGE A; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Olson DM, 2014, NEUROCRIT CARE, V20, P15, DOI 10.1007/s12028-013-9847-9; Olson DM, 2009, NEUROCRIT CARE, V11, P20, DOI 10.1007/s12028-008-9184-6; Pattinson K, 2005, BJA EDUC, V5, P130, DOI 10.1093/bjaceaccp/mki035; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Reilly P, 1997, HEAD INJURY PHYSL MA; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; SEBEL PS, 1983, BRIT J ANAESTH, V55, P1265, DOI 10.1093/bja/55.12.1265; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Wijayatilake DS, 2012, CURR OPIN ANESTHESIO, V25, P540, DOI 10.1097/ACO.0b013e328357960a	28	15	17	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2015	27	3					241	245					5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	DD0FW	WOS:000369596800007	25493928				2022-02-06	
J	de Guise, E; Alturki, AY; Lague-Beauvais, M; LeBlanc, J; Champoux, MC; Couturier, C; Anderson, K; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M; Frasnelli, J				de Guise, E.; Alturki, A. Y.; Lague-Beauvais, M.; LeBlanc, J.; Champoux, M. C.; Couturier, C.; Anderson, K.; Lamoureux, J.; Marcoux, J.; Maleki, M.; Feyz, M.; Frasnelli, J.			Olfactory and executive dysfunctions following orbito-basal lesions in traumatic brain injury	BRAIN INJURY			English	Article						Anosmia; cognition; olfaction; orbito-frontal lesion; traumatic brain injury	GLASGOW OUTCOME SCALE; POSTTRAUMATIC ANOSMIA; HEAD-INJURY; ODOR IDENTIFICATION; DISCRIMINATION; PERFORMANCE; IMPAIRMENT; DISABILITY; DEFICITS; TESTS	Objective: To study the acute relationship between olfactory function and traumatic brain injury (TBI), cognitive functions and outcome. Methods: Sixty-two patients with TBI were evaluated within the first 2 weeks following TBI. The Sniffin'Sticks identification test was used to assess olfaction. A neuropsychological evaluation was carried out to assess attention, verbal fluency, naming, memory, problem-solving and mental flexibility. The extended Glasgow Outcome Scale (GOSE) and the Disability Rating Scale (DRS) were rated at discharge from acute care. Results: Traumatic lesions located in the basal frontal area resulted in odour identification scores that were significantly lower than when lesions were elsewhere (p<0.001). A significant positive correlation was shown between odour identification scores and mental flexibility scores (p=0.004) and patients with hyposmia had worse performances on executive tests measuring problem-solving, verbal fluency and mental flexibility (p<0.01). Moreover, the odour identification score and the DRS total score were related (p=0.019). Conclusions: These findings add information regarding acute olfactory status following TBI and provide evidence on the importance of assessing olfaction very early post-TBI in order to plan intervention and determine what accident prevention advice will be required for home or work re-integration.	[de Guise, E.; Alturki, A. Y.; Marcoux, J.; Maleki, M.] McGill Univ, Dept Neurol & Neurosurg, Ctr Hlth, Montreal, PQ, Canada; [de Guise, E.; Anderson, K.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Alturki, A. Y.] King Fahad Med City, Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia; [Lague-Beauvais, M.; LeBlanc, J.; Champoux, M. C.; Couturier, C.; Anderson, K.; Feyz, M.] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ, Canada; [Lamoureux, J.] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ H3C 3J7, Canada; [Frasnelli, J.] Univ Quebec Trois Rivieres, Anat Dept, Trois Rivieres, PQ GA9 5H7, Canada; [Frasnelli, J.] Hop Sacre Coeur, Ctr Avance Etud Sommeil, Montreal, PQ H4J 1C5, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Pavillon Marie Victorin,CP 6128 Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	elaine.de.guise@umontreal.ca		Frasnelli, Johannes/0000-0002-8863-3982	Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bersani G, 2013, PSYCHIAT RES, V210, P208, DOI 10.1016/j.psychres.2013.05.032; Buron E, 2013, PSYCHOPATHOLOGY, V46, P63, DOI 10.1159/000338717; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Caminiti F, 2013, BRAIN INJURY, V27, P1715, DOI 10.3109/02699052.2013.823667; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chapados C, 2013, BRAIN, V136, P2966, DOI 10.1093/brain/awt228; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Hoover E, 2014, J ACOUST SOC AM, V135, P2166, DOI DOI 10.1121/1.4877039; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Magone T, 2013, US NEUROLOGY, V9, P61; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Novack TA, 2000, BRAIN INJURY, V14, P987; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; Signoret JL, 1989, 96 BEC FOND IPSEN; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Tao KK, 2012, J EMERG MED, V42, P180, DOI 10.1016/j.jemermed.2009.08.063; Tranel D, 2012, J CLIN EXP NEUROPSYC, V34, P117, DOI 10.1080/13803395.2011.633897; Uittenhove K, 2013, ACTA PSYCHOL, V143, P113, DOI 10.1016/j.actpsy.2013.02.007; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Wechsler D., 2008, WMS 3 MANUAL, V3rd; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238	38	15	16	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					730	738		10.3109/02699052.2015.1004748			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700008	25826471				2022-02-06	
J	Fredricks, TR; Nakazawa, M				Fredricks, Todd Robert; Nakazawa, Masato			Perceptions of Physicians in Civilian Medical Practice on Veterans' Issues Related to Health Care	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article								Context: The percentage of total US residents in the military is lower than ever before. Many civilians, including civilian physicians, have little knowledge of US military actions or the day-to-day experiences and working environments of veterans. Objective: To assess civilian physician knowledge of veterans' issues using a survey. Methods: A 10-item survey was distributed to physicians at 2 primary care-focused medical conferences in Ohio to determine self-reported levels of comfort and familiarity with veteran-oriented topics. Results: Of 350 surveys that were distributed, 141 surveys were returned. Of the 141 respondents, 101 practiced primary care, 19 practiced internal medicine, 16 practiced other specialties, and 5 did not report a specialty affiliation and were excluded from final analysis. A single respondent reported pediatrics as a specialty but indicated "not applicable" for all answers. This individual was excluded from final analysis. Overall, physicians reported feeling moderately comfortable with military terminology and uncomfortable with the diagnosis and management of traumatic brain injury. More than half of the respondents indicated that they were not comfortable discussing health-related exposures and associated risks that veterans might experience and that they were unfamiliar with referral and consultation services for veterans. The data collected had a high degree of reliability (Cronbach alpha-0.88). Respondents of both primary care and internal medicine specialties scored statistically significantly higher than the other respondents in questions on veterans' medical conditions, military terminology, and military health risks (P<.05), although these 2 groups scored similarly (P>.05). Specialty orientation did not affect responses for questions on other topics (P>.05) Conclusion: The data indicated an overall moderate level of familiarity among civilian physicians with veterans' issues. The results did not reveal an overall high level of comfort with any issues included in the survey. More research is needed to determine reasons behind the findings and methods to improve civilian physician comfort with various veterans' issues.	[Fredricks, Todd Robert] Ohio Univ, Heritage Coll Osteopath Med, Dept Family Med, 251 Grosvenor Hall, Athens, OH 45701 USA; [Nakazawa, Masato] Ohio Univ, Heritage Coll Osteopath Med, Off Res & Grants, Athens, OH 45701 USA		Fredricks, TR (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Family Med, 251 Grosvenor Hall, Athens, OH 45701 USA.	fredrick@ohio.edu					Agency for Healthcare Research and Quality, NUMB PRACT PRIM CAR; [Anonymous], WORLD WAR 2 VET; [Anonymous], STAT COUNT QUICKFACT; [Anonymous], PROJ VET POP 2013 20; [Anonymous], 1900, HIST NAT POP EST JUL; Au DH, 2012, CHEST, V141, P726, DOI 10.1378/chest.11-0362; Eikenberry KW, 2013, NY TIMES; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; Green LV, 2013, HEALTH AFFAIR, V32, P11, DOI 10.1377/hlthaff.2012.1086; Henry SG, 2012, PATIENT EDUC COUNS, V86, P297, DOI 10.1016/j.pec.2011.07.006; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Jeffreys MD, 2010, MIL MED, V175, P719, DOI 10.7205/MILMED-D-10-00054; Joos SK, 1996, J GEN INTERN MED, V11, P147, DOI 10.1007/BF02600266; Katz DA, 2014, J GEN INTERN MED, V29, P682, DOI 10.1007/s11606-013-2633-8; LaVela SL, 2012, PATIENT EDUC COUNS, V88, P420, DOI 10.1016/j.pec.2012.06.004; Lee YY, 2009, HEALTH CARE ANAL, V17, P244, DOI 10.1007/s10728-008-0100-1; Liang CY, 2013, BRIT J GEN PRACT, V63, pE354, DOI 10.3399/bjgp13X667222; Matthias MS, 2010, PAIN MED, V11, P1688, DOI 10.1111/j.1526-4637.2010.00980.x; Nichols L O, 1998, Tenn Med, V91, P94; Skelton I., 2013, JOINT FORCE Q, V64, P60; Street RL, 2005, MED CARE, V43, P960, DOI 10.1097/01.mlr.0000178172.40344.70; Suarez-Almazor ME, 2004, CURR OPIN RHEUMATOL, V16, P91, DOI 10.1097/00002281-200403000-00003; Tulsky JA, 2005, J PALLIAT MED, V8, P95, DOI DOI 10.1089/JPM.2005.8.S-95; Varney SM, 2012, SOUTH MED J, V105, P538, DOI 10.1097/SMJ.0b013e318268cd18; Wagner GJ, 2010, J PAIN SYMPTOM MANAG, V39, P527, DOI 10.1016/j.jpainsymman.2009.07.012; Weiner SJ, 2005, ANN INTERN MED, V142, P709, DOI 10.7326/0003-4819-142-8-200504190-00039	28	15	15	0	0	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	JUN	2015	115	6					360	368		10.7556/jaoa.2015.076			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V05YC	WOS:000213906900006	26024329				2022-02-06	
J	Laksari, K; Assari, S; Seibold, B; Sadeghipour, K; Darvish, K				Laksari, Kaveh; Assari, Soroush; Seibold, Benjamin; Sadeghipour, Keya; Darvish, Kurosh			Computational simulation of the mechanical response of brain tissue under blast loading	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain tissue; Quasilinear viscoelasticity; Hyperelasticity; Blast loading; Discontinuous Galerkin method; Injury biomechanics	INJURY; MODEL; HEAD; WAVE	In the present study, numerical simulations of nonlinear wave propagation and shock formation in brain tissue have been presented and a new mechanism of injury for blast-induced neurotrauma (BINT) is proposed. A quasilinear viscoelastic (QLV) constitutive material model was used that encompasses the nonlinearity as well as the rate dependence of the tissue relevant to BINT modeling. A one-dimensional model was implemented using the discontinuous Galerkin finite element method and studied with displacement- and pressure-input boundary conditions. The model was validated against LS-DYNA finite element code and theoretical results for specific conditions that resulted in shock wave formation. It was shown that a continuous wave can become a shock wave as it propagates in the QLV brain tissue when the initial changes in acceleration are beyond a certain limit. The high spatial gradient of stress and strain at the shock front cause large relative motions at the cellular scale at high temporal rates even when the maximum stresses and strains are relatively low. This gradient-induced local deformation may occur away from the boundary and is proposed as a contributing factor to the diffuse nature of BINT.	[Laksari, Kaveh; Assari, Soroush; Sadeghipour, Keya; Darvish, Kurosh] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA; [Seibold, Benjamin] Temple Univ, Dept Math, Philadelphia, PA 19122 USA		Darvish, K (corresponding author), Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA.	kdarvish@temple.edu		Darvish, Kurosh/0000-0002-6674-266X	American Heart AssociationAmerican Heart Association [11PRE7690042]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K25 HL086512-05]; NSFNational Science Foundation (NSF) [DMS-1318709]; Direct For Mathematical & Physical ScienNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1318641] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K25HL086512] Funding Source: NIH RePORTER	The authors acknowledge funding for this work from American Heart Association pre-doctoral fellowship under Grant Number 11PRE7690042 (K.L.), NHLBI under Grant Number K25 HL086512-05 (K.D.), and NSF under Grant Number DMS-1318709 (B.S.).	Bear M.F., 2007, NEUROSCIENCE; Blinkov SM., 1968, HUMAN BRAIN FIGURES; CDC, 2011, TRAUM BRAIN INJ FACT; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cockburn B., 2001, Journal of Scientific Computing, V16, P173, DOI 10.1023/A:1012873910884; Cockburn B, 1998, J COMPUT PHYS, V141, P199, DOI 10.1006/jcph.1998.5892; Coleman B. D., 1965, ARCH RATIONAL MECH A, V19, P239, DOI 10.1007/BF00250213; COLEMAN BD, 1966, ARCH RATION MECH AN, V22, P333, DOI 10.1007/BF00266558; Coleman BD, 1965, ARCH RATIONAL MECH A, V19, P317; Coleman BD, 1964, ARCH RATION MECH AN, V19, P1; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Evans LC., 2010, PARTIAL DIFFERENTIAL; Feng Y, 2013, J BIOMECH, V46, P863, DOI [10.1016/j.jbiomech.2012.12.024, DOI 10.1016/J.JBI0MECH.2012.12.024]; Hallquist JO, 2006, LS DYNA THEORY MANUA; Hesthaven JS, 2008, TEXTS APPL MATH, V54, P1; Hoberecht RW, 2009, THESIS U WASHINGTON; Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060; Karniadakis GE, 1999, SPECTRAL HP ELEMENT; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Logan JD, 2010, INTRO NONLINEAR PART, V93; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Noh WF, 1976, N77 NASA STIRECON, V77, P26430; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Takhounts EG, 2008, STAPP CAR C, V52, P1; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; VONNEUMANN J, 1950, J APPL PHYS, V21, P232, DOI 10.1063/1.1699639; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	35	15	15	1	27	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2015	14	3					459	472		10.1007/s10237-014-0616-2			14	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CI0ED	WOS:000354408100003	25205088	Green Accepted			2022-02-06	
J	Qiu, JL; Zhu, WL; Lu, YJ; Bai, ZF; Liu, ZG; Zhao, P; Sun, C; Zhang, YB; Li, H; Liu, W				Qiu, Jun-Ling; Zhu, Wen-Li; Lu, Yu-Jie; Bai, Zheng-Fa; Liu, Zhi-Gang; Zhao, Pei; Sun, Chao; Zhang, Ya-Bin; Li, Hua; Liu, Wei			The selective mGluR5 agonist CHPG attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-kappa B pathway in BV2 microglial cells	NEUROCHEMISTRY INTERNATIONAL			English	Article						SO2; Microglia; Inflammation; mGluR5; TSG-6; NF-kappa B	METABOTROPIC GLUTAMATE RECEPTORS; TRAUMATIC BRAIN-INJURY; SULFUR-DIOXIDE; RAT HIPPOCAMPUS; IN-VITRO; ACTIVATION; NEUROTOXICITY; APOPTOSIS; TSG-6; EXPRESSION	Sulfur dioxide (SO2) is a common air pollutant and can cause harmful insults on neurons. Microglial activation has been implicated in the signaling cascades that contribute to neuronal cell death in various neurological disorders. In the present study, we found that SO2 derivatives decreased cell viability via inducing oxidative stress, inflammatory responses and apoptotic cell death in BV2 microglial cells. Pretreatment with (RS)-2-chloro-5-hydroxyphenylglycine (CHPG), an mGluR5 agonist, significantly attenuated the SO2-induced cytotoxicity, which was fully prevented by the mGluR5 antagonist MPEP. CHPG increased the expression of TNF-alpha stimulated gene/protein 6 (TSG-6), but decreased the activation of nuclear factor-kappa B (NF-kappa B) after SO2 derivatives treatment in BV2 cells. In addition, knockdown of TSG-6 expression by specific targeted short interfering RNA (siRNA) partially reversed the protection induced by CHPG. Therefore, our findings reveal a mechanistic basis for exploring the association between SO2 exposure and neurological disorders, and also for opening up therapeutic approaches of ameliorating neuronal injury resulting from exposure in atmospheric polluting environment. (C) 2015 Elsevier Ltd. All rights reserved.	[Qiu, Jun-Ling; Lu, Yu-Jie; Bai, Zheng-Fa; Sun, Chao; Zhang, Ya-Bin; Liu, Wei] Shannxi Fourth Peoples Hosp, Basic Med Sci Res Ctr, Xian 710043, Shannxi, Peoples R China; [Zhu, Wen-Li; Zhao, Pei] Shannxi Fourth Peoples Hosp, Dept Neurol, Xian 710043, Shannxi, Peoples R China; [Liu, Zhi-Gang; Li, Hua] Shannxi Fourth Peoples Hosp, Dept Neurosurg, Xian 710043, Shannxi, Peoples R China		Li, H (corresponding author), Shannxi Fourth Peoples Hosp, Dept Neurosurg, Xian 710043, Shannxi, Peoples R China.	lihua_sx4y@126.com; liuwei_sx4y@126.com					Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Bisseret P, 2013, ORG BIOMOL CHEM, V11, P5393, DOI 10.1039/c3ob40997j; Bordi F, 1999, PROG NEUROBIOL, V59, P55, DOI 10.1016/S0301-0082(98)00095-1; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Cai C, 2008, CLIN EXP ALLERGY, V38, P1680, DOI 10.1111/j.1365-2222.2008.03053.x; Cape JN, 2003, ENVIRON INT, V29, P201, DOI 10.1016/S0160-4120(02)00180-0; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; DESANTIS V, 1986, ENVIRON RES, V41, P130, DOI 10.1016/S0013-9351(86)80175-X; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Rencuzogullari E, 2001, MUTAT RES-GEN TOX EN, V490, P107, DOI 10.1016/S1383-5718(00)00142-X; Sang N, 2009, ECOTOX ENVIRON SAFE, V72, P879, DOI 10.1016/j.ecoenv.2008.07.007; Sang N, 2011, TOXICOL SCI, V124, P400, DOI 10.1093/toxsci/kfr224; Sang N, 2010, TOXICOL SCI, V114, P226, DOI 10.1093/toxsci/kfq010; Wang XB, 2014, LIFE SCI, V98, P63, DOI 10.1016/j.lfs.2013.12.027; Winder DG, 1996, J NEUROSCI RES, V46, P131, DOI 10.1002/(SICI)1097-4547(19961015)46:2<131::AID-JNR1>3.0.CO;2-I; Yun Y, 2010, INHAL TOXICOL, V22, P919, DOI 10.3109/08958378.2010.494694; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	27	15	15	2	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN-JUL	2015	85-86						46	52		10.1016/j.neuint.2015.04.007			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK4QT	WOS:000356209000006	25953665				2022-02-06	
J	Visser-Keizer, AC; Hogenkamp, A; Westerhof-Evers, HJ; Egberink, IJL; Spikman, JM				Visser-Keizer, Annemarie C.; Hogenkamp, Antoinette; Westerhof-Evers, Herma J.; Egberink, Iris J. L.; Spikman, Jacoba M.			Dutch Multifactor Fatigue Scale: A New Scale to Measure the Different Aspects of Fatigue After Acquired Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Fatigue; Neuropsychology; Rehabilitation; Self-assessment	1ST 2 YEARS; POSTSTROKE FATIGUE; PSYCHOMETRIC PROPERTIES; STROKE; MILD; DEPRESSION; VALIDATION; HISTORY; ANXIETY; IMPACT	Objectives: To develop the Dutch Multifactor Fatigue Scale (DMFS), a new scale to assess the nature and impact of fatigue and coping with fatigue in the chronic phase after acquired brain injury (ABI) and to analyze the psychometric properties of this scale in a mixed group of patients with ABI. Design: Cross-sectional survey study. Setting: Academic rehabilitation center. Participants: A mixed sample of patients with ABI (N=134). For the development of the DMFS: community-dwelling adults with stroke (n=9) and traumatic brain injury (n=5). For analyses of the psychometric properties of the DMFS: community-dwelling adults with ischemic stroke (n=55), hemorrhagic stroke (n=22), traumatic brain injury (n=35), or other ABIs (n=22), all at least 6 months after brain injury. Interventions: Not applicable. Main Outcome Measures: DMFS, Hospital Anxiety and Depression Scale, Checklist Individual Strength, and Dutch Personality Questionnaire. Results: Exploratory and confirmatory factor analyses on data of 134 patients showed that the final DMFS consisted of 5 factors (explaining 55% of the variance): Impact of fatigue, Mental fatigue, Signs and Direct consequences of fatigue, Physical fatigue, and Coping with fatigue. All subscales of the DMFS showed sufficient to good reliability, good convergent validity with an existing fatigue scale, and good divergent validity with measures of mood and self-esteem. Conclusions: The DMFS is believed to improve the diagnostic process of fatigue in the chronic phase after ABI. As it measures several factors of fatigue after brain injury, therapeutic indications can be targeted to patients' needs. (C) 2015 by the American Congress of Rehabilitation Medicine	[Visser-Keizer, Annemarie C.; Hogenkamp, Antoinette; Westerhof-Evers, Herma J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, NL-9700 RB Groningen, Netherlands; [Visser-Keizer, Annemarie C.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands; [Hogenkamp, Antoinette] Ctr Child Psychiat & Learning Disabil, Groningen, Netherlands; [Westerhof-Evers, Herma J.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Egberink, Iris J. L.; Spikman, Jacoba M.] Univ Groningen, Dept Psychometr & Stat, Groningen, Netherlands		Visser-Keizer, AC (corresponding author), Univ Med Ctr Groningen, Dept Neuropsychol, AB50,POB 30-001, NL-9700 RB Groningen, Netherlands.	a.c.visser@umcg.nl		Egberink, Iris/0000-0003-0191-2733; Spikman, Jacoba/0000-0002-6477-0763	Foundation Beatrixoord North Netherlands, Center for Rehabilitation, University Medical Center Groningen, Groningen, The NetherlandsNetherlands Government [210.101]	Supported by the Foundation Beatrixoord North Netherlands, Center for Rehabilitation, University Medical Center Groningen, Groningen, The Netherlands (grant no. 210.101).	Amtmann D, 2012, REHABIL PSYCHOL, V57, P159, DOI 10.1037/a0027890; Andersen G, 2012, ACTA NEUROL SCAND, V125, P248, DOI 10.1111/j.1600-0404.2011.01557.x; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Barelds DPH, 2007, DPQ 2 DUTCH PERSONAL; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bogousslavsky J, 2003, STROKE, V34, P1046, DOI 10.1161/01.STR.0000061887.33505.B9; Bouma AM., 2012, HDB NEUROPSYCHOLOGIC; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Butt Z, 2013, J PSYCHOSOM RES, V74, P64, DOI 10.1016/j.jpsychores.2012.10.011; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Egberink I. J. L., 2014, COTAN BEOORDELING 19; Egberink IJL, 2014, COTAN REV 1999 CHECK; Egberink IJL, 2014, COTAN REV 2009 DUTCH; Eilertsen G, 2013, J ADV NURS, V69, P514, DOI 10.1111/jan.12002; Evers A, 2010, INT J TEST, V10, P295, DOI 10.1080/15305058.2010.518325; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Hubacher M, 2012, EUR NEUROL, V67, P377, DOI 10.1159/000336736; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kirkevold M, 2012, DISABIL REHABIL, V34, P665, DOI 10.3109/09638288.2011.615373; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kutlubaev MA, 2012, ACTA NEUROL SCAND, V125, P219, DOI 10.1111/j.1600-0404.2011.01618.x; Kutlubaev MA, 2013, CEREBROVASC DIS EXTR, V3, P26, DOI 10.1159/000347113; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mead GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016988; Naess H, 2012, CEREBROVASC DIS, V33, P461, DOI 10.1159/000336760; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Parks NE, 2012, CAN J NEUROL SCI, V39, P619, DOI 10.1017/S0317167100015353; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Radman N, 2012, NEUROLOGY, V79, P1422, DOI 10.1212/WNL.0b013e31826d5f3a; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tyson SF, 2014, CLIN REHABIL, V28, P804, DOI 10.1177/0269215514521043; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1994, Ned Tijdschr Geneeskd, V138, P2279; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Verhage F, 1964, THESIS VAN GORCUM AS; Winward C, 2009, STROKE, V40, P757, DOI 10.1161/STROKEAHA.108.527101; Zedlitz Aglaia M E E, 2011, ISRN Neurol, V2011, P627081, DOI 10.5402/2011/627081; Zetlitz AM, 2013, THESIS RADBOUD U NIJ; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	52	15	16	1	21	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2015	96	6					1056	1063		10.1016/j.apmr.2014.12.010			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CK7FM	WOS:000356398200012	25559057				2022-02-06	
J	Bruce, ED; Konda, S; Dean, DD; Wang, EW; Huang, JH; Little, DM				Bruce, Erica D.; Konda, Sneha; Dean, Dana D.; Wang, Ernest W.; Huang, Jason H.; Little, Deborah M.			Neuroimaging and traumatic brain injury: State of the field and voids in translational knowledge	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); Neuroimaging; Biomarkers; Magnetic resonance imaging (MRI)	MILD-COGNITIVE-IMPAIRMENT; CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; WHITE-MATTER INTEGRITY; TENSOR IMAGING DETECTS; ALZHEIMERS-DISEASE; MOUSE MODEL; WORKING-MEMORY	Traumatic brain injury (TBI) is a leading cause of death and disability in every developed country in the world and is believed to be a risk factor in the later development of depression, anxiety disorders and neurodegenerative diseases including chronic traumatic encephalopathy (CTE), Alzheimer's Disease (AD), Parkinson's Disease (PD), and amyotrophic lateral sclerosis (ALS). One challenge faced by those who conduct research into TBI is the lack of a verified and validated biomarker that can be used to diagnose TBI or for use as a prognostic variable which can identify those at risk for poor recovery following injury or at risk for neurodegeneration later in life. Neuroimaging continues to hold promise as a TBI biomarker but is limited by a lack of clear relationship between the neuropathology of injury/recovery and the quantitative and image based data that is obtained. Specifically lacking is the data on biochemical and biologic changes that lead to alterations in neuroimaging markers. There are multiple routes towards developing, the knowledge required to more definitively link pathology to imaging but the most efficient approach is expanded leveraging of in vivo human blood, serum, and imaging biomarkers with both in vivo and ex vivo animal findings. This review describes the current use and limitations of imaging in TBI including a discussion of currently used animal injury models and the available animal imaging data and extracted markers that hold the greatest promise for helping translate alterations in imaging back to injury pathology. Further, it reviews both the human and animal TBI literature supporting current standards, identifies the remaining voids in the literature, and briefly highlights recent advances in molecular imaging. This article is part of a Special Issue entitled 'Traumatic Brain Injury'. (C) 2015 Elsevier Inc. All rights reserved.	[Bruce, Erica D.] Baylor Univ, Dept Environm Sci, Inst Biomed Studies, Inst Ecol Earth & Environm Sci, Waco, TX 76798 USA; [Konda, Sneha; Little, Deborah M.] Texas A&M Hlth Sci Ctr, Coll Med, Inst Neurosci, Temple, TX 76508 USA; [Dean, Dana D.; Wang, Ernest W.; Huang, Jason H.; Little, Deborah M.] Baylor Scott & White Healthcare, Inst Neurosci, Temple, TX 76508 USA		Little, DM (corresponding author), Baylor Scott & White Hlth, Inst Neurosci, Sect Vet Biomed Res, 5701 Airport Rd,Mailbox MS AR D120, Temple, TX 76502 USA.	deborahmlittle@gmail.com	Huang, Jason H/J-4739-2019; Guenat, Heather/H-6528-2014; Bruce, Erica D./H-2194-2015	Huang, Jason H/0000-0002-4426-0168; Bruce, Erica D./0000-0002-4900-0496			Ackl N, 2005, NEUROSCI LETT, V384, P23, DOI 10.1016/j.neulet.2005.04.035; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Arfanakis K, 2002, MAGNET RESON MED, V47, P354, DOI 10.1002/mrm.10046; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Centers for Disease Control and Prevention (CDC) The National Institutes of Health (NIH) The Department of Defense (DoD) The Department of Veterans Affairs (VA) Leadership Panel, 2013, REP C TRAUM BRAIN IN; Cernak I., J CEREB BLOOD FLOW M, V30, P255; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004; Crandall M, 2011, ARCH SURG-CHICAGO, V146, P442, DOI 10.1001/archsurg.2011.34; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Dankbaar JW, 2009, J NEURORADIOLOGY, V36, P219, DOI 10.1016/j.neurad.2009.01.001; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Falini A, 2005, NEUROIMAGE, V26, P1159, DOI 10.1016/j.neuroimage.2005.03.005; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fellgiebel A, 2006, PSYCHIAT RES-NEUROIM, V146, P283, DOI 10.1016/j.pscychresns.2006.01.006; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Fujita Y, 2014, CHILD NERV SYST, V30, P1201, DOI 10.1007/s00381-014-2353-3; Gallagher C, 2013, J INT NEUROPSYCH SOC, V19, P349, DOI 10.1017/S1355617712001373; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; HILL A, 1981, ANN NEUROL, V10, P109, DOI 10.1002/ana.410100202; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Ibarretxe-Bilbao N, 2012, MOVEMENT DISORD, V27, P1746, DOI 10.1002/mds.25240; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jones RS, 2004, NEUROL RES, V26, P488, DOI 10.1179/016164104225017640; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021; Kantarci K, 2002, J INT NEUROPSYCH SOC, V8, P934, DOI 10.1017/S1355617702870084; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Lin AJ, 2011, ANN BIOMED ENG, V39, P1349, DOI 10.1007/s10439-011-0269-6; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall SA, 2012, MIL MED, V177, P76, DOI 10.7205/MILMED-D-12-00142; Mayer A., 2014, CONCUSSIONS ATHLETIC, P249; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Modrego Pedro J., 2006, Current Alzheimer Research, V3, P161, DOI 10.2174/156720506776383103; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Planetta PJ, 2013, AM J NEURORADIOL, V34, P74, DOI 10.3174/ajnr.A3178; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Prince DA, 2012, JASPERS BASIC MECH E; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Prodoehl J, 2013, MOVEMENT DISORD, V28, P1816, DOI 10.1002/mds.25491; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reimao S, 2011, NEURORADIOL J, V24, P177, DOI 10.1177/197140091102400203; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Sandry J, 2015, J NEUROL, V262, P59, DOI 10.1007/s00415-014-7523-4; Santos JMG, 2008, DEMENT GERIATR COGN, V26, P15, DOI 10.1159/000140624; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Selnes P, 2013, J ALZHEIMERS DIS, V33, P723, DOI 10.3233/JAD-2012-121603; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; TAYLOR GA, 1994, PEDIATR RADIOL, V24, P111, DOI 10.1007/BF02020166; Teipel SJ, 2010, J ALZHEIMERS DIS, V22, P507, DOI 10.3233/JAD-2010-100234; Tisserand DJ, 2006, BRAIN COGNITION, V60, P216; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; University of Michigan Functional MRI Laboratory, 2007, ART SPIN LAB; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; van Bruggen T, 2012, PSYCHIAT RES-NEUROIM, V203, P184, DOI 10.1016/j.pscychresns.2011.12.003; van Laar PJ, 2008, RADIOLOGY, V246, P198, DOI 10.1148/radiol.2453061932; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wee CY, 2011, LECT NOTES COMPUT SC, V6892, P277, DOI 10.1007/978-3-642-23629-7_34; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	146	15	15	0	24	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAY	2015	66		B		SI		103	113		10.1016/j.mcn.2015.03.017			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK7FT	WOS:000356398900006	25827094				2022-02-06	
J	Clark, JF; Colosimo, A; Ellis, JK; Mangine, R; Bixenmann, B; Hasselfeld, K; Graman, P; Elgendy, H; Myer, G; Divine, J				Clark, Joseph F.; Colosimo, Angelo; Ellis, James K.; Mangine, Robert; Bixenmann, Benjamin; Hasselfeld, Kimberly; Graman, Patricia; Elgendy, Hagar; Myer, Gregory; Divine, Jon			Vision Training Methods for Sports Concussion Mitigation and Management	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 99; Vision training; peripheral vision; functional peripheral vision; concussion; concussion management; diagnosis; rehabilitation; eyes; sight; seeing; sight	TEST-RETEST RELIABILITY; POSITION STATEMENT; PERFORMANCE; PROGRAM; BATTERS	There is emerging evidence supporting the use vision training, including light board training tools, as a concussion baseline and neuro-diagnostic tool and potentially as a supportive component to concussion prevention strategies. This paper is focused on providing detailed methods for select vision training tools and reporting normative data for comparison when vision training is a part of a sports management program. The overall program includes standard vision training methods including tachistoscope, Brock's string, and strobe glasses, as well as specialized light board training algorithms. Stereopsis is measured as a means to monitor vision training affects. In addition, quantitative results for vision training methods as well as baseline and post-testing *A and Reaction Test measures with progressive scores are reported. Collegiate athletes consistently improve after six weeks of training in their stereopsis, *A and Reaction Test scores. When vision training is initiated as a team wide exercise, the incidence of concussion decreases in players who participate in training compared to players who do not receive the vision training. Vision training produces functional and performance changes that, when monitored, can be used to assess the success of the vision training and can be initiated as part of a sports medical intervention for concussion prevention.	[Clark, Joseph F.] Univ Cincinnati, Neurol & Rehabilitat Med, Cincinnati, OH 45221 USA; [Colosimo, Angelo; Hasselfeld, Kimberly; Elgendy, Hagar; Divine, Jon] Univ Cincinnati, Dept Orthopaed Surg, Div Sports Med, Cincinnati, OH 45221 USA; [Ellis, James K.; Mangine, Robert] Univ Cincinnati, Dept Athlet, Cincinnati, OH 45221 USA; [Bixenmann, Benjamin] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45221 USA; [Graman, Patricia] Univ Cincinnati, Coll Educ Criminal Justice & Human Serv, Cincinnati, OH 45221 USA; [Myer, Gregory] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA		Hasselfeld, K (corresponding author), Univ Cincinnati, Dept Orthopaed Surg, Div Sports Med, Cincinnati, OH 45221 USA.	hasselky@ucmail.uc.edu	Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [EB007954]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB007954] Funding Source: NIH RePORTER	This work was supported, in part by the NIBIB (EB007954) and a charitable donation from Geraldine Warner.	Bigsby K, 2014, INT J SPORTS PHYS TH, V9, P436; Clark J. F., 2015, OPTOMETRY VISUAL PER, V3; Clark JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029109; Fleisig GS, 2006, AM J SPORT MED, V34, P423, DOI 10.1177/0363546505280431; Ghasemi A, 2011, PERCEPT MOTOR SKILL, V112, P161, DOI 10.2466/05.22.24.27.PMS.112.1.161-171; Gray R, 2009, RES Q EXERCISE SPORT, V80, P491; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hayes A, 2012, NEUROREHABILITATION, V31, P19, DOI 10.3233/NRE-2012-0771; Howard I., 2012, PERCEIVING IN DEPTH, P978; Kato T, 2002, PERCEPT MOTOR SKILL, V94, P380, DOI 10.2466/pms.2002.94.2.380; KLAVORA P, 1994, PERCEPT MOTOR SKILL, V79, P448, DOI 10.2466/pms.1994.79.1.448; KLAVORA P, 1995, PERCEPT MOTOR SKILL, V80, P607, DOI 10.2466/pms.1995.80.2.607; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Ramsey K, 2014, SEE HIT SAVE BRAIN G; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Schwab S, 2012, J SPORT SCI MED, V11, P624; Solomon J, 2013, COLL FOOTBALL CONCUS; SOMERS WW, 1984, OPHTHAL PHYSL OPT, V4, P245, DOI 10.1111/j.1475-1313.1984.tb00362.x; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Vesia M, 2008, PERCEPT MOTOR SKILL, V107, P14, DOI 10.2466/PMS.107.1.14-20; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Wolverton B, 2013, COACH MAKES THE CALL; Zupan M., 2015, TRAINING CONDITIONIN, V21, P11	25	15	15	2	26	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2015		99							e52648	10.3791/52648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR7MV	WOS:000361535300032	25992878	Green Published			2022-02-06	
J	Joseph, B; Pandit, V; Khalil, M; Kulvatunyou, N; Aziz, H; Tang, A; O'Keeffe, T; Hays, D; Gries, L; Lemole, M; Friese, RS; Rhee, P				Joseph, Bellal; Pandit, Viraj; Khalil, Mazhar; Kulvatunyou, Narong; Aziz, Hassan; Tang, Andrew; O'Keeffe, Terence; Hays, Daniel; Gries, Lynn; Lemole, Michael; Friese, Randall S.; Rhee, Peter			Use of Prothrombin Complex Concentrate as an Adjunct to Fresh Frozen Plasma Shortens Time to Craniotomy in Traumatic Brain Injury Patients	NEUROSURGERY			English	Article						Fresh frozen plasma; Prothrombin complex concentrate; Time to craniotomy; Traumatic brain injury	RECOMBINANT FACTOR VIIA; INTRACRANIAL HEMORRHAGE; COAGULOPATHY; REVERSAL; THERAPY; TESTS	BACKGROUND:The use of prothrombin complex concentrate (PCC) to reverse acquired (coagulopathy of trauma) and induced coagulopathy (preinjury warfarin use) is well defined.OBJECTIVE:To compare outcomes in patients with traumatic brain injury without warfarin therapy receiving PCC as an adjunct to fresh frozen plasma (FFP) therapy compared with patients receiving FFP therapy alone.METHODS:All patients with traumatic brain injury coagulopathy without warfarin therapy who received PCC (25 IU/kg) in conjunction with FFP or FFP alone at our Level I trauma center were reviewed. Coagulopathy was defined as an international normalized ratio >1.5. The groups (PCC + FFP vs FFP alone) were matched using propensity score matching on a 1:2 ratio for age, sex, Glasgow Coma Scale score, Injury Severity Score, head Abbreviated Injury Scale score, and international normalized ratio (INR) on presentation. The primary outcome measure was time to craniotomy. Secondary outcome measures were blood product requirements, cost of therapy, and mortality.RESULTS:A total of 1641 patients were reviewed, 222 of whom were included (PCC + FFP, 74; FFP, 148). The mean standard deviation age was 46.4 21.7 years, the median (range) Glasgow Coma Scale score was 8 (3-12), and the mean standard deviation INR on presentation was 1.92 0.6. PCC + FFP therapy was associated with an accelerated correction of INR (P = .001) and decrease in overall pack red blood cell (P = .035) and FFP (P = .041) administration requirement. Craniotomy was performed in 26.1% of patients (n = 58). Patients who received PCC + FFP therapy had faster time to craniotomy (P = .028) compared with patients who received FFP therapy alone.CONCLUSION:PCC as an adjunct to FFP decreases the time to craniotomy with faster correction of INR and concomitant decrease in the need for blood product requirement in patients with traumatic brain injury exclusive of prehospital warfarin therapy.ABBREVIATIONS:AIS, Abbreviated Injury ScaleFFP, fresh frozen plasmaINR, international normalized ratioPCC, prothrombin complex concentraterFVIIa, recombinant factor VIIaRHCT, repeat head computed tomography scanSD, standard deviationTBI, traumatic brain injury	[Joseph, Bellal; Pandit, Viraj; Khalil, Mazhar; Kulvatunyou, Narong; Aziz, Hassan; Tang, Andrew; O'Keeffe, Terence; Hays, Daniel; Gries, Lynn; Lemole, Michael; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Aziz, Hassan/ABA-5681-2021	Aziz, Hassan/0000-0003-0406-1946			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brown CVR, 2012, AM SURGEON, V78, P57; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; Faul M, 2010, TRAUMATIC BRAIN INJU; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; May AK, 1997, AM SURGEON, V63, P233; Pabinger-Fasching I, 2008, THROMB RES, V122, pS19, DOI 10.1016/S0049-3848(08)70005-7; Roitberg B, 2005, NEUROSURGERY, V57, P832, DOI 10.1227/01.NEU.0000180816.80626.C2; Safaoui MN, 2009, AM J SURG, V197, P785, DOI 10.1016/j.amjsurg.2008.04.003; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a	20	15	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2015	76	5					601	607		10.1227/NEU.0000000000000685			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CG3VY	WOS:000353208900012	25886249				2022-02-06	
J	Feng, T; Aono, K; Covassin, T; Chakrabartty, S				Feng, Tao; Aono, Kenji; Covassin, Tracey; Chakrabartty, Shantanu			Self-Powered Monitoring of Repeated Head Impacts Using Time-Dilation Energy Measurement Circuit	IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS			English	Article; Proceedings Paper	IEEE International Symposium on Circuits and Systems (ISCAS)	JUN 01-05, 2014	Melbourne, AUSTRALIA	IEEE		Biomechanics; concussion monitoring; energy harvesting; helmet sensors; piezo-floating-gate (PFG) sensors; self-powered sensors	KINEMATICS	Due to the current epidemic levels of sport-related concussions (SRC) in the U.S., there is a pressing need for technologies that can facilitate long-term and continuous monitoring of head impacts. Existing helmet-sensor technology is inconsistent, inaccurate, and is not economically or logistically practical for large-scale human studies. In this paper, we present the design of a miniature, battery-less, self-powered sensor that can be embedded inside sport helmets and can continuously monitor and store different spatial and temporal statistics of the helmet impacts. At the core of the proposed sensor is a novel time-dilation circuit that allows measurement of a wide-range of impact energies. In this paper an array of linear piezo-floating-gate (PFG) injectors has been used for self-powered sensing and storage of linear and rotational head-impact statistics. The stored statistics are then retrieved using a plug-and-play reader and has been used for offline data analysis. We report simulation and measurement results validating the functionality of the time-dilation circuit for different levels of impact energies. Also, using prototypes of linear PFG integrated circuits fabricated in a 0.5 mu m CMOS process, we demonstrate the functionality of the proposed helmet-sensors using controlled drop tests.	[Feng, Tao; Aono, Kenji; Chakrabartty, Shantanu] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Feng, T (corresponding author), Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA.	fengtao@egr.msu.edu; aonokenj@egr.msu.edu; covassin@ath.msu.edu; shantanu@egr.msu.edu	Aono, Kenji/O-8498-2019; Aono, Kenji/P-7033-2018	Aono, Kenji/0000-0002-7192-0061; Aono, Kenji/0000-0002-7192-0061	National Science FoundationNational Science Foundation (NSF) [CAREER: 0954752, GRFP: DGE-0802267]; National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF) [2013136776]	This work was supported by research grants from the National Science Foundation (CAREER: 0954752 and GRFP: DGE-0802267). This material is based upon work supported in part by the National Science Foundation Graduate Research Fellowship Program under Fellow No. 2013136776. This paper was recommended by Associate Editor V. Gruev.	Aono K, 2014, IEEE INT SYMP CIRC S, P1620, DOI 10.1109/ISCAS.2014.6865461; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Huang C, 2011, ELECTRON LETT, V47, P277, DOI 10.1049/el.2010.3430; Huang CL, 2012, IEEE J SOLID-ST CIRC, V47, P476, DOI 10.1109/JSSC.2011.2172159; Institute of Medicine (IOM) and National Research Council (NRC), 2013, SPORT REL CONC YOUTH; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sarkar P, 2013, IEEE T CIRCUITS-I, V60, P2311, DOI 10.1109/TCSI.2013.2245472; Sarkar P, 2013, IEEE T BIOMED CIRC S, V7, P437, DOI 10.1109/TBCAS.2012.2220764; Yang YW, 2009, J INTEL MAT SYST STR, V20, P2223, DOI 10.1177/1045389X09351757	18	15	15	0	14	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4545	1940-9990		IEEE T BIOMED CIRC S	IEEE Trans. Biomed. Circuits Syst.	APR	2015	9	2			SI		217	226		10.1109/TBCAS.2015.2403864			10	Engineering, Biomedical; Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering	CH3BJ	WOS:000353900400008	25838527				2022-02-06	
J	Mysliwiec, V; Capaldi, VF; Gill, J; Baxter, T; O'Reilly, BM; Matsangas, P; Roth, BJ				Mysliwiec, Vincent; Capaldi, Vincent F., II; Gill, Jessica; Baxter, Tristin; O'Reilly, Brian M.; Matsangas, Panagiotis; Roth, Bernard J.			Adherence to Positive Airway Pressure Therapy in US Military Personnel With Sleep Apnea Improves Sleepiness, Sleep Quality, and Depressive Symptoms	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE COLLISIONS; CPAP ADHERENCE; DAYTIME SLEEPINESS; NASAL CPAP; PREVALENCE; HYPOPNEA; VETERANS; OBESITY; IMPACT	Objectives: Obstructive sleep apnea (OSA) is frequently diagnosed in U.S. military personnel. OSA is associated with sleepiness, poor sleep quality, and service-related illnesses of insomnia, depression, post-traumatic stress disorder, and traumatic brain injury. Methods: Observational study of active duty military personnel with OSA and adherence to positive airway pressure (PAP) assessed with smart chip technology. Results: 58 men with mean age 36.2 +/- 7.7 years, mean body mass index 31.4 +/- 3.7 with mean apnea-hypopnea index (AHI) 19.1 +/- 19.0 are reported. 23 (39.7%) participants were adherent to PAP, and 35 (60.3%) were nonadherent. No significant differences in baseline demographics, apnea-hypopnea index, service-related illnesses, or clinical instrument scores. Military personnel adherent to PAP had significantly improved sleepiness (p = 0.007), sleep quality (p = 0.013), depressive symptoms (p = 0.01), energy/fatigue (p = 0.027), and emotional well-being (p = 0.024). Participants with moderate-severe OSA were more likely to be in the adherent group when compared with participants diagnosed with mild OSA. Conclusions: Military personnel with OSA have low adherence to PAP. Adherence is associated with improved depressive symptoms, sleepiness, sleep quality, energy/fatigue, emotional well-being, and social functioning. Future research should focus on interventions to improve the management of OSA in military personnel.	[Mysliwiec, Vincent; Baxter, Tristin; O'Reilly, Brian M.; Roth, Bernard J.] Madigan Army Med Ctr, Dept Pulm Sleep Med Crit Care, Tacoma, WA 98431 USA; [Capaldi, Vincent F., II] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Gill, Jessica] NIH, Bethesda, MD 20892 USA; [Matsangas, Panagiotis] US Navy, Postgrad Sch, Dept Operat Res, Monterey, CA 93943 USA		Mysliwiec, V (corresponding author), Madigan Army Med Ctr, Dept Pulm Sleep Med Crit Care, 9040A Fitzsimmons Ave, Tacoma, WA 98431 USA.		Gill, Gill M/Q-2020-2017		Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027] Funding Source: NIH RePORTER	The authors thank Angela Mysliwiec, MD, Madigan Army Medical Center, for editing assistance and review of the manuscript. Dr. Angela Mysliwiec did not receive compensation for her contributions. This study was supported, in part, by grant no. 60855 from the Center for Neuroscience and Regenerative Medicine.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; American Congress of Rehabilitation Medicine, DEF MILD TRAUM BRAIN; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P8; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Avlonitou E, 2012, SLEEP BREATH, V16, P563, DOI 10.1007/s11325-011-0543-8; Bardwell WA, 2001, PSYCHOSOM MED, V63, P579, DOI 10.1097/00006842-200107000-00010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; El-Solh AA, 2010, SLEEP, V33, P1495, DOI 10.1093/sleep/33.11.1495; Findley L, 2000, AM J RESP CRIT CARE, V161, P857, DOI 10.1164/ajrccm.161.3.9812154; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gay P, 2006, SLEEP, V29, P381, DOI 10.1093/sleep/29.3.381; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; GUILLEMINAULT C, 1977, ARCH INTERN MED, V137, P296, DOI 10.1001/archinte.137.3.296; Hartenbaum N, 2006, J OCCUP ENVIRON MED, V48, pS1, DOI 10.1097/00043764-200609001-00001; Haynes P, 2013, J CLIN SLEEP MED, V9, P424, DOI 10.5664/jcsm.2654; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; Henke KG, 2001, AM J RESP CRIT CARE, V163, P911, DOI 10.1164/ajrccm.163.4.9910025; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kjelsberg FN, 2005, SLEEP MED, V6, P341, DOI 10.1016/j.sleep.2005.02.004; Krakow B, 2000, J PSYCHOSOM RES, V49, P291, DOI 10.1016/S0022-3999(00)00147-1; Lettieri CJ, 2005, J CLIN SLEEP MED, V1, P381; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Means Melanie K, 2003, Sleep Breath, V7, P31, DOI 10.1007/s11325-003-0031-x; MILLMAN RP, 1989, J CLIN PSYCHIAT, V50, P348; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Park JG, 2011, MAYO CLIN PROC, V86, P549, DOI 10.4065/mcp.2010.0810; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Poulet C, 2009, SLEEP MED, V10, P993, DOI 10.1016/j.sleep.2009.01.007; Profant J, 2003, HEART LUNG, V32, P52, DOI 10.1067/mhl.2003.8; RAUSCHER H, 1993, CHEST, V103, P1675, DOI 10.1378/chest.103.6.1675; REYNOLDS CF, 1984, J CLIN PSYCHIAT, V45, P287; Salepci B, 2013, RESP CARE, V58, P1467, DOI 10.4187/respcare.02139; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Schroder Carmen M, 2005, Ann Gen Psychiatry, V4, P13, DOI 10.1186/1744-859X-4-13; Schwartz DJ, 2007, J CLIN SLEEP MED, V3, P631; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Serra MM, 2012, MIL MED, V177, P1387, DOI 10.7205/MILMED-D-12-00172; Sin DD, 2002, CHEST, V122, P1679, DOI 10.1378/chest.122.5.1679; Sinnott C, 2005, DIABETES CARE, V28, P1534, DOI 10.2337/diacare.28.6.1534; Smith TJ, 2012, OBESITY, V20, P1534, DOI 10.1038/oby.2012.25; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	54	15	15	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2015	180	4					475	482		10.7205/MILMED-D-14-00197			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF6UJ	WOS:000352691600016	25826354	Bronze			2022-02-06	
J	Xu, GT; Hu, B; Chen, GQ; Yu, XJ; Luo, JM; Lv, JY; Gu, J				Xu, Guangtao; Hu, Bo; Chen, Guiqian; Yu, Xiaojun; Luo, Jianming; Lv, Junyao; Gu, Jiang			Analysis of Blood Trace Elements and Biochemical Indexes Levels in Severe Craniocerebral Trauma Adults with Glasgow Coma Scale and Injury Severity Score	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						Trace element; Trauma; Craniocerebral injury; Injury severity score	UREA NITROGEN/CREATININE RATIO; IRON; COPPER; ZINC; DYSFUNCTION; CREATININE; MAGNESIUM; NITROGEN; PLASMA; ZN	We aimed to investigate the correlation between the Glasgow Coma Scale (GCS), the injury severity score (ISS) and serum levels of trace elements (TE) in severe trauma patients to analyze alteration of the levels of trace elements and serum biochemical indexes in the period of admission from 126 adult cases of severe brain trauma with traffic accidents. Multi-trace elements for patients in the trauma-TE groups were used. The results indicated that all patients presented an acute trace elements deficiency syndrome (ATEDs) after severe trauma, and the correlation between ISS and serum levels of Fe, Zn, and Mg was significant. Compared to the normal control group, levels of the trace elements in serum were significantly decreased after trauma, suggesting that enhancement of immunity to infection and multiple organ failure (MOF) via the monitoring and supplement of trace elements will be a good strategy to severe traumatic patients in clinics.	[Xu, Guangtao; Yu, Xiaojun; Luo, Jianming; Lv, Junyao; Gu, Jiang] Shantou Univ, Coll Med, Dept Forens & Pathol, Natl Key Disciplines, Shantou 515041, Guangdong, Peoples R China; [Xu, Guangtao; Chen, Guiqian] Jiaxing Univ, Dept Forens & Pathol, Coll Med, Jiaxing 314001, Zhejiang, Peoples R China; [Hu, Bo] Jiaxing Hosp Tradit Chinese Med, Dept Pathol, Jiaxing 314001, Zhejiang, Peoples R China		Yu, XJ (corresponding author), Shantou Univ, Coll Med, Dept Forens & Pathol, Natl Key Disciplines, Shantou 515041, Guangdong, Peoples R China.	2523381625@qq.com; xjyu@stu.edu.cn	Xu, Guangtao/L-8929-2017; Hu, Bo/I-2889-2019	Xu, Guangtao/0000-0001-5846-9280; Hu, Bo/0000-0001-8601-8284; Gu, Jiang/0000-0002-0706-8329	Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [LQ14H230001]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201330031]; National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458, 81400489, 81400654]	We are grateful to Miss Xingxing Wang and Mr. Bo Li for the data analysis. We appreciate the support from the Zhejiang Provincial Natural Science Foundation (LQ14H230001), Scientific Research Fund of Zhejiang Provincial Education Department (Y201330031), and the National Natural Science Foundation Council of China (30772458, 81400489, and 81400654).	Agay D, 2005, BURNS, V31, P366, DOI 10.1016/j.burns.2004.11.010; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blass SC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-157; Bonham M, 2002, BRIT J NUTR, V87, P393, DOI 10.1079/BJN2002558; Brisco MA, 2013, CIRC-HEART FAIL, V6, P233, DOI 10.1161/CIRCHEARTFAILURE.112.968230; Cortese-Krott MM, 2014, REDOX BIOL, V2, P945, DOI 10.1016/j.redox.2014.06.011; Decker H, 2000, J EXP BIOL, V203, P1777; Dlouhy AC, 2013, METAL IONS LIFE SCI, V12, P241, DOI 10.1007/978-94-007-5561-1_8; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Ge KY, 2000, J AM DIET ASSOC, V100, P885, DOI 10.1016/S0002-8223(00)00256-X; Geiger H, 2012, CLIN KIDNEY J, V5, P25, DOI 10.1093/ndtplus/sfr165; Georgetti Flávia Carolina Davini, 2006, Rev. bras. ter. intensiva, V18, P418, DOI 10.1590/S0103-507X2006000400017; Ghasemi A, 2010, BIOL TRACE ELEM RES, V136, P18, DOI 10.1007/s12011-009-8522-7; Guerrero-Romero F, 2002, ACTA DIABETOL, V39, P209, DOI 10.1007/s005920200036; Hoppe M, 2006, EUR J NUTR, V45, P37, DOI 10.1007/s00394-005-0560-0; Huang XL, 2014, CLIN LAB, V60, P1123, DOI 10.7754/Clin.Lab.2013.130530; Iankova Andriana, 2006, Emerg Nurse, V14, P30; Jang JY, 2014, J CRIT CARE, V29, pe5; Kehoe A, 2014, EMERG MED J; Kennedy AB, 2014, NUCLEIC ACIDS RES, V42, P12306, DOI 10.1093/nar/gku875; Liu Q, 2014, GENET MOL RES, V13, P7666, DOI 10.4238/2014.September.26.4; Liu XD, 2013, HEPATO-GASTROENTEROL, V60, P343, DOI 10.5754/hge11216; MORGAN DB, 1977, BMJ-BRIT MED J, V2, P929, DOI 10.1136/bmj.2.6092.929; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Palmer CS, 2013, INJURY, V44, P1437, DOI 10.1016/j.injury.2012.08.033; Panhwar AH, 2014, CLIN LAB, V60, P463, DOI 10.7754/Clin.Lab.2013.130122; Pineda O, 2001, NUTRITION, V17, P381, DOI 10.1016/S0899-9007(01)00519-6; Riccardi A, 2013, EUR REV MED PHARMACO, V17, P1800; Romani AMP, 2013, METAL IONS LIFE SCI, V12, P69, DOI 10.1007/978-94-007-5561-1_4; Saaka Mahama, 2009, East Afr J Public Health, V6, P55; Schrock JW, 2012, CLIN NEUROL NEUROSUR, V114, P881, DOI 10.1016/j.clineuro.2012.01.031; Smith ZA, 2014, J NEUROSURG-SPINE, V21, P495, DOI 10.3171/2014.3.SPINE14301; Strachan S., 2010, CURR ANAESTH CRIT CA, V21, DOI [10.1016/j.cacc.2009.08.004, DOI 10.1016/j.cacc.2009.08.004]; Thurnham DI, 2014, P NUTR SOC, V73, P1, DOI 10.1017/S0029665113003662; TraumaRegister DGU, 2014, INJURY, V45, pS14, DOI 10.1016/j.injury.2014.08.012; Ucar SK, 2010, J TRACE ELEM MED BIO, V24, P42, DOI 10.1016/j.jtemb.2009.10.004; Wang BH, 2007, J TRACE ELEM MED BIO, V21, P102, DOI 10.1016/j.jtemb.2007.03.006; WANG BH, 2005, J FORENSIC MED, V21, P42; Wang D, 2006, J SURG CONCEPTS PRAC, V11, P239; Wang GH, 2013, BIOL TRACE ELEM RES, V152, P300, DOI 10.1007/s12011-013-9623-x; Wang GH, 2012, BIOL TRACE ELEM RES, V147, P28, DOI 10.1007/s12011-011-9281-9; Yuan WA, 2010, J TRACE ELEM MED BIO, V24, P36, DOI 10.1016/j.jtemb.2009.08.002	42	15	21	1	16	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	APR	2015	164	2					192	197		10.1007/s12011-014-0225-z			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CD9SX	WOS:000351439700005	25575666				2022-02-06	
J	Solchenberger, B; Russell, C; Kremmer, E; Haass, C; Schmid, B				Solchenberger, Barbara; Russell, Claire; Kremmer, Elisabeth; Haass, Christian; Schmid, Bettina			Granulin Knock Out Zebrafish Lack Frontotemporal Lobar Degeneration and Neuronal Ceroid Lipofuscinosis Pathology	PLOS ONE			English	Article							PROGRANULIN-DEFICIENT MICE; TRAUMATIC BRAIN-INJURY; IN-VIVO; ACTIVATED MICROGLIA; EARLY MACROPHAGES; GENE-EXPRESSION; HOST-DEFENSE; MUTATIONS; MODEL; DEMENTIA	Loss of function mutations in granulin (GRN) are linked to two distinct neurological disorders, frontotemporal lobar degeneration (FTLD) and neuronal ceroid lipofuscinosis (NCL). It is so far unknown how a complete loss of GRN in NCL and partial loss of GRN in FTLD can result in such distinct diseases. In zebrafish, there are two GRN homologues, Granulin A (Grna) and Granulin B (Grnb). We have generated stable Grna and Grnb loss of function zebrafish mutants by zinc finger nuclease mediated genome editing. Surprisingly, the grna and grnb single and double mutants display neither spinal motor neuron axonopathies nor a reduced number of myogenic progenitor cells as previously reported for Grna and Grnb knock down embryos. Additionally, grna(-/-);grnb(-/-) double mutants have no obvious FTLD- and NCL-related biochemical and neuropathological phenotypes. Taken together, the Grna and Grnb single and double knock out zebrafish lack any obvious morphological, pathological and biochemical phenotypes. Loss of zebrafish Grna and Grnb might therefore either be fully compensated or only become symptomatic upon additional challenge.	[Solchenberger, Barbara; Haass, Christian; Schmid, Bettina] Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany; [Russell, Claire] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany; [Haass, Christian; Schmid, Bettina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany		Schmid, B (corresponding author), Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany.	Bettina.Schmid@dzne.de	Russell, Claire/A-4879-2012	Russell, Claire/0000-0002-6748-9301	International Max Planck Research School for Molecular and Cellular Life Sciences; Elite Network of Bavaria; Short Term Scientific Mission COST Action [BM0804]; Batten Disease Family Association; European Research Council under the European UnionEuropean Research Council (ERC) [321366-Amyloid];  [Sonderforschungsbereich 596]	This work was supported by the Sonderforschungsbereich 596, International Max Planck Research School for Molecular and Cellular Life Sciences (B. So.), the Elite Network of Bavaria (B. So.), a Short Term Scientific Mission COST Action BM0804 (B. So.), the Batten Disease Family Association (C.R.), the European Research Council under the European Union's Seventh Framework Program FP7/2007-2013)/ ERC Grant Agreement No. 321366-Amyloid (advanced grant to C.H.), the general legacy of Mrs. Ammer (to the Ludwig-Maximilians University/ C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bonvicini C, 2014, NEUROBIOL AGING, V35, P1206, DOI 10.1016/j.neurobiolaging.2013.10.097; Borst LB, 2013, VET PATHOL, V50, P457, DOI 10.1177/0300985811424731; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Chitramuthu BP, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-41; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; da Rosa CE, 2010, EXP GERONTOL, V45, P449, DOI 10.1016/j.exger.2010.03.012; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Muynck L, 2013, NEUROBIOLOGY AGING; Del Bo R, 2011, NEUROBIOL AGING, V32, P1157, DOI 10.1016/j.neurobiolaging.2009.06.006; den Broeder MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007910; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Follo C, 2013, INT J BIOCHEM CELL B, V45, P273, DOI 10.1016/j.biocel.2012.10.010; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Ghidoni R, 2012, BRAIN RES, V1476, P172, DOI 10.1016/j.brainres.2012.01.075; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Huang T, 2012, BIOCHEM BIOPH RES CO, V421, P214, DOI 10.1016/j.bbrc.2012.03.139; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Li YH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01176; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Matthews M, 2012, ILAR J, V53, P192, DOI 10.1093/ilar.53.2.192; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Nicolas Celine S, 1800, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patterson SE, 2008, DEV DYNAM, V237, P307, DOI 10.1002/dvdy.21400; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Schmid B, 2013, J NEUROCHEM, V127, P461, DOI 10.1111/jnc.12460; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	70	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118956	10.1371/journal.pone.0118956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	WOS:000352138500060	25785851	Green Published, gold, Green Accepted, Green Submitted			2022-02-06	
J	Kavosi, Z; Jafari, A; Hatam, N; Enaami, M				Kavosi, Zahra; Jafari, Abdosaleh; Hatam, Nahid; Enaami, Meysam			The Economic Burden of Traumatic Brain Injury Due to Fatal Traffic Accidents in Shahid Rajaei Trauma Hospital, Shiraz, Iran	ARCHIVES OF TRAUMA RESEARCH			English	Article						Economic Burden; Potential Years of Life Lost (PYLL); Productivity Lost; Traffic Accidents; Traumatic Brain Injury	HEALTH; LIFE	Background: Traumatic Brain Injuries (TBIs) as a result of traffic accidents are one of the major causes of deaths, which lead to the loss of individuals' productive and working years of life. Objectives: This study aimed to calculate the economic burden of traumatic brain injuries in fatal crashes at Shahid Rajaei Trauma Hospital, Shiraz, Iran for a period of five years. Patients and Methods: In this descriptive, cross-sectional study the population included people who had died as a result of TBIs during 2009 to 2013 in Shiraz Shahid Rajaei Trauma Hospital. Cost and demographic data were obtained from the participants' medical records using data gathering forms, and some other information was also collected via telephone calls to the victims' families. Economic burden of TBIs due to traffic accidents, which led to death, was estimated using the human capital as direct costs of treatment, and the number of potential years of life lost and lost productivity as indirect costs. Results: Deaths resulting from TBIs due to traffic accidents in Shiraz imposed 6.2 billion Rials (511000 USD) of hospital costs, 6390 potential years of life lost, and 506 billion Rials (20 million USD) of productivity lost. In the present study, the mean age of the individuals who died was 38.4 +/- 19.41 and the productivity lost per capita was 1.8 billion Rials (73000 USD). Conclusions: The findings of this study indicated that the economic burden of TBIs was high in fatal accidents in Fars Province so that it was equivalent to 0.00011% of Iran's Gross Domestic Product (GDP) in 2013. Therefore, more attention has to be paid to the rules to prevent the fatal accidents.	[Kavosi, Zahra] Shiraz Univ Med Sci, Sch Management & Informat Sci, Social Determinants Hlth Res Ctr, Shiraz, Iran; [Jafari, Abdosaleh] Shiraz Univ Med Sci, Sch Management & Med Informat, Hlth Econ Dept, Shiraz, Iran; [Hatam, Nahid] Shiraz Univ Med Sci, Sch Management & Med Informat, Shiraz, Iran; [Enaami, Meysam] Shiraz Univ Med Sci, Sch Management & Med Informat, Student Res Comm, Shiraz, Iran		Enaami, M (corresponding author), Shiraz Univ Med Sci, Sch Management & Med Informat, Student Res Comm, Shiraz, Iran.	meysamenami@yahoo.com	Jafari, Abdosaleh/AAD-2632-2020; hatam, nahid/K-6957-2016	Jafari, Abdosaleh/0000-0003-3035-2798; hatam, nahid/0000-0001-7738-1970			af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Akbari M. E., 2006, Eastern Mediterranean Health Journal, V12, P382; Al-Masaeid HR, 1999, ACCIDENT ANAL PREV, V31, P347, DOI 10.1016/S0001-4575(98)00068-2; Ayatollahi ST, 2009, IRAN J EPIDEMIOL, V4, P51; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Dixey RA, 1999, HEALTH EDUC RES, V14, P197, DOI 10.1093/her/14.2.197; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Karimi I, 2004, J HLTH ADM, V7, P22; Kayani NA, 2009, PUBLIC HLTH REP, V124, P551; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Passmore JW, 2010, B WORLD HEALTH ORGAN, V88, P783, DOI 10.2471/BLT.09.071662; Peden M., 2004, WORLD REPORT ROAD TR; Rezaei S, 2012, ARCH TRAUMA RES, V1, P93, DOI 10.5812/atr.6546; Rezaei Satar, 2014, J Inj Violence Res, V6, P57, DOI 10.5249/jivr.v6i2.191; Sanaei-Zadeh H, 2002, J CLIN FORENSIC MED, V9, P74, DOI DOI 10.1054/JCFM.2002.0547.[; Social Security Organization, 2014, TERMS BUR SUBS; Soori H, 1999, East Mediterr Health J, V5, P55; Soori H, 2009, HAKIM RES J, V12, P48; The World Bank, 2014, HEALTH; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; World Health Organization, 1993, HANDL LIF CAR PREV V	27	15	15	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	MAR	2015	4	1							e22594	10.5812/atr.22594			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	CP9GI	WOS:000360201400007	25834791	Green Published, Bronze			2022-02-06	
J	Kim, DY; Kobayashi, L; Chang, D; Fortlage, D; Coimbra, R				Kim, Dennis Yong; Kobayashi, Leslie; Chang, David; Fortlage, Dale; Coimbra, Raul			Early Pharmacological Venous Thromboembolism Prophylaxis Is Safe After Operative Fixation of Traumatic Spine Fractures	SPINE			English	Article						venous thromboembolism; spine fractures; pharmacological prophylaxis; trauma; epidural hematoma; complications; outcomes	MOLECULAR-WEIGHT HEPARIN; MAJOR TRAUMA; BRAIN-INJURY; DATA-BANK; 1602 EPISODES; RISK-FACTORS; SURGERY; THROMBOPROPHYLAXIS; ENOXAPARIN; PATIENT	Study Design. Retrospective cohort study. Objective. To examine the impact of early (<48 hr) versus late (>= 48 hr) initiation of pharmacological venous thromboembolism (VTE) prophylaxis on outcomes and complications among trauma patients undergoing operative fixation of spine fractures. Summary of Background Data. VTE complications are associated with poor outcomes after trauma. Although pharmacological prophylaxis decreases the risk of VTE after trauma, concerns regarding bleeding-related complications among certain patient subgroups persist. At present, there are limited data regarding the safety of early VTE prophylaxis in trauma patients undergoing operative fixation of spine fractures. Methods. We performed a 5-year retrospective analysis of our level 1 trauma center registry to identify consecutive patients undergoing operative fixation of spine fractures. Demographics, injury patterns and severity, details of operative procedures, timing of administration of VTE prophylaxis, and outcomes were analyzed. Patients receiving early VTE prophylaxis were compared with patients receiving late VTE prophylaxis. Multivariate analysis was performed to identify independent predictors of VTE. Results. Of 1432 patients with spine fractures, 206 patients (14.4%) underwent operative fixation. Forty-eight (23.3%) received early VTE prophylaxis and 158 (76.7%) received late VTE prophylaxis. No patient developed an epidural hematoma or postoperative bleeding necessitating intervention in either group. Thirteen patients (6.2%) developed VTE, of which 12 occurred in the late VTE prophylaxis group. Age 45 years or more (odds ratio = 5.12, 95% confidence interval = 1.01-25.94, P = 0.048) and traumatic brain injury (odds ratio = 6.94, 95% confidence interval = 1.19-40.35, P = 0.031) were independently associated with an increased risk for VTE. Conclusion. Pharmacological VTE prophylaxis initiated within 48 hours of operative fixation of traumatic spine fractures seems to be safe and is not associated with an increased risk of bleeding or neurological complications. Large, multicenter prospective studies are required to further define the efficacy and safety of an early pharmacological VTE prophylaxis strategy in this at-risk patient population.	[Kim, Dennis Yong; Kobayashi, Leslie; Chang, David; Fortlage, Dale; Coimbra, Raul] Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA		Coimbra, R (corresponding author), Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, 200 W Arbor Dr,8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			Bono CM, 2009, SPINE J, V9, P1046, DOI 10.1016/j.spinee.2009.09.005; Bryson DJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-14; Eberle BM, 2011, J TRAUMA, V70, P141, DOI 10.1097/TA.0b013e3182032f45; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Glotzbecker MP, 2010, SPINE, V35, pE413, DOI 10.1097/BRS.0b013e3181d9bb77; Glotzbecker MP, 2008, SPINE, V33, P2915, DOI 10.1097/BRS.0b013e318190702a; Glotzbecker MP, 2009, SPINE, V34, P291, DOI 10.1097/BRS.0b013e318195601d; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Jawa RS, 2011, J SURG RES, V167, P24, DOI 10.1016/j.jss.2010.09.046; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Kim DY, 2012, J TRAUMA ACUTE CARE, V72, P1286, DOI 10.1097/TA.0b013e31824ef9ec; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Pierce CA, 2008, J TRAUMA, V64, P932, DOI 10.1097/TA.0b013e318166b808; Platzer P, 2006, ACTA ORTHOP, V77, P755, DOI 10.1080/17453670610012944; Ploumis A, 2010, SPINE, V35, P323, DOI 10.1097/BRS.0b013e3181ca652e; Ploumis A, 2009, SPINE J, V9, P530, DOI 10.1016/j.spinee.2009.01.008; Rogers SO, 2007, J TRAUMA, V62, P562; Shackford SR, 2004, ANN SURG, V240, P496; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Velmahos GC, 2000, J TRAUMA, V49, P140, DOI 10.1097/00005373-200007000-00021	27	15	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAR 1	2015	40	5					299	304		10.1097/BRS.0000000000000754			6	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	CD0HO	WOS:000350751600015	25901977				2022-02-06	
J	Makowiecki, K; Garrett, A; Clark, V; Graham, SL; Rodger, J				Makowiecki, Kalina; Garrett, Andrew; Clark, Vince; Graham, Stuart L.; Rodger, Jennifer			Reliability of VEP Recordings Using Chronically Implanted Screw Electrodes in Mice	TRANSLATIONAL VISION SCIENCE & TECHNOLOGY			English	Article						visual evoke potential; reliability; chronic electrode implant; approximate entropy; electroencephalogram	VISUAL-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; MOUSE; CORTEX; RATS; ELECTROENCEPHALOGRAM; STIMULATION; COMPRESSION; INHIBITION	Purpose: Visual evoked potentials (VEPs) are widely used to objectively assess visual system function in animal models of ophthalmological diseases. Although use of chronically implanted electrodes is common in longitudinal VEP studies using rodent models, reliability of recordings over time has not been assessed. We compared VEPs 1 and 7 days after electrode implantation in the adult mouse. We also examined stimulus-independent changes over time, by assessing electroencephalogram (EEG) power and approximate entropy of the EEG signal. Methods: Stainless steel screws (600-mu m diameter) were implanted into the skull overlying the right visual cortex and the orbitofrontal cortex of adult mice (C57Bl/6J, n = 7). Animals were reanesthetized 1 and 7 days after implantation to record VEP responses (flashed gratings) and EEG activity. Brain sections were stained for glial activation (GFAP) and cell death (TUNEL). Results: Reliability analysis, using intraclass correlation coefficients, showed VEP recordings had high reliability within the same session, regardless of time after electrode implantation and peak latencies and approximate entropy of the EEG did not change significantly with time. However, there was poorer reliability between recordings obtained on different days, and a significant decrease in VEP amplitudes and EEG power. This amplitude decrease could be normalized by scaling to EEG power (within-subjects). Furthermore, glial activation was present at both time points but there was no evidence of cell death. Conclusions: These results indicate that VEP responses can be reliably recorded even after a relatively short recovery period but decrease response peak amplitude over time. Although scaling the VEP trace to EEG power normalized this decrease, our results highlight that time-dependent cortical excitability changes are an important consideration in longitudinal VEP studies. Translational Relevance: This study shows changes in VEP characteristics over time in chronically implanted mice. Thus, future preclinical longitudinal studies should consider time in addition to amplitude and latency when designing and interpreting research.	[Makowiecki, Kalina; Garrett, Andrew; Clark, Vince; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA, Australia; [Graham, Stuart L.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia		Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci M317, 35 Stirling Highway, Crawley, WA 6009, Australia.	jennifer.rodger@uwa.edu.au	Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229; Graham, Stuart/0000-0001-7519-969X; Makowiecki, Kalina/0000-0003-4550-3819	Neurotrauma Research Program (WA State Government); National Health and Medical Research Council Senior Research FellowshipNational Health and Medical Research Council of Australia; Australian Postgraduate AwardAustralian Government	Supported by grants from the Neurotrauma Research Program (WA State Government) and a The National Health and Medical Research Council Senior Research Fellowship (JR), as well as an Australian Postgraduate Award (KM).	Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Cambiaghi M, 2011, NEUROSCIENCE, V185, P161, DOI 10.1016/j.neuroscience.2011.04.022; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; CREEL D, 1974, VISION RES, V14, P725, DOI 10.1016/0042-6989(74)90070-4; Cruz JI, 1998, LAB ANIM-UK, V32, P18, DOI 10.1258/002367798780559383; Ding MC, 2008, NEUROSCIENCE, V154, P551, DOI 10.1016/j.neuroscience.2008.03.088; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; He B, 2002, CLIN NEUROPHYSIOL, V113, P227, DOI 10.1016/S1388-2457(01)00740-4; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Holland PR, 2010, CEPHALALGIA, V30, P519, DOI 10.1111/j.1468-2982.2009.02021.x; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; King CE, 1997, NEUROREPORT, V8, P1663; Klistorner AI, 2001, INVEST OPHTH VIS SCI, V42, P2145; Klistorner AI, 1998, AUST NZ J OPHTHALMOL, V26, pS91, DOI 10.1111/j.1442-9071.1998.tb01386.x; Kohtoh S, 2008, SLEEP BIOL RHYTHMS, V6, P163, DOI 10.1111/j.1479-8425.2008.00355.x; Lin JL, 2010, J CEREBR BLOOD F MET, V30, P1121, DOI 10.1038/jcbfm.2009.277; Makowiecki K, 2014, J NEUROSCI, V34, P10780, DOI 10.1523/JNEUROSCI.0723-14.2014; Manor T, 2008, NEUROL RES, V30, P1075, DOI 10.1179/174313208X346107; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Meeren HKM, 1998, EVOKED POTENTIAL, V108, P306, DOI 10.1016/S0168-5597(97)00101-9; Mitzdorf U., 1985, AM PHYSL SOC, V65, P37; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Peachey NS, 2003, DOC OPHTHALMOL, V107, P13, DOI 10.1023/A:1024448314608; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinto LH, 2000, MAMM GENOME, V11, P531, DOI 10.1007/s003350010102; Porciatti V, 1999, VISUAL NEUROSCI, V16, P721, DOI 10.1017/S0952523899164113; Porciatti Vittorio, 2002, Documenta Ophthalmologica, V104, P69, DOI 10.1023/A:1014463212001; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ridder WH, 2006, VISION RES, V46, P902, DOI 10.1016/j.visres.2005.09.006; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; You YY, 2012, INVEST OPHTH VIS SCI, V53, P1473, DOI 10.1167/iovs.11-8797; You YY, 2011, DOC OPHTHALMOL, V123, P109, DOI 10.1007/s10633-011-9288-8	40	15	15	0	3	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	2164-2591			TRANSL VIS SCI TECHN	Transl. Vis. Sci. Technol.	MAR	2015	4	2							15	10.1167/tvst.4.2.15			13	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	ED1DF	WOS:000388583500015	25938003	Green Published			2022-02-06	
J	Shi, ZF; Zhao, WJ; Xu, LX; Dong, LP; Yang, SH; Yuan, F				Shi Zhong Fang; Zhao Wei Jiang; Xu Li Xin; Dong Li Ping; Yang Shao Hua; Yuan Fang			Downregulation of Aquaporin 4 Expression through Extracellular Signal-regulated Kinases1/2 Activation in Cultured Astrocytes Following Scratch-injury	BIOMEDICAL AND ENVIRONMENTAL SCIENCES			English	Article						Astrocytes; Aquaporin 4; Scratch-injury; Extracellular signal-regulated kinases1/2	RAT ASTROCYTES; BRAIN EDEMA; MODEL; ERK	Objective To investigate the role of extracellular signal-regulated kinase1/2 (ERK1/2) pathway in the regulation of aquaporin 4 (AQP4) expression in cultured astrocytes after scratch-injury. Methods The scratch-injury model was produced in cultured astrocytes of rat by a 10-mu L plastic pipette tip. The morphological changes of astrocytes and lactate dehydrogenase (LDH) leakages were observed to assess the degree of scratch-injury. AQP4 expression was detected by immunofluorescence staining and Western blot, and phosphorylated-ERK1/2 (p-ERK1/2) expression was determined by Western blot. To explore the effect of ERK1/2 pathway on AQP4 expression in scratch-injured astrocytes, 10 mu mol/L U0126 (ERK1/2 inhibitor) was incubated in the medium at 30 min before the scratch-injury in some groups. Results Increases in LDH leakage were observed at 1, 12, and 24 h after scratch-injury, and AQP4 expression was reduced simultaneously. Decrease in AQP4 expression was associated with a significant increase in ERK1/2 activation. Furthermore, pretreatment with U0126 blocked both ERK1/2 activation and decrease in AQP4 expression induced by scratch-injury. Conclusion These results indicate that ERK1/2 pathway down-regulates AQP4 expression in scratch-injured astrocytes, and ERK1/2 pathway might be a novel therapeutic target in reversing the effects of astrocytes that contribute to traumatic brain edema.	[Shi Zhong Fang; Xu Li Xin; Dong Li Ping; Yang Shao Hua; Yuan Fang] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Pathophysiol, Beijing 100050, Peoples R China; [Shi Zhong Fang; Xu Li Xin; Dong Li Ping; Yang Shao Hua; Yuan Fang] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing 100050, Peoples R China; [Zhao Wei Jiang] Shantou Univ, Coll Med, Ctr Neurosci, Shantou 515041, Guangdong, Peoples R China; [Yang Shao Hua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA		Yuan, F (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Pathophysiol, Beijing 100050, Peoples R China.	florayuan@vip.sina.com		Zhao, Wei-jiang/0000-0002-6556-2827	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271286, 81228009]	This work was supported by the National Natural Science Foundation of China, No. 81271286 to YUAN Fang and No. 81228009 to YANG Shao Hua.	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Marmarou A, 2003, ACT NEUR S, V86, P7; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nielsen S, 1997, J NEUROSCI, V17, P171; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Qi YC, 2014, BIOMED ENVIRON SCI, V27, P410, DOI 10.3967/bes2014.070; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Tan L, 2014, BIOMED ENVIRON SCI, V27, P186, DOI 10.3967/bes2014.007; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yang M, 2013, J CELL BIOCHEM, V114, P111, DOI 10.1002/jcb.24308; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yuan F, 1996, SCI CHINA SER C, V39, P517; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang L, 2008, SHOUDU YIKE DAXUE XU, V29, P732; Zhao WJ, 2011, NEURAL REGEN RES, V6, P60, DOI 10.3969/j.issn.1673-5374.2011.01.010	26	15	18	1	7	CHINESE CENTER DISEASE CONTROL & PREVENTION	BEIJING	155 CHANGBAI RD, CHANGPING DISTRICT, BEIJING, 102206, PEOPLES R CHINA	0895-3988			BIOMED ENVIRON SCI	Biomed. Environ. Sci.	MAR	2015	28	3					199	205		10.3967/bes2015.026			7	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CH7KO	WOS:000354215300004	25800444				2022-02-06	
J	Webster, J; Taylor, A; Balchin, R				Webster, J.; Taylor, A.; Balchin, R.			Traumatic brain injury, the hidden pandemic: A focused response to family and patient experiences and needs	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							EXECUTIVE DYSFUNCTION	Introduction. Traumatic brain injury (TB!) has many potential cognitive, behavioural and psychological consequences, and contributes significantly to the national burden of disease and to ongoing violent behaviour. Few resources are available for the rehabilitation of patients with TBI in South Africa, and access to rehabilitation facilities in the public sector is limited. Consequently, it is the families impacted on by TBI that ultimately carry the care and rehabilitation burden once survivors are discharged from hospital. Families are generally ill equipped to cope with the complex and potentially long-term disabilities that accompany brain injury. Methods. Reviewing interviews with 175 family members and 354 patients recovering from TBI helped identify the key challenges that the survivors of TBI and their families face. Results. Nine problem areas were identified that formed the basis for development of a discharge resource, the S-Plan, which serves to inform patients and carers and provide practical solutions for the problems they face. Conclusion. The experiences of TBI survivors and their family members served to inform the development of simple, integrated coping strategies, namely two S-Plan tools, one for survivors and their families/caregivers and the other for care workers, in conjunction with counselling and support group processes. The S-Plan constitutes a discharge resource to inform patients and carers and provide practical solutions for the problems they face in caring for family members who have suffered TBI.	[Webster, J.] Groote Schuur Hosp, ComaCARE Trust, ZA-7925 Cape Town, South Africa; [Taylor, A.] Univ Cape Town, Fac Hlth Sci, Div Neurosurg, ZA-7925 Cape Town, South Africa; [Taylor, A.] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Balchin, R.] Univ Cape Town, Fac Humanities, Dept Psychol, ZA-7925 Cape Town, South Africa		Taylor, A (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Neurosurg, ZA-7925 Cape Town, South Africa.	allan.taylor@uct.ac.za			Nussbaum Foundation; Norwegian Centre for Human Rights; Western Cape Department of Social Development; Claude Leon Foundation	JW thanks the Nussbaum Foundation, the Norwegian Centre for Human Rights and the Western Cape Department of Social Development for their support of this research. RB sincerely thanks the Claude Leon Foundation for their funding and support of this research.	Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Carney N, 1999, REHABILITATION TRAUM; Chesnut RM, 1998, EVIDENCE REPORT REHA; de Villiers L, 2011, SAMJ S AFR MED J, V101, P345, DOI 10.7196/SAMJ.4588; Groenewald P., 2012, W CAPE MORTALITY PRO; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hassan STS, 2011, J NEPAL MED ASSOC, V50, P53; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; KOLB B, 2003, FUNDAMENTALS HUMAN N; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Matzopoulos R, 2010, HEALTH POLICY, V97, P62, DOI 10.1016/j.healthpol.2010.03.003; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; WALSH K, 1999, NEUROPSYCHOLOGY CLIN; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	16	15	16	0	9	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	MAR	2015	105	3					195	198		10.7196/SAMJ.9014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD8IA	WOS:000351337200018	26294826	gold, Green Submitted			2022-02-06	
J	Dzhala, V; Staley, KJ				Dzhala, Volodymyr; Staley, Kevin J.			Acute and Chronic Efficacy of Bumetanide in an in vitro Model of Posttraumatic Epileptogenesis	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Bumetanide; NKCC1; phenobarbital; posttraumatic seizures; Trauma	CATION-CHLORIDE COTRANSPORTERS; K-CL COTRANSPORTER; EXCITATORY ACTIONS; INTERICTAL SPIKES; CULTURE MODEL; SEIZURES; NKCC1; GABA; ROLES; ACCUMULATION	BackgroundSeizures triggered by acute injuries to the developing brain respond poorly to first-line medications that target the inhibitory chloride-permeable GABA(A) receptor. Neuronal injury is associated with profound increases in cytoplasmic chloride ([Cl-](i)) resulting in depolarizing GABA signaling, higher seizure propensity and limited efficacy of GABAergic anticonvulsants. The Na+-K+-2Cl(-) (NKCC1) cotransporter blocker bumetanide reduces [Cl-](i) and causes more negative GABA equilibrium potential in injured neurons. We therefore tested both the acute and chronic efficacy of bumetanide on early posttraumatic ictal-like epileptiform discharges and epileptogenesis. MethodsAcute hippocampal slices were used as a model of severe traumatic brain injury and posttraumatic epileptogenesis. Hippocampal slices were then incubated for 3weeks. After a 1-week latent period, slice cultures developed chronic spontaneous ictal-like discharges. The anticonvulsant and anti-epileptogenic efficacy of bumetanide, phenobarbital, and the combination of these drugs was studied. ResultsBumetanide reduced the frequency and power of early posttraumatic ictal-like discharges in vitro and enhanced the anticonvulsant efficacy of phenobarbital. Continuous 2-3weeks administration of bumetanide as well as phenobarbital in combination with bumetanide failed to prevent posttraumatic ictal-like discharges and epileptogenesis. ConclusionsOur data demonstrate a persistent contribution of NKCC1 cotransport in posttraumatic ictal-like activity, presumably as a consequence of chronic alterations in neuronal chloride homeostasis and GABA-mediated inhibition. New strategies for more effective reduction in posttraumatic and seizure-induced [Cl-](i) accumulation could provide the basis for effective treatments for posttraumatic epileptogenesis and the resultant seizures.	[Dzhala, Volodymyr; Staley, Kevin J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA		Staley, KJ (corresponding author), MGH Neurol, CNY 114,Room 2600,114 16th St, Charlestown, MA 02129 USA.	staley.kevin@mgh.harvard.edu			NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS 40109-13]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH106013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040109, R01NS074772] Funding Source: NIH RePORTER	This study was supported by NIH grant RO1 NS 40109-13 (NINDS). We thank Michelle Mail for technical assistance.	[Anonymous], 2014, PIL STUD BUM NEWB SE; [Anonymous], 2014, TREATM NEON SEIZ MED; BAK IJ, 1980, BRAIN RES, V197, P341, DOI 10.1016/0006-8993(80)91120-8; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Carmo KB, 2005, J PAEDIATR CHILD H, V41, P313, DOI 10.1111/j.1440-1754.2005.00638.x; Cleary RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057148; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 2014, J PHYSIOL-LONDON, V592, P4099, DOI 10.1113/jphysiol.2014.275529; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Hannaert P, 2002, N-S ARCH PHARMACOL, V365, P193, DOI 10.1007/s00210-001-0521-y; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hasbargen T, 2010, ANN NY ACAD SCI, V1198, P168, DOI 10.1111/j.1749-6632.2010.05462.x; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Khazipov R, 2004, EUR J NEUROSCI, V19, P590, DOI 10.1111/j.0953-816X.2003.03152.x; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Nardou R, 2011, BRAIN, V134, P987, DOI 10.1093/brain/awr041; Nardou R, 2009, J NEUROPHYSIOL, V101, P2878, DOI 10.1152/jn.90761.2008; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Pallud J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008065; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Sipila ST, 2009, J NEUROSCI, V29, P6982, DOI 10.1523/JNEUROSCI.0443-09.2009; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; Topfer M, 2014, EUR J NEUROSCI, V39, P673, DOI 10.1111/ejn.12424; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471	55	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	FEB	2015	21	2			SI		173	180		10.1111/cns.12369			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CA3YL	WOS:000348841000011	25495911	Green Published, Green Accepted			2022-02-06	
J	Zhumadilov, A; Gilman, CP; Viderman, D				Zhumadilov, Agzam; Gilman, Charles P.; Viderman, Dmitriy			Management of super-refractory status epilepticus with isoflurane and hypothermia	FRONTIERS IN NEUROLOGY			English	Article						SRSE; epilepsy; hypothermia; isoflurane; neurotrauma; neurocritical care	PROPYLENE-GLYCOL TOXICITY; TEMPERATURE	Super-refractory status epilepticus (SRSE) is defined as status epilepticus that continues 24 h or more after the onset of anesthesia, and includes those cases in which epilepsy is recurrent upon treatment reduction. We describe the presentation and successful management of a male patient with SRSE using the inhaled anesthetic isoflurane, and mild hypothermia (HT). The potential utility of combined HT and volatile anesthesia is discussed.	[Zhumadilov, Agzam; Viderman, Dmitriy] Republican Res Ctr Emergency Care, Astana 010000, Kazakhstan; [Gilman, Charles P.] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan; [Viderman, Dmitriy] Nazarbayev Univ, Sch Med, Astana, Kazakhstan		Zhumadilov, A (corresponding author), Republican Res Ctr Emergency Care, Dept Anesthesiol & Crit Med, 3 Kerey,Zhanibek Khanov St, Astana 010000, Kazakhstan.	agzamzh@gmail.com	Viderman, Dmitriy/P-7902-2019				Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Corry JJ, 2008, NEUROCRIT CARE, V9, P189, DOI 10.1007/s12028-008-9092-9; Dabir Shideh, 2015, Asian Cardiovasc Thorac Ann, V23, P292, DOI 10.1177/0218492314551972; Fugate JE, 2010, ANESTH ANALG, V111, P1520, DOI 10.1213/ANE.0b013e3181f6da34; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Hofer CK, 2005, J THORAC CARDIOV SUR, V129, P838, DOI 10.1016/j.jtcvs.2004.07.002; Ikeda T, 1998, ANESTHESIOLOGY, V88, P866, DOI 10.1097/00000542-199804000-00004; Kimberger O, 2008, BEST PRACT RES-CLIN, V22, P729, DOI 10.1016/j.bpa.2007.11.002; Loh GW, 2010, CURR OPIN CRIT CARE, V16, P128, DOI 10.1097/MCC.0b013e3283374e3c; Maze M, 1994, ANESTHESIA; Mirsattari SM, 2004, ARCH NEUROL-CHICAGO, V61, P1254, DOI 10.1001/archneur.61.8.1254; Motamedi GK, 2013, EPILEPSIA, V54, P959, DOI 10.1111/epi.12144; Neligan A, 2010, ARCH NEUROL-CHICAGO, V67, P931, DOI 10.1001/archneurol.2010.169; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Penberthy LT, 2005, SEIZURE-EUR J EPILEP, V14, P46, DOI 10.1016/j.seizure.2004.06.001; Pillai U, 2014, AM J THER, V21, pE106, DOI 10.1097/MJT.0b013e31824c407d; Rosenow F, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2007.01359.x; Rossetti AO, 2011, EPILEPSIA, V52, P64, DOI 10.1111/j.1528-1167.2011.03241.x; Shorvon S, 2012, BRAIN, V135, P2314, DOI 10.1093/brain/aws091; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Wilson KC, 2005, CHEST, V128, P1674, DOI 10.1378/chest.128.3.1674	21	15	15	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 28	2015	5								286	10.3389/fneur.2014.00286			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU7TG	WOS:000363743900001	25674075	Green Submitted, Green Published, gold			2022-02-06	
J	Ao, BT; Tobias, M; Ameratunga, S; McPherson, K; Theadom, A; Dowell, A; Starkey, N; Jones, K; Barker-Collo, S; Brown, P; Feigin, V				Ao, Braden Te; Tobias, Martin; Ameratunga, Shanthi; McPherson, Kathryn; Theadom, Alice; Dowell, Anthony; Starkey, Nicola; Jones, Kelly; Barker-Collo, Suzanne; Brown, Paul; Feigin, Valery		BIONIC Study Grp	Burden of Traumatic Brain Injury in New Zealand: Incidence, Prevalence and Disability-Adjusted Life Years	NEUROEPIDEMIOLOGY			English	Article						Traumatic brain injury; Incidence; Prevalence; Disability-adjusted life years and DISMOD	GLOBAL BURDEN; SPECTRUM; OUTCOMES; DISEASE; REHABILITATION; EPIDEMIOLOGY; HEALTH; COSTS	Objective: The study aimed to estimate the incidence, prevalence and disability-adjusted life years (DALY) for traumatic brain injury (TBI) in New Zealand (NZ) in 2010. Methods: A multi-state life table model was constructed using inputs from the Brain Injury Outcomes New Zealand in the Community study for the first-ever incidence of TBI in a lifetime and its severity distribution, from the NZ Ministry of Health's Mortality Collection for the data on TBI mortality and from Statistics of NZ for the population data. The modeled estimate of prevalence was combined with the disability weights for TBI (by stage and severity level) from the Global Burden of Disease 2010 study to obtain estimates of health loss (DALYs) for TBI. Results: Approximately, 11,300 first-ever incident TBIs occurred in NZ during 2010, with 527,000 New Zealanders estimated to have ever experienced a TBI (prevalent cases). The estimated 20,300 DALYs attributable to TBI accounted for 27% of total injury-related health loss and 2.4% of DALYs from all causes. Of the total DALYs attributable to TBI, 71% resulted from fatal injuries. However, nonfatal outcomes accounted for a substantial share of the burden (29%) with mild TBI making the greater contribution of non-fatal outcomes (56%). Conclusions: The burden of TBI in NZ is substantial, and mild TBI contributes to a major part of non-fatal outcomes. (C) 2015 S. Karger AG, Basel	[Ao, Braden Te; Theadom, Alice; Jones, Kelly; Feigin, Valery] Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci, Auckland 1142, New Zealand; [Ao, Braden Te] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Publ Hlth & Psychosocial Studies, Dept Biostat & Epidemiol, Auckland 1142, New Zealand; [McPherson, Kathryn] Auckland Univ Technol, Fac Hlth & Environm Sci, Hlth & Rehabil Res Inst, Auckland 1142, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Tobias, Martin] Minist Hlth, Hlth & Disabil Intelligence, Wellington, New Zealand; [Dowell, Anthony] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand; [Starkey, Nicola] Univ Waikato, Fac Arts & Social Sci, Sch Psychol, Hamilton, New Zealand; [Brown, Paul] Univ Calif, Sch Social Sci Humanities & Arts, Merced, CA USA		Ao, BT (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci, Private Bag 92006, Auckland 1142, New Zealand.	braden.teao@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019	Starkey, Nicola/0000-0002-4370-8186; McPherson, Kathryn/0000-0003-1240-8882; Ameratunga, Shanthi/0000-0001-8042-2251; Te Ao, Braden/0000-0002-1050-200X; McPherson, Kath/0000-0003-0487-8497; Theadom, Alice/0000-0003-0351-6216; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand; Waikato-Tainui doctoral grant	We would like to acknowledge our collaborators on the Brain Injury Outcomes New Zealand in the Community (BIONIC) study for providing data for our analyses. We wish to thank the research assistants, members of the BIONIC Steering Committee, BIONIC study participants, their families and friends and the Health Research Council of NZ for Raiding the research program. Braden Te Ao was supported by a PhD fellowship from the Health Research Council of New Zealand and a Waikato-Tainui doctoral grant. We acknowledge with gratitude the intellectual leadership and disability weights provided by Christopher Murray and colleagues at the GBD project, Institute for Health Metrics and Evaluation, University of Washington.	Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Barendregt JJ, 2005, EUR J EPIDEMIOL, V20, P827, DOI 10.1007/s10654-005-2227-9; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Che G, 2000, AGE STANDARDIZATION; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; JENNETT B, 1975, LANCET, V1, P480; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Ministry of Health and Accident Compensation Corporation, 2013, REP NZ BURD DIS INJ; Ministry of Health (New Zealand) Ways and Means, 2012, REP METH NZ BURD DIS; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Roberts MG, 2001, IMA J MATH APPL MED, V18, P119; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746	24	15	15	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2015	44	4					255	261		10.1159/000431043			7	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	CO0CJ	WOS:000358817400007	26088707				2022-02-06	
J	Azouvi, P; Vallat-Azouvi, C; Millox, V; Darnoux, E; Ghout, I; Azerad, S; Ruet, A; Bayen, E; Pradat-Diehl, P; Aegerter, P; Weiss, JJ; Jourdan, C				Azouvi, Philippe; Vallat-Azouvi, Claire; Millox, Valerie; Darnoux, Emmanuelle; Ghout, Idir; Azerad, Sylvie; Ruet, Alexis; Bayen, Eleonore; Pradat-Diehl, Pascale; Aegerter, Philippe; Weiss, Jean-Jacques; Jourdan, Claire			Ecological validity of the Dysexecutive Questionnaire: Results from the PariS-TBI study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Everyday function; Assessment; Executive functions; Rehabilitation	TRAUMATIC BRAIN-INJURY; EXECUTIVE DYSFUNCTION; RASCH ANALYSIS; HEAD-INJURY; SCALE; REHABILITATION; RATINGS; SAMPLE; SELF; DEX	The Dysexecutive Questionnaire (DEX; Wilson, Pettigrew, & Teasdale, 1998) has been designed to assess executive dysfunctions in daily life. However, its relationships with cognitive testing, mood, and the ability to fulfil daily life demands, have not yet been systematically addressed. The objective of this study was to address these issues in a prospective four-year follow-up study of patients with severe traumatic brain injury (TBI) (PariS-TBI study). One hundred and forty seven patients were included. The DEX (self-version) showed a good internal consistency. The total DEX score was significantly inversely correlated with years of education, but did not significantly correlate with any initial injury severity measure. The DEX was significantly and positively related to cognitive deficits, as assessed with the Neurobehavioral Rating Scale-Revised (NRS-R); with mood disorders, as assessed with the Hospital Anxiety and Depression Scale (HADS); with dependency in elementary and extended activities of daily living; and with non-return to work. In multivariate analyses, cognitive and mood impairments were significantly and independently related to the total DEX score. These results suggest that the DEX is a multidetermined sensitive questionnaire to detect everyday life difficulties in patients with severe TBI at a chronic stage.	[Azouvi, Philippe; Ruet, Alexis; Jourdan, Claire] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Azouvi, Philippe; Vallat-Azouvi, Claire; Ruet, Alexis; Jourdan, Claire] Univ Versailles St Quentin, EA 4047, HANDIReSP, Versailles, France; [Vallat-Azouvi, Claire; Millox, Valerie] Hop Raymond Poincare, Antenne UEROS UGECAMIF SAMSAH92, Garches, France; [Darnoux, Emmanuelle; Azerad, Sylvie; Weiss, Jean-Jacques] CRFTC, Paris, France; [Darnoux, Emmanuelle; Ghout, Idir; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, F-75634 Paris, France; [Pradat-Diehl, Pascale] Univ Paris 06, Paris, France		Azouvi, P (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	philippe.azouvi@rpc.aphp.fr	AEGERTER, Philippe/AAY-6003-2021; RUET, Alexis/L-8726-2015	AEGERTER, Philippe/0000-0002-9156-5028; RUET, Alexis/0000-0002-5080-5734	French Ministry of Health [AOM04084]; AP-HP (Departement de la Recherche Clinique et du Developpement); Institut de Recherche en Sante Publique (IRESP)	The first part of this study (first year follow-up) was funded by a grant from the French Ministry of Health [Programme Hospitalier de Recherche Clinique 2004, AOM04084] and supported by AP-HP (Departement de la Recherche Clinique et du Developpement). The second part of this study (4-year follow-up) was funded by a grant from the Institut de Recherche en Sante Publique (IRESP).	Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cazalis F, 2001, J INT NEUROPSYCH SOC, V7, P795, DOI 10.1017/S1355617701777028; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MAHONEY F I, 1965, Md State Med J, V14, P61; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Mooney B, 2006, APPL NEUROPSYCHOL, V13, P12, DOI 10.1207/s15324826an1301_2; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simblett SK, 2012, NEUROPSYCHOL REHABIL, V22, P874, DOI 10.1080/09602011.2012.703956; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stuss D. T., 2007, HUMAN FRONTAL LOBES, V2, P292; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; Vallat-Azouvi C, 2012, NEUROPSYCHOL REHABIL, V22, P634, DOI 10.1080/09602011.2012.681110; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	15	15	2	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2015	25	6					864	878		10.1080/09602011.2014.990907			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DP1TC	WOS:000378271300004	25523796				2022-02-06	
J	Bigler, ED; Jantz, PB; Farrer, TJ; Abildskov, TJ; Dennis, M; Gerhardt, CA; Rubin, KH; Stancin, T; Taylor, HG; Vannatta, K; Yeates, KO				Bigler, Erin D.; Jantz, Paul B.; Farrer, Thomas J.; Abildskov, Tracy J.; Dennis, Maureen; Gerhardt, Cynthia A.; Rubin, Kenneth H.; Stancin, Terry; Taylor, H. Gerry; Vannatta, Kathryn; Yeates, Keith Owen			Day of injury CT and late MRI findings: Cognitive outcome in a paediatric sample with complicated mild traumatic brain injury	BRAIN INJURY			English	Article						Complicated mild traumatic brain injury; magnetic resonance imaging; neuropsychological outcome; paediatric	ACUTE EPIDURAL HEMATOMA; CHILDREN TEA-CH; EVERYDAY ATTENTION; ADOLESCENTS; PERFORMANCE; MANAGEMENT; ATROPHY; VOLUME; ADHD; COMA	Objectives: Complicated mild traumatic brain injury (mTBI) or cmTBI is based on the presence of visibly identifiable brain pathology on the day-of-injury computed tomography (CT) scan. In a paediatric sample the relation of DOI CT to late MRI findings and neuropsychological outcome was examined. Methods: MRI (>12 months) was obtained in paediatric cmTBI patients and a sample of orthopaedically injured (OI) children. Those children with positive imaging findings (MRI+) were quantitatively compared to those without (MRI-) or with the OI sample. Groups were also compared in neurocognitive outcome from WASI sub-tests and the WISC-IV Processing Speed Index (PSI), along with the Test of Everyday Attention for Children (TEA-Ch) and a parent-rated behavioural functioning measure (ABAS-II). Results: Despite the MRI+ group having significantly more DOI CT findings than the MRI- group, no quantitative differences were found. WASI Vocabulary and Matrix Reasoning scores were significantly lower, but not PSI, TEA-Ch or ABAS-II scores. MRI+ and MRI- groups did not differ on these measures. Conclusions: Heterogeneity in the occurrence of MRI-identified focal pathology was not associated with uniform changes in quantitative analyses of brain structure in cmTBI. Increased number of DOI CT abnormalities was associated with lowered neuropsychological performance.	[Bigler, Erin D.; Farrer, Thomas J.; Abildskov, Tracy J.] Brigham Young Univ, Ctr Neurosci, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Farrer, Thomas J.; Abildskov, Tracy J.] Brigham Young Univ, Magnet Resonance Imaging MRI Res Facil, Provo, UT 84602 USA; [Bigler, Erin D.; Farrer, Thomas J.; Abildskov, Tracy J.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Jantz, Paul B.] Texas State Univ, Sch Psychol Program, San Marcos, TX USA; [Dennis, Maureen] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Gerhardt, Cynthia A.; Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Stancin, Terry] Metro Hlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Cleveland, Div Dev Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada		Bigler, ED (corresponding author), Brigham Young Univ, Ctr Neurosci, Dept Psychol, 1001 Kimball Tower, Provo, UT 84602 USA.	erin_bigler@byu.edu	Yeates, Keith/AAJ-4223-2020; Vannatta, Kathryn/E-4237-2011; Rubin, Kenneth H/M-5276-2018; Stancin, Terry/L-7993-2019	Rubin, Kenneth H/0000-0002-2608-2484; Farrer, Thomas J./0000-0001-8092-6214; Yeates, Keith/0000-0001-7680-2892	NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R01HD048946, 3R01HD048946-05S1]; Poelman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	Erin D. Bigler does provide expert neuropsychological testimony in paediatric brain injury cases. No other conflicts of interest are declared by the other authors. The research presented in this manuscript was supported by NIH/NICHD Grant Numbers 5R01HD048946 and 3R01HD048946-05S1 titled 'Social Outcomes of Pediatric Traumatic Brain Injury'. Funding was also provided in part by the Poelman Foundation which supports the Brain Imaging and Behavior Laboratory at Brigham Young University.	[Anonymous], 2009, IBM SPSS STAT; [Anonymous], 1999, WECHSLER ABBREVIATED; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassin SL, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P174; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bigler E. D., 2012, PTSD MILD TRAUMATIC, P15; Bigler ED, 2007, BRAIN INJURY MED PRI, P201; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Fayol P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P497, DOI 10.1016/j.annrmp.2008.06.003; Gean AD, 1994, IMAGING HEAD TRAUMA; Gene AD, 1994, IMAGING HEAD TRAUMA; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1998, TEST EVERYDAY ATTENT; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Muhlau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029809; Ortega-Carnicer J, 2005, RESUSCITATION, V64, P119, DOI 10.1016/j.resuscitation.2004.08.010; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEASDALE G, 1974, LANCET, V2, P81; Ulrich PT, 2008, J CHILD NEUROL, V23, P1066, DOI 10.1177/0883073808315411; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D, 2003, WECHSLER INTELLIGENC; Wilde EA, 2012, NEUROREHABILITATION, V31, P245, DOI 10.3233/NRE-2012-0794; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zollman FS, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P1	50	15	15	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1062	1070		10.3109/02699052.2015.1011234			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000007	26186038	Green Accepted			2022-02-06	
J	Brown, AW; Watanabe, TK; Hoffman, JM; Bell, KR; Lucas, S; Dikmen, S				Brown, Allen W.; Watanabe, Thomas K.; Hoffman, Jeanne M.; Bell, Kathleen R.; Lucas, Sylvia; Dikmen, Sureyya			Headache After Traumatic Brain Injury: A National Survey of Clinical Practices and Treatment Approaches	PM&R			English	Article							PREVALENCE	Background: Individuals with headache after traumatic brain injury (TBI) receive care in a wide variety of clinical locations by physicians trained in multiple specialties. Objective: To understand current practice patterns and perceptions of treatment issues among clinicians managing headache after TBI. Design: National survey of current clinical practice using a 20-item questionnaire developed by the authors. Participants: Survey respondents were members of the Central Nervous System Council list survey of the American Academy of Physical Medicine and Rehabilitation (N = 1782) and the American Headache Society membership (N = 1260). Methods: The survey was sent electronically to potential participants and was followed by 2 biweekly reminders. The survey queried the physicians' clinical setting; their use of headache classification systems, headache diaries, checklists, and diagnostic procedures; the pharmacologic and nonpharmacologic treatments prescribed; and headache chronicity and associated symptoms and disorders among their patients with TBI. Results: Completed surveys were received from 193 respondents. The use of standardized classification systems and checklists was commonly reported. Respondents used nonpharmacologic and pharmacologic treatment approaches with similar frequency and modest perceived success rates. A high frequency of headache-associated new sleep and mood disorders was reported. When response differences occurred between practice settings, they reflected a focus on headache diagnosis, classification, and pharmacologic treatment among neurology and specialty headache clinics, whereas a nonpharmacologic approach to management among TBI specialty and general rehabilitation clinicians was more commonly reported. Conclusion: Management strategies for treating headache after TBI vary widely among general and specialty clinical practices. This suggests that additional research is needed that would lead to an increase in the use of established headache classification and the development of standardized management approaches so that all practitioners who care for patients after TBI can provide consistent effective care.	[Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Watanabe, Thomas K.] Moss Rehab, Dept Phys Med & Rehabil, Philadelphia, PA USA; [Hoffman, Jeanne M.; Bell, Kathleen R.; Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Lucas, Sylvia] Univ Washington, Dept Neurol, Seattle, WA 98195 USA		Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Bell, Kathleen/0000-0002-0928-2046; Brown, Allen W./0000-0001-7228-3351	Mayo Clinic NIDRR TBI Model System Center grant [H133A070013]; Moss Rehab NIDRR TBI Model System Center grant [H133A120037]; University of Washington NIDRR TBI Model System Center grant [H133A070032]	This work was supported by Mayo Clinic NIDRR TBI Model System Center grant H133A070013, Moss Rehab NIDRR TBI Model System Center grant H133A120037, and University of Washington NIDRR TBI Model System Center grant H133A070032.	Beithon J, 2013, DIAGNOSIS TREATMENT; D'Amico D, 2011, NEUROL SCI, V32, pS71, DOI 10.1007/s10072-011-0552-1; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Lipton RB, 2001, HEADACHE, V41, P854; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	13	15	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JAN	2015	7	1					3	8		10.1016/j.pmrj.2014.06.016			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AZ2CF	WOS:000348041500010	25019492				2022-02-06	
J	Hussmann, B; Heuer, M; Lefering, R; Touma, A; Schoeneberg, C; Keitel, J; Lendemans, S				Hussmann, Bjoern; Heuer, Matthias; Lefering, Rolf; Touma, Alexander; Schoeneberg, Carsten; Keitel, Judith; Lendemans, Sven			Prehospital Volume Therapy as an Independent Risk Factor after Trauma	BIOMED RESEARCH INTERNATIONAL			English	Article							FLUID RESUSCITATION; CLINICAL-COURSE; MANAGEMENT; MORTALITY; EPIDEMIOLOGY; REPLACEMENT; TRANSPORT; PATTERNS; SURVIVAL; DEATHS	Background. Prehospital volume therapy remains widely used after trauma, while evidence regarding its disadvantages is growing. The primary objective of this study was to investigate the volume administered in a prehospital setting as an independent risk factor for mortality. Material and Methods. Patients who met the following criteria were analyzed retrospectively: Injury Severity Score = 16, primary admission (between 2002 and 2010), and age = 16 years. The following data had to be available: volume administered (including packed red cells), blood pressure, Glasgow Coma Scale, therapeutic measures, and laboratory results. Following a univariate analysis, independent risk factors for mortality after trauma were investigated using a multivariate regression analysis. Results. A collective of 7,641 patients met the inclusion criteria, showing that increasing volumes administered in a prehospital setting were an independent risk factor for mortality (odds ratio: 1.34). This tendency was even more pronounced in patients without severe traumatic brain injury (TBI) (odds ratio: 2.71), while the opposite tendency was observed in patients with TBI. Conclusions. Prehospital volume therapy in patients without severe TBI represents an independent risk factor for mortality. In such cases, respiratory and circulatory conditions should be stabilized during permissive hypotension, and patient transfer should not be delayed.	[Hussmann, Bjoern; Schoeneberg, Carsten; Keitel, Judith; Lendemans, Sven] Alfried Krupp Hosp Essen, Trauma Surg Dept, D-45131 Essen, Germany; [Heuer, Matthias] Philippusstift Essen, Surg Dept, D-45355 Essen, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [Touma, Alexander] Univ Hosp Essen, Trauma Surg Dept, D-45147 Essen, Germany		Hussmann, B (corresponding author), Alfried Krupp Hosp Essen, Trauma Surg Dept, Alfried Krupp Str 21, D-45131 Essen, Germany.	bjoern.hussmann@krupp-krankenhaus.de	Schoeneberg, Carsten/AAS-9274-2021	Schoeneberg, Carsten/0000-0001-5633-1616			American College of Surgeons Committee on Trauma, 2008, ATLS STUD COURS MAN; Bickell W H, 1998, Curr Opin Anaesthesiol, V11, P177, DOI 10.1097/00001503-199804000-00010; BICKELL WH, 1991, SURGERY, V110, P529; BICKELL WH, 1993, ANN EMERG MED, V22, P225, DOI 10.1016/S0196-0644(05)80208-2; BICKELL WH, 1994, AM J EMERG MED, V12, P36, DOI 10.1016/0735-6757(94)90194-5; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; BRANAS CC, 1995, ACAD EMERG MED, V2, P486, DOI 10.1111/j.1553-2712.1995.tb03245.x; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Cornwell EE, 2000, ARCH SURG-CHICAGO, V135, P315, DOI 10.1001/archsurg.135.3.315; DALTON AM, 1995, J ROY SOC MED, V88, pP213; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; Demetriades D, 1996, ARCH SURG-CHICAGO, V131, P133; Dula David J, 2002, Prehosp Emerg Care, V6, P417, DOI 10.1080/10903120290938058; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Haut ER, 2011, ANN SURG, V253, P371, DOI 10.1097/SLA.0b013e318207c24f; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; Hubetamann Bjorn, 2011, J Emerg Trauma Shock, V4, P465, DOI 10.4103/0974-2700.86630; Hussmann B, 2011, UNFALLCHIRURG, V114, P705, DOI 10.1007/s00113-010-1842-4; Hussmann B, 2012, CRIT CARE, V16, DOI 10.1186/cc11809; Hussmann B, 2013, INJURY, V44, P611, DOI 10.1016/j.injury.2012.02.004; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; Lendemans S, 2004, UNFALLCHIRURG, V107, P203, DOI 10.1007/s00113-004-0729-7; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; OGORMAN M, 1989, J TRAUMA, V29, P84, DOI 10.1097/00005373-198901000-00017; Pepe Paul E, 2002, Prehosp Emerg Care, V6, P81, DOI 10.1080/10903120290938887; Riddez L, 1998, J TRAUMA, V44, P433, DOI 10.1097/00005373-199803000-00001; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sloan EP, 2015, PREHOSP DISASTER MED, V30, P54, DOI 10.1017/S1049023X14001174; SLOVIS CM, 1990, AM J EMERG MED, V8, P305, DOI 10.1016/0735-6757(90)90080-J; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Soudry E, 2004, ISR MED ASSOC J, V6, P485; Talving P, 2005, PREHOSP DISASTER MED, V20, P228, DOI 10.1017/S1049023X00002582; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Turner J, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4310; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	38	15	15	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								354367	10.1155/2015/354367			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CG3NU	WOS:000353187700001	25949995	gold, Green Published, Green Submitted			2022-02-06	
J	Kim, SH; Saver, JL				Kim, Seo Hyun; Saver, Jeffrey L.			Initial Body Temperature in Ischemic Stroke Nonpotentiation of Tissue-Type Plasminogen Activator Benefit and Inverse Association With Severity	STROKE			English	Article						body temperature; outcome measures; stroke; tissue-type plasminogen activator	TRAUMATIC BRAIN-INJURY; THROMBOLYSIS; HYPOTHERMIA; TPA; ALTEPLASE; OUTCOMES; TRIALS; SIZE	Background and Purpose-Body temperature (BT) is an important physiological factor in acute ischemic stroke. However, the relationship of initial BT to stroke severity and degree of benefit from thrombolytic therapy has been delineated incompletely. Methods-We analyzed the public data set of the 2 National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator (tPA) stroke trials, comparing patients with lower (<37.0 degrees C) and higher (=37.0 degrees C) presenting BT. Results-Among 595 patients (297 placebo and 298 tPA treated) with documented initial BT, 77.1% had initial BT <37.0 degrees C and 22.9% >= 37.0 degrees C. Patients with higher initial BT had lower baseline stroke severity in both tPA-treated patients (the National Institute of Health Stroke Scale median, 11 versus 15; P=0.05) and placebo-treated patients (median, 13 versus 16; P<0.01). Patients with higher initial BT also had lower infarction volume on computed tomography at 3 months in both tPA-treated patients (median, 9.6 versus 16.7 cm(3); P=0.08) and placebo-treated patients (median, 13.1 versus 28.1 cm(3); P=0.02), but no clinical outcome differences. Analysis of lytic treatment effect found no heterogeneity in the degree of tPA benefit in both higher and lower BT groups (>= 37.0 degrees C: odds ratio for the modified Rankin Scale 0-1 outcome, 2.55; 95% confidence interval, 1.05-6.21 and <37.0 degrees C: odds ratio, 2.30; 95% confidence interval, 1.38-3.84; heterogeneity P=0.83). Conclusions-In patients with hyperacute stroke, higher presenting temperatures are associated with less severe neurological deficits and reduced final infarct volumes. Presenting temperature does not modify the benefit of tPA on 3-month favorable outcome.	[Kim, Seo Hyun] Yonsei Univ, Wonju Coll Med, Dept Neurol, Wonju, South Korea; [Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Stroke Ctr, Dept Neurol, Los Angeles, CA 90095 USA		Saver, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Stroke Ctr, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@mednet.ucla.edu		Saver, Jeffrey/0000-0001-9141-2251	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS044364] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS044364, U01 NS44364] Funding Source: Medline		Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Dabzl D, 2012, HARRISONS PRINCIPLES; de Ridder I, 2013, CEREBROVASC DIS, V35, P60, DOI 10.1159/000345335; de Ridder IR, 2013, INT J STROKE; Ernon L, 2006, ACTA NEUROL SCAND, V114, P23, DOI 10.1111/j.1600-0404.2006.00596.x; Hilz MJ, 2011, STROKE, V42, P1528, DOI 10.1161/STROKEAHA.110.607721; Idicula Titto T, 2008, J Stroke Cerebrovasc Dis, V17, P141, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.010; Karaszewski B, 2013, J CEREBR BLOOD F MET, V33, P1083, DOI 10.1038/jcbfm.2013.52; Karaszewski B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-123; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Kvistad CE, 2014, ACTA NEUROL SCAND, V129, P325, DOI 10.1111/ane.12184; Kvistad CE, 2012, VASC HEALTH RISK MAN, V8, P333, DOI 10.2147/VHRM.S31614; Kvistad CE, 2014, VASC HEALTH RISK MAN, V10, P49, DOI 10.2147/VHRM.S55423; Kvistad CE, 2013, VASC HEALTH RISK MAN, V9, P297, DOI 10.2147/VHRM.S44570; Lees JS, 2011, STROKE, V42, P2618, DOI 10.1161/STROKEAHA.110.611210; Levine SR, 2000, STROKE, V31, P2912; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Millan M, 2008, EUR J NEUROL, V15, P1384, DOI 10.1111/j.1468-1331.2008.02321.x; Naess H, 2010, ACTA NEUROL SCAND, V122, P414, DOI 10.1111/j.1600-0404.2010.01331.x; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Saver JL, 2007, STROKE, V38, P414, DOI 10.1161/01.STR.0000254580.39297.3c; Shaw GJ, 2007, PHYS MED BIOL, V52, P2953, DOI 10.1088/0031-9155/52/11/002; Shaw GJ, 2006, THROMB RES, V117, P603, DOI 10.1016/j.thromres.2005.05.005; Steiner AA, 2002, ANNU REV PHYSIOL, V64, P263, DOI 10.1146/annurev.physiol.64.081501.155856; Takagi K, 2003, J NEUROSURG, V98, P50, DOI 10.3171/jns.2003.98.1.0050; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; YENARI MA, 1995, THROMB RES, V77, P475, DOI 10.1016/0049-3848(95)93883-2	30	15	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	2015	46	1					132	136		10.1161/STROKEAHA.114.006107			5	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1XB	WOS:000346735800036	25424482	Green Accepted, Bronze			2022-02-06	
J	Lam, C; Lin, MR; Chu, SF; Tsai, SH; Bai, CH; Chiu, WT				Lam, Carlos; Lin, Mau-Roung; Chu, Shu-Fen; Tsai, Shin-Han; Bai, Chyi-Huey; Chiu, Wen-Ta			The Effect of Various Types of Motorcycle Helmets on Cervical Spine Injury in Head Injury Patients: A Multicenter Study in Taiwan	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; RISK; PATTERNS; NECK	Introduction. The relationship between cervical spine injury (CSI) and helmet in head injury (HI) patients following motorcycle crashes is crucial. Controversy still exists; therefore we evaluated the effect of various types of helmets on CSI in HI patients following motorcycle crashes and researched the mechanism of this effect. Patients and Methods. A total of 5225 patients of motorcycle crashes between 2000 and 2009 were extracted from the Head Injury Registry in Taiwan. These patients were divided into case and control groups according to the presence of concomitant CSI. Helmet use and types were separately compared between the two groups and the odds ratio of CSI was obtained by using multiple logistic regression analysis. Results. We observed that 173 (3.3%) of the HI patients were associated with CSI. The HI patients using a helmet (odds ratio (OR) = 0.31, 95% confidence interval (CI) = 0.19-0.49), full-coverage helmet (0.19, 0.10-0.36), and partial-coverage helmet (0.35, 0.21-0.56) exhibited a significantly decreased rate of CSI compared with those without a helmet. Conclusion. Wearing full-coverage and partial-coverage helmets significantly reduced the risk of CSI among HI patients following motorcycle crashes. This effect may be due to the smooth surface and hard padding materials of helmet.	[Lam, Carlos] Taipei Med Univ, Wan Fang Hosp, Dept Crit & Emergency Med, Taipei 116, Taiwan; [Lam, Carlos; Lin, Mau-Roung; Tsai, Shin-Han; Chiu, Wen-Ta] Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan; [Chu, Shu-Fen] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei 235, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Dept Emergency Med, Coll Med, Taipei 110, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Taipei 110, Taiwan; [Bai, Chyi-Huey] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei 110, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 116, Taiwan		Chiu, WT (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	wtchiu@tmu.edu.tw		Lam, Carlos/0000-0002-8051-7485	Department of Health, Executive Yuan [DOH100-TD-B-111-003]; National Health Research InstituteNational Health Research Institutes - Taiwan [NHRI-EX100-9707PI]	This study was financially supported by the Department of Health, Executive Yuan (Grant No. DOH100-TD-B-111-003) and National Health Research Institute (Grant No. NHRI-EX100-9707PI). The authors would like to thank Ta-Chien Chan and Chia-Kun Chang for providing assistance with this study. They are grateful for the assistance provided by the following 25 hospitals: National Taiwan University Hospital, Taipei Veterans General Hospital, Taipei Cathay General Hospital, Taipei City Hospital Renai Branch, Chung-Shan Hospital, Country Hospital, West Garden Hospital, Pojen General Hospital, Central Clinic Hospital, Taipei Mackay Memorial Hospital, Taipei City Hospital Heping Branch, Taipei City Hospital Yang-Ming Branch, Taipei City Hospital Zhongxing Branch, Songshan Armed Forces General Hospital, Taipei City Hospital Zhongxiao Branch, Taipei Jen-Chi Hospital, Taipei Medical University Hospital, TMU-Wan Fang Hospital, TMU-Shuang Ho Hospital, Tri-Service General Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Buddhist Tzu Chi General Hospital (Hualien), Mennonite Cherish Hospital, Hua-Lien Hospital, and Hualien Armed Forces General Hospital.	Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; BACHULIS BL, 1988, AM J SURG, V155, P708, DOI 10.1016/S0002-9610(88)80151-X; Camacho DLA, 1999, J BIOMECH, V32, P293, DOI 10.1016/S0021-9290(98)00178-X; Camacho DLA, 2001, J BIOMECH ENG-T ASME, V123, P432, DOI 10.1115/1.1389086; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Chu D, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-137; Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Goslar PW, 2008, J TRAUMA, V64, P190, DOI 10.1097/TA.0b013e3180f62eec; Health Promotion Administration and Ministry of Health and Welfare; (Republic of China), 2014, NATL HLTH INT SURV; Hitosugi M, 2004, AM J FOREN MED PATH, V25, P125, DOI 10.1097/01.paf.0000127397.67081.f5; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Japan Automobile Manufacturers Association and INC, 2013, MOT IND JAP 2011; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Lam C, 2011, ASIA-PAC J PUBLIC HE, V23, P957, DOI 10.1177/1010539510364669; Lee HY, 2010, AM J PUBLIC HEALTH, V100, P165, DOI 10.2105/AJPH.2008.159004; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Lin MR, 2004, NEUROEPIDEMIOLOGY, V23, P269, DOI 10.1159/000080091; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Ministry of Transportation and Communications of the Republic of China, 2014, STAT TRANSP COMM COU; Moskal A, 2008, INJURY PREV, V14, P238, DOI 10.1136/ip.2007.018093; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Nightingale RW, 1997, SPINE, V22, P2380, DOI 10.1097/00007632-199710150-00012; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; Piatt JH, 2006, J NEUROSURG-SPINE, V5, P210, DOI 10.3171/spi.2006.5.3.210; Robertson A, 2002, J TRAUMA, V53, P5, DOI 10.1097/00005373-200207000-00002; SINHA AK, 1995, INJURY, V26, P543, DOI 10.1016/0020-1383(95)00078-N; Sun JC, 2012, TRAFFIC INJ PREV, V13, P519, DOI 10.1080/15389588.2012.656857; Tian HL, 2009, J TRAUMA, V67, P1305, DOI 10.1097/TA.0b013e31819db57c; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; TSAI YJ, 1995, AM J EPIDEMIOL, V142, P974, DOI 10.1093/oxfordjournals.aje.a117746; Van Camp L A, 1998, Eur J Emerg Med, V5, P207; YEO JD, 1979, MED J AUSTRALIA, V2, P381, DOI 10.5694/j.1326-5377.1979.tb104193.x	37	15	16	0	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								487985	10.1155/2015/487985			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CB5VE	WOS:000349694900001	25705663	gold, Green Published			2022-02-06	
J	Lauterbach, MD; Notarangelo, PL; Nichols, SJ; Lane, KS; Koliatsos, VE				Lauterbach, Margo D.; Notarangelo, Paula L.; Nichols, Stephen J.; Lane, Kristy S.; Koliatsos, Vassilis E.			Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						traumatic brain injury; neurobehavioral; treatment	FOLLOW-UP; AXIS-I; DEPRESSION; DISORDERS; AGGRESSION; MOOD	Traumatic brain injury (TBI) causes a variety of neuropsychiatric problems that pose diagnostic and treatment challenges for providers. In this report, we share our experience as a referral neuropsychiatry program to assist the general psychiatrist when adult TBI patients with psychiatric symptoms present for evaluation and treatment. We completed a retrospective study of patients with moderate-to-severe TBI and severe neuropsychiatric impairments. We collected information on demographics, nature of injury, symptomatology, diagnoses, and treatments. Data analysis indicates that mood stabilization was a key concern, often requiring aggressive pharmacological management. Cognitive dysfunction was a problem for the majority of patients, but was only medicated in a third, due to poor efficacy or behavioral side effects. The co-occurrence of multiple TBI-related symptoms and diagnoses in this patient cohort emphasizes the need for individualized psychopharmacological approaches and interventions.	[Lauterbach, Margo D.; Notarangelo, Paula L.; Lane, Kristy S.; Koliatsos, Vassilis E.] Sheppard Pratt Hlth Syst, Neuropsychiat Program Sheppard Pratt, Baltimore, MD 21285 USA; [Nichols, Stephen J.] Univ Tennessee, Coll Med Chattanooga, Dept Emergency Med, Chattanooga, TN USA		Lauterbach, MD (corresponding author), Sheppard Pratt Hlth Syst, Neuropsychiat Program Sheppard Pratt, 6501 North Charles St,POB 6815, Baltimore, MD 21285 USA.	mlauterbach@sheppardpratt.org			Leonard and Helen R. Stulman Charitable Foundation; Women's Hospital Foundation, Inc.	The authors are supported by the Leonard and Helen R. Stulman Charitable Foundation and the Women's Hospital Foundation, Inc. Dr Lauterbach is a one-third owner of Brain Educators, LLC, publishers of The Brain Card (R). The authors report no other conflicts of interest in this work.	Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Deb S, 1999, AM J PSYCHIAT, V156, P374; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Silver JM, 2011, TXB TRAUMATIC BRAIN, P234; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	32	15	15	1	10	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						1601	1607		10.2147/NDT.S80457			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CM3KL	WOS:000357580800001	26170672	Green Published, Green Submitted, gold			2022-02-06	
J	Requejo, PS; Furumasu, J; Mulroy, SJ				Requejo, Philip S.; Furumasu, Jan; Mulroy, Sara J.			Evidence-Based Strategies for Preserving Mobility for Elderly and Aging Manual Wheelchair Users	TOPICS IN GERIATRIC REHABILITATION			English	Article						elderly and aging; evidenced-based practice; functional mobility; manual wheelchair; pain and dysfunction; quality of life; seating and positioning	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; SHOULDER JOINT KINETICS; TRAUMATIC BRAIN-INJURY; ARM DRIVE WHEELCHAIRS; UPPER EXTREMITY PAIN; UPPER-LIMB FUNCTION; PHYSICAL-ACTIVITY; INTERNATIONAL-CLASSIFICATION; MECHANICAL EFFICIENCY	Elderly and aging manual wheelchair users have an increased risk for accelerated loss of function and mobility that greatly limits independence and affects quality of life. This review addresses important issues for preserving function and mobility among elderly and aging individuals who use a manual wheelchair by presenting the current available evidence and recommendations. These include recommendations for maximizing function by decreasing pain, improving the ability to self-propel, and prolonging mobility and endurance through ergonomics, individualized wheelchair selection and configuration, and adaptations for increasing the capacity to handle the daily mobility demands through training, strengthening, and exercise. Each recommendation is supported by current research in each relevant area.	[Requejo, Philip S.; Furumasu, Jan; Mulroy, Sara J.] Rancho Los Amigos Natl Rehabil Ctr, Phys Therapy Dept, Downey, CA 90242 USA; [Requejo, Philip S.] Rancho Los Amigos Natl Rehabil Ctr, Rehabil Engn Program, Downey, CA 90242 USA; [Requejo, Philip S.; Mulroy, Sara J.] Rancho Los Amigos Natl Rehabil Ctr, Pathokinesiol Lab, Downey, CA 90242 USA		Requejo, PS (corresponding author), Rancho Los Amigos Natl Rehabil Ctr, Rehabil Engn Program, Downey, CA 90242 USA.	prequejo@dhs.lacounty.gov			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD049774] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD049774] Funding Source: NIH RePORTER		A Man-Made World, 2011, ECONOMIST; Ahmed Mohamed S, 2005, Phys Med Rehabil Clin N Am, V16, P19, DOI 10.1016/j.pmr.2004.06.017; Aissaoui R, 2002, AM J PHYS MED REHAB, V81, P94, DOI 10.1097/00002060-200202000-00004; Aissaoui R, 2001, ARCH PHYS MED REHAB, V82, P274, DOI 10.1053/apmr.2001.19473; Algood SD, 2004, ARCH PHYS MED REHAB, V85, P1865, DOI 10.1016/j.apmr.2004.04.043; Allam AM, 2013, PM&R, V5, P957, DOI 10.1016/j.pmrj.2013.05.015; Allen R, 2002, CLIN REHABIL, V16, P329, DOI 10.1191/0269215502cr499oa; Allison GT, 1996, DISABIL REHABIL, V18, P35, DOI 10.3109/09638289609167087; Alm M, 2008, J REHABIL MED, V40, P277, DOI 10.2340/16501977-0173; Ambrosio F, 2005, J SPINAL CORD MED, V28, P407, DOI 10.1080/10790268.2005.11753840; Ambrosio F, 2007, J REHABIL RES DEV, V44, P693, DOI 10.1682/JRRD.2006.02.0016; Andersen JH, 2002, SPINE, V27, P660; Arva J, 2001, MED ENG PHYS, V23, P699, DOI 10.1016/S1350-4533(01)00054-6; ASATO KT, 1993, IEEE T BIO-MED ENG, V40, P1320, DOI 10.1109/10.250587; Ataoglu E, 2013, SPINAL CORD, V51, P23, DOI 10.1038/sc.2012.51; Ballinger DA, 2000, ARCH PHYS MED REHAB, V81, P1575, DOI 10.1053/apmr.2000.18216; BAR CA, 1991, PROSTHET ORTHOT INT, V15, P232; Bashton D, 2012, DISABIL REHABIL-ASSI, V7, P75, DOI 10.3109/17483107.2011.574247; Bauer SM, 2011, DISABIL REHABIL-ASSI, V6, P243, DOI 10.3109/17483107.2010.529631; BAYLEY JC, 1987, J BONE JOINT SURG AM, V69A, P676, DOI 10.2106/00004623-198769050-00006; Beekman CE, 1999, PHYS THER, V79, P146, DOI 10.1093/ptj/79.2.146; Ben Mortenson W, 2012, J AM GERIATR SOC, V60, P1310, DOI 10.1111/j.1532-5415.2012.04038.x; Berven S, 2002, SEMIN NEUROL, V22, P167, DOI 10.1055/s-2002-36540; Bolin I, 2000, SPINAL CORD, V38, P425, DOI 10.1038/sj.sc.3101031; Bombardier CH, 2010, PHYS MED REH CLIN N, V21, P281, DOI 10.1016/j.pmr.2009.12.005; Boninger Michael L, 2013, Arch Phys Med Rehabil, V94, P2579, DOI 10.1016/j.apmr.2013.04.007; Boninger ML, 1997, AM J PHYS MED REHAB, V76, P420, DOI 10.1097/00002060-199709000-00013; Boninger ML, 2000, ARCH PHYS MED REHAB, V81, P608, DOI 10.1053/mr.2000.1455; Boninger ML, 1998, ARCH PHYS MED REHAB, V79, P1577, DOI 10.1016/S0003-9993(98)90424-5; Brasil, 2005, CONS CRED REV ISS PA, P1; Brault, 2012, CURRENT POPULATION R, VP70; Brault M. W, 2010, AM DISABILITIES 2010; Brienza D, 2010, J AM GERIATR SOC, V58, P2308, DOI 10.1111/j.1532-5415.2010.03168.x; Brienza DM, 1996, IEEE T REHABIL ENG, V4, P320, DOI 10.1109/86.547933; Brubaker C E, 1986, J Rehabil Res Dev, V23, P55; Buchholz AC, 2003, OBES RES, V11, P563, DOI 10.1038/oby.2003.79; Buchholz AC, 2009, APPL PHYSIOL NUTR ME, V34, P640, DOI 10.1139/H09-050; Burns SP, 1999, ARCH PHYS MED REHAB, V80, P566, DOI 10.1016/S0003-9993(99)90201-0; Byrne DW, 1996, SPINAL CORD, V34, P255, DOI 10.1038/sc.1996.46; Capoor Jaishree, 2005, Phys Med Rehabil Clin N Am, V16, P129, DOI 10.1016/j.pmr.2004.06.016; Chang FH, 2012, ARCH PHYS MED REHAB, V93, P2264, DOI 10.1016/j.apmr.2012.06.008; Charbonneau R, 2013, ARCH PHYS MED REHAB, V94, P1707, DOI 10.1016/j.apmr.2013.03.001; Charlifue S, 2010, PHYS MED REH CLIN N, V21, P383, DOI 10.1016/j.pmr.2009.12.002; Chen YY, 2005, ARCH PHYS MED REHAB, V86, P1208, DOI 10.1016/j.apmr.2004.12.023; Chow JW, 2009, ARCH PHYS MED REHAB, V90, P271, DOI 10.1016/j.apmr.2008.07.019; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Cohen RB, 1998, CLIN ORTHOP RELAT R, P95; Cooper RA, 1997, ARCH PHYS MED REHAB, V78, P1138, DOI 10.1016/S0003-9993(97)90141-6; Cooper RA, 1999, AM J PHYS MED REHAB, V78, P435, DOI 10.1097/00002060-199909000-00006; Cooper RA, 2001, ARCH PHYS MED REHAB, V82, P702, DOI 10.1053/apmr.2001.20836; Cooper RA, 1999, ARCH PHYS MED REHAB, V80, P462, DOI 10.1016/S0003-9993(99)90287-3; Cooper RA, 1996, J REHABIL RES DEV, V33, P45; Cowan R., 2007, MANUAL WHEELCHAIR PR; Cowan RE, 2009, ARCH PHYS MED REHAB, V90, P1076, DOI 10.1016/j.apmr.2008.10.034; Crawford A, 2008, DISABIL HEALTH J, V1, P7, DOI 10.1016/j.dhjo.2007.11.004; CRIMMINS EM, 1994, DEMOGRAPHY, V31, P159, DOI 10.2307/2061913; CRON L, 1993, AM J OCCUP THER, V47, P141, DOI 10.5014/ajot.47.2.141; CURTIS KA, 1995, PARAPLEGIA, V33, P290, DOI 10.1038/sc.1995.65; Curtis KA, 1999, ARCH PHYS MED REHAB, V80, P453, DOI 10.1016/S0003-9993(99)90285-X; Dallmeijer AJ, 2005, J REHABIL RES DEV, V42, P55, DOI 10.1682/JRRD.2004.08.0081; Dallmeijer AJ, 2004, SPINAL CORD, V42, P91, DOI 10.1038/sj.sc.3101566; Dalyan M, 1999, SPINAL CORD, V37, P191, DOI 10.1038/sj.sc.3100802; Davis JL, 1998, J REHABIL RES DEV, V35, P61; de Groot S, 2008, CLIN BIOMECH, V23, P434, DOI 10.1016/j.clinbiomech.2007.11.001; de Groot S, 2004, AM J PHYS MED REHAB, V83, P640, DOI 10.1097/01.phm.0000133437.58810.c6; de Groot S, 2002, MED SCI SPORT EXER, V34, P756, DOI 10.1097/00005768-200205000-00005; de Groot S, 2013, MED ENG PHYS, V35, P1476, DOI 10.1016/j.medengphy.2013.03.019; Desroches G, 2008, ARCH PHYS MED REHAB, V89, P1155, DOI 10.1016/j.apmr.2007.10.040; Dyson-Hudson TA, 2004, J SPINAL CORD MED, V27, P4, DOI 10.1080/10790268.2004.11753724; Fay BT, 2002, MED ENG PHYS, V24, P375, DOI 10.1016/S1350-4533(02)00037-1; Finlayson M, 2001, AM J OCCUP THER, V55, P545, DOI 10.5014/ajot.55.5.545; Finley MA, 2005, CLIN BIOMECH, V20, P32, DOI 10.1016/j.clinbiomech.2004.06.011; Fitzgerald SG, 2001, ARCH PHYS MED REHAB, V82, P1484, DOI 10.1053/apmr.2001.26139; Fliess-Douer O, 2012, ARCH PHYS MED REHAB, V93, P629, DOI 10.1016/j.apmr.2011.11.017; Forslund EB, 2007, SPINAL CORD, V45, P41, DOI 10.1038/sj.sc.3101935; Frost P, 2002, AM J IND MED, V41, P11, DOI 10.1002/ajim.10019; Gagnon D, 2005, SPINAL CORD, V43, P74, DOI 10.1038/sj.sc.3101660; Gagnon D, 2003, CLIN BIOMECH, V18, P319, DOI 10.1016/S0268-0033(03)00016-0; Gagnon D, 2008, J BIOMECH, V41, P1104, DOI 10.1016/j.jbiomech.2007.11.021; Gagnon D, 2009, J ELECTROMYOGR KINES, V19, P509, DOI 10.1016/j.jelekin.2007.12.005; Ganesh S, 2007, ARCH PHYS MED REHAB, V88, P434, DOI 10.1016/j.apmr.2006.12.045; GARBER SL, 1984, ARCH PHYS MED REHAB, V65, P579; GARG A, 1991, ERGONOMICS, V34, P289, DOI 10.1080/00140139108967314; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Gebrosky B, 2013, J REHABIL RES DEV, V50, P1373, DOI 10.1682/JRRD.2012.08.0155; Gefen A, 2014, OSTOMY WOUND MANAG, V60, P34; GELLMAN H, 1988, CLIN ORTHOP RELAT R, P132; GERHART KA, 1993, ARCH PHYS MED REHAB, V74, P1030, DOI 10.1016/0003-9993(93)90057-H; Ginis KAM, 2010, SPINAL CORD, V48, P65, DOI 10.1038/sc.2009.87; Ginn KA, 1997, PHYS THER, V77, P802, DOI 10.1093/ptj/77.8.802; Ginn KA, 2004, ARCH PHYS MED REHAB, V85, P1231, DOI 10.1016/j.apmr.2003.09.013; Groah SL, 2002, ARCH PHYS MED REHAB, V83, pS82, DOI 10.1053/apmr.2002.32182; Groah SL, 2012, AM J PHYS MED REHAB, V91, P80, DOI 10.1097/PHM.0b013e31821f70bc; Gronley JK, 2000, J REHABIL RES DEV, V37, P423; Gutierrez DD, 2005, J SPINAL CORD MED, V28, P222, DOI 10.1080/10790268.2005.11753816; Gutierrez DD, 2007, J SPINAL CORD MED, V30, P251, DOI 10.1080/10790268.2007.11753933; Harms M., 1990, PHYSIOTHERAPY, V76, P266; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P500, DOI 10.1053/mr.2000.3788; Hastings J, 2004, PHYS MED REH CLIN N, V15, P699, DOI DOI 10.1016/J.PMR.2003.12.005; Hastings Jennifer, 2004, Phys Med Rehabil Clin N Am, V15, P699; Haubert L.L., 2005, TOP SPINAL CORD INJ, V11, P64, DOI [10.1310/AX2M-7QBY-UVQP-C218, DOI 10.1310/AX2M-7QBY-UVQP-C218]; HILBERS PA, 1987, PHYS THER, V67, P1355, DOI 10.1093/ptj/67.9.1355; Hoenig H, 2003, AM J PUBLIC HEALTH, V93, P330, DOI 10.2105/AJPH.93.2.330; HOENIG H, 2004, ANN LONG TERM CARE, V12, P12; HOLDEN JM, 1988, APPL ERGON, V19, P281, DOI 10.1016/0003-6870(88)90075-0; Hosseini SM, 2012, ARCH PHYS MED REHAB, V93, P2237, DOI 10.1016/j.apmr.2012.05.021; Hsieh CC, 2011, ASSIST TECHNOL, V23, P1, DOI 10.1080/10400435.2010.541404; ITOI E, 1992, CLIN ORTHOP RELAT R, P165; JANSSEN TWJ, 1994, MED SCI SPORT EXER, V26, P661, DOI 10.1249/00005768-199406000-00002; Janssen-Potten YJM, 2000, ARCH PHYS MED REHAB, V81, P401, DOI 10.1053/mr.2000.3859; Karmarkar AM, 2012, ASSIST TECHNOL, V24, P155, DOI 10.1080/10400435.2012.659795; Kataoka M, 2012, SPINAL CORD, V50, P440, DOI 10.1038/sc.2011.170; KAYE HS, 2002, WHEELCHAIR USE US, P1; Kemp BJ., 2004, AGING DISABILITY WHA; Kemp BJ, 2005, PHYS MED REH CLIN N, V16, pvii; Kemp BJ., 2001, TOP SPINAL CORD INJ, V6, P116, DOI [10.1310/L8TF-65XD-8K1U-UE3M, DOI 10.1310/L8TF-65XD-8K1U-UE3M]; Kemp Bryan J, 2005, Phys Med Rehabil Clin N Am, V16, P1, DOI 10.1016/j.pmr.2004.06.009; Kernozek TW, 1998, ARCH PHYS MED REHAB, V79, P313, DOI 10.1016/S0003-9993(98)90012-0; Kilkens OJE, 2003, CLIN REHABIL, V17, P418, DOI 10.1191/0269215503cr633oa; Kirby RL, 2002, ARCH PHYS MED REHAB, V83, P10, DOI 10.1053/apmr.2002.26823; Koontz A, 2012, DISABIL REHABIL-ASSI, V7, P20, DOI 10.3109/17483107.2011.553983; Koontz AM, 2011, J REHABIL RES DEV, V48, P1015, DOI 10.1682/JRRD.2010.09.0169; Koontz AM, 2009, ARCH PHYS MED REHAB, V90, P1916, DOI 10.1016/j.apmr.2009.05.022; Koontz AM, 2005, J REHABIL RES DEV, V42, P447, DOI 10.1682/JRRD.2004.08.0106; Koontz AM, 2002, J REHABIL RES DEV, V39, P635; Kotajarvi BR, 2004, J REHABIL RES DEV, V41, P403, DOI 10.1682/JRRD.2003.01.0008; Kulig K, 1998, CLIN ORTHOP RELAT R, P132, DOI 10.1097/00003086-199809000-00016; Kulig K, 2001, CLIN BIOMECH, V16, P744, DOI 10.1016/S0268-0033(01)00066-3; Kwarciak AM, 2012, DISABIL REHABIL-ASSI, V7, P459, DOI 10.3109/17483107.2011.650781; Lalumiere M, 2013, J ELECTROMYOGR KINES, V23, P1434, DOI 10.1016/j.jelekin.2013.06.009; Lee Y, 2008, INT J GERIATR PSYCH, V23, P249, DOI 10.1002/gps.1870; Levy CE, 2004, ARCH PHYS MED REHAB, V85, P104, DOI 10.1016/S0003-9993(03)00426-X; Liu HY, 2010, J REHABIL RES DEV, V47, P441, DOI 10.1682/JRRD.2009.08.0137; Liu HY, 2008, J REHABIL RES DEV, V45, P1251, DOI 10.1682/JRRD.2007.12.0204; Louis N, 2010, CLIN BIOMECH, V25, P879, DOI 10.1016/j.clinbiomech.2010.07.002; Lukersmith S, 2013, AUST OCCUP THER J, V60, P378, DOI 10.1111/1440-1630.12077; LUNDQVIST C, 1991, SPINE, V16, P78, DOI 10.1097/00007632-199101000-00014; Mandy A, 2014, DISABIL REHABIL-ASSI, V9, P242, DOI 10.3109/17483107.2013.782575; Mandy A, 2007, DISABIL REHABIL-ASSI, V2, P255, DOI 10.1080/17483100701343624; Mao HF, 2006, ARCH PHYS MED REHAB, V87, P764, DOI 10.1016/j.apmr.2006.02.029; Margolis DJ, 2002, ANN EPIDEMIOL, V12, P321, DOI 10.1016/S1047-2797(01)00255-1; MASSE LC, 1992, J REHABIL RES DEV, V29, P12, DOI 10.1682/JRRD.1992.07.0012; McCarthy RE, 1999, ORTHOP CLIN N AM, V30, P435, DOI 10.1016/S0030-5898(05)70096-1; McCasland LD, 2006, JCR-J CLIN RHEUMATOL, V12, P179, DOI 10.1097/01.rhu.0000230532.54403.25; McClure PW, 2004, PHYS THER, V84, P832, DOI 10.1093/ptj/84.9.832; McGlinchey-Berroth R, 1995, J Spinal Cord Med, V18, P183; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1402, DOI 10.1016/S0003-9993(99)90251-4; MCLAURIN CA, 1991, PROSTHET ORTHOT INT, V15, P24; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; MENTER RR, 1991, PARAPLEGIA, V29, P613, DOI 10.1038/sc.1991.90; Miller L, 2000, J GERONTOL NURS, V26, P46; Mortenson WB, 2007, DISABIL REHABIL-ASSI, V2, P275, DOI 10.1080/17483100701475863; Mortenson WB, 2008, ARCH PHYS MED REHAB, V89, P1177, DOI 10.1016/j.apmr.2008.01.010; Mulroy SJ, 2011, PHYS THER, V91, P1766, DOI 10.2522/ptj.20110024; Mulroy SJ, 2004, ARCH PHYS MED REHAB, V85, P925, DOI 10.1016/j.apmr.2003.08.090; Mulroy SJ, 1996, ARCH PHYS MED REHAB, V77, P187, DOI 10.1016/S0003-9993(96)90166-5; Nash MS, 2008, ARCH PHYS MED REHAB, V89, P2080, DOI 10.1016/j.apmr.2008.05.018; Nawoczenski DA, 2012, ARCH PHYS MED REHAB, V93, P1421, DOI 10.1016/j.apmr.2012.02.034; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Newsam CJ, 2003, J SPINAL CORD MED, V26, P59, DOI 10.1080/10790268.2003.11753662; Newsam CJ, 1999, GAIT POSTURE, V10, P223, DOI 10.1016/S0966-6362(99)00034-X; NIESING R, 1990, MED BIOL ENG COMPUT, V28, P329, DOI 10.1007/BF02446151; Noonan VK, 2009, DISABIL REHABIL, V31, P1883, DOI 10.1080/09638280902846947; Paralyzed Veterans of America Consortium for Spinal Cord Medicine, 2005, J Spinal Cord Med, V28, P434; Patel J, 2011, CLIN ORTHOP RELAT R, V469, P1302, DOI 10.1007/s11999-010-1687-8; Payne LZ, 1997, AM J SPORT MED, V25, P801, DOI 10.1177/036354659702500612; PENTLAND W, 1995, PARAPLEGIA, V33, P367, DOI 10.1038/sc.1995.84; PENTLAND WE, 1994, PARAPLEGIA, V32, P219, DOI 10.1038/sc.1994.41; PERKS BA, 1994, J REHABIL RES DEV, V31, P297; Perry J, 1996, ARCH PHYS MED REHAB, V77, P350, DOI 10.1016/S0003-9993(96)90083-0; Phillips AA, 2011, SPINAL CORD, V49, P702, DOI 10.1038/sc.2010.193; Putzke JD, 2002, PAIN, V100, P231, DOI 10.1016/S0304-3959(02)00069-6; Rader J, 2000, J Gerontol Nurs, V26, P24; Rae MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000822; Ragnarsson KT, 2012, AM J PHYS MED REHAB, V91, P231, DOI 10.1097/PHM.0b013e3182489f5e; Rao S S, 1996, IEEE Trans Rehabil Eng, V4, P152, DOI 10.1109/86.536770; REDFORD JB, 1993, ARCH PHYS MED REHAB, V74, P877, DOI 10.1016/0003-9993(93)90016-4; Rejeski WJ, 2008, GERIATR GERONTOL INT, V8, P48, DOI 10.1111/j.1447-0594.2008.00446.x; Requejo P, 2008, TOP SPINAL CORD INJ, V13, P86, DOI DOI 10.1310/SCI1304-86; Requejo PS, 2007, J SPIN CORD MED TAMP; REYES ML, 1995, ARCH PHYS MED REHAB, V76, P433, DOI 10.1016/S0003-9993(95)80572-9; Rice LA, 2014, ARCH PHYS MED REHAB, V95, P10, DOI 10.1016/j.apmr.2013.06.028; Rice LA, 2013, ARCH PHYS MED REHAB, V94, P1230, DOI 10.1016/j.apmr.2013.03.008; Richter WM, 2007, ARCH PHYS MED REHAB, V88, P76, DOI 10.1016/j.apmr.2006.09.015; RODGERS MM, 1994, ARCH PHYS MED REHAB, V75, P85; Rodgers MM, 2003, J REHABIL RES DEV, V40, P27, DOI 10.1682/JRRD.2003.01.0027; RODRIGUEZ GP, 1989, ARCH PHYS MED REHAB, V70, P442, DOI 10.1016/0003-9993(89)90003-8; RODRIGUEZ GP, 1986, ARCH PHYS MED REHAB, V67, P177, DOI 10.1016/0003-9993(86)90073-0; Rousseau-Harrison K, 2009, DISABIL REHABIL-ASSI, V4, P344, DOI 10.1080/17483100903038550; Rushton PW, 2010, SPINAL CORD, V48, P691, DOI 10.1038/sc.2009.197; Sakakibara BM, 2013, ARCH PHYS MED REHAB, V94, P1031, DOI 10.1016/j.apmr.2013.01.016; Salisbury SK, 2006, SPINAL CORD, V44, P723, DOI 10.1038/sj.sc.3101908; SANDERSON DJ, 1985, J BIOMECH, V18, P423, DOI 10.1016/0021-9290(85)90277-5; Sawatzky BJ, 2004, ERGONOMICS, V47, P1475, DOI 10.1080/00140130412331290862; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; SHARKEY NA, 1995, AM J SPORT MED, V23, P270, DOI 10.1177/036354659502300303; Shields Margot, 2004, Health Rep, V15, P37; SIE IH, 1992, ARCH PHYS MED REHAB, V73, P44; Souza A, 2010, J REHABIL RES DEV, V47, P213, DOI 10.1682/JRRD.2009.07.0096; Steel EJ, 2012, AM J PHYS MED REHAB, V91, pS55, DOI 10.1097/PHM.0b013e31823d4ee6; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599; Szlachcic Y, 2007, J SPINAL CORD MED, V30, P473, DOI 10.1080/10790268.2007.11754580; Tam EW, 2003, ARCH PHYS MED REHAB, V84, P1466, DOI 10.1016/S0003-9993(03)00269-7; Thompson L, 1999, ASSIST TECHNOL, V11, P123, DOI 10.1080/10400435.1999.10131996; THOMPSON WG, 1990, RHEUM DIS CLIN N AM, V16, P803; Trefler E, 2004, ASSIST TECHNOL, V16, P18, DOI 10.1080/10400435.2004.10132071; Ulin S S, 1997, SCI Nurs, V14, P19; US Department of Health and Human Services Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO, pC; van der Woude L H, 1989, J Rehabil Res Dev, V26, P31; van der Woude LHV, 2009, J REHABIL MED, V41, P143, DOI 10.2340/16501977-0296; van Drongelen S, 2005, ARCH PHYS MED REHAB, V86, P1214, DOI 10.1016/j.apmr.2004.09.023; VANDERWOUDE LHV, 1995, J MED ENG TECHNOL, V19, P123, DOI 10.3109/03091909509012418; Varcin-Coad L, 1998, AAOHN J, V46, P530; VIDAL J, 1991, PARAPLEGIA, V29, P261, DOI 10.1038/sc.1991.37; Vissers M, 2008, J REHABIL MED, V40, P461, DOI 10.2340/16501977-0191; Walter JS, 2002, J REHABIL RES DEV, V39, P53; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Warms CA, 2008, DISABIL HEALTH J, V1, P236, DOI 10.1016/j.dhjo.2008.07.002; WATERS RL, 1985, J BONE JOINT SURG AM, V67A, P1245, DOI 10.2106/00004623-198567080-00016; World Health Organization, 2001, INT CLASS FUNCT DIS, P229; Wu HW, 1998, J BIOMECH ENG-T ASME, V120, P533, DOI 10.1115/1.2798024; Wu S.Y., 2000, PROJECTION CHRONIC I; Yassi A, 2001, SPINE, V26, P1739, DOI 10.1097/00007632-200108150-00002; [No title captured]	226	15	15	1	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0882-7524	1550-2414		TOP GERIATR REHABIL	Top. Geriatr. Rehabil.	JAN-MAR	2015	31	1					26	41		10.1097/TGR.0000000000000042			16	Gerontology; Rehabilitation	Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Rehabilitation	AZ0SK	WOS:000347954700005	26366040	Green Accepted			2022-02-06	
J	Souvenir, R; Doycheva, D; Zhang, JH; Tang, JP				Souvenir, Rhonda; Doycheva, Desislava; Zhang, John H.; Tang, Jiping			Erythropoietin in Stroke Therapy: Friend or Foe	CURRENT MEDICINAL CHEMISTRY			English	Article						Erythropoietin signaling; janus kinase 2; signal transducers and activators of transcription 3	RECOMBINANT-HUMAN-ERYTHROPOIETIN; FOCAL CEREBRAL-ISCHEMIA; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; NEONATAL HYPOXIA-ISCHEMIA; HIGH-DOSE ERYTHROPOIETIN; NEURAL PROGENITOR CELLS; NITRIC-OXIDE FORMATION; IN-VITRO MODEL	Recombinant human erythropoietin (rhEPO), over the past decade, was hailed as an auspicious therapeutic strategy for various types of brain injuries. The promising results from experiments conducted in animal models of stroke led to a hurried clinical trial that was swiftly aborted in Phase II. The multiple neuroprotective modalities of rhEPO failed to translate smoothly to human adult ischemic brain injury and provided limited aid to neonates. In light of the antithetical results, several questions were raised as to why and how this clinical trial failed. There was bolstering evidence from the preliminary studies that pointed to a bright future. Therefore, the objective of this review is to address these questions by discussing the signaling pathways of rhEPO that are reported to mediate the neuroprotective effect in various animal models of brain injury. Major biomedical bibliographical databases (MEDLINE, ISI, PubMed, and Cochrane Library) were searched with the use of keywords such as erythropoietin, stroke, neonatal hypoxia ischemia, intracerebral hemorrhage, etc. This article will discuss the confounding factors that influence the efficacy of rhEPO treatment hence challenging its clinical translatability. Lastly, rhEPO may still be a promising therapeutic candidate for neonates in spite of its shortcoming in clinical trial if caution is taken with the dose and duration of its administration.	[Souvenir, Rhonda] Loma Linda Univ, Sch Med, Dept Mol Genet & Microbiol, Loma Linda, CA 92350 USA; [Souvenir, Rhonda; Doycheva, Desislava; Zhang, John H.; Tang, Jiping] Loma Linda Univ, Dept Physiol & Pharmacol, Sch Med, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92350 USA		Tang, JP (corresponding author), Loma Linda Univ, Dept Physiol & Pharmacol, Sch Med, Loma Linda, CA 92350 USA.	jtang@llu.edu		Doycheva, Desislava/0000-0001-7795-5989; Souvenir, Rhonda/0000-0002-8880-2483	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060936, NS053407]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060936, R01NS053407] Funding Source: NIH RePORTER	This review was supported by NIH NS060936 to Tang and NIH NS053407 to Zhang.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Benders MJ, 2014, J PEDIATR-US, V164, P481, DOI 10.1016/j.jpeds.2013.10.084; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bugno M, 1995, NUCLEIC ACIDS RES, V23, P5041, DOI 10.1093/nar/23.24.5041; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Cao Yiting, 2010, Genes Cancer, V1, P50; Caro J, 1988, Contrib Nephrol, V66, P54; Casals-Pascual C, 2009, TRENDS PARASITOL, V25, P30, DOI 10.1016/j.pt.2008.10.002; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chau M, 2011, ACTA NEUROCHIR SUPPL, V111, P299, DOI 10.1007/978-3-7091-0693-8_50; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Cheng XA, 2011, NEUROSCI LETT, V493, P18, DOI 10.1016/j.neulet.2011.02.006; Chi OZ, 2008, PHARMACOLOGY, V82, P38, DOI 10.1159/000127839; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; DEARDEN NM, 1985, LANCET, V2, P255; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fan Q, 2006, EXP HEMATOL, V34, P1303, DOI 10.1016/j.exphem.2006.05.012; Fan XY, 2011, PEDIATR RES, V69, P56, DOI 10.1203/PDR.0b013e3181fcbef3; Fauchere JC, 2008, PEDIATRICS, V122, P375, DOI 10.1542/peds.2007-2591; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; Gonzalez FF, 2009, DEV NEUROSCI-BASEL, V31, P403, DOI 10.1159/000232558; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; Grasso G, 2002, J NEUROSURG, V96, P565, DOI 10.3171/jns.2002.96.3.0565; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; He Jin-Shui, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P586; Helbok R, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-32; Ihle J N, 1995, Semin Immunol, V7, P247, DOI 10.1006/smim.1995.0029; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Juul SE, 2008, PEDIATRICS, V122, P383, DOI 10.1542/peds.2007-2711; Kadri Z, 2000, CELL GROWTH DIFFER, V11, P573; Kanaan NM, 2006, BRAIN RES, V1068, P221, DOI 10.1016/j.brainres.2005.10.078; Kaplan N, 1996, ARCH BIOCHEM BIOPHYS, V326, P271, DOI 10.1006/abbi.1996.0076; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Kobayashi T, 2002, BIOCHEM BIOPH RES CO, V296, P145, DOI 10.1016/S0006-291X(02)00832-X; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Kumral A, 2004, BIOL NEONATE, V85, P51, DOI 10.1159/000074958; Kumral A, 2003, BIOL NEONATE, V84, P325, DOI 10.1159/000073642; Lacombe C, 1999, NEPHROL DIAL TRANSPL, V14, P22, DOI 10.1093/ndt/14.suppl_2.22; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Magnanti M, 2001, BLOOD, V98, P2872, DOI 10.1182/blood.V98.9.2872; Masuda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE1038, DOI 10.1152/ajpendo.2000.278.6.E1038; McPherson RJ, 2010, CURR OPIN PEDIATR, V22, P139, DOI 10.1097/MOP.0b013e328336eb57; Meyer MP, 2003, ARCH DIS CHILD-FETAL, V88, P41; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Rhee JS, 2004, CANCER RES, V64, P952, DOI 10.1158/0008-5472.CAN-03-2445; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Sattler MB, 2004, CELL DEATH DIFFER, V11, pS181, DOI 10.1038/sj.cdd.4401504; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SHUAI K, 1992, SCIENCE, V258, P1808, DOI 10.1126/science.1281555; SIESJO BK, 1985, J TOXICOL-CLIN TOXIC, V23, P267, DOI 10.3109/15563658508990634; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Sola A, 2005, PEDIATR RES, V57, P481, DOI 10.1203/01.PDR.0000155760.88664.06; Souvenir R, 2014, TRANSL STROKE RES, V5, P118, DOI 10.1007/s12975-013-0312-z; Souvenir R, 2011, NEUROBIOL DIS, V44, P28, DOI 10.1016/j.nbd.2011.05.020; Springborg JB, 2003, BRAIN RES, V984, P143, DOI 10.1016/S0006-8993(03)03124-X; Studer L, 2000, J NEUROSCI, V20, P7377; Sun Y, 2005, STROKE, V36, P1672, DOI 10.1161/01.STR.0000173406.04891.8c; Sun Y, 2004, J CEREBR BLOOD F MET, V24, P259, DOI 10.1097/01.WCB.0000110049.43905.AC; TAYLOR JE, 1994, CLIN NEPHROL, V41, P297; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tseng MY, 2010, J NEUROSURG, V112, P1235, DOI 10.3171/2009.10.JNS09954; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Worthmann H, 2013, STROKE, V44, P2128, DOI 10.1161/STROKEAHA.113.001145; Wu H, 1999, DEVELOPMENT, V126, P3597; Wu XC, 1999, EXP PHYSIOL, V84, P917; Wu XC, 1999, CLIN SCI, V97, P413, DOI 10.1042/CS19990055; Xiong T, 2011, INT J DEV NEUROSCI, V29, P583, DOI 10.1016/j.ijdevneu.2010.12.007; Yeo EJ, 2008, ANN HEMATOL, V87, P11, DOI 10.1007/s00277-007-0359-6; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816; Zhang L, 2010, PLOS ONE, V5	105	15	16	0	9	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2015	22	10					1205	1213		10.2174/0929867322666150114152134			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CD5WW	WOS:000351160400006	25620101	Green Accepted			2022-02-06	
J	Stenberg, M; Godbolt, AK; De Boussard, CN; Levi, R; Stalnacke, BM				Stenberg, Maud; Godbolt, Alison K.; De Boussard, Catharina Nygren; Levi, Richard; Stalnacke, Britt-Marie			Cognitive Impairment after Severe Traumatic Brain Injury, Clinical Course and Impact on Outcome: A Swedish-Icelandic Study	BEHAVIOURAL NEUROLOGY			English	Article							HIGHER CEREBRAL FUNCTIONS; NEUROLOGICAL-INSTITUTE SCREEN; DEPRESSION SCALE; HOSPITAL ANXIETY; SELF-AWARENESS; CARE PATHWAYS; HEAD-INJURY; BNI SCREEN; VALIDITY; POPULATION	Objective. To assess the clinical course of cognitive and emotional impairments in patients with severe TBI (sTBI) from 3 weeks to 1 year after trauma and to study associations with outcomes at 1 year. Methods. Prospective, multicenter, observational study of sTBI in Sweden and Iceland. Patients aged 18-65 years with acute Glasgow Coma Scale 3-8 were assessed with the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS) and the Hospital Anxiety and Depression Scale (HADS). Outcome measures were Glasgow Outcome Scale Extended (GOSE) and Rancho Los Amigos Cognitive Scale-Revised (RLAS-R). Results. Cognition was assessed with the BNIS assessed for 42 patients out of 100 at 3 weeks, 75 patients at 3 months, and 78 patients at 1 year. Cognition improved over time, especially from 3 weeks to 3 months. The BNIS subscales "orientation" and "visuospatial and visual problem solving" were associated with the GOSE and RLAS-R at 1 year. Conclusion. Cognition seemed to improve over time after sTBI and appeared to be rather stable from 3 months to 1 year. Since cognitive function was associated with outcomes, these results indicate that early screening of cognitive function could be of importance for rehabilitation planning in a clinical setting.	[Stenberg, Maud; Levi, Richard; Stalnacke, Britt-Marie] Umea Univ, Rehabil Med, Dept Community Med & Rehabil, S-90185 Umea, Sweden; [Godbolt, Alison K.; De Boussard, Catharina Nygren] Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden; [Godbolt, Alison K.; De Boussard, Catharina Nygren] Danderyd Hosp, Univ Dept Rehabil Med Stockholm, S-18288 Stockholm, Sweden		Stenberg, M (corresponding author), Umea Univ, Rehabil Med, Dept Community Med & Rehabil, S-90185 Umea, Sweden.	maud.stenberg@rehabmed.umu.se	Stenberg, Maud/AAX-4366-2021		AFA Insurance [060833, 130095]; Uppsala University Hospital; Danderyd Hospital; Umea University Hospital	The authors thank the patients and their relatives, the PRO-BRAIN collaborators, the clinical staff of their units, and their neurosurgical colleagues who allowed recruitment of their patients. They also thank Dr. Anna Tolli, Danderyd Hospital and Karolinska Institute; Dr. Kristina Lindgren, Karlstad Hospital; Dr. Bjorn Johansson, University Hospital Uppsala; and Dr. Christer Tengvar, University Hospital Uppsala, who assisted in assessment of patients. Paramedical staff contributing to the study included Stina Gunnarsson and Marina Bystrom Odhe (Linkoping), Anna-Lisa Nilsson (Umea), Marie Sandgren (Stockholm), Staffan Stenson (Uppsala), and Siv Svensson (Gothenburg). Seija Lund was nurse coordinator in Stockholmand Ingrid Morberg in Gothenburg. PRO-BRAIN collaborators are AKG, CND, Professor Jorgen Borg, Department of Clinical Sciences, Karolinska Institute, and University Department of Rehabilitation Medicine Stockholm, Danderyd Hospital, Stockholm, Sweden; Dr. Marie Lindgren, Department of Clinical Rehabilitation Medicine, County Council, Linkoping, Sweden; Dr. Gudrun Karlsdottir, Department of Rehabilitation Medicine, Landspitalinn, University Hospital, Reykjavik, Iceland; Dr. Trandur Ulfarsson, MD, Department of Rehabilitation Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden; and Dr. Marianne Lannsjo, Department of Neuroscience, Uppsala University and Department of Rehabilitation Medicine, Gavle and Sandviken Hospital, Sweden. This study was supported by Grants 060833 and 130095 from AFA Insurance and from ALF-grants from Uppsala University Hospital, Danderyd Hospital, and Umea University Hospital.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Borgaro SR, 2003, J HEAD TRAUMA REHAB, V18, P284, DOI 10.1097/00001199-200305000-00006; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Denvall V., 2008, BNI SCREEN HIGHER CE; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Hagen C, 1987, REHABILITATION HEAD; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Hung CI, 2012, INT J PSYCHIAT CLIN, V16, P33, DOI 10.3109/13651501.2011.617456; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Knottnerus AM, 2007, CLIN REHABIL, V21, P805, DOI 10.1177/0269215507079129; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Prigatano G., 1991, BNI Q, V7, P2; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TEASDALE G, 1974, LANCET, V2, P81; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	15	15	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								680308	10.1155/2015/680308			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ1FA	WOS:000366850100001	26783381	Green Published, gold, Green Submitted			2022-02-06	
J	Johnson, BN; Palmer, CP; Bourgeois, EB; Elkind, JA; Putnam, BJ; Cohen, AS				Johnson, Brian N.; Palmer, Chris P.; Bourgeois, Elliot B.; Elkind, Jaclynn A.; Putnam, Brendan J.; Cohen, Akiva S.			Augmented inhibition from cannabinoid-sensitive interneurons diminishes CA1 output after traurnatic brain injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						interneuron; traumatic brain injury; CA1; cholecystokinin; cannabinoid type 1 receptor; action potential; lateral fluid percussion; voltage-sensitive dye	GABAERGIC NEURONS; PYRAMIDAL NEURONS; AXON TERMINALS; GABA RELEASE; RECEPTOR; RAT; CB1; DEPOLARIZATION; HIPPOCAMPUS; SUPPRESSION	The neurological impairments associated with traumatic brain injury include learning and memory deficits and increased risk of seizures. The hippocampus is critically involved in both of these phenomena and highly susceptible to damage by traumatic brain injury. To examine network activity in the hippocampal CA1 region after lateral fluid percussion injury, we used a combination of voltage-sensitive dye, field potential, and patch clamp recording in mouse hippocampal brain slices. When the stratum radiatum (SR) was stimulated in slices from injured mice, we found decreased depolarization in SR and increased hyperpolarization in stratum oriens (SO), together with a decrease in the percentage of pyramidal neurons firing stimulus-evoked action potentials. Increased hyperpolarization in SO persisted when glutamatergic transmission was blocked. However, we found no changes in SO responses when the alveus was stimulated to directly activate SO. These results suggest that the increased SO hyperpolarization evoked by SR stimulation was mediated by interneurons that have cell bodies and/or axons in SR, and form synapses in stratum pyramidale and SO. A low concentration (100 nM) of the synthetic cannabinoid WIN55,212-2, restored CA1 output in slices from injured animals. These findings support the hypothesis that increased GABAergic signaling by cannabinoid-sensitive interneurons contributes to the reduced CA1 output following traumatic brain injury.	[Johnson, Brian N.; Elkind, Jaclynn A.; Putnam, Brendan J.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Palmer, Chris P.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Bourgeois, Elliot B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Cohen, Akiva S.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA		Cohen, AS (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Res Inst, Room 814,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 HD59288, RO1 NS069629]; Foerderer Foundation grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER	This work was supported in part by NIH grants R37 HD59288 and RO1 NS069629, and a Foerderer Foundation grant. The authors thank Colin Smith, Catherine Kopil, Eric Marsh, Michael Schell, Les Satin and Diego Contreras for critiquing an earlier draft of the manuscript.	Ameri A, 1999, BRIT J PHARMACOL, V126, P1831, DOI 10.1038/sj.bjp.0702478; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Basu J, 2013, NEURON, V79, P1208, DOI 10.1016/j.neuron.2013.07.001; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Cave C B, 1991, Hippocampus, V1, P329, DOI 10.1002/hipo.450010323; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Fink AE, 2009, J NEUROSCI, V29, P11203, DOI 10.1523/JNEUROSCI.1450-09.2009; Foldy C, 2010, NAT NEUROSCI, V13, P1047, DOI 10.1038/nn.2609; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Haller J, 2007, EUR J NEUROSCI, V25, P2445, DOI 10.1111/j.1460-9568.2007.05476.x; Hoffman AF, 2005, EUR J NEUROSCI, V22, P2387, DOI 10.1111/j.1460-9568.2005.04401.x; Hoffman AF, 2007, LEARN MEMORY, V14, P63, DOI 10.1101/lm.439007; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kojima S, 1999, J NEUROSCI, V19, P2580; KONNERTH A, 1987, J PHYSIOL-LONDON, V393, P681, DOI 10.1113/jphysiol.1987.sp016848; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Lee SH, 2010, J NEUROSCI, V30, P7993, DOI 10.1523/JNEUROSCI.6238-09.2010; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Minge D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026664; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Oz M, 2006, PHARMACOL THERAPEUT, V111, P114, DOI 10.1016/j.pharmthera.2005.09.009; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shen MX, 1998, BRAIN RES, V783, P77, DOI 10.1016/S0006-8993(97)01195-5; Shepherd GM, 2004, SYNAPTIC ORG BRAIN, V5; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takacs VT, 2015, BRAIN STRUCT FUNCT, V220, P919, DOI 10.1007/s00429-013-0692-6; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tyzio R, 2008, EUR J NEUROSCI, V27, P2515, DOI 10.1111/j.1460-9568.2008.06234.x; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wykes R, 2012, NEUROBIOL AGING, V33, P1609, DOI 10.1016/j.neurobiolaging.2011.05.001; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610	61	15	15	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	DEC 19	2014	8								435	10.3389/fncel.2014.00435			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX9RQ	WOS:000347240100001	25565968	Green Published, gold			2022-02-06	
J	McBride, DW; Szu, JI; Hale, C; Hsu, MS; Rodgers, VGJ; Binder, DK				McBride, Devin W.; Szu, Jenny I.; Hale, Chris; Hsu, Mike S.; Rodgers, Victor G. J.; Binder, Devin K.			Reduction of Cerebral Edema after Traumatic Brain Injury Using an Osmotic Transport Device	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; direct osmotherapy; osmotic transport device; cerebral edema; hollow fiber-hydrogel device	INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; PRESSURE; SERUM; MANNITOL; SALINE	Traumatic brain injury (TBI) is significant, from a public health standpoint, because it is a major cause of the morbidity and mortality of young people. Cerebral edema after a TBI, if untreated, can lead to devastating damage of the remaining tissue. The current therapies of severe TBI (sTBI), as outlined by the Brain Trauma Foundation, are often ineffective, thus a new method for the treatment of sTBI is necessary. Herein, the reduction of cerebral edema, after TBI, using an osmotic transport device (OTD) was evaluated. Controlled cortical impact (CCI) was performed on adult female CD-1 mice, and cerebral edema was allowed to form for 3 h, followed by 2 h of treatment. The treatment groups were craniectomy only, craniectomy with a hydrogel, OTD without bovine serum albumin (BSA), and OTD. After CCI, brain water content was significantly higher for animals treated with a craniectomy only, craniectomy with a hydrogel, and OTD without BSA, compared to that of control animals. However, when TBI animals were treated with an OTD, brain water content was not significantly higher than that of controls. Further, brain water content of TBI animals treated with an OTD was significantly reduced, compared to that of untreated TBI animals, TBI animals treated with a craniectomy and a hydrogel, and TBI animals treated with an OTD without BSA. Here, we demonstrate the successful reduction of cerebral edema, as determined by brain water content, after TBI using an OTD. These results demonstrate proof of principle for direct water extraction from edematous brain tissue by direct osmotherapy using an OTD.	[McBride, Devin W.; Hale, Chris; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Grp Biotransport & Bioreact Kinet Grp B2K, Riverside, CA 92521 USA; [McBride, Devin W.; Hale, Chris; Rodgers, Victor G. J.] Univ Calif Riverside, Ctr Bioengn Res, Riverside, CA 92521 USA; [Szu, Jenny I.; Hsu, Mike S.; Binder, Devin K.] Univ Calif Riverside, Sch Med, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [Szu, Jenny I.; Hsu, Mike S.; Binder, Devin K.] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA		Binder, DK (corresponding author), Univ Calif Riverside, Div Biomed Sci, 1247 Webber Hall, Riverside, CA 92521 USA.	dbinder@ucr.edu	Rodgers, Victor G/G-3652-2016; Rodgers, Victor G. J./AAF-3838-2021	Rodgers, Victor G/0000-0002-1857-8025; Rodgers, Victor G. J./0000-0002-1857-8025	National Institutes of Health (NIH K08 grant)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-059674]; NSF IGERT Video Bioinformatics FellowshipNational Science Foundation (NSF) [DGE 0903667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS059674] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (NIH K08 grant NS-059674; to D.K.B.). D.W.M. was supported by an NSF IGERT Video Bioinformatics Fellowship (grant no.: DGE 0903667). All ongoing studies are being carried out on protocols approved by the institutional animal care and use committee of the University of California Riverside. Portions of this work were presented in abstract form and poster/oral form at UC Neurotrauma, September 9, 2012; Neurotrauma 2012, July 25, 2012; and The 13th Annual UC Systemwide Bioengineering Symposium at University of California Berkeley, June 22, 2012.	BINGAMAN WE, 1995, NEUROL CLIN, V13, P479, DOI 10.1016/S0733-8619(18)30031-8; Buccola J. R., 2010, SIGNIFICANCE CHOICE; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castillo LB, 2009, CRIT CARE RESUSC, V11, P151; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CSENKER E, 1982, ARCH PSYCHIAT NERVEN, V231, P251, DOI 10.1007/BF00343295; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gill AS, 2011, J NEUROSURG, V114, P470, DOI 10.3171/2010.2.JNS091017; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; Kettenmann H., 2005, NEUROGLIA, V2nd ed.; Keyrouz SG, 2008, NEUROCRIT CARE, V9, P204, DOI 10.1007/s12028-008-9118-3; Marmarou A, 2003, ACT NEUR S, V86, P7; McBride D. W., 2013, THESIS U CALIFORNIA; McBride DW, 2012, J NEUROSURG, V116, P1389, DOI 10.3171/2012.2.JNS111540; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Truskey G.A., 2004, TRANSPORT PHENOMENA; VILKER VL, 1981, J COLLOID INTERF SCI, V79, P548, DOI 10.1016/0021-9797(81)90106-5; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Yousef MA, 1998, J COLLOID INTERF SCI, V207, P273, DOI 10.1006/jcis.1998.5789; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	25	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2014	31	23					1948	1954		10.1089/neu.2014.3439			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AT6US	WOS:000345075500008	24959845	Green Submitted, Green Published			2022-02-06	
J	Pasiali, V; LaGasse, AB; Penn, SL				Pasiali, Varvara; LaGasse, A. Blythe; Penn, Saundra L.			The Effect of Musical Attention Control Training (MACT) on Attention Skills of Adolescents with Neurodevelopmental Delays: A Pilot Study	JOURNAL OF MUSIC THERAPY			English	Article						attention; autism spectrum disorders; music therapy; neurodevelopmental disorder	TRAUMATIC BRAIN-INJURY; SPECTRUM DISORDERS; CHILDREN; AUTISM; PERFORMANCE; NETWORKS; DEFICITS; THERAPY; ADHD; RESPONSIVENESS	Background: Given the effect of musical training on the rate and accuracy of processing auditory information, therapeutic uses of music may potentially have remedial benefits for individuals with neurodevelopmental deficits. However, additional studies are needed to establish efficacy of music therapy interventions for attention skills in children/adolescents with neurodevelopmental disabilities including those with Autism Spectrum Disorders (ASD). Objective: To establish feasibility and preliminary efficacy of a group music therapy protocol to improve attention skills (sustained, selective, attentional control/switching) in adolescents diagnosed with autism and/or developmental delays. Methods: This single group pretest/posttest study took place in a private school for high functioning adolescents with neurodevelopmental delays. Nine students (4 males, 5 females), ages 13 to 20, participated in the study. Autism severity was assessed using the CARS2-HF and indicated the following distribution for study participants: severe (n = 3), mild (n = 4), or minimal/no (n = 2) symptoms. We assessed feasibility of implementing a 45-min Musical Attention Control Training (MACT) intervention delivered by a board-certified music therapist eight times over 6 weeks in a school setting. We also examined preliminary efficacy of the MACT to improve attention skills using the Test of Everyday Attention for Children (TEA-Ch). Results: Parental consent rate was 100%. All nine participants successfully completed testing measures and 6 weeks of the intervention. Average participation rate was 97%. Data analysis showed positive trends and improvements on measures of attentional control/switching and selective attention. Conclusions: The results showed that the intervention and testing measures were feasible to implement and acceptable to the participants who all completed the protocol. Data analysis demonstrated positive trends indicating that more research on the use of music therapy attention training in high-functioning adolescents with neurodevelopmental disabilities is warranted.	[Pasiali, Varvara; Penn, Saundra L.] Queens Univ Charlotte, Charlotte, NC 28274 USA; [LaGasse, A. Blythe] Colorado State Univ, Ft Collins, CO 80523 USA		Pasiali, V (corresponding author), Queens Univ Charlotte, 1900 Selwyn Ave, Charlotte, NC 28274 USA.	pasialiv@queens.edu	LaGasse, Blythe/AAB-9517-2021				Abikoff H, 1996, J LEARN DISABIL, V29, P238, DOI 10.1177/002221949602900302; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ames C, 2010, DEV REV, V30, P52, DOI 10.1016/j.dr.2009.12.003; BELMONTE M, 2000, AUTISM, V4, P269, DOI DOI 10.1177/1362361300004003004; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Brabender VA, 2004, ESSENTIALS GROUP THE; Carnahan C., 2009, EDUC TREAT CHILD, V32, P37, DOI [10.1353/etc.0.0047, DOI 10.1353/ETC.0.0047]; Ceccato E., 2006, NORD J MUSIC THER, V15, P110, DOI [10.1080/08098130609478158, DOI 10.1080/08098130609478158]; Ceccato E, 2012, AM J ALZHEIMERS DIS, V27, P301, DOI 10.1177/1533317512452038; DeBedout JK, 2006, J MUSIC THER, V43, P123, DOI 10.1093/jmt/43.2.123; Fan J, 2012, BRAIN BEHAV, V2, P647, DOI 10.1002/brb3.90; Finnigan E, 2010, AUTISM, V14, P321, DOI 10.1177/1362361309357747; Gagnon LG, 2012, NEUROPSYCHOL REHABIL, V22, P809, DOI 10.1080/09602011.2012.691044; Gardiner, 2005, RHYTHM MUSIC BRAIN, P179; Geist K., 2008, YOUNG CHILDREN, V63, P20; Geist K, 2012, MUSIC THER PERSPECT, V30, P141, DOI 10.1093/mtp/30.2.141; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Ivanov I, 2012, BRAIN BEHAV, V2, P741, DOI 10.1002/brb3.80; Jeong E, 2011, J MUSIC THER, V48, P551, DOI 10.1093/jmt/48.4.551; Kalas A, 2012, J MUSIC THER, V49, P430, DOI 10.1093/jmt/49.4.430; Kim J, 2009, AUTISM, V13, P389, DOI 10.1177/1362361309105660; Kinnealey M, 2012, AM J OCCUP THER, V66, P511, DOI 10.5014/ajot.2012.004010; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Mimmo-Smith I., 1999, TEST EVERY DAY ATTEN; Montgomery J, 2011, INT J REHABIL RES, V34, P330, DOI 10.1097/MRR.0b013e32834a8fa8; Mueller C., 2013, THESIS COLORADO; Ouellet S., 2012, CANADIAN J MUSIC THE, V18, P79; Padmala S, 2011, J COGNITIVE NEUROSCI, V23, P3419, DOI 10.1162/jocn_a_00011; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ravizza SM, 2013, DEV PSYCHOPATHOL, V25, P773, DOI 10.1017/S0954579413000163; Reitman M., 2006, DISS ABSTR INT, V66; Robb SL, 2003, J MUSIC THER, V40, P266, DOI 10.1093/jmt/40.4.266; Sanders J, 2008, RES AUTISM SPECT DIS, V2, P1, DOI 10.1016/j.rasd.2007.03.005; Shalev L, 2007, CHILD NEUROPSYCHOL, V13, P382, DOI 10.1080/09297040600770787; STANDLEY JM, 1996, MUSIC THERAPY PERSPE, V14, P87, DOI DOI 10.1093/MTP/14.2.87; Strait DL, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00113; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Sussman JE, 2009, J MUSIC THER, V46, P53, DOI 10.1093/jmt/46.1.53; Thaut MH, 2005, RHYTHM MUSIC BRAIN; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Van Bourgondien ME, 2010, CHILDHOOD AUTISM RAT; Wigram T, 2006, CHILD CARE HLTH DEV, V32, P535, DOI 10.1111/j.1365-2214.2006.00615.x; Wigram T., 2009, COMMUNICATIVE MUSICA, P423; Wolfe DE, 2009, J MUSIC THER, V46, P69, DOI 10.1093/jmt/46.1.69; [徐梦燕 Xu Mengyan], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P696	45	15	15	2	59	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	WIN	2014	51	4					333	354		10.1093/jmt/thu030			22	Music; Rehabilitation	Social Science Citation Index (SSCI)	Music; Rehabilitation	CA1SQ	WOS:000348692200003	25504177				2022-02-06	
J	Rowell, SE; Barbosa, RR; Lennox, TC; Fair, KA; Rao, AJ; Underwood, SJ; Schreiber, MA				Rowell, Susan E.; Barbosa, Ronald R.; Lennox, Tori C.; Fair, Kelly A.; Rao, Abigail J.; Underwood, Samantha J.; Schreiber, Martin A.			Moderate elevations in international normalized ratio should not lead to delays in neurosurgical intervention in patients with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	44th Annual Meeting of the Western-Trauma-Association	MAR 02-07, 2014	Steamboat Springs, CO	Western Trauma Assoc		Traumatic brain injury; thrombelastography; time to intervention; coagulopathy	FROZEN PLASMA TRANSFUSION; PROTHROMBIN TIME; COAGULATION; THROMBELASTOGRAPHY; COAGULOPATHY; TESTS	BACKGROUND: The management of severe traumatic brain injury (TBI) frequently involves invasive intracranial monitoring or cranial surgery. In our institution, intracranial procedures are often deferred until an international normalized ratio (INR) of less than 1.4 is achieved. There is no evidence that a moderately elevated INR is associated with increased risk of bleeding in patients undergoing neurosurgical intervention (NI). Thrombelastography (TEG) provides a functional assessment of clotting and has been shown to better predict clinically relevant coagulopathy compared with INR. We hypothesized that in patients with TBI, an elevated INR would result in increased time to NI and would not be associated with coagulation abnormalities based on TEG. METHODS: A secondary analysis of prospectively collected data was performed in trauma patients with intracranial hemorrhage that underwent NI (defined as cranial surgery or intracranial pressure monitoring) within 24 hours of arrival. Time from admission to NI was recorded. TEG and routine coagulation assays were obtained at admission. Patients were considered hypocoagulable based on INR if their admission INR was greater than 1.4 (high INR). Manufacturer-specified values were used to determine hypocoagulability for each TEG variable. RESULTS: Sixty-one patients (median head Abbreviated Injury Scale EATS] score, 5) met entry criteria, of whom 16% had high INR. Demographic, physiologic, and injury scoring data were similar between groups. The median time to NI was longer in patients with high INR (358 minutes vs. 184 minutes, p = 0.027). High-INR patients were transfused more plasma than patients with an INR of 1.4 or less (2 U vs. 0 U, p = 0.01). There was no association between an elevated INR and hypocoagulability based on TEG. CONCLUSION: TBI patients with an admission INR of greater than 1.4 had a longer time to NI. The use of plasma transfusion to decrease the INR may have contributed to this delay. A moderately elevated INR was not associated with coagulation abnormalities based on TEG. Routine plasma transfusion to correct a moderately elevated INR before NI should be reexamined. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Rowell, Susan E.; Lennox, Tori C.; Fair, Kelly A.; Underwood, Samantha J.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA; [Rao, Abigail J.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97239 USA; [Barbosa, Ronald R.] Legacy Emanuel Hosp & Hlth, Trauma Serv, Portland, OR USA		Rowell, SE (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rowells@ohsu.edu	Rowell, Susan/S-7480-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000128] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12 HL108974] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [5K12HLK108974-03] Funding Source: Medline		Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; Barton JS, 2013, HPB, V15, P865, DOI 10.1111/hpb.12051; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2006, NEUROSURGERY, V58, pS7, DOI 10.1227/01.NEU.0000210365.36914.E3; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Dzik WH, 2009, ROSSIS PRINCIPLES TR; Faul M, 2010, TRAUMATIC BRAIN INJU; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Holland L, 2006, CURR OPIN HEMATOL, V13, P447, DOI 10.1097/01.moh.0000245688.47333.b6; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Kim BS, 2008, NEUROSURGICAL EMERGE; Kumar M, 2013, CONSULTATIVE HEMOSTA; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; McCully SP, 2013, J TRAUMA ACUTE CARE, V75, P947, DOI 10.1097/TA.0b013e3182a9676c; National Institute for Health and Clinical Excellence, 2010, HEAD INJ QUICK REF; Osterud B, 1997, THROMB HAEMOSTASIS, V78, P755; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Schochl H, 2013, J TRAUMA ACUTE CARE, V74, P1587, DOI 10.1097/TA.0b013e31828c3171; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; West KL, 2011, J NEUROSURG, V114, P9, DOI 10.3171/2010.7.JNS091857; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	30	15	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2014	77	6					846	850		10.1097/TA.0000000000000459			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	AU8EE	WOS:000345828500010	25423533	Green Accepted			2022-02-06	
J	Wolf, H; Krall, C; Pajenda, G; Leitgeb, J; Bukaty, AJ; Hajdu, S; Sarahrudi, K				Wolf, Harald; Krall, Christoph; Pajenda, Gholam; Leitgeb, Johannes; Bukaty, Adam J.; Hajdu, Stefan; Sarahrudi, Kambiz			Alterations of the biomarker S-100B and NSE in patients with acute vertebral spine fractures	SPINE JOURNAL			English	Article						S100B; NSE; Vertebral spine fractures; Spinal cord injury; Spinal trauma; Biomarker; Neurologic deficit	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; SERUM S100B LEVELS; MINOR HEAD-INJURY; CORD-INJURY; PROTEIN; S-100-BETA; ELEVATION; FAMILY	BACKGROUND CONTEXT: Although several publications concerning the use of the biomarkers S100B and neuron-specific enolase (NSE) in vertebral spine fractures in animal experimental studies have proven their usefulness as early indicators of injury severity, there are no clinical reports on their effectiveness as indicators in patients with spinal injuries. As these biomarkers have been examined, with promising results, in patients with traumatic brain injury, there is a potential for their implementation in patients with vertebral spine fractures. PURPOSE: To investigate the early serum measurement of S100B and NSE in patients with vertebral spine fractures compared with those in patients with acute fractures of the proximal femur. STUDY DESIGN: Prospective longitudinal cohort study. PATIENT SAMPLE: A cohort of 34 patients admitted over an 18-month period to a single medical center for suspected vertebral spine trauma. Twenty-nine patients were included in the control group. OUTCOME MEASURES: S100B and NSE serum levels were assessed in different types of vertebral spine fractures. METHODS: We included patients older than 16 years with vertebral spine fractures whose injuries were sustained within 24 hours before admission to the emergency room and who had undergone a brief neurologic examination. Spinal cord injuries (SCIs) were classified as being paresthesias, incomplete paraplegias, or complete paraplegias. Blood serum was obtained from all patients within 24 hours after the time of injury. Serum levels of S100B and NSE were statistically analyzed using Wilcoxon signed-rank test. RESULTS: S100B serum levels were significantly higher in patients with vertebral spine fractures (p=.01). In these patients, the mean S100B serum level was 0.75 mu g/L (standard deviation [SD] 1.44, 95% confidence interval [CI] 0.24, 1.25). The mean S100B serum level in control group patients was 0.14 mu g/L (SD 0.11, 95% CI 0.10, 0.19). The 10 patients with neurologic deficits had significantly higher S100B serum levels compared with the patients with vertebral fractures but without neurologic deficits (p=.02). The mean S100B serum level in these patients was 1.18 mu g/L (SD 1.96). In the 26 patients with vertebral spine fractures but without neurologic injury, the mean S100B serum level was 0.42 mu g/L (SD 0.91, 95% CI 0.08, 0.76). The analysis revealed no significant difference in NSE levels. CONCLUSIONS: We observed a significant correlation not only between S100B serum levels and vertebral spine fractures but also between S100B serum levels and SCIs with neurologic deficit. These results may be meaningful in clinical practice and to future studies. (C) 2014 Elsevier Inc. All rights reserved.	[Wolf, Harald; Pajenda, Gholam; Leitgeb, Johannes; Hajdu, Stefan; Sarahrudi, Kambiz] Med Univ Vienna, Vienna Gen Hosp, Dept Trauma Surg, A-1090 Vienna, Austria; [Krall, Christoph] Med Univ Vienna, Dept Med Stat, A-1090 Vienna, Austria; [Bukaty, Adam J.] Med Univ Vienna, Vienna Gen Hosp, Dept Anaesthesia & Intens Care Med, A-1090 Vienna, Austria		Wolf, H (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Trauma Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	harald.wolf@meduniwien.ac.at					Aarabi B, 2012, J NEUROSURG-SPINE, V17, P243, DOI 10.3171/2012.6.SPINE12122; Benneker LM, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-13; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Einav S, 2012, J AM COLL CARDIOL, V60, P304, DOI 10.1016/j.jacc.2012.04.020; Korfias S, 2006, BRAIN INJURY, V20, P867, DOI 10.1080/02699050600832395; Lee SJ, 2010, EMERG MED J, V27, P209, DOI 10.1136/emj.2008.063743; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Marquardt G, 2011, NEUROL RES, V33, P421, DOI 10.1179/1743132810Y.0000000005; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	20	15	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2014	14	12					2918	2922		10.1016/j.spinee.2014.04.027			5	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	AU2EQ	WOS:000345429500021	24780247				2022-02-06	
J	Glushakov, AV; Fazal, JA; Narumiya, S; Dore, S				Glushakov, Alexander V.; Fazal, Jawad A.; Narumiya, Shuh; Dore, Sylvain			Role of the Prostaglandin E-2 EP1 Receptor in Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; MODEL; CYCLOOXYGENASE-2; RAT; CONTRIBUTES; INHIBITION; ISCHEMIA; SEIZURES; EPILEPSY; DAMAGE	Brain injuries promote upregulation of so-called proinflammatory prostaglandins, notably prostaglandin E-2 (PGE(2)), leading to overactivation of a class of its cognate G-protein-coupled receptors, including EP1, which is considered a promising target for treatment of ischemic stroke. However, the role of the EP1 receptor is complex and depends on the type of brain injury. This study is focused on the investigation of the role of the EP1 receptor in a controlled cortical impact (CCI) model, a preclinical model of traumatic brain injury (TBI). The therapeutic effects of post-treatments with a widely studied EP1 receptor antagonist, SC-51089, were examined in wildtype and EP1 receptor knockout C57BL/6 mice. Neurological deficit scores (NDS) were assessed 24 and 48 h following CCI or sham surgery, and brain immunohistochemical pathology was assessed 48 h after surgery. In wildtype mice, CCI resulted in an obvious cortical lesion and localized hippocampal edema with an associated significant increase in NDS compared to sham-operated animals. Post-treatments with the selective EP1 receptor antagonist SC-51089 or genetic knockout of EP1 receptor had no significant effects on cortical lesions and hippocampal swelling or on the NDS 24 and 48 h after CCI. Immunohistochemistry studies revealed CCI-induced gliosis and microglial activation in selected ipsilateral brain regions that were not affected by SC-51089 or in the EP1 receptor-deleted mice. This study provides further clarification on the respective contribution of the EP1 receptor in TBI and suggests that, under this experimental paradigm, the EP1 receptor would have limited effects in modulating acute neurological and anatomical pathologies following contusive brain trauma. Findings from this protocol, in combination with previous studies demonstrating differential roles of EP1 receptor in ischemic, neurotoxic, and hemorrhagic conditions, provide scientific background and further clarification of potential therapeutic application of prospective prostaglandin G-protein-coupled receptor drugs in the clinic for treatment of TBI and other acute brain injuries.	[Glushakov, Alexander V.; Fazal, Jawad A.; Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA		Glushakov, AV (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA.	glushav@ufl.edu; sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020; Glushakov, Alexander V/B-5452-2008	Glushakov, Alexander V/0000-0003-2872-8960; Dore, Sylvain/0000-0003-3771-5109	McKnight Brain Research Foundation; Brain and Spinal Cord Injury Research Trust Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS046400]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046400] Funding Source: NIH RePORTER	This work was supported by a grant from the McKnight Brain Research Foundation, Brain and Spinal Cord Injury Research Trust Fund (http://mbi.ufl.edu/2011/06/13/brain-and-spinal-cord-injury-research-trust-fund-bscirtf-awards/) (AVG, SD) and a grant from the National Institutes of Health NS046400 (http://www.nih.gov/) (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad Muzamil, 2010, Exp Transl Stroke Med, V2, P12, DOI 10.1186/2040-7378-2-12; Anglada-Huguet M, 2014, MOL NEUROBIOL, V49, P784, DOI 10.1007/s12035-013-8556-x; Audoly LP, 1999, AM J PHYSIOL-HEART C, V277, pH924, DOI 10.1152/ajpheart.1999.277.3.H924; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doi T, 2001, MOL BRAIN RES, V92, P107, DOI 10.1016/S0169-328X(01)00159-0; Dore S, 2006, TRENDS PHARMACOL SCI, V27, P458, DOI 10.1016/j.tips.2006.07.001; Fischborn SV, 2010, EPILEPSY RES, V91, P57, DOI 10.1016/j.eplepsyres.2010.06.012; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Govoni S, 2001, NEUROSCI LETT, V303, P91, DOI 10.1016/S0304-3940(01)01675-5; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Homayoun P, 1997, J NEUROCHEM, V69, P199; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kang YJ, 2008, KOREAN J PHYSIOL PHA, V12, P275, DOI 10.4196/kjpp.2008.12.5.275; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P277, DOI 10.1007/978-3-7091-0693-8_46; Kim YT, 2012, NEUROBIOL DIS, V48, P58, DOI 10.1016/j.nbd.2012.06.003; Kinirons P, 2006, SEIZURE-EUR J EPILEP, V15, P387, DOI 10.1016/j.seizure.2006.05.001; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McIntosh TK, 1996, LAB INVEST, V74, P315; Michelucci R, 2006, NEUROLOGY, V67, pS14, DOI 10.1212/WNL.67.12_suppl_4.S14; Mohan S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00031; Mohan Shekher, 2012, Front Neurol, V3, P145, DOI 10.3389/fneur.2012.00145; Oliveira MS, 2008, NEUROSCIENCE, V152, P1110, DOI 10.1016/j.neuroscience.2008.01.005; Pagni CA, 2005, ACT NEUR S, V93, P27; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saleem S, 2007, J NEUROSCI RES, V85, P2433, DOI 10.1002/jnr.21399; Saleem S, 2009, NEUROTOX RES, V15, P62, DOI 10.1007/s12640-009-9007-3; Shimamura M, 2013, J CEREBR BLOOD F MET, V33, P1207, DOI 10.1038/jcbfm.2013.69; Singh N, 2013, NEUROTOX RES, V24, P549, DOI 10.1007/s12640-013-9410-7; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; WILLMORE LJ, 1991, INT J DEV NEUROSCI, V9, P175, DOI 10.1016/0736-5748(91)90009-B; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017	65	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113689	10.1371/journal.pone.0113689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	WOS:000349145400078	25426930	Green Published, Green Submitted, gold			2022-02-06	
J	Du, Q; Yu, WH; Dong, XQ; Yang, DB; Shen, YF; Wang, H; Jiang, L; Du, YF; Zhang, ZY; Zhu, Q; Che, ZH; Liu, QJ				Du, Quan; Yu, Wen-Hua; Dong, Xiao-Qiao; Yang, Ding-Bo; Shen, Yong-Feng; Wang, Hao; Jiang, Li; Du, Yuan-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie			Plasma 8-iso-Prostaglandin F2 alpha concentrations and outcomes after acute intracerebral hemorrhage	CLINICA CHIMICA ACTA			English	Article						8-Iso-Prostaglandin F2 alpha; Intracerebral hemorrhage; Functional outcome; Mortality; Severity; Oxidative stress	OXIDATIVE STRESS; FREE-RADICALS; BRAIN-INJURY; BIOMARKERS; STROKE; RAT; ANTIOXIDANTS; ACTIVATION; PATHOLOGY; ISCHEMIA	Background: Higher plasma 8-iso-Prostaglandin F2 alpha concentrations have been associated with poor outcome of severe traumatic brain injury. We further investigated the relationships between plasma 8-iso-Prostaglandin F2 alpha concentrations and clinical outcomes in patients with acute intracerebral hemorrhage. Methods: Plasma 8-iso-Prostaglandin F2 alpha concentrations of 128 consecutive patients and 128 sex- and gender-matched healthy subjects were measured by enzyme-linked immunosorbent assay. We assessed their relationships with disease severity and clinical outcomes including 1-week mortality, 6-month mortality and unfavorable outcome (modified Rankin Scale score > 2). Results: Plasma 8-iso-Prostaglandin F2 alpha concentrations were substantially higher in patients than in healthy controls. Plasma 8-iso-Prostaglandin F2 alpha concentrations were positively associated with National Institutes of Health Stroke Scale (NIHSS) scores and hematoma volume using a multivariate linear regression. It emerged as an independent predictor for clinical outcomes of patients using a forward stepwise logistic regression. ROC curves identified the predictive values of plasma 8-iso-Prostaglandin F2 alpha concentrations, and found its predictive value was similar to NIHSS scores and hematoma volumes. However, it just numerically added the predictive values of NIHSS score and hematoma volume. Conclusions: Increased plasma 8-iso-Prostaglandin F2 alpha concentrations are associated with disease severity and clinical outcome after acute intracerebral hemorrhage. (C) 2014 Elsevier B.V. All rights reserved.	[Du, Quan; Yu, Wen-Hua; Dong, Xiao-Qiao; Yang, Ding-Bo; Shen, Yong-Feng; Wang, Hao; Jiang, Li; Du, Yuan-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, Affiliated Hangzhou Hosp, Hangzhou 310006, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, Affiliated Hangzhou Hosp, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Hangzhou Medical Research Fund Scheme A Class Project [2011A014]	The authors thank all staffs in the Department of Neurosurgery, the Hangzhou First People's Hospital for their technical support. This work was financially supported by a grant from the Hangzhou Medical Research Fund Scheme A Class Project (no. 2011A014).	Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; Alexandrova ML, 2011, J CLIN NEUROSCI, V18, P247, DOI 10.1016/j.jocn.2010.07.125; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Basu S, 2001, FEBS LETT, V508, P36, DOI 10.1016/S0014-5793(01)02998-2; Bhatia R, 2013, NEUROL INDIA, V61, P244, DOI 10.4103/0028-3886.115062; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brunetti L, 2002, LIFE SCI, V71, P2447, DOI 10.1016/S0024-3205(02)02037-4; Chen YC, 2011, J NEUROSURG, V115, P1184, DOI 10.3171/2011.7.JNS11718; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Elesber AA, 2006, FREE RADICAL RES, V40, P385, DOI 10.1080/10715760500539154; Elijovich L, 2008, SEMIN NEUROL, V28, P657, DOI 10.1055/s-0028-1105974; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x; Hoffman SW, 2000, J NEUROTRAUM, V17, P415, DOI 10.1089/neu.2000.17.415; Ji Li Li, 2009, Infectious Disorders - Drug Targets, V9, P428; Keep RF, 2008, ACT NEUR S, V105, P73; Kitagawa Y, 2014, CIRC J, V78, P315, DOI 10.1253/circj.CJ-13-1553; Kohler AC, 2014, J MOL CELL CARDIOL, V73, P92, DOI 10.1016/j.yjmcc.2014.03.001; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x; Owczarek D, 2010, INFLAMM BOWEL DIS, V16, P52, DOI 10.1002/ibd.20994; Peeling J, 1998, BRAIN RES, V795, P63, DOI 10.1016/S0006-8993(98)00253-4; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Szuldrzynski K, 2010, POL ARCH MED WEWN, V120, P19; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wagner KR, 2007, STROKE, V38, P753, DOI 10.1161/01.STR.0000255033.02904.db; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Wiswedel I, 2009, METHODS MOL BIOL, V580, P3, DOI 10.1007/978-1-60761-325-1_1; Woolley JF, 2013, TRENDS BIOCHEM SCI, V38, P556, DOI 10.1016/j.tibs.2013.08.009; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Yu GF, 2013, CLIN CHIM ACTA, V421, P7, DOI 10.1016/j.cca.2013.02.030; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014	42	15	15	0	86	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 1	2014	437						141	146		10.1016/j.cca.2014.07.014			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	AP7GX	WOS:000342246900025	25079083				2022-02-06	
J	Gibbs, LM				Gibbs, Lisa M.			Understanding the Medical Markers of Elder Abuse and Neglect: Physical Examination Findings	CLINICS IN GERIATRIC MEDICINE			English	Article						Elder abuse; Elder neglect; Medical markers; Physical injury	BRAIN-INJURY; STRANGULATION; MECHANISMS; FREQUENCY; PATTERNS; VICTIMS; RISK	A specific foundation of knowledge is important for evaluating potential abuse from physical findings in the older adult. The standard physical examination is a foundation for detecting many types of abuse. An understanding of traumatic injuries, including patterns of injury, is important for health care providers, and the inclusion of elder abuse in the differential diagnosis of patient care is essential. One must possess the skills needed to piece the history, including functional capabilities, and physical findings together. Armed with this skill set, health care providers will develop the confidence needed to identify and intervene in cases of elder abuse.	Univ Calif Irvine, Dept Family Med, Div Geriatr Med & Gerontol, Orange, CA 92868 USA		Gibbs, LM (corresponding author), Univ Calif Irvine, Dept Family Med, Div Geriatr Med & Gerontol, 101 City Dr, Orange, CA 92868 USA.	lgibbs@uci.edu					Alexandrescu DT, 2010, WILLIAMS HEMATOLOGY; Association for the Advancement of Wound Care (AAWC), 2010, ASS ADV WOUND CAR GU; Atanasijevic TC, 2005, J FORENSIC SCI, V50, P608; Bates-Jensen BM, 2009, HAZZARDS GERIATRIC M; Bird PE, 1998, J BURN CARE REHABIL, V19, P522, DOI 10.1097/00004630-199811000-00011; Bliss M R, 1998, J Tissue Viability, V8, P4; Brandeis G H, 2001, Adv Skin Wound Care, V14, P245, DOI 10.1097/00129334-200109000-00011; Brandeis GH, 2001, ADV SKIN WOUND CARE, V14, P245; Brown Kathleen, 2004, Nurse Pract, V29, P22, DOI 10.1097/00006205-200408000-00004; Brown KL, 2012, PRINCIPLES PRACTICE; Burgess AW, 2005, CLIN GERIATR MED, V21, P399, DOI 10.1016/j.cger.2004.10.005; Burkhart CN, 2011, TINTINALLIS EMERGENC; Chatham N, 2012, WOUND CARE ADVISOR, V1, P1; Collins KA, 2007, AM J FOREN MED PATH, V28, P157, DOI 10.1097/PAF.0b013e31805c93eb; Dem ling RH, 2010, CURRENT DIAGNOSIS TR; Faugno D, 2013, ADV EMERG NURS J, V35, P314, DOI 10.1097/TME.0b013e3182aa05d3; Fowler DR, 2011, TINTINALLIS EMERGENC; Fowler DR, 2011, TINTINALLIS EMERGENC; Friedman LS, 2011, J AM GERIATR SOC, V59, P417, DOI 10.1111/j.1532-5415.2010.03313.x; GERSTEIN AD, 1993, DERMATOL CLIN, V11, P749, DOI 10.1016/S0733-8635(18)30227-4; Greenbaum AR, 2004, BURNS, V30, P628, DOI 10.1016/j.burns.2004.03.019; HARPER RD, 1995, BURNS, V21, P205, DOI 10.1016/0305-4179(95)80010-L; Hawley DA, 2001, J EMERG MED, V21, P317, DOI 10.1016/S0736-4679(01)00401-2; Holbrook DS, 2013, J FORENSIC NURS, V9, P140, DOI 10.1097/JFN.0b013e31829beb1e; ISERSON KV, 1984, ANN EMERG MED, V13, P179, DOI 10.1016/S0196-0644(84)80609-5; Janniger CK, 2005, AM FAM PHYSICIAN, V72, P833; Johnson SC, 2009, HAZZARDS GERIATRIC M; Karch D, 2011, J INTERPERS VIOLENCE, V26, P137, DOI 10.1177/0886260510362890; Knox D M, 1994, Adv Wound Care, V7, P48; Knox DM, 1994, ADV WOUND CARE, V7, P54; Krob M J, 1986, J Burn Care Rehabil, V7, P529, DOI 10.1097/00004630-198611000-00017; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Lyder C. H., 2002, JAMA-J AM MED ASSOC, V289, P223, DOI [10.1001/jama.289.2.223, DOI 10.1001/jama.289.2.223]; Ma O, 2011, TINTINALLIS EMERGENC; Mosqueda L, 2005, J AM GERIATR SOC, V53, P1339, DOI 10.1111/j.1532-5415.2005.53406.x; Muller MJ, 2001, BRIT J SURG, V88, P583, DOI 10.1046/j.1365-2168.2001.01726.x; Munter DW, 2010, ATLAS EMERGENCY MED; Murphy K, 2013, CAN ASSOC RADIOL J, V64, P10, DOI 10.1016/j.carj.2012.12.001; National Burn Repository, 2012, REP DAT 2002 2011; National Pressure Ulcer Advisory Panel (NPUAP), NPUAP PRESS ULC STAG; Palmer M, 2013, J AM ACAD DERMATOL, V68, pE37, DOI 10.1016/j.jaad.2011.03.016; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Peck MD, 2012, BURNS, V38, P630, DOI 10.1016/j.burns.2011.12.028; Plattner T, 2005, FORENSIC SCI INT, V153, P202, DOI 10.1016/j.forsciint.2004.09.106; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Ropper AH, 2014, ADAMS VICTORS PRINCI; Saavedra, 2013, FITZPATRICKS COLOR A; Sartoretti C, 1997, J TRAUMA, V43, P570, DOI 10.1097/00005373-199710000-00002; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Stapczynski J., 2010, EMERGENCY MED REPORT, V31, P193; Usatine RP, 2013, COLOR ATLAS FAMILY M; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wiglesworth A, 2009, J AM GERIATR SOC, V57, P1191, DOI 10.1111/j.1532-5415.2009.02330.x; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; Yaar M, 2001, CLIN GERIATR MED, V17, P617, DOI 10.1016/S0749-0690(05)70089-6; Zelken JA, 2014, J ORAL MAXIL SURG, V72, P352, DOI 10.1016/j.joms.2013.08.015; Ziminski CE, 2013, J FORENSIC NURS, V9, P84, DOI 10.1097/JFN.0b013e31827d51d0	57	15	16	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0690	1879-8853		CLIN GERIATR MED	Clin. Geriatr. Med.	NOV	2014	30	4					687	+		10.1016/j.cger.2014.08.002			27	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	AT8SX	WOS:000345203300004	25439636				2022-02-06	
J	Hanks, RA; Rapport, LJ; Waldron-Perrine, B; Millis, SR				Hanks, Robin A.; Rapport, Lisa J.; Waldron-Perrine, Brigid; Millis, Scott R.			Role of Character Strengths in Outcome After Mild Complicated to Severe Traumatic Brain Injury: A Positive Psychology Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Community integration; Comorbidity; Quality of life; Patient outcome assessment; Rehabilitation	RANDOMIZED CONTROLLED-TRIAL; OLDER CANCER-PATIENTS; COMMUNITY INTEGRATION; NEGATIVE AFFECT; RATING-SCALE; COMORBIDITY; VALIDATION; INTERVENTIONS; PANAS	Objective: To examine the effects of character strengths on psychosocial outcomes after mild complicated to severe traumatic brain injury (TBI). Design: Prospective study with consecutive enrollment. Setting: A Midwestern rehabilitation hospital. Participants: Persons with mild complicated to severe TBI (N= 65). Interventions: Not applicable. Main Outcome Measures: Community Integration Measure, Disability Rating Scale, Modified Cumulative Illness Rating Scale, Positive and Negative Affect Schedule, Satisfaction with Life Scale, Values in Action Inventory of Strengths, and Wechsler Test of Adult Reading. Results: Character virtues and strengths were moderately associated with subjective outcomes, such that there were fewer and less strong associations between character virtues/strengths and objective outcomes than subjective outcomes. Specifically, positive attributes were associated with greater life satisfaction and perceived community integration. Fewer and less strong associations were observed for objective well-being; however, character strengths and virtues showed unique value in predicting physical health and disability. Positive affectivity was not meaningfully related to objective outcomes, but it was significantly related to subjective outcomes. In contrast, negative affectivity was related to objective but not subjective outcomes. Conclusions: Given the strength of the associations between positive aspects of character or ways of perceiving the world and positive feelings about one's current life situation, treatments focused on facilitating these virtues and strengths in persons who have experienced TBI may result in better perceived outcomes and potentially subsequently lower comorbidities. (C) 2014 by the American Congress of Rehabilitation Medicine	[Hanks, Robin A.; Waldron-Perrine, Brigid; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Rapport, Lisa J.] Wayne State Univ, Coll Liberal Arts & Sci, Dept Psychol, Detroit, MI USA		Hanks, RA (corresponding author), Rehabil Inst Michigan, 261 Mack Blvd,Ste 555, Detroit, MI 48201 USA.	rhanks@med.wayne.edu		Rapport, Lisa/0000-0001-8014-9523			Costa P. T., 1992, REVISED NEO PERSONAL; Dahlsgaard K, 2005, REV GEN PSYCHOL, V9, P203, DOI 10.1037/1089-2680.9.3.203; Di Libero F, 2001, ARCH GERONTOL GERIAT, V32, P15, DOI 10.1016/S0167-4943(00)00089-3; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Extermann M, 2000, CRIT REV ONCOL HEMAT, V35, P181, DOI 10.1016/S1040-8428(00)00090-1; Gable SL, 2005, REV GEN PSYCHOL, V9, P103, DOI 10.1037/1089-2680.9.2.103; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Holdnack H.A., 2001, WECHSLER TEST ADULT; Jones TG, 2003, CLIN NEUROPSYCHOL, V17, P3, DOI 10.1076/clin.17.1.3.15626; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kenny David A., 1998, HDB SOCIAL PSYCHOL, V1, P233, DOI DOI 10.1177/0146167208331253; KERCHER K, 1992, RES AGING, V14, P131, DOI 10.1177/0164027592142001; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ogedegbe GO, 2012, ARCH INTERN MED, V172, P322, DOI 10.1001/archinternmed.2011.1307; Park N, 2004, J SOC CLIN PSYCHOL, V23, P603, DOI 10.1521/jscp.23.5.603.50748; PAVOT W, 1993, SOC INDIC RES, V28, P1, DOI 10.1007/BF01086714; Peterson C, 2006, MICH PSYCH ASS MARCH; Peterson C., 2004, CHARACTER STRENGTHS; Peterson C, 2008, J TRAUMA STRESS, V21, P214, DOI 10.1002/jts.20332; Peterson JC, 2012, ARCH INTERN MED, V172, P329, DOI 10.1001/archinternmed.2011.1311; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ryff CD, 2006, PSYCHOTHER PSYCHOSOM, V75, P85, DOI 10.1159/000090892; Seligman C., 2006, J POSIT PSYCHOL, V1, P17, DOI [DOI 10.1080/17439760500372739, 10.1080/17439760500372739]; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	35	15	15	3	26	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2014	95	11					2096	2102		10.1016/j.apmr.2014.06.017			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AS3XC	WOS:000344207500014	25010535				2022-02-06	
J	Kim, SP; Kang, DS; Cheong, JH; Kim, JH; Song, KY; Kong, MH				Kim, Seung Pil; Kang, Dong Soo; Cheong, Jin Hwan; Kim, Jung Hee; Song, Kwan Young; Kong, Min Ho			Clinical Analysis of Epidural Fluid Collection as a Complication after Cranioplasty	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Cranioplasty; Epidural fluid collection; Size of skull defect	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DEFECT	Objective : The epidural fluid collection (EFC) as a complication of cranioplasty is not well-described in the literature. This study aimed to identify the predictive factors for the development of EFC as a complication of cranioplasty, and its outcomes. Methods : From January 2004 to December 2012, 117 cranioplasty were performed in our institution. One-hundred-and-six of these patients were classified as either having EFC, or not having EFC. The two groups were compared to identify risk factors for EFC. Statistical significance was tested using the t-test and chi-square test, and a logistic regression analysis. Results : Of the 117 patients undergoing cranioplasty, 59 (50.4%) suffered complications, and EFC occurred in 48 of the patients (41.0%). In the t-test and chi-test, risk factors for EFC were size of the skull defect (p=0.003) and postoperative air bubbles in the epidural space (p<0.001). In a logistic regression, the only statistically significant factor associated with development of EFC was the presence of postoperative air bubbles. The EFC disappeared or regressed over time in 30 of the 48 patients (62.5%), as shown by follow-up brain computed tomographic scan, but 17 patients (35.4%) required reoperation. Conclusion : EFC after cranioplasty is predicted by postoperative air bubbles in the epidural space. Most EFC can be treated conservatively. However, reoperation is necessary to resolve about a third of the cases. During cranioplasty, special attention is required when the skull defect is large, since EFC is then more likely.	[Kim, Seung Pil; Kang, Dong Soo; Kim, Jung Hee; Song, Kwan Young; Kong, Min Ho] Seoul Med Ctr, Dept Neurosurg, Seoul 131865, South Korea; [Cheong, Jin Hwan] Hanyang Univ, Guri Hosp, Dept Neurosurg, Guri, South Korea		Kang, DS (corresponding author), Seoul Med Ctr, Dept Neurosurg, 156 Sinnae Ro, Seoul 131865, South Korea.	kdsyjyw@hotmail.com					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cho KC, 2011, J KOREAN NEUROTRAUMA, V7, P74; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Lee JW, 2011, J KOREAN NEUROSURG S, V50, P231, DOI 10.3340/jkns.2011.50.3.231; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Oh CH, 2008, J KOREAN NEUROSURG S, V44, P211, DOI 10.3340/jkns.2008.44.4.211; Park JS, 2007, J KOREAN NEUROSURG S, V42, P89; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Simard JM, 2011, CURR TREAT OPTION NE, V13, P217, DOI 10.1007/s11940-010-0110-9; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Walcott BP, 2012, J NEUROTRAUM, V29, P1879, DOI 10.1089/neu.2012.2382; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053	21	15	20	0	5	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2014	56	5					410	418		10.3340/jkns.2014.56.5.410			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AW9AQ	WOS:000346550600008	25535519	Green Published, Green Submitted, gold			2022-02-06	
J	Kuhn, AW; Solomon, GS				Kuhn, Andrew Warren; Solomon, Gary S.			Supervision and Computerized Neurocognitive Baseline Test Performance in High School Athletes: An Initial Investigation	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; sports; neurocognitive testing; ImPACT	SPORTS-RELATED CONCUSSION; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSITION STATEMENT; NATIONAL ACADEMY; ONLINE VERSION; IMPACT; RELIABILITY; MANAGEMENT; SYMPTOMS; OBSERVER	Context: Computerized neuropsychological testing batteries have provided a time-efficient and cost-efficient way to assess and manage the neurocognitive aspects of patients with sport-related concussion. These tests are straightforward and mostly self-guided, reducing the degree of clinician involvement required by traditional clinical neuropsychological paper-and- pencil tests. Objective: To determine if self-reported supervision status affected computerized neurocognitive baseline test performance in high school athletes. Design: Retrospective cohort study. Settings: Supervised testing took place in high school computer libraries or sports medicine clinics. Unsupervised testing took place at the participant's home or another location with computer access. Patients or Other Participants: From 2007 to 2012, high school athletes across middle Tennessee (n = 3771) completed computerized neurocognitive baseline testing (Immediate Post-Concussion Assessment and Cognitive Testing [ImPACT]). They reported taking the test either supervised by a sports medicine professional or unsupervised. These athletes (n = 2140) were subjected to inclusion and exclusion criteria and then matched based on age, sex, and number of prior concussions. Main Outcome Measure(s): We extracted demographic and performance-based data from each de-identified baseline testing record. Paired t tests were performed between the self-reported supervised and unsupervised groups, comparing the following ImPACT baseline composite scores: verbal memory, visual memory, visual motor (processing) speed, reaction time, impulse control, and total symptom score. For differences that reached P < .05, the Cohen d was calculated to measure the effect size. Lastly, a chi(2) analysis was conducted to compare the rate of invalid baseline testing between the groups. All statistical tests were performed at the 95% confidence interval level. Results: Self-reported supervised athletes demonstrated better visual motor (processing) speed (P = .004; 95% confidence interval [0.28, 1.52]; d = 0.12) and faster reaction time (P < .001; 95% confidence interval [-0.026, -0.014]; d = 0.21) composite scores than self-reported unsupervised athletes. Conclusions: Speed-based tasks were most affected by self-reported supervision status, although the effect sizes were relatively small. These data lend credence to the hypothesis that supervision status may be a factor in the evaluation of ImPACT baseline test scores.	[Kuhn, Andrew Warren] Boston Univ, Boston, MA 02215 USA; [Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA		Solomon, GS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, T-4224 Med Ctr North, Nashville, TN 37232 USA.	gary.s.solomon@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Solomon, Gary/K-9011-2019	Kuhn, Andrew W/0000-0003-1836-7575; 			ALVES WM, 1987, CLIN SPORT MED, V6, P211; Axelrod B, 2000, ARCH CLIN NEUROPSYCH, V15, P379, DOI 10.1093/arclin/15.5.379; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Cohen J, 1969, STAT POWER ANAL BEHA; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Eastvold AD, 2012, CLIN NEUROPSYCHOL, V26, P520, DOI 10.1080/13854046.2012.663000; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; ImPACT, 2007, CLIN INT MAN; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jones NS, 2011, CLIN J SPORT MED, V21, P153; Kehrer CA, 2000, CLIN NEUROPSYCHOL, V14, P67, DOI 10.1076/1385-4046(200002)14:1;1-8;FT067; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008	34	15	15	0	14	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2014	49	6					800	805		10.4085/1062-6050-49.3.66			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	AY4NW	WOS:000347556500011	25299577	Green Published, Bronze			2022-02-06	
J	Miyashita, TL; Diakogeorgiou, E; Hellstrom, B; Kuchwara, N; Tafoya, E; Young, L				Miyashita, Theresa L.; Diakogeorgiou, Eleni; Hellstrom, Brian; Kuchwara, Nick; Tafoya, Erica; Young, Lori			High School Athletes' Perceptions of Concussion	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						high school athletes; concussions; knowledge; education		Background: The perception high school athletes have regarding concussions may influence their injury-reporting behavior, and if their perceptions are based on incorrect or incomplete information, they may be at risk for subsequent head injuries. Purpose: To determine whether the recent influx of concussion information has had a positive impact on high school athletes' knowledge of concussions, to determine their perceptions regarding the severity of a concussion injury, and to determine whether receiving correct information will potentially alter their future reporting behavior. Study Design: Cross-sectional study; Level of evidence, 4. Methods: A total of 454 high school athletes (212 females, 242 males; mean age, 15.7 +/- 1.15 years) from 6 different schools participated in an anonymous survey. The researchers met with teams individually at their high schools to collect data and provide an educational intervention regarding sports-related concussions. The survey questions assessed the athletes' personal injury histories and perceptions and knowledge of the severity of concussion injuries. Results: There was a difference in the number of athletes who reported having their "bell rung'' (n = 297) versus the number of athletes reporting at least 1 concussion (n = 172) (t (453) = -11.60, P =.000, d = -0.54). There was also a difference in the number of athletes who reported a history of at least 1 concussion at the beginning of the study session (n = 172) versus the number of athletes who reported at least 1 concussion at the end of the session (n = 292) (t (453) = -12.018, P =.000, d = 0.732). Fifty percent of athletes also stated that the importance of a game/event should dictate when they return to play. Conclusion: High school athletes continue to fail to realize when they have sustained a concussion. Additionally, athletes lack understanding regarding the severity and seriousness of a concussion. A better effort at formalized education must be made if the culture of sports is to change. Clinical Relevance: Allied health care professionals need to continue to put forth a great effort in educating all student athletes on what a concussion is and the dangers of a concussion injury. Preseason meetings should be used as an opportunity to provide formalized education to all student athletes.	Douglas Cty Sch Dist, Castle Rock, CO USA; [Miyashita, Theresa L.; Diakogeorgiou, Eleni] Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA; [Hellstrom, Brian; Kuchwara, Nick; Tafoya, Erica; Young, Lori] Metropolitan State Univ Denver, Denver, CO USA		Miyashita, TL (corresponding author), Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA.	miyashitat@sacredheart.edu					Aloi MS, PEDIATRIC CONCUSSION; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bailes JE, 2009, J INT NEUROPSYCH SOC, V15, P509, DOI 10.1017/S1355617709090936; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Lakhan SE, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-2; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Federation of State High School Associations, 2012 13 HIG SCHOOL A; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Solomos NJ, 2002, AM FAM PHYSICIAN, V65, P2435; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	41	15	15	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	NOV	2014	2	11							2325967114554549	10.1177/2325967114554549			5	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	V0R5T	WOS:000216494400001	26535279	gold, Green Published			2022-02-06	
J	Villasana, LE; Westbrook, GL; Schnell, E				Villasana, L. E.; Westbrook, G. L.; Schnell, E.			Neurologic impairment following closed head injury predicts post-traumatic neurogenesis	EXPERIMENTAL NEUROLOGY			English	Article						Closed head injury; Traumatic brain injury; Adult neurogenesis; Hippocampus; Neurologic severity score	TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; GLASGOW COMA SCALE; DENTATE GYRUS; GRANULE CELLS; NEURONAL DIFFERENTIATION; ABERRANT NEUROGENESIS; COGNITIVE RECOVERY; RATS; PROLIFERATION	In the mammalian hippocampus, neurogenesis persists into adulthood, and increased generation of newborn neurons could be of clinical benefit following concussive head injuries. Post-traumatic neurogenesis has been well documented using "open" traumatic brain injury (TBI) models in rodents: however, human TBI most commonly involves closed head injury. Here we used a closed head injury (CHI) model to examine post-traumatic hippocampal neurogenesis in mice. All mice were subjected to the same CHI protocol, and a gross-motor based injury severity score was used to characterize neurologic impairment 1 h after the injury. When analyzed 2 weeks later, post-traumatic neurogenesis was significantly increased only in mice with a high degree of transient neurologic impairment immediately after injury. This increase was associated with an early increase in c-fos activity, and subsequent reactive astrocytosis and microglial activation in the dentate gyrus. Our results demonstrate that the initial degree of neurologic impairment after closed head injury predicts the induction of secondary physiologic and pathophysiologic processes, and that animals with severe neurologic impairment early after injury manifest an increase in post-traumatic neurogenesis in the absence of gross anatomic pathology. Published by Elsevier Inc.	[Villasana, L. E.; Schnell, E.] OHSU, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA; [Westbrook, G. L.] OHSU, Vollum Inst, Portland, OR 97239 USA; [Schnell, E.] Portland VA Med Ctr, Portland, OR 97239 USA		Schnell, E (corresponding author), Portland VA Med Ctr, 3710 SW US Vet Hosp Rd,P3ANES, Portland, OR 97239 USA.	schneler@ohsu.edu		Schnell, Eric/0000-0002-5623-5015	Department of Veteran's Affairs Career Development Award (CDA-2); National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM082770]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH046613]; National Institutes of Health for the OHSU Imaging Center [P30-NS061800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM082770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS083109, P30NS061800] Funding Source: NIH RePORTER	We would like to thank Nee lay Pandit for constructing the closed-head weight drop device and for assistance generating pilot data for this study, and to Dr. Stefanie Kaech-Petrie for assistance with imaging. Funding for the present work was provided by a Department of Veteran's Affairs Career Development Award (CDA-2) to Dr. Schnell, a National Institute of General Medical Sciences T32-GM082770 to Dr. Villasana, a National Institute of Mental Health R01-MH046613 to Dr. Westbrook, and a National Institutes of Health P30-NS061800 for the OHSU Imaging Center.	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; [Anonymous], 2012, INJ PREV CONTR TRAUM; BARONE P, 1993, SYNAPSE, V14, P1, DOI 10.1002/syn.890140102; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Couillard-Despres S, 2011, EUR J NEUROSCI, V33, P1037, DOI 10.1111/j.1460-9568.2011.07601.x; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Ho NF, 2013, MOL PSYCHIATR, V18, P404, DOI 10.1038/mp.2013.8; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Ohira K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-12; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Parent JM, 1997, J NEUROSCI, V17, P3727; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schnell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048045; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; TEASDALE G, 1974, LANCET, V2, P81; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang F, 2010, J NEUROSCI RES, V88, P519, DOI 10.1002/jnr.22224; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	15	16	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2014	261						156	162		10.1016/j.expneurol.2014.05.016			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR4AX	WOS:000343531500016	24861442	Green Accepted			2022-02-06	
J	Walsh, J; Eccleston, C; Keogh, E				Walsh, Joseph; Eccleston, Christopher; Keogh, Edmund			Pain communication through body posture: The development and validation of a stimulus set	PAIN			English	Article						Pain; Communication; Body posture; Nonverbal behaviour	TRAUMATIC BRAIN-INJURY; FACIAL EXPRESSION; NONVERBAL-COMMUNICATION; POSTOPERATIVE PAIN; GENDER-DIFFERENCES; RECOGNITION; EMOTION; RELIABILITY; CHILDREN; BEHAVIOR	Pain can be communicated nonverbally through facial expressions, vocalisations, and bodily movements. Most studies have focussed on the facial display of pain, whereas there is little research on postural display. Stimulus sets for facial and vocal expressions of pain have been developed, but there is no equivalent for body-based expressions. Reported here is the development of a new stimulus set of dynamic body postures that communicate pain and basic emotions. This stimulus set is designed to facilitate research into the bodily communication of pain. We report a 3-phase development and validation study. First 16 actors performed affective body postures for pain, as well as happiness, sadness, fear, disgust, surprise, anger, and neutral expressions. Second, 20 observers independently selected the best image stimuli based on the accuracy of emotion identification and valence/arousal ratings. Third, to establish reliability, this accuracy and valence rating procedure was repeated with a second independent group of 40 participants. A final set of 144 images with good reliability was established and is made available. Results demonstrate that pain, along with basic emotions, can be communicated through body posture. Cluster analysis demonstrates that pain and emotion are recognised with a high degree of specificity. In addition, pain was rated as the most unpleasant (negative valence) of the expressions, and was associated with a high level of arousal. For the first time, specific postures communicating pain are described. The stimulus set is provided as a tool to facilitate the study of nonverbal pain communication, and its possible uses are discussed. (C) 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	[Walsh, Joseph; Eccleston, Christopher; Keogh, Edmund] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England		Walsh, J (corresponding author), Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England.	j.a.d.walsh@bath.ac.uk		Eccleston, Christopher/0000-0003-0698-1543; Keogh, Edmund/0000-0002-1615-3699; Walsh, Joseph/0000-0002-3402-8402	Graduate School Scholarship by University of Bath	This research was funded by a Graduate School Scholarship provided by the University of Bath. The authors thank Emma Fisher of the University of Bath for acting as the second coder for the Body Action Posture Coding System (BAP) results.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Bartlett MS, 2014, CURR BIOL, V24, P738, DOI 10.1016/j.cub.2014.02.009; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; BERMAN D, 1992, BRIT J CANCER, V66, pS84; BOUCHER JD, 1980, J CROSS CULT PSYCHOL, V11, P263, DOI 10.1177/0022022180113003; Burgoon JK, 2002, J COMMUN, V52, P657, DOI 10.1093/joc/52.3.657; Clarke JE, 2009, EUR J PAIN, V13, P305, DOI 10.1016/j.ejpain.2008.04.009; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Coulson M, 2004, J NONVERBAL BEHAV, V28, P117, DOI 10.1023/B:JONB.0000023655.25550.be; CRAIG KD, 1992, APS J, V1, P153; Craig KD, 2010, J PAIN, V11, P101, DOI 10.1016/j.jpain.2009.08.008; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; Dael N, 2012, J NONVERBAL BEHAV, V36, P97, DOI 10.1007/s10919-012-0130-0; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Dethier M, 2012, J CLIN EXP NEUROPSYC, V34, P936, DOI 10.1080/13803395.2012.702734; EKMAN P, 1965, J PERS SOC PSYCHOL, V2, P726, DOI 10.1037/h0022736; EKMAN P, 1967, PERCEPT MOTOR SKILL, V24, P711, DOI 10.2466/pms.1967.24.3.711; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 1976, PICTURE FACIAL AFFEC; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fillingim RB, 1995, PAIN FORUM, V4, P209, DOI 10.1016/S1082-3174(11)80022-X; Fleiss J, 2004, STAT METHODS RATES P; GEISSER ME, 1994, PAIN, V59, P79, DOI 10.1016/0304-3959(94)90050-7; Hand I, 2010, INT J PEDIAT, V2010, P1; Harrigan J.., 2005, NEW HDB METHODS NONV; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Jensen MP, 1996, PAIN, V67, P35, DOI 10.1016/0304-3959(96)03078-3; KEEFE FJ, 1982, BEHAV THER, V13, P363, DOI 10.1016/S0005-7894(82)80001-4; Keogh E, 2014, PAIN, V155, P1927, DOI 10.1016/j.pain.2014.06.024; Krahe C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00386; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; LaFrance M., 1978, INT J INTERCULT REL, V2, P71, DOI [10.1016/0147-1767(78)90029-9, DOI 10.1016/0147-1767(78)90029-9]; LaGuardia R, 1982, EFFECT SOCIAL SETTIN; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; MATSUMOTO D, 1990, MOTIV EMOTION, V14, P195, DOI 10.1007/BF00995569; MCGRATH PJ, 1985, ADV PAIN RES THER, V9, P395; Prkachin KM, 2008, PAIN, V139, P267, DOI 10.1016/j.pain.2008.04.010; Prkachin KM, 2007, CLIN J PAIN, V23, P270, DOI 10.1097/AJP.0b013e3180308d28; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Riedl V, 2011, NEUROIMAGE, V57, P206, DOI 10.1016/j.neuroimage.2011.04.011; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Sullivan MJL, 2004, PAIN, V107, P220, DOI 10.1016/j.pain.2003.11.003; TARBELL SE, 1992, PAIN, V50, P273, DOI 10.1016/0304-3959(92)90031-6; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Tsai PF, 2011, RES NURS HEALTH, V34, P218, DOI 10.1002/nur.20432; von Baeyer CL, 2007, PAIN, V127, P140, DOI 10.1016/j.pain.2006.08.014; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	52	15	15	1	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	NOV	2014	155	11					2282	2290		10.1016/j.pain.2014.08.019			9	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; Neurosciences & Neurology	AU1YM	WOS:000345413400011	25168671	Green Accepted			2022-02-06	
J	Kahveci, R; Gokce, EC; Gurer, B; Gokce, A; Kisa, U; Cemil, DB; Sargon, MF; Kahveci, FO; Aksoy, N; Erdogan, B				Kahveci, Ramazan; Gokce, Emre Cemal; Gurer, Bora; Gokce, Aysun; Kisa, Ucler; Cemil, Duran Berker; Sargon, Mustafa Fevzi; Kahveci, Fatih Ozan; Aksoy, Nurkan; Erdogan, Bulent			Neuroprotective effects of rosuvastatin against traumatic spinal cord injury in rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Methylprednisolone; Neuroprotection; Rat; Rosuvastatin; Spinal cord injury; Trauma	A REDUCTASE INHIBITOR; NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; LIPID-PEROXIDATION; FUNCTIONAL RECOVERY; SUPEROXIDE-DISMUTASE; CEREBRAL-ISCHEMIA; GLIAL APOPTOSIS; BRAIN-INJURY; CELL-DEATH	Rosuvastatin, which is a potent stain, has never been studied in traumatic spinal cord injury. The aim of this study was to investigate whether rosuvastatin treatment could protect the spinal cord after experimental spinal cord injury. Rats were randomized into the following five groups of eight animals each: control, sham, trauma, rosuvastatin, and methylprednisolone. In the control group, no surgical intervention was performed. In the sham group, only laminectomy was performed. In all the other groups, the spinal cord trauma model was created by the occlusion of the spinal cord with an aneurysm clip. In the spinal cord tissue, caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, nitric oxide levels, and superoxide dismutase levels were analyzed. Histopathological and ultrastructural evaluations were also performed. Neurological evaluation was performed using the Basso, Beattie, and Bresnahan locomotor scale and the inclined plane test After traumatic spinal cord injury, increases in caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels were detected. In contrast, the superoxide dismutase levels were decreased. After the administration of rosuvastatin, decreases were observed in the tissue caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels. In contrast, tissue superoxide dismutase levels were increased. Furthermore, rosuvastatin treatment showed improved results concerning the histopathological scores, the ultrastructural score and the functional tests. Biochemical, histopathological, ultrastructural analysis and functional tests revealed that rosuvastatin exhibits meaningful neuroprotective effects against spinal cord injury. (C) 2014 Elsevier B.V. All rights reserved.	[Kahveci, Ramazan] Kirikkale Yuksek Ihtisas Hosp, Dept Neurosurg, Minist Hlth, Kirikkale, Turkey; [Gokce, Emre Cemal; Cemil, Duran Berker; Erdogan, Bulent] Turgut Ozal Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Gurer, Bora] Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Beyin Cerrahi Serv, Minist Hlth, TR-34752 Istanbul, Turkey; [Gokce, Aysun] Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Pathol, Minist Hlth, Ankara, Turkey; [Kisa, Ucler; Aksoy, Nurkan] Kirikkale Univ, Fac Med, Dept Biochem, Kirikkale, Turkey; [Sargon, Mustafa Fevzi] Hacettepe Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey; [Kahveci, Fatih Ozan] Bulent Ecevit Univ, Fac Med, Dept Emergency Med, Zonguldak, Turkey		Gurer, B (corresponding author), Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Beyin Cerrahi Serv, Minist Hlth, TR-34752 Istanbul, Turkey.	boragurer@gmail.com	Kahveci, Fatih Ozan/ABC-7814-2021; Sargon, Mustafa F./AAZ-5470-2021; Gokce, Aysun/AAD-3055-2022; KISA, Ucler/V-5443-2017; Gurer, Bora/K-1177-2012	Sargon, Mustafa F./0000-0001-6360-6008; KISA, Ucler/0000-0002-8131-6810; Gurer, Bora/0000-0003-1500-6184			BALENTINE JD, 1978, LAB INVEST, V39, P236; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BORGENS RB, 1986, J COMP NEUROL, V250, P157, DOI 10.1002/cne.902500203; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DAWSON TM, 1994, ANN NY ACAD SCI, V738, P76; Dery MA, 2009, NEUROSCI LETT, V453, P73, DOI 10.1016/j.neulet.2009.01.062; Die J, 2010, BRAIN RES, V1346, P251, DOI 10.1016/j.brainres.2010.05.068; Dinc C, 2013, SPINE, V38, pE1649, DOI 10.1097/BRS.0000000000000055; Domoki F, 2010, NEUROCHEM INT, V56, P404, DOI 10.1016/j.neuint.2009.11.013; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-81; Fletcher B, 2005, CIRCULATION, V112, P3184, DOI 10.1161/CIRCULATIONAHA.105.169180; Han XG, 2012, NEUROSCI LETT, V521, P136, DOI 10.1016/j.neulet.2012.05.071; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; HSU C Y, 1990, Journal of Neurotrauma, V7, P115, DOI 10.1089/neu.1990.7.115; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jungner M, 2013, MICROVASC RES, V88, P48, DOI 10.1016/j.mvr.2013.03.004; KALTSCHMIDT B, 1993, MOL ASPECTS MED, V14, P171, DOI 10.1016/0098-2997(93)90004-W; Kaptanoglu E, 2002, J NEUROSURG, V97, P49, DOI 10.3171/spi.2002.97.1.0049; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kertmen H, 2013, EUR J PHARMACOL, V714, P148, DOI 10.1016/j.ejphar.2013.05.012; Kilic U, 2005, NEUROSCIENCE, V134, P901, DOI 10.1016/j.neuroscience.2005.04.063; Kurt G, 2009, SURG NEUROL, V71, P332, DOI 10.1016/j.surneu.2008.01.038; Laufs U, 2002, BRAIN RES, V942, P23, DOI 10.1016/S0006-8993(02)02649-5; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Liu XZ, 1997, J NEUROSCI, V17, P5395; Mann CM, 2010, EXP NEUROL, V221, P285, DOI 10.1016/j.expneurol.2009.11.006; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McKenney JM, 2003, CURR MED RES OPIN, V19, P689, DOI 10.1185/030079903125002405; McTaggart F, 2001, AM J CARDIOL, V87, p28B; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan WH, 2003, J NEUROIMMUNOL, V134, P111, DOI 10.1016/S0165-5728(02)00426-5; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Prinz V, 2008, STROKE, V39, P433, DOI 10.1161/STROKEAHA.107.492470; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Savoia Claudia, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P57; Schroter A, 2009, NEUROSCIENCE, V161, P753, DOI 10.1016/j.neuroscience.2009.04.016; Sheehy N, 2001, EXPERT OPIN INV DRUG, V10, P1847, DOI 10.1517/13543784.10.10.1847; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Sonmez E, 2013, SPINE, V38, P1253, DOI 10.1097/BRS.0b013e3182895587; Stepien K, 2005, PHARMACOL REP, V57, P561; SUN Y, 1988, CLIN CHEM, V34, P497; Tapia-Perez JH, 2010, NEUROSURG REV, V33, P259, DOI 10.1007/s10143-010-0259-4; Torres S, 2010, NEUROPATHOLOGY, V30, P36, DOI 10.1111/j.1440-1789.2009.01037.x; Ucak A, 2011, ANN VASC SURG, V25, P686, DOI 10.1016/j.avsg.2011.02.024; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Vaziri ND, 2004, BRAIN RES, V995, P76, DOI 10.1016/j.brainres.2003.09.056; Yavuz C, 2013, CNS NEUROL DISORD-DR, V12, P1011, DOI 10.2174/18715273113129990085; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Yin Y, 2013, NEUROCHEM INT, V62, P903, DOI 10.1016/j.neuint.2013.03.005; Zacco A, 2003, J NEUROSCI, V23, P11104	67	15	17	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	OCT 15	2014	741						45	54		10.1016/j.ejphar.2014.07.042			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AQ9CW	WOS:000343140600006	25084223				2022-02-06	
J	Tabansky, I; Quinkert, AW; Rahman, N; Muller, SZ; Lofgren, J; Rudling, J; Goodman, A; Wang, YP; Pfaff, DW				Tabansky, Inna; Quinkert, Amy Wells; Rahman, Nadera; Muller, Salomon Zev; Lofgren, Jesper; Rudling, Johan; Goodman, Alyssa; Wang, Yingping; Pfaff, Donald W.			Temporally-patterned deep brain stimulation in a mouse model of multiple traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Deep brain stimulation; Traumatic brain injury; Generalized arousal; Mouse; Central thalamus	INFERIOR COLLICULUS; AUDITORY-CORTEX; CNS AROUSAL; INFORMATION; IMPROVES; NEURONS; CODES; MICE; REPRESENTATIONS; PLASTICITY	We report that mice with closed-head multiple traumatic brain injury (TBI) show a decrease in the motoric aspects of generalized arousal, as measured by automated, quantitative behavioral assays. Further, we found that temporally-patterned deep brain stimulation (DBS) can increase generalized arousal and spontaneous motor activity in this mouse model of TBI. This arousal increase is input-pattern-dependent, as changing the temporal pattern of DBS can modulate its effect on motor activity. Finally, an extensive examination of mouse behavioral capacities, looking for deficits in this model of TBI, suggest that the strongest effects of TBI in this model are found in the initiation of any kind of movement. (C) 2014 Elsevier B.V. All rights reserved.	[Tabansky, Inna; Quinkert, Amy Wells; Rahman, Nadera; Muller, Salomon Zev; Lofgren, Jesper; Rudling, Johan; Goodman, Alyssa; Wang, Yingping; Pfaff, Donald W.] Rockefeller Univ, Neurobiol & Behav Lab, New York, NY 10065 USA; [Lofgren, Jesper; Rudling, Johan] Linkoping Univ, Fac Hlth Sci, S-58183 Linkoping, Sweden		Tabansky, I (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave,Box 275, New York, NY 10065 USA.	itabansky@rockefeller.edu	Krammel, Vera/N-4826-2014	Krammel, Vera/0000-0002-8273-8396; Tabansky, Inna/0000-0001-6454-1816; Quinkert, Amy/0000-0002-0165-6197	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01 NS067249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067249] Funding Source: NIH RePORTER	This research was funded by NIH 5R01 NS067249 to D. Pfaff with N. Schiff. Helpful discussions with Nicholas Schiff, Keith Purpura and Khatuna Gagnidze are gratefully acknowledged.	Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Bao T-H, 2014, J MOL NEUROSCI; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; COHEN JE, 1995, NATURE, V378, P610, DOI 10.1038/378610a0; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Di Lorenzo PM, 2009, BEHAV NEUROSCI, V123, P14, DOI 10.1037/a0014176; Faul M, 2010, TRAUMATIC BRAIN INJU; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; Gonzalez MMC, 2013, J NEUROTRAUM, V30, P119, DOI 10.1089/neu.2012.2499; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Kimmel DL, 2007, J NEUROSCI, V27, P7619, DOI 10.1523/JNEUROSCI.0386-07.2007; Kozloski J, 2000, J NEUROSCI, V20, P2400; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Laurent G, 1996, J NEUROSCI, V16, P3837; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Litvin Y, 2013, GENES BRAIN BEHAV, V12, P479, DOI 10.1111/gbb.12045; Malone BJ, 2010, J NEUROSCI, V30, P767, DOI 10.1523/JNEUROSCI.4170-09.2010; Marsat G, 2005, J NEUROSCI, V25, P6137, DOI 10.1523/JNEUROSCI.0646-05.2005; Mechler F, 1998, J NEUROSCI, V18, P6583; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Pfaff D, 2007, BIOESSAYS, V29, P803, DOI 10.1002/bies.20611; Quinkert AW, 2012, BEHAV BRAIN RES, V229, P349, DOI 10.1016/j.bbr.2012.01.025; Quinkert AW, 2011, P NATL ACAD SCI USA, V108, P15617, DOI 10.1073/pnas.1101894108; Quinkert AW, 2010, BEHAV BRAIN RES, V214, P377, DOI 10.1016/j.bbr.2010.06.009; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Sanchez JT, 2007, J NEUROSCI, V27, P1954, DOI 10.1523/JNEUROSCI.2894-06.2007; Schiff ND, 2008, NATURE, V452, P120, DOI 10.1038/nature06818; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2009, ANN NY ACAD SCI, V1157, P101, DOI 10.1111/j.1749-6632.2008.04123.x; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; Wasserman G.S., 1992, NEUROSIGNALS, V1, P117; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; Wenk GL., 1998, CURR PROTOC NEUROSCI, V4, P8, DOI [10.1002/0471142301.ns0805bs04, DOI 10.1002/0471142301.NS0805BS04]; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; Wu SH, 2004, J NEUROSCI, V24, P4625, DOI 10.1523/JNEUROSCI.0318-04.2004	47	15	15	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 14	2014	273						123	132		10.1016/j.bbr.2014.07.026			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AP7KN	WOS:000342256300015	25072520	Green Accepted			2022-02-06	
J	Alali, AS; Naimark, DMJ; Wilson, JR; Fowler, RA; Scales, DC; Golan, E; Mainprize, TG; Ray, JG; Nathens, AB				Alali, Aziz S.; Naimark, David M. J.; Wilson, Jefferson R.; Fowler, Robert A.; Scales, Damon C.; Golan, Eyal; Mainprize, Todd G.; Ray, Joel G.; Nathens, Avery B.			Economic Evaluation of Decompressive Craniectomy Versus Barbiturate Coma for Refractory Intracranial Hypertension Following Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						barbiturate; cost-effectiveness; decompressive craniectomy; intracranial pressure; quality-adjusted life years; traumatic brain injury	SEVERE HEAD-INJURY; COST-EFFECTIVENESS; UNITED-STATES; HEALTH; OUTCOMES; STRATEGIES; MORTALITY; PRESSURE; DECRA; MODEL	Objectives: Decompressive craniectomy and barbiturate coma are often used as second-tier strategies when intracranial hypertension following severe traumatic brain injury is refractory to first-line treatments. Uncertainty surrounds the decision to choose either treatment option. We investigated which strategy is more economically attractive in this context. Design: We performed a cost-utility analysis. A Markov Monte Carlo microsimulation model with a life-long time horizon was created to compare quality-adjusted survival and cost of the two treatment strategies, from the perspective of healthcare payer. Model parameters were estimated from the literature. Two-dimensional simulation was used to incorporate parameter uncertainty into the model. Value of information analysis was conducted to identify major drivers of decision uncertainty and focus future research. Setting: Trauma centers in the United States. Subjects: Base case was a population of patients (mean age = 25 yr) who developed refractory intracranial hypertension following traumatic brain injury. Interventions: We compared two treatment strategies: decompressive craniectomy and barbiturate coma. Measurements and Main Results: Decompressive craniectomy was associated with an average gain of 1.5 quality-adjusted life years relative to barbiturate coma, with an incremental cost-effectiveness ratio of $ 9,565/quality-adjusted life year gained. Decompressive craniectomy resulted in a greater quality-adjusted life expectancy 86% of the time and was more cost-effective than barbiturate coma in 78% of cases if our willingness-to-pay threshold is $ 50,000/quality-adjusted life year and 82% of cases at a threshold of $ 100,000/quality-adjusted life year. At older age, decompressive craniectomy continued to increase survival but at higher cost (incremental cost-effectiveness ratio = $ 197,906/ quality-adjusted life year at mean age = 85 yr). Conclusions: Based on available evidence, decompressive craniectomy for the treatment of refractory intracranial hypertension following traumatic brain injury provides better value in terms of costs and health gains than barbiturate coma. However, decompressive craniectomy might be less economically attractive for older patients. Further research, particularly on natural history of severe traumatic brain injury patients, is needed to make more informed treatment decisions.	[Alali, Aziz S.; Fowler, Robert A.; Scales, Damon C.; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Alali, Aziz S.; Naimark, David M. J.; Fowler, Robert A.; Scales, Damon C.; Golan, Eyal; Ray, Joel G.; Nathens, Avery B.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Alali, Aziz S.] Univ Ottawa, Div Neurosurg, Ottawa, ON, Canada; [Naimark, David M. J.; Ray, Joel G.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wilson, Jefferson R.; Mainprize, Todd G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Fowler, Robert A.; Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.; Scales, Damon C.; Golan, Eyal] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Ray, Joel G.; Nathens, Avery B.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Nathens, Avery B.] Univ Toronto, Dept Surg, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada		Alali, AS (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	aziz.alali@mail.utoronto.ca	Golan, Eyal/D-3086-2014	Golan, Eyal/0000-0002-2904-9321	Physicians' Services Inc. Foundation.; Heart and Stroke Foundation Clinician-Scientist Award; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Physicians' Services Incorporated Foundation; Canada Research Chair Program in Systems of Trauma Care	Dr. Alali was supported by grants from Physicians' Services Inc. Foundation. Dr. Fowler was supported by a Heart and Stroke Foundation Clinician-Scientist Award. Dr. Scales was supported by a New Investigator Award from the Canadian Institutes of Health Research and a Fellowship in Translational Health Research from Physicians' Services Incorporated Foundation. Dr. Ray holds a Canadian Institutes for Health Research Chair in Reproductive and Child Health Services and Policy Research. Dr. Nathens was supported by grants from Canada Research Chair Program in Systems of Trauma Care. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; American Health Care Association, 2012 REP SHORTF MED; Arias Elizabeth, 2012, Natl Vital Stat Rep, V61, P1; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Committee on Injury Scaling, 1998, ABBR INJ SCAL; Cooper DJ, 2011, MED J AUSTRALIA, V194, P437, DOI 10.5694/j.1326-5377.2011.tb03053.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; *CTR MED MED SERV, CMS FIL DOWNL MED PA; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gold M., 1996, COST EFFECTIVENESS H; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Kitagawa RS, 2013, WORLD NEUROSURG, V79, P82, DOI 10.1016/j.wneu.2012.10.031; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Marion DW, 2006, NEUROSURGERY, V58, P655; Naimark DMJ, 2013, MED DECIS MAKING, V33, P961, DOI 10.1177/0272989X13501558; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; Quinn RR, 2007, AM J KIDNEY DIS, V50, P421, DOI 10.1053/j.ajkd.2007.05.019; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; ROBERTS I, 2000, COCHRANE DB SYST REV, V2; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Schneider GH, 2002, ACT NEUR S, V81, P77; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shaw JW, 2010, VALUE HEALTH, V13, P278, DOI 10.1111/j.1524-4733.2009.00675.x; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2014, TRAUM BRAIN INJ MOD; U.S. Department of Labor Bureau of Labor Statistics, CONS PRIC IND; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	50	15	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2014	42	10					2235	2243		10.1097/CCM.0000000000000500			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP7BC	WOS:000342231500011	25054675				2022-02-06	
J	Barmparas, G; Liou, DZ; Lamb, AW; Gangi, A; Chin, M; Ley, EJ; Salim, A; Bukur, M				Barmparas, Galinos; Liou, Douglas Z.; Lamb, Alexander W.; Gangi, Alexandra; Chin, Mike; Ley, Eric J.; Salim, Ali; Bukur, Marko			Prehospital hypertension is predictive of traumatic brain injury and is associated with higher mortality	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; hypertension; adrenergic hyperactivity; prediction; score	GLASGOW COMA SCALE; SYMPATHETIC HYPERACTIVITY; CEREBRAL PERFUSION; RESISTANT RULES; IMPACT; PROPRANOLOL; CATECHOLAMINES; PERFORMANCE; ALCOHOL; PATIENT	BACKGROUND: The purpose of the current study was to investigate the effect of early adrenergic hyperactivity as manifested by prehospital (emergency medical service [EMS]) hypertension on outcomes of traumatic brain injury (TBI) patients and to develop a prognostic model of the presence of TBI based on EMS and admission (emergency department [ED]) hypertension. METHODS: This study is a retrospective review of the 2007 to 2008 National Trauma Data Bank including blunt trauma patients 15 years or older with available EMS and ED vital signs. Patients with head Abbreviated Injury Scale (AIS) score of 3 or greater were selected, and mortality was examined within EMS systolic blood pressure (SBP) groups: lower than 100 mm Hg, 110 mm Hg to 150 mm Hg, 160 mm Hg to 180 mm Hg, and 190 mm Hg to 230 mm Hg. A forward logistic regression model including the EMS heart rate, EMS SBP, EMS Glasgow Coma Scale (GCS) score, ED heart rate, and ED SBP was used to identify predictors of a TBI in patients with ED GCS score of less than or equal to 8, 9 to 13, and 14 to 15. RESULTS: For the 5-year study period, 315,242 patients met inclusion criteria. Adjusted odds for mortality increased in a stepwise fashion with increasing EMS SBP compared with patients with normal EMS SBP (adjusted odds ratio [95% confidence interval], 1.33 [1.22-1.44], p < 0.001, for EMS SBP of 160-180 mm Hg and 1.97 [1.76-2.21], p < 0.001, for EMS SBP of 190-230 mm Hg). A 7-point scoring system was developed for each ED GCS score group to predict the presence of a TBI. EMS SBP of greater than 150 mm Hg and ED SBP of greater than 150 mm Hg were both predictive of the presence of a TBI in patients with ED GCS score of 8 or less and in patients with ED GCS score of 9 to 13 or 14 to 15, respectively. CONCLUSION: Prehospital hypertension in TBI is associated with a higher mortality risk. Early hypertension in the prehospital setting and at admission can be used to predict the presence of such injuries. These findings may have important early triage and treatment implications. Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Barmparas, Galinos; Liou, Douglas Z.; Lamb, Alexander W.; Gangi, Alexandra; Chin, Mike; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA 90048 USA; [Salim, Ali] Brigham & Womens Hosp, Dept Surg, Div Acute Care Surg & Surg Crit Care, Boston, MA 02115 USA; [Bukur, Marko] Delray Med Ctr, Dept Surg, Div Trauma Surg & Surg Crit Care, Ft Lauderdale, FL USA; [Bukur, Marko] Broward Hlth Med Ctr, Dept Surg, Div Trauma Surg & Surg Crit Care, Ft Lauderdale, FL USA		Bukur, M (corresponding author), Delray Trauma Off, Delray Hlth Med Ctr, Fair Oaks Pavil,5352 Linton Blvd, Delray Beach, FL 33484 USA.	mbukur@browardhealth.org	Barmparas, Galinos/L-6530-2019	Gangi, Afshin/0000-0002-0952-7760; Bukur, Marko/0000-0002-1850-7147			Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Barmparas G, 2012, AM SURGEON, V78, P1166; CDC, TBI US REP TRAUM BRA; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; FRAYN KN, 1985, CIRC SHOCK, V16, P229; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Kemp CD, 2008, AM SURGEON, V74, P866; Kornblith LZ, 2013, J TRAUMA ACUTE CARE, V74, P1548, DOI 10.1097/TA.0b013e31829215eb; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2012, J TRAUMA ACUTE CARE, V72, P943, DOI 10.1097/TA.0b013e3182465527; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Morris GF, 1997, WESTERN J MED, V166, P415; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rados A, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-48; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Sloan AE, 2003, SEMIN RADIAT ONCOL, V13, P309, DOI 10.1016/S1053-4296(03)00030-4; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6	39	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2014	77	4					592	598		10.1097/TA.0000000000000382			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AQ8ZN	WOS:000343129700013	25250599				2022-02-06	
J	Callahan, DS; Kim, D; Bricker, S; Neville, A; Putnam, B; Smith, J; Bongard, F; Plurad, D				Callahan, Devon S.; Kim, Dennis; Bricker, Scott; Neville, Angela; Putnam, Brant; Smith, Jennifer; Bongard, Frederic; Plurad, David			Trends in Organ Donor Management: 2002 to 2012	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article								BACKGROUND: Refinements in donor management have resulted in increased numbers and quality of grafts after neurologic death. We hypothesize that the increased use of hormone replacement therapy (HRT) has been accompanied by improved outcomes over time. STUDY DESIGN: Using the Organ Procurement and Transplant Network donor database, all brain-dead donors procured from July 1, 2001 to June 30, 2012 were studied. Hormone replacement therapy was identified by an infusion of thyroid hormone. An expanded criteria donor was defined as age 60 years or older. Incidence of HRT administration and number of donors and organs recovered were calculated. Using the Organ Procurement and Transplant Network thoracic recipient database transplant list, wait times were examined. RESULTS: There were 74,180 brain-dead donors studied. Hormone replacement therapy use increased substantially from 25.6% to 72.3% of donors. However, mean number of organs procured per donor remained static (3.51 to 3.50; p = 0.083), and the rate of high-yield donors decreased (46.4% to 43.1%; p < 0.001). Incidence of traumatic brain injury donors decreased (42.1% to 33.9%; p < 0.001) relative to an increased number of expanded criteria donors (22.1% to 26%). Despite this, there has been an increase in the raw number of donors (20,558 to 24,308; p < 0.001) and organs (5,857 to 6,945; p < 0.001). There has been an increase in organs per traumatic brain injury donor (4.02 to 4.12; p = 0.002) and a decrease in days on the waiting list (462.2 to 170.4 days; p < 0.001) for a thoracic transplant recipient. CONCLUSIONS: The marked increase in the use of HRT in the management of brain-dead donors has been accompanied by increased organ availability overall. Potential mechanisms might include successful conversion of previously unacceptable donors and improved recovery in certain subsets of donors. (C) 2014 by the American College of Surgeons	[Callahan, Devon S.; Kim, Dennis; Bricker, Scott; Neville, Angela; Putnam, Brant; Smith, Jennifer; Bongard, Frederic; Plurad, David] Harbor UCLA Med Ctr, Div Trauma Surg Crit Care & Acute Care Surg, Los Angeles, CA 90502 USA		Plurad, D (corresponding author), Harbor UCLA Med Ctr, Div Trauma Surg Crit Care & Acute Care Surg, 1000 W Carson St,Box 42, Los Angeles, CA 90502 USA.	dplurad@dhs.lacounty.gov			Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [234-2005-37011C]	This work was supported in part by Health Resources and Services Administration contract 234-2005-37011C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Callahan DS, 2014, J SURG RES, V186, P452, DOI 10.1016/j.jss.2013.09.028; Cooper David K C, 2008, Int J Surg, V6, P3, DOI 10.1016/j.ijsu.2006.11.007; Kutsogiannis DJ, 2006, CAN J ANAESTH, V53, P820, DOI 10.1007/BF03022800; Macdonald PS, 2012, CRIT CARE MED, V40, P1635, DOI 10.1097/CCM.0b013e3182416ee7; Otth M, 2011, SWISS MED WEEKLY, V141, P13230; POWNER DJ, 1990, CRIT CARE MED, V18, P702; Rosendale JD, 2003, TRANSPLANTATION, V75, P1336, DOI 10.1097/01.TP.0000062839.58826.6D; Sampson BG, 2013, CRIT CARE RESUSC, V15, P21	8	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2014	219	4					752	756		10.1016/j.jamcollsurg.2014.04.017			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AP9TJ	WOS:000342422500020	25154673				2022-02-06	
J	Haldipur, P; Dupuis, N; Degos, V; Moniaux, N; Chhor, V; Rasika, S; Schwendimann, L; le Charpentier, T; Rougier, E; Amouyal, P; Amouyal, G; Dournaud, P; Brechot, C; El Ghouzzi, V; Faivre, J; Fleiss, B; Mani, S; Gressens, P				Haldipur, Parthiv; Dupuis, Nina; Degos, Vincent; Moniaux, Nicolas; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Amouyal, Paul; Amouyal, Gilles; Dournaud, Pascal; Brechot, Christian; El Ghouzzi, Vincent; Faivre, Jamila; Fleiss, Bobbi; Mani, Shyamala; Gressens, Pierre			HIP/PAP prevents excitotoxic neuronal death and promotes plasticity	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article								Objectives: Excitotoxicity plays a significant role in the pathogenesis of perinatal brain injuries. Among the consequences of excessive activation of the N-methyl-D-aspartate (NMDA)-type glutamate are oxidative stress caused by free radical release from damaged mitochondria, neuronal death and subsequent loss of connectivity. Drugs that could protect nervous tissue and support regeneration are attractive therapeutic options. The hepatocarcinoma intestine pancreas protein/pancreatitis-associated protein I (HIP/PAP) or Reg3 alpha, which is approved for clinical testing for the protection and regeneration of the liver, is upregulated in the central nervous system following injury or disease. Here, we examined the neuroprotective/neuroregenerative potential of HIP/PAP following excitotoxic brain injury. Methods: We studied the expression of HIP/PAP and two of its putative effectors, cAMP-regulated phosphoprotein 19 (ARPP19) and growth-associated protein 43 (GAP-43), in the neonatal brain, and the protective/regenerative properties of HIP/PAP in three paradigms of perinatal excitotoxicity: intracerebral injection of the NMDA agonist ibotenate in newborn pups, a pediatric model of traumatic brain injury, and cultured primary cortical neurons. Results: HIP/PAP, ARPP19, and GAP-43 were expressed in the neonatal mouse brain. HIP/PAP prevented the formation of cortical and white matter lesions and reduced neuronal death and glial activation following excitotoxic insults in vivo. In vitro, HIP/PAP promoted neuronal survival, preserved neurite complexity and fasciculation, and protected cell contents from reactive oxygen species (ROS)-induced damage. Interpretation: HIP/PAP has strong neuroprotective/neuroregenerative potential following excitotoxic injury to the developing brain, and could represent an interesting therapeutic strategy in perinatal brain injury.	[Haldipur, Parthiv; Mani, Shyamala] Natl Brain Res Ctr, Manesar, India; [Haldipur, Parthiv; Mani, Shyamala] IISC, Ctr Neurosci, Bangalore, Karnataka, India; [Dupuis, Nina; Degos, Vincent; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Dournaud, Pascal; El Ghouzzi, Vincent; Fleiss, Bobbi; Gressens, Pierre] INSERM, U1141, Paris, France; [Dupuis, Nina; Degos, Vincent; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Dournaud, Pascal; El Ghouzzi, Vincent; Fleiss, Bobbi; Gressens, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, UMRS 1141, Paris, France; [Dupuis, Nina; Degos, Vincent; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Dournaud, Pascal; El Ghouzzi, Vincent; Fleiss, Bobbi; Gressens, Pierre] PremUP, Paris, France; [Moniaux, Nicolas; Brechot, Christian; Faivre, Jamila] INSERM, U785, Ctr Hepatobiliaire, Villejuif, France; [Moniaux, Nicolas; Brechot, Christian; Faivre, Jamila] Univ Paris Sud, Fac Med, Villejuif, France; [Chhor, Vibol; Fleiss, Bobbi; Gressens, Pierre] Kings Coll London, St Thomas Hosp, Ctr Dev Brain, Div Imaging Sci & Biomed Engn,Kings Hlth Partners, London, England; [Amouyal, Paul; Amouyal, Gilles] Alfact Innovat, Paris, France		Gressens, P (corresponding author), Hop Robert Debre, INSERM, U1141, 48 Blvd Serurier, F-75019 Paris, France.	pierre.gressens@inserm.fr	gressens, pierre/M-7557-2017; Moniaux, Nicolas/Y-3243-2018; Fleiss, Bobbi/F-9899-2011; Haldipur, Parthiv/ABH-8875-2020	gressens, pierre/0000-0002-0909-4221; Moniaux, Nicolas/0000-0001-9718-1386; Fleiss, Bobbi/0000-0001-7828-673X; El Ghouzzi, Vincent/0000-0001-5894-8978; HALDIPUR, PARTHIV/0000-0003-2865-8683			Ampo KI, 2009, J NEUROTRAUM, V26, P1683, DOI [10.1089/neu.2008.0847, 10.1089/neu.2008-0847]; Averill S, 2002, J NEUROSCI, V22, P7493; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Carlsson Y, ANN NEUROL; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Degos V, 2013, ANESTHESIOLOGY, V118, P1123, DOI 10.1097/ALN.0b013e318286cf36; Delcour M, 2012, BRAIN PATHOL, V22, P1, DOI 10.1111/j.1750-3639.2011.00504.x; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Guo Q, 1999, P NATL ACAD SCI USA, V96, P4125, DOI 10.1073/pnas.96.7.4125; Gupta SK, 2010, J NEUROSCI, V30, P2755, DOI 10.1523/JNEUROSCI.4218-09.2010; Gupta SK, CELL DEATH DIFFER; Haldipur P, 2012, STEM CELLS DEV, V21, P1059, DOI 10.1089/scd.2011.0206; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Irwin N, P NATL ACAD SCI US; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kaindl AM, 2007, PROTEOM CLIN APPL, V1, P640, DOI 10.1002/prca.200600696; Keller M, 2008, EUR J NEUROSCI, V27, P874, DOI 10.1111/j.1460-9568.2008.06062.x; Klementiev B, EUR J NEUROSCI; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lieu HT, 2006, J HEPATOL, V44, pS136, DOI 10.1016/S0168-8278(06)80356-9; Lieu HT, 2006, HEPATOLOGY, V44, P1452, DOI 10.1002/hep.21434; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Lv YF, 2012, INFLAMM BOWEL DIS, V18, P1950, DOI 10.1002/ibd.22887; Marz-Weiss P, 2011, CELL MOL NEUROBIOL, V31, P1141, DOI 10.1007/s10571-011-9715-0; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; MARRET S, 1995, J NEUROPATH EXP NEUR, V54, P358, DOI 10.1097/00005072-199505000-00009; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Medja F, 2006, BRAIN, V129, P3209, DOI 10.1093/brain/awl239; Mesples B, 2005, ACTA PAEDIATR, V94, P185, DOI 10.1080/08035250410022378; Moniaux N, HUMAN HEPATOCARCINOM; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Palmer AM, J NEUROCHEM; Redecker C, 1998, DEV BRAIN RES, V109, P109, DOI 10.1016/S0165-3806(98)00065-0; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Viterbo D, 2008, J IMMUNOL, V181, P1948, DOI 10.4049/jimmunol.181.3.1948; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; White RE, 2012, NEUROREPORT, V23, P590, DOI 10.1097/WNR.0b013e3283540394; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029155	46	15	17	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	OCT	2014	1	10					739	754		10.1002/acn3.127			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V45KN	WOS:000209815600001	25493266	Green Submitted, gold, Green Published			2022-02-06	
J	Miller, BA; Bass, DI; Chern, JJ				Miller, Brandon A.; Bass, David I.; Chern, Joshua J.			Development of a de novo arteriovenous malformation after severe traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						AVM; arteriovenous malformation; traumatic brain injury; vascular disorders; trauma	CHILD; ANEURYSMS; RESECTION; DISEASE	Arteriovenous malformations (AVMs) are typically considered congenital lesions, although there is growing evidence for de novo formation of these lesions as well. The authors present the case of an AVM in the same cerebral cortex that had been affected by a severe traumatic brain injury (TBI) more than 6 years earlier. To the best of the authors' knowledge, this is the first report attributing the formation of an AVM directly to TBI.	[Miller, Brandon A.; Bass, David I.; Chern, Joshua J.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Chern, Joshua J.] Childrens Healthcare Atlanta, Pediat Neurosurg Associates, Atlanta, GA USA		Miller, BA (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, 1365-B Clifton Rd,Ste 6200, Atlanta, GA 30322 USA.	brandon.miller@emory.edu					Akimoto H, 2003, NEUROSURGERY, V52, P228, DOI 10.1097/00006123-200301000-00030; Alvarez H, 2012, J NEUROSURG-PEDIATR, V9, P327, DOI 10.3171/2011.12.PEDS11312; AWAD IA, 1990, J NEUROSURG, V72, P839, DOI 10.3171/jns.1990.72.6.0839; Bulsara KR, 2002, NEUROSURGERY, V50, P1137, DOI 10.1097/00006123-200205000-00036; DATTA NN, 2000, NEUROSURG FOCUS, V8; Du R, 2007, J NEUROSURG, V106, P470, DOI 10.3171/jns.2007.106.3.470; Gonzalez LF, 2005, J NEUROSURG, V102, P726, DOI 10.3171/jns.2005.102.4.0726; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Gross BA, 2012, J CLIN NEUROSCI, V19, P1093, DOI 10.1016/j.jocn.2011.11.021; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Jeffree RL, 2009, PEDIATR NEUROSURG, V45, P296, DOI 10.1159/000235604; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Mahajan A, 2010, NEUROSURG REV, V33, P115, DOI 10.1007/s10143-009-0227-z; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P238, DOI 10.3171/jns.2005.102.2.0238; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; POZZATI E, 1986, NEUROCHIRURGIA, V29, P61; Schmit BP, 1996, J NEUROSURG, V84, P677, DOI 10.3171/jns.1996.84.4.0677; Stevens J, 2009, AM J NEURORADIOL, V30, P111, DOI 10.3174/ajnr.A1255; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334	20	15	15	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2014	14	4					418	420		10.3171/2014.7.PEDS1431			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AQ7CN	WOS:000342970300014	25084086				2022-02-06	
J	Scheyerer, MJ; Dutschler, J; Billeter, A; Zimmermann, SM; Sprengel, K; Werner, CML; Simmen, HP; Wanner, GA				Scheyerer, Max J.; Duetschler, Joel; Billeter, Adrian; Zimmermann, Stefan M.; Sprengel, Kai; Werner, Clement M. L.; Simmen, Hans-Peter; Wanner, Guido A.			Effect of elevated serum alcohol level on the outcome of severely injured patients	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; ETHANOL LEVELS; INTOXICATION; PREVALENCE; CONSUMPTION; SEVERITY; MODERATE; ABUSE; MODEL	Background The influence of high blood alcohol level (BAL) on the outcome of severely injured patients and the corresponding pathophysiological changes is a controversial issue. Objective To carry out a prognostic study to compare the physiological values and short-term outcome of severely injured patients depending on their serum alcohol level. Methods A total of 383 severely injured patients with an Injury Severity Score (ISS) >= 17 were admitted to the trauma division between October 2008 and December 2009 and enrolled into this study. Patients were grouped according to their BAL (>0.5 parts per thousand, 'BAL positive' vs <0.5 parts per thousand, 'BAL negative'). Trauma mechanism, pattern of injury and its treatment, and a course of intensive care treatment, physiological parameters and outcome with respect to mortality were analysed. Results Both groups had similar ISS. In comparison with the BAL-negative group, patients in the BAL-positive group had a significantly lower Glasgow Coma Scale score (9.64 vs 12 points; p=0.005) and, although not significant, a trend towards higher values of the Abbreviated Injury Score for the head (3.29 vs 2.81 points; p=0.146). Furthermore, significantly higher lactate (3.11 mmol/L vs 2.02 mmol/L; p<0.001) levels and lower median arterial pressure values (87.9 mm Hg vs 99.4 mm Hg; p=0.006) were seen in the BAL-positive group at day of admission. However, the overall in-hospital mortality was comparable to that in BAL-negative patients (19.6% vs 21.5%). Similarly, hospital stay (15.29 vs 17.55 days) and duration of intensive care unit treatment (8.53 vs 8.36 days) were not significantly affected by a high BAL upon admission. Conclusions Severely injured patients with a raised BAL have a higher incidence of severe traumatic brain injury and worse initial physiological parameters. However, the survival rate and in-hospital stay is not influenced. This supports the theory of a neuroprotective role of alcohol.	[Scheyerer, Max J.; Duetschler, Joel; Billeter, Adrian; Zimmermann, Stefan M.; Sprengel, Kai; Werner, Clement M. L.; Simmen, Hans-Peter; Wanner, Guido A.] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland		Scheyerer, MJ (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Dept Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	maxjscheyerer@gmx.ch	Billeter, Adrian/O-2185-2019; Sprengel, Kai/G-4780-2014	Billeter, Adrian/0000-0001-8724-4793; Simmen, Hans-Peter/0000-0002-5201-4549; Sprengel, Kai/0000-0001-5921-8272			ANDERSEN JA, 1990, J TRAUMA, V30, P415, DOI 10.1097/00005373-199030040-00007; Berry C, 2010, AM SURGEON, V76, P1067; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Borges G, 2004, SOC SCI MED, V58, P1191, DOI 10.1016/S0277-9536(03)00290-9; Chen SC, 1999, J TRAUMA, V47, P881, DOI 10.1097/00005373-199911000-00011; Cherpitel CJ, 2004, ALCOHOL CLIN EXP RES, V28, p18S, DOI 10.1097/01.ALC.0000127411.61634.14; Cornwell EE, 1998, AM SURGEON, V64, P461; DAUGHTERS K, 1995, AM SURGEON, V61, P896; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; Dunne JR, 2005, J TRAUMA, V58, P959, DOI 10.1097/01.TA.0000158508.84009.49; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Porter RS, 2000, PEDIATR EMERG CARE, V16, P316, DOI 10.1097/00006565-200010000-00003; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; STEIN PD, 1988, J TRAUMA, V28, P465, DOI 10.1097/00005373-198804000-00008; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; TULLOH BR, 1994, INJURY, V25, P539, DOI 10.1016/0020-1383(94)90097-3; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; Yaghoubian A, 2009, AM SURGEON, V75, P950	30	15	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	OCT	2014	31	10					813	817		10.1136/emermed-2013-202804			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AP9EE	WOS:000342380600006	23850886				2022-02-06	
J	Luo, H; Pace, E; Zhang, XG; Zhang, JS				Luo, Hao; Pace, Edward; Zhang, Xueguo; Zhang, Jinsheng			Blast-induced tinnitus and spontaneous activity changes in the rat inferior colliculus	NEUROSCIENCE LETTERS			English	Article						Blast exposure; Tinnitus; Traumatic brain injury (TBI); Inferior colliculus; Spontaneous activity	DORSAL COCHLEAR NUCLEUS; TRAUMATIC BRAIN-INJURY; ACOUSTIC TRAUMA; HEARING-LOSS; HYPERACTIVITY; CHINCHILLAS; PLASTICITY; EXPOSURE; SOUND	High-pressure blast shockwaves are known to cause tinnitus. Imaging studies have shown that blast-induced tinnitus may result from damage to the inner ear structures and/or direct brain impact that trigger a cascade of neuroplastic changes in both auditory and non-auditory centers. Nevertheless, information is still lacking on the neurophysiological mechanisms underlying blast-induced tinnitus. In this study, we used a rat model and investigated the effect of blast-induced tinnitus on spontaneous activity in the inferior colliculus (IC) at one day, one month, and three months following blast. Our results showed that rats with behavioral evidence of tinnitus exhibited hyperactivity in all frequency regions at one day post-blast. Although the induced hyperactivity persisted throughout a three-month recording period, it was more robust in middle frequency loci at one month after blast exposure and in middle-to-high-frequency loci at three months after blast. Our results also showed increased bursting rate in the low and middle frequency regions at one day after blast, in the middle frequency region at one month after blast, and in all frequency regions at three months after blast. The findings suggest that neuroplasticity as reflected by shifted tonotopic representations of hyperactivity and bursting activity subserves blast-induced tinnitus and hearing impairment. (C) 2014 Published by Elsevier Ireland Ltd.	[Luo, Hao; Pace, Edward; Zhang, Xueguo; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48201 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48201 USA		Zhang, JS (corresponding author), Wayne State Univ, Sch Med, 5E UHC,4201 St Antoine, Detroit, MI 48201 USA.	Jinzhang@med.wayne.edu			US Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	This work was supported by the US Department of Defense (grant award #W81XWH-11-2-0031). The authors wish to thank Drs. Pamela VandeVord and Srini Kallakuri for their assistance during blast exposure using a shock tube in the Department of,Biomedical Engineering, Wayne State University.	Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Geckle L., 2004, FORC HLTH PROT C ALB; Izquierdo MA, 2008, NEUROSCIENCE, V154, P355, DOI 10.1016/j.neuroscience.2008.01.057; KALTENBACH JA, 2010, HEAR RES; Knipper M., 2013, PROG NEUROBIOL; Langers DRM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00002; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Luo H., 2014, J NEUROSCI RES; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; MERZENICH MM, 1974, BRAIN RES, V77, P397, DOI 10.1016/0006-8993(74)90630-1; Moller AR, 2006, PROG BRAIN RES, V157, P365, DOI 10.1016/S0079-6123(06)57022-0; Mulders WHAM, 2013, HEARING RES, V298, P104, DOI 10.1016/j.heares.2012.12.008; Mulders WHAM, 2011, J COMP NEUROL, V519, P2637, DOI 10.1002/cne.22644; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Richardson BD, 2012, BRAIN RES, V1485, P77, DOI 10.1016/j.brainres.2012.02.014; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Zhang JS, 2006, J NEUROSCI RES, V84, P819, DOI 10.1002/jnr.20985; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0	29	15	16	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 19	2014	580						47	51		10.1016/j.neulet.2014.07.041			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ0NC	WOS:000342479000010	25092609				2022-02-06	
J	Jazi, MS; Rezaei, A; Karami, G; Azarmi, F; Ziejewski, M				Jazi, Mehdi Salimi; Rezaei, Asghar; Karami, Ghodrat; Azarmi, Fardad; Ziejewski, Mariusz			A computational study of influence of helmet padding materials on the human brain under ballistic impacts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						ballistic impact; helmet; finite elements; TBI; pad	FINITE-ELEMENT-ANALYSIS; MECHANICAL-PROPERTIES; HEAD IMPACT; PART I; FOAMS	The results of a computational study of a helmeted human head are presented in this paper. The focus of the work is to study the effects of helmet pad materials on the level of acceleration, inflicted pressure and shear stress in a human brain model subjected to a ballistic impact. Four different closed cell foam materials, made of expanded polystyrene and expanded polypropylene, are examined for the padding material. It is assumed that bullets cannot penetrate the helmet shell. Finite element modelling of the helmet, padding system, head and head components is used for this dynamic nonlinear analysis. Appropriate contacts and conditions are applied between the different components of the head, as well as between the head and the pads, and the pads and the helmet. Based on the results of simulations in this work, it is concluded that the stiffness of the foam has a prominent role in reducing the level of the transferred load to the brain. A pad that is less stiff is more efficient in absorbing the impact energy and reducing the sudden acceleration of the head and consequently lowers the brain injury level. Using the pad with the least stiffness, the influence of the angle of impacts as well as the locations of the ballistic strike is studied.	[Jazi, Mehdi Salimi; Rezaei, Asghar; Karami, Ghodrat; Azarmi, Fardad; Ziejewski, Mariusz] N Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA		Karami, G (corresponding author), N Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA.	g.karami@ndsu.edu			Army Research Office	The authors would like to acknowledge the Army Research Office for the financial support of this research.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Altair Hyperworks, 2011, HYPERMESH US GUID VE; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Avalle M, 2001, INT J IMPACT ENG, V25, P455, DOI 10.1016/S0734-743X(00)00060-9; Baumgartner D., 2003, P RTO SPEC M NATO KO; CARROLL AW, 1978, ANN SURG, V188, P753, DOI 10.1097/00000658-197812000-00007; Chafi M. S., 2009, P I MECH ENG H, V18, P21; Chan M., 1980, P 24 STAPP CAR CRASH, P347; Digges KH, 1998, RTO HFM SPEC M MOD A; Dirisala V, 2012, INT J NUMER METH BIO, V28, P472, DOI 10.1002/cnm.1480; Gibson L. J., 1997, CELLULAR SOLIDS STRU, V2nd, DOI DOI 10.1017/CBO9781139878326; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kostopoulos V, 2002, COMPOS PART B-ENG, V33, P99, DOI 10.1016/S1359-8368(01)00066-X; Kurtaran H, 2003, THEOR APPL FRACT MEC, V40, P113, DOI 10.1016/S0167-8442(03)00039-9; Lee YS, 2010, J CELL PLAST, V46, P43, DOI 10.1177/0021955X09346363; LIDEN E, 1988, J TRAUMA, V28, pS145, DOI 10.1097/00005373-198801001-00029; LS-DYNA, 2007, LS DYNA US MAN VERS; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; MILTZ J, 1990, POLYM ENG SCI, V30, P129, DOI 10.1002/pen.760300210; Nahum AM, 1977, P 21 STAPP CAR CRASH; Othman RB, 2009, THESIS U SAINS MALAY; Pinnoji PK, 2007, SADHANA-ACAD P ENG S, V32, P445, DOI 10.1007/s12046-007-0034-6; Qiu Z., 2007, THESIS NATL U SINGAP; RAMON O, 1990, POLYM ENG SCI, V30, P197, DOI 10.1002/pen.760300402; RUAN JS, 1993, P 37 STAPP CAR CRASH; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Taylor PA, 2006, REPORT DOCUMENTS COM; Tham CY, 2008, INT J IMPACT ENG, V35, P304, DOI 10.1016/j.ijimpeng.2007.03.008; Turquier F, 1996, 962431 SAE; van Hoof J, 2001, 2006160 DREV CR; Van Hoof J, 1999, 18 INT S BALL SAN AN; Viot P, 2011, BEHAV POLYM MULTISCA; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yang J, 2010, COMPUT AIDED DES APP, V7, P59, DOI DOI 10.3722/cadaps.2010.59-73; Zhang J, 1998, INT J IMPACT ENG, V21, P369, DOI 10.1016/S0734-743X(97)00087-0; Zhou C., 1995, 95271421 SAE	41	15	16	3	61	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	SEP 10	2014	17	12					1368	1382		10.1080/10255842.2012.748755			15	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	AF1QH	WOS:000334487900008	23281845				2022-02-06	
J	Arenivas, A; Diaz-Arrastia, R; Spence, J; Cullum, CM; Krishnan, K; Bosworth, C; Culver, C; Kennard, B; de la Plata, CM				Arenivas, Ana; Diaz-Arrastia, Ramon; Spence, Jeffrey; Cullum, C. Munro; Krishnan, Kamini; Bosworth, Christopher; Culver, Carlee; Kennard, Beth; de la Plata, Carlos Marquez			Three approaches to investigating functional compromise to the default mode network after traumatic axonal injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Default mode network; Functional connectivity; TBI; Biomarker; Outcome; Traumatic axonal injury	RESTING-STATE NETWORKS; DIFFUSION TENSOR; STRUCTURAL CONNECTIVITY; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; PREFRONTAL CORTEX; CINGULATE CORTEX; BRAIN ACTIVITY; EARLY-STAGE; SCHIZOPHRENIA	The default mode network (DMN) is a reliably elicited functional neural network with potential clinical implications. Its discriminant and prognostic utility following traumatic axonal injury (TAI) have not been previously investigated. The present study used three approaches to analyze DMN functional connectedness, including a whole-brain analysis [A1], network-specific analysis [A2], and between-node (edge) analysis [A3]. The purpose was to identify the utility of each method in distinguishing between healthy and brain-injured individuals, and determine whether observed differences have clinical significance. Resting-state fMRI was acquired from 25 patients with TAI and 17 healthy controls. Patients were scanned 6-11 months post-injury, and functional and neurocognitive outcomes were assessed the same day. Using all three approaches, TAI subjects revealed significantly weaker functional connectivity (FC) than controls, and binary logistic regressions demonstrated all three approaches have discriminant value. Clinical outcomes were not correlated with FC using any approach. Results suggest that compromise to the functional connectedness of the DMN after TAI can be identified using resting-state FC; however, the degree of functional compromise to this network, as measured in this study, may not have clinical implications in chronic TAI.	[Arenivas, Ana; Cullum, C. Munro; Krishnan, Kamini; Bosworth, Christopher; Kennard, Beth; de la Plata, Carlos Marquez] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon; Cullum, C. Munro] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Spence, Jeffrey] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Clin Sci, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Culver, Carlee; de la Plata, Carlos Marquez] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75235 USA		de la Plata, CM (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 W Mockingbird Ln, Dallas, TX 75235 USA.	c.marquez@utdallas.edu	Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465; Diaz-Arrastia, Ramon/0000-0001-6051-3594	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS060827]; National Institutes of Health/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD48179, U01 HD42652]; Department of EducationUS Department of Education [H133 A020526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS060827, ZIANS003138] Funding Source: NIH RePORTER	This research was supported by funding to C. Marquez de la Plata (National Institutes of Health/National Institute of Neurological Disorders and Stroke K23 NS060827) and R. Diaz-Arrastia (National Institutes of Health/National Institute of Child Health and Human Development R01 HD48179, U01 HD42652, and Department of Education H133 A020526).	Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Duong MVA, 2005, J CEREBR BLOOD F MET, V25, P1245, DOI 10.1038/sj.jcbfm.9600122; Faul M, 2010, TRAUMATIC BRAIN INJU; Firbank MJ, 2007, NEUROIMAGE, V36, P1, DOI 10.1016/j.neuroimage.2007.02.027; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lowe MJ, 2010, MAGN RESON MATER PHY, V23, P279, DOI 10.1007/s10334-010-0230-y; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	67	15	16	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		407	419		10.1007/s11682-012-9191-2			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP9ZR	WOS:000342441400010	22847713				2022-02-06	
J	Classen, S; Cormack, NL; Winter, SM; Monahan, M; Yarney, A; Lutz, AL; Platek, K				Classen, Sherrilene; Cormack, Nicole Leigh; Winter, Sandra M.; Monahan, Miriam; Yarney, Abraham; Lutz, Amanda Link; Platek, Kyle			Efficacy of an Occupational Therapy Driving Intervention for Returning Combat Veterans	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						automobile driving; intervention study; polytrauma	BRAIN-INJURY; PERFORMANCE; FREEDOM; UTILITY	Polytrauma, including mild traumatic brain injury, posttraumatic stress disorder, and orthopedic conditions, is common among combat veterans (CVs) from Operations Enduring Freedom and Iraqi Freedom. Medical conditions, coupled with deployment-related training, may affect CVs' fitness to drive and contribute to post-deployment crash and injury risks. However, empirical interventions are lacking. Therefore, the study purpose was to examine the efficacy of an occupational therapy driving intervention (OT-DI) with pre and post testing of CVs. Using a DriveSafety 250 simulator, Occupational Therapy-Driver Rehabilitation Specialists recorded driving errors. Eight CVs (mean age = 39.83, SD = 7.80) received three OT-DI sessions, which incorporated strategies to address driving errors and visual search retraining. We determined baseline driving errors (mean = 31.63, SD = 8.96) were double the number of posttest errors (mean = 15.38, SD = 9.71). At posttesting, a significant (p < 0.05) decrease was noted for total errors and lane maintenance. Despite study constraints, preliminary data support the efficacy of the OT-DI.	[Classen, Sherrilene] Western Univ, Sch Occupat Therapy, London, ON N6G 1H1, Canada; [Classen, Sherrilene; Winter, Sandra M.; Monahan, Miriam] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Occupat Therapy, Gainesville, FL USA; [Classen, Sherrilene; Winter, Sandra M.; Monahan, Miriam; Yarney, Abraham] Univ Florida, Coll Publ Hlth & Hlth Profess, Inst Mobil Act & Participat, Gainesville, FL USA; [Cormack, Nicole Leigh] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Winter, Sandra M.] North Florida South Georgia Vet Hlth Syst, Vet Affairs Ctr Innovat Disabil & Rehabil Res CIN, Gainesvillesite, Gainesville, FL USA; [Lutz, Amanda Link; Platek, Kyle] Univ Florida, Hlth Rehabil Ctr Magnolia Parke, Gainesville, FL USA		Classen, S (corresponding author), Western Univ, Elborn Coll, Sch Occupat Therapy, 1201 Western Rd, London, ON N6G 1H1, Canada.	sclassen@uwo.ca		Classen, Sherrilene/0000-0002-0927-0344; Monahan, Miriam/0000-0003-1636-7969			American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Amick MM, 2013, J REHABIL RES DEV, V50, P463, DOI 10.1682/JRRD.2012.06.0108; Carlson K., 2009, THE ASSESSMENT AND T; Classen S., 2010, ADV TRANSPORTATION S, P45; Classen S, 2014, AM J OCCUP THER, V68, P405, DOI 10.5014/ajot.2014.010041; Classen S, 2012, AM J OCCUP THER, V66, P233, DOI 10.5014/ajot.2012.001834; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Congressional Research Service, 2014, U S MILITARY CASUALT; Defense and Veterans Brain Injury Center, 2014, DOD NUMBERS FOR TRAU; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Monahan M., 2009, VISUAL SEARCH SKILLS; National Institute of Neurological Disorders and Stroke, 2014, NINDS TRAUMATIC BRAI; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Pierce S., 2010, AM J OCCUPATIONAL S, V64, pS112, DOI DOI 10.5014/AJOT.2010.64S112; Zamorski M.A., 2012, NATO REPORT TR HFM 1	20	15	15	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	FAL	2014	34	4					176	182		10.3928/15394492-20141006-01			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AR1PO	WOS:000343357300002	25347755				2022-02-06	
J	Curtis, L; Epstein, P				Curtis, L.; Epstein, P.			Nutritional treatment for acute and chronic traumatic brain injury patients	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Brain concussion; Enteral nutrition; Probiotics; Fatty Acids, Omega-3	CHAIN AMINO-ACIDS; NEUROLOGIC RECOVERY; FUNCTIONAL RECOVERY; LIPOIC ACID; CITICOLINE; OUTCOMES; MODEL; SUPPLEMENTATION; PROBIOTICS; MAGNESIUM	Proper nutrition is critical for recovery from traumatic brain injury (TBI). Prompt enteral feeding of moderate to severe TBI patients has been associated with significantly lower mortality and rates of infection. Probiotic supplementation has been associated with significantly lower rates of infection in TBI and other trauma patients. Human studies have suggested that supplementation with omega 3 fats, vitamin D, N-Acetylcysteine branched chain aminoacids, and zinc may be helpful for recovery from TBI. Animal TBI models have suggested that alpha-lipoic acid, magnesium, taunine, coenzyme Q(10), and many phytonutrients (such as resveratrol) are also helpful. Unfortunately, recent human clinical trials with citicoline in TBI and stroke patients have produced disappointing results. Much more research is needed on multifaceted nutritional strategies to treat TBI patients in both the immediate post-injury phase and throughout the patients lifespan.	[Epstein, P.] Adv Neurodiagnost, Wheeling, IL USA		Curtis, L (corresponding author), 108-49 63rd Ave 6K, Forest Hills, NY 11375 USA.	luketcurtis@aol.com					Adibhatla RM, 2012, NATURE REV NEUROLOGY, P166; Agrawal R, 2010, NEUR M PLANN SOC NEU; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Barraud D, 2013, CHEST, V143, P646, DOI 10.1378/chest.12-1745; Barringer Nick, 2012, J Spec Oper Med, V12, P5; Bayir A, 2008, ACTA NEUROL BELG, V108, P149; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bica D, 2013, HIGH DOSE OMEGA 3 FA; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Blasco G, 2013, EFFICIENCY SMALL PEP; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Cahill LM, 2004, J HEAD TRAUMA REHAB, V19, P241, DOI 10.1097/00001199-200405000-00005; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN; Desai A, PLOS ONE, V9; Dhandapani M, 2013, J CLIN NURS IN PRESS; Diederich K, 2012, STROKE, V43, P1931, DOI 10.1161/STROKEAHA.112.654806; Duraski SA, 2014, REHABILITAT IN PRESS; Elovic EP, 2001, J HEAD TRAUMA REHAB, V16, P603, DOI 10.1097/00001199-200112000-00008; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Festa M, 1995, PHARM RES, V12, P1769; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Gomez-Pinilla F, 2011, PREV MED, V52, P575; Grieb P, 2014, CNS DRUGS, V28, P185, DOI 10.1007/s40263-014-0144-8; Gu WJ, 2013, JPEN-PARENTER ENTER, V37, P310, DOI 10.1177/0148607112463245; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hoane MR, 2008, MAGNESIUM RES, V21, P29; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; Itoh T, 2013, J NEURAL TRANSM, V120, P767, DOI 10.1007/s00702-012-0918-4; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Kabadi SV, 2010, ANN NY ACAD SCI, V1199, P105, DOI 10.1111/j.1749-6632.2009.05352.x; Kalayci M, 2011, BMC NEUROSCI, V29, P12; Leonardo CC, 2011, NUTR NEUROSCI, V14, P226, DOI 10.1179/1476830511Y.0000000013; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Li SY, 2012, NEUROBIOL DIS, V45, P624, DOI 10.1016/j.nbd.2011.10.008; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Matthews LR, 2013, INT J CASE REPORTS I, V4, P143, DOI DOI 10.5348/ijcri-2013-03-281-CS-2; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Pandya JD, 2014, EXPT NEUROL IN PRESS; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Ramos-Cabrer P, 2011, INT J PHARMACEUT, V405, P228, DOI 10.1016/j.ijpharm.2010.12.014; Roberts L, 2008, J AM COLL SURGEONS, V207, P276, DOI 10.1016/j.jamcollsurg.2008.02.015; Rocamonde B, 2012, NEUROSCIENCE, V224, P102, DOI 10.1016/j.neuroscience.2012.08.028; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Scrimgeour AG, 2014, J NEUROTRAU IN PRESS; Senol N, 2014, NEUROCHEM RES; Sheffield-Moore M, 2014, AMINO ACID SUPPLEMEN; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Stein DG, 2011, PHYS MED REHABIL, V3, P100; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun M, 2014, J NEUROTRAUMA; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tarozzi A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/415078; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Twyman D, 1997, CRIT CARE CLIN, V13, P39, DOI 10.1016/S0749-0704(05)70295-5; Wahls T, 2013, NUTR NEUROS IN PRESS; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; Wang Y, 2012, CHIN J INTEGR MED, V18, P690, DOI 10.1007/s11655-012-1053-7; West T, 2007, DEV NEUROSCI-BASEL, V29, P363, DOI 10.1159/000105477; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Yurgelun-Todd D, CITICOLINE OMEGA 3 F; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zorman G, 2013, MILD HYPOTHERMIA SUP	96	15	17	1	57	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2014	58	3					151	160					10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AR1XH	WOS:000343377400003	24844176				2022-02-06	
J	Foy, CML				Foy, Catherine M. L.			Long Term Efficacy of an Integrated Neurological and Vocational Rehabilitation Programme for Young Adults with Acquired Brain Injury	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Brain injuries; Traumatic brain injury; Rehabilitation; vocational; Return to work	PSYCHOSOCIAL ADJUSTMENT; COMMUNITY INTEGRATION; FOLLOW-UP; WORK; RETURN; EMPLOYMENT; PREDICTION; POPULATION; DISABILITY; STABILITY	Purpose To characterise and determine the pre-injury, injury and post-injury factors associated with vocational outcome 1-9 years post-discharge from a mixed therapy/educational/vocational rehabilitation (VR) residential programme. Methods 119 clients of working age when they acquired their brain injury and who had attended the centre between 2002 and 2011 were followed up at least 1 year post-discharge to determine their vocational outcome as part of an ongoing review/audit of the service. All clients had had a severe/very severe brain injury. Clients were classified as having a positive vocational outcome (working-paid/voluntary, full/part-time or undertaking full or part-time vocationally related education) or negative vocational outcome (undertaking neither work nor education). Results Over half of the clients attained a positive vocational outcome. Length of time since discharge did not differ between those clients with a positive or negative vocational outcome. Vocational outcome was predicted by cognitive and motor ability at discharge, and gender. Together these variables correctly classified the vocational outcome of 76 % of the clients. Conclusion Clients with severe/very severe brain injury can attain a positive vocational outcome following intensive neurorehabilitation consisting of traditional therapies in addition to educational and VR.	QEF Neuro Rehabil Serv, Banstead SM7 3EE, Surrey, England		Foy, CML (corresponding author), QEF Neuro Rehabil Serv, Banstead Pl,Pk Rd, Banstead SM7 3EE, Surrey, England.	Catherine.Foy@QEF.org.uk					Ashley MJ, 1997, BRAIN INJURY, V11, P677; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Burton A.K., 2006, IS WORK GOOD YOUR HL; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fleming J, 1999, BRAIN INJURY, V13, P417; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Sach T, 2011, CLIN REHABIL, V25, P957; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1999, BRAIN INJURY, V13, P973; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; The Neurological Alliance, 2003, NEUR ALL NEUR NUMB B; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; UK National Institute for Health and Clinical Excellence, 2003, HEAD INJ TRIAG ASS I, P4; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wilson FC, 2009, NEUROREHABILITATION, V24, P377, DOI 10.3233/NRE-2009-0492; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	44	15	15	0	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	SEP	2014	24	3					533	542		10.1007/s10926-013-9488-z			10	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	AN3KX	WOS:000340487900015	24347006				2022-02-06	
J	Goldin, Y; Cantor, JB; Tsaousides, T; Spielman, L; Gordon, WA				Goldin, Yelena; Cantor, Joshua B.; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne A.			Sexual Functioning and the Effect of Fatigue in Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; fatigue; sex; health; sexual functioning; traumatic brain injury	QUALITY-OF-LIFE; GENDER-DIFFERENCES; MILD; TBI; FREQUENCY; VALIDITY; MODERATE; NEUROENDOCRINE; PARTICIPATION; ASSOCIATION	Objectives: The primary objective was to examine specific aspects of sexual functioning (frequency, desired frequency, importance, and satisfaction) and their relationship to fatigue in individuals with traumatic brain injury (TBI) compared with those without brain injury. The relationship of demographic variables, emotional well-being, and health-related quality of life to sexual functioning was also explored. Participants: 200 community-dwelling adults with self-reported mild-to-severe TBI and 83 individuals without brain injury. Measures: Participation Objective, Participation Subjective, Fatigue Assessment Instrument, Global Fatigue Index, Beck Depression Inventory, and SF-36 Health Survey. Methods: Data were collected through administration of self-report measures and interviews as part of a larger study of post-TBI fatigue. Results: Several aspects of sexual activity (frequency, desired frequency, and importance) were closely related to specific features of fatigue among individuals with TBI. Women with TBI reported lower frequency and lower importance of sex than men. In individuals without brain injury, the impact of fatigue was limited to the frequency of sexual activity with no sex differences observed. Conclusions: Fatigue plays a different role in the subjective experience of sexual activity for men and women with TBI than for those without brain injuries. Fatigue and sex should be taken into account in future research and interventions focused on sexual function after TBI.	[Goldin, Yelena] JFK Johnson Rehabil Inst, Cognit Rehabil Dept, Edison, NJ 08820 USA; [Cantor, Joshua B.; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Goldin, Y (corresponding author), JFK Johnson Rehabil Inst, Cognit Rehabil Dept, 2048 Oak Tree Rd, Edison, NJ 08820 USA.	ygoldinlauretta@jfkhealth.org			National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A020501]	This study was supported by grant H133A020501 from the National Institute on Disability and Rehabilitation Research, United States Department of Education.	Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; [Anonymous], 2001, MAN US VERS 1; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; BELZA BL, 1995, J RHEUMATOL, V22, P639; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bormann J, 2001, J Assoc Nurses AIDS Care, V12, P75, DOI 10.1016/S1055-3290(06)60146-5; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; CALL V, 1995, J MARRIAGE FAM, V57, P639, DOI 10.2307/353919; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Dijkers MPJM, 2008, J HEAD TRAUMA REHAB, V23, P3, DOI 10.1097/01.HTR.0000308716.80590.6b; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; Elovic EP, 2005, ISS CLIN COGN NEUROP, P89; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; GORDON WA, 2003, PARTICIPATION OBJECT; Grady C, 1998, NURS RES, V47, P227, DOI 10.1097/00006199-199807000-00008; Griffith ER, 1990, REHABILITATION ADULT, P206; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; KRUPP LB, 1995, NEUROLOGY, V45, P1956, DOI 10.1212/WNL.45.11.1956; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lawton MP, 1999, J AGING HEALTH, V11, P169, DOI 10.1177/089826439901100203; Levine J, 2009, PHYS MED REH CLIN N, V20, P347, DOI 10.1016/j.pmr.2008.12.006; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meek PM, 2000, NURS RES, V49, P181, DOI 10.1097/00006199-200007000-00001; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Schwartz CE, 1996, ARCH PHYS MED REHAB, V77, P165, DOI 10.1016/S0003-9993(96)90162-8; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Winstead-Fry P, 1998, J Nurs Meas, V6, P111	60	15	15	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					418	426		10.1097/HTR.0b013e31829cf76d			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700010	23867995				2022-02-06	
J	Ko, AL; Nerva, JD; Chang, JJJ; Chesnut, RM				Ko, Andrew L.; Nerva, John D.; Chang, Jason J. J.; Chesnut, Randall M.			Traumatic Fracture of a Polymethyl Methacrylate Patient-Specific Cranioplasty Implant	WORLD NEUROSURGERY			English	Article						Cranioplasty fracture; Patient-specific implants; Pediatric neurosurgery; Synthetic cranioplasty; Traumatic brain injury		OBJECTIVE: To present a case of a traumatic fracture of a polymethyl methacrylate (PMMA) patient-specific implant (PSI) for cranioplasty. METHODS: A 14-year-old boy with a history of right decompressive hemicraniectomy and reconstructive cranioplasty with a PMMA PSI presented after an unhelmeted bicycle accident with somnolence, confusion, seizures, left hemiparesis, and an obviously deformed cranium. RESULTS: Computed tomography scan showed a comminuted, depressed fracture of the implant and cerebral contusions. The implant was seen to be shattered, resulting in displaced, overriding fragments and significant damage to underlying brain. The patient remained neurologically stable. To minimize the number of operations, intervention was delayed while a polyetheretherketone PSI was fabricated. During surgery, it was noted that the fractured pieces of the implant had caused dural lacerations, and some pieces were embedded in brain parenchyma. The fractured PMMA was removed, and the new implant was placed. The patient remained hemiparetic and was later transferred to an inpatient rehabilitation facility. CONCLUSIONS: PMMA PSIs are commonly used for large defects and generally have good outcomes with low rates of revision. The case report described involves a shattered PMMA PSI after a traumatic impact, which resulted in hemiparesis. The question arises if this type of complication can be easily avoided with the addition of titanium onlay to restrict displacement in the event of fracture. This onlay represents a minor change of technique that could prevent migration of fracture fragments.	[Ko, Andrew L.; Nerva, John D.; Chang, Jason J. J.; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Nerva, JD (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	jdnerva@uw.edu		Ko, Andrew/0000-0002-6253-9891			Eppley BL, 2005, J CRANIOFAC SURG, V16, P140, DOI 10.1097/00001665-200501000-00028; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Petridis AK, 2009, J CLIN NEUROSCI, V16, P1089, DOI 10.1016/j.jocn.2008.08.006; VANGOOL AV, 1985, J MAXILLOFAC SURG, V13, P2, DOI 10.1016/S0301-0503(85)80005-9	6	15	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP-OCT	2014	82	3-4							53600000000000	10.1016/j.wneu.2013.09.025			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AQ6HV	WOS:000342912300111	24056094				2022-02-06	
J	McCrea, M; Guskiewicz, K; Doncevic, S; Helmick, K; Kennedy, J; Boyd, C; Asmussen, S; Ahn, KW; Wang, Y; Hoelzle, J; Jaffee, M				McCrea, Michael; Guskiewicz, Kevin; Doncevic, Selina; Helmick, Katherine; Kennedy, Jan; Boyd, Cynthia; Asmussen, Sarah; Ahn, Kwang W.; Wang, Yanzhi; Hoelzle, James; Jaffee, Michael			Day of Injury Cognitive Performance on the Military Acute Concussion Evaluation (MACE) by US Military Service Members in OEF/OIF	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY	Objectives: The study investigated the clinical validity of the cognitive screening component of the Military Acute Concussion Evaluation (MACE) for the evaluation of acute mild traumatic brain injury (mTBI) in a military operational setting. Methods: This was a retrospective data study involving analysis of MACE data on Operation Enduring Freedom/Operation Iraqi Freedom deployed service members with mTBI. In total, 179 cases were included in analyses based on ICD-9 diagnostic codes and characteristics of mTBI, and availability of MACE data on day of injury. MACE data from the mTBI group was compared to a military sample without mTBI administered the MACE as part of a normative data project. Results: On day of injury, the mTBI group performed worse than controls on the MACE cognitive test (d = 0.90), with significant impairments in all cognitive domains assessed. MACE cognitive score was strongly associated with established indicators of acute injury severity. Lower MACE cognitive performance on day of injury was predictive of lengthier postinjury recovery time and time until return to duty after mTBI. Conclusions: Findings from the current study support the use of the MACE as a valid screening tool to assess for cognitive dysfunction in military service members during the acute phase after mTBI.	[McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; [Guskiewicz, Kevin] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Doncevic, Selina] Dept Vet Affairs, Bethesda, MD 20889 USA; [Kennedy, Jan; Boyd, Cynthia; Asmussen, Sarah] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Ahn, Kwang W.; Wang, Yanzhi] Med Coll Wisconsin, Dept Biostat, Milwaukee, WI 53226 USA; [Hoelzle, James] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Jaffee, Michael] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA		McCrea, M (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.			Guskiewicz, Kevin/0000-0002-8682-2130	United States Medical Research and Military Command (USAMRMC) through USAMRMC [PT 073286W81XWH-07-TBI-CA]	This study was funded by a cooperative agreement with the United States Medical Research and Military Command (USAMRMC) (PT 073286) through USAMRMC Funding Opportunity Number W81XWH-07-TBI-CA (M. McCrea, Principal Investigator).	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; *DVBIC, 2006, DEF VET BRAIN INJ CT; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	12	15	15	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP	2014	179	9					990	997		10.7205/MILMED-D-13-00349			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7LF	WOS:000349098100015	25181717	Bronze			2022-02-06	
J	Pi, XR; Zhou, L; Cui, L; Liu, AZ; Zhang, J; Ma, Y; Liu, BF; Cai, CQ; Zhu, CY; Zhou, TB; Chen, J; Zhou, Z; Wang, CM; Li, LQ; Li, SC; Wu, JZ; Xiao, B				Pi, Xiaorong; Zhou, Luo; Cui, Lei; Liu, Aizhong; Zhang, Jie; Ma, Yan; Liu, Bofu; Cai, Chaoqun; Zhu, Caiyun; Zhou, Tianbin; Chen, Jia; Zhou, Zhen; Wang, Chunmei; Li, Luoqing; Li, Shichuo; Wu, Jianzhong; Xiao, Bo			Prevalence and clinical characteristics of active epilepsy in southern Han Chinese	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Active epilepsy; Prevalence; Clinical characteristics; Treatment gap	TREATMENT GAP; RURAL CHINA; EPIDEMIOLOGY; POPULATION; SEIZURES; PROJECT	Purpose: To investigate the prevalence and clinical characteristics of active epilepsy in southern Han Chinese. Method: A door-to-door survey about epilepsy was conducted in communities identified by random cluster sampling among 20 villages and 3 communities of Yueyang city. A questionnaire for epilepsy based on the World Health Organization screening questionnaire was used. A final diagnosis of epilepsy was made by neurology specialists with the support of head magnetic resonance imaging (MRI), computed tomography (CT), and electroencephalography (EEG) if available. The prevalence, clinical characteristics, and treatment gap were analyzed in patients with active epilepsy within the past year and the past 5 years. Results: Active epilepsy was identified in 91 patients within the past year and 117 patients within the past 5 years. The one-year prevalence was 2.8 parts per thousand, and the five-year prevalence was 3.7 parts per thousand. The prevalence for epilepsy active within the last year and the last five years was significantly higher in rural areas than in urban areas (P < 0.05). Secondary generalized tonic-clonic seizures (53.8%) were the most common seizure type in patients whose epilepsy had been active in the last year. 34.1% of patients were diagnosed with structural or metabolic epilepsy. The most common cause for epilepsy was cerebrovascular disease (32.3%), followed by traumatic brain injury (29.0%). The treatment gap was 93.4%. Conclusion: The prevalence of epilepsy active within the last one and five years was higher in rural areas than in urban areas of Yueyang city. A large treatment gap exists in this area and a rational intervention strategy is needed. (C) 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Pi, Xiaorong; Ma, Yan; Liu, Bofu; Zhu, Caiyun; Zhou, Tianbin; Chen, Jia; Zhou, Zhen; Li, Luoqing] Yueyang 1 Peoples Hosp, Dept Neurol, Yueyang 414005, Hunan, Peoples R China; [Zhou, Luo; Cui, Lei; Xiao, Bo] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Liu, Aizhong; Wang, Chunmei] Cent S Univ, Sch Publ Hlth, Changsha 410008, Hunan, Peoples R China; [Zhang, Jie] Hunan Children Hosp, Dept Neurol, Changsha 410007, Hunan, Peoples R China; [Cai, Chaoqun] Yuehua Hosp, Dept Neurol, Yueyang 414014, Hunan, Peoples R China; [Li, Shichuo; Wu, Jianzhong] Inst Neurol Surg, Beijing 100037, Peoples R China		Xiao, B (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.	lazroy@live.cn; xiaobo62_xy@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071048]; explore program of Health Bureau of Hunan, China [B2010-110]	This study was supported by National Natural Science Foundation of China (No: 81071048), and the explore program of Health Bureau of Hunan, China (B2010-110).	[Anonymous], 2001, CHIN J NEUROL, V34, P187; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Fong GCY, 2008, SEIZURE-EUR J EPILEP, V17, P457, DOI 10.1016/j.seizure.2007.12.005; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; Hunter E, 2012, SEIZURE-EUR J EPILEP, V21, P691, DOI 10.1016/j.seizure.2012.07.009; LI SC, 1985, EPILEPSIA, V26, P391, DOI 10.1111/j.1528-1157.1985.tb05669.x; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Meinardi H, 2001, EPILEPSIA, V42, P136, DOI 10.1046/j.1528-1157.2001.32800.x; Meyer ACL, 2012, EPILEPSIA, V53, P2178, DOI 10.1111/epi.12002; Mung'ala-Odera V, 2008, SEIZURE-EUR J EPILEP, V17, P396, DOI 10.1016/j.seizure.2007.11.028; PLACENCIA M, 1992, BRAIN, V115, P783, DOI 10.1093/brain/115.3.783; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Tellez-Zenteno JF, 2004, EPILEPSIA, V45, P1623, DOI 10.1111/j.0013-9580.2004.24904.x; Tuan NA, 2008, EPILEPSIA, V49, P1634, DOI 10.1111/j.1528-1167.2008.01663.x; Wang WZ, 2008, B WORLD HEALTH ORGAN, V86, P964, DOI 10.2471/BLT.07.047050; Wang WZ, 2006, LANCET NEUROL, V5, P46, DOI 10.1016/S1474-4422(05)70254-4; Wang WZ, 2002, J CHIN MED, V82, P449; Xun Wu, 2006, CHINESE J INTERN MED, V45, P789; Zeng Jun, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P116	22	15	15	1	9	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	SEP	2014	23	8					636	640		10.1016/j.seizure.2014.05.002			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO7UR	WOS:000341558600009	24895053	Bronze			2022-02-06	
J	Ray, B; Sapp, D; Kincaid, A				Ray, Bradley; Sapp, Dona; Kincaid, Ashley			Traumatic Brain Injury among Indiana State Prisoners	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; traumatic brain injury; prevalence; prisoners; prior incarceration; psychiatric disorder	EPIDEMIOLOGIC CATCHMENT-AREA; TBI IDENTIFICATION METHOD; HEAD-INJURY; PSYCHIATRIC-DISORDERS; CRIMINAL BEHAVIOR; SEXUAL OFFENSES; PREVALENCE; POPULATION; RELIABILITY; VALIDITY	Research on traumatic brain injury among inmates has focused on comparing the rate of traumatic brain injury among offenders to the general population, but also how best to screen for traumatic brain injury among this population. This study administered the short version of the Ohio State University Traumatic Brain Injury Identification Method to all male inmates admitted into Indiana state prisons were screened for a month (N=831). Results indicate that 35.7% of the inmates reported experiencing a traumatic brain injury during their lifetime and that these inmates were more likely to have a psychiatric disorder and a prior period of incarceration than those without. Logistic regression analysis finds that a traumatic brain injury predicts the likelihood of prior incarceration net of age, race, education, and psychiatric disorder. This study suggests that brief instruments can be successfully implemented into prison screenings to help divert inmates into needed treatment.	[Ray, Bradley; Kincaid, Ashley] Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Indianapolis, IN 46202 USA; [Sapp, Dona] Indiana Univ Purdue Univ, Indiana Univ Publ Policy Inst, Indianapolis, IN 46204 USA		Ray, B (corresponding author), Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Business SPEA Bldg,801 West Michigan St, Indianapolis, IN 46202 USA.	bradray@iupui.edu	Ray, Bradley/C-1843-2017	Ray, Bradley/0000-0003-3643-775X	Indiana Criminal Justice Institute	Funded by a research grant from the Indiana Criminal Justice Institute to the Indiana University Public Policy Institute.	Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Centers for Disease Control, TRAUM BRAIN INJ PRIS; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Hawley CA, 2003, BRAIN INJURY, V17, P743, DOI 10.1080/0269905031000089341; Langevin R, 2006, BRAIN COGNITION, V60, P206; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Lewis DO, 1986, AM J PSYCHIAT, V26, P744; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; Morris SM, 1997, CRIM JUSTICE BEHAV, V24, P3, DOI 10.1177/0093854897024001001; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; TEPLIN LA, 1990, AM J PUBLIC HEALTH, V80, P663, DOI 10.2105/AJPH.80.6.663; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]	41	15	15	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2014	59	5					1248	1253		10.1111/1556-4029.12466			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	AQ3GO	WOS:000342679300009	24588316				2022-02-06	
J	Heuss, ND; Pierson, MJ; Montaniel, KRC; McPherson, SW; Lehmann, U; Hussong, SA; Ferrington, DA; Low, WC; Gregerson, DS				Heuss, Neal D.; Pierson, Mark J.; Montaniel, Kim Ramil C.; McPherson, Scott W.; Lehmann, Ute; Hussong, Stacy A.; Ferrington, Deborah A.; Low, Walter C.; Gregerson, Dale S.			Retinal dendritic cell recruitment, but not function, was inhibited in MyD88 and TRIF deficient mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Dendritic cells; Injury; Microglia; Retinal ganglion cells; NF kappa B	REGULATORY T-CELLS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; NF-KAPPA-B; ALZHEIMERS-DISEASE; NEUROPROTECTIVE AUTOIMMUNITY; NEURODEGENERATIVE DISEASES; ENDOTHELIAL-CELLS; GANGLION-CELLS	Background: Immune system cells are known to affect loss of neurons due to injury or disease. Recruitment of immune cells following retinal/CNS injury has been shown to affect the health and survival of neurons in several models. We detected close, physical contact between dendritic cells and retinal ganglion cells following an optic nerve crush, and sought to understand the underlying mechanisms. Methods: CD11c-DTR/GFP mice producing a chimeric protein of diphtheria toxin receptor (DTR) and GFP from a transgenic CD11c promoter were used in conjunction with mice deficient in MyD88 and/or TRIF. Retinal ganglion cell injury was induced by an optic nerve crush, and the resulting interactions of the GFP(hi) cells and retinal ganglion cells were examined. Results: Recruitment of GFP(hi) dendritic cells to the retina was significantly compromised in MyD88 and TRIF knockout mice. GFP(hi) dendritic cells played a significant role in clearing fluorescent-labeled retinal ganglion cells post-injury in the CD11c-DTR/GFP mice. In the TRIF and MyD88 deficient mice, the resting level of GFP(hi) dendritic cells was lower, and their influx was reduced following the optic nerve crush injury. The reduction in GFP(hi) dendritic cell numbers led to their replacement in the uptake of fluorescent-labeled debris by GFP(lo) microglia/macrophages. Depletion of GFP(hi) dendritic cells by treatment with diphtheria toxin also led to their displacement by GFP(lo) microglia/macrophages, which then assumed close contact with the injured neurons. Conclusions: The contribution of recruited cells to the injury response was substantial, and regulated by MyD88 and TRIF. However, the presence of these adaptor proteins was not required for interaction with neurons, or the phagocytosis of debris. The data suggested a two-niche model in which resident microglia were maintained at a constant level post-optic nerve crush, while the injury-stimulated recruitment of dendritic cells and macrophages led to their transient appearance in numbers equivalent to or greater than the resident microglia.	[Heuss, Neal D.; Pierson, Mark J.; Montaniel, Kim Ramil C.; McPherson, Scott W.; Lehmann, Ute; Hussong, Stacy A.; Ferrington, Deborah A.; Gregerson, Dale S.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [Low, Walter C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA		Gregerson, DS (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Lions Res Bldg Rm 314,2001 6th St SE, Minneapolis, MN 55455 USA.	grege001@umn.edu		Gregerson, Dale/0000-0001-5769-796X; Ferrington, Deborah/0000-0003-2561-7464	Wallin Neuroscience Discovery Fund (DSG); Minnesota Lions Clubs; Research to Prevent Blindness, Inc.Research to Prevent Blindness (RPB);  [R01-EY021003];  [T32-EY07133];  [T32-AG029796];  [P30-EY011374]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY011374, R01EY021003, T32EY007133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG029796] Funding Source: NIH RePORTER	Supported by R01-EY021003 (DSG); the Wallin Neuroscience Discovery Fund (DSG); T32-EY07133 (UL); T32-AG029796 (SH); P30-EY011374; the Minnesota Lions Clubs; and Research to Prevent Blindness, Inc. The authors thank Heidi Roehrich and Thien Sam for technical assistance. We also thank Dr. J Douglas Cameron for a helpful critique of the results.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Barton GHM, 2003, NAT IMMUNOL, V4, P432, DOI 10.1038/ni0503-432; Berry M, 2008, RESTOR NEUROL NEUROS, V26, P147; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P2913, DOI 10.1167/iovs.11-8564; Chou CF, 2013, AM J PREV MED, V45, P29, DOI 10.1016/j.amepre.2013.02.018; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Downes CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057948; Drouin-Ouellet J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-137; Esen N, 2006, J IMMUNOL, V176, P6802, DOI 10.4049/jimmunol.176.11.6802; Famakin BM, 2011, BRAIN RES, V1388, P148, DOI 10.1016/j.brainres.2011.02.074; Garcia GE, 2000, J LEUKOCYTE BIOL, V67, P577, DOI 10.1002/jlb.67.4.577; Garcia JA, 2013, J IMMUNOL, V191, P1063, DOI 10.4049/jimmunol.1300040; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Heuss ND, 2012, J IMMUNOL, V188, P1191, DOI 10.4049/jimmunol.1101621; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Kezic J, 2008, INVEST OPHTH VIS SCI, V49, P1599, DOI 10.1167/iovs.07-0953; Kezic J, 2010, INVEST OPHTH VIS SCI, V51, P5121, DOI 10.1167/iovs.10-5325; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Lehmann U, 2010, NEUROBIOL DIS, V40, P177, DOI 10.1016/j.nbd.2010.05.022; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Lim JE, 2011, AM J PATHOL, V179, P1095, DOI 10.1016/j.ajpath.2011.05.045; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-39; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Luhmann UFO, 2013, EXP EYE RES, V107, P80, DOI 10.1016/j.exer.2012.11.015; Mao XRR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-16; Mao XR, 2002, J BIOL CHEM, V277, P44911, DOI 10.1074/jbc.M204292200; McPherson SW, 2013, J IMMUNOL, V190, P4971, DOI 10.4049/jimmunol.1202625; Michaud JP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-5; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Mizrahi T, 2002, J IMMUNOL, V169, P5971, DOI 10.4049/jimmunol.169.10.5971; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Pang JJ, 2011, INVEST OPHTH VIS SCI, V52, P4886, DOI 10.1167/iovs.10-5921; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Payne Andrew J, 2013, Mo Med, V110, P429; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Pimentel-Coelho PM, 2013, J NEUROSCI, V33, P11556, DOI 10.1523/JNEUROSCI.0535-13.2013; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Popovic M, 2008, J LEUKOCYTE BIOL, V84, P215, DOI 10.1189/jlb.0907652; Qiu JH, 2002, J NEUROSCI, V22, P3504; Sanders VM, 2006, J NEUROIMMUNE PHARM, V1, P11, DOI 10.1007/s11481-005-9004-0; Schlamp CL, 2013, MOL VIS, V19, P1387; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Thumann G, 2012, CURR GENOMICS, V13, P350, DOI 10.2174/138920212801619214; Torres M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-19; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Voleti VB, 2013, MATURITAS, V75, P29, DOI 10.1016/j.maturitas.2013.01.018; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zhao L, 2009, EXP EYE RES, V88, P1004, DOI 10.1016/j.exer.2008.12.013	71	15	16	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	AUG 13	2014	11								143	10.1186/s12974-014-0143-1			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AN5UD	WOS:000340655900001	25116321	gold, Green Published			2022-02-06	
J	Moller, MC; de Boussard, CN; Oldenburg, C; Bartfai, A				Moller, Marika Christina; de Boussard, Catharina Nygren; Oldenburg, Christian; Bartfai, Aniko			An investigation of attention, executive, and psychomotor aspects of cognitive fatigability	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Sleep disturbances; Traumatic brain injury; Fatigue; Neuropsychological tests; Depression	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; MENTAL FATIGUE; OBJECTIVE MEASUREMENT; FUNCTIONAL MRI; HEAD-INJURY; MILD; PERFORMANCE; SYMPTOMS; SLEEP	Objective: Self-perceived mental fatigue is a common presenting symptom in many neurological diseases. Discriminating objective fatigability from self-perceived mental fatigue might facilitate neuropsychological diagnosis and treatment programs. However clinically valid neuropsychological instruments suitable for assessment of fatigability are still lacking. The prime aim of the study was to investigate aspects of cognitive fatigability and to identify properties of neuropsychological tests suitable to assess fatigability in patients with persistent cognitive complaints after mild brain injury. Another aim was to investigate whether cognitive fatigability captured by neuropsychological measures is influenced by depression or sleep disturbances. Method: Twenty-four patients with persistent cognitive symptoms after mild traumatic brain injury (mTBI), (aged 18-51 years) and 31 healthy controls (aged 20-49 years) underwent neuropsychological testing measuring three cognitive fatigability domains: Attention fatigability was assessed using the Ruff 2 & 7 Selective Attention Test, executive fatigability using the Color Word Test (Stroop), and psychomotor fatigability using the Digit Symbol Substitution Test from the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). Subjective fatigue was measured using the Fatigue Severity Scale and a questionnaire of everyday consequences of fatigue. Depression was screened using the Hospital Anxiety and Depression Scale and sleep disturbances using the Pittsburgh Sleep Quality Index. Results: The patients reported significantly more mental fatigue and performed worse on tests of psychomotor and executive fatigability than the healthy controls. Furthermore, the cognitive fatigability measures were not influenced by depression or sleep disturbances, as was the case in self-reported fatigue. Conclusion: Tests demanding executive or simultaneous processing of several neuropsychological functions seem most sensitive in order to capture cognitive fatigability. Clinical tests that can capture fatigability enable a deeper understanding of how fatigability might contribute to cognitive complaints and problems in maintaining daily activities.	[Moller, Marika Christina] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [de Boussard, Catharina Nygren; Oldenburg, Christian; Bartfai, Aniko] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden		Moller, MC (corresponding author), Danderyd Hosp, Dept Rehabil Med, S-18288 Stockholm, Sweden.	marika.moller@ds.se	Moller, Marika/S-5427-2019; MAller, Marika C/N-8782-2016	Moller, Marika/0000-0001-8700-5186; MAller, Marika C/0000-0001-8700-5186; Oldenburg, Christian/0000-0003-4647-9136; Bartfai, Aniko/0000-0002-0815-2485	Centre for Clinical Research Sormland, Uppsala University [82100]	This study was supported by the Centre for Clinical Research Sormland, Uppsala University [grant number 82100].	Ackerman PL., 2010, COGNITIVE FATIGUE MU, P11; Akerstedt T, 2010, IND HEALTH, V48, P209, DOI 10.2486/indhealth.48.209; Arnold LM, 2008, PSYCHOSOMATICS, V49, P185, DOI 10.1176/appi.psy.49.3.185; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bryant D, 2004, REHABIL PSYCHOL, V49, P114, DOI 10.1037/0090-5550.49.2.114; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Davis Mellar P, 2010, J Support Oncol, V8, P164; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; DeLuca J, 2005, ISS CLIN COGN NEUROP, P37; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; GRONWALL D, 1974, LANCET, V2, P605; Holtzer R, 2010, AGING NEUROPSYCHOL C, V18, P108, DOI 10.1080/13825585.2010.517826; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson S K, 1997, Appl Neuropsychol, V4, P145, DOI 10.1207/s15324826an0403_1; Kaplan E., 1994, WAIS R NI WAIS R SOM; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; Levi Y., 2013, J INT NEUROPSYCH SOC, V19, P1; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lorist MM, 2002, J PHYSIOL-LONDON, V545, P313, DOI 10.1113/jphysiol.2002.027938; Lorist MM, 2008, BRAIN RES, V1232, P113, DOI 10.1016/j.brainres.2008.07.053; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moller M. C., 2014, FATIGUE BIO IN PRESS; Moller MC, 2013, GYNECOL ENDOCRINOL, V29, P173, DOI 10.3109/09513590.2012.730568; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rosenthal TC, 2008, AM FAM PHYSICIAN, V78, P1173; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Schwid SR, 2003, MULT SCLER, V9, P503, DOI 10.1191/1352458503ms946oa; Schwid SR, 2002, J REHABIL RES DEV, V39, P211; Smith G. J. W., 1986, MANUAL CWT; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; Wechsler D., 2003, WAIS 3 SVENSK VERSIO; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; Zwarts MJ, 2008, CLIN NEUROPHYSIOL, V119, P2, DOI 10.1016/j.clinph.2007.09.126	55	15	15	2	34	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 9	2014	36	7					716	729		10.1080/13803395.2014.933779			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AR0XK	WOS:000343298000005	24965830				2022-02-06	
J	Fontes, RBV; Smith, AP; Munoz, LF; Byrne, RW; Traynelis, VC				Fontes, Ricardo B. V.; Smith, Adam P.; Munoz, Lorenzo F.; Byrne, Richard W.; Traynelis, Vincent C.			Relevance of early head CT scans following neurosurgical procedures: an analysis of 892 intracranial procedures at Rush University Medical Center Clinical article	JOURNAL OF NEUROSURGERY			English	Article						computed tomography; radiography; craniotomy; reoperation; traumatic brain injury	EXTERNAL VENTRICULAR DRAIN; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; SUBARACHNOID HEMORRHAGE; INJURY; PLACEMENT; ACCURACY; TRAUMA; CARE	Object. Early postoperative head CT scanning is routinely performed following intracranial procedures for detection of complications, but its real value remains uncertain: so-called abnormal results are frequently found, but active, emergency intervention based on these findings may be rare. The authors' objective was to analyze whether early postoperative CT scans led to emergency surgical interventions and if the results of neurological examination predicted this occurrence. Methods. The authors retrospectively analyzed 892 intracranial procedures followed by an early postoperative CT scan performed over a 1-year period at Rush University Medical Center and classified these cases according to postoperative neurological status: baseline, predicted neurological change, unexpected neurological change, and sedated or comatose. The interpretation of CT results was reviewed and unexpected CT findings were classified based on immediate action taken: Type I, additional observation and CT; Type II, active nonsurgical intervention; and Type III, surgical intervention. Results were compared between neurological examination groups with the Fisher exact test. Results. Patients with unexpected neurological changes or in the sedated or comatose group had significantly more unexpected findings on the postoperative CT (p < 0.001; OR 19.2 and 2.3, respectively) and Type 111111 interventions (p < 0.001) than patients at baseline. Patients at baseline or with expected neurological changes still had a rate of Type II/III changes in the 2.2%-2.4% range; however, no patient required an immediate return to the operating room. Conclusions. Over a 1-year period in an academic neurosurgery service, no patient who was neurologically intact or who had a predicted neurological change required an immediate return to the operating room based on early postoperative CT findings. Obtaining early CT scans should not be a priority in these patients and may even be cancelled in favor of MRI studies, if the latter have already been planned and can be performed safely and in a timely manner. Early postoperative CT scanning does not assure an uneventful course, nor should it replace accurate and frequent neurological checks, because operative interventions were always decided in conjunction with the neurological examination.	[Fontes, Ricardo B. V.; Smith, Adam P.; Munoz, Lorenzo F.; Byrne, Richard W.; Traynelis, Vincent C.] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA		Fontes, RBV (corresponding author), Rush Univ, Med Ctr, Dept Neurosurg, 1725 W Harrison,Ste 855, Chicago, IL 60612 USA.	ricardo_fontes@rush.edu	Byrne, Richard/Q-9644-2019				Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Byrne RW, 2011, NEUROSURGERY, V68, P1063, DOI 10.1227/NEU.0b013e318209cde0; DAUCH WA, 1994, NEUROSURG REV, V17, P141, DOI 10.1007/BF00698770; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; FUKAMACHI A, 1986, NEUROSURGERY, V19, P589, DOI 10.1227/00006123-198610000-00013; Garrett MC, 2013, NEUROSURGERY, V73, P209, DOI 10.1227/01.neu.0000430328.25516.dd; Horowitz SW, 1996, SKULL BASE SURG, V6, P199, DOI 10.1055/s-2008-1058626; Hsieh CT, 2011, ACTA NEUROL BELG, V111, P22; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Khaldi A, 2010, J NEUROSURG, V113, P1021, DOI 10.3171/2009.11.JNS081048; LIN JP, 1977, NEURORADIOLOGY, V12, P185, DOI 10.1007/BF00332366; MEYDINGLAMADE U, 1993, NEURORADIOLOGY, V35, P178, DOI 10.1007/BF00588487; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patil V, 2013, ACTA NEUROCHIR, V155, P1773, DOI 10.1007/s00701-013-1769-y; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; STAMMLER U, 1989, Neurosurgical Review, V12, P159, DOI 10.1007/BF01790640; Stein EG, 2010, J AM COLL RADIOL, V7, P351, DOI 10.1016/j.jacr.2009.12.015; Warmuth-Metz M, 2003, ACT NEUR S, V88, P13; Wilson TJ, 2013, J NEUROSURG, V119, P66, DOI 10.3171/2012.11.JNS111384; Wong JM, 2013, J NEUROSURG, V119, P215, DOI 10.3171/2013.3.JNS12253; YOSHIMIZU N, 1989, Neurosurgical Review, V12, P175, DOI 10.1007/BF01790642; Zar J.H., 2013, BIOSTATISTICAL ANAL BIOSTATISTICAL ANAL	25	15	15	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2014	121	2					307	312		10.3171/2014.4.JNS132429			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AL9PK	WOS:000339473000011	24878289				2022-02-06	
J	Hasegawa, K; Takeda, T; Nakajima, K; Ozawa, T; Ishigami, K; Narimatsu, K; Noh, K				Hasegawa, Ken; Takeda, Tomotaka; Nakajima, Kazunori; Ozawa, Takamitsu; Ishigami, Keiichi; Narimatsu, Keishiro; Noh, Kwantae			Does clenching reduce indirect head acceleration during rugby contact?	DENTAL TRAUMATOLOGY			English	Article						mouthguard; neck muscle; masseter muscle; concussion; clenching	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; PROTECTIVE EQUIPMENT; CONCUSSION; IMPACTS; RISK; BIOMECHANICS; PREVENTION; SPORT	Background: Concussions are common among athletes, with the potential to cause memory-related, physical, cognitive, emotional, and behavioral damage. A concussion is an acceleration/deceleration injury resulting from direct and indirect biomechanical forces transmitted to the cerebral tissues. From a sports dentistry viewpoint, increased mastication muscle activity or clenching due to the presence of a mouthguard may enhance cervical muscle activity, thereby reducing damage following impact. This relationship has not been previously investigated in the context of rugby. The purpose of this study was to investigate the effect of voluntary clenching on indirect head acceleration during attack-and defense-related drills. Materials and methods: A total of 12 high school rugby players participated in the study. Linear acceleration of the head was measured using an accelerometer that took measurements in three axes. Masseter and sternocleidomastoid muscle activities were measured using wireless electromyography. These data were synchronized using digital video imaging software for analysis. The study protocol was approved by the Tokyo Dental College Ethics Committee. Results and Conclusions: Within the limitations of this study, the following results were obtained: the activities performed during rugby practice involved relatively small indirect head acceleration and masseter and sternocleidomastoid muscle activities. After the young male rugby players were instructed to clench their masseter muscles, a marked decrease in head acceleration was observed.	[Hasegawa, Ken; Takeda, Tomotaka; Nakajima, Kazunori; Ozawa, Takamitsu; Ishigami, Keiichi; Narimatsu, Keishiro] Tokyo Dent Coll, Dept Sports Dent, Mihama Ku, Chiba 2618502, Japan; [Noh, Kwantae] Kyung Hee Univ, Dept Prosthodont, Sch Dent, Seoul, South Korea		Takeda, T (corresponding author), Tokyo Dent Coll, Dept Sports Dent, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	ttakeda@tdc.ac.jp	Noh, Kwantae/AAK-3492-2020; Meijer, Anna/K-5118-2016	Noh, Kwantae/0000-0003-3480-7737			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barth JT, 2001, J ATHL TRAINING, V36, P253; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cusimano MD., 2011, OPEN MED-WARSAW, V5, P57; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Ichii Y, 1999, J CLIN SPORT MED, V16, P234; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maeda Y, 1997, J JPN PROSTHODONT SO, V41, P489; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Miyahara T, 1996, J NEUROPHYSIOL, V76, P2033, DOI 10.1152/jn.1996.76.3.2033; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Neal Matthew T, 2012, Surg Neurol Int, V3, P16, DOI 10.4103/2152-7806.92930; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Satoh T, 1990, J JPN SOC BIOMECHANI, V14, P68; Sekimoto T, 1999, J JPN PROSTHODONT SO, V43, P568; SUMIYOSHI S, 1996, NIHON KOUKUU GEKA GA, V42, P1192; Taguchi Y, 2002, J JAPN SOC CLIN SPOR, V19, P609; Takada Y, 1998, Kokubyo Gakkai Zasshi, V65, P64; Takeda T, 2008, J KOREAN SPORTS DENT, V4, P20; Tsukimura Y, 2008, CLIN J SPORT MED, V16, P172; URBANOWICZ M, 1991, CRANIO, V9, P174, DOI 10.1080/08869634.1991.11678365; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Yokoyama Y, 1998, J JPN PROSTHODONT SO, V42, P90	39	15	16	1	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	AUG	2014	30	4					259	264		10.1111/edt.12082			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AM2YB	WOS:000339716400002	24138128				2022-02-06	
J	Kumar, RG; Bracken, MB; Clark, AN; Nick, TG; Melguizo, MS; Sander, AM				Kumar, Raj G.; Bracken, Michael B.; Clark, Allison N.; Nick, Todd G.; Melguizo, Maria S.; Sander, Angelle M.			Relationship of Preinjury Depressive Symptoms to Outcomes 3 mos After Complicated and Uncomplicated Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Preinjury Depression; Mild Traumatic Brain Injury; Complicated mTBI; Recovery	HEAD-INJURY; RISK-FACTORS; CES-D; NATURAL-HISTORY; PREDICTORS; SCALE; SENSITIVITY; DISORDER; RECOVERY; VALIDITY	Objective: This study examines the effect of preinjury depressive symptoms on outcomes 3 mos after complicated and uncomplicated cases of mild traumatic brain injury. Design: Preinjury depressive symptoms, experienced in the 30 days before injury, as measured by retrospective self-report, were assessed within the first 2 wks after injury. The outcome measures assessed at 3 mos after injury included affective/behavioral, cognitive, and physical problems and health-related quality-of-life. Results: There were 177 patients who completed both the baseline and 3-mo follow-up interviews. The sample was categorized by severity of depressive symptoms in the month before injury as normal, mild, or moderate-severe. Compared with those reporting no preinjury depressive symptoms, persons reporting moderate-severe depressive symptoms had significantly worse outcomes on the Affective and Behavioral and the Cognitive subscales of the Head Injury-Family Interview Problem Checklist and on the 36-item Short-Form Health Survey Mental Component Summary score. The group reporting mild preinjury depressive symptoms scored worse on a measure of cognitive symptoms compared with those with no preinjury depressive symptoms. There was no interaction between preinjury depressive symptoms and severity of the mild traumatic brain injury (complicated or uncomplicated) for any of the outcomes. Conclusion: Moderate to severe depressive symptoms in the month before injury seems to be a possible risk factor for poor affective/behavioral, cognitive, and mental health-related quality-of-life outcomes at 3 mos after mild traumatic brain injury. Clinicians and researchers should consider the impact of preinjury depression on the recovery process to provide at-risk patients adequate treatment soon after injury.	[Kumar, Raj G.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Publ Hlth, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Clark, Allison N.; Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Harris Hlth Syst & Brain Injury Res Ctr, TIRR Mem Hermann, Houston, TX 77030 USA; [Nick, Todd G.; Melguizo, Maria S.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Pediat, Little Rock, AR 72205 USA; [Nick, Todd G.; Melguizo, Maria S.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Biostat, Little Rock, AR 72205 USA		Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund, Houston, TX 77030 USA.				National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133B990014, H133B090023, H133A120020]	Supported, in part, by grants from the National Institute on Disability and Rehabilitation Research, United States Department of Education (grant nos. H133B990014, H133B090023, H133A120020).	[Anonymous], 1997, SURVEILLANCE TRAUMAT; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CDC Data & Statistics, FEAT EST 1 10 US AD; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Harrell F, 2009, RMS S FUNCTIONS BIOS; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M., 2008, MILD TRAUMATIC BRAIN; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; PARIKH RM, 1988, INT J PSYCHIAT MED, V18, P169, DOI 10.2190/BH75-EUYA-4FM1-J7QA; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; QuickStats, 2007, NAT HLTH NUTR EX SUR; R Development Core Team, 2012, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rosenberg, 2013, APPL REGRESSION ANAL; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; SAS Institute Inc, 2010, SAS 9 2 LANG REF CON; Sharp LK, 2002, AM FAM PHYSICIAN, V66, P1001; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; SHINAR D, 1986, STROKE, V17, P241, DOI 10.1161/01.STR.17.2.241; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ware J., 2000, SF 36 HLTH SURVEY MA; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	53	15	15	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2014	93	8					687	698		10.1097/PHM.0000000000000077			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AL7PT	WOS:000339327600006	24743469				2022-02-06	
J	Coqueugniot, H; Dutour, O; Arensburg, B; Duday, H; Vandermeersch, B; Tillier, AM				Coqueugniot, Helene; Dutour, Olivier; Arensburg, Baruch; Duday, Henri; Vandermeersch, Bernard; Tillier, Anne-marie			Earliest Cranio-Encephalic Trauma from the Levantine Middle Palaeolithic: 3D Reappraisal of the Qafzeh 11 Skull, Consequences of Pediatric Brain Damage on Individual Life Condition and Social Care	PLOS ONE			English	Article							CEREBRAL ASYMMETRIES; COMPUTED-TOMOGRAPHY; ENAMEL; INJURY; ISRAEL; PATHOLOGY; REMAINS; STRESS	The Qafzeh site (Lower Galilee, Israel) has yielded the largest Levantine hominin collection from Middle Palaeolithic layers which were dated to circa 90-100 kyrs BP or to marine isotope stage 5b-c. Within the hominin sample, Qafzeh 11, circa 1213 yrs old at death, presents a skull lesion previously attributed to a healed trauma. Three dimensional imaging methods allowed us to better explore this lesion which appeared as being a frontal bone depressed fracture, associated with brain damage. Furthermore the endocranial volume, smaller than expected for dental age, supports the hypothesis of a growth delay due to traumatic brain injury. This trauma did not affect the typical human brain morphology pattern of the right frontal and left occipital petalia. It is highly probable that this young individual suffered from personality and neurological troubles directly related to focal cerebral damage. Interestingly this young individual benefited of a unique funerary practice among the south-western Asian burials dated to Middle Palaeolithic.	[Coqueugniot, Helene; Dutour, Olivier; Duday, Henri; Vandermeersch, Bernard; Tillier, Anne-marie] Univ Bordeaux, CNRS, Unite Mixte Rech Prehist Actuel Culture Environm, Pessac, France; [Coqueugniot, Helene] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Dutour, Olivier; Duday, Henri] Ecole Prat Hautes Etud, Lab Anthropol Biol Paul Broca, Paris, France; [Dutour, Olivier] Univ Western Ontario, Dept Anthropol, London, ON, Canada; [Arensburg, Baruch] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Ramat Aviv, Israel; [Tillier, Anne-marie] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA		Coqueugniot, H (corresponding author), Univ Bordeaux, CNRS, Unite Mixte Rech Prehist Actuel Culture Environm, Pessac, France.	helene.coqueugniot@u-bordeaux.fr	Dutour, Olivier/AAG-2237-2020	DUTOUR, Olivier/0000-0001-8134-788X	Irene Levi Sala Care Archaeological Foundation	This research has been financially supported by the Irene Levi Sala Care Archaeological Foundation (http://prehistory.org.il/?page_id=894). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Balzeau A., 2013, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V25, P1, DOI 10.1007/s13219-012-0069-z; Berti PR, 1992, CHIETI ITALY J PALEO, V2, P19; Boutie P, 1989, BRIT ARCHAEOLOGICAL, V497, P213; Brodmann K ., 1909, VERGLEICHENDE LOKALI; CHUI HC, 1980, J NEUROL NEUROSUR PS, V43, P873, DOI 10.1136/jnnp.43.10.873; Churchill SE, 2009, J HUM EVOL, V57, P163, DOI 10.1016/j.jhevol.2009.05.010; Coqueugniot H, 1994, ANTHROPOLOGIE BRNO, VXXXII, P243; Coqueugniot H, 2013, French patent, Patent No. 1151284; Coqueugniot H., 2010, ACT C VIRT RETR 2009, V4, P177; Coqueugniot H, 2012, 19 EUR M PAL ASS LIL, V41; Coqueugniot H, 2012, AM J PHYS ANTHROPOL, V147, P312, DOI 10.1002/ajpa.21655; Cowgill LW, 2007, J HUM EVOL, V53, P213, DOI 10.1016/j.jhevol.2007.04.003; Dastugue, 1981, PALEORIENT, V7, P135, DOI [10.3406/paleo.1981.4292, DOI 10.3406/PALE0.1981.4292]; DeGusta D, 2002, J ARCHAEOL SCI, V29, P1435, DOI 10.1006/jasc.2001.0808; Dutailly B, 2009, 2009 16TH IEEE INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOLS 1-6, P2505, DOI 10.1109/ICIP.2009.5413911; Dutour O, 2012, 39 ANN M PAL ASS POR, V13-14; Etgen AM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1121; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; Grimaud-Herve D, 1997, EVOLUTION ENCEPHALE; Guyomarc'h P, 2013, FORENSIC SCI INT, V231, DOI 10.1016/j.forsciint.2013.04.007; Guyomarc'h P, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2012.01.008; HOLLOWAY R. L., 2004, HUMAN FOSSIL RECORD, V3; Hovers E., 2009, LITHIC ASSEMBLAGES Q; Hovers E, 1997, THESIS HEBRE U JERUS; HOWELL FC, 1958, HUNDERT JAHRE NEANDE, P185; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P6429, DOI 10.1073/pnas.0902614106; Kondo O, 2014, DYNAMICS LEARNING NE, V2, P183; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lloyd D, 2007, WHAT DO BRODMANN ARE; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Mann A, 2008, NEW INSIGHTS KRAPINA, P261; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McCown T. D., 1939, STONE AGE MOUNT CARM, V2; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; NEIBURGER EJ, 1990, AM J PHYS ANTHROPOL, V82, P231, DOI 10.1002/ajpa.1330820211; Rampont M, 1994, THESIS U L PASTEUR S; Schultz M, 1998, DENTAL ANTHROPOLOGY, P293; SCHWARCZ HP, 1988, J HUM EVOL, V17, P733, DOI 10.1016/0047-2484(88)90063-2; Skinner M, 1996, J ARCHAEOL SCI, V23, P833, DOI 10.1006/jasc.1996.0078; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Tillier A.-M., 2009, HOMME MORT EMERGENCE; Tillier A. - m, 2004, HUMAN PALEOECOLOGY L, P135; Tillier A-m., 1995, PALEORIENT, V21, P63, DOI [10.3406/paleo.1995.4618, DOI 10.3406/PALEO.1995.4618]; Tillier AM, 2001, AM J PHYS ANTHROPOL, V114, P166, DOI 10.1002/1096-8644(200102)114:2<166::AID-AJPA1017>3.0.CO;2-3; Tillier AM, 1984, PALEORIENT, V10, P7; Tillier AM., 1999, ENFANTS MOUSTERIENS; Tillier AM, PALEORIENT IN PRESS; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; TRINKAUS E, 1985, AM J PHYS ANTHROPOL, V67, P19, DOI 10.1002/ajpa.1330670105; Trinkaus E., 1983, SHANIDAR NEANDERTALS; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; VANDERME.B, 1970, CR ACAD SCI D NAT, V270, P298; Vandermeersch, 1981, HOMMES FOSSILES QAFZ; VANDERMEERSCH B, 1969, CR ACAD SCI D NAT, V268, P2562; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; Zollikofer CPE, 2002, P NATL ACAD SCI USA, V99, P6444, DOI 10.1073/pnas.082111899	62	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2014	9	7							e102822	10.1371/journal.pone.0102822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NT	WOS:000339614100060	25054798	Green Published, gold			2022-02-06	
J	Chen, X; Zhao, ZL; Chai, Y; Luo, LL; Jiang, RC; Zhang, JN				Chen, Xin; Zhao, Zilong; Chai, Yan; Luo, Lanlan; Jiang, Rongcai; Zhang, Jianning			The incidence of critical-illness-related-corticosteroid-insufficiency is associated with severity of traumatic brain injury in adult rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Critical illness related corticosteroid insufficiency; Corticosteroid response; Blood-brain barrier; Brain edema	RANDOMIZED CONTROLLED-TRIAL; AQUAPORIN 4; CELL-DEATH; HYDROCORTISONE; EDEMA; EXPRESSION; BARRIER; MEMORY	Traumatic brain injury (TB!) causes deleterious critical-illness-related-corticosteroid-insufficiency (CIRCI), leading to high mortality and morbidity. However, the incidence of CIRCI following different TBI severities is not fully defined. This study was designed to investigate mechanistically the effects of injury severity on corticosteroid response and the development of CIRCI in a rat model of experimentally controlled TBI. Adult male Wistar rats were randomly assigned to sham, mild injury, moderate injury or severe injury groups. TBI was induced using a fluid percussion device at magnitudes of 12-1.4 atm (mild injury), 2.0-22 atm (moderate injury), and 3.2-3.5 atm (severe injury). We first assessed the effects of injury severity on the mortality and CIRCI occurrence using electrical stimulation test to assess corticosteroid response. We also investigated a series of pathological changes in the hypothalamus, especially in the paraventricular nuclei (PVN), among different injury group including: apoptosis detected by a TUNEL assay, blood-brain-barrier (BBB) permeability assessed by brain water content and Evans Blue extravasation into the cerebral parenchyma, and BBB integrity evaluated by CD31 and Claudin-5 expression and transmission electron microscopy. We made the following observations. First, 6.7% of mild-injured, 13.3% of moderate-injured, and 68.8% of severe-injured rats developed CIRCI, with a peak incidence on post-injury day 7. Second, TBI-induced CIRCI is closely correlated with injury severity. As the injury severity rises both the incidence of CIRCI and mortality surge; Third, increased level of injury severity reduces the expression of endothelial tight junction protein, aggravate BBB permeability and exacerbate the ensuing neural apoptosis in the PVN of hypothalamus. These findings indicate that increased severity of TBI aggravate the incidence of CIRCI by causing damage to tight junctions of vascular endothelial cells and increasing neuronal apoptosis in the PVN of hypothalamus. (C) 2014 Elsevier B.V. All rights reserved.	[Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Luo, Lanlan] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China		Chen, X (corresponding author), Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	xinchentianjin@me.com; zilongzhaotianjin@hotmail.com; chaiyankelly@163.com; luolan116@sohu.com; jianghope111@163.com; jianningzhang@hotmail.com	Zhao, Zilong/AAZ-2196-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000533, 81370029]; Project of Tianjin Applied Basic and Cutting-edge Technological Research [13JCQNJC10500]	This work was supported by grants from the National Natural Science Foundation of China (grant nos. 81000533 and 81370029), and the Project of Tianjin Applied Basic and Cutting-edge Technological Research (13JCQNJC10500).	Annane D, 2010, CRIT CARE MED, V38, P721, DOI 10.1097/CCM.0b013e3181c54620; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Asehnoune K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-228; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cuesta JM, 2012, CRIT CARE MED, V40, P3283, DOI 10.1097/CCM.0b013e31826567eb; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; EDWARDS OM, 1986, MEDICINE, V65, P281; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; JAATTELA M, 1991, ENDOCRINOLOGY, V128, P623; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jung B, 2012, CRIT CARE, V16, DOI 10.1186/cc11871; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Kwon YS, 2010, INTENS CARE MED, V36, P1845, DOI 10.1007/s00134-010-1971-9; Lampron A, 2013, NEURON, V78, P214, DOI 10.1016/j.neuron.2013.04.005; Laurer H.L., 2002, ENCY HUMAN BRAIN, P93; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Martin LG, 2011, VET CLIN N AM-SMALL, V41, P767, DOI 10.1016/j.cvsm.2011.03.021; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Peng YS, 2009, CRIT CARE, V13, DOI 10.1186/cc7978; RINK A, 1995, AM J PATHOL, V147, P1575; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc13138; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Triantos CK, 2011, CLIN GASTROENTEROL H, V9, P595, DOI 10.1016/j.cgh.2011.03.033; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; Walker ML, 2011, AM SURGEON, V77, P579; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhao YD, 2001, WORLD J SURG, V25, P1202; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002	48	15	16	2	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUL 15	2014	342	1-2					93	100		10.1016/j.jns.2014.04.032			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK4SN	WOS:000338414500014	24819916				2022-02-06	
J	Missios, S; Bekelis, K				Missios, Symeon; Bekelis, Kimon			Transport Mode to Level I and II Trauma Centers and Survival of Pediatric Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ground emergency medical services; helicopter; mortality; NTDB; pediatric; traumatic brain injury	EMERGENCY MEDICAL-SERVICES; HELICOPTER TRANSPORT; HOSPITAL MORTALITY; GROUND TRANSPORT; DATA-BANK; PATTERNS; SYSTEM; ASSOCIATION; OUTCOMES; ADULTS	The use of helicopter emergency medical services (EMS) for pediatric trauma patients is an issue of debate. We investigated the association of helicopter transport with survival of pediatric patients with traumatic brain injury (TBI). We conducted a retrospective cohort study of pediatric patients with TBI who were transported to level I and II trauma centers and were registered in the National Trauma Data Bank (NTDB) between 2009 and 2011. We used regression techniques, integrating the results of propensity score matching, to investigate the association of helicopter transport with survival, in comparison with ground EMS. There were 15,704 pediatric patients with TBI who met the inclusion criteria. Of these, 3142 were transported via helicopters, and 12,562 via ground EMS. The mortality for children transported to level I trauma centers was 7.5% (183 deaths) for helicopter transport and 3.8% (337 deaths) for ground. Multivariable logistic regression analysis demonstrated an association of helicopter transport with increased survival (odds ratio [OR], 1.76; 95% confidence interval [CI], 1.27-2.46; absolute risk reduction [ARR], 2.70%). This persisted after propensity score matching (OR, 1.77; 95% CI, 1.25-2.52; ARR 2.73%). The mortality for children transported to level II trauma centers was 8.0% (52 deaths) for helicopter transport, and 4.4% (163 deaths) for ground. Multivariable logistic regression analysis demonstrated an association of helicopter transport with increased survival (OR, 2.35; 95% CI, 1.30-4.25; ARR 5.36%). This again persisted after propensity score matching (OR 2.56; 95% CI 1.28-5.11; ARR 6.14). Pediatric patients with TBI transported to level I and II trauma centers had improved survival in comparison with similar patients transported via ground EMS.	[Missios, Symeon] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03756 USA		Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, One Med Ctr Dr, Lebanon, NH 03756 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019				American College of Surgeons, 2011, ANN REPORT; Bankole S, 2011, PEDIATR CRIT CARE ME, V12, pE166, DOI 10.1097/PCC.0b013e3181f36f6e; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bhullar IS, 2010, AM SURGEON, V76, P966; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Bledsoe Bryan E, 2003, Emerg Med Serv, V32, P88; Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Di Bartolomeo S, 2001, ARCH SURG-CHICAGO, V136, P1293, DOI 10.1001/archsurg.136.11.1293; Eckstein M, 2002, J TRAUMA, V53, P340, DOI 10.1097/00005373-200208000-00025; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Galvagno SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub2; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hirano K., 2001, HEALTH SERV OUTCOME, V2, P259, DOI DOI 10.1023/A:1020371312283; Ho D, 2007, J STAT SOFTWARE; Honaker J., 2009, J STAT SOFTWARE; Imai K, 2009, ZELIG EVERYONES STAT; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Larson JT, 2004, J TRAUMA, V56, P89, DOI 10.1097/01.TA.0000061163.35582.A5; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Mitchell AD, 2007, CAN J SURG, V50, P129; Moront ML, 1996, J PEDIATR SURG, V31, P1183, DOI 10.1016/S0022-3468(96)90114-1; Oyetunji TA, 2011, J SURG RES, V165, pE37, DOI 10.1016/j.jss.2010.09.025; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Roudsari B, 2008, INJURY PREV, V14, P96, DOI 10.1136/ip.2007.017129; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; SCHILLER WR, 1988, J TRAUMA, V28, P1127, DOI 10.1097/00005373-198808000-00004; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; Sullivent EE, 2011, PREHOSP EMERG CARE, V15, P295, DOI 10.3109/10903127.2011.569849; Thomas SH, 2002, J TRAUMA, V52, P136, DOI 10.1097/00005373-200201000-00023; Thomas Stephen H, 2003, Curr Opin Anaesthesiol, V16, P153, DOI 10.1097/00001503-200304000-00008; Thomas Stephen H, 2002, Prehosp Emerg Care, V6, P359, DOI 10.1080/10903120290938508; Tortella B J, 1996, Air Med J, V15, P24, DOI 10.1016/S1067-991X(96)90015-2; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; Traumatic Brain Injury in the United States, EM DEP VIS HOSP DEAT	38	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1321	1328		10.1089/neu.2014.3325			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000009	24605922				2022-02-06	
J	Giustini, M; Longo, E; Azicnuda, E; Silvestro, D; D'Ippolito, M; Rigon, J; Cedri, C; Bivona, U; Barba, C; Formisano, R				Giustini, Marco; Longo, Eloise; Azicnuda, Eva; Silvestro, Daniela; D'Ippolito, Mariagrazia; Rigon, Jessica; Cedri, Cinzia; Bivona, Umberto; Barba, Carmen; Formisano, Rita			Health-related quality of life after traumatic brain injury: Italian validation of the QOLIBRI	FUNCTIONAL NEUROLOGY			English	Article						neuropsychological outcome; post-traumatic depression; quality of life; traumatic brain injury		The QOLIBRI (Quality of Life after Brain Injury) is a new international health-related quality of life (HRQoL) instrument developed for assessing the consequences of traumatic brain injury (TBI). We report the results of the Italian validation of the QOLIBRI. A total of 147 participants with TBI who had previously been discharged from the Santa Lucia Foundation rehabilitation hospital were recruited to investigate the concurrent validity of the Italian version of the QOLIBRI and to compare this instrument with several functional and cognitivebehavioral scales, taking into account various clinical parameters. The QOLIBRI met the standard criteria for internal consistency, homogeneity and test-retest reliability. The results suggest that it is very sensitive in relation to outcome as measured by the Extended Glasgow Outcome Scale (GOS-E) and other instruments for functional assessment of disability, emotions and subjective health status, including the Hospital Anxiety and Depression Scale and the Short-Form 36. The QOLIBRI avoids some of the limitations of traditional scales for quantifying residual functional capacity, such as the Glasgow Outcome Scale and the GOS-E, and may contribute to the achievement of better quality-controlled care, medical decision-making, rehabilitation planning, and measurement of well-being and HRQoL from the patient's perspective. However, a longitudinal study is needed to assess the responsiveness of the QOLIBRI to changes over time.	[Giustini, Marco; Longo, Eloise; Cedri, Cinzia] Italian Natl Inst Hlth, Environm & Trauma Unit, Rome, Italy; [Azicnuda, Eva; Silvestro, Daniela; D'Ippolito, Mariagrazia; Bivona, Umberto; Formisano, Rita] IRCCS Santa Lucia Fdn, Postcoma Unit, Rome, Italy; [Rigon, Jessica] IRCCS San Camillo Hosp Fdn, Venice, Italy; [Barba, Carmen] Univ Florence, A Meyer Childrens Hosp, Pediat Neurol Unit, Florence, Italy		Giustini, M (corresponding author), Italian Natl Inst Hlth, Environm & Trauma Unit, Rome, Italy.	marco.giustini@iss.it	Giustini, Marco/Q-3166-2017; barba, carmen/K-4942-2016; Barba, Carmen/AAB-7162-2022; Azicnuda, Eva/K-9010-2016; D'Ippolito, Mariagrazia/K-4010-2016	Giustini, Marco/0000-0003-2691-1956; barba, carmen/0000-0001-5445-5842; D'Ippolito, Mariagrazia/0000-0001-7818-7352	Italian Ministry of HealthMinistry of Health, Italy [RF2008, 31]; G.B. Baroni Foundation	This research was partially supported by the Italian Ministry of Health (grant RF2008, n.31) and received a grant from the G.B. Baroni Foundation.	Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Court, 1986, COLOURED PROGR MATRI; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Mauri M, 2006, FUNCT NEUROL, V21, P223; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; MOKKEN RJ, 1982, APPL PSYCH MEAS, V6, P417, DOI 10.1177/014662168200600404; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; STREINER D, 2006, HLTH MEASUREMENT SCA; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2004, ICD 10 INT STAT CLAS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	15	15	0	1	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	JUL-SEP	2014	29	3					167	176		10.11138/FNeur/2014.29.3.167			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V9O2N	WOS:000408857100004	25473736				2022-02-06	
J	Gracies, JM; Bayle, N; Goldberg, S; Simpson, DM				Gracies, Jean-Michel; Bayle, Nicolas; Goldberg, Sarah; Simpson, David M.			Botulinum Toxin Type B in the Spastic Arm: A Randomized, Double-Blind, Placebo-Controlled, Preliminary Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Botulinum toxin; Controlled clinical trials, randomized; Rehabilitation; Stroke	UPPER-LIMB SPASTICITY; STROKE; HEMIPARESIS; NEUROTOXIN; THERAPY; PARESIS; TRIAL	Objective: To determine the efficacy and safety of 2 doses of botulinum toxin type B (rimabotulinumtoxinB, BoNT/B) in spastic upper limb muscles. Design: Randomized, double-blind, placebo-controlled trial with a 3-month follow-up. Setting: Tertiary care center. Participants: Referred sample of adult hemiparetic patients (N=24) with disabling elbow flexor overactivity after stroke or traumatic brain injury. Interventions: Injection of 10,00011 of rimabotulinumtoxinB (fixed 250011 dose into elbow flexors; n=8), 15,00011 (5000U into elbow flexors; n=8), or placebo (n=8) into overactive upper limb muscles selected as per investigator's discretion. Main Outcome Measures: At 1 month postinjection, active range of elbow extension (goniometry; primary outcome); active upper limb function (Modified Frenchay Scale [MFS]); subjective global self-assessment (GSA) of arm pain, stiffness, and function; rapid alternating elbow flexion-extension movement frequency over the maximal range; elbow flexor spasticity grade and angle (Tardieu), and tone (Ashworth). Results: No adverse effects were associated with either BoNT/B dose. Both doses improved active elbow extension versus placebo (+8.3 degrees; 95% confidence interval, 1.1 degrees-15.5 degrees; analysis of covariance, P=.028). The high dose of BoNT/B also improved subject-perceived stiffness (P=.005) and the composite pain, stiffness, and function GSA (P=.017), effects that persisted 3 months from injection. No MFS change was demonstrated, although subjects with a baseline MFS <70/100 seemed more likely to benefit from BoNT/B. Conclusions: In this short-term study, BoNT/B up to 15,000U into spastic upper limb muscles, including the elbow flexors, was well tolerated and improved active elbow extension and subject-perceived stiffness. (C) 2014 by the American Congress of Rehabilitation Medicine	[Gracies, Jean-Michel; Bayle, Nicolas; Goldberg, Sarah; Simpson, David M.] Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA		Gracies, JM (corresponding author), Hop Univ Henri Mondor, Serv Reeduc Neurolocomotrice, 51 Av Marechal De Lattre De Tassigny, F-94010 Creteil, France.	jean-michel.gracies@hmn.aphp.fr		nicolas, bayle/0000-0002-3726-2712	Solstice Neurosciences, LLC.	Supported by Solstice Neurosciences, LLC.	Arezzo JC, 2009, TOXICON, V54, P690, DOI 10.1016/j.toxicon.2009.03.009; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Brashear A, 2004, ARCH PHYS MED REHAB, V85, P705, DOI 10.1016/j.apmr.2003.08.077; Brashear A, 2003, ARCH PHYS MED REHAB, V84, P103, DOI 10.1053/apmr.2003.50070; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Chang CL, 2009, ARCH PHYS MED REHAB, V90, P1462, DOI 10.1016/j.apmr.2009.03.008; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2010, ARCH PHYS MED REHAB, V91, P421, DOI 10.1016/j.apmr.2009.11.017; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, P9, DOI 10.1016/j.apmr.2008.04.030; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Gracies JM, 2002, HDB BOTULINUM TOXIN, P221; Meythaler JM, 2009, ARCH PHYS MED REHAB, V90, P1453, DOI 10.1016/j.apmr.2009.02.026; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2009, J NEUROL NEUROSUR PS, V80, P380, DOI 10.1136/jnnp.2008.159657; Vinti M, 2012, MUSCLE NERVE, V46, P926, DOI 10.1002/mus.23427	18	15	16	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2014	95	7					1303	1311		10.1016/j.apmr.2014.03.016			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AK5QA	WOS:000338479700012	24709034				2022-02-06	
J	Guo, J; Li, YQ; He, ZN; Zhang, B; Li, YH; Hu, JH; Han, MY; Xu, YL; Li, YF; Gu, J; Dai, B; Chen, Z				Guo, Jian; Li, Yiqiao; He, Zhennian; Zhang, Bin; Li, Yonghuan; Hu, Jianghua; Han, Mingyuan; Xu, Yuanlin; Li, Yongfu; Gu, Jie; Dai, Bo; Chen, Zhong			Targeting endothelin receptors A and B attenuates the inflammatory response and improves locomotor function following spinal cord injury in mice	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						endothelin receptors; inflammatory response; long-term neurological improvement; oxidative stress	HEME OXYGENASE-1; ETB-RECEPTOR; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; RAT-BRAIN; TNF-ALPHA; EXPRESSION; BARRIER; MATRIX-METALLOPROTEINASE-9; NEUTROPHIL	After spinal cord injury (SCI), the disruption of blood-spinal cord barrier by activation of the endothelin (ET) system is a critical event leading to leukocyte infiltration, inflammatory response and oxidative stress, contributing to neurological disability. In the present study, we showed that blockade of ET receptor A (ETAR) and/or ET receptor B (ETBR) prevented early inflammatory responses directly via the inhibition of neutrophil and monocyte diapedesis and inflammatory mediator production following traumatic SCI in mice. Long-term neurological improvement, based on a series of tests of locomotor performance, occurred only in the spinal cord-injured mice following blockade of ETAR and ETBR. We also examined the post-traumatic changes of the micro-environment within the injured spinal cord of mice following blockade of ET receptors. Oxidative stress reflects an imbalance between malondialdehyde and superoxide dismutase in spinal cord-injured mice treated with vehicle, whereas blockade of ETAR and ETBR reversed the oxidation state imbalance. In addition, hemeoxygenase-1, a protective protease involved in early SCI, was increased in spinal cord-injured mice following the blockade of ETAR and ETBR, or only ETBR. Matrix metalloproteinase-9, a tissue-destructive protease involved in early damage; was decreased in the injured spinal cord of mice following blockade of ETAR, ETBR or a combination thereof. The findings of the present study therefore suggested an association between ETAR and ETBR in regulating early pathogenesis of SCI and determining the outcomes of long-term neurological recovery.	[Guo, Jian; He, Zhennian; Zhang, Bin; Li, Yonghuan; Hu, Jianghua; Han, Mingyuan; Xu, Yuanlin; Li, Yongfu; Gu, Jie; Dai, Bo] Ningbo Beilun People Hosp, Dept Orthopaed Surg, Ningbo 315800, Zhejiang, Peoples R China; [Li, Yiqiao] Ningbo Beilun People Hosp, Cent Lab, Ningbo 315800, Zhejiang, Peoples R China; [Chen, Zhong] Zhejiang Univ, Dept Orthopaed Surg, Coll Med, Affiliated Hosp 1, Hangzhou 310000, Zhejiang, Peoples R China		Chen, Z (corresponding author), Zhejiang Univ, Dept Orthopaed Surg, Coll Med, Affiliated Hosp 1, 79 Qingchun Rd, Hangzhou 310000, Zhejiang, Peoples R China.	zhongchenmed@163.com			Science and Technology Bureau Foundation of Ningbo [2012A610230]	This study was supported by the Science and Technology Bureau Foundation of Ningbo (no. 2012A610230).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ahnstedt H, 2012, ACTA PHYSIOL, V205, P266, DOI 10.1111/j.1748-1716.2011.02392.x; Bao F, 2008, EXP NEUROL, V214, P160, DOI 10.1016/j.expneurol.2008.09.006; Barnes K, 1997, NEUROCHEM RES, V22, P1033, DOI 10.1023/A:1022435111928; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Chou AK, 2007, EXP BIOL MED, V232, P214; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; Dehouck MP, 1997, J CEREBR BLOOD F MET, V17, P464, DOI 10.1097/00004647-199704000-00012; DOUGLAS SA, 1995, CARDIOVASC RES, V29, P641, DOI 10.1016/0008-6363(96)88634-2; Fu LW, 2010, J PHYSIOL-LONDON, V588, P2473, DOI 10.1113/jphysiol.2010.188730; Gallelli L, 2005, J CELL BIOCHEM, V96, P858, DOI 10.1002/jcb.20608; Goldbaum O, 2001, J NEUROCHEM, V78, P1233, DOI 10.1046/j.1471-4159.2001.00507.x; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; HUGGINS JP, 1993, PHARMACOL THERAPEUT, V59, P55, DOI 10.1016/0163-7258(93)90041-B; ISHIKAWA K, 1992, J MED CHEM, V35, P2139, DOI 10.1021/jm00089a028; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; Kanno H, 2009, J NEUROTRAUM, V26, P31, DOI 10.1089/neu.2008.0667; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; Leonard MG, 2011, BRAIN RES, V1420, P48, DOI 10.1016/j.brainres.2011.08.075; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lindsey M, 2001, CIRCULATION, V103, P2181; Liu DX, 2001, J NEUROCHEM, V77, P1036, DOI 10.1046/j.1471-4159.2001.00306.x; Liu Y, 2002, J NEUROTRAUM, V19, P479, DOI 10.1089/08977150252932424; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; Nagasaka J, 1999, PHARMACOL BIOCHEM BE, V64, P171, DOI 10.1016/S0091-3057(99)00123-9; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Noble LJ, 2002, J NEUROSCI, V22, P7526; Okada M, 2002, CARDIOVASC DRUG REV, V20, P53; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Sallum CO, 2012, CHEM BIOL DRUG DES, V80, P374, DOI 10.1111/j.1747-0285.2012.01405.x; Salzman SK, 1996, J NEUROTRAUM, V13, P93, DOI 10.1089/neu.1996.13.93; Siren AL, 2000, NEUROCHEM RES, V25, P957, DOI 10.1023/A:1007552408463; Solini A, 2007, GROWTH FACTORS, V25, P392, DOI 10.1080/08977190801892341; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Wang HH, 2011, J CELL PHYSIOL, V226, P2244, DOI 10.1002/jcp.22560; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051853, 10.1371/journal.pone.0038381]; Zarpelon AC, 2012, CAN J PHYSIOL PHARM, V90, P187, DOI [10.1139/Y11-116, 10.1139/y11-116]	52	15	15	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUL	2014	34	1					74	82		10.3892/ijmm.2014.1751			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AK1MA	WOS:000338178000008	24756152	hybrid, Green Published, Green Submitted			2022-02-06	
J	Parma, C; Carney, D; Grim, R; Bell, T; Shoff, K; Ahuja, V				Parma, Carolyn; Carney, Daniel; Grim, Rod; Bell, Ted; Shoff, Kimberly; Ahuja, Vanita			Unnecessary Head Computed Tomography Scans: A Level 1 Trauma Teaching Experience	AMERICAN SURGEON			English	Article							NEW-ORLEANS CRITERIA; BRAIN-INJURY; EMERGENCY-DEPARTMENT; EXTERNAL VALIDATION; CT; RULE; GUIDELINES; MANAGEMENT	The Canadian CT Head Rule attempts to standardize the practice of obtaining head computed tomography (CT) scans in patients with minor head injury. Previous research indicates 10 to 35 per cent of CTscans performed do not meet these guidelines. The purpose of this study was to review our use of CTscans in the evaluation of mild traumatic brain injury and to identify 1) unnecessary head CTscans (UHCT); 2) variables associated with UHCT; and 3) associated costs. Using a trauma registry, inclusion criteria were age older than 18 years, Glasgow Coma Scale of 15, and at least one head CTscan. UHCTs were those without head injury, loss of consciousness, amnesia, or neurologic complaint. The proportion of patients meeting the criteria for UHCT was 24.2 per cent. Univariate analyses revealed ages 41 to 64 years, drug use, vehicular injury, and surgery within 24 hours were associated with UHCT (all P<0.05). UHCTs were associated with higher Injury Severity Scores (P = 0.008), ventilator days, and length of stay (all P<0.05). An average cost of $1,413 per CT equals $149,778 in extra costs. This study suggests that current practices at our Level I trauma center result in UHCT. Further investigation into best practices would benefit our center by reducing costs and providing quality patient care.	[Parma, Carolyn; Ahuja, Vanita] York Hosp, Dept Surg, York, PA 17405 USA; [Carney, Daniel; Shoff, Kimberly] York Hosp, Trauma Serv, York, PA 17405 USA; [Grim, Rod; Bell, Ted] York Hosp, Emig Res Ctr, York, PA 17405 USA		Parma, C (corresponding author), York Hosp, Dept Surg, 1001 South George St, York, PA 17405 USA.	cparma@wellspan.org					Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cook L S, 1994, Acad Emerg Med, V1, P227; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Joseph B, 2014, AM SURGEON, V80, P43; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; REINUS WR, 1993, ANN EMERG MED, V22, P1148, DOI 10.1016/S0196-0644(05)80981-3; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stein SC, 2007, J TRAUMA, V62, P1309; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	26	15	15	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUL	2014	80	7					664	668					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AK2WX	WOS:000338282000020	24987897				2022-02-06	
J	Piccolino, AL; Solberg, KB				Piccolino, Adam L.; Solberg, Kenneth B.			The Impact of Traumatic Brain Injury on Prison Health Services and Offender Management	JOURNAL OF CORRECTIONAL HEALTH CARE			English	Article						traumatic brain injury; offenders; correctional health services; prison; recidivism	HEAD-INJURY	A large percentage of incarcerated offenders report a history of traumatic brain injury (TBI) with concomitant neuropsychiatric and social sequelae. However, research looking at the relationship between TBI and delivery of correctional health services and offender management is limited. In this study, the relationships between TBI and use of correctional medical/psychological services, chemical dependency (CD) treatment completion rates, in-prison rule infractions, and recidivism were investigated. Findings indicated that TBI history has a statistically significant association with increased usage of correctional medical/psychological services, including crisis interventions services, and with higher recidivism rates. Results also showed a trend toward offenders with TBI incurring higher rates of in-prison rule infractions and lower rates of CD treatment completion. Implications and future directions for correctional systems are discussed.	[Piccolino, Adam L.] Minnesota Dept Correct, Shakopee, MN 55379 USA; [Solberg, Kenneth B.] St Marys Univ Minnesota, Doctoral Program Counseling Psychol, Minneapolis, MN USA		Piccolino, AL (corresponding author), Minnesota Dept Correct, 1010 West 6th Ave, Shakopee, MN 55379 USA.	adam.piccolino@state.mn.us					Bennett T. L., 2008, NEUROPSYCHOLOGY HDB, P535; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Centers for Disease Control and Prevention, 2011, TRAUM BRAIN INJ PRIS; Centers for Disease Control and Prevention, 2012, WHAT POT EFF TBI; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Glaze L. E., 2011, 236319 NCJ BUR JUST; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCrea M., 2008, MILD TRAUMATIC BRAIN; Merbitz C., 1995, J OFFENDER REHABILIT, V22, P11, DOI DOI 10.1300/J076V22N03_02; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Wald M. M., 2008, BRAIN INJURY PROFESS, V5, P22; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	23	15	15	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3458	1940-5200		J CORRECT HEALTH CAR	J. Correct. Health Care	JUL	2014	20	3					203	212		10.1177/1078345814530871			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AK3RR	WOS:000338342900004	24934838				2022-02-06	
J	Qi, L; Cui, XX; Dong, WF; Barrera, R; Coppa, GF; Wang, P; Wu, RQ				Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Coppa, Gene F.; Wang, Ping; Wu, Rongqian			Ghrelin Protects Rats Against Traumatic Brain Injury and Hemorrhagic Shock Through Upregulation of UCP2	ANNALS OF SURGERY			English	Article						ghrelin; hemorrhage; traumatic brain injury; UCP2	VAGUS NERVE-STIMULATION; MESSENGER-RNA EXPRESSION; UNCOUPLING PROTEIN-2; SECRETAGOGUE RECEPTOR; INTESTINAL DYSFUNCTION; HEAD-INJURY; HORMONE; HYPOTENSION; STOMACH; SEPSIS	Objective: To determine the mechanism responsible for ghrelin's neuroprotective effects after traumatic brain injury (TBI) and hemorrhagic shock. Background: Ghrelin, a gastrointestinal hormone, has been demonstrated to possess multiple functions, including upregulation of uncoupling protein 2 (UCP2) and stimulation of the vagus nerve. Recent evidence has indicated that ghrelin is neuroprotective. We, therefore, hypothesized that ghrelin protects rats against TBI and hemorrhagic shock through upregulation of UCP2, involving stimulation of the vagus nerve. Methods: Brain injury was induced by dropping a 450 g of weight from 1.5 m onto a steel helmet attached to the skull of male adult rats. Immediately after TBI, a midline laparotomy was performed, and both lumbar veins were isolated and severed at the junction with the vena cava. The abdomen was kept open for 20 minutes. At 45 minutes after TBI and uncontrolled hemorrhage (UH), ghrelin (4, 8, or 16 nmol/rat) or 1 mL of normal saline (vehicle) was intravenously administered. The Neurological Severity Scale (NSS), morphological alterations and beta-amyloid precursor protein expression in the brain, systemic organ injury markers (ie, alanine aminotransferase, aspartate aminotransferase, and lactate), and UCP2 expression in the cortex were measured. To determine whether the protective effect of ghrelin is mediated through upregulation of UCP2, genipin, a specific UCP2 antagonist, was administered intravenously before the injection of ghrelin in animals with TBI and UH. The role of the vagus nerve was assessed by performing vagotomy immediately before ghrelin administration. Results: Ghrelin attenuated brain injury and facilitated functional recovery after TBI and UH. Ghrelin increased UCP2 expression in the cortex, and administration of genipin abolished ghrelin's protection after TBI and UH. Furthermore, vagotomy prevented the beneficial effects of ghrelin and eliminated ghrelin-induced UCP2 upregulation after TBI and UH. Conclusions: The protective effects of ghrelin after TBI and UH seem to be related to upregulation of UCP2 expression in the brain and requiring the intact vagus nerve.	[Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] Long Isl Jewish Med Ctr, Manhasset, NY USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Wang, Ping; Wu, Rongqian] Feinstein Inst Med Res, Manhasset, NY USA; [Qi, Lei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China; [Wu, Rongqian] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33612 USA		Wu, RQ (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 8, Tampa, FL 33612 USA.	rwu1@health.usf.edu		Wu, Rongqian/0000-0003-0993-4531; Wang, Ping/0000-0002-1557-0394	Department of Defense/Deployment Related Medical Research Program [DR080669]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS072608]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072608] Funding Source: NIH RePORTER	Supported by a Department of Defense/Deployment Related Medical Research Program grant DR080669 (R. Wu) and a National Institutes of Health grant R21 NS072608 (R. Wu). The authors declare no conflicts of interest.	Aarabi B, 2009, CURR OPIN CRIT CARE, V15, P548, DOI 10.1097/MCC.0b013e32833190da; Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Ardesch JJ, 2007, SEIZURE-EUR J EPILEP, V16, P579, DOI 10.1016/j.seizure.2007.04.005; Ay I, 2009, NEUROSCI LETT, V459, P147, DOI 10.1016/j.neulet.2009.05.018; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Coduras A, 2010, J ALZHEIMERS DIS, V19, P601, DOI 10.3233/JAD-2010-1258; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047; Kim SH, 1997, J TRAUMA, V42, P213, DOI 10.1097/00005373-199702000-00006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lindqvist A, 2004, NUTR NEUROSCI, V7, P217, DOI 10.1080/10284150400011390; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Miyamoto O, 2003, NEUROREPORT, V14, P1971, DOI 10.1097/00001756-200310270-00018; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Richard D, 2001, BIOCHEM SOC T, V29, P812, DOI 10.1042/0300-5127:0290812; Sakata I, 2003, NEUROSCI LETT, V342, P183, DOI 10.1016/S0304-3940(03)00294-5; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Sato N, 2003, JPN J PHYSIOL, V53, P443, DOI 10.2170/jjphysiol.53.443; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wang GY, 2002, REGUL PEPTIDES, V105, P75, DOI 10.1016/S0167-0115(02)00012-5; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, CRIT CARE MED, V35, P912, DOI 10.1097/01.CCM.0000257327.61829.34; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002026; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011	63	15	19	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JUL	2014	260	1					169	178		10.1097/SLA.0000000000000328			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AI9XD	WOS:000337297900027	24670857				2022-02-06	
J	Qian, K; Gu, Y; Zhao, YM; Li, ZZ; Sun, M				Qian, Ke; Gu, Yi; Zhao, Yumei; Li, Zhenzong; Sun, Ming			Citicoline Protects Brain Against Closed Head Injury in Rats Through Suppressing Oxidative Stress and Calpain Over-Activation	NEUROCHEMICAL RESEARCH			English	Article						Citicoline; Closed head injury; Oxidative stress; Calpain; Corpus callosum; Hippocampus	TRANSIENT CEREBRAL-ISCHEMIA; CDP-CHOLINE; LIPID-PEROXIDATION; WHITE-MATTER; CORTICAL CONTUSION; STROKE; PATHOPHYSIOLOGY; REPERFUSION; METABOLISM; DISORDERS	Citicoline, a natural compound that functions as an intermediate in the biosynthesis of cell membrane phospholipids, is essential for membrane integrity and repair. It has been reported to protect brain against trauma. This study was designed to investigate the protective effects of citicoline on closed head injury (CHI) in rats. Citicoline (250 mg/kg i.v. 30 min and 4 h after CHI) lessened body weight loss, and improved neurological functions significantly at 7 days after CHI. It markedly lowered brain edema and blood-brain barrier permeability, enhanced the activities of superoxide dismutase and the levels of glutathione, reduced the levels of malondialdehyde and lactic acid. Moreover, citicoline suppressed the activities of calpain, and enhanced the levels of calpastatin, myelin basic protein and alpha II-spectrin in traumatic tissue 24 h after CHI. Also, it attenuated the axonal and myelin sheath damage in corpus callosum and the neuronal cell death in hippocampal CA1 and CA3 subfields 7 days after CHI. These data demonstrate the protection of citicoline against white matter and grey matter damage due to CHI through suppressing oxidative stress and calpain over-activation, providing additional support to the application of citicoline for the treatment of traumatic brain injury.	[Qian, Ke] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Gu, Yi; Zhao, Yumei; Sun, Ming] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropharmacol, Beijing 100050, Peoples R China; [Li, Zhenzong] Capital Med Univ, Beijing Neurosurg Inst, Dept Expt Zool, Beijing 100050, Peoples R China		Sun, M (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropharmacol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	sunming999@yahoo.com					Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Adibhatla Rao Muralikrishna, 2013, Nat Rev Neurol, V9, P173, DOI 10.1038/nrneurol.2012.166-c1; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Adibhatla RM, 2005, BRAIN RES, V1058, P193, DOI 10.1016/j.brainres.2005.07.067; Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; Adibhatla RM, 2003, J NEUROSCI RES, V73, P308, DOI 10.1002/jnr.10672; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; AGUILAR J, 1983, ARZNEIMITTELFORSCH, V33-2, P1051; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Alvarez-Sabin J, 2011, STROKE, V42, pS40, DOI 10.1161/STROKEAHA.110.606509; Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7; ARRIGONI E, 1987, BIOCHEM PHARMACOL, V36, P3697, DOI 10.1016/0006-2952(87)90022-0; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRALET J, 1991, BRAIN RES, V539, P175, DOI 10.1016/0006-8993(91)90703-X; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng CM, 1998, J NEUROSCI, V18, P5673; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Dhillon HS, 1999, J NEUROTRAUM, V16, P455, DOI 10.1089/neu.1999.16.455; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fresta M, 1999, PHARMACEUT RES, V16, P1843, DOI 10.1023/A:1018999225435; FRESTA M, 1994, J PHARM PHARMACOL, V46, P974, DOI 10.1111/j.2042-7158.1994.tb03252.x; GALLETTI P, 1985, BIOCHEM PHARMACOL, V34, P4121, DOI 10.1016/0006-2952(85)90204-7; Ghosh S, 2010, NEUROSCIENCE, V171, P1287, DOI 10.1016/j.neuroscience.2010.09.049; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; KAKIHANA M, 1988, STROKE, V19, P217, DOI 10.1161/01.STR.19.2.217; Knapp S, 1999, BRAIN RES, V822, P52, DOI 10.1016/S0006-8993(99)01072-0; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lopez Gonzalez-Coviella I, 1987, NEUROCHEM INT, V11, P293, DOI [10.1016/0197-0186(87)90049-0, DOI 10.1016/0197-0186(87)90049-0]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MASSARO AR, 1990, ITAL J NEUROL SCI, V11, P537, DOI 10.1007/BF02337436; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Miura S, 2009, BRAIN DEV-JPN, V31, P307, DOI 10.1016/j.braindev.2008.06.010; MOSS DE, 1991, PHARMACOL BIOCHEM BE, V39, P495, DOI 10.1016/0091-3057(91)90214-M; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Palace J, 2003, J NEUROL SCI, V206, P131, DOI 10.1016/S0022-510X(02)00419-7; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P253, DOI 10.1038/jcbfm.1985.32; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smith SL, 1996, J NEUROSURG, V84, P229, DOI 10.3171/jns.1996.84.2.0229; Sobrado M, 2003, NEUROSCIENCE, V118, P107, DOI 10.1016/S0306-4522(02)00912-0; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YOSHIDA K, 1993, BIOCHIM BIOPHYS ACTA, V1182, P215, DOI 10.1016/0925-4439(93)90143-O; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	68	15	15	1	10	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2014	39	7					1206	1218		10.1007/s11064-014-1299-x			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AM3BU	WOS:000339727300005	24691765				2022-02-06	
J	Sabour, H; Javidan, AN; Latifi, S; Larijani, B; Shidfar, F; Vafa, MR; Heshmat, R; Razavi, HE				Sabour, Hadis; Javidan, Abbas Norouzi; Latifi, Sahar; Larijani, Bagher; Shidfar, Farzad; Vafa, Mohammad Reza; Heshmat, Ramin; Razavi, Hassan Emami			Bone biomarkers in patients with chronic traumatic spinal cord injury	SPINE JOURNAL			English	Article						Bone biomarkers; Bone mineral density; Spinal cord injury; Bone alkaline phosphatase	MINERAL DENSITY; SERUM CONCENTRATIONS; OSTEOPOROSIS; METABOLISM; CALCITONIN; AGE; TURNOVER; TISSUE; LEVEL	BACKGROUND CONTEXT: Bone loss after spinal cord injury (SCI) occurs because of pathologic changes in osteoblastic and osteoclastic activities due to mechanical unloading. Some biochemical changes in bone metabolism after SCI are described before that were related to bone mineral loss. PURPOSE: Our purpose was to determine bone markers' changes and related effective factors in patients with chronic traumatic SCI. STUDY DESIGN: This investigation was designed as an observational cross-sectional study. PATIENT SAMPLE: All patients with chronic SCI who were referred to Brain and Spinal Injury Research Center and did not meet our exclusion criteria entered the study. OUTCOME MEASURES: Self-reporting measures including patient's demographic features and date of accident were obtained using a questionnaire and physiologic measures including spinal magnetic resonance imaging to determine the level of injury accompanied with physical examination along with dual-energy X-ray absorptiometry were performed. Blood samples were analyzed in the laboratory. METHODS: Dual-energy X-ray was used to determine bone mineral density in femoral and spinal vertebrae bone sites. Serum level of C-telopeptide cross-linked Type 1 collagen (CTX), parathyroid hormone, calcitonin, osteocalcin, and bone alkaline phosphatase (BALP) were measured. RESULTS: We detected a negative association between CTX level and bone mineral density in femoral and spinal bone sites that confirms that CTX is a bone resorption marker. C-telopeptide cross-linked Type 1 collagen and BALP levels did not show any significant correlation with postduration injury. Patients with spinal injury at lumbar level had the highest calcitonin level (p < .04). C-telopeptide cross-linked Type 1 collagen was positively related with osteocalcin and BALP (p < .0001, r = 0.51), and osteocalcin was positively related with BALP (p < .0001, r = 0.44). Osteocalcin was related negatively only to femoral intertrochanteric zone bone mineral density. CONCLUSIONS: Some bone biomarkers undergo noticeable changes after SCI. C-telopeptide cross-linked Type 1 collagen was positively correlated with BALP and osteocalcin that shows the coincidental occurrence of osteoblastic and osteoclastic activities. Our data also support this fact that although bone reduction after 2 years is slower than acute phase after SCI, bone resorption rate is higher than bone formation. These bone markers also revealed different site of action as osteocalcin level only affected femoral intertrochanteric bone mineral density. Generally, it seems that the coincidental consideration of these factors that influence bone mineral density can lead to a better understanding of bone changes after SCI. (C) 2014 Elsevier Inc. All rights reserved.	[Sabour, Hadis; Javidan, Abbas Norouzi; Latifi, Sahar; Razavi, Hassan Emami] Univ Tehran Med Sci, Imam Khomeini Hosp, Brain & Spinal Injury Res BASIR Ctr, Tehran, Iran; [Larijani, Bagher; Heshmat, Ramin] Univ Tehran Med Sci, Dept Endocrinol, Endocrinol & Metab Res Inst EMRI, Tehran, Iran; [Shidfar, Farzad; Vafa, Mohammad Reza] Iran Univ Med Sci, Dept Nutr, Tehran, Iran		Javidan, AN (corresponding author), Univ Tehran Med Sci, Imam Khomeini Hosp, Brain & Spinal Injury Res BASIR Ctr, Keshavarz Avenu, Tehran, Iran.	noroozia@tums.ac.ir	Vafa, Mohammadreza/AAC-3827-2019; Shidfar, Farzad/H-6651-2018; Heshmat, Ramin/S-7435-2017; larijani, Bagher/ABE-3315-2020	Shidfar, Farzad/0000-0002-6531-9253; larijani, Bagher/0000-0001-5386-7597; norouzi javidan, abbas/0000-0002-6611-3919; Latifi, Sahar/0000-0002-3512-0657; Vafa, Mohammadreza/0000-0001-7052-8810	Tehran University of Medical SciencesTehran University of Medical Sciences	Funding of this study was provided by Tehran University of Medical Sciences and up to our knowledge no conflict of interest exists.	Ali AT, 2006, AM J CLIN PATHOL, V126, P437, DOI 10.1309/9N346GXX67B6PX5W; Aloia John F, 2006, Endocr Pract, V12, P137; ARNSTEIN AR, 1973, CLIN ASPECTS METABOL, P253; Ashe Maureen C, 2007, Top Spinal Cord Inj Rehabil, V13, P123, DOI 10.1310/sci1301-123; Bagis S, 2002, TURKISH J RHEUMATOL, V17, P168; Battaglino RA, 2012, CURR OSTEOPOROS REP, V10, P278, DOI 10.1007/s11914-012-0117-0; BIERINGSORENSEN F, 1990, EUR J CLIN INVEST, V20, P330, DOI 10.1111/j.1365-2362.1990.tb01865.x; Bubbear JS, 2011, OSTEOPOROSIS INT, V22, P271, DOI 10.1007/s00198-010-1221-6; CAREY DE, 1985, ARCH PHYS MED REHAB, V66, P640; CHANTRAINE A, 1986, CALCIFIED TISSUE INT, V38, P323, DOI 10.1007/BF02555744; Demirel G, 1998, SPINAL CORD, V36, P822, DOI 10.1038/sj.sc.3100704; Edwards LA, 2008, AM J CLIN NUTR, V87, P600, DOI 10.1093/ajcn/87.3.600; Eser P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P197; Eser P, 2004, BONE, V34, P869, DOI 10.1016/j.bone.2004.01.001; Fattal C, 2011, ARCH PHYS MED REHAB, V92, P59, DOI 10.1016/j.apmr.2010.09.019; FREEHAFER AA, 1995, ARCH PHYS MED REHAB, V76, P823, DOI 10.1016/S0003-9993(95)80546-X; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Groah SL, 2010, PM&R, V2, P1080, DOI 10.1016/j.pmrj.2010.08.003; Health III H, 1973, CLIN ASPECTS METABOL, P257; Humble SR, 2011, ANAESTH INTENS CARE, V39, P682, DOI 10.1177/0310057X1103900425; Hummel K, 2012, SPINAL CORD, V50, P812, DOI 10.1038/sc.2012.67; Kudlacek S, 2003, BONE, V32, P681, DOI 10.1016/S8756-3282(03)00090-5; LIAN JB, 1988, CLIN ORTHOP RELAT R, P267; Maimoun L, 2006, SPINAL CORD, V44, P203, DOI 10.1038/sj.sc.3101832; Mechanick JI, 1997, ARCH PHYS MED REHAB, V78, P692, DOI 10.1016/S0003-9993(97)90075-7; MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214; Mohr T, 1997, CALCIFIED TISSUE INT, V61, P22, DOI 10.1007/s002239900286; Morse L. R., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P50; NAND S, 1976, ARCH PHYS MED REHAB, V57, P553; Nordin BEC, 1973, METABOLIC BONE STONE, P43; Paker N, 2007, NEUROSCIENCES, V12, P232; PIETSCHMANN P, 1992, PARAPLEGIA, V30, P204, DOI 10.1038/sc.1992.56; RIGGS BL, 1981, J CLIN INVEST, V67, P328, DOI 10.1172/JCI110039; Roberts D, 1998, J CLIN ENDOCR METAB, V83, P415, DOI 10.1210/jc.83.2.415; Sinaki M, 2001, PHYS MED REHABILITAT, P895; Steinschneider M, 2003, BMC MUSCULOSKEL DIS, V16, P4; Szollar SM, 1998, AM J PHYS MED REHAB, V77, P28, DOI 10.1097/00002060-199801000-00005; Szollar SM, 1997, ARCH PHYS MED REHAB, V78, P455, DOI 10.1016/S0003-9993(97)90155-6; Szulc P, 2001, J CLIN ENDOCR METAB, V86, P3162, DOI 10.1210/jc.86.7.3162; UEBELHART D, 1994, SCAND J REHABIL MED, V26, P197; VAZIRI ND, 1994, ARCH PHYS MED REHAB, V75, P766; von Muhlen DG, 2005, OSTEOPOROSIS INT, V16, P1721, DOI 10.1007/s00198-005-1910-8; WILMET E, 1995, PARAPLEGIA, V33, P674, DOI 10.1038/sc.1995.141; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6	45	15	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUL	2014	14	7					1132	1138		10.1016/j.spinee.2013.07.475			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	AK5LV	WOS:000338467000009	24139865				2022-02-06	
J	Tylicka, M; Matuszczak, E; Debek, W; Hermanowicz, A; Ostrowska, H				Tylicka, Marzena; Matuszczak, Ewa; Debek, Wojciech; Hermanowicz, Adam; Ostrowska, Halina			Circulating proteasome activity following mild head injury in children	CHILDS NERVOUS SYSTEM			English	Article						Mild head injury; Concussion; Head injury; Children; Circulating proteasome activity; Plasma	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; REDUCES INFARCTION; 20S PROTEASOME; LEUKOCYTE INFILTRATION; OXIDIZED PROTEINS; GENE-EXPRESSION; RAT MODEL; KAPPA-B; UBIQUITIN	The aim of the study is to characterize changes in circulating proteasome (c-proteasome) activity following mild traumatic brain injury in children. Fifty children managed at the Department of Pediatric Surgery because of concussion-mild head injury was randomly included into the study. The children were aged 11 months to 17 years (median = 10.07 + -1.91 years). Plasma proteasome activity was assessed using Suc-Leu-Leu-Val-Tyr-AMC peptide substrate, 2-6 h, 12-16 h, and 2 days after injury. Twenty healthy children admitted for planned inguinal hernia repair served as controls. Statistically significant elevation of plasma c-proteasome activity was noted in children with mild head injury 2-6 h, 12-16 h, and 2 days after the injury. Authors observed a statistically significant upward trend in the c-proteasome activity between 2-6 and 12-16 h after the mild head injury, consistent with the onset of the symptoms of cerebral concussion and a downward trend in the c-proteasome activity in the plasma of children with mild head injury between 12-16 h and on the second day after the injury, consistent with the resolving of the symptoms of cerebral concussion. Further studies are needed to demonstrate that the proteasome activity could be a prognostic factor, which can help in further diagnostic and therapeutic decisions in patients with head injury.	[Matuszczak, Ewa; Debek, Wojciech; Hermanowicz, Adam; Ostrowska, Halina] Med Univ Bialystok, Dept Pediat Surg, PL-15274 Bialystok, Poland; [Tylicka, Marzena] Med Univ Bialystok, Dept Biophys, PL-15089 Bialystok, Poland		Matuszczak, E (corresponding author), Med Univ Bialystok, Dept Pediat Surg, PL-15274 Bialystok, Poland.	ewamat@tlen.pl	Debek, Wojciech/S-8168-2018; Ostrowska, Halina/X-1832-2018; Hermanowicz, ahermanowicz/T-3500-2018; Matuszczak, Ewa/T-3497-2018; Tylicka, Marzena/AAV-7088-2020	Debek, Wojciech/0000-0001-6023-8510; Ostrowska, Halina/0000-0003-0706-8270; Hermanowicz, ahermanowicz/0000-0002-5723-6941; Matuszczak, Ewa/0000-0003-2425-9589; Tylicka, Marzena/0000-0002-9594-8173			Chambellan A, 2006, AM J RESP CELL MOL, V35, P424, DOI 10.1165/rcmb.2005-0251OC; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Dutaud D, 2002, J IMMUNOL METHODS, V260, P183, DOI 10.1016/S0022-1759(01)00555-5; Egerer K, 2002, J RHEUMATOL, V29, P2045; Halliwell B, 2002, ANN NY ACAD SCI, V962, P182, DOI 10.1111/j.1749-6632.2002.tb04067.x; Henninger N, 2006, NEUROSCI LETT, V398, P300, DOI 10.1016/j.neulet.2006.01.015; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; Martin S, 2004, NEUROSCI LETT, V357, P76, DOI 10.1016/j.neulet.2003.10.085; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Mengual E, 1996, J NEUROSCI, V16; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Ostrowska H, 2008, CLIN BIOCHEM, V41, P1377, DOI 10.1016/j.clinbiochem.2008.08.063; Piccinini M, 2003, J NEUROIMMUNOL, V135, P135, DOI 10.1016/S0165-5728(02)00439-3; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rehni AK, 2010, BIOL PHARM BULL, V33, P1953, DOI 10.1248/bpb.33.1953; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Szabo Z, 2010, BRAIN RES, V1341, P25, DOI 10.1016/j.brainres.2009.01.035; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Weih M, 2001, J CEREBR BLOOD F MET, V21, P1090, DOI 10.1097/00004647-200109000-00006; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Williams AJ, 2003, J CEREBR BLOOD F MET, V23, P75, DOI 10.1097/01.WCB.0000039285.37737.C2; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zhang L, 2001, STROKE, V32, P2926, DOI 10.1161/hs1201.100207	29	15	15	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2014	30	7					1191	1196		10.1007/s00381-014-2409-4			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AK7TR	WOS:000338631100008	24700339	Green Published, hybrid			2022-02-06	
J	Vandekerckhove, M; Plessers, M; Van Mieghem, A; Beeckmans, K; Van Acker, F; Maex, R; Markowitsch, H; Marien, P; Van Overwalle, F				Vandekerckhove, Marie; Plessers, Maarten; Van Mieghem, Arno; Beeckmans, Kurt; Van Acker, Frederik; Maex, Reinoud; Markowitsch, Hans; Marien, Peter; Van Overwalle, Frank			Impaired Facial Emotion Recognition in Patients With Ventromedial Prefrontal Hypoperfusion	NEUROPSYCHOLOGY			English	Article						emotion; emotion recognition; emotional facial expression; ventromedial prefrontal cortex	TRAUMATIC BRAIN-INJURY; EVENT-RELATED FMRI; FRONTAL-LOBE DAMAGE; SOCIAL-BEHAVIOR; CORTEX; EXPRESSIONS; METAANALYSIS; ACTIVATION; AMYGDALA; SELF	Empathy refers to our ability to recognize and share emotions by another human being. Impairment may underlie many of the emotional deficits commonly associated with a range of neuropsychiatric and neurological conditions. The prefrontal cortex (PFC) has long been implicated in these processes, but the specific contribution of subregions of the PFC remain unclear. Studies regarding the role of subregions of the prefrontal cortex such as the ventromedial prefrontal cortex (vmPFC)-in facial emotion recognition have yielded inconsistent results. The present study aimed to investigate the capacity to recognize nonverbal emotional facial expressions in a group of patients with the following: (a) perfusion deficits in the vmPFC (vmPFC group; N = 13), (b) hypoperfusions sparing the vmPFC (nonvmPFC group; N = 12), and in (c) a control group of healthy volunteers (control group; N = 17). Regions of hypoperfusion were identified by means of Single Photon Emission Computed Tomography (SPECT). Participants were asked to recognize facial expressions of the 7 basic emotions (happiness, fear, surprise, anger, disgust, sadness, or neutral). Detection of facial expressions of fear, disgust, and surprise was affected after functional disruption of the vmPFC. The present study confirms the role of the vmPFC in recognizing emotional facial expressions.	[Vandekerckhove, Marie] Vrije Univ Brussel, Res Grp Biol Psychol, B-1050 Brussels, Belgium; [Plessers, Maarten] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Van Mieghem, Arno] AZ Sint Lucas, AZ Sint Maarten, Dept Nucl Med, Mechelen, Malle, Belgium; [Beeckmans, Kurt] CEPOS, Duffel, Belgium; [Van Acker, Frederik] Open Univ Heerlen, Fac Psychol, Heerlen, Netherlands; [Maex, Reinoud] Ecole Normale Super, Grp Neural Theory & Computat Sci, F-75231 Paris, France; [Markowitsch, Hans] Univ Bielefeld, Res Grp Physiol Psychol, Bielefeld, Germany; [Marien, Peter] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Marien, Peter] ZNA Middelheim, Dept Neurol, Antwerp, Belgium; [Marien, Peter] ZNA Middelheim, Memory Clin, Antwerp, Belgium; [Van Overwalle, Frank] Vrije Univ Brussel, Res Grp Social Neurosci, B-1050 Brussels, Belgium		Vandekerckhove, M (corresponding author), Vrije Univ Brussel, Fac Psychol & Educ Sci, Dept Expt & Appl Psychol, Res Grp Biol Psychol, Pleinlaan 2, B-1050 Brussels, Belgium.	Marie.Vandekerckhove@vub.ac.be	Van Overwalle, Frank/AAS-2496-2021; Vandekerckhove, Marie/K-5775-2019	Van Overwalle, Frank/0000-0002-2538-9847; Maex, Reinoud/0000-0002-5543-8902	Bielefeld Cluster of Excellence (CITEC); Fund for Scientific Research Flanders (Belgium)FWO	The researchers would like to thank CEPOS for their cooperation. HJM was supported by a grant from the Bielefeld Cluster of Excellence (CITEC). MP was supported by a predoctoral Research Grant from the Fund for Scientific Research Flanders (Belgium).	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Benson D.F., 1986, FRONTAL LOBES; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gunning-Dixon FM, 2003, NEUROBIOL AGING, V24, P285, DOI 10.1016/S0197-4580(02)00099-4; Harciarek M, 2009, J CLIN EXP NEUROPSYC, V31, P322, DOI 10.1080/13803390802119930; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Kucharska-Pietura K., 2000, EUROPEAN NEUROPSYCHO, V10, P358, DOI [10.1016/S0924-977X(00)80470-8, DOI 10.1016/S0924-977X(00)80470-8]; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Lipsman N, 2014, NEUROIMAGE, V85, P769, DOI 10.1016/j.neuroimage.2013.05.104; Ma N, 2012, SOC NEUROSCI-UK, V7, P591, DOI 10.1080/17470919.2012.686925; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610, DOI 10.1152/jn.1999.82.3.1610; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ogai Masahiro, 2003, Neuroreport, V14, P559, DOI 10.1097/00001756-200303240-00006; Olszanowski M., 2008, WARSAW SET EMOTIONAL; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; ROGERS CR, 1957, J CONSULT PSYCHOL, V21, P95, DOI 10.1037/0022-006X.60.6.827; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Tsuchida A, 2012, CEREB CORTEX, V22, P2904, DOI 10.1093/cercor/bhr370; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; Willis ML, 2010, NEUROPSYCHOLOGIA, V48, P2182, DOI 10.1016/j.neuropsychologia.2010.04.010; Winecoff A, 2013, J NEUROSCI, V33, P11032, DOI 10.1523/JNEUROSCI.4317-12.2013	55	15	15	0	22	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2014	28	4					605	612		10.1037/neu0000057			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AL8OF	WOS:000339398000014	24773416				2022-02-06	
J	Yap, YC; Dickson, TC; King, AE; Breadmore, MC; Guijt, RM				Yap, Yiing C.; Dickson, Tracey C.; King, Anna E.; Breadmore, Michael C.; Guijt, Rosanne M.			Microfluidic culture platform for studying neuronal response to mild to very mild axonal stretch injuryn	BIOMICROFLUIDICS			English	Article							TRAUMATIC BRAIN-INJURY; IN-VITRO; NEUROSCIENCE RESEARCH; SOFT LITHOGRAPHY; MODEL; TRANSPORT; AXOTOMY; RAT; POLY(DIMETHYLSILOXANE); DEGENERATION	A new model for studying localised axonal stretch injury is presented, using a microfluidic device to selectively culture axons on a thin, flexible poly (dimethylsiloxane) membrane which can be deflected upward to stretch the axons. A very mild (0.5% strain) or mild stretch injury (5% strain) was applied to primary cortical neurons after 7 days growth in vitro. The extent of distal degeneration was quantified using the degenerative index (DI, the ratio of fragmented axon area to total axon area) of axons fixed at 24 h and 72 h post injury (PI), and immunolabelled for the axon specific, microtubule associated protein-tau. At 24 h PI following very mild injuries (0.5%), the majority of the axons remained intact and healthy with no significant difference in DI when compared to the control, but at 72 h PI, the DI increased significantly (DI = 0.11+/-0.03). Remarkably, dendritic beading in the somal compartment was observed at 24 h PI, indicative of dying back degeneration. When the injury level was increased (5% stretch, mild injury), microtubule fragmentation along the injured axons was observed, with a significant increase in DI at 24 h PI (DI = 0.17+/-0.02) and 72 h PI (DI = 0.18+/-0.01), relative to uninjured axons. The responses observed for both mild and very mild injuries are similar to those observed in the in vivo models of traumatic brain injury, suggesting that this model can be used to study neuronal trauma and will provide new insights into the cellular and molecular alterations characterizing the neuronal response to discrete axonal injury. (C) 2014 AIP Publishing LLC.	[Yap, Yiing C.; Dickson, Tracey C.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Yap, Yiing C.; King, Anna E.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas 7000, Australia; [Yap, Yiing C.; Breadmore, Michael C.] Univ Tasmania, Sch Phys Sci, ACROSS, Hobart, Tas 7001, Australia; [Yap, Yiing C.; Guijt, Rosanne M.] Univ Tasmania, Pharm Sch Med, ACROSS, Hobart, Tas 7001, Australia		Guijt, RM (corresponding author), Univ Tasmania, Pharm Sch Med, ACROSS, Private Bag 26, Hobart, Tas 7001, Australia.	Rosanne.Guijt@utas.edu.au	Breadmore, Michael/J-7628-2014; King, Anna/J-7927-2014; Guijt, Rosanne Marieke/R-2428-2017	Breadmore, Michael/0000-0001-5591-4326; King, Anna/0000-0003-1792-0965; Guijt, Rosanne Marieke/0000-0003-0011-5708; Dickson, Tracey/0000-0002-9196-1661; YAP, YIING CHIING/0000-0002-0713-8884	Select Foundation; Wicking Dementia Research and Education Centre; University Tasmania for a Graduate Research Scholarship; UTAS Cross Theme Grant; QEII Fellowship [DP0984745]	The authors would like to thank Mr. Graeme McCormark, Mr. Justin Dittman, and Mr. John Davis for their technical assistance in completing this work. This research was supported by Select Foundation (Fellowship to T. C. D.), the Wicking Dementia Research and Education Centre (Fellowship to A. E. K.), the University Tasmania for a Graduate Research Scholarship (Y.C.Y.) and UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant. M. C. B. would like to thank the Australian Research Council for funding and provision of a QEII Fellowship (DP0984745).	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Dolle JP, 2013, LAB CHIP, V13, P432, DOI 10.1039/c2lc41063j; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GALLANT PE, 1992, J NEUROPATH EXP NEUR, V51, P220, DOI 10.1097/00005072-199203000-00011; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Hosie KA, 2012, ASN NEURO, V4, P47, DOI 10.1042/AN20110031; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Johns C, 2008, J CHROMATOGR A, V1182, P205, DOI 10.1016/j.chroma.2008.01.014; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kazarian AA, 2010, ANALYST, V135, P1970, DOI 10.1039/c0an00010h; Kim YT, 2009, LAB CHIP, V9, P2576, DOI 10.1039/b903720a; Laker S. R., 2011, PM&R, V3, pS354; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Majumdar D, 2011, J NEUROSCI METH, V196, P38, DOI 10.1016/j.jneumeth.2010.12.024; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Nakayama Y, 2001, J NEUROTRAUM, V18, P545, DOI 10.1089/089771501300227341; Park JW, 2013, LAB CHIP, V13, P509, DOI 10.1039/c2lc41081h; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Siddique R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0676; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	45	15	16	1	29	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1932-1058			BIOMICROFLUIDICS	Biomicrofluidics	JUL	2014	8	4							044110	10.1063/1.4891098			12	Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology; Physics, Fluids & Plasmas	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Science & Technology - Other Topics; Physics	AS4EG	WOS:000344225400015	25379095	Green Published			2022-02-06	
J	Wu, CC; Tsai, TH; Chang, C; Lee, TT; Lin, C; Cheng, IHJ; Sun, MC; Chuang, YJ; Chen, BS				Wu, Chia-Chou; Tsai, Tsung-Han; Chang, Chieh; Lee, Tian-Thai; Lin, Che; Cheng, Irene Han-Juo; Sun, Mu-Chien; Chuang, Yung-Jen; Chen, Bor-Sen			On the Crucial Cerebellar Wound Healing-Related Pathways and Their Cross-Talks after Traumatic Brain Injury in Danio rerio	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ZEBRAFISH MODEL; CELL-MIGRATION; IMMUNE-SYSTEM; REGENERATION; NEUROTRANSMITTERS; NEUROGENESIS; CANNABINOIDS; PATHOGENESIS; MECHANISMS	Upon injury, the direct damage and the subsequent secondary injury in the brain often result in chronic neurological disorders. Due to multifactorial nature of secondary injury and subsequent complex cellular responses, much of the underlying mechanisms are unclear. This study used an adult zebrafish cerebellum injury model to investigate the phenotypes and the secondary injury responses for recovery mechanisms of injured brain. Using the time course microarray analysis, a candidate protein-protein interaction (PPI) network was refined as cerebellar wound healing PPI network by dynamic modeling and big data mining. Pathway enrichment and ontological analysis were incorporated into the refined network to highlight the main molecular scheme of cerebellar wound healing. Several significant pathways, including chemokine, Phosphatidylinositide 3-kinases, and axon guidance signaling pathway and their cross-talks through PI3K, PAK2, and PLXNA3 were identified to coordinate for neurogenesis and angiogenesis, which are essential for the restoration of the injured brain. Our finding provides an insight into the molecular restoration mechanisms after traumatic brain injury, and open up new opportunity to devise the treatment for traumatic brain injury in human.	[Wu, Chia-Chou; Tsai, Tsung-Han; Lin, Che; Chen, Bor-Sen] Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Deptartment Med Sci, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Cheng, Irene Han-Juo] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Deptartment Neurol, Changhua, Taiwan		Chen, BS (corresponding author), Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013	Wu, Chia-Chou/0000-0002-4009-6858; Chang, Jia-Hao/0000-0001-7843-2688	National Science Council of Taiwan, R.O.C.Ministry of Science and Technology, Taiwan [NSC 102-2745-E-007-001-ASP]	The work was supported by the National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; BLALOCK JE, 1992, CHEM IMMUNOL, V52, P1; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Cameron DA, 2005, MOL VIS, V11, P775; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Levin ED, 2009, FRONT NEUROSCI, P293; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Postlethwait J, 1999, METHOD CELL BIOL, V60, P149; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Qiu YH, 1996, ADV NEUROIMMUNOL, V6, P223, DOI 10.1016/S0960-5428(96)00018-6; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ridley AJ, 2001, J CELL SCI, V114, P2713; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Wang YC, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-20, 10.1186/1752-0509-4-S2-S1]; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19	49	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97902	10.1371/journal.pone.0097902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	WOS:000338278100009	24926785	Green Published, Green Submitted, gold			2022-02-06	
J	Chiu, HY; Lo, WC; Chiang, YH; Tsai, PS				Chiu, Hsiao-Yean; Lo, Wen-Cheng; Chiang, Yung-Hsiao; Tsai, Pei-Shan			The effects of sleep on the relationship between brain injury severity and recovery of cognitive function: A prospective study	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						Cognitive function; Traumatic brain injury; Severity of brain injury; Sleep	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; DISTURBANCES; ACTIGRAPHY; METAANALYSIS; RELIABILITY; PARAMETERS; LESIONS	Background: Disturbed sleep pattern is a common symptom after head trauma and its prevalence in acute traumatic brain injury (TBI) is less discussed. Sleep has a profound impact on cognitive function recovery and the mediating effect of disturbed sleep on cognitive function recovery has not been examined after acute TBI. Objectives: To identify the prevalence of disturbed sleep in mild, moderate, and severe acute TBI patients, and to determine the mediating effects of sleep on the relationship between brain injury severity and the recovery of cognitive function. Design: A prospective study design. Setting: Neurosurgical wards in a medical center in northern Taiwan. Participants: Fifty-two acute TBI patients between the ages of 18 and 65 years who had received a diagnosis of TBI for the first time, and were admitted to the neurosurgical ward. Method: The severity of brain injury was initially determined using the Glasgow Coma Scale. Each patient wore an actigraphy instrument on a non-paralytic or non-dominated limb for 7 consecutive days. A 7-day sleep diary was used to facilitate data analysis. Cognitive function was assessed on the first and seventh day after admission based on the Rancho Los Amigos Levels of Cognitive Functioning. Results: The mild (n = 35), moderate (n = 7) and severe (n = 10) TBI patients exhibited poorer sleep efficiency, and longer total sleep time (TST) and waking time after sleep onset, compared with the normative values for the sleep-related variables (P<.05 for all). The severe and moderate TBI patients had longer daytime TST than the mild TB! patients (P<.001), and the severe TBI patients had longer 24-h TST than the mild TBI patients (P = .001). The relationship between the severity of brain injury and the recovery of cognition function was mediated by daytime TST (t = -2.65, P = .004). Conclusions: Poor sleep efficiency, prolonged periods of daytime sleep, and a high prevalence of hypersomnia are common symptoms in acute TBI patients. The duration of daytime sleep mediates the relationship between the severity of brain injury and the recovery of cognition function. (C) 2013 Elsevier Ltd. All rights reserved.	[Chiu, Hsiao-Yean; Tsai, Pei-Shan] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan; [Lo, Wen-Cheng; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Lo, Wen-Cheng; Chiang, Yung-Hsiao] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan		Tsai, PS (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	ptsai@tmu.edu.tw			National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 102-2628-B-038-004-MY3, NSC 102-2811-B-038-028]	P.S. Tsai was supported, in part, by a grant (NSC 102-2628-B-038-004-MY3) from National Science Council, Taiwan. H.Y. Chiu was supported by the postdoctoral fellowship funding (NSC 102-2811-B-038-028) from the National Science Council, Taiwan.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dowling G A, 1985, J Neurosurg Nurs, V17, P129; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Flannery J, 1998, Rehabil Nurs, V23, P88; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Hagen C, 1998, LEVELS COGNITIVE FUN; Hagen C, 1979, LEVELS COGNITIVE FUN; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Jang IS., 2001, J PHYSL 3, V534; Kenny D.A., 2012, MEDIATION; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; MALKMUS D, 1980, REHABILITATION HEAD; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Overeem S., 2010, SLEEP DISORDER NEURO; Pandharipande P, 2006, CRIT CARE CLIN, V22, P313, DOI 10.1016/j.ccc.2006.02.010; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; TEASDALE G, 1974, LANCET, V2, P81; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	43	15	16	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	JUN	2014	51	6					892	899		10.1016/j.ijnurstu.2013.10.020			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	AH7ZL	WOS:000336353800008	24246095				2022-02-06	
J	Fares, Y; Fares, J; Gebeily, S				Fares, Youssef; Fares, Jawad; Gebeily, Souheil			Head and facial injuries due to cluster munitions	NEUROLOGICAL SCIENCES			English	Article						Cluster munitions; Cluster bombs; Head injuries; Face injuries; Psychological effects; Lebanon	PENETRATING CRANIOCEREBRAL INJURIES; GUNSHOT WOUNDS; BLAST	Cluster munitions are weapons that scatter smaller sub-munitions intended to kill or mutilate on impact. They have been used by the Israeli army in the south of Lebanon and are now scattered over wide rural areas affecting its inhabitants. Because of their easily "pickable" nature, sub-munitions can inflict injuries to the head and face regions. In this study, we aimed to explore the head and face injuries along with their clinical features in a group of Lebanese patients who suffered from such injuries due to a sub-munition's detonation. The study included all the cases reported between 14 August 2006 and 15 February 2013, with head and face injuries related to cluster bombs. Injuries were classified into brain, eye, otologic and auditory impairments, oral and maxillofacial, and skin and soft-tissue injuries. Psychological effects of these patients were also examined as for post-traumatic stress disorder, major depressive disorder, generalized anxiety disorder and acute stress syndrome. During the study period, there were 417 casualties as a result of cluster munitions' blasts. Out of the total number of victims, 29 (7 %) were injured in the head and the face region. The convention on cluster munitions of 2008 should be adhered to, as these inhumane weapons indiscriminately and disproportionately harm innocent civilians, thereby violating the well-established international principles governing conflict and war today.	[Fares, Youssef; Fares, Jawad] Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon; [Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Gebeily, Souheil] Lebanese Univ, Fac Med Sci, Div Neurol, Beirut, Lebanon		Fares, Y (corresponding author), Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon.	yfares@ul.edu.lb; jyf04@mail.aub.edu	Fares, Jawad/X-4341-2018	Fares, Jawad/0000-0002-5368-8764			Association A.P., 2013, DIAGN STAT MAN MENT, P271; Bandak FA, 1996, TRAUMATIC BRAIN INJU, P167; Beehner L., 2006, BACKGROUNDER; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Bryant K, 2009, B WORLD HEALTH ORGAN, V87, P8; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; COOPER PR, 1979, NEUROSURGERY, V4, P373, DOI 10.1227/00006123-197905000-00001; Corbman GR, 1997, ANXIETY DISORDERS CU; Fares Y, 2013, NEUROL SCI, V34, P2095, DOI 10.1007/s10072-013-1343-7; Fares Y, 2013, J INFECT PUBLIC HEAL, V6, P482, DOI 10.1016/j.jiph.2013.05.006; Fares Y, 2013, NEUROL SCI, V34, P1971, DOI 10.1007/s10072-013-1427-4; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Muzaffar W, 2000, BRIT J OPHTHALMOL, V84, P626, DOI 10.1136/bjo.84.6.626; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Torpy Janet M, 2011, JAMA, V305, P522, DOI 10.1001/jama.305.5.522	19	15	15	0	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2014	35	6					905	910		10.1007/s10072-013-1623-2			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI4BM	WOS:000336810500013	24389857				2022-02-06	
J	Kumar, A; Rinwa, P; Dhar, H				Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh			Microglial inhibitory effect of ginseng ameliorates cognitive deficits and neuroinflammation following traumatic head injury in rats	INFLAMMOPHARMACOLOGY			English	Article						Head trauma; Memory impairment; Microglia; Neuroinflammation; Oxidative stress	INDUCED HIPPOCAMPAL DAMAGE; BRAIN-INJURY; OXIDATIVE STRESS; IMMATURE RATS; MINOCYCLINE; GINSENOSIDES; CELLS; MODEL; NEURODEGENERATION; PATHOPHYSIOLOGY	Traumatic brain injury produces several neuropathological alterations, some of them are analogous to patients suffering from memory disorders. Role of neuroinflammation and oxidative stress has been suggested in the pathophysiology of brain injury-induced cognitive dysfunction. Therefore, the present study was designed to explore the possible role of ginseng and its interaction with minocycline (microglial inhibitor) against experimental brain trauma-induced behavioral, biochemical and molecular alterations. Wistar rats were exposed to brain traumatic injury using weight-drop method. Following injury and a post-injury rehabilitation period of 2 weeks, animals were administered vehicle/drugs for another 2 weeks. Brain injury caused significant memory impairment in Morris water maze task as evident from increase in escape latency and total distance travelled to reach the hidden platform. This was followed by a significant decrease in time spent in target quadrant and frequency of appearance in target quadrant. Further, there was a significant increase in oxidative stress markers, neuroinflammation (TNF-alpha and IL-6) and acetylcholinesterase levels in both cortex and hippocampal regions of traumatized rat brain. Ginseng (100 and 200 mg/kg) and minocycline (50 mg/kg) treatment for 2 weeks significantly attenuated all these behavioral, biochemical and molecular alterations. Further, combination of sub-effective doses of ginseng (50 and 100 mg/kg) and minocycline (25 mg/kg) potentiated their protective effects which was significant as compared to their effects alone. The results of the present study suggest that the therapeutic effects of ginseng might involve inhibition of microglial pathway against head trauma-induced cognitive impairment and neuroinflammation in rats.	[Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh] Panjab Univ, UGC Ctr Adv Study, Univ Inst Pharmaceut Sci, Div Pharmacol, Chandigarh 160014, India		Kumar, A (corresponding author), Panjab Univ, UGC Ctr Adv Study, Univ Inst Pharmaceut Sci, Div Pharmacol, Chandigarh 160014, India.	kumaruips@yahoo.com	KUMAR, ANIL -/D-7471-2011	KUMAR, ANIL -/0000-0002-9506-6197	Council of Scientific and Industrial Research (CSIR), New DelhiCouncil of Scientific & Industrial Research (CSIR) - India	Authors gratefully acknowledge the financial support of Council of Scientific and Industrial Research (CSIR), New Delhi for carrying out this work. Authors would also like to thank Dr. Thirunavukkarasu Angappan, Deputy General Manager at Panacea Biotec Ltd, Lalru for supplying Wistar rats for our experimental studies.	Abdel Baki SG, 2010, PLOS ONE, V5; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Al-Hazmi MA, 2013, TOXICOL IND HLTH; Banishin CG, 1989, RECENT ADV GINSENG S, P139; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Dean OM, 2012, CNS DRUGS, V26, P391, DOI 10.2165/11632000-000000000-00000; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Freire MAM, 2012, W INDIAN MED J, V61, P751; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Lam TI, 2013, NEUROREHABIL NEURAL; Lee JH, 2004, J BIOL CHEM, V279, P9912, DOI 10.1074/jbc.M310824200; Lee KW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-196; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lim JH, 1997, NEUROSCI RES, V28, P191, DOI 10.1016/S0168-0102(97)00041-2; Lin E, 2008, AM J CHINESE MED, V36, P981, DOI 10.1142/S0192415X08006399; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Luck H., 1971, CATALASE METHODS ENZ, P885; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller CS, 1999, TOXICOL IND HEALTH, V15, P284, DOI 10.1177/074823379901500302; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nah SY, 2009, BRAIN RES, V1248, P184, DOI 10.1016/j.brainres.2008.10.064; Nah SY, 2007, CNS DRUG REV, V13, P381; Lopez MVN, 2007, BBA-GEN SUBJECTS, V1770, P1308, DOI 10.1016/j.bbagen.2007.06.008; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pall ML, 2001, ANN NY ACAD SCI, V933, P323; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Qian Y. N., 2013, NEUROREPORT; Samukawa K, 2008, BIORHEOLOGY, V45, P689, DOI 10.3233/BIR-2008-0516; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Su Zhang-jie, 2008, Zhonghua Yi Xue Za Zhi, V88, P3003; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Wang T, 2013, J NEUROTRAUMA; Wang YL, 2011, NEUROSCI LETT, V487, P70, DOI 10.1016/j.neulet.2010.09.076; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zhang RH, 2009, AM J CHINESE MED, V37, P657, DOI 10.1142/S0192415X09007144	53	15	15	1	13	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0925-4692	1568-5608		INFLAMMOPHARMACOLOGY	Inflammopharmacology	JUN	2014	22	3					155	167		10.1007/s10787-013-0187-3			13	Immunology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy; Toxicology	AH8NH	WOS:000336394200002	24052247				2022-02-06	
J	Solbakk, AK; Lovstad, M				Solbakk, Anne-Kristin; Lovstad, Marianne			Effects of focal prefrontal cortex lesions on electrophysiological indices ofexecutive attention and action control	SCANDINAVIAN JOURNAL OF PSYCHOLOGY			English	Article						Neuropsychology; cognitive electrophysiology; event-related potentials; executive function; attention	CONTINGENT NEGATIVE-VARIATION; EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; ANTERIOR CINGULATE CORTEX; STOP-SIGNAL PARADIGM; HUMAN FRONTAL-CORTEX; EXECUTIVE FUNCTIONS; ORBITOFRONTAL CORTEX; RESPONSE-INHIBITION; INTEGRATIVE THEORY	The human capacity to maintain an overarching control over mental states and behavior relies on multiple, distributed and dynamically interacting brain networks, in which prefrontal cortex (PFC) plays a critical role. PFC exerts top-down executive control over subcortical and posterior cortical areas via extensive reciprocal connections. The orbital, lateral, and medial PFC subdivisions are associated with distinct executive functions, but their precise roles in large-scale neural networks remain to be determined. The main objective of our research program is to specify cognitive and neural mechanisms that govern executive control functions. We study effects of focal PFC lesions on behavioral and electrophysiological correlates of attention and action control utilizing experiments that relate to real-life requirements for executive control. We provide a selective review of studies on the impact of lesions to PFC subregions on novelty processing, anticipatory attention, and action preparation and motor inhibition. The studies provide evidence for the contribution of both lateral, dorsomedial and orbital PFC in novelty processing and dynamic contextual updating. We also report evidence for a role of lateral PFC in motor preparation and anticipatory attention. In contrast to the common view that orbitofrontal cortex plays a general role in inhibitory control, we report findings indicating an involvement in action outcome monitoring rather than in behavioral inhibition as such. We argue that improved understanding of how basic aspects of attentional control and inhibition is regulated in the brain, will shed light on the complex behavioral, cognitive and emotional problems experienced by patients with executive dysfunction.	[Solbakk, Anne-Kristin] Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Neurosurg, N-0424 Oslo, Norway; [Solbakk, Anne-Kristin] Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Psychosomat Med, N-0424 Oslo, Norway; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Res Dept, Nesodden, Norway; [Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway		Solbakk, AK (corresponding author), Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway.	annesolbakk@gmail.com					Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Barcelo F, 2007, CEREB CORTEX, V17, pI51, DOI 10.1093/cercor/bhm111; Barch D. M., 2002, PRINCIPLES FRONTAL L, P427; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Brown GG, 2006, ANNU REV CLIN PSYCHO, V2, P51, DOI 10.1146/annurev.clinpsy.2.022305.095241; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Chong H, 2008, J COGNITIVE NEUROSCI, V20, P120, DOI 10.1162/jocn.2008.20003; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Daffner KR, 2000, BRAIN, V123, P927, DOI 10.1093/brain/123.5.927; Daffner KR, 2003, J COGNITIVE NEUROSCI, V15, P294, DOI 10.1162/089892903321208213; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Funderud I, 2013, BRAIN RES, V1527, P174, DOI 10.1016/j.brainres.2013.06.017; Fuster J.M., 2013, PRINCIPLES FRONTAL L, V2nd ed., P11, DOI [10.1093/med/9780199837755.003.0002, DOI 10.1093/MED/9780199837755.003.0002]; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hooker C. I., 2002, ORBITOFRONTAL CORTEX, P307; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jung JL, 2011, INT J PSYCHOPHYSIOL, V79, P64, DOI 10.1016/j.ijpsycho.2010.09.014; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Karayanidis F, 2000, PSYCHOPHYSIOLOGY, V37, P319, DOI 10.1017/S004857720098051X; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knight RT., 2013, PRINCIPLES FRONTAL L; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Kok A, 2006, BRAIN RES, V1105, P1, DOI 10.1016/j.brainres.2006.03.027; Kotchoubey B, 2006, NEUROSCI BIOBEHAV R, V30, P42, DOI 10.1016/j.neubiorev.2005.04.002; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kramer UM, 2013, CORTEX, V49, P837, DOI 10.1016/j.cortex.2012.05.003; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lovstad M, 2012, BRAIN COGNITION, V80, P237, DOI 10.1016/j.bandc.2012.07.008; Lovstad M, 2012, J COGNITIVE NEUROSCI, V24, P378, DOI 10.1162/jocn_a_00099; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Nachev P, 2006, CURR OPIN NEUROL, V19, P586, DOI 10.1097/01.wco.0000247609.36482.ae; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; ONOFRJ M, 1991, ACTA NEUROL SCAND, V83, P273, DOI 10.1111/j.1600-0404.1991.tb04700.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Petrides M., 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramautar JR, 2006, BIOL PSYCHOL, V72, P96, DOI 10.1016/j.biopsycho.2005.08.001; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; ROTH WT, 1978, PSYCHOPHYSIOLOGY, V15, P17, DOI 10.1111/j.1469-8986.1978.tb01328.x; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; RUCHKIN DS, 1995, PSYCHOPHYSIOLOGY, V32, P399, DOI 10.1111/j.1469-8986.1995.tb01223.x; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; Solbakk A. K., 2012, NEUROPSYCHIATRY METH, P101; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Solbakk AK, 2014, J COGNITIVE NEUROSCI, V26, P1528, DOI 10.1162/jocn_a_00561; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; SQUIRES NK, 1975, CLIN NEUROPHYSIOL, V38, P387, DOI DOI 10.1016/0013-4694(75)90263-1; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; Turken A. U., 2008, BMC NEUROSCI, V9, P1655; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; Zappoli R, 2000, INT J PSYCHOPHYSIOL, V38, P109; Zappoli R, 2002, INT J PSYCHOPHYSIOL, V44, P117, DOI 10.1016/S0167-8760(01)00197-0	85	15	17	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0036-5564	1467-9450		SCAND J PSYCHOL	Scand. J. Psychol.	JUN	2014	55	3			SI		233	243		10.1111/sjop.12106			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AJ2UD	WOS:000337518200008	24602177				2022-02-06	
J	Manasse-Cohick, NJ; Shapley, KL				Manasse-Cohick, Nancy J.; Shapley, Kathy L.			Concussion Education for High School Football Players: A Pilot Study	COMMUNICATION DISORDERS QUARTERLY			English	Article						high school; cognitive impairments; exceptionalities; family/parent issues; survey; research; speech-language pathologists (SLPs)	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; HEAD-INJURY; EPIDEMIOLOGY; KNOWLEDGE	This survey study compared high school football players' knowledge and attitudes about concussion before and after receiving concussion education. There were no significant changes in the Concussion Attitude Index. Results revealed a statistically significant difference in the athletes' scores for the Concussion Knowledge Index, t(244) = 8.49, p = .000, and Cohen's d = 1.05. Concussion education can help football players learn signs, symptoms, and negative effects of mild brain injuries.	[Manasse-Cohick, Nancy J.] Calif State Univ Los Angeles, Los Angeles, CA 90032 USA; [Shapley, Kathy L.] Univ Arkansas, Little Rock, AR 72204 USA		Manasse-Cohick, NJ (corresponding author), Calif State Univ Los Angeles, Dept Commun Disorders, 5151 State Univ Dr, Los Angeles, CA 90032 USA.	ncohick@calstatela.edu					Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Center for Disease Control and Prevention, 2013, GET HEADS CONC SPORT; Center for Disease Control and Prevention, 2012, HEADS CONC; Centers for Disease Control and Prevention, 2011, NONF TRAUM BRAIN INJ; Clinic Mayo, 2011, POST CONCUSSION SYND; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M., 2008, MILD TRAUMATIC BRAIN; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; [No title captured]	16	15	15	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1525-7401	1538-4837		COMMUN DISORD Q	Comm. Disord. Q.	MAY	2014	35	3					182	185		10.1177/1525740113506605			4	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	AL7SP	WOS:000339335800006					2022-02-06	
J	McKinlay, A; Ligteringen, V; Than, M				McKinlay, Audrey; Ligteringen, Veronica; Than, Martin			A Comparison of Concussive Symptoms Reported by Parents for Preschool Versus School-Aged Children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						school age; preschool; mild traumatic brain injury; concussive symptoms	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; BIRTH COHORT; IDENTIFICATION; IMPAIRMENT; CHILDHOOD; AGREEMENT; COUNTY; SELF	Objective: To compare parental report of symptoms of concussion for children with superficial head injury versus children with a diagnosis of a mild traumatic brain injury (mTBI). Setting: Urban hospital emergency department. Participants: Parents of 159 children aged 2 to 12 years who presented with an injury to the head. Procedure: Parents were contacted within 1 week of injury and assigned into 3 groups according to their child's age and medical diagnosis (group 1, parents of 2- to 5-year-olds with mTBI (n = 39); group 2, parents of 6- to 12-year-olds with mTBI (n = 41); and group 3, parents of 2- to 12-year-olds with superficial injury to the head (n = 35). Results: Symptoms of concussion were reported in all groups; however, significantly fewer symptoms were reported for children with superficial injuries to the head than for children with mTBI (M = 2.51 vs M = 6.91; P < .001). For mTBI, parents of younger children reported significantly fewer symptoms than parents of older children (M = 5.23 vs M = 8.51; P < .001). Conclusions: A careful approach needs to be taken when evaluating the severity of mTBI for preschool children. Failure to do so may result in misidentification and subsequent lack of management.	[McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [McKinlay, Audrey] Univ Canterbury, Christchurch 1, New Zealand; [Ligteringen, Veronica] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Than, Martin] Christchurch Hosp, Emergency Dept, Christchurch, New Zealand		McKinlay, A (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus, Melbourne, Vic 3800, Australia.	audrey.mckinlay@monash.edu		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council/Accident Compensation Corporation of New Zealand	Dr McKinlay was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand.	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; HOLM S, 1979, SCAND J STAT, V6, P65; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klassen AF, 2006, CHILD CARE HLTH DEV, V32, P397, DOI 10.1111/j.1365-2214.2006.00609.x; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Lagattuta KH, 2012, J EXP CHILD PSYCHOL, V113, P211, DOI 10.1016/j.jecp.2012.04.001; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Sciberras E, 2011, J ATTEN DISORD, V15, P321, DOI 10.1177/1087054710361671; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Wiebe DJ, 2012, PEDIATR EMERG CARE, V28, P498, DOI 10.1097/PEC.0b013e3182586f76; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	24	15	15	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					233	238		10.1097/HTR.0b013e3182a2dd7f			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100011	23982792				2022-02-06	
J	Pitkanen, A; Immonen, R; Ndode-Ekane, X; Grohn, O; Stohr, T; Nissinen, J				Pitkanen, A.; Immonen, R.; Ndode-Ekane, X.; Grohn, O.; Stoehr, T.; Nissinen, J.			Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats	EPILEPSY RESEARCH			English	Article						Antiepileptic drug; Lateral fluid-percussion; Magnetic resonance imaging; Neurodegeneration	GATED SODIUM-CHANNELS; POSTTRAUMATIC SEIZURES; STATUS EPILEPTICUS; SLOW INACTIVATION; BINDING; DRUG; PROPHYLAXIS; EPILEPSY; MODEL; EPILEPTOGENESIS	In a subgroup of patients, traumatic brain injury (TBI) results in the occurrence of acute epileptic seizures or even status epilepticus, which are treated with antiepileptic drugs (AEDs). Recent experimental data, however, suggest that administration of AEDs at the early post-injury phase can compromise the recovery process. The present study was designed to assess the profile of a novel anticonvulsant, lacosamide (Vimpat (R)) on post-TBI structural, motor and cognitive outcomes. Moderate TBI was induced by lateral fluid-percussion injury in adult rats. Treatment with 0.9% saline or lacosamide (30 mg/kg, i.p.) was started at 30 min post-injury and continued at 8 h intervals for 3 d (total daily dose 90 mg/kg/d). Rats were randomly assigned to 4 treatment groups: sham-operated controls treated with vehicle (Sham-Veh) or lacosamide (Sham-LCM) and injured animals treated with vehicle (TBI-Veh) or lacosamide (TBI-LCM). As functional outcomes we tested motor recovery with composite neuroscore and beam-walking at 2, 7, and 15 d post-injury. Cognitive recovery was tested with the Morris water-maze at 12-14 d post-TBI. To assess the structural outcome, animals underwent magnetic resonance imaging (MRI) at 2 d post-TBI. At 16 d post-TBI, rats were perfused for histology to analyze cortical and hippocampal neurodegeneration and axonal damage. Our data show that at 2 d post-TBI, both the TBI-Veh and TBI-LCM groups were equally impaired in neuroscore. Thereafter, motor recovery occurred similarly during the first week. At 2 wk post-TBI, recovery of the TBI-LCM group lagged behind that in the TBI-VEH group (p < 0.05). Performance in beam-walking did not differ between the TBI-Veh and TBI-LCM groups. Both TBI groups were similarly impaired in the Morris water-maze at 2 wk post-TBI. MRI and histology did not reveal any differences in the cortical or hippocampal damage between the TBI-Veh and TBI-LCM groups. Taken together, acute treatment with LCM had no protective effects on post-TBI structural or functional impairment. Composite neuroscore in the TBI-LCM group lagged behind that in the TBI-Veh group at 15 d post-injury, but no compromise was found in other indices of post-TBI recovery in the LCM treated animals. (C) 2014 Elsevier B.V. All rights reserved.	Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, FI-70211 Kuopio, Finland; [Pitkanen, A.] Kuopio Univ Hosp, Dept Neurol, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi					Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Childers MK, 1997, BRAIN INJURY, V11, P537, DOI 10.1080/713802187; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cross SA, 2009, DRUGS, V69, P449, DOI 10.2165/00003495-200969040-00005; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; FREUND TF, 1992, BRAIN RES BULL, V28, P27, DOI 10.1016/0361-9230(92)90227-O; Geis C, 2011, NEUROPHARMACOLOGY, V61, P600, DOI 10.1016/j.neuropharm.2011.05.001; Halonen T, 1996, EUR J PHARMACOL, V299, P69, DOI 10.1016/0014-2999(95)00835-7; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Hernandez TD, 1997, TRENDS PHARMACOL SCI, V18, P59, DOI 10.1016/S0165-6147(96)01027-9; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Hup CK, 2010, MALAYS J MED SCI, V17, P36; Ivanhoe CB, 2004, J HEAD TRAUMA REHAB, V19, P29, DOI 10.1097/00001199-200401000-00004; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Keck CA, 2007, RESTOR NEUROL NEUROS, V25, P77; Koo TS, 2011, ARCH PHARM RES, V34, P2059, DOI 10.1007/s12272-011-1208-7; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Ma CY, 2010, CHIN J TRAUMATOL, V13, P293, DOI 10.3760/cma.j.issn.1008-1275.2010.05.008; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Montanez S, 2001, J NEUROTRAUM, V18, P1255, DOI 10.1089/089771501317095296; Narkilahti S, 2003, EUR J NEUROSCI, V18, P1486, DOI 10.1046/j.1460-9568.2003.02874.x; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Park KD, 2009, J MED CHEM, V52, P6897, DOI 10.1021/jm9012054; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Pitkanen A, 2004, EXPERT OPIN PHARMACO, V5, P777, DOI 10.1517/eoph.5.4.777.30162; Pitkanen A, 2007, SEIZURE FREEDOM CLIN, P9; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; Steinbaugh LA, 2012, EPILEPSY BEHAV, V23, P280, DOI 10.1016/j.yebeh.2011.12.005; Stohr T, 2007, EPILEPSY RES, V74, P147, DOI 10.1016/j.eplepsyres.2007.03.004; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Uebachs M, 2012, EPILEPSIA, V53, P1959, DOI 10.1111/j.1528-1167.2012.03675.x; Wang B, 2013, NEUROCRIT CARE, V19, P125, DOI 10.1007/s12028-012-9808-8; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wolff C, 2012, CNS NEUROSCI THER, V18, P493, DOI 10.1111/j.1755-5949.2012.00313.x; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132; Zaccara G, 2013, EPILEPSIA, V54, P66, DOI 10.1111/j.1528-1167.2012.03589.x	51	15	15	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	MAY	2014	108	4					653	665		10.1016/j.eplepsyres.2014.02.001			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG7UA	WOS:000335623100006	24636248				2022-02-06	
J	Russo, A; D'Onofrio, F; Conte, F; Petretta, V; Tedeschi, G; Tessitore, A				Russo, A.; D'Onofrio, F.; Conte, F.; Petretta, V.; Tedeschi, G.; Tessitore, A.			Post-traumatic headaches: a clinical overview	NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	6th ANIRCEF National Congress on Headache and Social Context	MAY 29-31, 2014	Asti, ITALY	ANIRCEF		Post-traumatic headache; PTH; Clinical aspects; Whiplash injury; Trauma	TRAUMATIC BRAIN-INJURY; CONCUSSION; SOLDIERS	Headache attributed to head and/or neck trauma or injury, the so-called post-traumatic headache (PTH), is the most common secondary headache disorder and one of the most controversial clinical entities in the headache field, due to its unclear pathophysiological mechanisms and the unsolved role of associated psychological and medico-legal aspects. PTH, as a significant cause of morbidity after traumatic brain injury, may occur as an isolated symptom or as one of a constellation of symptoms known as post-concussive syndrome. However, in many cases, PTH might also represent an accentuation of non-disabling, remote or infrequent pre-existing primary headaches rather than a new onset headache strictly related to the trauma. Recently, the International Classification of Headache Disorders attempted to classify PTH; however, many unsolved issues are still to be clarified. In this brief review, we will focus on PTH clinical aspects and diagnostic criteria.	[Russo, A.; Conte, F.; Tedeschi, G.; Tessitore, A.] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Russo, A.; Tedeschi, G.] IDC Hermitage Capodimonte, SUN FISM Ctr, Naples, Italy; [D'Onofrio, F.; Petretta, V.] San G Moscati Hosp Avellino, Div Neurol, Avellino, Italy		Tessitore, A (corresponding author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	alessandro.tessitore@unina2.it	Tessitore, Alessandro/K-3124-2018	Tessitore, Alessandro/0000-0003-1740-8566			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Ribeiro MDD, 2013, CEPHALALGIA, V33, P897, DOI 10.1177/0333102413479833; Ekbom K, 1999, CEPHALALGIA, V19, P73; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lainez MJA, 2011, CURR PAIN HEADACHE R, V15, P467, DOI 10.1007/s11916-011-0220-4; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Molnar L, 2014, J ANESTH, V28, P102, DOI 10.1007/s00540-013-1671-z; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; Obermann M, 2009, EXPERT REV NEUROTHER, V9, P1361, DOI [10.1586/ern.09.84, 10.1586/ERN.09.84]; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Reddy CC, 2011, PM&R, V3, pS396, DOI 10.1016/j.pmrj.2011.07.012; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Waung MW, 2012, CURR PAIN HEADACHE R, V16, P533, DOI 10.1007/s11916-012-0294-7; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	36	15	15	0	9	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2014	35			1			S153	S156		10.1007/s10072-014-1758-9			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	AI3EZ	WOS:000336744400029	24867854				2022-02-06	
J	Shaked, G; Douvdevani, A; Yair, S; Zlotnik, A; Czeiger, D				Shaked, Gad; Douvdevani, Amos; Yair, Silvia; Zlotnik, Alexander; Czeiger, David			The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Cell free DNA; Circulating DNA; Brain injury; Head trauma	GLASGOW COMA SCALE; FREE PLASMA DNA; BRAIN-INJURY; PREDICTIVE MARKER; NUCLEIC-ACIDS; CLASSIFICATION; DAMAGE; MORTALITY; FEATURES; SEPSIS	Background: Traumatic brain injury (TBI) is a major cause of death and disability. In this study a new method to measure cell free DNA (CFD) for the management of TBI is tested. Our hypothesis was that CFD concentrations correlate to the magnitude of brain damage, and may predict the outcome of injured patients. Methods: Twenty eight patients with isolated head injury were enrolled. Their demographic and clinical data were recorded. CFD levels were determined in patients' sera samples by a direct fluorescence method developed in our laboratory. Results: Mean admission CFD values were lower in patients with mild TBI compared to severe injury (760 +/- 340 ng/ml vs. 1600 +/- 2100 ng/ml, p = 0.03), and in patients with complete recovery upon discharge compared to patients with disabilities (680 +/- 260 ng/ml vs. 2000 +/- 2300 ng/ml, p = 0.003). Patients with high CFD values had a relative risk to require surgery of 1.5 (95% CI 0.83 to 2.9) a relative risk to have impaired outcome on discharge of 2.8 (95% CI 0.75 - 10), and a longer length of stay (12 +/- 13 days vs. 3.4 +/- 4.8 days, p = 0.02). CFD values did not correlate with CT scan based grading. Conclusions: CFD levels may be used as a marker to assess the severity of TBI and to predict the prognosis. Its use should be considered as an additional tool along with currently used methods or as a surrogate for them in limited resources environment.	[Shaked, Gad; Czeiger, David] Soroka Univ, Med Ctr, Dept Gen Surg, Trauma Unit, IL-84101 Beer Sheva, Israel; [Shaked, Gad; Yair, Silvia; Czeiger, David] Soroka Univ, Med Ctr, Dept Clin Biochem, IL-84101 Beer Sheva, Israel; [Douvdevani, Amos] Soroka Univ, Med Ctr, Dept Anesthesiol, IL-84101 Beer Sheva, Israel; [Zlotnik, Alexander] Soroka Univ, Med Ctr, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Beer Sheva, Israel		Shaked, G (corresponding author), Soroka Univ, Med Ctr, Dept Gen Surg, Trauma Unit, 68 Wingate St, IL-84101 Beer Sheva, Israel.	shakedg@bgu.ac.il	Douvdevani, Amos/E-3803-2010	Douvdevani, Amos/0000-0002-0197-6481	Dr. Montague Robin Fleisher Kidney Transplant Unit Fund	This work was supported by the "Dr. Montague Robin Fleisher Kidney Transplant Unit Fund". The fund was not involved in any way in the study. Amos Douvdevani submitted a US Patent Application No. 13/659,439 "Assay for Detecting Circulating Free Nucleic Acids". All other authors deny any other financial or personal relationships that might be considered as conflict of interest.	Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GERSTENBRAND F, 1970, Archiv fuer Psychiatrie und Nervenkrankheiten, V213, P264, DOI 10.1007/BF00342662; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; JENNETT B, 1975, LANCET, V1, P480; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Lo YMD, 2000, CLIN CHEM, V46, P319; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Rainer TH, 2006, ANN NY ACAD SCI, V1075, P271, DOI 10.1196/annals.1368.035; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160	34	15	16	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 19	2014	22								21	10.1186/1757-7241-22-21			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AG5MU	WOS:000335463900001	24641833	Green Published, gold			2022-02-06	
J	Ghorbani, P; Falken, M; Riddez, L; Sundelof, M; Oldner, A; Strommer, L				Ghorbani, Poya; Falken, Magnus; Riddez, Louis; Sundelof, Martin; Oldner, Anders; Strommer, Lovisa			Clinical review is essential to evaluate 30-day mortality after trauma	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Mortality; Trauma deaths; Clinical review; Dead on arrival	PERFORMANCE IMPROVEMENT; DEATHS; TIME; EPIDEMIOLOGY; DEFINITIONS; INJURIES; PATTERNS; SERVICE; IMPACT	Background: Securing high-quality mortality statistics requires systematic evaluation of all trauma deaths. We examined the proportion of trauma patients dying within 30 days from causes not related to the injury and the impact of exclusion of patients dead on arrival on 30-day trauma mortality. We also defined the demographics, injury characteristics, cause of death and time to death in patients admitted to our trauma center who died within 30 days, between 2007-2011. Methods: Demographics, injury characteristics, status alive/dead on arrival, cause of death and time to death of all patients were reviewed. Deaths were analyzed based on injury mechanism (penetrating, blunt trauma and low energy blunt trauma) and cause of death (traumatic brain injury (TBI), hemorrhage, organ dysfunction and other/unknown). Results: Of the 7422 admissions, 343 deaths were identified of which 36 (10.5%) involved causes not related to the injury. The overall age was 71 years, Injury Severity Score (ISS) 29 and time to death 24 hours (all medians). Fifty-four patients (17.6%) were dead on arrival. Exclusion of patients dead on arrival reduced the overall mortality rate (P < 0.05) and median ISS (P < 0.05) and increased median age (P < 0.01) and time to death (P < 0.001). Injury mechanism was penetrating trauma in 7.5%, blunt trauma in 56.0%, and low energy blunt trauma in 36.5%. TBI accounted for 58.6%; hemorrhage 16.3%, organ dysfunction 15.0%, and other/unknown for 10.1% of the deaths. Patients who died after low energy blunt trauma were older, had lower ISS and longer time to death compared to those who died after penetrating and blunt trauma (all P < 0.01). Conclusions: Clinical review of all trauma deaths was essential to interpret mortality. Thirty-day trauma mortality included 10.5% deaths not directly related to the injury and the exclusion of patients dead on arrival significantly affected the unadjusted mortality rate, ISS, median age and time to death.	[Ghorbani, Poya; Strommer, Lovisa] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden; [Falken, Magnus; Riddez, Louis; Sundelof, Martin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Oldner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Div Anesthesiol & Intens Care, Stockholm, Sweden; [Strommer, Lovisa] Karolinska Univ Hosp, Dept Surg Gastroenterol, S-17176 Stockholm, Sweden		Strommer, L (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden.	Lovisa.Strommer@karolinska.se	Oldner, Anders/Q-4353-2018	Oldner, Anders/0000-0003-1600-9221; Strommer, Lisa/0000-0001-5424-7111	Swedish Society of Medicine	We would like to thank Olof Brattstrom for his continuous efforts at the Trauma Registry at Karolinska University Hospital. We also would like to thank Lisbet Bergendal, Lena A Jansson and Tina Friberg for their hard work and invaluable contribution, which allows for our scholarly activities. The study was supported by funding from the Swedish Society of Medicine.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; *AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; Brattstrom O, 2012, EUR J EPIDEMIOL, V27, P233, DOI 10.1007/s10654-012-9651-4; CAYTEN CG, 1991, ANN SURG, V214, P510, DOI 10.1097/00000658-199110000-00015; Cayten CG, 1991, ANN SURG, V214, P520; Chalkley D, 2011, EMERG MED J, V28, P305, DOI 10.1136/emj.2009.085613; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Esposito TJ, 2012, J TRAUMA ACUTE CARE, V73, P587, DOI 10.1097/TA.0b013e318265ce05; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Groven S, 2011, J TRAUMA, V70, P569, DOI 10.1097/TA.0b013e31820d1a9b; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Pasquale MD, 1996, J TRAUMA, V41, P726, DOI 10.1097/00005373-199610000-00022; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Powell DW, 2004, J AM COLL SURGEONS, V199, P211, DOI 10.1016/j.jamcollsurg.2004.04.004; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; ROMANO PS, 1992, AM J EPIDEMIOL, V136, P863, DOI 10.1093/aje/136.7.863; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Skaga NO, 2008, INJURY, V39, P612, DOI 10.1016/j.injury.2007.11.426; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Van Haren RM, 2012, J TRAUMA ACUTE CARE, V73, P1512, DOI 10.1097/TA.0b013e318270d40f; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	24	15	15	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 13	2014	22								18	10.1186/1757-7241-22-18			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AF5ZT	WOS:000334794800001	24625137	Green Published, gold			2022-02-06	
J	Allen, AR; Eilertson, K; Chakraborti, A; Sharma, S; Baure, J; Habdank-Kolaczkowski, J; Allen, B; Rosi, S; Raber, J; Fike, JR				Allen, Antino R.; Eilertson, Kirsten; Chakraborti, Ayanabha; Sharma, Sourabh; Baure, Jennifer; Habdank-Kolaczkowski, Julian; Allen, Barrett; Rosi, Susanna; Raber, Jacob; Fike, John R.			Radiation exposure prior to traumatic brain injury induces responses that differ as a function of animal age	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						Radiation; age; hippocampus; neurogenesis; inflammation	HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; IRRADIATION; MICROGLIA	Purpose: Uncontrolled radiation exposure due to radiological terrorism, industrial accidents or military circumstances is a continuing threat for the civilian population. Age plays a major role in the susceptibility to radiation; younger children are at higher risk of developing cognitive deterioration when compared to adults. Our objective was to determine if an exposure to radiation affected the vulnerability of the juvenile hippocampus to a subsequent moderate traumatic injury. Materials and methods: Three-week-old (juvenile) and eight-week-old young adult C57BL/J6 male mice received whole body cesium-137 (Cs-137) irradiation with 4 gray (Gy). One month later, unilateral traumatic brain injury was induced using a controlled cortical impact system. Two months post-irradiation, animals were tested for hippocampus-dependent cognitive performance in the Morris water-maze. After cognitive testing, animals were euthanized and their brains frozen for immunohistochemical assessment of activated microglia and neurogenesis in the hippocampal dentate gyrus. Results: All animals were able to learn the water maze task; however, treatment effects were seen when spatial memory retention was assessed. Animals that received irradiation as juveniles followed by a moderate traumatic brain injury one month later did not show spatial memory retention, i.e., were cognitively impaired. In contrast, all groups of animals that were treated as adults showed spatial memory retention in the probe trials. Conclusion: Although the mechanisms involved are not clear, our results suggest that irradiation enhanced a young animal's vulnerability to develop cognitive injury following a subsequent traumatic injury.	[Allen, Antino R.; Chakraborti, Ayanabha; Sharma, Sourabh; Baure, Jennifer; Habdank-Kolaczkowski, Julian; Allen, Barrett; Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Allen, Antino R.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Eilertson, Kirsten] Gladstone Inst, Bioinformat Core, San Francisco, CA USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Div Neurosci, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA		Allen, AR (corresponding author), Univ Arkansas Med Sci, 4301 West Markham,Suite 441B-2, Little Rock, AR 72205 USA.	AAllen@uams.edu	Chakraborti, Ayanabha/N-1898-2019	Eilertson, Kirsten/0000-0003-4850-1210; Chakraborti, Ayanabha/0000-0003-2060-8200	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R33 AI08053]; National Institute of General Medical Sciences/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266] Funding Source: NIH RePORTER	The research described was supported by National Institutes of Health (NIH) grant R33 AI08053 and Award Number K12GM081266 from the National Institute of General Medical Sciences/National Institutes of Health.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Balk SJ, 2003, PEDIATRICS, V111, P1455; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Joo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025936; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Pandey BN, 2010, INT J RADIAT BIOL, V86, P613, DOI 10.3109/09553001003746059; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2010, TOXICOL PATHOL, V38, P198, DOI 10.1177/0192623309352003; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031094; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	29	15	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.	MAR	2014	90	3					214	223		10.3109/09553002.2014.859761			10	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AC8QA	WOS:000332797500002	24164494	Green Published, hybrid			2022-02-06	
J	Fridgeirsdottir, GA; Hillered, L; Clausen, F				Fridgeirsdottir, Gudrun Andrea; Hillered, Lars; Clausen, Fredrik			Escalated handling of young C57BL/6 mice results in altered Morris water maze performance	UPSALA JOURNAL OF MEDICAL SCIENCES			English	Article						Handling; mice; Morris water maze	TRAUMATIC BRAIN-INJURY; INBRED STRAINS; STRESS; BEHAVIOR; MEMORY; RAT; NEUTRALIZATION; ANXIETY; TESTS; TASKS	Background. The handling of experimental animals prior to experimental interventions is often poorly described, even though it may affect the final functional outcome. This study explores how the use of repeated handling of C57BL/6 mice prior to Morris water maze (MWM) tests can affect the performance. Methods and materials. The handled animals were subjected to the escalating handling protocol, with the investigator spending 5 min per day per cage for 8 days prior to the MWM test. On the last days of handling, the mice were introduced to water and the concept of a hidden platform. The MWM test consisted of four daily trials for 90 s per day for 4 days with a hidden platform. A probe test was performed 4 days after the last learning trial. Control animals were not handled prior to MWM. Results. Handling reduced the latency to find the platform on the first 2 days of the MWM tests and reduced thigmotaxis. The mice increased their swim speed and elicited more explorative behavior in the learning trials and to some lesser extent in the probe trials. Conclusions. The improvement in MWM navigation was most likely due to reduced stress and anxiety regarding the investigator and the test. Handled mice displayed less variability than non-handled mice, suggesting that by using a controlled handling protocol prior to the experiments fewer C57BL/6 mice would be needed to achieve statistically significant differences in studies of learning and spatial memory using MWM.	[Fridgeirsdottir, Gudrun Andrea; Hillered, Lars; Clausen, Fredrik] Uppsala Univ, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden		Clausen, F (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, Entrance 85,2nd Floor, S-75185 Uppsala, Sweden.	fredrik.clausen@neuro.uu.se		Hillered, Lars/0000-0002-2808-9292; Clausen, Fredrik/0000-0003-3592-4417	Swedish Brain Foundation; Uppsala University Hospital; Ahlen's Foundation; Uppsala University	The work was supported by grants from the Swedish Brain Foundation, Uppsala University Hospital, Ahlen's Foundation, and funds from Uppsala University.	Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; Beeler JA, 2006, PHYSIOL BEHAV, V87, P870, DOI 10.1016/j.physbeh.2006.01.037; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Bisaz R, 2011, HIPPOCAMPUS, V21, P56, DOI 10.1002/hipo.20723; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Cuadrado-Tejedor M, 2011, BEHAV BRAIN RES, V220, P338, DOI 10.1016/j.bbr.2011.01.005; Dalm S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039033; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Hu M, 2009, EUR J PHARMACOL, V622, P37, DOI 10.1016/j.ejphar.2009.09.031; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/NMETH.1500, 10.1038/nmeth.1500]; Leenaars M, 2009, ATLA-ALTERN LAB ANIM, V37, P297, DOI 10.1177/026119290903700312; Longordo F, 2011, SLEEP, V34, P679, DOI 10.1093/sleep/34.5.679; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Powell SB, 2004, BEHAV BRAIN RES, V152, P341, DOI 10.1016/j.bbr.2003.10.020; Tremml P, 2002, GENES BRAIN BEHAV, V1, P230, DOI 10.1034/j.1601-183X.2002.10405.x; UPCHURCH M, 1987, PHARMACOL BIOCHEM BE, V27, P143, DOI 10.1016/0091-3057(87)90488-6; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; Vecsey CG, 2013, SLEEP, V36, P601, DOI 10.5665/sleep.2556; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Wolff M, 2002, BEHAV BRAIN RES, V136, P463, DOI 10.1016/S0166-4328(02)00192-4; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130	34	15	15	0	17	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0300-9734	2000-1967		UPSALA J MED SCI	Ups. J. Med. Sci.	MAR	2014	119	1					1	9		10.3109/03009734.2013.847511			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB5KX	WOS:000331828500001	24172203	gold, Green Published			2022-02-06	
J	Makdissi, M; Davis, G; McCrory, P				Makdissi, Michael; Davis, Gavin; McCrory, Paul			Updated guidelines for the management of sports-related concussion in general practice	AUSTRALIAN FAMILY PHYSICIAN			English	Article						brain injuries; central nervous system diseases; brain concussion; sports medicine	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; EPIDEMIOLOGY; STATEMENT; SEQUELAE; DISEASE; IMPACT	Background Concussion is common in many sports and recreational activities. It is thought to reflect a functional rather than structural injury to the brain. The clinical features are typically short-lived and usually resolve spontaneously. Complications, however, can occur and may include prolonged symptoms and/or cognitive deficits in the short term, as well as depression and cumulative deterioration in brain function in the longer term. Objective This article will provide an updated clinical review of concussion in sport, with an emphasis on assessment and management in general practice. Discussion The critical issues in the clinical management of concussion in sport include making a diagnosis, differentiating between concussion and other pathologies (particularly structural head injury), recognising the presence of any modifying factors (which may increase the risk of complications) and determining when the patient can safely return to competition. The key components of safe return-to-play decisions include rest, neuropsychological testing and a graded program of exertion before return to sport.	[Makdissi, Michael; Davis, Gavin; McCrory, Paul] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Makdissi, Michael] Australasian Coll Sports Phys, Olymp Pk Sports Med Ctr, Melbourne, Vic, Australia		Makdissi, M (corresponding author), Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia.	makdissi@unimelb.edu.au	McCrory, Paul/Q-8688-2019	makdissi, michael/0000-0003-0334-7133; McCrory, Paul/0000-0003-4850-0568			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chadwick D, 1997, BRIT MED J, V314, P1283; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; RUTHERFORD WH, 1977, LANCET, V1, P1	33	15	15	0	15	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	MAR	2014	43	3					94	99					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS0DD	WOS:000343947700007	24600668				2022-02-06	
J	Richmond, TS; Guo, WS; Ackerson, T; Hollander, J; Gracias, V; Robinson, K; Amsterdam, J				Richmond, Therese S.; Guo, Wensheng; Ackerson, Theimann; Hollander, Judd; Gracias, Vicente; Robinson, Keith; Amsterdam, Jay			The Effect of Postinjury Depression on Quality of Life following Minor Injury	JOURNAL OF NURSING SCHOLARSHIP			English	Article						injuries; depression; quality of life; trauma; Cohort study	POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL STATUS QUESTIONNAIRE; TRAUMATIC INJURY; HEALTH-STATUS; BRAIN-INJURY; CARE; RECOVERY; INDEX; RELIABILITY; SURVIVORS	Purpose To describe quality of life (QoL) in the year following minor injury and to test the hypothesis that individuals with depression in the postinjury year experience lower QoL than do individuals with no depression. Design Prospective, longitudinal, cohort design. A total of 275 adults were randomly selected from injured patients presenting to an urban emergency department. Methods All participants underwent structured psychiatric diagnostic interviews immediately after injury and at 3, 6, and 12 months. The primary outcome, QoL, was measured using the Quality of Life Index. Covariates included demographics, injury status, preinjury functional status, preinjury social support, and anticipation of problems postdischarge. The General Estimating Equation was used to compare changes in QoL between participants with and without depression over 3, 6, and 12 months, adjusting for covariates. Results An 18.1% proportion (95% confidence interval [CI] 13.3, 22.9%) of the sample met criteria for a mood disorder in the postinjury year. The depressed group reported a QoL that was 4.2 points (95% CI 2.8-5.6) lower in the year postinjury compared with that of the nondepressed group. Conclusions Depression after minor injury negatively affects QoL even a full year postinjury. Clinical Relevance The findings of this study show that patients who have injuries that are treated and discharged from an emergency department can have significantly lower QoL in the year after that injury that is attributed, in part, to postinjury depression. Nurses should provide anticipatory guidance to patients that they may experience feelings of sadness or being "blue," and that if they do, they should seek care.	[Richmond, Therese S.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Guo, Wensheng; Hollander, Judd; Robinson, Keith; Amsterdam, Jay] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ackerson, Theimann] Univ Windsor, Ctr Execut & Profess Educ, Windsor, ON N9B 3P4, Canada; [Gracias, Vicente] Robert Wood Johnson Univ Hosp, New Brunswick, NJ USA		Richmond, TS (corresponding author), Univ Penn, Sch Nursing, Fagin Hall 330,418 Curie Blvd, Philadelphia, PA 19104 USA.	terryr@nursing.upenn.edu		Hollander, Judd/0000-0002-1318-2785	National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH63818]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH063818] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Mental Health R01 MH63818 to Dr. Richmond.	Aitken L. M., 2012, J CLIN NURS, DOI [10.1111/jocn.12026, DOI 10.1111/JOCN12026]; Aitken LM, 2012, J TRAUMA ACUTE CARE, V72, P1702, DOI 10.1097/TA.0b013e318246bfe9; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Borg T, 2010, INJURY, V41, P400, DOI 10.1016/j.injury.2009.11.006; Brasel KJ, 2010, J TRAUMA, V68, P263, DOI 10.1097/TA.0b013e3181caa58f; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; *CDC, 1999, MMWR-MORBID MORTAL W, V48, P241; Centers for Disease Control and Prevention (CDC), 2013, WEB BAS INJ STAT QUE; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cleary PD, 2000, QUAL LIFE RES, V9, P747, DOI 10.1023/A:1008977923785; Costanza R, 2007, ECOL ECON, V61, P267, DOI 10.1016/j.ecolecon.2006.02.023; Diggle PJ, 1994, ANAL LONGITUDINAL DA; FERRANS CE, 1992, RES NURS HEALTH, V15, P29, DOI 10.1002/nur.4770150106; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; First M.B., 1994, STRUCTURED CLIN INTE; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Gross T, 2011, SURGERY, V150, P985, DOI 10.1016/j.surg.2011.04.003; Gross T, 2010, J AM COLL SURGEONS, V211, P81, DOI 10.1016/j.jamcollsurg.2010.02.042; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; KELLER MB, 1987, ARCH GEN PSYCHIAT, V44, P540; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mason S, 2009, BRIT J CLIN PSYCHOL, V48, P31, DOI 10.1348/014466508X344799; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; O'Donnell ML, 2008, J CONSULT CLIN PSYCH, V76, P923, DOI 10.1037/a0012918; Orwelius L, 2012, J TRAUMA ACUTE CARE, V72, P504, DOI 10.1097/TA.0b013e31821a416a; Overgaard M, 2011, J TRAUMA, V71, P435, DOI 10.1097/TA.0b013e31820e7ec3; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Richmond TS, 2009, PSYCHOL MED, V39, P1709, DOI 10.1017/S0033291709005376; Richmond TS, 2011, J ADV NURS, V67, P2741, DOI 10.1111/j.1365-2648.2011.05749.x; Richmond TS, 2011, GEN HOSP PSYCHIAT, V33, P327, DOI 10.1016/j.genhosppsych.2011.05.003; Richmond TS, 2003, AM J CRIT CARE, V12, P197, DOI 10.4037/ajcc2003.12.3.197; Richmond TS, 2000, J ADV NURS, V32, P1341, DOI 10.1046/j.1365-2648.2000.01629.x; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Ringdal M, 2010, CRIT CARE MED, V38, P38, DOI 10.1097/CCM.0b013e3181b42909; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Sutherland AG, 2011, J ORTHOP TRAUMA, V25, P228, DOI 10.1097/BOT.0b013e3181ee40a9; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Trevino Colleen M, 2012, J Trauma Nurs, V19, P154, DOI 10.1097/JTN.0b013e318261d304; University of Illinois at Chicago, QUALITY LIFE; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Zarzaur BL, 2011, J TRAUMA, V70, P285, DOI 10.1097/TA.0b013e31820b5b80; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313	53	15	15	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6546	1547-5069		J NURS SCHOLARSHIP	J. Nurs. Scholarsh.	MAR	2014	46	2					116	124		10.1111/jnu.12064			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	AC2HT	WOS:000332321400007	24354500	Green Accepted			2022-02-06	
J	Robins, A; Pleiter, H; Latter, M; Phillips, CJC				Robins, A.; Pleiter, H.; Latter, M.; Phillips, C. J. C.			The efficacy of pulsed ultrahigh current for the stunning of cattle prior to slaughter	MEAT SCIENCE			English	Article						Halal; Welfare; Exsanguination; Reflex; Electro-encephalograph; Insensibility	HALAL SLAUGHTER; BLOOD-PRESSURE; ELECTROPORATION; DELIVERY; ARTERIES; QUALITY; CALVES; LAMBS; SHEEP	We present results from the development of a new system of reversible electrical stunning of cattle. A single-pulse ultra-high current (SPUC) was generated from a capacitance discharge current spike of at least 5000 Vat 70 A, for approximately 50 ms. Ninety-seven cattle were stunned in three experimental protocols. With improvements made to the design of the stun box and charge delivered, 38 cattle were either stunned and immediately jugulated or monitored for signs of reappearance of brain stem reflexes at which point a concussion stun was administered. This use of the SPUC charge, provided as a biphasic-pulse waveform, resulted in a high level of stunning efficacy, with unconsciousness lasting for up to 4 min. These results were supported by EEG data taken from a subsequent cohort of stunned cattle. The SPUC stun also apparently eliminated post-stun grand mal seizures that can occur following short-acting conventional electrical stun, with its associated negative consequences on operator safety and meat quality. (C) 2013 Elsevier Ltd. All rights reserved.	[Robins, A.; Latter, M.; Phillips, C. J. C.] Univ Queensland, Ctr Anim Welf & Eth, Sch Vet Sci, Gatton, Qld 4343, Australia; [Pleiter, H.] Meat & Livestock Australia, Brisbane, Qld, Australia		Robins, A (corresponding author), Univ Queensland, Ctr Anim Welf & Eth, Sch Vet Sci, Gatton, Qld 4343, Australia.		Robins, Andrew/A-1398-2008; Robins, Andrew/T-9034-2019	Robins, Andrew/0000-0001-7806-8409; 	MLA (Meat and Livestock, Australia); Came Technologies Ltd., N.Z.	This research was supported by the MLA (Meat and Livestock, Australia) and Came Technologies Ltd., N.Z.	American Veterinary Medical Association (AVMA), 2013, AVMA GUID EUTH AN; Anil H, 2012, EFFECTS SLAUGHTER ME; Anil MH, 2006, ANIM WELFARE, V15, P325; Australian Meat Industry Council (AMIC), 2009, NAT AN WELF STAND LI, P37; Berg C., 2007, Svensk Veterinartidning, V59, P21; COOK CJ, 1992, RES VET SCI, V52, P48, DOI 10.1016/0034-5288(92)90057-9; CSIRO, 2011, MEAT TECHN UPD EFF S; Daly C., 2005, INT S, p[77, 77]; Daly C. C., 1986, P EUR M MEAT RES WOR, V32, P103; De Vry J, 2010, PROG NEUROBIOL, V92, P227, DOI 10.1016/j.pneurobio.2010.10.001; Gilbert K. V., 1986, P 32 EUR M MEAT RES, V1, P117; GILBERT KV, 1982, MEAT SCI, V7, P197, DOI 10.1016/0309-1740(82)90086-9; Gregory NG, 2008, MEAT SCI, V79, P285, DOI 10.1016/j.meatsci.2007.09.012; Hanninen L, 2009, BEHAV RES METHODS, V41, P472, DOI 10.3758/BRM.41.2.472; Kirton A H, 1978, Meat Sci, V2, P199, DOI 10.1016/0309-1740(78)90005-0; NEWHOOK JC, 1982, MEAT SCI, V6, P295, DOI 10.1016/0309-1740(82)90040-7; Onenc A, 2004, MEAT SCI, V66, P809, DOI 10.1016/S0309-1740(03)00191-8; PETERSEN GV, 1986, MEAT SCI, V16, P1, DOI 10.1016/0309-1740(86)90008-2; Pleiter H, 2004, DEUT TIERARZTL WOCH, V111, P106; SHAW FD, 1990, NEW ZEAL VET J, V38, P14, DOI 10.1080/00480169.1990.35607; Singh BN, 1999, ANTI-CANCER DRUG, V10, P139, DOI 10.1097/00001813-199902000-00001; Wotton SB, 2000, VET REC, V147, P681	22	15	15	0	29	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	MAR	2014	96	3					1201	1209		10.1016/j.meatsci.2013.10.030			9	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	AB1ZU	WOS:000331593600012	24334041				2022-02-06	
J	Thais, MERD; Cavallazzi, G; Formolo, DA; de Castro, LD; Schmoeller, R; Guarnieri, R; Schwarzbold, ML; Diaz, AP; Hohl, A; Prediger, RDS; Mader, MJ; Linhares, MN; Staniloiu, A; Markowitsch, HJ; Walz, R				Rodrigues de Oliveira Thais, Maria Emilia; Cavallazzi, Gisele; Formolo, Douglas Afonso; de Castro, Lucas D'Avila; Schmoeller, Roseli; Guarnieri, Ricardo; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Hohl, Alexandre; Prediger, Rui D. S.; Mader, Maria Joana; Linhares, Marcelo Neves; Staniloiu, Angelica; Markowitsch, Hans J.; Walz, Roger			Limited predictive power of hospitalization variables for long-term cognitive prognosis in adult patients with severe traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							DIFFUSION-TENSOR; HEAD-INJURY; MODERATE; RECOVERY; OUTCOMES; TBI; CLASSIFICATION; METAANALYSIS; PERFORMANCE; DISORDERS	ObjectivesTraumatic brain injury (TBI) is a main cause of mortality and morbidity. Association studies between hospitalization variables and cognitive impairment after TBI are frequently retrospective, including non-consecutive patients showing variable degrees of TBI severity, and poor management of missing (drop out) cases. MethodsWe assessed prospectively the demographic and hospitalization variables of 234 consecutive patients with severe TBI (admission Glasgow Coma Scale [GCS] 8) and determined their independent association with cognitive performance in a representative sample (n=46) of surviving patients (n=172) evaluated 3 (1.8) years after hospitalization. ResultsIn all, 85% of patients were male and the mean age was 34 (SD +/- 13) years. The education level was 9 (+/- 4.7) years. As expected, education and age showed a moderately to strong linear relationship with the cognitive performance in 14 of 15 neuropsychological tests (R coefficient=0.6-0.8). The cognitive test scores were not independently associated with gender, admission GCS, associated trauma, and Marshal CT classification. Admission-elevated blood glucose levels and the presence of sub-arachnoid haemorrhage were independently associated with lower scores on Rey Auditory Verbal Learning retention and Logical Memory-I tests, respectively. ConclusionsAfter correction for education and age distribution, the variables that are commonly associated with mortality or Glasgow Outcome Scale including admission pupils' examination, Marshal CT Classification, GCS, and serum glucose showed a limited predictive power for long-term cognitive prognosis. Identification of clinical, radiological, and laboratory variables as well as new biomarkers independently associated with cognitive outcome remains an important challenge for further work involving severe TBI patients.	[Rodrigues de Oliveira Thais, Maria Emilia; Cavallazzi, Gisele; Formolo, Douglas Afonso; de Castro, Lucas D'Avila; Schmoeller, Roseli; Guarnieri, Ricardo; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Hohl, Alexandre; Prediger, Rui D. S.; Linhares, Marcelo Neves; Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Ctr Neurociencias Aplicadas CeNAp, Florianopolis, SC, Brazil; [Guarnieri, Ricardo; Diaz, Alexandre Paim; Linhares, Marcelo Neves; Walz, Roger] Hosp Governador Celso Ramos, Ctr Epilepsia Estado Santa Catarina CEPESC, Florianopolis, SC, Brazil; [Prediger, Rui D. S.] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, Florianopolis, SC, Brazil; [Mader, Maria Joana] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil; [Linhares, Marcelo Neves] Univ Fed Santa Catarina, HU, Serv Cirurgia, Unidade Neurocirurgia, Florianopolis, SC, Brazil; [Staniloiu, Angelica; Markowitsch, Hans J.] Univ Bielefeld, D-33615 Bielefeld, Germany; [Walz, Roger] Univ Fed Santa Catarina, HU, Dept Clin Med, Florianopolis, SC, Brazil		Walz, R (corresponding author), UFSC, Univ Hosp, Dept Clin Med, 3 Andar,Campus Univ, Trindade Florianopolis, SC, Brazil.	rogerwalz@hotmail.com	Diaz, Alexandre Paim/AAD-8323-2019; Schwarzbold, Marcelo Liborio/J-8960-2014; Prediger, Rui D/C-4036-2013; Prediger, Rui Daniel/AAV-3419-2020; Hohl, Alexandre/R-9269-2019; Diaz, Alexandre Paim/J-9042-2014; Walz, Roger/K-9096-2013	Diaz, Alexandre Paim/0000-0002-6591-6648; Prediger, Rui D/0000-0002-7547-6463; Prediger, Rui Daniel/0000-0002-7547-6463; Hohl, Alexandre/0000-0002-8073-5837; Walz, Roger/0000-0002-9875-6687; Formolo, Douglas/0000-0003-1908-8658	Programa de Apoio a Nucleos de Excelencia PRONEX - FAPESC/CNPq (NENASC Project); CNPq (Brazilian Council for Scientific and Technologic Development, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESC (Foundation for Scientific Research and Technology of the State of Santa Catarina)	This work was supported by Programa de Apoio a Nucleos de Excelencia PRONEX - FAPESC/CNPq (NENASC Project), CNPq (Brazilian Council for Scientific and Technologic Development, Brazil), and FAPESC (Foundation for Scientific Research and Technology of the State of Santa Catarina).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bayen E., 2012, J HEAD TRAUMA REHABI, DOI 10. 1097/HTR. 0b013e31825413cf; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; Davis OSP, 2009, PSYCHOL SCI, V20, P1301, DOI 10.1111/j.1467-9280.2009.02433.x; Thais MERD, 2012, CNS NEUROSCI THER, V18, P606, DOI 10.1111/j.1755-5949.2012.00346.x; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fraser RT, 2000, TRAUMATIC BRAIN INJU; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; HOLM S, 1979, SCAND J STAT, V6, P65; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Novack TA, 2000, BRAIN INJURY, V14, P987; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Rey A., 1958, EXAMEN CLIN PSICHOLO; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van Hooren SAH, 2007, AGING NEUROPSYCHOL C, V14, P40, DOI 10.1080/138255890969483; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wechsler D., 2004, WAIS 3 MANUAL ADM AV; Wechsler D., 1997, WECHSLER MEMORY SCAL; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	55	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2014	8	1					125	139		10.1111/jnp.12000			15	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AA9YD	WOS:000331448100008	23167479				2022-02-06	
J	Wang, HE; Brown, SP; MacDonald, RD; Dowling, SK; Lin, S; Davis, D; Schreiber, MA; Powell, J; van Heest, R; Daya, M				Wang, Henry E.; Brown, Siobhan P.; MacDonald, Russell D.; Dowling, Shawn K.; Lin, Steve; Davis, Daniel; Schreiber, Martin A.; Powell, Judy; van Heest, Rardi; Daya, Mohamud			Association of out-of-hospital advanced airway management with outcomes after traumatic brain injury and hemorrhagic shock in the ROC hypertonic saline trial	EMERGENCY MEDICINE JOURNAL			English	Article							RAPID-SEQUENCE INTUBATION; SEVERE HEAD-INJURY; RANDOMIZED-CONTROLLED-TRIAL; ENDOTRACHEAL INTUBATION; RESUSCITATION; HYPERVENTILATION; HYPOXIA; IMPACT	Objective Prior studies suggest adverse associations between out-of-hospital advanced airway management (AAM) and patient outcomes after major trauma. This secondary analysis of data from the Resuscitation Outcomes Consortium Hypertonic Saline Trial evaluated associations between out-of-hospital AAM and outcomes in patients suffering isolated severe traumatic brain injury (TBI) or haemorrhagic shock. Methods This multicentre study included adults with severe TBI (GCS <= 8) or haemorrhagic shock (SBP <= 70 mm Hg, or (SBP 71-90 mm Hg and heart rate >= 108 bpm)). We compared patients receiving out-ofhospital AAM with those receiving emergency department AAM. We evaluated the associations between airway strategy and patient outcomes (28-day mortality, and 6-month poor neurologic or functional outcome) and airway strategy, adjusting for confounders. Analysis was stratified by (1) patients with isolated severe TBI and (2) patients with haemorrhagic shock with or without severe TBI. Results Of 2135 patients, we studied 1116 TBI and 528 shock; excluding 491 who died in the field, did not receive AAM or had missing data. In the shock cohort, out-of-hospital AAM was associated with increased 28-day mortality (adjusted OR 5.14; 95% CI 2.42 to 10.90). In TBI, out-of-hospital AAM showed a tendency towards increased 28-day mortality (adjusted OR 1.57; 95% CI 0.93 to 2.64) and 6-month poor functional outcome (1.63; 1.00 to 2.68), but these differences were not statistically significant. Out-of-hospital AAM was associated with poorer 6-month TBI neurologic outcome (1.80; 1.09 to 2.96). Conclusions Out-of-hospital AAM was associated with increased mortality after haemorrhagic shock. The adverse association between out-of-hospital AAM and injury outcome is most pronounced in patients with haemorrhagic shock.	[Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35249 USA; [Brown, Siobhan P.; Powell, Judy] Univ Washington, Dept Biostat, Clin Trials Ctr, Seattle, WA 98195 USA; [MacDonald, Russell D.] Ornge Transport Med, Mississauga, ON, Canada; [MacDonald, Russell D.; Lin, Steve] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [MacDonald, Russell D.; Lin, Steve] St Michaels Hosp, Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dowling, Shawn K.] Univ Calgary, Dept Emergency Med, Calgary, AB, Canada; [Davis, Daniel] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA; [van Heest, Rardi] Royal Columbian Hosp, Trauma Serv, Vancouver, BC, Canada; [Daya, Mohamud] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA		Wang, HE (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, 619 19th St South,OHB 251, Birmingham, AL 35249 USA.	hwang@uabmc.edu	Daya, Mohamud R/A-9322-2012; Lin, Steve/H-3723-2013	Lin, Steve/0000-0002-8644-9719; Brown, Siobhan/0000-0002-4774-3122; Dowling, Shawn/0000-0002-6378-7299	National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U01 HL077863, HL077866, HL077867, HL077871, HL077872, HL077873, HL077881, HL077885, HL077887, HL077908]; US Army Medical Research & Material Command, The Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada; Heart, Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; American Heart AssociationAmerican Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077863, U01HL077881, U01HL077908, U01HL077871, U01HL077885, U01HL077872, U01HL077887, U01HL077866, U01HL077873, U01HL077867] Funding Source: NIH RePORTER	The Resuscitation Outcomes Consortium (ROC) is supported by a series of cooperative agreements to nine regional clinical centres and one Data Coordinating Center (5U01 HL077863-University of Washington Data Coordinating Center, HL077866-Medical College of Wisconsin, HL077867-University of Washington, HL077871-University of Pittsburgh, HL077872-St. Michael's Hospital, HL077873-Oregon Health and Science University, HL077881-University of Alabama at Birmingham, HL077885-Ottawa Hospital Research Institute, HL077887-University of Texas SW Medical Center/Dallas, HL077908-University of California San Diego) from the National Heart, Lung and Blood Institute in partnership with the US Army Medical Research & Material Command, The Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, and the Heart, Stroke Foundation of Canada and the American Heart Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung and Blood Institute or the National Institutes of Health.	Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Brasel KJ, J AM COLL SURG; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Davis DP, 2007, RESUSCITATION, V73, P354, DOI 10.1016/j.resuscitation.2006.09.015; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Guyette F, 2011, J TRAUMA, V70, P782, DOI 10.1097/TA.0b013e318210f5c9; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Newgard CD, 2008, RESUSCITATION, V78, P170, DOI 10.1016/j.resuscitation.2008.01.029; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Rubin D.B., 2004, MULTIPLE IMPUTATION; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang HE, 2009, ANN EMERG MED, V54, P645, DOI 10.1016/j.annemergmed.2009.05.024; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	25	15	19	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	MAR	2014	31	3					186	U110		10.1136/emermed-2012-202101			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AD8RG	WOS:000333532700004	23353663	Green Accepted			2022-02-06	
J	Wang, Y; Arun, P; Wei, YL; Oguntayo, S; Gharavi, R; Valiyaveettil, M; Nambiar, MP; Long, JB				Wang, Ying; Arun, Peethambaran; Wei, Yanling; Oguntayo, Samuel; Gharavi, Robert; Valiyaveettil, Manojkumar; Nambiar, Madhusoodana P.; Long, Joseph B.			Repeated Blast Exposures Cause Brain DNA Fragmentation in Mice	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; blast-induced neurotrauma; cell-free DNA; DNA damage; mitochondria	ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; NEUROPROTECTIVE EFFICACY; SELECTIVE VULNERABILITY; AMINOPROPYL CARBAZOLES; GLIAL PROLIFERATION; CELL-PROLIFERATION; COGNITIVE RECOVERY; MOUSE MODEL	The pathophysiology of blast-induced traumatic brain injury (TBI) and subsequent behavioral deficits are not well understood. Unraveling the mechanisms of injury is critical to derive effective countermeasures against this form of neurotrauma. Preservation of the integrity of cellular DNA is crucial for the function and survival of cells. We evaluated the effect of repeated blast exposures on the integrity of brain DNA and tested the utility of cell-free DNA (CFD) in plasma as a biomarker for the diagnosis and prognosis of blast-induced polytrauma. The results revealed time-dependent breakdown in cellular DNA in different brain regions, with the maximum damage at 24 h post-blast exposures. CFD levels in plasma showed a significant transient increase, which was largely independent of the timing and severity of brain DNA damage; maximum levels were recorded at 2?h after repeated blast exposure and returned to baseline at 24?h. A positive correlation was observed between the righting reflex time and CFD level in plasma at 2?h after blast exposure. Brain DNA damage subsequent to repeated blast was associated with decreased mitochondrial membrane potential, increased release of cytochrome C, and up-regulation of caspase-3, all of which are indicative of cellular apoptosis. Shock-wave-induced DNA damage and initiation of mitochondrial-driven cellular apoptosis in the brain after repeated blast exposures indicate that therapeutic strategies directed toward inhibition of DNA damage or instigation of DNA repair may be effective countermeasures.	[Wang, Ying; Arun, Peethambaran; Wei, Yanling; Oguntayo, Samuel; Gharavi, Robert; Valiyaveettil, Manojkumar; Nambiar, Madhusoodana P.; Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA		Long, JB (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	ying.wangv@us.army.mil; joseph.long@us.army.mil					Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Atkins C.M., 2010, EUR J NEUROSCI, V28, P35; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Langlois J, 2005, TRAUMATIC BRAIN INJU; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	56	15	15	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					498	504		10.1089/NEU.2013.3074			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600248	24074345				2022-02-06	
J	Yaeger, K; Alhilali, L; Fakhran, S				Yaeger, Karl; Alhilali, Lea; Fakhran, Saeed			Evaluation of Tentorial Length and Angle in Sleep-Wake Disturbances After Mild Traumatic Brain Injury	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						melatonin; mild traumatic brain injury; pineal gland; sleep-wake disturbances; tentorium	HEAD INJURY; MELATONIN; PHASE; DISORDERS	OBJECTIVE. The purpose of this study was to determine if there is an association between tentorial length and angle and sleep-wake disturbances in patients with mild traumatic brain injury (TBI). MATERIALS AND METHODS. MRI examinations of the brain of 34 consecutive patients with mild TBI with sleep-wake disturbance and 30 patients with mild TBI without sleep-wake disturbance were retrospectively reviewed. The length of the tentorium on a sagittal T1-weighted image (tentorial length) and the angle formed between the tentorium and a line through the foramen magnum (tentorial angle) were measured. Results were correlated with both neuropsychologic testing and any sleep-wake disturbance. RESULTS. No significant difference existed between patients with and without sleep-wake disturbances in terms of age (p = 0.44), sex (p = 0.13), Immediate Post-Concussion Assessment Cognitive Test total symptom score (p = 0.10), verbal memory score (p = 0.32), visual memory score (p = 0.31), processing speed (p = 0.15), or reaction time (p = 0.84). Tentorial length in patients with mild TBI with sleep-wake disturbances was significantly longer than patients with mild TBI without sleep-wake disturbances (p < 0.01), and tentorial angle was significantly smaller (p < 0.01). Tentorial angle was inversely correlated with length of time to recovery (p = 0.002), and tentorial length was directly correlated with length of time to recovery (p < 0.001). CONCLUSION. Among patients with mild TBI with similar cognitive function and symptom severity, those with sleep-wake disturbances have significantly longer tentorial length with a flatter angle than do patients with mild TBI without sleep symptoms, with length of time to recovery being directly correlated with tentorial length and indirectly correlated with tentorial angle. Direct impact between the tentorium and the pineal gland during mild TBI may lead to pineal gland injury, disruption of melatonin homeostasis, and sleep-wake disturbances.	[Yaeger, Karl; Alhilali, Lea; Fakhran, Saeed] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA		Yaeger, K (corresponding author), Univ Pittsburgh, Med Ctr, Dept Radiol, 3950 Presby South Towers,200 Lothrop St, Pittsburgh, PA 15213 USA.	yaegerk@upmc.edu					Al-Adawi S, 2009, BRAIN INJURY, V23, P559, DOI 10.1080/02699050902970745; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Faul M, 2010, TRAUMATIC BRAIN INJU; Hardeland R, 2012, SCI WORLD J, DOI 10.1100/2012/640389; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; McBride G., 2005, HAM2005062 NIWA, V45, P307; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Moskala Marek, 2004, Neurol Neurochir Pol, V38, P401; Nagtegaal JE, 1997, FUNCT NEUROL, V12, P345; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; van de Water ATM, 2011, J SLEEP RES, V20, P183, DOI 10.1111/j.1365-2869.2009.00814.x; van Wieringen S, 2001, CLIN DRUG INVEST, V21, P813, DOI 10.2165/00044011-200121120-00003; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wichmann MW, 1996, J SURG RES, V63, P256, DOI 10.1006/jsre.1996.0257	24	15	16	0	2	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	MAR	2014	202	3					614	618		10.2214/AJR.13.11091			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AC4SK	WOS:000332510900038	24555599				2022-02-06	
J	Kit, KA; Mateer, CA; Tuokko, HA; Spencer-Rodgers, J				Kit, Karen A.; Mateer, Catherine A.; Tuokko, Holly A.; Spencer-Rodgers, Julie			Influence of Negative Stereotypes and Beliefs on Neuropsychological Test Performance in a Traumatic Brain Injury Population	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Self-efficacy; Head-injury; Stereotype threat; Performance anxiety; Testing environment; Neuropsychology	WOMENS MATH PERFORMANCE; MEMORY TEST-PERFORMANCE; VERBAL LEARNING TEST; MILD HEAD-INJURY; DIAGNOSIS THREAT; SUBSEQUENT PERFORMANCE; COGNITIVE PERFORMANCE; SELF-EFFICACY; PRIOR SUCCESS; EXPECTATION	The impact of stereotype threat and self-efficacy beliefs on neuropsychological test performance in a clinical traumatic brain injury (TBI) population was investigated. A total of 42 individuals with mild-to-moderate TBI and 42 (age-, gender-, educationally matched) healthy adults were recruited. The study consisted of a 2 (Type of injury: control, TBI) x 2 (Threat Condition: reduced threat, heightened threat) between-participants design. The purpose of the reduced threat condition was to reduce negative stereotyped beliefs regarding cognitive effects of TBI and to emphasize personal control over cognition. The heightened threat condition consisted of an opposing view. Main effects included greater anxiety, motivation, and dejection but reduced memory self-efficacy for head-injured-groups, compared to control groups. On neuropsychological testing, the TBI-heightened-threat-group displayed lower scores on Initial Encoding (initial recall) and trended toward displaying lower scores on Attention (working memory) compared to the TBI-reduced-threat-group. No effect was found for Delayed Recall measures. Memory self-efficacy mediated the relation between threat condition and neuropsychological performance, indicating a potential mechanism for the threat effect. The findings highlight the impact of stereotype threat and self-referent beliefs on neuropsychological test performance in a clinical TBI population. (JINS, 2013, 20, 1-11)	[Kit, Karen A.; Mateer, Catherine A.; Tuokko, Holly A.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Spencer-Rodgers, Julie] Calif Polytech State Univ San Luis Obispo, Dept Psychol & Child Dev, San Luis Obispo, CA 93407 USA		Kit, KA (corresponding author), Victoria Gen Hosp, 1 Hosp Way, Victoria, BC V8Z 6R5, Canada.	kkaren32@gmail.com			Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC)	This research was supported by a doctoral fellowship by the Social Sciences and Humanities Research Council of Canada. The authors have no conflict of interest affecting this manuscript.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; ARVEY RD, 1990, PERS PSYCHOL, V43, P695, DOI 10.1111/j.1744-6570.1990.tb00679.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Ben-Zeev T, 2005, J EXP SOC PSYCHOL, V41, P174, DOI 10.1016/j.jesp.2003.11.007; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; BREWIN CR, 1985, BRIT J SOC PSYCHOL, V24, P37, DOI 10.1111/j.2044-8309.1985.tb00658.x; Brown RP, 2003, J EXP SOC PSYCHOL, V39, P626, DOI 10.1016/S0022-1031(03)00039-8; Brown RP, 2006, J APPL PSYCHOL, V91, P979, DOI 10.1037/0021-9010.91.4.979; CAVANAUGH JC, 1990, AGING COGNITION MENT, P189, DOI DOI 10.1016/S0166-4115(08)60788-8; CAVANAUGH JC, 2000, COGNITIVE AGING PRIM, P115; Chasteen AL, 2005, EXP AGING RES, V31, P235, DOI 10.1080/03610730590948177; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cole JC, 2006, J PSYCHOPHARMACOL, V20, P518, DOI 10.1177/0269881105058572; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P585, DOI 10.1016/0191-8869(89)90043-3; Crowe S. F., 2008, STUDIES NEUROPSYCHOL, P282; Davidson, 1988, COGNITIVE DEV ADULTH, P65, DOI DOI 10.1007/978-1-4612-3852-2; Davis C, 2006, J BLACK PSYCHOL, V32, P399, DOI 10.1177/0095798406292464; Dellefield K. D., 1996, NURS RES, V43, P284; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Desrichard O, 2005, EUR J SOC PSYCHOL, V35, P537, DOI 10.1002/ejsp.249; DIXON RA, 1983, J GERONTOL, V38, P682, DOI 10.1093/geronj/38.6.682; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; DOUGLAS D, 1975, J EXP PSYCHOL HUMAN, V1, P411, DOI 10.1037/0096-1523.1.4.411; FEATHER NT, 1966, J PERS SOC PSYCHOL, V3, P287, DOI 10.1037/h0022965; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gaertner S.L., 1986, PREJUDICE DISCRIMINA, P127; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; Hertzog C., 1994, METACOGNITION KNOWIN, P227; Keller J, 2003, PERS SOC PSYCHOL B, V29, P371, DOI 10.1177/0146167202250218; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; LACHMAN ME, 1992, J GERONTOL, V47, pP293, DOI 10.1093/geronj/47.5.P293; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Marx DM, 2006, J PERS SOC PSYCHOL, V91, P243, DOI 10.1037/0022-3514.91.2.243; MATHERLY TA, 1986, J SOC BEHAV PERS, V1, P267; Mayer DM, 2003, HUM PERFORM, V16, P207, DOI 10.1207/S15327043HUP1603_3; Mikulincer M., 2001, J SOC PSYCHOL, V130, P739; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; PERRY RP, 1990, J EDUC PSYCHOL, V82, P262, DOI 10.1037/0022-0663.82.2.262; Ployhart RE, 2003, HUM PERFORM, V16, P231, DOI 10.1207/S15327043HUP1603_4; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P433, DOI 10.1016/S0887-6177(99)00038-4; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ross SR, 2003, ARCH CLIN NEUROPSYCH, V18, P905, DOI 10.1016/S0887-6177(02)00169-5; RYAN JJ, 1984, INT J CLIN NEUROPSYC, V6, P239; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Sobel ME., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI DOI 10.2307/270723; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stewart-Williams S, 2004, HEALTH PSYCHOL, V23, P198, DOI 10.1037/0278-6133.23.2.198; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiner B., 1986, HDB MOTIVATION COGNI, P281; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WILSON TD, 1985, J PERS SOC PSYCHOL, V49, P287, DOI 10.1037/0022-3514.49.1.287; [No title captured], DOI DOI 10.1080/09602019108520164	73	15	15	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2014	20	2					157	167		10.1017/S1355617713001264			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	AC3VG	WOS:000332448700005	24352047				2022-02-06	
J	Roquilly, A; Seguin, P; Mimoz, O; Feuillet, F; Rosenczweig, E; Chevalier, F; Loutrel, O; Malledant, Y; Sebille, V; Asehnoune, K				Roquilly, Antoine; Seguin, Philippe; Mimoz, Olivier; Feuillet, Fanny; Rosenczweig, Elise; Chevalier, Franck; Loutrel, Olivier; Malledant, Yannick; Sebille, Veronique; Asehnoune, Karim		ATLANREA Study Grp	Risk factors for prolonged duration of mechanical ventilation in acute traumatic tetraplegic patients-a retrospective cohort study	JOURNAL OF CRITICAL CARE			English	Article						Cervical spine injury/tetraplegia; Mechanical ventilation/complications; Pneumonia; Atelectasis; Neurological recovery	SPINAL-CORD-INJURY; RANDOMIZED CONTROLLED-TRIAL; RESPIRATORY COMPLICATIONS; TIDAL VOLUMES; ICU PATIENTS; PNEUMONIA; PREVENTION; MORTALITY; OUTCOMES; COSTS	Purpose: Respiratory complications constitute an important determinant of length of stay in tetraplegic patients. In a population of tetraplegic patients, we investigated the factors involved in the duration of mechanical ventilation (MV) and whether the duration of MV was associated with the long-term neurologic status. Material and Methods: In a retrospective study in 3 intensive care units (ICUs) (January 2001 to December 2009), consecutive patients (>= 18 years) hospitalized for acute (<= 24 hours) traumatic tetraplegia were included in the study. Patients with severe brain injury or who died in the first 48 hours were excluded. The primary outcome was the duration of MV. The secondary outcomes were the American Spinal Injury Association (ASIA) motor score on ICU discharge and at 1 year. Results: A total of 164 consecutive adult patients with tetraplegia were analyzed. Median (interquartile range) ASIA motor scores were 15 (6-26) on admission, 22 (9-40) on ICU discharge (n = 145 survivors), and 37 (10-80) at 1 year (n = 52 complete follow-up). The median duration of MV was 11 (2-26) days. In multivariate analysis, MV duration increased with pneumonia (P < .0001), atelectasis (P = .0042), and tracheotomy (P < .0001). In exploratory analysis, an increased duration of MV was the only factor associated in multivariate analysis with a low ASIA motor score on ICU discharge (P = .0201) and at 1 year (P = .0003). Conclusions: Prevention of pneumonia and atelectasis is critical for the reduction of MV in tetraplegic patients. Prolonged MV was independently associated with poor neurologic status. (C) 2014 Elsevier Inc. All rights reserved.	[Roquilly, Antoine; Loutrel, Olivier; Asehnoune, Karim] Univ Hosp Nantes, Hotel Dieu HME, Anesthesia & Crit Care Dept, Intens Care Unit, Nantes, France; [Roquilly, Antoine; Loutrel, Olivier; Asehnoune, Karim] UPRES EA 3826 Therapeut Clin & Expt Infect, Nantes, France; [Seguin, Philippe; Malledant, Yannick] Univ Hosp Rennes, Anesthesia & Crit Care Dept, Intens Care Unit, Rennes, France; [Seguin, Philippe; Malledant, Yannick] INSERM U991 Foie Metab & Canc, Rennes, France; [Mimoz, Olivier; Chevalier, Franck] Univ Hosp Poitiers, Anesthesia & Crit Care Dept, Intens Care Unit, Poitiers, France; [Mimoz, Olivier; Chevalier, Franck] INSERM U1070, Poitiers, France; [Feuillet, Fanny; Sebille, Veronique] Univ Nantes, CHU Nantes EA UFR Pharm 4275, Nantes, France; [Rosenczweig, Elise] Univ Hosp Nantes, Hotel Dieu HME, Med Intens Care Unit, Nantes, France		Asehnoune, K (corresponding author), CHU Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, F-44035 Nantes 01, France.	karim.asehnoune@chu-nantes.fr	Sebille, Veronique/I-3309-2015; Roquilly, Antoine/P-9826-2017; Seguin, Philippe/P-9487-2019; Sebille, Veronique/L-8761-2015; Feuillet, Fanny/L-9041-2015	Seguin, Philippe/0000-0002-7774-4257; Malledant, yannick/0000-0001-6680-5184; Sebille, Veronique/0000-0002-0780-7742; mimoz, olivier/0000-0003-1737-7915			[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; Cotton BA, 2005, J TRAUMA, V59, P1400, DOI 10.1097/01.ta.0000196005.49422.e6; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; ElMasry WS, 1996, SPINE, V21, P614, DOI 10.1097/00007632-199603010-00015; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Kallel H, 2005, J TRAUMA, V59, P705, DOI 10.1097/01.ta.0000177749.09844.c6; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; KONRAD F, 1994, CHEST, V105, P237, DOI 10.1378/chest.105.1.237; Manzano F, 2008, CRIT CARE MED, V36, P2225, DOI 10.1097/CCM.0b013e31817b8a92; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; MCMICHAN JC, 1980, JAMA-J AM MED ASSOC, V243, P528, DOI 10.1001/jama.243.6.528; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Peterson WP, 1999, SPINAL CORD, V37, P284, DOI 10.1038/sj.sc.3100818; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Ganuza JR, 2011, J SPINAL CORD MED, V34, P76, DOI 10.1179/107902610X12886261091875; Roquilly A, 2013, AM J RESP CRIT CARE, V188, P958, DOI 10.1164/rccm.201301-0116OC; Sacks GD, 2011, J TRAUMA, V71, P1668, DOI 10.1097/TA.0b013e31823246a5; Societe Francaise d'anesthesie reanimation, 2003, C EXP 2003; Staudinger T, 2010, CRIT CARE MED, V38, P486, DOI 10.1097/CCM.0b013e3181bc8218; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; van Middendorp JJ, 2011, LANCET, V377, P1004, DOI 10.1016/S0140-6736(10)62276-3; Winslow C, 2002, CHEST, V121, P1548, DOI 10.1378/chest.121.5.1548; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	30	15	18	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2014	29	2							313.e7	10.1016/j.jcrc.2013.11.021			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3IB	WOS:000332409400032	24412010				2022-02-06	
J	Salibi, PN; Agarwal, V; Panczykowski, DM; Puccio, AM; Sheetz, MA; Okonkwo, DO				Salibi, Patrick N.; Agarwal, Vikas; Panczykowski, David M.; Puccio, Ava M.; Sheetz, Michael A.; Okonkwo, David O.			Lifetime Attributable Risk of Cancer From CT Among Patients Surviving Severe Traumatic Brain Injury	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						cancer; CT; radiation; traumatic brain injury	LONG-TERM SURVIVAL; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE	OBJECTIVE. The purpose of this study was to determine the lifetime attributable risk of cancer from CT among patients surviving severe traumatic brain injury. MATERIALS AND METHODS. A retrospective cross-sectional study was conducted with prospectively collected data on patients 16 years old and older admitted with a Glasgow coma scale score of 8 or less to a single level 1 trauma center from 2007 to 2010. The effective dose of each CT examination the patients underwent was predicted with literature-accepted effective dose values of standard helical CT protocols. The lifetime attributable risk of cancer and related mortality incurred as a result of CT were estimated with the cumulative effective dose incurred from the time of injury to a 1-year follow-up evaluation and with the approach established by the Biologic Effects of Ionizing Radiation VII report. RESULTS. The average patient was a 34-year-old man. The median number of CT examinations received during the first 12 months after injury was 20, and the average cumulative effective dose was 87 +/- 45 mSv. This resulted in increases in the lifetime incidence of all cancer types from 45.5% to 46.3% and in the lifetime incidence of cancer-related mortality from 22.1% to 22.5%. CONCLUSION. Radiation exposure from the use of CT in the evaluation and management of severe traumatic brain injury causes negligible increases in lifetime attributable risk of cancer and cancer-related mortality. Treating physicians should not allow the concern for future risk of radiation-induced cancer to influence decisions regarding radiographic evaluation in the acute treatment of traumatic brain injury.	[Salibi, Patrick N.; Panczykowski, David M.; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Agarwal, Vikas; Sheetz, Michael A.] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA		Agarwal, V (corresponding author), Univ Pittsburgh, Med Ctr, Dept Radiol, 200 Lothrop St,Presby South Tower,8N, Pittsburgh, PA 15213 USA.	agarwalv@upmc.edu					Brown AW, 2004, NEUROREHABILITATION, V19, P37; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Faul M, 2010, TRAUMATIC BRAIN INJU; Laack TA, 2011, J TRAUMA, V70, P1362, DOI 10.1097/TA.0b013e3181e1707f; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Mnyusiwalla A, 2009, NEURORADIOLOGY, V51, P635, DOI 10.1007/s00234-009-0543-6; Monson RR, 2006, HEALTH RISKS FROM EX; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yamauchi-Kawara C, 2010, BRIT J RADIOL, V83, P1029, DOI 10.1259/bjr/52267127	16	15	15	0	4	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	FEB	2014	202	2					397	400		10.2214/AJR.12.10294			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	299ZN	WOS:000330434300034	24370078				2022-02-06	
J	Sumowski, JF; Coyne, J; Cohen, A; DeLuca, J				Sumowski, James F.; Coyne, Julia; Cohen, Amanda; DeLuca, John			Retrieval Practice Improves Memory in Survivors of Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain trauma; Memory; Rehabilitation; Traumatic brain injuries	REHABILITATION	Objective: To investigate whether retrieval practice (RP) improves delayed recall after short and long delays in survivors of severe traumatic brain injury (TBI) relative to massed restudy (MR) and spaced restudy (SR). Design: 3(learning condition: MR, SR, RP)x 2(delayed recall: 30min, 1wk) within-subject experiment. Setting: Nonprofit medical rehabilitation research center. Participants: Memory-impaired (<5th percentile) survivors of severe TBI (N=10). Intervention: During RP, patients are quizzed on to-be-learned information shortly after it is presented, such that patients practice retrieval. MR consists of repeated restudy (ie, cramming) SR consists of restudy trials separated in time (ie, distributed learning). Main Outcome Measures: Forty-eight verbal paired associates (VPAs) were equally divided across 3 learning conditions (16 per condition). Delayed recall for one half of the VPAs was assessed after 30 minutes (8 per condition) and for the other half after 1 week (8 per condition). Results: There was a large effect of learning condition after the short delay (P<.001, eta(2)=.72), with much better recall of VPAs studied through RP (46.3%) relative to MR (12.5%) and SR (15.0%). This large effect of learning condition remained after the long delay (P=.001, eta(2)=.56), as patients recalled 11.3% of the VPAs studied through RP, but nothing through MR (0.0%) and only 1.3% through SR. That is, RP was essentially the only learning condition to result in successful recall after 1 week, with most patients recalling at least 1 VPA. Conclusions: The robust effect of RP among TBI survivors with severe memory impairment engenders confidence that this strategy would work outside the laboratory to improve memory in real-life settings. Future randomized controlled trials of RP training are needed. (C) 2014 by the American Congress of Rehabilitation Medicine	[Sumowski, James F.; Coyne, Julia; Cohen, Amanda; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Sumowski, James F.; DeLuca, John] Rutgers, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Coyne, Julia] Childrens Specialized Hosp, Mountainside, NJ USA		Sumowski, JF (corresponding author), Kessler Fdn Res Ctr, 300 Execut Dr,Ste 70, W Orange, NJ 07052 USA.	jsumowski@kesserfoundation.org			Kessler Foundation; Children's Specialized Hospital	Supported by the Kessler Foundation and Children's Specialized Hospital.	Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schuett S, 2009, NAT REV NEUROL, V5, P427, DOI 10.1038/nrneurol.2009.97; Sumowski JF, 2013, MULT SCLER J, V19, P1943, DOI 10.1177/1352458513485980; Sumowski JF, 2010, J INT NEUROPSYCH SOC, V16, P1147, DOI 10.1017/S1355617710001128; Sumowski JF, 2010, NEUROPSYCHOLOGY, V24, P267, DOI 10.1037/a0017533; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	10	15	15	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2014	95	2					397	400		10.1016/j.apmr.2013.10.021			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AA2LW	WOS:000330927100026	24231401				2022-02-06	
J	Tobin, JM; Dutton, RP; Pittet, JF; Sharma, D				Tobin, Joshua M.; Dutton, Richard P.; Pittet, Jean-Francois; Sharma, Deepak			Hypotensive resuscitation in a head-injured multi-trauma patient	JOURNAL OF CRITICAL CARE			English	Article						Resuscitation; Trauma Care; Traumatic Brain Injury; Hypotension	DAMAGE CONTROL RESUSCITATION; BRAIN-INJURY; RISK-FACTORS; INTRAOPERATIVE HYPOTENSION; BLOOD-PRESSURE; FLUID RESUSCITATION; INTRAVENOUS FLUID; HEMORRHAGIC-SHOCK; MORTALITY; CRANIOTOMY	The concept of permissive hypotension is a controversial topic in trauma care. While driving blood pressure to "normal" levels with large volume crystalloid infusions is not appropriate, definitive data on the target blood pressure for hypotensive resuscitation are lacking. Indeed, the concept of systolic blood pressure as a marker for resuscitation is arguable. In this case presentation, a panel of experts in trauma resuscitation discusses the merits and limitations of hypotensive resuscitation in the context of a patient who has sustained multiple injuries, including a head injury. The controversies highlighted herein call attention to the role of the intensivist in managing a continuing resuscitation while coordinating the care of other physicians whose therapies can run at cross-purposes to one another. The challenges of the practice of critical care in the 21st century are no more apparent than in the care of a complex trauma patient. (C) 2014 Elsevier Inc. All rights reserved.	[Tobin, Joshua M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Crit Care, Los Angeles, CA 90095 USA; [Dutton, Richard P.] Univ Chicago, Dept Anesthesia & Crit Care, Amer Soc Anesthesiologists, Anesthesia Qual Inst, Chicago, IL 60637 USA; [Pittet, Jean-Francois] Univ Alabama Birmingham, Div Crit Care Anesthesiol, Birmingham, AL USA; [Sharma, Deepak] Univ Washington, Div Neuroanesthesiol & Perioperat Neurosci, Seattle, WA 98195 USA		Tobin, JM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Crit Care, Los Angeles, CA 90095 USA.	jmtobin@mednet.ucla.edu; r.dutton@asahq.org; pittetj@uab.edu; dsharma@uw.edu					BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brown JB, 2013, J TRAUMA ACUTE CARE, V74, P1207, DOI 10.1097/TA.0b013e31828c44fd; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; de Biasi AR, 2011, TRANSFUSION, V51, P1925, DOI 10.1111/j.1537-2995.2010.03050.x; Duke MD, 2012, J TRAUMA ACUTE CARE, V73, P674, DOI 10.1097/TA.0b013e318265ce1f; Dutton RP, 2012, BRIT J ANAESTH, V109, pI39, DOI 10.1093/bja/aes389; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Hampton DA, 2013, J TRAUMA ACUTE CARE, V75, pS9, DOI 10.1097/TA.0b013e318290cd52; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Hodgetts T J, 2007, J R Army Med Corps, V153, P299; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Kopelman TR, 2010, J TRAUMA, V68, P1294; Lim, 1974, J AM COLL EMERG PHYS, V69, P368, DOI 10.1016/S0361-1124(74)80005-5; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Novak L, 1999, J TRAUMA, V47, P834, DOI 10.1097/00005373-199911000-00003; Pecha T, 2011, ANESTH ANALG, V113, P336, DOI 10.1213/ANE.0b013e31821d3dde; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Seamon MJ, 2010, J TRAUMA, V68, P1289, DOI 10.1097/TA.0b013e3181db05dc; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; SHAFTAN GW, 1965, SURGERY, V58, P851; Sharma D, 2012, J NEUROSURG ANESTH, V24, P178, DOI 10.1097/ANA.0b013e318254fb70; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; SHATNEY CH, 1995, AM J SURG, V170, P676, DOI 10.1016/S0002-9610(99)80040-3; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Stephens CT, 2009, ANESTH ANALG, V109, P866, DOI 10.1213/ane.0b013e3181ad87b0; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	35	15	16	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2014	29	2							313.e1	10.1016/j.jcrc.2013.11.017			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3IB	WOS:000332409400031	24388660				2022-02-06	
J	Danila, O; Hirdes, JP; Maxwell, CJ; Marrie, RA; Patten, S; Pringsheim, T; Jette, N				Danila, Oana; Hirdes, John P.; Maxwell, Colleen J.; Marrie, Ruth Ann; Patten, Scott; Pringsheim, Tamara; Jette, Nathalie			Prevalence of neurological conditions across the continuum of care based on interRAI assessments	BMC HEALTH SERVICES RESEARCH			English	Article						Nursing homes; Home care; Psychiatry; Epidemiology; interRAI	MULTIPLE-SCLEROSIS; HUNTINGTONS-DISEASE; ELDERLY-PEOPLE; NURSING-HOMES; INFORMATION; POPULATION; EPILEPSY; RELIABILITY; DEPRESSION; DISORDERS	Background: Although multiple studies have estimated the prevalence of neurological conditions in the general Canadian population, limited research exists regarding the proportion affected with these conditions in non-acute health care settings in Canada. Data from standardized clinical assessments based on the interRAI suite of instruments were used to estimate the prevalence of eight neurological conditions across the continuum of care including Alzheimer's disease, Parkinson's disease, epilepsy, traumatic brain injury, multiple sclerosis, cerebral palsy, Huntington's disease, and amyotrophic lateral sclerosis. Methods: Cohorts of individuals receiving care in nursing homes (N = 103, 820), home care (N = 91, 021), complex continuing care (N = 10,581), and psychiatric hospitals (N = 23,119) in Canada were drawn based on their most recent interRAI assessment within each sector for a six-month period in 2010. These data were linked to the Discharge Abstract Database and National Ambulatory Care Reporting System data sets to develop five different case definition scenarios for estimating prevalence. Results: The conditions with the highest estimated prevalences in these care settings in Canada were Alzheimer's disease and related dementias, Parkinson's disease, epilepsy, and traumatic brain injury. However, there were notable cross-sector differences in the prevalence of each condition, and regional variations. Prevalence estimates based on acute hospital administrative data alone were substantially lower for all conditions evaluated. Conclusions: The proportion of persons with neurological conditions in non-acute health care settings in Canada is substantially higher than is generally reported for the general population. It is essential for these care settings to have the expertise and resources to respond effectively to the strengths, preferences, and needs of the growing population of persons with neurological conditions. The use of hospital or emergency department records alone is likely to substantially underestimate the true prevalence of neurological conditions across the continuum of care. However, interRAI assessment records provide a helpful source of information for obtaining these estimates in nursing home, home care, and mental health settings.	[Danila, Oana; Hirdes, John P.; Maxwell, Colleen J.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Maxwell, Colleen J.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada; [Marrie, Ruth Ann] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Marrie, Ruth Ann] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Patten, Scott; Pringsheim, Tamara] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Patten, Scott; Pringsheim, Tamara; Jette, Nathalie] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Patten, Scott] Univ Calgary, Mathison Ctr Res & Educ Mental Hlth, Calgary, AB, Canada; [Pringsheim, Tamara; Jette, Nathalie] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Pringsheim, Tamara] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Jette, Nathalie] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jette, Nathalie] Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada		Danila, O (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada.	omdanila@uwaterloo.ca	Pringsheim, Tamara/L-5955-2019; Patten, Scott/B-4434-2011	Pringsheim, Tamara/0000-0002-8229-8431; Patten, Scott/0000-0001-9871-4041; Marrie, Ruth Ann/0000-0002-1855-5595	Public Health Agency of Canada [6271-15-2010/3970773]; Alberta Innovates Health Solutions; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	This study is part of the National Population Health Study of Neurological Conditions. We wish to acknowledge the membership of the Neurological Health Charities of Canada and the Public Health Agency of Canada for their contribution to the success of this initiative. Funding for the study was provided by the Public Health Agency of Canada, Project #6271-15-2010/3970773. The opinions expressed in this publication are those of the authors/researchers, and do not necessarily reflect the official views of the Public Health Agency of Canada.; N Jette is the holder of a Canada Research Chair in Neuroscience Health Services Research and a Population Health Investigator Award from Alberta Innovates Health Solutions.; JP Hirdes holds the Ontario Home Care Research and Knowledge Exchange Chair funded by the Ontario Ministry of Health and Long Term Care.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Bernabei R, 2009, INT GERONTOLOGY HAZZ, P69; Bronskill Susan E, 2011, Healthc Q, V14, P21; Canadian Institute for Health Information, 2010, DATA QUALITY DOCUMEN; Canadian Institute for Health Information, 2010, ANALYSIS IN BRIEF CA; Canadian Institute for Health Information, 2001, THE CANADIAN ENHANCE; Canadian Institute for Health Information, 2007, THE BURDEN OF NEUROL; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Costa Andrew P, 2010, Healthc Policy, V6, P32; Evans C, 2013, NEUROEPIDEMIOLOGY, V40, P195, DOI 10.1159/000342779; Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0; Finlayson M., 2002, INT J MS CARE, V4, P139, DOI DOI 10.7224/1537-2073-4.3.139; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Gambassi G, 1998, MED CARE, V36, P167, DOI 10.1097/00005650-199802000-00006; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Gray LC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-71; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Health Council of Canada, 2012, SENIORS IN NEED CARE; Hirdes JP, 2006, AGE AGEING, V35, P329, DOI 10.1093/ageing/afl036; Hirdes JP, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-27; Hirdes JP, 2011, CAN J AGING, V30, P371, DOI 10.1017/S0714980811000304; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hirdes JP, 2002, J BEHAV HEALTH SER R, V29, P419, DOI 10.1007/BF02287348; Juurlink D, 2006, TECHNICAL REPORT; Knight T, 2012, PEDIATR NEUROL, V47, P77, DOI 10.1016/j.pediatrneurol.2012.05.002; Marrie RA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-16; Marrie RA, 2013, NEUROEPIDEMIOLOGY, V40, P85, DOI 10.1159/000343188; Martens PJ, 2007, CAN J PSYCHIAT, V52, P581, DOI 10.1177/070674370705200906; Matthews KL, 2002, BIOL PSYCHIAT, V51, P407, DOI 10.1016/S0006-3223(01)01235-5; Minden SL, 2004, NEUROREHABILITATION, V19, P55; MOGHAL S, 1995, NEUROEPIDEMIOLOGY, V14, P297, DOI 10.1159/000109805; Novak MJU, 2011, INT REV NEUROBIOL, V98, P297, DOI 10.1016/B978-0-12-381328-2.00013-4; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Perlman CM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-15; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Reid AY, 2012, EPILEPSY RES, V102, P173, DOI 10.1016/j.eplepsyres.2012.05.009; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Steeves TD, 2012, MOVEMENT DISORD, V27, P1789, DOI 10.1002/mds.25244; Stolp-Smith KA, 1998, NEUROLOGY, V50, P1594, DOI 10.1212/WNL.50.6.1594; Tellez-Zenteno JF, 2004, EPILEPSIA, V45, P1623, DOI 10.1111/j.0013-9580.2004.24904.x; Wodchis WP, 2008, MED CARE, V46, P882, DOI 10.1097/MLR.0b013e3181789471; Wolfson C, 2009, NEUROEPIDEMIOLOGY, V33, P79, DOI 10.1159/000222089; World Health Organization, 2006, NEUROLOGICAL DISORDE	43	15	15	0	20	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	JAN 22	2014	14								29	10.1186/1472-6963-14-29			14	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	AA5ZN	WOS:000331178600001	24447344	Green Published, gold			2022-02-06	
J	Stubberud, J; Langenbahn, D; Levine, B; Stanghelle, J; Schanke, AK				Stubberud, Jan; Langenbahn, Donna; Levine, Brian; Stanghelle, Johan; Schanke, Anne-Kristine			Goal Management Training improves everyday executive functioning for persons with spina bifida: Self-and informant reports six months post-training	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive functioning; Cognitive rehabilitation; Brain injury; Goal management; Evidence-based	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; YOUNG-ADULTS; COGNITIVE REHABILITATION; FRONTAL-LOBE; ECOLOGICAL VALIDITY; CLINICAL NEUROPSYCHOLOGY; DYSEXECUTIVE SYNDROME; STRATEGY APPLICATION; DIRECTED BEHAVIOR	Executive dysfunction accounts for significant disability for many patients with spina bifida (SB), thus indicating the need for effective interventions aimed at improving executive functioning in this population. Goal Management Training (GMT) is a cognitive rehabilitation approach that targets disorganised behaviour resulting from executive dysfunction, and has received empirical support in studies of other patient groups. The purpose of this study was to determine if GMT would lead to perceived improved executive functioning in the daily lives of patients with SB, as evidenced by reduced report of dysexecutive problems in daily life on self- and informant questionnaires. Thirty-eight adults with SB were included in this randomised controlled trial (RCT). Inclusion was based upon the presence of executive functioning complaints. Experimental subjects (n = 24) received 21 hours of GMT, with efficacy of GMT being compared to results of subjects in a wait-list condition (n = 14). All subjects were assessed at baseline, post-intervention, and at six-month follow-up. Self-report measures indicated that the GMT group's everyday executive functioning improved significantly after training, lasting at least 6 months post-treatment.There were no significant effects on informant-report questionnaires. Overall, these findings indicate that executive difficulties in everyday life can be ameliorated for individuals with congenital brain dysfunction.	[Stubberud, Jan; Stanghelle, Johan; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway; [Langenbahn, Donna] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY USA; [Levine, Brian] Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada; [Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med, Toronto, ON, Canada; [Stanghelle, Johan] Univ Oslo, Dept Med, Oslo, Norway; [Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway		Stubberud, J (corresponding author), Sunnaas Rehabil Hosp, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.	Jan.stubberud@sunnaas.no	Stubberud, Jan/ABE-6922-2021; Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Stubberud, Jan/0000-0001-9592-8589	South-Eastern Norway Regional Health Authority [2011041]	This work was supported by the South-Eastern Norway Regional Health Authority (grant number 2011041).	Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Barf HA, 2009, DISABIL REHABIL, V31, P921, DOI 10.1080/09638280802358282; Barf HA, 2010, J REHABIL MED, V42, P56, DOI 10.2340/16501977-0481; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROADBENT DE, 1986, BRIT J CLIN PSYCHOL, V25, P285, DOI 10.1111/j.2044-8260.1986.tb00708.x; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burgess PW., 2005, EFFECTIVENESS REHABI; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Charney Edward B., 1992, P471; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cohen J., 2013, STAT POWER ANAL BEHA; Conners CK, 2000, CONNERS CPT 2 CONTIN; Coull J. T., 1995, THESIS CAMBRIDGE U; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2006, J INT NEUROPSYCH SOC, V12, P285, DOI 10.1017/S1355617706060371; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Evans J, 2005, EFFECTIVENESS REHABI, P247; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P53, DOI 10.1080/87565649609540640; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Friedman D, 2009, REHABIL PSYCHOL, V54, P16, DOI 10.1037/a0014279; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Greene CM, 2009, NEUROPSYCHOLOGIA, V47, P591, DOI 10.1016/j.neuropsychologia.2008.10.003; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Heffelfinger AK, 2008, J INT NEUROPSYCH SOC, V14, P793, DOI 10.1017/S1355617708081022; Hetherington R, 2006, CHILD NERV SYST, V22, P117, DOI 10.1007/s00381-005-1231-4; Holmbeck GN, 2010, J CONSULT CLIN PSYCH, V78, P511, DOI 10.1037/a0019599; Iddon JL, 2004, J NEUROL NEUROSUR PS, V75, P1112, DOI 10.1136/jnnp.2003.029058; In de Braek D. M., 2012, J ATTENTION DISORDER, DOI 10.1177/1087054712468052; Jackson J., 2011, CRITICAL CARE MED, DOI 10.1097/CCM.0b013e3182373115; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kelly NC, 2012, CHILD NEUROPSYCHOL, V18, P417, DOI 10.1080/09297049.2011.613814; LANDRY SH, 1993, J PEDIATR PSYCHOL, V18, P389, DOI 10.1093/jpepsy/18.3.389; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Levaux M.N., 2012, CASE REPORTS PSYCHIA, V2012; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B., 2008, COGNITIVE NEUROREHAB, V2nd, P464, DOI [10.1017/CBO9781316529898.033, DOI 10.1017/CBO9781316529898.033]; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Mataro M, 2001, NEUROPSYCHOL REV, V11, P169, DOI 10.1023/A:1012904907249; Mathias JL, 2003, APPL NEUROPSYCHOL, V10, P57, DOI 10.1207/S15324826AN1002_01; McCambridge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039116; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Merckelbach H, 1999, PERS INDIV DIFFER, V26, P961, DOI 10.1016/S0191-8869(98)00193-7; Mesulam M.-M., 2002, HUMAN FRONTAL LOBES, P8; Metzler-Baddeley C, 2010, APPL NEUROPSYCHOL, V17, P299, DOI 10.1080/09084282.2010.523394; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Raz N, 2009, NEUROPSYCHOL REV, V19, P411, DOI 10.1007/s11065-009-9122-1; Robertson I., 1996, GOAL MANAGEMENT TRAI; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rose BM, 2007, J PEDIATR PSYCHOL, V32, P983, DOI 10.1093/jpepsy/jsm042; Roth RM, 2005, BRIEF A BEHAV RATING; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simblett SK, 2012, NEUROPSYCHOL REHABIL, V22, P874, DOI 10.1080/09602011.2012.703956; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Smith A, 1996, NATURE, V380, P291, DOI 10.1038/380291a0; SNOW JH, 1994, ARCH CLIN NEUROPSYCH, V9, P277, DOI 10.1016/0887-6177(94)90033-7; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stubberud J, 2012, DISABIL REHABIL, V34, P740, DOI 10.3109/09638288.2011.619617; Stuss DT, 2007, J INT NEUROPSYCH SOC, V13, P120, DOI 10.1017/S1355617707070154; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tarazi RA, 2008, CLIN NEUROPSYCHOL, V22, P585, DOI 10.1080/13854040701425940; TIPPER SP, 1987, PERS INDIV DIFFER, V8, P667, DOI 10.1016/0191-8869(87)90064-X; Tuminello ER, 2012, CHILD NEUROPSYCHOL, V18, P105, DOI 10.1080/09297049.2011.590470; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550; Vinck A, 2006, J NEUROL NEUROSUR PS, V77, P1083, DOI 10.1136/jnnp.2005.075887; Vogel A, 2004, DEMENT GERIATR COGN, V17, P181, DOI 10.1159/000076354; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; World Health Organization, 2007, INT CLASS FUNCT DIS; Worthington A. D., 2005, HDB CLIN NEUROPSYCHO; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012; Zukerman JM, 2011, J PEDIATR PSYCHOL, V36, P265, DOI 10.1093/jpepsy/jsq075	120	15	15	1	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2014	24	1					26	60		10.1080/09602011.2013.847847			35	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	295GJ	WOS:000330104300002	24168074				2022-02-06	
J	Broshek, DK; Samples, H; Beard, J; Goodkin, HP				Broshek, Donna K.; Samples, Hillary; Beard, Jennifer; Goodkin, Howard P.			Current Practices of the Child Neurologist in Managing Sports Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; mild traumatic brain injury; head trauma; return to play; sports	TRAUMATIC BRAIN-INJURY; EXERCISE; SYMPTOMS	Given the 2010 position statement issued by the American Academy of Neurology that neurologists be consulted on return-to-play decisions following a concussion, we surveyed members of the Child Neurology Society to asses clinical practice management of concussion among child neurologists. Among the 239 respondents, the majority continued to rely on the American Academy of Neurology's 1997 Practice Parameter to guide their decision-making process. Although the 2008 consensus statement from the Third International Conference on Concussion in Sport (Zurich Guidelines) is currently considered the most up-to-date guideline, few respondents relied exclusively on this guideline. More respondents who completed continuing medical education on concussion reported making clinical decisions based on the Zurich guidelines. The finding that child neurologists who completed continuing medical education had a greater familiarity with the more recently proposed consensus-based concussion guidelines supports the development of additional education in sports concussion at all levels of child neurology training.	[Broshek, Donna K.; Samples, Hillary; Beard, Jennifer] Univ Virginia Hlth Syst, Brain Injury & Sports Concuss Inst, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia Hlth Syst, Brain Injury & Sports Concuss Inst, Dept Neurol, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia Hlth Syst, Brain Injury & Sports Concuss Inst, Dept Pediat, Charlottesville, VA USA		Goodkin, HP (corresponding author), Univ Virginia, Dept Neurol, POB 800394, Charlottesville, VA 22908 USA.	hpg9v@virginia.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815; Goodkin, Howard/0000-0003-0528-4949			American Academy of Neurology, 2010, POS STAT SPORTS CONC; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Ferriero Donna M, 2010, Ann Neurol, V67, pA5, DOI 10.1002/ana.22047; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Goodkin HP, 2011, SEMIN PEDIATR NEUROL, V18, P142, DOI 10.1016/j.spen.2011.05.013; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Schwarz A, 2010, NY TIMES; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	18	15	15	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2014	29	1					17	22		10.1177/0883073812464525			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	282UY	WOS:000329200300002	23143716				2022-02-06	
J	Canto, AI; Chesire, DJ; Buckley, VA; Andrews, TW; Roehrig, AD				Canto, Angela; Chesire, David; Buckley, Valerie; Andrews, Terrie; Roehrig, Alysia			Barriers to meeting the needs of students with traumatic brain injury	EDUCATIONAL PSYCHOLOGY IN PRACTICE			English	Article						TBI; brain injury; systems; service delivery; psychology; education; school	RESPONSE RATES; SCHOOL; CHILDREN; TBI; COLLABORATION; INTERVENTIONS; RETURN; WEB	Many students with traumatic brain injury (TBI) are identified by the medical community each year and many more experience head injuries that are not examined by medical personnel. School psychologists and allied consultants have important liaison roles to identify and assist these students post-injury. In this study, 75 school psychologists (the profession in the United States analogous to educational psychologists in the UK) were surveyed about their experiences meeting the needs of students after brain injury and asked to characterise barriers to service delivery in the schools. Qualitative analysis of respondents' descriptions of barriers suggested that school psychologists encounter substantial problems in: communication about the injury; lack of knowledge and training among school personnel; lack of resources available to assist students; perceived lack of importance of TBI by school personnel; procedural impediments; and problematic placement options for students with TBI. Results of this study highlight the potential for improving systemic approaches to meeting the needs of students with TBI.	[Canto, Angela; Andrews, Terrie; Roehrig, Alysia] Florida State Univ, Educ Psychol & Learning Syst, Tallahassee, FL 32306 USA; [Chesire, David] Univ Florida, Dept Surg, Jacksonville, FL USA; [Buckley, Valerie] Duval Cty Publ Sch, Except Educ Student Serv, Jacksonville, FL USA; [Andrews, Terrie] Baptist Hlth, Jacksonville, FL USA		Canto, AI (corresponding author), Florida State Univ, Educ Psychol & Learning Syst, Tallahassee, FL 32306 USA.	acanto@fsu.edu	Roehrig, Alysia/O-2630-2019		Florida State University Council	This research was funded by a grant from the Florida State University Council on Research and Creativity First Year Assistant Professor grant programme. The authors would like to specifically acknowledge and thank the participating school psychologists.	Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Ball H, 2013, EDUC PSYCHOL PRACT, V29, P69, DOI 10.1080/02667363.2012.755460; Bradley-Klug KL, 2010, J APPL SCH PSYCHOL, V26, P263, DOI 10.1080/15377903.2010.518583; Brantlinger E, 2005, EXCEPT CHILDREN, V71, P195, DOI 10.1177/001440290507100205; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Chesire DJ, 2011, J APPL SCH PSYCHOL, V27, P60, DOI 10.1080/15377903.2011.540513; Conoley JC, 1996, J LEARN DISABIL-US, V29, P662, DOI 10.1177/002221949602900610; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; DAVIES SC, 2013, TRAINERS FORUM J TRA, V31, P5; Elliot P., 2006, NEUROSURGERY, V58, P263; Ewing-Cobbs L, 2004, HANDBOOK OF PEDIATRIC PSYCHOLOGY IN SCHOOL SETTINGS, P313; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gopinath S. P., 1992, CLIN TREATMENT BRAIN; Guba E. G., 1998, LANDSCAPE QUALITATIV, P195; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Havey M. J., 2002, BEST PRACTICES SCH P, VIV, P1433; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 1999, BRAIN INJURY, V13, P447; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Johnson R. L., 2010, STATE INJURY INDICA; Lewandowski LJ, 2009, J APPL SCH PSYCHOL, V25, P95, DOI 10.1080/15377900802484547; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mellard D. F., 2008, ENCY SCH PSYCHOL; ROSENTHAL SL, 1993, J EDUC PSYCHOL CONS, V4, P391, DOI DOI 10.1207/S1532768XJEPC0404_7; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Shaw S. R., 2008, BEST PRACTICES SCH P, P1707; Shaw S. R., 2002, BEST PRACTICES SCH P, VIV, P1473; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	37	15	15	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0266-7363	1469-5839		EDUC PSYCHOL PRACT	Educ. Psychol. Pract.		2014	30	1					88	103		10.1080/02667363.2014.883498			16	Psychology, Educational	Emerging Sources Citation Index (ESCI)	Psychology	V59SJ	WOS:000210782400008					2022-02-06	
J	Habbal, D; Gosseries, O; Noirhomme, Q; Renaux, J; Lesenfants, D; Bekinschtein, TA; Majerus, S; Laureys, S; Schnakers, C				Habbal, Dina; Gosseries, Olivia; Noirhomme, Quentin; Renaux, Jerome; Lesenfants, Damien; Bekinschtein, Tristan A.; Majerus, Steve; Laureys, Steven; Schnakers, Caroline			Volitional electromyographic responses in disorders of consciousness	BRAIN INJURY			English	Article						Brain injury; consciousness; electromyogram; minimally conscious state; unresponsive wakefulness syndrome; vegetative state	VEGETATIVE STATE; MOVEMENT; SPASTICITY; AWARENESS; ACCURACY; SERIES; COMA	Objective: The aim of the study was to validate the use of electromyography (EMG) for detecting responses to command in patients in vegetative state/unresponsive wakefulness syndrome (VS/UWS) or in minimally conscious state (MCS). Methods: Thirty-eight patients were included in the study (23 traumatic, 25 patients >1 year post-onset), 10 diagnosed as being in VS/UWS, eight in MCS- (no response to command) and 20 in MCS+ (response to command). Eighteen age-matched controls participated in the experiment. The paradigm consisted of three commands (i.e. 'Move your hands', 'Move your legs' and 'Clench your teeth') and one control sentence (i.e. 'It is a sunny day') presented in random order. Each auditory stimulus was repeated 4 times within one block with a stimulus-onset asynchrony of 30 seconds. Results: Post-hoc analyses with Bonferroni correction revealed that EMG activity was higher solely for the target command in one patient in permanent VS/UWS and in three patients in MCS+. Conclusion: The use of EMG could help clinicians to detect conscious patients who do not show any volitional response during standard behavioural assessments. However, further investigations should determine the sensitivity of EMG as compared to neuroimaging and electrophysiological assessments.	[Habbal, Dina; Gosseries, Olivia; Noirhomme, Quentin; Renaux, Jerome; Lesenfants, Damien; Laureys, Steven; Schnakers, Caroline] Univ & Univ Hosp Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Habbal, Dina; Gosseries, Olivia; Noirhomme, Quentin; Renaux, Jerome; Lesenfants, Damien; Laureys, Steven; Schnakers, Caroline] Univ & Univ Hosp Liege, Dept Neurol, Liege, Belgium; [Bekinschtein, Tristan A.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Majerus, Steve; Schnakers, Caroline] Univ Liege, Dept Psychol Cognit & Behaviour, Liege, Belgium; [Schnakers, Caroline] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Schnakers, Caroline] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA		Schnakers, C (corresponding author), Univ Calif Los Angeles, Dept Psychol & Neurosurg, Los Angeles, CA 90095 USA.	cschnakers@ucla.edu	Laureys, Steven/AAN-2097-2021; Gosseries, Olivia/AAB-6469-2020	Laureys, Steven/0000-0002-3096-3807; Gosseries, Olivia/0000-0001-9011-7496; Bekinschtein, Tristan/0000-0001-5501-8628; Majerus, Steve/0000-0002-8206-8097; Noirhomme, Quentin/0000-0001-8247-4493	Belgian National Funds for Scientific Research (FNRS)Fonds de la Recherche Scientifique - FNRS; Fonds Leon Fredericq; James S. McDonnell Foundation; Mind Science Foundation; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Concerted Research Action; Public Utility Foundation 'Universite Europeenne du Travail'; Fondazione Europea di Ricerca Biomedica; European Commission (FP7 DECODER)European Commission	This study was funded by the Belgian National Funds for Scientific Research (FNRS), Fonds Leon Fredericq, James S. McDonnell Foundation; Mind Science Foundation; European Commission; Concerted Research Action; Public Utility Foundation 'Universite Europeenne du Travail' and 'Fondazione Europea di Ricerca Biomedica'. This project has also been funded with the support of the European Commission (FP7 DECODER). This publication only reflects the view of the authors and the Commission cannot be held responsible for any use which may be made of the information contained therein. The authors report no conflicts of interest.	Bekinschtein TA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00005; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2011, J PERIPHER NERV SYST, V16, P315, DOI 10.1111/j.1529-8027.2011.00363.x; Bekinschtein TA, 2008, J NEUROL NEUROSUR PS, V79, P826, DOI 10.1136/jnnp.2007.132738; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; De Luca CJ, 2010, J BIOMECH, V43, P1573, DOI 10.1016/j.jbiomech.2010.01.027; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hugger S, 2012, Int J Comput Dent, V15, P297; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Leeb R, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025011; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Natale M, 2012, CLIN NEUROL NEUROSUR, V114, P321, DOI 10.1016/j.clineuro.2011.10.046; Nojd N, 2008, METHOD INFORM MED, V47, P192, DOI 10.3414/ME9109; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Vanhaudenhuyse A, 2012, COMA DISORDERS CONSC, P25; von Wild K, 2012, J Med Life, V5, P3	25	15	16	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	9			SI		1171	1179		10.3109/02699052.2014.920519			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZX	WOS:000340455700006	24911192	Green Submitted			2022-02-06	
J	Karol, RL				Karol, Robert L.			Team models in neurorehabilitation: Structure, function, and culture change	NEUROREHABILITATION			English	Article						Team models; rehabilitation teams; multidisciplinary; interdisciplinary; transdisciplinary; role release; scope of practice; culture change	TRAUMATIC BRAIN-INJURY; REHABILITATION TEAM; INTERDISCIPLINARY TEAM; COLLABORATION; HOSPITALS	INTRODUCTION: Neurorehabilitation requires a team effort. Over time the nature of teams has evolved from single discipline work through multi-disciplinary and inter-disciplinary teams to trans-disciplinary teams. However, there are inconsistencies in the literature and clinical practice as to the structure and function of these team models. Each model engenders advantages over its predecessor and unless the models are well understood clinicians may labor in a model that is less efficacious than the most transcendent model. OBJECTIVES: To define and examine the models of single discipline care, multi-disciplinary teams, inter-disciplinary teams, and trans-disciplinary teams and to review in depth trans-disciplinary teams as the most advanced team model. This paper will also consider professional roles and integration across disciplines as well as the crucial topics of staff selection, attendance in rounds and the nature of rounds, staff physical plant assignments, and leadership responsibilities. Leadership responsibilities that will be addressed include scope of practice and role release, peer pressure, and culture change issues. CONCLUSIONS: The trans-disciplinary model is the gold standard for teams in neurorehabilitation because they entail more integrated service delivery than do other teams. Trans-disciplinary teams also represent a more persons-centered approach. To initiate a trans-disciplinary model, team members must have excellent communication and shared decision making including persons with brain injury. Leadership must address staff selection, scope of practice and role-release. Otherwise, the model will fail due to peer pressure and institutional or program cultural variables.	[Karol, Robert L.] Welcov Healthcare, Minneapolis, MN USA; [Karol, Robert L.] Karol Neuropsychol Serv & Consulting, Minneapolis, MN USA		Karol, RL (corresponding author), 9637 Anderson Lakes Pkwy 162, Minneapolis, MN 55344 USA.	karolneuropsych@aol.com					American Board of Professional Psychology, 2013, REHABILITATION PSYCH; American Board of Professional Psychology/American Board of Rehabilitation Psychology, 2012, CERT GUID PROC CAND; American Physical Therapy Association Section on Pediatrics, 2010, FACT SHEET; American Speech-Language-Hearing Association, 2003, TECHNICAL REPORT; Association of Rehabilitation Nurses, 2014, STRIV EXC ACH CERT R; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bergquist TF, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P38; Butt L., 2010, HDB REHABILITATION P, V2nd ed., P451, DOI [10.1037/15972-032, DOI 10.1037/15972-032]; Cheak-Zamora N, 2012, OXFORD HDB REHABILIT, P511; Commission on Accreditation of Rehabilitation Facilities, 2013, MED REH STAND MAN; Goonan M, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P406; Gordon R. M., PAIN MANAGE IN PRESS; Ivanhoe CB, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P385; Karol R.L., 2004, BRAIN INJ ASS MINN C; Karol R.L., 2011, 5 ANN NAT BRAIN INJ; Karol R. L., 1986, M MINN SPEECH LANG H; Karol RL, 2003, NEUROPSYCHOSOCIAL IN; Katz DI, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P2; King G, 2009, INFANT YOUNG CHILD, V22, P211, DOI 10.1097/IYC.0b013e3181abe1c3; KNEAFSEY R, 2002, BRIT J THERAPY REHAB, V9, P24; Law B. M., 2013, MONITOR PSYCHOL, V44, P40; Malec JF, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1288; MCEWEN I, 2000, PROVIDING PHYS THERA; Niemeier J., 2011, OVERCOMING GRIEF LOS; Novack TA., 2010, HDB REHABILITATION P, P165; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P299; Ravesloot C., 2012, OXFORD HDB REHABILIT, P143; Sander AM, 2008, J HEAD TRAUMA REHAB, V23, P271, DOI 10.1097/01.HTR.0000336839.68585.0f; Savage TA, 2009, PM&R, V1, P1091, DOI 10.1016/j.pmrj.2009.09.017; Sinclair LB, 2009, ARCH PHYS MED REHAB, V90, P1196, DOI 10.1016/j.apmr.2009.01.021; Smithson E, 2012, OXFORD HDB REHABILIT, P128; Smits SJ, 2003, ARCH PHYS MED REHAB, V84, P1332, DOI 10.1016/S0003-9993(03)00197-7; Stevenson J. E., 2014, PROFESSIONAL FUNCTIO; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P179, DOI 10.1016/j.apmr.2007.06.774; STRASSER DC, 1994, ARCH PHYS MED REHAB, V75, P177; Strasser DC, 2002, J REHABIL RES DEV, V39, P115; Turner-Stokes L., 2011, MULTIDISCIPLINARY RE; Umphred D., 2001, NEUROLOGICAL REHABIL, V4, P56; Umphred D. A., 2001, NEUROLOGICAL REHABIL, P3; VASH CL, 2004, PSYCHOL DISABILITY; Warren A. M., 2014, PROFESSIONAL FUNCTIO; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Winkler P. A., 2001, NEUROLOGICAL REHABIL, P416; World Confederation for Physical Therapy, 2011, POL STAT; Wright BA., 1972, REHABIL PSYCHOL, V19, P38, DOI DOI 10.1037/H0090869; [No title captured]; [No title captured]	47	15	15	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	4					655	669		10.3233/NRE-141080			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AK5CY	WOS:000338443100007	24796442				2022-02-06	
J	Ling, H; Kara, E; Revesz, T; Lees, AJ; Plant, GT; Martino, D; Houlden, H; Hardy, J; Holton, JL				Ling, Helen; Kara, Eleanna; Revesz, Tamas; Lees, Andrew J.; Plant, Gordon T.; Martino, Davide; Houlden, Henry; Hardy, John; Holton, Janice L.			Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Boxer; Dementia pugilistica; Chronic traumatic encephalopathy; Progressive supranuclear palsy; Tauopathy	NINDS NEUROPATHOLOGIC CRITERIA; CORTICOBASAL DEGENERATION; ALZHEIMERS-DISEASE; BRAIN-INJURY; NEUROFIBRILLARY TANGLES; TDP-43 IMMUNOREACTIVITY; DEMENTIA-PUGILISTICA; DYSTROPHIC NEURITES; PARKINSONS-DISEASE; RISK-FACTORS	We report the case of a 75-year-old ex-professional boxer who developed diplopia and eye movement abnormalities in his 60's followed by memory impairment, low mood and recurrent falls. Examination shortly before death revealed hypomimia, dysarthria, vertical supranuclear gaze palsy and impaired postural reflexes. Pathological examination demonstrated 4-repeat tau neuronal and glial lesions, including tufted astrocytes, consistent with a diagnosis of progressive supranuclear palsy. In addition, neurofibrillary tangles composed of mixed 3-repeat and 4-repeat tau and astrocytic tangles in a distribution highly suggestive of chronic traumatic encephalopathy were observed together with limbic TDP-43 pathology. Possible mechanisms for the co-occurrence of these two tau pathologies are discussed.	[Ling, Helen; Revesz, Tamas; Lees, Andrew J.; Hardy, John; Holton, Janice L.] UCL, UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, Queen Sq Brain Bank Neurol Disorders, London, England; [Ling, Helen; Kara, Eleanna; Revesz, Tamas; Lees, Andrew J.; Houlden, Henry; Hardy, John; Holton, Janice L.] UCL, UCL Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England; [Ling, Helen; Revesz, Tamas; Lees, Andrew J.; Hardy, John; Holton, Janice L.] UCL, Sara Koe PSP Res Ctr, Neurol Inst, London, England; [Plant, Gordon T.; Holton, Janice L.] UCL, UCL Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England; [Martino, Davide] Queen Elizabeth Hosp Woolwich, South London NHS Trust, London, England; [Martino, Davide] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England; [Martino, Davide] Queen Mary Univ London, Ctr Neurosci & Trauma, Blizard Inst, London, England		Holton, JL (corresponding author), UCL, UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, Queen Sq Brain Bank Neurol Disorders, London, England.	Janice.holton@ucl.ac.uk	Ling, Helen/J-3751-2013; Holton, Janice L/F-6831-2011; Houlden, Henry/C-1532-2008; Lees, Andrew J/A-6605-2009; Hardy, John/C-2451-2009	Holton, Janice L/0000-0002-3882-5249; Houlden, Henry/0000-0002-2866-7777; Lees, Andrew J/0000-0002-2476-4385; Hardy, John/0000-0002-3122-0423; Kara, Eleanna/0000-0001-5428-6743	Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]; Department of Health's NIHR Biomedical Research CentresNational Institute for Health Research (NIHR); National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia based at University College London Hospitals (UCLH), University College London (UCL); CBD solutions; PSP (Europe) Association Research Grants; UCL Impact studentship; Parkinson's disease foundation; Alzheimer's Research UKAlzheimer's Research UK (ARUK); Parkinson's UKParkinson's UK; Multiple System Atrophy Trust; PSP Association, Weston Trust-The Reta Lila Howard Foundation; Reta Lila Weston Institute for Neurological Studies; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802760, G1001253, MC_G1000735, G108/638, MR/J004758/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_G1000735, G1001253, G0802760, MR/J004758/1, G108/638] Funding Source: researchfish	This work was supported by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee. This work was undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The research was partly supported by the National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia based at University College London Hospitals (UCLH), University College London (UCL). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Funds for open access were provided by the Wellcome Trust.; HL is supported by CBD solutions and PSP (Europe) Association Research Grants and is employed by Reta Lila Weston Institute, Institute of Neurology, University College London.; EK is supported by UCL Impact studentship and Parkinson's disease foundation grant.; TR is supported by research grants from Alzheimer's Research UK, Parkinson's UK and the Multiple System Atrophy Trust.; AJL is supported by research grants from the PSP Association, Weston Trust-The Reta Lila Howard Foundation.; JLH is supported by the Reta Lila Weston Institute for Neurological Studies and research grants from Alzheimer's Research UK, Parkinson's UK and the Multiple System Atrophy Trust.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dickson D., 2011, NEURODEGENERATION MO, V2nd Edn, P135; FOSTER JB, 1976, LANCET, V1, P981; Fujioka S, 2013, NEUROLOGY, V80, P2076, DOI 10.1212/WNL.0b013e318294b2eb; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Ghebranious N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni155; Golbe LI, 1996, NEUROLOGY, V47, P148, DOI 10.1212/WNL.47.1.148; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Hayesmoore JBG, 2009, NEUROBIOL AGING, V30, P1652, DOI 10.1016/j.neurobiolaging.2007.12.017; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; Ince PG, 2008, GREENFIELDS NEUROPAT, P889; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Jung HH, 2012, EUR NEUROL, V67, P142, DOI 10.1159/000334731; Kaat LD, 2009, NEUROLOGY, V73, P98, DOI 10.1212/WNL.0b013e3181a92bcc; Kara E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.006; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Ling H, 2014, NEUROPATH APPL NEURO, V40, P149, DOI 10.1111/nan.12037; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lolekha P, 2010, MOVEMENT DISORD, V25, P1895, DOI 10.1002/mds.23210; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Massey LA, 2012, MOVEMENT DISORD, V27, P1755, DOI 10.1002/mds.24968; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Millspaugh JA, 1937, US NAV MED B, V35, P297; Mok HY, 1851, NEUROBIOL AGING; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; MUNOZ DG, 1992, AM J PATHOL, V140, P1167; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schwab C, 1997, ACTA NEUROPATHOL, V94, P486, DOI 10.1007/s004010050737; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tuite PJ, 2005, ARCH NEUROL-CHICAGO, V62, P1453, DOI 10.1001/archneur.62.9.1453; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Williams DR, 2007, MOVEMENT DISORD, V22, P2235, DOI 10.1002/mds.21698; Williams DR, 2005, BRAIN, V128, P1247, DOI 10.1093/brain/awh488; Yokota O, 2010, ACTA NEUROPATHOL, V120, P55, DOI 10.1007/s00401-010-0702-1; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	59	15	16	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.		2014	2								24	10.1186/2051-5960-2-24			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V9K3A	WOS:000422389300024	24559032	Green Published, gold			2022-02-06	
S	Pekic, S; Popovic, V		Fliers, E; Korbonits, M; Romijn, JA		Pekic, Sandra; Popovic, Vera			Alternative causes of hypopituitarism: traumatic brain injury, cranial irradiation, and infections	CLINICAL NEUROENDOCRINOLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							GROWTH-HORMONE DEFICIENCY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY FUNCTION; GAMMA-KNIFE SURGERY; CENTRAL-NERVOUS-SYSTEM; LONG-TERM; POSTTRAUMATIC HYPOPITUITARISM; HIGH-RISK; HYPOTHALAMOPITUITARY DYSFUNCTION; NEUROENDOCRINE DYSFUNCTION		[Pekic, Sandra; Popovic, Vera] Univ Belgrade, Fac Med, Belgrade, Serbia; [Pekic, Sandra; Popovic, Vera] Univ Clin Ctr Belgrade, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia		Popovic, V (corresponding author), Clin Endocrinol, Dr Subotica 13, Belgrade 11000, Serbia.	popver@eunet.rs	Pekic, Sandra/S-7175-2016				ADEM A, 1989, BRAIN RES, V503, P299, DOI 10.1016/0006-8993(89)91678-8; Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; AGHA A, 2005, AM J MED, V118, pE4167; AHMED SR, 1986, ACTA PAEDIATR SCAND, V75, P255, DOI 10.1111/j.1651-2227.1986.tb10195.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Arunkumar MJ, 2001, NEUROL INDIA, V49, P407; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Beca SG, 2012, PITUITARY, V15, P10, DOI 10.1007/s11102-008-0133-3; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bhandare N, 2008, HEAD NECK-J SCI SPEC, V30, P1182, DOI 10.1002/hed.20847; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; BURMAN P, 1993, LANCET, V342, P1492, DOI 10.1016/0140-6736(93)92975-Y; Burman P, 1996, CLIN ENDOCRINOL, V44, P319, DOI 10.1046/j.1365-2265.1996.617439.x; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; CDC, 2010, TRAUM BRAIN INJ US; CHEN MS, 1989, JPN J CLIN ONCOL, V19, P265; CHIENG PU, 1991, AM J NEURORADIOL, V12, P661; Ciappetta P, 2008, NEUROSURG REV, V31, P237, DOI 10.1007/s10143-007-0096-2; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; CONSTINE LS, 1987, J CLIN ONCOL, V5, P1841, DOI 10.1200/JCO.1987.5.11.1841; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Dalan R, 2008, PITUITARY, V11, P299, DOI 10.1007/s11102-007-0057-3; DANIEL PM, 1959, LANCET, V2, P927; DANIEL PM, 1966, PITUITARY GLAND, V2, P519; Darzy Ken H, 2005, Pituitary, V8, P203, DOI 10.1007/s11102-006-6042-4; Darzy KH, 2007, J CLIN ENDOCR METAB, V92, P1666, DOI 10.1210/jc.2006-2599; Darzy KH, 2009, PITUITARY, V12, P40, DOI 10.1007/s11102-008-0088-4; Darzy KH, 2009, CLIN ENDOCRINOL, V70, P287, DOI 10.1111/j.1365-2265.2008.03359.x; Darzy KH, 2009, NAT CLIN PRACT ENDOC, V5, P88, DOI 10.1038/ncpendmet1051; Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; Darzy KH, 2003, HORM RES, V59, P1, DOI 10.1159/000067834; De Bellis Annamaria, 2005, Pituitary, V8, P25; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; Dhanwal DK, 2010, PITUITARY, V13, P304, DOI 10.1007/s11102-010-0234-7; EDWARDS OM, 1986, MEDICINE, V65, P281; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; ESCAMILLA RF, 1971, CALIF MED, V115, P72; Fernandez A, 2009, ENDOCR-RELAT CANCER, V16, P733, DOI 10.1677/ERC-08-0231; FORSLUND T, 1992, J INTERN MED, V232, P87, DOI 10.1111/j.1365-2796.1992.tb00555.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Hautala T, 2002, CLIN INFECT DIS, V35, P96, DOI 10.1086/340859; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Heyman P, 2007, Euro Surveill, V12, pE15; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Ho KKY, 2000, LANCET, V356, P1125, DOI 10.1016/S0140-6736(00)02748-3; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Husain N, 2008, PITUITARY, V11, P313, DOI 10.1007/s11102-007-0068-0; Inoue HK, 1999, STEREOT FUNCT NEUROS, V72, P125, DOI 10.1159/000056448; Iplikcioglu AC, 2004, ACTA NEUROCHIR, V146, P521, DOI 10.1007/s00701-004-0256-x; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Jagannathan J, 2008, NEUROSURGERY, V62, P1262, DOI 10.1227/01.neu.0000333297.41813.3d; JOHANSSON JO, 1995, NEUROENDOCRINOLOGY, V61, P57, DOI 10.1159/000126813; JORGENSEN EV, 1993, J PEDIATR ENDOCRINOL, V6, P131; Kahler O., 1886, Z HEILK, V7, P105; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kim NH, 2001, J KOREAN MED SCI, V16, P355, DOI 10.3346/jkms.2001.16.3.355; Klebanov Iu A, 1990, Klin Med (Mosk), V68, P64; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2009, EUR J ENDOCRINOL, V161, pS75, DOI 10.1530/EJE-09-0328; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; LAM KSL, 1991, Q J MED, V78, P165; LAM KSL, 1993, ANN INTERN MED, V118, P701, DOI 10.7326/0003-4819-118-9-199305010-00007; Lamberts SWJ, 1998, LANCET, V352, P127; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LEIPER AD, 1987, ARCH DIS CHILD, V62, P1107, DOI 10.1136/adc.62.11.1107; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Li H, 2008, NEUROL INDIA, V56, P186; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LIM TH, 1986, AM J NEURORADIOL, V7, P633; Lissett CA, 2001, J CLIN ENDOCR METAB, V86, P663, DOI 10.1210/jc.86.2.663; LITTLEY MD, 1989, Q J MED, V70, P145; Liu WK, 2010, J CLIN NEUROSCI, V17, P1587, DOI 10.1016/j.jocn.2010.03.040; Mahajan T, 2000, J CLIN ENDOCR METAB, V85, P1473, DOI 10.1210/jc.85.4.1473; MARANON G, 1917, NOUV ICONOGR SALPET, V28, P185; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; Medic-Stojanoska M, 2009, PEDIAT HELATH, V3, P1; Military Health System, 2011, DOD WORLDW NUMB TRAU; MILLIGAN SA, 1984, AM J MED, V77, P760, DOI 10.1016/0002-9343(84)90381-4; Minniti G, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/482861; Moses AM, 2003, J CLIN ENDOCR METAB, V88, P51, DOI 10.1210/jc.2002-020879; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200; Nyberg F, 1996, HORM RES, V45, P18, DOI 10.1159/000184753; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; OGILVYSTUART AL, 1994, J CLIN ENDOCR METAB, V78, P1282, DOI 10.1210/jc.78.6.1282; OGILVYSTUART AL, 1994, CLIN ENDOCRINOL, V41, P163, DOI 10.1111/j.1365-2265.1994.tb02525.x; Park JE, 1996, CLIN NEPHROL, V46, P141; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Pekic S, 2005, ENDOCRINE, V26, P79, DOI 10.1385/ENDO:26:2:079; Pekic S, 2010, LANCET, V375, P432, DOI 10.1016/S0140-6736(09)61835-3; Pepene CE, 2010, PITUITARY, V13, P385, DOI 10.1007/s11102-008-0150-2; Plocinski Przemyslaw, 2007, Wiad Parazytol, V53, P263; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic V, 2002, J CLIN ENDOCR METAB, V87, P2095, DOI 10.1210/jc.87.5.2095; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Roth C, 2001, NEUROSCI LETT, V297, P45, DOI 10.1016/S0304-3940(00)01663-3; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; SAMAAN NA, 1987, J LAB CLIN MED, V109, P364; SAMAAN NA, 1982, INT J RADIAT ONCOL, V8, P1857, DOI 10.1016/0360-3016(82)90442-4; Schaefer S, 2008, EUR J ENDOCRINOL, V158, P3, DOI 10.1530/EJE-07-0484; Scheinpflug K, 2006, EXP CLIN ENDOCR DIAB, V114, P31, DOI 10.1055/s-2005-873014; Schmiegelow M, 2000, CLIN ENDOCRINOL, V53, P191; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; SETTERGREN B, 1992, NEPHRON, V61, P234, DOI 10.1159/000186883; SHALET SM, 1976, CANCER, V37, P1144, DOI 10.1002/1097-0142(197602)37:2+<1144::AID-CNCR2820370824>3.0.CO;2-U; Shalet SM, 1997, J ROY SOC MED, V90, P192, DOI 10.1177/014107689709000404; SHALET SM, 1976, ARCH DIS CHILD, V51, P489, DOI 10.1136/adc.51.7.489; SHALET SM, 1977, ACTA ENDOCRINOL-COP, V84, P673, DOI 10.1530/acta.0.0840673; Sharma MC, 2000, CLIN NEUROL NEUROSUR, V102, P72, DOI 10.1016/S0303-8467(00)00063-9; Sicignano G, 2012, RADIOTHER ONCOL, V104, P119, DOI 10.1016/j.radonc.2012.03.021; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; Starke RM, 2012, J NEUROSURG, V117, P129, DOI 10.3171/2012.4.JNS112250; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Stojanovic M, 2008, J CLIN ENDOCR METAB, V93, P2722, DOI 10.1210/jc.2008-0311; SUH DC, 1995, AM J NEURORADIOL, V16, P175; Tanriverdi F, 2008, J ENDOCRINOL INVEST, V31, P489, DOI 10.1007/BF03346395; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Torres A M, 2000, Endocr Pract, V6, P26; Treip C S, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P178; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; VALTONEN M, 1995, SCAND J INFECT DIS, V27, P515, DOI 10.3109/00365549509047057; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436; van Nieuwpoort IC, 2008, EUR J ENDOCRINOL, V159, pS53, DOI 10.1530/EJE-08-0279; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Vates GE, 2001, J NEUROSURG, V95, P233, DOI 10.3171/jns.2001.95.2.0233; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; Wilkinson CW, 2012, FRONT NEUROL, V3, P1; Zhang X, 2002, J CLIN PATHOL, V55, P965, DOI 10.1136/jcp.55.12.965; Zhang XL, 2012, CLIN NEUROL NEUROSUR, V114, P957, DOI 10.1016/j.clineuro.2012.02.020	172	15	15	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-444-62612-7; 978-0-444-59602-4	HAND CLINIC			2014	124						271	290					20	Endocrinology & Metabolism; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Endocrinology & Metabolism; Neurosciences & Neurology	BC1FG	WOS:000350056900020	25248593				2022-02-06	
J	Possin, KL; LaMarre, AK; Wood, KA; Mungas, DM; Kramer, JH				Possin, Katherine L.; LaMarre, Amanda K.; Wood, Kristie A.; Mungas, Dan M.; Kramer, Joel H.			Ecological Validity and Neuroanatomical Correlates of the NIH EXAMINER Executive Composite Score	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article							TRAUMATIC BRAIN-INJURY; SYSTEMS BEHAVIOR SCALE; MULTIPLE-SCLEROSIS; FRONTOTEMPORAL DEMENTIA; COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; PREFRONTAL CORTEX; CLINICAL-RESEARCH; DECISION-MAKING; DYSFUNCTION		[Possin, Katherine L.; LaMarre, Amanda K.; Wood, Kristie A.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mungas, Dan M.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA		Possin, KL (corresponding author), 675 Nelson Rising Lane,Ste 190,MC 1207, San Francisco, CA 94158 USA.	kpossin@memory.ucsf.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [HHSN271200623661C]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG037566, P01AG019724, P50AG023501]; Hellman Family Foundation; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG010220, P30AG010129, P50AG023501, K23AG037566, P01AG019724] Funding Source: NIH RePORTER	This work was supported by NINDS (J.K., HHSN271200623661C); NIA (K.P., K23AG037566), (J.K., P01AG019724 and P50AG023501); and by the Hellman Family Foundation (K.P.). We thank Stephen Wilson, Ph.D., for his guidance on the voxel-based morphometry methods, and our research participants for their generous time and efforts. We have no conflicts of interest to report.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P920, DOI 10.1080/13803390801888733; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; Boyle PA, 2004, CLIN NEUROPSYCHOL, V18, P75, DOI 10.1080/13854040490507172; Brown PD, 2003, J CLIN ONCOL, V21, P2519, DOI 10.1200/JCO.2003.04.172; Caeyenberghs K, 2012, BRAIN STRUCTURE FUNC; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; Champod AS, 2010, J NEUROSCI, V30, P3849, DOI 10.1523/JNEUROSCI.0097-10.2010; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Correa DD, 2010, CURR NEUROL NEUROSCI, V10, P232, DOI 10.1007/s11910-010-0108-4; Cummings J. L., 2007, HUMAN FRONTAL LOBES, P12; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Hayes S, 2013, PHYSIOTHERAPY, V99, P165, DOI 10.1016/j.physio.2012.05.002; Hellmuth J, 2012, NEUROLOGY, V78, P1824, DOI 10.1212/WNL.0b013e318258f785; Kramer J. H., 2013, J INT NEUROPSYCHOLOG, V19; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Malloy P, 2007, ALZHEIMERS DEMENT, V3, P200, DOI 10.1016/j.jalz.2007.04.374; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Parmenter BA, 2007, J INT NEUROPSYCH SOC, V13, P417, DOI 10.1017/S1355617707070580; Peinemann A, 2005, J NEUROL SCI, V239, P11, DOI 10.1016/j.jns.2005.07.007; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Possin K. L., 2013, NEUROLOGY; Provost JS, 2010, EUR J NEUROSCI, V32, P873, DOI 10.1111/j.1460-9568.2010.07333.x; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Robinson H., 2013, J INT NEUROPSYCHOLOG, V19; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tomaszewski S, 2009, CLIN NEUROPSYCHOL, V23, P446, DOI 10.1080/13854040802360558; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Vercelletto M, 2011, J ALZHEIMERS DIS, V23, P749, DOI 10.3233/JAD-2010-101632; Whitwell J. L., 2012, EUROPEAN J NEUROLOGY, V20, P629; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590	58	15	15	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2014	20	1					20	28		10.1017/S1355617713000611			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	AC2VC	WOS:000332373400005	23764015	Green Accepted			2022-02-06	
S	Shin, SS; Pathak, S; Presson, N; Bird, W; Wagener, L; Schneider, W; Okonkwo, DO; Fernandez-Miranda, JC		Niranjan, A; Lunsford, LD		Shin, Samuel S.; Pathak, Sudhir; Presson, Nora; Bird, William; Wagener, Lauren; Schneider, Walter; Okonkwo, David O.; Fernandez-Miranda, Juan C.			Detection of White Matter Injury in Concussion Using High-Definition Fiber Tractography	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; TENSOR; IMPAIRMENT; MRI	Over the last few decades, structural imaging techniques of the human brain have undergone significant strides. High resolution provided by recent developments in magnetic resonance imaging (MRI) allows improved detection of injured regions in patients with moderate-to-severe traumatic brain injury (TBI). In addition, diffusion imaging techniques such as diffusion tensor imaging (DTI) has gained much interest recently due to its possible utility in detecting structural integrity of white matter pathways in mild TBI (mTBI) cases. However, the results from recent DTI studies in mTBI patients remain equivocal. Also, there are important shortcomings for DTI such as limited resolution in areas of multiple crossings and false tract formation. The detection of white matter damage in concussion remains challenging, and development of imaging biomarkers for mTBI is still in great need. In this chapter, we discuss our experience with high-definition fiber tracking (HDFT), a diffusion spectrum imaging-based technique. We also discuss ongoing developments and specific advantages HDFT may offer concussion patients. (C) 2014 S. Karger AG, Basel	[Shin, Samuel S.; Okonkwo, David O.; Fernandez-Miranda, Juan C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Pathak, Sudhir; Presson, Nora; Bird, William; Wagener, Lauren; Schneider, Walter] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA		Fernandez-Miranda, JC (corresponding author), UPMC Presbyterian, Dept Neurol Surg, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	fernandezmirandajc@upmc.edu					Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fernandez-Miranda JC, 2010, J NEUROSURG, V113, P990, DOI 10.3171/2009.10.JNS09933; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Kraus J, 1989, EPIDEMIOLOGY MILD HE; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Verstynen T, 2011, J NEUROPHYSIOL, V105, P336, DOI 10.1152/jn.00698.2010; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642	26	15	15	0	4	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						86	93		10.1159/000358767	10.1159/isbn.978-3-318-02649-8		8	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000009	24923395				2022-02-06	
J	Sigurdardottir, S; Andelic, N; Roe, C; Schanke, AK				Sigurdardottir, S.; Andelic, N.; Roe, C.; Schanke, A. K.			Identifying longitudinal trajectories of emotional distress symptoms 5 years after traumatic brain injury	BRAIN INJURY			English	Article						Coping; distress; post-traumatic stress disorder; resilience; trauma; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE ACCIDENTS; DEPRESSION SCALE; HOSPITAL ANXIETY; PSYCHOMETRIC PROPERTIES; LIFE SATISFACTION; BURN INJURY; HEAD-INJURY; DSM-IV; RESILIENCE	Primary objective: To evaluate longitudinal trajectories of emotional distress symptoms after traumatic brain injury (TBI). Research design: Longitudinal study. Methods and procedures: Patients with mild-to-severe TBI, 118 patients participated at 3 months, 109 attended at 1-year and 89 attended the 5-year follow-up. Emotional distress was measured with the Impact of Event Scale-Revised. Patients were also assessed for coping style, anxiety, depression, substance abuse and trauma severity. Main outcomes and results: Based on growth mixture modelling, four trajectories of emotional distress symptoms were identified: 73.5% of patients were characterized by a pattern of resilience, 6.8% by a pattern of delayed distress, 14.6% by recovery and 5.1% by chronic distress. Relative to the resilience trajectory, avoidant-coping style and psychiatric problems were related to recovery and chronic trajectories. The delayed trajectory was similar to the resilience trajectory, except for elevated depressive and anxiety symptoms at 1- and 5-years. Demographics and injury-related variables were not significantly associated with emotional distress trajectories. Conclusions: Resilience was the most common trajectory following TBI. Patients characterized by recovery and chronic trajectories required attention and long-term clinical monitoring of their symptoms. Future research would benefit from longitudinal studies to analyse emotional distress symptoms and the strength of resilience over time.	[Sigurdardottir, S.; Schanke, A. K.] Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway; [Sigurdardottir, S.; Andelic, N.] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Sigurdardottir, S.; Andelic, N.; Roe, C.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, C.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Schanke, A. K.] Univ Oslo, Dept Psychol, Fac Social Sci, Oslo, Norway		Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway.	solrun.sigurdardottir@medisin.uio.no		Andelic, Nada/0000-0002-3719-4406	South-Eastern Norway Regional Health Authority [2005-217]	The authors are grateful to all the persons for their participation. Thanks to Morten Hestnes and Nils Oddvar Skaga from the Oslo University Hospital's Trauma Registry, for the extraction of trauma scores. S. Sigurdardottir received grant support from the South-Eastern Norway Regional Health Authority (Ref: 2005-217).	Amstadter AB, 2013, SOC PSYCH PSYCH EPID, V48, P215, DOI 10.1007/s00127-012-0537-2; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL REV 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonanno GA, 2002, J PERS SOC PSYCHOL, V83, P1150, DOI 10.1037//0022-3514.83.5.1150; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2012, SOC SCI MED, V74, P753, DOI 10.1016/j.socscimed.2011.11.022; Brewin CR, 2009, J TRAUMA STRESS, V22, P366, DOI 10.1002/jts.20443; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Foa EB, 1997, J CLIN PSYCHIAT, V58, P25; Gill IJ, 2014, BRAIN INJURY, V28, P1, DOI 10.3109/02699052.2013.851416; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; JOSEPH S, 1992, PERS INDIV DIFFER, V13, P1249, DOI 10.1016/0191-8869(92)90262-N; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Quale AJ, 2009, INJURY, V40, P498, DOI 10.1016/j.injury.2008.11.006; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Ruff R, 2013, NEUROREHABILITATION, V32, P771, DOI 10.3233/NRE-130901; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sveen J, 2011, J TRAUMA, V71, P1808, DOI 10.1097/TA.0b013e31822a30b8; Sveen J, 2010, J ANXIETY DISORD, V24, P618, DOI 10.1016/j.janxdis.2010.03.021; Sveen J, 2010, J BURN CARE RES, V31, P310, DOI 10.1097/BCR.0b013e3181d0f523; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; TEASDALE G, 1974, LANCET, V2, P81; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Weiss Daniel S., 1997, P399; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	15	16	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1542	1550		10.3109/02699052.2014.934285			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700005	25029224				2022-02-06	
J	Stratton, KJ; Hawn, SE; Amstadter, AB; Cifu, DX; Walker, WC				Stratton, Kelcey J.; Hawn, Sage E.; Amstadter, Ananda B.; Cifu, David X.; Walker, William C.			Correlates of pain symptoms among Iraq and Afghanistan military personnel following combat-related blast exposure	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast exposure; combat; depression; military; OIF/OEF/OND; pain; polytrauma; posttraumatic stress disorder; trauma; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; HEALTH-CARE UTILIZATION; VETERANS; PREVALENCE; COMORBIDITY; DEPRESSION; PTSD; WAR; PERSPECTIVE	Pain complaints are highly prevalent among military servicemembers and Veterans of the recent combat operations in Iraq and Afghanistan. The high comorbidity of pain with conditions such as posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) underscores the importance of a greater understanding of factors associated with complex polytraumatic injuries among military personnel. The present study aimed to identify correlates of current pain among 201 U.S. military personnel who reported at least one blast experience during combat deployment (age [mean +/- standard deviation]: 27.20 +/- 7.58 yr). Theoretically derived subsets of variables were analyzed in successive hierarchical regression models to determine correlates of self-reported pain symptoms. Preliminary models evaluated demographic features, medical and injury characteristics (e.g., TBI classification), psychosocial history (e.g., trauma exposure), and psychiatric variables. A final model was then derived, in which older age, possible or probable mild TBI, depression symptoms, and PTSD re-experiencing symptoms emerged as significant correlates of pain. The findings further the understanding of polytrauma symptoms among military personnel by identifying specific patient characteristics and comorbidity patterns related to pain complaints. Increased awareness of demographic, psychiatric, or medical factors implicated in pain will enhance comprehensive clinical assessment and intervention efforts.	[Stratton, Kelcey J.; Cifu, David X.; Walker, William C.] Hunter Holmes McGuire Dept Vet Affairs Med Ctr, Richmond, VA USA; Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stratton, Kelcey J.; Hawn, Sage E.; Amstadter, Ananda B.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Cifu, David X.; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA		Stratton, KJ (corresponding author), Hunter Holmes McGuire VA Med Ctr, 1201 Broad Rock Blvd 116-B, Richmond, VA 23249 USA.	Kelcey.Stratton@va.gov		Cifu, David/0000-0003-1600-9387	VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Program [W191ZSQ8118N6200001]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02AA023239] Funding Source: NIH RePORTER	This material was based on work supported by the VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment (K. J. Stratton) and is based upon work supported in part by the Defense and Veterans Brain Injury Center and the U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Program (grant W191ZSQ8118N6200001, W. C. Walker).	ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; Asmundson GJG, 2004, EUR J PAIN, V8, P345, DOI 10.1016/j.ejpain.2003.10.008; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Burris JL, 2009, J OROFAC PAIN, V23, P243; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Department of Veterans Affairs Veterans Health Administration Office of Public Health, 2013, AN VA HLTH CAR UT OP; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Gatchel RJ, 2004, AM PSYCHOL, V59, P795, DOI 10.1037/0003-066X.59.8.795; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huska J.A., 1993, P 9 ANN M INT SOC TR; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Jakupcak M, 2006, J TRAUMA STRESS, V19, P471, DOI 10.1002/jts.20145; Keogh E, 2006, EUR J PAIN, V10, P413, DOI 10.1016/j.ejpain.2005.05.007; Kubany ES., 2004, TRAUMATIC LIFE EVENT; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Masten AS, 2012, ANNU REV PSYCHOL, V63, P227, DOI 10.1146/annurev-psych-120710-100356; MCFARLANE AC, 1994, J PSYCHOSOM RES, V38, P715, DOI 10.1016/0022-3999(94)90024-8; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Moeller-Bertram T, 2014, PSYCHOSOMATICS, V55, P172, DOI 10.1016/j.psym.2013.01.011; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Outcalt SD, 2014, PAIN MED, V15, P1872, DOI 10.1111/pme.12045; Palyo SA, 2005, PAIN, V117, P121, DOI 10.1016/j.pain.2005.05.028; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Sherman JJ, 2000, CLIN J PAIN, V16, P127, DOI 10.1097/00002508-200006000-00006; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Sledjeski EM, 2008, J BEHAV MED, V31, P341, DOI 10.1007/s10865-008-9158-3; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Ullrich PM, 2013, REHABIL PSYCHOL, V58, P158, DOI 10.1037/a0032047; Villano CL, 2007, J REHABIL RES DEV, V44, P167, DOI 10.1682/JRRD.2006.05.0052; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0	42	15	15	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	8					1189	1202		10.1682/JRRD.2014.04.0111			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CA2ZZ	WOS:000348776400003	25789376	Bronze, Green Accepted			2022-02-06	
J	Vikane, E; Hellstrom, T; Roe, C; Bautz-Holter, E; Assmus, J; Skouen, JS				Vikane, Eirik; Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik; Assmus, Jorg; Skouen, Jan Sture			Missing a follow-up after mild traumatic brain injury-Does it matter?	BRAIN INJURY			English	Article						Attendance or not to follow up; mild traumatic brain injury; return-to-work	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; TASK-FORCE; RANDOMIZED-TRIAL; RETURN; SEVERITY; WORK	Objective: This study sought to identify potential differing clinical characteristics between patients with a mild traumatic brain injury (MTBI) who attended a planned follow-up session and not. This study investigated whether clinical characteristics and attendance for a planned follow-up service 2-months after injury could be related to return-to-work (RTW) 1-year later. Method: Prospective cohort study of 343 patients with MTBI admitted consecutively to the Department of Neurosurgery in 2009-2011. Demographic and clinical data were obtained from the hospital files and data about sick leave from The Norwegian Labour and Welfare Service. Patients were categorized into two groups according to their attendance. Results: One hundred and sixty-one (67%) patients attended (AG) and 80 (33%) did not (NAG) attend their follow-up appointments. The AG had significantly more frequently intracranial pathology on CT scan, had consumed less alcohol and were older. Logistic regression showed that follow-up attendance (OR=16.89) and sick leave before injury (OR=9.70) are unfavourably related to RTW at 12-months. Skull fracture and cause of injury had no influence of the outcome. Conclusion: Not attending the follow-up has a favourable outcome after MBTI, indicating that these patients have a reduced need for medical and rehabilitation support for their brain injury.	[Vikane, Eirik; Skouen, Jan Sture] Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway; [Vikane, Eirik; Skouen, Jan Sture] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie; Bautz-Holter, Erik] Univ Oslo, Fac Med, Oslo, Norway; [Assmus, Jorg] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway		Vikane, E (corresponding author), Haukeland Hosp, Dept Phys Med & Rehabil, POB 1400, N-5021 Bergen, Norway.	eirik.vikane@gmail.com	Hellstrom, Torgeir/AAY-6043-2021; Hellstrom, Torgeir/AAW-4301-2021	Hellstrom, Torgeir/0000-0003-0831-3274; 	Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds	The first author Vikane has been financially supported in this project by the Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds. The authors alone are responsible for the content and writing of the paper.	Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Heskestad B, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-10; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Matsukawa H, 2013, BRAIN INJURY, V27, P1409, DOI 10.3109/02699052.2013.823655; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	34	15	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1374	1380		10.3109/02699052.2014.919532			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200003	24946256				2022-02-06	
J	Xing, GQ; Janis, C; Jiang, XL; Wen, JL; Jia, M; Li, H				Xing, Guoqiang; Carlton, Janis; Jiang, Xiaolong; Wen, Jillian; Jia, Min; Li, He			Differential expression of brain cannabinoid receptors between repeatedly stressed males and females may play a role in age and gender-related difference in traumatic brain injury: implications from animal studies	FRONTIERS IN NEUROLOGY			English	Article						stress; anxiety; brain cannabinoid receptors; sex dimoiphism; TBI outcome		Inconsistent gender differences in the outcome of TBI have been reported.The mechanism is unknown. In a recent male animal study, repeated stress followed by TBI had synergistic effects on brain gene expression and caused greater behavioral deficits. Because females are more likely to develop anxiety after stress and because anxiety is mediated by cannabinoid receptors (CBRs) (CB1 and CB2), there is a need to compare CB1 and CB2 expression in stressed males and females. CB1 and CB2 mRNA expression was determined in the amygdala, hippocampus, prefrontal cortex (PFC), and hypothalamus of adolescent male and female rats after 3 days of repeated tail-shock stress using qPCR. PFC CB1 and CB2 protein levels were determined using Western blot techniques. Both gender and stress had significant effects on brain CB1 mRNA expression levels. Overall, females showed significantly higher CB1 and CB2 mRNA levels in all brain regions than males (p < 0.01). Repeated stress reduced CB1 mRNA levels in the amygdala, hippocampus, and PFC (p < 0.01, each). A gender x stress interaction was found in CB1 mRNA level in the hippocampus (p < 0.05), hypothalamus (p < 0.01), and PFC (p < 0.01). Within-sex one-way ANOVA analysis showed decreased CB1 mRNA in the hippocampus, hypothalamus, and PFC of stressed females (p < 0.01, each) but increased CB1 mRNA levels in the hypothalamus of stressed males (p < 01). There was a gender and stress interaction in prefrontal CB1 receptor protein levels (p < 0.05), which were decreased in stressed females only (p < 0.05). Prefrontal CB2 protein levels were decreased in both male and female animals after repeated stress (p < 0.05, each). High basal levels of CBR expression in young naive females could protect against TBI damage whereas stress-induced CBR deficits could predict a poor outcome of TBI in repeatedly stressed females. Further animal studies could help evaluate this possibility.	[Xing, Guoqiang; Carlton, Janis; Jiang, Xiaolong; Wen, Jillian; Jia, Min; Li, He] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA		Xing, GQ (corresponding author), Johns Hopkins Univ MCC, 9601 Med Ctr Dr,Suite 227, Rockville, MD 20850 USA.	gxing99@yahoo.com; he.li@usuhs.edu	Xing, Guoqiang/ABA-8450-2020		Lotus Biotech.com; Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences	This work was supported, in part, by Lotus Biotech.com and the Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences. Daniel Xing proofread this manuscript.	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Alvares LD, 2008, NEUROBIOL LEARN MEM, V90, P1, DOI 10.1016/j.nlm.2008.01.009; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bolognini D, 2010, BRIT J PHARMACOL, V160, P677, DOI 10.1111/j.1476-5381.2010.00756.x; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Busch L, 2006, CLIN EXP PHARMACOL P, V33, P258, DOI 10.1111/j.1440-1681.2006.04355.x; Butkevich I, 2009, HORM BEHAV, V55, P149, DOI 10.1016/j.yhbeh.2008.09.008; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Cardenas VA, 2011, PSYCHIAT RES-NEUROIM, V193, P93, DOI 10.1016/j.pscychresns.2011.01.013; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CAUDELL KA, 1995, WESTERN J NURS RES, V17, P672, DOI 10.1177/019394599501700607; Chhatwal JP, 2005, NEUROPSYCHOPHARMACOL, V30, P516, DOI 10.1038/sj.npp.1300655; Choi K, 2012, J PSYCHIATR RES, V46, P882, DOI 10.1016/j.jpsychires.2012.03.021; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Craft RM, 2005, LIFE SCI, V77, P2471, DOI 10.1016/j.lfs.2005.04.019; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; DEFONSECA FR, 1994, LIFE SCI, V54, P159, DOI 10.1016/0024-3205(94)00585-0; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Fan F, 1996, BRAIN RES, V706, P13, DOI 10.1016/0006-8993(95)01113-7; Fattore L, 2010, BRIT J PHARMACOL, V160, P544, DOI 10.1111/j.1476-5381.2010.00776.x; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Felmingham K, 2009, NEUROREPORT, V20, P1402, DOI 10.1097/WNR.0b013e3283300fbc; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gonzalez S, 2000, BIOCHEM BIOPH RES CO, V270, P260, DOI 10.1006/bbrc.2000.2406; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gudsnuk KMA, 2011, CLIN PERINATOL, V38, P703, DOI 10.1016/j.clp.2011.08.005; Haller J, 2002, EUR J NEUROSCI, V16, P1395, DOI 10.1046/j.1460-9568.2002.02192.x; Hedges DW, 2010, COGN BEHAV NEUROL, V23, P124, DOI 10.1097/WNN.0b013e3181e1cbe1; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; HILL JO, 1986, J NUTR, V116, P2000, DOI 10.1093/jn/116.10.2000; Hill MN, 2008, HIPPOCAMPUS, V18, P221, DOI 10.1002/hipo.20386; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Jiang XL, 2009, NEUROPSYCHOPHARMACOL, V34, P410, DOI 10.1038/npp.2008.71; Jonsson CA, 2013, BRAIN INJURY, V27, P831, DOI 10.3109/02699052.2013.775493; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Karsten Carley A, 2013, Front Psychiatry, V4, P89, DOI 10.3389/fpsyt.2013.00089; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; Lee TTY, 2013, NEUROSCIENCE, V249, P106, DOI 10.1016/j.neuroscience.2012.11.017; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039025; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Malcher-Lopes R, 2006, J NEUROSCI, V26, P6643, DOI 10.1523/JNEUROSCI.5126-05.2006; Marchalant Y, 2009, NEUROBIOL DIS, V34, P300, DOI 10.1016/j.nbd.2009.01.014; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; Marumo K, 2009, NEUROSCI RES, V63, P89, DOI 10.1016/j.neures.2008.10.012; Mauler F, 2003, CNS DRUG REV, V9, P343; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McLaughlin C R, 1993, Brain Res Dev Brain Res, V76, P75; Meulders A, 2012, PAIN, V153, P1030, DOI 10.1016/j.pain.2012.02.005; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V281, pE1333, DOI 10.1152/ajpendo.2001.281.6.E1333; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Nong L, 2002, J NEUROIMMUNOL, V127, P169, DOI 10.1016/S0165-5728(02)00113-3; Onaivi ES, 1999, PROG NEURO-PSYCHOPH, V23, P1063, DOI 10.1016/S0278-5846(99)00052-4; OVIEDO A, 1993, BRAIN RES, V616, P293, DOI 10.1016/0006-8993(93)90220-H; Palazuelos J, 2012, J BIOL CHEM, V287, P1198, DOI 10.1074/jbc.M111.291294; Pamplona FA, 2008, NEUROBIOL LEARN MEM, V90, P290, DOI 10.1016/j.nlm.2008.04.003; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Pratchett LC, 2010, PSYCHIAT CLIN N AM, V33, P465, DOI 10.1016/j.psc.2010.01.010; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reich CG, 2009, BEHAV BRAIN RES, V203, P264, DOI 10.1016/j.bbr.2009.05.013; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Ribeiro R, 2013, PROSTAG OTH LIPID M, V100, P1, DOI 10.1016/j.prostaglandins.2012.11.003; Richard D, 2009, BEST PRACT RES CL EN, V23, P17, DOI 10.1016/j.beem.2008.10.007; Roche M, 2007, EUR J NEUROSCI, V26, P2643, DOI 10.1111/j.1460-9568.2007.05861.x; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Silvestri C, 2011, REV ENDOCR METAB DIS, V12, P153, DOI 10.1007/s11154-011-9167-3; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Tang SL, 2005, J NEUROPHYSIOL, V94, P2983, DOI 10.1152/jn.01187.2004; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Tishkina A O, 2009, Dokl Biol Sci, V428, P403; Uriguen L, 2004, NEUROPHARMACOLOGY, V46, P966, DOI 10.1016/j.neuropharm.2004.01.003; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vettor R, 2009, BEST PRACT RES CL EN, V23, P51, DOI 10.1016/j.beem.2008.10.002; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vlachos I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001104; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wainwright NWJ, 2002, J AFFECT DISORDERS, V72, P33, DOI 10.1016/S0165-0327(01)00420-7; Weber K, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-63; Westenbroek C, 2005, HORM BEHAV, V47, P620, DOI 10.1016/j.yhbeh.2005.01.004; Widom CS, 2008, CHILD ABUSE NEGLECT, V32, P785, DOI 10.1016/j.chiabu.2007.12.006; Woodward SH, 2009, ARCH GEN PSYCHIAT, V66, P1373, DOI 10.1001/archgenpsychiatry.2009.160; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Xing G, 2013, POSTTRAUMATIC STRESS, P83; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Xing GQ, 2011, NEUROSCI LETT, V502, P5, DOI 10.1016/j.neulet.2011.05.013; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	130	15	15	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								161	10.3389/fneur.2014.00161			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300153	25221540	gold, Green Published			2022-02-06	
J	Zupan, B; Babbage, D; Neumann, D; Willer, B				Zupan, Barbra; Babbage, Duncan; Neumann, Dawn; Willer, Barry			Recognition of facial and vocal affect following traumatic brain injury	BRAIN INJURY			English	Article						Affect; facial; intensity; vocal	EMOTION RECOGNITION; NONVERBAL-COMMUNICATION; DIFFERENT MEDIA; PERCEPTION; EXPRESSIONS; DEFICITS; IMPAIRMENT; PROSODY; VOICE; FACE	Objective: Studies of facial affect recognition by people with traumatic brain injury (TBI) have shown this to be a significant problem. Vocal affect recognition also appears to be challenging for this population, but little is known about the degree to which one modality is impaired compared to the other. This study compared facial and vocal affect recognition of high and low intensity emotion expressions in people with moderate-to-severe TBI. Methods: The Diagnostic Analysis of Nonverbal Accuracy-2 (Adult Faces; Voices) was administered to 203 participants with TBI. Results: Adults with TBI identified vocal emotion expressions with greater accuracy than facial emotion expressions. Facial affect recognition impairment was identified in 34% of participants, 22% were classified as having vocal affect recognition impairment and 15% showed impairment in both modalities. Participants were significantly less accurate at identifying low vs high intensity emotion expressions in both modalities. Happy facial expressions were significantly better identified than all other emotions. Errors were distributed across the emotion categories for vocal expressions. Conclusions: The degree of facial affect impairment was significantly greater than vocal affect impairment in this sample of people with moderate-to-severe TBI. Low intensity emotion expressions were particularly problematic and an advantage for positively valenced facial emotion expressions was indicated.	[Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Babbage, Duncan] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Ctr Person Centred Res, Auckland, New Zealand; [Neumann, Dawn] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA		Zupan, B (corresponding author), Brock Univ, Dept Appl Linguist, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	bzupan@brocku.ca		Babbage, Duncan/0000-0002-9259-9246; Barbra, Zupan/0000-0002-4603-333X	National Institute on Disability and Rehabilitation Research (NIDDR) [H133G080043]	This work was funded through the National Institute on Disability and Rehabilitation Research (NIDDR; Award #H133G080043).	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BOWERS D, 1987, NEUROPSYCHOLOGIA, V25, P317, DOI 10.1016/0028-3932(87)90021-2; Bowers D., 1998, FLORIDA AFFECT BATTE; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Duke M.P., 2008, MANUAL RECEPTIVE TES; Ekman P., 1976, PICTURES FACIAL AFFE; Elfenbein HA, 2002, EMO SOC BEH, P37; Guercio JM, 2004, BRAIN INJURY, V18, P593, DOI 10.1080/02699050310001646116; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Keltner D, 2000, HDB EMOTIONS, V2, P236; Knapp M.L., 2010, NONVERBAL COMMUNICAT; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; McDonald S., 2002, AWARENESS SOCIAL INF; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Neumann D, 2014, J HEAD TRAUMA REHABI; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; NOWICKI S, 1993, J SOC PSYCHOL, V133, P749, DOI 10.1080/00224545.1993.9713934; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pell MD, 1997, BRAIN LANG, V57, P80, DOI 10.1006/brln.1997.1638; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; WALLBOTT HG, 1986, J PERS SOC PSYCHOL, V51, P690, DOI 10.1037/0022-3514.51.4.690; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	47	15	15	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1087	1095		10.3109/02699052.2014.901560			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200010	24701988				2022-02-06	
J	Rossi, S; Bozzali, M; Bari, M; Mori, F; Studer, V; Motta, C; Buttari, F; Cercignani, M; Gravina, P; Mastrangelo, N; Castelli, M; Mancino, R; Nucci, C; Sottile, F; Bernardini, S; Maccarrone, M; Centonze, D				Rossi, Silvia; Bozzali, Marco; Bari, Monica; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Gravina, Paolo; Mastrangelo, Nicolina; Castelli, Maura; Mancino, Raffaele; Nucci, Carlo; Sottile, Fabrizio; Bernardini, Sergio; Maccarrone, Mauro; Centonze, Diego			Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OPTICAL COHERENCE TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; NERVE-FIBER LAYER; COGNITIVE IMPAIRMENT; ENDOCANNABINOID SYSTEM; CB2 RECEPTORS; DISEASE; ATROPHY; ABNORMALITIES	Genetic ablation of type-1 cannabinoid receptors (CB(1)Rs) exacerbates the neurodegenerative damage of experimental autoimmune encephalomyelitis, the rodent model of multiple sclerosis (MS). To address the role on CB(1)Rs in the pathophysiology of human MS, we first investigated the impact of AAT trinucleotide short tandem repeat polymorphism of CNR1 gene on CB1R cell expression, and secondly on the inflammatory neurodegeneration process responsible for irreversible disability in MS patients. We found that MS patients with long AAT repeats within the CNR1 gene (>= 12 in both alleles) had more pronounced neuronal degeneration in response to inflammatory white matter damage both in the optic nerve and in the cortex. Optical Coherence Tomography (OCT), in fact, showed more severe alterations of the retinal nerve fiber layer (RNFL) thickness and of the macular volume (MV) after an episode of optic neuritis in MS patients carrying the long AAT genotype of CNR1. MS patients with long AAT repeats also had magnetic resonance imaging (MRI) evidence of increased gray matter damage in response to inflammatory lesions of the white matter, especially in areas with a major role in cognition. In parallel, visual abilities evaluated at the low contrast acuity test, and cognitive performances were negatively influenced by the long AAT CNR1 genotype in our sample of MS patients. Our results demonstrate the biological relevance of the (AAT)(n) CNR1 repeats in the inflammatory neurodegenerative damage of MS.	[Rossi, Silvia; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Castelli, Maura; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy; [Rossi, Silvia; Bozzali, Marco; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Castelli, Maura; Maccarrone, Mauro; Centonze, Diego] Fdn Santa Lucia, CERC, Rome, Italy; [Bari, Monica; Mastrangelo, Nicolina] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Chirurg, Rome, Italy; [Cercignani, Mara] Univ Sussex, Clin Imaging Sci Ctr, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Gravina, Paolo; Bernardini, Sergio] Policlin Tor Vergata, Dipartimento Med Lab, Rome, Italy; [Mancino, Raffaele; Nucci, Carlo] Univ Roma Tor Vergata, Dipartimento Biopatol, Clin Oculist, Rome, Italy; [Sottile, Fabrizio] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Bernardini, Sergio] Univ Roma Tor Vergata, Dipartimento Med Interna, Rome, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Sch Med, Ctr Integrated Res, Rome, Italy		Centonze, D (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy.	centonze@uniroma2.it	Centonze, Diego/J-7767-2016; Maccarrone, Mauro/K-5398-2012; Bozzali, Marco/AAC-1031-2022; Motta, Caterina/L-1513-2018	Centonze, Diego/0000-0002-8390-8545; Maccarrone, Mauro/0000-0002-3990-2963; Rossi, Silvia/0000-0003-3257-8248; Bozzali, Marco/0000-0002-0568-2026; Mori, Francesco/0000-0002-4761-6174; Cercignani, Mara/0000-0002-4550-2456; studer, valeria/0000-0003-2529-7640	Fondazione Italiana Sclerosi Multipla (FISM Special Project); Italian National Ministero dell'Universita	This investigation was supported by Fondazione Italiana Sclerosi Multipla (FISM Special Project to DC), and by the Italian National Ministero dell'Universita to DC and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar N, 2010, CAN J NEUROL SCI, V37, P608, DOI 10.1017/S0317167100010775; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2006, J NEUROL, V253, P1054, DOI 10.1007/s00415-006-0161-8; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Arevalo-Martin A, 2012, NEUROPHARMACOLOGY, V63, P385, DOI 10.1016/j.neuropharm.2012.04.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Catani MV, 2010, CURR NEUROVASC RES, V7, P311; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Fine EM, 2009, J CLIN EXP NEUROPSYC, V31, P624, DOI 10.1080/13803390802419017; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Forn C, 2007, HUM BRAIN MAPP, V28, P424, DOI 10.1002/hbm.20284; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Horakova D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-10; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Huey ED, 2009, NEUROLOGY, V72, P453, DOI 10.1212/01.wnl.0000341781.39164.26; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2009, CURR TOP BEHAV NEURO, V1, P65, DOI 10.1007/978-3-540-88955-7_3; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanz M, 2007, J NEUROL, V254, P43, DOI 10.1007/s00415-007-2011-8; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lidster K, 2012, CNS NEUROL DISORD-DR, V11, P518, DOI 10.2174/187152712801661185; Lou ZY, 2012, J NEUROSCI RES, V90, P84, DOI 10.1002/jnr.22721; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Patti F, 2009, MULT SCLER, V15, P779, DOI 10.1177/1352458509105544; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Ramil E, 2010, MULT SCLER J, V16, P139, DOI 10.1177/1352458509355071; Rao S., 1990, MANUAL BRIEF REPEATA; Reguero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026167; Rossi S, 2012, J NEUROSCI, V32, P13896, DOI 10.1523/JNEUROSCI.1515-12.2012; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P1242, DOI 10.1016/j.bbi.2011.03.017; Rossi S, 2011, MULT SCLER J, V17, P281, DOI 10.1177/1352458510388680; Rypma B, 2005, CORTEX, V41, P582, DOI 10.1016/S0010-9452(08)70198-9; Saito VM, 2012, CURR NEUROPHARMACOL, V10, P159, DOI 10.2174/157015912800604515; Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560	58	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82848	10.1371/journal.pone.0082848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	WOS:000329325200020	24391723	Green Published, Green Accepted, gold			2022-02-06	
J	Issar, NM; Hedera, P; Phibbs, FT; Konrad, PE; Neimat, JS				Issar, Neil M.; Hedera, Peter; Phibbs, Fenna T.; Konrad, Peter E.; Neimat, Joseph S.			Treating post-traumatic tremor with deep brain stimulation: Report of five cases	PARKINSONISM & RELATED DISORDERS			English	Article						Tremor; Post-traumatic; Deep brain stimulation; Ventral intermediate nucleus; Globus pallidus internus	HEAD-INJURY; THALAMIC-STIMULATION; STEREOTAXIC SURGERY; SEGMENTAL DYSTONIA; RUBRAL TREMOR	Background: Post-traumatic tremor is one of the most common movement disorders resulting from severe head trauma. However, literature regarding successful deep brain stimulation (DBS) treatment is scarce, resulting in ambiguity regarding the optimal lead location. Most cases support the ventral intermediate nucleus, but there is evidence to defend DBS of the zona incerta, ventral oralis anterior/posterior, and/or a combination of these targets. We report five patients with disabling post-traumatic tremor treated with DBS of the ventral intermediate nucleus and of the globus pallidus internus. Methods: Patients were referred to the Vanderbilt Movement Disorders Division, and surgical intervention was determined by a DBS Multidisciplinary Committee. Standard DBS procedure was followed. Results: Patients 1-4 sustained severe diffuse axonal injuries. Patients 1-3 underwent unilateral ventral intermediate nucleus DBS for contralateral tremor, while Patient 4 underwent bilateral ventral intermediate nucleus DBS. Patients 1-3 experienced good tremor reduction, while Patient 4 experienced moderate tremor reduction with some dystonic posturing of the hands. Patient 5 had dystonic posturing of the right upper extremity with tremor of the left upper extremity. He was treated with bilateral DBS of the globus pallidus internus and showed good tremor reduction at follow-up. Conclusion: Unilateral or bilateral DBS of the ventral intermediate nucleus and bilateral DBS of the globus pallidus internus may be effective and safe treatment modalities for intractable post-traumatic tremor. Further studies are needed to clarify the optimal target for surgical treatment of post-traumatic tremor. Published by Elsevier Ltd.	[Issar, Neil M.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Hedera, Peter; Phibbs, Fenna T.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Konrad, Peter E.; Neimat, Joseph S.] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN 37232 USA		Neimat, JS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN 37232 USA.	jneimat@gmail.com		Konrad, Peter/0000-0003-4223-0819			ANDREW J, 1982, J NEUROL NEUROSUR PS, V45, P815, DOI 10.1136/jnnp.45.9.815; ANDY OJ, 1983, APPL NEUROPHYSIOL, V46, P107; Broggi G, 2006, ACTA NEUROCHIR SUPPL, V99, P13, DOI 10.1007/978-3-211-35205-2_2; BROGGI G, 1993, MOVEMENT DISORD, V8, P206, DOI 10.1002/mds.870080217; Capelle HH, 2009, NEUROMODULATION, V12, P8, DOI 10.1111/j.1525-1403.2009.00183.x; ELLISON PH, 1978, NEUROLOGY, V28, P197, DOI 10.1212/WNL.28.2.197; Fahn S, 1988, PARKINSONS DIS MOVEM, P225; Foote KD, 2006, NEUROSURGERY, V58, P280, DOI 10.1227/01.NEU.0000192692.95455.FD; Foote KD, 2005, NEUROSURGERY, V56, P415, DOI 10.1227/01.NEU.0000147978.67424.42; Franzini A, 2011, J NEURAL TRANSM, V118, P1497, DOI 10.1007/s00702-011-0656-z; Green A, 2005, ACNR, V5, P38; HARMON R L, 1991, Brain Injury, V5, P213, DOI 10.3109/02699059109008092; HASSLER R, 1960, BRAIN, V83, P337, DOI 10.1093/brain/83.2.337; Hooper J, 2001, BRIT J NEUROSURG, V15, P435, DOI 10.1080/02688690120082468; Jacob PC, 1998, MOVEMENT DISORD, V13, P977, DOI 10.1002/mds.870130622; Koller W, 1997, ANN NEUROL, V42, P292, DOI 10.1002/ana.410420304; Koller WC, 2001, MOVEMENT DISORD, V16, P464, DOI 10.1002/mds.1089; Krauss JK, 2004, J CLIN NEUROPHYSIOL, V21, P18, DOI 10.1097/00004691-200401000-00004; KRAUSS JK, 1994, J NEUROSURG, V80, P810, DOI 10.3171/jns.1994.80.5.0810; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Louis ED, 2001, MOVEMENT DISORD, V16, P89, DOI 10.1002/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L; Lyons KE, 2008, NEUROTHERAPEUTICS, V5, P331, DOI 10.1016/j.nurt.2008.01.004; NGUYEN JP, 1993, ARCH NEUROL-CHICAGO, V50, P498, DOI 10.1001/archneur.1993.00540050050014; Oyama G, 2011, PARKINSONISM RELAT D, V17, P451, DOI 10.1016/j.parkreldis.2011.03.009; Raina GB, 2007, CLIN NEUROPHARMACOL, V30, P95, DOI 10.1097/01.WNF.0000240957.56939.E6; REMY P, 1995, NEUROLOGY, V45, P472, DOI 10.1212/WNL.45.3.472; Romito M, 2007, NEUROLOGY, V68, P875, DOI 10.1212/01.wnl.0000256816.83036.c9; SAMIE MR, 1990, NEUROLOGY, V40, P62, DOI 10.1212/WNL.40.1.62; Sun B, 2007, ACTA NEUROCHIR SUPPL, V97, P207; Umemura A, 2004, CLIN NEUROL NEUROSUR, V106, P280, DOI 10.1016/j.clineuro.2003.12.004; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Woehrle JC, 2009, STEREOT FUNCT NEUROS, V87, P379, DOI 10.1159/000249819	33	15	15	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	DEC	2013	19	12					1100	1105		10.1016/j.parkreldis.2013.07.022			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	295AV	WOS:000330089900006	23953511				2022-02-06	
J	Kumban, W; Amatachaya, S; Emasithi, A; Siritaratiwat, W				Kumban, Wannisa; Amatachaya, Sugalya; Emasithi, Alongkot; Siritaratiwat, Wantana			Effects of task-specific training on functional ability in children with mild to moderate cerebral palsy	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Cerebral palsy; five times sit-to-stand test; functional reach test; motor assessment scale; pediatric balance scale; task-specific training	RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; STAND PERFORMANCE; 5-TIMES-SIT-TO-STAND TEST; CONCURRENT VALIDITY; OLDER-PEOPLE; SIT; BALANCE; RELIABILITY; STRENGTH	Objective: To examine the relationship between Five times sit-to-stand Test (FTSST) and functional tests and investigate the effects of task-specific training on functional ability in children with mild to moderate cerebral palsy (CP). Methods: Twenty-one subjects were randomly assigned to experimental and control groups. Motor Assessment Scale (MAS: sit-to-stand), Pediatric Balance Scale (PBS), Functional Reach Test and FTSST were tested before training, after training and at follow-up at 6 weeks post training. Results: FTSST correlated significantly with MAS (rho = -0.733) and with PBS (rho = -0.813) in all children with CP. There were no significant differences in all outcomes between groups. However, FTSST and MAS in children with Gross Motor Function Classification System-Expanded and Revised levels I-II were significantly different between pre and post training within the experimental group (p = 0.03). Conclusions: FTSST is a reliable and valid functional outcome measure after the task-specific training in children with mild to moderate CP.	[Kumban, Wannisa; Amatachaya, Sugalya; Siritaratiwat, Wantana] Khon Kaen Univ, Improvement Phys Performance & Qual Life IPQ Res, Back Neck & Other Joint Pain Res Grp, Fac Associated Med Sci,Sch Phys Therapy, Khon Kaen 40002, Thailand; [Emasithi, Alongkot] Khon Kaen Univ, Fac Associated Med Sci, Sch Phys Therapy, Khon Kaen 40002, Thailand		Siritaratiwat, W (corresponding author), Khon Kaen Univ, Improvement Phys Performance & Qual Life IPQ Res, Back Neck & Other Joint Pain Res Grp, Fac Associated Med Sci,Sch Phys Therapy, Khon Kaen 40002, Thailand.	wantana@kku.ac.th	Amatachaya, Assoc. Prof. Sugalya/AAY-9500-2021	Amatachaya, Assoc. Prof. Sugalya/0000-0002-8125-5982	Postgraduate School, Faculty of Associated Medical Sciences, the Improvement of Physical Performance and Quality of Life (IPQ) research groups and Back, Neck and Other Joint Pain Research group, Khon Kaen University, Thailand	This study was partially supported by the Postgraduate School, Faculty of Associated Medical Sciences, the Improvement of Physical Performance and Quality of Life (IPQ) research groups and Back, Neck and Other Joint Pain Research group, Khon Kaen University, Thailand.	Bartlett Doreen, 2003, Pediatr Phys Ther, V15, P84, DOI 10.1097/01.PEP.0000067885.63909.5C; Blundell SW, 2003, CLIN REHABIL, V17, P48, DOI 10.1191/0269215503cr584oa; Canning CG, 2003, CLIN REHABIL, V17, P355, DOI 10.1191/0269215503cr620oa; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Dodd KJ, 2003, DEV MED CHILD NEUROL, V45, P652, DOI 10.1017/S0012162203001221; Donahoe B, 1994, PEDIAT PHYSICAL THER, V6, P189, DOI DOI 10.1097/00001577-199400640-00004; dos Santos AN, 2011, RES DEV DISABIL, V32, P2243, DOI 10.1016/j.ridd.2011.05.001; Franjoine Mary Rose, 2003, Pediatr Phys Ther, V15, P114, DOI 10.1097/01.PEP.0000068117.48023.18; Gan SM, 2008, NEUROREHAB NEURAL RE, V22, P745, DOI 10.1177/1545968308316474; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Kumban W, 2013, NEUROREHABILITATION, V32, P9, DOI 10.3233/NRE-130818; Liao HF, 2007, ARCH PHYS MED REHAB, V88, P25, DOI 10.1016/j.apmr.2006.10.006; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Lowes LP, 1996, PEDIATR PHYS THER, V8, P176; Meretta BM, 2006, J VESTIBUL RES-EQUIL, V16, P233; Mong YQ, 2010, ARCH PHYS MED REHAB, V91, P407, DOI 10.1016/j.apmr.2009.10.030; Munro BH, 2005, STAT METHODS HLTH CA, V5th; Palisano RJ., 2007, GMFCS E R GROSS MOTO; Park ES, 2003, GAIT POSTURE, V17, P43, DOI 10.1016/S0966-6362(02)00055-3; Ricken AXC, 2005, MOTOR CONTROL, V9, P357, DOI 10.1123/mcj.9.4.357; Salem Y, 2009, NEUROREHABILITATION, V24, P307, DOI 10.3233/NRE-2009-0483; Schmidt R, 2005, MOTOR CONTROL LEARNI, V4th; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; Wang TH, 2012, CLIN REHABIL, V26, P664, DOI 10.1177/0269215511426889; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034	25	15	15	1	19	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	DEC	2013	16	6					410	417		10.3109/17518423.2013.772672			8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	256OG	WOS:000327322600006	23477366				2022-02-06	
J	Liegeois, FJ; Mahony, K; Connelly, A; Pigdon, L; Tournier, JD; Morgan, AT				Liegeois, Frederique J.; Mahony, Kate; Connelly, Alan; Pigdon, Lauren; Tournier, Jacques-Donald; Morgan, Angela T.			Pediatric traumatic brain injury: Language outcomes and their relationship to the arcuate fasciculus	BRAIN AND LANGUAGE			English	Article						Pediatric brain injury; Expressive language; Dysarthria; Tractography; Arcuate fasciculus	UNCINATE FASCICULUS; AXONAL INJURY; HEAD-INJURY; DIFFUSION; TRACTOGRAPHY; RECOVERY; SPEECH; LATERALIZATION; PREDICTORS; PATHWAYS	Pediatric traumatic brain injury (TBI) may result in long-lasting language impairments alongside dysarthria, a motor-speech disorder. Whether this co-morbidity is due to the functional links between speech and language networks, or to widespread damage affecting both motor and language tracts, remains unknown. Here we investigated language function and diffusion metrics (using diffusion-weighted tractography) within the arcuate fasciculus, the uncinate fasciculus, and the corpus callosum in 32 young people after TBI (approximately half with dysarthria) and age-matched healthy controls (n = 17). Only participants with dysarthria showed impairments in language, affecting sentence formulation and semantic association. In the whole TBI group, sentence formulation was best predicted by combined corpus callosum and left arcuate volumes, suggesting this "dual blow" seriously reduces the potential for functional reorganisation. Word comprehension was predicted by fractional anisotropy in the right arcuate. The co-morbidity between dysarthria and language deficits therefore seems to be the consequence of multiple tract damage. (C) 2013 Elsevier Inc. All rights reserved.	[Liegeois, Frederique J.] UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London WC1N 1EH, England; [Mahony, Kate] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Connelly, Alan; Tournier, Jacques-Donald] Florey Neurosci Inst, Brain Res Inst, Melbourne, Vic, Australia; [Pigdon, Lauren; Morgan, Angela T.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Morgan, Angela T.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia		Liegeois, FJ (corresponding author), UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, 30 Guilford St, London WC1N 1EH, England.	f.liegeois@ucl.ac.uk	Connelly, Alan/A-9065-2013; Morgan, Angela/J-5235-2017	Connelly, Alan/0000-0001-7159-8079; Liegeois, Frederique/0000-0002-8640-6217; Morgan, Angela/0000-0003-1147-7405	Transport Accident Commission [D131]; Victorian neurotrauma initiative; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [607315, 1023043]	This study was supported by Grant D131 from the Transport Accident Commission: Victorian neurotrauma initiative, awarded to A.T.M., F.J.L., A.C., and J-D.T.; and National Health and Medical Research Council Grants nos. 607315 and 1023043 awarded to A.T.M.	Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M., 2011, CORTEX J DEVOTED STU; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Duffau H, 2009, J NEUROL, V256, P382, DOI 10.1007/s00415-009-0053-9; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Feldman H. M., 2008, DEV BEHAV PEDIAT, P467; Fletcher PT, 2010, NEUROIMAGE, V51, P1117, DOI 10.1016/j.neuroimage.2010.01.083; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020726; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Jones DK, 2012, NEUROIMAGE; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Josse G, 2008, J NEUROSCI, V28, P14132, DOI 10.1523/JNEUROSCI.4383-08.2008; Kim JN, 2006, NEUROREPORT, V17, P1279, DOI 10.1097/01.wnr.0000230516.86090.67; Kim SH, 2011, NEUROREHABILITATION, V29, P305, DOI 10.3233/NRE-2011-0706; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Lebel C, 2009, HUM BRAIN MAPP, V30, P3563, DOI 10.1002/hbm.20779; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Liegeois F, 2013, NEUROLOGY, V80, P926, DOI 10.1212/WNL.0b013e3182840c6d; Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; Northam GB, 2012, BRAIN, V135, P3781, DOI 10.1093/brain/aws276; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Prescher A., 2011, BRAIN LANGUAGE; Saporta ASD, 2011, PEDIATR NEUROL, V44, P270, DOI 10.1016/j.pediatrneurol.2010.11.006; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Semel E., 2006, CLIN EVALUATION LANG; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Trivedi R, 2009, PEDIATR RES, V66, P636, DOI 10.1203/PDR.0b013e3181bbc6b5; Verhoeven J. S., 2011, CEREBRAL CORTEX NEW; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Weiller C, 2011, BRAIN LANG, V118, P29, DOI 10.1016/j.bandl.2011.01.005; Wilson BJ, 2011, PEDIATR NEUROL, V44, P350, DOI 10.1016/j.pediatrneurol.2010.12.002; Wilson SM, 2012, BRAIN LANG, V122, P190, DOI 10.1016/j.bandl.2012.04.005; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061	75	15	15	3	29	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	DEC	2013	127	3					388	398		10.1016/j.bandl.2013.05.003			11	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	261PM	WOS:000327677100011	23756046	Green Published, hybrid			2022-02-06	
J	Vrkljan, BH; Myers, AM; Crizzle, AM; Blanchard, RA; Marshall, SC				Vrkljan, Brenda H.; Myers, Anita M.; Crizzle, Alexander M.; Blanchard, Robin A.; Marshall, Shawn C.			Evaluating medically at-risk drivers: A survey of assessment practices in Canada	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Assessment; Automobile driving; Automobiles; Clinical protocols; Safety	DRIVING CESSATION; OLDER DRIVER; ADULTS	Background. Assessing medical fitness to drive (FTD) can include both off-and on-road testing, although consistency of practice is unclear. Purpose. To examine actual practices being used to assess FTD at driver assessment centres (DACs) across Canada. Method. Surveys e-mailed to 90 DACs were returned by 47 assessors. Findings. The majority of respondents (89%) were occupational therapists. Assessors reported doing an average of eight FTD assessments per month (range = 1 to 40) at an average cost of $366 (SD = $225; range = $40 to $985). Referrals came from physicians (96%), other health professionals (70%), and licensing authorities (66%). Clients with stroke, dementia, traumatic brain injury, mild cognitive impairment, and multiple sclerosis composed 62% of estimated caseloads. Assessments took 3 hr on average (range = 1.24 to 4.5 hr); 64% reported they always took clients on road regardless of clinic results. Implications. Evidence-based guidelines for training and assessment are clearly needed given the inconsistency in practice.	[Vrkljan, Brenda H.] McMaster Univ, Sch Rehabil Sci, Occupat Therapy Program, Hamilton, ON L8S 1C7, Canada; [Myers, Anita M.; Blanchard, Robin A.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Crizzle, Alexander M.] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON L8S 1C7, Canada; [Marshall, Shawn C.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Marshall, Shawn C.] Ottawa Hosp Res Inst, Ottawa, ON, Canada		Vrkljan, BH (corresponding author), McMaster Univ, Sch Rehabil Sci, Occupat Therapy Program, 1400 Main St West, Hamilton, ON L8S 1C7, Canada.	vrkljan@mcmaster.ca			Ontario Neurotrauma Foundation	This project was funded by Ontario Neurotrauma Foundation as part of a larger project.	Adler G, 2006, J AGING STUD, V20, P227, DOI 10.1016/j.jaging.2005.09.003; Bedard M, 2011, J PRIM CARE COMMUNIT, V2, P133, DOI 10.1177/2150131910397704; Canadian Association of Occupational Therapists, 2009, CAOT POS STAT OCC TH; Canadian Medical Association, 2012, DET MED FITN OP MOT; Hogan DB, 2011, CAN GERIATR J, V14, P51; Kay L, 2008, ACCIDENT ANAL PREV, V40, P751, DOI 10.1016/j.aap.2007.09.012; Korner-Bitensky NA, 1998, AM J OCCUP THER, V52, P916, DOI 10.5014/ajot.52.10.916; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korner-Bitensky N, 2010, AM J OCCUP THER, V64, P316, DOI 10.5014/ajot.64.2.316; Marshall S., 2007, SENIOR DRIVER ASSESS; Marshall SC, 2013, ACCIDENT ANAL PREV, V61, P233, DOI 10.1016/j.aap.2013.07.007; Myers AM, 2011, EVALUATING POLICIES; Ontario Ministry of Transportation, 2013, MED REV SECT; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Rapoport MJ, 2007, CAN MED ASSOC J, V177, P599, DOI 10.1503/cmaj.070342; Unsworth CA, 2007, AM J OCCUP THER, V61, P493, DOI 10.5014/ajot.61.5.493; Vrkljan BH, 2011, CAN J OCCUP THER, V78, P80, DOI 10.2182/cjot.2011.78.2.3; Windsor TD, 2006, CLIN INTERV AGING, V1, P205, DOI 10.2147/ciia.2006.1.3.205	18	15	15	0	13	CANADIAN ASSOC OCCUPATIONAL THERAPISTS	OTTAWA	CTTC BLDG, 3400-1125 COLONEL BY DRIVE, OTTAWA, ONTARIO K1S 5R1, CANADA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	DEC	2013	80	5					295	303		10.1177/0008417413511788			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	302HO	WOS:000330594700009	24640644				2022-02-06	
J	Haran, FJ; Alphonso, AL; Creason, A; Campbell, JS; Johnson, D; Young, E; Tsao, JW				Haran, F. J.; Alphonso, Aimee L.; Creason, Alia; Campbell, Justin S.; Johnson, Dagny; Young, Emily; Tsao, Jack W.			Analysis of Post-Deployment Cognitive Performance and Symptom Recovery in US Marines	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; REACTION-TIME; CONCUSSION; SEQUELAE; FREEDOM; UTILITY; HEALTH; ANAM; IRAQ	Background: Computerized neurocognitive testing (NCAT) has been proposed to be useful as a screening tool for post-deployment cognitive deficits in the setting of mild traumatic brain injury (mTBI). We assessed the clinical utility of post-injury/post-deployment Automated Neurocognitive Assessment Metric (ANAM) testing, using a longitudinal design to compare baseline ANAM tests with two post-deployment ANAM tests in a group of Marines who experienced combat during deployment. Methods and Findings: Post-deployment cognitive performance and symptom recovery were compared in a subsample of 1324 U.S. Marines with high rates of combat exposure during deployment. Of the sample, 169 Marines had available baseline and twice repeated post-deployment ANAM results. A retrospective analysis of the ANAM data, which consisted of a self-report questionnaire about deployment-related blast exposure, recent history of mTBI, current clinical symptoms, and cognitive performance. Self-reported concussion sustained anytime during deployment was associated with a decrease in cognitive performance measured between 2-8 weeks post-deployment. At the second post-deployment test conducted on average eight months later, performance on the second simple reaction time test, in particular, remained impaired and was the most consistent and sensitive indicator of the cognitive decrements. Additionally, post-concussive symptoms were shown to persist in injured Marines with a self-reported history of concussion for an additional five months after most cognitive deficits resolved. Results of this study showed a measurable deployment effect on cognitive performance, although this effect appears to resolve without lasting clinical sequelae in those without history of deployment-related concussion. Conclusions: These results highlight the need for a detailed clinical examination for service members with history of concussion and persistent clinical symptoms. Reliance solely upon computerized neurocognitive testing as a method for identifying service members requiring clinical follow-up post-concussion is not recommended, as cognitive functioning only slowly returned to baseline levels in the setting of persistent clinical symptoms.	[Haran, F. J.] Navy Expt Div Unit, Biomed Res & Operat Dept, Panama City Beach, FL USA; [Alphonso, Aimee L.] Henry M Jackson Fdn Adv Mil Med, Arlington, VA USA; [Alphonso, Aimee L.] Walter Reed Natl Mil Med Ctr, Dept Orthoped & Rehabil, Bethesda, MD USA; [Creason, Alia] Univ Consulting Serv Inc, Arlington, VA USA; [Creason, Alia; Tsao, Jack W.] US Navy Bur Med & Surg BUMED, Traumat Brain Injury Programs, Wounded Ill & Injured Directorate, Arlington, VA USA; [Campbell, Justin S.] Naval Space & Warfare Syst Ctr Pacific, San Diego, CA USA; [Johnson, Dagny; Young, Emily] Eyak Corp, Arlington, VA USA		Haran, FJ (corresponding author), Navy Expt Div Unit, Biomed Res & Operat Dept, Panama City Beach, FL USA.	jay.haran@navy.mil		Campbell, Justin/0000-0002-3471-9430	Wounded, Ill & Injured Program, US Navy Bureau of Medicine and Surgery, Falls Church, VA	This study was funded by the Wounded, Ill & Injured Program, US Navy Bureau of Medicine and Surgery, Falls Church, VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Bass E, 2012, VET HLTH ADM TREATME; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Center DaVBI, 2012, DOD TBI WORLDW 200 2; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johansson B, 2009, MENTAL FATIGUE IMPAI, P13; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Roebuck-Spencer T, 2007, ARCH CLIN NEUROPSYCH, V22, pS79, DOI 10.1016/j.acn.2006.10.011; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	36	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79595	10.1371/journal.pone.0079595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261GG	WOS:000327652100012	24312183	Green Published, gold			2022-02-06	
J	Collie, A; Prang, KH				Collie, A.; Prang, K-H.			Patterns of healthcare service utilisation following severe traumatic brain injury: An idiographic analysis of injury compensation claims data	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain injury; Transport; Idiographic; Health service use; Trajectory	DEVELOPMENTAL TRAJECTORIES; SAS PROCEDURE; OUTCOMES; REHABILITATION; RECOVERY; PROFILE	Background: The rate and extent of recovery after severe traumatic brain injury (TBI) is heterogeneous making prediction of likely healthcare service utilisation (HSU) difficult. Patterns of HSU derived from nomothetic samples do not represent the diverse range of outcomes possible within this patient group. Group-based trajectory model is a semi-parametric statistical technique that seeks to identify clusters of individuals whose outcome (however measured) follows a similar pattern of change over time. Aim: To identify and characterise patterns of HSU in the 5-year period following severe TBI. Methods: Detailed healthcare treatment payments data in 316 adults with severe TBI (Glasgow Coma Scale score 3-8) from the transport accident compensation system in the state of Victoria, Australia was accessed for this analysis. A semi-parametric group-based trajectory analytical technique for longitudinal data was applied to monthly observation counts of HSU data to identify distinct clusters of participants' trajectories. Comparison between trajectory groups on demographic, injury, disability and compensation relevant outcomes was undertaken. Results: Four distinct patterns (trajectories) of HSU were identified in the sample. The first trajectory group comprised 27% of participants and displayed a rapid decrease in HSU in the first year post-injury. The second group comprised 24% of participants and showed a sharp peak in HSU during the first 12 months post-injury followed by a decline over time. The third group comprised 32% of participants and showed a slight peak in HSU in the first few months post-injury and then a slow decline over time. The fourth group comprised 17% of participants and displayed a steady rise in HSU up to 30 months post-injury, followed by a gradual decline to a level consistent with that received in the first months post-injury. Significant differences were observed between groups on factors such as age, injury severity, and use of disability services. Conclusions: There is substantial variation in patterns of HSU following severe TBI. Idiographic analysis can provide rich information for describing and understanding the resources required to help people with TBI. (C) 2013 Elsevier Ltd. All rights reserved.	[Collie, A.; Prang, K-H.] Monash Univ, Inst Safety Compensat & Recovery Res, Clayton, Vic 3800, Australia; [Collie, A.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia		Collie, A (corresponding author), Level 11,499 St Kilda Rd, Melbourne, Vic 3004, Australia.	alex.collie@monash.edu		Collie, Alex/0000-0003-2617-9339	Transport Accident Commission (TAC); WorkSafe Victoria via the Institute for Safety Compensation and Recovery Research	The authors thank Professor Bobby Jones for his assistance in using SAS Proc Traj for the data analysis. Funding for this project was provided by a research grant from the Transport Accident Commission (TAC) and WorkSafe Victoria via the Institute for Safety Compensation and Recovery Research. Views expressed are those of the authors and not the funding agencies.	American Medical Association, 1993, GUIDES EVALUATION PE; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Foster M, 2000, BRAIN INJURY, V14, P1035; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Hoeppner BB, 2008, ADDICT BEHAV, V33, P623, DOI 10.1016/j.addbeh.2007.11.005; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Lippel K, 2007, INT J LAW PSYCHIAT, V30, P427, DOI 10.1016/j.ijlp.2007.06.013; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Molenaar PCM., 2004, MEASUREMENT, V2, P201, DOI [10.1207/s15366359mea0204_1, DOI 10.1207/S15366359MEA0204_1]; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nandi A, 2009, ANN EPIDEMIOL, V19, P761, DOI 10.1016/j.annepidem.2009.06.005; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; OTTENBACHER KJ, 1990, AM J PHYS MED REHAB, V69, P286, DOI 10.1097/00002060-199012000-00002; Ponsford J., 2012, INPSYCH; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ruseckaite R, 2011, INJURY; Schmidt M, 2010, Z PSYCHOL, V218, P166, DOI 10.1027/0044-3409/a000026; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Transport Accident Commission (TAC), 2011, ANN REPORT, P1; Transport Accident Commission (TAC), 2012, MAK CLAIM; Transport Accident Commission (TAC), 2012, COMMUN LAW; Velicer WF, 2005, ED PSYCHOL MEASUREME, V65; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Windle M, 2004, DEV PSYCHOPATHOL, V16, P1007, DOI 10.1017/S0954579404040118; Xie HY, 2006, ADM POLICY MENT HLTH, V33, P423, DOI 10.1007/s10488-006-0048-0	32	15	15	0	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	NOV	2013	44	11					1514	1520		10.1016/j.injury.2013.03.006			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	227ZT	WOS:000325155000024	23566704				2022-02-06	
J	Gfeller, JD; Roskos, PT				Gfeller, Jeffrey D.; Roskos, P. Tyler			A Comparison of Insufficient Effort Rates, Neuropsychological Functioning, and Neuropsychiatric Symptom Reporting in Military Veterans and Civilians with Chronic Traumatic Brain Injury	BEHAVIORAL SCIENCES & THE LAW			English	Article							MEMORY MALINGERING TOMM; DISABILITY RATING-SCALE; METAANALYTIC METHODS; MISERABLE MINORITY; COGNITIVELY INTACT; EVALUATION CONTEXT; OEF/OIF VETERANS; VALIDITY; PERFORMANCE; VALIDATION	Neuropsychological evaluation of persons with chronic traumatic brain injury (TBI) symptoms is complicated by multiple factors. The authors explored the impact of mechanism of injury, effort testing performance, and neuropsychiatric status in a sample of military veterans (V-TBI) and civilians (C-TBI) with chronic TBI. V-TBI (n=74), C-TBI (n=67), and healthy civilian control (C-HC) participants (n=66), completed a battery of neuropsychological, effort, and self-report neuropsychiatric measures. Results indicated that C-HC and C-TBI participants exhibited comparably low failure rates on effort tests (6% and 3%, respectively). V-TBI participants exhibited significantly higher rates of failure (18%). Subgroups (n=20) of effort-screened participants matched for demographics and disability level were compared regarding neuropsychological performance and neuropsychiatric self-report. Both TBI groups exhibited limited neuropsychological impairment, relative to the C-HC participants. The V-TBI group exhibited pronounced neuropsychiatric symptomology compared with the other participant groups. The implications of these findings are discussed for evaluation in the context of disability and litigation. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Gfeller, Jeffrey D.; Roskos, P. Tyler] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Roskos, P. Tyler] St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA		Gfeller, JD (corresponding author), St Louis Univ, Dept Psychol, 221 North Grand Blvd, St Louis, MO 63103 USA.	gfellerj@slu.edu					Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bush S. S., 2013, MILD TRAUMATIC BRAIN, P381; Chafetz M. D., 2013, MILD TRAUMATIC BRAIN, P347; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conners C. K., 2000, CONNERS CONTINUOUS P; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Golden CJ, 1978, STROOP COLOR WORD TE; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, MANUAL WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G. L., 2010, J HEAD TRAUMA REHAB, V25, P576; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kaplan E, 1983, BOSTON NAMING TEST; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Matthews CG., 1964, INSTRUCTION MANUAL A; Meyers J. E., 1999, REY COMPLEX FIGURE T; Morey, 1991, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reitan RM, 1992, TRAIL MAKING TEST MA; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1997, ARCH CLIN NEUROPSYCH, V12, P418, DOI 10.1093/arclin/12.4.418; Vanderploeg R. D., 2013, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0b013e318281966e.; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Weathers F.W., 1993, 9 ANN C ISTSS; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; WechslerD, 2001, WECHSLER TEST ADULT; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	66	15	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		833	849		10.1002/bsl.2084			17	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400011	24123226				2022-02-06	
J	Laxe, S; Terre, R; Leon, D; Bernabeu, M				Laxe, Sara; Terre, Rosa; Leon, Daniel; Bernabeu, Montserrat			How does dysautonomia influence the outcome of traumatic brain injured patients admitted in a neurorehabilitation unit?	BRAIN INJURY			English	Article						Dysautonomia; outcome; PSH; rehabilitation; traumatic brain injury	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; AFFERENT STIMULI; OVERRESPONSIVENESS; SCALE	Background: Patients surviving severe traumatic brain injury (TBI) may suffer from symptoms presumed to be related to an excessive sympathetic production known as paroxysmal sympathetic hyperactivity (PSH). While this condition is more common in the acute phase, prognosis is less clear in rehabilitation settings. Aim: The goal of this study is to describe the functional status of patients with PSH admitted in a rehabilitation hospital and to determine its prognostic influence during rehabilitation. Methods: A cohort study was undertaken of all the patients admitted in a neurorehabilitation hospital suffering from PSH. Functional outcomes were reported according to the Glasgow outcome scale-extended (GOSE), the Disability Rating Scale (DRS) and the Functional Independence Measure (FIM). Results: Thirteen out of 39 patients suffered symptoms compatible with PSH. Neuroimaging of PSH patients showed more diffuse lesions. The FIM at admission was lower in the PSH group who was transferred for rehabilitation at an earlier stage. At discharge no differences were seen using the FIM, DRS and GOS-E. Conclusions: Functional status is similar and PSH does not appear to influence recovery during the rehabilitation, although PSH patients are more likely to undergo psychoactive medications and special care is needed to approach their caregivers that perceive PSH as a complication for rehabilitation.	[Laxe, Sara; Terre, Rosa; Leon, Daniel; Bernabeu, Montserrat] Univ Autonoma Barcelona, Inst Guttmann, Brain Injury Unit, Badalona 08916, Spain		Laxe, S (corresponding author), Univ Autonoma Barcelona, Inst Guttmann, Brain Injury Unit, Cami Can Ruti Sn, Badalona 08916, Spain.	slaxe@guttmann.com					Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P52, DOI 10.1016/S0003-9993(98)90208-8; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Penfield W., 1954, EPILEPSY FUNCTIONAL, P378; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358	23	15	16	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1383	1387		10.3109/02699052.2013.823648			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500007	24102213				2022-02-06	
J	Nelson, LA; MacDonald, M; Stall, C; Pazdan, R				Nelson, Lonnie A.; MacDonald, Margaret; Stall, Christina; Pazdan, Renee			Effects of Interactive Metronome Therapy on Cognitive Functioning After Blast-Related Brain Injury: A Randomized Controlled Pilot Trial	NEUROPSYCHOLOGY			English	Article						blast-related brain injury; cognitive rehabilitation; attention; memory; mTBI; recovery of function	OF-THE-LITERATURE; TEST-PERFORMANCE; REHABILITATION; SYMPTOMS; DISORDER; VALIDITY	Objective: We report preliminary findings on the efficacy of interactive metronome (IM) therapy for the remediation of cognitive difficulties in soldiers with persisting cognitive complaints following blast-related mild-to-moderate traumatic brain injury (TBI). Method: Forty-six of a planned sample of 50 active duty soldiers with persistent cognitive complaints following a documented history of blast-related TBI of mild-to-moderate severity were randomly assigned to receive either standard rehabilitation care (SRC) or SRC plus a 15-session standardized course of IM therapy. Primary outcome measures were Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Index Scores. Secondary outcome measures included selected subtests from the Delis Kaplan Executive Functioning System (Trail Making Test and Color Word Interference) and the Wechsler Adult Intelligence Scale Fourth Edition (Symbol Search, Digit Symbol Coding, Digit Span, and Letter Number Sequencing) as well as the Integrated Visual and Auditory Continuous Performance Test. Results: Significant group differences (SRC vs. IM) were observed for RBANS Attention (p = .044), Immediate Memory (p = .019), and Delayed Memory (p = .031) indices in unadjusted analyses, with the IM group showing significantly greater improvement at Time 2 than the SRC group, with effect sizes in the medium-to-large range in the adjusted analyses for each outcome (Cohen's d = 0.511, 0.768, and 0.527, respectively). Though not all were statistically significant, effects in 21 of 26 cognitive outcome measures were consistently in favor of the IM treatment group (binomial probability = .00098). Conclusion: The addition of IM therapy to SRC appears to have a positive effect on neuropsychological outcomes for soldiers who have sustained mild-to-moderate TBI and have persistent cognitive complaints after the period for expected recovery has passed.	[Nelson, Lonnie A.; MacDonald, Margaret; Stall, Christina; Pazdan, Renee] Def & Vet Brain Injury Ctr, Ft Carson, CO USA		MacDonald, M (corresponding author), 7489 Sutherland Circle, Ft Carson, CO 80913 USA.	margaret.e.macdonald3.ctr@mail.mil			Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; Henry M. Jackson Foundation [W91 YTZ-11-C-0033]	Supported by the Defense and Veterans Brain Injury Center and, in part, through contract support provided by the Henry M. Jackson Foundation for the Advancement of Military Medicine (contract # W91 YTZ-11-C-0033). Clinical Trial Registration clinicaltrials.gov; identifier: NCT01248390.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Department of the Army, 1999, PERS SEL CLASS MIL O; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Institute of Medicine, 2011, COGN REH THER TRAUM; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koomar J, 2001, AM J OCCUP THER, V55, P163, DOI 10.5014/ajot.55.2.163; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Levy M, 2005, NEUROREHABILITATION, V20, P279; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moucha R, 2006, PROG BRAIN RES, V157, P111, DOI 10.1016/S0079-6123(06)57007-4; Nelson LA, 2007, TOP STROKE REHABIL, V14, P59, DOI 10.1310/tsr1404-59; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Shaffer RJ, 2001, AM J OCCUP THER, V55, P155, DOI 10.5014/ajot.55.2.155; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Tinius TP, 2003, ARCH CLIN NEUROPSYCH, V18, P439, DOI 10.1016/S0887-6177(02)00144-0; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	48	15	15	0	24	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2013	27	6					666	679		10.1037/a0034117			14	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	252YX	WOS:000327049900005	24059443				2022-02-06	
J	Resch, JE; Macciocchi, S; Ferrara, MS				Resch, Jacob E.; Macciocchi, Stephen; Ferrara, Michael S.			Preliminary Evidence of Equivalence of Alternate Forms of the ImPACT	CLINICAL NEUROPSYCHOLOGIST			English	Article						Equivalence; Alternate forms; Concussion; Computerized neuropsychological tests; Psychometric; Cognitive	INTERNATIONAL-CONFERENCE; CONCUSSION; STATEMENT; SPORT; RELIABILITY; CAPACITY; MEMORY	The ImPACT (Immediate Postconcussion Assessment and Cognitive Testing) is a computerized neurocognitive test used to assist in the management of sport concussion management. A number of studies have documented the reliability and sensitivity of the ImPACT, but no studies have examined the equivalence of the ImPACT's alternate forms. The objective of our study was to determine the equivalence of the ImPACT's five alternate forms. Participants were administered alternate forms of ImPACT based on clinically relevant time frame derived from an extensive sports concussion database. Participants completed a baseline assessment followed by various combinations of the remaining alternate forms at 45 and 50 days. Inferential Confidence Intervals were calculated for each composite score for all alternate forms. We found non-equivalence between ImPACT form 1 and forms 2, 3, and 4 on the Verbal Memory and between forms 2 and 4. ImPACT forms 1 and 3 were not equivalent on the Visual Memory Composite. Finally, ImPACT forms 3 and 4 were not equivalent on the Visual Motor Speed and Reaction Time Composites. Alternate form equivalence is necessary to minimize measurement error and optimize clinical decision making. Clinicians using the ImPACT should consider non-equivalence of some forms on certain Composites when interpreting ImPACT following sports concussion.	[Resch, Jacob E.] Univ Texas Arlington, Dept Kinesiol, Brain Injury Lab, Arlington, TX USA; [Macciocchi, Stephen] Shepherd Ctr, Atlanta, GA USA; [Ferrara, Michael S.] Univ New Hampshire, Durham, NH 03824 USA		Resch, JE (corresponding author), ATC, Maverick Act Ctr 113, Box 19259, Arlington, TX 76019 USA.	resch@uta.edu		Resch, Jacob/0000-0001-6031-3197			Algina J., 2008, INTRO CLASSICAL MODE; BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CONNINE CM, 1990, J EXP PSYCHOL LEARN, V16, P1084, DOI 10.1037/0278-7393.16.6.1084; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 2003, WORD MEMORY TEST WIN; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; O'Neil-Pirozzi TM, 2012, BRAIN INJURY, V26, P1425, DOI 10.3109/02699052.2012.694561; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Tryon WW, 2008, PSYCHOL METHODS, V13, P272, DOI 10.1037/a0013158; Tryon WW, 2001, PSYCHOL METHODS, V6, P371, DOI 10.1037//1082-989X.6.4.371	21	15	15	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 1	2013	27	8					1265	1280		10.1080/13854046.2013.845247			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	273KW	WOS:000328534700005	24099175				2022-02-06	
J	Sieswerda-Hoogendoorn, T; Bilo, RAC; van Duurling, LLBM; Karst, WA; Maaskant, JM; van Aalderen, WMC; van Rijn, RR				Sieswerda-Hoogendoorn, Tessa; Bilo, Rob A. C.; van Duurling, Lonneke L. B. M.; Karst, Wouter A.; Maaskant, Jolanda M.; van Aalderen, Wim M. C.; van Rijn, Rick R.			Abusive head trauma in young children in the Netherlands: evidence for multiple incidents of abuse	ACTA PAEDIATRICA			English	Article						Child abuse; Child advocacy; Head injuries closed; Risk factors; Shaken baby syndrome	SHAKEN BABY SYNDROME; BRAIN-INJURY; CONSEQUENCE; PREVENTION; PROGRAM	AimWe investigated the prevalence of risk factors for and the prevalence of prior abuse in abusive head trauma victims in the Netherlands. MethodsWe performed a retrospective file review of all abusive head trauma cases in the Netherlands in which forensic medical expertise was requested by the courts, between 2005 and 2010. Outcome measures were risk factors and indicators for prior abuse. ResultsEighty-nine cases were included; 62% boys, median age 3.5months. Impact trauma was found in 48% of cases, with a male perpetrator in 79%. Prematurity, dysmaturity and twins/triplets were found in 27%, 23% and 10% of cases, respectively, maternal age under 20years in 17%. Of the parents, 60% had completed only primary or secondary education, 38% of the families were known to child welfare authorities. There was evidence for prior abuse in 81% of the cases. ConclusionThe high number of families with prior abuse indicates that both the healthcare system and child welfare authorities failed to protect some of the children that have been in their care. Our results highlight the importance of training healthcare and child welfare professionals in recognizing physical abuse, as well as the importance of optimizing abusive head trauma prevention strategies.	[Sieswerda-Hoogendoorn, Tessa; Bilo, Rob A. C.; Karst, Wouter A.; van Rijn, Rick R.] Netherlands Forens Inst, Sect Forens Pediat, Dept Forens Med, The Hague, Netherlands; [Sieswerda-Hoogendoorn, Tessa; van Rijn, Rick R.] Emma Childrens Hosp, Dept Radiol, Acad Med Ctr, Amsterdam, Netherlands; [van Duurling, Lonneke L. B. M.] Forens Med Child Abuse Ctr, Utrecht, Netherlands; [Maaskant, Jolanda M.; van Aalderen, Wim M. C.] Emma Childrens Hosp, Dept Pediat, Acad Med Ctr, Amsterdam, Netherlands		Sieswerda-Hoogendoorn, T (corresponding author), Netherlands Forens Inst, Dept Med Forens Invest, POB 24044, NL-2490 AA The Hague, Netherlands.	t.sieswerda@amc.nl	van Rijn, Rick/H-5526-2019	van Rijn, Rick/0000-0002-8876-6515			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Altman RL, 2011, PEDIATRICS, V128, pE1164, DOI 10.1542/peds.2010-3260; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bennett S, 2011, CHILD ABUSE NEGLECT, V35, P930, DOI 10.1016/j.chiabu.2011.05.018; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Child abuse physician association, 2012, VER VERTR KIND POS M; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Garssen J, 2010, MANY TEENAGE PREGNAN; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2010, ACAD PEDIATR, V10, P389, DOI 10.1016/j.acap.2010.08.005; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Ministry of Education CaS, 2011, ED LEV NETH; Mok JYQ, 2010, J EPIDEMIOL COMMUN H, V64, P1049, DOI 10.1136/jech.2009.090217; Netherlands Statistics, 2012, POP POP DYN MONTH QU; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Royal Dutch Medical Association, 2012, KNMG REP GUID CHILD; Sanderse C, 2012, BIRTH WHAT WERE MOST; STARLING SP, 1995, PEDIATRICS, V95, P259; Statistics Netherlands, 2008, NUMB FAM NUMB CHILDR; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Waelput AJM, 2012, WHAT IS INCIDENCE PR; Wobma E, 2011, ONE 6 FATHERS IS 40; Wobma E, 2011, NUMBER MULTIPLE BIRT	30	15	16	2	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.	NOV	2013	102	11					E497	E501		10.1111/apa.12377			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	229LF	WOS:000325265500007	23909838				2022-02-06	
J	Fozouni, N; Chopp, M; Nejad-Davarani, SP; Zhang, ZG; Lehman, NL; Gu, S; Ueno, Y; Lu, M; Ding, GL; Li, L; Hu, JN; Bagher-Ebadian, H; Hearshen, D; Jiang, Q				Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Lehman, Norman L.; Gu, Steven; Ueno, Yuji; Lu, Mei; Ding, Guangliang; Li, Lian; Hu, Jiani; Bagher-Ebadian, Hassan; Hearshen, David; Jiang, Quan			Characterizing Brain Structures and Remodeling after TBI Based on Information Content, Diffusion Entropy	PLOS ONE			English	Article							WATER DIFFUSION; NERVOUS-SYSTEM; TENSOR; MRI; ANISOTROPY; COEFFICIENT; MODEL; RECOVERY; TISSUES; INDEXES	Background: To overcome the limitations of conventional diffusion tensor magnetic resonance imaging resulting from the assumption of a Gaussian diffusion model for characterizing voxels containing multiple axonal orientations, Shannon's entropy was employed to evaluate white matter structure in human brain and in brain remodeling after traumatic brain injury (TBI) in a rat. Methods: Thirteen healthy subjects were investigated using a Q-ball based DTI data sampling scheme. FA and entropy values were measured in white matter bundles, white matter fiber crossing areas, different gray matter (GM) regions and cerebrospinal fluid (CSF). Axonal densities' from the same regions of interest (ROIs) were evaluated in Bielschowsky and Luxol fast blue stained autopsy (n = 30) brain sections by light microscopy. As a case demonstration, a Wistar rat subjected to TBI and treated with bone marrow stromal cells (MSC) 1 week after TBI was employed to illustrate the superior ability of entropy over FA in detecting reorganized crossing axonal bundles as confirmed by histological analysis with Bielschowsky and Luxol fast blue staining. Results: Unlike FA, entropy was less affected by axonal orientation and more affected by axonal density. A significant agreement (r = 0.91) was detected between entropy values from in vivo human brain and histologically measured axonal density from post mortum from the same brain structures. The MSC treated TBI rat demonstrated that the entropy approach is superior to FA in detecting axonal remodeling after injury. Compared with FA, entropy detected new axonal remodeling regions with crossing axons, confirmed with immunohistological staining. Conclusions: Entropy measurement is more effective in distinguishing axonal remodeling after injury, when compared with FA. Entropy is also more sensitive to axonal density than axonal orientation, and thus may provide a more accurate reflection of axonal changes that occur in neurological injury and disease.	[Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Gu, Steven; Ueno, Yuji; Ding, Guangliang; Li, Lian; Bagher-Ebadian, Hassan; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Lehman, Norman L.] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; [Hearshen, David] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Hu, Jiani] Harper Hospita, MR Ctr, Detroit, MI USA; [Fozouni, Niloufar; Chopp, Michael; Zhang, Zheng Gang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA		Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021; Lehman, Norman L/A-7351-2015; Ueno, Yuji/ABB-2492-2020	Li, Lian/0000-0003-0097-1184; Lehman, Norman/0000-0001-8394-2607; Nejad-Davarani, Siamak/0000-0002-2415-6689; Ding, Guangliang/0000-0003-1286-5901	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS64134, RO1 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants RO1 NS64134, RO1 AG037506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.3.CO;2-2; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, BIOESSAYS, V30, P1235, DOI 10.1002/bies.20851; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bastin ME, 1999, NEUROREPORT, V10, P1385, DOI 10.1097/00001756-199905140-00001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Callaghan P.T., 1991, PRINCIPLES NUCL MAGN; Chen Y, 2005, LECT NOTES COMPUT SC, V3565, P246; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Horsfield MA, 1998, J NEUROL NEUROSUR PS, V64, pS80; Inglis BA, 1999, AM J NEURORADIOL, V20, P713; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Jones DK, 1999, STROKE, V30, P393, DOI 10.1161/01.STR.30.2.393; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Metwalli Nader S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2260; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Shannon CE, 1997, M D COMPUT, V14, P306; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; von Bohlen und Halbach O, 1998, J NEUROSCI METH, V81, P169, DOI 10.1016/S0165-0270(98)00026-0; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wieshmann UC, 1999, NEUROIMAGE, V10, P225, DOI 10.1006/nimg.1999.0456; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zivadinov R, 2008, J NEUROL, V255, P61, DOI 10.1007/s00415-008-1009-1	54	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76343	10.1371/journal.pone.0076343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	WOS:000325894100021	24143186	Green Submitted, Green Published, gold			2022-02-06	
J	Hu, JH; Ugiliweneza, B; Meyer, K; Lad, SP; Boakye, M				Hu, Jiahui; Ugiliweneza, Beatrice; Meyer, Kimberly; Lad, Shivanand P.; Boakye, Maxwell			Trend and Geographic Analysis for Traumatic Brain Injury Mortality and Cost Based on MarketScan Database	JOURNAL OF NEUROTRAUMA			English	Article						hospital cost; length of stay; mortality rate; traumatic brain injury	HOSPITAL LENGTH; GENDER; MODERATE; OUTCOMES; CHARGES; ICISS; STAY	The objective of the current research was to examine the current epidemiology of traumatic brain injury (TBI); to determine the effects of geographic region, co-morbidities, year of injury, injury severity, and demographics on hospital costs, length of stay (LOS), and mortality. All subjects were drawn from the Thomason Reuters MarketScan((R)) database. Statistical methods used included descriptive analysis, bivariate analysis, logistic regression, and the Geographic Information System (GIS) software, ArcMap. We studied 76,313 patients with TBI from 2004 to 2009 (52,721 with commercial insurance and 23,592 with Medicare) from the MarketScan database. As age increased, mortality rate and median LOS increased. The median hospital costs for adults were the highest ($13,000 for ages 18-64) compared with children ($8000 for age 0-14) and elderly persons ($9000 for age 65). The mortality rate for the elderly population has decreased slightly (11.1% in 2004 to 9.9% in 2009 for men, and 7.0% to 6.9% for women); however, their hospital costs have increased significantly ($6899 in 2004 to $11,567 in 2009 for men; $6784 to $9782 for women). Concerning the impact of geography, the western United States (e.g., Washington and California) had lower mortality rates and higher median costs while the southeast United States had the highest mortality and mixed median costs. Both overall mortality and median LOS have remained relatively stable over the years. Hospital cost, however, has increased for the elderly population even after accounting for the inflation. There is significant geographic variation for both mortality and hospital costs.	[Hu, Jiahui] DuPont Manual High Sch, Louisville, KY USA; [Ugiliweneza, Beatrice] Univ Louisville, Ctr Adv Neurosurg, Dept Neurosurg, Louisville, KY 40202 USA; [Meyer, Kimberly] Univ Louisville Hosp, Louisville, KY USA; [Lad, Shivanand P.] Duke Univ, Med Ctr, Div Neurosurg, Durham, NC 27710 USA; [Boakye, Maxwell] Robley Rex VA Med Ctr, Dept Neurosurg, Louisville, KY USA		Boakye, M (corresponding author), Univ Louisville, Ctr Adv Neurosurg, 220 Abraham Flexner Way,1105, Louisville, KY 40202 USA.	max.boakye@louisville.edu	Meyer, Kimberly/L-5430-2019				Allison P, 1999, LOGISTIC REGRESSION; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brasel KJ, 2007, ARCH SURG-CHICAGO, V142, P461, DOI 10.1001/archsurg.142.5.461; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colantonio A, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Kurland K. S., 2006, GIS TUTORIAL FOR HEA; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; United States Department of Labor, 2012, CPI INFLATION CALCUL	22	15	15	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1755	1761		10.1089/neu.2013.2857			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000008	23642155				2022-02-06	
J	Grill, E; Klein, AM; Howell, K; Arndt, M; Bodrozic, L; Herzog, J; Jox, R; Koenig, E; Mansmann, U; Muller, F; Muller, T; Nowak, D; Schaupp, M; Straube, A; Bender, A				Grill, Eva; Klein, Anke-Maria; Howell, Kaitlen; Arndt, Marion; Bodrozic, Lydia; Herzog, Juergen; Jox, Ralf; Koenig, Eberhardt; Mansmann, Ulrich; Mueller, Friedemann; Mueller, Thomas; Nowak, Dennis; Schaupp, Matthias; Straube, Andreas; Bender, Andreas			Rationale and Design of the Prospective German Registry of Outcome in Patients With Severe Disorders of Consciousness After Acute Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anoxia; Brain injuries; Disability evaluation; Persistent vegetative state; Registries; Rehabilitation	ICF CORE SETS; VEGETATIVE STATE; ASSESSMENT SCALES; CARDIAC-ARREST; REHABILITATION; RELIABILITY; RECOVERY; LIFE; RESUSCITATION; PROGNOSIS	Objective: To describe the rationale and design of a new patient registry (Koma Outcome von Patienten der Fruhrehabilitation-Register [KOPF-R; Registry for Coma Outcome in Patients Undergoing Acute Rehabilitation]) that has the scope to examine determinants of long-term outcome and functioning of patients with severe disorders of consciousness (DOC). Design: Prospective multicenter neurologic rehabilitation registry. Setting: Five specialized neurologic rehabilitation facilities. Participants: Patients (N=42) with DOC in vegetative state or minimally conscious state (MCS) as defined by the Coma Recovery Scale Revised (CRS-R) after brain injury. Patients are being continuously enrolled. The data presented here cover the enrollment period from August 2011 to January 2012. Interventions: Not applicable. Main Outcome Measures: CRS-R, FIM, and emergence from MCS. Results: The registry was set up in 5 facilities across the state of Bavaria/Germany with a special expertise in the rehabilitation of acquired brain injury. Inclusion of patients started in August 2011. Measures include sociodemographic and clinical characteristics, course of acute therapy, electrophysiologic measures (evoked potentials, electroencephalogram), neuron-specific enolase, current medication, functioning, cognition, participation, quality of life, quantity and characteristics of rehabilitation therapy, caregiver burden, and attitudes toward end-of-life decisions. Main diagnoses were traumatic brain injury (24%), intracerebral or subarachnoid hemorrhage (31%), and anoxic-ischemic encephalopathy (45%). Mean CRS-R score +/- SD at admission to rehabilitation was 5.9 +/- 3.3, and mean FIM score +/- SD at admission was 18 +/- 0.4. Conclusions: The KOPF-R aspires to contribute prospective data on prognosis in severe DOC. (c) 2013 by the American Congress of Rehabilitation Medicine	[Grill, Eva; Mansmann, Ulrich; Mueller, Thomas] Univ Munich, Inst Med Informat Proc Biometry & Epidemiol, D-81377 Munich, Germany; [Grill, Eva] Univ Munich, Integrated Ctr Res & Treatment Vertigo Balance &, D-81377 Munich, Germany; [Klein, Anke-Maria; Howell, Kaitlen; Straube, Andreas; Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Howell, Kaitlen; Arndt, Marion; Bodrozic, Lydia; Bender, Andreas] Therapiezentrum Burgau, Burgau, Germany; [Herzog, Juergen] Schon Klin Munchen Schwabing, Munich, Germany; [Jox, Ralf] Univ Munich, Inst Eth Hist & Theory Med, D-81377 Munich, Germany; [Koenig, Eberhardt; Mueller, Friedemann] Schon Klin Bad Aibling, Bad Aibling, Germany; [Nowak, Dennis] Klin Kipfenberg, Kipfenberg, Germany; [Schaupp, Matthias] Neurol Clin, Bad Neustadt an der Saale, Germany		Bender, A (corresponding author), Univ Munich, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	anbender@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Bender, Andreas/0000-0002-6328-7104	Hannelore-Kohl-Stiftung, Germany [2011013]; Deutsche Stiftung Neurologie, Germany	Supported in part by the Hannelore-Kohl-Stiftung, Germany (grant no. 2011013 to AB) and the Deutsche Stiftung Neurologie, Germany.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bender A, 2012, J NEUROL, V259, P2481, DOI 10.1007/s00415-012-6573-8; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Geocadin RG, 2006, NEUROLOGY, V67, P105, DOI 10.1212/01.wnl.0000223335.86166.b4; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Grassel E, 1993, HAUSLICHE PFLEGE SKA; Grill E, 2011, J REHABIL MED, V43, P131, DOI 10.2340/16501977-0641; Grill E, 2011, J REHABIL MED, V43, P123, DOI 10.2340/16501977-0646; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Heck G, 2000, NEUROL REHABIL, V6, P125; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Thornton M, 2003, J GERONTOL B-PSYCHOL, V58, pS127, DOI 10.1093/geronb/58.2.S127; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f	29	15	17	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1870	1876		10.1016/j.apmr.2012.10.040			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	231TU	WOS:000325442100004	23732165				2022-02-06	
J	Renganathan, K; Gu, JY; Rayborn, ME; Crabb, JS; Salomon, RG; Collier, RJ; Kapin, MA; Romano, C; Hollyfield, JG; Crabb, JW				Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Salomon, Robert G.; Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Hollyfield, Joe G.; Crabb, John W.			CEP Biomarkers as Potential Tools for Monitoring Therapeutics	PLOS ONE			English	Article							5-HT1A RECEPTOR AGONIST; TRAUMATIC BRAIN-INJURY; FACTOR-H POLYMORPHISM; FACTOR-KAPPA-B; MACULAR DEGENERATION; BRUCHS MEMBRANE; SUPEROXIDE-DISMUTASE; DONOR EYES; DAMAGE; RAT	Background: Carboxyethylpyrrole (CEP) adducts are oxidative modifications derived from docosahexaenoate-containing lipids that are elevated in ocular tissues and plasma in age-related macular degeneration (AMD) and in rodents exposed to intense light. The goal of this study was to determine whether light-induced CEP adducts and autoantibodies are modulated by pretreatment with AL-8309A under conditions that prevent photo-oxidative damage of rat retina. AL-8309A is a serotonin 5-HT1A receptor agonist. Methods: Albino rats were dark adapted prior to blue light exposure. Control rats were maintained in normal cyclic light. Rats were injected subcutaneously 3x with 10 mg/kg AL-8309A (2 days, 1 day and 0 hours) before light exposure for 6 h (3.1 mW/cm(2), lambda=450 nm). Animals were sacrificed immediately following light exposure and eyes, retinas and plasma were collected. CEP adducts and autoantibodies were quantified by Western analysis or ELISA. Results: ANOVA supported significant differences in mean amounts of CEP adducts and autoantibodies among the light + vehicle, light + drug and dark control groups from both retina and plasma. Light-induced CEP adducts in retina were reduced similar to 20% following pretreatment with AL-8309A (n = 62 rats, p = 0.006) and retinal CEP immunoreactivity was less intense by immunohistochemistry. Plasma levels of light-induced CEP adducts were reduced at least 30% (n = 15 rats, p = 0.004) by drug pretreatment. Following drug treatment, average CEP autoantibody titer in light exposed rats (n = 22) was unchanged from dark control levels, and similar to 20% (p = 0.046) lower than in vehicle-treated rats. Conclusions: Light-induced CEP adducts in rat retina and plasma were significantly decreased by pretreatment with AL-8309A. These results are consistent with and extend previous studies showing AL-8309A reduces light-induced retinal lesions in rats and support CEP biomarkers as possible tools for monitoring the efficacy of select therapeutics.	[Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Crabb, John W.] Novartis Inst Biomed Res, Ft Worth, TX USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA		Crabb, JW (corresponding author), Cleveland Clin Fdn, Cole Eye Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	crabbj@ccf.org		Salomon, Robert/0000-0001-9456-3557	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM21249, EY14239, EY14240, EY15638]; Ohio Biomedical Research Technology Transfer grant [05-29]; Research Center grant from The Foundation Fighting Blindness; Llura and Gordon Gund Foundation; Research to Prevent Blindness (RPB)Research to Prevent Blindness (RPB); Macular Vision Research Foundation award; RPB Senior Investigator Award; Steinbach Award; Alcon Research LtdNovartis; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY014240, R56EY014240, R01EY014239, R24EY015638, R01EY016813, R21EY022134, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM021249] Funding Source: NIH RePORTER	This study was supported in part by National Institutes of Health (NIH) grants GM21249, EY14239, EY14240, EY15638, Ohio Biomedical Research Technology Transfer grant 05-29, a Research Center grant from The Foundation Fighting Blindness, the Llura and Gordon Gund Foundation, an unrestricted grant from Research to Prevent Blindness (RPB), a Macular Vision Research Foundation award to JGH, an RPB Senior Investigator Award to JWC, a Steinbach Award to JWC, Alcon Research Ltd, and The Cleveland Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 2003, BBA-MOL CELL RES, V1640, P85, DOI 10.1016/S0167-4889(03)00023-5; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; ALVAREZ RA, 1994, INVEST OPHTH VIS SCI, V35, P402; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bando H, 2007, EXP EYE RES, V84, P135, DOI 10.1016/j.exer.2006.09.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradford MM, 1976, CNS DRUGS, V72, P248, DOI 10.1016/0003-2697(76) 90527-3; Collier RJ, 2010, INVEST OPHTH VIS SCI, V52, P2118; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Cosi C, 2005, BRAIN RES, V1043, P32, DOI 10.1016/j.brainres.2005.02.072; Cowen DS, 1997, MOL PHARMACOL, V52, P221, DOI 10.1124/mol.52.2.221; Crabb JW, 2012, OXID STRESS APPL BAS, P65, DOI 10.1007/978-1-61779-606-7_3; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DELMELLE M, 1975, EXP EYE RES, V21, P369, DOI 10.1016/0014-4835(75)90047-0; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Druse MJ, 2006, BRAIN RES, V1092, P79, DOI 10.1016/j.brainres.2006.02.065; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fulton B, 1997, CNS DRUGS, V7, P68, DOI 10.2165/00023210-199707010-00007; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Marc RE, 2008, MOL VIS, V14, P782; Mauler F, 2005, J CEREBR BLOOD F MET, V25, P451, DOI 10.1038/sj.jcbfm.9600038; Miyagi M, 2002, MOL CELL PROTEOMICS, V1, P293, DOI 10.1074/mcp.M100034-MCP200; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Oosterink BJ, 2003, NEUROREPORT, V14, P57, DOI 10.1097/00001756-200301200-00011; Organisciak D, 2012, PHOTOCHEM PHOTOBIOL, V88, P1396, DOI 10.1111/j.1751-1097.2012.01134.x; R Development Team, 2008, R LANG ENV STAT COMP; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; RORABACHER DB, 1991, J ANAL CHEM+, V83, P139, DOI DOI 10.1021/AC00003A730; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; WANG N, 1992, CURR EYE RES, V11, P783, DOI 10.3109/02713689209000751; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200	56	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76325	10.1371/journal.pone.0076325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	WOS:000325427100059	24098476	Green Submitted, gold, Green Published			2022-02-06	
J	Andruszkow, H; Probst, C; Grun, O; Krettek, C; Hildebrand, F				Andruszkow, Hagen; Probst, Christian; Gruen, Orna; Krettek, Christian; Hildebrand, Frank			Does Additional Head Trauma Affect the Long-term Outcome After Upper Extremity Trauma in Multiple Traumatized Patients: Is There an Additional Effect of Traumatic Brain Injury?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							QUALITY-OF-LIFE; FOLLOW-UP; POLYTRAUMATIZED PATIENTS; SEVERITY SCORE; HEALTH SURVEY; MAJOR TRAUMA; FRACTURES; MODERATE; GENDER; COHORT	Musculoskeletal injuries are common in patients with multiple trauma resulting in pain, functional deficits, and disability. Traumatic brain injuries (TBIs) are common in severely injured patients potentially resulting in neurological impairment and permanent disability that would add to that from the musculoskeletal injuries. However, it is unclear to what degree the combination affects impairment. We therefore asked whether added upper extremity injuries or TBI worsened the functional, psychological, and vocational status in multiple trauma patients. We retrospectively reviewed 281 patients with multiple trauma: 229 with upper extremity injuries but without TBI (Group I), 32 with concomitant upper extremity injuries and TBI (Group II), and 20 with TBI but no upper extremity injuries (Group III). We assessed patients with the Glasgow Outcome Score (GOS), Hannover Score for Polytrauma Outcome, SF-12 (Physical Component Summary Score and Mental Component Summary Score), medical aid requirements, need of psychological support, and vocational living circumstances. The minimum followup was 10 years (median, 17.5 years; range, 10-28 years). Additional TBI in multiple trauma patients led to reduced function (GOS: Group I: 4.9 +/- 0.2, Group II: 4.5 +/- 0.7, Group III: 4.5 +/- 0.8) resulting in vocational restrictions (job change: Group I: 74%, Group II: 91%, Group III: 90%). The combination of upper extremity and TBIs did not result in worse long-term scores compared with TBI alone. Rehabilitation and social reintegration in multiple trauma patients with TBI requires particular emphasis to minimize disability and vocational isolation. Musculoskeletal injuries should not be neglected to ensure the maximum extremity function given the impaired cognitive functions after TBI. Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.	[Andruszkow, Hagen; Hildebrand, Frank] Univ Hosp Aachen, Dept Trauma & Reconstruct Surg, D-52074 Aachen, Germany; [Probst, Christian] Univ Witten Herdecke, Dept Trauma & Orthopaed Surg, Cologne Merheim Med Ctr, Fac Hlth,Sch Med, Cologne, Germany; [Gruen, Orna] Hannover Re Insurance, Hannover, Germany; [Krettek, Christian] Hannover Med Sch, Trauma Dept, Hannover, Germany		Andruszkow, H (corresponding author), Univ Hosp Aachen, Dept Trauma & Reconstruct Surg, Pauwelsstr 30, D-52074 Aachen, Germany.	handruszkow@ukaachen.de	Hildebrand, Frank/J-3176-2017	Krettek, Christian/0000-0001-9807-0020	Hannover Life Re-Insurance, Hannover, Germany	The institution of one or more of the authors (CP, CK, FH) has received, during the study period, funding from the Hannover Life Re-Insurance, Hannover, Germany.	Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dowrick AS, 2005, J TRAUMA, V58, P1175, DOI 10.1097/01.TA.0000169930.79684.4E; Dowrick AS, 2005, INJURY, V36, P468, DOI 10.1016/j.injury.2004.06.014; Ekholm R, 2006, J ORTHOP TRAUMA, V20, P591, DOI 10.1097/01.bot.0000246466.01287.04; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Helfet DL, 2003, J BONE JOINT SURG AM, V85A, P33, DOI 10.2106/00004623-200301000-00006; JENNETT B, 1975, LANCET, V1, P480; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Mkandawire NC, 2002, INJURY, V33, P111, DOI 10.1016/S0020-1383(01)00047-X; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Pfeifer R, 2012, J TRAUMA ACUTE CARE, V72, P467, DOI 10.1097/TA.0b013e318219fbfa; Probst C, 2010, J TRAUMA, V68, P706, DOI 10.1097/TA.0b013e3181a8b21c; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Stalp M, 2001, CHIRURG, V72, P312, DOI 10.1007/s001040051312; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Zeckey C, 2011, BRAIN INJURY, V25, P551, DOI 10.3109/02699052.2011.568036; Zelle BA, 2005, INJURY, V36, P169, DOI 10.1016/j.injury.2004.06.004; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670; Zunzunegui MV, 2001, J CLIN EPIDEMIOL, V54, P501, DOI 10.1016/S0895-4356(00)00325-5	36	15	15	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	2013	471	9					2899	2905		10.1007/s11999-013-3031-6			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	197VK	WOS:000322879800026	23657878	Green Published			2022-02-06	
J	Esbjornsson, E; Skoglund, T; Sunnerhagen, KS				Esbjornsson, Eva; Skoglund, Thomas; Sunnerhagen, Katharina S.			FATIGUE, PSYCHOSOCIAL ADAPTATION AND QUALITY OF LIFE ONE YEAR AFTER TRAUMATIC BRAIN INJURY AND SUSPECTED TRAUMATIC AXONAL INJURY; EVALUATIONS OF PATIENTS AND RELATIVES: A PILOT STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						head trauma; diffuse axonal injury; fatigue; cognition; quality of life; employment	SELF-AWARENESS; IMPACT; VALIDATION; MODERATE; IMPAIRMENT; DEPRESSION; SEQUELAE; RETURN; DAMAGE; SCALE	Objective: To describe fatigue and its relationship to cognition, psychosocial adjustment, quality of life (QoL), work status and relative's experiences 12 months after suspected traumatic axonal injury. Methods: Eighteen patients were assessed with the Daily Fatigue Impact Scale (D-FIS), the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS), the European Questionnaire 5 Dimensions health-related quality of life, the Glasgow Coma Outcome Scale Extended, and the European Brain Injury Questionnaire (EBIQ) (patient and relative). Return to work was registered. Results: At 1 year, fatigue still caused great problems in daily life. Although fatigue and cognition (BNIS) did not correlate, the more fatigued patients subjectively experienced significantly more cognitive dysfunction. Although D-FIS and QoL did not correlate, most patients reported that feelings of tiredness and dullness related to having lower QoL. However, lower QoL was associated with cognitive and attention disability (BNIS), subjective perception of executive dysfunction, lack of motivation, and mood disturbances (EBIQ). Neither fatigue nor cognition associated with return to work. The general consequences of traumatic axonal injury showed good agreement between patients' and relatives' experiences. Conclusion: The patient's subjective experience of the impact of traumatic axonal injury seems to be most essential, as it is the objective reality that the patient responds to, and this should therefore be assessed and treated.	[Esbjornsson, Eva; Skoglund, Thomas] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Sunnerhagen, Katharina S.] Univ Oslo, Sunnaas Rehabil Hosp, Fac Med, Oslo, Norway		Esbjornsson, E (corresponding author), Sahlgrens Univ Hosp, Dubbsgatan 14,3rd Floor, SE-41345 Gothenburg, Sweden.	esbjornsson@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400	Health and Medical Care Committee of Vastra Gotaland	The study was supported in part by a grant from the Health and Medical Care Committee of Vastra Gotaland. Cathrine Ritzen-Eriksson, Caisa Hofgren and Jerry Larsson have all been involved in logistics and assessments of patients. Without their input this work would not have been possible.	Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fisk JD, 2002, QUAL LIFE RES, V11, P263, DOI 10.1023/A:1015295106602; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; JENNETT B, 1975, LANCET, V1, P480; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Prigatano GP, 2005, ACT NEUR S, V93, P39; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 2008, BNI SCREEN HIGHER CE; Rosenstein LD., 1995, ADM SCORING MANUAL B; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; Szende Agota WA, 2004, MEASURING SELF REPOR; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	38	15	16	0	20	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					771	777		10.2340/16501977-1170			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500012	24002313	gold, Green Submitted			2022-02-06	
J	Kiehna, EN; Huffmyer, JL; Thiele, RH; Scalzo, DC; Nemergut, EC				Kiehna, Erin N.; Huffmyer, Julie L.; Thiele, Robert H.; Scalzo, David C.; Nemergut, Edward C.			Use of the intrathoracic pressure regulator to lower intracranial pressure in patients with altered intracranial elastance: a pilot study Clinical article	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; intracranial hypertension; intrathoracic pressure regulator	ORGAN PERFUSION PRESSURES; PORCINE MODEL	Object. The intrathoracic pressure regulator (ITPR) is a novel noninvasive device designed to increase circulation and blood pressure. By applying negative pressure during the expiratory phase of ventilation it decreases intrathoracic pressure and enhances venous return, which increases cardiac output. It is possible that the ITPR may both decrease intracranial pressure (ICP) and increase cerebral perfusion pressure (CPP) in brain-injured patients by decreasing cerebral venous blood volume and increasing cardiac output. The authors conducted an open-label, "first-in-humans" study of the ITPR in patients with an ICP monitor or external ventricular drain and altered intracranial elastance. Methods. This prospective randomized trial commenced July 2009. Baseline hemodynamic variables and ICP were recorded prior to inserting one of the two ITPRs into the ventilator circuit based on a randomization scheme. Depending on the device selected, activation provided either -5 or -9 mm Hg endotracheal tube pressure. Hemodynamic and ICP data were recorded sequentially every 2 minutes for 10 minutes. The first device was turned off for 10 minutes, then it was removed and the second device was applied, and then the procedure was repeated for the second device. Results. Ten patients with elevated ICP secondary to intracranial hemorrhage (n = 4), trauma (n = 2), obstructive hydrocephalus (n = 2), or diffuse cerebral processes (n = 2) were enrolled. Baseline ICP ranged from 12 to 38 mm Hg. With device application, a decrease in ICP was observed in 16 of 20 applications. During treatment with the 5 mm Hg device, there was a mean maximal decrease of 3.3 mm Hg in ICP (21.7 vs 18.4 mm Hg, p = 0.003), which was associated with an increase in CPP of 6.5 mm Hg (58.2 vs 64.7 mm Hg, p = 0.019). During treatment with the 9 mm Hg device, there was a mean maximal decrease of 2.4 mm Hg in ICP (21.1 vs 18.7 mm Hg, p = 0.044), which was associated with an increase in CPP of 6.5 mm Hg (59.2 vs 65.7 mm Hg, p = 0.001). Conclusions. This pilot study demonstrates that use of the ITPR in patients with altered intracranial elastance is feasible. Although this study was not powered to demonstrate efficacy, these data strongly suggest that the ITPR may be used to rapidly lower ICP and increase CPP without apparent adverse effects. Additional studies will be needed to assess longitudinal changes in ICP when the device is in use and to delineate treatment parameters.	[Kiehna, Erin N.] Hosp Sick Children, Dept Neurosurg, Toronto, ON M5G 1X8, Canada; [Huffmyer, Julie L.; Thiele, Robert H.; Scalzo, David C.; Nemergut, Edward C.] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22908 USA		Nemergut, EC (corresponding author), Univ Virginia Hlth Syst, Dept Anesthesiol, POB 800710, Charlottesville, VA 22908 USA.	en3x@virginia.edu		Thiele, Robert/0000-0001-7262-0653; Kiehna, Erin/0000-0002-2289-3917			Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Huffmyer JL, 2011, SHOCK, V35, P114, DOI 10.1097/SHK.0b013e3181f7d92b; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Yannopoulos D, 2005, CIRCULATION, V112, P803, DOI 10.1161/CIRCULATIONAHA.105.541508; Yannopoulos D, 2006, CRIT CARE MED, V34, pS495, DOI 10.1097/01.CCM.0000246082.10422.7E; Yannopoulos D, 2006, RESUSCITATION, V70, P445, DOI 10.1016/j.resuscitation.2006.02.005; Yannopoulos D, 2007, ANESTH ANALG, V104, P157, DOI 10.1213/01.ane.0000249047.80184.5a	9	15	16	2	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2013	119	3					756	759		10.3171/2013.4.JNS122489			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	204IJ	WOS:000323358700027	23706051				2022-02-06	
J	Li, AH; Zou, FH; Fu, HR; Cui, G; Yan, YH; Wu, QY; Gu, XX				Li, Aihong; Zou, Feihui; Fu, Hongran; Cui, Gang; Yan, Yaohua; Wu, Qiyun; Gu, Xingxing			Upregulation of CRM1 Relates to Neuronal Apoptosis after Traumatic Brain Injury in Adult Rats	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						CRM1; P27(Kip1); Traumatic brain injury; Apoptosis; Rat	NUCLEAR EXPORT; GROWTH-FACTOR; S-PHASE; P27(KIP1); DEGRADATION; PHOSPHORYLATION; BINDING; SKP2; EXPRESSION; INHIBITORS	Traumatic brain injury (TBI) initiates a complex series of neurochemical and signaling changes that leads to neuronal dysfunction and over-reactive astrocytes. There is increasing evidence that CRM1 mediated P27(Kip1), which is a potent inhibitor of G1 cyclin-dependent kinases complexes, nuclear export-dependent or -independent Jab1/CSN5, and cytoplasmic degradation in cells. Up to now, the function of CRM1 in central nervous system (CNS) is still with limited acquaintance. In our study, to investigate whether CRM1 is involved in CNS lesion, we performed a TBI model in adult rats. Western blot and RT-PCR analysis revealed that the level of protein and mRNA of CRM1 increased in ipsilateral brain cortex in comparison to the contralateral. Immunohistochemistry and immunofluorescence double labeling indicated that CRM1 was shutting into nucleus around the wound, and increased CRM1 co-localized with P27(Kip1). Terminal deoxynucleotidyl transferase deoxy-UTP-nick end labeling (TUNEL) staining suggested that CRM1 was involved in neuronal apoptosis after brain injury. We also investigated co-localization of CRM1 and active-caspase-3 in the ipsilateral brain cortex. In addition, the expression patterns of Bax and active-caspase-3 were parallel with that of CRM1. Based on our data, we suggested that CRM1 might play an important role in neuronal apoptosis following TBI, and might provide a basis for the further study on its role in regulating the expression of P27(Kip1) and cell cycle re-entry in TBI.	[Li, Aihong; Zou, Feihui; Fu, Hongran; Cui, Gang; Yan, Yaohua] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Wu, Qiyun; Gu, Xingxing] Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China		Wu, QY (corresponding author), Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	zoufeihui666@gmail.com; xiaofu6666@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31071288]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31071288) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; de Late PL, 2010, J BIOL CHEM, V285, P5594, DOI 10.1074/jbc.M109.068346; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Foster JS, 2003, J BIOL CHEM, V278, P41355, DOI 10.1074/jbc.M302830200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOGAN A, 1992, J NEUROSCI, V12, P3828; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Mock C, 2005, J TRAUMA, V59, P1243, DOI 10.1097/01.ta.0000197290.02807.de; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Muller D, 2000, EMBO J, V19, P2168, DOI 10.1093/emboj/19.10.2168; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Swanson C, 2000, P NATL ACAD SCI USA, V97, P7796, DOI 10.1073/pnas.97.14.7796; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wu XJ, 2012, J MOL NEUROSCI, V46, P184, DOI 10.1007/s12031-011-9572-9; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zou FH, 2013, J MOL NEUROSCI, V49, P395, DOI 10.1007/s12031-012-9906-2	49	15	15	1	14	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2013	51	1					208	218		10.1007/s12031-013-9994-7			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	211PJ	WOS:000323921000022	23494640				2022-02-06	
J	Sundaram, NK; Geer, EB; Greenwald, BD				Sundaram, Nina K.; Geer, Eliza B.; Greenwald, Brian D.			The Impact of Traumatic Brain Injury on Pituitary Function	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Hypopituitarism; Hormone replacement therapy; Screening; Diagnosis; Pathophysiology; Neurocognitive impairment; Outcome	GROWTH-HORMONE GH; QUALITY-OF-LIFE; BONE-MINERAL DENSITY; ADRENOCORTICOTROPIN STIMULATION TEST; ANEURYSMAL SUBARACHNOID HEMORRHAGE; INSULIN TOLERANCE-TEST; REPLACEMENT THERAPY; LONG-TERM; BODY-COMPOSITION; DEFICIENT PATIENTS	It is paramount that clinicians who care for patients with traumatic brain injury (TBI) at any point in time, including neurosurgeons, rehabilitation physicians, internists, neurologists, and endocrinologists, are aware of the prevalence of posttraumatic hypopituitarism and its impacts on acute and long-term recovery. This article reviews the natural history, pathophysiology, and presenting features of hypopituitarism occurring after TBI. Proposed methodologies for screening, diagnosis, and initiation of treatment are discussed, as well as the effect of hormone replacement therapy on clinical outcomes.	[Sundaram, Nina K.; Geer, Eliza B.] Mt Sinai Hosp, Med Ctr, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Greenwald, Brian D.] JFK Johnson Rehabil Ctr Head Injuries, Edison, NJ 08818 USA; [Greenwald, Brian D.] UMDNJ Robert Wood Johnson Med Sch, JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ 08818 USA		Geer, EB (corresponding author), Mt Sinai Hosp, Med Ctr, Div Endocrinol Diabet & Bone Dis, 1 Gustave L Levy Pl,Box 1055, New York, NY 10029 USA.	eliza.geer@mssm.edu					Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Alexander GM, 1998, HORM BEHAV, V33, P85, DOI 10.1006/hbeh.1998.1439; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Amory JK, 2004, J CLIN ENDOCR METAB, V89, P503, DOI 10.1210/jc.2003-031110; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P1600, DOI 10.1210/jc.87.4.1600; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P3368, DOI 10.1210/jc.87.7.3368; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Behre HM, 1997, J CLIN ENDOCR METAB, V82, P2386, DOI 10.1210/jc.82.8.2386; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Biller BMK, 2000, J CLIN ENDOCR METAB, V85, P970, DOI 10.1210/jc.85.3.970; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bleicken B, 2010, CLIN ENDOCRINOL, V72, P297, DOI 10.1111/j.1365-2265.2009.03596.x; Bollerslev J, 2006, EUR J ENDOCRINOL, V154, P537, DOI 10.1530/eje.1.02125; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Cherrier MM, 2003, J ANDROL, V24, P568; Chou YC, 2009, BRAIN INJURY, V23, P1095, DOI 10.3109/02699050903379396; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Cleemann L, 2009, EUR J ENDOCRINOL, V161, P251, DOI 10.1530/EJE-09-0020; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dokmetas HS, 2000, J CLIN ENDOCR METAB, V85, P3713, DOI 10.1210/jc.85.10.3713; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; EDWARDS OM, 1986, MEDICINE, V65, P281; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Faul M, 2010, TRAUMATIC BRAIN INJU; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Gotherstrom G, 2007, EUR J ENDOCRINOL, V156, P55, DOI 10.1530/eje.1.02317; Gotherstrom G, 2009, J CLIN ENDOCR METAB, V94, P809, DOI 10.1210/jc.2008-1538; Greenwald BD, 2009, MED MANAGEMENT ADULT, P363; Hana V, 2002, EUR J ENDOCRINOL, V147, P333, DOI 10.1530/eje.0.1470333; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; Institute of Medicine, 2009, GULF WAR HLTH, V7; Ives JC, 2007, J ATHL TRAINING, V42, P431; Jacobs DM, 1998, NEUROLOGY, V50, P368, DOI 10.1212/WNL.50.2.368; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khastgir G, 2003, J BONE MINER RES, V18, P925, DOI 10.1359/jbmr.2003.18.5.925; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langenheim J, 2013, HORM METAB RES, V45, P96, DOI 10.1055/s-0032-1316293; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Maruff P, 2005, HORM RES, V64, P100, DOI 10.1159/000089325; McAllister TW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1034; Miller KJ, 2006, INT J NEUROSCI, V116, P895, DOI 10.1080/00207450600550154; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Murray RD, 1999, CLIN ENDOCRINOL, V51, P565, DOI 10.1046/j.1365-2265.1999.00838.x; Napoli R, 2003, J CLIN ENDOCR METAB, V88, P2817, DOI 10.1210/jc.2003-030144; Oertel H, 2004, PSYCHONEUROENDOCRINO, V29, P839, DOI 10.1016/S0306-4530(03)00151-3; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poomthavorn P, 2007, EUR J PEDIATR, V166, P1163, DOI 10.1007/s00431-006-0406-7; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rosano GMC, 2006, ANN NY ACAD SCI, V1092, P341, DOI 10.1196/annals.1365.031; Rosario ER, 2012, J HEAD TRAUMA REHAB, V28, P1; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; Ross JL, 2000, NEUROLOGY, V54, P164, DOI 10.1212/WNL.54.1.164; Ross JL, 1998, J CLIN ENDOCR METAB, V83, P3198, DOI 10.1210/jc.83.9.3198; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels MH, 2007, THYROID, V17, P249, DOI 10.1089/thy.2006.0252; Sathiavageeswaran M, 2007, EUR J ENDOCRINOL, V156, P439, DOI 10.1530/eje.1.02346; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Schmidt IL, 2003, J CLIN ENDOCR METAB, V88, P4193, DOI 10.1210/jc.2002-021897; Schmidt R, 1996, J AM GERIATR SOC, V44, P1307, DOI 10.1111/j.1532-5415.1996.tb01400.x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Shalet SM, 2003, J CLIN ENDOCR METAB, V88, P4124, DOI 10.1210/jc.2003-030126; SHERWIN BB, 1994, ANN NY ACAD SCI, V743, P213, DOI 10.1111/j.1749-6632.1994.tb55794.x; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Silha JV, 2005, CLIN ENDOCRINOL, V63, P79, DOI 10.1111/j.1365-2265.2005.02303.x; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Soares CD, 2001, ARCH GEN PSYCHIAT, V58, P529; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Streeten DHP, 1996, J CLIN ENDOCR METAB, V81, P285, DOI 10.1210/jc.81.1.285; Takala RSK, 2006, NEUROCRIT CARE, V4, P21, DOI 10.1385/NCC:4:1:021; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Tuchelt H, 2000, CLIN ENDOCRINOL, V53, P301, DOI 10.1046/j.1365-2265.2000.01089.x; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Widdowson WM, 2008, J CLIN ENDOCR METAB, V93, P4413, DOI 10.1210/jc.2008-1239; Wiren L, 1998, CLIN ENDOCRINOL, V48, P613, DOI 10.1046/j.1365-2265.1998.00462.x; Woodhouse LJ, 1999, J CLIN ENDOCR METAB, V84, P4570, DOI 10.1210/jc.84.12.4570; Ye P, 1999, ENDOCRINOLOGY, V140, P3063, DOI 10.1210/en.140.7.3063; Ye P, 2002, J NEUROSCI, V22, P6041; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426; Zhong J, 2005, J NEUROSCI RES, V80, P481, DOI 10.1002/jnr.20490; Zweifel JE, 1997, PSYCHONEUROENDOCRINO, V22, P189, DOI 10.1016/S0306-4530(96)00034-0	134	15	15	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	SEP	2013	42	3					565	+		10.1016/j.ecl.2013.05.003			20	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	228MO	WOS:000325191100011	24011887				2022-02-06	
J	Abdel-Rahman, N; Siman-Tov, M; Peleg, K				Abdel-Rahman, Nura; Siman-Tov, Maya; Peleg, Kobi		Israel Trauma Grp	Ethnicity and road traffic injuries: differences between Jewish and Arab children in Israel	ETHNICITY & HEALTH			English	Article						ethnic groups; road traffic injury; children; trauma; minority and majority population	MORTALITY	Objective. To examine the differences and characteristics of road traffic injuries (RTIs) among Jewish and Arab children, ages 0-17 years, in Israel. Design. A retrospective study based on data from the Israeli National Trauma Registry between 2001 and 2010. This study relates specifically to traffic-related hospitalizations among children ages 0-17 years. Data include demographic, injury, and hospitalization characteristics. Descriptive statistics and adjusted logistic regression were used to examine the differences of RTIs between the two ethnic groups. Results. A total of 18,884 children were included, of which Arab children comprised 38.2% of the total and 44.1% of the severely injured. Among Arab children 41.8% were pedestrians compared to 33.4% among Jewish children (p<0.0001). Arab children were younger, had more severe injuries and more traumatic brain injury (TBI) compared to Jewish children. Adjusted logistic regression analysis shows that the probability of an Arab child, relative to a Jewish child, to undergo surgical procedures was 1.2 (p<0.0001), to be hospitalized in intensive care units (ICUs) was 0.8 (p=0.003), and to be transferred to rehabilitation was 0.5 (p<0.0001). There was no significant difference in inpatient mortality between the two ethnic groups. Conclusions. Arab children in Israel are more likely to be hospitalized due to road accidents in comparison to Jewish children. Intervention programs should focus on Arab children and their unique characteristics.	[Abdel-Rahman, Nura; Siman-Tov, Maya; Peleg, Kobi] Gertner Inst Epidemiol & Publ Hlth Policy, Israel Natl Ctr Trauma & Emergency Med, Ramat Gan, Israel; [Peleg, Kobi] Tel Aviv Univ, Sch Publ Hlth, Dept Disaster Management, IL-69978 Tel Aviv, Israel		Peleg, K (corresponding author), Gertner Inst Epidemiol & Publ Hlth Policy, Israel Natl Ctr Trauma & Emergency Med, Ramat Gan, Israel.	kobip@gertner.health.gov.il					Abu-Asbah K., 2009, MASSAR I PUBLICATION, V1058; Baron-Epel O., 2007, CHARACTERIZATION KNO; Campos-Outcalt D, 2003, INJURY PREV, V9, P251, DOI 10.1136/ip.9.3.251; CBS, 2010, 3 CBS SOC ISR; CBS, 2010, JER STAT ABSTR ISR 6; CBS, 2010, ROAD ACC CAS SPEC SE; CBS, 2011, JERUSALEM; Central Bureau of Statistics (CBS), 2009, LIC DRIV; Champion HR, 1995, TRAUMA, P53; Gitelman V., 2010, ACCID ANAL PREV, V44, P63, DOI [10.1016/j.aap.2010.11.01722062338, DOI 10.1016/J.AAP.2010.11.01722062338]; Gofin R, 2002, INT J EPIDEMIOL, V31, P593, DOI 10.1093/ije/31.3.593; Gofin R, 2007, ISRAEL MED ASSOC J, V9, P724; Laflamme L, 2000, Inj Prev, V6, P293, DOI 10.1136/ip.6.4.293; Lavancovsky M., 2011, BETERMEN SAFE KIDS I, V1072; MACKELLAR A, 1995, MED J AUSTRALIA, V162, P238, DOI 10.5694/j.1326-5377.1995.tb139875.x; Moran M, 2010, TRANSPORT RES F-TRAF, V13, P377, DOI 10.1016/j.trf.2010.07.001; Naeem Z, 2010, INT J HLTH SCI QASSI, V4, pV; National Road Safety Authority in Israel (RSA), 2003, CHAR CAUS CAR ACC AR; Peleg K., 2005, EQUALITY AVAILABILIT; Savitsky B, 2007, ETHNIC HEALTH, V12, P129, DOI 10.1080/13557850601002171; Steinbach R, 2010, HEALTH PLACE, V16, P34, DOI 10.1016/j.healthplace.2009.08.002; Stirbu I, 2006, J EPIDEMIOL COMMUN H, V60, P249, DOI 10.1136/jech.2005.037325; World Health Organization, 2009, GLOB STAT REP ROAD S	23	15	15	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-7858	1465-3419		ETHNIC HEALTH	Ethn. Health	AUG 1	2013	18	4					391	401		10.1080/13557858.2012.754405			11	Ethnic Studies; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ethnic Studies; Public, Environmental & Occupational Health	188RO	WOS:000322211500004	23289984				2022-02-06	
J	Greiner, MV; Berger, RP; Thackeray, JD; Lindberg, DM				Greiner, Mary V.; Berger, Rachel P.; Thackeray, Jonathan D.; Lindberg, Daniel M.		Examining Siblings Recognize Abuse	Dedicated Retinal Examination in Children Evaluated for Physical Abuse without Radiographically Identified Traumatic Brain Injury	JOURNAL OF PEDIATRICS			English	Article							HEPATIC TRANSAMINASES; SKELETAL SURVEYS; HEMORRHAGES; PREVALENCE; UTILITY	Objective To determine the rate of retinal hemorrhages in children evaluated for physical abuse without traumatic brain injury (TBI) by diagnostic imaging. Study design This study was a prospectively planned, secondary analysis of the Examining Siblings to Recognize Abuse (ExSTRA) research network, and included only index children who presented with concerns for abuse. Subjects were eligible for the parent study if they were less than 10 years old and evaluated by a Child Abuse Physician for concerns of physical abuse. Child Abuse Physicians recorded results of all screening testing and determination of the likelihood of abuse in each case. For this analysis, we examined the results of dedicated retinal examinations for children with neuroimaging that showed no TBI. Isolated skull fractures were not considered to be TBI. Results The original ExSTRA sample included 2890 index children evaluated for physical abuse. Of this group, 1692 underwent neuroimaging and 1122 had no TBI. Of these 1122 children, 352 had a dedicated retinal examination. Retinal hemorrhages were identified in 2 (0.6%) children. In both cases, there were few (defined as 3-10) hemorrhages isolated to the posterior poles; neither was diagnosed with physical abuse. The presence of facial bruising, altered mental status, or complex skull fractures was neither sensitive nor specific for retinal hemorrhage identification. Conclusions Forensically significant retinal hemorrhages are unlikely to be found in children evaluated for physical abuse without TBI on neuroimaging, and such children may not require routine dedicated retinal examination.	[Greiner, Mary V.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Berger, Rachel P.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Thackeray, Jonathan D.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Lindberg, Daniel M.] Boston Childrens Hosp, Brigham & Womens Hosp, Dept Emergency Med, Boston, MA USA		Greiner, MV (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,ML 3008, Cincinnati, OH 45229 USA.	mary.greiner@cchmc.org			Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program [H34MC19346-01-02]; Harvard Medical School	Supported by the Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program (H34MC19346-01-02). D. L. is funded in part by an Eleanor and Miles Shore Fellowship for Scholars in Medicine from Harvard Medical School. J.T. and D. L. have provided paid expert witness testimony, for both the prosecution and defense, in cases of alleged child abuse. The other authors declare no conflicts of interest.	Agrawal S, 2012, PEDIATRICS, V129, pE1388, DOI 10.1542/peds.2011-2772; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Levin AV, 2010, PEDIATRICS, V126, P376, DOI 10.1542/peds.2010-1397; Li SM, 2011, ARCH PEDIAT ADOL MED, V165, P913, DOI 10.1001/archpediatrics.2011.150; Lindberg D, 2009, PEDIATRICS, V124, P509, DOI 10.1542/peds.2008-2348; Lindberg DM, 2013, PEDIATRICS, V131, P268, DOI 10.1542/peds.2012-1952; Lindberg DM, 2012, PEDIATRICS, V130, P193, DOI 10.1542/peds.2012-0085; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Morad Y, 2004, J AAPOS, V8, P445, DOI 10.1016/j.jaapos.2004.06.007; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Offiah A, 2009, PEDIATR RADIOL, V39, P461, DOI 10.1007/s00247-009-1157-1; Pitetti RD, 2002, PEDIATRICS, V110, P557, DOI 10.1542/peds.110.3.557; Reece R.M., 2009, CHILD ABUSE MED DIAG, V3rd; Thackeray JD, 2010, PEDIATRICS, V125, pE1066, DOI 10.1542/peds.2009-2184; Ziemssen R, 2010, PEDIATRICS	23	15	15	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	AUG	2013	163	2					527	+		10.1016/j.jpeds.2013.01.063			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	198YG	WOS:000322959500045	23498157				2022-02-06	
J	Lee, SC; Kang, SW; Kim, MT; Kim, YK; Chang, WH; Im, SH				Lee, Sang Chul; Kang, Seong-Woong; Kim, Min Tae; Kim, Yong Kyun; Chang, Won Hyuk; Im, Sang Hee			Correlation Between Voluntary Cough and Laryngeal Cough Reflex Flows in Patients With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Aspiration; Brain injuries; Cough; Rehabilitation	ASPIRATION FOLLOWING STROKE; DEVELOPING PNEUMONIA; RISK	Objective: To correlate voluntary cough and laryngeal cough reflex (LCR) flows in patients with traumatic brain injury (TBI). Design: Cross-sectional study. Setting: University rehabilitation hospital. Participants: Patients with TBI (n=25) and healthy controls (n=48). Interventions: Not applicable. Main Outcome Measures: Peak cough flows (PCFs) and LCR flows were measured using a peak flow meter at the oral-nasal interface. The largest value of 3 attempts was recorded for PCF and LCR, respectively. LCR was elicited by 20% solution of pharmaceutic-grade citric acid dissolved in sterile .15M NaCl solution that was inhaled from a nebulizer. Results: PCF was 447.4 +/- 99.0L/min in the control group and 211.7 +/- 58.2L/min in the patient group. LCR was 209.2 +/- 63.8L/min in the control group and 170.0 +/- 59.7L/min in the patient group. Both PCF (P=.000) and LCR (P=.013) were significantly reduced in patients with TBI compared to that of the control group. LCR was strongly related to the PCF in both control (R=.645; P=.000) and patient (R=.711; P=.000) groups. Conclusions: As LCR can be measured as a numerical value and significantly correlates with PCF, LCR can be used to estimate cough ability of patients with TBI who cannot cooperate with PCF measurement. (c) 2013 by the American Congress of Rehabilitation Medicine	[Lee, Sang Chul; Kim, Min Tae; Kim, Yong Kyun; Im, Sang Hee] Kwandong Univ, Coll Med, Dept Phys Med & Rehabil, Gyunggi, South Korea; [Kang, Seong-Woong] Yonsei Univ, Coll Med, Rehabil Inst Muscular Dis, Dept Rehabil Med, Seoul, South Korea; [Chang, Won Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Phys & Rehabil Med, Suwon, South Korea		Im, SH (corresponding author), Kwandong Univ, Coll Med, Dept Phys Med & Rehabil, 697-24 Hwajungdong, Goyang, Gyunggi, South Korea.	dongin32@yahoo.com		IM, Sang Hee/0000-0001-5128-5526; Kang, Seong-Woong/0000-0002-7279-3893			Addington W Robert, 2005, Cough, V1, P4, DOI 10.1186/1745-9974-1-4; Addington WR, 1999, ARCH PHYS MED REHAB, V80, P150, DOI 10.1016/S0003-9993(99)90112-0; Addington WR, 1999, STROKE, V30, P1203, DOI 10.1161/01.STR.30.6.1203; Addington WR, 1998, AM J PHYS MED REHAB, V77, P523, DOI 10.1097/00002060-199811000-00014; Bach JR, 1996, CHEST, V110, P1566, DOI 10.1378/chest.110.6.1566; Croghan John E., 1994, Dysphagia, V9, P141, DOI 10.1007/BF00341256; Daniels SK, 1999, J NEUROIMAGING, V9, P91, DOI 10.1111/jon19999291; Hammond CAS, 2001, NEUROLOGY, V56, P502, DOI 10.1212/WNL.56.4.502; HORNER J, 1988, NEUROLOGY, V38, P317, DOI 10.1212/WNL.38.2.317; JOHNSON ER, 1993, ARCH PHYS MED REHAB, V74, P973; Nakajoh K, 2000, J INTERN MED, V247, P39, DOI 10.1046/j.1365-2796.2000.00565.x; Smithard DG, 1997, CLIN REHABIL, V11, P73, DOI 10.1177/026921559701100111; Wagner A, 2011, PHYS MED REHABILITAT, P1133; Ward K, 2010, EUR RESPIR J, V36, P1383, DOI 10.1183/09031936.00010510; Wiercisiewski DR, 1998, J HEAD TRAUMA REHAB, V13, P28, DOI 10.1097/00001199-199802000-00006	15	15	15	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2013	94	8					1580	1583		10.1016/j.apmr.2012.11.006			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	196TZ	WOS:000322801600021	23154134				2022-02-06	
J	Russell, KL; Berman, NEJ; Levant, B				Russell, Kristin L.; Berman, Nancy E. J.; Levant, Beth			Low brain DHA content worsens sensorimotor outcomes after TBI and decreases TBI-induced Timp1 expression in juvenile rats	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Traumatic brain injury; Juvenile; Sensorimotor; Docosahexaenoic acid; TIMP-1; Matrix metalloproteinase	POLYUNSATURATED FATTY-ACIDS; CENTRAL-NERVOUS-SYSTEM; DOCOSAHEXAENOIC ACID; TISSUE INHIBITOR; SPINAL-CORD; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; UNIQUE FEATURES; CORTICAL IMPACT; PEDIATRIC SKULL	The effects of dietary modulation of brain DHA content on outcomes after TBI were examined in a juvenile rat model. Long-Evans rats with normal or diet-induced decreases in brain DHA were subjected to a controlled cortical impact or sham surgery on postnatal day 17. Rats with the greatest decreases in brain DHA had the poorest sensorimotor outcomes after TBI. Ccl2, Gfap, and Mmp 9 mRNA levels, and MMP-2 and -9 enzymatic activities were increased after TBI regardless of brain DHA level. Lesion volume was not affected by brain DHA level. In contrast, TBI-induced Timp1 expression was lower in rats on the Deficient diet and correlated with brain DHA level. These data suggest that decreased brain DHA content contributes to poorer sensorimotor outcomes after TBI through a mechanism involving modulation of Timp1 expression. (C) 2013 Elsevier Ltd. All rights reserved.	[Russell, Kristin L.; Levant, Beth] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA		Levant, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	krussell@kumc.edu; nberman@kumc.edu; blevant@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 HD059939, P30 HD02528, P20 GM103418, T32 ES007079, T32 HD007523]; University of Kansas Medical Center Biomedical Research Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007523, R03HD059939] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER	The authors thank Andrew Ralya, Ph.D. and Patrick Gregg for technical assistance. Supported by NIH R03 HD059939 (B.L.), P30 HD02528 (B.L., N.E.J.B.), P20 GM103418 (B.L.), T32 ES007079 (K.L.R.), T32 HD007523 (K.L.R.), and the University of Kansas Medical Center Biomedical Research Training Program (K.L.R.).	Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Davis AS, 2010, APPL NEUROPSYCHOL, V17, P104, DOI 10.1080/09084281003708951; Faul M, 2010, TRAUMATIC BRAIN INJU; Favreliere S, 1998, LIPIDS, V33, P401, DOI 10.1007/s11745-998-0221-y; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; GALLI C, 1971, BIOCHIM BIOPHYS ACTA, V248, P449, DOI 10.1016/0005-2760(71)90233-5; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Gordon N, 1997, BRAIN DEV-JPN, V19, P165, DOI 10.1016/S0387-7604(96)00560-8; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Javierre C, 2006, J PHYSIOL BIOCHEM, V62, P271, DOI 10.1007/BF03165756; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jourquin J, 2005, EUR J NEUROSCI, V22, P2569, DOI 10.1111/j.1460-9568.2005.04426.x; Khan SA, 2003, J NUTR BIOCHEM, V14, P554, DOI 10.1016/S0955-2863(03)00098-6; Kozul CD, 2008, CHEM-BIOL INTERACT, V173, P129, DOI 10.1016/j.cbi.2008.02.008; Levant B, 2004, BEHAV BRAIN RES, V152, P49, DOI 10.1016/j.bbr.2003.09.029; Levant B, 2008, PSYCHONEUROENDOCRINO, V33, P1279, DOI 10.1016/j.psyneuen.2008.06.012; Levant B, 2006, PHYSIOL BEHAV, V89, P196, DOI 10.1016/j.physbeh.2006.06.007; Levant B, 2006, LIPIDS, V41, P407, DOI 10.1007/s11745-006-5114-6; Levant B, 2006, J NUTR, V136, P2236, DOI 10.1093/jn/136.8.2236; Levant B, 2010, PHYSIOL BEHAV, V101, P176, DOI 10.1016/j.physbeh.2010.04.038; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Narayana PA, 2004, J NEUROSCI RES, V78, P749, DOI 10.1002/jnr.20275; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Orr SK., 2012, PROSTAGLANDINS LEUKO; Ozias MK, 2007, J NUTR, V137, P125, DOI 10.1093/jn/137.1.125; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Rasband W.S, 1997, IMAGEJ US; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shaikh SR, 2012, J NUTR BIOCHEM, V23, P101, DOI 10.1016/j.jnutbio.2011.07.001; SHERWOOD NM, 1970, STEREOTAXIC ATLAS DE; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; SINCLAIR AJ, 1975, P NUTR SOC, V34, P287, DOI 10.1079/PNS19750051; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vancassel S, 2007, BEHAV BRAIN RES, V180, P119, DOI 10.1016/j.bbr.2007.02.032; Wainwright PE, 1998, J NUTR, V128, P661, DOI 10.1093/jn/128.3.661; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; WRIGHT LL, 1977, DEV PSYCHOBIOL, V10, P331, DOI 10.1002/dev.420100407; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Yang DY, 2007, NEUROTOXICOLOGY, V28, P1220, DOI 10.1016/j.neuro.2007.08.003; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	74	15	15	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	AUG	2013	89	2-3					97	105		10.1016/j.plefa.2013.05.004			9	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	198RH	WOS:000322939500006	23796971	Green Accepted			2022-02-06	
J	Sabre, L; Tomberg, T; Korv, J; Kepler, J; Kepler, K; Linnamagi, U; Asser, T				Sabre, L.; Tomberg, T.; Korv, J.; Kepler, J.; Kepler, K.; Linnamaegi, Ue; Asser, T.			Brain activation in the acute phase of traumatic spinal cord injury	SPINAL CORD			English	Article						traumatic spinal cord injury; functional magnetic resonance imaging; cortical reorganisation	MOTOR CORTEX; REORGANIZATION; SYSTEM; FMRI	Study design: Prospective clinical study. Background: The aim of the study was to investigate cortical reorganisation after traumatic spinal cord injury (TSCI) using functional magnetic resonance imaging (fMRI). Setting: Tartu University Hospital, Tartu, Estonia. Methods: We studied six right-handed tetraplegic TSCI patients at 1, 3 and 12 months after the injury and 12 age-and gender-matched healthy controls. Individuals performed simple test-rest cycles of flexion/extension of the right-hand fingers and flexion/extension of the right ankle during fMRI. The volumes of activation (VOA), maximum t-values, centres of gravity (COG) and weighted laterality indexes were calculated. Results: There was no recovery of neurologic function in three patients and, according to the American Spinal Injury Association (ASIA) Impairment Scale the remaining three recovered. A positive correlation between the VOA in the primary motor cortex and the ASIA Impairment Scale (1 month: r-0.82, P-0.002; 3 Month: r-0.63, P-0.03; 12 Month: r-0.23, P-0.52) was found. The study also revealed a pattern of cortical activation that was increased among the patients who recovered (in Brodmann area 4 (BA 4), P = 0.06; BA 1-2-3-5, P = 0.08; BA 6, P = 0.05). During the hand task there was an expansion of COG laterally, anteriorly and inferiorly among the patients who recovered. During the hand movement the cortical activation was less lateralised among the patients compared with the controls (P<0.05). Conclusion: Our study has found broadening of cortical activation and shift of COG during the first year after TSCI, depending on the recovery.	[Sabre, L.; Tomberg, T.; Korv, J.; Linnamaegi, Ue; Asser, T.] Univ Tartu, Dept Neurol & Neurosurg, EE-51014 Tartu, Estonia; [Tomberg, T.] Tartu Univ Hosp, Radiol Clin, Tartu, Estonia; [Kepler, J.] Parnu Hosp, Diagnost Serv, Parnu, Estonia; [Kepler, K.] Univ Tartu, Inst Phys, EE-51014 Tartu, Estonia		Sabre, L (corresponding author), Univ Tartu, Dept Neurol & Neurosurg, 8 L Puusepa St, EE-51014 Tartu, Estonia.	liis.sabre@ut.ee	Asser, Toomas/G-8446-2015; Sabre, Liis/D-7931-2014; Korv, Janika/I-4395-2015	Sabre, Liis/0000-0002-5727-8404; Korv, Janika/0000-0002-6074-0727	Estonian Science Foundation [7868]; Estonian Ministry of Education and ResearchMinistry of Education and Research, Estonia [SF0180064s07]	This study was supported by the Estonian Science Foundation research grant number 7868 and the targeted financing from the Estonian Ministry of Education and Research number SF0180064s07. We thank the nurses of the Radiology Clinic, Tartu University Hospital, for their kind help in performing the study.	Brett M., 2002, NEUROIMAGE, DOI 10.1016/S1053-8119(02)90010-8; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Kokotilo KJ, 2009, J NEUROL PHYS THER, V33, P45, DOI 10.1097/NPT.0b013e31819824f0; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Lotze M, 1999, RESTOR NEUROL NEUROS, V14, P183; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mikulis DJ, 2002, NEUROLOGY, V58, P794, DOI 10.1212/WNL.58.5.794; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Streletz Leopold J., 1995, Brain Topography, V7, P245, DOI 10.1007/BF01202383; Tomberg T, 2012, SPINAL CORD, V50, P885, DOI 10.1038/sc.2012.70; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010	19	15	20	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	AUG	2013	51	8					623	629		10.1038/sc.2013.41			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	196LS	WOS:000322777600008	23689388	Bronze			2022-02-06	
J	Wing, R; James, C				Wing, Robyn; James, Catherine			Pediatric Head Injury and Concussion	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Head injury; Concussion; Mild traumatic brain injury; Return to play; Postconcussive syndrome; Abusive head trauma; Pediatric	TRAUMATIC BRAIN-INJURY; CRANIAL COMPUTED-TOMOGRAPHY; SPORT-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; RAPID-SEQUENCE INTUBATION; GLASGOW COMA SCALE; HIGH-SCHOOL; STANDARDIZED ASSESSMENT; INTRACRANIAL-PRESSURE; SKULL FRACTURES	Children with head injuries frequently present to emergency departments. Even though most of these children have minor injuries, head injury is the most common cause of traumatic deaths in pediatric patients. The pediatric GCS and decision rules for obtaining head CT imaging help the provider evaluate head-injured infants and children. The provider must be vigilant to diagnose those who have life-threatening intracranial injuries or are victims of abusive head trauma. The goal of the emergency physician is to diagnose and treat the consequences of the primary injury and to limit or prevent secondary injury.	[Wing, Robyn; James, Catherine] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [James, Catherine] UMass Mem Med Ctr, Worcester, MA 01655 USA		James, C (corresponding author), UMass Mem Med Ctr, 55 Lake Ave North, Worcester, MA 01655 USA.	Catherine.james@umassmemorial.org		James, Catherine/0000-0002-3237-2699			Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; [Anonymous], 2012, CHILD MALTR 2011; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bean A, 2007, EMERG MED J, V24, P361, DOI 10.1136/emj.2007.048512; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Boston University, 2012, CAS STUD; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; de Louw A, 1994, Ned Tijdschr Geneeskd, V138, P2197; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Fastle RK, 2004, PEDIATR EMERG CARE, V20, P651, DOI 10.1097/01.pec.0000142947.35394.81; Faul M, 2012, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Injury Prevention and Control Program, 2012, SPORTS REL CONC HEAD; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; JENNETT B, 1976, LANCET, V1, P1031; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Karpas A, 2013, PEDIATR EMERG CARE, V29, P30, DOI 10.1097/PEC.0b013e31827b5090; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly JP, 1997, NEUROLOGY, V48, P581; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lee LK, 2011, J PEDIATR-US, V158, P1003, DOI 10.1016/j.jpeds.2010.11.036; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Luu JL, 2011, PEDIATR EMERG CARE, V27, P1113, DOI 10.1097/PEC.0b013e31823aff59; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Nigrovic LE, 2013, ANN EMERG MED, V61, P389, DOI 10.1016/j.annemergmed.2012.08.030; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Nowinski C, 2011, HEAD GAMES FOOTBALLS; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Parri N, 2013, J EMERG MED, V44, P135, DOI 10.1016/j.jemermed.2012.02.038; Patricios J, 2012, BRIT J SPORT MED, V46, P198, DOI 10.1136/bjsports-2011-090386; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Ramirez-Schrempp D, 2011, PEDIATR EMERG CARE, V27, P312, DOI 10.1097/PEC.0b013e3182131579; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Salhi B, 2007, ANN EMERG MED, V49, P84, DOI 10.1016/j.annemergmed.2006.09.003; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schunk JE, 2012, PEDIATR REV, V33, P398, DOI 10.1542/pir.33-9-398; Section on Radiology, 2009, PEDIATRICS, V123, P1430, DOI DOI 10.1542/PEDS.2009-0558; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sturm JJ, 2013, AM J EMERG MED, V31, P166, DOI 10.1016/j.ajem.2012.07.002; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Upshaw JE, 2012, PEDIATR EMERG CARE, V28, P926, DOI 10.1097/PEC.0b013e318267f674; Vaillancourt C, 2007, ANN EMERG MED, V49, P86, DOI 10.1016/j.annemergmed.2006.09.002; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	122	15	17	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2013	31	3					653	+		10.1016/j.emc.2013.05.007			25	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	207TQ	WOS:000323627700006	23915598				2022-02-06	
J	Yuan, QJ; Su, HX; Chiu, K; Wu, WT; Lin, ZX				Yuan, Qiuju; Su, Huanxing; Chiu, Kin; Wu, Wutian; Lin, Zhi-Xiu			Contrasting neuropathology and functional recovery after spinal cord injury in developing and adult rats	NEUROSCIENCE BULLETIN			English	Article						neonatal; spinal cord injury; regeneration; functional recovery; rat	NEONATAL RAT; CORTICOSPINAL AXONS; TRAUMATIC INJURY; DEVELOPING BRAIN; LESION SITE; REGENERATION; TRANSECTION; REGROWTH; DEGENERATION; NEURONS	Conflicting findings exist regarding the link between functional recovery and the regrowth of spinal tracts across the lesion leading to the restoration of functional contacts. In the present study, we investigated whether functional locomotor recovery was attributable to anatomical regeneration at postnatal day 1 (PN1), PN7, PN14 and in adult rats two months after transection injury at the tenth thoracic segment of the spinal cord. The Basso, Beattie, and Bresnahan scores showed that transection led to a failure of hindlimb locomotor function in PN14 and adult rats. However, PN1 and PN7 rats showed a significant level of stepping function after complete spinal cord transection. Unexpectedly, unlike the transected PN14 and adult rats in which the spinal cord underwent limited secondary degeneration and showed a scar at the lesion site, the rats transected at PN1 and PN7 showed massive secondary degeneration both anterograde and retrograde, leaving a > 5-mm gap between the two stumps. Furthermore, retrograde tracing with fluorogold (FG) also showed that FG did not cross the transection site in PN1 and PN7 rats as in PN14 and adult rats, and re-transection of the cord caused no apparent loss in locomotor performance in the rats transected at PN1. Thus, these three lines of evidence strongly indicated that the functional recovery after transection in neonatal rats is independent of regrowth of spinal tracts across the lesion site. Our results support the notion that the recovery of locomotor function in developing rats may be due to intrinsic adaptations in the spinal circuitry below the lesion that control hindlimb locomotor activity rather than the regrowth of spinal tracts across the lesion. The difference in secondary degeneration between neonatal and adult rats remains to be explored.	[Yuan, Qiuju; Chiu, Kin; Wu, Wutian] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Yuan, Qiuju; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Sch Chinese Med, Fac Sci, Shatin, Hong Kong, Peoples R China; [Su, Huanxing] Univ Macau, State Key Lab Qual Res Chinese Med, Macao, Macao, Peoples R China; [Su, Huanxing] Univ Macau, Inst Chinese Med Sci, Macao, Macao, Peoples R China; [Wu, Wutian] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Res Ctr Reprod Dev & Growth, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Jinan Univ, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China		Wu, WT (corresponding author), Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	wtwu@hkucc.hku.hk; linzx@cuhk.edu.hk	Su, Huanxing/X-3980-2019; Lin, Zhi-Xiu/H-2807-2016; Su, Huanxing/X-3954-2019; Chiu, Kin/ABI-7938-2020; Yuan, Qiuju/AAJ-3101-2020	Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; Chiu, Kin/0000-0001-6581-9007; 	Hong Kong SCI Fund; National Basic Research Development Program (973 program) of ChinaNational Basic Research Program of China [2011CB504402]	This work was supported by the Hong Kong SCI Fund and the National Basic Research Development Program (973 program) of China (2011CB504402).	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BATES CA, 1993, EXP NEUROL, V123, P106, DOI 10.1006/exnr.1993.1144; BERNSTEIN DR, 1981, NEUROSCI LETT, V26, P55, DOI 10.1016/0304-3940(81)90425-0; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; BRYZGORNIA WF, 1986, EXP NEUROL, V93, P195, DOI 10.1016/0014-4886(86)90159-7; CUMMINGS JP, 1981, EXP NEUROL, V74, P615, DOI 10.1016/0014-4886(81)90196-5; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Guzen FP, 2012, RESTOR NEUROL NEUROS, V30, P265, DOI 10.3233/RNN-2012-110184; Hase T, 2002, J NEUROTRAUM, V19, P267, DOI 10.1089/08977150252807009; Hase T, 2002, EUR J NEUROSCI, V15, P969, DOI 10.1046/j.1460-9568.2002.01932.x; KALIL K, 1982, J COMP NEUROL, V211, P265, DOI 10.1002/cne.902110305; Lee YS, 2004, J NEUROPATH EXP NEUR, V63, P233, DOI 10.1093/jnen/63.3.223-a; Li CY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042813, 10.1371/journal.pone.0044712]; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; SCHREYER DJ, 1983, NEUROSCIENCE, V9, P31, DOI 10.1016/0306-4522(83)90044-1; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; TOLBERT DL, 1987, J COMP NEUROL, V260, P299, DOI 10.1002/cne.902600210; Wakabayashi Y, 2001, SPINE, V26, P1215, DOI 10.1097/00007632-200106010-00009; Yuan QJ, 2006, BRAIN RES, V1113, P45, DOI 10.1016/j.brainres.2006.07.052; Yuan QJ, 2006, NEUROREPORT, V17, P711, DOI 10.1097/01.wnr.0000214390.35480.1a; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072	24	15	15	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067			NEUROSCI BULL	Neurosci. Bull.	AUG	2013	29	4			SI		509	516		10.1007/s12264-013-1356-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191DU	WOS:000322393600013	23846597	Green Published			2022-02-06	
J	Semyachkina-Glushkovskaya, OV; Lychagov, VV; Bibikova, OA; Semyachkin-Glushkovskiy, IA; Sindeev, SS; Zinchenko, EM; Kassim, MM; Ali, AF; Leith, A; Ulanova, MV; Tuchin, VV				Semyachkina-Glushkovskaya, Oxana V.; Lychagov, Vladislav V.; Bibikova, Olga A.; Semyachkin-Glushkovskiy, Igor A.; Sindeev, Sergey S.; Zinchenko, Ekaterina M.; Kassim, Mohhanad M.; Ali, Al-Fatle Fatema; Leith, Al Hassani; Ulanova, Maria V.; Tuchin, Valery V.			THE EXPERIMENTAL STUDY OF STRESS-RELATED PATHOLOGICAL CHANGES IN CEREBRAL VENOUS BLOOD FLOW IN NEWBORN RATS ASSESSED BY DOCT	JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES			English	Article						Doppler optical coherence tomography; stress-related intracranial hemorrhage; cerebral venous blood flow; adrenaline	SYMPTOMATIC INTRACRANIAL HEMORRHAGE; OPTICAL COHERENCE TOMOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURIES; FULL-TERM INFANTS; INTRACEREBRAL HEMORRHAGE; PERFUSION-PRESSURE; RISK-FACTORS; PREMATURE-INFANTS	In experiments on newborn rats with stress-related intracranial hemorrhage (ICH) using Doppler optical coherence tomography (DOCT) we have shown that latent stage of ICH (4 h after stress) is characterized by decrease of venous blood outflow and the loss of sensitivity of sagittal vein to vasoconstrictor effect of adrenaline. The incidence of ICH (24 h after stress) was accompanied by progression of early pathological changes in cerebral venous blood flow (CVBF) and development of venous insufficiency. Taking into consideration of this fact, we suggest that the suppression of CVBF related to the severity to the deleterious effect of stress on the brain hemodynamics in newborn rats. These facts allow us to conclude that the venous insufficiency with the loss of vasoconstrictor response to adrenaline is an informative and sensitive component of pattern of CVBF that can be important diagnostic criteria of risk of ICH development in newborns.	[Semyachkina-Glushkovskaya, Oxana V.; Lychagov, Vladislav V.; Bibikova, Olga A.; Semyachkin-Glushkovskiy, Igor A.; Sindeev, Sergey S.; Zinchenko, Ekaterina M.; Kassim, Mohhanad M.; Ali, Al-Fatle Fatema; Leith, Al Hassani; Ulanova, Maria V.; Tuchin, Valery V.] Saratov NG Chernyshevskii State Univ, Dept Biol, Saratov 410012, Russia; [Kassim, Mohhanad M.; Ali, Al-Fatle Fatema; Leith, Al Hassani] Al Mustansiriya Univ, Dept Biol, Baghdad, Iraq; [Tuchin, Valery V.] Russia Acad Sci, Inst Precise Mech & Control, Saratov, Russia; [Tuchin, Valery V.] Univ Oulu, Optoelect & Measurement Tech Lab, SF-90100 Oulu, Finland		Semyachkina-Glushkovskaya, OV (corresponding author), Saratov NG Chernyshevskii State Univ, Dept Biol, Astrachanskaya Str 83, Saratov 410012, Russia.	glushkovskaya@mail.ru	Tuchin, Valery V/C-7865-2013; Zinchenko, Ekaterina/F-8069-2015; Glushkovskaya, Oxana V/D-5190-2013; Lychagov, Vladislav V/A-3575-2014	Tuchin, Valery V/0000-0001-7479-2694; Zinchenko, Ekaterina/0000-0001-7926-1681; Glushkovskaya, Oxana V/0000-0001-6753-7513; 	RF Governmental contracts [11.519.11.2035, 14.B37.21.0728, 14.B37.21.0563, 14.B37.21.0216]; FiDiPro, Finland; TEKES Program, Finland [40111/11]; SCOPES EC; Uzb/Switz/RF; Swiss NSFSwiss National Science Foundation (SNSF) [IZ74ZO_137423/1]; RF President's grant "Scientific Schools" [1177.2012.2.]; Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [12-02-31204 mol-a, a-11-02-00560]	This work was supported in part by RF Governmental contracts 11.519.11.2035, 14.B37.21.0728, 14.B37.21.0563; 14.B37.21.0216 and grants: FiDiPro, TEKES Program (40111/11), Finland; SCOPES EC, Uzb/Switz/RF, Swiss NSF, IZ74ZO_137423/1; RF President's grant "Scientific Schools", 1177.2012.2., Russian Foundation for Basic Research Grant No. 12-02-31204 mol-a and No. a-11-02-00560.	ADELSON PD, 2003, PEDIATR CRIT CARE ME, V4, P12; Ahlqvist J, 2001, STROKE, V32, P276, DOI 10.1161/01.STR.32.1.275-a; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Annibale DJ, PERIVENTRICULAR HEMO; Ballabh P, 2004, PEDIATR RES, V56, P117, DOI 10.1203/01.PDR.0000130472.30874.FF; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; BARTOLOME JV, 1987, NEUROTOXICOLOGY, V8, P1; Bengel FM, 2009, J AM COLL CARDIOL, V54, P1, DOI 10.1016/j.jacc.2009.02.065; Beslow LA, 2010, STROKE, V41, P313, DOI 10.1161/STROKEAHA.109.568071; Bevan J A, 1981, HDB PHYSL          2, VII, P515; Bhattacharjee M, 2011, J INNOV OPT HEAL SCI, V4, P59, DOI 10.1142/S1793545811001083; BUSIJA DW, 1984, REV PHYSIOL BIOCH P, V101, P161, DOI 10.1007/BFb0027696; CAPLAN L, 1988, NEUROLOGY, V38, P624, DOI 10.1212/WNL.38.4.624; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Cassaglia PA, 2008, AM J PHYSIOL-REG I, V294, pR1255, DOI 10.1152/ajpregu.00332.2007; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Enmi J, 2004, INT CONGR SER, P150, DOI 10.1016/j.ics.2004.04.045; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; GhaziBirry HS, 1997, AM J NEURORADIOL, V18, P219; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Green MA, 2011, SEMIN NEPHROL, V31, P291, DOI 10.1016/j.semnephrol.2011.05.008; Guennadi S., 2012, J INNOV OPT HEAL SCI, V5; Gupta SN, 2009, PEDIATR NEUROL, V40, P1, DOI 10.1016/j.pediatrneurol.2008.09.019; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hanigan WC, 1995, CHILD NERV SYST, V11, P698, DOI 10.1007/BF00262235; Happe HK, 1999, J PHARMACOL EXP THER, V288, P1134; Helmchen F, 2008, METHOD ENZYMOL, V444, P231, DOI 10.1016/S0076-6879(08)02810-3; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Hojberg AS, 1997, DAN MED BULL, V44, P439; Jiang YJ, 2002, J CEREBR BLOOD F MET, V22, P689, DOI 10.1097/00004647-200206000-00007; Jordan LC, 2009, STROKE, V40, P1666, DOI 10.1161/STROKEAHA.108.541383; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; Kiening KL, 1998, ACT NEUR S, V71, P172; Koretsky AP, 2012, NEUROIMAGE, V62, P602, DOI 10.1016/j.neuroimage.2012.01.005; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Lammie GA, 2000, STROKE, V31, P1426, DOI 10.1161/01.STR.31.6.1426; Li XQ, 2011, J INNOV OPT HEAL SCI, V4, P325, DOI 10.1142/S1793545811001599; Li-Ping Y., 2012, J INNOV OPT HEAL SCI, V5; Liem KD, 2010, EARLY HUM DEV, V86, P155, DOI 10.1016/j.earlhumdev.2010.01.029; Lo WD, 2011, J CHILD NEUROL, V26, P1174, DOI 10.1177/0883073811408424; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097/00008480-200112000-00002; MCCALDEN TA, 1981, J AUTON PHARMACOL, V1, P421, DOI 10.1111/j.1474-8673.1981.tb00082.x; MEYER CHA, 1983, NEUROSURGERY, V12, P58, DOI 10.1227/00006123-198301000-00010; MORRIS MJ, 1980, BRAIN RES, V190, P268, DOI 10.1016/0006-8993(80)91178-6; *NAT CTR HLTH STAT, 2002, DEATHS PERC TOT DEAT; Osborn DA, 2003, PEDIATRICS, V112, P33, DOI 10.1542/peds.112.1.33; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Purves M. J., 1972, PHYSL CEREBRAL CIRCU, P427; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Semyachkina-Glushkovskaya O., 2013, J PHOTON LASERS MED, P1; Semyachkina-Glushkovskaya O., 2012, Patent, Patent No. [RF 072642, 072642]; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Srinivasan VJ, 2010, OPT EXPRESS, V18, P2477, DOI 10.1364/OE.18.002477; The Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, P7; van Amerom JFP, 2009, MAGN RESON IMAGING, V27, P38, DOI 10.1016/j.mri.2008.05.016; Vilensky MA, 2012, QUANTUM ELECTRON+, V42, P489, DOI 10.1070/QE2012v042n06ABEH014887; Volpe JJ, 2008, NEUROLOGY NEWBORN, V5th, P517; Weber TF, 2011, EUR J RADIOL, V80, P103, DOI 10.1016/j.ejrad.2010.06.045; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wintermark P., 2013, NEUROIMAGE IN PRESS, DOI [10.1016/j.neuroimage.2013.04.072, DOI 10.1016/J.NEUR0IMAGE.2013.04.072]; Yao JJ, 2010, OPT LETT, V35, P1419, DOI 10.1364/OL.35.001419	69	15	15	0	13	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5458	1793-7205		J INNOV OPT HEAL SCI	J. Innov. Opt. Health Sci.	JUL	2013	6	3							1350023	10.1142/S1793545813500235			10	Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Optics; Radiology, Nuclear Medicine & Medical Imaging	192XB	WOS:000322519900008		gold			2022-02-06	
J	Strauss, KI; Gruzdev, A; Zeldin, DC				Strauss, Kenneth I.; Gruzdev, Artiom; Zeldin, Darryl C.			Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: Effects of traumatic brain injury	PROSTAGLANDINS & OTHER LIPID MEDIATORS			English	Article						Brain injury recovery; Behavior; Cytochrome P450 eicosanoids; Arachidonic acid metabolism	EPOXYEICOSATRIENOIC ACIDS; ARACHIDONIC-ACID; FUNCTIONAL HYPEREMIA; RAT; EPOXYGENASE; MODEL; CYTOCHROME-P-450; PHOSPHOLIPIDS; METABOLITES; INHIBITORS	After traumatic brain injury (TBI), arachidonic acid (ArA) is released from damaged cell membranes and metabolized to many bioactive eicosanoids, including several epoxyeicosatrienoic acids (EETs). Soluble epoxide hydrolase (Ephx2, sEH) appears to be the predominant pathway for EET metabolism to less active dihydroxyeicosatrienoates (DHETs). Prior studies indicate that brain levels of EETs increase transiently after TBI and EETs have antiinflammatory and neuroprotective activities which may benefit the injured brain. If the net effect of increased EET levels in the injured brain is beneficial to recovery, then Ephx2 gene disruption would be expected to enhance elevated EET levels and improve recovery in the injured brain. Thus, Ephx2-KO (Ephx2(-/-) bred onto pure C57Bl/6 background) mice were compared to wild-type controls in a unilateral controlled cortical impact model of TBI. Before injury, animals behaved comparably in open field activity and neurologic reflexes. Interestingly, the Ephx2-KO mice showed improved motor coordination on a beam walk task, yet showed indications of defective learning in a test of working spatial memory. After surgery, brain-injured Ephx2-KO mice again had less of a deficit in the beam walk than wild-type, and the difference in latency (post - pre) showed a trend of protection for Ephx2-KO mice after TBI. Brain-injured mice showed no genotype differences in working memory. Surprisingly, sham-operated Ephx2-KO mice exhibited an injured phenotype for working memory, compared to sham-operated wild-type mice. Brain eicosanoid levels were measured using liquid chromatography with tandem mass spectrometry. Of the 20 eicosanoids evaluated, only 8,9-EET was elevated in the Ephx2-KO cerebral cortex (37 d post-surgery, in both sham and injured). Tissue DHET levels were below the limit of quantification. These results reflect a significant contribution of sEH deficiency in coordination of ambulatory movements and working spatial memory in the mouse. Further investigation of differential sEH expression and EET levels at earlier time points and across other brain regions may shed light on these behavioral differences. (C) 2012 Published by Elsevier Inc.	[Strauss, Kenneth I.] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA; [Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA		Strauss, KI (corresponding author), Michigan State Univ, Coll Human Med, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	kenneth.strauss@hc.msu.edu; artiom.gruzdev@nih.gov; zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS054890]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ZICES102425, ZIAES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054890] Funding Source: NIH RePORTER	This work was funded in part by NINDS Grant NS054890 (KIS). The authors would like to thank Laura Miller, J. Alyce Bradbury and Joan P. Graves for managing the animal colony, confirming genotypes and coordinating shipments. Thanks also to Analise Sauro and Jaimie Pineda for excellent technical assistance in the completion of this work.	Alkayed NJ, 1996, STROKE, V27, P971, DOI 10.1161/01.STR.27.5.971; BREZINSKI ME, 1990, P NATL ACAD SCI USA, V87, P6248, DOI 10.1073/pnas.87.16.6248; Campbell WB, 2000, TRENDS PHARMACOL SCI, V21, P125, DOI 10.1016/S0165-6147(00)01472-3; CAPDEVILA JH, 1987, BIOCHEM BIOPH RES CO, V146, P638, DOI 10.1016/0006-291X(87)90576-6; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; Christie MJ, 1999, INFLAMM RES, V48, P1, DOI 10.1007/s000110050367; Cronin A, 2011, J LIPID RES, V52, P712, DOI 10.1194/jlr.M009639; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hampson AJ, 2002, J NEUROSCI, V22, P257, DOI 10.1523/JNEUROSCI.22-01-00257.2002; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Higashimori H, 2010, AM J PHYSIOL-CELL PH, V299, pC1068, DOI 10.1152/ajpcell.00225.2010; Iliff JJ, 2009, AM J PHYSIOL-HEART C, V296, pH1352, DOI 10.1152/ajpheart.00950.2008; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; KARARA A, 1991, J BIOL CHEM, V266, P7561; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Kozak W, 2000, AM J PHYSIOL-REG I, V279, pR455, DOI 10.1152/ajpregu.2000.279.2.R455; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Marowsky A, 2009, NEUROSCIENCE, V163, P646, DOI 10.1016/j.neuroscience.2009.06.033; McAuliffe JJ, 2006, BRAIN RES, V1118, P208, DOI 10.1016/j.brainres.2006.08.030; Morisseau C, 2012, BIOCHEM BIOPH RES CO, V419, P796, DOI 10.1016/j.bbrc.2012.02.108; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakashima T, 1996, AM J PHYSIOL-REG I, V271, pR1274, DOI 10.1152/ajpregu.1996.271.5.R1274; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Peng XQ, 2002, AM J PHYSIOL-HEART C, V283, pH2029, DOI 10.1152/ajpheart.01130.2000; Revermann M, 2010, ARTERIOSCL THROM VAS, V30, P909, DOI 10.1161/ATVBAHA.110.204099; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Yue HF, 2007, J PHARMACEUT BIOMED, V43, P1122, DOI 10.1016/j.jpba.2006.10.009; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325	36	15	15	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-8823	2212-196X		PROSTAG OTH LIPID M	Prostaglandins Other Lipid Mediat.	JUL-AUG	2013	104				SI		18	24		10.1016/j.prostaglandins.2012.07.005			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	183GM	WOS:000321802500004	22922090	Green Accepted			2022-02-06	
J	Gurkoff, GG; Feng, JF; Van, KC; Izadi, A; Ghiasvand, R; Shahlaie, K; Song, M; Lowe, DA; Zhou, J; Lyeth, BG				Gurkoff, Gene G.; Feng, Jun-Feng; Van, Ken C.; Izadi, All; Ghiasvand, Rahil; Shahlaie, Kiarash; Song, Minsoo; Lowe, David A.; Zhou, Jia; Lyeth, Bruce G.			NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Hypoxia; Excitotoxicity; N-acetylaspartylglutamate (NAAG); Behavior; Pre-clinical	TRAUMATIC BRAIN-INJURY; N-ACETYLASPARTYLGLUTAMATE NAAG; METABOTROPIC GLUTAMATE RECEPTORS; FLUID PERCUSSION INJURY; EXCITATORY AMINO-ACIDS; EXTRACELLULAR GLUTAMATE; CELL-DEATH; HYPOTENSION; RAT; RELEASE	Immediately following traumatic brain injury (TBI) and TBI with hypoxia, there is a rapid and pathophysiological increase in extracellular glutamate, subsequent neuronal damage and ultimately diminished motor and Cognitive function. N-acetyl-aspartyl glutamate (NAAG), a prevalent neuropeptide in the CNS, is co-released with glutamate, binds to the presynaptic group II metabotropic glutamate receptor subtype 3 (mGluR3) and suppresses glutamate release. However, the catalytic enzyme glutamate carboxypeptidase II (GCP II) rapidly hydrolyzes NAAG into NAA and glutamate. Inhibition of the GCP II enzyme with NAAG peptidase inhibitors reduces the concentration of glutamate both by increasing the duration of NAAG activity on mGluR3 and by reducing degradation into NAA and glutamate resulting in reduced cell death in models of TB! and TBI with hypoxia. In the following study, rats were administered the NAAG peptidase inhibitor PGI-02776 (10 mg/kg) 30 min following TBI combined with a hypoxic second insult Over the two weeks following injury, PGI-02776-treated rats had significantly improved motor function as measured by increased duration on the rota-rod and a trend toward improved performance on the beam walk. Furthermore, two weeks post-injury, PGI-02776-treated animals had a significant decrease in latency to find the target platform in the Morris water maze as compared to vehicle-treated animals. These findings demonstrate that the application of NAAG peptidase inhibitors can reduce the deleterious motor and cognitive effects of TBI combined with a second hypoxic insult in the weeks following injury. (C) 2013 Elsevier B.V. All rights reserved.	[Gurkoff, Gene G.; Feng, Jun-Feng; Van, Ken C.; Izadi, All; Ghiasvand, Rahil; Shahlaie, Kiarash; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophon & Sci Technol, Sacramento, CA 95817 USA; [Feng, Jun-Feng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200027, Peoples R China; [Song, Minsoo; Lowe, David A.] PsychoGen Inc, Tarrytown, NY 10591 USA; [Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS61352, NS29995]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, R43NS061352] Funding Source: NIH RePORTER	This research was supported by NIH NS61352 (JZ & BGL) and NIH NS29995 (BGL).	Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bauman RA, 2005, BEHAV BRAIN RES, V160, P25, DOI 10.1016/j.bbr.2004.11.031; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kochanek PM, 1997, ACT NEUR S, V70, P109; Koura SS, 1998, ACT NEUR S, V71, P244; Luthi-Carter R, 1998, BRAIN RES, V795, P341, DOI 10.1016/S0006-8993(98)00244-3; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McSwain NE, 2004, J TRAUMA, V57, P8; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; Orlando LR, 1997, NEUROSCI LETT, V236, P91, DOI 10.1016/S0304-3940(97)00769-6; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Schweitzer C, 2000, NEUROPHARMACOLOGY, V39, P1700, DOI 10.1016/S0028-3908(99)00265-8; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 2006, ADV EXP MED BIOL, V576, P317; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	63	15	15	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 17	2013	1515						98	107		10.1016/j.brainres.2013.03.043			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	176QP	WOS:000321319500011	23562458	Green Accepted			2022-02-06	
J	Yang, JF; Han, YF; Ye, WW; Liu, F; Zhuang, K; Wu, GY				Yang, Jinfu; Han, Yongfeng; Ye, Weiwei; Liu, Feng; Zhuang, Kai; Wu, Guangyong			Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Alpha tocopherol; Traumatic brain injury; Nogo; Regeneration	OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; VITAMIN-E; INHIBITION; RECOVERY; NEURONS; LIGAND; REPAIR; DAMAGE; CELLS	Background: Neurite outgrowth inhibitor-A (Nogo-A), myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein are three myelin-associated proteins that act as inhibitors to central nervous system regeneration. Neurite outgrowth inhibitor-A imposes the strongest effect on inhibiting axonal regeneration after traumatic brain injury. Alphatocopherol, a member of the vitamin E family, is recognized as an active antioxidative substance. Its use has not been well studied in brain injury research, especially in axonal regeneration research. Methods: We obtained 99 intact adult male Sprague-Dawley rats (200-250 g) from the Experimental Animal Center of Central South University. We used the modified method of Freeney to generate moderate brain injury in the rats. We injected 600 mg/kg alpha-tocopherol intraperitoneally daily as traumatic brain injury (TBI) treatment. Then, we performed behavioral tests in the corresponding time point, examined brain tissues after hematoxylin-eosin staining to identify changes in cell morphology, and performed immunohistochemical staining and quantitative real-time polymerase chain reaction to detect the expression of NoGo and Nogo receptor (NgR) in brain tissue. Results: For the Neurological Severity Scores of rats, there were obvious differences among the three groups at the corresponding time points. Standard hematoxylin-eosin staining showed that the brain structure of a sham-operated group of rats was clear, uniform, and compact. A TBI group exhibited hemorrhage, edema, inflammatory cell infiltration, condensed nuclei, and necrosis. We also saw glial cells and fibrous tissue proliferation. The alpha-tocopherol-treated TBI group had similar but less severe changes than the TBI group. Expression of Nogo-A and NgR increased after TBI compared with the sham-operated group. However, Nogo-A and NgR expression was significantly lower in the alpha-tocopherol-treated TBI group compared with the TBI group. Similarly, results showed that functional neurological deficits among rats in the alpha-tocopherol-treated TBI group were less pronounced than in the TBI group (model group). Conclusions: Our data demonstrate that alpha-tocopherol-treated rats had reduced microscopic evidence of brain damage. Alpha-tocopherol reduced Nogo-A and NgR expression in brain tissue after traumatic brain injury and promoted nerve regeneration. Alpha-tocopherol treatment of TBI rats had a neuroprotective role in their recovery. (C) 2013 Elsevier Inc. All rights reserved.	[Yang, Jinfu; Han, Yongfeng; Ye, Weiwei; Liu, Feng; Zhuang, Kai; Wu, Guangyong] Cent South Univ, Xiangya Hosp 3, Dept Neurosurg, Changsha, Hunan, Peoples R China		Han, YF (corresponding author), First Hosp Shijiazhuang City, Dept Neurosurg, Shijiazhuang 050001, Hebei, Peoples R China.	maoping627@126.com					Bandtlow CE, 1997, EUR J NEUROSCI, V9, P2743, DOI 10.1111/j.1460-9568.1997.tb01703.x; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cherdyntseva N, 2005, J RADIAT RES, V46, P37, DOI 10.1269/jrr.46.37; Desrumaux C, 1999, FASEB J, V13, P883, DOI 10.1096/fasebj.13.8.883; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferreira MCD, 2005, FREE RADICAL BIO MED, V39, P1009, DOI 10.1016/j.freeradbiomed.2005.05.021; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Guo Q, 2007, NEUROSCI LETT, V422, P103, DOI 10.1016/j.neulet.2007.05.034; HARA H, 1990, BRAIN RES, V510, P335, DOI 10.1016/0006-8993(90)91386-U; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jin XL, 2012, CARDIOVASC TOXICOL, V12, P10, DOI 10.1007/s12012-011-9134-y; Kapelusiak-Pielok M, 2005, FOLIA NEUROPATHOL, V43, P103; Kemaloglu S, 2003, YONSEI MED J, V44, P955, DOI 10.3349/ymj.2003.44.6.955; Kramer JKG, 1997, LIPIDS, V32, P323, DOI 10.1007/s11745-997-0040-1; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mi YJ, 2012, CELL DEATH DIFFER, V19, P1175, DOI 10.1038/cdd.2011.206; Silva DNE, 2012, ACTA CIR BRAS, V27, P325, DOI 10.1590/S0102-86502012000400008; Ovalle F, 2012, ANN PLAS SURG, V68, P518, DOI 10.1097/SAP.0b013e3182380974; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Raicevic R, 2000, Vojnosanit Pregl, V57, P647; Ren ZW, 2012, REV NEUROSCIENCE, V23, P135, DOI 10.1515/revneuro-2011-0069; Schallert T, 1997, ADV NEUROL, V73, P229; Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Smolarek AK, 2011, NUTRIENTS, V3, P962, DOI 10.3390/nu3110962; Sperling O, 2003, NEUROSCI LETT, V351, P137, DOI 10.1016/S0304-3940(03)00858-9; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Whitlon DS, 2010, NEUROSCIENCE, V171, P23, DOI 10.1016/j.neuroscience.2010.08.069; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462	35	15	16	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 15	2013	182	2					E69	E77		10.1016/j.jss.2012.11.010			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	143ZI	WOS:000318907900004	23207171				2022-02-06	
J	Heffernan, ME; Huang, W; Sicard, KM; Bratane, BT; Sikoglu, EM; Zhang, NY; Fisher, M; King, JA				Heffernan, Meghan E.; Huang, Wei; Sicard, Kenneth M.; Bratane, Bernt T.; Sikoglu, Elif M.; Zhang, Nanyin; Fisher, Marc; King, Jean A.			Multi-Modal Approach for Investigating Brain and Behavior Changes in an Animal Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal model; cognition; functional connectivity; imaging; traumatic brain injury	AWAKE RAT-BRAIN; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; HEAD-INJURY; WATER-MAZE; MRI; NETWORKS; MEMORY; FATIGUE	Use of novel approaches in imaging modalities is needed for enhancing diagnostic and therapeutic outcomes of persons with a traumatic brain injury (TBI). This study explored the feasibility of using functional magnetic resonance imaging (fMRI) in conjunction with behavioral measures to target dynamic changes in specific neural circuitries in an animal model of TBI. Wistar rats were randomly assigned to one of two groups (traumatic brain injury/sham operation). TBI rats were subjected to the closed head injury (CHI) model. Any observable motor deficits and cognitive deficits associated with the injury were measured using beam walk and Morris water maze tests, respectively. fMRI was performed to assess the underlying post-traumatic cerebral anatomy and function in acute (24 hours after the injury) and chronic (7 and 21 days after the injury) phases. Beam walk test results detected no significant differences in motor deficits between groups. The Morris water maze test indicated that cognitive deficits persisted for the first week after injury and, to a large extent, resolved thereafter. Resting state functional connectivity (rsFC) analysis detected initially diminished connectivity between cortical areas involved in cognition for the TBI group; however, the connectivity patterns normalized at 1 week and remained so at the 3 weeks post-injury time point. Taken together, we have demonstrated an objective in vivo marker for mapping functional brain changes correlated with injury-associated cognitive behavior deficits and offer an animal model for testing potential therapeutic interventions options.	[Heffernan, Meghan E.; Huang, Wei; Sikoglu, Elif M.; Zhang, Nanyin; King, Jean A.] Univ Massachusetts, Sch Med, Ctr Comparat NeuroImaging, Dept Psychiat, Worcester, MA 01655 USA; [Sicard, Kenneth M.; Bratane, Bernt T.; Fisher, Marc] Univ Massachusetts, Mem Med Ctr, Dept Neurol, Worcester, MA 01655 USA		King, JA (corresponding author), Univ Massachusetts, Sch Med, 55 Lake Ave North, Worcester, MA 01655 USA.	Jean.King@umassmed.edu	Zhang, Nanyin/N-3457-2014	Zhang, Nanyin/0000-0002-5824-9058	Massachusetts General HospitalGeneral Electric	We would like to thank Dr. Michael Whalen from Massachusetts General Hospital for his support and collaboration during this study.	Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Liang ZF, 2012, NEUROIMAGE, V59, P1190, DOI 10.1016/j.neuroimage.2011.08.009; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Virley D, 2000, J CEREBR BLOOD F MET, V20, P563, DOI 10.1097/00004647-200003000-00015; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	30	15	15	1	15	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	11					1007	1012		10.1089/neu.2012.2366			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	166WD	WOS:000320589300011	23294038	Green Submitted, Bronze, Green Published			2022-02-06	
J	Holschneider, DP; Guo, YM; Wang, Z; Roch, M; Scremin, OU				Holschneider, Daniel P.; Guo, Yumei; Wang, Zhuo; Roch, Margareth; Scremin, Oscar U.			Remote Brain Network Changes after Unilateral Cortical Impact Injury and Their Modulation by Acetylcholinesterase Inhibition	JOURNAL OF NEUROTRAUMA			English	Article						cholinergic; diaschisis; functional brain mapping; functional connectivity; traumatic brain injury	CEREBRAL BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; BASAL GANGLIA; RESTING-STATE; MOTOR CORTEX; PARKINSONS-DISEASE; INDICATOR FRACTIONATION; SPATIAL NORMALIZATION; RECOVERY; RAT	We explored whether cerebral cortical impact injury (CCI) effects extend beyond direct lesion sites to affect remote brain networks, and whether acetylcholinesterase (AChE) inhibition elicits discrete changes in functional activation of motor circuits following CCI. Adult male rats underwent unilateral motor-sensory CCI or sham injury. Physostigmine (AChE inhibitor) or saline were administered subcutaneously continuously via implanted minipumps (1.6 micromoles/kg/day) for 3 weeks, followed by cerebral perfusion mapping during treadmill walking using [C-14]-iodoantipyrine. Quantitative autoradiographs were analyzed by statistical parametric mapping and functional connectivity (FC) analysis. CCI resulted in functional deficits in the ipsilesional basal ganglia, with increased activation contralesionally. Recruitment was also observed, especially contralesionally, of the red nucleus, superior colliculus, pedunculopontine tegmental nucleus, thalamus (ventrolateral n., central medial n.), cerebellum, and sensory cortex. FC decreased significantly within ipsi- and contralesional motor circuits and between hemispheres, but increased between midline cerebellum and select regions of the basal ganglia within each hemisphere. Physostigmine significantly increased functional brain activation in the cerebellar thalamocortical pathway (midline cerebellum -> ventrolateral thalamus -> motor cortex), subthalamic nucleus/zona incerta, and red nucleus and bilateral sensory cortex. In conclusion, CCI resulted in increased functional recruitment of contralesional motor cortex and bilateral subcortical motor regions, as well as recruitment of the cerebellar-thalamocortical circuit and contralesional sensory cortex. This phenomenon, augmented by physostigmine, may partially compensate motor deficits. FC decreased inter-hemispherically and in negative, but not positive, intra-hemispherical FC, and it was not affected by physostigmine. Circuit-based approaches into functional brain reorganization may inform future behavioral or molecular strategies to augment targeted neurorehabilitation.	[Holschneider, Daniel P.; Guo, Yumei; Wang, Zhuo] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.; Guo, Yumei; Wang, Zhuo] Univ So Calif, Keck Sch Med, Dept Behav Sci, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Dept Neurol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.; Roch, Margareth; Scremin, Oscar U.] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Scremin, Oscar U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA		Holschneider, DP (corresponding author), Univ So Calif, Dept Psychiat & Behav Sci, 1333 San Pablo St,MCH 51A,MC9151, Los Angeles, CA 90033 USA.	holschne@usc.edu			Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARRD)US Department of Veterans Affairs [B5089R]; VARR&D Research Career Scientist award (OUS)	This study was supported by a Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARR&D) #B5089R and a VARR&D Research Career Scientist award (OUS).	Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Aumann T D, 2002, Cerebellum, V1, P69, DOI 10.1080/147342202753203104; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; Barrett D, 2003, J NEUROSCI, V23, P5740; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Conti AC, 1998, J NEUROSCI, V18, P5663; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; De Filippi G, 2005, PROG BRAIN RES, V148, P309, DOI 10.1016/S0079-6123(04)48024-8; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dubois A, 2008, NEUROIMAGE, V40, P482, DOI 10.1016/j.neuroimage.2007.11.054; Esculier JF, 2012, J REHABIL MED, V44, P144, DOI 10.2340/16501977-0922; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fidalgo C, 2011, BRAIN RES, V1368, P143, DOI 10.1016/j.brainres.2010.10.066; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Gharbawie OA, 2005, BEHAV BRAIN RES, V156, P125, DOI 10.1016/j.bbr.2004.05.015; GOLDMAN H, 1973, AM J PHYSIOL, V224, P122, DOI 10.1152/ajplegacy.1973.224.1.122; Hanakawa T, 1999, ANN NEUROL, V45, P329, DOI 10.1002/1531-8249(199903)45:3<329::AID-ANA8>3.0.CO;2-S; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Holschneider DP, 2003, J CEREBR BLOOD F MET, V23, P925, DOI 10.1097/01.WCB.0000072797.66873.6A; Holschneider DP, 2002, AM J PHYSIOL-HEART C, V283, pH1713, DOI 10.1152/ajpheart.00362.2002; HORWITZ B, 1995, BEHAV BRAIN RES, V66, P187, DOI 10.1016/0166-4328(94)00139-7; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Koch G, 2009, NEUROLOGY, V73, P113, DOI 10.1212/WNL.0b013e3181ad5387; Langguth B, 2008, NEUROPHYSIOL CLIN, V38, P289, DOI 10.1016/j.neucli.2008.08.003; Lee JS, 2005, EUR J NUCL MED MOL I, V32, P696, DOI 10.1007/s00259-004-1739-y; Lewis DH, 2006, J NEUROIMAGING, V16, P272, DOI 10.1111/j.1552-6569.2006.00034.x; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Magnuson M, 2010, J MAGN RESON IMAGING, V32, P584, DOI 10.1002/jmri.22295; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; MEDINA L, 1995, BRAIN BEHAV EVOLUT, V46, P235, DOI 10.1159/000113277; Mountz J M, 2007, Eura Medicophys, V43, P221; Na J, 1997, NEUROSCI RES, V28, P77, DOI 10.1016/S0168-0102(97)00031-X; Nair HP, 1999, J NEUROSCI, V19, P8646; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Padilla E, 2011, BRAIN RES, V1387, P71, DOI 10.1016/j.brainres.2011.02.080; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Palmer SJ, 2009, EUR J NEUROSCI, V29, P2187, DOI 10.1111/j.1460-9568.2009.06753.x; PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Paxinos G, 2007, RAT BRAIN STEREOTACT; Paxinos G.U.C., 2005, RAT BRAIN STEREOTACT; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Ripolles P, 2012, NEUROIMAGE, V60, P1296, DOI 10.1016/j.neuroimage.2012.01.094; Roby-Brami A, 2003, ACTA NEUROL SCAND, V107, P369, DOI 10.1034/j.1600-0404.2003.00021.x; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; SCREMIN OU, 1990, J NEUROSCI RES, V26, P188, DOI 10.1002/jnr.490260208; Shumake J, 2004, BRAIN RES, V1030, P267, DOI 10.1016/j.brainres.2004.10.015; Smeets WJAJ, 2000, J ANAT, V196, P501, DOI 10.1046/j.1469-7580.2000.19640501.x; SONCRANT TT, 1986, BRAIN RES, V369, P1, DOI 10.1016/0006-8993(86)90507-X; Stumpf W., 1995, AUTORADIOGRAPHY CORR; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Turner JR, 2011, CEREBELLUM, V10, P748, DOI 10.1007/s12311-011-0285-y; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67; Von Monakow C., 1969, BRAIN BEHAV, VI, P27; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; WAN XST, 1992, NEUROSCIENCE, V49, P749, DOI 10.1016/0306-4522(92)90353-4; Wang Z, 2012, NEUROIMAGE, V59, P4168, DOI 10.1016/j.neuroimage.2011.11.047; Wang Z, 2011, PAIN, V152, P2746, DOI 10.1016/j.pain.2011.08.022; Warner JJ, 2001, ATLAS NEUROANATOMY S; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X; Wichmann T, 2011, NEUROSCIENCE, V198, P232, DOI 10.1016/j.neuroscience.2011.06.048; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yang J, 2007, NEUROIMAGE, V36, P755, DOI 10.1016/j.neuroimage.2007.03.010; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	93	15	15	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	11					907	919		10.1089/neu.2012.2657			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	166WD	WOS:000320589300002	23343118	Green Published			2022-02-06	
J	Lippa, SM; Hawes, S; Jokic, E; Caroselli, JS				Lippa, Sara M.; Hawes, Samuel; Jokic, Emily; Caroselli, Jerome S.			Sensitivity of the RBANS to acute traumatic brain injury and length of post-traumatic amnesia	BRAIN INJURY			English	Article						Traumatic brain injury; head injury; RBANS; post-traumatic amnesia	NEUROPSYCHOLOGICAL STATUS RBANS; REPEATABLE BATTERY; GALVESTON ORIENTATION; SCREENING-TEST; VALIDITY; SCHIZOPHRENIA; RELIABILITY; CONSTRUCT; DISEASE	Objective: Although the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) has been shown to be a useful tool in evaluating the cognitive status of patients with dementia, stroke, schizophrenia and post-acute traumatic brain injury (TBI), no studies have examined its utility in an acute TBI setting. The current study investigates the RBANS' sensitivity to acute TBI, hypothesizing that the presence and severity of injury is predictive of worse RBANS performance. Method: Neuropsychological testing was conducted an average of 6.1 days after emergence from post-traumatic amnesia (PTA). RBANS results were evaluated based on a normative basis, pre-injury estimates, and brain injury severity. Results: In this sample of acute TBI patients (n = 51), the mean index scores on the RBANS ranged from 1.59-2.36 SD below the mean of the standardization sample. Each WRAT-4 Reading sub-test score was above the corresponding RBANS Total Scale Index score (t(31) 10.32, p<0.001). Regression analyses revealed that Delayed Memory (beta = - 0.365, p<0.007) and Total Score (beta = -0.297, p<0.023) indices were significantly predicted by PTA length after controlling for age and education.	[Lippa, Sara M.; Hawes, Samuel; Jokic, Emily; Caroselli, Jerome S.] TIRR Mem Hermann Hosp, Dept Psychol Neuropsychol, Houston, TX 77030 USA; [Lippa, Sara M.; Caroselli, Jerome S.] Univ Houston, Dept Psychol, Houston, TX USA; [Hawes, Samuel] Sam Houston State Univ, Dept Psychol, Houston, TX USA; [Caroselli, Jerome S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Caroselli, JS (corresponding author), TIRR Mem Hermann Hosp, Dept Psychol Neuropsychol, 1333 Moursund St, Houston, TX 77030 USA.	jerome.caroselli@memorialhermann.org					Beatty WW, 2003, ARCH CLIN NEUROPSYCH, V18, P509, DOI 10.1016/S0887-6177(02)00148-8; Beglinger LJ, 2010, J CLIN EXP NEUROPSYC, V32, P573, DOI 10.1080/13803390903313564; Benton A. L., 1974, REVISED BENTON VISUA; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Freilich BM, 2007, PSYCHOL REP, V101, P119, DOI 10.2466/PR0.101.1.119-129; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Gontkovsky ST, 2002, PSYCHOL REP, V90, P858, DOI 10.2466/PR0.90.3.858-860; Hobart MP, 1999, AM J PSYCHIAT, V156, P1951; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Jennett B, 1975, Ciba Found Symp, P309; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Larson EB, 2005, J CLIN EXP NEUROPSYC, V27, P16, DOI 10.1080/138033990513564; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Pachet AK, 2007, CLIN NEUROPSYCHOL, V21, P286, DOI 10.1080/13854040500376823; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Stellton D., 2006, DISS ABSTR INT B, V67, P1200; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilde MC, 2006, CLIN NEUROPSYCHOL, V20, P702, DOI 10.1080/13854040500246901; Wilde MC, 2010, CLIN NEUROPSYCHOL, V24, P57, DOI 10.1080/13854040902984505; Wilk CM, 2004, SCHIZOPHR RES, V70, P175, DOI 10.1016/j.schres.2003.10.009; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	32	15	15	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					689	695		10.3109/02699052.2013.771793			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500008	23672444				2022-02-06	
J	Long, J; Cai, L; Li, JT; Zhang, L; Yang, HY; Wang, TH				Long, Jiang; Cai, Li; Li, Jintao; Zhang, Lei; Yang, Haiyang; Wang, Tinghua			JNK3 involvement in nerve cell apoptosis and neurofunctional recovery after traumatic brain injury star	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; JNK1; JNK2; JNK3; traumatic brain injury; TdT-mediated dUTP nick end labeling; reverse transcription-PCR; cell apoptosis; neurological function recovery; neuroregeneration	ACTIVATED PROTEIN-KINASE; CEREBRAL-ISCHEMIA; MAP KINASES; RAT-BRAIN; IN-VIVO; PATHWAYS; NEURONS; DEATH; P38; ERK	Increasing evidence has revealed that the activation of the JNK pathway participates in apoptosis of nerve cells and neurological function recovery after traumatic brain injury. However, which genes in the JNK family are activated and their role in traumatic brain injury remain unclear. Therefore, in this study, in situ end labeling, reverse transcription-PCR and neurological function assessment were adopted to investigate the alteration of JNK1, JNK2 and JNK3 gene expression in cerebral injured rats, and their role in cell apoptosis and neurological function restoration. Results showed that JNK3 expression significantly decreased at 1 and 6 hours and 1 and 7 days post injury, but that JNK1 and JNK2 expression remained unchanged. In addition, the number of apoptotic nerve cells surrounding the injured cerebral cortex gradually reduced over time post injury. The Neurological Severity Scores gradually decreased over 1, 3, 5, 14 and 28 days post injury. These findings suggested that JNK3 expression was downregulated at early stages of brain injury, which may be associated with apoptosis of nerve cells. Downregulation of JNK3 expression may promote the recovery of neurological function following traumatic brain injury.	[Long, Jiang; Cai, Li; Zhang, Lei; Yang, Haiyang] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming 650032, Yunnan Province, Peoples R China; [Li, Jintao; Wang, Tinghua] Kunming Med Univ, Inst Neurosci, Kunming 650500, Yunnan Province, Peoples R China		Long, J (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming 650032, Yunnan Province, Peoples R China.	longjiang69@163.com; tinghua_neuron@263.net					Atzori C, 2001, J NEUROPATHOL EXP NE, V60, P1190; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Choi WS, 2011, METHODS MOL BIOL, V758, P279, DOI 10.1007/978-1-61779-170-3_19; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng HL, 2000, ZHONGHUA CHUANGSHANG, V16, P97; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Hughes R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-69; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; Liu Y, 2012, BRAIN RES, V1445, P73, DOI 10.1016/j.brainres.2012.01.031; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; Mazzitelli S, 2011, J NEUROSCI, V31, P16969, DOI 10.1523/JNEUROSCI.4491-11.2011; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Park MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025976; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Repici M, 2011, CEREBELLUM, V10, P281, DOI 10.1007/s12311-010-0244-z; Schafers M, 2003, J NEUROSCI, V23, P2517; Shi S, 2009, CELL BIOL INT, V33, P1095, DOI 10.1016/j.cellbi.2009.06.029; Song B, 2012, NEUROREPORT, V23, P67, DOI 10.1097/WNR.0b013e32834e7d69; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Toyoda H, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-36; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang ZB, 2012, NEUROCHEM RES, V37, P948, DOI 10.1007/s11064-011-0687-8	38	15	15	0	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2013	8	16					1491	1499		10.3969/j.issn.1673-5374.2013.16.006			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	173ZD	WOS:000321121400006	25206445				2022-02-06	
J	Purohit, MP; Wells, RE; Zafonte, R; Davis, RB; Yeh, GY; Phillips, RS				Purohit, Maulik P.; Wells, Rebecca Erwin; Zafonte, Ross; Davis, Roger B.; Yeh, Gloria Y.; Phillips, Russell S.			Neuropsychiatric Symptoms and the Use of Mind-Body Therapies	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							ALTERNATIVE MEDICINE USE; STRESS REDUCTION; COMPLEMENTARY; ADULTS; ASSOCIATION; DEPRESSION; MIGRAINE	Objective: Neuropsychiatric symptoms affect 37% of US adults and present in many important diagnoses including posttraumatic stress disorder, traumatic brain injury, and chronic pain. However, these symptoms are difficult to treat with standard treatments, and patients may seek alternative options. In this study, we examined the use of mind-body therapies by adults with neuropsychiatric symptoms. Method: We compared mind-body therapy use (biofeedback, energy healing, meditation, guided imagery, yoga, deep-breathing exercises, hypnosis, progressive relaxation therapy, qigong, and tai chi) between adults with and without neuropsychiatric symptoms (anxiety, depression, insomnia, headaches, memory deficits, attention deficits, and excessive daytime sleepiness) in the 2007 National Health Interview Survey (N = 23,393). Use of >= 1 of these therapies in the prior 12 months was the primary outcome of interest. We also examined prevalence and reasons for mind-body therapy use in adults with neuropsychiatric symptoms. We performed logistic regression to examine the association between neuropsychiatric symptoms and mind-body therapy use to adjust for sociodemographic and clinical factors. Results: Adults with >= 1 neuropsychiatric symptom used mind-body therapies more than adults without symptoms (25.3% vs 15.0%, P<.001). Prevalence increased with increasing number of symptoms (21.5% for 1 symptom, 32.4% for >= 3 symptoms, P<.001); differences persisted after adjustment for potential confounders (odds ratios, 1.39 [95% CI, 1.26-1.53] and 2.48 [95% CI, 2.18-2.82]). Reasons for mind-body therapy use among adults with >= 1 symptom included the ineffectiveness or expense of conventional medicine (30.2%). Most adults (nearly 70%) with >= 1 symptom did not discuss their mind-body therapy use with a conventional provider. Conclusions: Adults with >= 1 neuropsychiatric symptom use mind-body therapies frequently; more symptoms are associated with increased use. Future research is needed to understand the efficacy of these therapies.	[Purohit, Maulik P.; Zafonte, Ross] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Purohit, Maulik P.; Zafonte, Ross] Harvard Univ, Spaulding Rehabil Hosp, Sch Med, Boston, MA USA; [Purohit, Maulik P.; Davis, Roger B.; Yeh, Gloria Y.; Phillips, Russell S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Wells, Rebecca Erwin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Wells, Rebecca Erwin] Harvard Univ, Faulkner Hosp, Sch Med, Boston, MA USA; [Phillips, Russell S.] Harvard Univ, Ctr Primary Care, Sch Med, Boston, MA USA		Purohit, MP (corresponding author), Spaulding Rehabil Hosp Network, 125 Nashua St,720, Boston, MA 02114 USA.	mpurohit1@partners.org			institutional National Research Service Award from the National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health [T32AT000051]; American Headache Society; National Institute of Child Health and Human Development Investigator Award [5R24HD065688-02]; Spaulding-Harvard Spinal Cord Injury Model System, US Department of Education, National Institute on Disability and Rehabilitation Research, Traumatic Brain Injury Model Systems grant [H133N110010]; Department of Defense InsightUnited States Department of Defense; Harvard Clinical Consortium PTSD/TBI study site (INTRuST), Department of Defense, US Army Medical Research and Materiel Command grant [W81XWH-08-2-0159]; Mid-Career Investigator Award from NCCAM, National Institutes of Health [K24AT000589]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [K24AT000589] Funding Source: NIH RePORTER; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT000051] Funding Source: NIH RePORTER	Drs Purohit and Wells were supported by an institutional National Research Service Award Number T32AT000051 from the National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health. Dr Wells was supported by a headache fellowship from the American Headache Society. Dr Zafonte was supported by National Institute of Child Health and Human Development Investigator Award 5R24HD065688-02; Spaulding-Harvard Spinal Cord Injury Model System, US Department of Education, National Institute on Disability and Rehabilitation Research, Traumatic Brain Injury Model Systems grant H133N110010; Department of Defense Insight; and Harvard Clinical Consortium PTSD/TBI study site (INTRuST), Department of Defense, US Army Medical Research and Materiel Command grant W81XWH-08-2-0159. Drs Phillips and Davis were supported by Mid-Career Investigator Award K24AT000589 from NCCAM, National Institutes of Health.	[Anonymous], WHAT IS COMPL ALT ME; [Anonymous], NHIS 2007 SURV DESCR; Bertisch SM, 2008, OBESITY, V16, P1610, DOI 10.1038/oby.2008.239; Bertisch SM, 2009, J PSYCHOSOM RES, V66, P511, DOI 10.1016/j.jpsychores.2008.12.003; Carlson MJ, 2006, DISABIL REHABIL, V28, P505, DOI 10.1080/09638280500212062; Geoffroy PA, 2012, PRESSE MED, V41, P455, DOI 10.1016/j.lpm.2011.08.008; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Gross CR, 2011, EXPLORE-NY, V7, P76, DOI 10.1016/j.explore.2010.12.003; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hetrick SE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007316.pub2; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Joo HM, 2010, J KOREAN NEUROSURG S, V47, P345, DOI 10.3340/jkns.2010.47.5.345; Kurth T, 2012, LANCET NEUROL, V11, P92, DOI 10.1016/S1474-4422(11)70266-6; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Plantinga L, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110244; Purohit MP, 2013, PM&R, V5, P24, DOI 10.1016/j.pmrj.2012.06.012; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Schurks M, 2011, CEPHALALGIA, V31, P1301, DOI 10.1177/0333102411415879; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vollestad J, 2011, BEHAV RES THER, V49, P281, DOI 10.1016/j.brat.2011.01.007; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; Wells RE, 2011, HEADACHE, V51, P1087, DOI 10.1111/j.1526-4610.2011.01917.x; Wells RE, 2011, NEUROEPIDEMIOLOGY, V36, P46, DOI 10.1159/000322949; Wells RE, 2010, J NEUROL, V257, P1822, DOI 10.1007/s00415-010-5616-2	26	15	15	4	49	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	JUN	2013	74	6					E520	+		10.4088/JCP.12m08246			11	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	AA5DE	WOS:000331115200001	23842021	Green Accepted			2022-02-06	
J	Soble, JR; Spanierman, LB; Smith, JF				Soble, Jason R.; Spanierman, Lisa B.; Smith, Julie Fitzgerald			Neuropsychological functioning of combat veterans with posttraumatic stress disorder and mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; Operation Enduring Freedom; Operation Iraqi Freedom combat veterans; Mild traumatic brain injury; Posttraumatic stress disorder	VERBAL-LEARNING TEST; POSTCONCUSSIVE SYMPTOMS; WAR VETERANS; HEAD-INJURY; IRAQ-WAR; MEMORY; AFGHANISTAN; ATTENTION; BLAST; PTSD	This study examined the neuropsychological performance of 125 outpatient Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with posttraumatic stress disorder (PTSD) and nonacute mild traumatic brain injury (TBI) (n=66) and PTSD (n=59) across multiple cognitive domains to determine whether mild TBI results in greater impairment among those with PTSD. Profile analyses revealed that veterans with PTSD and mild TBI did not differ significantly from those with just PTSD across domains, suggesting that comorbid mild TBI does not result in an additive effect. A norms-based comparison also revealed that neither group demonstrated impaired performance on any of the objective neuropsychological measures examined. However, both groups endorsed moderately elevated symptoms of depression and anxiety, indicating that comorbid psychopathology may contribute to subjective cognitive complaints.	[Soble, Jason R.] Univ Illinois, Dept Educ Psychol, Champaign, IL 61820 USA; [Spanierman, Lisa B.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Smith, Julie Fitzgerald] VA Illiana Healthcare Syst, Mental Hlth Serv, Danville, IL USA		Soble, JR (corresponding author), James A Haley VA Hosp, Dept Mental Hlth & Behav Sci Psychol 116B, 13000 N Bruce B Downs Blvd, Tampa, FL 33612 USA.	Jason.Soble@va.gov		Spanierman, Lisa/0000-0003-4878-9787			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carlozzi NE, 2011, STRESS HEALTH, V27, pE287, DOI 10.1002/smi.1355; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; DIKMEN S, 2009, NEUROPSYCHOLOGICAL A, P597; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gurvits TV, 2002, PSYCHIAT RES, V112, P263, DOI 10.1016/S0165-1781(02)00234-2; Hannay J. H., 2004, NEUROPSYCHOLOGICAL A, P133; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Kramer J. H., 2007, HUMAN FRONTAL LOBES, P279; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lorber W, 2010, PSYCHOTHERAPY, V47, P296, DOI 10.1037/a0021161; McCrae M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehl P.E, 1950, J CONSULT PSYCHOL, V14, P165, DOI [10.1037/h0058049, DOI 10.1037/H0058049]; Meyers JE., 1995, REY COMPLEX FIGURE T; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Sachinvala N, 2000, J NERV MENT DIS, V188, P818, DOI 10.1097/00005053-200012000-00005; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Slone L. B., 2008, WAR ZONE PRACTICAL G; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tanielian T., 2008, INVISIBLE WOUNDS WAR, P431; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wechsler D., 1997, ADM SCORING MANUAL W; Wichern DW., 2007, APPL MULTIVARIATE ST, V6; Wolfson, 1993, HALSTEAD REITAN NEUR; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137; [No title captured]	73	15	16	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN 1	2013	35	5					551	561		10.1080/13803395.2013.798398			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	161GJ	WOS:000320180200011	23672579				2022-02-06	
J	Tee, JW; Chan, CHP; Fitzgerald, MCB; Liew, SM; Rosenfeld, JV				Tee, J. W.; Chan, C. H. P.; Fitzgerald, M. C. B.; Liew, S. M.; Rosenfeld, J. V.			Epidemiological Trends of Spine Trauma: An Australian Level 1 Trauma Centre Study	GLOBAL SPINE JOURNAL			English	Article						spine trauma; epidemiology; demographics; spinal injury characteristics; neurological status; registry; prevention		Knowledge of current epidemiology and spine trauma trends assists in public resource allocation, fine-tuning of primary prevention methods, and benchmarking purposes. Data on all patients with traumatic spine injuries admitted to the Alfred Hospital, Melbourne between May 1, 2009, and January 1, 2011, were collected from the Alfred Trauma Registry, Alfred Health medical database, and Victorian Orthopaedic Trauma Outcomes Registry. Epidemiological trends were analyzed as a general cohort, with comparison cohorts of nonsurvivors versus survivors and elderly versus nonelderly. Linear regression analysis was utilized to demonstrate trends with statistical significance. There were 965 patients with traumatic spine injuries with 2,333 spine trauma levels. The general cohort showed a trimodal age distribution, male-to-female ratio of 2: 2, motor vehicle accidents as the primary spine trauma mechanism, 47.7% patients with severe polytrauma as graded using the Injury Severity Score (ISS), 17.3% with traumatic brain injury (TBI), the majority of patients with one spine injury level, 7% neurological deficit rate, 12.8% spine trauma operative rate, and 5.2% mortality rate. Variables with statistical significance trending toward mortality were the elderly, motor vehicle occupants, severe ISS, TBI, C1-2 dissociations, and American Spinal Injury Association (ASIA) A, B, and C neurological grades. Variables with statistical significance trending toward the elderly were females; low falls; one spine injury level; type 2 odontoid fractures; subaxial cervical spine distraction injuries; ASIA A, B, and C neurological grades; and patients without neurological deficits. Of the general cohort, 50.3% of spine trauma survivors were discharged home, and 48.1% were discharged to rehabilitation facilities. This study provides baseline spine trauma epidemiological data. The trimodal age distribution of patients with traumatic spine injuries calls for further studies and intervention targeted toward the 46-to 55-year age group as this group represents the main providers of financial and social security. The study's unique feature of delineating variables with statistical significance trending toward both mortality and the elderly also provides useful data to guide future research studies, benchmarking, public health policy, and efficient resource allocation for the management of spine trauma.	[Tee, J. W.; Chan, C. H. P.; Rosenfeld, J. V.] Alfred, Dept Neurosurg, Melbourne, Vic, Australia; [Tee, J. W.; Fitzgerald, M. C. B.] Alfred, Trauma Serv, Melbourne, Vic, Australia; [Liew, S. M.] Alfred, Dept Orthopaed, Melbourne, Vic, Australia; [Fitzgerald, M. C. B.] Alfred, Dept Emergency Med, Melbourne, Vic, Australia; [Tee, J. W.; Chan, C. H. P.; Fitzgerald, M. C. B.; Liew, S. M.; Rosenfeld, J. V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Liew, S. M.] VOTOR, Melbourne, Vic, Australia		Tee, JW (corresponding author), Level 1,Old Baker Bldg,Commercial Rd, Melbourne, Vic 3004, Australia.	Jin_Wee@hotmail.com	Rosenfeld, Jeffrey V/B-7249-2011	Fitzgerald, Mark/0000-0003-0183-7761			BLUMER CE, 1995, NEUROEPIDEMIOLOGY, V14, P258, DOI 10.1159/000109801; BRADLEY C, 2004, INJURY RES STAT SERI, V17; Couris CM, 2010, SPINAL CORD, V48, P39, DOI 10.1038/sc.2009.77; Dahlberg A, 2005, SPINAL CORD, V43, P47, DOI 10.1038/sj.sc.3101616; DIXON GS, 1993, NEUROEPIDEMIOLOGY, V12, P88, DOI 10.1159/000110305; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Hasler RM, 2011, EUR SPINE J, V20, P2174, DOI 10.1007/s00586-011-1866-7; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Jackson G, 2001, MAJOR TRAUMA DATA RE; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Koning W, 1989, Neurosurg Rev, V12 Suppl 1, P562, DOI 10.1007/BF01790703; Lenehan B, 2012, SPINE, V37, P321, DOI 10.1097/BRS.0b013e31822e5ff8; Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040; Norton L, 2010, INJURY RES STAT SERI, V52; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; O'Connor PJ, 2000, SPINAL CORD, V38, P597, DOI 10.1038/sj.sc.3101048; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; Pirouzmand F, 2010, J NEUROSURG-SPINE, V12, P131, DOI 10.3171/2009.9.SPINE0943; Roche SJ, 2008, INJURY, V39, P436, DOI 10.1016/j.injury.2007.12.012; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Tee JW, 2012, GLOB SPINE J, V2, P71, DOI 10.1055/s-0032-1319772; Tee JW, 2013, SPINE, V38, P169, DOI 10.1097/BRS.0b013e3182634cbf; Vaccaro AR, 2007, SPINE, V32, P2365, DOI 10.1097/BRS.0b013e3181557b92; Vaccaro AR, 2005, SPINE, V30, P2325, DOI 10.1097/01.brs.0000182986.43345.cb; Victorian State Trauma System (VSTS), 2010, VICT GOV HLTH INF; Wang HW, 2012, J NEUROSURG-SPINE, V17, P459, DOI 10.3171/2012.8.SPINE111003; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	28	15	16	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2192-5682	2192-5690		GLOB SPINE J	Glob. Spine J.	JUN	2013	3	2					75	84		10.1055/s-0033-1337124			10	Clinical Neurology; Orthopedics	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Orthopedics	V25EF	WOS:000215207200003	24436855	Green Published			2022-02-06	
J	Khan, F; Amatya, B				Khan, Fary; Amatya, Bhasker			USE OF THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF) TO DESCRIBE PATIENT-REPORTED DISABILITY IN PRIMARY BRAIN TUMOUR IN AN AUSTRALIAN COMMUNITY COHORT	JOURNAL OF REHABILITATION MEDICINE			English	Article						ICF; disability; brain tumour; outcome assessment; environmental factors	GUILLAIN-BARRE-SYNDROME; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; CORE SET; INPATIENT REHABILITATION; COGNITIVE DEFICITS; NECK-CANCER; OUTCOMES; PERSPECTIVE; DISEASE	Objective: To describe patient-reported disability in primary brain tumours using the International Classification of Functioning, Disability and Health (ICF); and comparison with categories within the core sets for stroke and traumatic brain injury. Method: A prospective community cross-sectional survey (n=106) following definitive treatment for primary brain tumours. Problems reported by participants were linked with ICF categories using 'linkage' rules. Participants rated 'activities and participation' and 'environmental factor' components of ICF checklist (using qualifiers); and responses compared with categories within core sets for stroke and traumatic brain injury. Results: Participant mean age 51 years, median time since diagnosis 2 years; over a third had high grade tumours. Participants considered 44 categories in 'activities and participation' and 16 categories (barriers) in 'environmental factors' as relevant (>= 10% response) using checklist. Reported problems included: Mobility, Domestic life, General tasks/demands; and Human made changes to environment. Although the linked categories for brain tumour survivors were similar to those in the core sets for stroke and traumatic brain injury, there was more commonality with the traumatic brain injury core set. Conclusion: The existing comprehensive stroke and traumatic brain injury core sets incorporate issues relevant to brain tumour survivors in post-acute settings. Findings from this report will assist in defining a future core set for brain tumour; the possibility however, of using a single core set relevant to most long-term neurological conditions needs to be explored.	[Khan, Fary; Amatya, Bhasker] Royal Melbourne Hosp, Dept Rehabil Med, Melbourne, Vic 3052, Australia; [Khan, Fary] Univ Melbourne, Dept Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Khan, Fary] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic 3004, Australia		Khan, F (corresponding author), Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Melbourne, Vic 3052, Australia.	fary.khan@mh.org.au	Amatya, Bhasker/E-1062-2017	Amatya, Bhasker/0000-0003-4793-1104	Victorian Cancer Agency	F. Khan received the Clinical Research Fellowship granted by Victorian Cancer Agency. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organisation with which the authors are associated.	Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Arber A, 2010, INT J PALLIAT NURS, V16, P24, DOI 10.12968/ijpn.2010.16.1.46180; Bartolo M, 2012, J NEURO-ONCOL, V107, P537, DOI 10.1007/s11060-011-0772-5; Bernsen RAJAM, 1997, J NEUROL NEUROSUR PS, V62, P637, DOI 10.1136/jnnp.62.6.637; Brain Foundation, 2011, BRAIN TUM BRAIN CANC; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2009, J CLIN EPIDEMIOL, V62, P912, DOI 10.1016/j.jclinepi.2008.04.011; Coenen M, 2011, J NEUROL, V258, P1477, DOI 10.1007/s00415-011-5963-7; Flowers A, 2000, Cancer Control, V7, P523; Franklin Deborah Julie, 2007, Phys Med Rehabil Clin N Am, V18, P899, DOI 10.1016/j.pmr.2007.07.007; Fu JB, 2010, AM J PHYS MED REHAB, V89, P205, DOI 10.1097/PHM.0b013e3181ca2306; Gabanelli P, 2005, NEUROL SCI, V26, pS51, DOI 10.1007/s10072-005-0408-7; Gehring K, 2008, LANCET NEUROL, V7, P548, DOI 10.1016/S1474-4422(08)70111-X; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Huang ME, 2011, PM&R, V3, P746, DOI 10.1016/j.pmrj.2011.05.020; Huang ME, 2001, BRAIN INJURY, V15, P843, DOI 10.1080/02699050010013653; International Classification of Functioning Disability and Health (ICF), 2012, COMPR ICF COR SET TR; Khan F, 2007, DISABIL REHABIL, V29, P205, DOI 10.1080/09638280600756141; Khan F, 2012, J REHABIL MED, V44, P570, DOI 10.2340/16501977-0972; Khan F, 2011, J REHABIL MED, V43, P638, DOI 10.2340/16501977-0826; Khan F, 2010, J REHABIL MED, V42, P708, DOI 10.2340/16501977-0592; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Leonardi M, 2009, DISABIL REHABIL, V31, pS88, DOI 10.3109/09638280903317732; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; Ng L, 2012, DISABIL REHABIL, V34, P295, DOI 10.3109/09638288.2011.606345; Ownsworth T, 2009, DISABIL REHABIL, V31, P1038, DOI 10.1080/09638280802509538; PARKIN DM, 2005, CANC INCIDENCE 5 CON, V1; Patton M.Q., 1990, QUALITATIVE EVALUATI; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Rooney A, 2010, COCHRANE DB SYST REV, V3; Stier-Jarmer M, 2005, DISABIL REHABIL, V27, P389, DOI 10.1080/09638280400014022; Sveen U, 2012, DISABIL REHABIL; Tang V, 2008, J NEUROL, V255, P820, DOI 10.1007/s00415-008-0695-z; Tschiesner U, 2011, INT J REHABIL RES, V34, P121, DOI 10.1097/MRR.0b013e328343d4bc; Tschiesner U, 2009, LARYNGOSCOPE, V119, P915, DOI 10.1002/lary.20211; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Weigl M, 2003, OSTEOARTHR CARTILAGE, V11, P519, DOI 10.1016/S1063-4584(03)00086-4; Weitzner MA, 1999, CANCER INVEST, V17, P285, DOI 10.3109/07357909909040599; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]	40	15	15	0	17	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2013	45	5					434	445		10.2340/16501977-1132			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	163OB	WOS:000320345700004	23584801	gold			2022-02-06	
J	Tanriverdi, F; Suer, C; Yapislar, H; Kocyigit, I; Selcuklu, A; Unluhizarci, K; Casanueva, FF; Kelestimur, F				Tanriverdi, Fatih; Suer, Cem; Yapislar, Hande; Kocyigit, Ismail; Selcuklu, Ahmet; Unluhizarci, Kursad; Casanueva, Felipe F.; Kelestimur, Fahrettin			Growth hormone deficiency due to sports-related head trauma is associated with impaired cognitive performance in amateur boxers and kickboxers as revealed by P300 auditory event-related potentials	CLINICAL ENDOCRINOLOGY			English	Article							ANTERIOR-PITUITARY FUNCTION; QUALITY-OF-LIFE; BRAIN-INJURY; GH REPLACEMENT; MULTIPLE CONCUSSIONS; ALZHEIMERS-DISEASE; LATENCY; THERAPY; ADULTS; HYPOPITUITARISM	Objectives It has been recently reported that boxing and kickboxing may cause pituitary dysfunction, GH deficiency in particular. The strong link between poor cognitive performance and GH deficiency due to causes other than head trauma and the improvement of cognitive function after GH replacement therapy have been previously shown. P300 auditory event-related potential (ERP) measure is widely used to evaluate cognitive performance. In this study, we investigated the relation between the GH-IGF-I axis and cognitive performance in boxers and kickboxers. Design and patients Forty-one actively competing or retired male boxers (n: 27) and kickboxers (n: 14) with a mean age of 29 center dot 04 +/- 9 center dot 30year and 14age- and education-matched healthy male controls were included in the study. For neuropsychological tests, the mini-mental state examination (MMSE) and Quality of Life Assessment of GH Deficiency in Adults (QoL-AGHDA) questionnaires were administered. Moreover, cognitive performance was evaluated according to P300 ERPs. Results Nine of 41 (21 center dot 9%) athletes had GH deficiency. P300 amplitudes were lower at all electrode sites in the GH-deficient group than in controls, and the differences were statistically significant at Fz and Oz electrode sites (P<0 center dot 05). When GH-deficient athletes were compared with GH-sufficient athletes, the P300 amplitudes were lower at all electrode sites in the GH-deficient group; these differences were statistically significant at Fz, Pz and Cz electrode sites (P<0 center dot 05). In all athletes, there were significant negative correlations between IGF-I levels vs P300 latencies, and there were significant positive correlations between IGF-I levels vs P300 amplitudes (P<0 center dot 05). Conclusion This study provides the first electrophysiological evidence for the close relation between the P300 ERPs and the GH-IGF-I axis in boxers and kickboxers.	[Tanriverdi, Fatih; Unluhizarci, Kursad; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Suer, Cem; Yapislar, Hande] Erciyes Univ, Sch Med, Dept Physiol, TR-38039 Kayseri, Turkey; [Kocyigit, Ismail] Erciyes Univ, Sch Med, Dept Internal Med, TR-38039 Kayseri, Turkey; [Selcuklu, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; [Casanueva, Felipe F.] Univ Santiago de Compostela, Dept Med, Complejo Hosp Univ Santiago CHUS, Santiago De Compostela, Spain; [Casanueva, Felipe F.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain		Tanriverdi, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fatihtan@erciyes.edu.tr	kelestimur, f/ABE-9873-2021; Yapislar, Hande/X-1407-2018; Suer, Cem/AAT-6501-2021	Suer, Cem/0000-0002-6455-6644; KOCYIGIT, ISMAIL/0000-0002-6654-4727	Scientific and Technical Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [SBAG-3017]	This work was partially supported by the Scientific and Technical Research Council of Turkey (TUBITAK, project no. SBAG-3017).	Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Bennys K, 2007, J CLIN NEUROPHYSIOL, V24, P405, DOI 10.1097/WNP.0b013e31815068d5; Braverman ER, 2003, CLIN ELECTROENCEPHAL, V34, P124, DOI 10.1177/155005940303400306; Creyghton Wouter M, 2004, Semin Vasc Med, V4, P167, DOI 10.1055/s-2004-835375; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghigo E, 2000, J PEDIATR ENDOCR MET, V13, P1493; Golgeli A, 2004, EUR J ENDOCRINOL, V150, P153, DOI 10.1530/eje.0.1500153; Golgeli A, 1999, INT J NEUROSCI, V99, P69; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; HAN VKM, 1995, ACTA PAEDIATR, V84, P3, DOI 10.1111/j.1651-2227.1995.tb13850.x; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Lamberts SWJ, 1998, LANCET, V352, P127; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; MCKENNA SP, 1994, PHARMACOECONOMICS, V6, P434, DOI 10.2165/00019053-199406050-00005; Naganuma Yoshihiro, 1993, No To Hattatsu, V25, P515; NESHIGE R, 1988, J NEUROL NEUROSUR PS, V51, P1120, DOI 10.1136/jnnp.51.9.1120; Oken Barry S., 1997, P529; ORTIZ AT, 2002, ACTAS ESP PSIQUIATRI, V30, P1; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Powell JW, 2001, J ATHL TRAINING, V36, P307; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tanriverdi Fatih, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P131, DOI 10.1586/14737167.6.2.131; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Walhovd KB, 2008, PSYCHOPHYSIOLOGY, V45, P545, DOI 10.1111/j.1469-8986.2008.00661.x; Wright MJ, 2001, BEHAV GENET, V31, P555, DOI 10.1023/A:1013393327704; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	44	15	15	1	28	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664			CLIN ENDOCRINOL	Clin. Endocrinol.	MAY	2013	78	5					730	737		10.1111/cen.12037			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	126KX	WOS:000317615300015	22994791				2022-02-06	
J	Whitney, KA				Whitney, Kriscinda A.			Predicting Test of Memory Malingering and Medical Symptom Validity Test Failure within a Veterans Affairs Medical Center: Use of the Response Bias Scale and the HenryHeilbronner Index	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Malingering; symptom validity testing; Forensic neuropsychology; Head injury; Traumatic brain injury	HENRY-HEILBRONNER INDEX; FAKE-BAD-SCALE; PERSONAL-INJURY LITIGANTS; DISABILITY CLAIMANTS; COGNITIVELY INTACT; HIGH SPECIFICITY; MILITARY SAMPLE; NORMATIVE DATA; MMPI-2; TOMM	The ability of the Response Bias Scale (RBS) and the HenryHeilbronner Index (HHI), along with several other MMPI-2 validity scales, to predict performance on two separate stand-alone symptom validity tests, the Test of Memory Malingering (TOMM) and the Medical Symptom Validity Test (MSVT), was examined. Findings from this retrospective data analysis of outpatients seen within a Veterans Affairs medical center (N 194) showed that group differences between those passing and failing the TOMM were largest for the RBS (d 0.79), HHI (d 0.75), and Infrequency (F; d 0.72). The largest group differences for those passing versus failing the MSVT were greatest on the HHI (d 0.83), RBS (d 0.80), and F (d 0.78). Regression analyses showed that the RBS accounted for the most variance in TOMM scores (20), whereas the HHI accounted for the most variance in MSVT scores (26). Nonetheless, due to unacceptably low positive and negative predictive values, caution is warranted in using either one of these indices in isolation to predict performance invalidity.	[Whitney, Kriscinda A.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN USA; [Whitney, Kriscinda A.] Indiana Univ Sch Med, Indianapolis, IN USA		Whitney, KA (corresponding author), Richard L Roudebush Vet Affairs Med Ctr 116P, 1481 W 10th St, Indianapolis, IN 46202 USA.	kamarks@iupui.edu					Allen L., 1997, CARB97 MANUAL FOR TH; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Devilly G. J., 2004, EFFECT SIZE GENERATO; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; Elhai JD, 2002, J PERS ASSESS, V79, P531, DOI 10.1207/S15327752JPA7903_08; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Graham J. R, 2005, MMPI 2 ASSESSING PER; Graham J.R., 1990, MMPI 2 ASSESSING PER; Green P., 2003, GREENS WORD MEMORY T; Green P., 2008, MANUAL FOR THE NONVE; Green P, 2004, GREENS MEDICAL SYMPT; Green P., 1996, THE WORD MEMORY TEST; Green P., 1995, MANUAL FOR THE ORAL; Green P., 2009, THE ADVANCED INTERPR; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Hathaway S. R., 1951, THE MINNESOTA MULTIP; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kaemmer, 1989, MINNESOTA MULTIPHASI; Lange RT, 2010, PSYCHIAT RES, V176, P229, DOI 10.1016/j.psychres.2009.03.004; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lipsey MW., 1990, DESIGN SENSITIVITY; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCaffrey R. J., 2003, PRACTITIONERS GUIDE; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; SHAW DJ, 1965, J CLIN PSYCHOL, V21, P405, DOI 10.1002/1097-4679(196510)21:4<405::AID-JCLP2270210416>3.0.CO;2-I; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P160, DOI 10.1080/13854046.2011.647084; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tellegen, 2008, MINNESOTA MULTIPHASI; Tombaugh T. N., 1996, TOMM TEST OF MEMORY; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tsushima WT, 2011, CLIN NEUROPSYCHOL, V25, P1403, DOI 10.1080/13854046.2011.613854; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P165, DOI 10.1093/arclin/acr013	58	15	15	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2013	28	3					222	235		10.1093/arclin/act012			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	138YK	WOS:000318547600003	23493404	Bronze			2022-02-06	
J	Carlson, BE; Stromwall, LK; Lietz, CA				Carlson, Bonnie E.; Stromwall, Layne K.; Lietz, Cynthia A.			Mental Health Issues in Recently Returning Women Veterans: Implications for Practice	SOCIAL WORK			English	Article						military; OEF/OIF; veterans; women	POSTTRAUMATIC-STRESS-DISORDER; MILITARY SEXUAL TRAUMA; FEMALE VETERANS; PSYCHIATRIC DIAGNOSES; GENDER-DIFFERENCES; SERVICE MEMBERS; WAR VETERANS; BRAIN-INJURY; PRIMARY-CARE; ALCOHOL-USE	Increasing numbers of women are found in the military, and they are now performing roles very similar to those of male service members. More returning servicewomen and veterans have been exposed to stressful and traumatic experiences, such as combat and difficult living circumstances, and military sexual trauma is common. These experiences have been found to be associated with adverse mental health outcomes, posttraumatic stress disorder, depression, and substance abuse in particular. Comorbidity rates are also high. In addition, more veterans are returning with injuries, including traumatic brain injuries. Although more women veterans of Operation Enduring Freedom and Operation Iraqi Freedom are seeking health services at Veterans Administration facilities, many are not. Thus, community-based social workers need to be familiar with the needs of this growing population to serve them effectively. Use of empirically supported assessment instruments and screening for military sexual trauma are recommended. Recommended interventions include the use of evidence-supported practices, such as cognitive behavioral treatment, and offering assistance to enhance social support among women veterans.	[Stromwall, Layne K.; Lietz, Cynthia A.] Arizona State Univ, Sch Social Work, Phoenix, AZ 85004 USA		Stromwall, LK (corresponding author), Arizona State Univ, Sch Social Work, Mail Code 3920,411 N Cent Ave,Suite 800, Phoenix, AZ 85004 USA.	stromwall@asu.edu					Babor TF, 1989, ALCOHOL HEALTH RES W, V13, P71; Barber JA, 2008, COMMUNITY MENT HLT J, V44, P433, DOI 10.1007/s10597-008-9146-7; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell E A, 1998, J Psychosoc Nurs Ment Health Serv, V36, P19; Bell ME, 2011, SOC WORK HEALTH CARE, V50, P34, DOI 10.1080/00981389.2010.513917; Berg I. K., 2008, INTERVIEWING FOR SOL; Bowling UB, 2008, PROF PSYCHOL-RES PR, V39, P451, DOI 10.1037/0735-7028.39.4.451; Bradley KA, 2001, PSYCHOL ADDICT BEHAV, V15, P297, DOI 10.1037/0893-164X.15.4.297; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Coyle BS, 1996, MIL MED, V161, P588, DOI 10.1093/milmed/161.10.588; Department of Defense, 2007, DEMOGRAPHICS 2007 PR; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Escalona R, 2004, PSYCHOSOMATICS, V45, P291, DOI 10.1176/appi.psy.45.4.291; Fontana A, 1998, PSYCHIATR SERV, V49, P658, DOI 10.1176/ps.49.5.658; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Gradus JL, 2008, J STUD ALCOHOL DRUGS, V69, P348, DOI 10.15288/jsad.2008.69.348; Graybeal C, 2001, FAM SOC-J CONTEMP H, V82, P233, DOI 10.1606/1044-3894.236; Hamilton AB, 2011, WOMEN HEALTH ISS, V21, pS203, DOI 10.1016/j.whi.2011.04.005; Hankin CS, 1999, J TRAUMA STRESS, V12, P601, DOI 10.1023/A:1024760900213; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Himmelfarb N, 2006, J TRAUMA STRESS, V19, P837, DOI 10.1002/jts.20163; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2010, RETURNING HOME FROM; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Johnson S. J., 2007, THE PSYCHOLOGICAL NE; Katz LS, 2007, PSYCHOL SERV, V4, P239, DOI DOI 10.1037/1541-1559.4.4.239; Kelly MM, 2008, J GEN INTERN MED, V23, P741, DOI 10.1007/s11606-008-0589-x; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; King DW, 1999, J ABNORM PSYCHOL, V108, P164, DOI 10.1037/0021-843X.108.1.164; Lietz C. A., FAMILIES IN SOCIETY; Maguen S, 2012, WOMEN HEALTH ISS, V22, pE61, DOI 10.1016/j.whi.2011.07.010; Malebranche K., 2011, OEF OIF WOMENS INITI; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Murdoch M, 2004, MIL MED, V169, P392, DOI 10.7205/MILMED.169.5.392; Murdoch M, 2005, MED CARE, V43, P112, DOI 10.1097/00005650-200502000-00004; Murdoch M, 1995, Arch Fam Med, V4, P411, DOI 10.1001/archfami.4.5.411; National Center for PTSD, 2011, PTSD SCREENING INSTR; National Center for PTSD, 2011, MOBILE APP PTSD COAC; National Center for Telehealth and Technology, 2011, WELLNESS RESOURCES F; Norwood AE, 1997, MIL MED, V162, P643, DOI 10.1093/milmed/162.10.643; Ouimette P, 2008, J ANXIETY DISORD, V22, P337, DOI 10.1016/j.janxdis.2007.02.010; Ouimette PC, 1996, J SUBST ABUSE, V8, P335, DOI 10.1016/S0899-3289(96)90188-1; Pfeiffer PN, 2011, GEN HOSP PSYCHIAT, V33, P29, DOI 10.1016/j.genhosppsych.2010.10.002; Pierce PF, 1997, AVIAT SPACE ENVIR MD, V68, P317; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosen LN, 1996, MIL MED, V161, P342, DOI 10.1093/milmed/161.6.342; Rowe EL, 2009, MIL PSYCHOL, V21, P387, DOI 10.1080/08995600902914768; Russell Marcia, 1994, Alcohol Health Res World, V18, P55; Sadler AG, 2000, OBSTET GYNECOL, V96, P473, DOI 10.1016/S0029-7844(00)00919-4; Saleebey D., 2009, STRENGTHS PERSPECTIV; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schultz J. R., 2006, CHILD SEXUAL ABUSE A; Skinner KM, 2000, J INTERPERS VIOLENCE, V15, P291, DOI 10.1177/088626000015003005; Stein MB, 2004, GEN HOSP PSYCHIAT, V26, P178, DOI 10.1016/j.genhosppsych.2003.11.003; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Suffoletta-Maierle Samantha, 2003, J Psychiatr Pract, V9, P367, DOI 10.1097/00131746-200309000-00005; Suris A, 2004, PSYCHOSOM MED, V66, P749, DOI 10.1097/01.psy.0000138117.58559.7b; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Turchik JA, 2010, AGGRESS VIOLENT BEH, V15, P267, DOI 10.1016/j.avb.2010.01.005; U.S. Department of Veterans Affairs, 2011, WOMEN VETERANS POPUL; U.S. Department of Veterans Affairs, 2011, THE CHANGING FACE OF; U.S. Department of Veterans Affairs, 2007, WOMEN VETERANS PAST; U.S. Department of Veterans Affairs, 2011, WOMENS TRAUMA RECOVE; U.S. Department of Veterans Affairs, 2011, POST TRAUMATIC STRES; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vogt DS, 2005, J TRAUMA STRESS, V18, P271; Weathers F. W., 1993, PAPER PRESENTED AT T; Wojcik BE, 2009, MIL MED, V174, P1010, DOI 10.7205/MILMED-D-01-6108; Wolfe J, 1998, J INTERPERS VIOLENCE, V13, P40, DOI 10.1177/088626098013001003	77	15	15	0	27	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0037-8046	1545-6846		SOC WORK	Soc. Work	APR	2013	58	2					105	114		10.1093/sw/swt001			10	Social Work	Social Science Citation Index (SSCI)	Social Work	137UG	WOS:000318463100002	23724574				2022-02-06	
J	Fox, WC; Park, MS; Belverud, S; Klugh, A; Rivet, D; Tomlin, JM				Fox, W. Christopher; Park, Min S.; Belverud, Shawn; Klugh, Arnett; Rivet, Dennis; Tomlin, Jeffrey M.			Contemporary imaging of mild TBI: the journey toward diffusion tensor imaging to assess neuronal damage	NEUROLOGICAL RESEARCH			English	Article						Diffusion tensor imaging; Mild traumatic brain injury; Neuroimaging; Non-invasive assessment	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; WHITE-MATTER ABNORMALITIES; CT HEAD RULE; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; GLUCOSE-METABOLISM; MEAN DIFFUSIVITY; UNITED-STATES; AXONAL INJURY	Objectives: To follow the progression of neuroimaging as a means of non-invasive evaluation of mild traumatic brain injury (mTBI) in order to provide recommendations based on reproducible, defined imaging findings. Methods: A comprehensive literature review and analysis of contemporary published articles was performed to study the progression of neuroimaging findings as a non-invasive 'biomarker' for mTBI. Results: Multiple imaging modalities exist to support the evaluation of patients with mTBI, including ultrasound (US), computed tomography (CT), single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI). These techniques continue to evolve with the development of fractional anisotropy (FA), fiber tractography (FT), and diffusion tensor imaging (DTI). Discussion: Modern imaging techniques, when applied in the appropriate clinical setting, may serve as a valuable tool for diagnosis and management of patients with mTBI. An understanding of modern neuroanatomical imaging will enhance our ability to analyse injury and recognize the manifestations of mTBI.	[Fox, W. Christopher; Park, Min S.; Belverud, Shawn; Klugh, Arnett; Tomlin, Jeffrey M.] USN, San Diego Med Ctr, Dept Neurosurg, San Diego, CA 92134 USA; [Rivet, Dennis] USN, Med Ctr Portsmouth, Dept Neurosurg, Portsmouth, VA USA; [Tomlin, Jeffrey M.] NATO Role III Multinatl Med Unit, Kandahar, Afghanistan		Fox, WC (corresponding author), USN, San Diego Med Ctr, Dept Neurosurg, San Diego, CA 92134 USA.	chrisfox26@gmail.com		Fox, W Christopher/0000-0002-7762-9902			Abu-Judeh HH, 1998, J NUCL MED, V39, P1357; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bigler ED, 2010, PSYCHOL INJ LAW, V3, P36, DOI 10.1007/s12207-010-9064-1; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Davis PC BJ, 2008, EXPERT PANEL NEUROLO; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hricak H, 2011, RADIOLOGY, V258, P889, DOI 10.1148/radiol.10101157; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koizumi H, 2010, J CEREBR BLOOD F MET, V30, P1673, DOI 10.1038/jcbfm.2010.75; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Moshel YA, 2009, J NEUROSURG-PEDIATR, V4, P495, DOI 10.3171/2009.7.PEDS09128; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SILVERMAN IE, 1993, J NUCL MED, V34, P1447; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	79	15	17	0	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					223	232		10.1179/1743132813Y.0000000162			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104QW	WOS:000316010700002	23485049				2022-02-06	
J	O'Kelly, J; Magee, WL				O'Kelly, Julian; Magee, Wendy L.			The complementary role of music therapy in the detection of awareness in disorders of consciousness: An audit of concurrent SMART and MATADOC assessments	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Music therapy; Assessment; Disorders of consciousness; MATADOC; SMART; Diagnosis	SENSORY MODALITY ASSESSMENT; TRAUMATIC BRAIN-INJURY; REHABILITATION TECHNIQUE; VEGETATIVE STATE; EPIDEMIOLOGY; TOOL	In the behavioural assessment of disorders of consciousness (DOC), best practice is for several different assessment tools to be used to encourage a variety of different responses indicative of awareness. Anecdotal evidence suggests a range of musical stimuli may be particularly effective in eliciting responses to guide the assessment process, although comparative data regarding behavioural domains is lacking. This study examined 42 concurrent records of patients assessed using the Sensory Modality Assessment and Rehabilitation Technique (SMART), and the Music Therapy Assessment Tool for Awareness in Disorders of Consciousness (MATADOC) to explore the relationship between diagnosis and behavioural characteristics of the cohort. Whilst the two tools produced a high level of agreement in diagnostic outcome (Spearman Rho .80), divergent diagnosis and weaker correlations between behavioural response items highlight contrasting sensitivities of the tools. Whilst MATADOC has higher sensitivity within auditory and visual domains relative to SMART, SMART has higher sensitivity in the motor domain. The significant contribution of musical response items in MATADOC, and the tactile response item in SMART, indicates both tools provide unique behavioural data predictive of awareness. Multidisciplinary assessment using SMART and MATADOC provides complementary data contributing to a fuller understanding of a patient's level of awareness.	[O'Kelly, Julian] Royal Hosp Neurodisabil, London SW15 3SW, England; [O'Kelly, Julian] Aalborg Univ, Aalborg, Denmark; [Magee, Wendy L.] Temple Univ, Boyer Coll Mus & Dance, Philadelphia, PA 19122 USA		O'Kelly, J (corresponding author), Royal Hosp Neurodisabil, West Hill, London SW15 3SW, England.	jokelly@rhn.org.uk	Magee, Wendy L./AAP-6839-2020	Magee, Wendy L./0000-0003-4350-1289	Aalborg University; Neuro-disability Research Trust; Music Therapy Charity	The authors would like to acknowledge the support of Dr Sophie Duport, Head of Research at the Royal Hospital for Neuro-disability (RHN); the RHN Music Therapy and Occupational Therapy staff; and funding from Aalborg University, the Neuro-disability Research Trust and the Music Therapy Charity.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Daveson BA, 2007, INT J THER REHABIL, V14, P545, DOI 10.12968/ijtr.2007.14.12.27760; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; Magee W.L., 2012, BRAIN INJURY, V26, P309; Magee W.L., 2012, MUSIC THERAPY UNPUB; Magee WL, 2007, NEUROREHABILITATION, V22, P319; Magee WL, 2005, NEUROPSYCHOL REHABIL, V15, P522, DOI 10.1080/09602010443000461; O'Kelly J., 2012, NORDIC J MU IN PRESS; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; *ROYAL COLL PHYS, 2003, VEG STAT GUID DIAGN; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, WHIM WESSEX HEAD INJ; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	20	15	15	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 1	2013	23	2					287	298		10.1080/09602011.2012.753395			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	105KU	WOS:000316068800008	23302033				2022-02-06	
J	Grottke, O; Frietsch, T; Maas, M; Lier, H; Rossaint, R				Grottke, O.; Frietsch, T.; Maas, M.; Lier, H.; Rossaint, R.			Dealing with massive bleeding and associated perioperative coagulopathy. Recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine	ANAESTHESIST			German	Article						Trauma; Blood transfusion; Coagulopathy; Damage control surgery; Resuscitation	PROTHROMBIN COMPLEX CONCENTRATE; FRESH-FROZEN PLASMA; ACTIVATED FACTOR-VII; LIFE-THREATENING HEMORRHAGE; RECOMBINANT-FACTOR-VIIA; TRAUMATIC BRAIN-INJURY; DILUTIONAL COAGULOPATHY; FIBRINOGEN CONCENTRATE; TRANSFUSION PROTOCOL; MAJOR TRAUMA	Massive bleeding with coagulopathy and hemorrhagic shock poses a potential threat to life in numerous clinical settings. Optimal treatment including the prevention of exsanguination necessitates a standardized and interdisciplinary approach. Several studies have shown the importance of massive transfusion protocols and standardized coagulation algorithms to improve survival of severely bleeding patients and to avoid secondary complications. Thus, the Helsinki declaration for patient safety in anesthesiology demands the implementation of clinical practice guidelines for the treatment of patients requiring massive transfusion. This paper introduces a standardized algorithm for the treatment of patients with massive bleeding which was developed in consensus with the German Society of Anaesthesiology and Intensive Care Medicine (DGAI).	[Grottke, O.; Rossaint, R.] Univ Klinikum Aachen, Anasthesiol Klin, D-52074 Aachen, Germany; [Frietsch, T.] Robert Bosch Klinikum Schillerhohe, Gerlingen, Germany; [Maas, M.] Univ Klinikum Munster, Klin Anasthesiol Operat Intens Med & Schmerzthera, Munster, Germany; [Lier, H.] Univ Klinikum Koln, Klin Anasthesiol & Operat Intens Med, Cologne, Germany		Grottke, O (corresponding author), Univ Klinikum Aachen, Anasthesiol Klin, Pauwelsstr 30, D-52074 Aachen, Germany.	ogrottke@ukaachen.de	Lier, Heiko/J-3005-2019; Frietsch, Thomas/ABE-1386-2021; Grottke, Oliver/F-1508-2018	Lier, Heiko/0000-0001-7374-4324; Grottke, Oliver/0000-0002-0722-3122; Maas, Matthias/0000-0001-8981-0939			Adam S, 2010, CLIN APPL THROMB-HEM, V16, P454, DOI 10.1177/1076029609336855; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub2; Carless PA, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001884.PUB2; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Dente CJ, 2009, J TRAUMA, V66, P1616, DOI 10.1097/TA.0b013e3181a59ad5; Desmurs-Clavel H, 2009, THROMB RES, V123, P796, DOI 10.1016/j.thromres.2008.07.007; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2008, ANESTH ANALG, V106, P1070, DOI 10.1213/ane.0b013e318165dfbb; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Engstrom M, 2006, J TRAUMA, V61, P624, DOI 10.1097/01.ta.0000226739.30655.75; Franchini M, 2010, CLIN OBSTET GYNECOL, V53, P219, DOI 10.1097/GRF.0b013e3181cc4378; Fries D, 2005, BRIT J ANAESTH, V95, P172, DOI 10.1093/bja/aei160; Fries D, 2009, CURR OPIN ANESTHESIO, V22, P267, DOI 10.1097/ACO.0b013e32832678d9; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Grottke O, 2010, BEST PRACT RES-CLIN, V24, P95, DOI 10.1016/j.bpa.2009.09.005; Grottke O, 2010, CRIT CARE, V14, DOI 10.1186/cc8960; Hanke AA, 2010, ANAESTHESIA, V65, P688, DOI 10.1111/j.1365-2044.2010.06367.x; Hardy JF, 2006, CAN J ANAESTH, V53, pS40, DOI 10.1007/BF03022251; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hedner Ulla, 2003, Clin Adv Hematol Oncol, V1, P112; Henrich W, 2008, J PERINAT MED, V36, P467, DOI 10.1515/JPM.2008.093; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Honickel M, 2011, THROMB HAEMOSTASIS, V106, P724, DOI 10.1160/TH11-02-0101; Inaba K, 2010, ARCH SURG-CHICAGO, V145, P899, DOI 10.1001/archsurg.2010.175; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Johansson PI, 2010, TRANSFUSION, V50, P701, DOI 10.1111/j.1537-2995.2009.02458.x; Kalina U, 2008, INT J CLIN PRACT, V62, P1614, DOI 10.1111/j.1742-1241.2008.01859.x; Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10488; Kozek-Langenecker SA, 2010, BEST PRACT RES-CLIN, V24, P27, DOI 10.1016/j.bpa.2009.09.009; Levi M, 2011, VOX SANG, V101, P154, DOI 10.1111/j.1423-0410.2011.01472.x; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Lier H, 2008, J TRAUMA, V65, P951, DOI 10.1097/TA.0b013e318187e15b; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; Liesenfeld KH, 2006, BRIT J CLIN PHARMACO, V62, P527, DOI 10.1111/j.1365-2125.2006.02667.x; Lissauer ME, 2011, AM J SURG, V202, P53, DOI 10.1016/j.amjsurg.2010.05.002; Maegele M, 2011, VOX SANG, V100, P231, DOI 10.1111/j.1423-0410.2010.01387.x; Mellin-Olsen J, 2010, EUR J ANAESTH, V27, P592, DOI 10.1097/EJA.0b013e32833b1adf; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Mitterlechner T, 2011, J THROMB HAEMOST, V9, P729, DOI 10.1111/j.1538-7836.2011.04211.x; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Nunez TC, 2010, J TRAUMA, V68, P1498, DOI 10.1097/TA.0b013e3181d3cc25; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Keeffe T, 2008, ARCH SURG-CHICAGO, V143, P686, DOI 10.1001/archsurg.143.7.686; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Schick KS, 2009, CRIT CARE, V13, DOI 10.1186/cc8186; Schochl H, 2012, HAMOSTASEOLOGIE, V32, P22, DOI 10.5482/ha-1178; Schochl H, 2010, ANAESTHESIA, V65, P199, DOI 10.1111/j.1365-2044.2009.06188.x; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schreiber MA, 2004, CRIT CARE CLIN, V20, P101, DOI 10.1016/S0749-0704(03)00095-2; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shanwell A, 2009, VOX SANG, V96, P316, DOI 10.1111/j.1423-0410.2009.01167.x; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stanworth SJ, 2004, BRIT J HAEMATOL, V126, P139, DOI 10.1111/j.1365-2141.2004.04973.x; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; van den Elsen MJLJ, 2010, CURR OPIN ANESTHESIO, V23, P269, DOI 10.1097/ACO.0b013e328336b8d0; Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x; Vincent JL, 2006, CRIT CARE, V10, DOI 10.1186/cc5026; VINCENT JL, 1983, CRIT CARE MED, V11, P449, DOI 10.1097/00003246-198306000-00012; Vivien B, 2005, CRIT CARE MED, V33, P1946, DOI 10.1097/01.CCM.0000171840.01892.36; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004; Yucel N, 2006, J TRAUMA, V60, P1228, DOI 10.1097/01.ta.0000220386.84012.bf; Zander R, 2010, WIEN KLIN WOCHENSCHR, V122, pS6	88	15	16	1	15	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	MAR	2013	62	3					213	+		10.1007/s00101-012-2136-8			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	130EC	WOS:000317894500009	23407716				2022-02-06	
J	Knutson, KM; Rakowsky, ST; Solomon, J; Krueger, F; Raymont, V; Tierney, MC; Wassermann, EM; Grafman, J				Knutson, Kristine M.; Rakowsky, Shana T.; Solomon, Jeffrey; Krueger, Frank; Raymont, Vanessa; Tierney, Michael C.; Wassermann, Eric M.; Grafman, Jordan			Injured brain regions associated with anxiety in Vietnam veterans	NEUROPSYCHOLOGIA			English	Article						Anxiety; Traumatic brain injury; Voxel-based lesion symptom mapping	POSTTRAUMATIC-STRESS-DISORDER; PENETRATING HEAD-INJURY; AVERSIVE VISUAL-STIMULI; BED NUCLEUS; ORBITOFRONTAL CORTEX; HIPPOCAMPAL-LESIONS; PREFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; HEMISPHERIC-ASYMMETRY; BASOLATERAL AMYGDALA	Anxiety negatively affects quality of life and psychosocial functioning. Previous research has shown that anxiety symptoms in healthy individuals are associated with variations in the volume of brain regions, such as the amygdala, hippocampus, and the bed nucleus of the stria terminalis. Brain lesion data also suggests the hemisphere damaged may affect levels of anxiety. We studied a sample of 182 male Vietnam War veterans with penetrating brain injuries, using a semi-automated voxel-based lesion-symptom mapping (VLSM) approach. VLSM reveals significant associations between a symptom such as anxiety and the location of brain lesions, and does not require a broad, subjective assignment of patients into categories based on lesion location. We found that lesioned brain regions in cortical and limbic areas of the left hemisphere, including middle, inferior and superior temporal lobe, hippocampus, and fusiform regions, along with smaller areas in the inferior occipital lobe, parahippocampus, amygdala, and insula, were associated with increased anxiety symptoms as measured by the Neurobehavioral Rating Scale (NRS). These results were corroborated by similar findings using Neuropsychiatric Inventory (NPI) anxiety scores, which supports these regions' role in regulating anxiety. In summary, using a semi-automated analysis tool, we detected an effect of focal brain damage on the presentation of anxiety. We also separated the effects of brain injury and war experience by including a control group of combat veterans without brain injury. We compared this control group against veterans with brain lesions in areas associated with anxiety, and against veterans with lesions only in other brain areas. Published by Elsevier Ltd.	[Knutson, Kristine M.; Tierney, Michael C.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bethesda, MD 20892 USA; [Rakowsky, Shana T.] Georgetown Univ, Georgetown Coll, Washington, DC USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Raymont, Vanessa] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Chicago, IL 60611 USA		Knutson, KM (corresponding author), NINDS, Behav Neurol Unit, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	knutsonk@ninds.nih.gov; jgrafman@ric.org	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Grafman, Jordan H./0000-0001-8645-4457; Knutson, Kristine/0000-0003-4626-4514	United States National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program; United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0675]	We especially thank the Vietnam War veterans who participated in this study. We thank the National Naval Medical Center for their support and provision of their facilities and S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for their invaluable help with the testing of participants and organization of this study. The work was supported by the United States National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program, and a project grant from the United States Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study, Grant DAMD17-01-1-0675). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, nor the United States Government.	Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; AMARAL D G, 1992, P1; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anderson AK, 2000, NEUROPSYCHOLOGY, V14, P526, DOI 10.1037/0894-4105.14.4.526; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; BLANCHARD RJ, 1993, BEHAV BRAIN RES, V58, P155, DOI 10.1016/0166-4328(93)90100-5; Blanco E, 2009, BEHAV BRAIN RES, V201, P338, DOI 10.1016/j.bbr.2009.03.001; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BUYDENSBRANCHEY L, 1990, J NERV MENT DIS, V178, P582, DOI 10.1097/00005053-199009000-00005; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; DAVIS M, 1994, INT REV NEUROBIOL, V36, P225, DOI 10.1016/S0074-7742(08)60305-0; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P553, DOI 10.1016/S0006-3223(01)01375-0; de Geus EJC, 2007, BIOL PSYCHIAT, V61, P1062, DOI 10.1016/j.biopsych.2006.07.026; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Dellacherie D, 2011, NEUROPSYCHOLOGIA, V49, P618, DOI 10.1016/j.neuropsychologia.2010.11.008; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RS, 1994, NEUROPSYCHIATRY TRAU; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; File SE, 1998, NEUROPSYCHOPHARMACOL, V19, P397, DOI 10.1016/S0893-133X(98)00035-9; First MB, STRUCTURED CLIN INTE; Fox AS, 2010, J NEUROSCI, V30, P7023, DOI 10.1523/JNEUROSCI.5952-09.2010; Gainotti G, 1972, Cortex, V8, P41; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Glascher J, 2003, J NEUROSCI, V23, P10274; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Gray JA, 1982, NEUROPSYCHOLOGY ANXI; Gray JA., 2000, NEUROPSYCHOLOGY ANXI; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heller W, 1998, COGNITION EMOTION, V12, P421; Heller W., 1990, PSYCHOL BIOL APPROAC, P167; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kier EL, 2004, AM J NEURORADIOL, V25, P677; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEE GP, 1988, NEUROLOGY, V38, P1233, DOI 10.1212/WNL.38.8.1233; Letizia B, 2008, J PSYCHIATR RES, V42, P752, DOI 10.1016/j.jpsychires.2007.08.004; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Liberzon I, 2000, NEUROPSYCHOPHARMACOL, V23, P508, DOI 10.1016/S0893-133X(00)00157-3; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Machado CJ, 2009, EMOTION, V9, P147, DOI 10.1037/a0014539; Mainio A, 2003, J NEUROL NEUROSUR PS, V74, P1278, DOI 10.1136/jnnp.74.9.1278; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mason WA, 2006, EMOTION, V6, P73, DOI 10.1037/1528-3542.6.1.73; Mathiak K. A., 2006, MAGNETIC RESONANCE M, V25, P177; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Montag C, 2012, NEUROSCIENCE, V217, P77, DOI 10.1016/j.neuroscience.2012.05.017; Mori S, 2005, MRI ATLAS HUMAN WHIT; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Oler JA, 2010, NATURE, V466, P864, DOI 10.1038/nature09282; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; REIMAN EM, 1984, NATURE, V310, P683, DOI 10.1038/310683a0; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; SANDERS SK, 1995, BIOL PSYCHIAT, V37, P473, DOI 10.1016/0006-3223(94)00183-4; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; Schiltz C, 2006, CEREB CORTEX, V16, P574, DOI 10.1093/cercor/bhj005; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spampinato MV, 2009, J NEUROPSYCH CLIN N, V21, P199, DOI 10.1176/appi.neuropsych.21.2.199; Spielberger CD., 1983, STATE TRAIT ANXIETY; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Syal S, 2012, METAB BRAIN DIS, V27, P299, DOI 10.1007/s11011-012-9299-5; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; Thomas KM, 2001, ARCH GEN PSYCHIAT, V58, P1057, DOI 10.1001/archpsyc.58.11.1057; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Truitt WA, 2007, PSYCHOPHARMACOLOGY, V191, P107, DOI 10.1007/s00213-006-0674-y; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uchidi R. R., 2000, PSYCHIAT RES-NEUROIM, V163, P21; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vythilingam M, 2000, PSYCHIAT RES-NEUROIM, V99, P75, DOI 10.1016/S0925-4927(00)00055-X; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; WELLER KL, 1982, BRAIN RES, V232, P255, DOI 10.1016/0006-8993(82)90272-4; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wright CI, 2003, BIOL PSYCHIAT, V54, P1067, DOI 10.1016/S0006-3223(03)00548-1	120	15	16	2	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAR	2013	51	4					686	694		10.1016/j.neuropsychologia.2013.01.003			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	121PV	WOS:000317257600012	23328629	Green Accepted			2022-02-06	
J	McCrea, HJ; Perrine, K; Niogi, S; Hartl, R				McCrea, Heather J.; Perrine, Kenneth; Niogi, Sumit; Haertl, Roger			Concussion in Sports	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; sports concussion; return to play; mild traumatic brain injury	REPETITIVE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; PATHOPHYSIOLOGY; EPIDEMIOLOGY; FOOTBALL; IMPACT	Context: Recently, concussion has become a topic of much discussion within sports. The goal of this review is to provide an overview of the literature concerning the definition of concussion, management of initial injury, return to play, and future health risks. Evidence Acquisition: This article reviews the most recent findings on recognizing and managing sports-related concussion, which has become a significant health risk. We reviewed articles from the literature discussing concussion and its effects. Results: Though concussion patients typically have negative head imaging, imaging is warranted in those with severe mechanism, significant loss of consciousness, focal neurologic deficit, or worsening symptoms. The existence of "second-impact syndrome," whereby a first minor head injury predisposes an athlete to later catastrophic injury, remains controversial; however, it is clear that concussion has significant effects on a patient and should be considered carefully in return-to-play decisions. Conclusions: A comprehensive understanding of concussion and its related risks is important in making return-to-play decisions as well as health care and league policy.	[McCrea, Heather J.; Perrine, Kenneth; Niogi, Sumit; Haertl, Roger] Weill Cornell Coll Med, New York, NY USA		Hartl, R (corresponding author), Weill Cornell Coll Med, Dept Neurol Surg, 525 East 68th St,Box 99, New York, NY 10065 USA.	roger@hartlmd.net					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jennett B, 1981, MANAGEMENT HEAD INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	21	15	15	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2013	5	2					160	164		10.1177/1941738112462203			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19YY	WOS:000214855500009	24427385	Green Published			2022-02-06	
J	Zou, XT; Wu, N; Tian, Y; Zhang, Y; Fitek, J; Maffeo, M; Niezrecki, C; Chen, J; Wang, XW				Zou, Xiaotian; Wu, Nan; Tian, Ye; Zhang, Yang; Fitek, John; Maffeo, Michael; Niezrecki, Christopher; Chen, Julie; Wang, Xingwei			Ultrafast Fabry-Perot fiber-optic pressure sensors for multimedia blast event measurements	APPLIED OPTICS			English	Article							SHOCK-WAVE	A shock wave (SW) is characterized as a large pressure fluctuation that typically lasts only a few milliseconds. On the battlefield, SWs pose a serious threat to soldiers who are exposed to explosions, which may lead to blast-induced traumatic brain injuries. SWs can also be used beneficially and have been applied to a variety of medical treatments due to their unique interaction with tissues and cells. Consequently, it is important to have sensors that can quantify SW dynamics in order to better understand the physical interaction between body tissue and the incident acoustic wave. In this paper, the ultrafast fiber-optic sensor based on the Fabry-Perot interferometric principle was designed and four such sensors were fabricated to quantify a blast event within different media, simultaneously. The compact design of the fiber-optic sensor allows for a high degree of spatial resolution when capturing the wavefront of the traveling SW. Several blast event experiments were conducted within different media (e. g., air, rubber membrane, and water) to evaluate the sensor's performance. This research revealed valuable knowledge for further study of SW behavior and SW-related applications. (C) 2013 Optical Society of America	[Zou, Xiaotian; Wang, Xingwei] Univ Massachusetts Lowell, Dept Biomed Engn & Biotechnol, Lowell, MA 01854 USA; [Wu, Nan; Tian, Ye; Zhang, Yang; Wang, Xingwei] Univ Massachusetts Lowell, Dept Elect & Comp Engn, Lowell, MA 01854 USA; [Fitek, John; Maffeo, Michael] USA, Natick Soldier Res Dev & Engn Ctr, Natick, MA 01760 USA; [Niezrecki, Christopher; Chen, Julie] Univ Massachusetts Lowell, Dept Mech Engn, Lowell, MA 01854 USA		Wang, XW (corresponding author), Univ Massachusetts Lowell, Dept Biomed Engn & Biotechnol, 1 Univ Ave, Lowell, MA 01854 USA.	xingwei_wang@uml.edu	Zou, Xiaotian/J-8657-2013; Tian, Ye/A-1090-2014	Tian, Ye/0000-0002-0785-1145	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-07-2-0081]	The authors are grateful for the collaboration with Natick Soldier Research, Development and Engineering Center for sharing the shock tube and the reference pressure sensors. The authors also appreciate the Army Research Laboratory for sponsoring this work (Nanomanufacturing of Multifunctional Sensors Award Number W911NF-07-2-0081).	CHAUSSY C, 1980, LANCET, V2, P1265; Delius M., 1994, Shock Waves, V4, P55, DOI 10.1007/BF01418569; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eaton WP, 1997, SMART MATER STRUCT, V6, P530, DOI 10.1088/0964-1726/6/5/004; Ikeda K, 1999, J TRAUMA, V47, P946, DOI 10.1097/00005373-199911000-00024; Liang SM, 2009, J MECH, V25, P313, DOI 10.1017/S172771910000277X; MacPherson WN, 2000, MEAS SCI TECHNOL, V11, P95, DOI 10.1088/0957-0233/11/2/302; MERZKIRCH W, 1974, APPL PHYS, V4, P363, DOI 10.1007/BF00928393; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes W, 2007, J MICROMECH MICROENG, V17, P1334, DOI 10.1088/0960-1317/17/7/016; RIDAH S, 1988, J APPL PHYS, V64, P152, DOI 10.1063/1.341448; Wang WH, 2009, OPT EXPRESS, V17, P16613, DOI 10.1364/OE.17.016613; Watson S, 2006, MEAS SCI TECHNOL, V17, P1337, DOI 10.1088/0957-0233/17/6/008; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wu N, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/5/055102; Wu N, 2011, OPT EXPRESS, V19, P10797, DOI 10.1364/OE.19.010797; Zou X., 2011, P SOC PHOTO-OPT INS, V8028; Zou XT, 2013, OPT LASER ENG, V51, P134, DOI 10.1016/j.optlaseng.2012.09.001; Zou XT, 2012, MEASUREMENT, V45, P1077, DOI 10.1016/j.measurement.2012.01.034	20	15	16	0	38	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 20	2013	52	6					1248	1254		10.1364/AO.52.001248			7	Optics	Science Citation Index Expanded (SCI-EXPANDED)	Optics	094TM	WOS:000315286700018	23434996				2022-02-06	
J	Dettmer, M; Pourmoghaddam, A; O'Connor, DP; Layne, CS				Dettmer, Marius; Pourmoghaddam, Amir; O'Connor, Daniel P.; Layne, Charles S.			Interaction of support surface stability and Achilles tendon vibration during a postural adaptation task	HUMAN MOVEMENT SCIENCE			English	Article						Learning; Sensory adaptation; Proprioception	HEALTHY-YOUNG ADULTS; HUMAN UPRIGHT STANCE; LOW-BACK-PAIN; APPROXIMATE ENTROPY; MUSCLE VIBRATION; CEREBRAL CONCUSSION; PARKINSONS-DISEASE; CONTROL MODEL; TIME-SERIES; RESPONSES	Orchestration of sensory-motor information and adaptation to internal or external, acute or chronic changes is one of the fundamental features of human postural control. The postural control system is challenged on a daily basis, and displays a remarkable ability to adapt to both long and short term challenges. To explore the interaction between support surface stability and Achilles tendon vibration during a period of adaptation we used both a linear measure and a non-linear measure derived from center-of-pressure (COP) data. An equilibrium score (ES), based upon peak amplitude of anterior-posterior sway towards theoretical limits of stability was the linear measure used to assess postural performance. We observed early effects of vibration on postural stability, depending on support characteristics. Participants were able to decrease sway with extended practice over days, independent of support surface stability. Approximate entropy analysis of COP data provided additional information about control adaptation processes. (C) 2013 Elsevier B.V. All rights reserved.	Univ Houston, Dept Hlth & Human Performance, Houston, TX 77204 USA; Ctr Neuromotor & Biomech Res, Houston, TX 77021 USA		Dettmer, M (corresponding author), 3855 Holman St,104C GAR, Houston, TX 77204 USA.	madettmer@uh.edu	Elkousy, Hussein/AAZ-5184-2021; Layne, Charles/AAV-5437-2021				Almeida GL, 2006, GAIT POSTURE, V23, P17, DOI 10.1016/j.gaitpost.2004.11.020; Barbieri G, 2008, EXP BRAIN RES, V185, P545, DOI 10.1007/s00221-007-1177-8; Benjuya N, 2004, J GERONTOL A-BIOL, V59, P166; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Bove M, 2003, J PHYSIOL-LONDON, V550, P617, DOI 10.1113/jphysiol.2003.043331; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; Carver S, 2006, BIOL CYBERN, V95, P123, DOI 10.1007/s00422-006-0069-5; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Ceyte H, 2007, NEUROSCI LETT, V416, P71, DOI 10.1016/j.neulet.2007.01.044; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Dusing SC, 2009, PHYS THER, V89, P1354, DOI 10.2522/ptj.20080361; Fransson PA, 2003, IEEE T BIO-MED ENG, V50, P1310, DOI 10.1109/TBME.2003.819851; Fransson PA, 2003, IEEE ENG MED BIOL, V22, P53, DOI 10.1109/MEMB.2003.1195696; Fransson PA, 2000, GAIT POSTURE, V12, P14, DOI 10.1016/S0966-6362(00)00052-7; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Gurfinkel' V. S., 1996, Fiziologiya Cheloveka, V22, P83; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; Hatzitaki V, 2004, EXP BRAIN RES, V154, P345, DOI 10.1007/s00221-003-1661-8; Hong SL, 2007, NEUROSCI LETT, V423, P104, DOI 10.1016/j.neulet.2007.06.043; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Isableu B, 2010, NEUROSCIENCE, V169, P1199, DOI 10.1016/j.neuroscience.2010.05.072; Ivanenko YP, 1999, EUR J NEUROSCI, V11, P647, DOI 10.1046/j.1460-9568.1999.00471.x; Ivanenko YP, 2000, NEUROSCI LETT, V292, P103, DOI 10.1016/S0304-3940(00)01438-5; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Leitner C, 2009, J ELECTROMYOGR KINES, V19, P380, DOI 10.1016/j.jelekin.2007.09.007; MATTHEWS PBC, 1986, J PHYSIOL-LONDON, V374, P73, DOI 10.1113/jphysiol.1986.sp016066; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Mergner T, 2003, PROG BRAIN RES, V142, P189; Mergner T, 2002, ADV EXP MED BIOL, V508, P147; NASHNER LM, 1982, J NEUROSCI, V2, P536; NeuroCom, 1991, EQ SYST DAT INT MAN; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1993, AM J PHYSIOL, V264, pR638, DOI 10.1152/ajpregu.1993.264.3.R638; Polonyova A, 2001, PHYSIOL RES, V50, P405; Radhakrishnan SM, 2011, EXP BRAIN RES, V213, P423, DOI 10.1007/s00221-011-2792-y; Ribot-Ciscar E, 1998, NEUROSCI LETT, V258, P147, DOI 10.1016/S0304-3940(98)00732-0; Roberts-Warrior D, 2000, BRAIN, V123, P2141, DOI 10.1093/brain/123.10.2141; Roll J P, 1993, J Vestib Res, V3, P259; ROLL JP, 1989, PROG BRAIN RES, V80, P113; Stergiou N, 2004, INNOVATIVE ANAL HUMA; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Termoz N, 2008, GAIT POSTURE, V27, P463, DOI 10.1016/j.gaitpost.2007.05.015; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thompson C, 2007, CLIN NEUROPHYSIOL, V118, P2456, DOI 10.1016/j.clinph.2007.08.013; Thompson C, 2011, HUM MOVEMENT SCI, V30, P153, DOI 10.1016/j.humov.2010.04.002; Tjernstrom F, 2005, J VESTIBUL RES-EQUIL, V15, P31; Tjernstrom F, 2002, GAIT POSTURE, V15, P75, DOI 10.1016/S0966-6362(01)00175-8; Tjernstrom F, 2010, J VESTIBUL RES-EQUIL, V20, P407, DOI 10.3233/VES-2010-0391; Turnock MJE, 2010, J MOTOR BEHAV, V42, P61, DOI 10.1080/00222890903397103; Vuillerme N, 2007, EXP BRAIN RES, V183, P323, DOI 10.1007/s00221-007-1047-4; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yardley L, 1998, J NEUROL NEUROSUR PS, V65, P679, DOI 10.1136/jnnp.65.5.679	60	15	15	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	FEB	2013	32	1					214	227		10.1016/j.humov.2012.12.002			14	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	133MC	WOS:000318141500017	23465726				2022-02-06	
J	Ennis, SK; Rivara, FP; Mangione-Smith, R; Konodi, MA; MacKenzie, EJ; Jaffe, KM				Ennis, Stephanie K.; Rivara, Frederick P.; Mangione-Smith, Rita; Konodi, Mark A.; MacKenzie, Ellen J.; Jaffe, Kenneth M.			Variations in the quality of inpatient rehabilitation care to facilitate school re-entry and cognitive and communication function for children with TBI	BRAIN INJURY			English	Article						Rehabilitation; return to school; cognition	TRAUMATIC BRAIN-INJURY; LONG-TERM NEEDS; OF-CARE; SOCIAL-PARTICIPATION; AGE-CHILDREN; INDICATORS; SERVICES; ADOLESCENTS; SEVERITY; STUDENTS	Objective: To examine variations in processes of paediatric inpatient rehabilitation care related to school re-entry and management of cognitive and communication impairments after traumatic brain injury. Design: Retrospective cohort study. Methods: Adherence to care processes recommended for children (aged 0-17) with moderate-to-severe traumatic brain injury and admitted for inpatient rehabilitation was assessed. Quality-of-care indicators for processes supporting school re-entry and cognitive and communication rehabilitation were applied to measure variations in care delivered to 174 children across nine facilities using medical record review. Main outcomes and results: Adherence rates (the number of times recommended care was delivered or attempted divided by the number of times care was indicated) were calculated, revealing substantial variations in care within and between facilities. Overall, children received 51.3% (95% CI 31.9-70.7) and 72.3% (95% CI 61.1-83.5), of the care recommended for school re-entry and cognitive and communication rehabilitation, respectively. Conclusion: Substantial variations exist in the delivery of paediatric inpatient rehabilitation care processes for managing school re-entry and cognitive and communication impairments after traumatic brain injury. Measures of association of these care processes with patient outcomes are necessary. Reduction in this variation is essential to improving quality of care.	[Ennis, Stephanie K.; Rivara, Frederick P.; Konodi, Mark A.; Jaffe, Kenneth M.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Ennis, Stephanie K.; Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Rivara, Frederick P.; Mangione-Smith, Rita] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.; Mangione-Smith, Rita] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [MacKenzie, Ellen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [MacKenzie, Ellen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA		Ennis, SK (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490,1959 NE Pacific St, Seattle, WA 98195 USA.	sakays@uw.edu			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD059049-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD059049] Funding Source: NIH RePORTER	This work was supported by Grant number R21 HD059049-01A1 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The authors have no conflicts of interest and no financial disclosures.	American Academy of Pediatrics Committee on Standards of Child Health, 1977, PREV CHILD HLTH CAR; American Speech Language and Hearing Association (ASHA) Rockville MD, 2009, TREATM EFF SUMM COGN, P1; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BROOK RH, 1994, METHODOLOGICAL PERSP; Carney N, 1999, Evid Rep Technol Assess (Summ), P1; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Commission on Accreditation of Rehabilitation Facilities. (CARF), 2009, MED REH STAND MAN; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Greenspan AI, 2000, BRAIN INJURY, V14, P417; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Janus PL, 1997, NEUROREHABILITATION, V9, P133, DOI 10.3233/NRE-1997-9205; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Min LC, 2007, MED CARE, V45, P480, DOI 10.1097/MLR.0b013e318030fff9; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Savage RC, 1997, J HEAD TRAUMA REHAB, V12, P11, DOI 10.1097/00001199-199704000-00003; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Shrout PE, 1979, INTRACLASS CORRELATI, V2, P420; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	36	15	15	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					179	188		10.3109/02699052.2012.729291			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500006	23384215				2022-02-06	
J	Gurkoff, GG; Gahan, JD; Ghiasvand, RT; Hunsaker, MR; Van, K; Feng, JF; Shahlaie, K; Berman, RF; Lyeth, BG; Folkerts, MM				Gurkoff, Gene G.; Gahan, Jennifer D.; Ghiasvand, Rahil T.; Hunsaker, Michael R.; Van, Ken; Feng, Jun-feng; Shahlaie, Kiarash; Berman, Robert F.; Lyeth, Bruce G.; Folkerts, Michael M.			Evaluation of Metric, Topological, and Temporal Ordering Memory Tasks after Lateral Fluid Percussion Injury	JOURNAL OF NEUROTRAUMA			English	Article						anatomical specificity; cognitive dysfunction; hippocampus; TBI; working memory	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; MINOR HEAD-INJURY; SPATIAL INFORMATION; DORSAL HIPPOCAMPUS; PARIETAL CORTEX; DENTATE GYRUS; COGNITIVE DEFICITS; DEVELOPING RAT; CELL-DEATH	Impairments in learning and memory occur in as many as 50% of patients following traumatic brain injury (TBI). Similar impairments occur in rodent models of TBI, and the development of new memory testing procedures provides an opportunity to examine how TBI affects memory processing in specific neural memory systems. Specifically, metric, topological, and temporal ordering tasks are object-based tests for memory of spatial orientation and temporal sequencing working memory developed for use in rodents. Previous studies demonstrated that specific lesions of the dentate gyrus/CA3 of the hippocampus and the parietal cortex resulted in deficits in the metric and topological spatial orientation tasks, respectively. Lesions of the CA1 impaired a rat's ability to recall the temporal order of odors. The purpose of the following study was to determine whether moderate lateral fluid percussion TBI would generate deficits in these working memory tasks, and whether observed deficits were associated with cell loss in the CA2/3 and/or CA1 of the hippocampus. Two weeks following a moderate lateral fluid percussion TBI, adult rats demonstrated significant deficits in both the metric and temporal ordering tasks (p < 0.05) but not in the topological task. Stereological analysis identified a significant reduction in neurons in the CA2/3 (p < 0.05) but not the CA1 of the hippocampus. These data demonstrate the utility of three object-based tasks to expand our understanding of how different neural memory systems are affected by TBI.	[Gurkoff, Gene G.; Gahan, Jennifer D.; Ghiasvand, Rahil T.; Hunsaker, Michael R.; Van, Ken; Feng, Jun-feng; Shahlaie, Kiarash; Berman, Robert F.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, Ctr Biophoton Sci & Technol, Natl Sci Fdn, Sacramento, CA 95817 USA; [Feng, Jun-feng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China; [Folkerts, Michael M.] Pepperdine Univ, Dept Psychol, Malibu, CA 90263 USA		Folkerts, MM (corresponding author), Pepperdine Univ, Dept Psychol, 24255 Pacific Coast Highway, Malibu, CA 90263 USA.	michael.folkerts@pepperdine.edu	Hunsaker, Michael Ryan/H-5975-2019	Hunsaker, Michael Ryan/0000-0001-9210-2458; Lyeth, Bruce/0000-0003-4811-1474	NSF Center for Biophotonics Science and Technology [PHY0120999]	This work was supported by the NSF Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center managed by the University of California at Davis under the cooperative agreement number PHY0120999. We thank Eric West, Vanessa Atkinson, and M. Hiram Dominguez for their expert technical assistance on this project.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Brooks D N, 1979, Int Rehabil Med, V1, P166; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Conti AC, 1998, J NEUROSCI, V18, P5663; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; DeCoteau WE, 1998, BEHAV NEUROSCI, V112, P68, DOI 10.1037/0735-7044.112.1.68; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; GALLISTEL CR, 1990, COGNITION, V37, P1, DOI 10.1016/0010-0277(90)90016-D; Gilbert PE, 2004, NEUROBIOL LEARN MEM, V81, P39, DOI 10.1016/S1074-7427(03)00069-8; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Goodrich-Hunsaker NJ, 2008, NEUROBIOL LEARN MEM, V90, P389, DOI 10.1016/j.nlm.2008.05.002; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Goodrich-Hunsaker NJ, 2005, BEHAV NEUROSCI, V119, P1307, DOI 10.1037/0735-7044.119.5.1307; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoge J, 2007, NEUROBIOL LEARN MEM, V88, P225, DOI 10.1016/j.nlm.2007.04.013; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P1877, DOI 10.1016/j.neuropsychologia.2004.05.008; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hunsaker MR, 2008, BEHAV NEUROSCI, V122, P643, DOI 10.1037/0735-7044.122.3.643; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Kesner RP, 2010, NEUROBIOL LEARN MEM, V93, P111, DOI 10.1016/j.nlm.2009.08.010; Kessels RPC, 2004, J INT NEUROPSYCH SOC, V10, P907, DOI 10.1017/S1355617704106140; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Laeng B, 2006, NEUROPSYCHOLOGIA, V44, P1595, DOI 10.1016/j.neuropsychologia.2006.01.023; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; POUCET B, 1993, PSYCHOL REV, V100, P163, DOI 10.1037/0033-295X.100.2.163; Poucet B, 2001, BEHAV PROCESS, V53, P155, DOI 10.1016/S0376-6357(00)00151-0; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; St-Laurent M, 2011, HIPPOCAMPUS, V21, P409, DOI 10.1002/hipo.20757; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	73	15	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					292	300		10.1089/neu.2012.2463			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300006	23140483				2022-02-06	
J	Kim, H; Colantonio, A; Dawson, DR; Bayley, MT				Kim, Hwan; Colantonio, Angela; Dawson, Deirdre R.; Bayley, Mark T.			Community integration outcomes after traumatic brain injury due to physical assault	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Brain injuries; Community integration; Outcomes assessment	FUNCTIONAL INDEPENDENCE MEASURE; QUALITY-OF-LIFE; INPATIENT REHABILITATION; MARITAL STABILITY; RISK-FACTORS; REINTEGRATION; DISCHARGE; ADULTS; PERSPECTIVES; PREDICTORS	Background. Community integration is considered an ultimate goal for rehabilitation after traumatic brain injury (TBI). Purpose. To determine (a) whether differences exist in rehabilitation outcomes between intentional and unintentional TBI populations and (b) whether TBI from assault is a predictor of community integration following inpatient rehabilitation. Method. Retrospective cohort study using population-based data from Canadian hospital administration records, 2001 to 2006. Outcome measure was the Reintegration to Normal Living Index (RNLI). Findings. From a sample of 243 persons, 24 (9.9%) had sustained TBI from physical assault. Persons with TBI from physical assault reported significantly lower scores on two items on the RNLI's Daily Functioning sub-scale: "recreation'' and "family role.'' Implications. These findings suggest that targeted intervention in these specific areas could be beneficial, which are often primarily addressed by occupational therapists in both inpatient rehabilitation and community settings.	[Kim, Hwan] Daegu Univ, Coll Rehabil Sci, Dept Occupat Therapy, Gyongsan 712714, Gyeongbuk, South Korea; [Kim, Hwan] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Kim, Hwan; Colantonio, Angela] UHN, Toronto Rehabil Inst, Toronto, ON, Canada; [Colantonio, Angela; Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre R.] Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Bayley, Mark T.] UHN, Toronto Rehabil Inst, Neuro Rehabil Program, Toronto, ON M5G 2A2, Canada; [Bayley, Mark T.] Univ Toronto, Fac Med, Div Physiatry, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121; Bayley, Mark/0000-0001-7860-9463; Colantonio, Angela/0000-0003-2094-4765	Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute; Toronto Rehabilitation Institute Foundation; Canadian Institutes of Health Research Strategic Team Grant [TIR-103946]	This study was supported by the Ontario Ministry of Health and Long Term Care, which provided funding under the Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute, and the Toronto Rehabilitation Institute Foundation. The Canadian Traumatic Brain Injury and Violence Research Team provided additional support through the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (No. TIR-103946) and the Ontario Neurotrauma Foundation.	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bourdeau I, 2008, INT J REHABIL RES, V31, P267, DOI 10.1097/MRR.0b013e3282fc0ff2; Bowman M, 2008, AUST J RURAL HEALTH, V16, P237, DOI 10.1111/j.1440-1584.2008.00970.x; Canadian Institute for Health Information, 2004, INP REH CAN 2002 200; Canadian Institute for Health Information, 2009, NAT REH REP SYST DAT; Carbonneau H, 2011, BRAIN IMPAIR, V12, P140, DOI 10.1375/brim.12.2.140; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; Centers for Disease Control and Prevention, 2007, INT CLASS DIS 9 REV; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Colantonio A, 2010, J REHABIL MED, V42, P773, DOI 10.2340/16501977-0582; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Cott C. A., 2006, HOSP REPORT REV NATL; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Donnelly C, 2005, SPINAL CORD, V43, P278, DOI 10.1038/sj.sc.3101702; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C., 2001, CRAIG HOSP INVENTORY; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Holford T. R., 2002, MULTIVARIATE METHODS, DOI [10.1093/acprof:oso/9780195124408.001.0001, DOI 10.1093/ACPROF:OSO/9780195124408.001.0001]; Hunt A., FACILITATING G UNPUB; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; Kim H, 2011, J TRAUMA, V71, P1219, DOI 10.1097/TA.0b013e3182190fa6; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mammi P, 2006, Eura Medicophys, V42, P17; Mayo NE, 2000, STROKE, V31, P1016, DOI 10.1161/01.STR.31.5.1016; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McColl MA, 2007, BRAIN IMPAIR, V8, P238, DOI DOI 10.1375/BRIM.8.3.238; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Murtezani Ardiana, 2009, Med Arh, V63, P216; Passalent LA, 2011, DISABIL REHABIL, V33, P579, DOI 10.3109/09638288.2010.500346; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pollock N., 2005, CANADIAN OCCUPATIONA; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wells JL, 2009, CAN J OCCUP THER, V76, P294, DOI 10.1177/000841740907600408; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; WOODDAUPHINEE S, 1987, J CHRON DIS, V40, P491, DOI 10.1016/0021-9681(87)90005-1; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583	57	15	15	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	FEB	2013	80	1					49	58		10.1177/0008417412473262			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	302HS	WOS:000330595300008	23550497				2022-02-06	
J	Shehadah, A; Chen, JL; Kramer, B; Zacharek, A; Cui, YS; Roberts, C; Lu, M; Chopp, M				Shehadah, Amjad; Chen, Jieli; Kramer, Brian; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Lu, Mei; Chopp, Michael			Efficacy of Single and Multiple Injections of Human Umbilical Tissue-Derived Cells following Experimental Stroke in Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBRAL-ISCHEMIA; STEM-CELLS; SYNAPTIC PLASTICITY; GENE-EXPRESSION; RECOVERY; SYNAPTOGENESIS; SYNAPTOPHYSIN	Introduction: Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regenerative treatment of stroke. In this study, we tested the efficacy of hUTC in experimental stroke and whether multiple injections of hUTC provide additional therapeutic benefits as compared to a single injection. Methods: Adult male Wistar rats were subjected to 2 hours of middle cerebral artery occlusion (MCAo), and randomly selected animals were injected (i.v) with 3 x 10(6) hUTC or with vehicle control (at day: 1, 1&3 or 1&7 after MCAo, n = 8-9/group). A battery of functional outcome tests was performed at days 1, 7, 14, 21, 28, 35, 42, 49, 56 and 63 after MCAo. Rats were sacrificed at 63 days after MCAo and lesion volumes were measured. To investigate the underlying mechanism of hUTC treatment of stroke, Von Willebrand Factor (vWF), and Synaptophysin immunostaining were performed. Results: All hUTC treated groups, single or multiple injections, had better functional recovery compared to control (p<0.01). There was no statistically significant difference between a single and multiple injections of hUTC (p = 0.23) or between different multiple injections groups (p>0.07) in functional outcome. All hUTC treatment groups showed significant increases in Synaptophysin, vascular density and perimeter compared to the control group (p<0.05). There was no statistically significant difference between a single and multiple injections of hUTC or between the two groups of multiple injections in all immunohistochemical measurements (p>0.1). Conclusion: hUTC treatment significantly improves long term functional outcome after stroke and promotes vascular density and synaptic plasticity. At the proscribed doses, multiple injections of hUTC were not superior to single injection therapy in both functional outcome and histological assessments.	[Shehadah, Amjad; Chen, Jieli; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Kramer, Brian] Adv Technol & Regenerat Med LLC, Somerville, NJ USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Shehadah, Amjad/0000-0001-8679-3774	Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ, USA; Advanced Technologies and Regenerative Medicine	This work was funded by Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ 08876, USA. The funders had no role in study design, data collection, analysis or preparation of the manuscript. Study design and decision to publish were approved by the funders.; The authors declare that one of our co-authors, Brian Kramer PhD, is an employee of Advanced Technologies and Regenerative Medicine, the commercial funder of the study. This affiliation does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors do not have any other declarations related to patents, products in development or marketed products.	Alder J, 2012, DEV NEUROBIOL, V72, P755, DOI 10.1002/dneu.20980; BARTH TM, 1990, STROKE, V21, P153; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Bohotin Catalina Roxana, 2004, Rom J Physiol, V41, P99; CABALKA LM, 1990, J COMP NEUROL, V295, P83, DOI 10.1002/cne.902950108; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2002, J NEUROL SCI, V199, P17, DOI 10.1016/S0022-510X(02)00075-8; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cui X, 2010, STROKE, V41, P2044, DOI 10.1161/STROKEAHA.110.589333; GARCIA JH, 1971, ACTA NEUROPATHOL, V18, P273, DOI 10.1007/BF00688441; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Mochizuki N, 2008, EXP NEUROL, V211, P194, DOI 10.1016/j.expneurol.2008.01.027; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rempe DA, 2002, NEUROLOGY, V59, P486, DOI 10.1212/WNL.59.4.486; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Sun JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024529; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zacharek A, 2009, STROKE, V40, P254, DOI 10.1161/STROKEAHA.108.524116; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang Y, 2011, CARDIOVASC PATHOL, V20, P204, DOI [10.1016/j.carpath.2010.06.007, 10.1088/1674-1056/20/11/110204]; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	47	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54083	10.1371/journal.pone.0054083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	WOS:000314759400119	23342081	Green Submitted, Green Published, gold			2022-02-06	
J	Matsuoka, Y; Nishi, D; Yonemoto, N; Hamazaki, K; Matsumura, K; Noguchi, H; Hashimoto, K; Hamazaki, T				Matsuoka, Yutaka; Nishi, Daisuke; Yonemoto, Naohiro; Hamazaki, Kei; Matsumura, Kenta; Noguchi, Hiroko; Hashimoto, Kenji; Hamazaki, Tomohito			Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial	BMC PSYCHIATRY			English	Article						Fish oil; Omega-3 fatty acid; Docosahexaenoic acid; Eicosapentaenoic acid; Posttraumatic stress disorder; Accidental injury; Prevention	TRAUMATIC BRAIN-INJURY; FOOD FREQUENCY QUESTIONNAIRE; DOCOSAHEXAENOIC ACID; ACCIDENTAL INJURY; JAPANESE VERSION; PSYCHIATRIC MORBIDITY; DOUBLE-BLIND; SECONDARY PREVENTION; SEAFOOD CONSUMPTION; HEALTH SURVEY	Background: Preclinical and clinical studies suggest that supplementation with omega-3 fatty acids after trauma might reduce subsequent posttraumatic stress disorder (PTSD). To date, we have shown in an open trial that PTSD symptoms in critically injured patients can be reduced by taking omega-3 fatty acids, hypothesized to stimulate hippocampal neurogenesis. The primary aim of the present randomized controlled trial is to examine the efficacy of omega-3 fatty acid supplementation in the secondary prevention of PTSD following accidental injury, as compared with placebo. This paper describes the rationale and protocol of this trial. Methods/design: The Tachikawa Project for Prevention of Posttraumatic Stress Disorder with Polyunsaturated Fatty Acid (TPOP) is a double-blinded, parallel group, randomized controlled trial to assess whether omega-3 fatty acid supplementation can prevent PTSD symptoms among accident-injured patients consecutively admitted to an intensive care unit. We plan to recruit accident-injured patients and follow them prospectively for 12 weeks. Enrolled patients will be randomized to either the omega-3 fatty acid supplement group (1,470 mg docosahexaenoic acid and 147 mg eicosapentaenoic acid daily) or placebo group. Primary outcome is score on the Clinician-Administered PTSD Scale (CAPS). We will need to randomize 140 injured patients to have 90% power to detect a 10-point difference in mean CAPS scores with omega-3 fatty acid supplementation compared with placebo. Secondary measures are diagnosis of PTSD and major depressive disorder, depressive symptoms, physiologic response in the experiment using script-driven imagery and acoustic stimulation, serum brain-derived neurotrophic factor, health-related quality of life, resilience, and aggression. Analyses will be by intent to treat. The trial was initiated on December 13 2008, with 104 subjects randomized by November 30 2012. Discussion: This study promises to be the first trial to provide a novel prevention strategy for PTSD among traumatized people.	[Matsuoka, Yutaka; Nishi, Daisuke] Natl Disaster Med Ctr, Dept Psychiat, Tachikawa, Tokyo 1900014, Japan; [Matsuoka, Yutaka; Yonemoto, Naohiro; Noguchi, Hiroko] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, Kodaira, Tokyo 1878551, Japan; [Matsuoka, Yutaka; Nishi, Daisuke; Matsumura, Kenta; Noguchi, Hiroko] Natl Ctr Neurol & Psychiat, NIMH, Kodaira, Tokyo 1878553, Japan; [Matsuoka, Yutaka; Nishi, Daisuke; Yonemoto, Naohiro; Hamazaki, Kei; Matsumura, Kenta; Noguchi, Hiroko; Hashimoto, Kenji; Hamazaki, Tomohito] Japan Sci & Technol Agcy, CREST, Tachikawa, Tokyo 1900014, Japan; [Hamazaki, Kei] Toyama Univ, Fac Med, Dept Publ Hlth, Toyama 9300194, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chuo Ku, Chiba 2608670, Japan; [Hamazaki, Tomohito] Toyama Univ, Inst Nat Med, Dept Clin Sci, Toyama 9300194, Japan		Matsuoka, Y (corresponding author), Natl Disaster Med Ctr, Dept Psychiat, 3256 Midoricho, Tachikawa, Tokyo 1900014, Japan.	yutaka@ncnp.go.jp	Naohiro, Yonemoto/Y-3761-2019; Matsumura, Kenta/ABH-9288-2020; Nishi, Daisuke/AAH-7211-2019; Matsuoka, Yutaka/N-1588-2019; Hashimoto, Kenji/I-5800-2015	Matsumura, Kenta/0000-0002-4271-1543; Nishi, Daisuke/0000-0001-9349-3294; Matsuoka, Yutaka/0000-0002-8690-8129; Hashimoto, Kenji/0000-0002-8892-0439	CREST, the Japan Science and Technology AgencyJapan Science & Technology Agency (JST); Japan Science and Technology Agency, CRESTJapan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST); Ministry of Health, Labor, and Welfare of JapanMinistry of Health, Labour and Welfare, Japan; Suntory Wellness Ltd; Eli Lilly Japan KKEli Lilly; Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical; Toray Industries, Inc.Toray Industries, Inc.; Foundation for Total Health PromotionFoundation for Total Health Promotion; Qol Co., Ltd; DHA & EPA Association; NTT DoCoMo, Inc.; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; NCNP; Tamura Foundation for Promotion of Science and Technology; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Polyene Project, Inc.; Open Research Center for Lipid Nutrition (Kinjo Gakuin University); Nippon Suisan Kaisha, Ltd.; Mochida Pharmaceutical Co., Ltd.; Meiji Yasuda Life Foundation of Health and WelfareMeiji Yasuda Life Foundation of Health and Welfare	This study was supported by CREST, the Japan Science and Technology Agency (YM). The funding body peer reviewed proposal documents which included digest version of this study protocol as part of the selection process. All of the supplements used in the study were supplied by Kentech Co, Ltd., Toyama, Japan. They had no role in the study design and conduct, in the collection, analysis and interpretation of the data, or in the preparation, review, and approval of the manuscript.; Dr. Matsuoka has received research support from the Japan Science and Technology Agency, CREST and the Ministry of Health, Labor, and Welfare of Japan, an Intramural Research Grant for Neurological and Psychiatric Disorders from NCNP and lecture fees from Suntory Wellness Ltd, Eli Lilly Japan KK, and Otsuka Pharmaceutical Co., Ltd. Dr. Nishi has received research support from Toray Industries, Inc. and the Foundation for Total Health Promotion, and lecture fees from Qol Co., Ltd, DHA & EPA Association, and NTT DoCoMo, Inc. Dr. K. Hamazaki has received research support from the Japan Society for the Promotion of Science, an Intramural Research Grant for Neurological and Psychiatric Disorders from NCNP, the Tamura Foundation for Promotion of Science and Technology, and the Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care, and consultant fees from Polyene Project, Inc. and Otsuka Pharmaceutical Co., Ltd., and lecture fees from Nippon Suisan Kaisha, Ltd. Dr. T. Hamazaki has received research support from the Japan Society for the Promotion of Science, Open Research Center for Lipid Nutrition (Kinjo Gakuin University), and Nippon Suisan Kaisha, Ltd., and consultant fees from Polyene Project, Inc. and Otsuka Pharmaceutical Co., Ltd., and lecture fees from Mochida Pharmaceutical Co., Ltd. Dr. Matsumura has received research support from the Japan Society for the Promotion of Science and the 26th Research Grant in Medical and Health Science from Meiji Yasuda Life Foundation of Health and Welfare. All other authors declare that they have no competing interests with this work.	Ando A, 1999, JPN J PSYCHOL, V70, P384, DOI 10.4992/jjpsy.70.384; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Asukai N., 2003, JAP J TRAUM STRESS, V1, P47; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Beltz BS, 2007, NEUROSCI LETT, V415, P154, DOI 10.1016/j.neulet.2007.01.010; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Ehlers A, 2003, ARCH GEN PSYCHIAT, V60, P1024, DOI 10.1001/archpsyc.60.10.1024; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Hamanaka S, 2006, GEN HOSP PSYCHIAT, V28, P234, DOI 10.1016/j.genhosppsych.2006.02.007; Hamazaki T, 1996, J CLIN INVEST, V97, P1129, DOI 10.1172/JCI118507; Hepp U, 2008, BRIT J PSYCHIAT, V192, P376, DOI 10.1192/bjp.bp.106.030569; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Itomura M, 2008, IN VIVO, V22, P131; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kobayashi M, 2003, J EPIDEMIOL, V13, pS64; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Martins JG, 2012, MOL PSYCHIATR, V17, P1144, DOI 10.1038/mp.2012.25; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Matsumura Kenta, 2011, Glob J Health Sci, V4, P3, DOI 10.5539/gjhs.v4n1p3; Matsuoka Y, 2009, SOC PSYCH PSYCH EPID, V44, P341; Matsuoka Y, 2008, CRIT CARE MED, V36, P74, DOI 10.1097/01.CCM.0000291650.70816.D6; Matsuoka Y, 2011, PSYCHOTHER PSYCHOSOM, V80, P310, DOI 10.1159/000322980; Matsuoka Y, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-3; Matsuoka Y, 2010, J CLIN PSYCHOPHARM, V30, P217, DOI 10.1097/JCP.0b013e3181d48830; Matsuoka Y, 2010, PSYCHOTHER PSYCHOSOM, V79, P56, DOI 10.1159/000259418; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nishi D, 2006, EMERG MED J, V23, P468, DOI 10.1136/emj.2005.029769; Nishi D, 2009, GEN HOSP PSYCHIAT, V31, P75, DOI 10.1016/j.genhosppsych.2008.09.002; Noaghiul S, 2003, AM J PSYCHIAT, V160, P2222, DOI 10.1176/appi.ajp.160.12.2222; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Sawazaki S, 1999, J NUTR SCI VITAMINOL, V45, P655, DOI 10.3177/jnsv.45.655; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Schnyder U, 2001, AM J RESP CRIT CARE, V164, P653, DOI 10.1164/ajrccm.164.4.2008087; Schnyder U, 2008, PSYCHOTHER PSYCHOSOM, V77, P111, DOI 10.1159/000112888; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Squire LR., 1987, MEMORY BRAIN; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; Suzuki S, 2004, BRIT J CANCER, V90, P787, DOI 10.1038/sj.bjc.6601621; Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576; TEASDALE G, 1974, LANCET, V2, P81; Tsubono Y, 1996, J Epidemiol, V6, P45; Tsugane S, 2003, J EPIDEMIOL, V13, pS2; Tucker PM, 2007, AM J PSYCHIAT, V164, P230, DOI 10.1176/appi.ajp.164.2.230; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Verger P, 2004, AM J PSYCHIAT, V161, P1384, DOI 10.1176/appi.ajp.161.8.1384; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Weiss D.S., 2007, CROSS CULTURAL ASSES, P219, DOI 10.1007/978-0-387-70990-1_10; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	79	15	15	0	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-244X		BMC PSYCHIATRY	BMC Psychiatry	JAN 5	2013	13								8	10.1186/1471-244X-13-8			13	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	099VE	WOS:000315649900001	23289548	Green Published, gold			2022-02-06	
J	Albers, CE; von Allmen, M; Evangelopoulos, DS; Zisakis, AK; Zimmermann, H; Exadaktylos, AK				Albers, C. E.; von Allmen, M.; Evangelopoulos, D. S.; Zisakis, A. K.; Zimmermann, H.; Exadaktylos, A. K.			What Is the Incidence of Intracranial Bleeding in Patients with Mild Traumatic Brain Injury? A Retrospective Study in 3088 Canadian CT Head Rule Patients	BIOMED RESEARCH INTERNATIONAL			English	Article							COMPUTED-TOMOGRAPHY	Objective. Only limited data exists in terms of the incidence of intracranial bleeding (ICB) in patients with mild traumatic brain injury (MTBI). Methods. We retrospectively identified 3088 patients (mean age 41 range (7-99) years) presenting with isolated MTBI and GCS 14-15 at our Emergency Department who had undergone cranial CT (CCT) between 2002 and 2011. Indication for CCT was according to the "Canadian CT head rules." Patients with ICB were either submitted for neurosurgical treatment or kept under surveillance for at least 24 hours. Pearson's correlation coefficient was used to correlate the incidence of ICB with age, gender, or intake of coumarins, platelet aggregation inhibitors, or heparins. Results. 149 patients (4.8%) had ICB on CCT. No patient with ICB died or deteriorated neurologically. The incidence of ICB increased with age and intake of anticoagulants without clinically relevant correlation (R = 0.11; P < 0.001; R = -0.06; P < 0.001). Conclusion. Our data show an incidence of 4.8% for ICB after MTBI. However, neurological deterioration after MTBI seems to be rare, and the need for neurosurgical intervention is only required in selected cases. Thegeneral need for CCT in patients after MTBI is therefore questionable, and clinical surveillance may be sufficient when CCT is not available.	[Albers, C. E.; von Allmen, M.; Evangelopoulos, D. S.; Zimmermann, H.; Exadaktylos, A. K.] Univ Bern, Inselspital, Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Zisakis, A. K.] Red Cross Hosp, Dept Neurosurg, Athens 11526, Greece		Exadaktylos, AK (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland.	aristomenis.exadaktylos@insel.ch	Albers, Christoph E./Y-9703-2019				Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dalbayrak S, 2011, TURK NEUROSURG, V21, P591, DOI [10.5137/1019-5149.JTN .3570-10.2, 10.5137/1019-5149.JTN.3570-10.2]; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pearson K, 1909, Science, V30, P23, DOI 10.1126/science.30.757.23; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Stein SC, 2000, NEW ENGL J MED, V343, P1570; Steyerberg, 2019, CLIN PREDICTION MODE; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	21	15	15	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								453978	10.1155/2013/453978			4	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	192JZ	WOS:000322481800001	23936802	Green Published, Green Submitted, gold			2022-02-06	
J	Balci, BD; Akdal, G; Yaka, E; Angin, S				Balci, Birgul Donmez; Akdal, Gulden; Yaka, Erdem; Angin, Salih			Vestibular rehabilitation in acute central vestibulopathy: A randomized controlled trial	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article						Acute stroke; posterior circulation; vestibular rehabilitation; balance	TRAUMATIC BRAIN-INJURY; PHYSICAL-THERAPY; VISUAL FEEDBACK; BALANCE; STROKE; HANDICAP; RECOVERY; ADAPTATION; DISORDERS; DIZZINESS	OBJECTIVE: To investigate the effects of two different rehabilitation programs in acute central vestibulopathy secondary to posterior circulation stroke. METHOD: A prospective randomized controlled study was conducted on 25 patients with posterior circulation stroke. Patients were instructed in routine balance and mobility exercises during the acute hospitalization period. At discharge, patients were assigned to either a rehabilitation or home exercise group. The home exercise group was instructed to perform the same exercise program provided in the course of hospitalization period. The rehabilitation group was randomized into the visual feedback posturography training or vestibular rehabilitation group. The balance and gait performance were assessed with clinical and objective measurements before and after 6 weeks of training. RESULTS: The balance and gait scores were significantly improved in both rehabilitation groups and in the home exercise group (p < 0.05), but no significant difference was found between the groups in terms of post-treatment values (p > 0.05). CONCLUSION: The improvements of balance and gait function in rehabilitation groups did not differ from the home exercise group. Rehabilitation programs were equally effective to improve the recovery in acute central vestibulopathy.	[Balci, Birgul Donmez; Angin, Salih] Dokuz Eylul Univ, Sch Physiotherapy & Rehabil, Izmir, Turkey; [Akdal, Gulden; Yaka, Erdem] Dokuz Eylul Univ, Dept Neurol, Fac Med, Izmir, Turkey		Balci, BD (corresponding author), Dokuz Eylul Univ, Sch Physiotherapy & Rehabil, Izmir, Turkey.	birgul.donmez@deu.edu.tr	Akdal, Gulden/AAG-4782-2019; BALCI, BIRGUL/AAA-2293-2020	Akdal, Gulden/0000-0002-2486-4490; BALCI, BIRGUL/0000-0002-0873-0900			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Badaracco C, 2007, OTOL NEUROTOL, V28, P809, DOI 10.1097/MAO.0b013e3180cab73f; Bamiou DE, 2000, SCAND AUDIOL, V29, P238, DOI 10.1080/010503900750022862; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; Cheng PT, 2004, CLIN REHABIL, V18, P747, DOI 10.1191/0269215504cr778oa; Cohen HS, 2002, ACTA OTO-LARYNGOL, V122, P841, DOI 10.1080/003655402/000028039; Davies P.M., 1985, GUIDE TREATMENT ADUL; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Gill-Body K.M., 2011, CURRENT CONCEPTS MAN, P1; GillBody KM, 1997, PHYS THER, V77, P534, DOI 10.1093/ptj/77.5.534; Godbout A, 1997, BRAIN INJURY, V11, P629, DOI 10.1080/026990597123188; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Hain TC, 2011, NEUROREHABILITATION, V29, P127, DOI 10.3233/NRE-2011-0687; Hall CD, 2009, OTOLARYNG CLIN N AM, V42, P161, DOI 10.1016/j.otc.2008.09.006; Hansson EE, 2005, SCAND J PRIM HEALTH, V23, P215, DOI 10.1080/02813430500287299; HERDMAN S J, 1989, Ear Nose and Throat Journal, V68, P961; Herdman S.J., 2007, VESTIBULAR REHABILIT, P322; HERDMAN SJ, 1995, OTOLARYNG HEAD NECK, V113, P77, DOI 10.1016/S0194-5998(95)70148-6; Herdman SJ, 1998, OTOLARYNG HEAD NECK, V119, P49, DOI 10.1016/S0194-5998(98)70195-0; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KREBS DE, 1993, OTOLARYNG HEAD NECK, V109, P735, DOI 10.1177/019459989310900417; Kruger E, 2007, TOP STROKE REHABIL, V14, P56, DOI 10.1310/tsr1405-56; Maeshima S, 2002, AM J PHYS MED REHAB, V81, P626, DOI 10.1097/00002060-200208000-00012; Marioni G, 2013, EUR ARCH OTO-RHINO-L, V270, P425, DOI 10.1007/s00405-012-1944-4; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Meli A, 2007, J PSYCHOSOM RES, V63, P185, DOI 10.1016/j.jpsychores.2007.02.007; MRUZEK M, 1995, LARYNGOSCOPE, V105, P686, DOI 10.1288/00005537-199507000-00004; Murray K, 2001, Physiother Res Int, V6, P251, DOI 10.1002/pri.232; OSullivan S., 2006, PHYS REHABILITATION, VFifth; SHEPARD NT, 1993, ANN OTO RHINOL LARYN, V102, P198, DOI 10.1177/000348949310200306; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Sihvonen SE, 2004, GERONTOLOGY, V50, P87, DOI 10.1159/000075559; Strupp M, 1998, NEUROLOGY, V51, P838, DOI 10.1212/WNL.51.3.838; Suarez H, 2003, ACTA OTO-LARYNGOL, V123, P143, DOI 10.1080/0036554021000028109; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P1013, DOI 10.1053/apmr.2002.33102; Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886; Whitney SL, 2000, J VESTIBUL RES-EQUIL, V10, P99; Whitney SL, 2011, NEUROREHABILITATION, V29, P157, DOI 10.3233/NRE-2011-0690	41	15	18	4	27	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2013	23	4-5					259	267		10.3233/VES-130491			9	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	262VX	WOS:000327767100009	24284606				2022-02-06	
J	Chan, V; Zagorski, B; Parsons, D; Colantonio, A				Chan, Vincy; Zagorski, Brandon; Parsons, Daria; Colantonio, Angela			Older Adults with Acquired Brain Injury: Outcomes After Inpatient Rehabilitation	CANADIAN JOURNAL ON AGING-REVUE CANADIENNE DU VIEILLISSEMENT			English	Article						aging; acquired brain injury; functional outcomes; rehabilitation	FUNCTIONAL OUTCOMES; LENGTH	This study examined a population-based profile of older adults with acquired brain injury, and their functional outcomes, in in-patient rehabilitation. Older adults aged 65 and older admitted to in-patient rehabilitation from acute care with traumatic brain injury (TBI) (n = 1214) or non-traumatic brain injury (nTBI) (n = 1,530) from 2003/04 to 2009/10 in Ontario were identified. Demographic and clinical characteristics and the total function score from the FIM((TM)()) Instrument were examined. The Discharge Abstract Database and National Rehabilitation Reporting System were used. Results indicated that older adults with TBI had significantly higher total function scores than those with nTBI at admission and at discharge (p<.001). However, both groups made significant (p<.001) and similar gains (p>.05) in total function scores. We conclude that older adults with TBI and nTBI make similar in-patient rehabilitation gains. Lower initial functional ability of nTBI patients on admission and patients' different clinical profiles have implications for clinical care and resources.	[Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Chan, Vincy; Colantonio, Angela] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Zagorski, Brandon] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Chan, Vincy/AAA-7813-2020	Colantonio, Angela/0000-0003-2094-4765; Chan, Vincy/0000-0002-6884-044X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Canadian Institute for Health Information, 2009, ALT LEV CAR CAN ALT LEV CAR CAN; Canadian Institute for Health Information, 2012, NAT REH REP SYST NRS; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A., 2011, ACQUIRED BRAIN INJUR; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Croxford R., 2006, CANADIAN I HLTH INFO; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; ERABI, 2011, FUNCT IND MEAS; Faul M, 2010, TRAUMATIC BRAIN INJU; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Statistics Canada, 2012, POP SEX AG GROUPS PR; Statistics Canada, 2012, PROJ POP AG GROUP AC; Statistics Canada, 2012, POP YEAR PROV TERR; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; W.H. Organization, 2006, NEUR DIS PUBL HLTH C	27	15	15	1	12	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0714-9808	1710-1107		CAN J AGING	Can. J. Aging-Rev. Can. Vieil.		2013	32	3					278	286		10.1017/S0714980813000317			9	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	216FS	WOS:000324268000007	23915910				2022-02-06	
J	Karpas, A; Finkelstein, M; Reid, S				Karpas, Anna; Finkelstein, Marsha; Reid, Samuel			Which Management Strategy Do Parents Prefer for Their Head-Injured Child Immediate Computed Tomography Scan or Observation?	PEDIATRIC EMERGENCY CARE			English	Article						head injury; computed tomography; observation	TRAUMATIC BRAIN-INJURY; RADIATION-EXPOSURE; UNITED-STATES; CT SCANS; RISKS; PATIENT; TRENDS; DEATH	Objective: The objectives of this study were to determine which method of head injury evaluation, immediate computed tomography (CT) or observation, parents would prefer for their child when given the opportunity to make an informed decision and to determine factors influencing preference. Methods: Parents of head-injured children 2 years or older who presented to a pediatric emergency department were eligible. After triage evaluation, and before physician assessment, research assistants presented educational materials regarding the method, risks, and benefits of both immediate CT and observation. Parents then completed a survey asking them their preference, reasons for preference, details of their child's injury, and demographic information. Results: One hundred thirty-four parents participated. After reviewing the educational materials, 53 (40%) preferred immediate CT; 77 (57%) preferred observation; 4 (3%) did not indicate a preference. Of those parents who preferred immediate CT, the leading reason given was, "I need to be 100% sure there is no bleeding in my child's brain." Of those parents who preferred observation, the 2 leading reasons given were, "I don't want my child to have a test unless he/she absolutely has to" and "I am concerned about the possibility of radiation causing a brain tumor." Injury mechanism, time between injury and presentation, time of day, child's age, worst symptom, previous CT, and demographic markers were not statistically associated with preference. Conclusions: When given the opportunity to make an informed decision regarding the evaluation of their head-injured child, parents were divided as to their preference. A small majority preferred observation.	[Finkelstein, Marsha] Childrens Hosp & Clin Minnesota, Res Program, Minneapolis, MN USA; [Finkelstein, Marsha] Childrens Hosp & Clin Minnesota, Sponsored Program, Minneapolis, MN USA		Reid, S (corresponding author), Childrens Hosp & Clin Minnesota, 345 N Smith Ave, St Paul, MN 55102 USA.	sam.reid@childrensmn.org			Children's Hospital and Clinics of Minnesota Internal Research Grant Program	This work was supported by a grant from the Children's Hospital and Clinics of Minnesota Internal Research Grant Program.	af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Baerlocher MO, 2010, JAMA-J AM MED ASSOC, V304, P2170, DOI 10.1001/jama.2010.1591; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Keays G, 2010, CAN J PUBLIC HEALTH, V101, P115, DOI 10.1007/BF03404354; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larson DB, 2007, AM J ROENTGENOL, V189, P271, DOI 10.2214/AJR.07.2248; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MAYER T, 1981, Journal of the American Medical Association, V245, P719, DOI 10.1001/jama.245.7.719; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954	22	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2013	29	1					30	35		10.1097/PEC.0b013e31827b5090			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	064FY	WOS:000313059600007	23283259				2022-02-06	
J	Kaufman, KR; Bisen, V; Zimmerman, A; Tobia, A; Mani, R; Wong, S				Kaufman, Kenneth R.; Bisen, Viwel; Zimmerman, Aphrodite; Tobia, Anthony; Mani, Ram; Wong, Stephen			Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior	EPILEPSY & BEHAVIOR CASE REPORTS			English	Article						Levetiracetam; Epilepsy; Depression; Suicide attempt; Impulsive-aggressive behavior; Traumatic brain injury; Psychiatric adverse effect; Therapeutic drug monitoring; Education	ANTIEPILEPTIC DRUGS; ILAE-COMMISSION; EPILEPSY; DISORDERS; ANXIETY; RISK	Levetiracetam (LEV) is a novel antiepileptic drug (AED) approved for the adjunctive treatment of generalized and partial seizures. LEV has no clinic-ally significant drug interactions and has limited adverse effects. The psychiatric adverse effects of LEV include de novo psychosis, affective disorder, and aggression. LEV-induced suicidal behavior has been reported infrequently with a past history of affective disorders. The authors report-an apparent dose/concentration-dependent LEV-induced de novo major depression with near fatal suicide attempt in a patient without prior history of affective disorder. Psychiatric evaluation with emphasis on historic/current affective disorders, impulsive-aggressive behaviors, and assessment of risk factors for suicidal behaviors is indicated in treating patients with epilepsy with LEV. Clinicians should consider therapeutic drug monitoring to optimize therapeutic LEV treatment. (C) 2013 The Authors. Published by Elsevier Inc.	[Kaufman, Kenneth R.; Bisen, Viwel; Zimmerman, Aphrodite; Tobia, Anthony; Mani, Ram] Rutgers Robert Wood Johnson Med Sch, Dept Psychiat, 125 Paterson St,Suite 2200, New Brunswick, NJ 08901 USA; [Kaufman, Kenneth R.; Zimmerman, Aphrodite; Wong, Stephen] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA; [Kaufman, Kenneth R.] Rutgers Robert Wood Johnson Med Sch, Dept Anesthesiol, New Brunswick, NJ 08901 USA; [Tobia, Anthony] Rutgers Robert Wood Johnson Med Sch, Dept Internal Med, New Brunswick, NJ 08901 USA		Kaufman, KR (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Psychiat, 125 Paterson St,Suite 2200, New Brunswick, NJ 08901 USA.	kenneth.kaufman@rutgers.edu					Adelow C, 2012, NEUROLOGY, V78, P396, DOI 10.1212/WNL.0b013e318245f461; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Cramer JA, 2003, EPILEPSY BEHAV, V4, P124, DOI 10.1016/S1525-5050(03)00005-2; Cumbo E, 2010, EPILEPSY BEHAV, V17, P461, DOI 10.1016/j.yebeh.2010.01.015; Dinkelacker V, 2003, EPILEPSY BEHAV, V4, P537, DOI 10.1016/j.yebeh.2003.07.008; Farooq MU, 2009, AM J HEALTH-SYST PH, V66, P541, DOI 10.2146/ajhp070607; Hehnstaedter C, 2008, EPILEPSY BEHAV, V13, P525; Helmstaedter C, 2013, EPILEPSIA, V54, P36, DOI 10.1111/j.1528-1167.2012.03603.x; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Kaminski RM, 2008, NEUROPHARMACOLOGY, V54, P715, DOI 10.1016/j.neuropharm.2007.11.021; Kaufman KR, 2011, EPILEPSY BEHAV, V21, P1, DOI 10.1016/j.yebeh.2011.03.011; Kaufman KR, 2011, EPILEPSY BEHAV, V20, P386, DOI 10.1016/j.yebeh.2010.11.014; Kaufman KR, 2004, EPILEPSY BEHAV, V5, P1017, DOI 10.1016/j.yebeh.2004.08.009; Lee JJ, 2011, J CLIN NEUROL, V7, P128, DOI 10.3988/jcn.2011.7.3.128; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Lyseng-Williamson KA, 2011, CNS DRUGS, V25, P901, DOI 10.2165/11208340-000000000-00000; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Mazza M, 2008, PROG NEURO-PSYCHOPH, V32, P539, DOI 10.1016/j.pnpbp.2007.10.015; Mula M, 2003, NEUROLOGY, V61, P704, DOI 10.1212/01.WNL.0000078031.32904.0D; Mula M, 2007, EPILEPSY BEHAV, V11, P130, DOI 10.1016/j.yebeh.2007.04.008; Mula M, 2013, EPILEPSIA, V54, P199, DOI 10.1111/j.1528-1167.2012.03688.x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Patsalos PN, 2004, CLIN PHARMACOKINET, V43, P707, DOI 10.2165/00003088-200443110-00002; Pompili M, 2012, CNS NEUROSCI THER, V18, P711, DOI 10.1111/j.1755-5949.2012.00364.x; Stephen IJ, 2011, SEIZURE, V20, P554; Stoltenberg SF, 2012, PROG NEURO-PSYCHOPH, V39, P182, DOI 10.1016/j.pnpbp.2012.06.012; *US FDA, STAT REV EV ANT DRUG; VanCott AC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-4; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166	30	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2213-3232			EPILEPSY BEHAV CASE	Epilepsy Behav. Case Rep.		2013	1						110	112		10.1016/j.ebcr.2013.07.002			3	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3S1S	WOS:000218537900029	25667841	Green Published, gold			2022-02-06	
J	Li, K; Robertson, J; Ramos, J; Gella, S				Li, Kitsum; Robertson, Julie; Ramos, Joshua; Gella, Stephanie			Computer-Based Cognitive Retraining for Adults with Chronic Acquired Brain Injury: A Pilot Study	OCCUPATIONAL THERAPY IN HEALTH CARE			English	Article						Attention; cerebrovascular accident; cognitive rehabilitation; computer-based intervention; memory; stroke; traumatic brain injury		This study evaluated the effectiveness of a computer-based cognitive retraining (CBCR) program on improving memory and attention deficits in individuals with a chronic acquired brain injury (ABI). Twelve adults with a chronic ABI demonstrating deficits in memory and attention were recruited from a convenience sample from the community. Using a quasi-experimental one-group pretest-posttest design, a significant improvement was found in both memory and attention scores postintervention using the cognitive screening tool. This study supported the effectiveness of CBCR programs in improving cognitive deficits in memory and attention in individuals with chronic ABI. Further research is recommended to validate these findings with a larger ABI population and to investigate transfer to improvement in occupational performance that supports daily living skills.	[Li, Kitsum; Robertson, Julie; Ramos, Joshua; Gella, Stephanie] Dominican Univ Calif, Sch Hlth & Nat Sci, Dept Occupat Therapy, San Rafael, CA 94901 USA		Li, K (corresponding author), Dominican Univ Calif, Dept Occupat Therapy, 50 Acacia Ave, San Rafael, CA 94901 USA.	Kitsum.Li@dominican.edu					Barnes DE, 2009, ALZ DIS ASSOC DIS, V23, P205, DOI 10.1097/WAD.0b013e31819c6137; Batchelor J, 1988, J HEAD TRAUMA REHAB, V3, P78, DOI DOI 10.1097/00001199-198809000-00012; Brain Injury Association of America, 2011, WHAT IS DIFF AC BRAI; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cognistat Cognitive Assessment, 2012, PEER REV ART; DASNAIR R, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002293.PUB2; DeFina P, 2009, CLIN NEUROPSYCHOL, V23, P1391, DOI 10.1080/13854040903058978; ECRI Institute, 2011, COGN REH THER TRAUM; Ellingsen KL., 2009, INT J DISABIL MANAG, V4, P1, DOI DOI 10.1375/JDMR.4.1.1; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Freire Fabio Rios, 2011, Dement. neuropsychol., V5, P17, DOI 10.1590/S1980-57642011DN05010004; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Handratta V, 2010, NEUROCASE, V16, P125, DOI 10.1080/13554790903329166; Holmqvist K, 2009, SCAND J OCCUP THER, V16, P13, DOI 10.1080/11038120802123520; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; Lincoln N. B., 2013, COCHRANE DB SYST REV, V2013, P1, DOI [10.1002/14651858.CD002842.pub2, DOI 10.1002/14651858.CD002842.PUB2]; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726	25	15	17	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0738-0577	1541-3098		OCCUP THER HEALTH CA	Occup. Ther. Health Care		2013	27	4					333	344		10.3109/07380577.2013.844877			12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V61DJ	WOS:000210878600004	24102589	Green Submitted			2022-02-06	
J	Shin, DD; Ozyurt, IB; Liu, TT				Shin, David D.; Ozyurt, I. Burak; Liu, Thomas T.			The Cerebral Blood Flow Biomedical Informatics Research Network (CBFBIRN) database and analysis pipeline for arterial spin labeling MRI data	FRONTIERS IN NEUROINFORMATICS			English	Article						database; data sharing; arterial spin labeling; cerebral blood flow; perfusion imaging; group analysis; magnetic resonance imaging		Arterial spin labeling (ASL) is a magnetic resonance imaging technique that provides a non-invasive and quantitative measure of cerebral blood flow (CBF). After more than a decade of active research, ASL is now emerging as a robust and reliable CBF measurement technique with increased availability and ease of use. There is a growing number of research and clinical sites using ASL for neuroscience research and clinical care. In this paper, we present an online CBF Database and Analysis Pipeline, collectively called the Cerebral Blood Flow Biomedical Informatics Research Network (CBFBIRN) that allows researchers to upload and share ASL and clinical data. In addition to serving the role as a central data repository, the CBFBIRN provides a streamlined data processing infrastructure for CBF quantification and group analysis, which has the potential to accelerate the discovery of new scientific and clinical knowledge. All capabilities and features built into the CBFBIRN are accessed online using a web browser through a secure login. In this work, we begin with a general description of the CBFBIRN system data model and its architecture, then devote the remainder of the paper to the CBFBIRN capabilities. The latter part of our work is divided into two processing modules: (1) Data Upload and CBF Quantification Module; (2) Group Analysis Module that supports three types of analysis commonly used in neuroscience research. To date, the CBFBIRN hosts CBF maps and associated clinical data from more than 1,300 individual subjects. The data have been contributed by more than 20 different research studies, investigating the effect of various conditions on CBF including Alzheimer's, schizophrenia, bipolar disorder, depression, traumatic brain injury, HIV, caffeine usage, and methamphetamine abuse. Several example results, generated by the CBFBIRN processing modules, are presented. We conclude with the lessons learned during implementation and deployment of the CBFBIRN and our experience in promoting data sharing.	[Shin, David D.; Liu, Thomas T.] Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA; [Ozyurt, I. Burak] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Shin, DD (corresponding author), Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, 9500 Gilman Dr 0677, La Jolla, CA 92093 USA.	ddshin@ucsd.edu; ttliu@ucsd.edu		Liu, Thomas/0000-0002-1978-7486	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH084796]	This work was supported by a grant from the National Institutes of Health (R01MH084796). The authors thank Peter Wong, Eman Ghobrial, and Valur Olafsson at the UCSD Center for Functional MRI and Jerod Rasmussen at the University of California Irvine for their assistance to this project. The authors also would like to acknowledge the FBIRN collaborators (U24-PR021992) for their generous contribution of clinical and ASL data to the CBFBIRN.	Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Anhoj J, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.4.e27; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Ford JM, 2009, SCHIZOPHRENIA BULL, V35, P58, DOI 10.1093/schbul/sbn140; Funai AK, 2008, IEEE T MED IMAGING, V27, P1484, DOI 10.1109/TMI.2008.923956; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Ho T.C., 2012, P AM AC CHILD AD PSY; Ho TC, 2013, J AM ACAD CHILD PSY, V52, P1076, DOI 10.1016/j.jaac.2013.07.008; Jung Y, 2010, MAGN RESON MED, V64, P799, DOI 10.1002/mrm.22465; Keator David B, 2009, Front Neuroinform, V3, P30, DOI 10.3389/neuro.11.030.2009; Kim SG, 1997, MAGNET RESON MED, V37, P425, DOI 10.1002/mrm.1910370321; Liu T. T., 2008, P INT SOC MAGN RES M; Marenco L, 2003, J AM MED INFORM ASSN, V10, P444, DOI 10.1197/jamia.M1303; Nadkarni PM, 1999, J AM MED INFORM ASSN, V6, P478, DOI 10.1136/jamia.1999.0060478; Ozyurt IB, 2010, NEUROINFORMATICS, V8, P231, DOI 10.1007/s12021-010-9078-6; Poline JB, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00009; Pollock JM, 2009, MAGN RESON IMAGING C, V17, P315, DOI 10.1016/j.mric.2009.01.008; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P15, DOI 10.1093/schbul/sbn159; Rasmussen J. M., 2010, P INT SOC MAGN RES M; Shin D.D., 2013, P INT SOC MAGN RES M; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Van Horn JD, 2009, NEUROIMAGE, V47, P1720, DOI 10.1016/j.neuroimage.2009.03.086; Wierenga CE, 2012, J CEREBR BLOOD F MET, V32, P1589, DOI 10.1038/jcbfm.2012.58; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	30	15	15	0	6	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5196			FRONT NEUROINFORM	Front. Neuroinformatics		2013	7								UNSP 21	10.3389/fninf.2013.00021			17	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	V36JA	WOS:000209207300020	24151465	Green Published, gold			2022-02-06	
J	Stenclik, JH; Miele, AS; Silk-Eglit, G; Lynch, JK; McCaffrey, RJ				Stenclik, Jessica H.; Miele, Andrea S.; Silk-Eglit, Graham; Lynch, Julie K.; McCaffrey, Robert J.			Can the Sensitivity and Specificity of the TOMM Be Increased with Differential Cutoff Scores?	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						cutoff scores; medico-legal; performance validity; symptom validity tests; Test of Memory Malingering	MEMORY MALINGERING TOMM; SCREENING MEASURE; TRIAL-1; INJURY; RATES	Accurate determination of performance validity is paramount in any neuropsychological assessment. Numerous freestanding symptom validity tests, like the Test of Memory Malingering (TOMM), have been developed to assist in this process; however, research and clinical experiences have suggested that each may not function with the same classification accuracy. In an effort to increase the TOMM's ability to accurately classify performance validity, recent research has investigated the use of nonstandard cutoff scores. The purpose of this study was to potentially validate the use of two, nonstandard cutoff scores (<49 on Trial 2 or the Retention Trial or <= 39 on Trial 1) applied to the TOMM in a medicolegal sample of mild traumatic brain injury litigants. Both descriptive and inferential statistics found that the cutoff of <49 on Trial 2 or the Retention Trial was the most sensitive to performance validity as compared with both the standard TOMM criteria and the cutoff of <= 39. These findings support the use of nonstandard cutoffs to increase the TOMM's classification accuracy.	[Stenclik, Jessica H.; Miele, Andrea S.; Silk-Eglit, Graham; McCaffrey, Robert J.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Lynch, Julie K.; McCaffrey, Robert J.] Albany Neuropsychol Associates, Albany, NY USA		Stenclik, JH (corresponding author), SUNY Albany, Dept Psychol, 1400 Washington Ave, Albany, NY 12222 USA.	JG826918@Albany.edu		Eglit, Graham/0000-0001-7592-9859			Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Gavett BE, 2005, APPL NEUROPSYCHOL, V12, P1, DOI 10.1207/s15324826an1201_1; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Hom J, 2002, DETECTION RESPONSE B; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rogers R., 1997, RES DISSIMULATION; Schroeder R, 2011, RNA BIOL, V8, P1; SCHROEDER RW, 2011, CLIN NEUROPSYCHOL, V25, P564; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler, 1997, WECHSLER ADULT INTEL	28	15	15	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2013	20	4					243	248		10.1080/09084282.2012.704603			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	298ST	WOS:000330345400002	23530574				2022-02-06	
J	Zaben, M; El Ghoul, W; Belli, A				Zaben, Malik; El Ghoul, Wessam; Belli, Antonio			Post-traumatic head injury pituitary dysfunction	DISABILITY AND REHABILITATION			English	Article						Concussion; head injury; hormone; metabolism; neuro-rehabilitation; pituitary	TRAUMATIC BRAIN-INJURY; CLINICAL-RESEARCH CENTER; GROWTH-HORMONE GH; REPLACEMENT THERAPY; DIABETES-INSIPIDUS; NATURAL-HISTORY; HYPOGONADAL MEN; HYPOPITUITARISM; PREVALENCE; REHABILITATION	Partial or complete pituitary dysfunction affects 33-50% of all traumatic brain injury (TBI) survivors and is a significant contributor to the overall disability burden. The hypophyseal vessels are anatomically vulnerable to shearing injuries, raised intracranial pressure and anterior base of skull fractures, and pituitary ischaemia or haemorrhage is a common finding at autopsy. Post-traumatic hypopituitarism (PTHP) can affect all grades of severity of injury and is often difficult to diagnose, as its features largely overlap with common post-concussive symptoms. PTHP has a wide range of manifestations, including fatigue, myopathy, cognitive difficulties, depression, behavioural changes or life-threatening complications such as sodium dysregulation and adrenal crisis. In some instances, mild PTHP can recover, at least partially, but cases of late onset are also known. At present, there is no consensus on whether all TBI patients should be screened (including mild TBI) and at what time points, given that neuroendocrine tests in the acute phase are simply likely to reflect a non-specific trauma response rather than true pituitary damage and that the time course of PTHP is unclear. A full investigation of the hypothalamic-pituitary axis requires specialized neuroendocrine assessment, including stimulation tests, as random hormone levels can be misleading in this context. Given the high incidence of TBI, this may have significant resource implications for Endocrinology services but, on the other hand, patients with PTHP may receive suboptimal rehabilitation unless the underlying hormone deficiency is identified and treated.	[Zaben, Malik] Univ Wales Hosp, Dept Neurosurg, Cardiff CF4 4XW, S Glam, Wales; [El Ghoul, Wessam] Southampton Univ Hosp, Wessex Neurol Ctr, Southampton, Hants, England; [Belli, Antonio] Queen Elizabeth Hosp, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England; [Belli, Antonio] Univ Birmingham, Birmingham B15 2TT, W Midlands, England		Belli, A (corresponding author), Univ Birmingham, Inst Biomed Res W, NIHR Surg Reconstruct & Microbiol Res Ctr, Neurotrauma & Neurodegenerat Sect,Sch Clin & Expt, Birmingham B15 2TT, W Midlands, England.	a.belli@bham.ac.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Zaben, Malik/0000-0002-7446-4532			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Alaca R, 2002, AM J PHYS MED REHAB, V81, P788, DOI 10.1097/00002060-200210000-00013; Banks E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1364; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Blair JC, 2010, BRIT J NEUROSURG, V24, P10, DOI 10.3109/02688690903536637; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Boughey JC, 2004, AM SURGEON, V70, P500; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Casanueva FF, 2005, J ENDOCRINOL INVEST, V28, P299; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Leal-Cerro Alfonso, 2009, Endocrinol Nutr, V56, P293, DOI 10.1016/S1575-0922(09)71944-8; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3654, DOI 10.1210/jc.81.10.3654; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3578, DOI 10.1210/jc.81.10.3578; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	35	15	16	1	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	6					522	525		10.3109/09638288.2012.697252			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	089XZ	WOS:000314944600012	22779906				2022-02-06	
J	Weise, G; Stoll, G				Weise, Gesa; Stoll, Guido			Magnetic resonance imaging of blood brain/nerve barrier dysfunction and leukocyte infiltration: closely related or discordant?	FRONTIERS IN NEUROLOGY			English	Article						contrast-enhanced MRI; gadolinium-DTPA; gadofluorine; iron oxide nanoparticles; blood brain barrier; neuroinflammation		Unlike other organs the nervous system is secluded from the rest of the organism by the blood brain barrier (BBB) or blood nerve barrier (BNB) preventing passive influx of fluids from the circulation. Similarly, leukocyte entry to the nervous system is tightly controlled. Breakdown of these barriers and cellular inflammation are hallmarks of inflammatory as well as ischemic neurological diseases and thus represent potential therapeutic targets. The spatiotemporal relationship between BBB/BNB disruption and leukocyte infiltration has been a matter of debate. We here review contrast-enhanced magnetic resonance imaging (MRI) as a non-invasive tool to depict barrier dysfunction and its relation to macrophage infiltration in the central and peripheral nervous system under pathological conditions. Novel experimental contrast agents like Gadofluorine M (Gf) allow more sensitive assessment of BBB dysfunction than conventional Gadolinium (Gd)-DTPA enhanced MRI. In addition, Gf facilitates visualization of functional and transient alterations of the BBB remote from lesions. Cellular contrast agents such as superparamagnetic iron oxide particles (SPIO) and perfluorocarbons enable assessment of leukocyte (mainly macrophage) infiltration by MR technology. Combined use of these MR contrast agents disclosed that leukocytes can enter the nervous system independent from a disturbance of the BBB, and vice versa, a dysfunctional BBB/BNB by itself is not sufficient to attract inflammatory cells from the circulation. We will illustrate these basic imaging findings in animal models of multiple sclerosis, cerebral ischemia, and traumatic nerve injury and review corresponding findings in patients.	[Weise, Gesa; Stoll, Guido] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Weise, Gesa] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Weise, Gesa] Translat Ctr Regenerat Med, Leipzig, Germany		Weise, G (corresponding author), Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Ischemia Res, Perlickstr 1, D-04103 Leipzig, Germany.	gesa.weise@izi.fraunhofer.de					Anzai Y, 2003, RADIOLOGY, V228, P777, DOI 10.1148/radiol.2283020872; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Bendszus M, 2005, ANN NEUROL, V57, P388, DOI 10.1002/ana.20404; Bendszus M, 2003, J NEUROSCI, V23, P10892; Bendszus M, 2008, BRAIN, V131, P2341, DOI 10.1093/brain/awn156; Bendszus Martin, 2005, Brain, V128, pE25, DOI 10.1093/brain/awh389; Berger C, 2006, NMR BIOMED, V19, P101, DOI 10.1002/nbm.1007; Bernd H, 2009, INVEST RADIOL, V44, P336, DOI 10.1097/RLI.0b013e3181a0068b; Bluemke DA, 2003, RADIOLOGY, V228, P457, DOI 10.1148/radiol.2282012061; BOULDIN TW, 1991, J NEUROPATH EXP NEUR, V50, P719, DOI 10.1097/00005072-199111000-00004; Brochet B, 2006, NEUROIMAGE, V32, P266, DOI 10.1016/j.neuroimage.2006.03.028; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Cudlip SA, 2002, J NEUROSURG, V96, P755, DOI 10.3171/jns.2002.96.4.0755; Deloire MSA, 2004, MULT SCLER, V10, P540, DOI 10.1191/1352458504ms1090oa; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Desestret V, 2009, STROKE, V40, P1834, DOI 10.1161/STROKEAHA.108.531269; Does MD, 1996, MAGNET RESON MED, V35, P207, DOI 10.1002/mrm.1910350212; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Dousset V, 2006, AM J NEURORADIOL, V27, P1000; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Ehrlich P., 1885, FARBANALYTISCHE STUD; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Farr TD, 2011, NMR BIOMED, V24, P35, DOI 10.1002/nbm.1553; FENSTERMACHER J, 1988, ANN NY ACAD SCI, V531, P29, DOI 10.1111/j.1749-6632.1988.tb51416.x; Filippi M, 2011, ARCH NEUROL-CHICAGO, V68, P1514, DOI 10.1001/archneurol.2011.914; Flogel U, 2011, AM J TRANSPLANT, V11, P235, DOI 10.1111/j.1600-6143.2010.03372.x; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; GRIFFIN JW, 1990, J NEUROCYTOL, V19, P367, DOI 10.1007/BF01188405; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Hitchens TK, 2011, MAGN RESON MED, V65, P1145, DOI 10.1002/mrm.22702; Hoehn M, 2007, J PHYSIOL-LONDON, V584, P25, DOI 10.1113/jphysiol.2007.139451; Kim J, 2008, ACTA RADIOL, V49, P580, DOI 10.1080/02841850802020484; Kleinschnitz C, 2005, J CEREBR BLOOD F MET, V25, P1548, DOI 10.1038/sj.jcbfm.9600151; Kleinschnitz C, 2003, J CEREBR BLOOD F MET, V23, P1356, DOI 10.1097/01.WCB.0000090505.76664.DB; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Knight RA, 1998, STROKE, V29, P144, DOI 10.1161/01.STR.29.1.144; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lacour-Petit MC, 2003, NEURORADIOLOGY, V45, P166, DOI 10.1007/s00234-002-0932-6; Ladewig G, 2009, EXP NEUROL, V220, P207, DOI 10.1016/j.expneurol.2009.08.027; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Liao CD, 2012, RADIOLOGY, V262, P161, DOI 10.1148/radiol.11110911; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Meding J, 2007, CONTRAST MEDIA MOL I, V2, P120, DOI 10.1002/cmmi.137; Merten CL, 1999, NEURORADIOLOGY, V41, P242, DOI 10.1007/s002340050740; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Nagaraja TN, 2007, MAGN RESON IMAGING, V25, P311, DOI 10.1016/j.mri.2006.09.003; Nighoghossian N, 2007, STROKE, V38, P303, DOI 10.1161/01.STR.0000254548.30258.f2; Parry A, 2002, J NEUROL, V249, P1279, DOI 10.1007/s00415-002-0837-7; Perry VH, 1997, MOL MED TODAY, V3, P335, DOI 10.1016/S1357-4310(97)01077-0; Rausch M, 2004, J MAGN RESON IMAGING, V20, P16, DOI 10.1002/jmri.20057; Rausch M, 2003, MAGNET RESON MED, V50, P309, DOI 10.1002/mrm.10541; Rausch M, 2001, MAGNET RESON MED, V46, P1018, DOI 10.1002/mrm.1290; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824; Saleh A, 2004, BRAIN, V127, P1670, DOI 10.1093/brain/awh191; Saleh A, 2007, STROKE, V38, P2733, DOI 10.1161/STROKEAHA.107.481788; Schroeter M, 1997, STROKE, V28, P382, DOI 10.1161/01.STR.28.2.382; Schulz Martina, 2005, Cerebrospinal Fluid Res, V2, P8, DOI 10.1186/1743-8454-2-8; Schwaninger M, 1999, J NEUROCHEM, V73, P1461, DOI 10.1046/j.1471-4159.1999.0731461.x; Sedlakova R, 1999, J SUBMICR CYTOL PATH, V31, P149; SEITZ RJ, 1989, MUSCLE NERVE, V12, P627, DOI 10.1002/mus.880120803; Silver NC, 2001, MULT SCLER J, V7, P75, DOI 10.1177/135245850100700201; Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Stoll G, 2012, WIRES NANOMED NANOBI, V4, P438, DOI 10.1002/wnan.1168; Stoll G, 2009, J NEUROL, V256, P1043, DOI 10.1007/s00415-009-5064-z; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Temme S, 2012, WIRES NANOMED NANOBI, V4, P329, DOI 10.1002/wnan.1163; Thorek DLJ, 2011, MOL IMAGING, V10, P206, DOI 10.2310/7290.2010.00042; Toews AD, 1998, J NEUROSCI RES, V53, P260, DOI 10.1002/(SICI)1097-4547(19980715)53:2<260::AID-JNR15>3.3.CO;2-V; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Tourdias T, 2012, RADIOLOGY, V264, P225, DOI 10.1148/radiol.12111416; Traboulsee A, 2003, MULT SCLER J, V9, P566, DOI 10.1191/1352458503ms958oa; Vellinga MM, 2008, BRAIN, V131, P800, DOI 10.1093/brain/awn009; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P774, DOI 10.1002/jmri.21678; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020; Witte OW, 1997, ADV NEUROL, V73, P207; Wolburg H, 2005, ACTA NEUROPATHOL, V109, P181, DOI 10.1007/s00401-004-0928-x; Wuerfel E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-70; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176	90	15	18	1	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 21	2012	3								178	10.3389/fneur.2012.00178			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VK3ZZ	WOS:000689536200001	23267343	gold, Green Published			2022-02-06	
J	Amorim, RL; Bor-Seng-Shu, E; Gattas, GS; Paiva, W; de Andrade, AF; Teixeira, MJ				Amorim, Robson Luis; Bor-Seng-Shu, Edson; Gattas, Gabriel S.; Paiva, Wellingson; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen			Decompressive craniectomy and cerebral blood flow regulation in head injured patients: A case studied by perfusion CT	JOURNAL OF NEURORADIOLOGY			English	Article						Traumatic brain injury; Decompressive craniectomy; Perfusion computed tomography; Cerebral hemodynamics	TRAUMATIC BRAIN-INJURY; HEMODYNAMIC-CHANGES; AUTOREGULATION	Previous studies have reported increased cerebral blood flow (CBF) velocity after decompressive craniectomy in traumatic brain injury (TBI) patients. A 27-year-old man presented with clinical and tomographic signs of cerebral herniation secondary to TBI. Prior to decompressive craniectomy, hemodynamic study by perfusion computed tomography (CT) indicated diffuse cerebral hyperperfusion. Following surgical decompression, the patient recovered neurologically and perfusion CT disclosed a decrease in the intensity of cerebral perfusion. The patient's blood pressure levels were similar at both pre- and postoperative perfusion CT examinations. This finding provides indirect evidence that decompressive craniectomy may improve mechanisms of CBF regulation in TBI, providing pathophysiological insights in the cerebral hemodynamics of TBI patients. This is the first report analyzing the hemodynamic changes through perfusion CT (PCT) in a patient with decompressive craniotomy due to TBI. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Amorim, Robson Luis; Bor-Seng-Shu, Edson; Paiva, Wellingson; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Sch Med, Dept Neurosurg, Sao Paulo, Brazil; [Gattas, Gabriel S.] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil		Amorim, RL (corresponding author), 718 Alves Guimaraes St,Appartment 112, BR-05410001 Sao Paulo, Brazil.	amorim.robson@uol.com.br	Paiva, Wellingson S/G-5517-2013; Amorim, Robson/AAK-1368-2021; BOR-SENG-SHU, EDSON/H-7784-2013; BOR-SENG-SHU, EDSON/AAC-9762-2019	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; BOR-SENG-SHU, EDSON/0000-0002-6713-8974			Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Engelhorn T, 2003, NEUROSCI LETT, V344, P127, DOI 10.1016/S0304-3940(03)00441-5; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Miller JD, 1992, J NEUROTRAUMA S1, P317; Urasaki E, 2001, NEUROL MED-CHIR, V41, P306, DOI 10.2176/nmc.41.306; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Wintermark M, 2006, J NEURORADIOLOGY, V33, P27, DOI 10.1016/S0150-9861(06)77225-X	10	15	16	0	4	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861			J NEURORADIOLOGY	J. Neuroradiol.	DEC	2012	39	5					346	349		10.1016/j.neurad.2012.02.006			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	067MO	WOS:000313298800010	22633048				2022-02-06	
J	Hoffmann, M; Lehmann, W; Rueger, JM; Lefering, R				Hoffmann, Michael; Lehmann, Wolfgang; Rueger, Johannes M.; Lefering, Rolf		Trauma Registry German Soc Trauma	Introduction of a novel trauma score	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Glasgow Coma Scale; pupil size; pupil reactivity; outcome; traumatic brain injury	GLASGOW COMA SCALE; HEAD-INJURED PATIENTS; BRAIN-INJURY; MORTALITY; PREDICTION; ADMISSION; SEVERITY; CARE	BACKGROUND: Early diagnosis of traumatic brain injury (TBI) and reliable prediction of outcome are essential for determining treatment strategies and allocating resources. This study introduces the Eppendorf-Cologne Scale (ECS) and evaluated its predictive accuracy for outcome and TBI presence compared with those of the Glasgow Coma Scale (GCS). METHODS: A retrospective cohort analysis of severely injured trauma patients registered in the Trauma Registry of the German Society for Trauma Surgery from 1993 to 2010 was conducted. Only directly admitted patients alive on admission and with complete data on GCS, pupil reactivity, and size were included. The ECS was modeled using pupil reactivity, size, and a modified GCS motor component. The unadjusted predictive role of each component was evaluated using multivariable regression analysis. The predictive power regarding the presence of TBI and outcome of the ECS and the GCS was modeled using area under the receiver operating characteristic (AUROC) curve analyses. RESULTS: A total of 28,305 patients fulfilled the study inclusion criteria. The ECS outmatched the predictive accuracy of the GCS for outcome (AUROC, 0.824; 95% confidence interval [95% CI], 0.817-0.831; and AUROC, 0.811; 95% CI, 0.804-0.818, respectively; r(s) = 0.887, p < 0.001) and TBI presence (AUROC, 0.813; 95% CI, 0.805-0.822; and AUROC, 0.777; 95% CI, 0.768-0.786, respectively; r(s) = 0.889, p < 0.001). Patients with TBI were five times more often unconscious at the scene and showed a 3.5-fold increased in-hospital mortality. An ECS score of 8 was associated with a 20-fold higher mortality compared with an ECS score of 0. The ECS differentiates patients with a fourfold higher mortality within the GCS 3 collective. CONCLUSION: The ECS shows a significantly higher accuracy for prediction of outcome and TBI presence compared with the GCS and provides a simple, yet reliable, stratification tool for early decision making. (J Trauma Acute Care Surg. 2012;73: 1607-1613. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Hoffmann, Michael; Lehmann, Wolfgang; Rueger, Johannes M.] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, D-20246 Hamburg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Cologne Merheim Med Ctr, Inst Res Operat Med, Cologne, Germany		Hoffmann, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Martinistr 52D, D-20246 Hamburg, Germany.	mi.hoffmann@web.de	Lehmann, Wolfgang/H-3555-2012				Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Crossman J, 1998, INJURY, V29, P435, DOI 10.1016/S0020-1383(98)00079-5; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoffmann M, 2011, BR J SURG S1, V99, P122; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Juarez V J, 1995, J Neurosci Nurs, V27, P283; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Namiki J, 2011, CLIN NEUROL NEUROSUR, V113, P393, DOI 10.1016/j.clineuro.2011.01.001; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Rehn M, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-17; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	25	15	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2012	73	6					1607	1613		10.1097/TA.0b013e318270d572			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	058FV	WOS:000312620400039	23188250				2022-02-06	
J	Lindgren, C; Nordh, E; Naredi, S; Olivecrona, M				Lindgren, Cecilia; Nordh, Erik; Naredi, Silvana; Olivecrona, Magnus			Frequency of Non-convulsive Seizures and Non-convulsive Status Epilepticus in Subarachnoid Hemorrhage Patients in Need of Controlled Ventilation and Sedation	NEUROCRITICAL CARE			English	Article						Epilepsy; Seizures; Non-convulsive seizures; Continuous electroencephalogram; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; CONTINUOUS EEG; ANTICONVULSANT PROPHYLAXIS; ELECTROGRAPHIC SEIZURES; INTRACRANIAL ANEURYSMS; EPILEPSY; MANAGEMENT; VASOSPASM	Background Non-convulsive seizures (NCSZ) can be more prevalent than previously recognized among comatose neuro-intensive care patients. The aim of this study was to evaluate the frequency of NCSZ and non-convulsive status epilepticus (NCSE) in sedated and ventilated subarachnoid hemorrhage (SAH) patients. Methods Retrospective study at a university hospital neuro-intensive care unit, from January 2008 until June 2010. Patients were treated according to a local protocol, and were initially sedated with midazolam or propofol or combinations of these sedative agents. Thiopental was added for treatment of intracranial hypertension. No wake-up tests were performed. Using NicoletOne(A (R)) equipment (VIASYS Healthcare Inc., USA), continuous EEG recordings based on four electrodes and a reference electrode was inspected at full length both in a two electrode bipolar and a four-channel referential montage. Results Approximately 5,500 h of continuous EEG were registered in 28 SAH patients (33 % of the patients eligible for inclusion). The median Glasgow Coma scale was 8 (range 3-14) and the median Hunt and Hess score was 4 (range 1-4). During EEG registration, no clinical seizures were observed. In none of the patients inter ictal epileptiform activity was seen. EEG seizures were recorded only in 2/28 (7 %) patients. One of the patients experienced 4 min of an NCSZ and one had a 5 h episode of an NCSE. Conclusion Continuous EEG monitoring is important in detecting NCSZ in sedated patients. Continuous sedation, without wake-up tests, was associated with a low frequency of subclinical seizures in SAH patients in need of controlled ventilation.	[Lindgren, Cecilia; Naredi, Silvana] Umea Univ, Div Anaesthesiol & Intens Care, Dept Surg & Perioperat Sci, S-90187 Umea, Sweden; [Nordh, Erik] Umea Univ, Div Clin Neurophysiol, Dept Pharmacol & Clin Neurosci, S-90187 Umea, Sweden; [Olivecrona, Magnus] Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, S-90187 Umea, Sweden		Lindgren, C (corresponding author), Umea Univ, Div Anaesthesiol & Intens Care, Dept Surg & Perioperat Sci, S-90187 Umea, Sweden.	cecilia.lindgren@anestesi.umu.se; erik.nordh@neuro.umu.se; silvana.naredi@anestesi.umu.se; magnus.olivecrona@neuro.umu.se	Viani, Rafael/V-1196-2018	Naredi, Silvana/0000-0002-4409-6089; Lindgren, Cecilia/0000-0002-4903-9374; Olivecrona, Magnus/0000-0001-8457-4711	Swedish Society of Medicine; Faculty of Medicine at Umea University	The kind cooperation and assistance of staff at the ICU, Umea University Hospital and at the Department of Neurophysiology in performing this study is gratefully acknowledged. This study was supported by grants from The Swedish Society of Medicine, and from the Faculty of Medicine at Umea University. A visiting professorship at the Rehabilitation Research Chair, King Saud University, Riyadh, Saudi Arabia, to author E.N. is gratefully acknowledged.	BAKER CJ, 1995, NEUROSURGERY, V37, P863, DOI 10.1227/00006123-199511000-00003; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Cascino GD, 2009, NEUROLOGY, V72, P1718, DOI 10.1212/WNL.0b013e3181a4e465; Chaisewikul R, 2001, COCHRANE DB SYST REV; Choi KS, 2009, J KOREAN NEUROSURG S, V46, P93, DOI 10.3340/jkns.2009.46.2.93; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2007, NEUROSURGERY, V61, P4; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; DEFALCO FA, 1992, EPILEPSIA, V33, P343; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gilmore E, 2010, NEUROLOGIST, V16, P165, DOI 10.1097/NRL.0b013e3181c7cd0b; Hanggi D, 2011, NEUROCRIT CARE, V15, P318, DOI 10.1007/s12028-011-9583-y; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; Hart Y, 2011, J NEUROSURG, V115, P1159, DOI 10.3171/2011.6.JNS101836; Hirsch LJ, 2008, EPILEPSIA, V49, P968, DOI 10.1111/j.1528-1167.2007.01481.x; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; KASSELL NF, 1982, NEUROSURGERY, V11, P337, DOI 10.1227/00006123-198209000-00001; Kriz J, 2003, EPILEPSY RES, V52, P215, DOI 10.1016/S0920-1211(02)00213-9; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; LARKIN JG, 1991, EPILEPSY RES, V9, P71, DOI 10.1016/0920-1211(91)90049-L; Lin CL, 2003, J NEUROSURG, V99, P978, DOI 10.3171/jns.2003.99.6.0978; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; MEYER FB, 1990, EPILEPSIA, V31, P68, DOI 10.1111/j.1528-1157.1990.tb05362.x; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Pinto AN, 1996, J NEUROL, V243, P161, DOI 10.1007/BF02444009; Rathakrishnan R, 2011, NEUROCRIT CARE, V14, P152, DOI 10.1007/s12028-010-9495-2; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Sakowitz OW, 2006, NEUROSURGERY, V58, P137, DOI 10.1227/01.NEU.0000194532.47239.7C; Schmidt JM, 2011, NEUROCRIT CARE, V14, P149, DOI 10.1007/s12028-011-9519-6; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Stuart RM, 2010, NEUROCRIT CARE, V13, P355, DOI 10.1007/s12028-010-9414-6; SUNDARAM MBM, 1986, CAN J NEUROL SCI, V13, P229, DOI 10.1017/S0317167100036325; TEASDALE G, 1974, LANCET, V2, P81; Theilen HJ, 2000, CRIT CARE MED, V28, P3522, DOI 10.1097/00003246-200010000-00029; Tomycz Luke, 2011, Surg Neurol Int, V2, P90, DOI 10.4103/2152-7806.82372; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Zapater P, 1998, BRAIN RES, V796, P311, DOI 10.1016/S0006-8993(98)00352-7; Zubkov Alexander Y, 2008, Rev Neurol Dis, V5, P178	50	15	16	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2012	17	3					367	373		10.1007/s12028-012-9771-4			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050QP	WOS:000312069400009	22932991	Green Submitted			2022-02-06	
J	Yuan, Q; Liu, H; Wu, X; Sun, YR; Yao, HJ; Zhou, LF; Hu, J				Yuan, Qiang; Liu, Hua; Wu, Xing; Sun, Yirui; Yao, Haijun; Zhou, Liangfu; Hu, Jin			Characteristics of acute treatment costs of traumatic brain injury in Eastern China-a multi-centre prospective observational study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain injury; Costs; Length of stay; Traumatic brain injury	HOSPITAL LENGTH; UNITED-STATES; HEAD-INJURY; CHARGES; OUTCOMES; STAY; CARE	Introduction: This study investigated acute treatment costs and related factors for traumatic brain injuries (TBI) in eastern China based on a prospective multicentre study. Materials and methods: Data were prospectively collected from 80 hospitals in eastern China by standardized structured questionnaires during 2004. Included patients were admitted to hospitals via an emergency service with a diagnosis of TBI. The total acute hospitalization treatment costs derived from unsubsidized total hospital billings were used as the main outcome measure. Univariate and multivariable regression models were used to examine factors associated with each outcome. Results: In total, 13,007 TBI cases were identified from 80 hospitals in eastern China. The median cost per hospitalization was $879 US (range, $72-45,894). The median cost per day was $79 (interquartile range, $49-126). The hospitalization costs varied based on the cause of TBI, with a median of $1017 for traffic accidents, $816 for falls, $490 for blows to the head, and $712 for falls. The hospitalization costs also varied by injury type with a mean of $918 for TBI associated with other injuries and $831 for isolated TBI. Using multiple regression analyses, lower admission Glasgow Coma score, longer hospital stay (LOS), male sex, transient patient status, traffic accident, injury occurring on a construction site, treatment at a tertiary hospital, neurosurgical intensive care unit (NICU) or ICU stay, associated polytrauma, and those who needed a neurosurgical operation had significantly higher total acute hospitalization costs than those of other groups. Good recovery and self-paying patients had lower total costs. A double LOS was associated with a 1.61 (95% confidence interval, 1.59-1.62) times higher hospital cost. Conclusion: Our results have potential implications for health-care resource planning during TBI treatment. Measures to prevent traffic accidents and reduce the LOS may help to reduce acute hospitalization costs. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.	[Wu, Xing; Sun, Yirui; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Yuan, Qiang; Yao, Haijun] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China; [Liu, Hua] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	297260090@qq.com; wacilii@163.com; bttnirvina@gmail.com; yirui.sun@live.cn; yaohaijun0913@126.com; sunyinfengabc@163.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30371454]; Shanghai Nature Science Foundation [0841195200]	This study was funded by National Natural Science Foundation of China (NSFC Grants 30371454), Shanghai Nature Science Foundation (0841195200).	American Association of Neurological Surgeons, 1996, J NEUROTRAUM, V13, P639; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Brell M, 2001, NEUROCIRUGIA, V12, P105; Brooks CA, 1995, J HEAD TRAUMA REHAB, V104, P1; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; Firsching R, 2001, WORLD J SURG, V25, P1221; Gardner R, 2007, ARCH PEDIAT ADOL MED, V161, P889, DOI 10.1001/archpedi.161.9.889; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Max W, 2001, J HEAD TRAUMA REHAB, V6, P26; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	16	15	19	2	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2094	2099		10.1016/j.injury.2012.03.028			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600022	22595490				2022-02-06	
J	LaBella, CR; Mjaanes, J				LaBella, Cynthia R.; Mjaanes, Jeffrey			Cheerleading Injuries: Epidemiology and Recommendations for Prevention	PEDIATRICS			English	Article						cheer; athletes; sports; adolescents; females	HIGH-SCHOOL; UNITED-STATES; NORTH-CAROLINA; RISK-FACTORS; CONCUSSION; FREQUENCY	Over the last 30 years, cheerleading has increased dramatically in popularity and has evolved from leading the crowd in cheers at sporting events into a competitive, year-round sport involving complex acrobatic stunts and tumbling. Consequently, cheerleading injuries have steadily increased over the years in both number and severity. Sprains and strains to the lower extremities are the most common injuries. Although the overall injury rate remains relatively low, cheerleading has accounted for approximately 66% of all catastrophic injuries in high school girl athletes over the past 25 years. Risk factors for injuries in cheerleading include higher BMI, previous injury, cheering on harder surfaces, performing stunts, and supervision by a coach with low level of training and experience. This policy statement describes the epidemiology of cheerleading injuries and provides recommendations for injury prevention. Pediatrics 2012;130:966-971									American Association of Cheerleading Coaches and Administrators, 2011 2012 SCH CHEERL; American Sports Data Inc, 2004, SUP SPORTS PART, VII; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Fort GG, 1999, AM J EMERG MED, V17, P432, DOI 10.1016/S0735-6757(99)90107-9; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2005, BRIT J SPORT MED, V39, P237, DOI 10.1136/bjsm.2004.014605; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; Julka B., 2009, HIGH SCH TODAY  0930; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mueller FO, 2009, CATASTROPHIC SPORTS; National Federation of State High School Associations, 2012 2013 SPIR RUL B; National Injury Information Clearinghouse, 2008, CHEERL INJ 1980 2007; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P595, DOI 10.4085/1062-6050-44.6.595; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567	21	15	16	7	45	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2012	130	5					966	971		10.1542/peds.2012-2480			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	029OT	WOS:000310505900067	23090348	Bronze			2022-02-06	
J	Lecours, A; Sirois, MJ; Ouellet, MC; Boivin, K; Simard, JF				Lecours, Alexandra; Sirois, Marie-Josee; Ouellet, Marie-Christine; Boivin, Karine; Simard, Jean-Francois			Long-Term Functional Outcome of Older Adults After a Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						older adults; rehabilitation; traumatic brain injury	INDEPENDENCE MEASURE; REHABILITATION; NEEDS; AGE; PREDICTION; MODERATE	Purpose: To identify factors associated with long-term independence in mobility and self-care activities of daily living of older adults after traumatic brain injury (TBI). Participants: One hundred thirty-six TBI survivors 55 years or older were assessed 2 to 4 years postinjury (mean of 3.2 years). Setting: Level I or level II trauma centers in Quebec, Canada. Main measures: Personal, injury-related, and environmental factors were gathered from hospital records or by telephone interview; a telephone version of the Functional Independence Measure motor scale was collapsed to 4 levels. Analysis: Logistic regression analyses identified factors associated with independence in mobility and self-care. Results: The strongest and most consistent factors associated with independence in mobility and self-care were fewer comorbid conditions, no difficulty of access to home modification services and home support services, male gender, younger age at time of injury, and shorter acute care length of stay. Conclusion: Factors associated with long-term functional outcome should be considered in the development of practice guidelines for rehabilitation of older adults who sustained a TBI.	[Lecours, Alexandra] Univ Quebec Trois Rivieres, Dept Ergotherapie, Bur 3831, Trois Rivieres, PQ G9A 5H7, Canada; [Lecours, Alexandra; Sirois, Marie-Josee; Simard, Jean-Francois] Hop Enfants Jesus, CHA Ctr Hosp Affilie Univ, Ctr FRSQ, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] CIRRIS, Quebec City, PQ, Canada		Lecours, A (corresponding author), Univ Quebec Trois Rivieres, Dept Ergotherapie, Bur 3831, Pavillon Sante,3351,Boul Forges, Trois Rivieres, PQ G9A 5H7, Canada.	Alexandra.Lecours@uqtr.ca	Lecours, Alexandra/AAY-5336-2021	Lecours, Alexandra/0000-0002-4485-7829; Sirois, Marie-josee/0000-0001-9775-6960; Ouellet, Marie-Christine/0000-0003-3477-1893	Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec [16891]; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [107583]	This study was funded by the Fonds de la Recherche en Sante du Quebec through a master (2008-2010) training award to A. Lecours (award no. 16891) and by the Canadian Institutes for Health Research (grant no. 107583).	Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Association des etablissements de readaptation en deficience physique du Quebec, 2010, STAT; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R, P73; Audet N, 2001, ENQUETE SOCIALE SANT; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bond T, 2001, APPL RASCH MODEL FUN; Chang W C, 1997, J Outcome Meas, V1, P192; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Dumont C, 2003, THESIS U LAV DEP SAN, P232; Dutch Injury Surveillance System (LIS), 1999, DAT 1999; Englander J, 2007, BRAIN INJURY MED PRI, P315; FIELDS RB, 1994, TXB GERIATRIC NEUROP, P479; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fleming J, 1999, BRAIN INJURY, V13, P417; Fougeyrollas P, 1998, CLASSIFICATION QUEBE, P38; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Goleburn G, 2001, J CLIN GEROPSYCHOL, V7, P161, DOI DOI 10.1023/A:1011335027445; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Gosman-Hedstrom G, 2000, DISABIL REHABIL, V22, P702, DOI 10.1080/09638280050191972; Gosman-Hedstrom G, 2004, DISABIL REHABIL, V26, P410, DOI 10.1080/09638280410001662978; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Information C. I. F. H, 2011, ONT TRAUM REG 2011 R; Institut Fur Experimentelle Psychologie, 2009, G POW 3; Jacoby SF, 2006, J NURS SCHOLARSHIP, V38, P133, DOI 10.1111/j.1547-5069.2006.00090.x; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; McCartan DP, 2008, BRAIN INJURY, V22, P305, DOI 10.1080/02699050801995124; Meldon SW, 2004, GERIATRIC EMERGENCY, P585; Ministere de la sante et des services sociaux, 2000, TRAUM PERS AG ORG IN; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nilsson AL, 2005, ACTA NEUROL SCAND, V111, P264, DOI 10.1111/j.1600-0404.2005.00404.x; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sirois MJ, 2009, AM J PHYS MED REHAB, V88, P387, DOI 10.1097/PHM.0b013e31819c592f; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Spirduso W., 2005, PHYS DIMENSIONS AGIN, P3; TEASDALE G, 1974, LANCET, V2, P81; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wright B., 1979, BEST TEST DESIGN RAS; Zasler N.D., 2007, BRAIN INJURY MED PRI, P1275	53	15	15	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					379	390		10.1097/HTR.0b013e31823b2385			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200009	22333676				2022-02-06	
J	Minns, RA; Jones, PA; Tandon, A; Fleck, BW; Mulvihill, AO; Elton, RA				Minns, Robert A.; Jones, Patricia A.; Tandon, Anamika; Fleck, Brian W.; Mulvihill, Alan O.; Elton, Robert A.			Prediction of Inflicted Brain Injury in Infants and Children Using Retinal Imaging	PEDIATRICS			English	Article						inflicted brain injury; infants and children; retinal hemorrhages; predictive probability	YOUNG-CHILDREN; OPHTHALMOLOGIC FINDINGS; HEAD TRAUMA; HEMORRHAGES; ABUSE; CLASSIFICATION	BACKGROUND: Retinal hemorrhages (RHs) occur in inflicted traumatic brain injury (ITBI), accidental traumatic brain injury (ATBI), and some medical conditions, although the reported number, distribution, type, and frequency vary greatly between these different etiologies. We hypothesize that these RH characteristics reliably help to distinguish ITBI from ATBI and nontraumatic etiologies. METHODS: A 6-year prospective observational study using wide-field retinal imaging (RetCam) was conducted within 24 hours of admission to PICU, on serially recruited children with traumatic and nontraumatic encephalopathies. "Definite" and "probable" ITBI cases were confirmed by multiagency child protection case conferences. Image analysis used digital color and grayscale images for retinal "zoning" and "layering" of hemorrhages. RESULTS: Significant differences were found between the mean numbers of hemorrhages in ATBI/ITBI, and ITBI/nontraumatic etiologies for the 3 retinal zones (range, P = .003-.009) and for the dot-blot hemorrhages (range P = .001-.002). The mean numbers of RHs per ITBI patient in the peripapillary, macula, and peripheral zones were 14, 28, and 31 respectively. RHs in ATBI were near the optic disc and more superficial than in ITBI, where hemorrhages involved deeper layers (range, P = .003-.039) and were more peripheral (P = .03). The positive predictive value for ITBI in children <3 years with >25 dot-blot (intraretinal) hemorrhages was 93%. CONCLUSIONS: This prospective study, which included all potential causes of RHs, with objective retinal methodology, has confirmed that a young age and a high dot-blot count are strong predictors of ITBI. This high predictive value may support medicolegal deliberations. Pediatrics 2012;130:e1227-e1234	[Elton, Robert A.] Univ Edinburgh, Dept Med Stat, Edinburgh EH9 1UW, Midlothian, Scotland; [Minns, Robert A.; Jones, Patricia A.] Royal Hosp Sick Children Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Tandon, Anamika; Fleck, Brian W.; Mulvihill, Alan O.] Royal Hosp Sick Children Edinburgh, Dept Pediat Ophthalmol, Edinburgh, Midlothian, Scotland		Minns, RA (corresponding author), Univ Edinburgh, Coll Med & Vet Med, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland.	robert.minns@ed.ac.uk			R.S. Macdonald Charitable Trust Edinburgh; Royal College of Surgeons Edinburgh; Friends of The Sick Kids Foundation, Edinburgh, Scotland	Funding was obtained from the R.S. Macdonald Charitable Trust Edinburgh, from the Royal College of Surgeons Edinburgh (Ophthalmology Grant), and from the Friends of The Sick Kids Foundation, Edinburgh, Scotland. The funders had no role in study design; in the collection, analysis, and interpretation of data; or in the writing of the report or the decision to submit the article for publication.	Arlotti SA, 2007, J AAPOS, V11, P175, DOI 10.1016/j.jaapos.2006.09.023; Barry GP, 2010, J AAPOS, V14, pe11; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Betz P, 1996, FORENSIC SCI INT, V78, P71, DOI 10.1016/0379-0738(95)01866-2; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; BUDENZ DL, 1994, OPHTHALMOLOGY, V101, P559; Dinakaran S, 2002, J AAPOS, V6, P221, DOI 10.1067/mpa.2002.124648; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fleck BW, 2010, BRIT J OPHTHALMOL, V94, P886, DOI 10.1136/bjo.2009.162271; Gilles EE, 2003, J PEDIATR-US, V143, P494, DOI 10.1067/S0022-3476(03)00416-5; Gilliland MGF, 2003, P AM AC FOR SCI M CH, P232; Healey K, 2006, AM J EMERG MED, V24, P616, DOI 10.1016/j.ajem.2005.11.016; Keenan H., 2002, INFLICTED CHILDHOOD, P3; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire S, 2008, BURNS, V34, P1072, DOI 10.1016/j.burns.2008.02.011; Mok JYQ, 1998, CHILD ABUSE REV, V7, P194; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Mulvihill AO, 2011, BRIT J OPHTHALMOL, V95, P99, DOI 10.1136/bjo.2009.168153; MUNGER CE, 1993, AM J FOREN MED PATH, V14, P193, DOI 10.1097/00000433-199309000-00004; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; RIFFENBURGH RS, 1991, OPHTHALMOLOGY, V98, P1519; Shaw AD, 2010, JAAPOS, V14, pe27; Sturm V, 2009, EYE, V23, P1535, DOI 10.1038/eye.2008.317; Tandon A, 2011, BRIT J OPHTHALMOL, V95, P1719, DOI 10.1136/bjophthalmol-2011-300248; THOMAS SA, 1991, PEDIATRICS, V88, P471; Togioka BM, 2009, J EMERG MED, V37, P98, DOI 10.1016/j.jemermed.2008.06.022; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037	34	15	15	0	8	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2012	130	5					E1227	E1234		10.1542/peds.2011-3274			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	029OT	WOS:000310505900022	23045566				2022-02-06	
J	Staffa, K; Ondruschka, B; Franke, H; Dressler, J				Staffa, Katharina; Ondruschka, Benjamin; Franke, Heike; Dressler, Jan			Cerebellar Gene Expression following Human Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						age of traumatic brain injuries; cerebellum; real-time polymerase chain reaction (PCR)	FIBRILLARY ACIDIC PROTEIN; MESSENGER-RNA EXPRESSION; HUMAN POSTMORTEM BRAIN; CLOSED-HEAD INJURY; CEREBRAL-CORTEX; SPINAL-CORD; TISSUE; ASTROCYTES; SERUM; S100B	Gene expression of specific brain biomarkers offers the possibility of shedding light on the difficult molecular pathways of traumatic brain injury (TBI) and may be useful to estimate the age of trauma. Gene expression rates of cerebellar injuries are not yet sufficiently established. In 12 cases (mean age 42 years) of TBI including a pathological change in cerebellum (with known survival times ranging from immediate death to 96 h), brain tissue samples from different brain regions were analyzed with real-time polymerase chain reaction (PCR) for expression of caspase-3, tyrosine kinase receptor B (TrkB), S100B, and glial fibrillary acidic protein (GFAP) mRNA. The pH was measured to gain information about a possible correlation to RNA degradation. For comparison, corresponding brain regions were arranged from control samples of subjects that died from sudden death. We found a correlation between pH and the degradation of RNA in samples from the contralateral site, where the samples with degraded RNA have a lower pH (p < 0.05). For short survival times, the expression changes of caspase-3 (p < 0.05) and the expression changes of TrkB (p < 0.1) in the cerebellum show a significant increase compared to the controls. The cerebellar gene expression changes seem to occur much faster and stronger compared to the other investigated regions, in particular the cerebral trauma site. These findings could make the cerebellum an important target area to study the expression changes after TBI.	[Staffa, Katharina; Ondruschka, Benjamin; Dressler, Jan] Univ Leipzig, Fac Med, Inst Legal Med, D-04103 Leipzig, Germany; [Franke, Heike] Univ Leipzig, Fac Med, Rudolf Boehm Inst Pharmacol & Toxicol, D-04103 Leipzig, Germany		Dressler, J (corresponding author), Univ Leipzig, Fac Med, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany.	Jan.Dressler@medizin.uni-leipzig.de					Ajtai BM, 1998, BRAIN RES, V802, P285, DOI 10.1016/S0006-8993(98)00622-2; Benisty S, 1998, NEUROSCIENCE, V86, P813, DOI 10.1016/S0306-4522(98)00126-2; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; GOLDBERG WJ, 1987, J NEUROSCI RES, V17, P391, DOI 10.1002/jnr.490170410; HAJOS F, 1989, EXP BRAIN RES, V78, P164; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hausmann R, 2007, INT J LEGAL MED, V121, P175, DOI 10.1007/s00414-006-0122-x; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P311, DOI 10.1016/0169-328X(94)00219-5; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Malhotra S. K., 1990, CYTOBIOS, V61, P246; Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; Nishio T, 2005, NEUROSCIENCE, V132, P87, DOI 10.1016/j.neuroscience.2004.12.028; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Reichenbach A, 2010, BRAIN RES REV, V63, P11, DOI 10.1016/j.brainresrev.2010.02.003; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Siesjo BK, 1996, ADV NEUROL, V71, P209; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Weber M, 2006, NEUROSCIENCE, V138, P1215, DOI 10.1016/j.neuroscience.2005.11.059	31	15	17	0	10	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2716	2721		10.1089/neu.2011.2246			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400013	23030803				2022-02-06	
J	Gazzellini, S; Strazzer, S; Stortini, M; Veredice, C; Beretta, E; Lispi, ML; Petacchi, ME; Menna, M; Cipriani, P; Zampolini, M; Castelli, E				Gazzellini, S.; Strazzer, S.; Stortini, M.; Veredice, C.; Beretta, E.; Lispi, M. L.; Petacchi, M. E.; Menna, M.; Cipriani, P.; Zampolini, M.; Castelli, E.			Pediatric rehabilitation of severe acquired brain injury: a multicenter survey	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Rehabilitation; Neuropsychology; Child	DISABILITY RATING-SCALE; QUALITY-OF-LIFE; HEAD-INJURY; EPIDEMIOLOGY; CHILDREN; PATHOPHYSIOLOGY; OUTCOMES; COMA; AGE	Background. Epidemiological and descriptive data concerning the clinical and socio-demographic characteristics of severe acquired brain injuries (TBI) in pediatric age are meager. In particular, in Italy we only find data concerning traumatic brain injury (TBI) in adults. Earlier data show that the most prevalent etiology in ABI is traumatic and that greater clinical impairments are reported for patients with non-traumatic etiologies. Aim. The main aims of the GISCAR (Gruppo Italiano per lo Studio delle Gravi Cerebrolesioni Acquisite e Riabilitazione) study are: 1) to define the clinical features of pediatric patients with severe neurological disabilities; 2) to determine the etiology and onset modality of the cerebral lesions; and 3) to analyse the characteristics of the rehabilitation processes and patient outcome in terms of disability, strategies for treatment and clinical picture. Design. Quasi-epidemiologic. Setting. In-patient. Population. 184 pediatric patients with severe ABI were recruited. Methods. Data collection was done by means of an assessment protocol created and used by a group of Italian neurorehabilitation centers. Traumatic and non traumatic aetiologies (NTBI) have been treated separately. Results. Traumatic etiology of ABI is the most prevalent (51.6%, N. 95) and about twice as many males as females are involved. Of these cases, 70.5% (N. 67) are the result of a car accident, either as a pedestrian or as a passenger, representing a crucial area for preventive action by the public health services. Eighty-six (46.7%) patients were in the acute state, 19 (10.3%) in subacute state and 76 (42.9%) in chronic condition. The results show that the positive trend for the TBI group was steeper than for NTBIs. Neuropsychological data are also discussed. Conclusions and clinical rehabilitation impact. We report the first Italian descriptive study on pediatric patients affected by ABI of traumatic or non traumatic etiology. The main points concerning rehabilitation are that major differences between aetiologies must be taken into account and that ABI of any severity in the acute phase may lead to long term disability, confirming the high social and economic impact of this pathology. Our study demonstrates the great importance of providing specialised rehabilitation centers for pediatric patients, and increases awareness of the importance of ABI prevention.	[Gazzellini, S.] Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, I-00050 Rome, Italy; [Strazzer, S.; Beretta, E.] La Nostra Famiglia, Eugenio Medea Sci Inst, Bosisio Parini, Lecco, Italy; [Petacchi, M. E.] La Nostra Famiglia, Eugenio Medea Sci Inst, Treviso, Italy; [Menna, M.] Assisi, Ist Seraf, Perugia, Italy; [Cipriani, P.] Stella Maris Sci Inst, Pisa, Italy; [Zampolini, M.] ASL 3 Umbria, Perugia, Italy		Gazzellini, S (corresponding author), Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, Via Torre di Palidoro, I-00050 Rome, Italy.	simone.gazzellini@opbg.net	Strazzer, Sandra/AAH-5712-2019; Beretta, Elena/AAH-5369-2019; veredice, chiara/AAC-5185-2022; Castelli, Enrico/J-1887-2012; Gazzellini, Simone/AAC-2721-2019; Zampolini, Mauro/B-7749-2009	Strazzer, Sandra/0000-0001-8414-6565; Beretta, Elena/0000-0002-8036-7624; Veredice, Chiara/0000-0003-2267-8077			Ashwal S, 2004, NEUROREHABILITATION, V19, P349; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; Baddeley A.D., 1986, WORKING MEMORY; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Boldrini P, 2004, NEUROL SCI, V25, pS255; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V6, P1; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; JENNETT B, 1975, LANCET, V1, P480; Johnson P, 2006, BRAIN COGNITION, V60, P205; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mazaux JM, 2001, J REHABIL MED, V33, P99; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Meyer P, 2006, ARCH PEDIATRIE, V13, P737, DOI 10.1016/j.arcped.2006.03.023; Piras F, 2011, EUR J PHYS REHAB MED, V47, P149; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rickels E, 2009, CHIRURG, V80, P153, DOI 10.1007/s00104-008-1655-y; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sans A, 2009, Rev Neurol, V48 Suppl 2, pS23; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193; Zampolini M, 2003, GIORNALE ITALIANO ME, V17, P15; Zampolini M., 2008, EUR MED PHYS, V44, P1	33	15	15	0	16	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	SEP	2012	48	3					423	431					9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	024EY	WOS:000310093000010	22522434				2022-02-06	
J	Patton, DA; McIntosh, AS; Kleiven, S; Frechede, B				Patton, Declan A.; McIntosh, Andrew S.; Kleiven, Svein; Frechede, Bertrand			Injury data from unhelmeted football head impacts evaluated against critical strain tolerance curves	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Brain injury; concussion; finite element; impact reconstruction; injury tolerance; strain	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; CEREBRAL CONCUSSION; EXPERIMENTAL-MODEL; SPORTS; TISSUE; EPIDEMIOLOGY; RESPONSES; SEVERITY; PLAYERS	Concussion is a prevalent injury in collision and contact sports, but the biomechanics of concussion has mainly been assessed for helmeted head impacts. Concussion and no-injury cases had previously been reconstructed using rigid body simulations from a larger video database of unhelmeted head impact cases from Australian rules football, rugby union and rugby league. The KTH finite element human head model was used to simulate the 27 concussion and 13 no-injury cases, and the maximum principle strain levels in the corpus callosum were evaluated. The rotational kinematics and strain levels were compared to critical strain tolerance curves and reconstructed pedestrian impacts from the literature. It was found that the 5% critical strain tolerance curve equated to a maximum principal strain level of approximately 0.20 and was associated with concussive impacts involving prolonged loss of consciousness. The results suggest rotational kinematics above 4500 rad/s(2) and 33 rad/s for peak resultant angular acceleration and maximum change in resultant angular velocity, respectively, as tentative tolerance levels for concussion involving prolonged loss of consciousness. Cases involving short duration or no loss of consciousness had similar rotational kinematics and strain levels in the corpus callosum, suggesting that these injuries are of similar severity. The findings support the hypothesis that sports concussions share some biomechanical characteristics with diffuse axonal injury.	[Patton, Declan A.; McIntosh, Andrew S.] Univ New S Wales, Fac Sci, Kensington, NSW 2052, Australia; [McIntosh, Andrew S.] Monash Univ, Australian Ctr Res Injury Sport & Prevent, Clayton, Vic 3800, Australia; [Kleiven, Svein] Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Frechede, Bertrand] UCBL IFSTTAR, UMRT9406, LBMC, Paris, France		Patton, DA (corresponding author), Univ New S Wales, Fac Sci, Kensington, NSW 2052, Australia.	declan@unswalumni.com	FRECHEDE, Bertrand/H-3091-2018	FRECHEDE, Bertrand/0000-0002-9292-3544			Ackerman MJ, 1998, P IEEE, V86, P504, DOI 10.1109/5.662875; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Beusenberg, 2001, P INT RES COUNC BIOK, P353; Beusenberg MC., 2000, P INT RES C BIOM IMP; Bottini E, 2000, BRIT J SPORT MED, V34, P94, DOI 10.1136/bjsm.34.2.94; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Cheng HM, 1996, PROCEEDINGS OF THE 1996 FIFTEENTH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE, P251, DOI 10.1109/SBEC.1996.493162; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; GAZZANIGA MS, 1998, COGNITIVE NEUROSCIEN; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; JENNETT B, 1975, LANCET, V1, P480; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2006, SCAND J FORENS SCI, V2, P73; Kleiven S., 2002, THESIS KTH ROYAL I T THESIS KTH ROYAL I T; Kleiven S, 2002, TRAFFIC INJ PREV, V3, P303, DOI DOI 10.1080/15389580214633; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2001, BRIT J SPORT MED, V35, P146, DOI 10.1136/bjsm.35.3.146; McCrory P, 2001, BRIT J SPORT MED; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 1993, 37 STAPP CAR CRASH C, P43; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Neale M, 2004, INT RES COUNC BIOM I; Newman J., 1999, INT RES COUNC BIOM I, P17; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nicolle S, 2005, BIORHEOLOGY, V42, P209; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P278, DOI 10.1097/00006565-200008000-00018; Powell JW, 2001, J ATHL TRAINING, V36, P307; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; RYAN GA, 1995, J NEUROTRAUM, V12, P627, DOI 10.1089/neu.1995.12.627; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Terrell TR, 2004, SOUTH MED J, V97, P837, DOI 10.1097/01.SMJ.0000140091.58338.1E; Thibault L.E., 1990, P INT C BIOM IMP LYO, P191; TNO, 2005, MAD HUM MOD MAN V6 2; Ungerleider LG., 1982, ANAL VISUAL BEHAV; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	67	15	15	1	17	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		177	184		10.1177/1754337112438305			8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000004					2022-02-06	
J	Patzkowski, JC; Blair, JA; Schoenfeld, AJ; Lehman, RA; Hsu, JR				Patzkowski, Jeanne C.; Blair, James A.; Schoenfeld, Andrew J.; Lehman, Ronald A.; Hsu, Joseph R.		Skeletal Trauma Res Consortium STR	Multiple associated injuries are common with spine fractures during war	SPINE JOURNAL			English	Article						Spine trauma; Combat trauma; Associated injuries; Polytrauma	OPERATION ENDURING FREEDOM; IRAQI FREEDOM; TRAUMA; WOUNDS	BACKGROUND CONTEXT: The nature of concomitant injuries associated with spine fractures in American military personnel engaged in Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) has been poorly documented in the literature. PURPOSE: To characterize the incidence and epidemiology of associated injuries (AIs) in American military personnel with spine fractures sustained during OEF and OIF from 2001 to 2009. STUDY DESIGN: Retrospective study. PATIENT SAMPLE: American military personnel who were injured in a combat zone and whose medical data were abstracted in the Joint Theater Trauma Registry (JTTR). OUTCOME MEASURES: Not applicable. METHODS: The JTTR was queried using International Statistical Classification of Disease, Ninth Revision codes to identify all individuals who sustained spine injuries in OEF or OIF from October 2001 to December 2009. Medical records of all identified service members were abstracted to ensure accuracy and avoid duplication. Demographic information, including sex, age, and military rank, were obtained for all patients. Information regarding fracture type, spine region, mechanism of injury, and the presence of AIs was collected for all patients. RESULTS: Seventy-eight percent of patients with a spine fracture sustained at least one AI, with an average of 3.4 AIs per patient. Musculoskeletal injuries were most common, followed by chest, abdomen, and traumatic brain injuries. Most patients were injured by an explosive mechanism (62%). Head and face traumas were more common with cervical fractures, chest with thoracic injuries, and abdominopelvic injuries with lumbosacral fractures. Pelvis and acetabulum fractures were common after helicopter crashes, tibia/fibula injuries after explosions, thoracoabdominal injuries after gunshot wounds, and traumatic brain injuries after falls. Most patients (76%) sustained multiple spine fractures. CONCLUSION: Spine fractures sustained in OEF and OIF have high rates of AIs. Musculoskeletal AIs are the most common, but visceral injuries adjacent to the spine fracture frequently occur. Multiple spine injuries are more prevalent after military trauma. Published by Elsevier Inc.	[Patzkowski, Jeanne C.; Blair, James A.] San Antonio Mil Med Ctr, Dept Orthopaed & Rehabil, Ft Sam Houston, TX 78234 USA; [Schoenfeld, Andrew J.] William Beaumont Army Med Ctr, Dept Orthoped, El Paso, TX 79920 USA; [Lehman, Ronald A.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed & Rehabil, Bethesda, MD 20889 USA; [Hsu, Joseph R.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA		Patzkowski, JC (corresponding author), San Antonio Mil Med Ctr, Dept Orthopaed & Rehabil, 3851 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	jeanne.patzkowski2@amedd.army.mil	Patzkowski, Jeanne/AAO-2102-2020	Schoenfeld, Andrew/0000-0002-3691-1215	DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); DMRDP; Geneva Foundation	JCP: Nothing to disclose. JAB: Nothing to disclose. AJS: Nothing to disclose. RAL: Grants: DARPA (I, Paid directly to institution/employer), DMRDP (H, Paid directly to institution/employer). JRH: Grants: Geneva Foundation (D, Paid direction to institution/employer).	Bagg Mark R, 2006, J Am Acad Orthop Surg, V14, pS7; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Chen Rigao, 2009, Orthopedics, V32, P322; Chu D, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-137; Cross Jessica D, 2011, J Surg Orthop Adv, V20, P56; Cross JD, 2011, J AM ACAD ORTHOP SUR, V19, pS1, DOI 10.5435/00124635-201102001-00002; Hannon M, 2009, J TRAUMA, V67, P1384, DOI 10.1097/TA.0b013e31819ea3e0; Hebert JS, 2000, SPINE, V25, P55, DOI 10.1097/00007632-200001010-00011; Helgeson MD, 2011, SPINE, V36, pE469, DOI 10.1097/BRS.0b013e3182077fd7; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Laurer H, 2007, EUR J TRAUMA EMERG S, V33, P476, DOI 10.1007/s00068-007-7124-3; Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Ragel Brian T, 2009, Spine (Phila Pa 1976), V34, P2400, DOI 10.1097/BRS.0b013e3181b7e585; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; Schoenfeld AJ, 2012, SPINE J, V12, P771, DOI 10.1016/j.spinee.2010.05.004; Vives MJ, 2008, J SPINAL DISORD TECH, V21, P281, DOI 10.1097/BSD.0b013e3181370703	18	15	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430			SPINE J	Spine Journal	SEP	2012	12	9			SI		791	797		10.1016/j.spinee.2011.10.001			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	016OF	WOS:000309527900012	22054909				2022-02-06	
J	Velez-Ruiz, NJ; Klein, JP				Velez-Ruiz, Naymee J.; Klein, Joshua P.			Neuroimaging in the Evaluation of Epilepsy	SEMINARS IN NEUROLOGY			English	Article						epilepsy; hippocampal sclerosis; cortical malformation; brain tumor; cavernous angioma; neurocutaneous disorder; traumatic brain injury	TEMPORAL-LOBE EPILEPSY; FOCAL CORTICAL DYSPLASIA; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; CEREBRAL GLUCOSE-METABOLISM; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL ATROPHY; TUBEROUS SCLEROSIS; SURGICAL-TREATMENT; INTRACRANIAL MENINGIOMAS; CAVERNOUS MALFORMATIONS	Neuroimaging has provided extraordinary insight into the pathologic substrate of epilepsy. The excellent spatial resolution and soft tissue contrast of magnetic resonance imaging (MRI) allows identification of a substantial number of pathologies including hippocampal sclerosis, malformations of cortical development, low grade tumors, and vascular abnormalities, among others. Complementary imaging modalities such as positron emission tomography, single photon emission computed tomography, and magnetoencephalography can be diagnostically helpful as well. Identification of a pathologic substrate is particularly important in patients with medically refractory epilepsy who are undergoing evaluation for surgery, and essential in determining the likelihood of seizure freedom after surgical intervention. This article reviews current and emerging neuroimaging techniques in the field of epilepsy.	[Velez-Ruiz, Naymee J.] Emory Univ Hosp, Dept Neurol, Div Epilepsy, Atlanta, GA 30322 USA; [Velez-Ruiz, Naymee J.] Emory Univ, Sch Med, Atlanta, GA USA; [Klein, Joshua P.] Brigham & Womens Hosp, Dept Neurol, Div Hosp Neurol, Boston, MA 02115 USA; [Klein, Joshua P.] Harvard Univ, Sch Med, Boston, MA USA		Velez-Ruiz, NJ (corresponding author), Emory Clin A, 1365 Clifton Rd, Atlanta, GA 30322 USA.	naymeejeannette@gmail.com					Alberstone CD, 2000, J NEUROSURG, V92, P79, DOI 10.3171/jns.2000.92.1.0079; Andrade CS, 2011, ARQ NEURO-PSIQUIAT, V69, P130, DOI 10.1590/S0004-282X2011000100024; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; AWAD IA, 1993, NEUROSURGERY, V33, P179, DOI 10.1227/00006123-199308000-00001; Bajic D, 2009, EUR RADIOL, V19, P2544, DOI 10.1007/s00330-009-1438-y; Barkovich AJ, 1997, NEUROLOGY, V49, P1148, DOI 10.1212/WNL.49.4.1148; Barkovich AJ, 2004, NEUROIMAG CLIN N AM, V14, P401, DOI 10.1016/j.nic.2004.04.003; Barry E., 2001, TREATMENT EPILEPSY P, P609; Baumann CR, 2006, EPILEPSIA, V47, P563, DOI 10.1111/j.1528-1167.2006.00468.x; Blum DE, 1998, EPILEPSIA, V39, P651, DOI 10.1111/j.1528-1157.1998.tb01434.x; Bruggemann JM, 2009, J CLIN NEUROSCI, V16, P780, DOI 10.1016/j.jocn.2008.08.025; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; CAVANAGH JB, 1956, BRIT MED J, V2, P1403, DOI 10.1136/bmj.2.5006.1403; Chang BS, 2003, EPILEPSY BEHAV, V4, P618, DOI 10.1016/j.yebeh.2003.09.006; Chapman K, 2005, J NEUROL NEUROSUR PS, V76, P710, DOI 10.1136/jnnp.2003.026757; Colombo N, 2003, EPILEPTIC DISORD, V5, pS67; Colombo N, 2003, AM J NEURORADIOL, V24, P724; CONNELLY A, 1994, NEUROLOGY, V44, P1411, DOI 10.1212/WNL.44.8.1411; DAUMASDUPORT C, 1988, NEUROSURGERY, V23, P545, DOI 10.1227/00006123-198811000-00002; Demir MK, 2006, EUR J RADIOL, V60, P48, DOI 10.1016/j.ejrad.2006.06.002; Detre JA, 1998, NEUROLOGY, V50, P926, DOI 10.1212/WNL.50.4.926; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Englot DJ, 2011, J NEUROSURG, V115, P1169, DOI 10.3171/2011.7.JNS11536; Eriksson SH, 2001, BRAIN, V124, P617, DOI 10.1093/brain/124.3.617; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; Foldvary N, 1999, EPILEPSIA, V40, P26, DOI 10.1111/j.1528-1157.1999.tb01984.x; FRANCESCHI M, 1995, J NEUROL NEUROSUR PS, V59, P427, DOI 10.1136/jnnp.59.4.427; Funke ME, 2011, EPILEPSIA, V52, P10, DOI 10.1111/j.1528-1167.2011.03144.x; GAILLARD WD, 1995, EPILEPSY RES, V20, P77, DOI 10.1016/0920-1211(94)00065-5; GARCIA PA, 1995, MAGN RESON IMAGING, V13, P1181, DOI 10.1016/0730-725X(95)02030-W; GASTAUT H, 1976, EPILEPSIA, V17, P337, DOI 10.1111/j.1528-1157.1976.tb03412.x; Ginat DT, 2012, RADIOGRAPHICS, V32, P499, DOI 10.1148/rg.322105761; Golby AJ, 2002, EPILEPSIA, V43, P855, DOI 10.1046/j.1528-1157.2002.20501.x; Griffiths PD, 1996, NEUROPEDIATRICS, V27, P284, DOI 10.1055/s-2007-973796; Gross BA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1165; Grossman RI, 2003, NEURORADIOLOGY REQUI, P231; Grossman RI, 2003, NEURORADIOLOGY REQUI, P243; Grossman RI, 2003, NEURORADIOLOGY REQUI, P98; Guerrini R, 2003, EPILEPTIC DISORD, V5, pS9; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Hakyemez B, 2006, NEURORADIOLOGY, V48, P513, DOI 10.1007/s00234-006-0094-z; Hammen T, 2007, SEIZURE-EUR J EPILEP, V16, P248, DOI 10.1016/j.seizure.2007.01.001; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Henry TR, 2011, RADIOLOGY, V261, P199, DOI 10.1148/radiol.11101651; JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869; Jansen A, 2009, CLIN NEUROL NEUROSUR, V111, P57, DOI 10.1016/j.clineuro.2008.08.005; JOHANNSSON JH, 1981, J NEUROSURG, V54, P58, DOI 10.3171/jns.1981.54.1.0058; Kahlenberg CA, 2012, SEIZURE-EUR J EPILEP, V21, P540, DOI 10.1016/j.seizure.2012.05.014; Kamimura T, 2006, EPILEPSIA, V47, P991, DOI 10.1111/j.1528-1167.2006.00511.x; Kim Sunhee, 2011, Int J Mol Imaging, V2011, P813028, DOI 10.1155/2011/813028; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; KING D, 1995, EPILEPSIA, V36, P905, DOI 10.1111/j.1528-1157.1995.tb01634.x; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Knowlton RC, 2006, ANN NEUROL, V59, P835, DOI 10.1002/ana.20857; KOELLER KK, 1992, AM J NEURORADIOL, V13, P1319; Koh S, 2000, EPILEPSIA, V41, P1206, DOI 10.1111/j.1528-1157.2000.tb00327.x; Kotagal P., 2001, TREATMENT EPILEPSY P, P627; KUZNIECKY R, 1993, ARCH NEUROL-CHICAGO, V50, P65, DOI 10.1001/archneur.1993.00540010059018; LEVESQUE MF, 1991, J NEUROSURG, V75, P364, DOI 10.3171/jns.1991.75.3.0364; Lieu AS, 2000, EPILEPSY RES, V38, P45; Lim CCT, 2005, AM J NEURORADIOL, V26, P61; Lippitz B, 1996, Acta Neurochir Suppl, V65, P108; Madan N, 2009, EPILEPSIA, V50, P9, DOI 10.1111/j.1528-1167.2009.02292.x; MANNO EM, 1994, NEUROLOGY, V44, P2331; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; Mathern GW, 2009, EPILEPSIA, V50, P45, DOI 10.1111/j.1528-1167.2009.02294.x; MCMURDO SK, 1987, AM J ROENTGENOL, V148, P791, DOI 10.2214/ajr.148.4.791; MEINERS LC, 1994, AM J NEURORADIOL, V15, P1547; Morris HH, 2001, TREATMENT EPILEPSIES, P615; Nagar VA, 2008, AM J NEURORADIOL, V29, P1147, DOI 10.3174/ajnr.A0996; OBrien TJ, 1997, EPILEPSIA, V38, P74, DOI 10.1111/j.1528-1157.1997.tb01080.x; Okada YC, 1997, ELECTROEN CLIN NEURO, V103, P474, DOI 10.1016/S0013-4694(97)00043-6; ORMSON MJ, 1986, RADIOLOGY, V160, P215, DOI 10.1148/radiology.160.1.3086931; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; Phi JH, 2010, J NUCL MED, V51, P728, DOI 10.2967/jnumed.109.070920; PRAYSON RA, 1993, EPILEPSIA, V34, P609, DOI 10.1111/j.1528-1157.1993.tb00436.x; Rabin ML, 2004, BRAIN, V127, P2286, DOI 10.1093/brain/awh281; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; RAYMOND AA, 1994, BRAIN, V117, P461, DOI 10.1093/brain/117.3.461; Reinsberger C, 2010, NEUROIMAGE, V52, P1238, DOI 10.1016/j.neuroimage.2010.04.264; Richardson MP, 2006, NEUROLOGY, V66, P699, DOI 10.1212/01.wnl.0000201186.07716.98; Riela A R, 1985, Pediatr Neurol, V1, P85, DOI 10.1016/0887-8994(85)90042-6; Ruggieri PM, 2004, NEUROLOGY, V62, pS27, DOI 10.1212/01.WNL.0000117581.46053.18; SACKELLARES JC, 1990, NEUROLOGY, V40, P1420, DOI 10.1212/WNL.40.9.1420; Sakamoto S, 2003, EPILEPSIA, V44, P1196, DOI 10.1046/j.1528-1157.2003.08603.x; Salamon N, 2008, NEUROLOGY, V71, P1594, DOI 10.1212/01.wnl.0000334752.41807.2f; Salamon N, 2006, BRAIN, V129, P352, DOI 10.1093/brain/awh681; Saloner D, 2010, J NEURO-ONCOL, V99, P333, DOI 10.1007/s11060-010-0367-6; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schwartz ES, 2010, PEDIATR RADIOL, V40, P50, DOI 10.1007/s00247-009-1451-y; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shorvon SD, 2009, EPILEPSIA, V50, P39, DOI 10.1111/j.1528-1167.2009.02038.x; Simos PG, 1999, J NEUROSURG, V91, P787, DOI 10.3171/jns.1999.91.5.0787; Sisodiya SM, 2000, BRAIN, V123, P1075, DOI 10.1093/brain/123.6.1075; Spanaki MV, 1999, J NUCL MED, V40, P730; SPENCER SS, 1994, EPILEPSIA, V35, pS72, DOI 10.1111/j.1528-1157.1994.tb05990.x; SPENCER SS, 1993, NEUROLOGY, V43, P2117, DOI 10.1212/WNL.43.10.2117; Spencer SS, 2001, TREATMENT EPILEPSY P, P1077; Stavrou I, 2008, NEUROSURGERY, V63, P888, DOI 10.1227/01.NEU.0000327881.72964.6E; Stufflebeam SM, 2011, NEUROSURG CLIN N AM, V22, P153, DOI 10.1016/j.nec.2010.11.006; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; SZELIES B, 1983, J COMPUT ASSIST TOMO, V7, P946, DOI 10.1097/00004728-198312000-00002; Tassi L, 2005, BRAIN, V128, P321, DOI 10.1093/brain/awh357; Theodore WH, 1997, EPILEPSIA, V38, P81, DOI 10.1111/j.1528-1157.1997.tb01081.x; Thiele EA, 2010, EPILEPSIA, V51, P90, DOI 10.1111/j.1528-1167.2009.02458.x; Velasco TR, 2011, NEUROSURGERY, V68, P431, DOI 10.1227/NEU.0b013e318201c293; von Oertzen J, 2002, NEUROLOGY, V58, P257, DOI 10.1212/WNL.58.2.257; von Oertzen J, 2002, J NEUROL NEUROSUR PS, V73, P643, DOI 10.1136/jnnp.73.6.643; Wang A, 2012, EPILEPSY RES TREAT, V2012, DOI DOI 10.1155/2012/198183; Wennberg R, 2011, CLIN NEUROPHYSIOL, V122, P1295, DOI 10.1016/j.clinph.2010.11.019; Widdess-Walsh P, 2005, EPILEPSY RES, V67, P25, DOI 10.1016/j.eplepsyres.2005.07.013; Wong CYO, 1996, J NUCL MED, V37, P1094; Woo CLF, 2001, PEDIATR NEUROL, V25, P295, DOI 10.1016/S0887-8994(01)00318-6; Yousem D. M., 2003, NEURORADIOLOGY REQUI; ZENTNER J, 1994, J NEUROL NEUROSUR PS, V57, P1497, DOI 10.1136/jnnp.57.12.1497	118	15	17	0	14	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	SEP	2012	32	4					361	373		10.1055/s-0032-1331809			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	077AD	WOS:000313999400007	23361482	Bronze			2022-02-06	
J	Matsukawa, H; Shinoda, M; Fuji, M; Takahashi, O; Murakata, A; Yamamoto, D; Sumiyoshi, S; Ishikawa, R				Matsukawa, Hidetoshi; Shinoda, Masaki; Fuji, Motoharu; Takahashi, Osamu; Murakata, Atsushi; Yamamoto, Daisuke; Sumiyoshi, Sosuke; Ishikawa, Ryoichi			Intraventricular hemorrhage on computed tomography and corpus callosum injury on magnetic resonance imaging in patients with isolated blunt traumatic brain injury Clinical article	JOURNAL OF NEUROSURGERY			English	Article						blunt traumatic brain injury; corpus callosum; diffuse axonal injury; intraventricular hemorrhage	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; PROGNOSIS; FEATURES; LESIONS	Object. Intraventricular hemorrhage (IVH) is widely regarded as one element of a complex involving severe blunt traumatic brain injury (TBI); corpus callosum injury (CCI) is recently considered to be one factor associated with poor outcome in patients with TBI. Although postmortem studies have focused on the relationship between IVH and CCI, there have been few investigations of IVH evidenced on CT scans as a predictor of CCI evidenced on MRI. Methods. The authors retrospectively reviewed prospectively collected data from 371 patients with blunt TBI, without trauma to the face, chest, abdomen, extremities, or pelvic girdle, requiring immediate therapeutic intervention. Their aim was to investigate whether IVH found on CT predicts CCI on MRI. Clinical and radiological data were collected between June 2003 and February 2011. First, the authors classified patients into groups of those with CCI and those without CCI, and they compared clinical and radiological findings between them. Then, they investigated prognostic factors that were related to the development of disability at 6 months after injury. The outcomes at 6 months after injury were evaluated using the Extended Glasgow Outcome Scale (GOS-E). Finally, the authors evaluated the correlation between the severity of the IVH on CT and the number of CCI lesions on MRI. The severity of the IVH was defined by the number of ventricles in which IVH was seen, and the number of CCI lesions was counted on the MRI study. Results. On multivariate logistic regression analysis, Glasgow Coma Scale score less than 9 (OR 2.70 [95% CI 1.10-6.27]), traffic accident (OR 2.59 [95% CI 1.37-4.93]), and IVH on CT (OR 3.31 [95% CI 1.25-8.49]) were significantly related to CCI. Multivariate analysis also showed that older age (p = 0.0001), male sex (OR 3.26 [95% CI 1.46-8.08], p = 0.0065), Glasgow Coma Scale score less than 9 (OR 8.27 [95% Cl 3.39-21.4], p < 0.0001), evidence of IVH on CT (OR 4.09 [95% CI 1.45-11.9], p = 0.0081), and evidence of CCI on MRI (OR 8.32 [95% CI 3.89-18.8], p < 0.0001) were associated with future development of disability (GOS-E score <= 6). Furthermore, simple regression analysis revealed the existence of a strong correlation between the severity of IVH and the number of CCI lesions (r = 0.0668, p = 0.0022). Conclusions. The authors' results suggest that evidence of IVH on CT may indicate CCI, which can lead to disability in patients with isolated blunt TBI. (http://thejns.org/doi/abs/10.3171/2012.5.JNS112318)	[Matsukawa, Hidetoshi; Shinoda, Masaki; Fuji, Motoharu; Murakata, Atsushi; Yamamoto, Daisuke; Sumiyoshi, Sosuke; Ishikawa, Ryoichi] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Div Gen Internal Med, Dept Med, Chuo Ku, Tokyo 1048560, Japan		Matsukawa, H (corresponding author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mahide@luke.or.jp			General Insurance Association of Japan; Smoking Research Foundation; St. Luke's Life Science Institute Research Grant for Clinical Epidemiology Research	This study was supported by a medical research grant on traffic accidents from The General Insurance Association of Japan (2010), a grant from the Smoking Research Foundation (2011), and St. Luke's Life Science Institute Research Grant for Clinical Epidemiology Research (2011).	Abraszko RA, 1995, BRIT J NEUROSURG, V9, P769, DOI 10.1080/02688699550040747; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; BERRY K, 1994, AM J FOREN MED PATH, V15, P132, DOI 10.1097/00000433-199406000-00008; Caille S, 2005, NEUROSURGERY, V57, P50, DOI 10.1227/01.NEU.0000163089.31657.08; Christie M, 1988, Br J Neurosurg, V2, P343, DOI 10.3109/02688698809001005; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; FRENCH BN, 1977, SURG NEUROL, V7, P171; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Inamasu J, 2001, AM J EMERG MED, V19, P167, DOI 10.1053/ajem.2001.21335; JAYAKUMAR PN, 1990, ACTA NEUROCHIR, V106, P48, DOI 10.1007/BF01809332; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kerr P, 1985, Clin Exp Neurol, V21, P123; KOBAYASHI S, 1985, CHILD NERV SYST, V1, P18, DOI 10.1007/BF00706725; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makino Y, 2004, J NEUROTRAUM, V21, P585, DOI 10.1089/089771504774129919; Matsukawa H, 2011, J NEUROSURG, V115, P1019, DOI 10.3171/2011.6.JNS11513; Matsukawa H, 2011, ACTA NEUROCHIR, V153, P1687, DOI 10.1007/s00701-011-1002-9; Maxeiner H., 2009, Legal Medicine, V11, P278, DOI 10.1016/j.legalmed.2009.08.005; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; OLIFF M, 1978, J COMPUT ASSIST TOMO, V2, P625, DOI 10.1097/00004728-197811000-00020; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; PIEK J, 1986, ACTA NEUROCHIR, V83, P105, DOI 10.1007/BF01402386; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Ryberg C, 2007, NEUROBIOL AGING, V28, P955, DOI 10.1016/j.neurobiolaging.2006.04.008; SATO M, 1987, ACTA NEUROCHIR, V88, P95, DOI 10.1007/BF01404144; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444	40	15	16	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2012	117	2					334	339		10.3171/2012.5.JNS112318			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	978ST	WOS:000306766800026	22702486				2022-02-06	
J	Phelan, HA; Eastman, AL; Madden, CJ; Aldy, K; Berne, JD; Norwood, SH; Scott, WW; Bernstein, IH; Pruitt, J; Butler, G; Rogers, L; Minei, JP				Phelan, Herb A.; Eastman, Alexander L.; Madden, Christopher J.; Aldy, Kim; Berne, John D.; Norwood, Scott H.; Scott, William W.; Bernstein, Ira H.; Pruitt, Jeffrey; Butler, Gordon; Rogers, Lowery; Minei, Joseph P.			TBI risk stratification at presentation: A prospective study of the incidence and timing of radiographic worsening in the Parkland Protocol	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Advanced Technology Applications for Combat Casualty Care Conference (ATACCC)	AUG 15-18, 2011	Fort Lauderdale, FL			Traumatic brain injury; venous thromboembolism; progression; prophylaxis	MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM PROPHYLAXIS; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; ENOXAPARIN PROPHYLAXIS; SAFETY; HEAD	BACKGROUND: We have created a theoretical algorithm for venous thromboembolism prophylaxis after traumatic brain injury (TBI) known as the Parkland Protocol, which stratifies patients into low-, medium-, and high-risk categories for spontaneous progression of hemorrhage. This prospective study characterizes the incidence and timing of radiographic progression of the TBI patterns in these categories. METHODS: Inclusion criterion was presentation with intracranial blood between February 2010 and March 2011; exclusion was receipt of only one computed tomographic scan of the head during the inpatient stay or preinjury warfarin. At admission, all patients were preliminarily categorized per the Parkland Protocol as follows: low risk (LR), patients meeting the modified Berne-Norwood criteria; moderate risk(MR), injuries larger than the modified Berne-Norwood criteria without requiring a neurosurgical procedure; high risk (HR), any patient with a craniotomy/monitor. RESULTS: A total of 245 patients with intracranial hemorrhage were enrolled during the 13-month study period. Of patients preliminarily classified as LR at admission (n = 136), progression was seen in 25.0%. Spontaneous worsening was seen in 7.4% of LR patients at 24 hours after injury, and no LR patients progressed at 72 hours after injury. In patients initially classified as MR at admission (n = 42), progression was seen in 42.9%, with 91.5% of patients demonstrating stable computed tomographic head scans at 72 hours after injury. In patients initially classified as HR (n = 67), 64.2% demonstrated spontaneous progression of their TBI patterns, with 10.5% continuing to progress at 72 hours after injury. Most repeat scans were performed as routinely scheduled studies (81-91%). CONCLUSION: Increases in the incidence of spontaneous worsening were seen as severities of injury progressed from the Parkland Protocol's LR to MR to HR arms. The time frames for these spontaneous worsenings seem to be such that the protocol's theoretical recommendations for venous thromboembolism prophylaxis are worth pursuing as future points of investigation. (J Trauma Acute Care Surg. 2012; 73: S122-S127. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Phelan, Herb A.] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Surg, Div Burns Trauma Crit Care, Dallas, TX 75390 USA; [Madden, Christopher J.; Scott, William W.] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Div Burns Trauma Crit Care & Neurol Surg, Dallas, TX USA; [Berne, John D.] E Texas Med Ctr, Dept Surg, Tyler, TX USA; [Norwood, Scott H.] Univ S Florida, Med Ctr, Dept Surg, Hudson, FL USA; [Bernstein, Ira H.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci Biostat, Dallas, TX USA; [Pruitt, Jeffrey; Butler, Gordon; Rogers, Lowery] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX USA		Phelan, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Surg, Div Burns Trauma Crit Care, 5323 Harry Hines Blvd,E5-508A, Dallas, TX 75390 USA.	herb.phelan@utsouthwestern.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024983] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 KL2 RR024983-01] Funding Source: Medline		Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Depew AJ, 2008, AM SURGEON, V74, P906; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d	13	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73			1			S122	S127		10.1097/TA.0b013e3182606327			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	992VP	WOS:000307808500022	22847081				2022-02-06	
J	Pickham, DM; Callcut, RA; Maggio, PM; Mell, MW; Spain, DA; Bech, F; Staudenmayer, K				Pickham, Danielle M.; Callcut, Rachael A.; Maggio, Paul M.; Mell, Matthew W.; Spain, David A.; Bech, Fritz; Staudenmayer, Kristan			Payer status is associated with the use of prophylactic inferior vena cava filter in high-risk trauma patients	SURGERY			English	Article							VENOUS THROMBOEMBOLISM; INSURANCE STATUS; PREVENTION	Background. It is controversial whether patients at high risk for pulmonary embolism (PE) should receive prophylactic inferior vena cava filters (IVC) filters. This lack of clarity creates the potential for variability and disparities in care. We hypothesized there would be differential use of prophylactic IVC filters for patients at high risk for PE on the basis of insurance status. Methods. We performed a retrospective analysis using the National Trauma Databank (2002-2007). We included adult patients at high risk for PE (traumatic brain injury or spinal cord injury) and excluded patients with a diagnosis of deep venous thrombosis (DVT) or PE. Logistic regression was performed to control for confounders and a hierarchical mixed effects model was used to control for center. Results. A prophylactic filter was placed in 3,331 (4.3%) patients in the study cohort. Patients without insurance had an IVC filter placed less often compared with those with any form of insurance (2.7% vs 4.9%, respectively). After adjusting for confounders, we found that patients without insurance were less likely to receive a prophylactic IVC filter even when we controlled for center (OR 5.3, P < .001). Conclusion. When guidelines lack clarity, unconscious bias has the potential to create a system with different levels of care based on socioeconomic disparities. (Surgery 2012;152:232-7.)	[Pickham, Danielle M.; Callcut, Rachael A.; Maggio, Paul M.; Mell, Matthew W.; Spain, David A.; Bech, Fritz; Staudenmayer, Kristan] Stanford Univ Hosp, Dept Surg, Stanford, CA 94305 USA		Staudenmayer, K (corresponding author), Stanford Univ, Dept Surg, 300 Pasteur Dr,Grant Bldg S-067, Stanford, CA 94305 USA.	kristans@stanford.edu	Callcut, Rachael/ABE-1484-2021				Bhalotra Sarita, 2007, J Natl Black Nurses Assoc, V18, P36; CHANG HJ, 1990, ARCH INTERN MED, V150, P83, DOI 10.1001/archinte.150.1.83; Dossett LA, 2011, J TRAUMA, V70, P1066, DOI 10.1097/TA.0b013e31821282d5; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Goodman DC, 2009, PEDIATR CLIN N AM, V56, P745, DOI 10.1016/j.pcl.2009.05.007; Gundle KR, 2010, J BONE JOINT SURG AM, V92A, P2452, DOI 10.2106/JBJS.I.01369; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Nasr DM, 2011, J STROKE CEREBROVASC; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 1998, ARCH SURG-CHICAGO, V133, P406, DOI 10.1001/archsurg.133.4.406; Shackford SR, 2007, J TRAUMA, V63, P764, DOI 10.1097/01.ta.0000240444.14664.5f; Stiefel Matt, 2008, Perm J, V12, P4; Trinh QD, 2012, CANCER-AM CANCER SOC, V118, P1894, DOI 10.1002/cncr.26527; Velmahos GC, 2000, J TRAUMA, V49, P140, DOI 10.1097/00005373-200007000-00021	14	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2012	152	2					232	237		10.1016/j.surg.2012.05.041			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	983ZP	WOS:000307157500013	22828145				2022-02-06	
J	Wilde, AM; Nailor, MD; Nicolau, DP; Kuti, JL				Wilde, Ashley M.; Nailor, Michael D.; Nicolau, David P.; Kuti, Joseph L.			Inappropriate Antibiotic Use Due to Decreased Compliance with a Ventilator-Associated Pneumonia Computerized Clinical Pathway: Implications for Continuing Education and Prospective Feedback	PHARMACOTHERAPY			English	Article						antimicrobial stewardship; ventilator-associated pneumonia; appropriate antibiotic therapy	INTENSIVE-CARE-UNIT; THERAPY; GUIDELINES; MANAGEMENT; IMPACT; METAANALYSIS; STEWARDSHIP; INFECTION; BACTERIA; OUTCOMES	Study Objective To assess the impact of noncompliance with a ventilator-associated pneumonia (VAP) computerized clinical pathway (CCP) on antibiotic use after removal of prospective antibiotic stewardship resources. Design Retrospective, observational, quasi-experimental study. Setting Three intensive care units (medical, surgical, and neurotrauma) in a large, tertiary care hospital. Patients A total of 136 patients with culture-positive VAP; 72 were treated from September 2006August 2007 (period 1), during which use of the CCP was mandatory along with aggressive stewardship support, and 64 were treated from September 2009April 2010 (period 2), during which use of the CCP was voluntary. Measurements and Main Results Compliance with use of the CCP was 100% during period 1 and 44% (28/64 patients) during period 2. For the 36 patients (56%) whose antibiotic selection did not comply with the CCP, empiric antibiotics were selected by provider discretion. Most patients had late-onset VAP and were similar with respect to age, sex, and comorbidities between the two periods. Staphylococcus aureus (1117% methicillin-resistant S. aureus) and Pseudomonas aeruginosa were the most common pathogens during both periods. The proportion of patients with appropriate antibiotics within 24 hours of VAP identification was not significantly different between period 1 (70.8%) and period 2 (56.3%, p=0.112). During period 2, patients who were treated according to the CCP were more likely to receive appropriate antibiotic therapy compared with patients treated according to provider discretion (82.1% vs 36.1%, p=0.001). Time to appropriate therapy was also shorter for patients treated according to the CCP (mean +/- SD 0.43 +/- 1.14 vs 1.29 +/- 1.36 days, p=0.003). Treatment with the CCP was the only variable significantly associated with appropriate antibiotic therapy (odds ratio 4.8, 95% confidence interval 2.110.9). Mortality was not significantly different between period 1 and period 2, and only Acute Physiology and Chronic Health Evaluation II score and admission with a head injury were predictive of death. Finally, a greater proportion of patients treated with the CCP were de-escalated from anti- Pseudomonas beta-lactams (85.0% vs 33.3%, p=0.006) when they were not necessary. Conclusion These data highlight the importance of continued stewardship resources after CCP implementation to ensure compliance and to maximize antibiotic stewardship outcomes.	[Nicolau, David P.; Kuti, Joseph L.] Hartford Hosp, Ctr Antiinfect Res & Dev, Hartford, CT 06102 USA; [Wilde, Ashley M.; Nailor, Michael D.] Univ Connecticut, Sch Pharm, Storrs, CT USA		Kuti, JL (corresponding author), Hartford Hosp, Ctr Antiinfect Res & Dev, 80 Seymour St, Hartford, CT 06102 USA.	jkuti@harthosp.org			Center for Anti-Infective Research and Development	Supported internally by the Center for Anti-Infective Research and Development.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arnold HM, 2011, SEMIN RESP CRIT CARE, V32, P215, DOI 10.1055/s-0031-1275534; Beardsley JR, 2006, CHEST, V130, P787, DOI 10.1378/chest.130.3.787; Carter BL, 2010, PHARMACOTHERAPY, V30, P228, DOI 10.1592/phco.30.3.228; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Dellit TH, 2008, INFECT CONT HOSP EP, V29, P525, DOI 10.1086/588160; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Eachempati SR, 2009, J TRAUMA, V66, P1343, DOI 10.1097/TA.0b013e31819dca4e; Garcin F, 2010, INTENS CARE MED, V36, P75, DOI 10.1007/s00134-009-1660-8; Green David L, 2005, J Intensive Care Med, V20, P296, DOI 10.1177/0885066605278650; Gums JG, 2010, PHARMACOTHERAPY, V30, P221, DOI 10.1592/phco.30.3.221; Ibrahim EH, 2001, CRIT CARE MED, V29, P1109, DOI 10.1097/00003246-200106000-00003; Kuti EL, 2008, J CRIT CARE, V23, P91, DOI 10.1016/j.jcrc.2007.08.007; Kuti JL, 2009, SEMIN RESP CRIT CARE, V30, P102, DOI 10.1055/s-0028-1119814; Bassi GL, 2010, CURR OPIN INFECT DIS, V23, P171, DOI 10.1097/QCO.0b013e328337241a; Nicasio AM, 2010, PHARMACOTHERAPY, V30, P453, DOI 10.1592/phco.30.5.453; Nicasio AM, 2010, J CRIT CARE, V25, P69, DOI 10.1016/j.jcrc.2009.02.014; Niederman MS, 2010, CLIN INFECT DIS, V51, pS93, DOI 10.1086/653055; Rello J, 2011, EUR RESPIR J, V37, P1332, DOI 10.1183/09031936.00093010; Shorr AF, 2005, CRIT CARE MED, V33, P46, DOI 10.1097/01.CCM.0000149852.32599.31; Thiel SW, 2009, CRIT CARE MED, V37, P819, DOI 10.1097/CCM.0b013e318196206b; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yong MK, 2010, J ANTIMICROB CHEMOTH, V65, P1062, DOI 10.1093/jac/dkq058	23	15	16	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008			PHARMACOTHERAPY	Pharmacotherapy	AUG	2012	32	8			SI		755	763		10.1002/j.1875-9114.2012.01161.x			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	982CM	WOS:000307019300010	23307523				2022-02-06	
J	Carney, N; Lujan, S; Dikmen, S; Temkin, N; Petroni, G; Pridgeon, J; Barber, J; Machamer, J; Cherner, M; Chaddock, K; Hendrix, T; Rondina, C; Videtta, W; Celix, JM; Chesnut, R				Carney, Nancy; Lujan, Silvia; Dikmen, Sureyya; Temkin, Nancy; Petroni, Gustavo; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Cherner, Mariana; Chaddock, Kelley; Hendrix, Terence; Rondina, Carlos; Videtta, Walter; Celix, Juanita M.; Chesnut, Randall			Intracranial Pressure Monitoring in Severe Traumatic Brain Injury in Latin America: Process and Methods for a Multi-Center Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						international; intracranial pressure monitoring; randomized controlled trial; traumatic brain injury	FLUENCY; MEMORY; SCALE; NORMS	In patients with severe traumatic brain injury (TBI), the influence on important outcomes of the use of information from intracranial pressure (ICP) monitoring to direct treatment has never been tested in a randomized controlled trial (RCT). We are conducting an RCT in six trauma centers in Latin America to test this question. We hypothesize that patients randomized to ICP monitoring will have lower mortality and better outcomes at 6-months post-trauma than patients treated without ICP monitoring. We selected three centers in Bolivia to participate in the trial, based on (1) the absence of ICP monitoring, (2) adequate patient accession and data collection during the pilot phase, (3) preliminary institutional review board approval, and (4) the presence of equipoise about the value of ICP monitoring. We conducted extensive training of site personnel, and initiated the trial on September 1, 2008. Subsequently, we included three additional centers. A total of 176 patients were entered into the trial as of August 31, 2010. Current enrollment is 81% of that expected. The trial is expected to reach its enrollment goal of 324 patients by September of 2011. We are conducting a high-quality RCT to answer a question that is important globally. In addition, we are establishing the capacity to conduct strong research in Latin America, where TBI is a serious epidemic. Finally, we are demonstrating the feasibility and utility of international collaborations that share resources and unique patient populations to conduct strong research about global public health concerns.	[Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Lujan, Silvia; Petroni, Gustavo; Rondina, Carlos] Hosp Emergencias, Rosario, Santa Fe, Argentina; [Dikmen, Sureyya; Temkin, Nancy; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Chaddock, Kelley; Celix, Juanita M.; Chesnut, Randall] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Cherner, Mariana; Hendrix, Terence] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina		Carney, N (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	carneyn@ohsu.edu	cherner, mariana/N-4810-2015	cherner, mariana/0000-0002-5479-7401; Chesnut, Randall/0000-0001-6377-3666	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDS through the Brain Disorders in the Developing World: Research Across the Lifespan program [R01 NS058302]; Integra Life-Sciences; InnerSpace; Integra LifeSciences-Duraplasty histology study; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058302] Funding Source: NIH RePORTER	This project was funded by the NIH and NINDS through the Brain Disorders in the Developing World: Research Across the Lifespan program, grant no. R01 NS058302 for Traumatic Brain Injury in Latin America: Lifespan Analysis.; Randy Chesnut has these consultant fees: Integra Life-Sciences $5000, InnerSpace $2000; grant from the Integra LifeSciences-Duraplasty histology study, amount in discussion. No competing financial interests exist for the remaining authors.	Benedict R., 1997, BRIEF VISUOSPATIAL M; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Chesnut R M, 1995, New Horiz, V3, P581; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Heaton R. K., 2004, REVISED COMPREHENSIV; Klove H., 1963, GROOVED PEGBOARD; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pardee R. E, 1999, MANUAL NORMAS PROCED; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson, 1993, HALSTEAD REITAN NEUR; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460	24	15	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	11					2022	2029		10.1089/neu.2011.2019			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	983CX	WOS:000307095800003	22435793	Green Published			2022-02-06	
J	Jourdan, C; Brugel, D; Hubeaux, K; Toure, H; Laurent-Vannier, A; Chevignard, M				Jourdan, Claire; Brugel, Dominique; Hubeaux, Katelyne; Toure, Hanna; Laurent-Vannier, Anne; Chevignard, Mathilde			Weight gain after childhood traumatic brain injury: a matter of concern	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							PITUITARY-FUNCTION; FOOD-INTAKE; OBESITY; CRANIOPHARYNGIOMA; HYPOPITUITARISM; CHILDREN	Aim The aim of the study was to assess weight changes after traumatic brain injury (TBI) in children and the factors influencing them. Method We conducted a longitudinal observational study of children with TBI of mixed severity who were consecutively admitted to one rehabilitation department (39 children; 23 males, 16 females; median age 8y 7mo; 25th to 75th centiles 3y 7mo11y 6mo). Weight and height before TBI were obtained from the childrens records and were measured monthly for 1 year after TBI. Body mass index (BMI) and BMI z-scores were calculated, and pre-TBI values were compared with the final values using paired tests. Linear mixed-effect interaction models were used to assess the effect of various factors on z-score evolution. Results Z-score curves revealed early weight loss followed by a rapid increase in weight. The mean BMI gain over the period under study was 0.9kg/m(2) (p < 0.001) and the mean z-score gain was 0.4 (p = 0.006). Six children had become overweight by the time of final assessment. Factors associated with a greater rate of increase in the post-TBI z-score were mobility restriction, male sex, and older age. Global pre- to post-TBI weight gain was significantly higher in males (z-score 0.7). Pituitary hormonal testing was available for 17 children at 3 months and for 27 at 1 year. Growth hormone deficiency was detected in one child. Interpretation Weight gain of children during the first year after TBI was rapid and excessive. Male sex was a risk factor for excessive weight gain.	[Jourdan, Claire] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Dept Phys Med & Rehabil, F-92380 Garches, France; [Jourdan, Claire] Univ Versailles St Quentin, UFR Med, Guyancourt, France; [Brugel, Dominique; Toure, Hanna; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Neurol Injuries, St Maurice, France; [Hubeaux, Katelyne] Hop Morvan, Dept Phys Med & Rehabil, Brest, France		Jourdan, C (corresponding author), Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France.	claire.jourdan@rpc.aphp.fr					Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; Ahmet A, 2006, J PEDIATR ENDOCR MET, V19, P121; [Anonymous], 2002, REC HAUT AUT SANT PR; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dolberg OT, 2005, PSYCHOPHARMACOLOGY, V179, P838, DOI 10.1007/s00213-004-2117-y; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hamchaoui S, 2010, CLIN NUTR, V5, P58; Harz KJ, 2003, J CLIN ENDOCR METAB, V88, P5227, DOI 10.1210/jc.2002-021797; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lek N, 2009, ARCH DIS CHILD, V94, P702, DOI 10.1136/adc.2008.147165; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lustig RH, 2001, PEDIATR CLIN N AM, V48, P909, DOI 10.1016/S0031-3955(05)70348-5; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Muller HL, 2001, KLIN PADIATR, V213, P244, DOI 10.1055/s-2001-16855; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Patradoon-Ho P, 2005, Pediatr Rehabil, V8, P303, DOI 10.1080/13638490500049578; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Sharples PM, 1998, INJURY YOUNG, P151; WHO, 2009, ANTHROPLUS PERS COMP	28	15	15	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JUL	2012	54	7					624	628		10.1111/j.1469-8749.2012.04291.x			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	958KK	WOS:000305235200015	22524689				2022-02-06	
J	Luo, JM; Liu, B; Xie, ZY; Ding, S; Zhuang, ZR; Lin, L; Guo, YC; Chen, H; Yu, XJ				Luo, JianMing; Liu, Bin; Xie, ZeYu; Ding, Shan; Zhuang, ZeRui; Lin, Lan; Guo, YanChun; Chen, Hui; Yu, Xiaojun			Comparison of manually shaped and computer-shaped titanium mesh for repairing large frontotemporoparietal skull defects after traumatic brain injury	NEUROSURGICAL FOCUS			English	Article						cranioplasty; titanium mesh; skull defect; frontotemporoparietal	CRANIOPLASTY; RECONSTRUCTION; IMPLANTS	Object. The object of this study was to compare the effects and complications of manual and computer-aided shaping of titanium meshes for repairing large frontotemporoparietal skull defects following traumatic brain injury. Methods. From March 2005 to June 2011, 161 patients with frontotemporoparietal skull defects were observed. Patients were divided into 2 groups according to the repair materials used for cranioplasty: 83 cases used computer-aided shaping for the titanium mesh, whereas the remaining 78 cases used a manually shaped titanium mesh. The advantages and disadvantages of the 2 methods were compared. Results. No case of titanium mesh loosening occurred in either group. Subcutaneous fluid collection, titanium mesh tilt, and temporal muscle pain were the most common complications. In the manually shaped group, there were 14 cases of effusion, 10 cases of titanium mesh tilt, and 15 cases of temporal muscle pain. In the computer-aided group, there were 6 cases of effusion, 3 cases of titanium mesh tilt, and 6 cases of temporal muscle pain. The differences were significant between the 2 groups (p < 0.05). Other common complications were scalp infection, exposure of titanium mesh, epidural hematoma, and seizures. In the computer-aided group, the operative time decreased (p < 0.01), the number of screws used was reduced (p < 0.01), and the satisfaction of patients was significantly increased (p < 0.05). Conclusions. Computer-aided shaping of titanium mesh for repairing large frontotemporoparietal skull defects decreases postoperative complications and the operative duration, reduces the number of screws used, increases the satisfaction of patients, and restores the appearance of the patient's head, making it an ideal choice for cranioplasty. (http://thejns.org/doi/abs/10.3171/2012.2.FOCUS129)	[Yu, Xiaojun] Shantou Univ Med Coll, Dept Forens Med, Shantou City 515031, Guangdong, Peoples R China; [Luo, JianMing; Liu, Bin; Xie, ZeYu; Ding, Shan; Zhuang, ZeRui; Lin, Lan; Guo, YanChun; Chen, Hui] Shantou Univ Med Coll, Affiliated Hosp 2, Dept Neurosurg, Shantou City 515031, Guangdong, Peoples R China		Yu, XJ (corresponding author), Shantou Univ Med Coll, Dept Forens Med, Xinling Rd 22, Shantou City 515031, Guangdong, Peoples R China.	cnxjyu@yahoo.com.cn			National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458]	This work was supported by a grant from the National Natural Science Foundation Council of China (no. 30772458).	BLAIR GAS, 1976, BRIT MED J, V2, P907, DOI 10.1136/bmj.2.6041.907; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Chiarini L, 2004, J CRANIO MAXILL SURG, V32, P5, DOI 10.1016/j.jcms.2003.08.005; D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Durand J L, 1997, Ann Chir Plast Esthet, V42, P75; EUFINGER H, 1995, INT J ORAL MAX SURG, V24, P104, DOI 10.1016/S0901-5027(05)80870-7; GLADSTONE HB, 1995, OTOLARYNG CLIN N AM, V28, P381; GORDON DS, 1974, BRIT MED J, V2, P478, DOI 10.1136/bmj.2.5917.478; Heissler E, 1998, INT J ORAL MAX SURG, V27, P334, DOI 10.1016/S0901-5027(98)80060-X; Joffe JM, 1999, INT J ORAL MAX SURG, V28, P309; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Pou Anna M, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P240, DOI 10.1097/00020840-200308000-00004; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026	17	15	17	0	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUL	2012	33	1							E13	10.3171/2012.2.FOCUS129			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	968PX	WOS:000305997400014	22746230				2022-02-06	
J	Waljas, M; Iverson, GL; Hartikainen, KM; Liimatainen, S; Dastidar, P; Soimakallio, S; Jehkonen, M; Ohman, J				Waljas, Minna; Iverson, Grant L.; Hartikainen, Kaisa M.; Liimatainen, Suvi; Dastidar, Prasun; Soimakallio, Seppo; Jehkonen, Mervi; Ohman, Juha			Reliability, validity and clinical usefulness of the BNI fatigue scale in mild traumatic brain injury	BRAIN INJURY			English	Article						Fatigue; measurement; mild traumatic brain injury	HEAD-INJURY; DEPRESSION; SYMPTOMS; IMPACT; VALIDATION; COMPLAINTS; RECOVERY	Objectives: The purpose of this study was to examine the reliability, validity and clinical usefulness of the Barrow Neurological Institute Fatigue Scale (BNI-FS) in patients with mild traumatic brain injuries (MTBI). Methods and procedure: Participants were 125 patients enrolled from the Emergency Department (ED) of Tampere University Hospital, Finland who had sustained an MTBI. The average number of days from injury to the interview and questionnaires was 24.1 (SD = 5.4, Range = 8-38). The patients were compared to a healthy control sample. Patients completed the Barrow Neurological Institute Fatigue Scale, Fatigue Impact Scale (FIS), Beck Depression Inventory-Second Edition (BDI-II), Rivermead Post-concussion Symptom Questionnaire (RPSQ) and the health assessment measure EuroQol five Dimension (EQ-5D) Visual Analogue Scale (VAS). Results: The MTBI group had significantly greater total scores on the BNI-FS than the control group (p < 0.005, Cohen's d = 0.40). The internal consistency reliability for the BNI-FS, as measured by Cronbach's alpha, was 0.96 for the MTBI group and 0.87 for the control group. The 10 items were submitted to an exploratory principal components factor analysis with varimax rotation in the MTBI group. A one-factor solution, accounting for 73.3% of the total variance, appropriately summarized the data. The correlation between the BNI-FS and other measures was rs = 0.68 (p < 0.001) for the BDI-II, rs = 0.68 (p < 0.001) for the RPSQ, rs = -0.39 (p < 0.001) for the EQ-5D VAS and rs = 0.84 (p < 0.001) for the FIS. Fatigue ratings correlated positively with number of days post-injury before returning to work (rs = 0.27, p < 0.006). Conclusion: The BNI-FS is a relatively new, brief and highly reliable measure of fatigue.	[Waljas, Minna; Ohman, Juha] Tampere Univ Hosp, Dept Neurosurg, FIN-33521 Tampere, Finland; [Waljas, Minna; Hartikainen, Kaisa M.; Dastidar, Prasun; Soimakallio, Seppo; Ohman, Juha] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hartikainen, Kaisa M.; Liimatainen, Suvi] Tampere Univ Hosp, Dept Neurosci & Rehabil, FIN-33521 Tampere, Finland; [Liimatainen, Suvi] Tampere Univ Hosp, Emergency Dept Acuta, FIN-33521 Tampere, Finland; [Dastidar, Prasun; Soimakallio, Seppo] Pirkanmaa Hosp Dist, Med Imaging Ctr, Tampere, Finland; [Jehkonen, Mervi] Univ Tampere, Dept Psychol, FIN-33101 Tampere, Finland		Waljas, M (corresponding author), Tampere Univ Hosp, Dept Neurosurg, POB 2000, FIN-33521 Tampere, Finland.	minna.waljas@pshp.fi	Jehkonen, Mervi/AAI-4596-2020	Iverson, Grant/0000-0001-7348-9570; Hartikainen, Kaisa/0000-0001-7278-9635; Ohman, Juha/0000-0002-6592-1367			Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Chwastiak LA, 2005, J PSYCHOSOM RES, V59, P291, DOI 10.1016/j.jpsychores.2005.06.001; Elovic EP, 2005, ISS CLIN COGN NEUROP, P89; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fisk JD, 2002, QUAL LIFE RES, V11, P263, DOI 10.1023/A:1015295106602; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	31	15	15	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					972	978		10.3109/02699052.2012.660511			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100008	22571230				2022-02-06	
J	Yang, RH; Wang, F; Hou, XH; Cao, ZP; Wang, B; Xu, XN; Hu, SJ				Yang, R. -H.; Wang, F.; Hou, X. -H.; Cao, Z. -P.; Wang, B.; Xu, X. -N.; Hu, S. -J.			DIETARY OMEGA-3 POLYUNSATURATED FATTY ACIDS IMPROVES LEARNING PERFORMANCE OF DIABETIC RATS BY REGULATING THE NEURON EXCITABILITY	NEUROSCIENCE			English	Article						fish oil; diabetes; learning and memory; hippocampal pyramidal neuron; excitability; potassium currents	HIPPOCAMPAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; POTASSIUM CHANNELS; DIFFERENTIAL EXPRESSION; MEMBRANE EXCITABILITY; ALZHEIMERS-DISEASE; DECLARATIVE MEMORY	Previous research has demonstrated that diabetes induced learning and memory deficits. However, the mechanism of memory impairment induced by diabetes is poorly understood. Dietary fatty acids, especially polyunsaturated fatty acids (PUFA), have been shown to enhance learning and memory and prevent memory deficits in various experimental conditions. Sprague-Dawley rats were used in the present study to investigate the effect of fish oil supplementation on spatial learning and memory of streptozotocin (STZ)-induced diabetic rats with the Morris Water Maze. The excitability of CA1 pyramidal neurons and the related ionic currents was also examined. Diabetes impaired spatial learning and memory of rats. Diabetes decreased the sodium currents and increased the potassium currents, and further led to the reduction of excitability of CA1 pyramidal neurons, effects which may contribute to the behavioral deficits. Fish oil dietary supplementation decreased the transient currents and Kv4.2 expression in the hippocampus and partially improved learning performance of diabetic rats. The results of the present study suggested that sodium and potassium currents contributed to the inhibitory effect of diabetes on neuron excitability, further influencing learning and memory processing. Dietary fish oil may modulate the membrane excitability and is a possible strategy for preventing the impairments of diabetes on hippocampal function. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Yang, R. -H.; Wang, F.; Hou, X. -H.; Cao, Z. -P.; Wang, B.; Xu, X. -N.] Fourth Mil Med Univ, Dept Nutr & Food Hyg, Minist Educ,Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China; [Hu, S. -J.] Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China		Yang, RH (corresponding author), Fourth Mil Med Univ, Dept Nutr & Food Hyg, Minist Educ,Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China.	fmmur.young@gmail.com; sjhu@fmmu.edu.cn			Program for Changjiang Scholars and Innovative Research Team in the University (PCSIRT)Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT); Science and Technology Program of Shaanxi Province [2011JM4002]	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in the University (PCSIRT). This work was supported by the Science and Technology Program of Shaanxi Province [2011JM4002].	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Azouz R, 1999, J NEUROSCI, V19, P2209; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Baldi E, 2005, NEUROSCI LETT, V378, P176, DOI 10.1016/j.neulet.2004.12.029; Baydas G, 2003, LIFE SCI, V73, P1907, DOI 10.1016/S0024-3205(03)00561-7; Biessels Geert Jan, 2007, Prim Care Diabetes, V1, P187, DOI 10.1016/j.pcd.2007.10.002; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Brismar T, 2007, PSYCHONEUROENDOCRINO, V32, P1041, DOI 10.1016/j.psyneuen.2007.08.002; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Candy SM, 2000, BRAIN RES, V863, P298, DOI 10.1016/S0006-8993(00)02171-5; Candy SM, 2000, NEUROSCI LETT, V279, P105, DOI 10.1016/S0304-3940(99)00954-4; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Conquer JA, 2000, LIPIDS, V35, P1305, DOI 10.1007/s11745-000-0646-3; CRAWFORD SG, 1995, HEREDITAS, V122, P73, DOI 10.1111/j.1601-5223.1995.00073.x; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1999, BEHAV BRAIN RES, V103, P123, DOI 10.1016/S0166-4328(99)00044-3; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giese KP, 1998, LEARN MEMORY, V5, P257; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hasanein P, 2010, NEUROBIOL LEARN MEM, V93, P472, DOI 10.1016/j.nlm.2010.01.004; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Heng LJ, 2011, BEHAV BRAIN RES, V224, P250, DOI 10.1016/j.bbr.2011.05.043; Hu Yuan-yuan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1336; Izumi Y, 2003, DIABETOLOGIA, V46, P1007, DOI 10.1007/s00125-003-1144-2; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Kawashima A, 2010, J NUTR BIOCHEM, V21, P268, DOI 10.1016/j.jnutbio.2008.12.015; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; McCarthy AM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e9; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; Northam EA, 2006, NAT CLIN PRACT NEURO, V2, P78, DOI 10.1038/ncpneuro0097; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Seo S, 2011, NEUROSCIENCE, V192, P28, DOI 10.1016/j.neuroscience.2011.07.007; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Tiwari V, 2009, PHARMACOL BIOCHEM BE, V93, P183, DOI 10.1016/j.pbb.2009.05.009; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Veigas JM, 2011, PHARMACOL RES, V63, P377, DOI 10.1016/j.phrs.2011.02.004; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Yang JJ, 2010, TOXICOL IN VITRO, V24, P397, DOI 10.1016/j.tiv.2009.10.019; Yang RH, 2008, BRAIN RES, V1230, P224, DOI 10.1016/j.brainres.2008.07.033; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Younga GS, 2005, REPROD NUTR DEV, V45, P549, DOI 10.1051/rnd:2005045	52	15	17	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 14	2012	212						93	103		10.1016/j.neuroscience.2012.04.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	962NB	WOS:000305550700009	22516014				2022-02-06	
J	Ashwell, Z; Mckay, MP; Brubacher, JR; Gareau, A				Ashwell, Zachary; Mckay, Mary Pat; Brubacher, Jeffery R.; Gareau, Annie			The Epidemiology of Mountain Bike Park Injuries at the Whistler Bike Park, British Columbia (BC), Canada	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						mountain biking; epidemiology; injury	BIKING INJURIES	Objective.-To describe the epidemiology of injuries sustained during the 2009 season at Whistler Mountain Bike Park. Methods.-A retrospective chart review was performed of injured bike park cyclists presenting to the Whistler Health Clinic between May 16 and October 12, 2009. Results.-Of 898 cases, 86% were male (median age, 26 years), 68.7% were Canadian, 19.4% required transport by the Whistler Bike Patrol, and 8.4% arrived by emergency medical services. Identification of 1759 specific injury diagnoses was made, including 420 fractures in 382 patients (42.5%). Upper extremity fractures predominated (75.4%), 11.2% had a traumatic brain injury, and 8.5% were transferred to a higher level of care: 7 by helicopter, 62 by ground, and 5 by personal vehicle. Two patients refused transfer. Conclusions.-Mountain bikers incurred many injuries with significant morbidity while riding in the Whistler Mountain Bike Park in 2009. Although exposure information is unavailable, these findings demonstrate serious risks associated with this sport and highlight the need for continued research into appropriate safety equipment and risk avoidance measures.	[Ashwell, Zachary] George Washington Univ, Sch Med, Washington, DC USA; [Mckay, Mary Pat] George Washington Univ, Dept Emergency Med, Washington, DC USA; [Brubacher, Jeffery R.] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Gareau, Annie] Whistler Hlth Care Ctr, Whistler, BC, Canada		Mckay, MP (corresponding author), 2150 Pennsylvania Ave,Suite 2B, Washington, DC 20037 USA.	mpmckay@gmail.com		Brubacher, Jeffrey/0000-0002-4866-4231			[Anonymous], AL BIK; Bullard MJ, 2008, CAN J EMERG MED, V10, P136; Carmont MR, 2008, BRIT MED BULL, V85, P101, DOI 10.1093/bmb/ldn009; CHOW TK, 1993, WESTERN J MED, V159, P145; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Deer Valley expanded biking and hiking trail access now open, SKI CHANNEL NEWS; Dodwell ER, 2010, AM J SPORT MED, V38, P1647, DOI 10.1177/0363546510365532; Kim PTW, 2006, J TRAUMA, V60, P312, DOI 10.1097/01.ta.0000202714.31780.5f; Kronisch RL, 1996, MED SCI SPORT EXER, V28, P1351, DOI 10.1097/00005768-199611000-00002; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; Nelson NG, 2011, AM J SPORT MED, V39, P404, DOI 10.1177/0363546510383478; Outdoor Foundation, OUTD RECR PART REP 2; Wikipedia, LIFT ACC MOUNT BIK	13	15	15	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	SUM	2012	23	2					140	145		10.1016/j.wem.2012.02.002			6	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Sport Sciences	956OD	WOS:000305098100009	22656660	Bronze			2022-02-06	
J	Chiu, CC; Li, YN; Lin, LJ; Hsiao, CT; Hsiao, KY; Chen, IC				Chiu, Chun-Cheng; Li, Yi-Nong; Lin, Leng-Jye; Hsiao, Cheng-Ting; Hsiao, Kuang-Yu; Chen, I-Chuan			Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						D-dimer; ICH; Mortality; Spontaneous intracerebral hemorrhage	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ACTIVATION; COAGULOPATHY; HEMOSTASIS; PLASMA; SCALE; SCORE; COMA	It has been found that the hemostatic system is activated following a brain injury. To explore the role of D-dimer in spontaneous intracerebral hemorrhage (ICH), this prospective study aimed to evaluate the association between serum D-dimer concentration, clinical outcome and radiographic findings of ICH patients in the emergency department (ED). Patients with acute (<24 hours) spontaneous ICH were enrolled in this study. The D-dimer concentration was related to: baseline ICH volume (r = 0.198. p = 0.01); Glasgow Coma Scale (GCS) score 3-8 (p = 0.01); GCS score 13-15 (p = 0.002); midline shift >15 mm (p = 0.016); and to subarachnoid extension of the blood (p < 0.0001). Diabetes mellitus (odds ratio [OR]: 2.93; 95% confidence interval [CI]: 1.1-7.76, p = 0.031), ICH volume (OR: 1.16; 95% CI: 1.07-1.27, p < 0.0001) and D-dimer concentration (OR: 2.72; 95% CI: 1.08-6.9, p = 0.002) were associated with 30-day mortality. This study shows that in patients with spontaneous ICH, a higher initial D-dimer concentration is associated with higher 30-day mortality. (C) 2011 Elsevier Ltd. All rights reserved.	[Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Puzih City 613, Chiayi County, Taiwan; Chang Gung Univ, Coll Med, Tao Yuan, Taiwan		Chen, IC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 6 W Sec,Jiapu Rd, Puzih City 613, Chiayi County, Taiwan.	giomacky@gmail.com			Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPG660283]	This study was supported by the Chang Gung Memorial Hospital research program CMRPG660283.	Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FUJII Y, 1995, NEUROSURGERY, V37, P226, DOI 10.1227/00006123-199508000-00006; Fujii Y, 2001, STROKE, V32, P883, DOI 10.1161/01.STR.32.4.883; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Ikeda K, 1997, NEUROSURGERY, V41, P344, DOI 10.1097/00006123-199708000-00002; Ilveskero S, 2005, NEUROSURGERY, V57, P16, DOI 10.1227/01.NEU.0000163085.48999.D6; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; JUVELA S, 1990, STROKE, V21, P566, DOI 10.1161/01.STR.21.4.566; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Parra A, 2006, NAT CLIN PRACT NEURO, V2, P592, DOI 10.1038/ncpneuro0341; Pathak A, 2005, Neurol India, V53, P178; Peltonen S, 1997, J NEUROSURG, V87, P207, DOI 10.3171/jns.1997.87.2.0207; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Takahashi H, 1998, AM J HEMATOL, V59, P110; Ungerstedt JS, 2003, J NEUROSURG ANESTH, V15, P13, DOI 10.1097/00008506-200301000-00003	28	15	18	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2012	19	6					810	813		10.1016/j.jocn.2011.08.032			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	955SH	WOS:000305040700007	22377638				2022-02-06	
J	Kong, WM; Tang, D; Luo, XY; Yu, ITS; Liang, YX; He, YH				Kong, Wenming; Tang, Dan; Luo, Xiaoyuan; Yu, Ignatius Tak Sun; Liang, Youxin; He, Yonghua			Prediction of Return to Work Outcomes Under an Injured Worker Case Management Program	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Case management; Return to work; Intervention; Occupational injury	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; LOW-BACK-PAIN; VOCATIONAL-REHABILITATION; MENTAL-HEALTH; SICK LEAVE; INTERVENTIONS; WORKPLACE; DISABILITY	Introduction Many factors affect worker return to work (RTW) after occupational injury, among which effective case management strategies play a particularly vital role in prompting workers for a successful RTW. Objectives This study aimed at predicting the RTW outcome and optimizing the intervention scheme of a case management program initiated in China. Methods A retrospective cohort was formed with 523 injured workers treated at a rehabilitation center for work injuries in southern China. The social demographic information, medical data and intervention process were extracted from the medical records of the rehabilitation center. A Cox Regression Model was used to examine the predictors of RTW case management. Results 261 patients (77.9%) out of the 335 valid subjects successfully returned to work after median absence duration of 36.0 days. A computer skills training program was a positive factor for RTW outcomes (hazard ratio 1.5, P < 0.001). Psychological counseling was possibly an important measure to improve RTW with a hazard ratio of 3.4 (95% CI 0.94-16, P > 0.05). Disability adjustment accommodations did not specifically benefit RTW. Education level, family's attitude to RTW, personal perceptions about social support for RTW, and injury severity were significantly associated with outcomes of RTW. Conclusions It was implied that RTW intervention should be focused on a specific skill reconstruction and training which was presumably related with labor market needs. However, tailored psychological counseling and disability adjustment activity should not be ignored in RTW.	[Yu, Ignatius Tak Sun; He, Yonghua] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Kong, Wenming] Zhengjiang Prov Inst Dermatoses Prevent & Cure, Deqing Cty 313200, Zhejiang, Peoples R China; [Tang, Dan; Luo, Xiaoyuan] Guangdong Prov Work Injury Rehabil Ctr, Guangzhou 510970, Guangdong, Peoples R China; [Liang, Youxin; He, Yonghua] Fudan Univ, Sch Publ Health, Fudan Liberty Mutual SafeWork Ctr, Shanghai 200032, Peoples R China		He, YH (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Room 416,4-F,Sch Public Hlth Bldg, Shatin, Hong Kong, Peoples R China.	yhhe@cuhk.edu.hk	Yu, Ignatius Tak Sun/A-9936-2008				Adams H, 2007, J OCCUP REHABIL, V17, P305, DOI 10.1007/s10926-007-9082-3; ALTMAIER EM, 1992, PAIN, V49, P329, DOI 10.1016/0304-3959(92)90240-C; Ammendolia C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-65; [Anonymous], 2005, MENT HLTH POL PROGR; Athanasou James A, 2005, Med Leg J, V73, P29; Baril R, 2003, SOC SCI MED, V57, P2101, DOI 10.1016/S0277-9536(03)00131-X; Bloch FS, 1997, INT SOCIAL SECURITY, V50, P3; Braathen TN, 2007, J REHABIL MED, V39, P493, DOI 10.2340/16501977-0081; Briand C, 2007, INT J LAW PSYCHIAT, V30, P444, DOI 10.1016/j.ijlp.2007.06.014; Brouwers EPM, 2006, GEN HOSP PSYCHIAT, V28, P223, DOI 10.1016/j.genhosppsych.2006.02.005; Cheng ASK, 2011, J OCCUP REHABIL, V21, pS44, DOI 10.1007/s10926-010-9272-2; CRISP R, 1992, J REHABIL, V58, P27; Dan T, 2011, J OCCUP REHABIL, V21, P55; Drews B, 2007, SCAND J PUBLIC HEALT, V35, P86, DOI 10.1080/14034940600868598; Durand MJ, 2002, J OCCUP REHABIL, V12, P191, DOI 10.1023/A:1016846712499; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Feuerstein M, 2003, J OCCUP ENVIRON MED, V45, P803, DOI 10.1097/01.jom.0000079091.95532.92; Feuerstein M, 2011, J OCCUP REHABIL, V21, pS5, DOI 10.1007/s10926-011-9295-3; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; Franche RL, 2002, J OCCUP REHABIL, V12, P233, DOI 10.1023/A:1020270407044; Hagen EM, 2000, SPINE, V25, P1973, DOI 10.1097/00007632-200008010-00017; He YH, 2010, J OCCUP REHABIL, V20, P378, DOI 10.1007/s10926-010-9232-x; Hess DW, 2000, ARCH PHYS MED REHAB, V81, P359, DOI 10.1053/apmr.2000.0810359; Jang Y, 2005, ARCH PHYS MED REHAB, V86, P681, DOI 10.1016/j.apmr.2004.10.025; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Lai HS, 2007, J OCCUP REHABIL, V17, P712, DOI 10.1007/s10926-007-9110-3; Li-Tsang CWP, 2008, J OCCUP REHABIL, V18, P299, DOI 10.1007/s10926-008-9138-z; Li-Tsang WPC, 2006, J OCCUP REHABIL, V17, P270; Loisel P, 1997, SPINE, V22, P2911, DOI 10.1097/00007632-199712150-00014; Rebergen DS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-183; Salazar M K, 1999, AAOHN J, V47, P348; Scheel IB, 2002, SPINE, V27, P2734, DOI 10.1097/00007632-200212010-00014; Shaw W, 2008, J OCCUP REHABIL, V18, P2, DOI 10.1007/s10926-007-9115-y; Sullivan MJL, 2005, J OCCUP REHABIL, V15, P475, DOI 10.1007/s10926-005-8029-9; Tompa E, 2008, J OCCUP REHABIL, V18, P16, DOI 10.1007/s10926-007-9116-x; van der Klink JJL, 2003, OCCUP ENVIRON MED, V60, P429, DOI 10.1136/oem.60.6.429; Verbeek JH, 2002, SPINE, V27, P1844, DOI 10.1097/00007632-200209010-00006; Xiaohong G, 2010, SAFETY, V31, P1; Xu YW, 2007, J OCCUP REHABIL, V17, P727, DOI 10.1007/s10926-007-9105-0; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0	41	15	16	0	27	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	JUN	2012	22	2					230	240		10.1007/s10926-011-9343-z			11	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	926DS	WOS:000302812100008	22120023				2022-02-06	
J	McGinn, MJ; Colello, RJ; Sun, D				McGinn, Melissa J.; Colello, Raymond J.; Sun, Dong			Age-related proteomic changes in the subventricular zone and their association with neural stem/progenitor cell proliferation	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						subventricular zone; aging; neurogenesis; proteome	TRAUMATIC BRAIN-INJURY; STEM-CELLS; DENTATE GYRUS; 2-DIMENSIONAL ELECTROPHORESIS; ALZHEIMERS-DISEASE; PROGENITOR CELLS; ADULT; NEUROGENESIS; NEURONS; RAT	In the mammalian central nervous system, generation of new neurons persists in the subventricular zone (SVZ) throughout life. However, the capacity for neurogenesis in this region declines with aging. Recent studies have examined the degree of these age-related neurogenic declines and the changes of cytoarchitecture of the SVZ with aging. However, little is known about the molecular changes in the SVZ with aging. In this study, we dissected the SVZs from rats aged postnatal day 28, 3 months, and 24 months. The SVZ tissues were processed for 2-D gel electrophoresis to identify protein changes following aging. Protein spots were subsequently subjected to mass spectrometry analysis to compare age-related alterations in the SVZ proteome. We also examined the level of cell proliferation in the SVZ in animals of these three age groups by using bromodeoxyuridine labeling. We found significant age-related changes in the expression of several proteins that play critical roles in the proliferation and survival of neural stem/progenitor cells in the SVZ. Among these proteins, glial fibrillary acidic protein, ubiquitin carboxy terminal hydrolase 1, glutathione S-transferase omega, and preproalbumin were increased with aging, whereas collapsin response-mediated protein 4 (CRMP-4), CRMP-5, and microsomal protease ER60 exhibited declines with aging. We have also observed a significant decline of neural stem/progenitor cell proliferation in the SVZ with aging. These alterations in protein expression in the SVZ with aging likely underlie the diminishing proliferative capacity of stem/progenitor cells in the aging brain. (c) 2012 Wiley Peridicals, Inc.	[Sun, Dong] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; [McGinn, Melissa J.; Colello, Raymond J.] Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Sun, D (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, POB 980631, Richmond, VA 23298 USA.	dsun@vcu.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055086, NS048377]; NIH-NINDS centerUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R21NS048377, R01NS055086] Funding Source: NIH RePORTER	Contract grant sponsor: NIH/NINDS; Contract grant number: NS055086 (to D.S.); Contract grant number: NS048377 (to R.J.C.).; Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS center core grant 5P30NS047463.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Alonso G, 2001, GLIA, V34, P253, DOI 10.1002/glia.1059; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Babu GJ, 2004, ANAL BIOCHEM, V325, P121, DOI 10.1016/j.ab.2003.10.024; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Celli CM, 2003, CANCER RES, V63, P6016; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Colello RJ, 2002, ELECTROPHORESIS, V23, P144, DOI 10.1002/1522-2683(200201)23:1<144::AID-ELPS144>3.0.CO;2-P; Della-Maggiore V, 2002, REV NEUROSCIENCE, V13, P167; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; GOLDFIEN RD, 1991, J IMMUNOL, V146, P3703; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Harada T, 2004, AM J PATHOL, V164, P59, DOI 10.1016/S0002-9440(10)63096-9; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hopkins A., 1993, CLIN NEUROLOGY MODER; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Limke TL, 2002, J CELL MOL MED, V6, P475, DOI 10.1111/j.1582-4934.2002.tb00451.x; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Lubec G, 2003, PROG NEUROBIOL, V69, P193, DOI 10.1016/S0301-0082(03)00036-4; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Madhavan L, 2005, ANN NY ACAD SCI, V1049, P185, DOI 10.1196/annals.1334.017; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.3.CO;2-H; Nacher J, 2000, J COMP NEUROL, V424, P628, DOI 10.1002/1096-9861(20000904)424:4<628::AID-CNE5>3.0.CO;2-4; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rodriguez JJ, 2009, NEUROREPORT, V20, P907, DOI 10.1097/WNR.0b013e32832be77d; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; SELKOE DJ, 1992, SCI AM, V267, P135, DOI 10.1038/scientificamerican0992-134; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Taylor CM, 2003, PROTEOMICS, V3, P1303, DOI 10.1002/pmic.200300451; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Walter J, 2011, NEUROBIOL AGING, V32, P1906, DOI 10.1016/j.neurobiolaging.2009.11.011; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wu Y, 2005, NEUROCHEM INT, V46, P565, DOI 10.1016/j.neuint.2005.01.002	65	15	16	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2012	90	6					1159	1168		10.1002/jnr.23012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	922GV	WOS:000302536300006	22344963	Green Accepted			2022-02-06	
J	Murphy, A; Kaufman, MS; Molton, I; Coppel, DB; Benson, J; Herring, SA				Murphy, Ashley; Kaufman, Marla S.; Molton, Ivan; Coppel, David B.; Benson, John; Herring, Stanley A.			Concussion Evaluation Methods Among Washington State High School Football Coaches and Athletic Trainers	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SENSITIVITY	Objective: To evaluate awareness of concussion assessment methods and to determine whether there are differences among Washington State high school football coaches and athletic trainers in urban versus rural school districts. Design: A Catalyst WebQ survey link was randomly sent by e-mail to varsity head football coaches, athletic trainers, and athletic directors in Washington State school districts. Participants: Survey participants were high school varsity head football coaches and athletic trainers from a total of 106 Washington State high schools. Methods: A 12-item questionnaire on Catalyst WebQ was distributed via e-mail. The survey inquired about use of the methods of concussion assessment, both on the field and for follow-up; participants' concussion education training; and familiarity with Washington State's Zackery Lystecit Law. Main Outcome Measurements: The survey examined differences in concussion management practices between rural and urban school districts and also between coaches and athletic trainers in Washington State, specifically regarding the use of the Standardized Concussion Assessment Tool 2 (SCAT2) and neurocognitive testing (NCT). Results: Twenty-seven of 48 respondents (56%) used the SCAT2 for on-the-field assessment; urban respondents were significantly more likely to use SCAT2 (P < .05). The difference between coaches and athletic trainers with respect to SCAT2 use was not significant (P = .08). NCT was used by 18 of 58 respondents (31%). This was more commonly used by those in urban districts (P < .01) and by athletic trainers (P < .01). Eleven of these 18 individuals (61%) reported that a neuropsychologist interpreted the results; the rest used other providers not specifically trained in neuropsychology. There was no statistically significant correlation between years of experience and use of the SCAT2, but those with more than 10 years of experience were less likely to use NCT (P < .01). All respondents reported being familiar with Washington State's Zackery Lystedt Law, but only 44.1% reported that the law changed their concussion management. Conclusions: There were statistically significant differences between SCAT2 and NCT use for respondents from urban and rural districts, and also between coaches and athletic trainers, as well as NCT use among respondents with varying years of experience. Further understanding and identification of barriers that limit identification and management of concussions in high school athletes are crucial to prevent serious permanent injury. Additional education is necessary to ensure that athletic trainers and coaches are aware of current recommendations within the medical literature for the evaluation and management of concussions. PM R 2012;4:4.19-426	[Kaufman, Marla S.; Herring, Stanley A.] Univ Washington, Med Ctr, Dept Rehabil Med, Dept Orthopaed & Sports Med,Dept Neurol Surg, Seattle, WA 98105 USA; [Murphy, Ashley] Univ Washington, Sch Med, Seattle, WA 98105 USA		Kaufman, MS (corresponding author), Univ Washington, Med Ctr, Dept Rehabil Med, Dept Orthopaed & Sports Med,Dept Neurol Surg, 4245 Roosevelt Way NE, Seattle, WA 98105 USA.	kaufman2@uw.edu			Medical Student Research Training Program, University of Washington School of Medicine, Seattle, WA	Research support: Medical Student Research Training Program, University of Washington School of Medicine, Seattle, WA	[Anonymous], 2009, SCAT2 SPORT CONC ASS; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Ferrara Michael S., 2001, J Athl Train, V36, P145; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; ImPACT, 2009, BEST APPR CONC MAN; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schootman M, 1999, BRAIN INJURY, V13, P995; Washington State Department of Health, 2008, GUID US RUR URB CLAS; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	24	15	15	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2012	4	6					419	426		10.1016/j.pmrj.2012.03.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	969EO	WOS:000306038700005	22732154				2022-02-06	
J	Tomasevic, G; Laurer, HL; Mattiasson, G; van Steeg, H; Wieloch, T; McIntosh, TK				Tomasevic, Gregor; Laurer, Helmut L.; Mattiasson, Gustav; van Steeg, Harry; Wieloch, Tadeusz; McIntosh, Tracy K.			Delayed neuromotor recovery and increased memory acquisition dysfunction following experimental brain trauma in mice lacking the DNA repair gene XPA	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; xeroderma pigmentosum; neuronal cell death; Morris water maze; neuroscoring; transgenic mouse	NUCLEOTIDE EXCISION-REPAIR; CONTROLLED CORTICAL IMPACT; XERODERMA-PIGMENTOSUM; MAMMALIAN-CELLS; OXIDATIVE DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; POSTTRAUMATIC HYPOTHERMIA; NEUROLOGICAL DISEASE; BEHAVIORAL DEFICITS; MITOCHONDRIAL-DNA	Object. This study investigates the outcome after traumatic brain injury (TBI) in mice lacking the essential DNA repair gene xeroderma pigmentosum group A (XPA). As damage to DNA has been implicated in neuronal cell death in various models, the authors sought to elucidate whether the absence of an essential DNA repair factor would affect the outcome of TBI in an experimental setting. Methods. Thirty-seven adult mice of either wild-type (n = 18) or XPA-deficient ("knock-out" [n = 19]) genotype were subjected to controlled cortical impact experimental brain trauma, which produced a focal brain injury. Sham-injured mice of both genotypes were used as controls (9 in each group). The mice were subjected to neurobehavoral tests evaluating learning/acquisition (Morris water maze) and motor dysfunction (Rotarod and composite neuroscore test), pre- and postinjury up to 4 weeks. The mice were killed after 1 or 4 weeks, and cortical lesion volume, as well as hippocampal and thalamic cell loss, was evaluated. Hippocampal staining with doublecortin antibody was used to evaluate neurogenesis after the insult. Results. Brain-injured XPA(-/-) mice exhibited delayed recovery from impairment in neurological motor function, as well as pronounced cognitive dysfunction in a spatial learning task (Morris water maze), compared with injured XPA(+/+) mice (p < 0.05). No differences in cortical lesion volume, hippocampal damage, or thalamic cell loss were detected between XPA(+/+) and XPA(-/-) mice after brain injury. Also, no difference in the number of cells stained with doublecortin in the hippocampus was detected. Conclusions. The authors' results suggest that lack of the DNA repair factor XPA may delay neurobehavioral recovery after TBI, although they do not support the notion that this DNA repair deficiency results in increased cell or tissue death in the posttraumatic brain. (http://thejns.org/doi/abs/10.3171/2012.2.JNS11888)	[Tomasevic, Gregor; Mattiasson, Gustav; Wieloch, Tadeusz] Wallenberg Neurosci Ctr, Expt Brain Res Lab, SE-22184 Lund, Sweden; [Laurer, Helmut L.; McIntosh, Tracy K.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [van Steeg, Harry] Natl Inst Publ Hlth & Environm, Dept Carcinogenesis Mutagenesis & Genet, NL-3720 BA Bilthoven, Netherlands		Tomasevic, G (corresponding author), Wallenberg Neurosci Ctr, Expt Brain Res Lab, BMC A13, SE-22184 Lund, Sweden.	gregor.tomasevic@med.lu.se		Wieloch, Tadeusz/0000-0002-7669-2520	NIH from the National Institute of Neurological Disorders and Stroke [P50-NS08803]; NIH from the National Institute of General Medical SciencesGeneral Electric [R01-GM34690]; Veterans AdministrationUS Department of Veterans Affairs [74R]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2008-3134]; EU through the European Stroke Network [201024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER	This study was supported in part by NIH Grant No. P50-NS08803 from the National Institute of Neurological Disorders and Stroke, Grant No. R01-GM34690 from the National Institute of General Medical Sciences, a Veterans Administration Merit Review grant (74R), the Swedish Research Council (No. 2008-3134), and the EU 7th work program through the European Stroke Network (Grant No. 201024).	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Brooks PJ, 1998, MUTAT RES-DNA REPAIR, V408, P37, DOI 10.1016/S0921-8777(98)00018-4; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chen KH, 1998, NUCLEIC ACIDS RES, V26, P2001, DOI 10.1093/nar/26.8.2001; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; deVries A, 1996, SEMIN CANCER BIOL, V7, P229, DOI 10.1006/scbi.1996.0031; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Druzhyna N, 1998, MUTAT RES-DNA REPAIR, V409, P81, DOI 10.1016/S0921-8777(98)00042-1; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Franklin K.P.G., 1996, MOUSE BRAIN STEREOTA; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goosen N, 2010, DNA REPAIR, V9, P593, DOI 10.1016/j.dnarep.2010.02.015; GREWAL RP, 1991, MED HYPOTHESES, V34, P171, DOI 10.1016/0306-9877(91)90188-5; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Kisby GE, 1997, NEUROREPORT, V8, P1337, DOI 10.1097/00001756-199704140-00004; Kohji T, 1998, NEUROSCI LETT, V243, P133, DOI 10.1016/S0304-3940(98)00109-8; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Lovell MA, 1999, J NEUROCHEM, V72, P771, DOI 10.1046/j.1471-4159.1999.0720771.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIMAKI T, 1989, ACTA NEUROL SCAND, V80, P136, DOI 10.1111/j.1600-0404.1989.tb03855.x; MIMAKI T, 1986, ANN NEUROL, V20, P70, DOI 10.1002/ana.410200112; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; Nakamura J, 1999, CANCER RES, V59, P2522; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; ROBBINS JH, 1991, BRAIN, V114, P1335, DOI 10.1093/brain/114.3.1335; ROBBINS JH, 1993, EUR NEUROL, V33, P188, DOI 10.1159/000116932; ROYTTA M, 1986, ACTA NEUROL SCAND, V73, P191; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SANCAR A, 1995, J BIOL CHEM, V270, P15915, DOI 10.1074/jbc.270.27.15915; Sancar A, 1995, ANNU REV GENET, V29, P69, DOI 10.1146/annurev.ge.29.120195.000441; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; WOOD RD, 1995, PHILOS T ROY SOC B, V347, P69, DOI 10.1098/rstb.1995.0011	61	15	15	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2012	116	6					1368	1378		10.3171/2012.2.JNS11888			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	945RP	WOS:000304294000033	22462511				2022-02-06	
J	Unger, T; Lakowa, N; Bette, S; Engele, J				Unger, Tina; Lakowa, Nicole; Bette, Stefanie; Engele, Juergen			Transcriptional Regulation of the GLAST/EAAT-1 Gene in Rat and Man	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Glutamate transporters; 3 '-UTR; Enhancer elements; Repressor elements	GLUTAMATE TRANSPORTER EXPRESSION; TRAUMATIC BRAIN-INJURY; GLIAL GLUTAMATE; ASTROCYTES; DISEASE; REGION; GLT-1; MICE; SCHIZOPHRENIA; MECHANISMS	Various acute and chronic brain diseases result in disturbed expression of the glial glutamate transporters, GLAST/EAAT-1 and GLT-1/EAAT-2, and subsequent secondary neuronal cell death. The idea that glutamate-induced brain damage can be prevented by restoring glutamate homeostasis in the injured brain, focussed previous efforts on identifying the network controlling astrocytic glutamate transport. Since most of this work was performed with rat astrocytes, we now sought to compare the transcriptional regulation of the GLAST/EAAT-1 gene in rat and man. Reporter gene assay demonstrated that the human GLAST/EAAT-1 promoter comprises the 2.3 kb region immediately flanking the 5'-end of the human GLAST/EAAT-1 gene. Cloning of the previously unknown promoter of rat GLAST/EAAT-1 gene demonstrated maximal reporter gene activity with a sequence comprising the 1.5 kb region flanking the 5'-end of the gene as well as non-coding exon 1, and intron 1-2. Although the promoter regions from both species lacked sequence homology, they contained numerous identical consensus motifs. In human promoter constructs, dbcAMP, PACAP, EGF, and TGF alpha, which represent potent stimulators of endogenous GLAST/EAAT-1 expression, only further increased reporter gene activity in the presence of the GLAST/EAAT-1 3'-UTR. By contrast, the rat GLAST/EAAT-1 3'-UTR only mediated the stimulatory increases of dbcAMP. Moreover, the GLAST/EAAT-1 3'-UTR repressed constitutive GLAST/EAAT-1 expression in man, but enhanced GLAST/EAAT-1 transcription in rat. Together, our findings suggest the existence of close functional similarities of the GLAST/EAAT-1 promoter regions in man and rat and further point to a species-specific function of the GLAST/EAAT-1 3'-UTR in constitutive and regulated GLAST/EAAT-1 expression.	[Unger, Tina; Lakowa, Nicole; Bette, Stefanie; Engele, Juergen] Univ Leipzig, Inst Anat, Fac Med, D-04103 Leipzig, Germany		Engele, J (corresponding author), Univ Leipzig, Inst Anat, Fac Med, Liebigstr 13, D-04103 Leipzig, Germany.	engj@medizin.uni-leipzig.de					Allritz C, 2010, J NEUROSCI RES, V88, P1234, DOI 10.1002/jnr.22303; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Figiel M, 2000, J NEUROSCI, V20, P3596, DOI 10.1523/JNEUROSCI.20-10-03596.2000; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Foran E, 2011, GLIA, V59, P1719, DOI 10.1002/glia.21218; Hazell AS, 2010, GLIA, V58, P148, DOI 10.1002/glia.20908; Hewett JA, 2009, J NEUROCHEM, V110, P1717, DOI 10.1111/j.1471-4159.2009.06288.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Ketheeswaranathan P, 2011, BRAIN RES, V1418, P93, DOI 10.1016/j.brainres.2011.08.029; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schluter K, 2002, EUR J NEUROSCI, V16, P836, DOI 10.1046/j.1460-9568.2002.02130.x; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Smicun Y, 1998, EUR J BIOCHEM, V251, P704, DOI 10.1046/j.1432-1327.1998.2510704.x; Swanson RA, 1997, J NEUROSCI, V17, P932; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Thomas MA, 2010, BIOCHEM J, V425, P575, DOI 10.1042/BJ20091109; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667; Zhang R, 2009, J GENET GENOMICS, V36, P1, DOI 10.1016/S1673-8527(09)60001-1	34	15	15	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2012	32	4					539	547		10.1007/s10571-011-9790-2			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	934AF	WOS:000303410000007	22252783				2022-02-06	
J	Weber, M; Edwards, MG				Weber, Mareen; Edwards, Martin Gareth			Sport Concussion Knowledge in the UK General Public	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Rehabilitation; Assessment	TRAUMATIC BRAIN-INJURY; MISCONCEPTIONS; STATEMENT	This is the first study to assess sport concussion knowledge and the effect of sport concussion self-report on knowledge in the UK general public. In the online survey, participants (n 227) stated personal sport concussion history, injury indicators, and rated 26 injury statements for truthfulness using definite (true, false) or non-definite (probably true, probably false) response options. As anticipated, knowledge was limited. Few statement ratings were definite, and misconceptions prevailed. The injurys seriousness was systematically underestimated, suggesting that knowledge may not be sufficient for injury self-diagnosis and self-recovery measures. Sport concussion self-report was associated with more definite than non-definite statement ratings. However, response accuracy did not differ. This suggested that personal injury experience may yield a false sense of security. The use of accessible, easy-to-use tools needs to be promoted to improve sport practice safety.	[Weber, Mareen] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02478 USA; [Weber, Mareen; Edwards, Martin Gareth] Univ Birmingham, Coll Life & Environm Sci, Sch Sport & Exercise Sci, Birmingham, W Midlands, England; [Edwards, Martin Gareth] Catholic Univ Louvain, Inst Rech Sci Psychol, B-1348 Louvain, Belgium		Weber, M (corresponding author), Harvard Univ, McLean Hosp, Sch Med, 115 Mill St, Belmont, MA 02478 USA.	mweber@mclean.harvard.edu		Edwards, Martin/0000-0003-4532-2436	University of Birmingham	This work was supported by a University of Birmingham PhD scholarship.	Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; De Beaumont L., 2009, BRAIN, V1, P1; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; Ferrara Michael S., 2001, J Athl Train, V36, P145; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110	17	15	15	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2012	27	3					355	361		10.1093/arclin/acs029			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	930SA	WOS:000303158400011	22377909	Bronze			2022-02-06	
J	Nemati, F; Kolb, B				Nemati, Farshad; Kolb, Bryan			Recovery from medial prefrontal cortex injury during adolescence: Implications for age-dependent plasticity	BEHAVIOURAL BRAIN RESEARCH			English	Article						Adolescence; Dendritic reorganization; Functional recovery; Medial prefrontal cortex injury; Neuroplasticity	EARLY-ONSET SCHIZOPHRENIA; TRAUMATIC BRAIN-INJURY; CORTICAL ATROPHY; FEMALE RATS; ADULT RATS; LESIONS; ASYMMETRY; VOLUME; MOTOR; MATURATION	Focal cortical injuries generate various behavioral deficits associated with different morphological changes. The age and the area of the injury determine the nature and extent of recovery represented by the level of performance in various behavioral tasks. Previously, we have shown that motor cortex injury in early (but not late) adolescence leads to behavioral deficits that do not recover spontaneously with time. Considering the fact that the pace of brain maturation differs in different brain areas, we undertook to examine the pattern of spontaneous recovery following medial prefrontal cortex (mPFC) lesion in early or late adolescence. A battery of motor tasks (postural asymmetry, skilled reaching, sunflower seed manipulation, forepaw inhibition in swimming) was used to investigate the pattern of behavioral recovery following mPFC lesions. Golgi-Cox analysis was used to examine dendritic reorganization of the relevant brain areas. The results indicated that rats perform poorly when receiving mPFC injuries in late adolescence in contrast to when they receive the lesion in early adolescence. Almost opposite pattern of recovery following motor cortex and medial prefrontal injuries in early and late adolescence will be discussed as an age-area dependent model for prognosis of brain injury during adolescence. (C) 2012 Elsevier B.V. All rights reserved.	[Nemati, Farshad; Kolb, Bryan] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada		Nemati, F (corresponding author), Univ Lethbridge, Dept Neurosci, 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	farshad.nemati@uleth.ca		Nemati, Farshad/0000-0002-4989-889X	Alberta Heritage Foundation for Medical Research/Hotchkiss Brain InstituteAlberta Heritage Foundation for Medical Research; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	This research was supported by an Alberta Heritage Foundation for Medical Research/Hotchkiss Brain Institute postdoctoral fellowship to FN and a Canadian Institutes for Health Research grant to BK. We thank Sharon Mustard, Ayuno Nakahashi, Serah Raza, Rayan Rota, and Saif Zahir for their technical assistance.	Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; ANDREASEN NC, 1982, AM J PSYCHIAT, V139, P297; Brenhouse HC, 2011, NEUROSCI BIOBEHAV R, V35, P1687, DOI 10.1016/j.neubiorev.2011.04.013; Collinson SL, 2003, BRIT J PSYCHIAT, V183, P114, DOI 10.1192/bjp.183.2.114; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; DeVito EE, 2005, EUR J ANAESTH, V22, P23; Ferrari MCL, 2006, ARQ NEURO-PSIQUIAT, V64, P741, DOI 10.1590/S0004-282X2006000500008; Gaser C, 2004, AM J PSYCHIAT, V161, P154, DOI 10.1176/appi.ajp.161.1.154; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Highley JR, 1998, SCHIZOPHR RES, V34, P13, DOI 10.1016/S0920-9964(98)00077-2; HOFFMAN RE, 1989, SCHIZOPHRENIA BULL, V15, P477, DOI 10.1093/schbul/15.3.477; Janssen J, 2008, J AM ACAD CHILD PSY, V47, P1311, DOI 10.1097/CHI.0b013e318184ff48; John JP, 2009, SCHIZOPHR RES, V109, P148, DOI 10.1016/j.schres.2008.12.019; Kellogg CK, 1998, PERSPECT DEV NEUROBI, V5, P219; Kolb B, 1996, BEHAV BRAIN RES, V79, P1, DOI 10.1016/0166-4328(95)00254-5; KOLB B, 1981, NEUROPSYCHOLOGIA, V19, P491, DOI 10.1016/0028-3932(81)90016-6; KOLB B, 1982, EXP NEUROL, V78, P348, DOI 10.1016/0014-4886(82)90053-X; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; Kolb B, 2000, RESTOR NEUROL NEUROS, V17, P61; KOLB B, 1976, SCIENCE, V193, P335, DOI 10.1126/science.935872; KOLB B, 1995, BEHAV NEUROSCI, V109, P285, DOI 10.1037/0735-7044.109.2.285; KOLB B, 1978, BRAIN RES, V151, P135, DOI 10.1016/0006-8993(78)90956-3; Kolb B., 1995, BRAIN PLASTICITY BEH; MASSMAN PJ, 1986, INT J NEUROSCI, V30, P87, DOI 10.3109/00207458608985659; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Meduri M, 2010, PSYCHIAT RES-NEUROIM, V183, P52, DOI 10.1016/j.pscychresns.2010.01.014; Meehan SK, 2011, HUM BRAIN MAPP, V32, P290, DOI 10.1002/hbm.21019; Metz GA., 2005, BEHAV LAB RAT HDB TE; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nemati F, 2010, BEHAV NEUROSCI, V124, P612, DOI 10.1037/a0020911; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; NONNEMAN AJ, 1981, J COMP PHYSIOL PSYCH, V95, P588, DOI 10.1037/h0077800; Owler BK, 2004, J CEREBR BLOOD F MET, V24, P17, DOI 10.1097/01.WCB.0000093326.88757.49; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pienaar IS, 2007, RESTOR NEUROL NEUROS, V25, P513; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert T, 1997, ADV NEUROL, V73, P229; Sholl DA, 1956, ORG CEREBRAL CORTEX; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2010, BRAIN COGNITION, V72, P160, DOI 10.1016/j.bandc.2009.11.003; STEWART J, 1988, BEHAV NEURAL BIOL, V49, P344, DOI 10.1016/S0163-1047(88)90354-8; VANEDEN CG, 1990, PROG BRAIN RES, V85, P169; Whishaw IQ, 1998, BEHAV BRAIN RES, V96, P79, DOI 10.1016/S0166-4328(97)00200-3; Whishaw IQ, 2004, J NEUROTRAUM, V21, P1584, DOI 10.1089/neu.2004.21.1584; Zilles K., 1985, CORTEX RAT STEREOTAX	51	15	15	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR 1	2012	229	1					168	175		10.1016/j.bbr.2012.01.002			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	915SL	WOS:000302047600021	22261018				2022-02-06	
J	Piper, GL; Kaplan, LJ				Piper, Greta L.; Kaplan, Lewis J.			Fluid and Electrolyte Management for the Surgical Patient	SURGICAL CLINICS OF NORTH AMERICA			English	Article						Fluid balance; Electrolyte balance; Acid-base assessment; Plasma volume; Hyperchloremic metabolic acidosis	SPONTANEOUS BACTERIAL PERITONITIS; DAMAGE CONTROL RESUSCITATION; SEVERE HEMORRHAGIC-SHOCK; TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; ALBUMIN; MORTALITY; PLASMA; PARACENTESIS; EXPANSION	For surgical patients, appropriate selection and administration of fluids can mitigate against organ failure, whereas improper dosing can exacerbate already injured systems. Fluid and electrolyte goals and deficiencies must be defined for individual patients to provide the appropriate combination of resuscitation and maintenance fluids. Specific electrolyte abnormalities should be anticipated, identified, and corrected to optimize organ functions. Using the strong-ion approach to acid-base assessment, delivered fluids that contain calculated amounts of electrolytes will interact with the patient's plasma charge and influence the patient's pH, allowing the clinician to achieve a more precise end point.	[Piper, Greta L.; Kaplan, Lewis J.] Yale Univ, Sch Med, Sect Trauma Surg Crit Care & Surg Emergencies, Dept Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Trauma Surg Crit Care & Surg Emergencies, Dept Surg, New Haven, CT 06520 USA		Kaplan, LJ (corresponding author), Yale Univ, Sch Med, Sect Trauma Surg Crit Care & Surg Emergencies, Dept Surg, 330 Cedar St,BB 310, New Haven, CT 06520 USA.	Lewis.Kaplan@yale.edu					Alderson P, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001208.pub3, 10.1002/14651858.CD001208.pub4]; Bavir H, 2003, CRIT CARE MED S1, V31, pS112; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Byrnes MC, 2011, CURR OPIN CLIN NUTR, V14, P186, DOI 10.1097/MCO.0b013e328341ed93; Choi CH, 2005, J GASTROEN HEPATOL, V20, P1215, DOI 10.1111/j.1440-1746.2005.03861.x; Cohn SM, 2007, J TRAUMA, V62, P44, DOI 10.1097/TA.0b013e31802eb817; Crookes BA, 2005, J TRAUMA, V58, P806, DOI 10.1097/01.TA.0000158269.68409.1C; Davidson IJ, 2006, EUR J ANAESTH, V23, P721, DOI 10.1017/S0265021506000639; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Duchesne JC, 2011, AM SURGEON, V77, P201; Fallon W F, 1993, Curr Opin Gen Surg, P40; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Fuentebella J, 2009, PEDIATR CLIN N AM, V56, P1201, DOI 10.1016/j.pcl.2009.06.006; Hai S. A., 2004, JPMA Journal of the Pakistan Medical Association, V54, P434; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Kaplan LJ, 2008, SHOCK, V29, P662, DOI [10.1097/SHK.0b013e3181618946, 10.1097/shk.0b013e3181618946]; Kaplan LJ, 2006, J TRAUMA, V61, P90, DOI 10.1097/01.ta.0000222578.85413.4e; Kaplan LJ, 2010, CURR OPIN CRIT CARE, V16, P323, DOI 10.1097/MCC.0b013e32833c0957; Kaplan LJ, 2009, J TRAUMA, V66, P1045, DOI 10.1097/TA.0b013e31819a04be; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; KRAUSZ MM, 1995, SHOCK, V3, P69, DOI 10.1097/00024382-199501000-00012; LEE JA, 1981, ANAESTHESIA, V36, P1115, DOI 10.1111/j.1365-2044.1981.tb08698.x; Moore B, 1911, BIOCHEM J, V5, pib3, DOI [10.1042/bj005000i, DOI 10.1042/BJ005000I]; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; Narula N, 2011, CAN J GASTROENTEROL, V25, P373, DOI 10.1155/2011/586702; Ragaller MJR, 2001, J AM SOC NEPHROL, V12, P533; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roche AM, 2006, ANESTH ANALG, V102, P1274, DOI 10.1213/01.ane.0000197694.48429.94; SILVA MRF, 1987, AM J PHYSIOL, V253, pH751, DOI 10.1152/ajpheart.1987.253.4.H751; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Umgelter A, 2008, CRIT CARE, V12, DOI 10.1186/cc6765; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	38	15	15	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	APR	2012	92	2					189	+		10.1016/j.suc.2012.01.004			18	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	926LH	WOS:000302832000003	22414407				2022-02-06	
J	Taft, CT; Kachadourian, LK; Suvak, MK; Pinto, LA; Miller, MM; Knight, JA; Marx, BP				Taft, Casey T.; Kachadourian, Lorig K.; Suvak, Michael K.; Pinto, Lavinia A.; Miller, Mark M.; Knight, Jeffrey A.; Marx, Brian P.			Examining Impelling and Disinhibiting Factors for Intimate Partner Violence in Veterans	JOURNAL OF FAMILY PSYCHOLOGY			English	Article						trauma; veterans; violence; aggression; head injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; AGGRESSION; PERPETRATION; PERSONALITY; VALIDITY; SCALE	We examined correlates of intimate partner violence (IPV) in a military Veteran sample (N = 129) using Finkel's (2007) framework for understanding the interactions between impelling and disinhibiting risk factors. Correlates investigated included head contact events (HCEs), posttraumatic stress disorder (PTSD) symptoms, and antisocial features. Results indicated that antisocial features were significantly associated with IPV at the bivariate level. PTSD symptoms also were associated with IPV, but this association was marginally significant. Tests of moderation provided support for the expectation that HCEs would potentiate associations between antisocial features and IPV. HCEs also moderated the association between PTSD symptoms and IPV. However, contrary to expectations, the opposite pattern emerged such that PTSD symptoms were associated with a higher rate of IPV for those without a history of HCEs. Study findings have potentially important implications for furthering our understanding of the complex etiology of IPV in this population.	[Taft, Casey T.; Kachadourian, Lorig K.; Miller, Mark M.; Knight, Jeffrey A.; Marx, Brian P.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Taft, Casey T.; Kachadourian, Lorig K.; Miller, Mark M.; Knight, Jeffrey A.; Marx, Brian P.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Suvak, Michael K.] Suffolk Univ, Dept Psychol, Boston, MA USA; [Pinto, Lavinia A.] Kent State Univ, Dept Psychol, Kent, OH USA		Taft, CT (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, 150 S Huntington Ave 116B-4, Boston, MA 02130 USA.	Casey.Taft@va.gov	Marx, Brian/AAK-5072-2020; Miller, Mark Webber/G-7322-2011	Miller, Mark Webber/0000-0001-6393-8563	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08 MH7311701A2, R01 MH079806] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH079806, K08MH073117] Funding Source: NIH RePORTER		Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; Butcher J, 1990, DEV USE MMPI 2 CONTE; Chemtob CM, 1997, J TRAUMA STRESS, V10, P17, DOI 10.1002/jts.2490100104; Cohen R A, 1999, Violence Vict, V14, P397; Finkel EJ, 2007, REV GEN PSYCHOL, V11, P193, DOI 10.1037/1089-2680.11.2.193; Gagnon DR, 2008, J TRAUMA STRESS, V21, P448, DOI 10.1002/jts.20359; Greve KW, 2001, BRAIN INJURY, V15, P255; Hamberger L. K., 2007, INT HDB PSYCHOPATHIC, V1, P497; Harenski CL, 2010, BRIT J PSYCHOL, V101, P401, DOI 10.1348/000712609X471067; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Lilienfeld SO, 1996, PSYCHOL ASSESSMENT, V8, P281, DOI 10.1037/1040-3590.8.3.281; Miller M. W., RESILIENCE IN PRESS, P56; Miller MW, 2003, CLIN PSYCHOL-SCI PR, V10, P373, DOI 10.1093/clipsy/bpg040; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Neumann CS, 2008, J CONSULT CLIN PSYCH, V76, P893, DOI 10.1037/0022-006X.76.5.893; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Taft C. T., 2010, US MILITARY FAMILIES; Taft CT, 2009, AM J ORTHOPSYCHIAT, V79, P461, DOI 10.1037/a0016657	23	15	15	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0893-3200			J FAM PSYCHOL	J. Fam. Psychol.	APR	2012	26	2					285	289		10.1037/a0027424			5	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	921RU	WOS:000302495800014	22369461	Green Accepted			2022-02-06	
J	Csokay, A; Emelifeonwu, JA; Fugedi, L; Valalik, I; Lang, J				Csokay, Andras; Emelifeonwu, John Amaechi; Fuegedi, Laszlo; Valalik, Istvan; Lang, Jozsef			The importance of very early decompressive craniectomy as a prevention to avoid the sudden increase of intracranial pressure in children with severe traumatic brain swelling (retrospective case series)	CHILDS NERVOUS SYSTEM			English	Article						Decompressive craniectomy; Traumatic brain swelling; Vascular tunnel	HEAD-INJURY	The purpose of the retrospective case series of eight consecutive patients is to call our attention to the optimal timing of decompressive craniectomy (DC) in children. We report the outcomes of eight children under the age of 12 with severe head injuries. DC was performed at different intracranial pressure (ICP; 20 and 25 mmHg) levels. Our results suggest that above 20 mmHg, very fast progression of ICP (within15min) can occur, which may limit the time available to plan and perform DC with a successful patient outcome. Considering the anamnestic data, it could be useful to perform DC at 20-22 mmHg ICP in young patients in order to prevent the potential of very fast brain swelling if there is no possibility to perform durotomy within 20 min after the onset of raising the ICP. It is especially considerable in poor countries where the emergency route could be less organized because of locations of building and extreme load of the staff. Further controlled trials are necessary to evaluate the indication and standardization of early decompressive craniectomy as a standard preventive therapy in pediatric severe traumatic brain swelling.	[Csokay, Andras; Fuegedi, Laszlo; Valalik, Istvan; Lang, Jozsef] BAZ Cty Hosp, Dept Neurosurg, H-3501 Miskolc, Hungary; [Emelifeonwu, John Amaechi; Lang, Jozsef] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales		Csokay, A (corresponding author), BAZ Cty Hosp, Dept Neurosurg, 72-76 Szentpeteri Kapu 76, H-3501 Miskolc, Hungary.	csokaya@gmail.com					Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Csokay A, 2011, NEUROL RES, V33, P747, DOI 10.1179/1743132811Y.0000000001; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Sahuquillo J, 2009, COCHRANE DATABASE SY; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	15	15	16	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2012	28	3					441	444		10.1007/s00381-011-1661-0			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	897OY	WOS:000300663300018	22207401				2022-02-06	
J	Rammo, RA; DeFazio, MV; Bullock, MR				Rammo, Richard A.; DeFazio, Michael V.; Bullock, M. Ross			Management of Migrating Intracranial Bullets: Lessons Learned from Surviving an AK-47 Bullet Through the Lateral Brainstem	WORLD NEUROSURGERY			English	Article						Bullet; Foreign-body; Gunshot wound; Intracranial; Migration; Missile; Penetrating brain injury; Spontaneous movement; Traumatic brain injury	SPONTANEOUS MOVEMENT	OBJECTIVE: Survival after a gunshot wound (GSW) to the head is becoming more common, with an accompanying increase in spontaneous migration of these intracranial bullet fragments. This phenomenon is well described in current literature and is a potentially life-threatening delayed complication of GSW to the head. METHODS: We present the case of a 17-year-old boy who survived a penetrating GSW to the cranium and cerebellum after an accident involving an AK (Automatic Kalashnikov)-47 (7.62 mm). RESULTS: Following initial attempts to remove the bullet and associated hematoma from the cerebellar hemisphere, intraoperative fluoroscopy revealed that the bullet had migrated to lie within the right middle cerebellar peduncle with the development of intraoperative cardiac arrhythmia. The bullet could not be retrieved without risk of damage to the superior and inferior cerebellar arteries. The patient then developed bacterial meningitis, and further imaging revealed the bullet had again migrated under the cerebellar cortex to an accessible location. The infection was treated with aggressive antibiotic therapy and the bullet was removed from the posterior fossa, thus preventing recurrence of infection and further migration. The patient regained full motor, speech, and proprioceptive function within months after injury. CONCLUSION: The potential for spontaneous migration exists with any penetrating brain injury involving a retained foreign body. When a retained intracranial foreign body is unable to be safely extracted during initial debridement, close clinical evaluation is essential and plain-film or computed tomographic imaging should be considered in order to enhance the early detection of delayed-onset life-threatening deterioration, such as meningitis and occlusion of cerebrospinal fluid drainage, because of spontaneous migration.	[Bullock, M. Ross] Univ Miami, Dept Neurol Surg, Miller Sch Med, Coral Gables, FL 33124 USA; Jackson Mem Hosp, Lois Pope LIFE Ctr, Miami, FL 33136 USA		Bullock, MR (corresponding author), Univ Miami, Dept Neurol Surg, Miller Sch Med, Coral Gables, FL 33124 USA.	rbullock@med.miami.edu					Aarabi B, 2001, J TRAUMA, V51, pS3; Agrawal A, 2008, J NEPAL MED ASSOC, V47, P145; [Anonymous], 2001, J TRAUMA, V51, pS34; [Anonymous], 2001, J TRAUMA, V51, pS16; ARASIL E, 1982, J NEUROSURG, V56, P158, DOI 10.3171/jns.1982.56.1.0158; Duman H, 2002, NEUROL MED-CHIR, V42, P332, DOI 10.2176/nmc.42.332; Fujimoto Y, 2001, NEUROL MED-CHIR, V41, P499, DOI 10.2176/nmc.41.499; Griva F, 2000, SURG NEUROL, V54, P267, DOI 10.1016/S0090-3019(00)00300-1; Hughes BD, 2006, J NEUROSURG, V105, P233, DOI 10.3171/ped.2006.105.3.233; Kamenski Robert S, 2008, J Trauma, V65, pE13, DOI 10.1097/01.ta.0000224219.64266.4c; Karabagli H, 2005, PEDIATR NEUROSURG, V41, P148, DOI 10.1159/000085873; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; KERIN DS, 1983, SURG NEUROL, V20, P301, DOI 10.1016/0090-3019(83)90084-8; Kocak A, 2004, AM J FOREN MED PATH, V25, P246, DOI 10.1097/01.paf.0000127403.97576.0b; MILHORAT TH, 1993, NEUROSURGERY, V32, P140; Misser SK, 2005, SAMJ S AFR MED J, V95, P661; OTT K, 1976, J NEUROSURG, V44, P80, DOI 10.3171/jns.1976.44.1.0080; Ozkan U, 2006, CLIN NEUROL NEUROSUR, V108, P573, DOI 10.1016/j.clineuro.2005.03.002; Rapp LG, 1999, NEUROL RES, V21, P475, DOI 10.1080/01616412.1999.11740961; RENGACHARY SS, 1992, NEUROSURGERY, V30, P291, DOI 10.1227/00006123-199202000-00029; Rinaldi A, 2000, J Neurosurg Sci, V44, P107; Salvati M, 1997, J Neurosurg Sci, V41, P423; Yadav YR, 2006, NEUROL INDIA, V54, P453, DOI 10.4103/0028-3886.28138; YOUNG WF, 1993, SOUTHERN MED J, V86, P557, DOI 10.1097/00007611-199305000-00014	24	15	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR-APR	2012	77	3-4							591.e19	10.1016/j.wneu.2011.06.015			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	961GG	WOS:000305451600053	22120363				2022-02-06	
J	Sturm, JJ; Pierzchala, A; Simon, HK; Hirsh, DA				Sturm, Jesse J.; Pierzchala, Amanda; Simon, Harold K.; Hirsh, Daniel A.			Ondansetron Use in the Pediatric Emergency Room for Diagnoses Other Than Acute Gastroenteritis	PEDIATRIC EMERGENCY CARE			English	Article						gastroenteritis; vomiting; ondansetron	RANDOMIZED CONTROLLED-TRIAL; ORAL ONDANSETRON; CHILDREN; PLACEBO	Background: Ondansetron is widely used in the pediatric emergency department (PED) for vomiting and acute gastroenteritis (GE). Little is known about the spectrum of its use in diagnoses other than acute GE. Objective: The objective of this study was to evaluate the spectrum of diagnoses for which ondansetron is used in the PED. Methods: Medical records from 2 tertiary care PEDs from January 2006 to December 2008 were retrospectively reviewed. Patients 3 months to 18 years of age given ondansetron in the PED were identified. Patients without a primary discharge diagnosis (based on International Classification of Diseases, Ninth Revision code) of vomiting or GE were defined as non-GE. Patient age, initial triage level (1 = lowest acuity, 5 = highest), route of administration (enteral vs parenteral), primary diagnosis, disposition, and prescription for ondansetron at discharge were recorded; GE and non-GE patients were compared based on age and triage acuity. Results: There were 32,971 patients who received ondansetron in the PED; 12,620 (38%) were non-GE patients. Non-GE patients were older (8.3 vs 4.3 years, P < 0.001) and of higher average initial triage level (2.95 vs 2.33, P < 0.001) compared with GE patients. Within non-GE patients, 79% received ondansetron enterally, 71% were discharged, and 37% of those discharged received an ondansetron prescription. The most common primary diagnoses for non-GE discharged patients were fever (15%), abdominal pain/tenderness (13%), head injury/concussion (7%), pharyngitis (6%), viral infection (6%), migraine variants (5%), and otitis media (5%). The most common diagnoses of patients admitted were appendicitis (11%), asthma (6%), pneumonia (4%), and diabetes (4%). Conclusions: Although ondansetron is a widely accepted treatment for GE in children, this study identifies a broader spectrum of primary diagnoses for which ondansetron is being used.	[Sturm, Jesse J.; Pierzchala, Amanda; Simon, Harold K.; Hirsh, Daniel A.] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30307 USA		Sturm, JJ (corresponding author), Emory Univ, Childrens Healthcare Atlanta, 1784 Delaware Ave NE, Atlanta, GA 30307 USA.	jesse.sturm@gmail.com					[Anonymous], 2009, DRUG TOPICS, V155, P24; Freedman SB, 2006, NEW ENGL J MED, V354, P1698, DOI 10.1056/NEJMoa055119; Garra G, 2009, ANN EMERG MED, V53, P528, DOI 10.1016/j.annemergmed.2008.06.003; Langston WT, 2008, ANN EMERG MED, V52, P30, DOI 10.1016/j.annemergmed.2008.01.326; Leung Alexander K C, 2007, Paediatr Drugs, V9, P175, DOI 10.2165/00148581-200709030-00006; PDR Editorial Staff, 2004, RED BOOK UPD; Ramsook C, 2002, ANN EMERG MED, V39, P397, DOI 10.1067/mem.2002.122706; Reeves JJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e62; Roslund G, 2008, ANN EMERG MED, V52, P22, DOI 10.1016/j.annemergmed.2007.09.010; Steel R, 1997, PRINCIPLES PROCEDURE, P520; Stork CM, 2006, ACAD EMERG MED, V13, P1027, DOI 10.1197/j.aem.2006.05.018; Sturm JJ, 2010, ANN EMERG MED, V55, P415, DOI 10.1016/j.annemergmed.2009.11.011; Szajewska H, 2007, ALIMENT PHARM THER, V25, P393, DOI 10.1111/j.1365-2036.2006.03231.x	13	15	15	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2012	28	3					247	250		10.1097/PEC.0b013e3182494d87			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	905JN	WOS:000301268500007	22344213				2022-02-06	
J	Zhu, L; Ji, XJ; Wang, HD; Pan, H; Chen, M; Lu, TJ				Zhu, Lin; Ji, Xiang-jun; Wang, Han-dong; Pan, Hao; Chen, Min; Lu, Ting-jia			Zinc neurotoxicity to hippocampal neurons in vitro induces ubiquitin conjugation that requires p38 activation	BRAIN RESEARCH			English	Article						Neuron; Ubiquitin; Zinc; Traumatic brain injury; p38	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; 12-LIPOXYGENASE ACTIVATION; PROTEASOME SYSTEM; CORTICAL-NEURONS; DEATH; DEGRADATION; ERYTHROPOIETIN; EXPRESSION; RECEPTOR	There is increasing evidence showing that zinc plays a key role in inducing neuronal death during central nervous system injury. However, the underlying mechanisms are poorly understood. Here we assessed the effect of zinc on ubiquitin conjugation and subsequent neurodegeneration using cultured hippocampal cells. We report that cultured neurons are vulnerable to increased level of extracellular Zn2+. Zn2+-induced poly-ubiquitination in cultured neurons is in a concentration- and time-dependent manner. Furthermore our data demonstrated that Zn2+-induced ubiquitination requires p38 activation. These findings indicate that excessive zinc could impair the protein degradation pathway and may be a crucial factor mediating neuronal death following traumatic brain injury. Crown Copyright (C) 2012 Published by Elsevier B.V. All rights reserved.	[Zhu, Lin; Ji, Xiang-jun; Wang, Han-dong; Pan, Hao] Nanjing Univ, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Chen, Min; Lu, Ting-jia] Chinese Acad Sci, Inst Neurosci State, Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Dept Neurosurg, Jinling Hosp, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	wanghandong61@126.com	Chen, Min/A-1134-2014		Jinling Hospital of Nanjing [2008033]; Postdoctoral Foundation of Jiangsu Province, China [1002049C]; Postdoctoral Science FoundationChina Postdoctoral Science Foundation [201150M1572]	The authors gratefully acknowledge Professor Zhi-Qi Xiong (Institute of Neuroscience State, Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) for technical assistance. This work was financially supported by grants of the Jinling Hospital of Nanjing (Grant No 2008033), the Postdoctoral Foundation of Jiangsu Province (Grant No 1002049C) the China Postdoctoral Science Foundation (Grant No 201150M1572). We declare that there is no conflict of interest. The authors declare no conflict of interest.	Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Daniels WMU, 2004, METAB BRAIN DIS, V19, P79, DOI 10.1023/B:MEBR.0000027419.79032.bd; Figueiredo-Pereira ME, 1999, MOL BIOL REP, V26, P65, DOI 10.1023/A:1006909918866; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Ide T, 1999, J CEREBR BLOOD F MET, V19, P750, DOI 10.1097/00004647-199907000-00004; Kim I, 2004, EXP CELL RES, V298, P229, DOI 10.1016/j.yexcr.2004.04.017; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Kiss P, 2005, BIOCHEM J, V391, P301, DOI 10.1042/BJ20050523; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Li SH, 2000, J BIOL CHEM, V275, P13386, DOI 10.1074/jbc.275.18.13386; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Mittal S, 2010, NEUROSCI RES, V68, P159, DOI 10.1016/j.neures.2010.08.002; Mizukami K, 2002, ACTA NEUROPATHOL, V103, P453, DOI 10.1007/s00401-001-0489-1; Morimoto T, 1996, AM J PATHOL, V148, P249; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2004, CURR MOL MED, V4, P87, DOI 10.2174/1566524043479211; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; Stefanidou M, 2006, ARCH TOXICOL, V80, P1, DOI 10.1007/s00204-005-0009-5; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weber A, 2005, NEUROBIOL DIS, V20, P594, DOI 10.1016/j.nbd.2005.04.016; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Yamamoto Y, 2008, CARDIOVASC RES, V79, P89, DOI 10.1093/cvr/cvn076; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Zhang YM, 2004, J NEUROSCI, V24, P10616, DOI 10.1523/JNEUROSCI.2469-04.2004; Zhang Y, 2007, MOL MED, V13, P350, DOI 10.2119/2007-00042.Zhang; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	46	15	15	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 15	2012	1438						1	7		10.1016/j.brainres.2011.12.031			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	913IB	WOS:000301869500001	22261248				2022-02-06	
J	Schultz, S; DeSilva, M; Gu, TT; Qiang, M; Whang, K				Schultz, Stephen; DeSilva, Mauris; Gu, Ting Ting; Qiang, Mei; Whang, Kyumin			Effects of the Analgesic Acetaminophen (Paracetamol) and its para-Aminophenol Metabolite on Viability of Mouse-Cultured Cortical Neurons	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY			English	Article							ENDOCANNABINOID SYSTEM; PHARMACOKINETICS; AUTISM; PLASMA	Acetaminophen has been used as an analgesic for more than a hundred years, but its mechanism of action has remained elusive. Recently, it has been shown that acetaminophen produces analgesia by the activation of the brain endocannabinoid receptor CB1 through its para-aminophenol (p-aminophenol) metabolite. The objective of this study was to determine whether p-aminophenol could be toxic for in vitro developing mouse cortical neurons as a first step in establishing a link between acetaminophen use and neuronal apoptosis. We exposed developing mouse cortical neurons to various concentrations of drugs for 24 hr in vitro. Acetaminophen itself was not toxic to developing mouse cortical neurons at therapeutic concentrations of 10-250 mu g/ml. However, concentrations of p-aminophenol from 1 to 100 mu g/ml produced significant (p < 0.05) loss of mouse cortical neuron viability at 24 hr compared to the controls. The naturally occurring endocannabinoid anandamide also caused similar 24-hr loss of cell viability in developing mouse cortical neurons at concentrations from 1 to 100 mu g/ml, which indicates the mechanism of cell death could be through the cannabinoid receptors. The results of our experiments have shown a detrimental effect of the acetaminophen metabolite p-aminophenol on in vitro developing cortical neuron viability which could act through CB1 receptors of the endocannabinoid system. These results could be especially important in recommending an analgesic for children or individuals with traumatic brain injury who have developing cortical neurons.	[Schultz, Stephen; DeSilva, Mauris] USA, Med Res Unit San Antonio, Ft Sam Houston, TX 78234 USA; [Gu, Ting Ting; Qiang, Mei; Whang, Kyumin] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA		Schultz, S (corresponding author), USA, Med Res Unit San Antonio, 3650 Chambers Pass, Ft Sam Houston, TX 78234 USA.	stephen.t.schultz@amedd.army.mil	Whang, Kyumin/AAT-7006-2020		Naval Medical Research Unit San Antonio [G1008]	This project was funded by work unit number G1008 from the Naval Medical Research Unit San Antonio.	ALBERT KS, 1974, J PHARMACOKINET BIOP, V2, P381, DOI 10.1007/BF01071309; Anavi-Goffer S, 2009, CHEMBIOCHEM, V10, P1591, DOI 10.1002/cbic.200800827; Anderson BJ, 1998, BRIT J CLIN PHARMACO, V46, P237, DOI 10.1046/j.1365-2125.1998.00780.x; Becker KG, 2010, MED HYPOTHESES, V74, P7, DOI 10.1016/j.mehy.2009.08.033; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Bessems JGM, 2001, CRIT REV TOXICOL, V31, P55, DOI 10.1080/20014091111677; Campolongo P, 2009, INT REV NEUROBIOL, V85, P117, DOI 10.1016/S0074-7742(09)85009-5; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Douglas DR, 1996, ACAD EMERG MED, V3, P740, DOI 10.1111/j.1553-2712.1996.tb03508.x; GAZZARD BG, 1973, J PHARM PHARMACOL, V25, P964, DOI 10.1111/j.2042-7158.1973.tb09987.x; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Jager Gerry, 2008, Curr Drug Abuse Rev, V1, P114; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; Pasquariello N, 2009, J BIOL CHEM, V284, P29413, DOI 10.1074/jbc.M109.044412; Qiang M, 2005, MOL PHARMACOL, V67, P2115, DOI 10.1124/mol.104.010751; Schultz ST, 2008, AUTISM, V12, P293, DOI 10.1177/1362361307089518; Schultz ST, 2010, ACTA NEUROBIOL EXP, V70, P227; Shelov SP, 1998, CARING YOUR BABY YOU	18	15	16	2	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1742-7835			BASIC CLIN PHARMACOL	Basic Clin. Pharmacol. Toxicol.	FEB	2012	110	2					141	144		10.1111/j.1742-7843.2011.00767.x			4	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	907RD	WOS:000301434200005	21771276	Bronze			2022-02-06	
J	Rosi, S; Ferguson, R; Fishman, K; Allen, A; Raber, J; Fike, JR				Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Raber, Jacob; Fike, John R.			The Polyamine Inhibitor Alpha-Difluoromethylornithine Modulates Hippocampus-Dependent Function after Single and Combined Injuries	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-SUPEROXIDE DISMUTASE; NEURAL PRECURSOR CELLS; LONG-TERM-MEMORY; EARLY GENE ARC; ORNITHINE-DECARBOXYLASE; CRANIAL IRRADIATION; ADULT NEUROGENESIS; DENTATE GYRUS	Exposure to uncontrolled irradiation in a radiologic terrorism scenario, a natural disaster or a nuclear battlefield, will likely be concomitantly superimposed on other types of injury, such as trauma. In the central nervous system, radiation combined injury (RCI) involving irradiation and traumatic brain injury may have a multifaceted character. This may entail cellular and molecular changes that are associated with cognitive performance, including changes in neurogenesis and the expression of the plasticity-related immediate early gene Arc. Because traumatic stimuli initiate a characteristic early increase in polyamine metabolism, we hypothesized that treatment with the polyamine inhibitor alpha-difluoromethylornithine (DFMO) would reduce the adverse effects of single or combined injury on hippocampus structure and function. Hippocampal dependent cognitive impairments were quantified with the Morris water maze and showed that DFMO effectively reversed cognitive impairments after all injuries, particularly traumatic brain injury. Similar results were seen with respect to the expression of Arc protein, but not neurogenesis. Given that polyamines have been found to modulate inflammatory responses in the brain we also assessed the numbers of total and newly born activated microglia, and found reduced numbers of newly born cells. While the mechanisms responsible for the improvement in cognition after DFMO treatment are not yet clear, the present study provides new and compelling data regarding the potential use of DFMO as a potential countermeasure against the adverse effects of single or combined injury.	[Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Rosi, Susanna; Ferguson, Ryan] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Fike, John R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr ONPRC, Portland, OR 97201 USA		Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	john.fike@ucsf.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R33 AI080531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R33AI080531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) grant R33 AI080531. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; COFFINO P, 1991, J CELL BIOCHEM, V45, P54, DOI 10.1002/jcb.240450112; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; FIKE JR, 1994, RADIAT RES, V138, P99, DOI 10.2307/3578852; FIKE JR, 1995, INT J RADIAT ONCOL, V32, P1035, DOI 10.1016/0360-3016(95)00030-3; GERRISH KE, 1993, LIFE SCI, V52, P1101, DOI 10.1016/0024-3205(93)90431-2; Gilad GM, 2007, J NEUROSCI RES, V85, P594, DOI 10.1002/jnr.21152; Gilad GM, 2003, CELL MOL NEUROBIOL, V23, P637, DOI 10.1023/A:1025036532672; GOBBEL GT, 1991, RADIAT RES, V128, P306, DOI 10.2307/3578054; Gupta N, 2009, NEUROSCIENCE, V161, P691, DOI 10.1016/j.neuroscience.2009.03.075; Gupta N, 2012, PHARMACOL BIOCHEM BE, V100, P464, DOI 10.1016/j.pbb.2011.10.011; Gupta S, 2000, CANCER RES, V60, P5125; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Kilpelainen P, 2000, J NEUROSCI RES, V62, P675, DOI 10.1002/1097-4547(20001201)62:5<675::AID-JNR6>3.0.CO;2-S; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malaterre J, 2004, EUR J NEUROSCI, V20, P317, DOI 10.1111/j.1460-9568.2004.03498.x; MANETTA A, 1988, European Journal of Gynaecological Oncology, V9, P222; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris R., 1984, J NEUROSCI METHODS, V11; Nakagawa M, 1996, INT J RADIAT ONCOL, V36, P113, DOI 10.1016/S0360-3016(96)00239-8; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S., 2010, HIPPOCAMPUS; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shinohara C, 1997, CANCER RES, V57, P2694; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; Sparapani M, 1996, EXP BRAIN RES, V108, P433; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Temiz C, 2005, J CLIN NEUROSCI, V12, P449, DOI 10.1016/j.jocn.2004.05.019; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Wheeler DL, 2003, CANCER RES, V63, P3037; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097	68	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31094	10.1371/journal.pone.0031094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	WOS:000301704200060	22299052	gold, Green Published, Green Submitted			2022-02-06	
J	Liu, EH; Li, CM; Govindasamy, M; Neo, HJ; Lee, TL; Low, CM; Tachibana, S				Liu, Eugene H.; Li, Chunmei; Govindasamy, Malathi; Neo, Hong Jye; Lee, Tat Leang; Low, Chian Ming; Tachibana, Shinro			Elevated prepronociceptin, nociceptin/orphanin FQ and nocistatin concentrations in rat chronic constriction nerve injury and diabetic neuropathic pain models	NEUROSCIENCE LETTERS			English	Article						Nociceptin/orphanin FQ; Nocistatin; Prepronociceptin; Chronic constriction nerve injury; Diabetic neuropathic pain	RECEPTOR; PROTEIN; SYSTEM	Nociceptin/orphanin FQ(N/OFQ) and nocistatin are derived from the same precursor peptide, prepronociceptin. N/OFQ and nocistatin have been postulated to participate in pain modulation. In this study, we investigated whether the prepronociceptin, N/OFQ and nocistatin concentrations in the brain and spinal cord would be altered in chronic constriction injury and diabetic rat neuropathic pain models. Total brain and spinal cord lysates as well as serum from rats that had undergone chronic constriction injury and streptozocin-induced diabetic neuropathy were used to determine the concentrations of three peptides using competitive radioimmunoassay. We found that N/OFQ and prepronociceptin concentrations were significantly raised in both rat neuropathic pain models. Nocistatin was raised in the brains of post traumatic neuropathy pain rats. Overall, our data have demonstrated for the first time that prepronociceptin. N/OFQ and nocistatin concentrations are significantly altered at different tissues of two rat neuropathy pain models. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Liu, Eugene H.; Li, Chunmei; Govindasamy, Malathi; Neo, Hong Jye; Lee, Tat Leang; Low, Chian Ming; Tachibana, Shinro] Natl Univ Hlth Syst, Dept Anaesthesia, Yong Loo Lin Sch Med, Singapore 119074, Singapore; [Low, Chian Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore		Liu, EH (corresponding author), Natl Univ Hlth Syst, Dept Anaesthesia, Yong Loo Lin Sch Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.	Eugene_Liu_HC@nuhs.edu.sg	Neo, Harvey/AAH-8483-2019; Low, Chian-Ming/V-9271-2017	Low, Chian-Ming/0000-0002-1154-4842	National Medical Research Council in SingaporeNational Medical Research Council, Singapore	This work was supported by a grant from the National Medical Research Council in Singapore.	Bridges D, 2001, BRIT J ANAESTH, V87, P12, DOI 10.1093/bja/87.1.12; COURTEIX C, 1993, PAIN, V53, P81, DOI 10.1016/0304-3959(93)90059-X; Fantin M, 2007, BRIT J PHARMACOL, V152, P549, DOI 10.1038/sj.bjp.0707377; Fioravanti B, 2008, CURR TOP MED CHEM, V8, P1442, DOI 10.2174/156802608786264227; Fu X, 2006, BRAIN RES, V1078, P212, DOI 10.1016/j.brainres.2006.01.026; Gavioli EC, 2008, PEPTIDES, V29, P1404, DOI 10.1016/j.peptides.2008.04.004; Himukashi S, 2005, ACTA ANAESTH SCAND, V49, P771, DOI 10.1111/j.1399-6576.2005.00723.x; Joseph T, 2007, PEPTIDES, V28, P1433, DOI 10.1016/j.peptides.2007.05.009; Liu EHC, 2006, NEUROSCI LETT, V397, P59, DOI 10.1016/j.neulet.2005.11.060; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Muth-Selbach U, 2004, ANESTHESIOLOGY, V101, P753, DOI 10.1097/00000542-200409000-00025; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rizzi A, 2006, PAIN, V124, P100, DOI 10.1016/j.pain.2006.03.021; Sandnini M, 2005, EUR J PHARMACOL, V507, P43, DOI 10.1016/j.ejphar.2004.11.030	15	15	15	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JAN 6	2012	506	1					104	106		10.1016/j.neulet.2011.10.059			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	891GK	WOS:000300205000021	22075222				2022-02-06	
J	Radley, E; Akram, A; Grubb, BD; Gibson, CL				Radley, Elizabeth; Akram, Asha; Grubb, Blair D.; Gibson, Claire L.			Investigation of the mechanisms of progesterone protection following oxygen-glucose deprivation in organotypic hippocampal slice cultures	NEUROSCIENCE LETTERS			English	Article						Oxygen-glucose deprivation; Progesterone; Allopregnanolone; Neuroprotection; Hippocampal cultures	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; NEUROACTIVE STEROIDS; RAT; NEUROPROTECTION; ALLOPREGNANOLONE; NEUROSTEROIDS; ISCHEMIA; RECEPTOR; STROKE	This study aimed to test the hypothesis that progesterone is neuroprotective against oxygen-glucose deprivation (OGD) through its conversion to the active metabolite allopregnanolone (AlloP) and the potentiation of GABA(A) receptors. Organotypic hippocampal cultures were exposed to 2 h of OGD and the resulting cell death was quantified 24 h later using combined propidium iodide and Hoechst immunostaining. Initially, we confirmed, that both progesterone and AlloP were protective in terms of reducing cell death following OGD in hippocampal cultures and for both, the optimal level of protection was observed at a concentration of 0.1 mu M. However, the protective effect of progesterone was absent in the presence of finasteride (10 mu M) which inhibits the metabolism of progesterone to active metabolites, including AlloP. In addition, the concurrent application of picrotoxin (100 mu M), a potent GABA(A) receptor antagonist, prevented the protection previously seen by either progesterone or AlloP alone. These results indicate that progesterone protects hippocampal cultures from cell death following OGD largely due to its conversion to AlloP and that GABA(A) receptors are important mediators of the protective effects of both progesterone and AlloP. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Radley, Elizabeth; Akram, Asha; Gibson, Claire L.] Univ Leicester, Sch Psychol, Leicester LE1 9HN, Leics, England; [Grubb, Blair D.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England		Gibson, CL (corresponding author), Univ Leicester, Sch Psychol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	cg95@le.ac.uk		Gibson, Claire/0000-0002-3358-7341; Radley, Elizabeth/0000-0002-8156-1381	Nuffield Foundation [URB/39341]; School of Psychology Research Committee	This study was supported by funds from the Nuffield Foundation (URB/39341 to CLG) and the School of Psychology Research Committee. The authors would like to thank Dr Lucia Pinon for help and advice regarding preparation of the hippocampal slices. Dr Gibson thanks the University of Leicester for granting a period of study leave which enabled the completion of this piece of work.	Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GEE KW, 1988, MOL NEUROBIOL, V2, P291, DOI 10.1007/BF02935636; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Izumi Y, 2007, EUR J NEUROSCI, V26, P1881, DOI 10.1111/j.1460-9568.2007.05809.x; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Lyden PD, 1997, INT REV NEUROBIOL, V40, P233; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932	31	15	15	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JAN 6	2012	506	1					131	135		10.1016/j.neulet.2011.10.065			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	891GK	WOS:000300205000027	22079341				2022-02-06	
J	Bailey, BM; Liesemer, K; Statler, KD; Riva-Cambrin, J; Bratton, SL				Bailey, Beau M.; Liesemer, Kate; Statler, Kimberly D.; Riva-Cambrin, Jay; Bratton, Susan L.			Monitoring and prediction of intracranial hypertension in pediatric traumatic brain injury: Clinical factors and initial head computed tomography	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; pediatrics; Marshall score; coma; intracranial hypertension; cerebral perfusion pressure	PRESSURE MONITORS; HEMORRHAGIC COMPLICATIONS; SCAN CHARACTERISTICS; LINEAR RELATIONSHIP; YOUNG-CHILDREN; RISK-FACTORS; CLASSIFICATION; HYPOTENSION; ICP	BACKGROUND: Control of intracranial hypertension (ICH) in patients with traumatic brain injury (TBI) is standard care. However, predicting risk for ICH is essential to balance risks and benefits of intracranial pressure (ICP) monitoring. Current recommendations for ICP monitoring in pediatric trauma patients are extrapolated from adult studies. METHODS: This retrospective study evaluated 299 children admitted to Primary Children's Medical Center with moderate to severe TBI. ICP monitors were used in 120. Demographic, injury, and admission computed tomography (CT) scan characteristics were compared with determine factors associated with monitoring among those with less severe head CT findings. Among all monitored patients, clinical and radiographic features were compared for early ICH defined as any sustained ICP >= 20 mm Hg in the first 24 hours. RESULTS: Factors independently associated with monitoring children with Marshall I or II scores included presence of intraventricular hemorrhage (odds ratio [OR], 21.4; 95% confidence interval [CI], 4.0-114.7) and greater injury severity scores (ISS) (OR, 9.5 [95% CI, 2.9-31.1] for ISS 21 to 29 and OR, 14.3 [95% CI, 4.3-50.5] for ISS >29 compared with ISS <21). Among those with a normal head CT, 9 of 68 had an ICP monitor placed because of the inability to localize pain. Of these, 78% (7 of 9) had early ICH. Among monitored patients radiologic and clinical features of injury severity were not useful to distinguish risk for early ICH. CONCLUSIONS: Among children with severe TBI, a normal head CT does not exclude ICH. Need for ICP monitoring should be determined by depth of coma in addition to radiographic imaging. J Trauma. 2012;72: 263-270. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Liesemer, Kate; Statler, Kimberly D.; Bratton, Susan L.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care Med, Salt Lake City, UT 84118 USA; [Riva-Cambrin, Jay] Univ Utah, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, Salt Lake City, UT 84118 USA; [Bratton, Susan L.] Primary Childrens Med Ctr, Dept Pediat, Div Crit Care Med, Salt Lake City, UT 84103 USA; [Bailey, Beau M.] Univ Utah, Sch Med, Kaysville, UT USA		Bratton, SL (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Crit Care Med, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84118 USA.	Susan.Bratton@hsc.utah.edu	Bratton, Susan L./O-2353-2013	Bratton, Susan L./0000-0002-4605-8078	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC1NS068943-01]; Neurosurgery Research and Education Foundation (AANS); Hydrocephalus Association Mentored Young Investigator Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC1NS068943] Funding Source: NIH RePORTER	Grant received from National Institute of Neurological Disorders and Stroke, grant number 1RC1NS068943-01, Neurosurgery Research and Education Foundation (AANS), Hydrocephalus Association Mentored Young Investigator Award.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; Bratton S. L., 2007, J NEUROTRAUMA S1, V24, pS37; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK WC, 1989, NEUROSURGERY, V25, P20; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; Marmarou A, 2005, ACT NEUR S, V95, P277; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Wang D, 2004, J TRAUMA, V56, P972; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	26	15	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					263	270		10.1097/TA.0b013e31822a9512			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	898IF	WOS:000300734800048	21841509				2022-02-06	
J	Beaupre, M; De Guise, E; McKerral, M				Beaupre, Michelle; De Guise, Elaine; McKerral, Michelle			The Association between Pain-Related Variables, Emotional Factors, and Attentional Functioning following Mild Traumatic Brain Injury	REHABILITATION RESEARCH AND PRACTICE			English	Article							REACTION-TIME; HEAD-INJURY; SELECTIVE ATTENTION; NEUROPSYCHOLOGICAL ASSESSMENT; POSTCONCUSSIVE SYMPTOMS; DEFICITS; PATHOPHYSIOLOGY; CONCUSSION; MODERATE; RELIABILITY	This study examined how MTBI concomitants such as pain variables, depression, and anxiety were related to attentional functioning at different stages of recovery. Participants having sustained a MTBI who were in the earlier phase of recovery showed, compared to controls, slower reaction times and larger intra-individual variability on a Computerized Pictorial Stroop Task (CPST). They also reported more post-concussion symptoms, pain intensity and disability, whereas MTBI participants who were in the later phase of recovery presented a higher rate of post-concussive symptoms and somewhat higher pain intensity/disability. MTBI participants' scores on the cognitive items of the post-concussion symptoms scale were positively correlated with reaction times on the CPST, while pain intensity/disability levels were negatively correlated with standard attention measures. Results indicate that obtaining response times and intra-individual variability measures using tests such as the CPST represents an effective means for measuring recovery of attentional function, and that pain intensity/disability should be systematically assessed after a MTBI.	[Beaupre, Michelle; McKerral, Michelle] Univ Montreal, Ctr Interdisciplinary Res Rehabilitat, Ctr Readaptat Lucie Bruneau, Montreal, PQ H2H 2N8, Canada; [Beaupre, Michelle; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H2H 2N8, Canada; [De Guise, Elaine] McGill Univ, Montreal Gen Hosp, TBI Program, Hlth Ctr, Montreal, PQ H3G 1A4, Canada		McKerral, M (corresponding author), Univ Montreal, Ctr Interdisciplinary Res Rehabilitat, Ctr Readaptat Lucie Bruneau, Montreal, PQ H2H 2N8, Canada.	michelle.mckerral@umontreal.ca			Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC); Quebec Rehabilitation Research Network; Centre de Readaptation Lucie-Bruneau	This work was supported by the Social Sciences and Humanities Research Council of Canada (scholarship to M. Beaupre), as well as by grants (to M. McKerral) from the Quebec Rehabilitation Research Network and the Centre de Readaptation Lucie-Bruneau.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beck AT, 1990, BECK ANXIETY INVENTO; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; De Houwer J, 2010, PSYCHON B REV, V17, P699, DOI 10.3758/PBR.17.5.699; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; GODEFROY O, 1994, J NEUROL SCI, V126, P168, DOI 10.1016/0022-510X(94)90268-2; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Khatibi A, 2009, PAIN, V142, P42, DOI 10.1016/j.pain.2008.11.020; Kindt M, 1999, J PSYCHOPATHOL BEHAV, V21, P207, DOI 10.1023/A:1022873331067; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kolassa IT, 2005, PSYCHOPHYSIOLOGY, V42, P520, DOI 10.1111/j.1469-8986.2005.00315.x; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; POLLARD CA, 1984, PERCEPT MOTOR SKILL, V59, P974, DOI 10.2466/pms.1984.59.3.974; Prins ML, 2003, DEV BRAIN RES, V140, P93, DOI 10.1016/S0165-3806(02)00588-6; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Robertson I., 1994, TEST EVERYDAY ATTENT; Roelofs J, 2002, EUR J PAIN-LONDON, V6, P273, DOI 10.1053/eujp.2002.0337; Roy S., 2007, J VIS, V7, P944, DOI [10.1167/7.9.944, DOI 10.1167/7.9.944]; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; SELZER ME, 1995, J NEUROL REHABIL, V9, P55; Shallice T., 1990, NEUROPSYCHOLOGY TOME; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vernon-Wilkinson R., 1993, ARCH CLIN NEUROPSYCH, V9, P2; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wood RL, 2007, J NEUROL NEUROSUR PS, V78, P552, DOI 10.1136/jnnp.2006.113845; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	69	15	15	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2867	2090-2875		REHABIL RES PRACT	Rehabil. Res. Pract.		2012	2012								924692	10.1155/2012/924692			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V18NK	WOS:000214757900043	22577557	gold, Green Published			2022-02-06	
J	Chen, BJ; Zuberi, M; Borgens, RB; Cho, Y				Chen, Bojun; Zuberi, Mahvash; Borgens, Richard Ben; Cho, Youngnam			Affinity for, and localization of, PEG-functionalized silica nanoparticles to sites of damage in an ex vivo spinal cord injury model	JOURNAL OF BIOLOGICAL ENGINEERING			English	Article							POLYETHYLENE-GLYCOL; MOLECULAR REPAIR; MEMBRANE-FUSION; NERVE MEMBRANES; POLOXAMER 188; RECOVERY; CELLS; NEUROPROTECTION; BRAIN; TOXICITY	Background: Traumatic spinal cord injury (SCI) leads to serious neurological and functional deficits through a chain of pathophysiological events. At the molecular level, progressive damage is initially revealed by collapse of plasma membrane organization and integrity produced by breaches. Consequently, the loss of its role as a semi-permeable barrier that generally mediates the regulation and transport of ions and molecules eventually results in cell death. In previous studies, we have demonstrated the functional recovery of compromised plasma membranes can be induced by the application of the hydrophilic polymer polyethylene glycol (PEG) after both spinal and brain trauma in adult rats and guinea pigs. Additionally, efforts have been directed towards a nanoparticle-based PEG application. The in vivo and ex vivo applications of PEG-decorated silica nanoparticles following CNS injury were able to effectively and efficiently enhance resealing of damaged cell membranes. Results: The possibility for selectivity of tetramethyl rhodamine-dextran (TMR) dye-doped, PEG-functionalized silica nanoparticles (TMR-PSiNPs) to damaged spinal cord was evaluated using an ex vivo model of guinea pig SCI. Crushed and nearby undamaged spinal cord tissues exhibited an obvious difference in both the imbibement and accumulation of the TMR-PSiNPs, revealing selective labeling of compression-injured tissues. Conclusions: These data show that appropriately functionalized nanoparticles can be an efficient means to both 1.) carry drugs, and 2.) apply membrane repair agents where they are needed in focally damaged nervous tissue.	[Chen, Bojun; Zuberi, Mahvash; Borgens, Richard Ben; Cho, Youngnam] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA; [Borgens, Richard Ben] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Cho, Youngnam] Natl Canc Ctr, Mol Imaging & Therapy Branch, Goyang Si 410769, Gyeonggi Do, South Korea		Borgens, RB (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA.	cpr@purdue.edu			General Funds from the CPR (State of Indiana) [HB 1440]	We would gratefully like to thank Debra Bohnert for her expert surgery and handling of these whole animal experiments. We appreciate the excellent illustrations and graphics by Michel Schweinsberg, and the administrative assistance of Jennifer Danaher for manuscript preparation. This research was supported by General Funds from the CPR (State of Indiana HB 1440), and an endowment from Mrs. Mari Hulman George.	Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; BITTNER GD, 1986, BRAIN RES, V367, P351, DOI 10.1016/0006-8993(86)91617-3; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Borgens RB, 2002, J EXP BIOL, V205, P1; Borgens RB, 2001, NEUROSURGERY, V49, P370, DOI 10.1097/00006123-200108000-00021; Borgens RB, 2001, J NEUROSCI RES, V66, P1179; Borgens RB, 1989, ELECTRIC FIELDS VERT, P117; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Brent J, 2001, DRUGS, V61, P979, DOI 10.2165/00003495-200161070-00006; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Caravati EM, 2005, CLIN TOXICOL, V43, P327, DOI 10.1080/07313820500184971; Cho Y, 2008, SMALL, V4, P1676, DOI 10.1002/smll.200800838; Cho Y, 2008, NANOMEDICINE-UK, V3, P507, DOI 10.2217/17435889.3.4.507; Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028; Cho Youngnam, 2010, J Biol Eng, V4, P2, DOI 10.1186/1754-1611-4-2; Cho Y, 2010, J NEUROSCI RES, V88, P1433, DOI 10.1002/jnr.22309; Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162; Cole A, 2005, TOXICOL IN VITRO, V19, P215, DOI 10.1016/j.tiv.2004.10.007; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Detlof MR, 2006, J NEUROL PHYS THER, V30, P201; Detloff MR, 2005, J NEUROTRAUM, V22, P1219; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Donaldson J, 2002, NEUROSURGERY, V50, P147, DOI 10.1097/00006123-200201000-00023; Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s; Fang N, CHITOSAN INDUCED RES; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Koob Andrew O, 2008, J Biol Eng, V2, P9, DOI 10.1186/1754-1611-2-9; Koob AO, 2006, J NEUROSCI RES, V83, P1558, DOI 10.1002/jnr.20837; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/neu.2004.21.1767; Lee RC, 2002, ANN NY ACAD SCI, V961, P271, DOI 10.1111/j.1749-6632.2002.tb03100.x; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lentz BR, 2007, EUR BIOPHYS J BIOPHY, V36, P315, DOI 10.1007/s00249-006-0097-z; Liu-Snyder P, 2007, J EXP BIOL, V210, P1455, DOI 10.1242/jeb.02756; Luo J, 2004, J NEUROTRAUM, V21, P994, DOI 10.1089/0897715041651097; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; MACDONALD RI, 1985, BIOCHEMISTRY-US, V24, P4058, DOI 10.1021/bi00336a039; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; Merchant FA, 1998, J SURG RES, V74, P131, DOI 10.1006/jsre.1997.5252; Mohanraj V. J., 2006, Tropical Journal of Pharmaceutical Research, V5, P561; Palmer JS, 1998, J UROLOGY, V159, P2136, DOI 10.1016/S0022-5347(01)63295-6; Quinlan JG, 2006, NEUROMUSCULAR DISORD, V16, P855, DOI 10.1016/j.nmd.2006.09.016; SCHNEIDERMAN S, 1979, SOMAT CELL GENET, V5, P263, DOI 10.1007/BF01539165; Schwab Jan M., 2001, Trends in Neurosciences, V24, P437, DOI 10.1016/S0166-2236(00)01893-2; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi YZ, 2010, NAT NANOTECHNOL, V5, P80, DOI [10.1038/nnano.2009.303, 10.1038/NNANO.2009.303]; SZABO G, 1982, CYTOMETRY, V3, P59, DOI 10.1002/cyto.990030113; Webster R, 2009, MILESTONES DRUG THER, P127, DOI 10.1007/978-3-7643-8679-5_8; Weinreb G, 2007, BIOPHYS J, V92, P4012, DOI 10.1529/biophysj.106.090043; Zuberi Mahvash, 2008, J Biol Eng, V2, P17, DOI 10.1186/1754-1611-2-17	54	15	17	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-1611			J BIOL ENG	J. Biol. Eng.		2012	6	1							18	10.1186/1754-1611-6-18			10	Biochemical Research Methods; Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	V31TG	WOS:000208905300018	22979980	Green Published, gold			2022-02-06	
J	Chiu, CYP; Tlustos, SJ; Walz, NC; Holland, SK; Eliassen, JC; Bernard, L; Wade, SL				Chiu, C. -Y. Peter; Tlustos, Sarah J.; Walz, Nicolay Chertkoff; Holland, Scott K.; Eliassen, James C.; Bernard, Lori; Wade, Shari L.			Neural Correlates of Risky Decision Making in Adolescents With and Without Traumatic Brain Injury Using the Balloon Analog Risk Task	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							BART	We studied risky decision making (RDM) in 8 healthy adolescents (TC) and 11 adolescents with mild to moderate traumatic brain injuries (TBI) using the Balloon Analog Risk Task (BART) and functional magnetic resonance imaging (fMRI). Participants inflated simulated balloons (with more points awarded to bigger balloons), which might burst at any time. Increasing brain activation levels were associated with increasing balloon size in a largely bilateral network, including cerebellar, inferior parietal, limbic, and frontal areas. Both groups performed similarly and activated similar networks.	[Chiu, C. -Y. Peter; Tlustos, Sarah J.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp, Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, Cincinnati, OH USA; [Holland, Scott K.] Cincinnati Childrens Hosp, Med Ctr, Commun Sci Res Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Eliassen, James C.] Univ Cincinnati, Coll Med, Ctr Imaging Res, Cincinnati, OH 45221 USA; [Bernard, Lori; Wade, Shari L.] Cincinnati Childrens Hosp, Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH USA		Chiu, CYP (corresponding author), Univ Cincinnati, Dept Psychol, ML0376, Cincinnati, OH 45221 USA.	peter.chiu@uc.edu		Holland, Scott/0000-0003-3719-0875	NIH from the National Institute of Mental Health [RO1-MH073764]; National Institute on Disability and Rehabilitation Research in the Department of Education [H133G050239]; Ohio Department of Public Safety; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (1) NIH grant RO1-MH073764 from the National Institute of Mental Health (to S. Wade); (2) H133G050239 from the National Institute on Disability and Rehabilitation Research in the Department of Education (to S. Wade); and (3) EMS/Trauma grant from the Ohio Department of Public Safety (to S. Wade).	Bornovalova MA, 2009, PHARMACOL BIOCHEM BE, V93, P258, DOI 10.1016/j.pbb.2008.10.023; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038	8	15	15	2	13	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		2012	37	2					176	183		10.1080/87565641.2011.632796			8	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	912LK	WOS:000301799300005	22339229	Green Accepted			2022-02-06	
J	Deng, ZH; Yan, GT; Wang, LH; Zhang, JY; Xue, H; Zhang, K				Deng, Zi-Hui, Jr.; Yan, Guang-Tao; Wang, Lu-Huan; Zhang, Jin-Ying; Xue, Hui; Zhang, Kai			Leptin relieves intestinal ischemia/reperfusion injury by promoting ERK1/2 phosphorylation and the NO signaling pathway	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Leptin; nitric oxide; intestinal I/R injury; mucosal repair; oxygen radicals	CYTOSOLIC PHOSPHOLIPASE A(2); ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; ETHANOL CYTOTOXICITY; PROTECTION; PROSTAGLANDIN; ACTIVATION; EXPRESSION; CYTOKINE; PROTEIN	BACKGROUND: Recently, research has indicated that leptin plays a protective role in traumatic brain and liver injury. We studied the protective effect of leptin on intestinal I/R injury and examined its mechanism by using mice intestinal I/R model and murine peritoneal macrophage hypoxia/reoxygenation (H/R) injury model. METHODS: Leptin was intraperitoneally administrated at 45 minutes after ischemia, then reperfusion for two hours. Cells were treated with different concentrations of leptin at three hours after hypoxia, then reoxygenation for six hours. Mice intestines were harvested for histopathologic properties. The malondialdehyde, nitric oxide (NO), interleukin-6, and total antioxidative capacity were detected according to respective assay kit. Phosphorylated extracellular regulated kinase1/2 (p-ERK1/2) and phosphorylated cytosolic phospholipase A(2) (p-cPLA(2)) were determined by Western blot assay. RESULTS: Here, we show that leptin reduced intestinal histologic alterations, malondialdehyde and interleukin-6 levels but increased the endogenous leptin expression and NO production in the intestines. Leptin also increased the NO and total antioxidative capacity levels in cells. We further demonstrated that leptin markedly activated ERK1/2 in the intestines and activated ERK1/2 and cPLA(2) in the cells. Moreover, the protective effect of leptin against intestinal I/R injury and elevated NO production was attenuated by blocking the ERK1/2 pathway. CONCLUSIONS: These data demonstrate that leptin ameliorated intestinal I/R and peritoneal macrophage H/R injury by enhancing ERK1/2 phosphorylation and promoting the NO production signaling pathway. (J Trauma. 2012;72: 143-149. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Deng, Zi-Hui, Jr.; Yan, Guang-Tao; Wang, Lu-Huan; Zhang, Jin-Ying; Xue, Hui; Zhang, Kai] Gen Hosp PLA, Biochem Res Lab, Basic Med Inst, Beijing, Peoples R China		Yan, GT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Biochem Res Lab, Basic Med Inst, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yan301@263.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670821]	Supported by the National Natural Science Foundation of China (No. 30670821).	BARATTA M, 2002, MED SCI MONITOR, V8, P282; Breithaupt-Faloppa AC, 2009, SHOCK, V32, P55, DOI 10.1097/SHK.0b013e31818bb7a1; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Fernandez-Riejos P, 2008, CLIN EXP IMMUNOL, V151, P505, DOI 10.1111/j.1365-2249.2007.03563.x; Hacioglu A, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-37; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Lanas A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2465; Lin J, 2004, PEPTIDES, V25, P2187, DOI 10.1016/j.peptides.2004.08.006; Lin Ji, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P1254; Mahapatra SK, 2009, TOXICOL MECH METHOD, V19, P100, DOI 10.1080/15376510802255184; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Sainz N, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/784343; Slomiany BL, 2008, J PHYSIOL PHARMACOL, V59, P301; Slomiany B. L., 2009, Inflammopharmacology, V17, P6, DOI 10.1007/s10787-008-8037-4; Slomiany BL, 2005, J PHYSIOL PHARMACOL, V56, P531; Sukhotnik I, 2009, PEDIATR RES, V66, P648, DOI 10.1203/PDR.0b013e3181be9f84; Yan GT, 2009, EUR J PHARMACOL, V616, P244, DOI 10.1016/j.ejphar.2009.06.039; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	21	15	16	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					143	149		10.1097/TA.0b013e3182222f67			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	898IF	WOS:000300734800030	21857261				2022-02-06	
J	Dethier, M; Blairy, S; Rosenberg, H; McDonald, S				Dethier, Marie; Blairy, Sylvie; Rosenberg, Hannah; McDonald, Skye			Spontaneous and posed emotional facial expressions following severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Posed facial expression; Spontaneous facial expression; Traumatic brain injury; Nonverbal communication; Interpersonal functioning	PERSONALITY-ASSESSMENT INVENTORY; FOCAL CEREBRAL-LESIONS; CLOSED-HEAD-INJURY; NEUROPSYCHIATRIC DISORDERS; DIFFERENT MEDIA; RECOGNITION; IMPAIRMENT; DEFICITS; PERCEPTION; SEQUELAE	The current study aimed to test the intensity of spontaneous emotional expressions and the accuracy of posed emotional expressions in patients with severe traumatic brain injury (TBI). Method: Twenty-three participants with TBI and 27 matched control participants were asked to relate personal angry, happy, and sad events (spontaneous expressivity) and to pose angry, happy, and sad expressions in response to a photo or word cue (posed expressivity). Their emotional facial expressions were coded via judges' ratings. Results: Participants with TBI had less intense sad expressions when relating a sad event than did control participants. No group difference emerged in the happy and angry events, the latter possibly due to differentially low interrater reliability for anger ratings. Participants with TBI were impaired in their ability to pose sad emotions. Conclusions: These preliminary findings suggest that patients with TBI are impaired at expressing sad expressions either spontaneously or deliberately. This may reflect difficulties in the initiation or suppression of facial expression as well as an impaired semantic knowledge of the facial configuration of sad expression.	[Dethier, Marie] Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, B-4000 Liege, Belgium; [Rosenberg, Hannah; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia		Dethier, M (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, Blvd Rectorat 3,B33, B-4000 Liege, Belgium.	marie.dethier@ulg.ac	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094	University of LiegeUniversity of Liege	This study was supported by a research grant from the University of Liege. This study is the result of collaboration between the University of New South Wales and the University of Liege and was conducted while the first author was visiting the University of New South Wales. The authors wish to thank all the people with traumatic brain injuries and community controls who willingly donated their time to participate in this research. We also would like to acknowledge the contribution of Rebekah Randall who assisted with data collection and entry.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Blanchard J. J., 1998, HDB SOCIAL FUNCTIONI; BOROD JC, 1990, J COMMUN DISORD, V23, P247, DOI 10.1016/0021-9924(90)90003-H; Brozgold A Z, 1998, Appl Neuropsychol, V5, P15, DOI 10.1207/s15324826an0501_2; Calvo MG, 2010, VIS COGN, V18, P1274, DOI 10.1080/13506285.2010.481867; Camras L. A., 1994, NATURE EMOTION, P347; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Dethier M., 2011, EMOTIONAL REGU UNPUB; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; Elfenbein HA, 2010, J PERS SOC PSYCHOL, V98, P301, DOI 10.1037/a0017766; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FRIDLUND AJ, 1991, J PERS SOC PSYCHOL, V60, P229, DOI 10.1037/0022-3514.60.2.229; Fridlund AJ., 1994, HUMAN FACIAL EXPRESS; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kornreich C, 2002, ALCOHOL ALCOHOLISM, V37, P394, DOI 10.1093/alcalc/37.4.394; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Matsumoto D., 1988, JAPANESE CAUCASIAN F; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; Parkinson B, 2005, PERS SOC PSYCHOL REV, V9, P278, DOI 10.1207/s15327957pspr0904_1; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schneider W., 2002, E PRIME REFERENCE GU; Shamay-Tsoory SG, 2007, EMPATHY IN MENTAL ILLNESS, P89, DOI 10.1017/CBO9780511543753.007; Smith M C, 1996, J Int Neuropsychol Soc, V2, P383; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; StatSoft I, 2011, STATISTICA VERS 10 D; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEDDELL RA, 1988, NEUROPSYCHOLOGIA, V26, P373, DOI 10.1016/0028-3932(88)90092-9; WEDDELL RA, 1994, BRAIN COGNITION, V25, P161, DOI 10.1006/brcg.1994.1029; WEDDELL RA, 1990, NEUROPSYCHOLOGIA, V28, P49, DOI 10.1016/0028-3932(90)90085-3; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	65	15	17	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	9					936	947		10.1080/13803395.2012.702734			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	030YB	WOS:000310604900005	22827155				2022-02-06	
J	Luo, YH; Li, ZX; Chen, HX				Luo, Yunhua; Li, Zhaoxia; Chen, Hongxi			Finite-element study of cerebrospinal fluid in mitigating closed head injuries	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Cerebrospinal fluid; intracranial pressure; closed head injury; mild impact; finite-element modeling	DYNAMIC-RESPONSE; LARGE-DEFORMATION; BRAIN-INJURY; IMPACT; SIMULATION; MODEL; BIOMECHANICS; HELMETS; FUTURE; STATE	The mechanism of cerebrospinal fluid in mitigating closed head injuries caused by mild impacts was investigated by finite-element modeling. Three biomechanical models were constructed. In these models, cerebrospinal fluid was considered as a soft solid material, an inviscid fluid without intracranial pressure, and an inviscid fluid with normal intracranial pressure, respectively, while other conditions such as the finite-element mesh, the impact, and the boundary conditions were kept the same. The recently developed nearest nodes finite-element method was adopted to deal with large deformations in brain tissue. Results obtained from the numerical studies showed that cerebrospinal fluid was able to remarkably reduce the maximum peak strains, especially the shear strains induced by impacts and transmitted to the brain. Cerebrospinal fluid with intracranial pressure was able to further buffer relative oscillations between the skull and the brain.	[Luo, Yunhua; Li, Zhaoxia; Chen, Hongxi] Univ Manitoba, Fac Engn, Dept Mech & Mfg Engn, Winnipeg, MB R3T 5V6, Canada		Luo, YH (corresponding author), Univ Manitoba, Fac Engn, Dept Mech & Mfg Engn, Winnipeg, MB R3T 5V6, Canada.	Yunhua.Luo@ad.umanitoba.ca		Luo, Yunhua/0000-0003-0271-1319	Manitoba Health Research Council (MHRC)	The reported research has been supported by an Establishment Grant awarded to the first author by the Manitoba Health Research Council (MHRC), which is gratefully acknowledged.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Al-Bsharat A, 1999, INTRACRANIAL PRESSUR, V42, P113; BISHOP PJ, 1993, ASTM STP, V1212, P175; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; CHAN HS, 1974, P 18 STAPP CAR CRASH, P557; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; Dassios G, 1998, COMPUT MECH, V21, P382, DOI 10.1007/s004660050315; Davis J.L., 1988, WAVE PROPAGATION SOL; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Faul M., 2010, TECHNICAL REPORT; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; Gong SW, 2008, IEEE T BIO-MED ENG, V55, P1226, DOI 10.1109/TBME.2007.912431; Halabieh O, 2008, LECT NOTES COMPUT SC, V5104, P107, DOI 10.1007/978-3-540-70521-5_12; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Haw-Ming Huang, 1995, Chinese Journal of Medical and Biological Engineering, V15, P127; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Jirousek O., 2006, Proceedings of the Fourth IASTED International Conference on Biomechanics; Jirousek O, 2005, VDI BER, V1899, P463; KHALIL TB, 1982, P 26 STAPP CAR CRASH, P87; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; KLEIVEN S, 2002, THESIS ROYAL I TECHN; KORMI K, 1992, J BIOMED ENG, V14, P203, DOI 10.1016/0141-5425(92)90053-N; Kuijpers A. H. W. M., 1996, Computer Methods in Biomechanics and Biomedical Engineering, P207; Leestma J, 1987, FORENSIC NEUROPATHOL; Lovas A., 1995, Acta Technica Academiae Scientiarum Hungaricae, V107, P83; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Luo Y., 2008, ADV THEORETICAL APPL, V1, p225 ; Luo Y, 2008, ADV THEOR APPL MECH, V1, P31; Luo YH, 2008, FINITE ELEM ANAL DES, V44, P797, DOI 10.1016/j.finel.2008.06.004; Luo YH, 2008, INT J SOLIDS STRUCT, V45, P5074, DOI 10.1016/j.ijsolstr.2008.05.006; Luo YH, 2010, INT J NUMER METH BIO, V26, P1125, DOI 10.1002/cnm.1184; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; McGuine T, 1997, AM SOC TEST MATER, V1305, P83, DOI 10.1520/STP11775S; Mehta B. V., 1996, Computer Methods in Biomechanics and Biomedical Engineering, P217; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mota A, 2003, COMPUT MECH, V31, P115, DOI 10.1007/s00466-002-0398-8; Nahum AM, 1977, P 21 STAPP CAR CRASH; NICKELL RE, 1974, J ENG IND-T ASME, V96, P490, DOI 10.1115/1.3438355; Ogden, 1984, NONLINEAR ELASTIC DE; PFEFFERBAUM A, 1986, J COMPUT ASSIST TOMO, V10, P571, DOI 10.1097/00004728-198607000-00004; Prange M, 2001, BIOENG C, V50, P833; Rousseau P, 2009, J ASTM INT, V6, P11; Ruan J, 1995, P 1995 BIOENG C JUN, P319; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Ruan S-J, 2004, CHIN J BIOMED ENG, V23, P52; Shealy JE, 2009, AM SOC TEST MATER, V1510, P39, DOI 10.1520/STP47464S; Stalnaker RL., 1973, HUMAN IMPACT RESPONS, P85; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Sussman T, COMPUT STRUCT, V26, P357; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Ueno JW, 1991, 2 DIMENSIONAL FINITE, V126, P121; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yang KH, 2003, INT J VEHICLE DES, V32, P116, DOI 10.1504/IJVD.2003.003240; Zhang JY, 2007, PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007, P605; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1; Zou H, 2008, INT J CRASHWORTHINES, V13, P337, DOI 10.1080/13588260801943047	70	15	16	1	15	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.		2012	226	H7					499	509		10.1177/0954411912445729			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	012AL	WOS:000309207600001	22913097				2022-02-06	
J	Mohammad-Gharibani, P; Tiraihi, T; Mesbah-Namin, SA; Arabkheradmand, J; Kazemi, H				Mohammad-Gharibani, Payam; Tiraihi, Taki; Mesbah-Namin, Seyed Alireza; Arabkheradmand, Jalil; Kazemi, Hadi			Induction of bone marrow stromal cells into GABAergic neuronal phenotype using creatine as inducer	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						BMSCs; GABAergic-like neurons; induction; creatine	IN-VITRO DIFFERENTIATION; EMBRYONIC STEM-CELLS; TRAUMATIC BRAIN-INJURY; NEURAL STEM; SUBTYPE SPECIFICATION; HUNTINGTON-DISEASE; SURVIVAL; PRECURSORS; GENERATION; RAT	Purpose: Deficits involving GABAergic neurons have been reported in aging, central nervous trauma and neurodegenerative disorders; bone marrow stromal cells (BMSCs) have been proposed as a feasible source of donor cells in replacement cell therapy. In this study, the effects of creatine on transdifferentiating BMSCs into GABAergic-like neurons were evaluated in vitro. Methods: The BMSCs were isolated from adult rats, preinduced by beta-mercaptoethanol (BME) and retinoic acid (RA), and then induced by creatine into GABAergic-like neurons. The cells were characterized using different differentiation markers. The functionality of the differentiated cells was evaluated using FM1-43. Results: The isolated cells expressed Oct-4 and were immunoreactive to fibronectin and CD44. The highest percentages of cells immunoreactive to nestin and neurofilament-68 were found at the second day of preinduction. At the induction stage, there were increases in the number of cells immunoreactive to neurofilament-200, MAP-2, synapsin I, synaptophysin, and NeuN. The percentages of the immunoreactive cells to GABAergic neuron markers increased. The optimal induction dose was 5 mM. The dose of 10mM showed a decline in the expression of most of these markers. The functionality test indicated that the synaptic vesicles were released upon stimulation. Conclusion: Creatine can induce the differentiation of BMSCs to the GABAergic neuronal phenotype within one week.	[Tiraihi, Taki] Tarbiat Modares Univ, Fac Med Sci, Dept Anat Sci, Tehran 14115111, Iran; [Mohammad-Gharibani, Payam; Arabkheradmand, Jalil; Kazemi, Hadi] Univ Tehran, Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Mesbah-Namin, Seyed Alireza] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran 14115111, Iran; [Mohammad-Gharibani, Payam] Tarbiat Modares, Dept Anat Sci, Fac Med Sci, Tehran, Iran		Tiraihi, T (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Anat Sci, Tehran 14115111, Iran.	takialtr@modares.ac.ir		Gharibani, Payam/0000-0002-4546-0890	Shefa Neurosciences Research Center at Khatam Al-Anbia Hospital, Tehran, Iran [86-N-105]; Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	The project was funded by Shefa Neurosciences Research Center at Khatam Al-Anbia Hospital, Tehran, Iran (Grant # 86-N-105). We are also grateful for the support of the Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. We express deep gratitude to Professor Dr Howard Prentice (Department of Biomedical Science, Charles E Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, United States of America) and Mrs H. AliAkbar for editing the manuscript.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Adhihetty PJ, 2008, NEUROMOL MED, V10, P275, DOI 10.1007/s12017-008-8053-y; Andres RH, 2005, CELL TRANSPLANT, V14, P537, DOI 10.3727/000000005783982756; Andres RH, 2005, J NEUROCHEM, V95, P33, DOI 10.1111/j.1471-4159.2005.03337.x; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Arlotta P, 2003, ANN NY ACAD SCI, V991, P229; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bosch M, 2004, EXP NEUROL, V190, P42, DOI 10.1016/j.expneurol.2004.06.027; Brewer GJ, 2000, J NEUROCHEM, V74, P1968, DOI 10.1046/j.1471-4159.2000.0741968.x; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; COCHARD P, 1984, J NEUROSCI, V4, P2080; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Cousin M., 2003, CURR PROT NEUROSCI, P261; Croft AP, 2004, STEM CELLS DEV, V13, P409, DOI 10.1089/scd.2004.13.409; Deldicque L, 2008, J APPL PHYSIOL, V104, P371, DOI 10.1152/japplphysiol.00873.2007; Dubois-Dauphin ML, 2010, BIOMATERIALS, V31, P7032, DOI 10.1016/j.biomaterials.2010.06.017; Ducray A, 2006, NEUROSCI LETT, V395, P57, DOI 10.1016/j.neulet.2005.10.051; Ducray AD, 2007, J NEUROSCI RES, V85, P1863, DOI 10.1002/jnr.21337; Ducray AD, 2007, BRAIN RES, V1137, P50, DOI 10.1016/j.brainres.2006.12.038; Flames N, 2005, NEURON, V46, P377, DOI 10.1016/j.neuron.2005.04.020; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gavalda N, 2004, MOL CELL NEUROSCI, V25, P460, DOI 10.1016/j.mcn.2003.11.012; Gharibani PM, 2010, RESTOR NEUROL NEUROS, V28, P367, DOI 10.3233/RNN-2010-0539; Goldman SA, 2007, CLIN PHARMACOL THER, V82, P453, DOI 10.1038/sj.clpt.6100337; Gualano B, 2010, AM J KIDNEY DIS, V55, pE7, DOI 10.1053/j.ajkd.2009.10.053; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, STEM CELLS, V24, P949, DOI 10.1634/stemcells.2005-0192; Horn M, 1999, CARDIOVASC RES, V43, P117, DOI 10.1016/S0008-6363(99)00075-9; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Juravleva E, 2005, J NEUROSCI RES, V79, P224, DOI 10.1002/jnr.20291; Kilic G, 2002, BIOPHYS J, V83, P849, DOI 10.1016/S0006-3495(02)75213-2; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Maisano X, 2009, NEUROTHERAPEUTICS, V6, P263, DOI 10.1016/j.nurt.2009.01.011; Mathew SS, 2008, J NEUROSCI, V28, P725, DOI 10.1523/JNEUROSCI.3625-07.2008; Matthews RT, 1998, J NEUROSCI, V18, P156; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Mohammad-Gharibani Payam, 2009, IRANIAN BIOMEDICAL JOURNAL, V13, P137; Murashov AK, 2004, FASEB J, V18, P252, DOI 10.1096/fj.04-2251fje; Naghdi M, 2009, CYTOTHERAPY, V11, P137, DOI 10.1080/14653240802716582; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Pavan B, 2011, DRUG DISCOV TODAY, V16, P520, DOI 10.1016/j.drudis.2011.03.010; Pena-Altamira E, 2005, BRAIN RES, V1058, P183, DOI 10.1016/j.brainres.2005.07.011; Persky AM, 2003, J CLIN PHARMACOL, V43, P29, DOI 10.1177/0091270002239703; Rawson ES, 2011, NUTRITION, V27, P451, DOI 10.1016/j.nut.2010.04.001; ROMAND R, 1988, BRAIN RES, V462, P167, DOI 10.1016/0006-8993(88)90601-4; Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Shin E, 2012, STEM CELL REV REP, V8, P513, DOI 10.1007/s12015-011-9290-2; Tabrizi SJ, 2005, NEUROLOGY, V64, P1655, DOI 10.1212/01.WNL.0000160388.96242.77; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; Tewarie RSN, 2009, J SPINAL CORD MED, V32, P105, DOI 10.1080/10790268.2009.11760761; Thompson K, 2009, NEUROTHERAPEUTICS, V6, P284, DOI 10.1016/j.nurt.2009.01.016; Undamatla J, 2001, CELL MOTIL CYTOSKEL, V49, P16, DOI 10.1002/cm.1017; Wang N, 2011, FOOD CHEM TOXICOL, V49, P2975, DOI 10.1016/j.fct.2011.06.080; Westmoreland JJ, 2001, BIOCHEM BIOPH RES CO, V284, P674, DOI 10.1006/bbrc.2001.5031; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu Yongchao, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P488; WUARIN L, 1991, DEV BIOL, V144, P429, DOI 10.1016/0012-1606(91)90435-6; Zhang SF, 2011, NEURODEGENER DIS, V8, P194, DOI 10.1159/000321681; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhong JY, 2011, DEVELOPMENT, V138, P409, DOI 10.1242/dev.061051	72	15	19	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	6					511	525		10.3233/RNN-2012-100155			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	030MU	WOS:000310575600006	22903159				2022-02-06	
J	Morali, G; Montes, P; Gonzalez-Burgos, I; Velazquez-Zamora, DA; Cervantes, M				Morali, Gabriela; Montes, Pedro; Gonzalez-Burgos, Ignacio; Velazquez-Zamora, Dulce A.; Cervantes, Miguel			Cytoarchitectural characteristics of hippocampal CA1 pyramidal neurons of rats, four months after global cerebral ischemia and progesterone treatment	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Progesterone neuroprotection; global cerebral ischemia; hippocampal pyramidal neurons cytoarchitecture; dendritic spines; rat	NEUROTROPHIC FACTOR EXPRESSION; DENDRITIC SPINE DENSITY; TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; LONG-TERM; ARTERY OCCLUSION; MOLECULAR-MECHANISMS; FUNCTIONAL DEFICITS; MEMORY DEFICITS; CARDIAC-ARREST	Purpose: To analyze the cytoarchitectural characteristics of the remaining pyramidal neurons in the hippocampal CA1 subfield of rats, four months after global cerebral ischemia (GCI) and progesterone treatment. Methods: Dendritic arborization, and density and shape of the dendritic spines of CA1 pyramidal neurons in brains of intact rats, or rats submitted 120 days earlier to GCI and treatment with progesterone (8 mg/kg) or its vehicle, at 15 min, and 2, 6, 24, 48, and 72 h after the onset of reperfusion, were analyzed in samples processed by a modified Golgi method. Results: Few impregnated CA1 pyramidal neurons were identified in the ischemic vehicle-treated rats, with a short apical dendrite devoid of bifurcations and dendritic spines. In contrast, the remaining CA1 pyramidal neurons sampled from ischemic progesterone-treated rats showed sinuously branched dendrites with similar number of bifurcations and whole density of spines, and higher proportional density of mushroom spines than those in the intact group. Conclusions: These cytoarchitectural characteristics may underlie the long-term preservation of place learning and memory functions seen after ischemia and progesterone neuroprotective treatment, possibly compensating for the severe reduction in neuronal population.	[Morali, Gabriela; Montes, Pedro] UMAE Hosp Especialidades, Ctr Med Nacl Siglo XXI, Unidad Invest Med Farmacol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Gonzalez-Burgos, Ignacio; Velazquez-Zamora, Dulce A.] Univ Guadalajara, Ctr Invest Biomed Occidente, Div Neurociencias, Lab Psicobiol,IMSS, Guadalajara 44430, Jalisco, Mexico; [Gonzalez-Burgos, Ignacio; Velazquez-Zamora, Dulce A.] Univ Guadalajara, CUCBA, Guadalajara 44430, Jalisco, Mexico; [Cervantes, Miguel] Univ Michoacana SNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico		Morali, G (corresponding author), UMAE Hosp Especialidades, Ctr Med Nacl Siglo XXI, Unidad Invest Med Farmacol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Montes, Pedro/0000-0003-1630-5047	Instituto Mexicano del Seguro Social, MEXICO [2006/1A/I/029, FIS/IMSS/PROT/196]	Partially supported by Instituto Mexicano del Seguro Social, MEXICO (2006/1A/I/029; FIS/IMSS/PROT/196).	Arvidsson A, 2001, NEUROSCIENCE, V106, P27, DOI 10.1016/S0306-4522(01)00268-8; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Crepel V, 2003, J CELL MOL MED, V7, P401, DOI 10.1111/j.1582-4934.2003.tb00242.x; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Gonzalez SL, 2009, CELL MOL NEUROBIOL, V29, P27, DOI 10.1007/s10571-008-9291-0; Gonzalez-Burgos I, 2007, NEUROSCI LETT, V423, P162, DOI 10.1016/j.neulet.2007.06.050; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; GONZALEZBURGOS I, 1992, BIOTECH HISTOCHEM, V67, P288, DOI 10.3109/10520299209110037; GOULD E, 1990, J NEUROSCI, V10, P1286; HARRIS KM, 1989, HIPPOCAMPUS NEW VIST, P17; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Jourdain P, 2002, J NEUROSCI, V22, P3108, DOI 10.1523/JNEUROSCI.22-08-03108.2002; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; KOGURE K, 1988, NEUROCHEM PATHOL, V9, P145; Kovalenko T, 2006, HIPPOCAMPUS, V16, P814, DOI 10.1002/hipo.20211; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Letechipia-Vallejo G, 2007, J PINEAL RES, V42, P139, DOI 10.1111/j.1600-079X.2006.00395.x; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; MUDRICK LA, 1989, BRAIN RES, V493, P179, DOI 10.1016/0006-8993(89)91014-7; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; OLSEN GM, 1994, BEHAV NEUROSCI, V108, P681, DOI 10.1037/0735-7044.108.4.681; Olvera-Cortes E, 2002, BRAIN RES BULL, V58, P261, DOI 10.1016/S0361-9230(02)00769-4; ONODERA H, 1990, NEUROSCIENCE, V38, P125, DOI 10.1016/0306-4522(90)90379-I; Plamondon H, 2008, PHYSIOL BEHAV, V95, P492, DOI 10.1016/j.physbeh.2008.07.020; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Ruan YW, 2006, NEUROSCIENCE, V140, P191, DOI 10.1016/j.neuroscience.2006.01.039; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schmidt-Kastner R, 2001, MOL BRAIN RES, V92, P157, DOI 10.1016/S0169-328X(01)00157-7; Silva AJ, 1998, NEUROBIOL LEARN MEM, V70, P44, DOI 10.1006/nlme.1998.3837; Skibo GG, 2010, VITAM HORM, V82, P107, DOI 10.1016/S0083-6729(10)82006-0; Spruston N., 2007, HIPPOCAMPUS BOOK, P133; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Velazquez-Zamora D.A., 2011, BRAIN RES IN PRESS; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	63	15	15	1	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	1					1	8		10.3233/RNN-2011-0605			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	901HN	WOS:000300955300001	22377905				2022-02-06	
J	Patel, TP; Ventre, SC; Meaney, DF				Patel, Tapan P.; Ventre, Scott C.; Meaney, David F.			Dynamic Changes in Neural Circuit Topology Following Mild Mechanical Injury In Vitro	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Concussions; Calcium indicator dyes; Stochastic integrate-and-fire model; Neural network; Synchrony; Cluster; Excitatory tone; Calpain	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; CULTURED NEURONS; CALCIUM; MODEL; NETWORK; DEFORMATION; CONCUSSION; RESOLUTION; RECEPTORS	Despite its enormous incidence, mild traumatic brain injury is not well understood. One aspect that needs more definition is how the mechanical energy during injury affects neural circuit function. Recent developments in cellular imaging probes provide an opportunity to assess the dynamic state of neural networks with single-cell resolution. In this article, we developed imaging methods to assess the state of dissociated cortical networks exposed to mild injury. We estimated the imaging conditions needed to achieve accurate measures of network properties, and applied these methodologies to evaluate if mild mechanical injury to cortical neurons produces graded changes to either spontaneous network activity or altered network topology. We found that modest injury produced a transient increase in calcium activity that dissipated within 1 h after injury. Alternatively, moderate mechanical injury produced immediate disruption in network synchrony, loss in excitatory tone, and increased modular topology. A calcium-activated neutral protease (calpain) was a key intermediary in these changes; blocking calpain activation restored the network nearly completely to its pre-injury state. Together, these findings show a more complex change in neural circuit behavior than previously reported for mild mechanical injury, and highlight at least one important early mechanism responsible for these changes.	[Patel, Tapan P.; Ventre, Scott C.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, 220 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Patel, Tapan/0000-0001-8959-6645; Meaney, David/0000-0002-0954-4122	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department of DefenseUnited States Department of Defense [W911NF-10-1-0526]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176] Funding Source: NIH RePORTER	We thank Dr. Pallab Singh (University of Pennsylvania) for providing NMDAR and AMPAR activation profiles and for helpful discussions that led to the development of our stochastic integrate-and-fire model. Funding for this work was provided from the National Institutes of Health and the Department of Defense (W911NF-10-1-0526).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bialonski S, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051909; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Dev KK, 1996, J NEUROCHEM, V67, P2609; DiFiori JP, 2010, CURR SPORT MED REP, V9, P35, DOI 10.1249/JSR.0b013e3181caba67; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fetcho JR, 1998, HISTOCHEM J, V30, P153, DOI 10.1023/A:1003243302777; French DA, 2006, J COMPUT NEUROSCI, V21, P227, DOI 10.1007/s10827-006-7815-5; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P5882; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li XL, 2007, J NEUROPHYSIOL, V98, P3341, DOI 10.1152/jn.00977.2007; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mittmann W, 2011, NAT NEUROSCI, V14, P1089, DOI 10.1038/nn.2879; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; Nenadic Z, 2005, IEEE T BIO-MED ENG, V52, P74, DOI 10.1109/TBME.2004.839800; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pardo E, 2006, ULTRASONICS, V44, pE1063, DOI 10.1016/j.ultras.2006.05.101; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rummel C, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066703; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Sieg F, 1999, J NEUROTRAUM, V16, P1197, DOI 10.1089/neu.1999.16.1197; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; vanVreeswijk C, 1996, SCIENCE, V274, P1724; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	64	15	15	0	13	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		23	36		10.1007/s10439-011-0390-6			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700003	21994056	Green Accepted			2022-02-06	
J	Romesser, J; Booth, J; Benge, J; Pastorek, N; Helmer, D				Romesser, Jennifer; Booth, Jane; Benge, Jared; Pastorek, Nicholas; Helmer, Drew			Mild traumatic brain injury and pain in Operation Iraqi Freedom/Operation Enduring Freedom veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						back pain; headaches; loss of consciousness; mental health treatment; mild traumatic brain injury; OIF/OEF veterans; pain; pain interference; polytrauma; posttraumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; COMORBID CHRONIC PAIN; PREVALENCE; AFGHANISTAN; DEPRESSION; POLYTRAUMA; SEVERITY; HEALTH	The purpose of this study was to describe the pain experience in Operation Iraqi Freedom/Operation Enduring Freedom veterans with and without a history of mild traumatic brain injury (mTBI) who present to polytrauma clinics for evaluation and management. We sought to evaluate the relationship between a veteran's history of mTBI and posttraumatic stress (PTS) on axial pain, head/headache pain, and pain interference. We performed retrospective chart reviews of 529 Iraq/Afghanistan veterans referred for evaluation at two Department of Veterans Affairs medical centers. Problems with head/headache, low back, and neck pain were frequently endorsed. Subjective pain interference was reported in 21% of patients without a history of mTBI, 31.9% of patients with a history of mTBI with disorientation only, and 36.1% of patients with a history of mTBI with loss of consciousness. Statistically significant differences existed between the mTBI groups on PTS symptom endorsement, and PTS was predictive of pain experience and interference. A history of mTBI with loss of consciousness predicted head/headache pain, but otherwise did not predict pain or pain interference. PT'S was strongly related to the pain experience. Pain is common in polytrauma patients. PTS severity is strongly associated with both pain report and pain interference, with head/headache pain showing a unique association with a history of mTBI. Implications for evaluation and management of pain in this complex population are discussed.	[Romesser, Jennifer] George E Wahlen Dept Veteran Affairs VA Med Ctr, Salt Lake City, UT USA; [Romesser, Jennifer] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA; [Booth, Jane; Pastorek, Nicholas] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Booth, Jane] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Benge, Jared] Jack C Montgomery VA Med Ctr, Dept Phys Med & Rehabil, Muskogee, OK USA; [Pastorek, Nicholas] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Helmer, Drew] Michael E DeBakey Veteran Affairs Med Ctr, Neurorehabil Neurons Networks VA Rehabil Res & De, Houston, TX USA; [Helmer, Drew] Baylor Coll Med, Dept Med, Div Gen Med, Houston, TX 77030 USA		Romesser, J (corresponding author), George E Wahlen Dept Veteran Affairs Med Ctr, 500 Foothill Dr,116B OPMH, Salt Lake City, UT 84148 USA.	jennifer.romesser@va.gov		Benge, Jared/0000-0001-6201-3278; Pastorek, Nicholas/0000-0002-9290-380X			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Belmont PJ, 2011, J TRAUMA, V71, pE1, DOI 10.1097/TA.0b013e3181edebed; *DVVIS WORK GROUP, CLIN PRACT GUID LIN, P64349; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hauret KG, 2010, AM J PREV MED, V38, pS61, DOI 10.1016/j.amepre.2009.10.021; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kalra R, 2008, FED PRACT, V25, P36; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ohayon MM, 2004, J CLIN PSYCHIAT, V65, P5; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherbourne CD, 2009, J GEN INTERN MED, V24, P620, DOI 10.1007/s11606-009-0956-2; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Tunks ER, 2008, CAN J PSYCHIAT, V53, P224, DOI 10.1177/070674370805300403; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474	27	15	15	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1127	1135		10.1682/JRRD.2010.12.0238			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100014	23341284	Bronze			2022-02-06	
J	Stevens, LF; Arango-Lasprilla, JC; Deng, XY; Schaaf, KW; Aragon, CJD; Quijano, MC; Kreutzer, J				Stevens, Lillian Flores; Carlos Arango-Lasprilla, Juan; Deng, Xiaoyan; Schaaf, Kathryn Wilder; De los Reyes Aragon, Carlos Jose; Cristina Quijano, Maria; Kreutzer, Jeffrey			Factors associated with depression and burden in Spanish speaking caregivers of individuals with traumatic brain injury	NEUROREHABILITATION			English	Article						Caregivers; depression; burden	TREATING FAMILIES; HEALTH; PREDICTORS; DISTRESS; CARERS; NEEDS; TBI; REHABILITATION; PERSPECTIVE; VALIDATION	Objective: To determine which factors are highly associated with burden and depression in a group of caregivers of persons with Traumatic Brain Injury (TBI) in Colombia, South America. Design: Prospective. Participants: Fifty-one pairs of individuals with TBI and their caregivers from two major cities in Colombia completed a comprehensive psychosocial evaluation that included information related to patient and caregiver sociodemographic factors, patient factors, and caregiver estimation of patient neurobehavioral functioning. Outcome measures: Caregiver burden (Zarit Burden Interview) and caregiver depression (PHQ-9). Results: Generalized linear models revealed that patient language problems and caregiver perception of patient functioning on six neurobehavioral domains were related to caregiver burden. Caregiver socioeconomic status and caregiver perception of patient functioning on six neurobehavioral domains were related to caregiver depression. These variables were then selected as candidates for the multiple regression models, which were fit separately for caregiver depression and burden, and revealed that caregivers' perception of patient depression was the only factor associated with both caregiver burden and depression. Conclusion: Caregivers' perception of patient depression was the single best predictor of both caregiver burden and depression. Implications for treatment based on these preliminary findings are discussed.	[Stevens, Lillian Flores] Hunter Holmes McGuire VAMC, Richmond, VA 23249 USA; [Schaaf, Kathryn Wilder; Kreutzer, Jeffrey] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, IKERBASQUE, Basque Fdn Sci, Bilbao, Spain; [Deng, Xiaoyan] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [De los Reyes Aragon, Carlos Jose] Univ Norte, Dept Psychol, Barranquilla, Colombia; [Cristina Quijano, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia		Stevens, LF (corresponding author), Hunter Holmes McGuire VAMC, 1201 Broad Rock Blvd,116-B, Richmond, VA 23249 USA.	Lillian.Stevens@va.gov	De los Reyes Aragon, Carlos Jose/P-3516-2019; De los Reyes Aragon, Carlos Jose CDA/E-2585-2015	De los Reyes Aragon, Carlos Jose/0000-0003-4472-0635; De los Reyes Aragon, Carlos Jose CDA/0000-0003-4472-0635; Quijano Martinez, Maria Cristina/0000-0003-3548-1628			Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; Anez Luis M, 2005, J Psychiatr Pract, V11, P221; Beck A.T, 1976, COGNITIVE THERAPY EM; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Centers for Disease Control and Prevention (CDC), MAN PEOPL HAV TBI; Cuellar I, 1995, J COMMUNITY PSYCHOL, V23, P339, DOI 10.1002/1520-6629(199510)23:4<339::AID-JCOP2290230406>3.0.CO;2-7; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; DEPOMPEI R, 1994, TOP LANG DISORD, V15, P68, DOI 10.1097/00011363-199411000-00007; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hayes SC, 2004, PRACTICAL GUIDE ACCE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karlikaya G., 2005, INTERNET J NEUROLOGY, V4; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Livingston MG., 1990, REHABILITATION ADULT, P225; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; MILLER B, 1991, J HEALTH SOC BEHAV, V32, P165, DOI 10.2307/2137150; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; Pereira F., 2007, AVANCES PSIQUIATRIA, V8, P153; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Sander AM, 2007, NEUROREHABILITATION, V22, P9; SIEGEL K, 1991, CANCER, V68, P1131, DOI 10.1002/1097-0142(19910901)68:5<1131::AID-CNCR2820680541>3.0.CO;2-N; TEASDALE G, 1974, LANCET, V2, P81; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	55	15	16	0	17	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	31	4					443	452		10.3233/NRE-2012-00815			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	052GV	WOS:000312186600014	23232169				2022-02-06	
J	Strangman, GE; O'Neil-Pirozzi, TM; Supelana, C; Goldstein, R; Katz, DI; Glenn, MB				Strangman, Gary E.; O'Neil-Pirozzi, Therese M.; Supelana, Christina; Goldstein, Richard; Katz, Douglas I.; Glenn, Mel B.			Fractional anisotropy helps predicts memory rehabilitation outcome after traumatic brain injury	NEUROREHABILITATION			English	Article						Cognitive rehabilitation; memory; diffusion tensor imaging; behavioral neurology; semantic clustering; brain trauma; structural neuroimaging	DIFFUSE AXONAL INJURY; WHITE-MATTER; COGNITIVE REHABILITATION; CORPUS-CALLOSUM; WORKING-MEMORY; MOTOR AREAS; HEAD-INJURY; TENSOR; MODERATE; RECOVERY	Traumatic brain injury (TBI) commonly results in residual memory difficulties. Such deficits are amenable to cognitive rehabilitation, but optimal selection of rehabilitation interventions remains a challenge. We hypothesized that diffusion tensor imaging (DTI) could be used to predict which individuals were likely to benefit from a specific memory rehabilitation intervention. Thirty-seven individuals with TBI, of all severities, first underwent DTI scanning, along with 18 matched controls. Participants with TBI then attended a 12-session memory intervention emphasizing internal memory strategies (I-MEMS). Primary outcome measures (HVLT, RBMT) were collected at the time of DTI scanning, and both immediately and one month post-therapy. In contrast to typical neuroimaging analysis, fractional anisotropy (FA) was used to predict long-term outcome scores, adjusting for typical predictors (injury severity, age, education, time since injury, pretest score). FA of the parahippocampal white matter was a significant negative predictor of HVLT, while the anterior corpus callosum, left anterior internal capsule, and right anterior corona radiata were negative predictors of RBMT outcome. The importance of these predictors rivaled those of pretest scores. Thus, FA measures may provide substantial predictive value for other cognitive interventions as well. The reason why higher FA was associated with less successful response to cognitive intervention remains unclear and will require further study.	[Strangman, Gary E.] Harvard Univ, Dept Psychiat, Sch Med, Neural Syst Grp, Charlestown, MA 02129 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Glenn, Mel B.] Harvard Univ, Dept Phys Med & Rehabil, Sch Med, Charlestown, MA 02129 USA		Strangman, GE (corresponding author), Harvard Univ, Dept Psychiat, Sch Med, Neural Syst Grp, 149 13th St,Suite 2651, Charlestown, MA 02129 USA.	strang@nmr.mgh.harvard.edu		Strangman, Gary/0000-0001-8896-2164; Katz, Douglas/0000-0002-7502-8505	National Institute on Disability and Rehabilitation Research, Department of Education [H133A020513]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS: K25-NS046554]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25NS046554] Funding Source: NIH RePORTER	We would like to thank Dana Christina, Kalika Kelkar, the Statewide Head Injury Program, and Community Rehabilitation Care for their help and support. The contents of this publication were developed under a grant from the National Institute on Disability and Rehabilitation Research, Department of Education (H133A020513). However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government. Support for this project also came from the NIH (NINDS: K25-NS046554).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benedict, 2001, HOPKINS VERBAL LEARN; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; COUGHLAN AK, 1979, J NEUROL NEUROSUR PS, V42, P914, DOI 10.1136/jnnp.42.10.914; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Faust M, 2008, BRAIN LANG, V105, P220, DOI 10.1016/j.bandl.2007.12.002; Filley CM, 2005, ANN NY ACAD SCI, V1064, P162, DOI 10.1196/annals.1340.028; Filley CM, 2005, PSYCHIAT CLIN N AM, V28, P685, DOI 10.1016/j.psc.2005.05.008; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Giles GM, 2001, BRAIN DAM B, P231; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Han BS, 2007, NEUROREHABILITATION, V22, P151; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Nair DG, 2007, NEUROIMAGE, V34, P253, DOI 10.1016/j.neuroimage.2006.09.010; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Strangman Gary E, 2009, Front Neuroinform, V3, P12; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang JY, 2011, NEUROIMAGE; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Wei CW, 2008, ARCH PHYS MED REHAB, V89, pS85, DOI 10.1016/j.apmr.2008.07.005; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wilson B, 2003, RIVERMEAD BEHAV M S2; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yin X, 2011, HUM BRAIN MAPP	78	15	15	0	14	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	3					295	310		10.3233/NRE-2012-0797			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	028QC	WOS:000310436200006	23093456	Bronze			2022-02-06	
J	Subaiya, S; Roberts, I; Komolafe, E; Perel, P				Subaiya, Saleena; Roberts, Ian; Komolafe, Edward; Perel, Pablo			Predicting intracranial hemorrhage after traumatic brain injury in low and middle-income countries: A prognostic model based on a large, multi-center, international cohort	BMC EMERGENCY MEDICINE			English	Article						Neurosurgery; Trauma; Developing countries; Intracranial hemorrhage; Traumatic brain injury		Background: Traumatic brain injury (TBI) affects approximately 10 million people annually, of which intracranial hemorrhage is a devastating sequelae, occurring in one-third to half of cases. Patients in low and middle-income countries (LMIC) are twice as likely to die following TBI as compared to those in high-income countries. Diagnostic capabilities and treatment options for intracranial hemorrhage are limited in LMIC as there are fewer computed tomography (CT) scanners and neurosurgeons per patient as in high-income countries. Methods: The Medical Research Council CRASH-1 trial was utilized to build this model. The study cohort included all patients from LMIC who received a CT scan of the brain (n = 5669). Prognostic variables investigated included age, sex, time from injury to randomization, pupil reactivity, cause of injury, seizure and the presence of major extracranial injury. Results: There were five predictors that were included in the final model; age, Glasgow Coma Scale, pupil reactivity, the presence of a major extracranial injury and time from injury to presentation. The model demonstrated good discrimination and excellent calibration (c-statistic 0.71). A simplified risk score was created for clinical settings to estimate the percentage risk of intracranial hemorrhage among TBI patients. Conclusion: Simple prognostic models can be used in LMIC to estimate the risk of intracranial hemorrhage among TBI patients. Combined with clinical judgment this may facilitate risk stratification, rapid transfer to higher levels of care and treatment in resource-poor settings.	[Subaiya, Saleena] New York Presbyterian, Dept Emergency Med, New York, NY 10038 USA; [Roberts, Ian; Perel, Pablo] CRASH Trials Coordinating Ctr, London Sch Hyg & Trop Med, London, England; [Komolafe, Edward] Obafemi Awolowo Univ, Dept Neurosurg, Ife, Nigeria		Subaiya, S (corresponding author), New York Presbyterian, Dept Emergency Med, New York, NY 10038 USA.	sas9141@nyp.org		komolafe, edward/0000-0003-1261-3501; /0000-0002-2342-301X			Aarli JA, 2007, NEUROLOGY, V69, P1715, DOI 10.1212/01.wnl.0000285102.47543.02; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Bandiera G, 2003, ANN EMERG MED, V42, P395, DOI 10.1016/S0196-0644(03)00422-0; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Edwards P, 2005, LANCET, V365, P1957; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; KUMAR B, 1989, MED SCI LAW, V29, P333, DOI 10.1177/002580248902900414; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Palanca Sylvia, 2003, Emerg Med (Fremantle), V15, P423, DOI 10.1046/j.1442-2026.2003.00496.x; Perel P, 2006, BMC MED INFORM DECIS, V6, P1; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; The CRASH trial management group, 2001, BMC Emerg Med, V1, P1; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; World Bank, 2006, WORLD DEV IND; World Health Organization, 2010, GLOB FOR IMPR DEV CO	34	15	15	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.		2012	12								17	10.1186/1471-227X-12-17			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V55CD	WOS:000210469800017	23157693	Green Published, Green Accepted, gold			2022-02-06	
J	Sundstrom, T; Helland, CA; Aarhus, M; Wester, K				Sundstrom, Terje; Helland, Christian Andre; Aarhus, Mads; Wester, Knut			What is the Pressure in Chronic Subdural Hematomas? A Prospective, Population-Based Study	JOURNAL OF NEUROTRAUMA			English	Article						clinical management of CNS injury; CT scanning; geriatric brain injury; head trauma; ICP	CLOSED-SYSTEM DRAINAGE; INTRACRANIAL-PRESSURE; ARACHNOID CYSTS; IRRIGATION; RECOVERY; ADULTS; VOLUME	Surgery for chronic subdural hematoma (CSDH) is performed to relieve brain displacement and high intracranial pressure (ICP). However, the intraoperative impression is often that the pressure inside the CSDH is low, despite marked clinical symptoms. We wanted to quantify the CSDH pressure and relate this to radiological and clinical characteristics. This prospective, population-based study of unilateral CSDHs was conducted over a 3-year period. CSDHs that were secondary to other conditions, re-operations, or CSDHs requiring other procedures than burr hole craniostomy under local anesthesia were excluded. Subdural pressure registration was performed via a simple manometric technique, and full compliance with a standardized protocol was mandatory. Sixty patients were included (mean age 76.2 years; for men, 77.4, and for women, 72.9). The mean pressure in the CSDHs was 15.2 cm H(2)O (range, 0-40) with no gender difference. Men had significantly larger volumes (mean 158.1 vs. 103.2 cm(3)) and midline shifts (mean 1.04 vs. 0.68 cm) than did women. Large hematomas with large midline shifts had higher pressures and more often required repeat surgery. With a patient's increasing age, the volumes and midline shifts seemed to become larger, whereas the pressures became lower. We did not find an association between repeat surgery and pressure or age. Our results are generally in line with those of previous studies reporting quantitative pressure registrations. However, there are important disparities regarding methodology, not least when comparing with various subjective scales that are widely used in clinical practice. A mean subdural pressure of 15.2 cm H(2)O is probably within the range of a normal ICP.	[Sundstrom, Terje] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; Univ Bergen Bergen, Dept Surg Sci, Bergen, Norway		Sundstrom, T (corresponding author), Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway.	terje.sundstrom@gmail.com		Helland, Christian/0000-0001-7754-5955; Sundstrom, Terje/0000-0002-6503-7141			ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Bratton B. L., 2007, J NEUROTRAUM, V24, pS45; DEVOLDER AG, 1994, J NEUROL NEUROSUR PS, V57, P296, DOI 10.1136/jnnp.57.3.296; FRIDEN HG, 1983, NEUROSURGERY, V13, P351, DOI 10.1227/00006123-198310000-00002; Gaab M., 1979, NEUROSURGERY, V4, pS476; GJERRIS F, 1980, ACTA NEUROCHIR, V54, P53, DOI 10.1007/BF01401943; Helland CA, 2007, J NEUROL NEUROSUR PS, V78, P1129, DOI 10.1136/jnnp.2006.107995; Horiguchi T, 2000, World J Biol Psychiatry, V1, P159, DOI 10.3109/15622970009150585; ISHIKAWA T, 1992, J NEUROL NEUROSUR PS, V55, P401, DOI 10.1136/jnnp.55.5.401; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; Matsumoto M, 1999, ACTA NEUROCHIR, V141, P177, DOI 10.1007/s007010050283; Merlicco G, 1995, NEUROSURG REV, V18, P247, DOI 10.1007/BF00383875; MINNS RA, 1984, ARCH DIS CHILD, V59, P486, DOI 10.1136/adc.59.5.486; Nakaguchi H, 2000, J NEUROSURG, V93, P791, DOI 10.3171/jns.2000.93.5.0791; Ogasawara K, 2000, SURG NEUROL, V54, P155, DOI 10.1016/S0090-3019(00)00281-0; Santarius T, 2004, BRIT J NEUROSURG, V18, P328, DOI 10.1080/02688690400004845; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Sgouros S, 2001, PEDIATR NEUROSURG, V35, P188, DOI 10.1159/000050420; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Tabaddor K, 1979, NEUROSURGERY, V4, pS476; Takeda N, 2006, ACTA NEUROCHIR, V148, P541, DOI 10.1007/s00701-005-0689-x; Tanaka A, 1997, SURG NEUROL, V47, P346, DOI 10.1016/S0090-3019(96)00369-2; Tsurushima H, 2000, NEUROL MED-CHIR, V40, P339, DOI 10.2176/nmc.40.339; Zaatreh MM, 2002, PEDIATR NEUROL, V26, P134, DOI 10.1016/S0887-8994(01)00379-4	25	15	17	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					137	142		10.1089/neu.2011.1776			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300016	21635185				2022-02-06	
J	Wallenquist, U; Holmqvist, K; Hanell, A; Marklund, N; Hillered, L; Forsberg-Nilsson, K				Wallenquist, U.; Holmqvist, K.; Hanell, A.; Marklund, N.; Hillered, L.; Forsberg-Nilsson, K.			Ibuprofen attenuates the inflammatory response and allows formation of migratory neuroblasts from grafted stem cells after traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Neural stem cell; regeneration; transplantation; controlled cortical impact; eGFP	CONTROLLED CORTICAL IMPACT; GENE-EXPRESSION; FORM NEURONS; MICE; RATS; CYCLOOXYGENASE-2; RECOVERY; NEURODEGENERATION; TRANSPLANTATION; INTEGRATION	Purpose: There is hope for neural stem and progenitor cells (NSPC) to enhance regeneration when transplanted to the injured brain after traumatic brain injury (TBI). So far, the therapeutic effects of NSPC transplantation have been hampered mainly by the notable death of the transplanted cells. Neuroinflammation may lead to additional cell death after TBI and we hypothesized that survival of grafted NSPC could be enhanced by anti-inflammatory treatment. Methods: Mice that were subjected to controlled cortical impact TBI and grafted with NSPC, were treated with the non-steroidal anti-inflammatory drug ibuprofen. Results: Ibuprofen was found to down-regulate the TBI-induced inflammatory response. In addition, migrating neuroblasts from transplanted cells were observed near the contusion and in the ipsilateral hippocampus in ibuprofen-treated animals only, suggesting that the anti-inflammatory treatment had beneficial effects on graft survival and/or differentiation. However, Morris Water Maze performance or TBI-induced tissue loss was not influenced by ibuprofen treatment. Conclusions: Our data suggests that anti-inflammatory strategies may be a complement to enhance the outcome for the cell transplants following TBI.	[Wallenquist, U.; Forsberg-Nilsson, K.] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Wallenquist, U.; Hanell, A.; Marklund, N.; Hillered, L.] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden; [Holmqvist, K.] MSD, N-3011 Drammen, Norway		Forsberg-Nilsson, K (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.	karin.nilsson@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Hanell, Anders/E-4776-2011	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Hanell, Anders/0000-0001-9369-3886; Hillered, Lars/0000-0002-2808-9292; Marklund, Niklas/0000-0002-9797-5626	Swedish Research Council MedicineSwedish Research Council; Uppsala University Hospital	This study was supported by grants from the Swedish Research Council Medicine (LH and KFN) and Uppsala University Hospital (LH). The authors would like to thank the animal facility personnel for excellent assistance with animal care.	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Antezana DF, 2003, J NEUROSURG, V98, P860, DOI 10.3171/jns.2003.98.4.0860; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Brannvall K, 2006, NEUROREPORT, V17, P623; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Casper D, 2000, NEUROSCI LETT, V289, P201, DOI 10.1016/S0304-3940(00)01294-5; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; COLE DJ, 1993, J PHARMACOL EXP THER, V266, P1713; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kudo C, 2003, BIOCHEM PHARMACOL, V66, P289, DOI 10.1016/S0006-2952(03)00235-1; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Magge SN, 2009, J NEUROSCI RES, V87, P1547, DOI 10.1002/jnr.21983; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481	43	15	18	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	1					9	19		10.3233/RNN-2011-0606			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	901HN	WOS:000300955300002	22377906				2022-02-06	
J	Yao, CH; Chang, RL; Chang, SL; Tsai, CC; Tsai, FJ; Chen, YS				Yao, Chun-Hsu; Chang, Ruey-Lin; Chang, Shih-Liang; Tsai, Chin-Chuan; Tsai, Fuu-Jen; Chen, Yueh-Sheng			Electrical stimulation improves peripheral nerve regeneration in streptozotocin-induced diabetic rats	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Electrical stimulation; peripheral nerve regeneration; diabetes; rehabilitation; peripheral neurotrauma	GENE-RELATED PEPTIDE; SCIATIC-NERVE; WALLERIAN DEGENERATION; ENHANCED REMYELINATION; MELLITUS; INJURY; MACROPHAGES; NEUROPATHY; REGULATORS; RECOVERY	We discuss if percutaneous electrical stimulation (ES) at 1 mA and 2 Hz after peripheral nerve transection could enhance axonal regeneration and functional recovery in diabetic animals. METHODS: Four groups of adult rats (group A: normal rats; group B: normal rats with ES; group C: streptozotocin-induced diabetic rats; and group D: streptozotocin-induced diabetic rats with ES) were subjected to sciatic nerve section followed by repair using silicone rubber conduits across a 10-mm gap. Rats in groups B and D received ES for 15 minutes every other day for three weeks. The groups A and C received no ES. RESULTS: At four weeks after surgery in groups B and D, immunohistochemical staining showed that lamina I and II regions in the dorsal horn ipsilateral to the injury were significantly calcitonin gene-related peptide-immunolabeled, and a significantly higher number of macrophages were recruited in the distal sciatic nerve compared with group C. In groups A, B, and D, electrophysiological results showed higher levels of reinnervation with significantly shorter latencies and faster nerve conductive velocities, and the histologic evaluations showed relatively larger mean values of myelinated axon densities and endoneurial areas compared with group C. CONCLUSIONS: Thus, the ES may improve the recovery of a severe peripheral nerve injury in diabetic animals, which could be considered as a supplementary treatment in diabetic neurotrauma. (J Trauma. 2012;72: 199-205. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Yao, Chun-Hsu; Chang, Ruey-Lin; Tsai, Fuu-Jen; Chen, Yueh-Sheng] China Med Univ, Lab Biomat, Sch Chinese Med, Taichung, Taiwan; [Yao, Chun-Hsu] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Chang, Shih-Liang] Da Yeh Univ, Dept Med Bot & Hlth Applicat, Changhua, Taiwan; [Tsai, Chin-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Tsai, Chin-Chuan] E DA Hosp, Chinese Med Dept, Kaohsiung, Taiwan		Chen, YS (corresponding author), China Med Univ, Lab Biomat, Sch Chinese Med, Taichung, Taiwan.	yuehsc@mail.cmu.edu.tw	Chang, Shih-Liang/E-5328-2012; Tsai, Fuu-Jen/J-4140-2015	Chang, Shih-Liang/0000-0001-5884-3850; 	National Science Council of the Republic of China, TaiwanMinistry of Science and Technology, Taiwan [NSC99-2221-E-039-006-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]	Supported by National Science Council of the Republic of China, Taiwan [Contract No. NSC99-2221-E-039-006-MY3] and Taiwan Department of Health Clinical Trial and Research Center of Excellence [Contract No. DOH100-TD-B-111-004].	Adeghate E, 2006, ANN NY ACAD SCI, V1084, P296, DOI 10.1196/annals.1372.030; Alrashdan MS, 2010, ACTA NEUROL BELG, V110, P168; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Chen YS, 2010, J NEUROPATH EXP NEUR, V69, P294, DOI 10.1097/NEN.0b013e3181d26487; Dahlin LB, 2008, NEUROREPORT, V19, P987, DOI 10.1097/WNR.0b013e328302f4ec; Dellon A Lee, 2007, Clin Podiatr Med Surg, V24, P425, DOI 10.1016/j.cpm.2007.03.003; Gao J, 2010, BRAIN RES, V1313, P53, DOI 10.1016/j.brainres.2009.11.072; Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412; Huang JH, 2010, NEUROREHAB NEURAL RE, V24, P736, DOI 10.1177/1545968310368686; Kennedy JM, 2000, BRAIN, V123, P2118, DOI 10.1093/brain/123.10.2118; Kennedy JM, 2005, J PERIPHER NERV SYST, V10, P144, DOI 10.1111/j.1085-9489.2005.0010205.x; Kennedy JM, 2002, DIABETES, V51, P2233, DOI 10.2337/diabetes.51.7.2233; Lago N, 2007, J NEUROSCI RES, V85, P2800, DOI 10.1002/jnr.21286; Lee TH, 2010, IEEE ENG MED BIO, P1511, DOI 10.1109/IEMBS.2010.5626837; Loesch A, 2010, ANGIOLOGY, V61, P651, DOI 10.1177/0003319709360030; LONGO FM, 1986, MUSCLE NERVE, V9, P385, DOI 10.1002/mus.880090502; Lu MC, 2008, NEUROREHAB NEURAL RE, V22, P367, DOI 10.1177/1545968307313507; Lu MC, 2009, J TRAUMA, V67, P1066, DOI 10.1097/TA.0b013e318182351a; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Serafin A, 2010, MUSCLE NERVE, V41, P630, DOI 10.1002/mus.21564; Shen LF, 2009, J NEUROCHEM, V108, P1187, DOI 10.1111/j.1471-4159.2008.05865.x; Suzuki C, 2000, NEUROLOGY, V54, P1932, DOI 10.1212/WNL.54.10.1932; Terada M, 1998, J NEUROL SCI, V155, P23, DOI 10.1016/S0022-510X(97)00269-4; Toth CC, 2009, J NEUROPATH EXP NEUR, V68, P326, DOI 10.1097/NEN.0b013e31819ac71b; Wan LD, 2010, NEUROSCIENCE, V169, P1029, DOI 10.1016/j.neuroscience.2010.05.051; Wan LD, 2010, J NEUROSCI RES, V88, P2578, DOI 10.1002/jnr.22426; WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Yeh CC, 2010, NEUROREHAB NEURAL RE, V24, P730, DOI 10.1177/1545968310376758; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zochodne DW, 2007, DIABETES-METAB RES, V23, P490, DOI 10.1002/dmrr.716	32	15	16	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					199	205		10.1097/TA.0b013e31822d233c			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	898IF	WOS:000300734800037	22310128				2022-02-06	
J	Al-Dorzi, HM; Tamim, HM; Cherfan, A; Hassan, MA; Taher, S; Arabi, YM				Al-Dorzi, Hasan M.; Tamim, Hani M.; Cherfan, Antoine; Hassan, Mohamad A.; Taher, Saadi; Arabi, Yaseen M.			Impact of computerized physician order entry (CPOE) system on the outcome of critically ill adult patients: a before-after study	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Intensive care unit; critical illness; CPOE; safety management; mortality; morbidity	INTENSIVE-CARE-UNIT; ADVERSE DRUG EVENTS; UNEXPECTED INCREASED MORTALITY; INFORMATION TECHNOLOGIES; UNINTENDED CONSEQUENCES; IMPLEMENTATION; ERRORS; RATES	Background: Computerized physician order entry (CPOE) systems are recommended to improve patient safety and outcomes. However, their effectiveness has been questioned. Our objective was to evaluate the impact of CPOE implementation on the outcome of critically ill patients. Methods: This was an observational before-after study carried out in a 21-bed medical and surgical intensive care unit (ICU) of a tertiary care center. It included all patients admitted to the ICU in the 24 months pre- and 12 months post-CPOE (Misys (R)) implementation. Data were extracted from a prospectively collected ICU database and included: demographics, Acute Physiology and Chronic Health Evaluation (APACHE) II score, admission diagnosis and comorbid conditions. Outcomes compared in different pre- and post-CPOE periods included: ICU and hospital mortality, duration of mechanical ventilation, and ICU and hospital length of stay. These outcomes were also compared in selected high risk subgroups of patients (age 12-17 years, traumatic brain injury, admission diagnosis of sepsis and admission APACHE II > 23). Multivariate analysis was used to adjust for imbalances in baseline characteristics and selected clinically relevant variables. Results: There were 1638 and 898 patients admitted to the ICU in the specified pre- and post-CPOE periods, respectively (age = 52 +/- 22 vs. 52 +/- 21 years, p = 0.74; APACHE II = 24 +/- 9 vs. 24 +/- 10, p = 0.83). During these periods, there were no differences in ICU (adjusted odds ratio (aOR) 0.98, 95% confidence interval [CI] 0.7-1.3) and in hospital mortality (aOR 1.00, 95% CI 0.8-1.3). CPOE implementation was associated with similar duration of mechanical ventilation and of stay in the ICU and hospital. There was no increased mortality or stay in the high risk subgroups after CPOE implementation. Conclusions: The implementation of CPOE in an adult medical surgical ICU resulted in no improvement in patient outcomes in the immediate phase and up to 12 months after implementation.	[Al-Dorzi, Hasan M.; Tamim, Hani M.; Cherfan, Antoine; Hassan, Mohamad A.; Taher, Saadi; Arabi, Yaseen M.] King Abdul Aziz Med City, Riyadh 11426, Saudi Arabia; [Al-Dorzi, Hasan M.; Tamim, Hani M.; Arabi, Yaseen M.] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh 11426, Saudi Arabia		Arabi, YM (corresponding author), King Abdul Aziz Med City, Riyadh 11426, Saudi Arabia.	yaseenarabi@yahoo.com		Al-Dorzi, Hasan M/0000-0002-3772-8949; Arabi, Yaseen/0000-0001-5735-6241			Amarasingham R, 2009, ARCH INTERN MED, V169, P108, DOI 10.1001/archinternmed.2008.520; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Arabi Y, 2006, CRIT CARE MED, V34, P605, DOI 10.1097/01.CCM.0000203947.60552.DD; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Ash JS, 2003, J AM MED INFORM ASSN, V10, P229, DOI 10.1197/jamia.M1204; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Bouadma L, 2005, INTENS CARE MED, V31, P1446, DOI 10.1007/s00134-005-2766-2; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; Collins Sarah, 2006, AMIA Annu Symp Proc, P895; Colpaert K, 2006, CRIT CARE, V10, DOI 10.1186/cc3983; Del Beccaro MA, 2006, PEDIATRICS, V118, P290, DOI 10.1542/peds.2006-0367; Eslami S, 2008, INT J MED INFORM, V77, P365, DOI 10.1016/j.ijmedinf.2007.10.001; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Harrison MI, 2007, J AM MED INFORM ASSN, V14, P542, DOI 10.1197/jamia.M2384; Institute of Medicine, 2001, CROSSING QUALITY CHA; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; Keene A, 2007, PEDIATR CRIT CARE ME, V8, P268, DOI 10.1097/01.PCC.0000260781.78277.D9; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Longhurst CA, 2010, PEDIATRICS, V126, P14, DOI 10.1542/peds.2009-3271; Mekhjian HS, 2002, J AM MED INFORM ASSN, V9, P529, DOI 10.1197/jamia.M1038; Nebeker JR, 2005, ARCH INTERN MED, V165, P1111, DOI 10.1001/archinte.165.10.1111; Papshev D, 2001, AM J MANAG CARE, V7, P725; Rana R, 2006, CRIT CARE MED, V34, P1892, DOI 10.1097/01.CCM.0000220766.13623.FE; Sittig DF, 2006, PEDIATRICS, V118, P797, DOI 10.1542/peds.2005-3132; Southon FCG, 1997, J AM MED INFORM ASSN, V4, P112, DOI 10.1136/jamia.1997.0040112; Thompson W, 2004, CRIT CARE MED, V32, P1306, DOI 10.1097/01.CCM.0000127783.47103.8D; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; Upperman JS, 2005, J PEDIATR SURG, V40, P57, DOI 10.1016/j.jpedsurg.2004.09.024	32	15	15	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6947			BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	NOV 19	2011	11								71	10.1186/1472-6947-11-71			9	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Informatics	869KA	WOS:000298595600001	22098683	Green Published, gold			2022-02-06	
J	Guskiewicz, KM; Broglio, SP				Guskiewicz, Kevin M.; Broglio, Steven P.			Sport-Related Concussion: On-Field and Sideline Assessment	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Mild traumatic brain injury; Symptom assessment; Balance and postural control; Neuropsychological function; Emergency action plan	COLLEGIATE FOOTBALL PLAYERS; ERROR SCORING SYSTEM; HIGH-SCHOOL; NEUROPSYCHOLOGICAL PERFORMANCE; INTERNATIONAL-CONFERENCE; POSTURAL STABILITY; SYMPTOMS; EPIDEMIOLOGY; STATEMENT; PREVENTION	The careful and well-planned sideline assessment of concussion can be the difference between a good and bad outcome when managing sport-related concussion. In most cases, the sideline assessment serves as a triage for determining if an injury, such as a concussion, has actually occurred, and if so, establishes a benchmark for determining whether a more serious and potentially catastrophic condition could be developing. Concussions can evolve into something more serious if signs and symptoms go undetected or are ignored. Although these are very rare events, they must always be at the forefront of the clinician's mind.	[Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700,South Rd, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Guskiewicz, Kevin/0000-0002-8682-2130			Agel J, 2007, J ATHL TRAINING, V42, P249; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio S. P., J NEUROTRAU IN PRESS; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Patel AV, 2007, J ATHL TRAINING, V42, P66; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Romberg M.H, 1853, MANUAL NERVOUS DIS M, V2nd; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; SANDERS MJ, 2001, HEAD FACIAL TRAUMA M, P624; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	38	15	15	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					603	+		10.1016/j.pmr.2011.08.003			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	858SI	WOS:000297822600004	22050938				2022-02-06	
J	Matsukawa, H; Shinoda, M; Fujii, M; Takahashi, O; Yamamoto, D; Murakata, A; Ishikawa, R				Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Takahashi, Osamu; Yamamoto, Daisuke; Murakata, Atsushi; Ishikawa, Ryoichi			Genu of corpus callosum as a prognostic factor in diffuse axonal injury Clinical article	JOURNAL OF NEUROSURGERY			English	Article						corpus callosum; diffuse axonal injury; genu of corpus callosum; outcome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MODERATE	Object. Previous studies have shown a relationship between a patient's stage of diffuse axonal injury (DAI) and outcome. However, few studies have assessed whether a specific lesion or type of corpus callosum injury (CCI) influences outcome in patients with DAI. The authors investigated the effect of various DAIs and CCIs on outcome in patients with traumatic brain injury (TBI). Methods. The authors retrospectively reviewed 78 consecutive patients with DAI who were seen between May 2004 and March 2010. Outcome was evaluated using the Extended Glasgow Outcome Scale (EGOS) 1 year after TBI. Patients with single DAIs had only 1 of the 3 lesions (lobar, CC, or brainstem). Patients with dual DAIs had 2 of these lesions, and those with triple DAIs had all of these lesions. Furthermore, the authors defined single, dual, and triple CCIs by using 3 lesions (genu, body, splenium) in the same way among patients with single (CC) DAIs. Univariate and multivariate logistic regression analyses were performed to evaluate the relationships between these lesions and outcome in patients with DAI. Results. Fifty patients had single DAIs: 34 in the lobar area, 11 in the CC, and 5 in the brainstem. Twenty had dual DAIs, and 8 had triple DAIs. Of the 11 CCIs, 9 were single and 2 were dual CCIs. Among these lesions, only those in the genu were related to disability. The authors dichotomized patients into those with and without genu lesions, regardless of other injuries. Multinomial logistic regression analysis showed that a genu lesion (OR 18, 95% CI 2.2-32; p = 0.0021) and a pupillary abnormality (OR 14, 95% CI 1.6-24; p = 0.0068) were associated with disability (EGOS <= 6) in patients with DAI. Conclusions. Regardless of the number of lesions, the existence of a genu lesion suggested disability 1 year after TBI in patients with DAI. (DOI: 10.3171/2011.6.JNS11513)	[Matsukawa, Hidetoshi] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Div Gen Internal Med, Dept Med, Tokyo 1048560, Japan		Matsukawa, H (corresponding author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mahide@luke.or.jp			General Insurance Association of Japan	This study was supported by a medical research grant on traffic accidents from the General Insurance Association of Japan in 2010. The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this paper.	Aglioti S, 1998, NEUROPSYCHOLOGIA, V36, P1015, DOI 10.1016/S0028-3932(98)00055-4; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Caille S, 2005, NEUROSURGERY, V57, P50, DOI 10.1227/01.NEU.0000163089.31657.08; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1994, RADIOLOGY, V191, P1; GODERSKY JC, 1990, ACT NEUR S, V51, P311; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Ryberg C, 2007, NEUROBIOL AGING, V28, P955, DOI 10.1016/j.neurobiolaging.2006.04.008; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	27	15	15	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2011	115	5					1019	1024		10.3171/2011.6.JNS11513			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	839OR	WOS:000296377800027	21780860				2022-02-06	
J	Shamim, MS; Qadeer, M; Murtaza, G; Enam, SA; Farooqi, NB				Shamim, Muhammad Shahzad; Qadeer, Mohsin; Murtaza, Ghulam; Enam, S. Ather; Farooqi, Najiha B.			Emergency department predictors of tracheostomy in patients with isolated traumatic brain injury requiring emergency cranial decompression	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; tracheostomy; mechanical ventilation	PROLONGED ENDOTRACHEAL INTUBATION; VENTILATOR-ASSOCIATED PNEUMONIA; LUND CONCEPT; OUTCOMES; EPIDEMIOLOGY; TRACHEOTOMY	Object. Patients with severe traumatic brain injury (TBI) frequently require a tracheostomy for prolonged mechanical ventilation and/or pulmonary toilet. It is now proven that the earlier the procedure is done, the more beneficial it is to the patient. The present study was carried out to determine if the requirement of a tracheostomy can be predicted on arrival of a patient to the emergency department. The prediction can potentially aid in combining the procedure with cranial decompression. In this study, the authors' aim was to determine the emergency department predictors of tracheostomy in patients with isolated TBI requiring emergency cranial decompression. Methods. The authors performed a retrospective chart review of all patients who underwent surgery for isolated TBI and required more than 4 days of mechanical ventilation. Multivariate logistic regression analysis was used for predictive indicators. Results. In patients with isolated severe TBI, a patient age of 31-50 years, the presence of preexisting medical comorbid conditions, a delay in emergency department arrival exceeding 1.5 hours, an abnormal pupil response on arrival, and a preoperative neurological worsening during hospital stay were independent predictors of the requirement for tracheostomy. These findings were validated in a small cohort of patients and were found to be significant. Conclusions. Requirement of a tracheostomy can be predicted in patients with severe TBI on arrival to the emergency department. These results were validated in a small cohort of patients, and it was found that the positive predictive value of requirement of tracheostomy was directly proportional to the number of predictors present. Larger prospective studies with appropriate control groups are further recommended to validate the authors' findings. (DOI: 10.3171/2011.7.JNS101829)	[Shamim, Muhammad Shahzad; Qadeer, Mohsin; Murtaza, Ghulam; Enam, S. Ather; Farooqi, Najiha B.] Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Karachi 74800, Pakistan		Shamim, MS (corresponding author), Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, POB 3500,Stadium Rd, Karachi 74800, Pakistan.	shahzad.shamim@aku.edu					Agrawal Amit, 2009, J Emerg Trauma Shock, V2, P56, DOI 10.4103/0974-2700.44687; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Branco BC, 2011, J TRAUMA, V70, P111, DOI 10.1097/TA.0b013e3181d9a559; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Gurkin MA, 2002, AM SURGEON, V68, P324; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Holmgren EF, 2007, J ORAL MAXIL SURG, V65, P2005, DOI 10.1016/j.joms.2007.05.019; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Kane T D, 1997, Respir Care Clin N Am, V3, P1; Kollef MH, 1999, CRIT CARE MED, V27, P1714, DOI 10.1097/00003246-199909000-00003; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Nordstrom CH, 2007, INTENS CARE MED, V33, P558, DOI 10.1007/s00134-006-0521-y; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Richard I, 2005, ANN FR ANESTH, V24, P659, DOI 10.1016/j.annfar.2005.03.010; Ross BJ, 1996, AM SURGEON, V62, P19; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Vincent JL, 2001, J CHEMOTHERAPY, V13, P211, DOI 10.1179/joc.2001.13.Supplement-2.211	23	15	15	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2011	115	5					1007	1012		10.3171/2011.7.JNS101829			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	839OR	WOS:000296377800025	21819192				2022-02-06	
J	Zgaljardic, DJ; Yancy, S; Temple, RO; Watford, MF; Miller, R				Zgaljardic, Dennis J.; Yancy, Sybil; Temple, Richard O.; Watford, Monica F.; Miller, Rebekah			Ecological Validity of the Screening Module and the Daily Living Tests of the Neuropsychological Assessment Battery Using the Mayo-Portland Adaptability Inventory-4 in Postacute Brain Injury Rehabilitation	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; neuropsychological assessment; ecological validity; outcomes assessment; postacute brain injury rehabilitation	ALZHEIMERS-DISEASE; DRIVING ABILITY; NAB; DEMENTIA; PERFORMANCE; MODERATE; SAMPLE; STROKE; SKILLS; ATTENTION	Purpose: The assessment of ecological validity of neuropsychological measures is an area of growing interest, particuliuly in the postacute brain injury rehabilitation (PABIR) setting, as there is an increasing demand for clinicians to address functional and real-world outcomes. In the current study, we assessed the predictive value of the Screening module and the Daily Living tests of the Neuropsychological Assessment Battery (NAB) using clinician ratings from the Mayo-Portland Adaptability Inventory-4 (MPAI-4) in patients with moderate to severe traumatic brain injury. Method: Forty-seven individuals were each administered the NAB Screening module (NAB-SM) and the NAB Daily Living (NAB-DL) tests following admission to a residential PABIR program. MPAI-4 ratings were also obtained at admission. Linear regression analysis was used to examine the association between these functional and neuropsychological assessment measures. Results: We replicated prior work (Temple at al., 2009) and expanded evidence for the ecological validity of the NAB-SM. Furthermore, our findings support the ecological validity of the NAB-DL Bill Payment, Judgment, and Map Reading tests with regards to functional skills and real-world activities. Conclusions: The current study supports prior work from our lab assessing the predictive value of the NAB-SM, as well as provides evidence for the ecological validity for select NAB-DL tests in patients with moderate to severe traumatic brain injury admitted to a residential PABIR program.	[Zgaljardic, Dennis J.; Miller, Rebekah] Transit Learning Ctr, Dept Neuropsychol, Galveston, TX 77550 USA; [Zgaljardic, Dennis J.; Watford, Monica F.] Univ Texas Med Branch, Sch Hlth Profess, Dept Rehabil Sci, Galveston, TX 77555 USA; [Zgaljardic, Dennis J.] Univ Texas Med Branch, Sch Hlth Profess, Dept Neurol, Galveston, TX 77555 USA; [Yancy, Sybil] Transit Learning Ctr, Dept Occupat Therapy, Galveston, TX 77550 USA; [Temple, Richard O.] CORE Hlth Care, Dripping Springs, TX USA		Zgaljardic, DJ (corresponding author), Transit Learning Ctr, Dept Neuropsychol, 1528 Postoff St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org					[Anonymous], 1997, GUID UN DAT SET MED; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Cahn-Weiner DA, 2009, EPILEPTIC DISORD, V11, P222, DOI 10.1684/epd.2009.0265; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Duchek JM, 1997, ALZ DIS ASSOC DIS, V11, P48, DOI 10.1097/00002093-199706001-00011; Duchek JM, 1998, J GERONTOL B-PSYCHOL, V53, P130; Fischer J. S., 2004, NEUROPSYCHOLOGICAL A, P729; Fong KNK, 2001, BRAIN INJURY, V15, P443, DOI 10.1080/02699050010005940; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Iverson GL, 2007, APPL NEUROPSYCHOL, V14, P178, DOI 10.1080/09084280701508952; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; LEONBERGER FT, 1989, PROF PSYCHOL-RES PR, V20, P411, DOI 10.1037/0735-7028.20.6.411; Long C. J., 1996, ECOLOGICAL VALIDITY, P15; Lynch WJ, 2004, J HEAD TRAUMA REHAB, V19, P180, DOI 10.1097/00001199-200403000-00009; Malec J. F., 2003, MANUAL MAYO PORTLAND; Ott BR, 2003, J GERIATR PSYCH NEUR, V16, P151, DOI 10.1177/0891988703255688; PARASURAMAN R, 1991, HUM FACTORS, V33, P539, DOI 10.1177/001872089103300506; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Silva MT, 2009, REV ASSOC MED BRAS, V55, P484, DOI 10.1590/S0104-42302009000400027; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Tate R. L., 2010, COMPENDIUM TESTS SCA, P643; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; White T, 2003, NEUROPSYCHOLOGICAL A; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yantz CL, 2010, NEUROPSYCHOL REHABIL, V20, P725, DOI 10.1080/09602011003765690; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	36	15	16	0	16	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2011	56	4					359	365		10.1037/a0025466			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	862AQ	WOS:000298062600009	21928919				2022-02-06	
J	Zhu, M; Li, MW; Yang, F; Ou, XM; Ren, QX; Gao, H; Zhu, CQ; Guo, JC				Zhu, Min; Li, Mingwei; Yang, Fan; Ou, Xiaomin; Ren, Qingxiao; Gao, Hui; Zhu, Cuiqing; Guo, Jingchun			Mitochondrial ERK plays a key role in delta-opioid receptor neuroprotection against acute mitochondrial dysfunction	NEUROCHEMISTRY INTERNATIONAL			English	Article						Delta-opioid receptor; Primary rat cortical neuron cultures; Sodium azide; Mitogen-activated protein kinases; Neuroprotection; Acute mitochondrial dysfunction	PROTECTS CORTICAL-NEURONS; TRAUMATIC BRAIN-INJURY; INDUCED APOPTOSIS; CYTOCHROME-C; CELL-DEATH; ACTIVATION; INHIBITION; HEART; MECHANISMS; GLUTAMATE	It is well established that stimulating delta-opioid receptor (DOR) with its specific agonists elicits neuroprotection against hypoxia/ischemia. Mitochondrial dysfunction plays a key role in hypoxic neuronal injury, but the effects of DOR activation on mitochondrial dysfunction in neurons are poorly elucidated. In this investigation, we studied the effects of [D-Ala2, D-Leu5] enkephalin (DADLE), a potent DOR agonist, on acute mitochondrial dysfunction and ensuing cell damage induced by sodium azide in primary rat cortical neuronal cultures, and explored possible mechanisms underlying. Here, we show that DADLE reverses NaN3-induced acute mitochondrial dysfunction by selectively activating DOR, mainly including mitochondrial membrane depolarization, mitochondrial Ca2+ overload and reactive oxygen species generation. DOR stimulation also inhibits cytochrome c release and caspase-3 activation, and attenuates neuronal death caused by acute NaN3 insults. Furthermore. DOR activation with DADLE protects neurons from acute NaN3 insults mainly through PKC-ERK pathway, and mitochondrial ERK activation is especially required for DOR neuroprotection against acute mitochondrial dysfunction. (C) 2011 Elsevier B.V. All rights reserved.	[Zhu, Min; Li, Mingwei; Yang, Fan; Ou, Xiaomin; Ren, Qingxiao; Gao, Hui; Zhu, Cuiqing; Guo, Jingchun] Fudan Univ, Shanghai Med Coll, Dept Neurobiol, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China		Guo, JC (corresponding author), Room 809,Zhidao Bldg,138 YiXueYuan Rd, Shanghai 200032, Peoples R China.	jingchunguo@shmu.edu.cn		Ou, Xiaomin/0000-0001-9162-1950; Ou, Xiaomin/0000-0002-4626-4429	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30873318]; Science and Technology Commission of ShanghaiScience & Technology Commission of Shanghai Municipality (STCSM) [06DZ19734]	This work was supported by National Natural Science Foundation of China (No. 30873318), and the Science and Technology Commission Program of Shanghai (No. 06DZ19734).	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bell SP, 2000, J AM COLL CARDIOL, V36, P2296, DOI 10.1016/S0735-1097(00)01011-1; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Chao DM, 2008, CEREB CORTEX, V18, P2217, DOI 10.1093/cercor/bhm247; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Engedal N, 2003, J BIOL CHEM, V278, P10934, DOI 10.1074/jbc.M211556200; Gao Y, 2003, J NEUROSCI, V23, P11770; Gaspar T, 2008, J CEREBR BLOOD F MET, V28, P1090, DOI 10.1038/sj.jcbfm.9600611; Grammatopoulos T, 2002, MOL BRAIN RES, V99, P114, DOI 10.1016/S0169-328X(02)00101-8; Halestrap AP, 1999, BIOCHEM SOC SYMP, V66, P181, DOI 10.1042/bss0660181; He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Iwata M, 2007, BRIT J ANAESTH, V99, P538, DOI 10.1093/bja/aem220; Kaneko T, 2005, BRIT J ANAESTH, V95, P662, DOI 10.1093/bja/aei228; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Kowalczyk Joanna Ewa, 2008, Postepy Biochem, V54, P209; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Laing JM, 2010, J NEUROCHEM, V112, P662, DOI 10.1111/j.1471-4159.2009.06475.x; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Li YC, 2010, J NEUROCHEM, V114, P62, DOI 10.1111/j.1471-4159.2010.06720.x; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; Malek SA, 2003, J NEUROSCI, V23, P3826; Marino S, 2007, NEUROTOXICOLOGY, V28, P622, DOI 10.1016/j.neuro.2007.01.005; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; Maslov L N, 2009, Ross Fiziol Zh Im I M Sechenova, V95, P1175; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Penna C, 2008, J CELL MOL MED, V12, P435, DOI 10.1111/j.1582-4934.2007.00210.x; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Risso F, 2004, NEUROPHARMACOLOGY, V47, P65, DOI 10.1016/j.neuropharm.2004.02.018; Ryazantseva N. V., 2009, Uspekhi Fiziologicheskikh Nauk, V40, P3; Satoh M, 1995, PHARMACOL THERAPEUT, V68, P343, DOI 10.1016/0163-7258(95)02011-X; Selvatici R, 2009, NEUROCHEM RES, V34, P909, DOI 10.1007/s11064-008-9852-0; Seymour EM, 2003, J SURG RES, V114, P187, DOI 10.1016/S0022-4804(03)00248-8; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Sun K, 2009, BRAIN RES, V1292, P100, DOI 10.1016/j.brainres.2009.06.104; Uppington KM, 2008, J NEUROCHEM, V105, P842, DOI 10.1111/j.1471-4159.2007.05192.x; Wang ZJ, 2006, ACTA PHARMACOL SIN, V27, P145, DOI 10.1111/j.1745-7254.2006.00259.x; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2002, AM J PHYSIOL-CELL PH, V282, pC1225, DOI 10.1152/ajpcell.00226.2001; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhang Z, 1999, J NEUROCHEM, V73, P1502, DOI 10.1046/j.1471-4159.1999.0731502.x; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zhu M, 2009, BRAIN RES, V1252, P183, DOI 10.1016/j.brainres.2008.11.030	55	15	15	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2011	59	6					739	748		10.1016/j.neuint.2011.08.005			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	853BH	WOS:000297400700001	21864608				2022-02-06	
J	Bouilleret, V; Cardamone, L; Liu, C; Koe, AS; Fang, K; Williams, JP; Myers, DE; O'Brien, TJ; Jones, NC				Bouilleret, Viviane; Cardamone, Lisa; Liu, Cyril; Koe, Amelia S.; Fang, Ke; Williams, John P.; Myers, Damian E.; O'Brien, Terence J.; Jones, Nigel C.			Confounding Neurodegenerative Effects of Manganese for In Vivo MR Imaging in Rat Models of Brain Insults	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						manganese-enhanced MRI; traumatic brain injury; neurodegeneration; manganese toxicity	MN-ENHANCED MRI; HIPPOCAMPAL VOLUMETRICS; POSTTRAUMATIC EPILEPSY; MAJOR DEPRESSION; INJURY; MEMRI; NEUROTOXICITY; ACTIVATION; TOXICITY; STRESS	Purpose: To examine the long-term consequences of manganese exposure due to the use of manganese-enhanced magnetic resonance imaging (MEMRI) in a model of closed head injury, the fluid-percussion injury (FPI) model. Materials and Methods: Two groups of adult male Wistar rats (n = 72) were studied with either MEMRI, whereby rats receive MnCl2 (100 mg/kg intraperitoneally) 24 hours prior to scanning, or standard MRI (sMRI) with no contrast agent. Rats from both groups underwent FPI or sham injury and were longitudinally assessed for 6 months for neurological toxicity using behavioral tests, EEG recording, and MRI scanning. Results: Regardless of whether they received FPI. MEMRI animals showed progressive signs of cerebral toxicity compared with sMRI rats, including significantly reduced weight gain, progressive brain volume decrease, and increased anxiety and depressive-like behaviors. Conclusion: Long-term structural and functional consequences of using manganese as a contrast agent for MRI can confound experimental outcomes and must be taken into account when designing longitudinal imaging studies using manganese-enhanced MRI.	[Bouilleret, Viviane; Cardamone, Lisa; Liu, Cyril; Koe, Amelia S.; Williams, John P.; Myers, Damian E.; O'Brien, Terence J.; Jones, Nigel C.] Univ Melbourne, Dept Med RMH, Parkville, Vic 3052, Australia; [Bouilleret, Viviane] CHU Bicetre, ApHp, Dept Neurophysiol & Epilepsy, Paris, France; [Fang, Ke] Florey Neurosci Inst, Small Anim MRI Facil, Parkville, Vic, Australia		Jones, NC (corresponding author), Univ Melbourne, Dept Med RMH, Parkville, Vic 3052, Australia.	ncjones@unimelb.edu.au	Bouilleret, viviane/AAQ-5878-2021; O'Brien, Terence/AAU-5525-2021; Myers, Damian E/L-5302-2013; O'Brien, Terence/L-8102-2013; Jones, Nigel C/K-7773-2012	Jones, Nigel/0000-0002-1080-8439; O'Brien, Terence/0000-0002-7198-8621; Myers, Damian/0000-0002-7569-9907	Victorian Neurotrauma Initiative	Contract grant sponsor: Victorian Neurotrauma Initiative grant.	Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Aoki I, 2003, MAGNET RESON MED, V50, P7, DOI 10.1002/mrm.10528; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Association AP, 2000, DIAGN STAT MAN MENT; Bock NA, 2008, NMR BIOMED, V21, P473, DOI 10.1002/nbm.1211; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bouilleret V, 2009, NEUROIMAGE, V45, P267, DOI 10.1016/j.neuroimage.2008.12.019; Brown J. S., 2002, ENV CHEM TOXINS PSYC; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brurok H, 1999, BIOCHEM BIOPH RES CO, V254, P768, DOI 10.1006/bbrc.1998.0131; CHANDRA SV, 1976, ARCH TOXICOL, V35, P319, DOI 10.1007/BF00570272; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Erikson KM, 2004, SCI TOTAL ENVIRON, V334, P409, DOI 10.1016/j.scitotenv.2004.04.044; Erikson KM, 2003, NEUROCHEM INT, V43, P475, DOI 10.1016/S0197-0186(03)00037-8; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hsu YH, 2007, BRAIN, V130, P3124, DOI 10.1093/brain/awm207; Itoh K, 2008, NEUROSCIENCE, V154, P732, DOI 10.1016/j.neuroscience.2008.03.080; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; KLAASSEN CD, 1974, TOXICOL APPL PHARM, V29, P458, DOI 10.1016/0041-008X(74)90117-3; Lee Bruce, 2005, NeuroRx, V2, P372; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMillan DE, 1999, NEUROTOXICOLOGY, V20, P499; MEIRI U, 1972, SCIENCE, V176, P308, DOI 10.1126/science.176.4032.308; Murayama Y, 2006, MAGN RESON IMAGING, V24, P349, DOI 10.1016/j.mri.2005.12.031; Nairismagi J, 2006, NEUROIMAGE, V30, P130, DOI 10.1016/j.neuroimage.2005.09.007; Neumeister A, 2005, BIOL PSYCHIAT, V57, P935, DOI 10.1016/j.biopsych.2005.01.016; Obenaus A, 2007, EPILEPSIA, V48, P11, DOI 10.1111/j.1528-1167.2007.01237.x; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Racette BA, 2005, MOVEMENT DISORD, V20, P492, DOI 10.1002/mds.20381; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; Serrano F, 2008, MAGN RESON MED, V60, P169, DOI 10.1002/mrm.21648; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, SCHIZOPHRENIA BULL, V34, P595, DOI 10.1093/schbul/sbn056; Silva AC, 2008, J NEUROSCI METH, V167, P246, DOI 10.1016/j.jneumeth.2007.08.020; SLOOT WN, 1994, BRAIN RES, V657, P124, DOI 10.1016/0006-8993(94)90959-8; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Takeda A, 1998, BRAIN RES BULL, V45, P149, DOI 10.1016/S0361-9230(97)00330-4; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thuen M, 2005, J MAGN RESON IMAGING, V22, P492, DOI 10.1002/jmri.20400; Van der Linden A, 2004, NMR BIOMED, V17, P602, DOI 10.1002/nbm.936; van Raay L, 2009, J NEUROSCI METH, V179, P184, DOI 10.1016/j.jneumeth.2009.01.024; Watanabe T, 2006, MAGN RESON IMAGING, V24, P209, DOI 10.1016/j.mri.2005.10.034; Watanabe T, 2004, NMR BIOMED, V17, P554, DOI 10.1002/nbm.937; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WOLF GL, 1983, AM J ROENTGENOL, V141, P193, DOI 10.2214/ajr.141.1.193; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477	59	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	OCT	2011	34	4					774	784		10.1002/jmri.22669			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	826ZP	WOS:000295394400005	21769969				2022-02-06	
J	Chen, Y; Montcalm-Smith, E; Schlaerth, C; Auker, C; McCarron, RM				Chen, Ye; Montcalm-Smith, Elizabeth; Schlaerth, Christine; Auker, Charles; McCarron, Richard M.			Acclimation to decompression: stress and cytokine gene expression in rat lungs	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						decompression sickness; inflammation; dive	TRAUMATIC BRAIN-INJURY; BUBBLE FORMATION; SICKNESS; PATHOPHYSIOLOGY; ACTIVATION; ALPHA; HEART; MODEL; EGR-1	Chen Y, Montcalm-Smith E, Schlaerth C, Auker C, McCarron RM. Acclimation to decompression: stress and cytokine gene expression in rat lungs. J Appl Physiol 111: 1007-1013, 2011. First published July 14, 2011; doi:10.1152/japplphysiol.01402.2010.-Previous studies demonstrated that animals exposed to repeated compression-decompression stress acclimated (i.e., developed reduced susceptibility) to rapid decompression. This study endeavored to characterize inflammatory and stress-related gene expression and signal transduction associated with acclimation to rapid decompression. Rats were divided into four groups: 1) control-sham: pressure naive rats; 2) acclimation-sham: nine acclimation dives [70 feet seawater (fsw), 30 min]; 3) control-dive: test dive only (175 fsw, 60 min); and 4) acclimation-dive: nine acclimation dives and a test dive. After the test dive, rats were observed for decompression sickness (DCS). Expression of 13 inflammatory and stress-related genes and Akt (or PKB, a serine/threonine protein kinase) and MAPK phosphorylation of lung tissue were examined. The expression of immediate early gene/transcription factor early growth response gene 1 (Egr-1) was observed in both control and acclimation animals with DCS but not in animals without DCS. Increased Egr-1 in control-dive animals with DCS was significantly greater than in acclimation-dive animals with DCS. TNF-alpha, IL-1 beta, IL-6, and IL-10 were significantly elevated in control-DCS animals. Acclimation-DCS animals had increased TNF-alpha, but there was no change in IL-1 beta, IL-6, and IL-10. High levels of Akt phosphorylation were observed in lungs of acclimation-sham, acclimation-dive, and control-dive animals; phosphorylated ERK1/2 was only observed in animals with DCS. This study suggests that activation of ERK1/2 and upregulation of Egr-1 and its target cytokine genes by rapid decompression may play a role in the initiation and progression of DCS. It may be that the downregulated expression of these genes in animals with DCS is associated with previous exposure to repeated compression-decompression cycles. This study represents an initial step toward understanding the molecular mechanisms associated with acclimation to decompression.	[Chen, Ye; Auker, Charles; McCarron, Richard M.] USN, Dept NeuroTrauma, Med Res Ctr, Silver Spring, MD 20910 USA; [Montcalm-Smith, Elizabeth; Schlaerth, Christine] USN, Dept Undersea Med, Med Res Ctr, Silver Spring, MD 20910 USA; [Auker, Charles] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA		Chen, Y (corresponding author), USN, Dept NeuroTrauma, Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Ye.Chen@med.navy.mil			Office of Naval Research Work UnitOffice of Naval Research [602236N.4122.A0301]	This work was funded by the Office of Naval Research Work Unit Number 602236N.4122.A0301.	Bakovic D, 2008, AVIAT SPACE ENVIR MD, V79, P626, DOI 10.3357/ASEM.2244.2008; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bigley NJ, 2008, J INTERF CYTOK RES, V28, P55, DOI 10.1089/jir.2007.0084; BUTLER BD, 1991, AVIAT SPACE ENVIR MD, V62, P997; CAGNOL S, FEBS J, V277, P2; Doolette DJ, 2003, UNDERSEA HYPERBAR M, V30, P127; ECKENHOFF RG, 1990, J APPL PHYSIOL, V69, P914, DOI 10.1152/jappl.1990.69.3.914; Ersson A, 1998, UNDERSEA HYPERBAR M, V25, P217; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Huang KL, 2003, J APPL PHYSIOL, V94, P1485, DOI 10.1152/japplphysiol.00952.2002; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; JUN T, 1999, SCI STKE, pPE1; Kaufmann K, 2001, J NEUROL SCI, V189, P83, DOI 10.1016/S0022-510X(01)00562-7; Kaur K, 2009, HEART FAIL REV, V14, P113, DOI 10.1007/s10741-008-9104-z; Kim HS, 2005, FASEB J, V19, P1042, DOI 10.1096/fj.04-2841fje; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Levett DZH, 2008, POSTGRAD MED J, V84, P571, DOI 10.1136/pgmj.2008.068320; LILLO RS, 1985, J APPL PHYSIOL, V59, P1503, DOI 10.1152/jappl.1985.59.5.1503; Montcalm-Smith E, 2007, AVIAT SPACE ENVIR MD, V78, P87; MONTCALMSMITH EA, J APPL PHYSL, V108, P596; Muth CM, 2000, ANAESTHESIST, V49, P302, DOI 10.1007/s001010050832; Pontier JM, 2009, AVIAT SPACE ENVIR MD, V80, P15, DOI 10.3357/ASEM.2347.2009; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Su CL, 2004, AM J PHYSIOL-REG I, V287, pR1214, DOI 10.1152/ajpregu.00260.2004; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Vann RD, 2008, AVIAT SPACE ENVIR MD, V79, P797, DOI 10.3357/ASEM.2316.2008; WALDER D. N., 1966, ANN ROY COLL SURG ENGL, V38, P288; WARD CA, 1987, J APPL PHYSIOL, V62, P1160, DOI 10.1152/jappl.1987.62.3.1160; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	31	15	20	1	5	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	OCT	2011	111	4					1007	1013		10.1152/japplphysiol.01402.2010			7	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	834OR	WOS:000295972000009	21757575				2022-02-06	
J	Ham, HY; Lee, JK; Jang, JW; Seo, BR; Kim, JH; Choi, JW				Ham, Hyung-Yong; Lee, Jung-Kil; Jang, Jae-Won; Seo, Bo-Ra; Kim, Jae-Hyoo; Choi, Jeong-Wook			Post-Traumatic Cerebral Infarction: Outcome after Decompressive Hemicraniectomy for the Treatment of Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain trauma; Cerebral infarction; Decompressive craniectomy	CLINICAL-COURSE; CRANIECTOMY; PREDICTORS; SECONDARY; SURGERY; CT	Objective : Posttraumatic cerebral infarction (PTCI), an infarction in well-defined arterial distributions after head trauma, is a known complication in patients with severe head trauma. The primary aims of this study were to evaluate the clinical and radiographic characteristics of PTCI, and to assess the effect on outcome of decompressive hemicraniectomy (DHC) in patients with PTCI. Methods : We present a retrospective analysis of 20 patients with PTO who were treated between January 2003 and August 2005. Twelve patients among them showed malignant PTO, which is defined as PTCI including the territory of Middle Cerebral Artery (MCA). Medical records and radiologic imaging studies of patients were reviewed. Results : Infarction of posterior cerebral artery distribution was the most common site of PTCI. Fourteen patients underwent DHC an average of 16 hours after trauma. The overall mortality rate was 75%. Glasgow outcome scale (GOS) of survivors showed that one patient was remained in a persistent vegetative state, two patients were severely disabled and only two patients were moderately disabled at the time of discharge. Despite aggressive treatments, all patients with malignant PTO had died. Malignant PTCI was the indicator of poor clinical outcome. Furthermore, Glasgow coma scale (GCS) at the admission was the most valuable prognostic factor. Significant correlation was observed between a GCS less than 5 on admission and high mortality (p<0.05). Conclusion : In patients who developed non-malignant PTCI and GCS higher than 5 after head injury, early DHC and duroplasty should be considered, before occurrence of irreversible ischemic brain damage. High mortality rate was observed in patients with malignant PTCI or PTCI with a GCS of 3-5 at the admission. A large prospective randomized controlled study will be required to justify for aggressive treatments including DHC and medical treatment in these patients.	[Ham, Hyung-Yong; Lee, Jung-Kil; Jang, Jae-Won; Seo, Bo-Ra; Kim, Jae-Hyoo] Chonnam Natl Univ, Sch Med, Dept Neurosurg, Kwangju 501757, South Korea; [Ham, Hyung-Yong; Lee, Jung-Kil; Jang, Jae-Won; Seo, Bo-Ra; Kim, Jae-Hyoo] Res Inst Med Sci, Kwangju 501757, South Korea; [Choi, Jeong-Wook] GwangJu Woori Hosp, Dept Neurosurg, Kwangju, South Korea		Lee, JK (corresponding author), Chonnam Natl Univ, Sch Med, Dept Neurosurg, Kwangju 501757, South Korea.	jkl@chonnam.ac.kr					Doerfler A, 2001, STROKE, V32, P813, DOI 10.1161/01.STR.32.3.813; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Harscher S, 2006, ACTA NEUROCHIR, V148, P31, DOI 10.1007/s00701-005-0617-0; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Inamasu J, 2002, CHILD NERV SYST, V18, P175, DOI 10.1007/s003810100506; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; KEANE JR, 1980, ANN NEUROL, V8, P186, DOI 10.1002/ana.410080209; Krieger DW, 1999, STROKE, V30, P287, DOI 10.1161/01.STR.30.2.287; LAINE FJ, 1995, AM J ROENTGENOL, V165, P967, DOI 10.2214/ajr.165.4.7677003; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Mori K, 2001, ACTA NEUROCHIR, V143, P483, DOI 10.1007/s007010170078; Mori K, 2001, ACTA NEUROCHIR, V143, P491; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; Robertson SC, 2004, NEUROSURGERY, V55, P55, DOI 10.1227/01.NEU.0000126875.02630.36; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; SATO M, 1986, NEUROSURGERY, V18, P300, DOI 10.1227/00006123-198603000-00007; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Server A, 2001, ACTA RADIOL, V42, P254; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; WEISBERG LA, 1979, COMPUT TOMOGR, V3, P15, DOI 10.1016/0363-8235(75)90004-6	29	15	19	0	8	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	OCT	2011	50	4					370	376		10.3340/jkns.2011.50.4.370			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	843NF	WOS:000296678000015	22200021	Green Published, Green Submitted, gold			2022-02-06	
J	Kovarsky, D; Schiemer, C; Murray, A				Kovarsky, Dana; Schiemer, Christine; Murray, Allison			Humor, Rapport, and Uncomfortable Moments in Interactions With Adults With Traumatic Brain Injury	TOPICS IN LANGUAGE DISORDERS			English	Article						communication disorders; interaction; rapport; traumatic brain injury	ENGAGEMENT; THERAPY; TALK	We examined uncomfortable moments that damaged rapport during group interactions between college students in training to become speech-language pathologists and adults with traumatic brain injury. The students worked as staff in a community-based program affiliated with a university training program that functioned as a recreational gathering place for any adult with traumatic brain injury who wished to attend. Analysis revealed the interactional difficulties experienced by the student staff as they tried to manage offensive humor produced by an individual with traumatic brain injury without interfering with rapport. Nevertheless, successive instances of sexually explicit humor resulted in rapport being damaged to such an extent that it eventually derailed the entire interaction. Results are discussed in terms of those aspects of context outside the communicative intentions of any of the interactants that contributed to this breach in rapport.	[Kovarsky, Dana; Schiemer, Christine; Murray, Allison] Univ Rhode Isl, Dept Communicat Disorders, Kingston, RI 02881 USA		Kovarsky, D (corresponding author), Univ Rhode Isl, Dept Communicat Disorders, Kingston, RI 02881 USA.	danakovarsky5@gmail.com					Erickson F., 1982, COUNSELOR GATEKEEPER; Glenn Philip., 2003, LAUGHTER INTERACTION; Hagen C., 1998, RANCHO LEVELS COGNIT; Kinsman RA, 2008, J CLIN NURS, V17, P1088, DOI 10.1111/j.1365-2702.2007.02090.x; Kovarsky Dana, 2009, Seminars in Speech and Language, V30, P27, DOI 10.1055/s-0028-1104532; Levinson, 1987, POLITENESS SOME UNIV; Scollon Ron., 1995, INTERCULTURAL COMMUN; Simmons-Mackie N, 2003, APHASIOLOGY, V17, P751, DOI 10.1080/02687030344000229; Simmons-Mackie Nina, 2009, Seminars in Speech and Language, V30, P18, DOI 10.1055/s-0028-1104531; Spencer-Oatey H, 2002, J PRAGMATICS, V34, P529, DOI 10.1016/S0378-2166(01)00039-X; Spencer-Oatey Helen, 2005, J POLITENESS RES-LAN, V1, P95, DOI DOI 10.1515/JPLR.2005.1.1.95; Straehle Carolyn, 1993, FRAMING DISCOURSE, P210; Tennant K F, 1990, J Gerontol Nurs, V16, P11; Walsh IP, 2007, TOP LANG DISORD, V27, P24, DOI 10.1097/00011363-200701000-00004; Walsh Irene P., 2009, Seminars in Speech and Language, V30, P37, DOI 10.1055/s-0028-1104533; Wooten P., 1993, PULMONARY REHABILITA, P422; ZAJDMAN A, 1995, J PRAGMATICS, V23, P325, DOI 10.1016/0378-2166(94)00038-G	17	15	15	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	OCT-DEC	2011	31	4					325	335		10.1097/TLD.0b013e3182358e98			11	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	846PG	WOS:000296915100005					2022-02-06	
J	Li, XG; von Holst, H; Kleiven, S				Li, Xiaogai; von Holst, Hans; Kleiven, Svein			Influence of gravity for optimal head positions in the treatment of head injury patients	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Brain edema; Finite element method; Gravitational force; Neurosurgery	PRESSURE; HYDROCEPHALUS; PATHOPHYSIOLOGY; EDEMA	Brain edema is a major neurological complication of traumatic brain injury (TBI), commonly including a pathologically increased intracranial pressure (ICP) associated with poor outcome. In this study, gravitational force is suggested to have a significant impact on the pressure of the edema zone in the brain tissue and the objective of the study was to investigate the significance of head position on edema at the posterior part of the brain using a finite element (FE) model. A detailed FE model including the meninges, brain tissue and a fully connected cerebrospinal fluid (CSF) system was used in this study. Brain tissue was modelled as a poroelastic material consisting of an elastic solid skeleton composed of neurons and neuroglia, permeated by interstitial fluid. The effect of head positions (supine and prone position) due to gravity was investigated for a localized brain edema at the posterior part of the brain. The water content increment at the edema zone remained nearly identical for both positions. However, the interstitial fluid pressure (IFP) inside the edema zone decreased around 15% by having the head in a prone position compared with a supine position. The decrease of IFP inside the edema zone by changing patient position from supine to prone has the potential to alleviate the damage to central nervous system nerves. These observations indicate that considering the patient's head position during intensive care and at rehabilitation might be of importance to the treatment of edematous regions in TBI patients.	[Li, Xiaogai; von Holst, Hans; Kleiven, Svein] KTH Royal Inst Technol, Div Neuron Engn, S-14152 Huddinge, Sweden; [von Holst, Hans] Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Stockholm, Sweden		Li, XG (corresponding author), KTH Royal Inst Technol, Div Neuron Engn, Alfred Nobels Alle 10, S-14152 Huddinge, Sweden.	xiaogai@kth.se		Li, Xiaogai/0000-0001-8522-4705	Swedish Research CouncilSwedish Research CouncilEuropean Commission [621-2008-3400]; Chinese Council Scholarship (CSC)	We are grateful for the technical support from Comsol support on the implementation of poroelastisity in the software. We would like to acknowledge financial support provided by the Swedish Research Council D.nr. 621-2008-3400, and the Chinese Council Scholarship (CSC) for the first author.	AGACHE PG, 1980, ARCH DERMATOL RES, V269, P221, DOI 10.1007/BF00406415; ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Coffey AM, 2010, PROC SPIE, V7625, DOI 10.1117/12.844477; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Dutta-Roy T, 2008, J BIOMECH, V41, P2263, DOI 10.1016/j.jbiomech.2008.04.014; Edsbagge M, 2004, AM J PHYSIOL-REG I, V287, pR1450, DOI 10.1152/ajpregu.00215.2004; Feigin V. L., 2007, HDB CLIN NEUROEPIDEM, P197; Hertelendy AJ, 2009, CRITICAL CARE TRANSP, P364; Hinghofer-Szalkay H, 2011, EUR J APPL PHYSIOL, V111, P163, DOI 10.1007/s00421-010-1646-9; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Ju WK, 2009, MOL VIS, V15, P120; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Kim JH, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3169248; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Levine DN, 1999, B MATH BIOL, V61, P875, DOI 10.1006/bulm.1999.0116; LI XG, 2009, P WORLD C MED PHYS B, P1478; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2003, ACT NEUR S, V86, P7; Miga MI, 2001, NEUROSURGERY, V49, P75, DOI 10.1097/00006123-200107000-00012; Mindermann T, 1999, J CLIN NEUROSCI, V6, P464, DOI 10.1016/S0967-5868(99)90001-2; NAGASHIMA T, 1990, Neurologia Medico-Chirurgica, V30, P1, DOI 10.2176/nmc.30.1; NAGASHIMA T, 1987, NEUROSURGERY, V21, P898, DOI 10.1227/00006123-198712000-00019; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; REULEN HJ, 1973, ACTA NEUROCHIR, V29, P29, DOI 10.1007/BF01414614; Smillie A, 2005, J FLUID MECH, V539, P417, DOI 10.1017/S0022112005005707; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	31	15	15	1	9	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2011	153	10					2057	2064		10.1007/s00701-011-1078-2			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	818WU	WOS:000294787400021	21739174				2022-02-06	
J	McDevitt, JK; Tierney, RT; Mansell, JL; Driban, JB; Higgins, M; Toone, N; Mishra, A; Krynetskiy, E				McDevitt, Jane K.; Tierney, Ryan T.; Mansell, Jamie L.; Driban, Jeffrey B.; Higgins, Michael; Toone, Nieka; Mishra, Anarug; Krynetskiy, Evgeny			Neuronal structural protein polymorphism and concussion in college athletes	BRAIN INJURY			English	Article						Single nucleotide polymorphism; neurofilament heavy; MTBI	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E; UNITED-STATES; APOE PROMOTER; EPIDEMIOLOGY; ALLELE; MILD	Objective: To examine the association between a neuronal structural protein polymorphism and the frequency and severity of concussions in college athletes. Methods: Forty-eight athletes with previous self-reported history of a concussion were matched with 48 controls that did not report a history of concussion. Each group was genotyped for neurofilament heavy (NEFH) polymorphism rs# 165602 in this retrospective case-control study. Results: There was no significant association (chi(2) = 0.487, p = 0.485) between carrying the NEFH rare allele and a history of one or more concussions due to small effect sizes. A Fisher's exact test revealed no significant association (p = 1.00, phi = -0.03) between the presence of NEFH rare allele and a history of multiple concussions. The independent t-tests revealed no significant differences in duration of signs and symptoms (t = 1.41, p = 0.17, d = 0.48) or return to play (t = 0.23, p = 0.82, d = 0.08) between NEFH rare allele carrier and non-carriers. Conclusions: Among college athletes, carrying the rare allele assessed may not influence an athlete's susceptibility to sustaining a concussion or return to play duration following a concussion.	[McDevitt, Jane K.; Tierney, Ryan T.; Driban, Jeffrey B.; Toone, Nieka] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Mansell, Jamie L.] Lincoln Univ, Dept Hlth Phys Educ & Recreat, Chester Cty, PA USA; [Higgins, Michael] Towson Univ, Dept Kinesiol, Towson, MD USA; [Mishra, Anarug; Krynetskiy, Evgeny] Temple Sch Pharm, Philadelphia, PA USA		McDevitt, JK (corresponding author), 139 Pearson Hall,Broad St & Montgomery Ave, Philadelphia, PA 19122 USA.	jane.mcdevitt@temple.edu	Driban, Jeffrey/H-3486-2019	Driban, Jeffrey/0000-0001-6098-4273	Jayne Haines Center for Pharmacogenomics and Drug Safety of Temple University School of Pharmacy	This work was supported by the Jayne Haines Center for Pharmacogenomics and Drug Safety of Temple University School of Pharmacy.	Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Cohen J., 2013, STAT POWER ANAL BEHA; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GELEHRTER T, 1998, PRINCIPLES MEDICAL G; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; GODSEL LM, 2007, CELL, V18, P28; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; HISANAGA S, 1988, J MOL BIOL, V202, P297, DOI 10.1016/0022-2836(88)90459-7; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LASEK RJ, 1988, STUDYING INTRINSIC D, P1; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Nawashiro H, 2000, J CEREBR BLOOD F MET, V20, P1040, DOI 10.1097/00004647-200007000-00003; ROTH S, 2007, GENETICS PRIMER EXER, P37; SALADIN K, 2007, ANATOMY PHYSL UNITY, P83; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sosin DM, 1996, BRAIN INJURY, V10, P47; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Thurman DJ, 2001, HEAD TRAUMA THERAPEU; Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025	30	15	15	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2011	25	11					1108	1113		10.3109/02699052.2011.607790			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WC	WOS:000295614900009	21902461				2022-02-06	
J	Sozda, CN; Larson, MJ; Kaufman, DAS; Schmalfuss, IM; Perlstein, WM				Sozda, Christopher N.; Larson, Michael J.; Kaufman, David A. S.; Schmalfuss, Ilona M.; Perlstein, William M.			Error-related processing following severe traumatic brain injury: An event-related functional magnetic resonance imaging (fMRI) study	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Traumatic brain injury; TBI; Cognitive control; Performance monitoring; Anterior cingulate cortex; ACC	ANTERIOR CINGULATE CORTEX; WORKING-MEMORY LOAD; CLOSED-HEAD INJURY; COGNITIVE CONTROL; PREFRONTAL CORTEX; SEVERE TBI; POSTTRAUMATIC AMNESIA; CONFLICT DETECTION; NEURONAL-ACTIVITY; NEURAL ACTIVITY	Continuous monitoring of one's performance is invaluable for guiding behavior towards successful goal attainment by identifying deficits and strategically adjusting responses when performance is inadequate. In the present study, we exploited the advantages of event-related functional magnetic resonance imaging (fMRI) to examine brain activity associated with error-related processing after severe traumatic brain injury (sTBI). fMRI and behavioral data were acquired while 10 sTBI participants and 12 neurologically-healthy controls performed a task-switching cued-Stroop task. fMRI data were analyzed using a random-effects whole-brain voxel-wise general linear model and planned linear contrasts. Behaviorally, sTBI patients showed greater error-rate interference than neurologically-normal controls. fMRI data revealed that, compared to controls, sTBI patients showed greater magnitude error-related activation in the anterior cingulate cortex (ACC) and an increase in the overall spatial extent of error-related activation across cortical and subcortical regions. Implications for future research and potential limitations in conducting fMRI research in neurologically-impaired populations are discussed, as well as some potential benefits of employing multimodal imaging (e.g., fMRI and event-related potentials) of cognitive control processes in TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Sozda, Christopher N.; Larson, Michael J.; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; [Schmalfuss, Ilona M.] Univ Florida, Dept Med, Gainesville, FL USA; [Perlstein, William M.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Perlstein, William M.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Kaufman, David A. S.] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Schmalfuss, Ilona M.] N Florida S Georgia Vet Adm Hosp, Gainesville, FL USA		Perlstein, WM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, HSC Box 100165, Gainesville, FL 32610 USA.	wmp@phhp.ufl.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01-MH01857, R21-MH073076]; Evelyn F. McKnight Brain Research Grant Program; Florida Brain and Spinal Cord Injury Research Trust; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH001857, R21MH073076] Funding Source: NIH RePORTER	This original research manuscript, or parts of it, have not been and will not be submitted elsewhere for publication. This work was supported by NIH grants K01-MH01857 and R21-MH073076, and by grants from the Evelyn F. McKnight Brain Research Grant Program, and the Florida Brain and Spinal Cord Injury Research Trust Fund awarded to WMP. The work was submitted by the first author in partial fulfillment of requirements for the Master of Science degree. We extend our appreciation to Ashley Carroll, Neha Dixit, Cortney Mauer, Megan McIntyre, Drew Nagle, Paul Seignourel, Floris Singletary, Allen Sirizi, and Raechel Steckley for their assistance in participant recruitment and data acquisition.	Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Donamayor N, 2012, HUM BRAIN MAPP, V33, P1621, DOI 10.1002/hbm.21305; Easdon C, 2004, BRAIN COGNITION, V54, P136; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hayes JP, 2009, PSYCHIAT RES-NEUROIM, V172, P7, DOI 10.1016/j.pscychresns.2008.05.005; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Horn L.J., 1999, PHYSICAL MED REHABIL, P1281; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Larson K.J., INT J PSYCH IN PRESS; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lovell Mark R., 1994, P133; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Spielberger CD., 1970, STATE TRAIT ANXIETY; Spreen O, 1991, COMPENDIUM NEUROPSYC; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Talairach J., 1988, COPLANAR STEROTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; Wechsler D., 1981, WAIS R MANUAL; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X	67	15	15	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760			INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		97	106		10.1016/j.ijpsycho.2011.06.019			10	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600011	21756946	Green Accepted			2022-02-06	
J	Tsitsopoulos, PP; Tobieson, L; Enblad, P; Marklund, N				Tsitsopoulos, Parmenion P.; Tobieson, Lovisa; Enblad, Per; Marklund, Niklas			Surgical treatment of patients with unilateral cerebellar infarcts: clinical outcome and prognostic factors	ACTA NEUROCHIRURGICA			English	Article						Cerebellar infarct; External ventricular drainage; Surgical decompression; Modified Rankin Scale; Outcome; Age	ENDOSCOPIC 3RD VENTRICULOSTOMY; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; OCCLUSIVE HYDROCEPHALUS; OBSTRUCTIVE HYDROCEPHALUS; POSTERIOR-FOSSA; MANAGEMENT; HEMORRHAGE; CRANIECTOMY; EXPERIENCE	There are limited data on the long-term outcome and on factors influencing the prognosis in patients with cerebellar infarcts treated with surgical decompression. Thirty-two patients (age 64.3 +/- 9.9 years) with expansive unilateral cerebellar infarcts were retrospectively evaluated. All patients were treated with ventriculostomy, suboccipital decompressive craniectomy and removal of the necrotic tissue. The Glasgow Coma Scale (GCS) and the Reaction Level Scale (RLS) scores evaluated the level of consciousness during hospitalization, while the modified Rankin Scale (mRS) was used for the 6-month and long-term outcome. Predicting factors were analyzed using a univariate logistic regression model. The median time from ictus to surgery was 48.4 h (range 8-120 h). Before surgery, the median GCS score was 9 (3-13). At discharge, the GCS score improved to 13.6 (7-15) (p < 0.05 compared to preoperative scores). At the long-term follow-up (median 67.5 months), ten patients were dead, and 77% of survivors had a good outcome (mRS score of a parts per thousand currency sign2). The number of days on a ventilator and the GCS score prior to surgery and at discharge were strong predictors of clinical outcome (p < 0.05), although one third of patients with a GCS a parts per thousand currency signaEuro parts per thousand 8 at the time of surgery had a good long-term outcome. In patients a parts per thousand yen70 years old, 50% had a good long-term outcome, and advanced age was not associated with a bad result (p > 0.05). Our results imply that surgical evacuation of significant cerebellar infarctions may be considered also in patients with advanced age and/or a decreased level of consciousness.	[Marklund, Niklas] Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden; [Tsitsopoulos, Parmenion P.; Tobieson, Lovisa; Enblad, Per; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden		Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden.	niklas.marklund@neurokir.uu.se		Marklund, Niklas/0000-0002-9797-5626	Uppsala University; Swedish Brain Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission	The authors wish to acknowledge the NCC staff of Uppsala University Hospital and Marten Melbius, Department of Neuroradiology at Uppsala University Hospital, for their valuable assistance in gathering the data, and Associate Professor Anders Wanhainen for statistical discussion. The study was financially supported by Uppsala University, the Swedish Brain Foundation and the Swedish Research Council.	AUER LM, 1986, ACTA NEUROCHIR, V79, P74, DOI 10.1007/BF01407448; Baldauf J, 2006, NEUROSURGERY, V59, P539, DOI 10.1227/01.NEU.0000228681.45125.E9; BERTALANFFY H, 1992, CLIN NEUROL NEUROSUR, V94, P19, DOI 10.1016/0303-8467(92)90113-H; CHEN HJ, 1992, STROKE, V23, P957, DOI 10.1161/01.STR.23.7.957; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; FAIRBURN B, 1956, BMJ-BRIT MED J, V1, P1335, DOI 10.1136/bmj.1.4979.1335; FEELY MP, 1979, NEUROSURGERY, V4, P7, DOI 10.1227/00006123-197901000-00003; Gurol ME, 2008, CURR TREAT OPTION NE, V10, P138, DOI 10.1007/s11940-008-0015-z; HEROS RC, 1982, STROKE, V13, P106, DOI 10.1161/01.STR.13.1.106; HEROS RC, 1992, STROKE, V23, P937, DOI 10.1161/01.STR.23.7.937; HORNIG CR, 1994, STROKE, V25, P372, DOI 10.1161/01.STR.25.2.372; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jauss M, 1999, J NEUROL, V246, P257, DOI 10.1007/s004150050344; Juttler E, 2009, STROKE, V40, P3060, DOI 10.1161/STROKEAHA.109.550913; KASE CS, 1993, STROKE, V24, P76, DOI 10.1161/01.STR.24.1.76; Khaja AM, 2007, LANCET, V369, P319, DOI 10.1016/S0140-6736(07)60154-8; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; KRIEGER D, 1993, ELECTROEN CLIN NEURO, V88, P261, DOI 10.1016/0168-5597(93)90050-Y; Kudo Hiroshi, 2007, J Stroke Cerebrovasc Dis, V16, P259, DOI 10.1016/j.jstrokecerebrovasdis.2007.09.001; LAUN A, 1984, ACTA NEUROCHIR, V71, P295, DOI 10.1007/BF01401324; LINDGREN SO, 1956, J NEUROSURG, V13, P575, DOI 10.3171/jns.1956.13.6.0575; Mohsenipour I, 1999, ZBL NEUROCHIR, V60, P68; Pfefferkorn T, 2009, STROKE, V40, P3045, DOI 10.1161/STROKEAHA.109.550871; Raco A, 2003, NEUROSURGERY, V53, P1061, DOI 10.1227/01.NEU.0000088766.34559.3E; RIEKE K, 1993, CEREBROVASC DIS, V3, P45, DOI 10.1159/000108670; SHENKIN HA, 1982, LANCET, V2, P429; TANEDA M, 1982, J NEUROSURG, V57, P83, DOI 10.3171/jns.1982.57.1.0083; Tatu L, 1996, NEUROLOGY, V47, P1125, DOI 10.1212/WNL.47.5.1125; TEASDALE G, 1974, LANCET, V2, P81; Tsitsopoulos PP, 2011, ACTA NEUROL SCAND, V123, P345, DOI 10.1111/j.1600-0404.2010.01404.x; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8; WEISBERG LA, 1986, NEUROLOGY, V36, P858, DOI 10.1212/WNL.36.6.858; Weisscher N, 2008, J NEUROL, V255, P867, DOI 10.1007/s00415-008-0796-8; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; WOOD MW, 1969, J NEUROSURG, V30, P260, DOI 10.3171/jns.1969.30.3part1.0260; Yoshimura K, 2007, MINIM INVAS NEUROSUR, V50, P270, DOI 10.1055/s-2007-990293	37	15	18	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	OCT	2011	153	10					2075	2083		10.1007/s00701-011-1120-4			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	818WU	WOS:000294787400024	21833781				2022-02-06	
J	Zlotnik, A; Gruenbaum, BF; Klin, Y; Gruenbaum, SE; Ohayon, S; Sheiner, E; Kuts, R; Boyko, M; Bichovsky, Y; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Gruenbaum, Benjamin Fredrick; Klin, Yael; Gruenbaum, Shaun Evan; Ohayon, Sharon; Sheiner, Eyal; Kuts, Ruslan; Boyko, Matthew; Bichovsky, Yoav; Shapira, Yoram; Teichberg, Vivian I.			The Effects of Insulin, Glucagon, Glutamate, and Glucose Infusion on Blood Glutamate and Plasma Glucose Levels in Naive Rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						endocrine; glucagon; glucose; glutamate; insulin; neuroprotection	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; AMINO-ACIDS; CEREBROSPINAL-FLUID; INDUCED HYPOGLYCEMIA; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; ISCHEMIC-STROKE; AMPA SUBTYPE; ISLET CELLS	Background: Elevated levels of glutamate in brain fluids, in the context of several neurodegenerative conditions, are associated with a worsened neurological outcome. Because there is a clear relationship between brain glutamate levels and glutamate levels in the blood, and an association of the latter with stress, the purpose of this study was to investigate the effects of glucose, insulin, and glucagon on rat blood glutamate levels. Methods: Rats received either 1 mL/100 g of rat body weight (BW) intravenous isotonic saline (control), 150 mg/1 mL/100 g BW intravenous glucose, 75 mg/1 mL/100 g BW intravenous glutamate, 50 mu g/100 g BW intraparitoneal glucagon, or 0.2 UI/100 g BW intraparitoneal insulin. Blood samples were subsequently drawn at 0, 30, 60, 90, and 120 minutes for determination of blood glutamate and glucose levels. Results: We observed a significant decrease in blood glutamate levels at 30 minutes after injection of glucose (P < 0.05), at 30 and 60 minutes after injection of insulin (P < 0.05), and at 90 and 120 minutes after injection of glucagon. Plasma glucose levels were elevated after infusion of glutamate and glucose but were decreased after injection of insulin. Conclusions: The results of this study demonstrate that glucose, insulin, and glucagon significantly reduce blood glutamate levels. The effect of insulin is immediate and transient, whereas the effect of glucagon is delayed but longer lasting, suggesting that the sensitivity of pancreatic glucagon and insulin-secreting cells to glutamate is dependent on glucose concentration. The results of this study provide insight into blood glutamate homeostasis and may assist in the implementation of new therapies for brain neuroprotection from excess glutamate.	[Zlotnik, Alexander; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Kuts, Ruslan; Boyko, Matthew; Bichovsky, Yoav; Shapira, Yoram] Ben Gurion Univ Negev, Div Anesthesiol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Sheiner, Eyal] Ben Gurion Univ Negev, Dept Obstet & Gynecol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Gruenbaum, Shaun Evan] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Div Anesthesiol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	SHEINER, EYAL/F-1488-2012	Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd; Irwin Green Fund for Studying the Development of the Brain; Carl and Micaela Einhorn-Dominic Institute for Brain Research	Supported in part by grants to VIT from the Nella and Leon Benoziyo Center for Neurological Diseases, Braintact Ltd, the Irwin Green Fund for Studying the Development of the Brain, and the Carl and Micaela Einhorn-Dominic Institute for Brain Research. VIT is the incumbent of the Louis and Florence Katz-Cohen Chair of Neuropharmacology.	ASSAN R, 1977, DIABETES, V26, P300, DOI 10.2337/diabetes.26.4.300; BAUM D, 1979, AM J PHYSIOL, V237, pE404, DOI 10.1152/ajpendo.1979.237.5.E404; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; BERTRAND G, 1995, AM J PHYSIOL-ENDOC M, V269, pE551, DOI 10.1152/ajpendo.1995.269.3.E551; BUTCHER SP, 1987, J NEUROCHEM, V48, P722, DOI 10.1111/j.1471-4159.1987.tb05576.x; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; DEFEO P, 1989, AM J PHYSIOL, V257, pE35, DOI 10.1152/ajpendo.1989.257.1.E35; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; FELIG P, 1976, DIABETES, V25, P1091, DOI 10.2337/diabetes.25.12.1091; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; GRINO M, 1992, ENDOCRINOLOGY, V131, P2763, DOI 10.1210/en.131.6.2763; Harbrecht BG, 2004, SHOCK, V22, P157, DOI 10.1097/01.shk.0000131579.22409.33; HAVEL PJ, 1989, ENDOCR REV, V10, P332, DOI 10.1210/edrv-10-3-332; Huypens P, 2000, DIABETOLOGIA, V43, P1012, DOI 10.1007/s001250051484; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; Kerner A, 2007, NEUROL RES, V29, P647, DOI 10.1179/016164107X248983; Koura SS, 1998, ACT NEUR S, V71, P244; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; MORITA Y, 1962, ENDOCRINOL JAPON, V9, P103; MORITA Y, 1962, ENDOCRINOL JAPON, V9, P57; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Rotllant J, 1997, J FISH BIOL, V51, P21, DOI 10.1111/j.1095-8649.1997.tb02510.x; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; THOMASSEN A, 1991, METABOLISM, V40, P378, DOI 10.1016/0026-0495(91)90148-P; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2007, NEUROCHEM RES; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	48	15	15	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2011	23	4					323	328		10.1097/ANA.0b013e3182299b15			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	818ML	WOS:000294755700006	21836527				2022-02-06	
J	Zurek, J; Fedora, M				Zurek, Jiri; Fedora, Michal			Dynamics of Glial Fibrillary Acidic Protein During Traumatic Brain Injury in Children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Glial fibrillary acidic protein; brain injury; outcome; children	PRACTICAL SCALE; DAMAGE; BIOMARKERS; DIAGNOSIS; SERUM; GFAP	Backgrounds: Glial fibrillary acidic protein (GFAP) is a monomeric intermediate filament protein found in the astroglial cytoskeleton and is not found outside the central nervous system. It is a brain-specific protein that is released after traumatic brain injury (TBI). Methods: This prospective study enrolled 59 children who had TBI, as verified by computed tomography. Daily GFAP measurement began at admission (< 12 hours after trauma) and continued for 6 days. Blood samples were analyzed for GFAP by enzyme-linked immunosorbent assay. Outcome was assessed using the Glasgow Outcome Scale (GOS) at 6 months after injury. Results: The median serum levels of GFAP at admission were 7.47 ng/mL in patients who died, compared with 0.12 ng/mL in patients who survived (p = 0.002). GFAP levels were significantly higher in patients who had a poor outcome 6 months after injury than in those who were alive or had good outcome (p < 0.001). The area under the receiver operating characteristic curve for GFAP was 0.833 for day 0 and 0.884 for day 2. Conclusions: These results suggest that determination of serum levels of GFAP may add to the clinical assessment of the primary damage and prediction of outcome after severe TBI.	[Zurek, Jiri; Fedora, Michal] Univ Childrens Hosp, Dept Anesthesia & Intens Care, Brno 62500, Czech Republic		Zurek, J (corresponding author), Univ Childrens Hosp, Dept Anesthesia & Intens Care, Cernopolni 9, Brno 62500, Czech Republic.	jzurek@fnbrno.cz		Zurek, Jiri/0000-0002-6409-2560			Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; GALEA E, 1995, J NEUROSCI RES, V41, P452, DOI 10.1002/jnr.490410404; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; JENNETT B, 1975, LANCET, V1, P480; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kraus J, 1996, NEUROTRAUMA, P13; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4	17	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					854	859		10.1097/TA.0b013e3182140c8c			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	833ZT	WOS:000295925700020	21986734				2022-02-06	
J	Fahlenkamp, AV; Coburn, M; Haase, H; Kipp, M; Ryang, YM; Rossaint, R; Beyer, C				Fahlenkamp, Astrid V.; Coburn, Mark; Haase, Hajo; Kipp, Markus; Ryang, Yu-Mi; Rossaint, Rolf; Beyer, Cordian			Xenon Enhances LPS-Induced IL-1 beta Expression in Microglia via the Extracellular Signal-Regulated Kinase 1/2 Pathway	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Anaesthetics; Inhalation; Xenon Mitogen-activated protein kinases; Phosphoprotein phosphatases	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; INFLAMMATORY RESPONSE; TNF-ALPHA; CARDIOPULMONARY BYPASS; STIMULATED MACROPHAGES; SODIUM ORTHOVANADATE; GENE-EXPRESSION; ACTIVATION; CELLS	The extracellular signal-regulated kinase (ERK) is involved in the cytokine production of immune cells. In this study, we show the influence of xenon on phosphatase activity, ERK 1/2 signalling and cytokine expression in microglia. The murine microglia cell line BV-2 was treated with 50 ng/ml lipopolysaccharide (LPS) and 74% xenon in 21% O-2 and 5% CO2. Cytokine levels were examined by gene expression analysis, Western blot and enzyme-linked immunosorbent assay. Phosphatase inhibition was assessed with p-nitrophenylphosphate and phosphorylation of ERK 1/2 via Western blot. Xenon significantly enhanced LPS-mediated IL-1 beta expression. ERK 1/2 phosphorylation was observed after xenon or LPS treatment which was inhibited by the use of the MEK inhibitor U0126. Xenon and LPS in combination superimposed individual effects on ERK 1/2 activation. Xenon decreased cellular phosphatase activity in microglia by 20% and inhibited dephosphorylation of ERK 1/2 up to 1 h. The blocking of ERK 1/2 reduced IL-1 beta expression in xenon and LPS-treated cells to a level obtained by LPS alone. In conclusion, xenon enhanced LPS-induced IL-1 beta expression in microglia by activation of ERK 1/2 signalling. Xenon's interference with phosphatases may be a key feature to affect multiple intracellular signalling pathways.	[Fahlenkamp, Astrid V.; Coburn, Mark; Rossaint, Rolf] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anaesthesiol, Fac Med, D-52074 Aachen, Germany; [Fahlenkamp, Astrid V.; Kipp, Markus; Beyer, Cordian] Rhein Westfal TH Aachen, Inst Neuroanat, Fac Med, D-52074 Aachen, Germany; [Haase, Hajo] Rhein Westfal TH Aachen, Inst Immunol, Univ Hosp Aachen, Fac Med, D-52074 Aachen, Germany; [Ryang, Yu-Mi] Tech Univ Munich, Dept Neurosurg, Klinikum Rechts Isar, D-81675 Munich, Germany		Coburn, M (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anaesthesiol, Fac Med, Pauwelsstr 30, D-52074 Aachen, Germany.	mcoburn@ukaachen.de	Haase, Hajo/B-9280-2009; Kipp, Markus/K-2694-2015; Ryang, Yu-Mi/Q-8373-2016	Haase, Hajo/0000-0002-1622-8718; Ryang, Yu-Mi/0000-0002-9045-5038; Coburn, Mark/0000-0002-7930-0270	Air Liquide Sante International; RWTH Aachen University	Dr. Coburn and Prof. Dr. Rossaint received lecture and consultant fees from Air Liquide Sante International, a company interested in developing clinical applications for medical gases including xenon. None of the remaining authors received any corporate support, honoraria etc.; The study was supported by two grants allocated to A. Fahlenkamp (Forschungsrotation, START, both RWTH Aachen University).	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Clark JA, 2005, J CARDIOTHOR VASC AN, V19, P488, DOI 10.1053/j.jvca.2005.05.007; Coburn M, 2005, BRIT J ANAESTH, V94, P198, DOI 10.1093/bja/aei023; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; de Rossi LW, 2004, ANESTH ANALG, V98, P1007, DOI 10.1213/01.ANE.0000106860.27791.44; Feng YZ, 2008, BRAIN RES BULL, V76, P102, DOI 10.1016/j.brainresbull.2008.01.012; Gabbita SP, 2000, ARCH BIOCHEM BIOPHYS, V376, P1, DOI 10.1006/abbi.1999.1685; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gerling N, 2004, NEUROCHEM INT, V44, P505, DOI 10.1016/j.neuint.2003.08.013; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hasegawa Y, 2003, J CEREBR BLOOD F MET, V23, P1040, DOI 10.1097/01.WCB.0000085160.71791.3F; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kriz Jasna, 2006, Critical Reviews in Neurobiology, V18, P145; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Mio Y, 2009, ANESTH ANALG, V108, P858, DOI 10.1213/ane.0b013e318192a520; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Saravanan P, 2009, BRIT J ANAESTH, V103, P805, DOI 10.1093/bja/aep297; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Torres M, 2002, ANN NY ACAD SCI, V973, P345, DOI 10.1111/j.1749-6632.2002.tb04663.x; Weber NC, 2006, BRIT J ANAESTH, V97, P298, DOI 10.1093/bja/ael153; Weber NC, 2005, BRIT J PHARMACOL, V144, P123, DOI 10.1038/sj.bjp.0706063; Weber NC, 2006, EUR J PHARMACOL, V539, P1, DOI 10.1016/j.ejphar.2006.03.054; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Wu J, 2008, ACTA NEUROCHIR SUPPL, V105, P59	45	15	15	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2011	45	1					48	59		10.1007/s12031-010-9432-z			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	798GT	WOS:000293191300007	20680516				2022-02-06	
J	Huang, YH; Lee, TC; Chen, WF; Wang, YM				Huang, Yu-Hua; Lee, Tao-Chen; Chen, Wu-Fu; Wang, Yi-Ming			Safety of the Nonabsorbable Dural Substitute in Decompressive Craniectomy for Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Dural substitute; Neuro-Patch; Complications; Decompressive craniectomy	ADHESION PREVENTIVE MATERIAL; SITE INFECTIONS; COMPLICATIONS; CRANIOTOMY; CLOSURE	Background: Artificial dural substitutes are increasingly being used in decompressive craniectomy to prevent peridural fibrosis and facilitate cranioplasty for patients with head injury. The safety of the dural substitute should be systemically evaluated. We focus on Neuro-Patch (B. Braun, Boulogne, France), a nonabsorbable substitute and commonly used by neurosurgeons. Methods: In this retrospective study, 132 patients undergoing 135 craniectomies and cranioplasties for traumatic brain injury were enrolled. We subdivided the operations into two groups on the basis of whether Neuro-Patch was used (N = 50) or not (N = 85). Risk factors of neurosurgical site infection were assessed first. Then, we compared the occurrence of infective, hemorrhagic, and hydrodynamic morbidities after craniectomy and cranioplasty between the two groups. Results: The incidence of neurosurgical site infection after craniectomy or cranioplasty showed no intergroup difference (p = 1.000). Postoperatively, extra-axial hematoma, which consists of subdural or epidural hematoma, occurred in 9 of 50 craniectomies (18.00%) with Neuro-Patch and 3 of 85 craniectomies (3.53%) without Neuro-patch, which was significantly different (p = 0.009). The rates of hydrodynamic morbidities (subdural hygroma or cerebrospinal fluid leakage) after the procedures were similar between the two groups. Conclusions: The use of Neuro-Patch does not increase the incidence of neurosurgical site infection and hydrodynamic complications, including subdural hygroma and cerebrospinal fluid leakage, after decompressive craniectomy or cranioplasty for severe traumatic brain injury. However, extra-axial hematoma at the site of craniectomy is more often encountered in patients with Neuro-Patch and forms a compressive lesion on the adjacent brain.	[Huang, Yu-Hua; Lee, Tao-Chen; Chen, Wu-Fu; Wang, Yi-Ming] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Chang Gung Mem Hosp,Dept Neurosurg, Kaohsiung, Taiwan		Huang, YH (corresponding author), Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Niao Sung Hsiang 800, Kaohsiung Hsien, Taiwan.	newlupin2001@yahoo.com.tw					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; CARVI Y, 2006, NEUROL RES, V28, P139, DOI DOI 10.1179/016164106X98008; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Gouda JJ, 1997, NEUROSURGERY, V41, P943, DOI 10.1097/00006123-199710000-00033; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; JACCARD E, 1983, NEUROCHIRURGIE, V29, P333; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Kawaguchi T, 2003, NEUROL MED-CHIR, V43, P320, DOI 10.2176/nmc.43.320; Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010; Lee CH, 2007, CLIN NEUROL NEUROSUR, V109, P667, DOI 10.1016/j.clineuro.2007.05.015; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Robertson SC, 1997, NEUROSURGERY, V40, P201, DOI 10.1097/00006123-199701000-00046; TANAKA Y, 1987, SURG NEUROL, V27, P353, DOI 10.1016/0090-3019(87)90010-3; THOMPSON D, 1994, J NEUROL NEUROSUR PS, V57, P646, DOI 10.1136/jnnp.57.5.646; Vakis A, 2006, CLIN NEUROL NEUROSUR, V108, P798, DOI 10.1016/j.clineuro.2005.11.026; Verheggen R, 1997, ACTA NEUROCHIR, V139, P1074, DOI 10.1007/BF01411563; von Wild KRH, 1999, SURG NEUROL, V52, P418, DOI 10.1016/S0090-3019(99)00125-1; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	21	15	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2011	71	3					533	537		10.1097/TA.0b013e318203208a			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	818MX	WOS:000294756900007	21768912				2022-02-06	
J	Keenan, MA				Keenan, Mary Ann			The Management of Spastic Equinovarus Deformity Following Stroke and Head Injury	FOOT AND ANKLE CLINICS			English	Article						Equinovarus deformity; Split anterior tibialis tendon transfer (SPLATT); Foot deformity	TIBIAL-TENDON TRANSFER; GAIT ANALYSIS; TOE FLEXORS; EQUINUS; ADULT; FOOT; HEMIPLEGIA; SCALE	Spastic equinovarus foot deformity is common in patients with upper motor neuron syndrome following stroke and traumatic brain injury. Equinovarus posture of the foot causes significant problems with shoe wear, standing, transfers, and walking. The deformity often cannot be managed with nonsurgical treatments such as chemodenervation, orthoses, and physical therapy. In fact, these modalities may be more costly and less effective than surgical treatment This article describes evaluation and surgical techniques of combined multitendon transfers and lengthenings for correction of spastic equinovarus deformity. These tendon transfers reliably result in improvement in quality of life.	Univ Penn, Dept Orthopaed Surg, Sch Med, Philadelphia, PA 19104 USA		Keenan, MA (corresponding author), Univ Penn, Dept Orthopaed Surg, Sch Med, 3400 Spruce St,2 Silverstien Pavill, Philadelphia, PA 19104 USA.	MaryAnn.Keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				ASHWORTH B, 1964, PRACTITIONER, V192, P540; BANKS HH, 1977, CLIN ORTHOP RELAT R, P70; BARNES MJ, 1991, J BONE JOINT SURG AM, V73A, P734, DOI 10.2106/00004623-199173050-00012; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; DiGiovanni CW, 2002, J BONE JOINT SURG AM, V84A, P962, DOI 10.2106/00004623-200206000-00010; Dunkerley D R, 1985, Int Rehabil Med, V7, P39; EDWARDS P, 1993, FOOT ANKLE, V14, P335, DOI 10.1177/107110079301400605; Fuller DA, 2004, ORTHOPEDICS, V27, P372; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; HOFFER MM, 1974, ORTHOP CLIN N AM, V5, P31; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Hosalkar H, 2008, CLIN ORTHOP RELAT R, V466, P2500, DOI 10.1007/s11999-008-0395-0; JORDAN C, 1988, CLIN ORTHOP RELAT R, P102; Keenan M A, 1988, Orthop Rev, V17, P1185; KEENAN MA, 1984, CLIN ORTHOP RELAT R, P165; Keenan MA, 1999, NEUROREHABILITATION, V12, P119; KEENAN MA, 1984, FOOT ANKLE, V5, P35, DOI 10.1177/107110078400500105; KEENAN MAE, 1987, FOOT ANKLE, V7, P333, DOI 10.1177/107110078700700604; Keenan MAE, 1999, J HEAD TRAUMA REHAB, V14, P163, DOI 10.1097/00001199-199904000-00006; KEENAN MAE, 2001, CHAPMANS OPERATIVE O, P3201; LAWRENCE SJ, 1994, FOOT ANKLE INT, V15, P340, DOI 10.1177/107110079401500610; LEMPERG R, 1969, ACTA ORTHOP SCAND, V40, P507, DOI 10.3109/17453676909046536; Mayer NH, 2008, SPASTICITY OTHER FOR, P11; Namdari S, 2009, FOOT ANKLE INT, V30, P923, DOI 10.3113/FAI.2009.0923; ONO K, 1980, INT ORTHOP, V4, P225, DOI 10.1007/BF00268160; Patterson, 1989, J NEUROL REHABIL, V3, P205, DOI DOI 10.1177/136140968900300406; PERRY J, 1987, CLIN ORTHOP RELAT R, P8; Perry J, 1978, CLIN ORTHOP RELAT R, V131, P4753; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; Reddy S, 2008, CLIN ORTHOP RELAT R, V466, P1683, DOI 10.1007/s11999-008-0250-3; ROPER BA, 1978, J BONE JOINT SURG BR, V60, P533, DOI 10.1302/0301-620X.60B4.711804; Silfverskiold N, 1924, ACTA CHIR SCAND, V56, P315; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1234, DOI 10.1016/j.apmr.2004.11.016; Walshe FMR, 1923, BRAIN, V46, P1, DOI 10.1093/brain/46.1.1; WATERS RL, 1982, J BONE JOINT SURG AM, V64, P284, DOI 10.2106/00004623-198264020-00022	35	15	15	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1083-7515	1558-1934		FOOT ANKLE CLIN	Foot Ankle Clin.	SEP	2011	16	3					499	514		10.1016/j.fcl.2011.07.002			16	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	837NF	WOS:000296209800011	21925364				2022-02-06	
J	Kung, WM; Tsai, SH; Chiu, WT; Hung, KS; Wang, SP; Lin, JW; Lin, MS				Kung, Woon-Man; Tsai, Shin-Han; Chiu, Wen-Ta; Hung, Kuo-Sheng; Wang, Shin-Ping; Lin, Jia-Wei; Lin, Muh-Shi			Correlation between Glasgow coma score components and survival in patients with traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury (TBI); Glasgow coma scale (GCS); Eye; Motor; Verbal combinations; Survival prediction	SCALE SCORE; HEAD-INJURY; SEVERITY; OUTCOMES	Background: The Glasgow coma scale (GCS) score is used in the initial evaluation of patients with traumatic brain injury (TBI); however, the determination of an accurate score is not possible in all clinical situations. Our aim is to determine if the individual components of the GCS score, or combinations of them, are useful in predicting mortality in patients with TBI. Methods: The components of the GCS score and the receiver-operating characteristic (ROC) curves were analyzed from 27,625 cases of TBI in Taiwan. Results: The relationship between the survival rate and certain eye (E), motor (M) and verbal (V) score combinations for GCS scores of 6, 11, 12 and 13 were statistically significant. The areas under ROC curve of E + V, M + V and M alone were 0.904, 0.903 and 0.900, respectively, representing the 3 most precise combinations for predicting mortality. The area under the ROC curve for the complete GCS score (E + M + V) was 0.885. Patients with lower E, M and V score respectively, and lower complete GCS scores had higher hazard of death than those with the highest scores. Conclusion: The results of this study indicate that the 3 fundamental elements comprising the Glasgow coma scale, E, M, and V individually, and in certain combinations are predictive of the survival of TBI patients. This observation is clinically useful when evaluating TBI patients in whom a complete GCS score cannot be obtained. (C) 2010 Elsevier Ltd. All rights reserved.	[Kung, Woon-Man; Tsai, Shin-Han; Chiu, Wen-Ta; Hung, Kuo-Sheng; Lin, Jia-Wei; Lin, Muh-Shi] Taipei Med Univ, Dept Neurosurg, Wan Fang Hosp, Taipei, Taiwan; [Lin, Muh-Shi] Taipei Cty Hosp, Dept Neurosurg, Taipei, Taiwan; [Tsai, Shin-Han; Chiu, Wen-Ta; Hung, Kuo-Sheng; Wang, Shin-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chiu, Wen-Ta; Lin, Jia-Wei; Lin, Muh-Shi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Lin, Muh-Shi] Taipei City Hosp, Dept Neurosurg, Xiao Branch, Taipei, Taiwan; [Lin, Muh-Shi] Taipei Med, Dept Surg, Sch Med, Taipei, Taiwan; [Kung, Woon-Man] Chang Bing Show Chwan Mem Hosp, Dept Neurosurg, Changhua, Taiwan		Lin, MS (corresponding author), Taipei Med Univ, Dept Neurosurg, Wan Fang Hosp, 111,Sect 3,Hsing Long Rd, Taipei, Taiwan.	neurosurgery2005@yahoo.com.tw	Kung, Woon-Man/Q-3012-2019; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/U-7004-2019	Kung, Woon-Man/0000-0001-8311-2902; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/0000-0002-9798-8160	National Health Research Institute, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX99-9707PI]; Department of Health, Executive Yuan, Taiwan [DOH99-TD-B-111-003]	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: National Health Research Institute, Taiwan (Grant No. NHRI-EX99-9707PI); Department of Health, Executive Yuan, Taiwan (Grant No. DOH99-TD-B-111-003).	Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; MCNETT M, 2007, J NEUROSCI NURS, V39, P668; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; PARKINSON D, 1985, CAN J SURG, V28, P79; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109	16	15	18	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	SEP	2011	42	9					940	944		10.1016/j.injury.2010.09.019			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	811IP	WOS:000294202400018	21067749				2022-02-06	
J	Akin, FW; Murnane, OD; Pearson, A; Byrd, S; Kelly, JK				Akin, Faith W.; Murnane, Owen D.; Pearson, Amber; Byrd, Stephanie; Kelly, J. Kip			Normative Data for the Subjective Visual Vertical Test during Centrifugation	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						Saccule and utricle; subjective visual vertical; vestibular function tests	UNILATERAL LOSS; TILT	Background: The otoliths act as gravito-inertial force sensors and contribute to the perception of spatial orientation. The perception of gravitational vertical can be assessed by asking a subject to adjust a light bar to the vertical. Prior to clinical use of the SVV (subjective visual vertical) test, normative data and test-retest reliability must be established. Purpose: To obtain normative data and determine the test-retest reliability for the SVV test performed in static and dynamic test conditions. Research Design: A descriptive design was used to obtain normative data. Study Sample: Twenty-four young adults with no history of neurological disease, middle-ear pathology, open or closed head injury, cervical injury, or audiovestibular disorder participated in the study. Data Collection and Analysis: The SVV angle was measured in the static position and in three dynamic conditions: (1) on-axis clockwise (CW) rotation, (2) off-axis CW rotation of right ear, and (3) off-axis CW rotation of left ear. Results: In young healthy individuals, the SVV was <2 degrees for static and on-axis rotation, and shifted up to 11 degrees during unilateral centrifugation. Test-retest reliability of the SVV was good for all test conditions. Conclusions: The normative data obtained in this study may be useful in identifying patients with chronic utricular dysfunction. We recommend the use of difference angles (on-axis SVV - off-axis SVV) to remove baseline bias and decrease the variability of the SVV angles for the off-axis conditions.	[Akin, Faith W.; Murnane, Owen D.; Pearson, Amber; Byrd, Stephanie; Kelly, J. Kip] James H Quillen VA Med Ctr, Mountain Home, TN USA; [Akin, Faith W.; Murnane, Owen D.] E Tennessee State Univ, Dept Audiol & Speech Language Pathol, Johnson City, TN 37614 USA		Akin, FW (corresponding author), VAMC, Mountain Home, TN 37684 USA.	Faith.akin@va.gov			Auditory and Vestibular Dysfunction Research Enhancement Award Program; Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.C.US Department of Veterans Affairs;  [C6241R]	Support for this study was provided by a Merit Review (C6241R) and the Auditory and Vestibular Dysfunction Research Enhancement Award Program sponsored by the Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.C.	Bohmer A, 1995, J Vestib Res, V5, P35; Bohmer A, 1996, BRAIN RES BULL, V40, P423, DOI 10.1016/0361-9230(96)00137-2; Bohmer A, 1999, J VESTIBUL RES-EQUIL, V9, P413; Chang CM, 2010, OTOLARYNG HEAD NECK, V143, P418, DOI 10.1016/j.otohns.2010.04.269; Clarke AH, 2001, ACTA OTO-LARYNGOL, P84; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; FRIEDMANN G, 1970, BRAIN, V93, P313, DOI 10.1093/brain/93.2.313; GLOSTER J, 1953, T OPHTHAL SOC UK, V73, P421; Gomez Garcia A., 2003, ENT-EAR NOSE THROAT, V82, P442, DOI DOI 10.1177/014556130308200614; Goto F, 2003, AURIS NASUS LARYNX, V30, P29, DOI 10.1016/S0385-8146(02)00110-4; HALMAGYI G, 2007, VESTIBULAR REHABILIT, P144; Helling K, 2006, ACTA OTO-LARYNGOL, V126, P587, DOI 10.1080/00016480500450008; Kobayashi H, 2002, AURIS NASUS LARYNX, V29, P325, DOI 10.1016/S0385-8146(02)00058-5; Merchant SN, 2000, ANN OTO RHINOL LARYN, V109, P3, DOI 10.1177/00034894001090S502; Min KK, 2007, OTOL NEUROTOL, V28, P520, DOI 10.1097/01.mao.0000271674.41307.f2; Mossman S, 1997, NEUROLOGY, V49, P491, DOI 10.1212/WNL.49.2.491; Neal E, 1926, AM J PSYCHOL, V37, P287, DOI 10.2307/1413700; Nowe V, 2003, J VESTIBUL RES-EQUIL, V13, P17; Paige G D, 1992, J Vestib Res, V2, P133; Su HC, 2004, OTOL NEUROTOL, V25, P977, DOI 10.1097/00129492-200411000-00019; Tian JR, 2002, EXP BRAIN RES, V145, P142, DOI 10.1007/s00221-002-1111-z; Tribukait A, 1996, BRAIN RES BULL, V40, P375, DOI 10.1016/0361-9230(96)00130-X; Vibert D, 1999, J VESTIBUL RES-EQUIL, V9, P145; Welgampola MS, 2001, CLIN NEUROPHYSIOL, V112, P1971, DOI 10.1016/S1388-2457(01)00645-9; WETZIG J, 1990, ACTA ASTRONAUT, V21, P519, DOI 10.1016/0094-5765(90)90070-2; WITKIN HA, 1948, J EXP PSYCHOL, V38, P603, DOI 10.1037/h0055372	26	15	16	0	7	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	JUL-AUG	2011	22	7			SI		460	468		10.3766/jaaa.22.7.6			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	831DD	WOS:000295708000006	21993051				2022-02-06	
J	Evans, K; Hux, K				Evans, Kelli; Hux, Karen			Comprehension of indirect requests by adults with severe traumatic brain injury: Contributions of gestural and verbal information	BRAIN INJURY			English	Article						TBI; inferencing; non-verbal cues	SOCIAL-PERCEPTION; HEAD-INJURY; RECOGNITION; DEFICITS; EMOTION; NEUROPRAGMATICS; COMMUNICATION; IMPAIRMENT; DISCOURSE; COGNITION	Purpose: The researchers sought to determine the extent to which individuals with and without traumatic brain injury (TBI) integrate gestural and verbal information when interpreting indirect requests. Method: Eighteen adults with cognitive-communication impairments secondary to severe TBI and 18 neurologically-intact adults viewed video vignettes depicting actors conversing in everyday contexts and concluding with indirect requests. Indirect requests were presented in three conditions: verbal information only (VO), gestural information only (GO) and combined verbal and gestural information (VG). Following each vignette, participants answered prediction and interpretation probes. Results: Statistical analysis revealed comparable performance patterns across participant groups, with significantly better performance in the VG condition than either the VO or GO conditions; however, neurologically-intact participants performed significantly better than participants with TBI in all conditions. Further analysis involved categorization of incorrect responses to determine the basis for participant errors. Conclusion: Overall, results suggest that individuals with brain injury benefit from a combination of gestural and verbal information when interpreting indirect requests; however, interpretations by individuals with brain injury are less accurate than interpretations made by neurologically-intact individuals. Incorrect responses tend to be abstract rather than literal and inaccurate with regard to a speaker's intended meaning.	[Evans, Kelli] Univ S Alabama, Dept Speech Pathol & Audiol, Mobile, AL 36688 USA; [Hux, Karen] Univ Nebraska, Barkley Mem Ctr, Lincoln, NE USA		Evans, K (corresponding author), Univ S Alabama, Dept Speech Pathol & Audiol, 5721 USA Dr N,HAHN 1119, Mobile, AL 36688 USA.	kellievans@usouthal.edu	Hux, Karen/AAQ-2078-2020				Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; BAVELAS JB, 1992, DISCOURSE PROCESS, V15, P469, DOI 10.1080/01638539209544823; BAVELAS JB, 1994, RES LANG SOC INTERAC, V27, P201, DOI DOI 10.1207/S15327973RLSI2703_3; Beattie Geoffrey, 2003, GESTURE, V3, P127, DOI DOI 10.1075/GEST.3.2.02HOL; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Cassell J., 1999, PRAGMAT COGN, V7, P1, DOI [10.1075/pc.7.1.03cas, DOI 10.1075/PC.7.1.03CAS]; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hagen C., 2000, TBI REH MAN CAR ENV; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hux K., 2008, J MED SPEECH LANGUAG, V16, P83; Jacobs N, 2007, J MEM LANG, V56, P291, DOI 10.1016/j.jml.2006.07.011; Kelly SD, 1999, J MEM LANG, V40, P577, DOI 10.1006/jmla.1999.2634; Kertesz A., 1982, W APHASIA BATTERY WA; Kertesz A., 2007, WAB R W APHASIA BATT; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McNeill D., 2005, GESTURE THOUGHT; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059	36	15	15	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					767	776		10.3109/02699052.2011.576307			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600013	21561291				2022-02-06	
J	Kerr, K; Oram, J; Tinson, H; Shum, D				Kerr, Katelyn; Oram, Joanne; Tinson, Helen; Shum, David			The correlates of aggression in people with acquired brain injury: A preliminary retrospective study	BRAIN INJURY			English	Article						Activities of daily living; aggression; violence; head injury; length of stay; traumatic brain injury	LONG-TERM SURVIVORS; IMPULSIVE AGGRESSION; VIOLENCE; BEHAVIOR; SETTINGS; ASSAULT; PATIENT; WARDS	Primary objective: To identify correlates of aggressive behaviours in patients with acquired brain injury (ABI). Methods and procedures: During a 16 month period, patients who had ABI and who had been aggressive during hospitalization (n = 32) were identified by hospital staff. A comprehensive chart review of these patients was completed. Results were compared against results of a matched patient sample who had not been aggressive (32). Main outcomes and results: Five variables which were significantly correlated with aggression were entered into a standard logistic regression. The model explained 61.4% of the total variance and successfully predicted 87.5% of the non-aggressive group and 78.1% of the aggressive group. The overall correct prediction rate was 82.8%. Of the five variables, four were found to significantly contribute to the predictive ability of the model: An education of 10 years or less, a history of aggression, dependence on staff for assistance with activities of daily living and a hospitalization period of 51 days or more. Conclusions: The results highlight some variables related to aggression by patients with ABI in the hospital environment and can be utilized in staff education and training programmes to increase the awareness of risk factors.	[Kerr, Katelyn; Shum, David] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Kerr, Katelyn; Oram, Joanne; Tinson, Helen] Princess Alexandra Hosp, Dept Psychol, Brisbane, Qld 4102, Australia; [Shum, David] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Kerr, Katelyn] Toowong Private Hosp, Brisbane, Qld, Australia		Kerr, K (corresponding author), Toowong Private Hosp, 496 Milton Rd, Milton, Qld 4066, Australia.	katelyn01@hotmail.com	Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262	Commonwealth Government	The authors wish to acknowledge the staff of the two hospital wards that participated in the study for their assistance and support. The writing of this article was supported through a writing bursary obtained through the Griffith University Primary Health Care Research Evaluation and Development (PHCRED) program, funded by the Commonwealth Government.	Alderman N, 2002, BRAIN INJURY, V16, P469, DOI 10.1080/02699050110118458; Arnetz JE, 2000, J ADV NURS, V31, P668, DOI 10.1046/j.1365-2648.2000.01322.x; Bandura A., 1973, AGGRESSION SOCIAL LE; BERKOWITZ L, 1981, J PERS SOC PSYCHOL, V40, P687, DOI 10.1037/0022-3514.40.4.687; BOWIE V, 1989, COPING VIOLENCE GUID; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Carter R, 2000, HIGH RISK VIOLENCE N, V6, P5; COMBS AW, 1952, J ABNORM SOC PSYCH, V47, P420, DOI 10.1037/h0057196; Dollard J, 1939, FRUSTRATION AGGRESSI; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Farrell GA, 1999, J ADV NURS, V29, P532, DOI 10.1046/j.1365-2648.1999.00920.x; Ferguson T. J., 1983, AGGRESSION THEORETIC, V1, P41; FORRESTER K, 1995, EMERGENCE OFFICIAL N, V1, P5; Geen Russell G., 1977, ADV EXPT SOCIAL PSYC, V10, P1, DOI DOI 10.1016/S0065-2601(08)60353-6; Greve KW, 2002, PERS INDIV DIFFER, V32, P639, DOI 10.1016/S0191-8869(01)00066-6; Greve KW, 2001, BRAIN INJURY, V15, P255; HIRSCHI T, 1977, AM SOCIOL REV, V42, P571, DOI 10.2307/2094556; Holden R J, 1985, Aust Nurses J, V15, P44; HUESMANN LR, 1984, DEV PSYCHOL, V46, P1071; Institute of Medicine, 2005, IMPR QUAL HLTH CAR M; Kozlowska K, 1997, AUST NZ J PSYCHIAT, V31, P641, DOI 10.3109/00048679709062676; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lyneham J, 2000, Aust J Adv Nurs, V18, P8; McKenna BG, 2003, INT J MENT HEALTH NU, V12, P56, DOI 10.1046/j.1440-0979.2003.00269.x; Minium EW, 1993, STAT REASONING PSYCH; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nijman HLI, 1999, PSYCHIATR SERV, V50, P832, DOI 10.1176/ps.50.6.832; O'Connell B, 2000, J CLIN NURS, V9, P602, DOI 10.1046/j.1365-2702.2000.00401.x; Owen C, 1998, PSYCHIATR SERV, V49, P1452, DOI 10.1176/ps.49.11.1452; Pallant J., 2005, SPSS SURVIVOR MANUAL, V2nd; Pescosolido BA, 1999, AM J PUBLIC HEALTH, V89, P1339, DOI 10.2105/AJPH.89.9.1339; Poster EC, 1996, ARCH PSYCHIAT NURS, V10, P365, DOI 10.1016/S0883-9417(96)80050-1; *REH I CHIC, 1992, REH I CHIC FUNCT ASS; *ROYAL COLL PSYCH, 1998, OP41 ROYAL COLL PSYC; SANDEL EM, 1996, ARCH PHYS MED REHAB, V77, P617; SILVER JM, 1987, PSYCHIAT ANN, V17, P375, DOI 10.3928/0048-5713-19870601-08; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Sommargren C E, 1994, AACN Clin Issues Crit Care Nurs, V5, P516; *SPSS INC, 2005, STAT PACK SOC SCI WI; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Wen X., 1997, DEFINITION PREVALENC; Whittington R, 1996, J ADV NURS, V24, P326, DOI 10.1046/j.1365-2648.1996.18114.x; Winstanley S, 2002, ACTA PSYCHIAT SCAND, V106, P144, DOI 10.1034/j.1600-0447.106.s412.31.x; WOOD RL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P153; Zernike W, 1998, Int J Nurs Pract, V4, P126, DOI 10.1046/j.1440-172X.1998.00073.x	45	15	15	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					729	741		10.3109/02699052.2011.580315			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600009	21561292				2022-02-06	
J	Schonberger, M; Ponsford, J; Reutens, D; Beare, R; Clarke, D; O'Sullivan, R				Schoenberger, Michael; Ponsford, Jennie; Reutens, David; Beare, Richard; Clarke, David; O'Sullivan, Richard			The relationship between mood disorders and MRI findings following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; depression; magnetic resonance imaging	II PSYCHIATRIC-DISORDERS; AXIS-I; DEPRESSION; ANXIETY; SYMPTOMS	Background: High rates of depression have been reported in individuals with traumatic brain injury (TBI). The purpose of the current study was to investigate the relationship between structural MRI findings and the development of novel cases of post-injury depression in this population Methods: The study has a cross-sectional design. Assessments were conducted on average 2.2 years post-injury. Participants were 54 individuals (76% male, mean age 35 years, median PTA duration 16 days) who had sustained a TBI. Depression was assessed with the Structured Clinical Interview for DSM-IV (SCID-IV). Structural MRI scans were performed with a 1.5 Tesla machine. Results: The presence of lesions in the frontal, temporal, parietal and the sublobar regions was not related to depression. However, an imbalance of left vs right frontal and parietal viable brain volumes was related to the development of depression. Discussion: These findings are in support of Heller's model of emotion processing, but should be replicated using larger samples. Potential clinical implications are discussed in the manuscript.	[Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, D-79106 Freiburg, Germany; [Schoenberger, Michael; Ponsford, Jennie; Clarke, David] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Schoenberger, Michael; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Reutens, David; Beare, Richard] Monash Univ, Dept Med, Monash Med Ctr, Melbourne, Vic 3004, Australia; [Reutens, David] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Beare, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia		Schonberger, M (corresponding author), Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, Engelberger Str 41, D-79106 Freiburg, Germany.	michael.schoenberger@psychologie.uni-freiburg.de	Reutens, David/C-7226-2018	Beare, Richard/0000-0002-7530-5664; Reutens, David/0000-0002-1652-9369			Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Deb S, 1999, AM J PSYCHIAT, V156, P374; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Heller W, 1998, COGNITION EMOTION, V12, P421; Heller W., 1993, NEUROPSYCHOLOGY, V7, P476, DOI DOI 10.1037/0894-4105.7.4.476; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Keller J, 2000, J ABNORM PSYCHOL, V109, P3, DOI 10.1037/0021-843X.109.1.3; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Larsen R.J., 1992, REV PERSONALITY SOCI, P25; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	37	15	15	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					543	550		10.3109/02699052.2011.565013			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300001	21534732				2022-02-06	
J	Shindler, KS; Chatterjee, D; Biswas, K; Goyal, A; Dutt, M; Nassrallah, M; Khan, RS; Das Sarma, J				Shindler, Kenneth S.; Chatterjee, Dhriti; Biswas, Kaushiki; Goyal, Ashish; Dutt, Mahasweta; Nassrallah, Mayssa; Khan, Reas S.; Das Sarma, Jayasri			Macrophage-Mediated Optic Neuritis Induced by Retrograde Axonal Transport of Spike Gene Recombinant Mouse Hepatitis Virus	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Axonal transport; Demyelination; Mouse hepatitis virus; Multiple sclerosis; Optic neuritis; Spike glycoprotein	CD8(+) T-CELLS; GLYCOPROTEIN-E; CORONAVIRUS; DEMYELINATION; SPREAD; INFECTION; DAMAGE; MODEL; MICE; PROTEINS	After intracranial inoculation, neurovirulent mouse hepatitis virus (MHV) strains induce acute inflammation, demyelination, and axonal loss in the central nervous system. Prior studies using recombinant MHV strains that differ only in the spike gene, which encodes a glycoprotein involved in virus-host cell attachment, demonstrated that spike mediates anterograde axonal transport of virus to the spinal cord. A demyelinating MHV strain induces optic neuritis, but whether this is due to the retrograde axonal transport of viral particles to the retina or due to traumatic disruption of retinal ganglion cell axons during intracranial inoculation is not known. Using recombinant isogenic MHV strains, we examined the ability of recombinant MHV to induce optic neuritis by retrograde spread from the brain through the optic nerve into the eye after intracranial inoculation. Recombinant demyelinating MHV induced macrophage infiltration of optic nerves, demyelination, and axonal loss, whereas optic neuritis and axonal injury were minimal in mice infected with the nondemyelinating MHV strain that differs in the spike gene. Thus, optic neuritis was dependent on a spike glycoprotein-mediated mechanism of viral antigen transport along retinal ganglion cell axons. These data indicate that MHV spreads by retrograde axonal transport to the eye and that targeting spike protein interactions with axonal transport machinery is a potential therapeutic strategy for central nervous system viral infections and associated diseases.	[Chatterjee, Dhriti; Biswas, Kaushiki; Goyal, Ashish; Das Sarma, Jayasri] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, India; [Shindler, Kenneth S.; Dutt, Mahasweta; Nassrallah, Mayssa; Khan, Reas S.] Univ Penn, Scheie Eye Inst, Philadelphia, PA USA; [Shindler, Kenneth S.; Dutt, Mahasweta; Nassrallah, Mayssa; Khan, Reas S.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA USA		Das Sarma, J (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, India.	dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020	majumder, dhriti/0000-0001-9292-6430	Du Pre Foundation; Indian Institute of Science Education and Research-Kolkata; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG3774A2/1]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY015098, EY019014]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); University Grant Commission, IndiaUniversity Grants Commission, India; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K08EY015098, R01EY019014] Funding Source: NIH RePORTER	The authors thank the Du Pre Foundation for support of AG.; This work was supported by the Indian Institute of Science Education and Research-Kolkata's startup money, by a research grant from the National Multiple Sclerosis Society to JDS (RG3774A2/1), and by National Institutes of Health grants (EY015098 and EY019014) and Career Development Award from Research to Prevent Blindness to KSS. DC and KB are supported by University Grant Commission, India.	BENNUN A, 1982, J IMMUNOL, V129, P303; Cunningham AL, 2006, J INFECT DIS, V194, pS11, DOI 10.1086/505359; Dandekar AA, 2001, J VIROL, V75, P6115, DOI 10.1128/JVI.75.13.6115-6120.2001; Das Sarma J, 2000, J VIROL, V74, P9206, DOI 10.1128/JVI.74.19.9206-9213.2000; Das Sarma J, 2002, J NEUROVIROL, V8, P381, DOI [10.1080/13550280260422686, 10.1080/13550280290100815]; Das Sarma J, 2001, J NEUROVIROL, V7, P432; Das Sarma J, 2001, EXP MOL PATHOL, V71, P1; Das Sarma J, 2010, INTERDISCIP PERSPECT, V2010; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Jin YH, 2009, J VIROL, V83, P10981, DOI 10.1128/JVI.01398-09; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Lancaster KZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000791; LAVI E, 1986, LAB ANIM SCI, V36, P130; McGraw HM, 2009, J VIROL, V83, P8315, DOI 10.1128/JVI.00633-09; McGraw HM, 2009, J VIROL, V83, P4791, DOI 10.1128/JVI.02341-08; Navas S, 2001, J VIROL, V75, P2452, DOI 10.1128/JVI.75.5.2452-2457.2001; PASICK JMM, 1994, J VIROL, V68, P2915, DOI 10.1128/JVI.68.5.2915-2928.1994; PERLMAN S, 1990, J EXP MED, V172, P1127, DOI 10.1084/jem.172.4.1127; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; Shindler KS, 2008, J VIROL, V82, P8882, DOI 10.1128/JVI.00920-08; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; van Rossum D, 2008, GLIA, V56, P271, DOI 10.1002/glia.20611; Vaughan JC, 2009, BIOPHYS J, V97, P1647, DOI 10.1016/j.bpj.2009.07.011; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001	32	15	16	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2011	70	6					470	480		10.1097/NEN.0b013e31821da499			11	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	766AV	WOS:000290751700006	21572336	Green Accepted, Green Published, Bronze			2022-02-06	
J	Johnson, LSM				Johnson, L. Syd M.			Concussion in youth ice hockey: It's time to break the cycle	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							SPORT-RELATED CONCUSSION; BODY-CHECKING; INJURY; BODYCHECKING; CHILDHOOD; PLAYERS; RATES		Dalhousie Univ, Halifax, NS, Canada		Johnson, LSM (corresponding author), Dalhousie Univ, Halifax, NS, Canada.	syd.johnson@dal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 77670]; Therapeutic Hopes and Ethical Concerns: Clinical research in the neurosciences; States of Mind: Emerging issues in neuroethics [NNF 80045]	Research funded by Canadian Institutes of Health Research, MOP 77670, Therapeutic Hopes and Ethical Concerns: Clinical research in the neurosciences, and NNF 80045, States of Mind: Emerging issues in neuroethics.	American Academy of Pediatrics. Committee on Sports Medicine and Fitness, 2000, PEDIATRICS, V105, P657; Bey T, 2009, WEST J EMERG MED, V10, P6; *BOST U CTR STUD T, 2009, 18 YEAR OLD HIGH SCH; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cusimano Michael D, 2011, Open Med, V5, pe57; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; GULLI C, 2011, MACLEANS        0204, P50; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hicks B, 2009, HARD TIMES AHEAD NAT; *HOCKEYCANADA, 2011, BACKGR CHECK; KALCHMAN L, 2003, MAKING NHL VERY LONG; Kissick J, 2007, CANADIAN ACAD SPORT; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Molsa J, 2003, AM J SPORT MED, V31, P751; Montelparel WJ, 2004, AM SOC TEST MATER, V1446, P70, DOI 10.1520/STP11610S; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; *NHL, 2011, NHL CONC RIS ACC HIT; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; rosen D., 2011, NEW CONCUSSION PROTO; ROSEN D, 2010, CAN CONCUSSED PLAYER; RUTHERFORD K, 2009, QUEB HOCK BUCK TREND; *US HOCK, HOCK US BOD RUL PROP; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	33	15	15	0	7	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 3Y6, CANADA	0820-3946			CAN MED ASSOC J	Can. Med. Assoc. J.	MAY 17	2011	183	8					921	924		10.1503/cmaj.110282			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762AZ	WOS:000290446000058	21502353	Green Published, gold			2022-02-06	
J	Bulger, EM				Bulger, Eileen M.			7.5% Saline and 7.5% Saline/6% Dextran for Hypovolemic Shock	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	US Army-Institute-of-Surgical-Research Prehospital Fluid Conference	JAN 08-09, 2010	Ft Worth, TX	USArmy Inst Surg Res & Casual Care Res, US Army Med Res Mat Command			RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; HYPERTONIC RESUSCITATION; HEMORRHAGIC-SHOCK; INFLAMMATORY RESPONSE; MULTICENTER TRIAL; SODIUM-CHLORIDE; HYPOTENSION; EFFICACY		Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA		Bulger, EM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, Box 359796,325 9th Ave, Seattle, WA 98104 USA.	ebulger@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM076101] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL073233, R01 HL073233-01] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM076101, R01 GM076101-01A1] Funding Source: Medline		Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Gurfinkel V, 2003, J TRAUMA, V54, P1137, DOI 10.1097/01.TA.0000064452.37534.29; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Rizoli SB, 1999, J SURG RES, V83, P130, DOI 10.1006/jsre.1999.5581; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Wade C, 1997, Acta Anaesthesiol Scand Suppl, V110, P77; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; YOUNES RN, 1992, SURGERY, V111, P380	20	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2011	70	5		S			S27	S29		10.1097/TA.0b013e31821a559a			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	762RU	WOS:000290499200010	21666775	Green Accepted			2022-02-06	
J	Cherian, L; Goodman, JC; Robertson, C				Cherian, Leela; Goodman, J. Clay; Robertson, Claudia			Improved Cerebrovascular Function and Reduced Histological Damage with Darbepoietin Alfa Administration after Cortical Impact Injury in Rats	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							TRAUMATIC BRAIN-INJURY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; NITRIC-OXIDE SYNTHASE; DARBEPOETIN-ALPHA; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; TISSUE PROTECTION; GENE-EXPRESSION; IN-VIVO; MODEL	Darbepoetin alfa (darbEpo) is an erythropoietic glycoprotein that activates the erythropoietin receptor. The aim of our study was to determine whether darbEpo is neuroprotective in a cortical impact injury (CII) model and to determine the characteristics of dose response and time window. To better understand the vascular mechanism of darbEpo neuroprotection, the reactivity of cerebral blood flow (CBF) to L-arginine administration was also studied. Rats were given saline or darbEpo from 2.5 to 50 mu g/kg at 5 min after CII or a dose of 25 mu g/kg darbEpo at times ranging from 5 min to 24 h after CII. Histological assessment was determined 2 weeks after a severe CII. Other rats were given either darbEpo (25 mu g/kg) or saline daily for 3 days before injury. Five minutes after severe CII, they were given either L-arginine or D-arginine. Hemodynamic variables were monitored for 2 h after injury. In the dose-response study, darbEpo in doses of 25 and 50 mu g/kg significantly reduced contusion volume from 39.1 +/- 6.7 to 8.1 +/- 3.1 and 11.2 +/- 6.0 mm(3), respectively. In the time window study, darbEpo reduced contusion volume when given in a dose of 25 mu g/kg at 5 min to 6 h after the impact injury. In animals pretreated with darbEpo, the CBF response to L-arginine was significantly greater than in the animals pretreated with saline. These data demonstrate that darbEpo has neuroprotective effects in traumatic brain injury in a dose-and time-dependent manner and that vascular effects of darbEpo may have a role in neuroprotection.	[Cherian, Leela; Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, J. Clay] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA		Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	lcherian@bcm.tmc.edu			National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]; Amgen, Inc.Amgen; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke [Grant P01-NS38660] and a grant from Amgen, Inc.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Aydin A, 2003, BRAIN DEV-JPN, V25, P494, DOI 10.1016/S0387-7604(03)00039-1; Baker JE, 2007, J CARDIOVASC PHARM, V49, P337, DOI 10.1097/FJC.0b013e318040cf81; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Brendt P, 2009, SHOCK, V31, P50, DOI 10.1097/SHK.0b013e31817c0188; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Emir M, 2004, TRANSPLANT P, V36, P2935, DOI 10.1016/j.transproceed.2004.11.101; Fishbane S, 2004, KIDNEY INT, V65, P452, DOI 10.1111/j.1523-1755.2004.00400.x; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Kanellakis P, 2010, BRIT J PHARMACOL, V160, P2085, DOI 10.1111/j.1476-5381.2010.00876.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Mann C, 2008, EXP NEUROL, V211, P34, DOI 10.1016/j.expneurol.2007.12.013; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Shafi NI, 2008, J NEUROTRAUM, V25, P257, DOI 10.1089/neu.2007.0347; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Wang XQ, 1999, HYPERTENSION, V33, P894, DOI 10.1161/01.HYP.33.3.894; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yidirim E, 2005, J TRAUMA, V58, P1252, DOI 10.1097/01.TA.0000169803.09482.F8; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	40	15	16	1	2	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	MAY	2011	337	2					451	456		10.1124/jpet.110.176602			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	752EG	WOS:000289671600013	21270134	Green Published			2022-02-06	
J	Wright, MJ; Schmitter-Edgecombe, M				Wright, Matthew J.; Schmitter-Edgecombe, Maureen			The Impact of Verbal Memory Encoding and Consolidation Deficits During Recovery From Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						memory; neuropsychology; traumatic brain injury	CLOSED-HEAD INJURY; TEMPORAL-LOBE EPILEPSY; DIFFUSE AXONAL INJURY; LEARNING TEST; COGNITIVE REHABILITATION; RETRIEVAL DEFICITS; IMPAIRED PATIENTS; EPISODIC MEMORY; FOCAL LESIONS; HERA MODEL	Objective: Encoding and consolidation deficits appear to account for verbal memory impairment following traumatic brain injury (TBI). It is unknown whether these abilities vary during TBI recovery. We sought to determine the pattern and impact of verbal encoding and consolidation deficits following TBI. Methods: Twenty-three participants with moderate-to-severe TBI and 25 age-and education-matched control participants' verbal memory abilities were assessed at 2 time points approximately 1 year apart; assessments occurred at acute and chronic visits for TBI survivors. Main Outcome Measures: Rey Auditory Verbal Learning Test and Item Specific Deficit Approach indices of encoding, consolidation, and retrieval deficits. Results: In contrast to the controls, participants with TBI showed impaired verbal memory characterized by encoding and consolidation deficits at both time points. The TBI group's short-delayed recall and consolidation scores improved between the acute and chronic assessments. Encoding (primary) and consolidation (secondary) deficits emerged as predictors of acute and chronic recall in the TBI group. Also, acute visit encoding deficits predicted chronic visit delayed recall in TBI survivors, but acute consolidation deficits did not. Conclusions: These findings suggest that memory rehabilitation efforts focused on improving encoding of verbal material may be useful during both the acute and chronic phases of recovery following TBI.	[Wright, Matthew J.] Harbor UCLA Med Ctr, Dept Psychiat, Psychol Div, Torrance, CA 90502 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Wright, MJ (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, Psychol Div, 1124 W Carson St,B-4 S, Torrance, CA 90502 USA.	mwright@labiomed.org			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS047690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	The authors thank Jonathan Anderson, Randy McDonald, Logan Gantz, and Michael Walton for their assistance in data collection and coding. This research was supported by National Institute of Neurological Disorders and Stroke (NINDS) Grant NS047690.	AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003; Alessio A, 2004, EPILEPSY BEHAV, V5, P22, DOI 10.1016/j.yebeh.2003.10.010; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Bernard F, 2001, NEUROREPORT, V12, P1737, DOI 10.1097/00001756-200106130-00044; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; COHEN NJ, 2004, COGNITIVE NEUROSCIEN, P322; Craik FIM, 2002, MEMORY, V10, P305, DOI 10.1080/09658210244000135; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.3.CO;2-W; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; ELLIS HC, 1983, FUNDAMENTALS HUMAN M, P84; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M, 2010, TRAUMATIC BRAIN INJU; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Lezak M, 2004, NEUROPSYCHOLOGICAL A, P158; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P414; LILLIE RA, 2010, EVERYDAY IMPACT TRAU, P302; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Nyberg L, 2002, COGNITIVE BRAIN RES, V13, P281, DOI 10.1016/S0926-6410(02)00052-6; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schmidt M., 1996, REY AUDITORY VERBAL; SQUIRE LR, 1994, INT REV NEUROBIOL, V37, P243; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; SQUIRE LR, 1980, NEUROPSYCHOLOGIA, V18, P369, DOI 10.1016/0028-3932(80)90134-7; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; Turkstra LS, 2005, J MED SPEECH-LANG PA, V13, P205; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vingerhoets G, 2006, EPILEPSY BEHAV, V8, P422, DOI 10.1016/j.yebeh.2005.11.013; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Wright MJ, 2009, J CLIN EXP NEUROPSYC, V31, P790, DOI 10.1080/13803390802508918; WRIGHT MJ, WORKING MEM IN PRESS; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263	61	15	16	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2011	26	3					182	191		10.1097/HTR.0b013e318218dcf9			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	760CY	WOS:000290301800002	21552067				2022-02-06	
J	Barr, TL; Alexander, S; Conley, Y				Barr, Taura L.; Alexander, Sheila; Conley, Yvette			Gene Expression Profiling for Discovery of Novel Targets in Human Traumatic Brain Injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						traumatic brain injury; gene expression profiling; genomics; biomarkers	BLOOD MONONUCLEAR-CELLS; MULTIPLE-SCLEROSIS PATIENTS; ACUTE ISCHEMIC-STROKE; CONTROL MAQC PROJECT; SUBSTANTIA-NIGRA; MICROARRAY ANALYSIS; PARKINSONS-DISEASE; GENOMIC RESPONSES; OLIGONUCLEOTIDE ARRAYS; ALZHEIMERS-DISEASE	Several clinical trials have failed to demonstrate a significant effect on outcome following human traumatic brain injury (TBI) despite promising results obtained in preclinical animal studies. These failures may be due in part to a misinterpretation of the findings obtained in preclinical animal models of TBI, a misunderstanding of the complexity of the human response to TBI, limited knowledge about the biological pathways that interact to contribute to good and bad outcomes after brain injury, and the effects of genomic variability and environment on individual recovery. Recent publications suggest that data obtained from gene expression profiling studies of complex neurological diseases such as stroke, multiple sclerosis (MS), Alzheimer's and Parkinson's may contribute to a more informed understanding of what affects outcome following TBI. These data may help to bridge the gap between successful preclinical studies and negative clinical trials in humans to reveal novel targets for therapy. Gene expression profiling has the capability to identify biomarkers associated with response to TBI, elucidate complex genetic interactions that may play a role in outcome following TBI, and reveal biological pathways related to brain health. This review highlights the current state of the literature on gene expression profiling for neurological disease and discusses its ability to aid in unraveling the variable human response to TBI and the potential for it to offer treatment strategies in an area where we currently have limited therapeutic options primarily based on supportive care.	[Barr, Taura L.] W Virginia Univ, Sch Nursing, Morgantown, WV 26506 USA; [Barr, Taura L.] W Virginia Univ, Ctr Neurosci, Morgantown, WV 26506 USA; [Alexander, Sheila; Conley, Yvette] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA		Barr, TL (corresponding author), W Virginia Univ, Sch Nursing, Biomed Res Bldg,1 Med Ctr Dr,Off 313,POB 9303, Morgantown, WV 26506 USA.	tbarr@hsc.wvu.edu		Conley, Yvette/0000-0002-1784-6067	predoctoral Intramural Research Training Award via the Graduate Partnerships Program through the National Institute of Nursing Research, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: A predoctoral Intramural Research Training Award via the Graduate Partnerships Program through the National Institute of Nursing Research, National Institutes of Health.	Achiron A, 2006, AUTOIMMUN REV, V5, P517, DOI 10.1016/j.autrev.2006.02.009; Achiron A, 2004, ANN NEUROL, V55, P410, DOI 10.1002/ana.20008; Achiron A, 2007, ANN NY ACAD SCI, V1107, P155, DOI 10.1196/annals.1381.017; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; Arthur AT, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-17; Baird AE, 2006, PHARMACOGENOMICS, V7, P141, DOI 10.2217/14622416.7.2.141; Baker J, 2007, PHARMACOGENOMICS, V8, P397, DOI 10.2217/14622416.8.4.397; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Basso G, 2007, BLOOD CELL MOL DIS, V39, P164, DOI 10.1016/j.bcmd.2007.05.004; Becker KG, 1997, J NEUROIMMUNOL, V77, P27, DOI 10.1016/S0165-5728(97)00045-3; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chacon Marcus R, 2008, Curr Cardiol Rep, V10, P37, DOI 10.1007/s11886-008-0008-2; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; DeRisi J, 1996, NAT GENET, V14, P457; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; *EXP AN, 2007, EXPR PROF WHOL BLOOD; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A; Goertsches R, 2007, Int MS J, V14, P98; Grond-Ginsbach C, 2008, J NEUROL, V255, P723, DOI 10.1007/s00415-008-0784-z; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hershey AD, 2004, HEADACHE, V44, P994, DOI 10.1111/j.1526-4610.2004.04193.x; Hong J, 2004, J NEUROIMMUNOL, V152, P126, DOI 10.1016/j.jneuroim.2004.03.004; Iglesias AH, 2004, J NEUROIMMUNOL, V150, P163, DOI 10.1016/j.jneuroim.2004.01.017; JERNE NK, 1985, EMBO J, V4, P847, DOI 10.1002/j.1460-2075.1985.tb03709.x; Kalman J, 2005, PSYCHIAT GENET, V15, P1; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Koike F, 2003, J NEUROIMMUNOL, V139, P109, DOI 10.1016/S0165-5728(03)00155-3; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lindberg RLP, 2006, EXPERT REV MOL DIAGN, V6, P843, DOI 10.1586/14737159.6.6.843; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Maouche S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-302; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Miller Renee M, 2006, NeuroRx, V3, P319, DOI 10.1016/j.nurx.2006.05.008; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Miller RM, 2005, NEUROBIOL AGING, V26, P765, DOI 10.1016/j.neurobiolaging.2004.12.002; Miller RM, 2004, J NEUROSCI, V24, P7445, DOI 10.1523/JNEUROSCI.4204-03.2004; Moore DF, 2005, CIRCULATION, V111, P212, DOI 10.1161/01.CIR.0000152105.79665.C6; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Paintlia AS, 2004, J NEUROSCI RES, V77, P63, DOI 10.1002/jnr.20130; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sharp FR, 2007, STROKE, V38, P691, DOI 10.1161/01.STR.0000247940.27518.38; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Sharp FR, 2006, EPILEPSIA, V47, P1603, DOI 10.1111/j.1528-1167.2006.00809.x; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Tajouri L, 2007, CURR GENOMICS, V8, P181, DOI 10.2174/138920207780833829; Tang Y, 2005, ARCH NEUROL-CHICAGO, V62, P210, DOI 10.1001/archneur.62.2.210; Tang Y, 2004, ANN NEUROL, V56, P808, DOI 10.1002/ana.20291; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tang Y, 2001, ANN NEUROL, V50, P699, DOI 10.1002/ana.10042; Tang Y, 2003, J CEREBR BLOOD F MET, V23, P310, DOI 10.1097/01.WCB.0000048518.34839.DE; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Whitney LW, 1999, ANN NEUROL, V46, P425; Whitney LW, 2001, J NEUROIMMUNOL, V121, P40, DOI 10.1016/S0165-5728(01)00438-6; Woo Yong, 2004, J Biomol Tech, V15, P276; Yang T, 2004, MOL BRAIN RES, V132, P155, DOI 10.1016/j.molbrainres.2003.10.014; Zhou Yi-wu, 2002, Fa Yi Xue Za Zhi, V18, P146; 2006, MICROARRAY PLATFORM	85	15	16	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	APR	2011	13	2					140	153		10.1177/1099800410385671			14	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	735ZP	WOS:000288459600004	21112922				2022-02-06	
J	Donovan, NJ; Heaton, SC; Kimberg, CI; Wen, PS; Waid-Ebbs, JK; Coster, W; Singletary, F; Velozo, CA				Donovan, Neila J.; Heaton, Shelley C.; Kimberg, Cara I.; Wen, Pey-Shan; Waid-Ebbs, J. Kay; Coster, Wendy; Singletary, Floris; Velozo, Craig A.			Conceptualizing functional cognition in traumatic brain injury rehabilitation	BRAIN INJURY			English	Article						Brain injury; cognition; cognition disorders; outcomes research; function	PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; ECOLOGICAL VALIDITY; SELF-AWARENESS; NEUROPSYCHOLOGICAL TESTS; HEALTH OUTCOMES; ERROR-AWARENESS; WORKING-MEMORY; HEAD-INJURY; ITEM BANKS	Primary objective: To conceptualize functional cognitive constructs across the continuum of traumatic brain injury (TBI) recovery, to form the foundation for the Computer Adaptive Measure of Functional Cognition for TBI (CAMFC-TBI). Background: TBI often has a profound impact on a survivor's ability to return to previous level of functioning and significantly reduces the overall quality of life for survivors and caregivers. Few assessments are designed to evaluate TBI's impact on cognitive functioning in everyday life. Neuropsychological tests are time consuming and may have questionable ecological validity for predicting functional outcomes. Global functional assessments contain few cognitive items and may lack psychometric rigour. Presently there is a lack of efficient, precise, ecologically valid functional cognitive measures. Main outcome and results: Studies that used neuropsychological and global functional assessments were reviewed to direct conceptualization of functional cognitive constructs across TBI recovery stages. An advisory panel reviewed study methodology and functional cognitive constructs development. They validated the need for the CAMFC-TBI and the six functional cognitive constructs: attention, memory, processing speed, executive functioning, social communication and emotional management. Conclusion: Conceptualizing functional cognitive constructs is the first step in CAMFC-TBI development. Future project stages include item pool development, qualitative testing, field-testing, psychometric analysis and computerized adaptive test programming.	[Donovan, Neila J.] Louisiana State Univ, Dept Commun Sci & Disorders, Baton Rouge, LA 70803 USA; [Donovan, Neila J.; Velozo, Craig A.] Univ Florida, N Florida S Georgia Vet Hlth Syst Rehabil Outcome, Gainesville, FL USA; [Donovan, Neila J.; Waid-Ebbs, J. Kay; Velozo, Craig A.] Univ Florida, Brain Rehabil Res Ctr, Gainesville, FL USA; [Heaton, Shelley C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Kimberg, Cara I.] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA; [Wen, Pey-Shan; Velozo, Craig A.] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA; [Coster, Wendy] Boston Univ, Dept Occupat Therapy, Boston, MA 02215 USA; [Singletary, Floris] Brooks Ctr Rehabil Studies, Jacksonville, FL USA		Donovan, NJ (corresponding author), Louisiana State Univ, Dept Commun Sci & Disorders, 72 Hatcher Hall, Baton Rouge, LA 70803 USA.	ndonovan@lsu.edu		Wen, Pey-Shan/0000-0002-8921-8801	National Institute of Health National Center for Medical Rehabilitation Research [5R21HD045869-03]; Office of Veterans Affairs Rehabilitation Research and Development at the VA RR&D/HSR&D Rehabilitation Outcomes Research Center at the North Florida/South Georgia Veterans Medical Center in Gainesville, Florida [04296H]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD045869] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This study was supported by a grant from the National Institute of Health National Center for Medical Rehabilitation Research # 5R21HD045869-03. Dr Donovan's work was funded in part by the Office of Veterans Affairs Rehabilitation Research and Development Associate Investigator Award #04296H at the VA RR&D/HSR&D Rehabilitation Outcomes Research Center at the North Florida/South Georgia Veterans Medical Center in Gainesville, Florida.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arpinelli F, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-85; Arthanat S, 2004, DISABIL REHABIL, V26, P235, DOI 10.1080/09638280310001644889; Benson D.F., 1986, FRONTAL LOBES; Bergeson AG, 2004, CLIN NEUROPSYCHOL, V18, P509, DOI 10.1080/1385404049052414; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Cantagallo A, 2006, BRAIN INJURY, V20, P913, DOI 10.1080/02699050600832742; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; COLLINS JG, 1993, VITAL HLTH STAT, V2, P1; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Cook KF, 2007, QUAL LIFE RES, V16, P121, DOI 10.1007/s11136-007-9177-5; Cook KF, 2005, HEALTH SERV RES, V40, P1694, DOI 10.1111/j.1475-6773.2005.00446.x; Coster WJ, 2004, ARCH PHYS MED REHAB, V85, P2030, DOI 10.1016/j.apmr.2004.05.002; Coyne KS, 2006, UROLOGY, V68, P9, DOI 10.1016/j.urology.2006.05.042; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; D'Zurilla T.J., 1999, PROBLEM SOLVING THER, V2nd edn; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; DeLisa JA, 2004, ARCH PHYS MED REHAB, V85, P531, DOI 10.1016/j.apmr.2003.12.003; Demir SO, 2006, BRAIN INJURY, V20, P1383, DOI 10.1080/02699050601081844; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Doward LC, 2004, VALUE HEALTH, V7, P4; Elliott D, 2006, J CLIN EPIDEMIOL, V59, P153, DOI 10.1016/j.jclinepi.2005.06.010; *FED DRUG ADM, 2009, GUID IND PAT REP OUT, P37; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Fries JF, 2006, ANN RHEUM DIS, V65, P16, DOI 10.1136/ard.2006.059279; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Gioia GA., 1996, BEHAV RATING INVENTO; Gioia GA IP, 2000, BEHAV RATING INVENTO; GOLEMAN D, 1998, HARVARD BUSINESS NOV, P93; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Hahn EA, 2006, MED CARE, V44, pS189, DOI 10.1097/01.mlr.0000245145.21869.5b; Haley SM, 2004, MED CARE, V42, P49, DOI 10.1097/01.mlr.0000103520.43902.6c; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; JENNETT B, 1975, LANCET, V1, P480; Jette AM, 2003, J REHABIL MED, V35, P145, DOI 10.1080/16501970310010501; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luria A.R., 1966, HIGHER CORTICAL FUNC; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McHorney CA, 1997, ANN INTERN MED, V127, P743, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00061; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MOSCOVITCH M, 1979, HDB BEHAV NEUROBIOLO, V2; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Revicki DA, 2007, QUAL LIFE RES, V16, P717, DOI 10.1007/s11136-006-9153-5; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Robertson I., 1994, TEST EVERYDAY ATTENT; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SBORDONE R, 1997, NEUROPSYCHOLOGY HDB, P365; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Silverberg ND, 2007, J INT NEUROPSYCH SOC, V13, P898, DOI 10.1017/S1355617707071135; Sneeuw KCA, 2002, J CLIN EPIDEMIOL, V55, P1130, DOI 10.1016/S0895-4356(02)00479-1; Sohlberg M., 2001, COGNITIVE REHABILITA; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; State University of New York at Buffalo, 1993, GUID US UN DAT SET M; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Townend W, 2001, J NEUROL NEUROSUR PS, V70, P267; Tupper D., 1990, NEUROPSYCHOLOGY EVER, P3, DOI DOI 10.1007/978-1-4613-1503-2_1; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Velozo CA, 1999, AM J OCCUP THER, V53, P83, DOI 10.5014/ajot.53.1.83; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; World Health Organization, 2001, INT CLASS FUNCT DISA	96	15	15	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2011	25	4					348	364		10.3109/02699052.2011.556105			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600004	21323413				2022-02-06	
J	Jawaid, A; Poon, M; Strutt, AM; Rice, LK; McDowell, EJ; Salamone, AR; Qureshi, SU; Simpson, E; Appel, SH; York, MK; Schulz, PE				Jawaid, A.; Poon, M.; Strutt, A. M.; Rice, L. K.; McDowell, E. J.; Salamone, A. R.; Qureshi, S. U.; Simpson, E.; Appel, S. H.; York, M. K.; Schulz, P. E.			Does apolipoprotein E genotype modify the clinical expression of ALS?	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						cohort study; motor neuron disease; neurological disorders; neuromuscular diseases; research methods	AMYOTROPHIC-LATERAL-SCLEROSIS; APOE EPSILON-4 ALLELE; CLOSED-HEAD INJURY; E-DEFICIENT MICE; ALZHEIMERS-DISEASE; E POLYMORPHISM; ONSET; AGE; ASSOCIATION; GENE	Background: The presence of the apolipoprotein E (ApoE) 4 genotype is associated with an earlier age of onset for Alzheimer's disease (AD) and several other neurodegenerative disorders. The objective of this study was to investigate the effect of ApoE genotypes on the clinical course of amyotrophic lateral sclerosis (ALS). Methods: Eight hundred and fifty-two consecutive patients with sporadic ALS evaluated at a tertiary care center were investigated for the effect of ApoE genotype on age of onset, rate of motor disease progression, cognitive functioning, and survival in ALS. Results: The frequencies of individual ApoE genotypes did not differ between patients with ALS and ALS-free Caucasian populations. Patients with different ApoE genotypes did not differ in the age of onset for ALS (years) (ApoE2 = 57.8 +/- 13.7, ApoE3 = 57.3 +/- 13.7, ApoE4 = 57.7 +/- 13.2; P = 0.97), the rate of disease progression (Appel ALS score/month) (ApoE2 = 2.91 +/- 2.66, ApoE3 = 2.67 +/- 2.66, ApoE4 = 2.61 +/- 2.47; P = 0.89), cognitive status (% cognitively impaired) (ApoE2 = 31.7, ApoE3 = 26.8, ApoE4 = 34.3, P = 0.28), or survival in years (ApoE2 = 3.79 +/- 3.70, ApoE3 = 3.17 +/- 2.27, ApoE4 = 3.05 +/- 1.75; P = 0.85). Conclusions: Our results suggest that ApoE genotype does not modify clinical course of sporadic ALS, in stark contrast to the influence of ApoE genotype on the disease course of AD and other neurodegenerative disorders.	[Jawaid, A.; Poon, M.; Strutt, A. M.; Rice, L. K.; McDowell, E. J.; Salamone, A. R.; Qureshi, S. U.; York, M. K.; Schulz, P. E.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Simpson, E.; Appel, S. H.] Methodist Neurol Inst, Houston, TX USA		Schulz, PE (corresponding author), Univ Texas Hlth Sci Ctr Houston, 6410 Fannin,Suite 1014, Houston, TX 77030 USA.	Paul.E.Schulz@uth.tmc.edu		Jawaid, Ali/0000-0002-5126-6744			APPEL V, 1987, ANN NEUROL, V22, P328, DOI 10.1002/ana.410220308; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bedlack RS, 2000, ARCH NEUROL-CHICAGO, V57, P1561, DOI 10.1001/archneur.57.11.1561; Borroni B, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-31; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brooks BR, 1996, NEUROLOGY, V47, pS71, DOI 10.1212/WNL.47.4_Suppl_2.71S; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Drory VE, 2001, J NEUROL SCI, V190, P17, DOI 10.1016/S0022-510X(01)00569-X; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; HIXSON JE, 1990, J LIPID RES, V31, P545; Jawaid A, 2010, EUR J NEUROL, V17, P733, DOI 10.1111/j.1468-1331.2009.02923.x; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Li YJ, 2004, NEUROGENETICS, V5, P209, DOI 10.1007/s10048-004-0193-0; Li YJ, 2004, NEUROLOGY, V62, P2005, DOI 10.1212/01.WNL.0000128089.53030.AC; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Louko AM, 2006, ACTA NEUROL SCAND, V114, P315, DOI 10.1111/j.1600-0404.2006.00676.x; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Moulard B, 1996, J NEUROL SCI, V139, P34, DOI 10.1016/0022-510X(96)00085-8; MUI S, 1995, ANN NEUROL, V38, P460, DOI 10.1002/ana.410380318; Muller W, 1998, BRAIN PATHOL, V8, P641; Parmenter BA, 2007, MULT SCLER J, V13, P25, DOI 10.1177/1352458506070682; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Schiefermeier M, 2000, BRAIN, V123, P585, DOI 10.1093/brain/123.3.585; Srinivasan R, 2006, J NEUROL NEUROSUR PS, V77, P154, DOI 10.1136/jnnp.2005.063966; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Tian J, 2004, J NEUROL NEUROSUR PS, V75, P696, DOI 10.1136/jnnp.2003.012096; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tsuang DW, 2002, ARCH NEUROL-CHICAGO, V59, P1622, DOI 10.1001/archneur.59.10.1622; Van Everbroeck B, 2001, NEUROSCI LETT, V313, P69, DOI 10.1016/S0304-3940(01)02264-9; Verpillat P, 2002, EUR J HUM GENET, V10, P399, DOI 10.1038/sj.ejhg.5200820; Zetterberg H, 2008, J NEUROL SCI, V273, P67, DOI 10.1016/j.jns.2008.06.025	39	15	15	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	APR	2011	18	4					618	624		10.1111/j.1468-1331.2010.03225.x			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	736OI	WOS:000288503600017	20880000				2022-02-06	
J	Menzler, K; Thiel, P; Hermsen, A; Chen, X; Benes, L; Miller, D; Sure, U; Knake, S; Rosenow, F				Menzler, Katja; Thiel, Patricia; Hermsen, Anke; Chen, Xu; Benes, Ludwig; Miller, Dorothea; Sure, Ulrich; Knake, Susanne; Rosenow, Felix			The role of underlying structural cause for epilepsy classification: Clinical features and prognosis in mesial temporal lobe epilepsy caused by hippocampal sclerosis versus cavernoma	EPILEPSIA			English	Article						Cavernoma; Hippocampal sclerosis; Mesiotemporal lobe epilepsy; Vascular lesions; Epileptogenicity	SURGERY; PREDICTORS; LOBECTOMY	Purpose: The recent "Report of the ILAE Commission on Classification and Terminology" recommends an epilepsy classification that gives more emphasis to the underlying structural or metabolic cause rather than to the localization of the epileptogenic zone. The aim of the present study was to investigate differences in clinical features, treatment response, and prognosis in patients with mesial temporal lobe epilepsy (MTLE) caused by hippocampal sclerosis (MTLE-HS) or singular mesiotemporal cavernomas (MTLE-C) in order to evaluate the impact of underlying pathology on the course of the disease while controlling for localization. Methods: Age at onset, age at surgery, seizure frequency and semiology, pharmacoresistance, psychiatric comorbidities, memory deficits, or initial precipitating insults (e. g., febrile seizures, traumatic brain injury, infection of the central nervous system, birth complications) as well as postoperative outcome were compared in eleven patients with MTLE-C and 33 patients with MTLE-HS using nonparametric statistical methods. Key Findings: The postoperative outcome was significantly better in patients with MTLE-C, even after controlling for preoperative epilepsy duration. Patients with MTLE-HS more frequently were drug resistant (88% vs. 36%) and more often presented with an initial precipitating insult (70% vs. 27%) and with automotor seizures (79% vs. 46%). Significance: The results suggest that patients with MTLE-C show a more favorable postoperative outcome, supporting the commission's suggestion to put more emphasis on the underlying cause in future epilepsy classifications.	[Menzler, Katja; Thiel, Patricia; Hermsen, Anke; Knake, Susanne; Rosenow, Felix] Univ Hosp Giessen & Marburg, Dept Neurol, Interdisciplinary Epilepsy Ctr, Marburg, Germany; [Chen, Xu] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Peoples R China; [Benes, Ludwig; Miller, Dorothea; Sure, Ulrich] Univ Hosp Giessen & Marburg, Interdisciplinary Epilepsy Ctr, Dept Neurosurg, Marburg, Germany; [Miller, Dorothea; Sure, Ulrich] Univ Hosp Essen, Dept Neurosurg, Essen, Germany		Rosenow, F (corresponding author), Univ Marburg, Dept Neurol, Interdisciplinary Epilepsy Ctr, Rudolf Bultmann Str 8, D-35033 Marburg, Germany.	rosenow@med.uni-marburg.de	Knake, Susanne/AAJ-4487-2021; Miller, Dorothea/ABB-2588-2020	Miller, Dorothea/0000-0001-7851-1917; Knake, Susanne/0000-0002-6298-0513			[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baumann CR, 2007, EPILEPSIA, V48, P559, DOI 10.1111/j.1528-1167.2006.00941.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Diehl B, 2003, SEIZURE-EUR J EPILEP, V12, P307, DOI 10.1016/S1059-1311(02)00272-8; Elsharkawy AE, 2009, J NEUROSURG, V110, P1135, DOI 10.3171/2008.6.JNS17613; Engel J, 1993, SURG TREATMENT EPILE, P609, DOI DOI 10.1159/000325660; Janszky J, 2005, EPILEPSY RES, V64, P35, DOI 10.1016/j.eplepsyres.2005.02.004; Jeong SW, 1999, EPILEPSIA, V40, P1735, DOI 10.1111/j.1528-1157.1999.tb01591.x; Jutila L, 2002, J NEUROL NEUROSUR PS, V73, P486, DOI 10.1136/jnnp.73.5.486; Kanner AM, 2009, NEUROLOGY, V72, P793, DOI 10.1212/01.wnl.0000343850.85763.9c; KUZNIECKY R, 1993, ARCH NEUROL-CHICAGO, V50, P65, DOI 10.1001/archneur.1993.00540010059018; Lortie A, 2002, EPILEPSY RES, V51, P133, DOI 10.1016/S0920-1211(02)00102-X; Menzler K, 2010, NEUROSURGERY, V67, P918, DOI 10.1227/NEU.0b013e3181eb5032; Radhakrishnan K, 1998, NEUROLOGY, V51, P465, DOI 10.1212/WNL.51.2.465; Semah F, 2005, EPILEPTIC DISORD, V7, pS10; Semah F, 2002, ARCH NEUROL-CHICAGO, V59, P1042, DOI 10.1001/archneur.59.6.1042-a; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x	20	15	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	APR	2011	52	4					707	711		10.1111/j.1528-1167.2011.02984.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	745HO	WOS:000289156700009	21426322				2022-02-06	
J	Potter, MR; Snyder, AJ; Smith, GA				Potter, Matthew R.; Snyder, Ashley J.; Smith, Gary A.			Boxing Injuries Presenting to US Emergency Departments, 1990-2008	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; PROFESSIONAL BOXERS; AMATEUR; RISK; DIFFUSION; CHILDREN	Background: Boxing injuries can have serious consequences. Purpose: To examine the epidemiology of boxing injuries in the U.S. with attention to head injuries and children. Methods: National estimates of boxing injuries were calculated using data from the National Electronic Injury Surveillance System. Injury rates per 1000 participants for the year 2003 were calculated using boxing participation data. Data analysis was conducted in 2009-2010. Results: An estimated 165,602 individuals (95% CI=134891, 196313) sustained boxing injuries that resulted in a visit to a U.S. hospital emergency department from 1990 through 2008. An average of 8716 (95% CI=7078, 10354) injuries occurred annually, and there was a statistically significant increase in the annual number of injuries during the 19-year study period (slope=610, p<0.001). The rate of injury was 12.7 per 1000 participants. Those injured were predominately male (90.9%). The most common diagnosis was fracture (27.5%), and the most common body regions injured were the hand (33.0%) and head and neck (22.5%). Punching bag-related injuries accounted for 36.8% of boxing injuries. The percentage of injuries that were concussions/closed head injuries in the group aged 12-17 years (8.9%) was similar to that in the group aged 18-24 years (8.1%) and the group aged 25-34 years (8.5%). Conclusions: These findings, based on a nationally representative sample, indicate that injuries related to boxing are increasing in number. Increased efforts are needed to prevent boxing injuries. (Am J Prev Med 2011;40(4):462-467) (C) 2011 American Journal of Preventive Medicine	[Potter, Matthew R.; Snyder, Ashley J.; Smith, Gary A.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [Potter, Matthew R.; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Gary.Smith@nationwidechildrens.org			Ohio State University College of MedicineOhio State University	The authors gratefully acknowledge the student stipend support provided to author MRP during this study from the Dorothy M. Bennett and Clark L. Bennett Medical Research Scholarship Fund at the Ohio State University College of Medicine.	American Medical Association, H 470 963 BOX INJ; *AUSTR MED ASS, 2007, BOX AUSTR MED ASS PO; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; *BRIT MED ASS, BOX UPD BOARD SCI; *CAN MED ASS, 2001, CMA POL BOX; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; McCrory P, 2002, BRIT J SPORT MED, V36, P2, DOI 10.1136/bjsm.36.1.2; McCrory P, 2007, BMJ-BRIT MED J, V335, P781, DOI 10.1136/bmj.39352.454792.80; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NEISS, 2000, NAT EL INJ SURV SYST; Pearn J, 1998, J PAEDIATR CHILD H, V34, P311, DOI 10.1046/j.1440-1754.1998.00231.x; Playfor SD, 1999, J PAEDIATR CHILD H, V35, P223; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Risser WL, 1997, PEDIATRICS, V99, P134; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; 2004, SUPERSTUDY SPORTS PA, V2	26	15	15	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	APR	2011	40	4					462	467		10.1016/j.amepre.2010.12.018			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	734FN	WOS:000288319700010	21406281				2022-02-06	
J	Shi, W; Zhao, W; Shen, A; Shao, B; Wu, XJ; Yang, J; Ni, LC; Wu, QY; Chen, JA				Shi, Wei; Zhao, Wei; Shen, Aiguo; Shao, Bai; Wu, Xiujie; Yang, Jiao; Ni, Lanchun; Wu, Qiyun; Chen, Jian			Traumatic Brain Injury Induces an Up-Regulation of Hs1-Associated Protein X-1 (Hax-1) in Rat Brain Cortex	NEUROCHEMICAL RESEARCH			English	Article						Hax-1; Traumatic brain injury; Rats; Neurons	CELL-DEATH; APOPTOSIS; MECHANISMS; CASPASE-3; IDENTIFICATION; INHIBITION; EXPRESSION; INTERACTS; CLEAVAGE; NEURONS	HS1-associated protein X-1 (Hax-1) is an intracellular protein with anti-apoptotic properties that, in addition to suppressing cell death by inhibiting the activation of initiator caspase-9 and death caspase-3, is involved in an increasing number of signaling cascades. However, its expression and function in the central nervous system lesion are still unclear. In this study, we performed a traumatic brain injury (TBI) model in adult rats and investigated the dynamic changes of Hax-1 expression in the brain cortex. Western blot and immunohistochemistry analysis revealed that Hax-1 was present in normal brain. It gradually increased, reached a peak at day 3 after TBI, and then declined during the following days. Double immunofluorescence staining showed that Hax-1 immunoreactivity (IR) was found in neurons, but not astrocytes and microglia. Moreover, the 3rd day post injury was the apoptotic peak implied by the alteration of caspase-3, Bcl-2 and TUNEL. All these results suggested that Hax-1 may be involved in the pathophysiology of TBI and further research is needed to have a good understanding of its function and mechanism.	[Shi, Wei; Zhao, Wei; Shen, Aiguo; Wu, Xiujie; Yang, Jiao; Ni, Lanchun; Wu, Qiyun; Chen, Jian] Nantong Univ, Coll Med, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China; [Shao, Bai] Nantong Univ, Affiliated Dongtai Hosp, Dept Neurosurg, Yancheng 224200, Peoples R China		Wu, QY (corresponding author), Nantong Univ, Coll Med, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China.	ntwuqiyun@163.com.cn; chenjian9079@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320, 31070723, 81070275]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009157, BK2009161]; Nature Science Foundation of JiangsuNatural Science Foundation of Jiangsu Province [09KJB320011]	This work was supported by the National Natural Science Foundation of China (No. 30770488, No. 30870320, No. 31070723 and No. 81070275); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009157 and No. BK2009161); Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011).	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Erhardt L, 1996, EUR HEART J, V17, P1781; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; Grzybowska EA, 2006, GENE, V371, P84, DOI 10.1016/j.gene.2005.11.035; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; Hippe A, 2006, GENE, V379, P116, DOI 10.1016/j.gene.2006.04.027; Kang YJ, 2010, BIOCHEM BIOPH RES CO, V393, P794, DOI 10.1016/j.bbrc.2010.02.084; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AY, 2008, MOL CELLS, V25, P86; LOGAN A, 1992, J NEUROSCI, V12, P3828; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Marshall L F, 2000, Clin Neurosurg, V46, P105; Mirmohammadsadegh A, 2003, J INVEST DERMATOL, V120, P1045, DOI 10.1046/j.1523-1747.2003.12247.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587	31	15	15	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2011	36	3					375	382		10.1007/s11064-010-0332-y			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	716RB	WOS:000286990100003	21136158				2022-02-06	
J	Sulaiman, AM; Denman, N; Buchanan, S; Porter, N; Vesi, S; Sharpe, R; Graham, DI; Maxwell, WL				Sulaiman, Ahmed Mohammed; Denman, Nicola; Buchanan, Shaun; Porter, Nicola; Vesi, Sauparnika; Sharpe, Rachel; Graham, David I.; Maxwell, William L.			Stereology and Ultrastructure of Chronic Phase Axonal and Cell Soma Pathology in Stretch-Injured Central Nerve Fibers	JOURNAL OF NEUROTRAUMA			English	Article						programmed cell death; retinal ganglion cell; secondary axotomy	TRAUMATIC BRAIN-INJURY; RETINAL GANGLION-CELLS; SITU DNA FRAGMENTATION; OPTIC-NERVE; WHITE-MATTER; WALLERIAN DEGENERATION; QUANTITATIVE-ANALYSIS; CYTOSKELETAL CHANGES; LONGITUDINAL CHANGES; PROGRESSIVE ATROPHY	Magnetic resonance imaging (MRI) suggests that with survival after human traumatic brain injury (TBI), there is ongoing loss of white and grey matter from the injured brain during the chronic phase. However; direct quantitative experimental evidence in support of this observation is lacking. Using the guinea pig stretch-injury optic nerve model, quantitative evidence by stereology of damage to the optic nerve and retina was sought. Stretch injury was applied to the right optic nerve of 15 adult male guinea pigs. Three animals each at 1, 2, 3, 8, or 12 weeks' survival were killed and prepared for transmission electron microscopy (TEM). The estimated number of intact and injured axons within bins of transverse diameters 0-0.5, 0.51-1.0, 1.01-1.5, 1.51-2.0, 2.01-2.5, and 2.51-3.0 mu m in the middle segment of each injured optic nerve and from 5 control animals were compared across all survival time points. The estimated numbers of intact and pyknotic retinal ganglion cells from the same animals were also compared. Loss of myelinated fibers continued throughout the experimental period. The most rapid loss was of the largest fibers; loss of intermediate-sized fibers continued, but the numbers of the smallest fibers increased from 3 weeks onward. There was hypertrophy and proliferation of glial cells within the surrounding neuropil. A relatively low-grade loss of retinal ganglion cells occurred throughout the experiment, with about 60% remaining at 12 weeks' survival. We provide quantitative evidence that after traumatic axonal injury (TAI) there is a continuing loss of nerve fibers and their cell bodies from a CNS tract over a 3-month post-traumatic interval.	[Maxwell, William L.] Univ Glasgow, Dept Anat, Sch Med Vet Med & Life Sci MVLS, Coll Med Vet Med & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Maxwell, William L.] Univ Glasgow, Dept Human Anat, Coll Med Vet Med & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Graham, David I.] So Gen Hosp, Univ Div Neuropathol, Glasgow G51 4TF, Lanark, Scotland		Maxwell, WL (corresponding author), Univ Glasgow, Dept Anat, Sch Med Vet Med & Life Sci MVLS, Coll Med Vet Med & Life Sci, Thomson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	William.Maxwell@gla.ac.uk		Porter, Nicola/0000-0003-1582-9383			Agudo M, 2008, MOL VIS, V14, P1050; BARRON KD, 1986, J NEUROCYTOL, V15, P345, DOI 10.1007/BF01611437; BAUR PS, 1977, J MICROSC-OXFORD, V109, P315, DOI 10.1111/j.1365-2818.1977.tb01145.x; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BIGLER ED, 2011, BRAIN IMAGI IN PRESS; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Butt AM, 2004, EYE, V18, P1110, DOI 10.1038/sj.eye.6701595; CELLERINO A, 2000, J NEUROSCI, V20, P1; COE R, 2002, EFFECT SIZE CALCULAT; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Couto LA, 2004, J NEUROSCI RES, V77, P410, DOI 10.1002/jnr.20170; CRAGG BG, 1961, J PHYSIOL-LONDON, V157, P315, DOI 10.1113/jphysiol.1961.sp006724; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; FRIEDE RL, 1986, ACTA NEUROPATHOL, V72, P74, DOI 10.1007/BF00687950; FRIEDE RL, 1967, J COMP NEUROL; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JAFARI SS, 1998, THESIS U GLASGOW; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KREUTZBERG GW, 1971, ACTA NEUROPATHOL, V17, P220, DOI 10.1007/BF00685055; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Marques SA, 2003, BRAIN RES, V969, P1, DOI 10.1016/S0006-8993(02)03834-9; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Narciso MS, 2001, AN ACAD BRAS CIENC, V73, P231, DOI 10.1590/S0001-37652001000200008; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; RINK A, 1995, AM J PATHOL, V147, P1575; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; SAATMAN KE, 2009, HDB NEUROCHEMISTRY M, P344; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Staal JA, 2009, J NEUROTRAUM, V26, P781, DOI 10.1089/neu.2008.0669; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; SULAMAIN MA, 2005, THESIS U GLASGOW GLA; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WEGNER JE, 1976, BIOL GUINEA PIG; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	73	15	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2011	28	3					383	400		10.1089/neu.2010.1707			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	734WD	WOS:000288370600005	21190396				2022-02-06	
J	Arellano-Orden, V; Leal-Noval, SR; Cayuela, A; Munoz-Gomez, M; Ferrandiz-Millon, C; Garcia-Alfaro, C; Marin-Caballos, A; Dominguez-Roldan, JM; Murillo-Cabezas, F				Arellano-Orden, Victoria; Leal-Noval, Santiago R.; Cayuela, Aurelio; Munoz-Gomez, Manuel; Ferrandiz-Millon, Carmen; Garcia-Alfaro, Claudio; Marin-Caballos, Antonio; Ma. Dominguez-Roldan, Jose; Murillo-Cabezas, Francisco			Gender Influences Cerebral Oxygenation After Red Blood Cell Transfusion in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Brain tissue oxygen pressure; Cerebral oxygenation; Gender; Severe traumatic brain injury and transfusion	PROGESTERONE; RATS; MORTALITY; ESTROGEN; LESIONS; CORTEX; WORSE; AGE	Important differences with respect to gender exist in the prognosis and mortality of traumatic brain injury (TBI) patients. The objective of this study was to assess the role of gender as an independent factor in cerebral oxygenation variations following red blood cell transfusion (RBCT). This retrospective analysis of a prospective study was conducted on patients with severe TBI. Hemoglobin levels were measured at baseline and 6 h after transfusion. Brain tissue oxygen pressure (PbrO(2)), cerebral perfusion pressure (CPP), intracranial pressure (ICP), and mean arterial pressure (MAP) were measured at baseline, at the end of RBCT and at 1, 2, 3, 4, 5, and 6 h after transfusion. After the patients were stratified into two groups according to gender, the effect of RBCT on PbrO(2) (cerebral oxygenation) was analyzed using a multivariate analysis of variance with repeated measures (MANOVA). The MANOVA was repeated after adjusting for all covariables with baseline differences between groups. At baseline, we found differences in age (P = 0.01), weight (P = 0.03), MAP (P = 0.01), ISS (P = 0.05), and CCP (P = 0.01) between the groups. After adjusting for these co-variables, we observed that gender and age were related to the increase in PbrO(2) (P = 0.05 and P = 0.04, respectively). Our results suggest that the effect of RBCT on cerebral oxygenation, as measured by PbrO(2), is greater in women than in men.	[Leal-Noval, Santiago R.] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Serv Cuidados Crit & Urgencias, Seville 41013, Spain; [Munoz-Gomez, Manuel] Univ Malaga, Sch Med, Malaga, Spain; [Cayuela, Aurelio] Hosp Virgen del Rocio, Div Stat, Seville, Spain; [Arellano-Orden, Victoria; Leal-Noval, Santiago R.; Ferrandiz-Millon, Carmen; Garcia-Alfaro, Claudio; Marin-Caballos, Antonio; Ma. Dominguez-Roldan, Jose; Murillo-Cabezas, Francisco] Hosp Virgen del Rocio, Neuro Crit Care Div, Seville, Spain		Leal-Noval, SR (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Serv Cuidados Crit & Urgencias, Avda Manuel Siurot S-N, Seville 41013, Spain.	srleal@telefonica.net	Noval, Santiago/K-4515-2019; Cayuela, Aurelio/AAZ-1294-2020; Dominguez-Roldan, Jose-Maria/M-1728-2016; Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016; Cayuela, Aurelio/C-6698-2012	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; Cayuela, Aurelio/0000-0002-4936-9402	Spanish Government funds (Fondo de Investigacion Sanitaria-FIS-Proyecto de Investigacion) [PI 081069]; Consejeria de Salud de la Junta de Andalucia (Proyecto de Investigacion)Junta de Andalucia [PI 0157/2006]; Fundacion MAP-FRE	This study is supported by Spanish Government funds (Fondo de Investigacion Sanitaria-FIS-Proyecto de Investigacion: PI 081069), by Consejeria de Salud de la Junta de Andalucia (Proyecto de Investigacion: PI 0157/2006) and by Fundacion MAP-FRE 2008.	Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; DEEGAN BM, 31 ANN INT C IEEE EM; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Herrmann MJ, 2006, NEUROBIOL AGING, V27, P888, DOI 10.1016/j.neurobiolaging.2005.04.013; Juraska JM, 1990, CEREBRAL CORTEX RAT, P483; Kaldi I, 2004, EUR J OPHTHALMOL, V14, P306, DOI 10.5301/EJO.2008.1363; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kolb B, 1996, BEHAV NEUROSCI, V110, P1271, DOI 10.1037/0735-7044.110.6.1271; KOLB B, 1995, BEHAV NEUROSCI, V109, P285, DOI 10.1037/0735-7044.109.2.285; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	26	15	16	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2011	14	1					18	23		10.1007/s12028-010-9441-3			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	708WF	WOS:000286394300004	20838931				2022-02-06	
J	Lorenz, LS; Chilingerian, JA				Lorenz, Laura S.; Chilingerian, Jon A.			Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 48; person-centered care; participatory visual methods; photovoice; photo-elicitation; narrative medicine; acquired brain injury; disability; rehabilitation; palliative care	BRAIN-INJURY; KNOWLEDGE; EXPERIENCE; CHILDREN; ILLNESS; CANCER	The Institute of Medicine has targeted patient-centeredness as an important area of quality improvement. A major dimension of patient-centeredness is respect for patient's values, preferences, and expressed needs. Yet specific approaches to gaining this understanding and translating it to quality care in the clinical setting are lacking. From a patient perspective quality is not a simple concept but is best understood in terms of five dimensions: technical outcomes; decision-making efficiency; amenities and convenience; information and emotional support; and overall patient satisfaction. Failure to consider quality from this five-pronged perspective results in a focus on medical outcomes, without considering the processes central to quality from the patient's perspective and vital to achieving good outcomes. In this paper, we argue for applying the concept of fair process in clinical settings. Fair process involves using a collaborative approach to exploring diagnostic issues and treatments with patients, explaining the rationale for decisions, setting expectations about roles and responsibilities, and implementing a core plan and ongoing evaluation. Fair process opens the door to bringing patient expertise into the clinical setting and the work of developing health care goals and strategies. This paper provides a step by step illustration of an innovative visual approach, called photovoice or photo-elicitation, to achieve fair process in clinical work with acquired brain injury survivors and others living with chronic health conditions. Applying this visual tool and methodology in the clinical setting will enhance patient-provider communication; engage patients as partners in identifying challenges, strengths, goals, and strategies; and support evaluation of progress over time. Asking patients to bring visuals of their lives into the clinical interaction can help to illuminate gaps in clinical knowledge, forge better therapeutic relationships with patients living with chronic conditions such as brain injury, and identify patient-centered goals and possibilities for healing. The process illustrated here can be used by clinicians, ( primary care physicians, rehabilitation therapists, neurologists, neuropsychologists, psychologists, and others) working with people living with chronic conditions such as acquired brain injury, mental illness, physical disabilities, HIV/AIDS, substance abuse, or post-traumatic stress, and by leaders of support groups for the types of patients described above and their family members or caregivers.	[Lorenz, Laura S.] Brandeis Univ, Inst Behav Hlth, Waltham, MA 02254 USA; [Lorenz, Laura S.; Chilingerian, Jon A.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA		Lorenz, LS (corresponding author), Brandeis Univ, Inst Behav Hlth, Waltham, MA 02254 USA.	llorenz@brandeis.edu		Chilingerian, Jon/0000-0001-9317-9000; Lorenz, Laura/0000-0003-0898-4537	Brain Injury Association of Massachusetts; Statewide Health Injury Program of the Massachusetts Rehabilitation Commission; Agency for Healthcare Research in QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality; Schneider Institutes for Health Policy at the Heller School for Social Policy and Management, Brandeis University	We thank the 14 brain injury patients who are members of the "Amazing" Brain Injury Survivor Support Group in Framingham, MA or accessing outpatient services through Spaulding Rehabilitation Hospital for participating in the study that led to this paper. Funding and other support for the study were provided by the Brain Injury Association of Massachusetts, the Statewide Health Injury Program of the Massachusetts Rehabilitation Commission, and the Agency for Healthcare Research in Quality and the Schneider Institutes for Health Policy at the Heller School for Social Policy and Management, Brandeis University, through a doctoral training fellowship in health services research and policy analysis.	Berland G, 2007, NEW ENGL J MED, V357, P2533, DOI 10.1056/NEJMp0706823; Boyle P. J, 2001, PARK RIDGE CTR B REL, V19, P479; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chilingerian JA, 2006, MANAGING LEADING ALL, P191; Committee on Quality of Health Care in America Institute of Medicine, 2001, CROSSING QUALITY CHA; Entwistle V, 2002, EUR J CANCER CARE, V11, P232, DOI 10.1046/j.1365-2354.2002.00344.x; Guillemin M, 2004, QUAL HEALTH RES, V14, P272, DOI 10.1177/1049732303260445; Hagen C, 1997, DALLAS TEXAS RANCHOS; Herzlinger, 2004, CONSUMER DRIVEN HLTH, P443, DOI Jossey-Bass; Kim WC, 1997, HARVARD BUS REV, V75, P65; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin T, 2007, TOP STROKE REHABIL, V14, P72, DOI 10.1310/tsr1401-72; Lorenz L. S., 2007, 13 ANN NRSA TRAIN RE; Lorenz L. S., 2009, DOING YOUR OWN PHOTO; Lorenz L. S., 2010, DISABILITY SOC; Lorenz LS, 2010, VISUAL STUD, V25, P210, DOI 10.1080/1472586X.2010.523273; Lorenz LS, 2010, SOCIOL HEALTH ILL, V32, P862, DOI 10.1111/j.1467-9566.2010.01244.x; Lorenz LS, 2009, HEALTH EXPECT, V12, P262, DOI 10.1111/j.1369-7625.2009.00560.x; OAKLEY A, 1995, BRIT MED J, V310, P1029, DOI 10.1136/bmj.310.6986.1029; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Prior L, 2003, SOCIOL HEALTH ILL, V25, P41, DOI 10.1111/1467-9566.00339; Radley A, 2003, QUAL HEALTH RES, V13, P77, DOI 10.1177/1049732302239412; Rich M, 2000, J ADOLESCENT HEALTH, V27, P155, DOI 10.1016/S1054-139X(00)00114-2; Rich M., 2004, VISUAL ANTHR REV, V20, P17, DOI DOI 10.1525/VAR.2004.20.ISSUE-1; Sherry M, 2006, I ONLY HAD BRAIN DEC; Van der Heyden L, 2005, FAM BUS REV, V18, P1, DOI 10.1111/j.1741-6248.2005.00027.x; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Yin RK, 2003, CASE STUDY RES DESIG	30	15	15	1	3	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	FEB	2011		48							e2342	10.3791/2342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36LG	WOS:000209212900007	21372785	Bronze, Green Submitted, Green Published			2022-02-06	
J	Mihara, Y; Dohi, K; Yofu, S; Nakamachi, T; Ohtaki, H; Shioda, S; Aruga, T				Mihara, Yuko; Dohi, Kenji; Yofu, Sachiko; Nakamachi, Tomoya; Ohtaki, Hirokazu; Shioda, Seiji; Aruga, Tohru			Expression and Localization of the Orexin-1 Receptor (OX1R) After Traumatic Brain Injury in Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Orexin-1 receptor (OX1R); Orexin; Traumatic brain injury; Neuron; Microglia; Immunohistochemistry	NARCOLEPSY; MICROGLIA; APOPTOSIS; DEFICIENCY; PEPTIDES; NEURONS	Orexins are neuropeptides that have a wide range of physiological effects, and recent studies have suggested that the orexin system may be involved in traumatic brain injury. However, the expression and localization of orexin receptors have not been examined yet under brain injury conditions. In the present study, we used immunohistochemical techniques to investigate the expression of orexin-1 receptor (OX1R) and its time-dependent changes in the mouse brain after controlled cortical impact (CCI) injury. OX1R-like immunoreactivity was first detected 6 h after injury in the surrounding penumbra of the injury. The intensity of this immunoreactivity was increased at 12 h, peaked at day 1, and then decreased from day 2 to day 7. To identify the cellular localization of OX1R, we also performed double-immunohistochemical staining with OX1R and several cell marker antibodies. OX1R-like immunopositive cells were clearly co-localized with immunoreactivity for the neuronal marker NeuN at day 7. It was also expressed on the periphery of cells immunopositive for CD11b, a microglial cell marker, at days 1 and 7. These results suggest that orexin and its receptor may play roles in traumatic brain injury, and that OX1R is induced in neurons and microglial cells after traumatic brain injury.	[Dohi, Kenji; Yofu, Sachiko; Nakamachi, Tomoya; Ohtaki, Hirokazu; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Mihara, Yuko; Dohi, Kenji; Aruga, Tohru] Showa Univ, Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan		Shioda, S (corresponding author), Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shioda@med.showa-u.ac.jp		dohi, kenji/0000-0002-4451-0382	Ministry of Education, Science, Sports and CultureMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Showa University; Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22791695] Funding Source: KAKEN	This study was supported in part by grants from the Ministry of Education, Science, Sports and Culture, from a Showa University Grant-in Aid for Innovative Collaborative Research Projects, and from a Special Research Grant-in Aid for Development of Characteristic Education from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Adeghate E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008587; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Conti AC, 1998, J NEUROSCI, V18, P5663; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dohi K, 2005, PEPTIDES, V26, P2339, DOI 10.1016/j.peptides.2005.04.004; Dohi K, 2006, NEUROPEPTIDES, V40, P245, DOI 10.1016/j.npep.2006.06.003; Drouot X, 2003, NEUROLOGY, V61, P540, DOI 10.1212/01.WNL.0000078194.53210.48; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hervieu GJ, 2001, NEUROSCIENCE, V103, P777, DOI 10.1016/S0306-4522(01)00033-1; Ida T, 2000, BIOCHEM BIOPH RES CO, V270, P318, DOI 10.1006/bbrc.2000.2412; Irving EA, 2002, NEUROSCI LETT, V324, P53, DOI 10.1016/S0304-3940(02)00176-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Nakamachi T, 2005, REGUL PEPTIDES, V126, P49, DOI 10.1016/j.regpep.2004.08.037; Nishino S, 2005, SLEEP MED REV, V9, P269, DOI 10.1016/j.smrv.2005.03.004; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Savitz SI, 1998, NEUROSURGERY, V42, P555, DOI 10.1097/00006123-199803000-00026; Stricker-Krongrad A, 2002, BIOCHEM BIOPH RES CO, V296, P129, DOI 10.1016/S0006-291X(02)00848-3; Suzuki R, 2002, NEUROSCI LETT, V324, P5, DOI 10.1016/S0304-3940(02)00140-4; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201	31	15	16	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2011	43	2					162	168		10.1007/s12031-010-9438-6			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	711QK	WOS:000286606300006	20803175				2022-02-06	
J	Rice, AC; Chiou, VL; Zuckoff, SB; Shapiro, SM				Rice, Ann C.; Chiou, Victoria L.; Zuckoff, Sarah B.; Shapiro, Steven M.			Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction	BRAIN RESEARCH			English	Article						Brainstem auditory evoked potentials; Neonates; Gunn rats	JAUNDICED GUNN-RATS; EVOKED-POTENTIAL ABNORMALITIES; TRAUMATIC BRAIN-INJURY; INDUCED NEURONAL LOSS; NEUROLOGICAL DYSFUNCTION; GLUCURONYL TRANSFERASE; MICROGLIAL ACTIVATION; ACUTE HYPOGLYCEMIA; COCHLEAR NUCLEUS; STEM RESPONSE	Excessive hyperbilirubinemia in human neonates can cause permanent dysfunction of the auditory system, as assessed with brainstem auditory evoked potentials (BAEPs). Jaundiced Gunn rat pups (jjs) exhibit similar BAEP abnormalities as hyperbilirubinemic neonates. Sulfadimethoxine (sulfa) administration to jjs, which displaces bilirubin from serum albumin into tissues including brain, exacerbates acute toxicity. Minocycline administered prior to sulfa in jjs protects against BAEP abnormalities. This study evaluates the neuroprotective capabilities of minocycline HCl (50 mg/kg) administered 30 or 120 min after sulfa (200 mg/kg) in 16 days old jjs. BAEPs are recorded at 6 or 24 h post-sulfa. Abnormal BAEP waves exhibit increased latency and decreased amplitude. The sulfa/saline treated jjs exhibited a significantly increased interwave interval between waves I and II (I-II IWI) and significantly decreased amplitudes of waves II and III compared to the saline/saline jjs. The minocycline 30 min post-sulfa (sulfa/mino + 30) group was not significantly different from the saline/saline control group, indicating neuroprotection. The minocycline 120 min post-sulfa (sulfa/mino + 120) group had a significantly decreased amplitude of wave III at both 6 and 24 h. These studies indicate that minocycline has a graded neuroprotective effect when administered after acute bilirubin neurotoxicity. (C) 2010 Elsevier B.V. All rights reserved.	[Rice, Ann C.; Chiou, Victoria L.; Zuckoff, Sarah B.; Shapiro, Steven M.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA		Rice, AC (corresponding author), Virginia Commonwealth Univ, Dept Neurol, Box 980599, Richmond, VA 23298 USA.	acrice@vcu.edu; vchiou@wfubmc.edu; sarah.zuckoff@grnail.com; sshapiro@vcu.edu			NIH R01United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DC000369]; ADWilliams memorial trust; Jeffress memorial trust; Child Neurology Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000369] Funding Source: NIH RePORTER	These studies were supported by NIH R01 grant DC000369 and ADWilliams memorial trust to SMS, Jeffress memorial trust to ACR and Child Neurology Foundation Medical Scholarship to VC. We greatly appreciate the assistance of Dr. Robert J. Hamm with the statistical analyses.	Bhutani VK, 2004, SEMIN PERINATOL, V28, P319, DOI 10.1053/j.semperi.2004.09.006; BUCHWALD JS, 1975, SCIENCE, V189, P382, DOI 10.1126/science.1145206; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Firat Y, 2008, AM J OTOLARYNG, V29, P339, DOI 10.1016/j.amjoto.2008.02.001; Fruehwald-Schultes B, 2000, DIABETES CARE, V23, P1059, DOI 10.2337/diacare.23.8.1059; FULLERTON BC, 1990, HEARING RES, V49, P363, DOI 10.1016/0378-5955(90)90114-5; Galbraith G, 2006, J NEUROSCI METH, V153, P214, DOI 10.1016/j.jneumeth.2005.10.017; Geiger AS, 2007, NEONATOLOGY, V92, P219, DOI 10.1159/000103740; Giordano P, 2006, Acta Otorhinolaryngol Ital, V26, P198; Hoi-Hansen T, 2009, J RENIN-ANGIO-ALDO S, V10, P216, DOI 10.1177/1470320309343007; HUANG C, 1980, BRAIN RES, V184, P215, DOI 10.1016/0006-8993(80)90601-0; Husain K, 2004, HEARING RES, V191, P110, DOI 10.1016/j.heares.2004.01.011; Jacob RJ, 1999, DIABETES, V48, P141, DOI 10.2337/diabetes.48.1.141; Johnson L, 2009, J PERINATOL, V29, pS25, DOI 10.1038/jp.2008.211; JOHNSON L, 1959, AMA J DIS CHILD, V97, P591, DOI 10.1001/archpedi.1959.02070010593009; JOHNSON L, 1961, AM J DIS CHILD, V101, P322, DOI 10.1001/archpedi.1961.04020040050007; Kaplan M, 2004, CLIN PERINATOL, V31, P555, DOI 10.1016/j.clp.2004.05.001; KERN W, 1994, J NEUROPHYSIOL, V72, P678, DOI 10.1152/jn.1994.72.2.678; LARROCHE JCL, 1968, KERNICTERUS HDB CLIN, P491; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Maier K, 2007, NEUROBIOL DIS, V25, P514, DOI 10.1016/j.nbd.2006.10.022; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maisels MJ, 2000, MG CLIN PED, P139; MARKAND ON, 1994, J CLIN NEUROPHYSIOL, V11, P319, DOI 10.1097/00004691-199405000-00004; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Meli DN, 2006, INFECT IMMUN, V74, P3890, DOI 10.1128/IAI.01949-05; MOLLER AR, 1994, J CLIN NEUROPHYSIOL, V11, P284, DOI 10.1097/00004691-199405000-00002; MUNTE TF, 1995, NEUROREPORT, V6, P1509; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; Perlstein M. A., 1960, PEDIATR CLIN N AM, V7, P665; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Ping JL, 2007, J NEUROSCI METH, V161, P11, DOI 10.1016/j.jneumeth.2006.10.001; Popelar J, 2006, NEUROBIOL AGING, V27, P490, DOI 10.1016/j.neurobiolaging.2005.03.001; Quintero EM, 2006, BRAIN RES, V1093, P198, DOI 10.1016/j.brainres.2006.03.104; Rice AC, 2008, PEDIATR RES, V64, P265, DOI 10.1203/PDR.0b013e31817d9be0; Rice AC, 2006, BRAIN RES, V1107, P215, DOI 10.1016/j.brainres.2006.06.005; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Shaia WT, 2002, HEARING RES, V173, P82, DOI 10.1016/S0378-5955(02)00631-7; SHAPIRO SM, 1988, DEV BRAIN RES, V41, P147, DOI 10.1016/0165-3806(88)90178-2; SHAPIRO SM, 1989, ANN OTO RHINOL LARYN, V98, P308, DOI 10.1177/000348948909800414; SHAPIRO SM, 1991, HEARING RES, V57, P16; SHAPIRO SM, 1988, PEDIATR RES, V23, P306, DOI 10.1203/00006450-198803000-00015; SHAPIRO SM, 1993, PEDIATR RES, V34, P629, DOI 10.1203/00006450-199311000-00014; Shapiro SM, 2007, NEONATOLOGY, V92, P248, DOI 10.1159/000103743; Shapiro Steven M, 2005, J Perinatol, V25, P54, DOI 10.1038/sj.jp.7211157; Stevenson David K, 2004, Adv Pediatr, V51, P263; Strachan MWJ, 2003, DIABETOLOGIA, V46, P97, DOI 10.1007/s00125-002-0950-2; STREBEL L, 1971, PEDIATR RES, V5, P548, DOI 10.1203/00006450-197110000-00007; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; VOLPE JJ, 2001, BILIRUBIN BRAIN INJU, P490; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P436, DOI 10.1016/0168-5597(91)90092-C; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P422, DOI 10.1016/0168-5597(91)90091-B	55	15	17	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JAN 12	2011	1368						290	298		10.1016/j.brainres.2010.10.052			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714ZJ	WOS:000286849900031	20971088	Green Accepted			2022-02-06	
J	Amdur, D; Batres, A; Belisle, J; Brown, JH; Cornis-Pop, M; Mathewson-Chapman, M; Harms, G; Hunt, SC; Kennedy, P				Amdur, Deborah; Batres, Alfonso; Belisle, Janet; Brown, John H., Jr.; Cornis-Pop, Micaela; Mathewson-Chapman, Marianne; Harms, Gregory; Hunt, Stephen C.; Kennedy, Peggy			VA Integrated Post-Combat Care: A Systemic Approach to Caring for Returning Combat Veterans	SOCIAL WORK IN HEALTH CARE			English	Article						veteran; post-combat care; continuum of care; reintegration	TRAUMATIC BRAIN-INJURY; POLYTRAUMA REHABILITATION; AFGHANISTAN; IRAQ; HEALTH; WAR; RISK; PAIN	The Department of Veterans Affairs (VA's) mission is to care for those who have borne the battle. As medical technology has advanced, more and more of our returning combat Veterans survive what would have been fatal wounds in previous conflicts (Gawande, 2004). But survival is only the immediate goal-our job is to restore Veterans to the greatest level of health, independence, and quality of life that is medically possible. The VA is achieving this goal through close collaboration with the Department of Defense (DoD) to facilitate a smooth transition and continuum of care that ensures Veterans and Service Members receive the care they deserve. This article describes VA's system of Veteran-centered, post-combat care programs that rely on significant involvement of social workers to support Service Members, Veterans and their families through recovery, rehabilitation, and re-integration into their home communities.	[Batres, Alfonso; Harms, Gregory] Dept Vet Affairs, Readjustment Counseling Serv, Washington, DC USA; [Amdur, Deborah] Off Care Management & Social Work, Dept Vet Affairs, Washington, DC 20420 USA; [Belisle, Janet] Off Care Management & Social Work Serv, Dept Vet Affairs Cent Off, Dept Vet Affairs, Washington, DC USA; [Brown, John H., Jr.] VHA OEF OIF Outreach Off, Dept Vet Affairs, Washington, DC USA; [Cornis-Pop, Micaela] Off Rehabil Serv, Dept Vet Affairs, Richmond, VA USA; [Hunt, Stephen C.] Puget Sound Healthcare Syst, Post Deployment Integrated Care Initiat, Seattle, WA USA		Amdur, D (corresponding author), Off Care Management & Social Work, Dept VA, 810 Vermont Ave NW,Room 475C, Washington, DC 20420 USA.	Deborah.Amdur@va.gov					Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Helmer DA, 2007, J OCCUP ENVIRON MED, V49, P475, DOI 10.1097/JOM.0b013e318042d682; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McFarlane AC, 2009, CURR OPIN PSYCHIATR, V22, P369, DOI 10.1097/YCO.0b013e32832c9064; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907	12	15	15	1	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0098-1389			SOC WORK HEALTH CARE	Soc. Work Health Care		2011	50	7			SI		564	575		10.1080/00981389.2011.554275			12	Social Work	Social Science Citation Index (SSCI)	Social Work	888PI	WOS:000300015600007	21846255				2022-02-06	
B	Cozza, SJ; Guimond, JM		Wadsworth, SM; Riggs, D		Cozza, Stephen J.; Guimond, Jennifer M.			Working with Combat-Injured Families Through the Recovery Trajectory	RISK AND RESILIENCE IN U S MILITARY FAMILIES			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; OPERATION IRAQI FREEDOM; MULTIPLE-SCLEROSIS; SOCIAL SUPPORT; HEALTH-STATUS; CHILDREN; PARENTS; ADJUSTMENT; REHABILITATION	Combat injury can profoundly affect the children and families of service members. The range of experiences for these families varies depending the specific injury type, severity, and recovery trajectory; composition of the family; developmental age of the children; preexisting parent, child, or family characteristics; as well as the longer-term functional impact on the injured parent. Following the injury children and adolescents may display distress, emotional or behavioral problems, risk-taking behaviors, increased helpfulness within the family, or motivation to participate in community service. The impact on children is influenced by the capacity of both the injured and noninjured parents to cope effectively, maintain effective parenting, and help the child adjust to changes in family relationships and circumstances. Interventions with combat-injured families should focus on reducing distress, supporting healthy child and parent functioning, and encouraging constructive communication within families and with service providers about the injury.	[Cozza, Stephen J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA		Cozza, SJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA.	scozza@usuhs.mil		Guimond, Jennifer/0000-0002-8887-5885			ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; [Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; ANTHONY EJ, 1970, CHILD HIS FAMILY, P131; ARMISTEAD L, 1995, CLIN PSYCHOL REV, V15, P409, DOI 10.1016/0272-7358(95)00023-I; BEARDSLEE WR, 1984, PEDIATR ANN, V13, P32; BEARDSLEE WR, 1994, HDB DEPRESSION CHILD; BRETON JJ, 1993, J AM ACAD CHILD PSY, V32, P438, DOI 10.1097/00004583-199303000-00028; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Charles N, 2007, NEUROREHABILITATION, V22, P61; CHESNUT RM, 1999, REHABILITATION TRAUM; Cohen J.A., 2006, INTERVENTIONS FOLLOW, P227; COYNE JC, 1991, ANNU REV PSYCHOL, V42, P401, DOI 10.1146/annurev.ps.42.020191.002153; Cozza S. J., 2009, P WORKGR INT COMB IN; Cozza SJ, 2005, PSYCHIAT QUART, V76, P371, DOI 10.1007/s11126-005-4973-y; COZZA SJ, 2009, DISCUSSIONS CO UNPUB; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; De Judicibus MA, 2004, ADOLESCENCE, V39, P551; Diareme S, 2006, EUR CHILD ADOLES PSY, V15, P309, DOI 10.1007/s00787-006-0534-7; DOHRENWEND BS, 1981, STRESSFUL LIFE EVENT; Ducharme JM, 2002, AM J ORTHOPSYCHIAT, V72, P585, DOI 10.1037/0002-9432.72.4.585; FINNEY JW, 1998, DEV ISSUES CLIN TREA, V1, P433; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Halcomb Elizabeth, 2005, Contemp Nurse, V19, P232; Kelley SDM, 1997, REHABIL COUNS BULL, V41, P105; KINZIE JD, 1986, J AM ACAD CHILD PSY, V25, P370, DOI 10.1016/S0002-7138(09)60259-4; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Korneluk Y G, 1998, Clin Child Fam Psychol Rev, V1, P179, DOI 10.1023/A:1022654831666; Kotchick BA, 1997, BEHAV MODIF, V21, P409, DOI 10.1177/01454455970214002; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Laor N, 1996, ARCH GEN PSYCHIAT, V53, P416, DOI 10.1001/archpsyc.1996.01830050052008; LECLERE FB, 1994, J MARRIAGE FAM, V56, P457, DOI 10.2307/353112; Lester P, 2003, J DEV BEHAV PEDIATR, V24, P242, DOI 10.1097/00004703-200308000-00004; MacGregor AJ, 2009, INJURY, V40, P1004, DOI 10.1016/j.injury.2009.04.006; Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599; MCFARLANE AC, 1987, J AM ACAD CHILD PSY, V26, P764, DOI 10.1097/00004583-198709000-00025; McLaughlin AM, 1992, J COGNITIVE REHABILI, V10, P12; Meiser-Stedman R, 2007, J ABNORM CHILD PSYCH, V35, P191, DOI 10.1007/s10802-006-9068-1; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pakenham KI, 2006, CLIN REHABIL, V20, P709, DOI 10.1191/0269215506cre976oa; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; PETERS LC, 1985, J CHRON DIS, V38, P301, DOI 10.1016/0021-9681(85)90076-1; Pfefferbaum B, 1997, J AM ACAD CHILD PSY, V36, P1503, DOI 10.1016/S0890-8567(09)66558-8; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; POWER PW, 1979, FAM COORD, V28, P616, DOI 10.2307/583526; PYNOOS RS, 1989, J AM ACAD CHILD PSY, V28, P236, DOI 10.1097/00004583-198903000-00015; Rutter, 1966, CHILDREN SICK PARENT; RUTTER M, 1984, PSYCHOL MED, V14, P853, DOI 10.1017/S0033291700019838; SACK WH, 1995, J AM ACAD CHILD PSY, V34, P1160, DOI 10.1097/00004583-199509000-00013; Saltzman William R., 2009, FOCUS MILITARY FAMIL; Urbach J R, 1989, Psychiatr Med, V7, P17; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; *US DEP DEF, 2010, MIL CAS INF; US Department of Defense, 2007, DEM 2007 PROF MIL CO; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Visser-Meily A, 2005, STROKE, V36, P2436, DOI 10.1161/01.STR.0000185681.33790.0a; Visser-Meily A, 2005, J REHABIL MED, V37, P236, DOI 10.1080/16501970510025990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zatzick DF, 2001, GEN HOSP PSYCHIAT, V23, P114, DOI 10.1016/S0163-8343(01)00140-2; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	61	15	15	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-7063-3				2011							259	277		10.1007/978-1-4419-7064-0_13	10.1007/978-1-4419-7064-0		19	Psychology, Clinical; Psychology, Developmental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology	BSJ70	WOS:000284727200013					2022-02-06	
J	Doig, E; Fleming, J; Cornwell, P; Kuipers, P				Doig, Emmah; Fleming, Jennifer; Cornwell, Petrea; Kuipers, Pim			Comparing the experience of outpatient therapy in home and day hospital settings after traumatic brain injury: patient, significant other and therapist perspectives	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; occupational therapy; environment	REHABILITATION; STROKE; ENVIRONMENT; OUTCOMES	Purpose. To explore how therapy in a home and day hospital setting impacts on rehabilitation processes and outcomes from the perspective of the patients, their significant others and their treating occupational therapists. Method. Fourteen participants with severe traumatic brain injury received a one-to-one, goal-directed, client-centred outpatient occupational therapy programme (a) in their home for 6 weeks and (b) in a day hospital clinic for 6 weeks. The experience of rehabilitation in both settings was explored using semi-structured interviews with the participants, their significant others and their treating occupational therapists. Results. Participants and their significant others described the two environments as disparate with home-based therapy perceived as more relaxing, normal, satisfying and effective. The approach to therapy at home was commonly described as 'real-life' whereas the therapy approach in day hospital was characterised as 'simulation of real life tasks' and 'remedial exercises'. Participants' experience of therapy relationships at home was characterised as 'friendship', in which the therapist was a 'visitor', whereas in the hospital, participants were characterised as 'patients' and therapists as 'bosses' and 'teachers'. Conclusion. The experience of home-based therapy was perceived as more convenient, positive and preferred by patients and their family members. Therapists described more therapeutic benefits and the ability to work more effectively on activity and participation level goals in the client's real-life environment.	[Doig, Emmah; Fleming, Jennifer; Cornwell, Petrea] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer; Cornwell, Petrea] Princess Alexandra Hosp, Brisbane, Qld 4072, Australia; [Kuipers, Pim] Griffith Univ, Griffith Hlth Inst, Ctr Functioning & Hlth Res, Meadowbrook, Qld 4131, Australia		Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	emmah.doig@optusnet.com.au	Doig, Emmah/AAG-6674-2021; Cornwell, Petrea/AAE-5547-2019	Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286	Princess Alexandra Hospital Foundation; Queensland Health Community Rehabilitation Research Scheme; University of QueenslandUniversity of Queensland	We wish to thank the participants, their significant others and the treating therapists for their participation. We thank the Princess Alexandra Hospital Foundation and the Queensland Health Community Rehabilitation Research Scheme for providing grants to undertake this research.; The principal researcher was in receipt of a University of Queensland Postgraduate Research Scholarship whilst conducting this research.	*AIHW, 2003, ICF AUSTR US GUID DI; Bairstow P J, 1997, Aust Health Rev, V20, P55; Bjorkdahl A, 2006, CLIN REHABIL, V20, P1038, DOI 10.1177/0269215506071230; Bottari C., 2006, AUST OCCUP THER J, V53, P98, DOI DOI 10.1111/J.1440-1630.2006.00547.X; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; *CRAIG HOSP RES DE, 2001, CRAIG HOSP INV UNPUB; DOIG EJ, J HEAD TRAUMA UNPUB; DOIG EJ, DISABIL REH IN PRESS; DOIG EJ, 2010, AM J OCCUP THER, V64, P1; Graneheim U, 2002, NURS EDUC TODAY, V24, P105, DOI DOI 10.1016/J.NEDT.2003.10.001; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Malec J. F., 2003, MANUAL MAYO PORTLAND; Mayo NE, 2000, STROKE, V31, P1016, DOI 10.1161/01.STR.31.5.1016; Pace GM, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199602000-00004; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Pollock N, 1998, CANADIAN OCCUPATIONA; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Rogers JC, 1997, AM J OCCUP THER, V51, P410, DOI 10.5014/ajot.51.6.410; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Wottrich AW, 2007, PHYS THER, V87, P778, DOI 10.2522/ptj.20060152	26	15	15	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2011	33	13-14					1203	1214		10.3109/09638288.2010.525286			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	768QH	WOS:000290950400014	20977391				2022-02-06	
J	Hauke, J; Fimm, B; Sturm, W				Hauke, Johanna; Fimm, Bruno; Sturm, Walter			Efficacy of alertness training in a case of brainstem encephalitis: Clinical and theoretical implications	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Arousal deficit; Alertness training; Improvement of attention functions; Long-term effects	COGNITIVE REHABILITATION; SUSTAINED ATTENTION; INTRINSIC ALERTNESS; RIGHT-HEMISPHERE; LOCUS-COERULEUS; NEGLECT; TASK; INFORMATION; MODULATION; NETWORKS	Although attention functions are often impaired after stroke, traumatic brain injury or inflammatory diseases, little is known about the time course and the long-term efficacy of training-induced improvement. The present single case study evaluates the time course and longitudinal stability of attention improvement after alertness training by repeatedly testing the subject between individual training sessions as well as one and seven months after the end of the training. The outpatient (M.P.) trained developed severe alertness deficits following brainstem encephalitis in 2003 without signs of cortical damage, and since then had not achieved full recovery. In 2008, M.P. participated in 15 treatment sessions on 15 separate working days over a period of three weeks. In each session a 45-minute alertness training task was administered, using the CogniPlus ALERT computer training program. Attention performance was assessed by neuropsychological tests four years, one year, and immediately before the therapy after every third training session and three times after the termination of therapy. Furthermore, a self-report questionnaire measured subjective experience of attention in everyday life situations. In order to compare the performance between training sessions, a procedure specialised for psychometric single-case diagnosis was used to analyse the data. Surprisingly, even after three consecutive training sessions, M.P. showed immense improvement in alertness. Furthermore, after two weeks she felt more energetic and more able to concentrate. Six months after the end of the training the improvement remained stable. The unexpectedly fast time course of recovery induced by the training, as well as the stable long-term effects, probably depend on intact cortical structures. In M.P. it appeared that top-down control of the alertness network on impaired brainstem arousal structures had been re-activated by the training procedure and had remained stable across a long time period.	[Sturm, Walter] Rhein Westfal TH Aachen, Univ Hosp, Neurol Clin, Sect Clin Neuropsychol, D-52074 Aachen, Germany		Sturm, W (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Neurol Clin, Sect Clin Neuropsychol, Pauwelsstr 30, D-52074 Aachen, Germany.	sturm@neuropsych.rwth-aachen.de					Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Cantagallo, 2003, Z NEUROPSYCHOL, V14, P283, DOI [10.1024/1016-264X.14.4.283, DOI 10.1024/1016-264X.14.4.283]; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Dreisbach G, 2008, PSYCHOL RES-PSYCH FO, V72, P355, DOI 10.1007/s00426-007-0131-5; Engelberts NHJ, 2002, EPILEPSIA, V43, P587, DOI 10.1046/j.1528-1157.2002.29401.x; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Goschke T, 2008, PSYCHOL SCI, V19, P25, DOI 10.1111/j.1467-9280.2008.02042.x; Horn W, 1983, LEISTUNGSPRUFSYSTEM; Huber H. P., 1973, PSYCHOMETRISCHE EINZ; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; PARDO JV, 1990, NATURE, V349, P61; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Plohmann AM, 1998, J NEUROL NEUROSUR PS, V64, P455, DOI 10.1136/jnnp.64.4.455; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1997, IMAGES MINDS, P153; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Sturm W, 2006, RESTOR NEUROL NEUROS, V24, P371; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P434, DOI 10.1016/j.neuropsychologia.2003.09.001; Sturm W., 2005, AUFMERKSAMKEITSSTORU; STURM W, 2007, MANUAL WIENER TESTSY; Sturm W, 2008, HDB NEURO BIOPSYCHOL, P329; Thimm M, 2006, NEUROPSYCHOLOGIA, V44, P1230, DOI 10.1016/j.neuropsychologia.2005.09.008; Thimm M, 2009, CORTEX, V45, P850, DOI 10.1016/j.cortex.2008.10.007; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Walker AD, 2009, PSYCHOPHYSIOLOGY, V46, P217, DOI 10.1111/j.1469-8986.2008.00718.x; WILLMES K, 1990, APHASIOLOGY, V4, P415, DOI 10.1080/02687039008249092; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P315, DOI 10.1007/s002130050351; Zimmermann P, 2007, TEST ATTENTIONAL PER; Zimmermann P., 1997, FRAGEBOGEN ERLEBTER	37	15	15	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	2					164	182	PII 931808942	10.1080/09602011.2010.541792			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	733NZ	WOS:000288270700002	21391120				2022-02-06	
J	Kim, JH; Park, SH; Kim, YW; Ha, JM; Bae, SS; Lee, GS; Cho, SI; Choi, BT; Shin, HK				Kim, Ji Hyun; Park, Sun Haeng; Kim, Young Whan; Ha, Jung Min; Bae, Sun Sik; Lee, Guem San; Cho, Su In; Choi, Byung Tae; Shin, Hwa Kyoung			The Traditional Herbal Medicine, Dangkwisoo-San, Prevents Cerebral Ischemic Injury through Nitric Oxide-Dependent Mechanisms	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							BLOOD-FLOW; SYNTHASE; DAMAGE; MICE	Dangkwisoo-San (DS) is an herbal extract that is widely used in traditional Korean medicine to treat traumatic ecchymosis and pain by promoting blood circulation and relieving blood stasis. However, the effect of DS in cerebrovascular disease has not been examined experimentally. The protective effects of DS on focal ischemic brain were investigated in a mouse model. DS stimulated nitric oxide (NO) production in human brain microvascular endothelial cells (HBMECs). DS (10-300 mu g/mL) produced a concentration-dependent relaxation in mouse aorta, which was significantly attenuated by the nitric oxide synthase (NOS) inhibitor L-NAME, suggesting that DS causes vasodilation via a NO-dependent mechanism. DS increased resting cerebral blood flow (CBF), although it caused mild hypotension. To investigate the effect of DS on the acute cerebral injury, C57/BL6J mice received 90 min of middle cerebral artery occlusion followed by 22.5 h of reperfusion. DS administered 3 days before arterial occlusion significantly reduced cerebral infarct size by 53.7% compared with vehicle treatment. However, DS did not reduce brain infarction in mice treated with the relatively specific endothelial NOS (eNOS) inhibitor, N-5-(1-iminoethyl)-L-ornithine, suggesting that the neuroprotective effect of DS is primarily endothelium-dependent. This correlated with increased phosphorylation of eNOS in the brains of DS-treated mice. DS acutely improves CBF in eNOS-dependent vasodilation and reduces infarct size in focal cerebral ischemia. These data provide causal evidence that DS is cerebroprotective via the eNOS-dependent production of NO, which ameliorates blood circulation.	[Kim, Ji Hyun; Park, Sun Haeng; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Div Meridian & Struct Med, Sch Korean Med, Yangsan 626870, South Korea; [Kim, Young Whan; Ha, Jung Min; Bae, Sun Sik] Pusan Natl Univ, Dept Pharmacol, Sch Med, Yangsan 626870, South Korea; [Lee, Guem San; Cho, Su In] Pusan Natl Univ, Div Pharmacol, Sch Korean Med, Yangsan 626870, South Korea		Shin, HK (corresponding author), Pusan Natl Univ, Div Meridian & Struct Med, Sch Korean Med, Yangsan 626870, South Korea.	julie@pusan.ac.kr			Pusan National UniversityPusan National University	This work was supported for two years by Pusan National University Research Grant.	Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hua Q, 2008, BIOL PHARM BULL, V31, P633, DOI 10.1248/bpb.31.633; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MIN HJ, 2002, BRAIN RES, V946, P139; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Park WH, 2005, PHYTOTHER RES, V19, P846, DOI 10.1002/ptr.1700; Qiu Jane, 2007, Nat Rev Drug Discov, V6, P506; Rehni AK, 2008, FUND CLIN PHARMACOL, V22, P179, DOI 10.1111/j.1472-8206.2008.00567.x; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang NY, 2004, AM J CHINESE MED, V32, P587, DOI 10.1142/S0192415X04002223; Wolff DJ, 1998, EUR J PHARMACOL, V350, P325, DOI 10.1016/S0014-2999(98)00267-2; ZHANG FY, 1994, J CEREBR BLOOD F MET, V14, P217, DOI 10.1038/jcbfm.1994.28	22	15	16	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2011	2011						1	8		10.1155/2011/718302			8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	802SK	WOS:000293531100001		Green Published, gold, Green Submitted			2022-02-06	
J	Liddle, J; Fleming, J; McKenna, K; Turpin, M; Whitelaw, P; Allen, S				Liddle, Jacki; Fleming, Jennifer; McKenna, Kryss; Turpin, Merrill; Whitelaw, Penny; Allen, Shelley			Driving and driving cessation after traumatic brain injury: processes and key times of need	DISABILITY AND REHABILITATION			English	Article						Brain injury; driving; occupational therapy	COMMUNITY INTEGRATION; OLDER DRIVERS; REINTEGRATION; CONSTRUCTION; TRANSITION; OUTCOMES; SUPPORT; RETURN	Purpose. The ability to drive safely is commonly affected by traumatic brain injury (TBI). Driving is a role and activity that is highly valued and also associated with successful community reintegration after TBI. Relatively little is understood about the processes of interruption to driving and potential return to driving that can be experienced by people with TBI and their family members (FMs). Exploring the way in which driving interruption, return to driving and permanent cessation of driving happen for people with TBI, their FMs and health professionals (HPs) who work with them can enable a fuller understanding of the experiences and needs and enhance the rehabilitation approaches in this situation. Method. A descriptive phenomenological approach was used to explore the experience with the aim of improving services for people with TBI. Semi-structured interviews about driving and driving cessation were conducted with 15 people with TBI, 10 FMs and 10 HPs who had experience in driving and driving cessation issues. Results. The findings reveal experiences of the process of driving and driving cessation contextualised within experiences of the accident and treatment process. Participants identified key times of need in relation to driving: being told about driving restrictions, understanding driving restrictions, the 'on hold' period, and returning to driving. Conclusions. The processes surrounding driving and driving cessation after TBI are complex. Informational, support and practical needs differ at the different times. There are key times where people may need further support to improve rehabilitation outcomes. Rehabilitation approaches may particularly need to provide clear, consistent information about driving restrictions, and the process required for returning to driving. While recovery time appears necessary for allowing a safe return to driving, active support for continued involvement in the community using alternative transport may reduce the frustration and disengagement experienced by people in the 'on hold' period.	[Liddle, Jacki; Fleming, Jennifer; McKenna, Kryss; Turpin, Merrill; Whitelaw, Penny; Allen, Shelley] Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld, Australia		Liddle, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia.	j.liddle@uq.edu.au	Liddle, Jacki/F-6872-2010	Liddle, Jacki/0000-0002-6336-9898; Turpin, Merrill/0000-0001-7946-0883	School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC)	This project was funded by a School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC) Rehabilitation Research Grant. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Austroads, 2003, ASS FITN DRIV; Brooks N, 2005, BRAIN INJURY, V19, P165, DOI 10.1080/02699050410001720004; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Hakamies-Blomqvist L, 1998, ACCIDENT ANAL PREV, V30, P305, DOI 10.1016/S0001-4575(97)00106-1; HakamiesBlomqvist L, 1996, J AM GERIATR SOC, V44, P650, DOI 10.1111/j.1532-5415.1996.tb01826.x; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Langdridge D., 2007, PHENOMENOLOGICAL PSY; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Liddle J, 2004, QUAL HEALTH RES, V14, P1396, DOI 10.1177/1049732304268793; Liddle J, 2007, AUST OCCUP THER J, V54, P303, DOI 10.1111/j.1440-1630.2006-00614.x; Liddle J, 2009, BRAIN IMPAIR, V10, P271, DOI 10.1375/brim.10.3.271; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Mezuk B, 2008, J GERONTOL B-PSYCHOL, V63, pS298, DOI 10.1093/geronb/63.5.S298; Molnar L. J., 2008, PROMISING APPROACHES; Novack TA, 2000, BRAIN INJURY, V14, P987; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Qualitative Solutions and Research, 1999, NVIVO REF GUID SOFTW; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Verburg G, 2003, NEUROREHABILITATION, V18, P113	30	15	16	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	25-26					2574	2586		10.3109/09638288.2011.582922			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	851RO	WOS:000297288800019	21671828				2022-02-06	
J	Pielmaier, L; Maercker, A				Pielmaier, Laura; Maercker, Andreas			Psychological adaptation to life-threatening injury in dyads: the role of dysfunctional disclosure of trauma	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						disclosure of trauma; communication; dyads; significant other; posttraumatic stress disorder; medical trauma; traumatic brain injury; accident	POSTTRAUMATIC-STRESS-DISORDER; SHORT SCREENING SCALE; BRAIN-INJURY; SOCIAL ACKNOWLEDGMENT; SYMPTOMS; PREDICTORS; RISK; VETERANS; SUPPORT; POLICE	Background: Certain modes of trauma disclosure have been found to be associated with more severe symptoms of posttraumatic stress (PTS) in different trauma populations: the reluctance to disclose trauma-related thoughts and feelings, a strong urge to talk about it, and physical as well as emotional reactions during disclosure. Although social-contextual influences gain more and more interest in trauma research, no study has yet investigated these "dysfunctional disclosure tendencies" and their association with PTS from an interpersonal perspective. Objective: (1) To replicate previous findings on dysfunctional disclosure tendencies in patients with life-threatening injury and their significant others and (2) to study interpersonal associations between dysfunctional disclosure style and PTS at a dyadic level. Method: PTS symptom severity and self-reports on dysfunctional disclosure tendencies were assessed in N = 70 dyads comprising one individual with severe traumatic brain injury and a significant other ("proxy") 3 months after injury. Results: Regression analyses predicting PTS symptom severity revealed dysfunctional disclosure tendencies to have incremental validity above and beyond sex, age, and trauma severity within the individual (both patient and proxy), with moderate effect sizes. The interaction between patient's and proxy's disclosure style explained additional portions of the variance in patients' PTS symptom severity. Conclusions: Findings suggest that dysfunctional disclosure tendencies are related to poorer psychological adaptation to severe traumatic brain injury. This intrapersonal association may be exacerbated by dysfunctional disclosure tendencies on the part of a significant other. Although the results require replication in other trauma samples without brain injury to further generalize the findings beyond the observed population, the study contributes to the expanding literature on the crucial role of interpersonal relationships in trauma recovery.	[Pielmaier, Laura; Maercker, Andreas] Univ Zurich, Dept Psychol Psychopathol & Clin Intervent, Zurich, Switzerland		Pielmaier, L (corresponding author), Univ Zurich, Dept Psychol Psychopathol & Clin Intervent, Zurich, Switzerland.	l.pielmaier@psychologie.uzh.ch	Maercker, Andreas/D-2814-2017	Maercker, Andreas/0000-0001-6925-3266			American Association for the Advancement for Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Andersen B. L., 2001, PSYCHOSOC INTERV, P99, DOI [10.1037/10402-006, DOI 10.1037/10402-006]; Belsher BE, 2012, PSYCHOL TRAUMA-US, V4, P386, DOI 10.1037/a0024362; Bohnert KM, 2011, INT J METH PSYCH RES, V20, pE1, DOI 10.1002/mpr.331; Bolton EE, 2003, J TRAUMA STRESS, V16, P203, DOI 10.1023/A:1023754820991; Bootzin RR, 1997, PSYCHOL SCI, V8, P167, DOI 10.1111/j.1467-9280.1997.tb00404.x; Bowen A, 2010, ANXIETY STRESS COPIN, V23, P449, DOI 10.1080/10615800903414315; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Cohen J., 2013, STAT POWER ANAL BEHA; Davidson AC, 2008, J LANG SOC PSYCHOL, V27, P51, DOI 10.1177/0261927X07309511; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehring T, 2008, COGNITIVE THER RES, V32, P488, DOI 10.1007/s10608-006-9089-7; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Goff BSN, 2005, J MARITAL FAM THER, V31, P145, DOI 10.1111/j.1752-0606.2005.tb01552.x; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hoyt T, 2010, INT J STRESS MANAGE, V17, P78, DOI 10.1037/a0017453; Institute of Medicine Committee on Treatment of Posttraumatic Stress Disorder Board on Population Health and Public Health Practice, 2008, TREATM POSTTR STRESS; Jacques-Tiura AJ, 2010, J TRAUMA DISSOCIATIO, V11, P174, DOI 10.1080/15299730903502938; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Leibowitz RQ, 2008, GEN HOSP PSYCHIAT, V30, P100, DOI 10.1016/j.genhosppsych.2007.11.004; Lepore SJ, 1996, J PERS SOC PSYCHOL, V70, P271, DOI 10.1037/0022-3514.70.2.271; Lepore SJ, 2007, SOC PERSONAL PSYCHOL, V1, P313, DOI 10.1111/j.1751-9004.2007.00013.x; Maercker A, 1998, DIAGNOSTICA, V44, P130; Maercker A., 2011, SOCIOINTERPERS UNPUB; Maercker A, 2009, EUR PSYCHOL, V14, P249, DOI 10.1027/1016-9040.14.3.249; McAdam JL, 2009, AM J CRIT CARE, V18, P200, DOI 10.4037/ajcc2009252; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ern.11.94, 10.1586/ERN.11.94]; Monson C. M., 2010, INTERPERSONAL PROCES, P178; Monson CM, 2009, J TRAUMA STRESS, V22, P276, DOI 10.1002/jts.20432; Monson CM, 2005, PTSD RES Q, V16, P1, DOI DOI 10.1016/J.CPR.2009.09.002; Mueller J., 2000, Z FUER POLITISCHE PS, V8, P413; Mueller J, 2008, CAN J PSYCHIAT, V53, P160, DOI 10.1177/070674370805300306; Mueller J, 2009, CAN J PSYCHIAT, V54, P547, DOI 10.1177/070674370905400807; Muller J, 2006, Z KL PSYCH PSYCHOTH, V35, P49, DOI 10.1026/1616-3443.35.1.49; Mundy E, 2004, CURR OPIN PSYCHIATR, V17, P123, DOI 10.1097/00001504-200403000-00009; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; PENNEBAKER JW, 1986, J ABNORM PSYCHOL, V95, P274, DOI 10.1037/0021-843X.95.3.274; Pennebaker JW, 2001, CURR DIR PSYCHOL SCI, V10, P90, DOI 10.1111/1467-8721.00123; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Renshaw KD, 2008, J FAM PSYCHOL, V22, P586, DOI 10.1037/0893-3200.22.3.586; Siegrist P., 2010, TRAUMA GEWALT, V3, P208; Stephens C, 1999, ANXIETY STRESS COPIN, V12, P247, DOI 10.1080/10615809908250477; Taku K, 2009, J SOC CLIN PSYCHOL, V28, P1226, DOI 10.1521/jscp.2009.28.10.1226; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P603; Ullman Sarah E, 2003, J Child Sex Abus, V12, P89, DOI 10.1300/J070v12n01_05; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; West S. G., 1991, MULTIPLE REGRESSION; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zetsche U, 2009, J BEHAV THER EXP PSY, V40, P499, DOI 10.1016/j.jbtep.2009.07.001	58	15	15	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2011	2								8749	10.3402/ejpt.v2i0.8749			12	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	V31EX	WOS:000208868000025	22893822	Green Published, gold, Green Accepted			2022-02-06	
J	Rochat, L; Beni, C; Billieux, J; Annoni, JM; Van der Linden, M				Rochat, Lucien; Beni, Catia; Billieux, Joel; Annoni, Jean-Marie; Van der Linden, Martial			How Impulsivity Relates to Compulsive Buying and the Burden Perceived by Caregivers after Moderate-to-Severe Traumatic Brain Injury	PSYCHOPATHOLOGY			English	Article						Impulsivity; Executive functions; Compulsive buying; Burden; Traumatic brain injury; Urgency	VALIDATION; DISTRESS; BEHAVIOR; MODEL	Background: Impulsivity is a core feature in patients with traumatic brain injury (TBI). The aim of the study is to investigate how a specific dimension of impulsivity, namely urgency (the tendency to act rashly when distressed), might shed new light on the aetiology of compulsive buying proneness in patients with TBI and to explore how urgency and compulsive buying relate to the burden perceived by the caregivers. Sampling and Methods: Caregivers of 74 patients with TBI were given 3 questionnaires in order to assess their subjective burden as well as patients' impulsivity and compulsive buying proneness. Results: Both urgency and compulsive buying tendencies significantly increased after TBI. Furthermore, path analyses revealed that current urgency was both directly and indirectly related to the subjective burden perceived by the caregivers, and this indirect pathway was mediated by compulsive buying. Conclusion: Urgency plays a central role in understanding specific problematic behaviours after TBI and their impact on caregivers. These findings are discussed in light of the cognitive processes underlying the urgency component of impulsivity in relation to the occurrence of compulsive buying behaviours after TBI. Copyright (C) 2011 S. Karger AG, Basel	[Rochat, Lucien; Beni, Catia; Billieux, Joel; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, CH-1205 Geneva, Switzerland; [Rochat, Lucien; Billieux, Joel; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, CH-1205 Geneva, Switzerland; [Annoni, Jean-Marie] Univ Hosp Geneva, Neuropsychol Unit, Geneva, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, Liege, Belgium		Rochat, L (corresponding author), Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, 40 Blvd Pont Arve, CH-1205 Geneva, Switzerland.	Lucien.Rochat@unige.ch		Rochat, Lucien/0000-0002-9992-2720; Billieux, Joel/0000-0002-7388-6194			Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Billieux J, 2007, ADDICT BEHAV, V32, P1189, DOI 10.1016/j.addbeh.2006.08.007; Billieux J, 2008, PERS INDIV DIFFER, V44, P1432, DOI 10.1016/j.paid.2007.12.011; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Billieux J, 2008, APPL COGNITIVE PSYCH, V22, P1195, DOI 10.1002/acp.1429; BLAUG M, 1972, HIGH EDUC, V1, P53, DOI 10.1007/BF01956881; BURSTEIN A, 1993, PSYCHOSOMATICS, V34, P194, DOI 10.1016/S0033-3182(93)71920-9; Byrne B., 2001, STRUCTURAL EQUATION; Byrne B.M., 1994, STRUCTURAL EQUATION; CHRISTENSON GA, 1994, J CLIN PSYCHIAT, V55, P5; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fischer S, 2004, PSYCHOL ADDICT BEHAV, V18, P269, DOI 10.1037/0893-164X.18.3.269; Fischer S, 2003, INT J EAT DISORDER, V33, P406, DOI 10.1002/eat.10165; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Kellett S, 2009, CLIN PSYCHOL PSYCHOT, V16, P83, DOI 10.1002/cpp.585; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lejoyeux M, 1997, J CLIN PSYCHIAT, V58, P169, DOI 10.4088/JCP.v58n0406; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Miltenberger RG, 2003, J BEHAV THER EXP PSY, V34, P1, DOI 10.1016/S0005-7916(03)00002-8; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; van den Heuvel OA, 2010, J NEUROL SCI, V289, P55, DOI 10.1016/j.jns.2009.08.043; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Whiteside SP, 2005, EUR J PERSONALITY, V19, P559, DOI 10.1002/per.556; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; Wood RL, 2001, BRAIN DAM B, P3; Zarit SH., 1985, HIDDEN VICTIMS ALZHE	38	15	16	0	7	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0254-4962	1423-033X		PSYCHOPATHOLOGY	Psychopathology		2011	44	3					158	164		10.1159/000322454			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	747SB	WOS:000289338600004	21372628	Green Submitted			2022-02-06	
B	Zupanc, GKH		Seki, T; Sawamoto, K; Parent, JM; AlvarezBuylla, A		Zupanc, Guenther K. H.			Adult Neurogenesis in Teleost Fish	NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY			English	Article; Book Chapter							CENTRAL-NERVOUS-SYSTEM; LONG-TERM PERSISTENCE; NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; TRAUMATIC BRAIN-INJURY; POST-EMBRYONIC GROWTH; MULLER GLIAL CELLS; OPTIC TECTUM; PROLIFERATION ZONES; ENTORHINAL CORTEX	Adult neurogenesis in the brain of teleost fish has been studied since the 1960s. These investigations have demonstrated mitotic activity in dozens of brain areas and relative rates of cell proliferation 10-100 times higher than in the adult mammalian brain. The source of the new cells are stem cells in distinct proliferation zones, which give rise to both neurons and glial cells. Depending on the brain region, the young cells either reside in close vicinity to the proliferation zone from which they originate, or they migrate long distance to specific target areas. During migration, they are guided by radial glial fibers. Approximately half the young cells undergo apoptotic cell death within the first few weeks of their life; the other half persist long term. This continuous addition of new cells to the population of older cells leads to a permanent growth of the brain. A major function of adult neurogenesis in teleosts appears to be to ensure numerical matching of neurons in the central nervous system and sensory receptors cells or muscle fibers in the periphery. Neurogenesis also plays a central role in brain repair by replacing cells lost to injury by newly generated ones. Large-scale identification of regeneration-associated proteins by proteome analysis has revealed cytoskeletal proteins essential for the formation of new cells, proteins involved in cell proliferation, cellular motility, neuroprotection, and energy metabolism, as well as a zinc finger protein that may act as a transcriptional regulator.	Northeastern Univ, Dept Biol, Boston, MA 02115 USA		Zupanc, GKH (corresponding author), Northeastern Univ, Dept Biol, 134 Mugar Life Sci Bldg,360 Huntington Ave, Boston, MA 02115 USA.	g.zupanc@neu.edu					ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ANDERSON MJ, 1987, MOL BRAIN RES, V2, P131, DOI 10.1016/0169-328X(87)90006-4; ANDERSON MJ, 1983, ANAT REC, V205, P73, DOI 10.1002/ar.1092050110; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; BRADFORD MR, 1995, BRAIN BEHAV EVOLUT, V46, P259; Butler AB, 2000, NEUROSCI LETT, V293, P95, DOI 10.1016/S0304-3940(00)01497-X; Cameron DA, 2000, VISUAL NEUROSCI, V17, P789, DOI 10.1017/S0952523800175121; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Candal E, 2005, DEV BRAIN RES, V154, P101, DOI 10.1016/j.devbrainres.2004.10.008; CARLSEN J, 1982, J COMP NEUROL, V208, P196, DOI 10.1002/cne.902080208; Clint SC, 2002, NEUROREPORT, V13, P317, DOI 10.1097/00001756-200203040-00014; Clint SC, 2001, DEV BRAIN RES, V130, P15, DOI 10.1016/S0165-3806(01)00193-6; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; CORWIN JT, 1981, J COMP NEUROL, V201, P541, DOI 10.1002/cne.902010406; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Ebbesson, 1980, COMP NEUROLOGY TELEN, P41, DOI 10.1007/978-1-4613-2988-6_3; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FINE ML, 1989, BRAIN BEHAV EVOLUT, V34, P13, DOI 10.1159/000116487; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GROSCHE J, 1995, NEUROSCI LETT, V185, P119, DOI 10.1016/0304-3940(94)11239-F; HAGEDORN M, 1992, J COMP NEUROL, V321, P193, DOI 10.1002/cne.903210203; Han ZG, 1999, J BIOL CHEM, V274, P35741, DOI 10.1074/jbc.274.50.35741; HARTIG W, 1995, J NEUROCYTOL, V24, P507, DOI 10.1007/BF01179976; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; HERRUP K, 1987, J NEUROSCI, V7, P829; Herrup K, 1996, DEV BRAIN RES, V96, P28, DOI 10.1016/0165-3806(96)00069-7; Higgs DM, 2002, JARO-J ASSOC RES OTO, V3, P174, DOI 10.1007/s101620020035; Hinsch K, 2007, NEUROSCIENCE, V146, P679, DOI 10.1016/j.neuroscience.2007.01.071; Hinsch K, 2006, J NEUROSCI METH, V158, P75, DOI 10.1016/j.jneumeth.2006.05.020; HITCHCOCK PF, 1992, J NEUROBIOL, V23, P187, DOI 10.1002/neu.480230209; Insausti R, 2002, BRAIN RES BULL, V57, P557, DOI 10.1016/S0361-9230(01)00684-0; JANSSEN J, 1987, BRAIN BEHAV EVOLUT, V30, P210, DOI 10.1159/000118647; JOHNS PR, 1977, J COMP NEUROL, V176, P331, DOI 10.1002/cne.901760303; JOHNS PR, 1982, J NEUROSCI, V2, P178; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KERR JFR, 1995, METHOD CELL BIOL, V46, P1; Kirsche W., 1967, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V77, P313; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; KOUMANS JTM, 1995, COMP BIOCHEM PHYS A, V110, P3, DOI 10.1016/0300-9629(94)00150-R; Kranz D, 1970, Z. mikrosk.-anat. Forsch., V82, P42; KRANZ D, 1970, Zeitschrift fuer Mikroskopisch-Anatomische Forschung (Leipzig), V82, P264; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee TH, 2002, J BIOL CHEM, V277, P44826, DOI 10.1074/jbc.M205667200; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; LEWIS GP, 1989, EXP EYE RES, V49, P93, DOI 10.1016/0014-4835(89)90079-1; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lund LM, 1996, J NEUROBIOL, V31, P476; Lund LM, 2002, EXP NEUROL, V178, P306, DOI 10.1006/exnr.2002.8034; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MAGRASSI L, 1995, ANAT EMBRYOL, V192, P77; MANSOURROBAEY S, 1990, J HIRNFORSCH, V31, P495; Marcus RC, 1999, VISUAL NEUROSCI, V16, P417, DOI 10.1017/S095252389916303X; MEYER RL, 1978, EXP NEUROL, V59, P99, DOI 10.1016/0014-4886(78)90204-2; Moore S, 1996, PROG NEUROBIOL, V48, P441, DOI 10.1016/0301-0082(95)00051-8; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nguyen V, 1999, J COMP NEUROL, V413, P385, DOI 10.1002/(SICI)1096-9861(19991025)413:3<385::AID-CNE3>3.0.CO;2-P; Nieuwenhuys R., 1990, Cerebral Cortex, V8A, P31; NORTHCUTT RG, 1995, BRAIN BEHAV EVOLUT, V46, P275, DOI 10.1159/000113279; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Osada T, 2002, CYTOGENET GENOME RES, V97, P7, DOI 10.1159/000064037; Ott R, 1997, NEUROSCI LETT, V221, P185, DOI 10.1016/S0304-3940(96)13322-X; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; PEACEA V, 2001, EXP NEUROL, V172, P1; Portavella M, 2004, J NEUROSCI, V24, P2335, DOI 10.1523/JNEUROSCI.4930-03.2004; POUWELS E, 1978, ANAT EMBRYOL, V152, P291, DOI 10.1007/BF00350526; POUWELS E, 1978, ANAT EMBRYOL, V153, P37, DOI 10.1007/BF00569848; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rahmann H., 1968, Journal fuer Hirnforschung, V10, P279; Rajendran RS, 2008, DEV NEUROBIOL, V68, P1257, DOI 10.1002/dneu.20656; Rajendran RS, 2007, DEV NEUROBIOL, V67, P1334, DOI 10.1002/dneu.20365; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAYMOND PA, 1983, J NEUROSCI, V3, P1077; RAYMOND PA, 1983, J NEUROSCI, V3, P1092; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Reier P., 1983, SPINAL CORD RECONSTR, P163; Richter W, 1970, Z. mikrosk.-anat. Forsch., V82, P76; RICHTER W, 1970, Zeitschrift fuer Mikroskopisch-Anatomische Forschung (Leipzig), V81, P530; Rodriguez F, 2002, J NEUROSCI, V22, P2894, DOI 10.1523/JNEUROSCI.22-07-02894.2002; ROWE RWD, 1969, J ANAT, V104, P519; Rowlerson A., 2001, Fish Physiology, V18, P103; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; SIRBULESCU RF, BRAIN RES R IN PRESS; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Soutschek J, 1996, DEV BRAIN RES, V97, P279, DOI 10.1016/S0165-3806(96)00145-9; Soutschek J, 1995, NEUROSCI LETT, V202, P133, DOI 10.1016/0304-3940(95)12231-1; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Takeda A, 2008, NEUROSCIENCE, V151, P1132, DOI 10.1016/j.neuroscience.2007.10.059; TETZLAFF W, 1991, J NEUROSCI, V11, P2528; Vajda FJE, 2002, J CLIN NEUROSCI, V9, P4, DOI 10.1054/jocn.2001.1027; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Groen T, 2002, BRAIN RES BULL, V57, P553, DOI 10.1016/S0361-9230(01)00683-9; Vargas JP, 2000, BRAIN RES, V865, P77, DOI 10.1016/S0006-8993(00)02220-4; Waxman S.G., 1986, P183; WEATHERLEY AH, 1985, EXPERIENTIA, V41, P353, DOI 10.1007/BF02004500; WETTS R, 1983, DEV BRAIN RES, V10, P41, DOI 10.1016/0165-3806(83)90119-0; Williams RW, 2000, RES PRO CEL, V30, P21; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Wullimann M. F., 1996, NEUROANATOMY ZEBRAFI; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; ZAKON HH, 1984, J COMP NEUROL, V228, P557, DOI 10.1002/cne.902280408; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355; Zikopoulos B, 2000, BRAIN BEHAV EVOLUT, V56, P310, DOI 10.1159/000047215; Zimmerman AM, 1999, J EXP ZOOL, V284, P299, DOI 10.1002/(SICI)1097-010X(19990801)284:3&lt;299::AID-JEZ7&gt;3.0.CO;2-6; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y; Zupanc GKH, 2009, NEUROSCIENCE, V159, P1338, DOI 10.1016/j.neuroscience.2009.02.014; Zupanc GKH, 1996, J COMP NEUROL, V370, P443; ZUPANC GKH, 1995, J COMP NEUROL, V353, P213, DOI 10.1002/cne.903530205; Zupanc GKH, 1998, EXP NEUROL, V152, P221, DOI 10.1006/exnr.1998.6853; Zupanc GKH, 1999, J EXP BIOL, V202, P1435; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 2003, BRAIN BEHAV EVOLUT, V62, P31, DOI 10.1159/000071958; Zupanc GKH, 2003, GLIA, V43, P77, DOI 10.1002/glia.10236; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182; ZUPANC GKH, 1992, P NATL ACAD SCI USA, V89, P9539, DOI 10.1073/pnas.89.20.9539; ZUPANC GKH, 2006, EVOLUTION NERVOUS SY, P485; Zupanc GKH, 2007, PROTEOM CLIN APPL, V1, P1362, DOI 10.1002/prca.200700420; Zupanc GKH, 2006, REGEN MED, V1, P207, DOI 10.2217/17460751.1.2.207; Zupanc GKH, 2011, ADV NEUROBIOL, V2, P511, DOI 10.1007/978-1-4419-7197-5_20; Zupanc GKH, 2009, SEMIN CELL DEV BIOL, V20, P683, DOI 10.1016/j.semcdb.2008.12.001; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007; Zupanc Guenther K. H., 2008, V52, P571; Zupanc MM, 2006, BRAIN RES, V1095, P26, DOI 10.1016/j.brainres.2006.04.005; Zupanc MM, 2006, PROTEOMICS, V6, P677, DOI 10.1002/pmic.200500167	144	15	15	0	4	SPRINGER-VERLAG TOKYO	TOKYO	37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN			978-4-431-53932-2				2011							137	167		10.1007/978-4-431-53933-9_5			31	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BWB24	WOS:000293357800005					2022-02-06	
J	Bartnik-Olson, BL; Oyoyo, U; Hovda, DA; Sutton, RL				Bartnik-Olson, Brenda L.; Oyoyo, Udochukwu; Hovda, David A.; Sutton, Richard L.			Astrocyte Oxidative Metabolism and Metabolite Trafficking after Fluid Percussion Brain Injury in Adult Rats	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; compartmentation; fluid percussion injury; glutamate; glutamine; neuron	PYRUVATE-CARBOXYLASE; GLUCOSE-METABOLISM; GLUTAMATE METABOLISM; CEREBRAL CONCUSSION; EX-VIVO; MITOCHONDRIAL; COMPARTMENTATION; NEURONS; SPECTROSCOPY; SUBSTRATE	Despite various lines of evidence pointing to the compartmentation of metabolism within the brain, few studies have reported the effect of a traumatic brain injury (TBI) on neuronal and astrocyte compartments and/or metabolic trafficking between these cells. In this study we used ex vivo C-13 NMR spectroscopy following an infusion of [1-C-13] glucose and [1,2-C-13(2)] acetate to study oxidative metabolism in neurons and astrocytes of sham-operated and fluid percussion brain injured (FPI) rats at 1, 5, and 14 days post-surgery. FPI resulted in a decrease in the 13 C glucose enrichment of glutamate in neurons in the injured hemisphere at day 1. In contrast, enrichment of glutamine in astrocytes from acetate was not significantly decreased at day 1. At day 5 the C-13 enrichment of glutamate and glutamine from glucose in the injured hemisphere of FPI rats did not differ from sham levels, but glutamine derived from acetate metabolism in astrocytes was significantly increased. The C-13 glucose enrichment of the C3 position of glutamate (C3) in neurons was significantly decreased ipsilateral to FPI at day 14, whereas the enrichment of glutamine in astrocytes had returned to sham levels at this time point. These findings indicate that the oxidative metabolism of glucose is reduced to a greater extent in neurons compared to astrocytes following a FPI. The increased utilization of acetate to synthesize glutamine, and the acetate enrichment of glutamate via the glutamate-glutamine cycle, suggests an integral protective role for astrocytes in maintaining metabolic function following TBI-induced impairments in glucose metabolism.	[Bartnik-Olson, Brenda L.] Loma Linda Univ, Dept Radiol, Sch Publ Hlth, Loma Linda, CA 92354 USA; [Bartnik-Olson, Brenda L.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Bartnik-Olson, Brenda L.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Bartnik-Olson, BL (corresponding author), Loma Linda Univ, Dept Radiol, Sch Publ Hlth, 11234 Anderson St,Room B623, Loma Linda, CA 92354 USA.	bbartnik@llu.edu		Bartnik-Olson, Brenda/0000-0002-1137-9437	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS27544, P01NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, R01NS027544] Funding Source: NIH RePORTER	We thank Dr. N.G. Harris for his review and comments on the manuscript. This work was supported by the UCLA Brain Injury Research Center and Award Numbers R01NS27544 and P01NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health.	Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; BADARGOFFER RS, 1990, BIOCHEM J, V266, P133, DOI 10.1042/bj2660133; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.3.CO;2-5; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hertz L, 2003, NEUROCHEM RES, V28, P243, DOI 10.1023/A:1022377100379; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Melo TM, 2006, NEUROCHEM INT, V48, P498, DOI 10.1016/j.neuint.2005.12.037; Merle M, 2002, J NEUROCHEM, V82, P47, DOI 10.1046/j.1471-4159.2002.00924.x; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Peng L, 2007, J NEUROSCI RES, V85, P3480, DOI 10.1002/jnr.21262; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Qu H, 2000, DEV NEUROSCI-BASEL, V22, P429, DOI 10.1159/000017472; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schousboe A, 1997, GLIA, V21, P99; Serres S, 2008, J CEREBR BLOOD F MET, V28, P712, DOI 10.1038/sj.jcbfm.9600568; Serres S, 2007, J NEUROCHEM, V101, P1428, DOI 10.1111/j.1471-4159.2006.04442.x; SHANK RP, 1985, BRAIN RES, V329, P364, DOI 10.1016/0006-8993(85)90552-9; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Shokati T, 2005, NEUROCHEM RES, V30, P1269, DOI 10.1007/s11064-005-8798-8; Sonnewald U, 2003, NMR BIOMED, V16, P424, DOI 10.1002/nbm.837; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; SUTTON RL, 2005, 4717 SOC NEUR; Taylor A, 1996, DEV NEUROSCI-BASEL, V18, P434, DOI 10.1159/000111438; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; VANDENBE.CJ, 1971, BIOCHEM J, V123, P211, DOI 10.1042/bj1230211; VANDENBERG CJ, 1969, BIOCHEM J, V113, P281, DOI 10.1042/bj1130281; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Waagepetersen HS, 2005, NEUROCHEM INT, V47, P92, DOI 10.1016/j.neuint.2005.04.012; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YU ACH, 1983, J NEUROCHEM, V41, P1484, DOI 10.1111/j.1471-4159.1983.tb00849.x; YU ACH, 1984, J NEUROCHEM, V42, P951, DOI 10.1111/j.1471-4159.1984.tb12696.x	58	15	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2010	27	12					2191	2202		10.1089/neu.2010.1508			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	691PN	WOS:000285093400009	20939699	Green Published			2022-02-06	
J	Hammond, FM; Malec, JF				Hammond, F. M.; Malec, J. F.			The Traumatic Brain Injury Model Systems: a longitudinal database, research, collaboration and knowledge translation	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Database; Outcome assessment (health care)		In 1988, the National Institute on Disability and Rehabilitation Research (NIDRR) launched the Traumatic Brain Injury Model Systems (TBIMS) program, creating the longest and largest longitudinal database on individuals with moderate-to-severe traumatic brain injury (TB!) available today. In addition to sustaining the longitudinal database, centers that successfully compete to be part of the TBIMS centers are also expected to complete local and collaborative research projects to further scientific knowledge about TBI. The research has focused on areas of the NIDRR Long Range Plan which emphasizes employment, health and function, technology for access and function, independent living and community integration, and other associated disability research areas. Centers compete for funded participation in the TBIMS on a 5-year cycle. Dissemination of scientific knowledge gained through the TBIMS is the responsibility of both individual centers and the TBIMS as a whole. This is accomplished through multiple venues that target a broad audience of those who need to receive the information and learn how to best apply it to practice. The sites produce many useful websites, manuals, publications and other materials to accomplish this translation of knowledge to practice.	[Hammond, F. M.; Malec, J. F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indianapolis, IN USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indianapolis, IN USA.						*CTR OUTC MEAS BRA, TBI MOD SYST DAT CTR; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; *NAT I DIS REH REH, NOT FIN LONG RANG PL; *NIDRR TRAUM BRAIN, TRAUM BRAIN INJ MOD; 2010 TBIMS PRESENTAT	5	15	16	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	DEC	2010	46	4					545	548					4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	712SX	WOS:000286687600010	21224786				2022-02-06	
J	Otapowicz, D; Sobaniec, W; Okurowska-Zawada, B; Artemowicz, B; Sendrowski, K; Kulak, W; Bockowski, L; Kuzia-Smigielska, J				Otapowicz, D.; Sobaniec, W.; Okurowska-Zawada, B.; Artemowicz, B.; Sendrowski, K.; Kulak, W.; Bockowski, L.; Kuzia-Smigielska, J.			Dysphagia in children with infantile cerebral palsy	ADVANCES IN MEDICAL SCIENCES			English	Article						cerebral palsy; deglutition disorders; eating problems; dysarthria	TRAUMATIC BRAIN-INJURY; PREVALENCE; GROWTH	Purpose: Dysphagia is a significant health problem in children with infantile cerebral palsy (ICP), but not frequently discussed in the literature. The study objective was to analyse dysphagia symptoms in children with a pyramidal form of ICP, including the oral and pharyngeal phases of deglutition and dysarthria severity. We searched for a correlation between dysphagia severity and ICP type, mental development and occurrence of epilepsy. Material and Methods: A total of 67 children with a pyramidal form of infantile cerebral palsy were studied. Data were obtained based on case history elicited from the mothers, analysis of medical and psychological documentation, and logopaedic examination, including an examination of the action of swallowing. Results: Dysphagia symptoms were found in 41 (61%) studied children, most frequently referring only to the oral phase (25 children), with concomitant mild and moderate dysarthria. Oral and pharyngeal dysfunctions were observed in 14 children and coexisted with more pronounced dysarthria symptoms. The most severe disorders were mainly found in the pharyngeal phase in 2 children. A statistically significant correlation was noted between the severity of dysphagia symptoms and the ICP type (p<0.044) and mental development (p<0.00002)' Conclusions: Swallowing dysfunctions occur in the majority of children (> 50%) with ICP. More serious disorders involving the oral and pharyngeal phases mainly affect children with tetraplegia and profound mental impairment. These disorders continue from early infancy through childhood and adolescence and improvement has been mainly observed when only the oral phase of swallowing is affected. These are always accompanied by dysarthria symptoms, which are especially severe when dysphagia involves the oral and pharyngeal phases. Early assessment and stimulation of the swallowing function should be a common element in the rehabilitation and care of children with ICP	[Otapowicz, D.; Sobaniec, W.; Artemowicz, B.; Sendrowski, K.; Bockowski, L.; Kuzia-Smigielska, J.] Med Univ Bialystok, Dept Pediat Neurol & Rehabil, PL-15274 Bialystok, Poland; [Okurowska-Zawada, B.; Kulak, W.] Med Univ Bialystok, Dept Pediat Rehabil, PL-15274 Bialystok, Poland		Otapowicz, D (corresponding author), Med Univ Bialystok, Dept Pediat Neurol & Rehabil, 17 Waszyngtona Str, PL-15274 Bialystok, Poland.	dorota667@wp.pl	Kulak, Wojciech/T-4796-2018; Bockowski, Leszek/S-7862-2018; Okurowska-Zawada, Bozena/T-4992-2018	Kulak, Wojciech/0000-0003-1118-9139; Bockowski, Leszek/0000-0003-4522-8415; Okurowska-Zawada, Bozena/0000-0002-1915-4320; , Dorota/0000-0002-8036-1273			Borkowska M, 1989, ABC REHABILITACJI MO, P91; Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; Calis EAC, 2008, DEV MED CHILD NEUROL, V50, P625, DOI 10.1111/j.1469-8749.2008.03047.x; CLOUSE RE, 2002, SLEISENGER FORDTRANS, P561; Croghan John E., 1994, Dysphagia, V9, P141, DOI 10.1007/BF00341256; Czochanska J, 1997, MOZGOWE PORAZENIE DZ, P16; Dabska M, 1997, MOZGOWE PORAZENIE DZ, P13; Del Giudice E, 1999, BRAIN DEV-JPN, V21, P307, DOI 10.1016/S0387-7604(99)00025-X; Dilling-Ostrowska E, 2002, POSTEPY DIAGNOSTYCE, V4, P57; Gisel E, 1992, CEREBRAL PALSY TODAY, V2, P1; Gisel E, 2008, DEV DISABIL RES REV, V14, P165, DOI 10.1002/ddrr.21; Gisel Erika G., 1994, Dysphagia, V9, P180, DOI 10.1007/BF00341263; Haberfellner H, 2001, DYSPHAGIA, V16, P83, DOI 10.1007/s004550010006; HELFRICHMILLER KR, 1986, ARCH PHYS MED REHAB, V67, P520; Humbert IA, 2007, DYSPHAGIA, V22, P266, DOI 10.1007/s00455-007-9080-9; JONES PM, 1989, DEV MED CHILD NEUROL, V31, P404; Kulak W, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P74; Kulak W, 2008, ADV MED SCI-POLAND, V53, P42, DOI 10.2478/v10039-008-0006-z; Kulak W, 2007, Adv Med Sci, V52 Suppl 1, P180; Lefton-Greif MA, 2008, PHYS MED REH CLIN N, V19, P837, DOI 10.1016/j.pmr.2008.05.007; Mackiewicz B, 2001, LOGOPEDIA, V29, P87; Mazanek E., 1997, MOZGOWE PORAZENIE DZ, P72; Michalowicz R, 2001, NEUROLOGIA DZIECIECA, P118; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Otapowicz D, 2007, Adv Med Sci, V52 Suppl 1, P188; Otapowicz D, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P78; PARROTT L C, 1992, Dysphagia, V7, P209; Reilly S, 1996, J PEDIATR-US, V129, P877, DOI 10.1016/S0022-3476(96)70032-X; Reilly S, 2008, DEV MED CHILD NEUROL, V50, P567, DOI 10.1111/j.1469-8749.2008.03049.x; Robertson SJ, 1987, DYSARTHRIA PROFILE; Rogers Brian, 1996, Seminars in Speech and Language, V17, P269, DOI 10.1055/s-2008-1064104; Saarinen T, 2006, CEREB CORTEX, V16, P212, DOI 10.1093/cercor/bhi099; Smigielska-Kuzia J, 1997, KWAS WALPROINOWY HIS, P115; STALLINGS VA, 1993, DEV MED CHILD NEUROL, V35, P126; Stecko E, 2002, ZABURZENIA MOWY DZIE; Stecko E, 2001, MOZGOWE PORAZENIE DZ, P348; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Vik T, 2001, Tidsskr Nor Laegeforen, V121, P1570; Wasko-Czopnik D, 1999, NOWA MEDYCYNA, V10, P5	39	15	20	1	10	MEDICAL UNIV BIALYSTOK	BIALYSTOK	UL KILINSKIEGO 1, BIALYSTOK, 15-089, POLAND	1896-1126			ADV MED SCI-POLAND	Adv. Med. Sci.	DEC	2010	55	2					222	227		10.2478/v10039-010-0034-3			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	697OL	WOS:000285522800017	20934964				2022-02-06	
J	Kondo, K; Maruishi, M; Ueno, H; Sawada, K; Hashimoto, Y; Ohshita, T; Takahashi, T; Ohtsuki, T; Matsumoto, M				Kondo, Keita; Maruishi, Masaharu; Ueno, Hiroki; Sawada, Kozue; Hashimoto, Yukari; Ohshita, Tomohiko; Takahashi, Tetsuya; Ohtsuki, Toshiho; Matsumoto, Masayasu			The pathophysiology of prospective memory failure after diffuse axonal injury - Lesion-symptom analysis using diffusion tensor imaging	BMC NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; EVENT; COMPONENTS; ANISOTROPY; REGIONS; TIME	Background: Prospective memory (PM) is one of the most important cognitive domains in everyday life. The neuronal basis of PM has been examined by a large number of neuroimaging and neuropsychological studies, and it has been suggested that several cerebral domains contribute to PM. For these activation studies, a constellation of experimental PM trials was developed and adopted to healthy subjects. In the present study, we used a widely used clinical PM assessment battery to determine the lesions attributable to PM failure, with the hypothesis that lesion-symptom analysis using diffusion tensor imaging (DTI) in subjects with diffuse axonal injury (DAI) can reveal the neuronal basis of PM in everyday life. Results: Fourteen DAI patients (age: range of 18-36, median 24) participated in this study. PM failure was scored in the range of 0-6 using three sub-tests of the Rivermead Behavioural Memory Test. The PM scores of DAI patients were in the range of 2-6 (median 4.5, inter-quartile range 2.25). The severity of axonal injury following DAI was examined using fractional anisotropy (FA), one of the DTI parameters, at voxel level in each subject. We then obtained clusters correlated with PM failure by conducting voxel-based regression analysis between FA values and PM scores. Three clusters exhibited significant positive correlation with PM score, the left parahippocampal gyrus, left inferior parietal lobe, and left anterior cingulate. Conclusions: This is the first lesion-symptom study to reveal the neuronal basis of PM using DTI on subjects with DAI. Our findings suggest that the neuronal basis of PM is in the left parahippocampal gyrus, left inferior parietal lobe, and/or left anterior cingulate. These findings are similar to those of previous activation studies with loading experimental PM tasks.	[Kondo, Keita; Ueno, Hiroki; Ohshita, Tomohiko; Takahashi, Tetsuya; Ohtsuki, Toshiho; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, Hiroshima, Japan; [Kondo, Keita; Maruishi, Masaharu; Ueno, Hiroki; Sawada, Kozue; Hashimoto, Yukari] Hiroshima Prefectural Rehabil Ctr, Hiroshima Higher Brain Funct Ctr, Higashihiroshima, Japan; [Hashimoto, Yukari] Fukuyama Univ, Dept Psychol, Fukuyama, Hiroshima, Japan; [Maruishi, Masaharu] Hiroshima Prefectural Coll Hlth Sci, Dept Commun Sci & Disorders, Hiroshima, Japan		Takahashi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	tetakaha@mac.com	Takahashi, Tetsuya/ABG-8566-2021	Takahashi, Tetsuya/0000-0001-6891-0842	General Insurance Association of Japan; Ministry of Health, Labour, and Welfare of JapanMinistry of Health, Labour and Welfare, Japan	We thank the entire staff of the Hiroshima Higher Brain Function Center for assistance in subject recruitment and testing. This research was supported in part by grants from the General Insurance Association of Japan and from the Ministry of Health, Labour, and Welfare of Japan.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ardekani BA, 2003, NEUROREPORT, V14, P2025, DOI 10.1097/00001756-200311140-00004; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Asari T, 2005, NEUROIMAGE, V26, P694, DOI 10.1016/j.neuroimage.2004.12.063; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Cockburn J, 1996, J CLIN EXP NEUROPSYC, V18, P304, DOI 10.1080/01688639608408284; Einstein G.O., 2007, PROSPECTIVE MEMORY O, V1, DOI DOI 10.4135/9781452225913; EVANS RW, 1992, NEUROL CLIN, V10, pR11; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1017/S0048577201981867; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; McDaniel M. A., 2007, PROSPECTIVE MEMORY O, P171; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NARAYAN RK, 1989, TXB HEAD INJURY, P23; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa	39	15	16	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	NOV 20	2010	11								147	10.1186/1471-2202-11-147			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	691CD	WOS:000285057000001	21092119	Green Published, gold			2022-02-06	
J	Baird, LC; Newman, CB; Volk, H; Svinth, JR; Conklin, J; Levy, ML				Baird, Lissa C.; Newman, C. Benjamin; Volk, Hunter; Svinth, Joseph R.; Conklin, Jordan; Levy, Michael L.			Mortality Resulting From Head Injury in Professional Boxing	NEUROSURGERY			English	Article						Boxing; Head trauma; mortality	MEDICAL ASPECTS; BRAIN-INJURY; BIOMECHANICS; CONCUSSION; FATALITIES; FOOTBALL; PUNCH	BACKGROUND: The majority of boxing-related fatalities result from traumatic brain injury. Biomechanical forces in boxing result in rotational acceleration with resultant subdural hematoma and diffuse axonal injury. OBJECTIVE: Given the inherent risk and the ongoing criticism boxing has received, we evaluated mortalities associated with professional boxing. METHODS: We used the Velaquez Fatality Collection of boxing injuries and supplementary sources to analyze mortality from 1950 to 2007. Variables evaluated included age at time of death, association with knockout or other outcome of match, rounds fought, weight class, location of fight, and location of pretermial event. RESULTS: There were 339 mortalities between 1950 and 2007 (mean age, 24 +/- 3.8 years); 64% were associated with knockout and 15% with technical knockout. A higher percentage occured in the lower weight classes. The preterminal event occured in the ring (61%), in the locker room (17%), and outside the arena (22%), We evaluated for significant changes after 1983 when championship bouts were reduced from 15 to 12 rounds. CONCLUSION: There was a significant decline in mortality after 1983. We found no significant variables to support that this decline is related to a reduction in rounds. Rather, we hypothesize the decline to be the result of a reduction in exposure to repetitive head trauma (shorter careers and fewer fights), along with increased medical oversight and stricter safety regulations. Increased efforts should be made to improve medical supervisions of boxers. Mandatory central nervous system imaging after a knockout could lead to a significant reduction in associated mortality	[Baird, Lissa C.; Newman, C. Benjamin; Volk, Hunter; Levy, Michael L.] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA; [Svinth, Joseph R.; Conklin, Jordan] Rady Childrens Hosp San Diego, San Diego, CA USA		Levy, ML (corresponding author), 8010 Frost St,Ste 502, San Diego, CA USA.	mlevy@chsd.org	Levy, Michael/AAL-4647-2020				ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BORGES R, 25 YEARS IS LONG TIM; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; COHEN L, 1984, CAN MED ASSOC J, V130, P767; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Ghiselli G, 2003, CLIN SPORT MED, V22, P445, DOI 10.1016/S0278-5919(02)00109-6; GONZALES TA, 1951, JAMA-J AM MED ASSOC, V146, P1506, DOI 10.1001/jama.1951.03670160048012; Hodgson V. R., 1972, P 16 STAPP CAR CRASH; Joch W, 1981, BIOMECHANICS A, P343; JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KING AI, 1995, BIOMEDICAL ENG HDB, P357; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037; MCCOWN IA, 1959, AM J SURG, V98, P509, DOI 10.1016/0002-9610(59)90545-8; Miele VJ, 2007, NEUROSURGERY, V60, P307, DOI 10.1227/01.NEU.0000249247.48299.5B; Miele Vincent J, 2006, Neurosurg Focus, V21, pE8; Moore M, 1980, Phys Sportsmed, V8, P101, DOI 10.1080/00913847.1980.11710972; MORRISON RG, 1986, JAMA-J AM MED ASSOC, V255, P2475, DOI 10.1001/jama.255.18.2475; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PINCEMAILLE Y, 1989, P 33 STAPP CAR CRASH; POLIN AW, 1996, NEUROLOGY TRAUMA, P166; REFSHAUGE JG, 1963, MED J AUSTRALIA, V1, P611, DOI 10.5694/j.1326-5377.1963.tb25567.x; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; SERCL M., 1962, WORLD NEUROL, V3, P351; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; SUGAR BR, 1981, RING RECORD BOOK BOX; Svinth J., 2007, J COMBATIVE SPORT; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Unterharnscheidt F J, 1972, Scand J Rehabil Med, V4, P77; VIANO D, 1988, P 32 STAPP CAR CRASH; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; WHITING WC, 1988, AM J SPORT MED, V16, P130, DOI 10.1177/036354658801600207	40	15	16	1	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2010	67	5					1444	1450		10.1227/NEU.0b013e3181e5e2cd			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	671DF	WOS:000283479500062	20948404				2022-02-06	
J	Friedman, DE; Tobias, RS; Akman, CI; Smith, EO; Levin, HS				Friedman, David E.; Tobias, Ronnie S.; Akman, Cigdem I.; Smith, E. O'Brian; Levin, Harvey S.			Recurrent seizure-related injuries in people with epilepsy at a tertiary epilepsy center: A 2-year longitudinal study	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Seizure; Injury; Head injury	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; HEAD-INJURY; DYSFUNCTION; HISTORY	Though seizure-related injuries (SRIs) among people with epilepsy (PWE) have recently gained much attention in the literature, most studies are retrospective and data are gathered indirectly through questionnaires or medical record documentation. We investigated SRIs and their associated risks in PWE attending a tertiary care center with direct and systematic inquiries during routine clinic follow-up visits over a 2-year period (N=306). Past SRIs occurred in 54% of all patients, and 24% experienced recurrent SRIs during the study period. On multiple regression analyses, past SRI was associated with tonic-clonic seizures (TCSs) (3.2, 95% CI = 1.7-5.8) and cognitive handicap (4.3, 95% CI 1.5-16.1), and recurrent SRI was associated with TCSs (3.5, 95% CI=1.6-7.9). Most recurrent SRIs (72%) involved head injury. SRIs are common when assessed systematically in a tertiary care setting, and TCSs represent a risk factor for recurrent SRIs. The potential clinical impact of recurrent SRIs on PWE requires further study. (C) 2010 Elsevier Inc. All rights reserved.	[Friedman, David E.; Tobias, Ronnie S.; Akman, Cigdem I.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Smith, E. O'Brian] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Friedman, DE (corresponding author), 1 Baylor Plaza,NB 302, Houston, TX 77030 USA.	defriedm@bcm.tmc.edu					Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1989, EPILEPSIA, V30, P348, DOI 10.1111/j.1528-1157.1989.tb05308.x; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Beghi E, 2002, EPILEPSIA, V43, P1076, DOI 10.1046/j.1528-1157.2002.18701.x; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLUME WT, 1973, BRAIN, V96, P289, DOI 10.1093/brain/96.2.289; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DESAI BT, 1983, ANN EMERG MED, V12, P543, DOI 10.1016/S0196-0644(83)80294-7; Duncan JS, 2003, ANN NEUROL, V54, P421, DOI 10.1002/ana.10710; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Friedman DE, 2010, EPILEPSIA, V51, P43, DOI 10.1111/j.1528-1167.2009.02170.x; Hermann BP, 2006, ANN NEUROL, V60, P80, DOI 10.1002/ana.20872; Krauss GL, 1999, NEUROLOGY, V52, P1324, DOI 10.1212/WNL.52.7.1324; Lawn ND, 2004, NEUROLOGY, V63, P1565, DOI 10.1212/01.WNL.0000142991.14507.B5; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; NAKKEN KO, 1993, EPILEPSIA, V34, P836, DOI 10.1111/j.1528-1157.1993.tb02099.x; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; Pellock JM, 2000, MENT RETARD DEV D R, V6, P309, DOI 10.1002/1098-2779(2000)6:4<309::AID-MRDD10>3.0.CO;2-I; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELLJONES DL, 1989, J NEUROL NEUROSUR PS, V52, P659, DOI 10.1136/jnnp.52.5.659; Sherrard J, 2002, J INTELL DISABIL RES, V46, P6, DOI 10.1046/j.1365-2788.2002.00346.x; SPITZ MC, 1994, EPILEPSIA, V35, P764, DOI 10.1111/j.1528-1157.1994.tb02508.x; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Thompson PJ, 2005, EPILEPSIA, V46, P1780, DOI 10.1111/j.1528-1167.2005.00279.x; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	30	15	16	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2010	19	3					400	404		10.1016/j.yebeh.2010.07.029			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	696OV	WOS:000285451600033	20851687				2022-02-06	
J	Almosnino, S; Pelland, L; Stevenson, JM				Almosnino, Sivan; Pelland, Lucie; Stevenson, Joan M.			Retest Reliability of Force-Time Variables of Neck Muscles Under Isometric Conditions	JOURNAL OF ATHLETIC TRAINING			English	Article						injuries; concussions; muscle strength; sports	INTRACLASS CORRELATIONS; CERVICAL STRENGTH; REPRODUCIBILITY; EXTENSION; FLEXION; WOMEN	Context: Proper conditioning of the neck muscles may play a role in reducing the risk of neck injury and, possibly, concussions in contact sports. However, the ability to reliably measure the force-time-based variables that might be relevant for this purpose has not been addressed. Objective: To assess the between-days reliability of discrete force-time based variables of neck muscles during maximal voluntary isometric contractions in 5 directions. Design: Cohort study. Setting: University research center. Patients or Other Participants: Twenty-six highly physically active men (age = 21.6 +/- 2.1 years, height = 1.85 +/- 0.09 m, mass = 81.6 +/- 9.9 kg, head circumference = 0.58 +/- 0.01 m, neck circumference = 0.39 +/- 0.02 m). Intervention(s): We used a custom-built testing apparatus to measure maximal voluntary isometric contractions of the neck muscles in 5 directions (extension, flexion, protraction, left lateral bending, and right lateral bending) on 2 separate occasions separated by 7 to 8 days. Main Outcome Measure(s): Variables measured were peak force (PF), rate of force development (RFD), and time to 50% of PF (T50PF). Reliability indices calculated for each variable comprised the difference in scores between the testing sessions, with corresponding 95% confidence intervals, the coefficient of variation of the typical error of measurement (CVTE), and intraclass correlation coefficients (ICC [3,3]). Results: No evidence of systematic bias was detected for the dependent measures across any movement direction; retest differences in measurements were between 1.8% and 2.7%, with corresponding 95% confidence interval ranges of less than 10% and overlapping zero. The CVTE was lowest for PF (range, 2.4%-6.3%) across all testing directions, followed by RFD (range, 4.8%-9.0%) and T50PF (range, 7.1%-9.3%). The ICC score range for all dependent measures was 0.90 to 0.99. Conclusions: Discrete variables representative of the force-generating capacity of neck muscles under isometric conditions can be measured with an acceptable degree of reliability. This finding has possible applications for investigating the role of neck muscle strength-training programs in reducing the risk of injuries in sport settings.	[Pelland, Lucie; Stevenson, Joan M.] Queens Univ, Sch Rehabil Therapy, Kingston, ON K7L 3N6, Canada; [Almosnino, Sivan; Stevenson, Joan M.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada; [Almosnino, Sivan; Pelland, Lucie] Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON, Canada		Pelland, L (corresponding author), Queens Univ, Sch Rehabil Therapy, Louise D Acton Bldg,31 George St, Kingston, ON K7L 3N6, Canada.	Lucie.Pelland@queensu.ca			Ontario Neurotrauma Foundation; Queen's University Advisory Research Council	Funding was provided by the Ontario Neurotrauma Foundation and the Queen's University Advisory Research Council (Dr Pelland). We thank Sam Pedlow and Alexis Twiddy for their contributions.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; AMUNDSEN LR, 1990, MUSCLE STRENGTH TEST, P89; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Barry BK, 2005, EXP BRAIN RES, V162, P122, DOI 10.1007/s00221-004-2127-3; Burnett Angus F, 2005, Work, V25, P205; Cagnie B, 2007, ARCH PHYS MED REHAB, V88, P1441, DOI 10.1016/j.apmr.2007.06.776; Conley MS, 1997, EUR J APPL PHYSIOL, V75, P443, DOI 10.1007/s004210050186; Dvir Z, 2003, ISOKINET EXERC SCI, V11, P49, DOI 10.3233/IES-2003-0109; Dvir Z, 2008, J MANIP PHYSIOL THER, V31, P518, DOI 10.1016/j.jmpt.2008.08.008; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Geertsen SS, 2008, J APPL PHYSIOL, V105, P915, DOI 10.1152/japplphysiol.01155.2007; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, NEW VIEW STAT; Hunter JP, 2004, MED SCI SPORT EXER, V36, P850, DOI 10.1249/01.MSS.0000126467.58091.38; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; LEVOSKA S, 1992, CLIN BIOMECH, V7, P33, DOI 10.1016/0268-0033(92)90005-O; Olivier PE, 2008, J SCI MED SPORT, V11, P96, DOI 10.1016/j.jsams.2007.01.009; Ordway NR, 1999, SPINE, V24, P240, DOI 10.1097/00007632-199902010-00008; Portero P, 2001, EUR J APPL PHYSIOL, V84, P540, DOI 10.1007/s004210100399; Seng KY, 2002, CLIN BIOMECH, V17, P545, DOI 10.1016/S0268-0033(02)00067-0; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; STONE MH, 2008, PRINCIPLES PRACTICE, P225; Strimpakos N, 2004, ARCH PHYS MED REHAB, V85, P1309, DOI 10.1016/j.apmr.2003.08.104; Strimpakos N., 2001, PHYS THER REV, V6, P39; Symons TB, 2005, J GERONTOL A-BIOL, V60, P114, DOI 10.1093/gerona/60.1.114; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Valkeinen H, 2002, EUR J APPL PHYSIOL, V88, P247, DOI 10.1007/s00421-002-0709-y; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Walmsley RP, 1996, ISOKINET EXERC SCI, V6, P117, DOI 10.3233/IES-1996-6207; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Ylinen JJ, 1999, CLIN BIOMECH, V14, P217, DOI 10.1016/S0268-0033(98)00063-1	34	15	16	1	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2010	45	5					453	458		10.4085/1062-6050-45.5.453			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	654GZ	WOS:000282157800003	20831389	Green Published			2022-02-06	
J	Aydin, S; Overwater, E; Saltzherr, TP; Jin, PHPFK; van Exter, P; Ponsen, KJ; Luitse, JSK; Goslings, JC				Aydin, Sema; Overwater, Eline; Saltzherr, Teun Peter; Jin, P. H. Ping Fung Kon; van Exter, Pieternel; Ponsen, Kees Jan; Luitse, Jan S. K.; Goslings, J. Carel			The Association of Mobile Medical Team Involvement on On-Scene Times and Mortality in Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Trauma; Mobile medical team; On-scene time; Mortality; Prehospital care	ENDOTRACHEAL INTUBATION; SERVICES EMS; SURVIVAL; IMPACT; CARE; INJURY; SCOOP; SCORE; LIFE	Objectives: Mobile medical teams (MMTs) provide specialized care on-scene with the purpose to improve outcome. However, this additional care could prolong the on-scene time (OST), which is related to mortality. The purpose of this study was to assess the effects of MMT involvement on the mortality rate and on the OST, in a Dutch consecutive cohort of Level I trauma patients. Methods: All patients who required presentation in the trauma resuscitation room in an urban Level I trauma center were included in this prospective study during the period of November 2005 till November 2007. For data collection, we used both pre- and in-hospital registration systems. Outcome measures were 30-day mortality and OST. Results: In total, 1,054 patients were analyzed. In 172 (16%) patients, the MMT was involved. Mortality was significantly higher in the MMT group compared with patients treated without MMT involvement; 9.9% versus 2.7%, respectively (p < 0.001). Significantly higher Injury Severity Scores, intervention rates, and a significantly lower Triage Revised Trauma Score were found in patients treated by MMT. After adjustment for patient and injury characteristics, no association could be found between MMT involvement and higher mortality (95% CI, 0.581-3.979; p = 0.394). In patients with severe traumatic brain injury (GCS score <= 8) in whom a MMT was involved, the mortality was 25.5%, compared with 32.7% in those without MMT involvement (p = 0.442). The mean OST was prolonged (2.7 minutes) when MMT was involved (26.1 vs. 23.4 minutes; p = 0.003). Conclusions: In this study, OSTs were long compared with PHTLS recommendations. MMT involvement slightly prolonged the OST. Trauma patients with MMT involvement had a high mortality, but after correction for patient and injury characteristics, the mortality rate did not significantly differ from patients without MMT involvement.	[Aydin, Sema; Overwater, Eline; Saltzherr, Teun Peter; Jin, P. H. Ping Fung Kon; Ponsen, Kees Jan; Luitse, Jan S. K.; Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Trauma Unit, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [van Exter, Pieternel] Reg Ambulance Serv RAVAA, Amsterdam, Netherlands		Saltzherr, TP (corresponding author), Univ Amsterdam, Acad Med Ctr, Trauma Unit, Dept Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.p.saltzherr@amc.uva.nl		Overwater, Eline/0000-0002-0993-5035			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Birk Hans O, 2002, Prehosp Disaster Med, V17, P167; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; BOYD DR, 1983, WORLD J SURG, V7, P149, DOI 10.1007/BF01655923; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cornwell EE, 2000, ARCH SURG-CHICAGO, V135, P315, DOI 10.1001/archsurg.135.3.315; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; GOLD CR, 1987, ANN EMERG MED, V16, P797, DOI 10.1016/S0196-0644(87)80578-4; Gonzalez RP, 2006, J TRAUMA, V61, P404, DOI 10.1097/01.ta.0000229816.16305.94; Lemson J, 2008, Ned Tijdschr Geneeskd, V152, P1106; McSwain NE, 2006, PREHOSPITAL TRAUMA L; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; Petri R W, 1995, Prehosp Disaster Med, V10, P24; Ringburg AN, 2007, J TRAUMA, V63, P258, DOI 10.1097/01.ta.0000240449.23201.57; Roorda J, 1996, INJURY, V27, P163, DOI 10.1016/0020-1383(95)00218-9; Sampalis J S, 1994, Prehosp Disaster Med, V9, P178; SAMPALIS JS, 1993, J TRAUMA, V34, P252, DOI 10.1097/00005373-199302000-00014; Spaite DW, 2003, ANN EMERG MED, V42, P729, DOI 10.1016/S0196-0644(03)00822-9; van Olden GDJ, 2003, INJURY, V34, P191, DOI 10.1016/S0020-1383(02)00202-4; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Zink BJ, 2004, ANN EMERG MED, V44, P451, DOI 10.1016/j.annemergmed.2004.05.001	23	15	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2010	69	3					589	593		10.1097/TA.0b013e3181e74858			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	649HX	WOS:000281760800023	20838130				2022-02-06	
J	Bouzat, P; Francony, G; Brun, J; Lavagne, P; Picard, J; Broux, C; Declety, P; Jacquot, C; Albaladejo, P; Payen, JF				Bouzat, Pierre; Francony, Gilles; Brun, Julien; Lavagne, Pierre; Picard, Julien; Broux, Christophe; Declety, Philippe; Jacquot, Claude; Albaladejo, Pierre; Payen, Jean-Francois			Detecting traumatic internal carotid artery dissection using transcranial Doppler in head-injured patients	INTENSIVE CARE MEDICINE			English	Article						Transcranial Doppler; Trauma; Carotid dissection; Internal carotid	EARLY-DIAGNOSIS; ULTRASOUND; ANGIOGRAPHY; TOMOGRAPHY; STENOSIS; CRITERIA; IMPROVES; THERAPY	The early diagnosis of traumatic internal carotid artery dissection (TICAD) is essential for initiating appropriate treatment and improving outcome. We searched for criteria from transcranial Doppler (TCD) measurements on admission that could be associated with subsequent TICAD diagnosis in patients with traumatic brain injury (TBI). We conducted a retrospective 1:4 matched (age, mean arterial blood pressure) cohort study of 11 TBI patients with TICAD and absent or mild brain lesions on initial CT scan, 22 TBI controls with comparable brain CT scan lesions (controls 1), and 22 TBI controls with more severe brain CT scan lesions (controls 2) on admission. TCD measurements were obtained on admission from both middle cerebral arteries (MCA). All patients had subsequent CT angiography to diagnose TICAD. A > 25% asymmetry in the systolic blood flow velocity between the two MCA was found in 9/11 patients with TICAD versus 0/22 in controls 1 and 5/22 in controls 2 (p < 0.01). The combination of this asymmetry with an ipsilateral pulsatility index a parts per thousand currency sign0.80 was found in 9/11 patients with TICAD versus none in the two groups of controls (p < 0.01). Our results suggest that significant asymmetry in the systolic blood flow velocity between the MCAs and a reduced ipsilateral pulsatility index could be criteria from TCD measurements associated with the occurrence of TICAD in head-injured patients. If prospectively validated, these findings could be incorporated in screening protocols for TICAD in patients with TBI.	[Payen, Jean-Francois] Hop Albert Michallon, F-38043 Grenoble, France; [Bouzat, Pierre; Francony, Gilles; Brun, Julien; Lavagne, Pierre; Picard, Julien; Broux, Christophe; Declety, Philippe; Jacquot, Claude; Albaladejo, Pierre; Payen, Jean-Francois] Albert Michallon Hosp, Dept Anesthesiol & Crit Care, F-38000 Grenoble, France		Payen, JF (corresponding author), Hop Albert Michallon, BP 217, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	Bouzat, Pierre/L-6881-2014; albaladejo, pierre/M-6901-2014; Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/AAC-4105-2019	Bouzat, Pierre/0000-0003-4667-6738			ACHTEREEKTE HAM, 1994, SURG NEUROL, V42, P240, DOI 10.1016/0090-3019(94)90270-4; Arthurs ZM, 2008, INJURY, V39, P1232, DOI 10.1016/j.injury.2008.02.042; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Can U, 1997, STROKE, V28, P1966, DOI 10.1161/01.STR.28.10.1966; DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Hartmann A, 2000, CEREBROVASC DIS, V10, P33, DOI 10.1159/000016022; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon RK, 2008, ANN NY ACAD SCI, V1142, P200, DOI 10.1196/annals.1444.015; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; ROMNER B, 1994, ACTA NEUROCHIR, V126, P185, DOI 10.1007/BF01476431; SCHNEIDER PA, 1988, STROKE, V19, P589, DOI 10.1161/01.STR.19.5.589; Shafe M, 2004, ACAD EMERG MED, V11, P774, DOI 10.1197/j.aem.2004.02.518; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Srinivasan J, 1996, STROKE, V27, P1226, DOI 10.1161/01.STR.27.7.1226; Yang ST, 2006, J CLIN NEUROSCI, V13, P123, DOI 10.1016/j.jocn.2005.02.016	24	15	15	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	SEP	2010	36	9					1514	1520		10.1007/s00134-010-1919-0			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638PV	WOS:000280908000009	20490780				2022-02-06	
J	Crockett, A; Stawicki, SP; Thomas, YM; Jarvis, AM; Wang, CF; Beery, PR; Whitmill, ML; Lindsey, DE; Steinberg, SM; Cook, CH				Crockett, Andrew; Stawicki, Stanislaw P.; Thomas, Yalaunda M.; Jarvis, Amy M.; Wang, Cecily F.; Beery, Paul R.; Whitmill, Melissa L.; Lindsey, David E.; Steinberg, Steven M.; Cook, Charles H.			Tree Stands, Not Guns, are the Midwestern Hunter's Most Dangerous Weapon	AMERICAN SURGEON			English	Article							INJURIES; FALLS	Although the prevailing stereotype is that most hunting injuries are gunshot wounds inflicted by intoxicated hunting buddies, our experience led us to hypothesize that falls comprise a significant proportion of hunting related injuries. Trauma databases of two Level I trauma centers in central Ohio were queried for all hunting related injuries during a 10-year period. One hundred and thirty patients were identified (90% male, mean age 41.0 years, range 17-76). Fifty per cent of injuries resulted from falls, whereas gunshot wounds accounted for 29 per cent. Most hunters were hunting deer and 92 per cent of falls were from tree stands. Alcohol was involved in only 2.3 per cent, and drugs of abuse in 4.6 per cent. Of gunshots, 58 per cent were self-inflicted, and 42 per cent were shot by another hunter. Tree stand falls were highly morbid, with 59 per cent of fall victims suffering spinal fractures, 47 per cent lower extremity fractures, 18 per cent upper extremity fractures, and 18 per cent closed head injuries. Surgery was required for 81 per cent of fall-related injuries, and 8.2 per cent of fall victims had permanent neurological deficits. In contrast to prevailing beliefs, in our geographic area tree-stand falls are the most common mechanism of hunting related injury requiring admission to a Level 1 trauma center.	[Crockett, Andrew; Stawicki, Stanislaw P.; Thomas, Yalaunda M.; Jarvis, Amy M.; Wang, Cecily F.; Beery, Paul R.; Whitmill, Melissa L.; Lindsey, David E.; Steinberg, Steven M.; Cook, Charles H.] Ohio State Univ, Med Ctr, Dept Surg, Div Crit Care Trauma & Burn, Columbus, OH 43210 USA		Cook, CH (corresponding author), 410 W 10th Ave,N749 Doan Hall, Columbus, OH 43210 USA.	charles.cook@osumc.edu	Cook, Charles/AAE-3222-2020; Steinberg, Steven/E-4142-2011; Lindsey, David E/E-3517-2011; Cook, Charles/D-5574-2009	Cook, Charles/0000-0003-4446-3616; Stawicki, Stanislaw/0000-0002-8893-6668			*CDCP, 1996, MMWR-MORBID MORTAL W, V45, P884; Christensen TL, 2008, SOUTH MED J, V101, P383, DOI 10.1097/SMJ.0b013e318167a851; Fayssoux RS, 2008, SPINE J, V8, P522, DOI 10.1016/j.spinee.2006.11.005; Gates RL, 2002, J TRAUMA, V53, P705, DOI 10.1097/00005373-200210000-00014; Halanski Matthew A, 2008, WMJ, V107, P20; Huiras C M, 1990, Wis Med J, V89, P573; Metz M, 2004, SOUTH MED J, V97, P715, DOI 10.1097/00007611-200408000-00003; *ODNR, 2009, HUNT ED MAN; Reishus AD, 2007, WILD ENVIRON MED, V18, P20, DOI 10.1580/06-WEME-OR-014R1.1; ROSE WD, 1994, J WILDERNESS MED, V5, P382, DOI 10.1580/0953-9859-5.4.382; Smith JL, 2005, J TRAUMA, V58, P582, DOI 10.1097/01.TA.0000151348.91729.B6	11	15	15	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2010	76	9					1006	1010					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	643LD	WOS:000281297000018	20836352				2022-02-06	
J	Hart, T; Sherer, M; Temkin, N; Whyte, J; Dikmen, S; Heinemann, AW; Bell, K				Hart, Tessa; Sherer, Mark; Temkin, Nancy; Whyte, John; Dikmen, Sureyya; Heinemann, Allen W.; Bell, Kathleen			Participant-Proxy Agreement on Objective and Subjective Aspects of Societal Participation Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						participation; proxy report; traumatic brain injury	COMMUNITY INTEGRATION; PRACTICAL SCALE; HEAD-INJURY; OUTCOMES; REHABILITATION; AWARENESS; CONCORDANCE; ORIENTATION; RELATIVES; MODERATE	Objective: To examine congruence between participant (P) and significant other (SO) reports on societal participation in 3 objective domains (economic, community, and social activities) and subjective satisfaction with participation at 1 year after traumatic brain injury (TBI). Participants: Ninety-seven persons with moderate to severe TBI and their SOs (27 spouses/partners, 47 parents, 23 other relatives/friends). Main outcome measure: Community Participation Indicators questionnaire, divided into Objective (Economic, Community, Social) and Subjective (Satisfaction) subscales. Design: Prospective correlational study. Results: P-SO congruence differed by domain of participation, with Economic and Community indicators showing higher agreement than Social and Satisfaction items. Congruence was not affected by P-SO relationship or whether the pair lived together. However, pairs who spent at least daily time together had significantly higher agreement on Satisfaction items than pairs who were together less often. Congruence was not predicted by SOs' self-reported degree of awareness of Ps' concerns. Severity of TBI, within the range represented in this sample, had no effect on P-SO congruence in any domain. Conclusion: In research on participation after TBI, proxy report may be an acceptable substitute for missing participant report on productivity and community activity outcomes. However, proxy responses should be used with caution for questions about social activities and degree of satisfaction with participation.	[Hart, Tessa; Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Temkin, Nancy; Dikmen, Sureyya; Bell, Kathleen] Univ Washington, Seattle, WA 98195 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 60 E Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu	Heinemann, Allen W/K-6283-2012; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326; Whyte, John/0000-0002-4381-1474; Bell, Kathleen/0000-0002-0928-2046	National Institute on Disability and Rehabilitation Research [H133A040004, H133A070040, H133B040032, H133A02051, H133A020514]	This work was funded by grants H133A040004, H133A070040, H133B040032, H133A02051, and H133A020514 from the National Institute on Disability and Rehabilitation Research. The authors thank Jason Barber for database development and Kelly Bognar, Caron Morita, Rebecca Hardin, Leslie Kempthorne, Aaron Scrol, and Ashley Swearingen for data collection and data management. Mary Czerniak assisted with the manuscript preparation.	Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dawson DR, 2005, J HEAD TRAUMA REHAB, V20, P426, DOI 10.1097/00001199-200509000-00004; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; HEINEMANN AW, MEASURING P IN PRESS; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Magasi SR, 2008, J SPINAL CORD MED, V31, P145, DOI 10.1080/10790268.2008.11760705; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; TEASDALE G, 1974, LANCET, V2, P81; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091	33	15	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2010	25	5					339	348		10.1097/HTR.0b013e3181c7e60b			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	649JR	WOS:000281765400006	20042981				2022-02-06	
J	Antonucci, F; Cerri, C; Maya-Vetencourt, JF; Caleo, M				Antonucci, F.; Cerri, C.; Maya-Vetencourt, J. F.; Caleo, M.			ACUTE NEUROPROTECTION BY THE SYNAPTIC BLOCKER BOTULINUM NEUROTOXIN E IN A RAT MODEL OF FOCAL CEREBRAL ISCHAEMIA	NEUROSCIENCE			English	Article						stroke; synaptic transmission; glutamate release; hippocampus; SNAP-25	ENDOTHELIN-1 INDUCED LESIONS; INDUCED NEURONAL INJURY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; STROKE; GLUTAMATE; EPILEPSY; RELEASE; CORTEX; MICRODIALYSIS	Evidence indicates that accumulation of excitotoxic mediators, such as glutamate, contributes to neuronal damage after an ischaemic insult. It is not clear, however, whether this accumulation is due to excess synaptic release or to impaired uptake. To test a role for synaptic release, here we investigated the neuroprotective potential of the synaptic blocker botulinum neurotoxin E (BoNT/E), that prevents vesicle fusion via the cleavage of the SNARE (soluble NSF-attachment receptor) protein SNAP-25 (synaptosomal-associated protein of 25 kDa). Focal ischaemia was induced in vivo by infusing the potent vasoconstricting peptide endothelin-1 (ET-1) into the CA1 area of the hippocampus in adult rats; BoNT/E or vehicle were administered into the same site 20 min later. Injection of ET-1 was found to produce a transient and massive increase in glutamate release that was potently antagonized by BoNT/E. To assess whether blocking transmitter release translates into neuroprotection, the extent of the ischaemic damage was determined 24 h and 6 weeks after the insult. We found that BoNT/E administration consistently reduced the loss of CA1 pyramidal neurons at 24 h. The neuroprotective effect of BoNT/E, however, was no longer significant at 6 weeks. These data provide evidence that blockade of synaptic transmitter release delays neuronal cell death following focal brain ischaemia, and underline the importance of assessing long-term neuroprotection in experimental stroke studies. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Antonucci, F.; Caleo, M.] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Cerri, C.; Maya-Vetencourt, J. F.] Scuola Normale Super Pisa, I-56100 Pisa, Italy		Caleo, M (corresponding author), CNR, Ist Neurosci, Via G Moruzzi 1, I-56100 Pisa, Italy.	caleo@in.cnr.it	Maya-Vetencourt, Jose Fernando/Q-6539-2019; Maya-Vetencourt, JF/AAT-5130-2020	Maya-Vetencourt, Jose Fernando/0000-0003-3808-8944; Antonucci, Flavia/0000-0002-0198-4529; CALEO, MATTEO/0000-0002-4333-6378	International Institute for Research in Paraplegia (Zurich, Switzerland) [P94]; Regione ToscanaRegione Toscana; Italian Ministry of Education, University and ResearchMinistry of Education, Universities and Research (MIUR) [2008338WNL]	This work was supported by a grant (P94) from the International Institute for Research in Paraplegia (Zurich, Switzerland), by Regione Toscana and by the Italian Ministry of Education, University and Research (PRIN grant 2008338WNL and FIRB project "CHEM-Profarma-NET"). We thank V.H. Perry (Univ. Southampton) for help in setting up the ET-1 ischaemia model. We are indebted to Adriano Tacchi for histological work and to Dr. A. Viegi for help with the HPLC system. Nicola Carucci participated in some experiments. We thank to C. Montecucco and O. Rossetto (University of Padua. Italy) for providing antibodies against cleaved SNAP-25.	Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; ASHTON AC, 1988, J NEUROCHEM, V50, P1808, DOI 10.1111/j.1471-4159.1988.tb02482.x; Bartus RT, 1998, BRAIN RES, V790, P1, DOI 10.1016/S0006-8993(97)01414-5; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Berger C, 2002, STROKE, V33, P519, DOI 10.1161/hs0102.100878; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bogaert L, 2000, BRAIN RES, V887, P266, DOI 10.1016/S0006-8993(00)02959-0; Bozzi Y, 2006, NEUROTOX RES, V9, P197, DOI 10.1007/BF03033939; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Costantin L, 2005, J NEUROSCI, V25, P1943, DOI 10.1523/JNEUROSCI.4402-04.2005; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Fuxe K, 1997, NEUROREPORT, V8, P2623, DOI 10.1097/00001756-199707280-00040; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Gilmour G, 2004, BEHAV BRAIN RES, V150, P171, DOI 10.1016/j.bbr.2003.07.006; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hughes PM, 2003, J NEUROPATH EXP NEUR, V62, P1276, DOI 10.1093/jnen/62.12.1276; Larsson E, 2001, BRAIN RES, V913, P117, DOI 10.1016/S0006-8993(01)02762-7; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; LUSTIG HS, 1992, NEUROSCI LETT, V139, P15, DOI 10.1016/0304-3940(92)90847-Z; Mateffyova A, 2006, EUR J NEUROSCI, V24, P351, DOI 10.1111/j.1460-9568.2006.04910.x; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; MONYER H, 1992, NEURON, V8, P967, DOI 10.1016/0896-6273(92)90211-U; NIKOLOV R, 1993, EUR J PHARM-ENVIRON, V248, P205, DOI 10.1016/0926-6917(93)90044-Q; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; SCHIAVO G, 1995, METHOD ENZYMOL, V248, P643; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SHARKEY J, 1995, J NEUROSCI METH, V60, P125, DOI 10.1016/0165-0270(95)00003-D; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Shuaib A, 2008, EUR NEUROL, V59, P4, DOI 10.1159/000109254; UEKI A, 1993, EXP BRAIN RES, V96, P89, DOI 10.1007/BF00230442; VALTYSSON J, 1994, ACTA NEUROCHIR, V129, P58, DOI 10.1007/BF01400874; Van Hemelrijck A, 2003, J NEUROCHEM, V87, P66, DOI 10.1046/j.1471-4159.2003.01977.x; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Verderio C, 2007, TRAFFIC, V8, P142, DOI 10.1111/j.1600-0854.2006.00520.x; Vidwans AS, 2004, EXP NEUROL, V190, P91, DOI 10.1016/j.expneurol.2004.06.018; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	44	15	15	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	AUG 11	2010	169	1					395	401		10.1016/j.neuroscience.2010.04.059			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	621LB	WOS:000279579200039	20447449				2022-02-06	
J	Bourdeaux, C; Brown, J				Bourdeaux, Chris; Brown, Jules			Sodium Bicarbonate Lowers Intracranial Pressure After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Intracranial pressure; Osmotherapy; Sodium bicarbonate; Hypertonic solutions	LACTATED RINGERS SOLUTION; HYPERTONIC SALINE; BLOOD-FLOW; CHLORIDE; MANAGEMENT; ACIDOSIS; INFUSION; SURGERY	Hypertonic saline is routinely used to treat rises in intracranial pressure (ICP) post-traumatic head injury. Repeated doses often cause a hyperchloremic metabolic acidosis. We investigated the efficacy of 8.4% sodium bicarbonate as an alternative method of lowering ICP without generating a metabolic acidosis. We prospectively studied 10 episodes of unprovoked ICP rise in 7 patients treated with 85 ml of 8.4% sodium bicarbonate in place of our usual 100 ml 5% saline. We measured ICP and mean arterial pressure continuously for 6 h after infusion. Serum pH, pCO(2), [Na+], and [Cl-] were measured at baseline, 30 min, 60 min and then hourly for 6 h. At the completion of the infusion (t = 30 min), the mean ICP fell from 28.5 mmHg (+/- 2.62) to 10.33 mmHg (+/- 1.89), P < 0.01. Mean ICP remained below 20 mmHg at all time points for 6 h. Mean arterial pressure was unchanged leading to an increased cerebral perfusion pressure at all time points for 6 h post-infusion. pH was elevated from 7.45 +/- A 0.05 at baseline to 7.50 +/- A 0.05, P < 0.01 at t = 30 min, and remained elevated. Serum [Na+] increased from 145.4 +/- A 6.02 to 147.1 +/- A 6.3 mmol/l, P < 0.01 at t = 30 min. pCO(2) did not change. A single dose of 8.4% sodium bicarbonate is effective at treating rises in ICP for at least 6 h. Serum sodium was raised but without generation of a hyperchloremic metabolic acidosis.	[Bourdeaux, Chris; Brown, Jules] Frenchay Hosp, Dept Anaesthesia, Bristol BS16 1LE, Avon, England		Bourdeaux, C (corresponding author), Frenchay Hosp, Dept Anaesthesia, Frenchay Pk Rd, Bristol BS16 1LE, Avon, England.	chrisbourdeaux@gmail.com; Jules.brown@nbt.nhs.uk			Frenchay Hospital Intensive Care Unit	The authors would like to thank Dr Will English for his help preparing the protocol and all the nursing staff at Frenchay Hospital Intensive Care Unit for their help and support of this study.	Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Hansen PB, 1998, HYPERTENSION, V32, P1066, DOI 10.1161/01.HYP.32.6.1066; Nakashima K, 1996, ACTA NEUROL SCAND, V93, P96, DOI 10.1111/j.1600-0404.1996.tb00561.x; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; SCHIEVE JF, 1953, J CLIN INVEST, V32, P33, DOI 10.1172/JCI102707; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Waters JH, 1999, CRIT CARE MED, V27, P2142, DOI 10.1097/00003246-199910000-00011; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006; YOUNG RSK, 1984, ACTA NEUROPATHOL, V65, P124, DOI 10.1007/BF00690465	18	15	17	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2010	13	1					24	28		10.1007/s12028-010-9368-8			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	620NF	WOS:000279505900005	20422466				2022-02-06	
J	Cadosch, D; Thyer, M; Gautschi, OP; Lochnit, G; Frey, SP; Zellweger, R; Filgueira, L; Skirving, AP				Cadosch, Dieter; Thyer, Matthew; Gautschi, Oliver P.; Lochnit, Guenter; Frey, Soenke P.; Zellweger, Rene; Filgueira, Luis; Skirving, Allan P.			Functional and proteomic analysis of serum and cerebrospinal fluid derived from patients with traumatic brain injury: a pilot study	ANZ JOURNAL OF SURGERY			English	Article						cerebrospinal fluid; osteogenic effect; proteomic analysis; serum; traumatic brain injury	CALLUS FORMATION; HEAD; ELECTROPHORESIS; PROTEINS; S100B	Background: An enhanced fracture healing response has been reported in patients with traumatic brain injury (TBI). This has been attributed to circulating humoral factors that are thought to be proteins produced and released by the injured brain. However, these factors remain unknown. The aim of this study was to identify osteogenic factors in serum and cerebrospinal fluid (CSF) from TBI patients. This was carried out using in vitro proliferation assays with the human foetal osteoblastic 1.19 cell line (hFOB) combined with a novel proteomic approach. Methods: Serum was collected from brain-injured (n = 12) and non-brain-injured (n = 9) patients with a comorbid femur shaft fracture. Similarly, CSF was obtained from TBI (n = 7) and non-TBI (n = 9) patients. The osteoinductive potential of these samples was determined by measuring the in vitro proliferation rate of hFOB cells. Highly osteogenic serum and CSF samples of TBI patients were chosen for protein analysis and were compared to those of non-brain-injured patients. A new hFOB cell-based method was used to enrich the proteins in these samples, which had a functional affinity for these osteoprogenitor cells. These enriched protein fractions were mapped using two-dimensional gel electrophoresis and protein imaging methods displaying serum and CSF proteins of brain-injured and control subjects that had an affinity for human osteoprogenitor cells. Results: Serum and CSF derived from brain-injured patients demonstrated a greater osteoinductive potential (P < 0.05) than their non-brain-injured counterparts. Clear-cut differences in the pattern of proteins in two-dimensional gels were detected between TBI and control patients. Fourteen proteins were exclusively present in the serum of TBI patients, while other proteins were either up- or downregulated in samples collected from TBI patients (P < 0.05). Conclusion: Osteoinductive factors are present in the serum and CSF of brain-injured patients. These may include one or more of those proteins identified as having an affinity for osteoprogenitor cells that are either exclusively present or up- or downregulated in the serum and CSF of brain-injured patients.	[Cadosch, Dieter; Thyer, Matthew; Gautschi, Oliver P.; Frey, Soenke P.; Filgueira, Luis] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA 6009, Australia; [Cadosch, Dieter; Gautschi, Oliver P.; Frey, Soenke P.; Zellweger, Rene; Skirving, Allan P.] Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA, Australia; [Lochnit, Guenter] Inst Biochem, Giessen, Germany		Cadosch, D (corresponding author), Univ Western Australia, Sch Anat & Human Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	dcadosch@gmx.net	Filgueira, Luis/B-6492-2008	Filgueira, Luis/0000-0002-2266-6650			Banner LR, 1997, EXP NEUROL, V147, P1, DOI 10.1006/exnr.1997.6536; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brenner C., 2004, ONCOGENOMICS MOL APP; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CELIS JE, 1994, ELECTROPHORESIS, V15, P309, DOI 10.1002/elps.1150150153; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.0.CO;2-C; Denslow N, 2003, J NEUROTRAUM, V20, P401, DOI 10.1089/089771503765355487; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; LEMKE R, 1999, GLIA, V75, P1; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; RABILLOUD T, 1994, ELECTROPHORESIS, V15, P278, DOI 10.1002/elps.1150150147; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shehab D, 2002, J NUCL MED, V43, P346; THYER M, 2007, ANN SCI M AUSTR ORTH; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Whiteaker JR, 2007, J PROTEOME RES, V6, P828, DOI 10.1021/pr0604920	30	15	18	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JUL-AUG	2010	80	7-8					542	547		10.1111/j.1445-2197.2010.05268.x			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	635PN	WOS:000280668500017	20795970				2022-02-06	
J	Chieregato, A; Martino, C; Pransani, V; Nori, G; Russo, E; Noto, A; Simini, B				Chieregato, A.; Martino, C.; Pransani, V.; Nori, G.; Russo, E.; Noto, A.; Simini, B.			Classification of a traumatic brain injury: the Glasgow Coma scale is not enough	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							HEAD-INJURY; MODERATE	Background Classifying the severity of a traumatic brain injury (TBI) solely by means of the Glasgow Coma scale (GCS) is under scrutiny, because it overlooks other important clinical signs. Clinicians treating patients with acute TBI are well placed to suggest which variables, in addition to the GCS, should concur in a new classification of TBI. Methods In Italy, acute TBI patients are treated by anaesthetists, and so we asked them, in a questionnaire survey, to rate the weight they give to the GCS and to other clinical variables in their approach to TBI. Because sedation may underestimate GCS scores, we also inquired whether anaesthetists select sedatives that allow drug-free GCS scores. The questionnaire was distributed to 1334 anaesthetists attending courses on neurotrauma; the response rate was 63%. Results Two thirds of the respondents believe that the definition of severe TBI should include, in addition to GCS scores, pupil reactivity to light and computer tomogram (CT) findings, the variables that guide Italian anaesthetists in TBI management. Most respondents (68.2%) administer sedation which allows prompt neurological evaluation and reliable GCS scoring. A minority of respondents (9.3%) withhold or antagonize sedation, delay tracheal intubation or allow patient-ventilator asynchrony. Conclusions Italian anaesthetists would welcome a definition of TBI severity that includes CT findings and pupil reactivity in addition to the GCS.	[Chieregato, A.; Martino, C.; Pransani, V.; Nori, G.; Russo, E.] Osped Bufalini, UO Anestesia & Rianimaz, Cesena, Italy; [Noto, A.] Univ Messina, Osped G Martino, Unita Cardiovasc & Torac, Messina, Italy; [Simini, B.] Osped Gen Prov, UO Anestesia Rianimaz & Terapia Antalg, Lucca, Italy		Chieregato, A (corresponding author), Osped Gen Provinciale M Bufalini, UO Anestesia & Rianimaz, Viale Ghirotti 286, I-47023 Cesena, Italy.	achiere@ausl-cesena.emr.it	Noto, Alberto/G-6468-2012; Russo, Emanuele/AAP-5645-2020	Russo, Emanuele/0000-0002-6531-5527; Martino, Costanza/0000-0002-2691-0059; Noto, Alberto/0000-0002-1490-9317			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Burmeister LF, 2003, ANESTHESIOLOGY, V99, P1251; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1977, LANCET, V1, P878; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHAPIRO HM, 1975, ANESTHESIOLOGY, V43, P445, DOI 10.1097/00000542-197510000-00010; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569	18	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JUL	2010	54	6					696	702		10.1111/j.1399-6576.2010.02234.x			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	604QA	WOS:000278292400005	20397980				2022-02-06	
J	Fariniuk, LF; de Sousa, MH; Westphalen, VPD; Carneiro, E; Neto, UXS; Roskamp, L; Cavali, AE				Fariniuk, Luiz Fernando; de Sousa, Maria Helena; Dietzel Westphalen, Vania Portela; Carneiro, Everdan; Silva Neto, Ulisses X.; Roskamp, Liliane; Cavali, Ana Egide			Evaluation of care of dentoalveolar trauma	JOURNAL OF APPLIED ORAL SCIENCE			English	Article						Tooth injury; Dentoalveolar trauma; Examination; Prevalence	DENTAL INJURIES; UNIVERSITY; PROGNOSIS; CHILDREN; TEETH; AGE	Objectives: The aim of this study was to evaluate cases of dental trauma treated at the specialized center of Pontifical Catholic University of Parana, Curitiba, Brazil, during a period of 2 years. Material and methods: A total of 647 patients were evaluated and treated between 2003 and 2005. Data obtained from each patient were tabulated and analyzed as to gender, age, etiology, time elapsed after the injury, diagnosis (type of trauma), and affected teeth. Results: The results revealed that male individuals aged 7 to 13 years presented the highest prevalence of injury, and falling was the main causal factor. In most cases, the time elapsed between the accident and the first care ranged from 4 to 24 h. A total of 1,747 teeth were affected, with higher incidence of concussion/subluxation and coronal fracture, followed by lateral luxation and avulsion. The permanent maxillary central incisors were the most commonly affected teeth. Conclusion: The frequency and causes of dentoalveolar trauma should be investigated for identification of risk groups, treatment demands and costs in order to allow for the establishment of effective preventive measures that can reduce the treatment duration and costs for both patients and oral health services.	[Fariniuk, Luiz Fernando; de Sousa, Maria Helena; Dietzel Westphalen, Vania Portela; Carneiro, Everdan; Silva Neto, Ulisses X.; Cavali, Ana Egide] Pontif Catholic Univ Parana, Dept Dent, Curitiba, Parana, Brazil		Fariniuk, LF (corresponding author), Rua Imaculada Conceicao 1115, BR-80215000 Curitiba, Parana, Brazil.	fariniuk@uol.com.br	Westphalen, Vania Portela Ditzel/G-7318-2012; da Silva Neto, Ulisses Xavier/C-3170-2017; da Silva Neto, Ulisses Xavier/G-7484-2012; ROSKAMP, LILIANE/H-9282-2012; Carneiro, Everdan/B-5881-2013; Carneiro, Everdan/I-3924-2016; Fariniuk, Luiz F/C-1678-2014	Westphalen, Vania Portela Ditzel/0000-0003-2313-7117; da Silva Neto, Ulisses Xavier/0000-0002-9143-2671; ROSKAMP, LILIANE/0000-0002-2331-0090; Carneiro, Everdan/0000-0002-7883-5396; Fariniuk, Luiz F/0000-0003-0731-9893			Al-Jundi SH, 2004, DENT TRAUMATOL, V20, P1, DOI 10.1111/j.1600-4469.2004.00218.x; Andreasen J O, 1970, Scand J Dent Res, V78, P329; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; ANDREASEN JO, 1990, ENDOD DENT TRAUMATOL, V6, P78; De Rossi Moara, 2009, Braz. Dent. J., V20, P259, DOI 10.1590/S0103-64402009000300016; Garcia-Ballesta C, 2003, RCOE, V8, P131; Grimm S, 2004, DENT TRAUMATOL, V20, P134, DOI 10.1111/j.1600-4469.2004.00238.x; Haavikko K, 1976, Proc Finn Dent Soc, V72, P152; Jackson NG, 2006, DENT TRAUMATOL, V22, P179, DOI 10.1111/j.1600-9657.2006.00369.x; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-9657.2003.00203.x; Panzarini Sônia Regina, 2008, Braz. oral res., V22, P229; Rocha MJD, 2001, DENT TRAUMATOL, V17, P245; RODRIGUEZ JG, 2004, ACTA ODONTOL VENEZ, V42, P209; Roskamp L, 2009, J PERIODONTOL, V80, P1121, DOI 10.1902/jop.2009.090019; Sakai Vivien Thiemy, 2005, J. Appl. Oral Sci., V13, P340, DOI 10.1590/S1678-77572005000400005; Sandalli N, 2005, DENT TRAUMATOL, V21, P188, DOI 10.1111/j.1600-9657.2005.00309.x; Scariot R, 2009, J APPL ORAL SCI, V17, P195, DOI 10.1590/S1678-77572009000300012; SHINYA K, 1993, ANN PLAS SURG, V30, P417, DOI 10.1097/00000637-199305000-00005; Silva AC, 2004, DENT TRAUMATOL, V20, P6	19	15	17	0	7	UNIV SAO PAULO FAC ODONTOLOGIA BAURU	BAURU-SP	AL DR OCTAVIO PINHEIRO BRISOLLA, 9-75, BAURU-SP, 17012-901, BRAZIL	1678-7757			J APPL ORAL SCI	J. Appl. Oral Sci.	JUL-AUG	2010	18	4					343	345		10.1590/S1678-77572010000400004			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	648KK	WOS:000281692300004	20835567	Green Published, gold, Green Submitted			2022-02-06	
J	Schaller, B; Evangelopoulos, DS; Muller, C; Martinolli, L; Pouljadoff, MP; Zimmermann, H; Exadaktylos, AK				Schaller, Benoit; Evangelopoulos, Dimitrios Stergios; Mueller, Christian; Martinolli, Luca; Pouljadoff, Marie Pierre; Zimmermann, Heinz; Exadaktylos, Aristomenis K.			Do we really need 24-h observation for patients with minimal brain injury and small intracranial bleeding? The Bernese Trauma Unit Protocol	EMERGENCY MEDICINE JOURNAL			English	Article							MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; PROPOSAL	Background Traumatic brain injury is one of the most common reasons for admission to hospital emergency departments. However, optimal diagnosis and treatment protocols remain controversial. The aim of this study is to assess whether a specific group of patients can be discharged from the hospital without 24-h neurological observation. Methods Retrospective analysis was performed for 1078 patients with a minor isolated head injury admitted to the authors' Emergency Department for 24-h observation. Exclusion criteria included intracranial bleeds with maximum diameter above 5 mm or multiple (>1) bleeds, a history of inherited coagulopathy or anticoagulant therapy, platelet aggregation inhibitor therapy, intoxication or multiple associated injuries. Furthermore, patients who had no-one to observe them at home or who lived more than 1 h away were excluded from the study. Results 110 patients presented with an isolated small intracranial bleed (<5 mm) with a Glasgow Coma Scale (GCS) of 13-15. Of these patients, 46% exhibited small intracerebral haematomas, 23% traumatic subarachnoid haematomas, 9% epidural haematomas and 7% subdural haematomas. Nine patients presented with a GCS of 13/15, 30 patients with a GCS 14/15 and 71 patients with a GCS 15/15. 85% of all patients regained GCS 15/15 within 1 h after admission and 15% within 2 h after admission. All patients maintained their GCS 15/15 over the 24-h period. Conclusions Standard 24-h observation may not be required for adult patients with single intracranial bleeds with maximum diameter less than 5 mm, without a history of inherited coagulopathy or anticoagulant therapy, platelet aggregation inhibitor therapy, intoxication or multiple associated injuries. The decision for discharging patients may be made from the clinical picture. This might help to spare hospital resources and reduce unnecessary hospitalisations.	[Schaller, Benoit; Evangelopoulos, Dimitrios Stergios; Mueller, Christian; Martinolli, Luca; Pouljadoff, Marie Pierre; Zimmermann, Heinz; Exadaktylos, Aristomenis K.] Inselspital Bern, Dept Emergency Med, CH-3010 Bern, Switzerland		Evangelopoulos, DS (corresponding author), Inselspital Bern, Dept Orthopaed, CH-3010 Bern, Switzerland.	ds.evangelopoulos@gmail.com		Schaller, Benoit/0000-0002-6861-2340			Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Fabbri A, 2004, EUR J EMERG MED, V11, P65, DOI 10.1097/00063110-200404000-00002; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; WALLING AD, IS CT SCANNING INDIC	13	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL	2010	27	7					537	539		10.1136/emj.2009.073031			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	616UK	WOS:000279235500015	20360489				2022-02-06	
J	Vincent, AL; Kelly, P				Vincent, Andrea L.; Kelly, Patrick			Retinal haemorrhages in inflicted traumatic brain injury: the ophthalmologist in court	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						child abuse; medicolegal; retinal haemorrhage; shaken baby syndrome; traumatic brain injury	SHAKEN BABY SYNDROME; HEAD-INJURIES; COHERENCE TOMOGRAPHY; YOUNG-CHILDREN; INFANTS; FOLDS; RETINOPATHY; PREVALENCE; MECHANISMS; OUTCOMES	P>Child abuse is a significant social and public health problem in many societies. One particular form of physical abuse is inflicted traumatic brain injury (ITBI) - the so-called 'Shaken Baby Syndrome'. One of the key features associated with ITBI is characteristic ocular findings - only observed on fundal examination. It is crucial not to miss the diagnosis of ITBI as there may be implications for the safety of the child. The ophthalmologist is one key contributor to the process required to make the diagnosis of ITBI accurately and on the basis of all the relevant evidence. This article discusses some medicolegal implications of examining a child with retinal haemorrhages in the context of suspected ITBI, with practical advice for the ophthalmologist to be as objective and prepared as possible. The scientific validity of some alternative explanations advanced in court is discussed, with a strong emphasis on the literature.	[Vincent, Andrea L.] Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Natl Eye Ctr, Auckland 1142, New Zealand; [Vincent, Andrea L.] Univ Auckland, Eye Dept, Greenlane Clin Ctr, Auckland 1142, New Zealand; [Kelly, Patrick] Univ Auckland, Dept Paediat, Fac Med & Hlth Sci, Auckland 1142, New Zealand; [Kelly, Patrick] Auckland Dist Hlth Board, Starship Childrens Hosp, Te Puaruruhau Child Abuse Assessment Unit, Auckland, New Zealand		Vincent, AL (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Natl Eye Ctr, Private Bag 92019, Auckland 1142, New Zealand.	a.vincent@auckland.ac.nz	Vincent, Andrea L/A-5389-2013	Vincent, Andrea L/0000-0002-4185-3267; Kelly, Patrick/0000-0002-8813-8877			Arlotti SA, 2007, J AAPOS, V11, P175, DOI 10.1016/j.jaapos.2006.09.023; Aryan HE, 2005, J CLIN NEUROSCI, V12, P624, DOI 10.1016/j.jocn.2005.05.005; Baker ML, 2008, J CLIN NEUROSCI, V15, P313, DOI 10.1016/j.jocn.2006.09.011; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; BUYS YM, 1992, OPHTHALMOLOGY, V99, P1718; Carraro MC, 2001, EUR J HAEMATOL, V67, P238, DOI 10.1034/j.1600-0609.2001.00539.x; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; COATES J, 2004, N Z MED J, V117, P792; Curcoy AI, 2009, ARCH DIS CHILD, V94, P873, DOI 10.1136/adc.2007.132522; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duhaime AC, 2008, J NEUROSURG-PEDIATR, V2, P320, DOI 10.3171/PED.2008.2.11.320; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Gago LC, 2003, RETINA-J RET VIT DIS, V23, P724, DOI 10.1097/00006982-200310000-00027; Gardner HB, 2007, PEDIATR NEUROSURG, V43, P433, DOI 10.1159/000106399; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; GILLILAND MGF, 1993, AM J FOREN MED PATH, V14, P187, DOI 10.1097/00000433-199309000-00003; Glick JC, 2007, PEDIATR NEUROSURG, V43, P436, DOI 10.1159/000106400; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; Hans SA, 2009, GRAEF ARCH CLIN EXP, V247, P561, DOI 10.1007/s00417-008-0994-1; Herr S, 2004, PEDIATRICS, V113, P1658, DOI 10.1542/peds.113.6.1658; Hughes LA, 2006, J AAPOS, V10, P102, DOI 10.1016/j.jaapos.2005.12.005; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KAUR B, 1992, SURV OPHTHALMOL, V37, P1, DOI 10.1016/0039-6257(92)90002-B; KELLY P, 2004, N Z MED J, V117, P1; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kivlin JD, 2001, CURR OPIN OPHTHALMOL, V12, P158, DOI 10.1097/00055735-200106000-00002; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Leestma, 2006, J AM PHYS SURG, V11, P14; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; LEVIN AV, 2000, RECENT ADV PAEDIAT, V18, P151; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; MASSICOTTE SJ, 1991, OPHTHALMOLOGY, V98, P1124; Meier P, 2005, GRAEF ARCH CLIN EXP, V243, P824, DOI 10.1007/s00417-005-1213-y; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Parr J., 1989, INTRO OPHTHALMOLOGY; Pierce MC, 2008, ANNU REV BIOMED ENG, V10, P85, DOI 10.1146/annurev.bioeng.9.060906.151907; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Rangarajan N, 2009, J AAPOS, V13, P364, DOI 10.1016/j.jaapos.2008.11.006; *RANZCR, 2005, GUID EXP WITN; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reece RM, 2008, AM J PREV MED, V34, pS116, DOI 10.1016/j.amepre.2007.11.005; Sandramouli S, 1997, ARCH DIS CHILD, V76, P449, DOI 10.1136/adc.76.5.449; Schloff S, 2002, OPHTHALMOLOGY, V109, P1472, DOI 10.1016/S0161-6420(02)01086-2; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; Spivack B, 2001, AM J FOREN MED PATH, V22, P332, DOI 10.1097/00000433-200109000-00028; Spraul CW, 1997, SURV OPHTHALMOL, V42, P3, DOI 10.1016/S0039-6257(97)84041-6; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Sturm V, 2008, AM J OPHTHALMOL, V146, P363, DOI 10.1016/j.ajo.2008.04.023; Sturm V, 2009, AM J OPHTHALMOL, V147, P561, DOI 10.1016/j.ajo.2008.11.013; Superstein R, 2000, CAN J OPHTHALMOL, V35, P385, DOI 10.1016/S0008-4182(00)80126-X; Tyagi AK, 1998, BRIT J OPHTHALMOL, V82, P659, DOI 10.1136/bjo.82.6.659; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2009, CHILD NERV SYST, V25, P639, DOI 10.1007/s00381-008-0775-5; Watts P, 2008, EYE, V22, P1514, DOI 10.1038/eye.2008.224; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037	75	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1442-6404	1442-9071		CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	JUL	2010	38	5					521	532		10.1111/j.1442-9071.2010.02324.x			12	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	622HA	WOS:000279650800016	20491801	Bronze			2022-02-06	
J	Dhandapani, SS; Manju, D; Vivekanandhan, S; Agarwal, M; Mahapatra, AK				Dhandapani, S. S.; Manju, D.; Vivekanandhan, S.; Agarwal, M.; Mahapatra, A. K.			Prospective longitudinal study of biochemical changes in critically ill patients with severe traumatic brain injury: Factors associated and outcome at 6 months	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						biochemical changes; factors; outcome; traumatic brain injury		Biochemical prognostic markers of severe traumatic brain injury have not been clearly identified. This study was conducted to study biochemical changes in patients with severe traumatic brain injury, with respect to neurological outcome. Adult patients admitted within 24 hours of traumatic brain injury with Glasgow Coma Score 4-8, were prospectively studied for changes in various biochemical parameters. Outcome was assessed at 6 months. The mean serum albumin levels showed progressive fall till 2 weeks from 3.23 g/dL to nadir value of 2.86 g/dL, followed by mild increase to 2.99 g/dL at 3 weeks (p<0.001). The mean daily urine creatinine values demonstrated significant fall from 1255.4 mg/d to 1010.2 mg/d at 3 weeks (p<0.001). There was significant increase in mortality at 2 months among patients with atleast 15% fall in serum albumin and urine creatinine less than 1000 mg/d at 3 weeks (p < 0.005). Unfavorable outcome was noted in 12 out of 15, with at least 15% fall in serum albumin at 3 weeks, compared to 11 out of 25, with less than 15% fall in serum albumin (p=0.03). Unfavorable outcome was also noted in 16 out of 22, with low urine creatinine (< 1000 mg/d) at 3 weeks, compared to 6 out of 17, with normal urine creatinine (p=0.02). In patients with severe TBI, unfavorable neurological outcome at 6 months was associated with 15% fall of serum albumin or low urinary creatinine at 3 weeks, more so with the former.	[Dhandapani, S. S.; Mahapatra, A. K.] All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India; [Manju, D.; Agarwal, M.] All India Inst Med Sci, Dept Neuronursing, New Delhi, India; [Vivekanandhan, S.] All India Inst Med Sci, Dept Neurobiochem, New Delhi, India		Dhandapani, SS (corresponding author), All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India.	ssdhandu@rediffmail.com	Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255; Dhandapani, Manju/0000-0003-3351-3841			Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; BOOSALIS MG, 1989, CRIT CARE MED, V17, P741, DOI 10.1097/00003246-198908000-00004; BRADLEY JA, 1981, INTENS CARE MED, V7, P291, DOI 10.1007/BF01709724; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; DEVILLOTA ED, 1980, INTENS CARE MED, V7, P19, DOI 10.1007/BF01692917; FLECK A, 1985, LANCET, V1, P781; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Henry JB, 2001, CLIN DIAGNOSIS MANAG, P249; JENNETT B, 1975, LANCET, V1, P480; Johnson AM, 1999, TIETZ BOOK CLIN CHEM, P507; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1988, J NEUROSURG, V69, P386, DOI 10.3171/jns.1988.69.3.0386; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; REINHARDT GF, 1980, JPEN-PARENTER ENTER, V4, P357, DOI 10.1177/0148607180004004357; Shine M., 1994, MODERN NUTR HLTH DIS, P812; Veldee MS, 1999, TIETZ TXB CLIN CHEM, P1359; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	20	15	15	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2010	7	1					23	27		10.1016/S0973-0508(10)80007-3			5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M1N	WOS:000218381400006					2022-02-06	
J	Edvardsson, B; Persson, S				Edvardsson, Bengt; Persson, Staffan			Reversible cerebral vasoconstriction syndrome associated with autonomic dysreflexia	JOURNAL OF HEADACHE AND PAIN			English	Article						Reversible cerebral vasoconstriction syndrome; Autonomic dysreflexia; Cerebral infarct; Thunderclap headache; Hypertension; Reversible posterior leukoencephalopathy syndrome	THUNDERCLAP HEADACHE; POSTERIOR LEUKOENCEPHALOPATHY; ANGIOPATHY; PATIENT	A 32-year-old man with a residual spastic quadriparesis from a traumatic C5-C6 fracture experienced a severe thunderclap headache. The medical history revealed an episode of autonomic dysreflexia (AD) due to neurogenic bladder/urinary tract infection (UTI). Blood pressure monitoring at admission revealed hypertension; blood pressure reaching 160/100 mmHg (average blood pressure in these patients and also in this patient being 90/60 mmHg). CT scan of the head, cerebrospinal fluid examination, CT angiography and MR angiography of the brain vessels were normal. Another UTI and a subsequent spell of AD were diagnosed. The patient continued to experience recurrent thunderclap headaches. Selective catheter cerebral angiography revealed multiple calibre changes in the intracranial blood vessels. A diagnosis of reversible cerebral vasoconstriction syndrome (RCVS) due to AD was considered. A magnetic resonance imaging (MRI) of the brain after 2 weeks revealed ischaemic changes in the left hemisphere. Follow-up brain MRI after 3 weeks showed reduction in size of the ischaemic changes, and catheter angiography after 6 weeks demonstrated improvement/normalization. A diagnosis of RCVS could be established. Repeated MRI/CT of the brain after 6 months demonstrated a large infarction in the left hemisphere. RCVS has been reported to occur in various clinical settings. It can occur in the setting of AD in patients with traumatic cervical cord injury. Prompt recognition of RCVS may be of vital importance to avoid further morbidity in patients with spinal cord injury.	[Edvardsson, Bengt; Persson, Staffan] Univ Lund Hosp, Fac Neurol, Dept Neurol, S-22185 Lund, Sweden		Edvardsson, B (corresponding author), Univ Lund Hosp, Fac Neurol, Dept Neurol, S-22185 Lund, Sweden.	Bengt.Edvardsson@med.lu.se					Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; CALL GK, 1988, STROKE, V19, P1159, DOI 10.1161/01.STR.19.9.1159; Chaves CJ, 2008, SPINAL CORD, V46, P760, DOI 10.1038/sc.2008.38; Chen SP, 2006, NEUROLOGY, V67, P2164, DOI 10.1212/01.wnl.0000249115.63436.6d; Chen SP, 2008, ANN NEUROL, V63, P751, DOI 10.1002/ana.21384; Chen SP, 2006, CEPHALALGIA, V26, P530, DOI 10.1111/j.1468-2982.2005.01063.x; Dodick DW, 2002, J NEUROL NEUROSUR PS, V72, P6, DOI 10.1136/jnnp.72.1.6; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Ducros Anne, 2009, Pract Neurol, V9, P256, DOI 10.1136/jnnp.2009.187856; Elstner M, 2009, CEPHALALGIA, V29, P677, DOI 10.1111/j.1468-2982.2008.01768.x; Gerretsen P, 2007, CAN J NEUROL SCI, V34, P467, DOI 10.1017/S0317167100007381; Gerretsen P, 2009, CURR NEUROL NEUROSCI, V9, P108, DOI 10.1007/s11910-009-0018-5; Koopman K, 2008, J HEADACHE PAIN, V9, P389, DOI 10.1007/s10194-008-0068-0; McClain WA, 1999, AM J EMERG MED, V17, P238, DOI 10.1016/S0735-6757(99)90113-4; Schwedt TJ, 2006, LANCET NEUROL, V5, P621, DOI 10.1016/S1474-4422(06)70497-5; Singhal AB, 2004, ARCH NEUROL-CHICAGO, V61, P411, DOI 10.1001/archneur.61.3.411; Valles M, 2005, SPINAL CORD, V43, P738, DOI 10.1038/sj.sc.3101780; Warlow C., 2008, STROKE PRACTICAL MAN, V3rd; YARKONY GM, 1986, ARCH PHYS MED REHAB, V67, P834	19	15	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1129-2369			J HEADACHE PAIN	J. Headache Pain	JUN	2010	11	3					277	280		10.1007/s10194-010-0196-1			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	593JO	WOS:000277450200013	20186562	Green Published, hybrid			2022-02-06	
J	Hoh, DJ; Liu, CY; Wang, MY				Hoh, Daniel J.; Liu, Charles Y.; Wang, Michael Y.			A radiographic computed tomography-based study to determine the ideal entry point, trajectory, and length for safe fixation using C-2 pars interarticularis screws Clinical article	JOURNAL OF NEUROSURGERY-SPINE			English	Article						axis; C-2; pars interarticularis; instrumentation; vertebral artery; transverse foramen	ATLANTOAXIAL TRANSARTICULAR SCREW; TRAUMATIC BRAIN-INJURY; VERTEBRAL ARTERY INJURY; ANATOMICAL EVALUATION; PEDICLE; C2; AXIS; COMPLEX; STABILIZATION; ARTHRODESIS	Object. Effective methods for fixation of the axis include C1-2 transarticular and C-2 pedicle screw placement. Both techniques pose a risk of vertebral artery (VA) injury in patients with narrow pedicles or an enlarged, high-riding VA. Pars screws at C-2 avoid the pedicle, but can cause VA injury with excessively long screws. Therefore, the authors evaluated various entry points and trajectories to determine ideal pars screw lengths that avoid breaching the transverse foramen. Methods. Both pars were studied on 50 CT scans (100 total). Various pars lengths were assessed using 2 entry points and 3 trajectories (6 measurements). Entry point A was the superior one-fourth of the lateral mass. Entry point B was 3-mm rostral to the inferior aspect of the lateral mass. Using entry points A and B, Trajectory 1 was the minimum distance to the transverse foramen; Trajectory 2 was the maximum distance to the transverse foramen; and Trajectory 3 was the steepest angle to the pars/C-2 superior facet junction without transverse foramen breach. Results. The mean patient age was 46 17 years, and 84% of the CT scans reviewed were obtained in men. There was no significant difference in right or left measurements. Entry point B demonstrated greater pars lengths for each trajectory compared with entry point A (p < 0.0001). For both entry points, Trajectory 3 provided the greatest pars length. Using Trajectory 3 with entry point B, 84, 95, and 99% had a pars length that measured 18, 16, and 14 mm, respectively. Using Trajectory 3 with Entry point A, only 41, 64, and 87% had a pars length that measured 18, 16, and 14 mm, respectively. Conclusions. Using an entry point 3-mm rostral to the inferior edge of the lateral mass and a trajectory directed toward the superior facet/pars junction, 99% of partes interarticularis in this study would tolerate a 14-mm screw without breach of the transverse foramen. (DOI: 10.3171/2009.12.SPINE09543)	[Hoh, Daniel J.; Liu, Charles Y.] Univ So Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90033 USA; [Wang, Michael Y.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Coral Gables, FL 33124 USA		Hoh, DJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurol Surg, 1200 N State St,Suite 5046, Los Angeles, CA 90033 USA.	dhoh@usc.edu					AbouMadawi A, 1997, J BONE JOINT SURG BR, V79B, P820; Aryan HE, 2008, J NEUROSURG-SPINE, V8, P222, DOI 10.3171/SPI/2008/8/3/222; Benzel EC, 1996, SPINE, V21, P2301, DOI 10.1097/00007632-199610010-00028; Cacciola F, 2004, NEUROL INDIA, V52, P178; Chen JF, 2005, J NEUROSURG-SPINE, V2, P386, DOI 10.3171/spi.2005.2.3.0386; Dickman CA, 1998, NEUROSURGERY, V43, P275, DOI 10.1097/00006123-199808000-00056; Ebraheim N, 1996, SPINE, V21, P691, DOI 10.1097/00007632-199603150-00005; Ebraheim NA, 1998, J SPINAL DISORD, V11, P521; Ebraheim NA, 2001, SPINE, V26, P34; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; GEORGE B, 1987, VERTEBRAL ARTERY PAT, P6; Gluf WM, 2005, J NEUROSURG-SPINE, V2, P155, DOI 10.3171/spi.2005.2.2.0155; Goel A, 2002, NEUROSURGERY, V51, P1351, DOI 10.1097/00006123-200212000-00004; GROB D, 1992, SPINE, V17, P480, DOI 10.1097/00007632-199205000-00003; Haid RW, 2001, NEUROSURGERY, V49, P65, DOI 10.1097/00006123-200107000-00010; Haid RW, 2001, NEUROSURGERY, V49, P71, DOI 10.1097/00006123-200107000-00011; Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014; Hedequist D, 2009, J PEDIATR ORTHOPED, V29, P21, DOI 10.1097/BPO.0b013e3181924367; Henriques T, 2000, SPINE, V25, P2877, DOI 10.1097/00007632-200011150-00007; Hott JS, 2005, J NEUROSURG-SPINE, V2, P175, DOI 10.3171/spi.2005.2.2.0175; Kazan S, 2000, CLIN ANAT, V13, P237, DOI 10.1002/1098-2353(2000)13:4<237::AID-CA2>3.0.CO;2-K; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Liu MF, 2005, AM J TRANSPLANT, V5, P434; Madawi AA, 1997, J NEUROSURG, V86, P961, DOI 10.3171/jns.1997.86.6.0961; Magerl F, 1987, CERVICAL SPINE, P322; Mandel IM, 2000, SPINE, V25, P1542, DOI 10.1097/00007632-200006150-00014; Menendez JA, 2007, NEUROSURGERY, V60, P103, DOI 10.1227/01.NEU.0000249220.50085.E4; Mitchell TC, 1999, J ORTHOP TRAUMA, V13, P483, DOI 10.1097/00005131-199909000-00004; Mummaneni PV, 2005, NEUROL INDIA, V53, P408, DOI 10.4103/0028-3886.22606; Naderi S, 2004, J NEUROSURG-SPINE, V1, P306, DOI 10.3171/spi.2004.1.3.0306; Neo M, 2003, SPINE, V28, P666, DOI 10.1097/00007632-200304010-00009; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Ondra SL, 2006, SPINE, V31, pE263, DOI 10.1097/01.brs.0000214882.34674.be; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Paramore CG, 1996, J NEUROSURG, V85, P221, DOI 10.3171/jns.1996.85.2.0221; Resnick DK, 2002, SPINE, V27, P1494, DOI 10.1097/00007632-200207150-00003; STARNES MJ, 2008, J EMERG MED; Wright NM, 1998, J NEUROSURG, V88, P634, DOI 10.3171/jns.1998.88.4.0634; XU RM, 1995, SPINE, V20, P259, DOI 10.1097/00007632-199502000-00001; Yoshida M, 2006, SPINE, V31, pE513, DOI 10.1097/01.brs.0000224516.29747.52	41	15	15	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654			J NEUROSURG-SPINE	J. Neurosurg.-Spine	JUN	2010	12	6					602	612		10.3171/2009.12.SPINE09543			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	600YG	WOS:000278024300003	20515344				2022-02-06	
J	Honeybul, S; Ho, KM; Lind, CRP; Gillett, GR				Honeybul, Stephen; Ho, Kwok M.; Lind, Christopher R. P.; Gillett, Grant R.			Decompressive craniectomy for neurotrauma: the limitations of applying an outcome prediction model	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Complications; Outcome; Neurotrauma	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; COMPLICATIONS; VALIDATION; MANAGEMENT	There is currently much interest in the use of decompressive craniectomy for patients with severe head injury. A number of studies have demonstrated that not only can the technique lower intracranial pressure but can also improve outcome. Whilst many patients who would otherwise have died or had a poor outcome now go on to make a good recovery, there is little doubt that complications can have a very significant impact on long term outcome. By using the corticosteroid randomisation after significant head injury (CRASH) collaborators outcome prediction model, three patients were selected who had a similar outcome prediction. All three patients developed intracranial hypertension following trauma and had a decompressive craniectomy. Despite having a similar outcome prediction only one patient made an uneventful recovery. The remaining two patients suffered significant complications. This report illustrates the potential clinical applications and limitations of an outcome prediction model and demonstrates the impact that complications can have on eventual outcome.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher R. P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Lind, Christopher/K-3629-2012; Ho, Kwok M./E-3546-2010	Lind, Christopher/0000-0001-9991-1725; Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GILLETT GR, 2001, NZ MED J, V1130, P188; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; HONEYBUL S, 2009, J CLIN NEUR IN PRESS; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tokoro K, 1989, Neurol Med Chir (Tokyo), V29, P196, DOI 10.2176/nmc.29.196; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	30	15	17	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2010	152	6					959	964		10.1007/s00701-010-0626-5			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	597TA	WOS:000277783300005	20349359				2022-02-06	
J	Weddell, RA				Weddell, Rodger A.			Relatives' Criticism Influences Adjustment and Outcome After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anger; Brain injuries; Depression; Expressed emotion; Family; Rehabilitation	EMOTIONAL OVER-INVOLVEMENT; EXPRESSED EMOTION; HEAD-INJURY; SCHIZOPHRENIC-PATIENTS; 1ST-EPISODE PSYCHOSIS; FAMILY INTERVENTION; SELF-AWARENESS; DEPRESSION; PREDICTORS; DISTRESS	Objectives: To apply some of the methods developed to study the effects of relatives' expressed emotion (EE) on psychiatric relapse rates and to test the prediction that relatives' criticism and psychiatric distress would be associated with outcome and emotional distress after traumatic brain injury (TBI). Design: Retrospective cohort design with correlational analyses of quantitative and qualitative measures of TBI outcomes. Setting: The author interviewed participants in the hospital. The research assistant interviewed close relatives at home. Participants: Participants and relatives (N=78) were interviewed 34.3 +/- 15.2 months (mean +/- SD) after a severe TBI. Interventions: None. Main Outcome Measures: Dependent variables in a series of hierarchical linear regression models were participants' scores on the Zung Depression Scale, Spielberger Trait Anxiety Inventory, State-Trait Anger Expression Inventory, an Anger Towards Relative questionnaire constructed for this study, and Extended Glasgow Outcome Scores. Participant-independent variables were social class, posttraumatic amnesia, Wechsler Memory Scale Delayed Recall score, WAIS-R intelligence quotient, and a short version of the Smell Identification Test. Relative independent variables were the number of critical comments directed toward participants in the interview and psychiatric distress as measured by the General Health Questionnaire. Results: The contributions of variance associated with relative independent variables (predominantly criticism) were significant in stage 2 of most hierarchical regression analyses after the adjustments for variance associated with participant independent variables made in stage I. Conclusions: Future application of EE research methods is warranted. If the present results are replicated, then evidence-based family interventions developed by EE researchers to reduce criticism might also improve TBI outcomes.	[Weddell, Rodger A.] ABM Univ Hlth Board, Neuropsychol Dept, Morriston Hosp, Swansea, W Glam, Wales; [Weddell, Rodger A.] Univ Coll Swansea, Dept Psychol, Swansea, W Glam, Wales		Weddell, RA (corresponding author), ABM Univ Hlth Board, Neuropsychol Dept, Morriston Hosp, Swansea, W Glam, Wales.	r.wedd@yahoo.co.uk			Headway (Swansea)	Supported in part by Headway (Swansea).	Alvarez-Jimenez M, 2010, PSYCHOL MED, V40, P63, DOI 10.1017/S0033291708004765; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Bentsen H, 1996, BRIT J PSYCHIAT, V169, P622, DOI 10.1192/bjp.169.5.622; Boye B, 2001, ACTA PSYCHIAT SCAND, V104, P42, DOI 10.1034/j.1600-0447.2001.00190.x; Breitborde NJK, 2009, SOC PSYCH PSYCH EPID, V44, P716, DOI 10.1007/s00127-008-0492-0; BRESSI C, 1996, NEW TREND EXPER CLIN, V12, P135; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; EVANS RL, 1987, ARCH PHYS MED REHAB, V68, P508; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grice SJ, 2009, BEHAV RES THER, V47, P783, DOI 10.1016/j.brat.2009.06.004; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; IVISON DJ, 1977, AUST PSYCHOL, V12, P303, DOI 10.1080/00050067708254291; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEFF J, 1994, BRIT J PSYCHIAT, V164, P71, DOI 10.1192/S0007125000292775; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Martin JH., 2003, NEUROANATOMY TEXT AT; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MELAMED S, 1985, SCAND J REHABIL MED, P21; Mittelman MS, 2004, J GERONTOL B-PSYCHOL, V59, pP27, DOI 10.1093/geronb/59.1.P27; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Muntaner C, 2004, EPIDEMIOL REV, V26, P53, DOI 10.1093/epirev/mxh001; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; *OPCS, 1980, OPCS CLASS OCC 1980; Peterson EC, 2004, PSYCHIATRY, V67, P197, DOI 10.1521/psyc.67.2.197.35959; Pilling S, 2002, PSYCHOL MED, V32, P763, DOI 10.1017/S0033291702005895; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Raune D, 2004, BRIT J PSYCHIAT, V184, P321, DOI 10.1192/bjp.184.4.321; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Scazufca M, 1998, PSYCHOL MED, V28, P453, DOI 10.1017/S0033291797005977; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shimodera S, 2000, COMPR PSYCHIAT, V41, P392, DOI 10.1053/comp.2000.9019; Smejkal V, 2003, Bratisl Lek Listy, V104, P184; Spielberger CD., 1988, STATE TRAIT ANGER EX; Spielberger CD., 1983, STATE TRAIT ANXIETY; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; VAUGHN C, 1976, BRIT J SOC CLIN PSYC, V15, P157, DOI 10.1111/j.2044-8260.1976.tb00021.x; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; WEDDELL RA, 1987, SCAND J REHABIL MED, V19, P93; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZATORRE RJ, 1991, BRAIN, V114, P71; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	69	15	15	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2010	91	6					897	904		10.1016/j.apmr.2010.01.020			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	610SM	WOS:000278755800011	20510981				2022-02-06	
J	Davis, AR; Shear, DA; Chen, ZY; Lu, XCM; Tortella, FC				Davis, Angela R.; Shear, Deborah A.; Chen, Zhiyong; Lu, Xi-Chun M.; Tortella, Frank C.			A comparison of two cognitive test paradigms in a penetrating brain injury model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Penetrating brain injury; Morris water maze; Novel object recognition	ONE-TRIAL TEST; MEMORY; RATS; RECOGNITION; MOTOR	A rat model of penetrating ballistic-like brain injury (PBBI) was recently established to study military-relevant severe traumatic brain injury (TBI). The purpose of this study was to conduct a side-by-side evaluation of two well-established cognitive testing paradigms: the novel object recognition (NOR) task and the Morris water maze (MWM) task. Accordingly, male Sprague-Dawley rats were subjected to PBBI and their cognitive abilities were assessed at 7 and 21 days post-PBBI. Although PBBI animals had more difficulty completing both tasks compared to sham animals, their performance on the NOR task was confounded by a high degree of within-group variability that was likely due to attention deficits produced by the injury. In contrast, PBBI produced consistent, significant spatial learning deficits in the MWM task. Overall, these results suggest that the MWM task provides a more appropriate cognitive test for the PBBI model that would be useful for testing promising neuroprotective therapeutics. Published by Elsevier B.V.	[Davis, Angela R.; Shear, Deborah A.; Chen, Zhiyong; Lu, Xi-Chun M.; Tortella, Frank C.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Davis, Angela R.] Geneva Fdn, Lakewood, WA 98499 USA		Shear, DA (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Angela.R.Davis@amedd.army.mil; Deborah.Shear@amedd.army.mil; Zhiyong.Chen@us.army.mil; May.Lu@us.army.mil; Frank.C.Tortella@us.army.mil	Shear, Deborah/B-3607-2011		Department of the Army [W81XWH-08-2-0127]	This work was supported by the Department of the Army, award W81XWH-08-2-0127, with The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, as the awarding and administering acquisition office. The information has been reviewed by the Walter Reed Army Institute of Research with no objection to its presentation and/or publication. The content of the information are the private views of the authors and does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred.	Abe H, 2004, NEUROSCI LETT, V356, P191, DOI 10.1016/j.neulet.2003.11.049; BELLAMY R, 1998, TXB MILITARY MED 1; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ENNACEUR A, 1989, BEHAV BRAIN RES, V33, P197, DOI 10.1016/S0166-4328(89)80051-8; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313	15	15	16	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAY 30	2010	189	1					84	87		10.1016/j.jneumeth.2010.03.012			4	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	604PL	WOS:000278290900013	20346980				2022-02-06	
J	Archer, KR; Castillo, RC; MacKenzie, EJ; Bosse, MJ				Archer, Kristin R.; Castillo, Renan C.; MacKenzie, Ellen J.; Bosse, Michael J.		LEAP Study Grp	Perceived Need and Unmet Need for Vocational, Mental Health, and Other Support Services After Severe Lower-Extremity Trauma	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	85th Annual Meeting of the American-Congress-of-Rehabilitation-Medicine	OCT 16, 2008	Toronto, CANADA	Amer Congress Rehabil Med		Health services; Health services needs and demand; Lower extremity; Rehabilitation	POSTTRAUMATIC-STRESS-DISORDER; LOWER-LIMB AMPUTATION; VEHICLE ACCIDENT VICTIMS; LONG-TERM OUTCOMES; MAJOR TRAUMA; BRAIN-INJURY; ORTHOPEDIC TRAUMA; SELF-MANAGEMENT; FOLLOW-UP; PHYSICAL INJURY	Objectives: To examine the perceived need and unmet need for support services, the reasons for not obtaining services, and the factors contributing to unmet need for vocational and mental health services in patients with traumatic lower-extremity injury. Design: Multicenter, prospective observational study. Setting: Eight level I trauma centers. Participants: Patients (N=545) undergoing lower-extremity reconstruction or amputation from March 1994 to June 1997. Interventions: Not applicable. Main Outcome Measures: Perceived need and unmet need for support services at 3, 6, and 12 months after hospitalization. Results: Eighty-five percent of patients reported a need for at least 1 support service, and 32% reported an unmet need over the 12 months. The highest perceived need was for home nursing and legal, and for unmet need was vocational and mental health services. The main reason for patients not trying to obtain mental health assistance was thinking they would get better on their own, and for other support services was not knowing where to go. Patients treated by reconstruction compared with amputation, and being nonwhite were statistically associated with unmet needs for vocational and mental health services. Conclusions: The results suggest a significant amount of unmet need for vocational and mental health services during the first year after hospitalization in the severe lower-extremity trauma population with perceived need. Areas for future research are to objectively measure need and unmet need, and further investigate the disparities in unmet need by race and treatment type in this patient population. Recommendations for trauma centers include education and screening for mental health conditions and the need for support services during hospitalization and clinic visits, and increasing communication between surgeons and providers specializing in vocational, psychological, and socioeconomic issues.	[Archer, Kristin R.] Vanderbilt Univ, Med Ctr, Vanderbilt Orthopaed Inst, Dept Orthopaed & Rehabil,Sch Med, Nashville, TN 37232 USA; [Castillo, Renan C.; MacKenzie, Ellen J.] Johns Hopkins Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Injury Res & Policy, Baltimore, MD USA; [Bosse, Michael J.] Carolinas Med Ctr, Dept Orthopaed Surg, Charlotte, NC 28203 USA		Archer, KR (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Orthopaed Inst, Dept Orthopaed & Rehabil,Sch Med, Med Ctr ES Tower,Suite 4200, Nashville, TN 37232 USA.	kristin.archer@vanderbilt.edu			NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R0I-AR42659] Funding Source: Medline; NCIPC CDC HHS [CE00198-03] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR042659] Funding Source: NIH RePORTER		Airey CM, 2001, DISABIL REHABIL, V23, P509; Atherton R, 2006, DISABIL REHABIL, V28, P1201, DOI 10.1080/09638280600551674; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; BRENNEMAN FD, 1995, J TRAUMA, V39, P320, DOI 10.1097/00005373-199508000-00021; Butcher JL, 1996, J TRAUMA, V41, P4, DOI 10.1097/00005373-199607000-00002; Carson JW, 2006, J PAIN, V7, P615, DOI 10.1016/j.jpain.2006.02.008; Castillo RC, 2005, ARCH PHYS MED REHAB, V86, P1722, DOI 10.1016/j.apmr.2005.03.005; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Crichlow RJ, 2006, J BONE JOINT SURG AM, V88A, P1927, DOI 10.2106/JBJS.D.02604; Darnall BD, 2005, ARCH PHYS MED REHAB, V86, P650, DOI 10.1016/j.apmr.2004.10.028; Ephraim PL, 2006, ARCH PHYS MED REHAB, V87, P328, DOI 10.1016/j.apmr.2005.11.010; Escolar-Reina P, 2009, ARCH PHYS MED REHAB, V90, P1734, DOI 10.1016/j.apmr.2009.05.012; FISHER GM, 1992, SOC SECUR BULL, V55, P3; FRIEMAN M, 1998, HLTH SERV RES 1, V33, P867; Gallagher P, 2007, AM J PHYS MED REHAB, V86, P205, DOI 10.1097/PHM.0b013e3180321439; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; HOLBROOK TL, 1994, J TRAUMA, V36, P74, DOI 10.1097/00005373-199401000-00011; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Koren D, 1999, AM J PSYCHIAT, V156, P367; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; MacKenzie EJ, 2000, J ORTHOP TRAUMA, V14, P455, DOI 10.1097/00005131-200009000-00001; MACKENZIE EJ, 1993, J ORTHOP TRAUMA, V7, P393, DOI 10.1097/00005131-199310000-00001; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; McCarthy M L, 1998, J Hand Ther, V11, P32; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; MCCARTHY ML, 1995, J TRAUMA, V39, P828, DOI 10.1097/00005373-199511000-00005; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; MICHAELS AJ, 1998, SURG FORUM, V49, P534; Mngadi S, 1992, J APPL REHABILITATIO, V23, P12, DOI 10.1891/0047-2220.23.2.12; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Wegener ST, 2009, ARCH PHYS MED REHAB, V90, P373, DOI 10.1016/j.apmr.2008.08.222; Zatzick D, 2004, J TRAUMA, V57, P360, DOI 10.1097/01.TA.0000141332.43183.7F; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941; Zatzick DF, 2001, MED CARE, V39, P327, DOI 10.1097/00005650-200104000-00004; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	57	15	16	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2010	91	5					774	780		10.1016/j.apmr.2010.01.006			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	594LK	WOS:000277539000015	20434616				2022-02-06	
J	Olivecrona, M; Wildemyr, Z; Koskinen, LOD				Olivecrona, Magnus; Wildemyr, Zandra; Koskinen, Lars-Owe D.			The apolipoprotein E epsilon 4 allele and outcome in severe traumatic brain injury treated by an intracranial pressure-targeted therapy	JOURNAL OF NEUROSURGERY			English	Article						apolipoprotein E; epsilon 4 allele; severe traumatic brain injury; outcome; prediction	E-DEFICIENT MICE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; E GENOTYPE; E POLYMORPHISM; APOE-EPSILON-4 ALLELE; APOE GENOTYPE; ASSOCIATION; REGENERATION	Object. In this paper, the authors' goal was to study the influence of the apolipoprotein E epsilon 4 allele on the clinical outcome in patients treated for severe traumatic brain injury (TBI) with an intracranial pressure (ICP)-targeted therapy based on the Lund concept. Methods. The authors conducted a prospective double-blinded randomized trial in which they examined patients with severe TBI. Inclusion criteria consisted of a Glasgow Coma Scale (GCS) score <= 8 at the time of intubation and sedation, patient age between 15 and 70 years, an initial cerebral perfusion pressure > 10 mm Hg, and arrival to the hospital < 24 hours after trauma. Blood samples for the analysis of apolipoprotein E allele types were collected. Independent staff members evaluated outcomes by obtaining Glasgow Outcome Scale (GOS) scores at 3, 12, and 24 months. Results. The occurrence of the epsilon 4 allele was analyzed in 46 patients (mean age 35 +/- 2.2 years with a median GCS score of 6 [range 3-8]). The epsilon 4 allele was present in 39.1% of the patients. The ICP, cerebral perfusion pressure, and injury severity score were not statistically significantly different between the groups. The median GOS score at 3 months was 3.5, and at 12 and 24 months was 4 (range 1-5). Except for the GOS score at 3 months, which was dichotomized as favorable (GOS Score 4 or 5) and unfavorable (GOS Scores 1-3), no statistically significant differences in outcome, irrespective of GOS dichotomization used, were found between the patients with the epsilon 4 allele and those without. The presence of the epsilon 4 allele did not predict for clinical outcome, but GCS and ICP did. Conclusions. The presence of epsilon 4 is not associated with long-term clinical outcome in patients with severe TBI treated with an ICP targeted therapy, based on the Lund concept. (DOI: 10.3171/2009.8.JNS09636)	[Olivecrona, Magnus; Wildemyr, Zandra; Koskinen, Lars-Owe D.] Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, S-90185 Umea, Sweden; [Wildemyr, Zandra] Univ Uppsala Hosp, Dept Neurosurg, Uppsala, Sweden		Olivecrona, M (corresponding author), Univ Hosp, Dept Neurosurg, SE-90185 Umea, Sweden.	magnus.olivecrona@vll.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Olivecrona, Magnus/0000-0001-8457-4711	foundation for clinical neurosciences at Umea University; Kempe Foundation; Tore Nilsson's Fund; Capio Research Fund	This study was financially supported by the foundation for clinical neurosciences at Umea University, the Kempe Foundation, Tore Nilsson's Fund, and Capio Research Fund.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Fontanella M, 2007, J NEUROSURG, V106, P245, DOI 10.3171/jns.2007.106.2.245; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; JENNETT B, 1975, LANCET, V1, P480; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Kerr ME, 2003, CRIT CARE MED, V31, P2371, DOI 10.1097/01.CCM.0000080484.72004.C4; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Leung CHS, 2002, STROKE, V33, P548, DOI 10.1161/hs0202.102326; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; OLIVECRONA M, 2009, J NEUROTRAUMA; OLIVECRONA M, 2008, EUR J ANAESTH, V25, P4; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; PITAS RE, 1987, J BIOL CHEM, V262, P14352; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZANNIS VI, 1982, J LIPID RES, V23, P911	42	15	16	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAY	2010	112	5					1113	1119		10.3171/2009.8.JNS09636			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	591BW	WOS:000277273600030	19747047				2022-02-06	
J	Jung, GO; Yoon, MR; Kim, SJ; Sin, MJ; Kim, EY; Moon, JI; Kim, JM; Choi, GS; Kwon, CHD; Cho, JW; Lee, SK				Jung, G. O.; Yoon, M. R.; Kim, S. -J.; Sin, M. J.; Kim, E. Y.; Moon, J. I.; Kim, J. M.; Choi, G. -S.; Kwon, C. H. D.; Cho, J. -W.; Lee, S. K.			The Risk Factors of Delayed Graft Function and Comparison of Clinical Outcomes After Deceased Donor Kidney Transplantation: Single-Center Study	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	11th Congress of the Asian-Society-of-Transplantation	OCT 01-04, 2009	Beirut, LEBANON	Asian Soc Transplantat			CADAVERIC RENAL-TRANSPLANTATION; OF-WISCONSIN SOLUTION; LONG-TERM SURVIVAL; ALLOGRAFT SURVIVAL; MULTIORGAN DONORS; ACUTE REJECTION; PRESERVATION; IMPACT	Introduction. The aim of this study was to analyze risk factors for delayed graft function (DGF) after deceased donor kidney transplantation and to compare the clinical outcomes of non-DGF versus DGF recipients. Patients and methods. From January 2004 to June 2008, 75/154 kidneys were transplanted into 74 recipients. We classified the recipients into two groups: group 1 (n = 61) without DGF and group 2 (n = 13) with DGF. Results. On univariate analysis, recipient age (P = .048) cause of brain death (traumatic brain injury vs disease, P = .016), blood urea nitrogen (P = .002), serum creatinine (P = .001), arterial pH (P = .019), and serum sodium level (P = .012) just before organ procurement showed significant differences. On multivariate analysis, the cause of brain death (P = .015, hazard ratio [HR]: 7.086), the terminal serum creatinine >= 1.5 mg/dL before organ procurement (P = .007, HR: 10.132), and recipient age over >= 50 years (P = .021, HR: 7.767) were independent risk factors for the development of DGF. Graft failures occurred among 5/74 recipients with 5-year graft survivals between group 1 and group 2 of 91.7% and 84.6%, respectively. Patient death occurred in five cases, most by due to infection. The 5-year patient survival between groups 1 and 2 were 93.9% and 84.6%, respectively (P = .106). Conclusion. The independent risk factors for DGF were the cause of brain death, the terminal creatinine level, and the recipient age. In deceased donor kidney transplantation, DGF may have less effect on long-term patient and graft survivals.	[Jung, G. O.; Kim, S. -J.; Moon, J. I.; Kim, J. M.; Choi, G. -S.; Kwon, C. H. D.; Cho, J. -W.; Lee, S. K.] Sungkyunkwan Univ, Sch Med, Div Transplantat, Dept Surg,Samsung Med Ctr, Seoul 135710, South Korea		Kim, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Div Transplantat, Dept Surg,Samsung Med Ctr, Ilwondong 50, Seoul 135710, South Korea.	kmhyj111@skku.edu	kim, jm/O-5935-2014; Kwon, Choon Hyuck David/H-7263-2019; Kim, Jong Man/AAH-5295-2020; Kim, Sung Joo/C-9604-2011	Kwon, Choon Hyuck David/0000-0002-1082-3321; 			ALMOND PS, 1991, TRANSPLANT P, V23, P1304; Boom H, 2000, KIDNEY INT, V58, P859, DOI 10.1046/j.1523-1755.2000.00235.x; Bronzatto EJM, 2009, TRANSPL P, V41, P849, DOI 10.1016/j.transproceed.2009.02.004; Chatziantoniou C, 2008, CURR OPIN NEPHROL HY, V17, P76, DOI 10.1097/MNH.0b013e3282f1bb69; Giral-Classe M, 1998, KIDNEY INT, V54, P972, DOI 10.1046/j.1523-1755.1998.00071.x; Hetzel GR, 2002, TRANSPL INT, V15, P10, DOI 10.1007/s00147-001-0368-7; Humar A, 2002, CLIN TRANSPLANT, V16, P425, DOI 10.1034/j.1399-0012.2002.02055.x; Koning OHJ, 1997, TRANSPLANTATION, V63, P1620, DOI 10.1097/00007890-199706150-00015; KONING OHJ, 1995, TRANSPLANT P, V27, P752; Marcen R, 1998, TRANSPLANTATION, V66, P461, DOI 10.1097/00007890-199808270-00008; Marshall R, 1996, SURGERY, V120, P663, DOI 10.1016/S0039-6060(96)80014-6; McLaren AJ, 1999, CLIN TRANSPLANT, V13, P266, DOI 10.1034/j.1399-0012.1999.130308.x; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Patel SJ, 2008, TRANSPLANTATION, V86, P313, DOI 10.1097/TP.0b013e31817ef190; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pfaff WW, 1998, TRANSPLANTATION, V65, P219; Quiroga I, 2006, NEPHROL DIAL TRANSPL, V21, P1689, DOI 10.1093/ndt/gfl042; Rodrigo E, 2004, AM J TRANSPLANT, V4, P1163, DOI 10.1111/j.1600-6143.2004.00488.x; ROSENTHAL JT, 1991, TRANSPLANTATION, V51, P1115; Sellers MT, 2000, CLIN TRANSPLANT, V14, P543, DOI 10.1034/j.1399-0012.2000.140605.x; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	22	15	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2010	42	3					705	709		10.1016/j.transproceed.2010.02.063			5	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	588VV	WOS:000277103500009	20430152				2022-02-06	
J	Rasmusson, CG; Koch, G				Rasmusson, Carl Gosta; Koch, Goran			Assessment of traumatic injuries to primary teeth in general practise and specialized paediatric dentistry	DENTAL TRAUMATOLOGY			English	Article							PRIMARY INCISORS; PRIMARY DENTITION; CHILDREN	Aim: The aim of this prospective study was to compare diagnosis, severity of trauma and treatment of traumatic injuries to the primary dentition in two groups of children, the first recommended for treatment by general practitioners and the second referred for treatment by a specialist paediatric dentist. Materials and methods: A total of 323 children with traumatic injuries, 184 boys and 139 girls aged 7-83 months, participated in the study. All the children had first presented at a Public Dental Service clinic where they were examined by general dentists who decided, based on the severity of the trauma, to assign each child to one of the following two groups: Group A - recommended for treatment at the general practise (166 children with 257 traumatized incisor teeth). Group B - recommended for referral to a specialist in paediatric dentistry (157 children with 261 traumatized incisor teeth). Even in Group A, the specialist controlled the treatment decisions. The clinical diagnose and follow-up followed the recommendations presented by Andreasen & Andreasen. Results: The distribution of trauma by age was similar in both groups, with about 60% occurring between 1 and 3 years. More injured teeth were extracted in children in Group B (n = 111) than in Group A (n = 33). A higher percentage of intruded primary incisors were recorded in Group B (24%) compared with Group A (16%). Similarly, the percentage of concussions/subluxations, lateral luxations and complicated crown fractures was higher in Group B than in Group A. Conclusions: The group referred for specialist treatment had more severe injuries and needed more complicated treatment than the group recommended for care by general dentists. However, the rate of sequelae in permanent successors was the same in both.	[Rasmusson, Carl Gosta] Publ Dent Hlth, Specialist Unit, Dept Pedodont, Uddevalla, Sweden; [Koch, Goran] Inst Postgrad Dent Educ, Dept Paediat Dent, Jonkoping, Sweden		Rasmusson, CG (corresponding author), Fornstigen 3, SE-45533 Munkedal, Sweden.	ansacege@swipnet.se					Andreasen J O, 1972, Int J Oral Surg, V1, P235, DOI 10.1016/S0300-9785(72)80042-5; Andreasen JO, 1994, TXB COLOR ATLAS TRAU, V3rd, P151; Borum MK, 1998, ENDOD DENT TRAUMATOL, V14, P31; BORUM MK, 1994, THESIS COPENHAGEN U; CROLL TP, 1987, J DENT CHILD, V54, P401; Diab M, 2000, QUINTESSENCE INT, V31, P327; Flores MT, 2002, DENT TRAUMATOL, V18, P287, DOI 10.1034/j.1600-9657.2002.00153.x; Holan G, 2004, DENT TRAUMATOL, V20, P276, DOI 10.1111/j.1600-9657.2004.00285.x; Horie N, 2005, DENT TRAUMATOL, V21, P201, DOI 10.1111/j.1600-9657.2005.00313.x; JACOBSEN I, 1978, ACTA ODONTOL SCAND, V36, P199, DOI 10.3109/00016357809004668; JOHO JP, 1980, J DENT CHILD, V47, P167; Odersjo ML., 2001, EUR J PAEDIATR DENT, V4, P165; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; Robertson A, 1997, EUR J ORAL SCI, V105, P196, DOI 10.1111/j.1600-0722.1997.tb00201.x; Schroder U, 1977, Swed Dent J, V1, P95; SONIS A L, 1987, Journal of Pedodontics, V11, P247	16	15	17	0	8	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	APR	2010	26	2					129	132		10.1111/j.1600-9657.2009.00862.x			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	568OD	WOS:000275531100003	20141524				2022-02-06	
J	Cheng, BH; Yang, XX; Chen, CC; Cheng, DF; Xu, XD; Zhang, XW				Cheng, Baohua; Yang, Xinxin; Chen, Chengchun; Cheng, Danfu; Xu, Xudong; Zhang, Xuewen			D-beta-Hydroxybutyrate Prevents MPP plus -Induced Neurotoxicity in PC12 Cells	NEUROCHEMICAL RESEARCH			English	Article						Parkinson's disease; D-beta-Hydroxybutyrate; Apoptosis; MPP; PC12	TRAUMATIC BRAIN-INJURY; ION-INDUCED APOPTOSIS; KETOGENIC DIET; KAINIC ACID; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; KETONE-BODIES; RAT-BRAIN; COMPLEX-I	Numerous studies show that D-beta-Hydroxybutyrate (D beta HB) is neuroprotective. The present study was to explore the neuroprotective effects of D beta HB against the cell death and apoptosis induced by 1-methyl-4-phenylpyridinium ion (MPP+) in PC12 cells. PC12 cells were pretreated with D beta HB and followed by MPP+ exposure. The cell viability was determined by MTT assay. The morphological characteristics of apoptosis was observed by Acridine Orange (AO) staining and apoptotic rates were measured by flow cytometer. The product of lipid peroxidation, malondialdehyde (MDA), was measured using thiobarbituric acid method. The mitochondrial membrane potential (MMP), intracellular ROS and total glutathione were detected by microplate reader. In PC12 cells, pretreatment with D beta HB significantly reduced MPP+-induced the decrease of cell viability. AO staining and flow cytometric analysis found D beta HB inhibited MPP+-induced apoptosis. The measurement of MDA formation showed that D beta HB alleviated lipid peroxidation induced by MPP+. The loss of MMP induced by MPP+ was preventive by D beta HB. The changes of intracellular ROS and total glutathione induced by MPP+ were reversed by D beta HB. D beta HB protected PC12 cells against MPP+-induced death and apoptosis.	[Cheng, Baohua; Yang, Xinxin; Xu, Xudong; Zhang, Xuewen] Jining Med Univ, Jining, Shandong, Peoples R China; [Yang, Xinxin; Cheng, Danfu] Rizhao Peoples Hosp, Rizhao, Shandong, Peoples R China; [Chen, Chengchun] Wenzhou Med Coll, Wenzhou, Zhejiang, Peoples R China		Cheng, BH (corresponding author), Jining Med Univ, Jining, Shandong, Peoples R China.	apple9red@yahoo.com.cn					Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; Bo J, 2005, NEUROSCI RES, V53, P183, DOI 10.1016/j.neures.2005.06.014; Chalimoniuk M, 2006, CELL MOL NEUROBIOL, V26, P1153, DOI 10.1007/s10571-006-9078-0; Chen J, 2006, APOPTOSIS, V11, P943, DOI 10.1007/s10495-006-6715-5; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Freeman JM, 1998, PEDIATRICS, V102, P1358, DOI 10.1542/peds.102.6.1358; GO KG, 1988, METAB BRAIN DIS, V3, P257, DOI 10.1007/BF00999535; Guzman M, 2001, TRENDS ENDOCRIN MET, V12, P169, DOI 10.1016/S1043-2760(00)00370-2; HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409; HAWKINS RA, 1986, AM J PHYSIOL, V250, pE169, DOI 10.1152/ajpendo.1986.250.2.E169; HEIKKILA RE, 1989, MOL CHEM NEUROPATHOL, V10, P171, DOI 10.1007/BF03159727; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Imamura K, 2006, J NEUROSCI RES, V84, P1376, DOI 10.1002/jnr.21021; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Jellinger KA, 2000, J NEURAL TRANSM, V107, P1, DOI 10.1007/s007020050001; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jin BK, 1998, NEUROSCI LETT, V245, P61, DOI 10.1016/S0304-3940(98)00170-0; Kang XG, 2007, TOXICOL IN VITRO, V21, P1003, DOI 10.1016/j.tiv.2007.02.004; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; KINSMAN SL, 1992, EPILEPSIA, V33, P1132, DOI 10.1111/j.1528-1157.1992.tb01770.x; KIRSCH JR, 1984, STROKE, V15, P319, DOI 10.1161/01.STR.15.2.319; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; Lee CS, 2005, EUR J PHARMACOL, V527, P23, DOI 10.1016/j.ejphar.2005.10.008; Lee CS, 2003, NEUROCHEM RES, V28, P1833, DOI 10.1023/A:1026119708124; Liang LP, 2007, J NEUROSCI, V27, P4326, DOI 10.1523/JNEUROSCI.0019-07.2007; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; Mejia-Toiber J, 2006, NEUROCHEM RES, V31, P1399, DOI 10.1007/s11064-006-9189-5; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; Nakamura S, 2003, INVEST OPHTH VIS SCI, V44, P4682, DOI 10.1167/iovs.03-0198; Nehlig A, 1996, DEV NEUROSCI-BASEL, V18, P426, DOI 10.1159/000111437; Noh HS, 2006, J NEUROSCI RES, V84, P1829, DOI 10.1002/jnr.21057; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Noh HS, 2005, EPILEPSY RES, V65, P153, DOI 10.1016/j.eplepsyres.2005.05.008; Noh HS, 2006, NEUROSCI LETT, V395, P87, DOI 10.1016/j.neulet.2005.10.073; Noh HS, 2005, BRAIN RES, V1042, P114, DOI 10.1016/j.brainres.2005.01.097; Oida Y, 2006, BRAIN RES, V1082, P196, DOI 10.1016/j.brainres.2006.01.116; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Perkins CL, 2000, CANCER RES, V60, P1645; POLLAY M, 1980, J NEUROSCI RES, V5, P163, DOI 10.1002/jnr.490050208; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; Sawada H, 2002, NEUROPHARMACOLOGY, V42, P1056, DOI 10.1016/S0028-3908(02)00049-7; Segura-Aguilara J, 2004, NEUROTOX RES, V6, P615, DOI 10.1007/BF03033456; Seyfried J, 2000, NEUROCHEM INT, V36, P489, DOI 10.1016/S0197-0186(99)00156-4; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Takata MK, 2005, J BIOSCI BIOENG, V100, P511, DOI 10.1263/jbb.100.511; Tatton WG, 1999, PARKINSONISM RELAT D, V5, P221, DOI 10.1016/S1353-8020(99)00041-3; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Troy CM, 2002, J NEUROSCI RES, V69, P145, DOI 10.1002/jnr.10294; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004	66	15	16	0	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2010	35	3					444	451		10.1007/s11064-009-0078-6			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	553YV	WOS:000274403600012	19851865				2022-02-06	
J	Duquette, J; McKinley, P; Mazer, B; Gelinas, I; Vanier, M; Benoit, D; Gresset, J				Duquette, Josee; McKinley, Patricia; Mazer, Barbara; Gelinas, Isabelle; Vanier, Marie; Benoit, Dana; Gresset, Jacques			Impact of Partial Administration of the Cognitive Behavioral Driver's Inventory on Concurrent Validity for People With Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						automobile driving; brain injuries; cognition; reproducibility of results; stroke; task performance and analysis	STROKE; SKILLS; DAMAGE	OBJECTIVES. We sought to determine whether the partial administration of the Cognitive Behavioral Driver's Inventory (CBDI) has a significant effect on its concurrent validity. METHOD. Data were extracted from charts of clients with cerebrovascular accident or traumatic brain injury from three centers. The CBDI was administered either completely or partially (right and left perimetry or Wechsler Adult Intelligence Scale Revised (WAIS-R; Wechsler, 1982; Picture Completion and Digit Symbol tests were not completed). Concurrent validity indicators were calculated for the CBDI and three different scenarios of partial administration of the CBDI. RESULTS. Only 52% of the road test failures were predicted correctly by the completely administered CBDI. Nonadministration of the WAIS-R rarely modified the CBDI results. Omission of perimetry scores tended to increase the sensitivity and decrease the specificity (not significantly). CONCLUSION. The CBDI should be used as a complement, not a substitution, for a road test. Partially administrating the CBDI, specifically excluding perimetry measures, can affect its concurrent validity.	[Duquette, Josee; Gresset, Jacques] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [McKinley, Patricia; Mazer, Barbara; Gelinas, Isabelle; Vanier, Marie; Benoit, Dana] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Quebec City, PQ, Canada; [Duquette, Josee; Benoit, Dana] Constance Lethbridge Rehabil Ctr, Montreal, PQ, Canada; [Gresset, Jacques] Univ Montreal, Ecole Optometrie, Quebec City, PQ, Canada; [Vanier, Marie] Univ Montreal, Ecole Readaptat, Quebec City, PQ, Canada; [Vanier, Marie] Inst Readaptat Montreal, Quebec City, PQ, Canada; [Mazer, Barbara; Gelinas, Isabelle] Jewish Rehabil Hosp, Laval, PQ, Canada; [McKinley, Patricia; Mazer, Barbara; Gelinas, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3G 1Y5, Canada		Duquette, J (corresponding author), Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada.	isabelle.gelinas@mcgill.ca		Duquette, Josee/0000-0002-0258-1166			Antrim J. M., 1989, COGNITIVE REHABILITA, V7, P16; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; BRACY OL, 1985, COGNITIVE REHABILITA, V4, P10; DUBINSKY RM, 1991, NEUROLOGY, V41, P517, DOI 10.1212/WNL.41.4.517; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; ENGUM ES, 1989, COGNITIVE REHABILITA, V7, P22; ENGUM ES, 1990, COGNIT REHABIL, V2, P20; ENGUM ES, 1988, COGNITIVE REHABILITA, V6, P12; Engum ES, 1990, COGNITIVE REHABILITA, V8, P20; FEINSTEIN AR, 1977, CLIN BIOSTATISTICS; GOLPER LAC, 1980, ARCH PHYS MED REHAB, V61, P34; Klavora P, 2000, ARCH PHYS MED REHAB, V81, P701, DOI 10.1016/S0003-9993(00)90096-0; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; KORNERBITENSKY N, 1990, CAN FAM PHYSICIAN, V36, P323; LAMBERT EW, 1990, COGNITIVE REHABILITA, V8, P34; LeBlang Theodore R, 1979, Loyola Univ Chic Law J, V10, P203; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [DOI 10.1007/978-1-4613-2173-6_19, 10.1007/978-1-4613-2173-6_19]; Noreau L, 1999, SPINAL CORD, V37, P730, DOI 10.1038/sj.sc.3100918; QUIGLEY FL, 1983, AM J OCCUP THER, V37, P474, DOI 10.5014/ajot.37.7.474; Reitan R, 1986, TRAIL MAKING TEST MA; SHORE D, 1980, ARCH PHYS MED REHAB, V61, P481; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SPRIGLE S, 1995, OCCUP THER J RES, V15, P147, DOI 10.1177/153944929501500301; Thomas S.A., 2005, AUST OCCUP THER J, V52, P57, DOI DOI 10.1111/J.1440-1630.2005.00456.X; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; WEAVER J, 1989, DRIVER PERFORMANCE T; WECHSLER D, 1982, WECHSLER ADULT INTEL	28	15	15	0	1	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAR-APR	2010	64	2			SI		279	287		10.5014/ajot.64.2.279			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	583YR	WOS:000276717100009	20437915	Green Submitted			2022-02-06	
J	Rao, V; Rosenberg, P; Miles, QS; Patadia, D; Treiber, K; Bertrand, M; Norton, M; Steinberg, M; Tschanz, J; Lyketsos, C				Rao, Vani; Rosenberg, Paul; Miles, Quincy Samus; Patadia, Deepa; Treiber, Kate; Bertrand, Melaine; Norton, Maria; Steinberg, Martin; Tschanz, JoAnn; Lyketsos, Constantine			Neuropsychiatric Symptoms in Dementia Patients With and Without a History of Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							QUALITY-OF-LIFE; LONG-TERM-CARE; ALZHEIMERS-DISEASE; CACHE COUNTY; BEHAVIORAL DISTURBANCES; ASSOCIATION; PREVALENCE; VALIDATION; INVENTORY; RESIDENTS	The authors aim to determine if a history of traumatic brain injury (TBI) assessed before dementia onset is associated with a higher risk of neuropsychiatric symptoms after dementia onset. A population-based incident series of people with dementia were assessed for TBI prior to onset of dementia and for neuropsychiatric symptoms after the onset, using the Neuropsychiatric Inventory. Participants with predementia TBI were more likely to exhibit disinhibition (12.7% versus 5.4%, OR = 2.8, p = 0.02), but not other neuropsychiatric symptoms. Traumatic brain injury may increase the risk of disinhibition in patients with dementia. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22: 166-172)	[Rao, Vani] Johns Hopkins Univ, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Johns Hopkins Sch Med, Baltimore, MD 21224 USA; [Patadia, Deepa] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Rootstown, OH 44272 USA; [Treiber, Kate; Norton, Maria; Tschanz, JoAnn] Utah State Univ, Logan, UT 84322 USA		Rao, V (corresponding author), Johns Hopkins Univ, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Johns Hopkins Sch Med, 5300 Alpha Commons Dr,4th Floor,444, Baltimore, MD 21224 USA.	vrao@jhmi.edu	Tschanz, JoAnn T./E-5986-2010	Steinberg, Martin/0000-0001-8800-8020	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG11380, AG18712, AG21136]; Cache County Study; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG018712, R01AG011380, R01AG021136] Funding Source: NIH RePORTER	This work was supported by NIH grants AG11380, AG18712, and AG21136. We thank the neurogenetics laboratory of the Bryan Alzheimer's Disease Research Center at Duke University for the APOE genotyping. We are grateful to Drs. Kathleen A. Welsh-Bohmer and John C. S. Breitner, current and former principal investigators of the Cache County Study, for sharing the data and for their support and encouragement of this manuscript.; These results were presented as a poster by DP at Northeastern Ohio Universities College of Medicine's Summer Research Fellowship Program on 9/3/08 in Rootstown, Ohio, and as an oral presentation at Summa Health System on 1/8/09 in Akron, Ohio. DP is a Medical Student Training in Aging Research (MSTAR) scholar and presented these results at the 2009 American Geriatric Society Annual Scientific Meeting.	Alkhalil Chadi, 2004, Am J Ther, V11, P231, DOI 10.1097/00045391-200405000-00013; Bassiony MM, 2003, PSYCHOSOMATICS, V44, P388, DOI 10.1176/appi.psy.44.5.388; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Cohen-Mansfield J, 2005, ALZ DIS ASSOC DIS, V19, P37, DOI 10.1097/01.wad.0000155066.39184.61; Creese J, 2008, INT PSYCHOGERIATR, V20, P149, DOI 10.1017/S1041610207005339; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davis JD, 2007, J NEUROPSYCH CLIN N, V19, P43, DOI 10.1176/appi.neuropsych.19.1.43; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; Fernandez HH, 2000, MOVEMENT DISORD, V15, P490, DOI 10.1002/1531-8257(200005)15:3<490::AID-MDS1011>3.0.CO;2-E; Freymann N, 2005, PHARMACOPSYCHIATRY, V38, P144, DOI 10.1055/s-2005-864127; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Greve KW, 2001, BRAIN INJURY, V15, P255; Ikeda M, 2004, J NEUROL NEUROSUR PS, V75, P146; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Lyketsos CG, 2006, J NEUROPSYCH CLIN N, V18, P445, DOI 10.1176/appi.neuropsych.18.4.445; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Politis AM, 2004, INT J GERIATR PSYCH, V19, P1087, DOI 10.1002/gps.1215; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Samus QM, 2005, GERONTOLOGIST, V45, P19, DOI 10.1093/geront/45.suppl_1.19; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tschanz JT, 2002, NEUROPSY NEUROPSY BE, V15, P28; Tun SM, 2007, AM J GERIAT PSYCHIAT, V15, P314, DOI 10.1097/01.JGP.0000239263.52621.97	32	15	16	0	2	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2010	22	2					166	172		10.1176/jnp.2010.22.2.166			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	595ZY	WOS:000277654200004	20463110	Green Accepted			2022-02-06	
J	Lechner, R; Achatz, G; Hauer, T; Palm, HG; Lieber, A; Willy, C				Lechner, R.; Achatz, G.; Hauer, T.; Palm, H. -G.; Lieber, A.; Willy, C.			Patterns and causes of injuries in a contemporary combat environment	UNFALLCHIRURG			German	Article						Combat injuries; Military surgery; Wounds; Injuries; Injury pattern	PENETRATING MISSILE INJURIES; OPERATION IRAQI FREEDOM; CASUALTIES; AFGHANISTAN; WAR; EXPERIENCE; MANAGEMENT; TRAUMA; SINGLE; CARE	Epidemiological analyses of injury patterns and mechanisms help to identify the expertise military surgeons need in a combat setting and accordingly help to adjust infrastructure and training requirements. Therefore, a MEDLINE search (1949-2009), World Wide Web search (keywords "combat, casualties, war, military, wounded and neurosurgery") and an analysis of deaths among allied war casualties in Afghanistan and Iraq were performed. Up to 10th December 2009 there had been 4,688 allied military deaths in Iraq and 1,538 in Afghanistan. Of these 22% died in non-hostile action, 33% in direct combat situations and the majority of 45% in indirect combat actions. The leading causes of injury were explosive devices (70%) and gunshot wounds. Chest or abdominal injuries (40%) and traumatic brain injuries (35%) were the main causes of death for soldiers killed in action. The case fatality rate in Iraq is approximately half that of the Vietnam War, whereas the killed-in-action rate in Afghanistan (18.7%) is similar to the Vietnam War (20%); however, the amputation rate is twice as high in modern conflicts. Approximately 8-15% of the fatal injuries seem to be potentially survivable. Military surgeons must have an excellent expertise in a wide variety of surgical specialties. Life saving emergency care, especially in the fields of thoracic, visceral and vascular surgery as well as practical skills in the fields of neurosurgery and oral and maxillofacial surgery are required. Additionally, it is of vital importance to ensure the availability of sufficient tactical and strategic medical evacuation capabilities for the wounded.	[Lechner, R.; Achatz, G.; Hauer, T.] Bundeswehrkrankenhaus Ulm, Chirurg Zentrum, Klin Unfallchirurg & Orthopadie, D-89081 Ulm, Germany; [Lieber, A.] Bundeswehrkrankenhaus Berlin, Abt Allgemein Viszeral Gefass & Thoraxchirurg, Berlin, Germany		Lechner, R (corresponding author), Bundeswehrkrankenhaus Ulm, Chirurg Zentrum, Klin Unfallchirurg & Orthopadie, Oberer Eselsberg 40, D-89081 Ulm, Germany.	RaimundEdgarLechner@Bundeswehr.org	Willy, Christian/AAJ-3174-2021				Appenzeller GN, 2004, MIL MED, V169, P187, DOI 10.7205/MILMED.169.3.187; BAER D, 2005, MILITARY NEEDS COMBA; Brusov PG, 2005, WORLD J SURG, V29, pS25, DOI 10.1007/s00268-004-2081-z; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Clouse WD, 2006, ANN VASC SURG, V20, P429, DOI 10.1007/s10016-006-9090-3; Cohen SP, 2005, ANESTH ANALG, V101, P1098, DOI 10.1213/01.ane.0000169332.45209.cf; COVEY C, 2006, ANN M MARCH 2006 AM; Davidovic L, 1997, Cardiovasc Surg, V5, P37, DOI 10.1016/S0967-2109(96)00067-1; Davidovic LB, 2005, VASCULAR, V13, P141; Dyer O, 2005, BRIT MED J, V330, P557, DOI 10.1136/bmj.330.7491.557; Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gomez R, 2009, J AM COLL SURGEONS, V208, P348, DOI 10.1016/j.jamcollsurg.2008.11.012; Hinsley DE, 2005, BRIT J SURG, V92, P637, DOI 10.1002/bjs.4911; Hodgetts TJ, 2006, LANCET, V367, P1393, DOI 10.1016/S0140-6736(06)68604-2; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; HYER R, 2006, MEDSCAPE MED NEWS 20; Kashuk JL, 2009, J AM COLL SURGEONS, V209, P134, DOI 10.1016/j.jamcollsurg.2009.01.049; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Lakstein D, 2005, MIL MED, V170, P427, DOI 10.7205/MILMED.170.5.427; LEE C, 2005, SURVEY BLAST TRAUMA; McPherson JJ, 2006, J TRAUMA, V60, P573, DOI 10.1097/01.ta.0000209179.79946.92; Mody RM, 2009, J TRAUMA, V67, P758, DOI 10.1097/TA.0b013e3181af6aa6; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P12, DOI 10.1016/j.jamcollsurg.2005.04.009; Murray CK, 2009, MIL MED, V174, P598, DOI 10.7205/MILMED-D-03-8008; Peoples GE, 2005, MIL MED, V170, P462, DOI 10.7205/MILMED.170.6.462; PHILPOTT T, 2005, RISE SURVIVAL RATE; Ramalingam T, 2005, ANN ROY COLL SURG, V87, P113, DOI 10.1308/1478708051685; Ramasamy A, 2009, ANN ROY COLL SURG, V91, P551, DOI 10.1308/003588409X464720; Ramasamy A, 2009, INJURY, V40, P493, DOI 10.1016/j.injury.2008.03.028; Rich NM, 2005, J AM COLL SURGEONS, V200, P321, DOI 10.1016/j.jamcollsurg.2004.10.028; SCHLESINGER R, 2003, COMBAT WOUNDS PROVIN; Seal A, 2006, LANCET, V367, P1393, DOI 10.1016/S0140-6736(06)68605-4; Sise MJ, 2006, J TRAUMA, V60, P1162; VICK K, 2004, WASHINGTON POST FORE; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1347	38	15	15	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	FEB	2010	113	2					106	113		10.1007/s00113-009-1732-9			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	553RR	WOS:000274385000004	20101383				2022-02-06	
J	DeFina, PA; Fellus, J; Thompson, JWG; Eller, M; Moser, RS; Frisina, PG; Schatz, P; DeLuca, J; Zigarelli-McNish, M; Prestigiacomo, CJ				DeFina, Philip A.; Fellus, Jonathan; Thompson, James W. G.; Eller, Monika; Moser, Rosemarie Scolaro; Frisina, Pasquale G.; Schatz, Philip; DeLuca, John; Zigarelli-McNish, Maria; Prestigiacomo, Charles J.			Improving outcomes of severe disorders of consciousness	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article							PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; DBS THERAPY; HEAD-INJURY; COMA; ZOLPIDEM; RECOVERY; MODEL; SCALE	Purpose: To evaluate the efficacy of an Advanced Care Protocol (ACP) in improving rates of clinical progression and emergence in patients with Severe Disorders of Consciousness (SDOC). Methods: Forty-one patients with SDOC were assigned to groups: Vegetative State (VS) traumatic etiology (VS-TBI), VS non-traumatic etiology (VS-NTBI), Minimally Conscious State (MCS-TBI), MCS non-traumatic etiology (MCS-NTBI). Design was a within-subjects retrospective case series measuring pre-post ACP intervention data. The ACP was administered sequentially over 12 weeks, incorporating traditional therapies (occupational, physical, speech), pharmaceuticals, median nerve stimulation, and neutraceuticals. Main Outcome Measures were: Pre- and post-treatment Disability Rating Scale (DRS), Functional Independence Measure (FIM), Glasgow Coma Scale (GCS), and Coma Recovery Scale-Revised (CRS-R); clinical diagnosis (VS, MCS, emerged) using criteria from the American Academy of Neurology and Mohonk Report. Results: Patients significantly improved across all outcome measures, from baseline to discharge. Clinical improvement of 100% of MCS patients and 78-86% of VS patients was observed following ACP treatment. Significant differences between ACP vs. the published "standard of care" rates, in favor of the ACP, based on DRS scores and on clinical status at discharge. Conclusions: These strikingly positive results of a novel multimodal intervention are a valuable contribution to this frontier of investigation.	[DeFina, Philip A.; Thompson, James W. G.; Moser, Rosemarie Scolaro] Int Brain Res Fdn Inc, Edison, NJ 08837 USA; [Fellus, Jonathan; Eller, Monika; Frisina, Pasquale G.; DeLuca, John; Zigarelli-McNish, Maria] Kessler Inst Rehabil, W Orange, NJ USA; [Moser, Rosemarie Scolaro] RSM Psychol Ctr LLC, Lawrenceville, NJ USA; [Frisina, Pasquale G.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, Cerebrovasc Ctr, Newark, NJ 07103 USA		DeFina, PA (corresponding author), Int Brain Res Fdn Inc, 100 Menlo Pk,Suite 412, Edison, NJ 08837 USA.	pdefina@ibrfinc.org	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378; Schatz, Philip/0000-0002-6222-6545	International Brain Research Foundation, Inc. (IBRF), Edison NJ	Private funding for this study was provided by the International Brain Research Foundation, Inc. (IBRF), Edison NJ.	*AM MED ASS, 2009, CURR PROC TERM; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Coleman MR, 2009, PROG BRAIN RES, V177, P231, DOI 10.1016/S0079-6123(09)17716-6; COOPER E, 2006, RIGHT MEDIAN NERVE S; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; DeFina P, 2009, CLIN NEUROPSYCHOL, V23, P1391, DOI 10.1080/13854040903058978; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, pR7, DOI 10.1097/00001199-199708000-00001; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Kidd PM, 2009, ALTERN MED REV, V14, P14; Kuznetsova AY, 2008, J COMPUT NEUROSCI, V24, P314, DOI 10.1007/s10827-007-0057-3; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; *MOH NY, 2006, MOH REP REP C IMPR O; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Shepperd S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000086; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Sosin DM, 1996, BRAIN INJURY, V10, P47; TEASDALE G, 1974, LANCET, V2, P81; UEMURA Y, 1991, STROKE, V22, P1548, DOI 10.1161/01.STR.22.12.1548; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 1999, REHABILITATION ADULT, P435; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; Yamamoto T, 2003, ACTA NEUROCHIR SUPPL, V87, P15	46	15	16	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2010	28	6					769	780		10.3233/RNN-2010-0548			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	692GM	WOS:000285141300006	21209492				2022-02-06	
J	DeJong, J; Donders, J				DeJong, Joy; Donders, Jacobus			Cluster subtypes on the California Verbal Learning Test-Second Edition (CVLT-II) in a traumatic brain injury sample	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Learning; Memory; Cluster analysis; Traumatic brain injury	CONFIRMATORY FACTOR-ANALYSIS; STANDARDIZATION SAMPLE; WAIS-III; RECALL DISCRIMINABILITY; CRITERION VALIDITY; CHILDRENS VERSION; 2ND EDITION; WISC-III; PERFORMANCE; MEMORY	Subtypes of learning and memory on the California Verbal Learning Test-Second Edition (CVLT-II; Delis, Kramer, Kaplan, Ober, 2000) were examined in a clinical sample of 223 persons with traumatic brain injury (TBI), screened to remove individuals with complicating premorbid (e.g., psychiatric) or comorbid (e.g., financial compensation-seeking) histories. The z scores from 4 key CVLT-II variables were entered into a two-stage cluster analysis. These variables were selected to represent 4 latent constructs, identified in a recent confirmatory factor analysis: List A1 (Attention Span), List A5 (Learning Efficiency), Long Delay Free Recall (Delayed Memory), and False Positives (Inaccurate Memory). Six reliable subtypes were found (similar to those in the standardization sample) that were differentiated by both level and pattern of performance, with differences in level of performance meaningfully related to length of coma. In conclusion, the impact of TBI on CVLT-II performance can be manifested in various patterns that are not specifically unique, but are affected by injury severity.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com			Campbell Foundation	This research was supported by a grant from the Campbell Foundation.	Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; BLASHFIELD RK, 1976, PSYCHOL BULL, V83, P377, DOI 10.1037/0033-2909.83.3.377; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CARTER RL, 1989, PSYCHOMETRIKA, V54, P9, DOI 10.1007/BF02294446; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CVLT 2 COMPREHENSIVE; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1999, DEV NEUROPSYCHOL, V15, P395, DOI 10.1080/87565649909540757; Donders J, 2008, J CLIN EXP NEUROPSYC, V30, P741, DOI 10.1080/13803390701689595; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Donders J, 2006, PSYCHOL ASSESSMENT, V18, P458, DOI 10.1037/1040-3590.18.4.458; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; Fuerst DR, 1995, CHILD NEUROPSYCHOL, V1, P38, DOI 10.1080/09297049508401341; Hair J.F., 2002, READING UNDERSTANDIN, P147; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MILLIGAN GW, 2003, HDB PSYCHOL RES METH, V2, P165; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; *SAS I, 1990, SAS STAT US GUID VER, V0001; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; Strong CAH, 2005, J CLIN EXP NEUROPSYC, V27, P746, DOI 10.1081/13803390490919155; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Wechsler WD., 2008, WECHSLER ADULT INTEL; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	33	15	15	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	9					953	960	PII 921416138	10.1080/13803391003645640			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	676CU	WOS:000283888500005	20408004				2022-02-06	
J	Gary, KW; Ketchum, JM; Arango-Lasprilla, JC; Kreutzer, JS; Novack, T; Copolillo, A; Deng, XY				Gary, Kelli W.; Ketchum, Jessica M.; Arango-Lasprilla, Juan Carlos; Kreutzer, Jeffrey S.; Novack, Thomas; Copolillo, Al; Deng, Xiaoyan			Differences in employment outcomes 10 years after traumatic brain injury among racial and ethnic minority groups	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Traumatic brain injury; employment; minorities		Employment outcomes of racial and ethnic minority groups with traumatic brain injury (TBI) have not been thoroughly examined in the research literature beyond five years. The objective of this study was to examine differences in employment outcomes 10 years after TBI among racial and ethnic minorities. Using a multi-center, nationwide database, 382 participants (194 minorities and 188 whites) with primarily moderate to severe TBI from 16 TBI Model System Centers were examined. A logistic regression model indicated that the odds of being competitively employed versus not competitively employed at 10 years follow-up were 2.370 times greater for whites as compared to minorities after adjusting for age at injury, pre-injury employment status, cause of injury, and total length of stay (LOS). In addition, the odds of being competitively employed at 10 years follow-up versus not being competitively employed ranged from being 1.485 to 2.553 greater for those who were younger, employed at injury, had shorter total LOS, and non-violent injuries, respectively. This study supports previous research illustrating that compared to whites, employment is less promising for minorities after TBI both short and long term. Recommendations are suggested to help rehabilitation professionals target the specific needs of minorities with TBI in order to address employment disparities through culturally-based interventions and service delivery.	[Gary, Kelli W.] Virginia Commonwealth Univ, Dept Rehabil Counseling, 730 E Broad St,POB 980330, Richmond, VA 23298 USA; [Ketchum, Jessica M.; Deng, Xiaoyan] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Arango-Lasprilla, Juan Carlos; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Novack, Thomas] Univ Alabama, Dept Phys Med, Birmingham, AL, England; [Novack, Thomas] Univ Alabama, Dept Rehabil & Psychol, Birmingham, AL, England; [Copolillo, Al] Virginia Commonwealth Univ, Dept Occupat Therapy, Richmond, VA USA		Gary, KW (corresponding author), Virginia Commonwealth Univ, Dept Rehabil Counseling, 730 E Broad St,POB 980330, Richmond, VA 23298 USA.	williamsjonk@vcu.edu	Ketchum, Jessica/AAE-8200-2020		National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of EducationUS Department of Education [H133A070036, H133A070039]	The development of this manuscript was funded by the National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of Education (grant nos. H133A070036 and H133A070039).	Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gamble D, 2003, J REHABIL, V69, P31; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Haskins AR, 2006, PHYS THER, V86, P19, DOI 10.1093/ptj/86.1.19; Holmes M Anita P, 2007, N C Med J, V68, P376; Icard LD, 2003, HEALTH SOC WORK, V28, P214, DOI 10.1093/hsw/28.3.214; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lewis A, 2009, DISABIL REHABIL, V31, P1136, DOI 10.1080/09638280902773737; Mochari Heidi, 2006, Prev Cardiol, V9, P8, DOI 10.1111/j.1520-037X.2005.3703.x; Moss Kathryn, 2007, FUTURE DISABILITY AM, P453; PARRINO TA, 1990, AM J MED, V89, P491, DOI 10.1016/0002-9343(90)90381-M; Ponton M.O., 2001, NEUROPSYCHOLOGY HISP; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rumala BB, 2007, J NATL MED ASSOC, V99, P1000; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Smedley B, 2002, COMMITTEE UNDERSTAND; State University of New York at Buffalo, 1997, GUID UN SET MED REH; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; TBIMS National Database and Statistical Center, 2009, TRAUM BRAIN INJ MOD; TEASDALE G, 1974, LANCET, V2, P81; Tysinger J W, 1987, J Allied Health, V16, P209; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Wiggs JS, 2000, J NATL MED ASSOC, V92, P125; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	40	15	15	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2010	33	1					65	75		10.3233/JVR-2010-0516			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V71ZA	WOS:000211610900007					2022-02-06	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			Recreational physical activities among children with a history of severe traumatic brain injury	BRAIN INJURY			English	Article						LTPA, leisure time physical activity; TBI, traumatic brain injury; TD, typically developed; G&S, Godin and Shephard; TUG, timed up and go test; FRT, functional reach test; EEI, energy expenditure index	DISABILITIES; RELIABILITY; PARTICIPATION; EXERCISE; CAPACITY; PEOPLE; SWAY	Objective: To describe leisure time physical activity (LTPA) and physical capabilities such as balance, muscle strength and walking performance and to evaluate the associations between physical capabilities and LTPA among children post-traumatic brain injury (TBI) as compared to a peer group of typically-developed (TD) controls. Participants: Convenience sample of 15 children, 1.5-7 years post-severe TBI and 15 age- and sex-matched controls. Main outcome measures: LTPA by the Godin and Shephard (G&S) questionnaire. Balance tests-the Timed Up and Go test (TUG) and functional reach test (FRT). Maximal isometric strength was assessed by using a hand-held dynamometer; walking dynamics were recorded by an electronic mat and the 6 minute walk test and energy expenditure index (EEI). Perceived exertion was rated by the OMNI scale. Results: Children post-severe TBI participate significantly less in LTPA as compared to TD controls (p < 0.01). Walking performance was comparable between groups except for step length which was significantly shorter among children post-TBI. Hip extensor strength and balance performance were significantly lower among children post-TBI. Balance performance was positively associated with LTPA. Conclusions: This study suggests that attention should be directed towards improving balance performance as part of the training repertoire of children and adolescents with post-severe TBI. The efficacy of such a training programme, in particular its contribution to LTPA participation, should then be further assessed.	[Katz-Leurer, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Meyer, Shirley] Alyn Childrens Orthoped Hosp, Jerusalem, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Meyer, Shirley] Rehabil Ctr, Jerusalem, Israel; [Keren, Ofer] Sheba Med Ctr, Head Trauma Rehabil Dept, Tel Aviv, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; DAMIANO DL, 1995, DEV MED CHILD NEUROL, V37, P731, DOI 10.1111/j.1469-8749.1995.tb15019.x; DAULT MC, 1999, P 11 INT S AD PHYS E, P59; Donahoe B, 1994, PEDIAT PHYSICAL THER, V6, P189, DOI DOI 10.1097/00001577-199400640-00004; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, pV, DOI 10.1097/00001199-199808000-00001; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P254, DOI 10.1097/PEP.0b013e3181820dd8; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P259, DOI 10.1097/PEP.0b013e3181824782; Kinne S, 2004, AM J PUBLIC HEALTH, V94, P443, DOI 10.2105/AJPH.94.3.443; Kosak M, 2005, J REHABIL RES DEV, V42, P103, DOI 10.1682/JRRD.2003.11.0171; Livingstone MBE, 2000, MED SCI SPORT EXER, V32, P1513, DOI 10.1097/00005768-200008000-00022; Lowes LP, 1996, PEDIATR PHYS THER, V8, P176; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; RIDDLE DL, 1989, PHYS THER, V69, P182, DOI 10.1093/ptj/69.3.182; Rimmer JH, 2006, DISABIL REHABIL, V28, P1087, DOI 10.1080/09638280500493860; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Robertson RJ, 2006, MED SCI SPORT EXER, V38, P158, DOI 10.1249/01.mss.0000190595.03402.66; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SALLIS JF, 1993, MED SCI SPORT EXER, V25, P99, DOI 10.1249/00005768-199301000-00014; Shaughnessy M, 2006, REHABIL NURS, V31, P15, DOI 10.1002/j.2048-7940.2006.tb00005.x; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; World Health Organization, 2007, INT CLASS FUNCT DIS	29	15	16	1	18	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	13-14					1561	1567		10.3109/02699052.2010.523046			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800005	20973625				2022-02-06	
J	Kave, G; Kukulansky-Segal, D; Avraham, A; Herzberg, O; Landa, J				Kave, Gitit; Kukulansky-Segal, Dorit; Avraham, Ayelet; Herzberg, Orly; Landa, Janna			Searching for the Right Word: Performance on Four Word-Retrieval Tasks Across Childhood	CHILD NEUROPSYCHOLOGY			English	Article						Word retrieval; Naming; Verbal fluency; Language; Executive lexical search	HOMOPHONE MEANING GENERATION; BOSTON NAMING TEST; TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; VERBAL FLUENCY TASKS; SCHOOL-AGED CHILDREN; EXECUTIVE FUNCTIONS; NORMATIVE DATA; SPEECH PRODUCTION; FRONTAL-LOBE	Word retrieval was assessed in 207 normally developing Hebrew-speaking children aged 8-17 through four tasks: picture naming, phonemic fluency, semantic fluency, and homophone meaning generation (HMGT). Scores on all tests correlated positively and significantly with participant age. Yet, age effects and the correlation between age and test scores were weakest for the naming test and strongest for the HMGT. We discuss the nature of the word search involved in each task and suggest that the more executive demands required by a test the steeper the slope of performance increase on this test.	[Kave, Gitit] Open Univ, Dept Educ & Psychol, IL-43107 Raanana, Israel; [Kukulansky-Segal, Dorit; Avraham, Ayelet; Herzberg, Orly; Landa, Janna] Safra Childrens Hosp, Dept Pediat Rehabil, Sheba Med Ctr, Ramat Gan, Israel; [Herzberg, Orly] Tel Aviv Univ, Dept Commun Disorders, IL-69978 Tel Aviv, Israel		Kave, G (corresponding author), Open Univ, Dept Educ & Psychol, Dorothy Rothschild Campus,1 Univ Rd,POB 808, IL-43107 Raanana, Israel.	gkave@012.net.il		Kave, Gitit/0000-0002-4950-5507; Herzberg, Osnat/0000-0003-2823-7627	Chief Scientist Office of the Israeli Ministry of Health, Israel [3000003639]; Open University of Israel [46310]	This work was partially supported by grant # 3000003639 from the Chief Scientist Office of the Israeli Ministry of Health, Israel, as well as by research fund # 46310 from the Open University of Israel. We wish to thank Suzy Bracha, Odelya Chiprot, Nilly Degany, Inbar Morag, Hadas Nagar-Turgeman, Adi Shaked, Shani Waidergorean, and Rivka Ziv for their help in data collection and preparation. There are no financial or other relationships that could be interpreted as a conflict of interests.	Ameel E, 2008, J MEM LANG, V58, P262, DOI 10.1016/j.jml.2007.01.006; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Biemiller A, 2006, J EDUC PSYCHOL, V98, P44, DOI 10.1037/0022-0663.98.1.44; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Caramazza A, 2004, J EXP PSYCHOL LEARN, V30, P278, DOI 10.1037/0278-7393.30.1.278; Caramazza A, 2001, J EXP PSYCHOL LEARN, V27, P1430, DOI 10.1037//0278-7393.27.6.1430; Castner JE, 2008, J INT NEUROPSYCH SOC, V14, P890, DOI 10.1017/S1355617708081046; Cohen MJ, 1999, ARCH CLIN NEUROPSYCH, V14, P433, DOI 10.1016/S0887-6177(98)00038-9; Crawford JR, 2002, J INT NEUROPSYCH SOC, V8, P547, DOI 10.1017/S1355617702814291; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Hurks PPM, 2006, J CLIN EXP NEUROPSYC, V28, P684, DOI 10.1080/13803390590954191; Jescheniak JD, 2003, J EXP PSYCHOL LEARN, V29, P432, DOI 10.1037/0278-7393.29.3.432; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Kaplan E, 1983, BOSTON NAMING TEST; Kave G, 2006, DEV NEUROPSYCHOL, V29, P493, DOI 10.1207/s15326942dn2903_7; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Kave G, 2005, BRAIN LANG, V92, P204, DOI 10.1016/j.bandl.2004.06.004; KAVE G, PSYCHOL AGI IN PRESS; Kave G, 2008, J CLIN EXP NEUROPSYC, V30, P349, DOI 10.1080/13803390701416197; Kave G, 2007, J INT NEUROPSYCH SOC, V13, P424, DOI 10.1017/S1355617707070622; Kim H, 2008, CLIN NEUROPSYCHOL, V22, P84, DOI 10.1080/13854040601064526; KINDLON D, 1984, BRAIN LANG, V21, P255, DOI 10.1016/0093-934X(84)90050-6; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; Marien P, 1998, BRAIN LANG, V65, P447, DOI 10.1006/brln.1998.2000; Matute E, 2004, DEV NEUROPSYCHOL, V26, P647, DOI 10.1207/s15326942dn2602_7; McGregor KK, 2002, J SPEECH LANG HEAR R, V45, P332, DOI 10.1044/1092-4388(2002/026); Miozzo M, 2004, COGN NEUROPSYCHOL, V21, P840, DOI 10.1080/02643290342000573; Pineda D, 1998, INT J NEUROSCI, V96, P177, DOI 10.3109/00207459808986466; Prigatano GP, 2008, J INT NEUROPSYCH SOC, V14, P143, DOI 10.1017/S1355617708080089; Prigatano GP, 2008, BRAIN INJURY, V22, P491, DOI 10.1080/02699050802084902; Ravid D, 2002, J CHILD LANG, V29, P417, DOI 10.1017/S0305000902005111; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Sauzeon H, 2004, BRAIN LANG, V89, P192, DOI 10.1016/S0093-934X(03)00367-5; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Storms G, 2004, BRAIN LANG, V91, P274, DOI 10.1016/j.bandl.2004.03.005; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Warrington EK, 2000, J INT NEUROPSYCH SOC, V6, P643, DOI 10.1017/S1355617700666018	45	15	15	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.		2010	16	6					549	563	PII 922984093	10.1080/09297049.2010.485124			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	675XM	WOS:000283874300002	20544436				2022-02-06	
J	Kirsch, NL; de Leon, MB; Maio, RF; Millis, SR; Tan-Schriner, CU; Frederiksen, S				Kirsch, Ned L.; de Leon, Marita B.; Maio, Ronald F.; Millis, Scott R.; Tan-Schriner, Cheribeth U.; Frederiksen, Shirley			Characteristics of a Mild Head Injury Subgroup With Extreme, Persisting Distress on the Rivermead Postconcussion Symptoms Questionnaire	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; WHITE-MATTER INJURY; QUALITY-OF-LIFE; SOCIAL SUPPORT; FOLLOW-UP; RECOVERY; PREDICTORS; SEVERITY; DEPRESSION	Kirsch NL, de Leon MB, Maio RF, Millis SR, Tan-Schriner CU, Frederiksen S. Characteristics of a mild head injury subgroup with extreme, persisting distress on the Rivermead Postconcussion Symptoms Questionnaire. Arch Phys Med Rehabil 2010;91:35-42. Objective: To examine baseline variables and identify characteristics of participants with extremely high reports of symptoms (ie, outliers) 12 months after mild head injury (MHI). Design: A prospective cohort study of MHI with and without loss of consciousness (LOC) and/or posttraumatic amnesia (PTA) recruited from and interviewed at the emergency department (ED), with a follow-up telephone interview at 12 months. Setting: Level II community hospital ED. Participants: Participants (n=58) with MHI and LOC less than or equal to 30 minutes and/or PTA less than 24 hours and participants (n=173) with MHI but no PTA/LOC. Inclusion criteria: age greater than or equal to I 8 years, less than or equal to 24 hours after injury, Glasgow Coma Scale score greater than or equal to 13, and discharge from the ED. Fourteen (6%) participants had extremely high scores on the Rivermead Postconcussion Symptoms Questionnaire (RPQ). Main Outcome Measures: RPQ and questions on health services use and litigation. Results: Characterizing the outlier cases are prior head injury, preinjury disability, history of substance use, unemployment, and elevated somatic symptoms at the ED. At 12 months, outliers had higher use of health services and litigation. Conclusions: The existence of a subgroup with a distinctive pattern of baseline characteristics in combination with elevated somatic symptoms at the time of presentation to the ED suggests that further taxonomic distinctions may be warrented for the MHI population, each requiring appropriately targeted interventions for addressing symptomatic complaints.	[Kirsch, Ned L.; de Leon, Marita B.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Maio, Ronald F.; Frederiksen, Shirley] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Maio, Ronald F.] Univ Michigan, Injury Res Ctr, Ann Arbor, MI 48109 USA; [Millis, Scott R.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Tan-Schriner, Cheribeth U.] Michigan Publ Hlth Inst, Okemos, MI USA		Kirsch, NL (corresponding author), Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, 355 Briarwood Circle, Ann Arbor, MI 48109 USA.	nlkirsch@umich.edu			Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR523223-01]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Center for Medical Rehabilitation Research [5-T32-HD007422-17]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422] Funding Source: NIH RePORTER	Supported by the Centers for Disease Control (grant no. R49/CCR523223-01), the National Institutes of Health, the National Institute of Child Health and Human Development, and the National Center for Medical Rehabilitation Research (grant no. 5-T32-HD007422-17).	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cattelani R, 1996, BRAIN INJURY, V10, P187, DOI 10.1080/026990596124502; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Hoffman R. G., 1999, J FORENSIC NEUROPSYC, V1, P3, DOI DOI 10.1300/J151V01N02_02; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; McLean SA, 2004, MED HYPOTHESES, V63, P653, DOI 10.1016/j.mehy.2004.03.022; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Ocana M, 2000, BRAIN COGNITION, V44, P83, DOI 10.1006/brcg.1999.1211; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; SPINOS PC, 2007, EUR J NEUROL S1, V14, P165; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Uomoto JM, 2004, REHABIL PSYCHOL, V49, P334, DOI 10.1037/0090-5550.49.4.334; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Whiteneck G, 2001, COLORADO TRAUMATIC B; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	67	15	15	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2010	91	1					35	42		10.1016/j.apmr.2009.09.019			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	592YG	WOS:000277417300006	20103394				2022-02-06	
J	Labombarda, F; Deniselle, MCG; De Nicola, AF; Gonzalez, SL				Labombarda, Florencia; Gonzalez Deniselle, Maria Claudia; Federico De Nicola, Alejandro; Laura Gonzalez, Susana			Progesterone and the Spinal Cord: Good Friends in Bad Times	NEUROIMMUNOMODULATION			English	Article						Spinal cord injury; Progesterone; Brain-derived neurotrophic factor; Oligodendrocytes; Remyelination	NEUROTROPHIC FACTOR; NEUROPROTECTION; INJURY; EXPRESSION; RAT	In recent years, a growing list of publications point to the value of steroid hormones as an interesting option for the treatment of several type of lesions and diseases of the nervous system. Progesterone, well known for its role in pregnancy, has recently been shown to exert neuroprotective and promyelinating effects in both, the peripheral and central nervous system, including the injured spinal cord. Previous work from our laboratory has shown that progesterone actions in experimental models of spinal neurodegeneration or injury may involve the modulation of brain-derived neurotrophic factor, a neurotrophin with important implications in neuronal survival and axonal regeneration. The spinal cord is target for progesterone since neurons and glial cells express the intracellular receptors for this neuroactive steroid. However, the presence in the spinal cord of new membrane receptors and the enzymes involved in progesterone metabolism to its reduced derivatives, which modulate the activity of neurotransmitter receptors, suggest that progesterone actions involve pleiotropic mechanisms. Our recent data uncovering several molecular events may help to understand the protective and promyelinating actions of progesterone and further support the role of this steroid as a promising therapeutic agent for neurotrauma and/or neurodegenerative diseases. Copyright (C) 2010 S. Karger AG, Basel	[Labombarda, Florencia; Gonzalez Deniselle, Maria Claudia; Federico De Nicola, Alejandro; Laura Gonzalez, Susana] Consejo Nacl Invest Cient & Tecn, Lab Bioquim Neuroendocrina, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina		Gonzalez, SL (corresponding author), Univ Buenos Aires, Fac Med, Paraguay 2155,C1121ABG, Buenos Aires, DF, Argentina.	sugonza@dna.uba.ar			University of Buenos AiresUniversity of Buenos Aires [M808, M611]; National Research Council of ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5542]; FONCYTFONCyT [00291]	The authors acknowledge the support of the University of Buenos Aires (M808, M611), the National Research Council of Argentina (CONICET, PIP 5542) and FONCYT (BID 1728 OC AR/PICT 2006 No. 00291).	Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Gonzalez SL, 2009, CELL MOL NEUROBIOL, V29, P27, DOI 10.1007/s10571-008-9291-0; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; NACIMIENTO W, 1995, ACTA NEUROPATHOL, V90, P552	10	15	18	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2010	17	3					146	149		10.1159/000258709			4	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	552VS	WOS:000274322300004	20134188				2022-02-06	
J	Larsen, JD; Allen, MD; Bigler, ED; Goodrich-Hunsaker, NJ; Hopkins, RO				Larsen, James D.; Allen, Mark D.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.			Different patterns of cerebral activation in genuine and malingered cognitive effort during performance on the Word Memory Test	BRAIN INJURY			English	Article						fMRI; Word Memory Test; neuropsychological assessment; symptom validity testing; effort testing; malingering	TRAUMATIC BRAIN-INJURY; FMRI; EXAGGERATION; RECOGNITION; IMPAIRMENT; RETRIEVAL; DECEPTION; ATTENTION; RESPONSES; SEVERITY	Primary objective: The Word Memory Test (WMT) is a popular symptom validity test in which individuals are required to remember and recall semantically-related word pairs. Research shows successful WMT completion employs a wide neural network which is involved in tasks requiring high cognitive effort. The primary purpose of this study was to replicate earlier fMRI findings using a larger sample and extend previous findings by including male and female subjects. The second purpose was to investigate the neural networks involved during intentional malingering on the WMT. Research design: For all trials, a time-series ANCOVA design was implemented using SPM5 software. Methods and procedures: Ten subjects (five male and five female) underwent fMRI imaging while completing the WMT in full-effort and simulated poor effort conditions. Main outcome and results: Full-effort trials found activation peaks in dorsolateral prefrontal cortex, superior parietal lobe, anterior cingulate, bilateral lingual cortices and anterior insula/frontal operculum, supporting earlier findings. Simulated poor effort trials had similar foci of activation, with additional peak strength in surrounding cortical regions identified previously as relevant to simulated malingering. No sex differences were observed in either condition. Conclusions: These findings demonstrate the neural underpinnings of WMT performance in normal and simulated performance.	[Larsen, James D.; Allen, Mark D.; Bigler, Erin D.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larsen, James D.] Univ Hawaii, Dept Psychol, Honolulu, HI 96822 USA; [Allen, Mark D.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.; Hopkins, Ramona O.] Univ Utah, Utah Brain Inst, Salt Lake City, UT USA; [Goodrich-Hunsaker, Naomi J.] Calif State Univ Sacramento, NeuroTherapeut Res Inst, Davis Med Ctr, Sacramento, CA 95819 USA; [Goodrich-Hunsaker, Naomi J.] Calif State Univ Sacramento, Dept Psychiat & Behav Sci, Davis Med Ctr, Sacramento, CA 95819 USA; [Hopkins, Ramona O.] Intermountain Med Ctr, Dept Med, Div Pulm & Crit Care, Murray, UT USA		Allen, MD (corresponding author), Brigham Young Univ, Dept Psychol, 1022 SWKT, Provo, UT 84602 USA.	m_allen@byu.edu			College of Family, Home and Social Science, Brigham Young University	Dr Erin Bigler does forensic consultation where similar to 70% of the referrals are from the plaintiff side and 30% defense. There are no other financial interests or relationships that could be interpreted as conflicts of interest associated with any authors of this manuscript. Portions of this project were funded by grants from the College of Family, Home and Social Science, Brigham Young University.	Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bles M, 2008, NEUROCASE, V14, P82, DOI 10.1080/13554790801992784; BOONE KB, 2007, ASSESSMENT FEIGNED N; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Cabeza R, 2003, NEUROPSYCHOLOGIA, V41, P241, DOI 10.1016/S0028-3932(02)00156-2; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Csernansky JG, 2008, AM J PSYCHIAT, V165, P937, DOI 10.1176/appi.ajp.2008.08050700; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; DICHTER GS, SCHIZOPHREN IN PRESS; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Garn CL, 2009, CORTEX, V45, P610, DOI 10.1016/j.cortex.2008.02.004; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P., 2003, MANUAL WORD MEMORY T; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kingery L. R., 2007, ASSESSMENT FEIGNED C, P13; Kuo WJ, 2003, NEUROIMAGE, V18, P720, DOI 10.1016/S1053-8119(03)00015-6; Lee TMC, 2009, BRAIN COGNITION, V69, P406, DOI 10.1016/j.bandc.2008.09.002; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Radulescu AR, 2008, NEUROPSYCHOBIOLOGY, V57, P206, DOI 10.1159/000151731; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Steinbrink C, 2009, HUM BRAIN MAPP, V30, P2401, DOI 10.1002/hbm.20674; Toga AW, 2007, NEUROIMAGE, V37, P1045, DOI 10.1016/j.neuroimage.2007.02.018; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vijayaraghavan L, 2008, NEUROPSYCHOLOGY, V22, P412, DOI 10.1037/0894-4105.22.3.412; White T, 2008, SCHIZOPHRENIA BULL, V34, P18, DOI 10.1093/schbul/sbm110; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	54	15	15	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	2					89	99		10.3109/02699050903508218			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	597BF	WOS:000277729500004	20085446				2022-02-06	
S	Merikangas, KR; Swanson, SA		Stein, MB; Steckler, T		Merikangas, Kathleen Ries; Swanson, Sonja Alsemgeest			Comorbidity in Anxiety Disorders	BEHAVIORAL NEUROBIOLOGY OF ANXIETY AND ITS TREATMENT	Current Topics in Behavioral Neurosciences		English	Article; Book Chapter						Comorbidity; Anxiety disorders; NCS-R; Epidemiology; Family studies; Medical conditions	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; NATIONAL EPIDEMIOLOGIC SURVEY; MAJOR DEPRESSIVE DISORDER; CORONARY-HEART-DISEASE; SUBSTANCE USE DISORDERS; MENTAL-DISORDERS; PANIC-ATTACKS; CO-MORBIDITY; SOCIAL PHOBIA	Ever since Feinstein coined the term "comorbidity", referring to the presence of any additional coexisting ailment in a patient with a particular index disease (J Chronic Dis 23:455-468, 1970), aspects of the phenomenon have been extensively studied. The aims of this chapter are: (1) to summarize the evidence of psychiatric comorbidity in anxiety disorders from adult population-based studies; (2) to present findings from the National Comorbidity Survey Replication (NCS-R); (3) to summarize evidence of psychiatric comorbidity in anxiety disorders from child and adolescent population-based samples; (4) to provide a summary of evidence on comorbidity from family and genetic studies; and (5) to examine patterns of comorbidity between anxiety disorders and medical conditions. Throughout each of these aims, implications of the comorbidity are explored, including whether these patterns reflect a need for redefining the disorders or rather an etiologic or even causal path.	[Merikangas, Kathleen Ries; Swanson, Sonja Alsemgeest] NIMH, Genet Epidemiol Res Branch, Mood & Anxiety Disorders Program, US Dept HHS,NIH, Bethesda, MD 20892 USA; [Merikangas, Kathleen Ries] NIMH, Intramural Res Program, Bethesda, MD 20892 USA		Merikangas, KR (corresponding author), NIMH, Genet Epidemiol Res Branch, Mood & Anxiety Disorders Program, US Dept HHS,NIH, 35 Convent Dr,MSC 3720, Bethesda, MD 20892 USA.	Kathleen.Merikangas@nih.gov		Merikangas, Kathkeen/0000-0002-4667-2414	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIAMH002804] Funding Source: NIH RePORTER		Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28; ANDERSON JC, 1987, ARCH GEN PSYCHIAT, V44, P69; ANGOLD A, 1993, AM J PSYCHIAT, V150, P1779; ANGST J, 1993, INT CLIN PSYCHOPHARM, V8, P21, DOI 10.1097/00004850-199309001-00003; Aschenbrand SG, 2003, J AM ACAD CHILD PSY, V42, P1478, DOI 10.1097/00004583-200312000-00015; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P24; Barger SD, 2005, J AFFECT DISORDERS, V88, P87, DOI 10.1016/j.jad.2005.05.012; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; BIRD HR, 1988, ARCH GEN PSYCHIAT, V45, P1120; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Bovasso G, 1999, COMPR PSYCHIAT, V40, P469, DOI 10.1016/S0010-440X(99)90092-5; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; BRADY EU, 1992, PSYCHOL BULL, V111, P244, DOI 10.1037/0033-2909.111.2.244; BRESLAU N, 1991, PSYCHIAT RES, V37, P11, DOI 10.1016/0165-1781(91)90102-U; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; CANINO GJ, 1987, ARCH GEN PSYCHIAT, V44, P727; CHEN YW, 1995, AM J PSYCHIAT, V152, P280; Coelho HF, 2007, J AFFECT DISORDERS, V100, P103, DOI 10.1016/j.jad.2006.10.001; CORYELL W, 1986, AM J PSYCHIAT, V143, P508; Craske MG, 2001, J AM ACAD CHILD PSY, V40, P556, DOI 10.1097/00004583-200105000-00015; DAVIDSON JRT, 1993, PSYCHOL MED, V23, P709, DOI 10.1017/S0033291700025484; Depla MFIA, 2008, SOC PSYCH PSYCH EPID, V43, P200, DOI 10.1007/s00127-007-0291-z; EATON WW, 1990, ARCH GEN PSYCHIAT, V47, P819; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; GELLER B, 1995, J AFFECT DISORDERS, V34, P259, DOI 10.1016/0165-0327(95)00023-G; Giaconia RM, 2000, AM J ORTHOPSYCHIAT, V70, P253, DOI 10.1037/h0087634; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Goodwin RD, 2003, PSYCHOL MED, V33, P879, DOI 10.1017/S0033291703007633; Goodwin RD, 2003, J ASTHMA, V40, P139, DOI 10.1081/JAS-120017984; Goodwin RD, 2003, PSYCHIAT RES, V117, P159, DOI 10.1016/S0165-1781(02)00320-7; Goodwin RD, 2002, PSYCHOSOM MED, V64, P862, DOI 10.1097/01.PSY.0000038935.67401.F3; Goodwin RD, 2002, CHEST, V122, P645, DOI 10.1378/chest.122.2.645; Goodwin RD, 2008, J PSYCHIATR RES, V43, P239, DOI 10.1016/j.jpsychires.2008.05.006; Gotlib I.H., 1992, PSYCHOL ASPECTS DEPR; Grant BF, 2005, PSYCHOL MED, V35, P1747, DOI 10.1017/S0033291705006069; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Grant BF, 2005, J PSYCHIATR RES, V39, P1, DOI 10.1016/j.jpsychires.2004.05.004; Green H, 2005, MENTAL HLTH CHILDREN; Hamalainen J, 2008, DEPRESS ANXIETY, V25, P27, DOI 10.1002/da.20256; Haines H, 2001, HEART, V85, P385, DOI 10.1136/heart.85.4.385; Hansen S, 2003, PSYCHIAT CLIN N AM, V26, P693, DOI 10.1016/S0193-953X(03)00037-6; Harter MC, 2003, EUR ARCH PSY CLIN N, V253, P313, DOI 10.1007/s00406-003-0449-y; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hasler G, 2005, AM J RESP CRIT CARE, V171, P1224, DOI 10.1164/rccm.200412-1669OC; Hayward C, 2000, J AM ACAD CHILD PSY, V39, P207, DOI 10.1097/00004583-200002000-00021; HELZER JE, 1991, PSYCHIAT DISORDERS A; Johnson JG, 2000, JAMA-J AM MED ASSOC, V284, P2348, DOI 10.1001/jama.284.18.2348; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kagan J., 1997, GALENS PROPHECY TEMP; Kalaydjian A, 2008, PSYCHOSOM MED, V70, P773, DOI 10.1097/PSY.0b013e31817f9e80; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; KASHANI JH, 1990, AM J PSYCHIAT, V147, P313; KATON W, 1989, J CLIN PSYCHIAT, V50, P299; Kessler RC, 1999, PSYCHOL MED, V29, P555, DOI 10.1017/S0033291799008375; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; KEYL PM, 1990, AM J EPIDEMIOL, V131, P301, DOI 10.1093/oxfordjournals.aje.a115499; Klein DN, 2003, PSYCHOL MED, V33, P703, DOI 10.1017/S0033291703007487; Kovalenko PA, 2001, AUST NZ J PSYCHIAT, V35, P815, DOI 10.1046/j.1440-1614.2001.00961.x; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Kubzansky LD, 2006, ANN BEHAV MED, V31, P21, DOI 10.1207/s15324796abm3101_5; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Lewinsohn PM, 1997, J ANXIETY DISORD, V11, P377, DOI 10.1016/S0887-6185(97)00017-0; LEWINSOHN PM, 1993, J ABNORM PSYCHOL, V102, P133, DOI 10.1037/0021-843X.102.1.133; Low NCP, 2008, J PSYCHIATR RES, V42, P596, DOI 10.1016/j.jpsychires.2007.07.002; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Lydiard RB, 2001, J CLIN PSYCHIAT, V62, P17; MAIER W, 1995, J PSYCHIAT RES, V29, P375, DOI 10.1016/0022-3956(95)00024-Y; MAIER W, 1994, J PSYCHIAT RES, V28, P303, DOI 10.1016/0022-3956(94)90013-2; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; MERIKANGAS KR, 1990, ARCH GEN PSYCHIAT, V47, P849; MERIKANGAS KR, 1995, EUR ARCH PSY CLIN N, V244, P297, DOI 10.1007/BF02190407; Merikangas KR, 2003, ARCH GEN PSYCHIAT, V60, P993, DOI 10.1001/archpsyc.60.9.993; MERIKANGAS KR, 1990, COMORBIDITY MOOD ANX; Middeldorp CM, 2005, PSYCHOL MED, V35, P611, DOI 10.1017/S003329170400412X; MOLDIN SO, 1993, PSYCHOL MED, V23, P755, DOI 10.1017/S0033291700025526; Nestadt G, 2003, BIOL PSYCHIAT, V53, P914, DOI 10.1016/S0006-3223(02)01677-3; Ortega AN, 2004, PSYCHOSOMATICS, V45, P93, DOI 10.1176/appi.psy.45.2.93; Ortega AN, 2002, J NERV MENT DIS, V190, P275, DOI 10.1097/00005053-200205000-00001; ORVASCHEL H, 1995, J AM ACAD CHILD PSY, V34, P1525, DOI 10.1097/00004583-199511000-00020; Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518; Peterlin BL, 2008, HEADACHE, V48, P517, DOI 10.1111/j.1526-4610.2008.00917.x; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Ratcliffe GE, 2009, GEN HOSP PSYCHIAT, V31, P14, DOI 10.1016/j.genhosppsych.2008.09.006; REINHERZ HZ, 1989, J AM ACAD CHILD PSY, V28, P942, DOI 10.1097/00004583-198911000-00021; ROGERS MP, 1994, INT J PSYCHIAT MED, V24, P83, DOI 10.2190/TXM9-EVX8-Q4WT-G03J; Rohde P, 1996, J AM ACAD CHILD PSY, V35, P101, DOI 10.1097/00004583-199601000-00018; ROHDE P, 1991, J ABNORM PSYCHOL, V100, P214, DOI 10.1037/0021-843X.100.2.214; Sareen J, 2005, DEPRESS ANXIETY, V21, P193, DOI 10.1002/da.20072; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Sareen J, 2006, PSYCHIAT RES, V142, P11, DOI 10.1016/j.psychres.2006.01.009; Saunders K, 2008, NEUROLOGY, V70, P538, DOI 10.1212/01.wnl.0000297192.84581.21; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SCHNEIER FR, 1992, ARCH GEN PSYCHIAT, V49, P282; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Slattery MJ, 2002, J AM ACAD CHILD PSY, V41, P947, DOI 10.1097/00004583-200208000-00013; Smoller JW, 2007, ARCH GEN PSYCHIAT, V64, P1153, DOI 10.1001/archpsyc.64.10.1153; Spencer TJ, 2006, J CLIN PSYCHIAT, V67, P27; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; STEWART WF, 1989, PSYCHOSOM MED, V51, P559, DOI 10.1097/00006842-198909000-00007; Stinson FS, 2007, PSYCHOL MED, V37, P1047, DOI 10.1017/S0033291707000086; STRAUSS CC, 1988, J ABNORM CHILD PSYCH, V16, P57, DOI 10.1007/BF00910500; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Swartz KL, 2000, ARCH GEN PSYCHIAT, V57, P945, DOI 10.1001/archpsyc.57.10.945; SWENDSEN J, 2009, MENTAL DISORDERS RIS; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; WACKER HR, 1992, INT J METH PSYCH RES, V2, P91; Waldie KE, 2002, J NEUROL NEUROSUR PS, V72, P86, DOI 10.1136/jnnp.72.1.86; WISE MG, 1990, J CLIN PSYCHIAT, V51, P27; WITTCHEN H U, 1989, Psychiatrie and Psychobiologie, V4, P315; WITTCHEN HU, 1994, ARCH GEN PSYCHIAT, V51, P355; WITTCHEN HU, 1999, CHILDHOOD ONSET ADUL, P259; Zimmermann P, 2003, PSYCHOL MED, V33, P1211, DOI 10.1017/S0033291703008158	119	15	15	0	8	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	1866-3370		978-3-642-02911-0	CURR TOP BEHAV NEURO	Cur. Top. Behav. Neurosci.		2010	2						37	59		10.1007/7854_2009_32	10.1007/978-3-642-02912-7		23	Behavioral Sciences; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology	BPM17	WOS:000279232700003	21309105				2022-02-06	
J	Sonnenberg, LK; Dupuis, A; Rumney, PG				Sonnenberg, Lyn K.; Dupuis, Annie; Rumney, Peter G.			Pre-school traumatic brain injury and its impact on social development at 8 years of age	BRAIN INJURY			English	Article						Paediatric; acquired brain injury; social development; cognition; Mayo Portland Adaptive Inventory; outcomes	LONG-TERM OUTCOMES; CHILDREN; CHILDHOOD; PLASTICITY	Objective: To confirm the clinical impression that younger pre-school children (<4 years at time of injury) who are referred to a tertiary care centre for management with moderate-to-severe traumatic brain injury (TBI) have poorer social, cognitive, physical and emotional outcomes compared to older pre-schoolers (4-6 years at time of injury) and to describe the prevalence and severity of their social impairment at 8 years of age. Methods: This is a retrospective review of pre-schoolers with moderate-to-severe TBI from 1995-2009. Their social, cognitive, physical and emotional outcomes were assessed at 8 years of age using the Mayo-Portland Adaptability Inventory-Paediatric. Results: Of 130 pre-schoolers enrolled in the database who sustained a TBI < 6 years, 93 were seen at 8 years of age (57 males, 36 females). Younger pre-schoolers (n = 61, mean 2.6 years) had inferior social outcomes (p = 0.04) and cognitive abilities (p = 0.006), trended toward poorer physical outcomes (p = 0.1), with no difference for emotional outcomes (p = 0.2), compared to older pre-schoolers (n = 32, mean 5.0 years). Overall, 19/93 had normal social function, 38/93 had mild impairment, 21/93 had moderate impairment and 15/93 had severe impairment to social function. Conclusions: Children <4 years at the time of moderate-to-severe TBI have poorer social, cognitive and physical outcomes compared to older pre-schoolers.	[Rumney, Peter G.] Univ Toronto, Bloorview Kids Rehab, Div Dev Pediat, Sect Head Brain Injury & Rehabil Team, Toronto, ON M4G 1R8, Canada; [Sonnenberg, Lyn K.] Univ Alberta, Div NeuroDev NeuroMotor Paediat, Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Dupuis, Annie] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada		Rumney, PG (corresponding author), Univ Toronto, Bloorview Kids Rehab, Div Dev Pediat, Sect Head Brain Injury & Rehabil Team, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	prumney@bloorview.ca		Sonnenberg, Lyn/0000-0002-9982-4282; Dupuis, Annie/0000-0002-8704-078X			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; DIXON SD, 2006, ENCOUNTERS CHILDREN, P831; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Malec J., 2005, MAYO PORTLAND ADAPTA; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Pan SY, 2006, INJURY PREV, V12, P155, DOI 10.1136/ip.2005.010561; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	16	15	15	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	7-8					1003	1007		10.3109/02699052.2010.489033			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000010	20545454				2022-02-06	
J	Schrupp, LE; Ciuffreda, KJ; Kapoor, N				Schrupp, Laura E.; Ciuffreda, Kenneth J.; Kapoor, Neera			Foveal versus eccentric retinal critical flicker frequency in mild traumatic brain injury	OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION			English	Article						Traumatic brain injury; Acquired brain injury; Critical flicker fusion frequency; Motion sensitivity; Light sensitivity; Temporal processing		BACKGROUND: The purpose of this study was to assess the critical flicker fusion frequency (CFF) at the fovea and at 10 degrees of horizontal retinal eccentricity and to determine if there was a correlation between CFF and the degree of light and motion sensitivity in individuals with mild traumatic brain injury (TBI). METHODS: Mean CFF thresholds at the fovea, and 10 degrees to the left and right of the fovea, were obtained in 14 mild TBI and 29 visually normal subjects. A questionnaire was used to quantify the degree of light and motion sensitivity and related factors. RESULTS: There was no effect of age on CFF under any test condition in either group, nor was there a relation in the TBI group between reported light or motion sensitivity and CFF. Peripheral CFF values were lower in both populations. Among the TBI subjects, there was a trend for lower peripheral CFF values in the periphery and greater mean variability under all 3 test conditions. CONCLUSIONS: Decreased sensitivity and increased variability in CFF measurements in the TBI population can be attributed to damage to the higher visual pathways. Optometry 2009;80:642-650	[Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Vis Sci, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T35EY020481] Funding Source: NIH RePORTER		AUSTIN MW, 1994, CURR EYE RES, V13, P717, DOI 10.3109/02713689409047005; BATTERSBY WS, 1951, J EXP PSYCHOL, V42, P135, DOI 10.1037/h0057037; BATTERSBY WS, 1951, J EXP PSYCHOL, V42, P59, DOI 10.1037/h0063538; Callaway EM, 2005, J PHYSIOL-LONDON, V566, P13, DOI 10.1113/jphysiol.2005.088047; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Carmel D, 2006, CURR BIOL, V16, P907, DOI 10.1016/j.cub.2006.03.055; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Chen PC, 2000, J FORMOS MED ASSOC, V99, P45; del Romo GB, 2005, INVEST OPHTH VIS SCI, V46, P1107, DOI 10.1167/iovs.04-1138; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; GRANIT R, 1930, AM J PHYSIOL, V95, P313; Hammond BR, 2005, OPHTHAL PHYSL OPT, V25, P315, DOI 10.1111/j.1475-1313.2005.00271.x; JACKOWSKI MM, 2001, VISUAL VESTIBULAR CO, P145; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KOOI KA, 1958, NEUROLOGY, V8, P764, DOI 10.1212/WNL.8.10.764; Kurylo DD, 2006, BRAIN INJURY, V20, P237, DOI 10.1080/02699050500487415; KUYK TK, 1991, OPTOMETRY VISION SCI, V68, P786, DOI 10.1097/00006324-199110000-00005; LACHENMAYR BJ, 1994, INVEST OPHTH VIS SCI, V35, P2741; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; McKendrick A.M., 2003, ADLERS PHYSL EYE, P511; MERIGAN WH, 1990, VISUAL NEUROSCI, V5, P347, DOI 10.1017/S0952523800000432; POINTER JS, 1989, VISION RES, V29, P1133, DOI 10.1016/0042-6989(89)90061-8; Porter TC, 1902, P R SOC LONDON, V70, P313, DOI 10.1098/rspl.1902.0032; RANINEN A, 1987, J OPT SOC AM A, V4, P1620, DOI 10.1364/JOSAA.4.001620; SCHWARTZ SH, 2004, VISUAL PERCEPTION CL, P197; Seiple W, 1996, J OPT SOC AM A, V13, P658, DOI 10.1364/JOSAA.13.000658; SNELGAR RS, 1985, DOC OPHTHALMOL, V60, P79, DOI 10.1007/BF00164571; Talcott JB, 1998, NEURO-OPHTHALMOLOGY, V20, P187, DOI 10.1076/noph.20.4.187.3931; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; ZIHL J, 1990, CLIN VISION SCI, V5, P185	34	15	15	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-1839			OPTOMETRY	Optometry	NOV	2009	80	11					642	650		10.1016/j.optm.2009.04.097			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	V18QL	WOS:000208019200009	19861221				2022-02-06	
J	McQuay, N; Cipolla, J; Franges, EZ; Thompson, GE				McQuay, Nathaniel, Jr.; Cipolla, James; Franges, Eleanor Z.; Thompson, Gregory E.			The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial? Clinical article	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; recombinant activated factor VIIa; emergency craniectomy	CLOSED-HEAD-INJURY; EPIDEMIOLOGY; HEMOPHILIA; CIRRHOSIS; REVERSAL; DEATHS	Object. The role of recombinant activated factor VII (rFVIIa) in traumatic brain injury (TBI) has not been well established. This study evaluates the outcomes of using rFVIIa as first-line therapy in patients with a severe TBI requiring emergent craniotomy that are coagulopathic. Methods. The authors retrospectively reviewed patients admitted between 2003 and 2006 to a Level I trauma center with a severe TBI requiring an emergency craniotomy. Eighteen patients with coagulopathy that was corrected using rFVIIa were identified. Variables evaluated included age, injury severity score, head abbreviated injury score, Glasgow Coma Scale score, international normalized ratio, time to operation, operative procedure, thromboembolic events, and death. Results. The cohort consisted of 18 patients, predominantly male (55.6%) with a mean age of 80.5 years. The most common mechanism of injury was a fall. Coagulopathy was due to premorbid anticoagulants in 50% of the cohort. Time from admission to operation was 130 minutes. Coagulopathy reversal was complete in all 18 cases (100%). A high mortality rate (55.6%) was attributed to a high incidence of withdrawal of care (50%). The incidence of thromboembolic events was low (5.6%). Survivors, when compared with nonsurvivors, had a >3-fold increase in postoperative Glasgow Coma Scale score for similar preoperative scores. A good functional outcome was achieved in 75% of survivors with a mean follow-up period of 4.2 months. Conclusions. The use of rFVIIa in the correction of coagulopathy in patients having sustained severe TBI requiring emergency craniotomy appears to be safe and effective even among the elderly. This allows a shorter transit time to craniotomy. Its effects on mortality and long-term neurological outcome requires further investigation prospectively. (DOI: 10.3171/2009.4.JNS081611)	[McQuay, Nathaniel, Jr.; Cipolla, James] Univ Penn Hlth Syst, Dept Surg, Trauma Crit Div, St Lukes Hosp, Bethlehem, PA USA; [Franges, Eleanor Z.; Thompson, Gregory E.] St Lukes Hosp, Dept Neurosurg, Bethlehem, PA USA		McQuay, N (corresponding author), 801 Ostrum St, Bethlehem, PA 18015 USA.	mcquayn@slhn.org					Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Dager WE, 2006, PHARMACOTHERAPY, V26, P1091, DOI 10.1592/phco.26.8.1091; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Johansson PI, 2008, VOX SANG, V94, P113, DOI 10.1111/j.1423-0410.2007.01011.x; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; May AK, 1997, AM SURGEON, V63, P233; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; NESBITT L, 2006, ACAD EMERG MED, V13, pS72; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Roitberg B, 2005, NEUROSURGERY, V57, P832, DOI 10.1227/01.NEU.0000180816.80626.C2; Sachs B, 2007, SPINE, V32, P2285, DOI 10.1097/BRS.0b013e3181557d45; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stephens JM, 2007, EXPERT OPIN PHARMACO, V8, P1127, DOI 10.1517/14656566.8.8.1127; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Yusim Y, 2006, J CLIN ANESTH, V18, P545, DOI 10.1016/j.jclinane.2006.02.012	29	15	16	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2009	111	4					666	671		10.3171/2009.4.JNS081611			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	503PL	WOS:000270550000007	19425887				2022-02-06	
J	Rochette, LM; Conner, KA; Smith, GA				Rochette, Lynne M.; Conner, Kristen A.; Smith, Gary A.			The contribution of traumatic brain injury to the medical and economic outcomes of motor vehicle-related injuries in Ohio	JOURNAL OF SAFETY RESEARCH			English	Article						Injury; Brain; Traumatic; Traffic accidents; Trauma; Drinking; Alcohol; Protective devices; Prevention	UNITED-STATES; HOSPITALIZATION; HELMET; CARE; GUIDELINES; MORTALITY; ALCOHOL	Objective: To describe traumatic brain injury (TBI) among injured roadway users. Aim I assessed the association of age, gender, alcohol/drug use, safety equipment use, type of roadway user, metropolitan area, and primary payer with motor vehicle-related TBI outcome. Aim 2 assessed the relationship of motor vehicle-related TBI and risk/protective factors with medical and economic outcomes. Methods: Population-level hospital and trauma databases from the Ohio Hospital Association and Ohio Department of Public Safety, respectively, were probabilistically linked for 2003 through 2006. Injured roadway users (motor vehicle occupants, motorcyclists, bicyclists, pedestrians, and others) were assessed for TBI, ventilator use, intensive care unit (ICU) admission, injury severity score (ISS), need for rehabilitation, death, and total hospital charges. Results: The odds of a motor vehicle-related TBI were greater among those not using safety equipment (OR = 1.56). The interactions of alcohol/drug use by gender and of alcohol/drug use by location were significant. Sustaining a TBI increased the odds of requiring ventilation (OR = 3.66), being admitted to the ICU (OR = 2.51), having a high ISS (OR = 4.24), requiring rehabilitation (OR = 2.22), or death (OR = 2.52). When compared with a non-TBI, total hospital charges increased by a factor of 1.35 for a TBI. Hospital charges were $46,441 on average for individuals who sustained a TBI, whereas mean hospital charges were $32,614 for patients with a non-TBL Conclusions: Among injured roadway users, individuals who sustain a TBI are more likely to require extensive medical care and have injuries resulting in death. Impact on industry: Prevention strategies aimed at reducing alcohol use and increasing safety device use should be encouraged to reduce the burden of TBL (C) 2009 National Safety Council and Elsevier Ltd. All rights reserved.	[Rochette, Lynne M.; Conner, Kristen A.; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA		Rochette, LM (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	lynne.rochette@nationwidechildrens.org					Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Butler M. A., 1994, RURAL URBAN CONTINUU; *CDCP TASK FORC CO, 2005, GUID COMM PREV SERV; Coben JH, 2007, ACCIDENT ANAL PREV, V39, P190, DOI 10.1016/j.aap.2006.06.018; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; GABELLA B, 1995, ACCIDENT ANAL PREV, V27, P363, DOI 10.1016/0001-4575(94)00079-2; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hillary FG, 2002, BRAIN INJURY, V16, P729, DOI 10.1080/02699050110119844; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Langlois JA, 2006, TRAUMATIC BRAIN INJU; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGlincy MH, 2004, ASA P JOINT STAT M, P4001; Peden M., 2004, WHOEDMPAR20045, P31; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X	26	15	17	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	OCT	2009	40	5					353	358		10.1016/j.jsr.2009.08.003			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	532PC	WOS:000272760900003	19932315				2022-02-06	
J	Ivancevic, VG				Ivancevic, Vladimir G.			New mechanics of traumatic brain injury	COGNITIVE NEURODYNAMICS			English	Article						Traumatic brain injuries; Coupled loading-rate hypothesis; Euclidean jolt; Coupled Newton-Euler dynamics; Brain's dislocations and disclinations	FINITE-ELEMENT-ANALYSIS; CEREBROSPINAL-FLUID MOTION; ROTATIONAL ACCELERATION; PROFESSIONAL FOOTBALL; COMPACT-BONE; MODEL; STRAIN; BIOMECHANICS; DEFORMATION; IMPACT	The prediction and prevention of traumatic brain injury is a very important aspect of preventive medical science. This paper proposes a new coupled loading-rate hypothesis for the traumatic brain injury (TBI), which states that the main cause of the TBI is an external Euclidean jolt, or SE(3)-jolt, an impulsive loading that strikes the head in several coupled degrees-of-freedom simultaneously. To show this, based on the previously defined covariant force law, we formulate the coupled Newton-Euler dynamics of brain's micro-motions within the cerebrospinal fluid and derive from it the coupled SE(3)-jolt dynamics. The SE(3)-jolt is a cause of the TBI in two forms of brain's rapid discontinuous deformations: translational dislocations and rotational disclinations. Brain's dislocations and disclinations, caused by the SE(3)-jolt, are described using the Cosserat multipolar viscoelastic continuum brain model.	Def Sci & Technol Org, Land Operat Div, Adelaide, SA, Australia		Ivancevic, VG (corresponding author), Def Sci & Technol Org, Land Operat Div, Adelaide, SA, Australia.	Vladimir.Ivancevic@dsto.defence.gov.au					Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Bilby, 1968, FRACTURE ADVANCED TR, V1, P159; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Chen Z, 2008, COGN NEURODYNAMICS, V2, P257, DOI 10.1007/s11571-008-9047-z; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; Cosserat E, 1898, CR HEBD ACAD SCI, V126, P1089; Cosserat ECF., 1909, THEORIE CORPS DEFORM; EDELEN DGB, 1980, INT J ENG SCI, V18, P1095, DOI 10.1016/0020-7225(80)90112-3; Eringen, 2002, NONLOCAL CONTINUUM F; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guan Y, 2006, BIOMED SCI INSTRUM, V42, P199; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Ivancevic V, 2004, SIAM REV, V46, P455, DOI 10.1137/S003614450341313X; IVANCEVIC V, 2007, NEUROFUZZY ASS MACHI; IVANCEVIC V, 2007, COMPLEX DYNAMICS ADV; IVANCEVIC V, 2006, HUMAN LIKE BIOMECHAN; IVANCEVIC V, 2007, APPL DIFFERENTIAL GE; Ivancevic VG, 2007, STUD COMPUT INTELL, V60, P1, DOI 10.1007/978-3-540-71561-0; IVANCEVIC VG, 2007, HIGH DIMENSIONAL CHA; Ivancevic V, 2006, INT J HUM ROBOT, V3, P205, DOI 10.1142/S0219843606000680; Ivancevic V, 2007, PHYSICA A, V382, P616, DOI 10.1016/j.physa.2007.04.025; Ivancevic VG, 2008, UNDERST COMPLEX SYST, P1; JIAN G, 1995, APPL MATH MECH, V16, P493; KADIC A, 1983, GAUGE THEORY DISLOCA; KRABBEL G, 1995, J NEUROTRAUM, V12, P735, DOI 10.1089/neu.1995.12.735; LAKES RS, 1985, J APPL MECH-T ASME, V52, P234, DOI 10.1115/1.3169009; Lamb H., 1932, HYDRODYNAMICS; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leonard NE, 1997, AUTOMATICA, V33, P331, DOI 10.1016/S0005-1098(96)00176-8; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; MAIER SE, 1994, RADIOLOGY, V193, P477, DOI 10.1148/radiology.193.2.7972766; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MASON M, 2007, DISCOVER MAGAZI 0223; Mindlin R., 1965, INT J SOLID STRUCT, V1, P265, DOI DOI 10.1016/0020-7683(65)90033-8; MISRA JC, 1985, MATH MODELLING, V6, P83, DOI 10.1016/0270-0255(85)90001-6; MISRA JC, 1984, J BIOMECH, V17, P459, DOI 10.1016/0021-9290(84)90014-9; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; National Cholesterol Education Program (US). Expert Panel on Detection Treatment of High Blood Cholesterol in Adults, 2002, EXP PAN DET TREATM H; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; PARK HC, 1986, J BIOMECH, V19, P385, DOI 10.1016/0021-9290(86)90015-1; Park J, 2005, IEEE T ROBOT, V21, P850, DOI 10.1109/TRO.2005.852253; Pena A, 2005, ACT NEUR S, V95, P333; Rapp PE, 2007, COGN NEURODYNAMICS, V1, P287, DOI 10.1007/s11571-007-9027-8; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Sokoloff L, 2008, COGN NEURODYNAMICS, V2, P1, DOI 10.1007/s11571-007-9033-x; TAKAHASHI T, 2007, P 29 ANN INT C IEEE; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; VOO K, 2006, MED BIOL ENG COMPUT, V34, P375; Wolfson DR, 2005, P I MECH ENG H, V219, P63, DOI 10.1243/095441105X9237; YANG JFC, 1981, J BIOMECH ENG-T ASME, V103, P275, DOI 10.1115/1.3138292; YANG JFC, 1982, J BIOMECH, V15, P91, DOI 10.1016/0021-9290(82)90040-9; Yang W, 2001, J MECH PHYS SOLIDS, V49, P2431, DOI 10.1016/S0022-5096(01)00046-1; Yoganandan N, 2008, ANN BIOMED ENG, V36, P406, DOI 10.1007/s10439-007-9422-7; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018; [No title captured]; [No title captured]	71	15	15	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics	SEP	2009	3	3					281	293		10.1007/s11571-008-9070-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	483VX	WOS:000269000200009	19031012	Green Submitted, Green Published			2022-02-06	
J	Hanten, G; Li, XQ; Newsome, MR; Swank, P; Chapman, SB; Dennis, M; Barnes, M; Ewing-Cobbs, L; Levin, HS				Hanten, Gerri; Li, Xiaoqi; Newsome, Mary R.; Swank, Paul; Chapman, Sandra B.; Dennis, Maureen; Barnes, Marcia; Ewing-Cobbs, Linda; Levin, Harvey S.			Oral Reading and Expressive Language After Childhood Traumatic Brain Injury Trajectory and Correlates of Change Over Time	TOPICS IN LANGUAGE DISORDERS			English	Article						childhood TBI; cognition; expressive language; outcome; reading	CLOSED-HEAD INJURY; WORKING-MEMORY; CHILDREN	Oral reading and expressive language skills were examined in 2 cohorts of children aged 5-15 years, who had mild, moderate, or severe traumatic brain injury. Children recruited prospectively from time of injury were assessed on 5 occasions over 2 years in a longitudinal study of change in reading skills, using the Gray Oral Reading Test-3rd Edition, and in expressive language, using the Formulated Sentences subtest of the Clinical Evaluation of Language Fundamentals-3rd Edition. Contributions of related cognitive-linguistic skills were also examined. Children recruited retrospectively were studied on a single occasion in a cross-sectional design investigating the contribution of age-related variables to the reading and sentence formulation scores. Similar to previous studies of childhood traumatic brain injury, children injured when younger initially showed a more rapid rate of recovery but poorer overall performance on outcome measures than did children injured when older. Socioeconomic status strongly predicted outcome for both reading and expressive language.	[Hanten, Gerri; Li, Xiaoqi; Newsome, Mary R.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; [Swank, Paul; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr, Dept Pediat, Houston, TX USA; [Barnes, Marcia] Univ Texas Houston Hlth Sci Ctr, Dept Pediat, Childrens Learning Inst, Houston, TX USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Dennis, Maureen] Hosp Sick Children, Toronto, ON M5G 1X8, Canada		Hanten, G (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 1709 Dryden Rd,Ste 725, Houston, TX 77030 USA.	ghanten@bcm.edu					Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DENCKLA M B, 1974, Cortex, V10, P186; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; HANTEN G, 2008, COGNITIVE NEUROREHAB, P487; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Semel E., 1995, CLIN EVALUATION LANG, VThird; STALLINGS GA, 1995, INT NEUR ASS 23 ANN; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WEIDERHOLT JL, 1992, GRAY ORAL READING TE; Wolf M, 2000, J LEARN DISABIL-US, V33, P387, DOI 10.1177/002221940003300409; WOODCOCK R, 1989, W JOHNSON TESTS ACHI; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	20	15	15	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2009	29	3					236	248		10.1097/TLD.0b013e3181b531f0			13	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	488HT	WOS:000269340700005					2022-02-06	
J	Teasdale, TW; Emslie, H; Quirk, K; Evans, J; Fish, J; Wilson, BA				Teasdale, Thomas W.; Emslie, Hazel; Quirk, Kirsten; Evans, Jonathan; Fish, Jessica; Wilson, Barbara A.			Alleviation of carer strain during the use of the NeuroPage device by people with acquired brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							PAGING SYSTEM; CAREGIVER BURDEN; RELATIVES; MEMORY	Background: Previous studies have demonstrated the efficacy of a paging system, NeuroPage (Cambridgeshire Primary Care Trust Corporation, Fulbourn, Cambridgeshire, UK), in compensating for memory and planning dysfunctions in people with acquired brain injury (ABI; mainly stroke or traumatic brain injury). In this study, the degree to which this efficacy is accompanied by a reduced experience of strain among carers of patients with ABI was investigated. Methods: Carers of 99 people with ABI completed a questionnaire concerning strain resulting from caring for the injured individual. The questionnaire was completed at the following three time points: before the use of NeuroPage, at the end of a 7-week period of use, and, for one subgroup, a further 7 weeks after withdrawal of NeuroPage. Results: There were significant reductions in strain reported by carers following the 7-week period of NeuroPage use (Cohen's d = 0.3-0.4). This finding persisted when the carer was a spouse or a parent. The reduced strain among carers continued even after withdrawal of NeuroPage. Conclusion: The efficacy of the NeuroPage paging system for people with ABI appears to result in reduced strain for their carers.	[Emslie, Hazel; Fish, Jessica; Wilson, Barbara A.] MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Teasdale, Thomas W.] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Quirk, Kirsten; Evans, Jonathan; Wilson, Barbara A.] Princess Wales Hosp, Oliver Zangwill Ctr, Ely, Wales; [Evans, Jonathan] Univ Glasgow, Fac Med, Sect Psychol Med, Glasgow G12 8QQ, Lanark, Scotland		Wilson, BA (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England.	barbara.wilson@mrc-cbu.cam.ac.uk		Fish, Jessica/0000-0002-9337-1489	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105559837] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U105559837] Funding Source: Medline		Baronet AM, 1999, CLIN PSYCHOL REV, V19, P819, DOI 10.1016/S0272-7358(98)00076-2; Chipchase SY, 2001, DISABIL REHABIL, V23, P768; Ferrario SR, 2003, INT J GERIATR PSYCH, V18, P1110, DOI 10.1002/gps.1021; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Howell DC., 2002, STAT METHODS PSYCHOL, V5; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477	13	15	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2009	80	7					781	783		10.1136/jnnp.2008.162966			3	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	458TQ	WOS:000267046800015	19246477	Green Submitted, Bronze			2022-02-06	
J	Walz, NC; Yeates, KO; Taylor, HG; Stancin, T; Wade, SL				Walz, Nicolay Chertkoff; Yeates, Keith Owen; Taylor, H. Gerry; Stancin, Terry; Wade, Shari L.			First-Order Theory of Mind Skills Shortly After Traumatic Brain Injury in 3-to 5-Year-Old Children	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							APPEARANCE-REALITY DISTINCTION; CHILDHOOD HEAD-INJURY; FALSE BELIEF; SOCIAL COMPETENCE; OUTCOMES; COGNITION; RECOVERY; TERM	Post-acute effects of early childhood traumatic brain injury (TBI) on first-order theory of mind (ToM) skills were examined in 86 children with orthopedic injury (OI). 42 children with moderate TBI, and 17 children with severe TBI aged 3 to 5 years at the time of injury. Three-year-olds with TBI performed more poorly than 3-year-olds with OI on an apperance-reality task. The severe TBI group was impaired on false-contents tasks compared to the moderate TBI and OI groups. Age and IQ were strong predictors of ToM performance; however, the relationship between ToM and IQ was not as strong for children with TBI.	[Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp, Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, Cincinnati, OH 45229 USA; [Walz, Nicolay Chertkoff; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Ctr Biobehav Hlth, Res Inst, Columbus, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Pediat Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp, Med Ctr, Div Pediat Rehabil, Cincinnati, OH 45229 USA		Walz, NC (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, MLC 10006,2800 Winslow Ave, Cincinnati, OH 45229 USA.	nicolay.walz@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729, R01 HD042729-05, K23 HD046690, R01 HD042729] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD046690] Funding Source: NIH RePORTER		Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; *CDCP, 2000, TRAUM BRAIN INJ US A; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; EILIOTT C, 1990, DIFFERENTIAL ABILITY; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FLAVELL JH, 1983, COGNITIVE PSYCHOL, V15, P95, DOI 10.1016/0010-0285(83)90005-1; FLAVELL JH, 1986, MONOGR SOC RES CHILD, V51, pR1, DOI 10.2307/1165866; GOPNIK A, 1988, CHILD DEV, V59, P26, DOI 10.2307/1130386; Grady CL, 2002, CAN J PSYCHIAT, V47, P327, DOI 10.1177/070674370204700403; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Ladd GW, 1999, ANNU REV PSYCHOL, V50, P333, DOI 10.1146/annurev.psych.50.1.333; Langlois JA, 2006, TRAUMATIC BRAIN INJU; PARKER JG, 1987, PSYCHOL BULL, V102, P357, DOI 10.1037/0033-2909.102.3.357; Perner J, 2002, CHILD DEV, V73, P752, DOI 10.1111/1467-8624.00436; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Rice C, 1997, DEV PSYCHOL, V33, P54, DOI 10.1037/0012-1649.33.1.54; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TAYLOR HG, 1997, J INT NEUROPSYCH SOC, V3, P1; TAYLOR HG, 2008, J INT NEUROPSYCH SOC, V14, P1; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; WIIG EH, 1995, TEST LANGUAGE COMPET; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	38	15	15	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JUL-AUG	2009	34	4					507	519		10.1080/87565640902964490			13	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	478GN	WOS:000268575900009	20183714	Green Accepted			2022-02-06	
J	Dixon, MR; Tibbetts, PA				Dixon, Mark R.; Tibbetts, Pamela A.			THE EFFECTS OF CHOICE ON SELF-CONTROL	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						brain injury; choice; delayed reinforcement; impulsivity; self-control	DEFICIT HYPERACTIVITY DISORDER; DELAYED REINFORCEMENT; BRAIN-INJURY; CHILDREN; IMPULSIVITY; PREFERENCE; PARADIGM; BEHAVIOR; AUTISM	Three adolescents with traumatic brain injury performed a physical therapy task in the absence of programmed consequences or duration requirements. Next, the experimenter gave the participants the options of a smaller immediate reinforcer with no response requirement or a larger delayed reinforcer with a response requirement. Self-control training exposed participants to a procedure during which they chose between a smaller immediate reinforcer and a progressively increasing delayed reinforcer whose values varied and were determined by a die roll. The participants chose whether they or the experimenter rolled the die. All participants initially demonstrated low baseline durations of the physical therapy task, chose the smaller immediate reinforcer during the choice baseline, and changed their preference to the larger delayed reinforcer during self-control training.	[Dixon, Mark R.] So Illinois Univ, Inst Rehabil, Behav Anal & Therapy Program, Carbondale, IL 62901 USA		Dixon, MR (corresponding author), So Illinois Univ, Inst Rehabil, Behav Anal & Therapy Program, Carbondale, IL 62901 USA.	mdixon@siu.edu					Binder LM, 2000, J APPL BEHAV ANAL, V33, P233, DOI 10.1901/jaba.2000.33-233; DeLeon IG, 1996, J APPL BEHAV ANAL, V29, P519, DOI 10.1901/jaba.1996.29-519; Dixon MR, 2004, J APPL BEHAV ANAL, V37, P101, DOI 10.1901/jaba.2004.37-101; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P371, DOI 10.1901/jaba.2003.36-371; Dixon MR, 2001, J APPL BEHAV ANAL, V34, P491, DOI 10.1901/jaba.2001.34-491; Dixon MR, 2000, J APPL BEHAV ANAL, V33, P611, DOI 10.1901/jaba.2000.33-611; FALCOMATA TF, 2004, EUROPEAN J BEHAV ANA, V5, P5; FERSTER CB, 1953, J EXP PSYCHOL, V45, P218, DOI 10.1037/h0062158; Fisher WW, 1997, J APPL BEHAV ANAL, V30, P423, DOI 10.1901/jaba.1997.30-423; GROSCH J, 1981, J EXP ANAL BEHAV, V35, P3, DOI 10.1901/jeab.1981.35-3; MAZUR JE, 1978, J EXP ANAL BEHAV, V30, P11, DOI 10.1901/jeab.1978.30-11; Neef NA, 2005, J APPL BEHAV ANAL, V38, P23, DOI 10.1901/jaba.2005.146-02; Neef NA, 2001, J APPL BEHAV ANAL, V34, P397, DOI 10.1901/jaba.2001.34-397; Neef NA, 2001, J APPL BEHAV ANAL, V34, P57, DOI 10.1901/jaba.2001.34-57; RAGOTZY SP, 1988, J EXP ANAL BEHAV, V49, P191, DOI 10.1901/jeab.1988.49-191; Reeve SA, 2007, J APPL BEHAV ANAL, V40, P123, DOI 10.1901/jaba.2007.11-05; SCHWEITZER JB, 1988, J EXP ANAL BEHAV, V50, P173, DOI 10.1901/jeab.1988.50-173; Stromer R, 2000, J APPL BEHAV ANAL, V33, P359, DOI 10.1901/jaba.2000.33-359; Vollmer TR, 1999, J APPL BEHAV ANAL, V32, P451, DOI 10.1901/jaba.1999.32-451	19	15	18	0	16	JOURNAL APPL BEHAV ANAL	LAWRENCE	DEPT HUMAN DEVELOPMENT, UNIV KANSAS, LAWRENCE, KS 66045 USA	0021-8855			J APPL BEHAV ANAL	J. Appl. Behav. Anal.	SUM	2009	42	2					243	252		10.1901/jaba.2009.42-243			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	460YJ	WOS:000267229000004	19949512	Green Published, Bronze			2022-02-06	
J	Foley, C; Bracker, K; Drellich, S				Foley, Catherine; Bracker, Kiko; Drellich, Sharon			Hypothalamic-pituitary axis deficiency following traumatic brain injury in a dog	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						central diabetes insipidus; growth hormone deficiency; hypothyroidism; hypoadrenocorticism	CENTRAL DIABETES-INSIPIDUS; HEAD TRAUMA; HYPOPITUITARISM; SECONDARY; DYSFUNCTION; CAT	Objective To describe endocrine dysfunction associated with traumatic brain injury in a dog. Summary A 12-week-old dog presented with traumatic brain injury and did not respond to traditional supportive care. Continued hypothermia, electrolyte derangements, hypotension, and hyposthenuria prompted screening for and detection of several hypothalamic-pituitary disorders including: hypoadrenocorticism, central diabetes insipidus, hypothyroidism, and growth hormone deficiency. Electrolyte abnormalities, urine osmolarity, and blood pressure improved with treatment for the associated disorders. New or Unique Information Provided This is the first report of generalized hypothalamic-pituitary dysfunction or panhypopituitarism following traumatic brain injury in a dog.	[Foley, Catherine; Bracker, Kiko; Drellich, Sharon] Angell Anim Med Ctr, Boston, MA 02130 USA		Foley, C (corresponding author), Angell Anim Med Ctr, 350 S Huntington Ave, Boston, MA 02130 USA.	ce.foley@yahoo.com					Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; AUTHEMENT JM, 1989, J AM VET MED ASSOC, V194, P683; Barrett AW, 2007, AM POLIT RES, V35, P3, DOI 10.1177/1532673X06292816; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Campbell FE, 2005, AUST VET J, V83, P732, DOI 10.1111/j.1751-0813.2005.tb11578.x; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; De Tanti A, 2005, BRAIN INJURY, V19, P1277, DOI 10.1080/02699050500309270; DiBartola SP, 2006, FLUID ELECTROLYTE AC, P47; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; GREENWOOD FC, 1964, BRIT MED J, V1, P25, DOI 10.1136/bmj.1.5374.25; GUYTON AC, 2006, TXB MED PHYSL, P923; HOERLEIN B, 1978, CANINE NEUROLOGY DIA, P7; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mellanby RJ, 2005, J FELINE MED SURG, V7, P135, DOI 10.1016/j.jfms.2004.08.002; MILLER ME, 1979, ANATOMY DOG, P107; Platt SR, 1999, J AM ANIM HOSP ASSOC, V35, P117, DOI 10.5326/15473317-35-2-117; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SIEGEL ET, 1977, ENDOCRINE DIS DOG, P8; Smith JR, 2004, J SMALL ANIM PRACT, V45, P405, DOI 10.1111/j.1748-5827.2004.tb00256.x; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807	22	15	15	1	9	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1479-3261			J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	JUN	2009	19	3					269	274		10.1111/j.1476-4431.2009.00409.x			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	456KM	WOS:000266844700006	19691512				2022-02-06	
J	Vincent, DS; Berg, BW; Ikegami, K				Vincent, Dale S.; Berg, Benjamin W.; Ikegami, Keiichi			Mass-Casualty Triage Training for International Healthcare Workers in the Asia-Pacific Region Using Manikin-Based Simulations	PREHOSPITAL AND DISASTER MEDICINE			English	Article						Asia-Pacific; healthcare providers; manikin; mass-casualty incident; simulation; training; triage		Introduction: More than half of the world's disasters occur in the Asia-Pacific region. A simulation-based exercise to teach healthcare workers prehospital triage, tagging, and treatment methods was used to link disaster management theory to practice with a student-centered, hands-on educational activity. Various strategies for teaching disaster health education have been advocated, and best-practice disaster education models continue to be sought. Methods: A manikin-based, primary triage and treatment course was adapted for international healthcare providers in the Asia-Pacific region using symbolic representations of triage categories and physical findings. The pedagogical construct that was used was an interactive, formative assessment in which faculty members mediated learner information gathering and interpretation during four simulation scenarios. After establishing a multi-casualty disaster context, a wireless, audience response system anonymously collected learner responses to four clinical situations: (1) leg wound (hemorrhagic shock/immediate); (2) chest wound (tension pneumothorax/immediate); (3) head wound (traumatic brain injury/expectant); and (4) limb trauma (leg fracture/delayed). Results: There were 182 healthcare providers from eight Asia-Pacific countries (including the US) that participated in four simulation seminars. The simulation sessions were successfully tailored to groups of learners that varied in size and professional composition. Expectant and delayed triage categories posed the greatest challenge to learners. In one of two groups that were queried, learner self-confidence in applying principles of triage and treatment improved significantly. At the conclusion of the simulation sessions, learners strongly agreed that manikin-based simulation improved their understanding of triage, and should be used to teach principles of primary triage and treatment. Conclusions: Simulation training represents an opportunity to engage learners regardless of language and cultural barriers. Simulation-based training can be effective in introducing healthcare professionals to principles of primary triage and treatment in an effective and culturally sensitive manner. The characteristics of the course with respect to planned formative assessment and culturally competent scholarship were reviewed.	[Vincent, Dale S.] Univ Hawaii, John Burns Sch Med, Med Educ Bldg,212 651 Halo St, Honolulu, HI 96813 USA; [Berg, Benjamin W.; Ikegami, Keiichi] Dokkyo Med Univ, Koshigaya Hosp, Koshigaya, Japan		Vincent, DS (corresponding author), Univ Hawaii, John Burns Sch Med, Med Educ Bldg,212 651 Halo St, Honolulu, HI 96813 USA.	dvincent@hawaii.edu	Berg, Benjamin/AAL-3277-2021	Berg, Benjamin/0000-0002-4748-5020			Coelho E, CRYSTAL CLEAR; Collins Linda J., 2007, Medical Reference Services Quarterly, V26, P81, DOI 10.1300/J115v26n01_08; Cowie B., 1999, ASSESS EDUC, V6, P101, DOI [10.1080/09695949993026, DOI 10.1080/09695949993026]; Felder R. M., 1994, COOPERATIVE LEARNING; Forrest F, 1998, HOSP MED, V59, P653; Garner A, 2001, ANN EMERG MED, V38, P541, DOI 10.1067/mem.2001.119053; Garner Alan, 2003, Emerg Med (Fremantle), V15, P475, DOI 10.1046/j.1442-2026.2003.00505.x; Grube JA, 2004, J HEALTHC QUAL, V26, P19; Grube Jean A, 2004, J Healthc Qual, V26, P19; Jacobs DG, 2006, J TRAUMA, V61, P135, DOI 10.1097/01.ta.0000222384.18838.02; Jenkins JL, 2008, PREHOSP DISASTER MED, V23, P3, DOI 10.1017/S1049023X00005471; Kobayashi L, 2007, ACAD EMERG MED, V14, P1141, DOI 10.1197/j.aem.2007.05.015; Latessa R, 2005, FAM MED, V37, P12; Meleis AI, 1996, ADV NURS SCI, V19, P1, DOI 10.1097/00012272-199612000-00003; Murray V, 2006, PREHOSP DISASTER MED, V21, P156, DOI 10.1017/S1049023X00003629; Paschal CB, 2002, ADV PHYSIOL EDUC, V26, P299, DOI 10.1152/advan.00030.2002; Pradhan A, 2005, AM J OBSTET GYNECOL, V193, P1827, DOI 10.1016/j.ajog.2005.07.075; Prince Michael, 2007, J COLL SCI TEACH, V36, P14, DOI DOI 10.1002/J.2168-9830.2006.TB00884.X; Seynaeve Geert, 2004, Prehosp Disaster Med, V19, pS17; Sharma B R, 2005, J Clin Forensic Med, V12, P64, DOI 10.1016/j.jcfm.2005.01.006; Soh Eugene K, 2004, Hawaii Med J, V63, P294; Subbarao I, 2008, DISASTER MED PUBLIC, V2, P57, DOI 10.1097/DMP.0b013e31816564af; Torbeck L, 2007, MED EDUC, V41, P1088, DOI 10.1111/j.1365-2923.2007.02864.x; Vincent DS, 2003, J TELEMED TELECARE, V9, pS71, DOI 10.1258/135763303322596336; Vincent DS, 2002, J TELEMED TELECARE, V8, P71, DOI 10.1258/13576330260440925; WHO pamphlet, 2001, 001 WHO PROJ ICP DPR; [No title captured]	27	15	15	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSPITAL DISASTER	Prehospital Disaster Med.	JUN	2009	24	3					206	213		10.1017/S1049023X00006828			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V82LQ	WOS:000212319700010	19618356				2022-02-06	
J	Bahloul, M; Ben Hamida, C; Chelly, H; Chaari, A; Kallel, H; Dammak, H; Rekik, N; Bahloul, K; Ben Mahfoudh, K; Hachicha, M; Bouaziz, M				Bahloul, Mabrouk; Ben Hamida, Chokri; Chelly, Hedi; Chaari, Adel; Kallel, Hatem; Dammak, Hassen; Rekik, Noureddine; Bahloul, Kamel; Ben Mahfoudh, Kheireddine; Hachicha, Mongia; Bouaziz, Mounir			Severe head injury among children: Prognostic factors and outcome	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Acute head injury; Children; Intensive care unit; Motor vehicle accident	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; PEDIATRIC TRAUMA; INTENSIVE-CARE; SCORE; PREDICTORS; SCALE; CLASSIFICATION; HYPERGLYCEMIA; DEFINITIONS	Aim: To determine predictive factors of mortality among children after traumatic brain injury. Methods: A retrospective study over 8 years of 222 children with severe head injury (Glasgow Coma Scale score <= 8) admitted to a university hospital (Sfax, Tunisia). Basic demographic, clinical, biological and radiological data were recorded on admission and during intensive care unit stay. Results: The study included 163 boys (73.4%) and 59 girls, with mean age 7.54 +/- 3.8 years. The main cause of trauma was road traffic accident (75.7%). Mean Glasgow Coma Scale score was 6 +/- 1.5, mean Injury Severity Score (ISS) was 28.2 +/- 6.9, mean Paediatric Trauma Score (PTS) was 3.7 +/- 2.1 and mean Paediatric Risk of Mortality (PRISM) was 14.3 +/- 8.5; 54 children (24.3%) died. Univariate analysis showed that low PTS on admission, high ISS or PRISM, presence of shock or meningeal haemorrhage or bilateral mydriasis, and serum glucose > 10 mmol l(-1) were associated with mortality rate. Multivariate analysis showed that factors associated with a poor prognosis were PRISM > 20 and bilateral mydriasis on admission. Conclusions: In Tunisia, head injury is a frequent cause of hospital admission and is most often due to road traffic accidents. Short-term prognosis is poor, with a high mortality rate (24.3%), and is influenced by demographic, clinical, radiological and biological factors. (C) 2008 Elsevier Ltd. All rights reserved.	[Bahloul, Mabrouk; Ben Hamida, Chokri; Chelly, Hedi; Chaari, Adel; Kallel, Hatem; Dammak, Hassen; Rekik, Noureddine; Bouaziz, Mounir] Habib Bourguiba Univ Hosp, Dept Intens Care, Sfax, Tunisia; [Bahloul, Kamel] Habib Bourguiba Univ Hosp, Dept Neurosurg, Sfax, Tunisia; [Ben Mahfoudh, Kheireddine] Habib Bourguiba Univ Hosp, Dept Radiol, Sfax, Tunisia; [Hachicha, Mongia] Hedi Chaker Univ Hosp, Dept Paediat, Sfax, Tunisia		Bahloul, M (corresponding author), Hop Habib Bourguiba, Serv Reanimat Med, Route Ain Km 1, Sfax 3029, Tunisia.	bahloulmab@yahoo.fr	Solebo, Colette N/B-6615-2008	Solebo, Colette N/0000-0001-9764-2541; Bahloul, Mabrouk/0000-0002-6488-8294			Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Castello FV, 1999, CRIT CARE MED, V27, P985, DOI 10.1097/00003246-199905000-00041; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Diamond PT, 1996, BRAIN INJURY, V10, P413, DOI 10.1080/026990596124278; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FUKUDAT T, 1996, SHINKEI GEKA, V24, P723; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Granry JC, 2002, ANN FR ANESTH, V21, P148, DOI 10.1016/S0750-7658(01)00521-4; GREGER NG, 1986, AM J DIS CHILD, V140, P551, DOI 10.1001/archpedi.1986.02140200061028; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hill DA, 1997, J TRAUMA, V42, P62, DOI 10.1097/00005373-199701000-00011; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JAMSHID G, 2000, LANCET, V356, P923; JENNETT B, 1975, LANCET, V1, P480; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Kumaraswamy N, 2002, J CLIN NEUROSCI, V9, P251, DOI 10.1054/jocn.2001.1047; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARQUETTE CH, 1993, AM REV RESPIR DIS, V148, P138, DOI 10.1164/ajrccm/148.1.138; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; PFENNINGER EG, 1991, ACTA ANAESTH SCAND, V35, P148, DOI 10.1111/j.1399-6576.1991.tb03263.x; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; SIMPSON D, 1982, LANCET, V2, P450; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; *US DEP HHS, 1994, AHCPR PUBL, P12; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	51	15	16	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2009	40	5					535	540		10.1016/j.injury.2008.04.018			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	450UV	WOS:000266427500013	18703191				2022-02-06	
J	Kinsella, GJ; Ong, B; Tucker, J				Kinsella, Glynda J.; Ong, Ben; Tucker, Jodie			Traumatic Brain Injury and Prospective Memory in a Virtual Shopping Trip Task: Does It Matter Who Generates the Prospective Memory Target?	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; prospective memory; naturalistic task; generation effect	WORKING-MEMORY; PERFORMANCE; EVENT; ADULTS; TIME	The current study aimed to investigate prospective memory in traumatic brain injury by using a laboratory-based but naturalistic style assessment task. The objective was to determine if performance differed when the prospective memory targets were self-generated or experimenter-generated (a generation effect). Sixteen people who had sustained a traumatic brain injury and had received rehabilitation were compared to 16 healthy age-matched control participants on a naturalistic virtual measure of shopping and prospective memory. Results demonstrated that the traumatic brain group was less accurate in overall prospective remembering performance than the control group but there was a lack of difference between the self-and experimenter-generated prospective memory targets for both participant groups. Both retrospective memory and executive attention of working memory were associated with prospective memory performance in the naturalistic task. The findings of the study suggest that the generation effect commonly observed in retrospective memory performance may not impact performance in prospective memory.	[Kinsella, Glynda J.; Ong, Ben; Tucker, Jodie] La Trobe Univ, Melbourne, Vic 3086, Australia		Kinsella, GJ (corresponding author), La Trobe Univ, Melbourne, Vic 3086, Australia.	g.kinsella@latrobe.edu.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934			Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bertsch S, 2007, MEM COGNITION, V35, P201, DOI 10.3758/BF03193441; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen J., 2013, STAT POWER ANAL BEHA; Einstein G. O., 2004, MEMORY FITNESS GUIDE; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Logie R, 2004, EUR J COGN PSYCHOL, V16, P441, DOI 10.1080/09541440340000114; Marsh RL, 2000, APPL COGNITIVE PSYCH, V14, pS29, DOI 10.1002/acp.769.abs; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mulligan NW, 2004, J EXP PSYCHOL LEARN, V30, P838, DOI 10.1037/0278-7393.30.4.838; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Rendell PG, 2007, J INT NEUROPSYCH SOC, V13, P410, DOI 10.1017/S1355617707070579; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Titov N, 2000, BRAIN INJURY, V14, P877; Titov N, 2001, APPL COGNITIVE PSYCH, V15, P61, DOI 10.1002/1099-0720(200101/02)15:1<61::AID-ACP689>3.0.CO;2-Y; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	32	15	15	0	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2009	10	1			SI		45	51		10.1375/brim.10.1.45			7	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	443CQ	WOS:000265888200007					2022-02-06	
J	Pedersen, MO; Larsen, A; Pedersen, DS; Stoltenberg, M; Penkowa, M				Pedersen, Mie Ostergaard; Larsen, Agnete; Pedersen, Dan Sonne; Stoltenberg, Meredin; Penkowa, Milena			Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Dissolucytosis; Growth factor; Metallic gold; Regeneration; Traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; NEURAL STEM-CELLS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; II-DEFICIENT MICE; REACTIVE ASTROCYTES; IN-VITRO; ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX	Traumatic brain injury represents a leading cause of morbidity in young individuals and there is an imperative need for neuroprotective treatments limiting the neurologic impairment following such injury. It has recently been demonstrated that bio-liberated gold ions liberated from small metallic gold implants reduce inflammation and neuronal apoptosis, while generating an increased neuronal stem cell response following focal brain damage. In this study mice were subjected to a unilateral traumatic cryo-lesion with concomitant injection of 25-45 mu m gold particles near the lesion. Placebo-treated mice subjected to cryo-lesion served as controls. The effects of gold-treatment were investigated by examining gold-induced growth factor expression (VEGF and FGF) in the first two weeks after the insult, and the extent of the neurostimulatory effect of gold was explored by comparing cell proliferation in the subventricular zone as judged by immunohistochemical staining for CDC47. Vimentin staining revealed a decrease in activated microglia and a transient astrogliosis in response to the gold liberation. Moreover, gold ions significantly increase the expression of VEGF and FGF following trauma and a significant increase in cell proliferation in both the ipsilateral and the contralateral subventricular zone was found in response to gold-treatment. In conclusion: we confirmed the previously demonstrated anti-inflammatory effect of bioliberated gold ions, and further show that metallic gold increases growth factor expression and adult neurogenesis.	[Pedersen, Mie Ostergaard; Pedersen, Dan Sonne; Penkowa, Milena] Univ Copenhagen, Panum Inst, Sect Neuroprotect, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Larsen, Agnete; Stoltenberg, Meredin] Univ Aarhus, Inst Anat, Aarhus, Denmark		Pedersen, MO (corresponding author), Univ Copenhagen, Panum Inst, Sect Neuroprotect, Dept Neurosci & Pharmacol, Blegdamsvej 3,Bldg 18-1-45, DK-2200 Copenhagen N, Denmark.	mieped@stud.ku.dk		Larsen, Agnete/0000-0001-8765-8443	IMK Almene Fond; Aase and Ejnar Danielsens Fond; Hede Nielsen Fonden; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Horslev Fonden; Vera og Carl Michaelsens Legat; Fonden til Laegevidenskabens Fremme; Eva & Henry Fraenkels Mindefond; Dir. Leo Nielsens Legat; Kathrine og Vigo Skovgaards Fond; Kong Christian d. X's fond; Th. Maigaard's Eftf. Fru Lily Benthine Lunds Fond [1/6 1978]; Toyota Fonden; Hotelejer Edvard Johnsen og hustrus fond; Health Science at Aarhus University; Aarhus University Research Foundation	The authors are grateful for the skillful technical assistance and help of Magdalena Maria Kus, Dorete Jensen, Albert Meier, and Majken Sand. We thank our colleges Linda Locht, MD and Sara Marklund for their help in the operating theatre. We gratefully acknowledge the financial support from the following foundations: IMK Almene Fond, Aase and Ejnar Danielsens Fond, Hede Nielsen Fonden, Direktor Jacob Madsen og Hustru Olga Madsens Fond, the Horslev Fonden, Vera og Carl Michaelsens Legat, Fonden til Laegevidenskabens Fremme, Eva & Henry Fraenkels Mindefond, Dir. Leo Nielsens Legat, Kathrine og Vigo Skovgaards Fond, Kong Christian d. X's fond, Th. Maigaard's Eftf. Fru Lily Benthine Lunds Fond af 1/6 1978, Toyota Fonden, Hotelejer Edvard Johnsen og hustrus fond as well as the Faculty of Health Science at Aarhus University and the Aarhus University Research Foundation.	Agasse F, 2007, EUR J NEUROSCI, V26, P3036, DOI 10.1111/j.1460-9568.2007.05915.x; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; AZUMI N, 1987, AM J CLIN PATHOL, V88, P286, DOI 10.1093/ajcp/88.3.286; Bot PT, 2008, CURR MED CHEM, V15, P786, DOI 10.2174/092986708783955554; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Danscher G, 2002, HISTOCHEM CELL BIOL, V117, P447, DOI 10.1007/s00418-002-0400-8; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Eisler R, 2003, INFLAMM RES, V52, P487, DOI 10.1007/s00011-003-1208-2; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Griem P, 1996, Z RHEUMATOL, V55, P348; Heyworth BE, 2008, J HAND SURG-AM, V33A, P40, DOI 10.1016/j.jhsa.2007.10.009; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kabir N, 2005, ENDOCRINOLOGY, V146, P4054, DOI 10.1210/en.2005-0122; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Larsen A, 2008, HISTOCHEM CELL BIOL, V130, P681, DOI 10.1007/s00418-008-0448-1; Larsen A, 2007, HISTOCHEM CELL BIOL, V128, P1, DOI 10.1007/s00418-007-0295-5; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Meng H, 2006, NEUROSCI LETT, V393, P97, DOI 10.1016/j.neulet.2005.09.044; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Monfils MH, 2006, EUR J NEUROSCI, V24, P739, DOI 10.1111/j.1460-9568.2006.04939.x; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Nagashima M, 2000, RHEUMATOLOGY, V39, P1255, DOI 10.1093/rheumatology/39.11.1255; Nagashima M, 1999, CLIN EXP IMMUNOL, V116, P360; Nakagawa T, 2005, NEUROBIOL DIS, V20, P275, DOI 10.1016/j.nbd.2005.03.009; Paxinos G., 1997, MOUSE BRAIN STEREOTA; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 1999, EXP NEUROL, V156, P149, DOI 10.1006/exnr.1998.7009; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2006, DAN MED BULL, V53, P105; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schiff MH, 2000, SEMIN ARTHRITIS RHEU, V30, P196, DOI 10.1053/sarh.2000.16641; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Simard AR, 2004, NEUROREPORT, V15, P2305, DOI 10.1097/00001756-200410250-00001; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sun Yong, 2002, Sheng Li Ke Xue Jin Zhan, V33, P313; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thibeault SL, 2008, ANN OTO RHINOL LARYN, V117, P221, DOI 10.1177/000348940811700310; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Traber KE, 1999, INT IMMUNOL, V11, P143, DOI 10.1093/intimm/11.2.143; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; YANNI G, 1994, ANN RHEUM DIS, V53, P315, DOI 10.1136/ard.53.5.315; Yoshida S, 1999, INT IMMUNOL, V11, P151, DOI 10.1093/intimm/11.2.151; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhang CX, 2003, CURR OPIN CHEM BIOL, V7, P481, DOI 10.1016/S1367-5931(03)00081-4; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040	62	15	15	0	5	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	MAY	2009	24	5					573	586					14	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	417ZG	WOS:000264116400006	19283666				2022-02-06	
J	Staal, JA; Dickson, TC; Chung, RS; Vickers, JC				Staal, Jerome A.; Dickson, Tracey C.; Chung, Roger S.; Vickers, James C.			Disruption of the Ubiquitin Proteasome System following Axonal Stretch Injury Accelerates Progression to Secondary Axotomy	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; axonal swellings; cytoskeleton; lactacystin; MG132; neurofilament; ubiquitin	TRAUMATIC BRAIN-INJURY; SPINAL-CORD TRAUMA; WALLERIAN DEGENERATION; IN-VITRO; NEURODEGENERATIVE DISEASES; ISCHEMIC TOLERANCE; CEREBRAL-CORTEX; LACTACYSTIN; EXPRESSION; PROTEIN	The ubiquitin proteasome system (UPS) plays a vital role in the regulation of protein degradation. Ubiquitination of proteins has been implicated in the pathological cascade associated with neuronal degeneration in both neurodegenerative disease and following acquired central nervous system (CNS) injury. In the present study, we have investigated the role of the UPS following mild to moderate in vitro axonal stretch injury to mature primary cortical neurons, a model of the evolving axonal pathology characteristic of diffuse axonal injury following brain trauma. Transient axonal stretch injury in this model does not involve primary axotomy. However, delayed accumulation of ubiquitin in neuritic swellings at 48 h post-injury (PI) was present in axonal bundles, followed by approximately 60% of axonal bundles progressing to secondary axotomy at 72 h PI. This delayed accumulation of ubiquitin was temporally and spatially associated with cytoskeletal damage. Pharmacological inhibition of the UPS with both MG132 and lactacystin prior to axonal injury resulted in a significant (p < 0.05) increase in the number of axonal bundles progressing to secondary axotomy at 48 and 72 h PI. These results demonstrate that, following mild to moderate transient axonal stretch injury, UPS activity may assist structural reorganization within axons, potentially impeding secondary axotomy. Protein ubiquitination in the axon may therefore have a protective role relative to the diffuse axonal changes that follow traumatic brain injury.	[Staal, Jerome A.; Dickson, Tracey C.; Chung, Roger S.; Vickers, James C.] Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas 7001, Australia		Vickers, JC (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Bag 29, Hobart, Tas 7001, Australia.	James.Vickers@utas.edu.au	Vickers, James C/J-7464-2014; Chung, Roger/ABF-8395-2020	Vickers, James C/0000-0001-5671-4879; Chung, Roger/0000-0002-9286-947X; Dickson, Tracey/0000-0002-9196-1661	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Royal Hobart Hospital Research Foundation; Tasmanian Masonic Centenary Medical Research Foundation	This research was supported by the National Health and Medical Research Council; the Royal Hobart Hospital Research Foundation; and the Tasmanian Masonic Centenary Medical Research Foundation ( fellowship to Dr. Jerome Andrew Staal).	Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; BIZZI A, 1991, BRAIN RES, V548, P292, DOI 10.1016/0006-8993(91)91135-N; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Du YL, 2008, EXP BIOL MED, V233, P881, DOI 10.3181/0712-RM-329; Ehlers MD, 2004, TRENDS NEUROSCI, V27, P3, DOI 10.1016/j.tins.2003.10.015; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Korhonen L, 2004, J CELL BIOL, V165, P27, DOI 10.1083/jcb.200311091; Li GL, 1996, ACTA NEUROPATHOL, V91, P155, DOI 10.1007/s004010050407; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; MARTIN JE, 1990, BRAIN, V113, P1553, DOI 10.1093/brain/113.5.1553; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pan TH, 2008, BRAIN RES, V1222, P222, DOI 10.1016/j.brainres.2008.05.022; Peng ZF, 2008, NITRIC OXIDE-BIOL CH, V18, P136, DOI 10.1016/j.niox.2007.11.002; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Yew EHJ, 2005, J NEUROCHEM, V94, P943, DOI 10.1111/j.1471-4159.2005.03220.x; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang PY, 2008, ACTA PHYS-CHIM SIN, V24, P143, DOI 10.3866/PKU.WHXB20080125; Zhu W, 2008, J NEUROCHEM, V105, P1970, DOI 10.1111/j.1471-4159.2008.05330.x	45	15	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2009	26	5					781	788		10.1089/neu.2008.0669			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	452XM	WOS:000266574500012	19416018				2022-02-06	
J	Garg, S; Dobbs, MB; Schoenecker, PL; Luhmann, SJ; Gordon, JE				Garg, Sumeet; Dobbs, Matthew B.; Schoenecker, Perry L.; Luhmann, Scott J.; Gordon, J. Eric			Surgical treatment of traumatic pediatric humeral diaphyseal fractures with titanium elastic nails	JOURNAL OF CHILDRENS ORTHOPAEDICS			English	Article						Complications; Elastic nails; Fixation; Fracture; Humerus; Intramedullary; Pediatric; Trauma		Background Nearly all pediatric humeral shaft fractures can be successfully treated with closed methods. Some patients, however, require internal fixation either because of an inability to maintain an adequate reduction, significant soft tissue injury, or concomitant fractures. Methods This is a retrospective review of all traumatic humeral shaft fractures treated at our hospitals between 1999 and 2006. Thirteen pediatric patients ranging in age from 4.8 to 16.7 years (mean age 12.0 years) were treated surgically with titanium elastic nails (TENs). Relative surgical indications included open fractures, inability to maintain an acceptable reduction, the presence of ipsilateral forearm fractures (floating elbow), concomitant lower extremity fractures, and closed head injury. Two patients had associated radial nerve injury at presentation. Results The patients were followed for a mean of 29 months. All fractures healed in good alignment. There were no intraoperative complications, including neurologic or vascular injury, and no patient developed an infection postoperatively. Two patients had nail migration, one of whom developed nail protrusion through the skin. One patient with preoperative radial nerve injury ultimately underwent tendon transfer to restore wrist extension. Of the 13 patients, 12 reported a full return to sports and other activities with no limitations or discomfort. Conclusions When surgical stabilization of pediatric humeral shaft fractures is indicated, TEN fixation is effective and has a high rate of union and a low rate of complications. This technique is familiar to most orthopaedic surgeons treating pediatric fractures.	[Garg, Sumeet; Dobbs, Matthew B.; Schoenecker, Perry L.; Luhmann, Scott J.; Gordon, J. Eric] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA; [Garg, Sumeet; Dobbs, Matthew B.; Schoenecker, Perry L.; Luhmann, Scott J.; Gordon, J. Eric] St Louis Childrens Hosp, 1 Childrens Pl,Suite 4S20, St Louis, MO 63110 USA; [Dobbs, Matthew B.; Schoenecker, Perry L.; Luhmann, Scott J.; Gordon, J. Eric] St Louis Shriners Hosp, St Louis, MO USA		Gordon, JE (corresponding author), St Louis Childrens Hosp, 1 Childrens Pl,Suite 4S20, St Louis, MO 63110 USA.	Gordone@wustl.edu		Garg, Sumeet/0000-0003-1703-0276			Beaty J H, 1992, Instr Course Lect, V41, P369; BRUMBACK RJ, 1986, J BONE JOINT SURG AM, V68A, P960, DOI 10.2106/00004623-198668070-00002; Caviglia H, 2005, CLIN ORTHOP RELAT R, P49, DOI 10.1097/01.blo.0000156452.91271.fb; Chapman JR, 2000, J ORTHOP TRAUMA, V14, P162, DOI 10.1097/00005131-200003000-00002; Flynn JM, 2004, J AM ACAD ORTHOP SUR, V12, P347, DOI 10.5435/00124635-200409000-00009; Flynn JM, 2001, J PEDIATR ORTHOPED, V21, P4, DOI 10.1097/01241398-200101000-00003; Glanzmann MC, 2007, J CHILD ORTHOP, V1, P97, DOI 10.1007/s11832-007-0018-4; Gordon JE, 2007, J PEDIATR ORTHOPED, V27, P442, DOI 10.1097/01.bpb.0000271333.66019.5c; Green JK, 2005, J ORTHOP RES, V23, P1315, DOI 10.1016/j.orthres.2005.04.007; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HALL RF, 1987, J BONE JOINT SURG AM, V69A, P558, DOI 10.2106/00004623-198769040-00013; Herring JA, 2002, TACHDJIANS PEDIAT OR, P2132; Knorr P, 2003, EUR J PEDIATR SURG, V13, P44, DOI 10.1055/s-2003-38288; Kubiak EN, 2005, J BONE JOINT SURG AM, V87A, P1761, DOI 10.2106/JBJS.C.01616; LASCOMBES P, 1990, J PEDIATR ORTHOPED, V10, P167; LIGIER JN, 1985, Z KINDERCHIR, V40, P209; LIGIER JN, 1988, J BONE JOINT SURG BR, V70, P74, DOI 10.1302/0301-620X.70B1.3339064; Luhmann SJ, 2003, J PEDIATR ORTHOPED, V23, P443; Peter R E, 1992, J Orthop Trauma, V6, P14; Roposch A, 2000, J BONE JOINT SURG AM, V82A, P1447, DOI 10.2106/00004623-200010000-00011; Roposch A, 2002, J PEDIATR ORTHOPED, V22, P556; Shazar N, 1998, ORTHOPEDICS, V21, P641; Stannard JP, 2003, J BONE JOINT SURG AM, V85A, P2103, DOI 10.2106/00004623-200311000-00007; Webb L, 2003, SKELETAL TRAUMA CHIL, P322; Williams PR, 1998, INJURY, V29, P661, DOI 10.1016/S0020-1383(98)00158-2; Zatti G, 1998, J TRAUMA, V45, P1046, DOI 10.1097/00005373-199812000-00012	27	15	17	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	1863-2521	1863-2548		J CHILD ORTHOP	J. Child. Orthop.	APR	2009	3	2					121	127		10.1007/s11832-009-0166-9			7	Orthopedics; Pediatrics	Emerging Sources Citation Index (ESCI)	Orthopedics; Pediatrics	V27MG	WOS:000215363300006	19308623	Green Published			2022-02-06	
J	Kim, HK; Park, S; Srinivasan, MA				Kim, Hyun K.; Park, Shinsuk; Srinivasan, Mandayam A.			Developments in brain-machine interfaces from the perspective of robotics	HUMAN MOVEMENT SCIENCE			English	Article						Brain-machine interface; Neuroprosthesis; Neuro-robot	MOTOR CORTICAL REPRESENTATION; ARM MOVEMENTS; COMPUTER INTERFACE; MUSCLE ACTIVATION; IMPEDANCE CONTROL; CONTROL SIGNALS; NEURAL-CONTROL; FORCE; CORTEX; PERFORMANCE	Many patients suffer from the loss of motor skills, resulting from traumatic brain and spinal cord injuries, stroke, and many other disabling conditions. Thanks to technological advances in measuring and decoding the electrical activity of cortical neurons, brain-machine interfaces (BMI) have become a promising technology that can aid paralyzed individuals. In recent studies on BMI, robotic manipulators have demonstrated their potential as neuroprostheses. Restoring motor skills through robot manipulators controlled by brain signals may improve the quality of life of people with disability. This article reviews current robotic technologies that are relevant to BMI and suggests strategies that could improve the effectiveness of a brain-operated neuroprosthesis through robotics. (C) 2009 Elsevier B.V. All rights reserved.	[Park, Shinsuk] Korea Univ, Dept Mech Engn, Seoul 136713, South Korea; [Kim, Hyun K.] Samsung Elect Co Ltd, Mechatron & Mfg Technol Ctr, Suwon, South Korea; [Srinivasan, Mandayam A.] MIT, Touch Lab, Cambridge, MA 02139 USA		Park, S (corresponding author), Korea Univ, Dept Mech Engn, Anam Dong, Seoul 136713, South Korea.	sspark@alum.mit.edu					Ambrose RO, 2000, IEEE INTELL SYST APP, V15, P57, DOI 10.1109/5254.867913; Bicchi A, 2001, IROS 2001: PROCEEDINGS OF THE 2001 IEEE/RJS INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1864, DOI 10.1109/IROS.2001.976345; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Buneo CA, 2003, EXP BRAIN RES, V153, P134, DOI 10.1007/s00221-003-1586-2; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Burstedt MKO, 1997, EXP BRAIN RES, V117, P67, DOI 10.1007/s002210050200; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Endo G, 2005, IEEE INT CONF ROBOT, P596; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; GISZTER SF, 1993, J NEUROSCI, V13, P467; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Grasso R, 2004, BRAIN, V127, P1019, DOI 10.1093/brain/awh115; HANNAFORD B, 1991, IEEE T SYST MAN CYB, V21, P1764; Hashimoto K, 2006, IEEE INT CONF ROBOT, P1213, DOI 10.1109/ROBOT.2006.1641874; HAYATI S, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P1310, DOI 10.1109/ROBOT.1989.100161; Hirai K, 1998, IEEE INT CONF ROBOT, P1321, DOI 10.1109/ROBOT.1998.677288; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HOGAN N, 1985, J DYN SYST-T ASME, V107, P1, DOI 10.1115/1.3140702; Hogan N, 2002, J MECH MED BIOL, V2, P359, DOI 10.1142/S0219519402000460; Humphrey D R, 1983, Adv Neurol, V39, P347; Jones L, 1997, PRESENCE-VIRTUAL AUG, V6, P29, DOI 10.1162/pres.1997.6.1.29; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; KIM H, 2006, THESIS MIT CAMBRIDGE; Kim HK, 2007, IEEE T BIO-MED ENG, V54, P1520, DOI 10.1109/TBME.2007.900818; Kim HK, 2006, IEEE T BIO-MED ENG, V53, P1164, DOI 10.1109/TBME.2006.870235; Kim J, 2004, PRESENCE-TELEOP VIRT, V13, P328, DOI 10.1162/1054746041422370; KIMURA H, 2003, 8 INT C SIM AD BEH, P201; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Lebedev MA, 2001, EUR J NEUROSCI, V13, P1002, DOI 10.1046/j.0953-816x.2001.01457.x; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; MASSIMINO MJ, 1994, HUM FACTORS, V36, P145, DOI 10.1177/001872089403600109; MATARIC M, 1998, P 5 INT C SOC AD BEH, P165; McMahon TA., 1984, MUSCLES REFLEXES LOC; MEEK S G, 1989, Journal of Rehabilitation Research and Development, V26, P53; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MORITA T, 1995, IEEE INT CONF ROBOT, P2469, DOI 10.1109/ROBOT.1995.525630; MORRELL JB, 1995, P IEEE RSJ INT C INT, V1, P391; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; NIEMEYER G, 1991, IEEE J OCEANIC ENG, V16, P152, DOI 10.1109/48.64895; Obermaier B, 2003, IEEE T NEUR SYS REH, V11, P422, DOI 10.1109/TNSRE.2003.816866; Park JH, 2001, IEEE T ROBOTIC AUTOM, V17, P870, DOI 10.1109/70.976014; PESERAN B, 2002, NAT NEUROSCI, V5, P805; Rancourt D, 2001, J MOTOR BEHAV, V33, P193, DOI 10.1080/00222890109603150; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; SALISBURY K, 1988, IEEE T AERO ELEC SYS, V24, P591, DOI 10.1109/7.9687; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schmidt E. M., 1999, CRC METH NEUROSCI S; SCHMIDT EM, 1980, ANN BIOMED ENG, V8, P339, DOI 10.1007/BF02363437; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Schwartz AB, 2001, CURR OPIN NEUROBIOL, V11, P701, DOI 10.1016/S0959-4388(01)00272-0; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Sheridan TB, 1992, TELEROBOTICS AUTOMAT; TAGA G, 1995, BIOL CYBERN, V73, P97, DOI 10.1007/s004220050166; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Taylor DM, 2003, IEEE T NEUR SYS REH, V11, P195, DOI 10.1109/TNSRE.2003.814451; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Todorov E., 2003, PROGR MOTOR CONTROL, V3, P125; Tonietti G, 2005, IEEE INT CONF ROBOT, P526; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; TURKI L, 1995, P 4 IEEE INT WORKSH, V5, P141; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Williamson M.M., 1995, P 1995 IEEE RSJ INT, P1208, DOI DOI 10.1109/IROS.1995.525827; Williamson MM, 1998, NEURAL NETWORKS, V11, P1379, DOI 10.1016/S0893-6080(98)00048-3; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zinn M, 2004, IEEE INT CONF ROBOT, P249, DOI 10.1109/ROBOT.2004.1307159; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1016/0013-4694(91)90040-B	92	15	16	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2009	28	2					191	203		10.1016/j.humov.2008.12.001			13	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	433AV	WOS:000265176700003	19230997				2022-02-06	
J	Pyne-Geithman, GJ; Caudell, DN; Cooper, M; Clark, JF; Shutter, LA				Pyne-Geithman, Gail J.; Caudell, Danielle N.; Cooper, Matthew; Clark, Joseph F.; Shutter, Lori A.			Dopamine D-2-Receptor-Mediated Increase in Vascular and Endothelial NOS Activity Ameliorates Cerebral Vasospasm After Subarachnoid Hemorrhage In Vitro	NEUROCRITICAL CARE			English	Article						Vasospasm; Intracranial; Subarachnoid hemorrhage (SAH); Dopamine; Nitric oxide; Nitric oxide synthase	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE; INTRAVENOUS-INFUSION; DOUBLE-BLIND; BLOOD-FLOW; NIMODIPINE; THERAPY; PHOSPHORYLATION; BROMOCRIPTINE	Cerebral vasospasm after subarachnoid hemorrhage (SAH) is a serious complication resulting in delayed neurological deficit, increased morbidity, mortality, longer hospital stays, and rehabilitation time. It afflicts approximately 35 per 100,000 Americans per year, and there is currently no effective therapy. We present in vitro data suggesting that increasing intrinsic nitric oxide relaxation pathways in vascular smooth muscle via dopaminergic agonism ameliorates cerebral vasospasm after SAH. Cerebrospinal fluid (CSF) from patients with cerebral vasospasm after SAH (CSFV) was used to induce vasospasm in porcine carotid artery in vitro. Dopamine was added to test its ability to reverse spasm, and specific dopamine receptor antagonists were used to determine which receptor mediated the protection. Immunohistochemical techniques confirmed the presence of dopamine receptor subtypes and the involvement of NOS in the mechanism of dopamine protection. Dopamine receptor 1, 2, and 3 subtypes are all present in porcine carotid artery. Dopamine significantly reversed spasm in vitro (67% relaxation), and this relaxation was prevented by Haloperidol, a D2R antagonist (10% relaxation, P < 0.05), but not by D-1 or D-3-receptor antagonism. Both eNOS and iNOS expression were increased significantly in response to CSFV alone, and this was significantly enhanced by addition of dopamine, and blocked by Haloperidol. Cerebral vasospasm is significantly reversed in a functional measure of vasospasm in vitro by dopamine, via a D2R-mediated pathway. The increase in NOS protein seen in both the endothelium and vascular smooth muscle in response to CSFV is enhanced by dopamine, also in a D2R-dependent mechanism.	[Pyne-Geithman, Gail J.; Caudell, Danielle N.; Cooper, Matthew; Clark, Joseph F.; Shutter, Lori A.] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA; [Shutter, Lori A.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA; [Shutter, Lori A.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA		Pyne-Geithman, GJ (corresponding author), Univ Cincinnati, Dept Neurol, 3125 Eden Ave,2324 Vontz Ctr, Cincinnati, OH 45267 USA.	pynegj@ucmail.uc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R0 1NS049428]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK060444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049428] Funding Source: NIH RePORTER	The authors thank Dr. Kenneth Wagner for excellent discussions and Mrs. Shauna Beiler for porcine tissue supply. They also thank Amanda Harm and Ashlie Saffire for immunohistochemical technical assistance. This project was funded by NIH 5R0 1NS049428 (Pyne-Geithman PI).	AFSHAR JKB, 1995, J NEUROSURG, V83, P118, DOI 10.3171/jns.1995.83.1.0118; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Cadoux-Hudson TAD, 2001, ACTA NEUROCHIR, V143, P65, DOI 10.1007/s007010170140; CALNE DB, 1974, BMJ-BRIT MED J, V4, P442, DOI 10.1136/bmj.4.5942.442; Choi JK, 2006, NEUROIMAGE, V30, P700, DOI 10.1016/j.neuroimage.2005.10.029; Clark JF, 2001, ACTA NEUROCHIR, V143, P721, DOI 10.1007/s007010170052; Costa MA, 2006, LIFE SCI, V78, P1543, DOI 10.1016/j.lfs.2005.07.024; Czerniczyniec A, 2007, BBA-BIOENERGETICS, V1767, P1118, DOI 10.1016/j.bbabio.2007.07.005; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; GILSBACH JM, 1990, NEUROSURGERY, V26, P458, DOI 10.1227/00006123-199003000-00013; Haynes V, 2004, J BIOENERG BIOMEMBR, V36, P341, DOI 10.1023/B:JOBB.0000041765.27145.08; Koide M, 2002, NEUROSURGERY, V51, P1468, DOI 10.1227/01.NEU.0000036389.57399.DS; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Lee KH, 2006, NEUROCRIT CARE, V4, P68, DOI 10.1385/NCC:4:1:068; Melis MR, 1996, EUR J NEUROSCI, V8, P2056, DOI 10.1111/j.1460-9568.1996.tb00725.x; MILLER JA, 1995, STROKE, V26, P2260, DOI 10.1161/01.STR.26.12.2260; MONCADA S, 1991, PHARMACOL REV, V43, P109; OHMAN J, 1991, J NEUROSURG, V74, P8, DOI 10.3171/jns.1991.74.1.0008; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Pluta RM, 1996, J NEUROSURG, V84, P648, DOI 10.3171/jns.1996.84.4.0648; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Pyne GJ, 2000, BBA-GEN SUBJECTS, V1474, P283, DOI 10.1016/S0304-4165(00)00030-1; Pyne GJ, 1998, BIOPHYS J, V74, pA256; Salum C, 2006, PSYCHOPHARMACOLOGY, V185, P133, DOI 10.1007/s00213-005-0277-z; Sammut S, 2006, NEUROPSYCHOPHARMACOL, V31, P493, DOI 10.1038/sj.npp.1300826; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; Schneider WN, 1999, BRAIN INJURY, V13, P863; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Teitelman E, 2001, AM J PSYCHIAT, V158, P970, DOI 10.1176/appi.ajp.158.987.970-a; VONESSEN C, 1981, STROKE, V12, P331, DOI 10.1161/01.STR.12.3.331; VONESSEN C, 1980, SURG NEUROL, V13, P181; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; WHITFIELD PC, 1994, BRIT J HOSP MED, V52, P539; Wolf EW, 1998, J NEUROSURG, V89, P279, DOI 10.3171/jns.1998.89.2.0279; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	39	15	18	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2009	10	2					225	231		10.1007/s12028-008-9143-2			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	414XP	WOS:000263898800013	18807216	Green Accepted			2022-02-06	
J	Siegmund, GP; Blouin, JS				Siegmund, Gunter P.; Blouin, Jean-Sebastien			Head and neck control varies with perturbation acceleration but not jerk: implications for whiplash injuries	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							REAR-END IMPACTS; FACET JOINT KINEMATICS; POSTURAL RESPONSES; MUSCLE-ACTIVITY; SEATED SUBJECTS; STARTLE; HUMANS; TRANSLATION; VARIABILITY; MOVEMENTS	Recent studies have proposed that a high rate of acceleration onset, i.e. high jerk, during a low-speed vehicle collision increases the risk of whiplash injury by triggering inappropriate muscle responses and/or increasing peak head acceleration. Our goal was to test these proposed mechanisms at realistic jerk levels and then to determine how collision jerk affects the potential for whiplash injuries. Twenty-three seated volunteers (8 F, 15 M) were exposed to multiple experiments involving perturbations simulating the onset of a vehicle collision in eyes open and eyes closed conditions. In the first experiment, subjects experienced five forward and five rearward perturbations to look for the inappropriate muscle responses and 'floppy' head kinematics previously attributed to high jerk perturbations. In the second experiment, we independently varied the jerk (similar to 125 to 3 000 ms(-3)) and acceleration (similar to 0.65 to 2.6 g) of the perturbation to assess their effect on the electromyographic (EMG) responses of the sternocleidomastoid (SCM), scalene (SCAL) and cervical paraspinal (PARA) muscles and the kinematic responses of the head and neck. In the first experiment, we found neither inappropriate muscle responses nor floppy head kinematics when subjects had their eyes open, but observed two subjects with floppy head kinematics with eyes closed. In the second experiment, we found that about 70% of the variations in the SCM and SCAL responses and about 95% of the variations in head/neck kinematics were explained by changes in perturbation acceleration in both the eyes open and eyes closed conditions. Less than 2% of the variation in the muscle and kinematic responses was explained by changes in perturbation jerk and, where significant, response amplitudes diminished with increasing jerk. Based on these findings, collision jerk appears to have little or no role in the genesis of whiplash injuries in low-speed vehicle crashes.	[Siegmund, Gunter P.] MEA Forens Engn & Scientists, Richmond, BC V7A 4S5, Canada; [Siegmund, Gunter P.; Blouin, Jean-Sebastien] Univ British Columbia, Sch Human Kinet, Vancouver, BC V5Z 1M9, Canada		Siegmund, GP (corresponding author), MEA Forens Engn & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada.	gunter.siegmund@meaforensic.com	Siegmund, Gunter P/B-7003-2013	Siegmund, Gunter/0000-0003-2387-941X	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; BC Neurotrauma Grant; MEA Forensic Engineers Scientists; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Chiropractic Research Foundation; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	This work was funded by the Natural Sciences and Engineering Research Council of Canada, BC Neurotrauma Grant and MEA Forensic Engineers & Scientists. JSB received salary support from the Canadian Institutes of Health Research - Canadian Chiropractic Research Foundation and Michael Smith Foundation for Health Research.	Allum JHJ, 1997, J VESTIBUL RES-EQUIL, V7, P189; Blouin JS, 2007, J APPL PHYSIOL, V102, P1574, DOI 10.1152/japplphysiol.00703.2006; Blouin JS, 2006, J PHYSIOL-LONDON, V573, P857, DOI 10.1113/jphysiol.2006.108274; Blouin JS, 2006, SPINE, V31, P146, DOI 10.1097/01.brs.0000195157.75056.df; Blouin JS, 2003, NEUROSCI LETT, V347, P1, DOI 10.1016/S0304-3940(03)00632-3; Blouin JS, 2003, EXP BRAIN RES, V150, P458, DOI 10.1007/s00221-003-1466-9; Brault JR, 2000, CLIN BIOMECH, V15, P426, DOI 10.1016/S0268-0033(99)00097-2; Buchanan JJ, 1999, J NEUROPHYSIOL, V81, P2325, DOI 10.1152/jn.1999.81.5.2325; Castro W H, 1997, Eur Spine J, V6, P366, DOI 10.1007/BF01834062; Corna S, 1999, EXP BRAIN RES, V124, P331, DOI 10.1007/s002210050630; EVANS RW, 1992, NEUROL CLIN, V10, P975, DOI 10.1016/S0733-8619(18)30191-9; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; GRESTY M, 1989, MOVEMENT DISORD, V4, P233, DOI 10.1002/mds.870040305; GUITTON D, 1986, EXP BRAIN RES, V64, P59; Hernandez IA, 2006, EUR SPINE J, V15, P876, DOI 10.1007/s00586-005-0956-9; Hynes LM, 2008, ACCIDENT ANAL PREV, V40, P1063, DOI 10.1016/j.aap.2007.11.012; Ivancic PC, 2004, EUR SPINE J, V13, P61, DOI 10.1007/s00586-003-0590-3; Jones TA, 1998, J VESTIBUL RES-EQUIL, V8, P253; Kanaya T, 1995, J PHYSIOL-LONDON, V489, P895, DOI 10.1113/jphysiol.1995.sp021102; KRAFFT M, 2005, P 19 ESV C; Krafft M., 2002, TRAFFIC INJ PREV, V3, P141, DOI [10.1080/15389580212001, DOI 10.1080/15389580212001]; Kumar S, 2002, SPINE, V27, P1044, DOI 10.1097/00007632-200205150-00009; Kumar S, 2000, ACCIDENT ANAL PREV, V32, P233, DOI 10.1016/S0001-4575(99)00114-1; Magnusson ML, 1999, EUR SPINE J, V8, P118, DOI 10.1007/s005860050140; Ono K, 1996, ACCIDENT ANAL PREV, V28, P493, DOI 10.1016/0001-4575(96)00019-X; ONO K, 1997, P 41 STAPP CAR CRASH, V41, P39; PADGAOKAR AJ, 1975, T AM SOC MECH ENG, V75, P522; Pearson AM, 2004, SPINE, V29, P390, DOI 10.1097/01.BRS.0000090836.50508.F7; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Siegmund GP, 2002, EXP BRAIN RES, V144, P314, DOI 10.1007/s00221-002-1048-2; SIEGMUND GP, 1997, P 41 STAPP CAR CRASH, V41, P357; Siegmund GP, 2008, EXERC SPORT SCI REV, V36, P76, DOI 10.1097/JES.0b013e318168f1ce; Siegmund Gunter P, 2004, Stapp Car Crash J, V48, P419; Siegmund GP, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-80; Stemper BD, 2004, SPINE, V29, P1764, DOI 10.1097/01.BRS.0000134563.10718.A7; Sterner Y, 2004, J REHABIL MED, V36, P193, DOI 10.1080/16501970410030742; SZABO TJ, 1996, P 40 STAPP CAR CRASH, V40, P295; Vibert N, 2006, GAIT POSTURE, V23, P355, DOI 10.1016/j.gaitpost.2005.04.006; Vibert N, 2001, J PHYSIOL-LONDON, V532, P851, DOI 10.1111/j.1469-7793.2001.0851e.x	40	15	15	1	10	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	APR	2009	587	8					1829	1842		10.1113/jphysiol.2009.169151			14	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	439GY	WOS:000265616800017	19237420	Green Published			2022-02-06	
J	Wang, SM; Tsai, HP; Huang, JJ; Huang, HC; Lin, JL; Liu, PH				Wang, Shang-Ming; Tsai, Hui-Ping; Huang, Jiun-Jen; Huang, Hsuan-Chi; Lin, Jia-Li; Liu, Pei-Hsin			Inhibition of nitric oxide synthase promotes facial axonal regeneration following neurorrhaphy	EXPERIMENTAL NEUROLOGY			English	Article						Axotomy; Facial motoneuron; NO; NOS; Oxidative stress; Electromyography; Peripheral nerve repair; Axonal regeneration; NOS inhibitor; Neuromuscular junction	TRAUMATIC BRAIN-INJURY; SPINAL ROOT AVULSION; MICROTUBULE-ASSOCIATED PROTEIN-2; IN-VITRO; ENDOTHELIAL-CELLS; OXIDATIVE DAMAGE; MOTONEURON DEATH; MOUSE MODEL; ADULT RATS; NERVE	Reconnection of interrupted peripheral nerve by microsurgical suture is a common clinical practice. However, the extent to which peripheral neurorrhaphy improves nerve regeneration and functional recovery remains unsatisfactory. Here, we used anatomical and electrophysiological techniques to investigate the temporal correlation between the expressions of oxidative stress-related biomarkers such as neuronal nitric oxide synthase (nNOS) and the facial axonal regeneration after an immediate facial nerve repair in adult rats since peripheral nerve lesion is well known to induce a dramatic increase of NOS expression in the affected neuronal cell bodies. We found that compared to nerve cut without suture, facial nerve repair not only caused the facial axonal regeneration but also consistently prevented the fluctuations of expressions of oxidative stress-related biomakers in 10 weeks postlesion. To further elucidate the role of nitric oxide (NO) in the axonal degeneration/regeneration, four different NOS inhibitors were applied to additional rats after facial nerve Cut or repair. Both of facial nerve cut + NOS inhibition and facial nerve repair + NOS inhibition were seen to prevent the alterations of expressions of the biomakers, no matter which NOS inhibitor was used. Moreover, we found that facial nerve repair + NOS inhibition promoted earlier and better axonal regeneration than facial nerve repair, demonstrated by labeling of neuromuscular junctions, retrograde tracing, and electromyography. These results provide direct evidence that peripheral nerve Suture and/or treatment of NOS inhibitors can maintain the homeostasis of oxidative stress-related biomarkers, especially nNOS in neuronal cell bodies. These actions may thus facilitate the axonal regeneration. (C) 2009 Elsevier Inc. All rights reserved.	[Huang, Hsuan-Chi; Liu, Pei-Hsin] Tzu Chi Univ, Inst Physiol & Anat Med, Hualien 97004, Taiwan; [Wang, Shang-Ming; Tsai, Hui-Ping; Huang, Jiun-Jen; Lin, Jia-Li] Tzu Chi Univ, Inst Neurosci, Hualien, Taiwan		Liu, PH (corresponding author), Tzu Chi Univ, Inst Physiol & Anat Med, 701,Sect 3,Chung Yang Rd, Hualien 97004, Taiwan.	peihsin@mail.tcu.edu.tw		Liu, Pei-Hsin/0000-0002-1398-7006	Tzu Chi University [TCMRC94017]	The study was supported by research grants from the Tzu Chi University to Pei-Hsin Liu (TCMRC94017).	Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Cappelletti G, 2004, FEBS LETT, V562, P35, DOI 10.1016/S0014-5793(04)00173-5; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Frankfurt OS, 1996, EXP CELL RES, V226, P387, DOI 10.1006/excr.1996.0240; FU SY, 1995, J NEUROSCI, V15, P3876; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; Garthwaite G, 2002, NEUROSCIENCE, V109, P145, DOI 10.1016/S0306-4522(01)00447-X; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GuntinasLichius O, 1997, J COMP NEUROL, V387, P234, DOI 10.1002/(SICI)1096-9861(19971020)387:2<234::AID-CNE5>3.0.CO;2-1; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; He Y, 2002, J NEUROSCI, V22, P5982; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Keilhoff G, 2002, J NEUROSCI RES, V68, P432, DOI 10.1002/jnr.10229; Landino LM, 2007, CHEM RES TOXICOL, V20, P1693, DOI 10.1021/tx7001492; Landino LM, 2004, J BIOL CHEM, V279, P35101, DOI 10.1074/jbc.M405471200; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu PH, 2006, J NEUROTRAUM, V23, P1857, DOI 10.1089/neu.2006.23.1857; Liu PH, 2004, ANAT EMBRYOL, V207, P439, DOI 10.1007/s00429-003-0361-2; Marino J, 2003, J NEUROSCI, V23, P4299; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Obal I, 2006, J COMP NEUROL, V499, P17, DOI 10.1002/cne.21041; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Raivich G, 1998, J NEUROSCI, V18, P5804; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Rothe F, 2002, NITRIC OXIDE-BIOL CH, V6, P9, DOI 10.1006/niox.2001.0390; RUAN RS, 1995, BRAIN RES, V698, P163, DOI 10.1016/0006-8993(95)00887-V; Shrager P, 1998, J NEUROPHYSIOL, V79, P529, DOI 10.1152/jn.1998.79.2.529; Stenger S, 1995, EUR J PHARMACOL, V294, P703, DOI 10.1016/0014-2999(95)00618-4; Stoll G, 1999, BRAIN PATHOL, V9, P313; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; Varathan V, 2001, J NEUROSCI RES, V66, P428, DOI 10.1002/jnr.1235; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wu WT, 2004, J NEUROTRAUM, V21, P1050, DOI 10.1089/0897715041651006; Wu WT, 2003, J NEUROTRAUM, V20, P603, DOI 10.1089/089771503767168528; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; ZEMBOWICZ A, 1991, P NATL ACAD SCI USA, V88, P11172, DOI 10.1073/pnas.88.24.11172	51	15	18	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2009	216	2					499	510		10.1016/j.expneurol.2009.01.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424ZK	WOS:000264606600032	19320008				2022-02-06	
J	Formisano, R; Cicinelli, P; Buzzi, MG; Brunelli, S; Zafonte, R; Vinicola, V; Gabrielli, A; Sabatini, U				Formisano, Rita; Cicinelli, Paola; Buzzi, Maria Gabriella; Brunelli, Stefano; Zafonte, Ross; Vinicola, Vincenzo; Gabrielli, Andrea; Sabatini, Umberto			Blink reflex changes in parkinsonism following severe traumatic brain injury correlates with diffuse axonal injury	MEDICAL SCIENCE MONITOR			English	Article						post-traumatic parkinsonism; severe traumatic brain injury; coma; blink reflex habituation; diffuse axonal injury	PERSISTENT VEGETATIVE STATE; RECOVERY; BLEPHAROSPASM; DEFINITION; LEVODOPA; LESIONS	Background: Survivors Of severe traumatic brain injury (TBI) may show transient or persistent extrapyramidal symptoms such as rigidity, akinesia and parkinsonian posture, associated with hypomimia, not estinguishable glabellar tap reflex, seborrhea and hypersalivation. The Blink Reflex (BR), all electrically-induced reflex, is abnormal in Parkinson's disease (PD) and in some parkinsonisms. The aim of the study was to investigate BR habituation and its recovery cycle in survivors of severe TBI suffering from parkinsonian syndrome and the possible correlation with neuroimaging findings. Material/Methods: Twenty-three patients (18 males, 5 females; mean age 23.7 years, range 13-35), who sustained a severe TBI, (Glasgow Coma Scale or GCS, lower than 8 in the first. 48 hours), and followed by coma for a duration equal or longer than 15 days, Were studied during the post-acute or chronic phase. Enrollement criteria include the presence of at least 3 extrapyramidal symptoms. BR was elicited by electrical stimulation of the supraorbital nerve and responses Were recorded With surface electrodes from the orbicularis oculi muscle ipsilateral to the stimulation. A repeated series of 10 electrical stimuli was applied at. the frequencies of stimulation of 0.3, 0.5, 0.7, 1.0, 1.5, 2.0 and 3.0 Hz, respectively. Values between 0.5 and 1 Hz were considered as normal, according to the international literature, Cerebral Magnetic Resonance (C-MRI), with fist sequences was performed within 3 months after brain injury. Ten healthy subjects, age and sex matched, served as controls and underwent. the same procedure. Results: Nineteen of the twenty-three patients (82.6%) showed a significantly reduced BR habituation in comparison with controls. This findings highly correlated with C-MRI diagnosis of Diffuse Axonal Injury (DAI). A normal BR habituation was found in only 4 out of 23 patients (17%). in these subjects, C-MRI revealed focal lesions rather than DAI. Conclusions: BR changes correlate with parkinsonian signs and neuroimaging findings. BR may have a role as a diagnostic tool in post-traumatic parkinsonism and as a prognostic tool to evaluate the effect Of therapeutic options.	[Formisano, Rita; Cicinelli, Paola; Buzzi, Maria Gabriella; Brunelli, Stefano; Vinicola, Vincenzo; Sabatini, Umberto] Rehabil Hosp, Santa Lucia Fdn, Post Coma Unit, I-00179 Rome, Italy; [Zafonte, Ross] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Gabrielli, Andrea] Univ Florida, Div Crit Care Med, Jacksonville, FL USA		Formisano, R (corresponding author), Rehabil Hosp, Santa Lucia Fdn, Post Coma Unit, Via Ardeatina 354, I-00179 Rome, Italy.	r.formisano@hsantalucia.it	Brunelli, Stefano/D-4967-2014; Sabatini, Umberto/A-8484-2010; Sabatini, Umberto/K-4659-2016; Buzzi, Maria Gabriella/K-5468-2016	Sabatini, Umberto/0000-0001-5321-8626; Buzzi, Maria Gabriella/0000-0003-1307-8707			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams R. D., 1976, PRINCIPLES NEUROLOGY; [Anonymous], 2003, Clin Med (Lond), V3, P249; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Basso MA, 1996, J NEUROSCI, V16, P7318; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Chia LG, 1997, NEUROLOGY, V49, P874, DOI 10.1212/WNL.49.3.874; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; Eekhof JLA, 1996, MUSCLE NERVE, V19, P10, DOI 10.1002/(SICI)1097-4598(199601)19:1<10::AID-MUS2>3.0.CO;2-B; Esteban A, 1999, NEUROPHYSIOL CLIN, V29, P7, DOI 10.1016/S0987-7053(99)80039-2; Formisano R, 2005, ACT NEUR S, V93, P201; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Jellinger K, 1966, Wien Z Nervenheilkd Grenzgeb, V23, P40; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P1082; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KARSON CN, 1982, ANN NEUROL, V12, P580, DOI 10.1002/ana.410120614; KIMURA J, 1973, BRAIN, V96, P87, DOI 10.1093/brain/96.1.87; Lees AJ, 1997, REV NEUROL-FRANCE, V153, P541; LINDENBERG R, 1964, Dtsch Z Nervenheilkd, V185, P637; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MATSUMOTO H, 1992, J NEUROL SCI, V107, P155, DOI 10.1016/0022-510X(92)90283-Q; Napolitano A, 1997, EUR NEUROL, V38, P119, DOI 10.1159/000113174; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; RUMPL E, 1982, ELECTROEN CLIN NEURO, V54, P406, DOI 10.1016/0013-4694(82)90204-8; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; TEASDALE G, 1974, LANCET, V2, P81; Zijlmans JCM, 2004, MOVEMENT DISORD, V19, P630, DOI 10.1002/mds.20083; [No title captured]	37	15	15	0	4	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAR	2009	15	3					CR101	CR106					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	434MY	WOS:000265280000008	19247239				2022-02-06	
J	Greenwald, BND; Rigg, JL				Greenwald, Bria N. D.; Rigg, John L.			Neurorehabilitation in Traumatic Brain Injury: Does It Make a Difference?	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						brain injury; evidence; rehabilitation	REHABILITATION; ATTENTION; SEIZURES; CRITERIA	Each year, 1.4 million people in the United States are seen in a hospital for a traumatic brain injury. Those with moderate-to-serve traumatic brain injury frequently go through a course of inpatient neurorehabilitation prior to discharge back into the community. A broad overview of neurorehabilitation is presented, including the standards for admission to inpatient rehabilitation and the members and roles of the neurorehabilitation team. Common medical complications that are managed after moderate-to-severe traumatic brain injury are reviewed. The spectrum of arousal issues is summarized. The evidence regarding neurorehabilitation is then reviewed. Future studies that are underway to better understand the utility of neurohabilitation are then discussed. Mt Sinai J Med 76:182-189, 2009(C) 2009 Mount Sinai School of Medicine	[Greenwald, Bria N. D.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Rigg, John L.] SE Reg Med Command, Dwight D Eisenhower Army Med Ctr, Traumat Brain Injury Program, Ft Gordon, GA USA		Greenwald, BND (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA.	brian.greenwald@mountsinai.org					ALADAWI S, 2005, J APPL RES, V5, P2005; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; WATANABE TK, 2001, PHYS MED REHABILITAT, V15, P283; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P940; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3	22	15	15	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	MAR-APR	2009	76	2					182	189		10.1002/msj.20103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427OE	WOS:000264787800011	19306378				2022-02-06	
J	Karasu, A; Sabanci, PA; Cansever, T; Hepgul, KT; Imer, M; Dolas, I; Taviloglu, K				Karasu, Aykut; Sabanci, Pulat Akin; Cansever, Tufan; Hepgul, Kemal Tanju; Imer, Murat; Dolas, Ilyas; Taviloglu, Korhan			Epidemiological study in head injury patients	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			Turkish	Article						Epidemiology; craniocerebral trauma; traumatic brain injury	TRAUMATIC BRAIN-INJURY	BACKGROUND The aim of this study was to determine the hospital-based epidemiological data of the head injury patients who admitted to our Emergency Surgery Department. METHODS The records of the patients (284 males [66%], 146 females [34%]; mean age 30 19) with head injury who admitted to our Emergency Surgery Department between 01.01.2006 - 31.12.2006 were analyzed retrospectively. RESULTS Among the age groups, most head injuries occurred in children (22%) and young adults (30%). The most common trauma types were due to falls (40%) and motor vehicle accidents (37%). The mortality rate in head injury patients was 11%, serious morbidity was 2%, and the rate of deaths from head injury among all deaths in 2006 was 30%. CONCLUSION According to these data, the most common causes of death in head-injured patients are falls (0-16 years of age) and outside vehicle traffic accidents and cranial gunshot wounds (16-35 years of age), especially for males. Admission Glasgow Coma Score is an important prognostic factor in head-injured patients. Primary precautions for head injury must be taken according to each age group. Further development of the diagnosis and treatment options will help to lower the mortality and morbidity of patients with traumatic brain injury.	[Karasu, Aykut; Sabanci, Pulat Akin; Cansever, Tufan; Hepgul, Kemal Tanju; Imer, Murat; Dolas, Ilyas] Istanbul Univ, Istanbul Fac Med, Dept Neurosurg, TR-34093 Istanbul, Turkey; [Taviloglu, Korhan] Istanbul Univ, Istanbul Fac Med, Dept Trauma, TR-34093 Istanbul, Turkey; [Taviloglu, Korhan] Istanbul Univ, Istanbul Fac Med, Emergency Surg Serv, TR-34093 Istanbul, Turkey		Sabanci, PA (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Neurosurg, TR-34093 Istanbul, Turkey.	sabanci.akin@gmail.com	Hepgul, Kemal Tanju/AAV-1510-2020; SABANCI, PULAT AKIN/AAT-1325-2020; Dolas, Ilyas/AAD-6885-2020				Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Kahende J., 2007, Morbidity and Mortality Weekly Report, V56, P993; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kiris T, 1998, ULUSAL TRAVMA DERGIS, V4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Peden M., 2002, INJURY CHART BOOK GR; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009	9	15	17	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAR	2009	15	2					159	163					5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	415QF	WOS:000263948700011	19353319				2022-02-06	
J	Wakeland, W; Agbeko, R; Vinecore, K; Peters, M; Goldstein, B				Wakeland, Wayne; Agbeko, Rachel; Vinecore, Kevin; Peters, Mark; Goldstein, Brahm			Assessing the prediction potential of an in silico computer model of intracranial pressure dynamics	CRITICAL CARE MEDICINE			English	Article						computer modeling; in silico; prediction; traumatic brain injury; intracranial pressure	MATHEMATICAL-MODEL; CEREBRAL HEMODYNAMICS; AUTOREGULATION; INJURY; SYSTEM; TESTS	Objective: Traumatic brain injury (TBI) frequently results in poor outcome, suggesting that new approaches are needed. We hypothesized that a patent-specific in silico computer model of intracranial pressure (ICP) dynamics may predict the ICP response to therapy. Design: In silico model analysis of prospectively collected data. Setting: Twenty-three and 16-bed pediatric intensive care units in two tertiary care academic hospitals. Patients: Nine subjects with severe TBI undergoing ICP monitoring (7 M/2 F, age range 3-17 years). Interventions: Random changes in head-of-bed (HOB) (0 degrees, 10 degrees, 20 degrees, 30 degrees, 40 degrees) elevation and respiratory rate (to achieve a Delta ETco(2) = +/- 3-4 mm Hg) were performed daily according to a study protocol as long as an intracerebral monitoring device was in place. Methods and Main Outcome Measures: A six-compartment dynamic ICP model was developed based on published equations and parametric data (baseline model parameter values). For each of 24 physiologic challenge sessions, patient-specific model parameter values were estimated that minimized the model fitness error, the difference between model-calculated ICP and observed ICP, both for baseline parameters and patient-specific parameter. Next, model prediction error was measured using two analyses. First, a "within" session analysis estimated parameter values using data from an initial Segment A, and then used those parameter values to predict the ICP during a later Segment B. The predicted ICP for B was compared with the observed ICP for B. Second, a "between" session analysis was performed. This analysis used parameter values estimated from earlier sessions to predict the ICP in later sessions. Fitness and prediction errors were measured in terms of mean absolute error (MAE). To normalize the errors, MAE was divided by the mean absolute deviation (MAD) for the associated segment or session, yielding a measure for both model fitness error and model prediction error that is favorable when <1. Results: For baseline parameter values, MAE/MAD was <1 in 2 of 24 (8%) sessions. For session-specific parameter values, MAE/MAD was <1 in 21 of 24 (88%) sessions and <0.5 in 9 of 24 (38%) sessions. Sessions with low (<12 mm Hg) (n = 8; 33%) or high (>18 mm Hg) (n = 6; 25%) ICP had lower error than moderate ICP (12-18 mm Hg) (n = 10; 42%). MAE/MAD was <1 for 6 of 22 (27%) for within-session predictions and 3 of 31 (10%) for between-session predictions. Conclusions: The protocol for collecting physiologic data in subjects with severe TBI was feasible. The in silico ICP model with session-specific parameters accurately reproduced observed ICP response to changes in head-of-bed and respiration rate. We demonstrated modest success at predicting future ICP within a session and to a lesser extent between sessions. (Crit Care Med 2009; 37: 1079-1089)	[Wakeland, Wayne] Portland State Univ, Syst Sci Grad Program, Portland, OR 97207 USA; [Agbeko, Rachel; Peters, Mark] Inst Child Hlth, Partex Unit, Crit Care Grp, London, England; [Vinecore, Kevin] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Peters, Mark] Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London WC1N 3JH, England; [Goldstein, Brahm] Novo Nordisk Inc, Princeton, NJ USA		Wakeland, W (corresponding author), Portland State Univ, Syst Sci Grad Program, Portland, OR 97207 USA.	wakeland@pdx.edu	Peters, Mark/AAD-7518-2019	Peters, Mark/0000-0003-3653-4808	Thrasher Research Fund; GOSH/UCL Institute of Child Health; Department of Health's NIHR Biomedical Research CentresNational Institute for Health Research (NIHR)	Supported, in part, by a grant from the Thrasher Research Fund. This work was undertaken at GOSH/UCL Institute of Child Health, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Almog Y, 1998, J AUTONOM NERV SYST, V69, P39, DOI 10.1016/S0165-1838(98)00006-X; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Goldstein B, 1994, Pediatr Rev, V15, P213, DOI 10.1542/pir.15-6-213; HOFFMANN B, 1987, ACTA NEUROCHIR SUPP, V40, P117; Hu X, 2007, IEEE T BIO-MED ENG, V54, P597, DOI 10.1109/TBME.2006.890130; Lodi CA, 1998, AM J PHYSIOL-HEART C, V274, pH1729, DOI 10.1152/ajpheart.1998.274.5.H1729; Rosner Michael J., 1993, P57; TEASDALE G, 1974, LANCET, V2, P81; Ursino M, 2000, AM J PHYSIOL-HEART C, V279, pH2439, DOI 10.1152/ajpheart.2000.279.5.H2439; URSINO M, 1995, IEEE T BIO-MED ENG, V42, P529, DOI 10.1109/10.387192; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; Ursino M, 2001, ANN BIOMED ENG, V29, P563, DOI 10.1114/1.1380423; Ursino M, 2000, J VASC RES, V37, P123, DOI 10.1159/000025723; Vinecore K, 2007, PEDIATR CRIT CARE ME, V8, P563, DOI 10.1097/01.PCC.0000288715.66726.64; Wakeland W, 2005, WIT TR BIOMED HEALTH, V8, P57; Wakeland W, 2005, ACT NEUR S, V95, P321; WAKELAND W, 2004, ANN INT C IEEE ENG M, P746; Wakeland W, 2008, COMPUT BIOL MED, V38, P1024, DOI 10.1016/j.compbiomed.2008.07.004; White JRM, 2002, CRIT CARE MED, V30, pS478, DOI 10.1097/00003246-200211001-00013; SYSTEMS THINKING ED	22	15	15	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	MAR	2009	37	3					1079	1089		10.1097/CCM.0b013e31819b629d			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413FW	WOS:000263779300040	19237921	Green Submitted			2022-02-06	
J	Doll, H; Truebel, H; Kipfmueller, F; Schaefer, U; Neugebauer, EAM; Wirth, S; Maegele, M				Doll, Hinnerk; Truebel, Hubert; Kipfmueller, Florian; Schaefer, Ute; Neugebauer, Edmund A. M.; Wirth, Stefan; Maegele, Marc			Pharyngeal Selective Brain Cooling Improves Neurofunctional and Neurocognitive Outcome after Fluid Percussion Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						cognition; neurofunction; selective brain cooling; therapeutic hypothermia; traumatic brain injury	CONTROLLED CORTICAL IMPACT; MODERATE HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; BEHAVIORAL DEFICITS; PROTECTION; CARE; DYSFUNCTION; TEMPERATURE	Therapeutic hypothermia (TH) after cardiac arrest reduces mortality and improves neurological outcome. Experimental TH after traumatic brain injury (TBI) indicated similar effects, but benefits were not reproducible in large clinical trials. Therefore, a novel approach of pharyngeal selective brain cooling (pSBC) was tested in respect to neurological outcome in a model of experimental TBI. Male Sprague-Dawley rats were subjected to lateral fluid percussion (LFP) brain injury and received pSBC for 3 h post-injury. All animals were examined for neuromotor and sensorimotor dysfunction and coordination: before and after injury, and during recovery on day post-injury (DPI) 7 and 14 using (i) the standardized Composite Neuroscore (NS) test and (ii) the Rotarod test. Recovery of cognitive function was assessed on days 10-14 using (iii) the Barnes Circular Maze (BCM). In pSBC-animals, brain temperature was selectively lowered to 33 +/- 0.5 degrees C at 15 min post-injury, keeping rectal temperature at a physiologic level. All animals subjected to TBI via LFP showed an identical pattern of severe neurofunctional impairment at 24 h after injury. In the time course of the experiment, pSBC-animals showed superior neurofunctional recovery on DPI 7 (p = 0.03) and 14 (p = 0.002). Similarly, distance, time, and maximum speed on the Rota-Rod were significantly increased in pSBC-animals on DPI 7 (p < 0.01) and 14 (p < 0.01), as well as latency, distance, and mean number of errors in the BCM on DPI 14 (p < 0.01). The novel approach of pSBC was associated with improved neuromotor, sensormotor, and neurocognitive outcome after experimental TBI.	[Doll, Hinnerk; Truebel, Hubert; Kipfmueller, Florian; Wirth, Stefan] Univ Witten Herdecke, Dept Pediat, HELIOS, Klinikum Wuppertal, D-42283 Wuppertal, Germany; [Truebel, Hubert] Bayer HealthCare, Wuppertal, Germany; [Doll, Hinnerk; Schaefer, Ute; Neugebauer, Edmund A. M.; Maegele, Marc] Univ Witten Herdecke, IFOM, Cologne, Germany; [Maegele, Marc] Univ Witten Herdecke, CMMC, Dept Traumat & Orthopaed Surg, Cologne, Germany		Truebel, H (corresponding author), Univ Witten Herdecke, Dept Pediat, HELIOS, Klinikum Wuppertal, Heusnerstr 40, D-42283 Wuppertal, Germany.	hubert.trubel@yale.edu			Witten/Herdecke University (Germany)	The skillful illustrations and art work by Lukas Kretschmer and the technical assistance by Rainer Kobrich, Ph.D. (Maquet (R), Germany) and the research group of Prof. Zarnker at Witten/Herdecke University are greatly appreciated. This study was supported by a staff position (Rotationsstelle 2006) at the Witten/Herdecke University (Germany).	Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bastian P, 2006, MOL CANCER RES, V4, P411, DOI 10.1158/1541-7786.MCR-06-0030; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Davies A R, 2005, Crit Care Resusc, V7, P238; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn TR, 1999, PEDIATRICS, V103, P1079, DOI 10.1542/peds.103.5.1079; Harris BA, 2007, BRIT J ANAESTH, V98, P93, DOI 10.1093/bja/ael308; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horn AR, 2006, SAMJ S AFR MED J, V96, P976; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Polderman KH, 2002, CRIT CARE MED, V30, P1932, DOI 10.1097/00003246-200208000-00058; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Reynolds JC, 2007, RESUSCITATION, V74, P13, DOI 10.1016/j.resuscitation.2006.10.032; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Schafer S, 2008, DRUG DISCOV TODAY, V13, P913, DOI 10.1016/j.drudis.2008.03.026; Scott Eileen M, 2006, AORN J, V83, P1090, DOI 10.1016/S0001-2092(06)60120-8; Scott EM, 2006, AORN J, V83, P1107; SINSON G, 1995, J NEUROCHEM, V65, P2209; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Thoresen M, 2001, PEDIATR RES, V49, P594, DOI 10.1203/00006450-200104000-00024; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tooley JR, 2005, ARCH DIS CHILD-FETAL, V90, P262, DOI 10.1136/adc.2003.044305; Trubel H, 2004, INTENS CARE MED, V30, P1829, DOI 10.1007/s00134-004-2350-1; Trubel H, 2003, BIOMED TECH, V48, P298, DOI 10.1515/bmte.2003.48.11.298; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X	53	15	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					235	242		10.1089/neu.2008.0741			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100006	19196073				2022-02-06	
J	Anderson, JW; Schmitter-Edgecombe, M				Anderson, Jonathan W.; Schmitter-Edgecombe, Maureen			Predictions of episodic memory following moderate to severe traumatic brain injury during inpatient rehabilitation	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Memory awareness; Memory monitoring; Metamemory; Metacognition	CLOSED-HEAD-INJURY; SELF-AWARENESS; FRONTAL-LOBE; POSTTRAUMATIC AMNESIA; TEMPORAL-LOBE; METAMEMORY; PERFORMANCE; RETRIEVAL; ACCURACY; DEFICITS	We examined memory self-awareness and memory self-monitoring abilities during inpatient rehabilitation in participants with moderate to severe traumatic brain injury (TBI). A total of 29 participants with moderate to severe TBI and 29 controls matched on age, gender, and education completed a performance prediction paradigm. To assess memory self-awareness, participants predicted the amount of information they would remember before completing list-learning tasks and visual-spatial memory tasks. Memory self-monitoring was assessed by participants' ability to increase accuracy of their predictions after experience with the tests. Although the TBI participants performed more poorly than controls on both episodic memory tasks, no significant group differences emerged in memory self-awareness or memory self-monitoring. The TBI participants predicted that their memory performances would be poorer than that of controls, accurately adjusted their predictions in accordance with the demands of the tasks, and successfully modified their predictions following experience with the tasks. The results indicate that moderate to severe TBI individuals in the early stages of recovery can competently assess the demands of externally driven metamemorial situations and utilize experience with task to accurately update their knowledge of memory abilities.	[Anderson, Jonathan W.] Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Pullman, WA 99164 USA		Anderson, JW (corresponding author), Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA.	janderson@mail.ewu.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	This study was partially supported by Grant R01 NS47690 from the National Institute of Neurological Disorders and Stroke (NINDS). We would like to thank Randi McDonald, Shital Pavawalla, Jennifer McWilliams, Michelle Nuegen, Matthew Wright, and Ellen Woo for their support in coordinating data collection. We would also like to thank the traumatic brain injury participants and the members of the Head Injury Research Team for their help in collecting and scoring the data.	BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton AL, 1994, MULTILINGUAL APHASIA; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Bunnell JK, 1999, NEW ZEAL J PSYCHOL, V28, P23; Cohen J, 1983, APPL MULTIPLE REGRES, P56; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Fleming JM, 1996, BRAIN INJURY, V10, P1; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GERMAN DJ, 1990, NATL COLL ED TEST AD; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; HERTZOG C, 1994, AGING COGNITION, V1, P203, DOI DOI 10.1080/13825589408256577; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Koriat A, 2001, J EXP PSYCHOL LEARN, V27, P34, DOI 10.1037//0278-7393.27.1.34; Koriat A., 2000, OXFORD HDB MEMORY, P333; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Leckey GS, 2002, J INT NEUROPSYCH SOC, V8, P48, DOI 10.1017/S1355617701020057; Lee GP, 1997, CLIN NEUROPSYCHOL, V11, P59, DOI 10.1080/13854049708407030; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Myers J. L., 2003, RES DESIGN STAT ANAL; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Schmitter-Edgecombe M, 2007, NEUROPSYCHOLOGY, V21, P224, DOI 10.1037/0894-4105.21.2.224; Smith A., 1991, SYMBOL DIGIT MODALIT; Tabachnick B. G., 2001, COMPUTERASSISTED RES; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vilkki J, 1999, NEUROPSYCHOLOGY, V13, P298, DOI 10.1037/0894-4105.13.2.298; Wechsler D., 1997, MANUAL WECHSLER ADUL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zachary R., 1991, SHIPLEY I LIVING SCA	48	15	16	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	4					425	438	PII 901418785	10.1080/13803390802232667			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	435HH	WOS:000265334200005	18686113	Green Accepted			2022-02-06	
J	Gregory, NG; Spence, JY; Mason, CW; Tinarwo, A; Heasman, L				Gregory, N. G.; Spence, J. Y.; Mason, C. W.; Tinarwo, A.; Heasman, L.			Effectiveness of poll stunning water buffalo with captive bolt guns	MEAT SCIENCE			English	Article						Captive bolt; Gun; Stunning; Water buffalo; Slaughter; Concussion; Abattoir		Practical experience has indicated that shooting water buffalo with a captive bolt gun in the front of the head does not always produce an effective stun. Slaughtermen have been claiming that the poll position is more reliable, but under present EU regulations this shooting position is not allowed for domesticated bovines. This study examined the effectiveness of shooting water buffalo with captive bolt guns in the poll region. The depth of concussion was assessed in 30 water buffalo from physical collapse, presence or absence of corneal and palpebral reflexes, normal rhythmic breathing, eyeball rotation, nystagmus and whether the animal was re-shot. All except one animal collapsed immediately. The one animal that failed to collapse was not breathing. The prevalence of a shallow depth of concussion in the poll shot animals was 53%. Two had been shot through the spinal cord, and with the exception of those plus one other in which the bolt did not penetrate the brain, the other animals were considered to be adequately stunned. Post mortem examination of the brain showed that 79% of the under thirty month old animals were shot in the midbrain or brain stem, but these regions had to be avoided in over thirty month old animals because of the risk of damaging the brain stem sample needed for BSE testing, In addition, three water buffalo were shot in the crown position and one in the front of the head. The frontal position was ineffective as the animal did not collapse, and all animals shot in the crown position resumed breathing shortly after shooting, indicating a shallow depth of concussion. It is concluded that poll shooting can be effective in water buffalo, but it produces a shallow depth of concussion compared with frontal shooting in cattle. It requires accurate placement of the gun to ensure that buffalo are not shot through the spinal cord instead of the brain. Vigilance is needed in ensuring that the animals are stuck Promptly so that none recover consciousness. (C) 2008 Elsevier Ltd. All rights reserved.	[Gregory, N. G.] BBSRC, Hatfield AL9 7TA, Herts, England; [Spence, J. Y.; Mason, C. W.; Tinarwo, A.] Humane Slaughter Assoc, Old Sch, Wheathampstead AL4 8AN, England; [Heasman, L.] Westpoint Vet Grp, Warnham RH12 3SH, England; [Gregory, N. G.] Univ London Royal Vet Coll, Hatfield AL9 7TA, Herts, England		Gregory, NG (corresponding author), BBSRC, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	ngregory@rvc.ac.uk		Tinarwo, Ambrose/0000-0002-3699-3599	Scottish Executive Environment and Rural Affairs Department	This work was supported by the Scottish Executive Environment and Rural Affairs Department. We wish to thank the abattoirs and their staff for their assistance with this work, and Frances Moreno and Mar Alonso of the Meat Hygiene Service for help in establishing the trials.	ARNE L, 1975, HDB CLIN NEUROLOGY, V23, P459; CURRIER RD, 1969, HDB CLIN NEUROLOGY, V2, P217; DALY CC, 1986, HUMANE SLAUGHTER ANI, P15; FORSTER S, 2007, BETABUNG WASSERBUFFE; Gregory NG, 2008, MEAT SCI, V80, P2, DOI 10.1016/j.meatsci.2008.05.019; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; MEYER F, 2005, RUNDSCHAU FLEISCHHYG, P248; OMAE T, 1989, HDB CLIN NEUROLOGY, V54, P287; SAPER CB, 1985, HDB CLIN NEUROLOGY, V45, P107	9	15	16	0	51	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740			MEAT SCI	Meat Sci.	JAN	2009	81	1					178	182		10.1016/j.meatsci.2008.07.016			5	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	372UU	WOS:000260928300024	22063979				2022-02-06	
J	Himanen, L; Portin, R; Tenovuo, O; Taiminen, T; Koponen, S; Hiekkanen, H; Helenius, H				Himanen, Leena; Portin, Raija; Tenovuo, Olli; Taiminen, Tero; Koponen, Salla; Hiekkanen, Heli; Helenius, Hans			Attention and depressive symptoms in chronic phase after traumatic brain injury	BRAIN INJURY			English	Article						TBI; attention; depression; reaction time	HEAD-INJURY; MAJOR DEPRESSION; MILD; COGNITION; DISORDER; RECOVERY; DEFICITS	Objective: To study whether attention deficits differ between TBI (traumatic brain injury) patients with and without depressive symptoms. Method: The study group (n = 61, mean age = 59 years) consisted of symptomatic TBI patients injured on average 30 years earlier. They were studied with a broad range of attention tasks including computerized methods. The patients were divided into those with depressive symptoms (n = 32) and those without (n = 29), according to the short form of the Beck depression scale with a cut-off score of 5. In addition, a diagnosis of major depression was applied according to the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (n = 6). The groups with depression or depressive symptoms were compared with the non-depressed TBI patients and with an age- and education-matched healthy control group (n = 31). Results: Cognitive methods that require flexibility (Trail making B, Card sorting, Word fluency) and working memory (Subtraction test) were sensitive to discriminate TBI patients without depressive symptoms from the control subjects (p 0.001). Only a few methods were able to discriminate the TBI patients with depressive symptoms from those without (p 0.001 for Simple reaction time, p 0.003 for Vigilance test). The depressed TBI patients (assessed by SCAN) did not differ from the non-depressed TBI patients in attention functions. Conclusions: The results suggest that problems in complex attention processing are more specific to TBI, while slowness in simple psychomotor speed and impaired sustained attention may be mostly related to depressive symptoms in patients with chronic TBI sequelae.	[Himanen, Leena; Portin, Raija; Tenovuo, Olli; Hiekkanen, Heli] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland; [Taiminen, Tero; Koponen, Salla] Turku Univ Hosp, Dept Psychiat, FIN-20520 Turku, Finland; [Helenius, Hans] Univ Turku, Dept Biostat, SF-20500 Turku, Finland		Himanen, L (corresponding author), Turku Univ Hosp, Dept Neurol 720, PL 52, FIN-20521 Turku, Finland.	ls.himanen@pp1.inet.fi		Himanen, Leena/0000-0001-7261-8027			Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; BLEIBERG J, 1997, CLIN NEUROPSYCHOL, V14, P287; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; COFFEY CE, 1990, AM J PSYCHIAT, V147, P187; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franulic A, 2000, BRAIN INJURY, V14, P431; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Hickie I, 1999, PSYCHIAT RES-NEUROIM, V92, P75, DOI 10.1016/S0925-4927(99)00038-4; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KUJALA P, 1994, BRAIN, V117, P1115, DOI 10.1093/brain/117.5.1115; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Revonsuo A., 1995, COGNISPEED COMPUTER; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Tavares JVT, 2003, PSYCHOL MED, V33, P959, DOI 10.1017/S0033291703008432; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	35	15	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	3					220	227	PII 908613377	10.1080/02699050902748323			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	406AJ	WOS:000263267100005	19205958				2022-02-06	
J	Mascialino, G; Hirshson, C; Egan, M; Cantor, J; Ashman, T; Tsaousides, T; Spielman, L				Mascialino, Guido; Hirshson, Chari; Egan, Mathew; Cantor, Joshua; Ashman, Teresa; Tsaousides, Theodore; Spielman, Lisa			Objective and subjective assessment of long-term community integration in minority groups following traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; community integration; minorities; minority status	QUALITY-OF-LIFE; FUNCTIONAL OUTCOMES; RACIAL DISPARITIES; SATISFACTION; REHABILITATION; IMPACT; PARTICIPATION; PERSPECTIVE; MODERATE; HEALTH	Previous studies that used objective measures of community integration found that in the first year after injury, minority groups with traumatic brain injury (TBI) exhibit lower levels of community integration than White participants. The objective of this study was to determine if this discrepancy persists beyond one year post injury, and if assessing subjective components of community integration helps understand these differences. Participants were 360 community dwelling adults with TBI including 29% from minority backgrounds. Mean time post injury was 8.66 years (SD = 9.94). Main outcome measure utilized was the Participation Objective Participation Subjective (POPS). Multiple regression indicated that minority status predicted levels of transportation use (p < 0.01), with white participants reporting less use, after controlling for demographic and injury variables. When looking at subjective indicators, minority status predicted levels of dissatisfaction with community, civic, life and leisure participation (p < 0.01), and total levels of participation (p < 0.0125), with White participants reporting significantly less dissatisfaction. Findings indicate that differences between minorities and white participants in objective aspects of community integration after one year post-injury are only evident in levels of transportation use. However, when looking at subjective indicators differences between groups are present in other areas. These findings underscore the importance of considering the consumer's subjective experience when providing services to minorities in a rehabilitation setting.	[Mascialino, Guido; Hirshson, Chari; Egan, Mathew; Cantor, Joshua; Ashman, Teresa; Tsaousides, Theodore; Spielman, Lisa] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Mascialino, G (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	Guido.Mascialino@mountsinai.org	Ashman, Teresa/B-1621-2013	MASCIALINO, GUIDO/0000-0001-7408-6546			Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown M, 2006, PARTICIPATION OBJECT; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Burnett DM, 2000, BRAIN INJURY, V14, P713; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; *CORM AM, 1993, J HEAD TRAUMA REHAB, V8, P86; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; HOLM S, 1979, SCANDINAVIAN J STAT, V6; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Minnes P, 2001, NEUROREHABILITATION, V16, P3; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Ruff RM, 1999, BRAIN INJURY, V13, P943; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; [No title captured]	34	15	15	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	24	1					29	36		10.3233/NRE-2009-0451			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	412DS	WOS:000263704400004	19208955				2022-02-06	
J	Moochhala, S; Wu, J; Lu, J				Moochhala, Shabbir; Wu, Jian; Lu, Jia			Hemorrhagic shock: an overview of animal models	FRONTIERS IN BIOSCIENCE-LANDMARK			English	Article						Hemorrhagic Shock; Animal Models; Review	TRAUMATIC BRAIN-INJURY; 3-PERCENT HYPERTONIC SALINE; UNCONTROLLED HEMORRHAGE; FLUID RESUSCITATION; SURVIVAL-TIME; PORCINE MODEL; RODENT MODEL; RAT MODEL; HEPATOCELLULAR FUNCTION; REGIONAL HEMODYNAMICS	Extensive efforts have been made to try to elucidate the pathophysiological mechanisms and the immunologic alterations associated with severe hemorrhage. A broad variety of experimental conditions have been established that enable investigators to study the effects of hypovolemic shock and to assess the potential benefits of a wide spectrum of treatment options. However, translating these experimental findings into clinically applicable therapy has been challenging, suggesting the need for a better understanding of the animal models being used. As certain advantages and disadvantages are associated with the different models of hemorrhage (such as controlled and uncontrolled hemorrhagic shock and combined trauma with hemorrhagic shock models, for this review, we have selected representative studies that reflect the current status of experimental shock research that looks at acute blood loss, and that may serve as a guide when considering which model or models to apply	[Moochhala, Shabbir; Wu, Jian; Lu, Jia] Def Med & Environm Res Inst, DSO Natl Labs Kent Ridge, Combat Casualty Care Programme, Combat Care Lab, Singapore 117510, Singapore		Moochhala, S (corresponding author), Def Med & Environm Res Inst, DSO Natl Labs Kent Ridge, Combat Casualty Care Programme, Combat Care Lab, 27 Med Dr, Singapore 117510, Singapore.	mshabbir@dso.org.sg		MOOCHHALA, SHABBIR/0000-0003-4521-3192			Alam HB, 2002, J TRAUMA, V52, P18, DOI 10.1097/00005373-200201000-00006; Alkan A, 2006, EUR J EMERG MED, V13, P281, DOI 10.1097/00063110-200610000-00007; Atan MS, 2004, J NEUROSURG, V101, P138, DOI 10.3171/jns.2004.101.1.0138; Awasthi V, 2007, J APPL PHYSIOL, V103, P28, DOI 10.1152/japplphysiol.00136.2006; Batchinsky AI, 2007, CRIT CARE MED, V35, P519, DOI 10.1097/01.CCM.0000254065.44990.77; BELLAMY RF, 1984, MIL MED, V149, P55; Bruscagin V, 2002, J TRAUMA, V52, P1147, DOI 10.1097/00005373-200206000-00021; Bruttig SP, 2005, SHOCK, V24, P92, DOI 10.1097/01.shk.0000168872.37660.d2; Burris D, 1999, J TRAUMA, V46, P216, DOI 10.1097/00005373-199902000-00003; Cabrales P, 2007, SHOCK, V27, P380, DOI 10.1097/01.shk.0000239782.71516.ba; Cheung ATW, 2007, ARTIF CELL BLOOD SUB, V35, P173, DOI 10.1080/10731190601188257; Cheung AT, 2006, CLIN HEMORHEOL MICRO, V34, P325; Chiara O, 2003, CRIT CARE MED, V31, P1915, DOI 10.1097/01.CCM.0000074725.62991.42; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Cooper ES, 2007, CRIT CARE MED, V35, P1724, DOI 10.1097/01.CCM.0000266590.25109.F2; Drobin D, 2005, J TRAUMA, V59, P976, DOI 10.1097/01.ta.0000178902.24330.f5; FJITZPATRICK CM, 2005, J TRAUMA, V59, P273; Fujiyoshi N, 2006, SURGERY, V140, P810, DOI 10.1016/j.surg.2006.03.003; Garcia-Martinez D, 2006, SHOCK, V26, P379, DOI 10.1097/01.shk.0000226339.48033.8b; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Hall C, 2007, ARTIF CELL BLOOD SUB, V35, P259, DOI 10.1080/10731190701378568; HAUSER GJ, 1995, RES COMMUN MOL PATH, V90, P289; Hermann J, 2007, ANESTHESIOLOGY, V107, P273, DOI 10.1097/01.anes.0000270756.11669.64; Josephsen GD, 2005, MICROSC MICROANAL, V11, P500, DOI 10.1017/S1431927605050567; Kaplan LJ, 2006, J TRAUMA, V61, P90, DOI 10.1097/01.ta.0000222578.85413.4e; Kauvar DS, 2006, J AM COLL SURGEONS, V202, P888, DOI 10.1016/j.jamcollsurg.2006.03.003; Kentner R, 2007, RESUSCITATION, V72, P295, DOI 10.1016/j.resuscitation.2006.05.025; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; Krausz MM, 2000, SHOCK, V13, P230, DOI 10.1097/00024382-200003000-00010; Krismer AC, 2006, CRIT CARE MED, V34, P2175, DOI 10.1097/01.CCM.0000229886.98002.2B; Kudo Y, 2006, CRIT CARE MED, V34, P2820, DOI 10.1097/01.CCM.0000242522.48734.64; Kuebler JF, 2001, J SURG RES, V97, P196, DOI 10.1006/jsre.2001.6155; Lee J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2715189; Lin T, 2007, SURGERY, V141, P784, DOI 10.1016/j.surg.2007.01.014; LONGNECKER DE, 1976, ANESTHESIOLOGY, V45, P516; LONGNECKER DE, 1982, ANESTHESIOLOGY, V57, P177, DOI 10.1097/00000542-198209000-00006; Macias CA, 2007, ANN SURG, V245, P305, DOI 10.1097/01.sla.0000236626.57752.8e; Norio H, 2002, J TRAUMA, V52, P1056, DOI 10.1097/00005373-200206000-00006; PAGEL PS, 1991, ANESTHESIOLOGY, V74, P539, DOI 10.1097/00000542-199103000-00024; PAGEL PS, 1991, ANESTHESIOLOGY, V74, P900, DOI 10.1097/00000542-199105000-00016; Paran H, 2005, AM J SURG, V190, P463, DOI 10.1016/j.amjsurg.2005.03.032; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Poloujadoff MP, 2007, ANESTHESIOLOGY, V107, P591, DOI 10.1097/01.anes.0000281926.54940.6a; Puig NR, 2002, INT IMMUNOPHARMACOL, V2, P95, DOI 10.1016/S1567-5769(01)00151-5; Raddatz A, 2006, AM J RESP CRIT CARE, V174, P198, DOI 10.1164/rccm.200508-1221OC; Raman KG, 2006, AM J PHYSIOL-GASTR L, V291, pG556, DOI 10.1152/ajpgi.00055.2006; Reynolds PS, 2007, SHOCK, V28, P45, DOI 10.1097/shk.0b013e31802eb779; Riddez L, 2002, SHOCK, V17, P377, DOI 10.1097/00024382-200205000-00006; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Rushing GD, 2006, ANN SURG, V243, P652, DOI 10.1097/01.sla.0000216759.36819.1b; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; SAWYER DC, 1971, J APPL PHYSIOL, V30, P36, DOI 10.1152/jappl.1971.30.1.36; Schulman AM, 2003, J TRAUMA, V55, P298, DOI 10.1097/01.TA.0000028970.50515.A0; SEYDE WC, 1984, ANESTHESIOLOGY, V61, P686, DOI 10.1097/00000542-198412000-00010; SEYDE WC, 1985, AM J PHYSIOL, V249, pH164, DOI 10.1152/ajpheart.1985.249.1.H164; Shah KJ, 2002, SHOCK, V18, P242, DOI 10.1097/00024382-200209000-00007; Shirhan M, 2004, LIFE SCI, V76, P661, DOI 10.1016/j.lfs.2004.07.015; Sinert R, 2005, ACAD EMERG MED, V12, P1141, DOI [10.1111/j.1553-2712.2005.tb01488.x, 10.1197/j.aem.2005.07.016]; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; Sondeen JL, 2004, SHOCK, V22, P163, DOI 10.1097/01.shk.0000129202.76706.bd; Stapley SA, 2002, SHOCK, V17, P146, DOI 10.1097/00024382-200202000-00011; Stepaniak PC, 2007, AVIAT SPACE ENVIR MD, V78, pA14; Stern SA, 2000, SHOCK, V14, P616, DOI 10.1097/00024382-200014060-00008; Stern SA, 2000, ACAD EMERG MED, V7, P847, DOI 10.1111/j.1553-2712.2000.tb02060.x; Suzuki T, 2006, CYTOKINE, V34, P76, DOI 10.1016/j.cyto.2006.04.007; Szalay L, 2006, AM J PHYSIOL-REG I, V290, pR812, DOI 10.1152/ajpregu.00658.2005; Takasu A, 2002, RESUSCITATION, V54, P303, DOI 10.1016/S0300-9572(02)00148-X; Takasu A, 2006, J TRAUMA, V61, P1330, DOI 10.1097/01.ta.0000245980.12711.6a; Toda Y, 2007, INT J MOL MED, V19, P237; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; Varela JE, 2003, SHOCK, V20, P476, DOI 10.1097/01.SHK.0000094036.09886.9b; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Watters JM, 2006, J TRAUMA, V61, P75, DOI 10.1097/01.ta.0000222723.54559.47; WEISKOPF RB, 1981, ANESTH ANALG, V60, P481; Westphal G, 2007, ARTIF ORGANS, V31, P284, DOI 10.1111/j.1525-1594.2007.00377.x; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; Wichmann MW, 1996, J SURG RES, V63, P256, DOI 10.1006/jsre.1996.0257; WIGGERS CJ, 1950, PHYSL SHOCK; Yang RJ, 2006, J TRAUMA, V61, P1343, DOI 10.1097/01.ta.0000222955.14191.08; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Yang SB, 2003, IEE P-VIS IMAGE SIGN, V150, P6, DOI 10.1049/ip-vis:20030165; Yannopoulos D, 2007, ANESTH ANALG, V104, P157, DOI 10.1213/01.ane.0000249047.80184.5a; Young MA, 2005, CRIT CARE MED, V33, P1794, DOI 10.1097/01.CCM.0000172648.55309.13	83	15	18	0	14	FRONTIERS IN BIOSCIENCE INC	IRVINE	16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA	1093-9946	1093-4715		FRONT BIOSCI-LANDMRK	Front. Biosci.	JAN	2009	14						4631	4639		10.2741/3555			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	497LM	WOS:000270060800071	19273377				2022-02-06	
J	Muccio, CF; De Simone, M; Esposito, G; De Blasio, E; Vittori, C; Cerase, A				Muccio, Carmine Franco; De Simone, Marta; Esposito, Gennaro; De Blasio, Elvio; Vittori, Cesare; Cerase, Alfonso			Reversible post-traumatic bilateral extensive restricted diffusion of the brain. A case study and review of the literature	BRAIN INJURY			English	Article; Proceedings Paper	22nd Congress of the Associazione-Italiana-di-Neuroradiologia	OCT 04-06, 2006	Milan, ITALY	Assoc Italiana Neuroradiol		Apparent diffusion coefficient; diffusion weighted imaging; excitotoxic injury; magnetic resonance imaging; reversible restricted diffusion; traumatic brain injury	AXONAL INJURY; MAGNETIC-RESONANCE; WEIGHTED MR; IMAGING ABNORMALITIES; CORPUS-CALLOSUM; CELLULAR EDEMA; HEAD-INJURY; TIME-COURSE; STROKE; COEFFICIENT	Primary objective: To increase the knowledge about diffuse traumatic brain injury (TBI) by reporting the magnetic resonance imaging (MRI) findings observed in a patient with reversible extensive restricted diffusion of the brain at diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps. Case study: An 18-year-old patient was admitted after high-energy closed TBI. Glasgow Coma Scale score was 4. Head computed tomography showed small left frontal and temporal haemorrhagic contusions and a small haemorrhage in the left thalamus. Ten days later, brain MRI showed diffuse high-signal intensity on T2-weighted images and DWI and restricted diffusion in the subcortical white matter of both centri semiovali, genu and splenium of corpus callosum and parietal cortex bilaterally (mean ADC value = 0.434-0.811 10-3 mm2 s-1). Eleven days later, follow-up brain MRI showed gliotic changes in the left splenium of corpus callosum, a clearcut decrease of T2-weighted high-signal intensity and resolution of abnormalities at DWI and ADC maps in all other involved sites. This was confirmed 36 days later. Three months later, the patient did not show neurological, cognitive or neuropsychiatric deficits. Conclusions: In the patient reported herein, closed TBI most likely induced diffuse excitotoxic injury of the brain which resulted in mainly reversible cytotoxic or intramyelinic oedema.	[Muccio, Carmine Franco; De Simone, Marta; Esposito, Gennaro] Azienda Osped Gaetano Rummo, Unit Neuroradiol, Dept Neurosci, I-82100 Benevento, Italy; [De Blasio, Elvio] Azienda Osped Gaetano Rummo, Dept Resuscitat & Intens Care, I-82100 Benevento, Italy; [Vittori, Cesare] Policlin Univ Santa Maria Scotte, Azienda Osped Univ Senese, Unit Neuroanesthesia & NeuroCrit Care, Dept Anesthesia & Crit Care, Siena, Italy; [Cerase, Alfonso] Policlin Univ Santa Maria Scotte, Azienda Osped Univ Senese, Unit Diagnost & Therapeut Neuroradiol, Siena, Italy; [Cerase, Alfonso] Policlin Univ Santa Maria Scotte, Azienda Osped Univ Senese, InterDepartmental Ctr Nucl Magnet Resonance, Siena, Italy		Muccio, CF (corresponding author), Azienda Osped Gaetano Rummo, Unit Neuroradiol, Dept Neurosci, Via Angelo 1, I-82100 Benevento, Italy.	cfmuccio@yahoo.it		Cerase, Alfonso/0000-0003-4753-6649; Muccio, Carmine Franco/0000-0003-4582-4348; Vittori, Cesare/0000-0001-8631-9853			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BATTISTI C, 2009, NEUROLOGICAL SC 0321; Chu K, 2002, ARCH NEUROL-CHICAGO, V59, P123, DOI 10.1001/archneur.59.1.123; Colagrande S, 2005, RADIOL MED, V109, P1; DARDZINSKI BJ, 1993, MAGNET RESON MED, V30, P318, DOI 10.1002/mrm.1910300307; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; Ebisu T, 1997, RADIOLOGY, V203, P823, DOI 10.1148/radiology.203.3.9169711; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fiehler J, 2004, STROKE, V35, P514, DOI 10.1161/01.STR.0000114873.28023.C2; Fiehler J, 2003, STROKE, V34, pE87, DOI 10.1161/01.STR.0000078660.31648.3C; Gallucci M, 2007, NEURORADIOLOGY, V49, P541, DOI 10.1007/s00234-007-0235-z; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KLATZO I, 1994, ACTA NEUROCHIR, P3; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2001, J NEUROSURG, V94, P349; Mascalchi M, 2005, RADIOL MED, V109, P155; Mateo Magdalena A, 2003, Lippincotts Case Manag, V8, P203, DOI 10.1097/00129234-200309000-00005; Maxwell WL, 1997, J NEUROTRAUM, V14, P755; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moritani T, 2005, AM J NEURORADIOL, V26, P216; Muttikkal TJE, 2008, NEURORADIOL J, V21, P817, DOI 10.1177/197140090802100611; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Nicoli F, 2003, STROKE, V34, pE82, DOI 10.1161/01.STR.0000078659.43423.0A; Pizzini F, 2003, RIV NEURORADIOL, V16, P207, DOI 10.1177/197140090301600202; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; SHARP FR, 1998, STROKE PATHOPHYSIOLO, P54; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Takanashi J, 2005, ARCH NEUROL-CHICAGO, V62, P1481, DOI 10.1001/archneur.62.9.1481; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Turkin AM, 2003, RIV NEURORADIOL, V16, P1055, DOI 10.1177/197140090301600602; Unterberg AW, 1997, ACT NEUR S, V70, P106; Warach S, 1996, STROKE, V27, P1254; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	50	15	15	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	5					466	472	PII 910862176	10.1080/02699050902841912			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Rehabilitation	439NL	WOS:000265633700011	19408169				2022-02-06	
J	Pyun, SB; Yang, H; Lee, S; Yook, J; Kwon, J; Byun, EM				Pyun, Sung-Bom; Yang, Heeseung; Lee, Sangil; Yook, Jinsook; Kwon, Jaesung; Byun, Eun-Mi			A home programme for patients with cognitive dysfunction: A pilot study	BRAIN INJURY			English	Article						Stroke; cognitive therapy; cognition disorders; activites of daily living	TRAUMATIC BRAIN-INJURY; REHABILITATION; STROKE; IMPAIRMENT; DEMENTIA; OUTCOMES; FREQUENCY; APHASIA	Objective: To evaluate the effectiveness of a 12-week individualized home programme of rehabilitation for patients with cognitive impairment. Methods: Six patients with cognitive dysfunction, after haemorrhagic stroke, participated in this study. A programme was carried out in the home environment that consisted of four mixed training programmes: cognitive remediation therapy, story retelling, cognitive enhancing games and aerobic exercise. The patients performed the home programme for 2 hours a day, 7 days a week, for 12 weeks. The main outcomes were measured using the MMSE, Neurobehavioural Cognitive Status Examination (NCSE), domain-specific computerized neuropsychological test for attention, memory and executive function, the Lowenstein Occupational Therapist Cognitive Assessment (LOTCA), the Modified Barthel Index (MBI) and the Seoul-Instrumental Activity of Daily Living (S-IADL). Results: After completion of a 12-week home programme, the patients' S-IADL scores improved significantly (p 0.05). The patients' MMSE and NCSE scores improved marginally, with mean score changes of 4.2 (p = 0.058), 4.7 (p = 0.078) and 6.8 (p = 0.068) points, respectively. However, the patients' domain-specific cognitive test and LOTCA scores did not significantly change. Conclusion: The results of this study showed that an individualized home programme improved IADL performance in patients with cognitive dysfunction and may have a beneficial effect on cognition, as assessed by general cognitive measures.	[Pyun, Sung-Bom] Korea Univ, Med Ctr, Dept Phys Med & Rehabil, Coll Med, Seoul 136705, South Korea; [Yang, Heeseung] Seoul Vet Hosp, Dept Phys Med & Rehabil, Seoul, South Korea; [Lee, Sangil; Yook, Jinsook; Kwon, Jaesung; Byun, Eun-Mi] Asan Med Ctr, Dept Phys Med & Rehabil, Seoul, South Korea		Pyun, SB (corresponding author), Korea Univ, Med Ctr, Dept Phys Med & Rehabil, Coll Med, 5 Ga 126-1 Anam Dong, Seoul 136705, South Korea.	rmpyun@korea.ac.kr			Korea government (MOST)Ministry of Science and Technology (MOST) KoreaKorean Government [R01-2006-000-10733-0]	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST) (R01-2006-000-10733-0). This study was presented at the 10 November 2006 AAPM&R Annual Assembly in Hawaii.	Aftonomos LB, 1999, STROKE, V30, P1370, DOI 10.1161/01.STR.30.7.1370; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Cappa SF, 2005, EUR J NEUROL, V12, P665; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cordoliani-Mackowiak MA, 2003, ARCH NEUROL-CHICAGO, V60, P585, DOI 10.1001/archneur.60.4.585; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Ivan CS, 2004, STROKE, V35, P1264, DOI 10.1161/01.STR.0000127810.92616.78; Jordan BD, 2000, JAMA-J AM MED ASSOC, V283, P3123, DOI 10.1001/jama.283.23.3123; Jung HY, 2007, ANN REHABIL MED-ARM, V31, P283; Kase CS, 1998, STROKE, V29, P805, DOI 10.1161/01.STR.29.4.805; KATZ N, 1989, AM J OCCUP THER, V43, P184, DOI 10.5014/ajot.43.3.184; 구형모, 2004, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V43, P189; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Macko R F, 2005, Top Stroke Rehabil, V12, P45; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; Marsh EB, 2006, PROG BRAIN RES, V157, P143, DOI 10.1016/S0079-6123(06)57009-8; Pace GM, 1999, BRAIN INJURY, V13, P535; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Serrano S, 2007, STROKE, V38, P105, DOI 10.1161/01.STR.0000251804.13102.c0; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	27	15	16	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	7-8					686	692	PII 912684686	10.1080/02699050902997862			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	462QL	WOS:000267370600013	19557572				2022-02-06	
J	Ryan, KA; Rapport, LJ; Harper, KT; Fuerst, D; Bieliauskas, L; Khan, O; Lisak, R				Ryan, Kelly A.; Rapport, Lisa J.; Harper, Kaja Telmet; Fuerst, Darren; Bieliauskas, Linas; Khan, Omar; Lisak, Robert			Fitness to drive in multiple sclerosis: Awareness of deficit moderates risk	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Multiple sclerosis; Driving; Awareness of deficit; Fitness to drive	TRAUMATIC BRAIN-INJURY; OLDER DRIVERS; NEUROPSYCHOLOGICAL ASPECTS; AUTOBIOGRAPHICAL MEMORY; EXECUTIVE FUNCTIONS; STROKE PATIENTS; PERFORMANCE; IMPAIRMENT; PREDICTORS; INDIVIDUALS	Fitness to drive was examined among 78 individuals with multiple sclerosis (MS) who participated with a knowledgeable informant. Illness severity, neuropsychological functioning, and external social influences each made unique contributions to the prediction of driving status. Among drivers, perceptions of social influences against driving accounted for the most variance in miles driven, whereas social influences, informants' perceptions of the patients' fitness to drive, and illness severity accounted for the most variance in adverse driving incidents. Importantly, awareness of deficit moderated fitness to drive: Drivers who were unaware of their deficits perceived less need to engage in compensatory behaviors; moreover, as perceived need to compensate decreased, miles driven and driving incidents increased. The findings have implications for interventions with persons with MS who drive.	[Rapport, Lisa J.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Bieliauskas, Linas] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Khan, Omar; Lisak, Robert] Wayne State Univ, Sch Med, Dept Neurol, Multiple Sclerosis Ctr, Detroit, MI 48201 USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Rapport, Lisa/0000-0001-8014-9523			Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Arthur W, 2001, HUM FACTORS, V43, P1, DOI 10.1518/001872001775992507; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BEATTY PA, 1977, J NERV MENT DIS, V164, P42, DOI 10.1097/00005053-197701000-00008; BEATTY WW, 1995, NEUROPSYCHOLOGY, V9, P198, DOI 10.1037/0894-4105.9.2.198; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; Benton AL, 1994, MULTILINGUAL APHASIA; BOYLE EA, 1991, ARCH NEUROL-CHICAGO, V48, P1150, DOI 10.1001/archneur.1991.00530230058022; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Brouwer W H, 1994, Disabil Rehabil, V16, P149; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; CAMPBELL MK, 1993, J GERONTOL, V48, pS230, DOI 10.1093/geronj/48.4.S230; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Chipchase SY, 2003, DISABIL REHABIL, V25, P712, DOI 10.1080/0963828031000062651; Coleman Bryer R, 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fisk GD, 1997, ARCH PHYS MED REHAB, V78, P1338, DOI 10.1016/S0003-9993(97)90307-5; Fisk GD, 2002, ARCH PHYS MED REHAB, V83, P469, DOI 10.1053/apmr.2002.31179; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Goodyear K, 2003, CLIN MED, V3, P86, DOI 10.7861/clinmedicine.3-1-86; GRANT I, 1989, CURR PROB N, V10, P17; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Hohol MJ, 1997, ARCH NEUROL-CHICAGO, V54, P1018, DOI 10.1001/archneur.1997.00550200074013; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Kenealy PM, 2000, J CLIN EXP NEUROPSYC, V22, P125, DOI 10.1076/1380-3395(200002)22:1;1-8;FT125; Kenealy PM, 2002, J INT NEUROPSYCH SOC, V8, P855, DOI 10.1017/S1355617702860143; KNECHT J, 1977, SCHWEIZ MED WSCHR, V107, P373; Knight RG, 1997, J CLIN EXP NEUROPSYC, V19, P7, DOI 10.1080/01688639708403832; Kotterba S, 2003, EUR NEUROL, V50, P160, DOI 10.1159/000073057; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lincoln N., 1992, CLIN REHABIL, V6, P275, DOI DOI 10.1177/026921559200600402; Lings S, 2002, ACTA NEUROL SCAND, V105, P169, DOI 10.1034/j.1600-0404.2002.1o165.x; LINGS S, 1991, APPL ERGON, V22, P75, DOI 10.1016/0003-6870(91)90305-2; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lyman JM, 2001, ACCIDENT ANAL PREV, V33, P413, DOI 10.1016/S0001-4575(00)00055-5; Mackenzie C, 2003, APHASIOLOGY, V17, P107, DOI 10.1080/729255215; MARCOTTE T, 2000, J INT NEUROPSYCHOL S, V0006, P00233; Marie RM, 2001, REV NEUROL-FRANCE, V157, P402; MAROTTOLI RA, 1993, J GERONTOL, V48, pS255, DOI 10.1093/geronj/48.5.S255; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Owsley C, 2004, J AM GERIATR SOC, V52, P1901, DOI 10.1111/j.1532-5415.2004.52516.x; Paul R H, 1997, J Int Neuropsychol Soc, V3, P246; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; Provinciali L, 1999, ACTA NEUROL SCAND, V100, P156; Rao S., 1990, MANUAL BRIEF REPEATA; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Regard M, 1981, THESIS U VICTORIA BR; Reitan R, 1988, HALSTEAD REITAN NEUR; RON MA, 1991, PSYCHOL MED, V21, P59, DOI 10.1017/S0033291700014653; Ryan KA, 2007, CLIN NEUROPSYCHOL, V21, P239, DOI 10.1080/13854040600582460; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke Anne-Kristine, 1995, Tidsskrift for den Norske Laegeforening, V115, P1349; Schultheis MT, 2002, ARCH PHYS MED REHAB, V83, P1175, DOI 10.1053/apmr.2002.34279; Schultheis MT, 2001, NEUROLOGY, V56, P1089, DOI 10.1212/WNL.56.8.1089; Schulz M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000571; Shawaryn MA, 2002, ARCH PHYS MED REHAB, V83, P1123, DOI 10.1053/apmr.2002.33730; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherman TE, 2007, J CLIN EXPT NEUROPSY, V12, P1; Smith A., 1991, SYMBOL DIGIT MODALIT; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; Spreen O, 1991, COMPENDIUM NEUROPSYC; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; [No title captured]	79	15	15	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	1					126	139	PII 793716857	10.1080/13803390802119922			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	384IT	WOS:000261739200013	18608652				2022-02-06	
J	Scarponi, F; Sattin, D; Leonardi, M; Raggi, A; Zampolini, M				Scarponi, Federico; Sattin, Davide; Leonardi, Matilde; Raggi, Alberto; Zampolini, Mauro			The description of severe traumatic brain injury in light of the ICF classification	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; ICF; disability	QUALITY-OF-LIFE; INTERNATIONAL-CLASSIFICATION; HEALTH ICF; ABI REHABILITATION; CORE SETS; DISABILITY; DISORDERS; OUTPATIENT; RETURN; MODEL	Purpose. To review on the application of the ICF Classification to assess the person with traumatic brain injury (TBI) and his/her interaction with the environment. Method. Studies and reviews about the use of ICF in TBI have been included, by searching in Pubmed and in the proceedings of international meetings. Results. Eleven studies have been identified and classified into three types: (a) application of the classification; (b) single case study; (c) the use of other scales. Some studies are related to the application of ICF checklist. Finally, we analyse the most used ICF codes. Conclusions. The ICF is a useful tool describes conditions and needs of patients with TBI. A diffuse utilisation could become the key resource for both health professionals and administrators that are in charge of allocating resources to pursue quality of life improvement. The ICF could be applied as a shared language to define health programmes' goals and as system for carrying out epidemiological studies. For this reason, it is desirable to define and validate the ICF Core Sets for TBI to provide a mean to be easily used, comprehensive and universal.	[Scarponi, Federico; Zampolini, Mauro] San Giovanni Battista Hosp, Dept Rehabil, Foligno, Italy; [Sattin, Davide; Leonardi, Matilde; Raggi, Alberto] Neurol Inst C Besta IRCCS, Neurol Publ Hlth & Disabil Unit, Milan, Italy		Zampolini, M (corresponding author), San Giovanni Battista Hosp, Dept Rehabil, Local Hlth Serv 3, Foligno, Italy.	mauro.zampolini@tin.it	Sattin, Davide/K-5963-2016; leonardi, matilde/J-9997-2018; Zampolini, Mauro/B-7749-2009; Raggi, Alberto/K-5787-2016; Scarponi, Federico/K-5714-2018	Sattin, Davide/0000-0001-7736-4337; leonardi, matilde/0000-0003-0552-8923; Raggi, Alberto/0000-0002-7433-7779; Scarponi, Federico/0000-0001-9683-8104			Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Chiambretto P, 2006, G Ital Med Lav Ergon, V28, P15; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Francescutti C, 2009, DISABIL REHABIL, V31, pS46, DOI 10.3109/09638280903317757; Fries W, 2008, REHABILITATION, V47, P265, DOI 10.1055/s-2008-1081473; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Larkins Brigette, 2007, Seminars in Speech and Language, V28, P334, DOI 10.1055/s-2007-986530; LAXE S, 2009, 5 WORLD C INT SOC PH, P117; Leonardi M, 2009, DISABIL REHABIL, V31, pS128, DOI 10.3109/09638280903317765; Maini M, 2008, DISABIL REHABIL, V30, P1146, DOI 10.1080/09638280701478397; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODONOVAN MA, 2009, DISABIL REHABIL, V21, P1; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; PISTARINI C, 2009, 5 WORLD C INT SOC PH, P118; Post MWM, 2008, J REHABIL MED, V40, P620, DOI 10.2340/16501977-0223; Rauch A, 2008, EUR J PHYS REHAB MED, V44, P329; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stucki A, 2008, SLEEP MED, V9, P191, DOI 10.1016/j.sleep.2007.01.019; Stucki G, 2008, EUR J PHYS REHAB MED, V44, P343; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, DISABIL REHABIL, V24, P281, DOI 10.1080/09638280110105222; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thonnard J L, 2007, Eura Medicophys, V43, P525; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; World Health Organization, 2006, INT CLASS FUNCT DIS; ZAMPOLINI M, 2006, INDIVIDUAZIONE INDIC, P405	40	15	15	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2009	31			1			S134	S143		10.3109/09638280903317906			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	553BB	WOS:000274338300021	19968526				2022-02-06	
J	Thomas, MD; Skilbeck, CE; Slatyer, M				Thomas, M. D.; Skilbeck, C. E.; Slatyer, M.			Pre-injury estimates of subjective quality of life following traumatic brain injury	BRAIN INJURY			English	Article						Subjective Quality of life; traumatic brain injury; confirmatory factor analysis; Quality of Life Inventory	SATISFACTION; RECOMMENDATIONS; DOMAINS; MODEL	Primary objective: To compare the pre-injury subjective quality of life (SQOL) estimates of a representative sample of adults with TBI, using the Quality of Life Inventory (QOLI) with the measure's generic US-based norms and identify a factor structure for the instrument within the local TBI population. Research design: A population-based, cross-sectional design conducted with data collected by the Neurotrauma Register of Tasmania (2003-2005). Methods and procedures: As soon as possible following their emergence from post-traumatic amnesia, 470 participants provided pre-injury estimates of their SQOL using the QOLI. The distribution of this sample was compared with the measure's normative distribution. The sample was separated evenly into two groups (n = 235) for separate exploratory and confirmatory factor analyses. Main outcomes and results: Small differences were found between the pre-injury estimates and the QOLI's US-based normative distribution. Corrections were provided to clinical classification ranges for this population. Three factors were identified and confirmed for the QOLI in separate TBI samples. Conclusion: The results of this study support the use of the QOLI in measuring SQOL in TBI rehabilitation and outcomes research.	[Thomas, M. D.; Skilbeck, C. E.] Charles Sturt Univ, Sch Social Sci & Liberal Studies, Bathurst, NSW 2795, Australia; [Slatyer, M.] Univ Tasmania, Sch Med, Hobart, Tas 7001, Australia; [Slatyer, M.] Royal Hobart Hosp, Hobart, Tas, Australia		Thomas, MD (corresponding author), Charles Sturt Univ, Sch Social Sci & Liberal Studies, Panorama Ave, Bathurst, NSW 2795, Australia.	psychflyer@hotmail.com			Motor Accident Insurance Board (Tasmania, Australia)	We would like to express our gratitude to the participants and staff involved in this study. This research was made possible by project funding for the Neurotrauma Register of Tasmania, by the Motor Accident Insurance Board (Tasmania, Australia).	ABBEY A, 1985, SOC INDIC RES, V16, P1, DOI 10.1007/BF00317657; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Brown P, 1998, MOVEMENT DISORD, V13, P56, DOI 10.1002/mds.870130114; Browne MW, 1993, ALTERNATIVE WAYS ASS; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Claiborne N, 1999, SOC WORK HEALTH CARE, V28, P77, DOI 10.1300/J010v28n03_05; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Eng W, 2005, J ANXIETY DISORD, V19, P143, DOI 10.1016/j.janxdis.2004.01.007; Fidell L.S., 2001, USING MULTIVARIATE S, V4th; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORTUNE N, 1999, DEFINITION INCIDENCE; Frisch M.B., 1994, QUALITY LIFE INVENTO; Frisch MB, 1998, CLIN PSYCHOL-SCI PR, V5, P19, DOI 10.1111/j.1468-2850.1998.tb00132.x; Hillier SL, 1997, BRAIN INJURY, V11, P649; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Joreskog K. G., 1993, LISREL 8 USERS REFER; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kendall E, 1998, J REHABIL, V64, P16; Maruish ME., 1999, USE PSYCHOL TESTING, P1277; McAlinden NM, 2006, COMPR PSYCHIAT, V47, P309, DOI 10.1016/j.comppsych.2005.09.003; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; O'Cleirigh C, 2006, AIDS BEHAV, V10, P53, DOI 10.1007/s10461-005-9027-9; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1037/0033-2909.107.2.238; [No title captured]; [No title captured]; [No title captured]	41	15	15	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	6					516	527	PII 911809026	10.1080/02699050902926333			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	451SF	WOS:000266489800005	19484625				2022-02-06	
J	Lemoyne, R; Coroian, C; Mastroianni, T; Grundfest, W				Lemoyne, Robert; Coroian, Cristian; Mastroianni, Timothy; Grundfest, Warren			QUANTIFIED DEEP TENDON REFLEX DEVICE FOR RESPONSE AND LATENCY, THIRD GENERATION	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Reflex quantification; wireless accelerometers; neurorehabilitation; traumatic brain injury	STRETCH REFLEX; DEMYELINATING POLYNEUROPATHY; QUANTITATIVE-EVALUATION; SPINAL SHOCK; SPASTICITY; PATELLAR; INJURY	Deep tendon reflex is fundamental for a neurological examination. A hyperactive reflex response is correlated with spasticity, which can also be associated with the degree of damage to the supraspinal input, essentially assessing the severity of traumatic brain injury. Clinical evaluation of the myotatic stretch reflex is provided by the National Institute of Neurological Disorders and Stroke (NINDS) Myotatic Reflex Scale (0 to 4); however, the results of the NINDS Myotatic Reflex Scale vary in terms of interpretation and lack temporal data. Deep tendon reflex can assess the severity and degree of peripheral neuropathy. Subsequent to the neurological examination, suspect patients are often referred to a specialist for definitive electrodiagnostic testing. A study by Cocito found that 28% of the prescriptions for testing were considered to be inappropriate. Therefore, the solution is a fully quantified tendon reflex evaluation system. The input force of the reflex hammer is derived from a predetermined potential energy setting. Tandem wireless three-dimensional (3D) microelectromechanical systems (MEMS) accelerometers quantify the output and latency time of the reflex. The wireless 3D MEMS accelerometers are positioned to a standard anchor point near the ankle and reflex hammer swing arm. Reflex response is quantified by the maximum and minimum components of the acceleration profile. The temporal disparity between hammer strike and response defines the latency of the reflex loop. The quantified data collected from wireless 3D MEMS accelerometers are conveyed to a portable computer. Enclosed are the initial test and evaluation and the description of such a device, which quantitatively evaluates the reflex response and latency using wireless 3D MEMS accelerometers, while demonstrating precision for reproducibility.	[Lemoyne, Robert; Coroian, Cristian] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mastroianni, Timothy] Cognit Engn, Pittsburgh, PA USA; [Grundfest, Warren] Univ Calif Los Angeles, Biomed Engn IDP, Los Angeles, CA 90095 USA		Lemoyne, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250	UCLA IGERT NSFNational Science Foundation (NSF)	Support from the UCLA IGERT NSF fellowship has been instrumental.	Cocito D, 2006, NEUROL SCI, V26, P419, DOI 10.1007/s10072-006-0525-y; Cozens JA, 2000, J NEUROL NEUROSUR PS, V68, P581, DOI 10.1136/jnnp.68.5.581; Faist M, 1999, BRAIN, V122, P567, DOI 10.1093/brain/122.3.567; Frijns CJM, 1997, CLIN NEUROL NEUROSUR, V99, P31, DOI 10.1016/S0303-8467(96)00593-8; Grundfest, 2007, 37 SOC NEUR ANN M; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Jafari R, 2005, PROCEEDINGS OF MOBIQUITOUS 2005, P479; Jea, 2005, 35 SOC NEUR ANN M; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Karandreas N, 2000, Electromyogr Clin Neurophysiol, V40, P83; Ko HY, 1999, SPINAL CORD, V37, P402, DOI 10.1038/sj.sc.3100840; KURUOGLU HR, 1994, MUSCLE NERVE, V17, P145, DOI 10.1002/mus.880170203; Lebiedowska MK, 2003, ARCH PHYS MED REHAB, V84, P828, DOI 10.1016/S0003-9993(02)04946-8; LEMOYNE R, 2005, UCLA COMMUNICATION; LEMOYNE R, 2006, 15 INT C MECH MED BI; LEMOYNE R, 2006, 36 SOC NEUR ANN M; Lemoyne R, 2008, J MECH MED BIOL, V8, P75, DOI 10.1142/S0219519408002462; Litvan I, 1996, NEUROLOGY, V47, P969, DOI 10.1212/WNL.47.4.969; Mamizuka N, 2007, J BIOMECH, V40, P2107, DOI 10.1016/j.jbiomech.2006.10.003; Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253; McCabe, 1999, INTRO PRACTICE STAT; Pagliaro P, 1999, J ELECTROMYOGR KINES, V9, P141, DOI 10.1016/S1050-6411(98)00045-5; TOFT E, 1989, ACTA NEUROL SCAND, V79, P384, DOI 10.1111/j.1600-0404.1989.tb03805.x; van Dijk GW, 1999, NEUROLOGY, V53, P1573, DOI 10.1212/WNL.53.7.1573; VandeCrommert HWAA, 1996, BRAIN RES, V734, P341, DOI 10.1016/0006-8993(96)00885-2; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600	26	15	15	1	5	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194			J MECH MED BIOL	J. Mech. Med. Biol.	DEC	2008	8	4					491	506		10.1142/S0219519408002772			16	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	389LN	WOS:000262094200003					2022-02-06	
J	Mitchell, CS; Lee, RH				Mitchell, Cassie S.; Lee, Robert H.			Pathology Dynamics Predict Spinal Cord Injury Therapeutic Success	JOURNAL OF NEUROTRAUMA			English	Article						combination therapy; neuroprotection; secondary insult; spinal cord injury; therapeutic treatment window; traumatic brain injury	NMDA RECEPTOR ACTIVATION; MEDIATED NEURONAL APOPTOSIS; SODIUM-CHANNEL BLOCKERS; SECONDARY INJURY; INFLAMMATORY RESPONSE; NITRIC-OXIDE; MITOCHONDRIAL-FUNCTION; CEREBELLAR GLOMERULUS; GLUTAMATE SPILLOVER; WHITE-MATTER	Secondary injury, the complex cascade of cellular events following spinal cord injury (SCI), is a major source of post-insult neuron death. Experimental work has focused on the details of individual factors or mechanisms that contribute to secondary injury, but little is known about the interactions among factors leading to the overall pathology dynamics that underlie its propagation. Prior hypotheses suggest that the pathology is dominated by interactions, with therapeutic success lying in combinations of neuroprotective treatments. In this study, we provide the first comprehensive, system-level characterization of the entire secondary injury process using a novel relational model methodology that aggregates the findings of similar to 250 experimental studies. Our quantitative examination of the overall pathology dynamics suggests that, while the pathology is initially dominated by "fire-like," rate-dependent interactions, it quickly switches to a "flood-like," accumulation-dependent process with contributing factors being largely independent. Our evaluation of similar to 20,000 potential single and combinatorial treatments indicates this flood-like pathology results in few highly influential factors at clinically realistic treatment time frames, with multi-factor treatments being merely additive rather than synergistic in reducing neuron death. Our findings give new fundamental insight into the understanding of the secondary injury pathology as a whole, provide direction for alternative therapeutic strategies, and suggest that ultimate success in treating SCI lies in die pursuit of pathology dynamics in addition to individually involved factors.	[Lee, Robert H.] Emory Univ, Atlanta, GA 30322 USA; Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA		Lee, RH (corresponding author), Emory Univ, 107 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA.	rlee2@emory.edu		Mitchell, Cassie/0000-0002-5472-6355	National Science Foundation (NSF)National Science Foundation (NSF); Integrative Graduate Education and Research Traineeship FellowshipNational Science Foundation (NSF) [DGE-0333411]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [NS046891]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046851] Funding Source: NIH RePORTER	This work is supported by the National Science Foundation (NSF) Via a Graduate Research Fellowsl-dp and an Integrative Graduate Education and Research Traineeship Fellowship (DGE-0333411) to C.S.M. Additional support was provided by the Human Brain Project (NINDS, NIMH, NIBIB NS046891) to R.H.L.	Agrawal SK, 1996, J NEUROSCI, V16, P545; Agrawal SK, 1997, J NEUROSCI, V17, P1055; Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Blight AR, 2006, J NEUROTRAUM, V23, P586, DOI 10.1089/neu.2006.23.586; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Carriedo SG, 1998, J NEUROSCI, V18, P7727; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Churchwell KB, 1996, J NEUROSCI, V16, P7447; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cullen DK, 2006, J NEUROTRAUM, V23, P986; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; FADEN AI, 1987, J NEUROCHEM, V48, P1809, DOI 10.1111/j.1471-4159.1987.tb05740.x; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEHLINGS MG, 1995, SPINE, V20, P2187, DOI 10.1097/00007632-199510001-00002; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fujiki M, 2005, BRAIN RES, V1053, P175, DOI 10.1016/j.brainres.2005.06.055; Gaviria M, 2006, NEUROBIOL DIS, V22, P694, DOI 10.1016/j.nbd.2006.01.011; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Gomes-Leal W, 2004, EXP NEUROL, V190, P456, DOI 10.1016/j.expneurol.2004.06.028; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; HALL ED, 1993, RES P ARNMD, V71, P81; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Hu S, 1997, NEUROCHEM INT, V30, P427, DOI 10.1016/S0197-0186(96)00078-2; Iwai T, 2002, CARDIOVASC RES, V55, P141, DOI 10.1016/S0008-6363(02)00282-1; JURKOWITZALEXANDER MS, 1992, J NEUROCHEM, V59, P344, DOI 10.1111/j.1471-4159.1992.tb08910.x; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; Li S, 2001, NEUROSCIENCE, V107, P675, DOI 10.1016/S0306-4522(01)00385-2; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu-Snyder P, 2007, J EXP BIOL, V210, P1455, DOI 10.1242/jeb.02756; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mattiasson G, 2004, CYTOM PART A, V62A, P89, DOI 10.1002/cyto.a.20089; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Mitchell CS, 2007, J NEURAL ENG, V4, P380, DOI 10.1088/1741-2560/4/4/004; Mitchell CS, 2007, J NEURAL ENG, V4, P276, DOI 10.1088/1741-2560/4/3/013; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; OBRIEN MF, 1994, SPINE, V19, P2321, DOI 10.1097/00007632-199410150-00012; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Saftenku EE, 2005, J THEOR BIOL, V234, P363, DOI 10.1016/j.jtbi.2004.11.036; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Tator C H, 1999, Neurosurg Focus, V6, pe8; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Vela JM, 2002, J NEUROTRAUM, V19, P1503, DOI 10.1089/089771502320914723; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; White RJ, 1996, J NEUROSCI, V16, P5688; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029; YANASE M, 1995, J NEUROSURG, V83, P884, DOI 10.3171/jns.1995.83.5.0884; Yoshioka A, 1996, J NEUROSCI RES, V46, P427; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhao WH, 2004, J NEUROPATH EXP NEUR, V63, P964, DOI 10.1093/jnen/63.9.964	84	15	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2008	25	12					1483	1497		10.1089/neu.2008.0658			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	400IY	WOS:000262862500010	19125684	Green Published			2022-02-06	
J	McGrath, N; Dowds, MM; Goldstein, R				McGrath, Neal; Dowds, Murdo M., Jr.; Goldstein, Richard			Clinical Supervision of a Client With Traumatic Brain Injury in a Host Home Placement Using Video Teleconferencing: A Case Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						clinical supervision; community reintegration; traumatic brain injury; video teleconferencing	TELEREHABILITATION; TELEHEALTH	To examine the use of video teleconferencing (VTC) technology in the supervision of a 41-year-old man with expressive aphasia during community reintegration in a host home setting 3 years after severe traumatic brain injury (TBI). Design: U sing a 3-month A-B-A design, weekly VTC meetings were substituted for in-person visits by the client's case coordinator. Main outcome measures: Weekly ratings of satisfaction with the medium of communication used (VTC vs in-person meetings) by each participant. Results: The client and the case coordinator found VTC meetings to be as effective as face-to-face supervision visits for communication of clinical concerns and problems. The client reported feeling self-conscious about having the equipment in his living space because of privacy concerns. The mentor reported that VTC helped focus on questions and answers in goal-oriented conversations, was easier to schedule, and had the advantage of not requiring preparation of the house for in-person meetings. Reported disadvantages included feelings of camera shyness as well as impatience due to slow video transmission speed at times. The case coordinator also found VTC meetings easier to schedule and reported savings in travel time and expense. Reported disadvantages included reduced transmission quality and speed on some occasions. The cost break-even point for VTC was reached at I year with substitution of VTC sessions for half of weekly case coordinator home visits and 2 home visits per year by the coordinator's supervisor. Conclusion: VTC might be liberally substituted for in-person supervision visits in the context of an ongoing clinical relationship during Community reintegration following TBI.	[McGrath, Neal] Ctr Comprehens Serv New England, Braintree, MA 02184 USA; [Dowds, Murdo M., Jr.] Harvard Univ, Sch Med, Boston, MA USA; [Goldstein, Richard] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA		McGrath, N (corresponding author), Ctr Comprehens Serv New England, 639 Granite St Suite 215, Braintree, MA 02184 USA.	nealmc-grath@rcn.com					Ball C J, 1995, J Telemed Telecare, V1, P22; BASHSHUR RL, 1995, J MED SYST, V19, P81, DOI 10.1007/BF02257059; DONIGER M, 1986, CANADIAN J PSYCHIAT, V31, P32; EDGINGTON ES, 1967, J PSYCHOL, V65, P195, DOI 10.1080/00223980.1967.10544864; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; GUYATT GH, 1990, ANN INTERN MED, V112, P293, DOI 10.7326/0003-4819-112-4-293; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Liss HJ, 2002, REHABIL PSYCHOL, V47, P8, DOI 10.1037/0090-5550.47.1.8; Rosen MJ, 1999, NEUROREHABILITATION, V12, P11; Schopp L, 2000, PROF PSYCHOL-RES PR, V31, P179, DOI 10.1037/0735-7028.31.2.179; Todman J. B., 2001, SINGLE CASE SMALL N; VANDAMME G, 1993, SCRT SINGLE CASE RAN; WANG S, 2003, STROKE          0918; 2003, FED REG         0220, V68; 2000, FED REG         1228, V65	15	15	15	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					388	393		10.1097/01.HTR.0000341434.74875.c8			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300004	19033831				2022-02-06	
J	Pillay, NS; Kellaway, LA; Kotwal, GJ				Pillay, Nirvana S.; Kellaway, Laurie A.; Kotwal, Girish J.			Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model	BEHAVIOURAL BRAIN RESEARCH			English	Article						Alzheimer's disease; inflammation; cheeseboard maze; complement; memory	BETA-PEPTIDE; BRAIN-INJURY; A-BETA; ACTIVATION; SYSTEM; RAT; INFLAMMATION; RECOVERY; CASCADE; BINDING	Vaccinia virus complement control protein (VCP) inhibits both the classical and alternate complement pathways. In diseases such as traumatic brain injury (TBI) and Alzheimer's disease (AD), pathological inflammation is caused by amongst several factors, prolonged or inappropriate activation of the complement system and is a significant cause of neurodegeneration. This study investigates for the first time the use of a cheeseboard maze to evaluate cognitive deficits and the effect of VCP on memory processes in 2- and 3-month-old mice that express mutant amyloid precursor protein (APPswe) and mutant presenilin 1 (Ps1dE9) that correspond to a form of early onset AD. A four-phase training schedule was carried out on the cheeseboard maze before intracranial injections of 5 mu l of VCP (1.7 mu g/mu l) or 5 mu l saline. Two weeks later the effect of VCP on memory was evaluated. A statistically significant decrease in goal latency in VCP-treated mice than saline-treated transgenic mice in both the first probe and reverse tasks was observed. Similarly, after a second intracranial VCP or saline injection performed 2 months later, the 6.5- and 7.5-month aged VCP-injected mice performed significantly better in goal latency in both second probe and reverse tasks than saline-treated mice. These data also demonstrated that the use of a dry maze is a sensitive technique for distinguishing cognitive measures between non-transgenic and APPswe/PS1De9 transgenic mice at a much earlier stage. (C) 2008 Elsevier B.V. All rights reserved.	[Kotwal, Girish J.] InflaMed Inc, Louisville, KY 40241 USA; [Kotwal, Girish J.] Inst Infect Dis & Mol Med, Cape Town, South Africa		Kotwal, GJ (corresponding author), InflaMed Inc, 4664 Shenandoah Dr, Louisville, KY 40241 USA.	GJKOTW01@gmail.com					Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bergamaschini L, 1999, CLIN EXP IMMUNOL, V115, P526; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Daly J, 1998, NEUROBIOL AGING, V19, P619, DOI 10.1016/S0197-4580(98)00100-6; DALY J, 1997, IMMUNOLOGIST, V5, P157; DOUGLAS RJ, 1966, J COMP PHYSIOL PSYCH, V62, P171, DOI 10.1037/h0023668; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Jarvenpaa T, 2003, NEUROBIOL AGING, V24, P941, DOI 10.1016/S0197-4580(03)00008-3; JIANG HX, 1994, J IMMUNOL, V152, P5050; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X; Kirwan CB, 2005, NEUROBIOL LEARN MEM, V83, P65, DOI 10.1016/j.nlm.2004.08.001; Kotwal G, 1998, 10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, P315; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Kotwal GJ, 1997, J LEUKOCYTE BIOL, V62, P415, DOI 10.1002/jlb.62.4.415; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; OKUSAWA S, 1987, J IMMUNOL, V139, P2635; OKUSAWA S, 1988, J EXP MED, V168, P443, DOI 10.1084/jem.168.1.443; Pillay NS, 2007, BRAIN RES, V1153, P158, DOI 10.1016/j.brainres.2007.03.056; Pillay Nirvana S., 2004, Current Alzheimer Research, V1, P295, DOI 10.2174/1567205043331965; Pillay NS, 2005, ANN NY ACAD SCI, V1056, P450, DOI 10.1196/annals.1352.021; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Takabayashi T, 1996, J IMMUNOL, V156, P3455; Tenner AJ, 2001, NEUROBIOL AGING, V22, P849, DOI 10.1016/S0197-4580(01)00301-3; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X	31	15	15	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 10	2008	192	2					173	177		10.1016/j.bbr.2008.03.038			5	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	333RO	WOS:000258170200003	18490064				2022-02-06	
J	Ben Salem, D; Walker, PM; Bejot, Y; Aho, SL; Vernier, BTA; Rouaud, O; Ricolfi, F; Brunotte, F				Ben Salem, Douraied; Walker, Paul M.; Bejot, Yannick; Aho, Serge L.; Vernier, Beatrice T. A.; Rouaud, Olivier; Ricolfi, Frederic; Brunotte, Francois			N-Acetylaspartate/Creatine and Choline/Creatine Ratios in the Thalami, Insular Cortex and White Matter as Markers of Hypertension and Cognitive Impairment in the Elderly	HYPERTENSION RESEARCH			English	Article						hypertension; proton magnetic resonance spectroscopy; Trail Making Test; elderly	MAGNETIC-RESONANCE SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; LONGITUDINAL CHANGES; SUBCORTICAL LESIONS; VASCULAR DEMENTIA; STROKE PATIENTS; NORMATIVE DATA; BASE-LINE; TRAIL	Our objective was to investigate the influence of hypertension on N-acetylaspartate (NAA) and choline (Cho) ratios in brain tissues in a community-dwelling elderly population. Brain flexibility was also evaluated with regard to the same metabolite ratios. Proton magnetic resonance spectroscopy (MRS) and the Trail Making Test (TMT) were performed in 80 subjects (75.7 +/- 4 years old) from the Three-City Study. Fifty-eight participants had hypertension. The NAA/creatine (Cr) and Cho/Cr ratios were obtained in the insular cortex, the thalami and the deep periventricular white matter. In addition, the B-A score of the TMT was evaluated. Uniand multi-variate analyses were performed in order to examine the relationships among these data. In the insula and the thalami of the hypertensive group, NAA/Cr ratios were significantly lower (1.39 +/- 0.23 and 1.52 +/- 0.23, respectively; p=0.01) than those in the normotensive control goup (1.52 +/- 0.25 and 1.70 +/- 0.19, respectively; p < 0.0001), whereas no such reduction was observed in the periventricular white matter of older hypertensive brains. Moreover, the NAA or Cho ratios were significantly correlated with the TMT B-A scores at the level of the thalami, insula and periventricular white matter. These statistical results were confirmed by the multivariate analysis. In an elderly population, hypertension leads to a reduction in NAA/Cr ratios in the insula and the thalami, possibly due to a decrease in blood flow through small perforating and cortical arteries. The TMT B-A test appears to be relevant not only for the frontal areas but also for more remote areas such as the thalami, the insula and the deep periventricular white matter. (Hypertens Res 2008; 31: 1851-1857)	[Ben Salem, Douraied; Ricolfi, Frederic] Univ Hosp Dijon, Dept Neuroradiol, F-21033 Dijon, France; [Aho, Serge L.] Univ Hosp Dijon, Epidemiol Unit, F-21033 Dijon, France; [Walker, Paul M.; Brunotte, Francois] Univ Burgundy, CNRS, UMR 5158, Le2i, Dijon, France; [Bejot, Yannick; Rouaud, Olivier] Univ Burgundy, CEP EA 4184, Dijon, France; [Vernier, Beatrice T. A.] Dijon Three City Ctr, Dijon, France		Ben Salem, D (corresponding author), Univ Hosp Dijon, Dept Neuroradiol, 3 Rue Fg Raines, F-21033 Dijon, France.	douraied.bensalem@chu-dijon.fr	Bejot, Yannick/D-3942-2019; BEJOT, Yannick/E-6088-2010; AHO, ludwig/AAR-5753-2021; Salem, Douraied Ben/AAF-4698-2020; Serge, Aho Glele Ludwig/AAP-8863-2021	Bejot, Yannick/0000-0001-7848-7072; Serge, Aho Glele Ludwig/0000-0001-7590-8644; BEN SALEM, DOURAIED/0000-0001-5532-2208; Rouaud, Olivier/0000-0001-9767-8421	Faculty of Medicine of Dijon; Fondation pour la Recherche MedicaleFondation pour la Recherche Medicale; Sanofi-Synthelabo Company	The spectroscopic part of this study was supported by a research grant from the Faculty of Medicine of Dijon. The Three-City study is supported by the Fondation pour la Recherche Medicale and the Sanofi-Synthelabo Company.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Beason-Held LL, 2007, STROKE, V38, P1766, DOI 10.1161/STROKEAHA.106.477109; Charlton RA, 2007, BRAIN RES, V1164, P108, DOI 10.1016/j.brainres.2007.06.027; Cook IA, 2002, ARCH NEUROL-CHICAGO, V59, P1612, DOI 10.1001/archneur.59.10.1612; Firbank MJ, 2007, J NEUROL, V254, P713, DOI 10.1007/s00415-006-0238-4; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fujishima M, 1995, Hypertens Res, V18, P111, DOI 10.1291/hypres.18.111; Gianaros PJ, 2006, NEUROIMAGE, V31, P754, DOI 10.1016/j.neuroimage.2006.01.003; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Goldstein IB, 1998, STROKE, V29, P765, DOI 10.1161/01.STR.29.4.765; Guenot M, 2004, ADV TECH STAND NEUR, V29, P265; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; Inzitari M, 2007, J NEUROL SCI, V257, P166, DOI 10.1016/j.jns.2007.01.026; KAWAMURA J, 1991, STROKE, V22, P609, DOI 10.1161/01.STR.22.5.609; Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549; Marshall GA, 2006, INT J GERIATR PSYCH, V21, P32, DOI 10.1002/gps.1419; MENTIS MJ, 1994, STROKE, V25, P601, DOI 10.1161/01.STR.25.3.601; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Miller SP, 2000, NEUROLOGY, V54, P1465, DOI 10.1212/WNL.54.7.1465; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; O'Sullivan M, 2005, NEUROLOGY, V65, P1584, DOI 10.1212/01.wnl.0000184480.07394.fb; Ohmine T, 2008, HYPERTENS RES, V31, P75, DOI 10.1291/hypres.31.75; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ross AJ, 2006, J GERONTOL A-BIOL, V61, P291, DOI 10.1093/gerona/61.3.291; SANDER D, 1994, STROKE, V25, P1730, DOI 10.1161/01.STR.25.9.1730; Sijens PE, 2003, RADIOLOGY, V226, P889, DOI 10.1148/radiol.2263011937; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; SULTZER DL, 1995, ARCH NEUROL-CHICAGO, V52, P773, DOI 10.1001/archneur.1995.00540320049012; Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Twisk J., 2003, APPL LONGITUDINAL DA; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Walker PM, 2006, J NEUROL NEUROSUR PS, V77, P596, DOI 10.1136/jnnp.2005.078238; Walker PM, 2004, J NEUROL SCI, V220, P23, DOI 10.1016/j.jns.2004.01.012; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	42	15	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636			HYPERTENS RES	Hypertens. Res.	OCT	2008	31	10					1851	1857		10.1291/hypres.31.1851			7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	394QE	WOS:000262461400004	19015591	Bronze			2022-02-06	
J	Jagannathan, P; Jagannathan, J				Jagannathan, Pavan; Jagannathan, Jay			RETRACTED: Molecular mechanisms of traumatic brain injury in children (Retracted article. See vol. 26, pg Nil_0078, 2009)	NEUROSURGICAL FOCUS			English	Article; Retracted Publication						management; outcome; pediatric trauma	SEVERE HEAD-INJURY; FLUID-PERCUSSION INJURY; D-ASPARTATE ANTAGONISTS; LONG-TERM POTENTIATION; DEVELOPING RAT-BRAIN; CEREBRAL-BLOOD-FLOW; CEREBROSPINAL-FLUID; APOPTOTIC NEURODEGENERATION; IN-VITRO; INTRACRANIAL HYPERTENSION	Despite advances in molecular biology and genetics, the precise pathophysiology of traumatic brain injury (TBI) in children is unknown. In this paper the authors review what is currently known about intra- and extracellular responses to pediatric TBI and relate these factors to future investigations. Although hyperemia and vascular congestion have long been thought to be the hallmarks of pediatric TBI, on a cellular level, calcium influx as well as modulation of local neurotransmitters appears to play a major role in its onset. Recent genetic and proteomic research has identified specific neurotrophic factors as well as apoptotic and antiapoptotic genes that appear to control the progression of inflammation and neuronal damage. The search for a therapeutic target will ultimately require a thorough understanding of these factors and their interplay on a proteomic, genomic, and neuromic level.	[Jagannathan, Jay] Univ Virginia Hlth Syst, Dept Neurosurg, Charlottesville, VA 22908 USA; [Jagannathan, Pavan] Landon Sch, Bethesda, MD USA		Jagannathan, J (corresponding author), Univ Virginia Hlth Syst, Dept Neurosurg, Box 800212, Charlottesville, VA 22908 USA.	jj5a@hscmail.mcc.virginia.edu					Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Adelson P D, 2000, Clin Neurosurg, V47, P319; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Blitzer R, 2003, J AM ACAD CHILD PSY, V42, P998, DOI 10.1097/01.CHI.0000046894.27264.9D; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Di X, 2000, ACT NEUR S, V76, P379; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Ikonomidou C, 1995, CURR OPIN NEUROL, V8, P487, DOI 10.1097/00019052-199512000-00017; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 1996, CRIT REV NEUROBIOL, V10, P239; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Jones PA, 2005, ACT NEUR S, V95, P29; JOURDAN C, 1993, NEUROCHIRURGIE, V39, P304; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Pickard JD, 2005, ACT NEUR S, V95, P459; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Crespo ART, 2007, BRAIN INJURY, V21, P441, DOI 10.1080/02699050701311125; Robertson CL, 2004, DEV BRAIN RES, V151, P141, DOI 10.1016/j.devbrainres.2004.04.007; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; TAYLOR CP, 1995, TRENDS PHARMACOL SCI, V16, P309, DOI 10.1016/S0165-6147(00)89060-4; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	85	15	16	0	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2008	25	4							E6	10.3171/FOC.2008.25.10.E6			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	355HX	WOS:000259701100006	18828704	Bronze			2022-02-06	
J	Kendall, E; Terry, DJ				Kendall, Elizabeth; Terry, Deborah J.			Understanding adjustment following traumatic brain injury: Is the Goodness-of-Fit coping hypothesis useful?	SOCIAL SCIENCE & MEDICINE			English	Article						Traumatic brain injury; Goodness-of-Fit hypothesis; Coping; Psychosocial adjustment; Australia	PSYCHOSOCIAL ADJUSTMENT; COMMUNITY SAMPLE; MENTAL-HEALTH; STRATEGIES; CONTROLLABILITY; FUTURE; MODEL	Coping efforts have been recognised as an important aspect of resilience following traumatic brain injury, but little is known about what constitutes effective coping in this population. This longitudinal research examined the usefulness of the Goodness-of-Fit hypothesis, drawn from the Lazarus and Folkman [(1984). Stress, appraisal and coping. NY: Springer.] theory of stress and coping, as a way of understanding coping effectiveness. The hypothesis suggests that the nature and success of specific coping strategies will be associated with the controllability of the event. If an event is relatively uncontrollable, then emotion-focused or perception-focused coping may be more effective than problem-focused coping. In contrast, a controllable event may be best managed through problem-focused coping. Ninety people with traumatic brain injury, drawn from the inpatient rehabilitation unit of a major metropolitan hospital in Australia, and their relatives participated in this longitudinal study. No support was found for the Goodness-of-Fit model, either in the short term or the long term. Although the use of problem-focused coping strategies was positively associated with short-term and long-term role functioning, it was not associated with long-term emotional well-being if the situation was perceived to be controllable. The findings suggest that the persistent use of problem-focused coping in response to the difficulties created by traumatic brain injury can be associated with emotional distress in the long term. Reasons for this finding are explored and its implications are discussed. (C) 2008 Elsevier Ltd. All rights reserved.	[Kendall, Elizabeth] Griffith Univ, Griffith Inst Hlth & Med Res, Ctr Natl Res Disabil & Rehabil Med, Meadowbrook, Qld 4131, Australia; [Terry, Deborah J.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia		Kendall, E (corresponding author), Griffith Univ, Griffith Inst Hlth & Med Res, Ctr Natl Res Disabil & Rehabil Med, Logan Campus,Univ Dr, Meadowbrook, Qld 4131, Australia.	e.kendall@griffith.edu.au	kendall, elizabeth/F-5065-2013	Kendall, Elizabeth/0000-0003-2399-1460			ALDWIN CM, 1987, J PERS SOC PSYCHOL, V53, P337, DOI 10.1037/0022-3514.53.2.337; Bedford A, 1997, PERS INDIV DIFFER, V22, P493, DOI 10.1016/S0191-8869(96)00242-5; BEDFORD A, 1976, BRIT J SOC CLIN PSYC, V15, P387, DOI 10.1111/j.2044-8260.1976.tb00050.x; Billings A G, 1981, J Behav Med, V4, P139, DOI 10.1007/BF00844267; Brown JE, 2000, QUAL LIFE RES, V9, P75, DOI 10.1023/A:1008995814965; Cohen J., 1983, APPL MULTIPLE REGRES; CONWAY VJ, 1992, AUST J PSYCHOL, V44, P1, DOI 10.1080/00049539208260155; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DAVIS PJ, 1987, J PERS SOC PSYCHOL, V52, P155, DOI 10.1037/0022-3514.52.1.155; DEROGATIS LR, 1986, J PSYCHOSOM RES, V30, P77, DOI 10.1016/0022-3999(86)90069-3; Endler NS, 2000, PERS INDIV DIFFER, V29, P951, DOI 10.1016/S0191-8869(99)00246-9; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Folkman S., 1984, STRESS; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; Jennett B, 1981, MANAGEMENT HEAD INJU; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KENDALL E, 1997, J HEAD TRAUMA REHAB, V12, P69; Kendall E, 2001, BRAIN IMPAIR, V2, P81; Lazarus R.S., 1990, PSYCHOL INQ, V1, P3, DOI [10.1207/s15327965pli0101_1, DOI 10.1207/S15327965PLI0101_1]; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; MCCOLL MA, 1995, SOC SCI MED, V41, P395, DOI 10.1016/0277-9536(94)00338-T; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Park CL, 2001, J CONSULT CLIN PSYCH, V69, P481, DOI 10.1037//0022-006X.69.3.481; Stanton AL, 2002, PSYCHO-ONCOLOGY, V11, P93, DOI 10.1002/pon.574; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Terry DJ, 1998, J PERS SOC PSYCHOL, V74, P1078, DOI 10.1037/0022-3514.74.4.1078; THOITS PA, 1984, REV PERSONALITY SOCI; VITALIANO PP, 1990, J PERS SOC PSYCHOL, V59, P582, DOI 10.1037/0022-3514.59.3.582; West S. G., 1991, MULTIPLE REGRESSION; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Zakowski SG, 2001, ANN BEHAV MED, V23, P158, DOI 10.1207/S15324796ABM2303_3; [No title captured]	36	15	16	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	OCT	2008	67	8					1217	1224		10.1016/j.socscimed.2008.05.033			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	362MC	WOS:000260200800003	18625542				2022-02-06	
J	Wang, Y; Zhao, J; Kalsotra, A; Turman, CM; Grill, RJ; Dash, PK; Strobel, HW				Wang, Ying; Zhao, Jing; Kalsotra, Auinash; Turman, Cheri M.; Grill, Raymond J.; Dash, Pramod K.; Strobel, Henry W.			CYP4Fs Expression in Rat Brain Correlates with Changes in LTB4 Levels after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	International Symposium on Traumatic Brain Injury Research Priorities	OCT 13-16, 2005	Johnstown, PA	John P Murtha Neursci & Pain Inst, Natl Brain Injury Res, Treatments & Training Fdn, Brain Injury Assoc Amer		cytochrome P450 4Fs (CYP4Fs); inflammation; leukotriene B-4 (LTB4); omega-hydroxylation; traumatic brain injury (TBI)	PROTEIN EXPRESSION; ARACHIDONIC-ACID; CEREBRAL-CORTEX; CDNA CLONING; CYTOCHROME-P450; INFLAMMATION; SPECIFICITY; METABOLISM; RECEPTORS; CYTOKINES	Cytochrome P450 (CYP) 4Fs constitute a subgroup of the cytochrome P450 superfamily and are involved in cellular protection and metabolism of numerous molecules, including drugs, toxins, and eicosanoids. CYP4Fs are widely distributed in rat brain with each isoform having a unique distribution pattern throughout different brain regions. The present study shows that traumatic brain injury (TBI) triggers inflammation and elicits changes in mRNA expression of CYP4Fs in the frontal and occipital lobes and the hippocampus. At 24 h post-injury, almost all CYP4F mRNA expression is suppressed compared with sham control throughout these three regions, while at 2 weeks post-injury, all CYP4F mRNAs increase, reaching levels higher than those at 24 h post-injury or uninjured controls. These changes in CYP4F levels inversely correlate with levels of leukotriene B4 (LTB4) levels in the brain following injury at the same time points. TBI also causes changes in CYP4F protein expression and localization around the injury site. CYP4F1 and CYP4F6 immunoreactivity increases in surrounding astrocytes, while CYP4F4 immunoreactivity shifts from endothelia of cerebral vessels to astrocytes.	[Wang, Ying; Kalsotra, Auinash; Turman, Cheri M.; Strobel, Henry W.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA; [Zhao, Jing; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Grill, Raymond J.; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA		Strobel, HW (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77225 USA.	henry.w.strobel@uth.tmc.edu		Kalsotra, Auinash/0000-0002-1011-0006; Dash, Pramod/0000-0001-6746-1002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044174, R01NS049409, R01NS035457] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35457, NS049409, NS44174] Funding Source: Medline		Amaral SL, 2003, AM J PHYSIOL-HEART C, V284, pH1528, DOI 10.1152/ajpheart.00406.2002; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Boehme CL, 2001, NEUROTOX RES, V3, P329, DOI 10.1007/BF03033194; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Bylund J, 2003, ARCH BIOCHEM BIOPHYS, V412, P34, DOI 10.1016/S0003-9861(03)00030-4; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cui X, 2003, BBA-GEN SUBJECTS, V1619, P325, DOI 10.1016/S0304-4165(02)00491-9; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Frontczak-Baniewicz M, 2002, NEUROENDOCRINOL LETT, V23, P396; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Hoagland KM, 2001, NEPHROL DIAL TRANSPL, V16, P2283, DOI 10.1093/ndt/16.12.2283; Jiang M, 2004, CIRC RES, V94, P167, DOI 10.1161/01.RES.0000111523.12842.FC; Jin RY, 1998, ARCH BIOCHEM BIOPHYS, V359, P89, DOI 10.1006/abbi.1998.0880; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Kalsotra A, 2002, DRUG METAB DISPOS, V30, P1022, DOI 10.1124/dmd.30.9.1022; Kawashima H, 1995, BIOCHEM BIOPH RES CO, V217, P1137, DOI 10.1006/bbrc.1995.2887; Kawashima H, 1997, ARCH BIOCHEM BIOPHYS, V347, P148, DOI 10.1006/abbi.1997.0342; Kawashima H, 1996, J BIOL CHEM, V271, P28176, DOI 10.1074/jbc.271.45.28176; KIKUTA Y, 1993, J BIOL CHEM, V268, P9376; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nicholson TE, 1999, BRAIN RES, V827, P12, DOI 10.1016/S0006-8993(99)01261-5; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Poloyac SM, 2006, J CEREBR BLOOD F MET, V26, P1551, DOI 10.1038/sj.jcbfm.9600309; SAITO T, 1981, J BIOL CHEM, V256, P984; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Williams J F, 1991, J Fla Med Assoc, V78, P517; Xu FY, 2004, J PHARMACOL EXP THER, V308, P887, DOI 10.1124/jpet.103.059626; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x	37	15	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2008	25	10					1187	U23		10.1089/neu.2008.0542			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	370XK	WOS:000260796200007	18847377	Green Published			2022-02-06	
J	Ciavarro, C; Dobson, M; Goodman, D				Ciavarro, Chad; Dobson, Mike; Goodman, David			Implicit learning as a design strategy for learning games: Alert Hockey	COMPUTERS IN HUMAN BEHAVIOR			English	Article						Implicit learning; Computer games; Brain concussion	ROLE MODELS	Concussion education and prevention for youth hockey players has been an issue of recent concern amongst sport medicine practitioners and hockey's administrative bodies. This article details the assessment of a sports-action hockey video game that aims to reduce the aggressive and negligent behaviours that can lead to concussions. The game, termed Alert Hockey, was designed to modify game playing behaviour by embedding an implicit teaching mechanism within the gameplay. In Alert Hockey, participants were expected to learn by simply playing to win, in contrast to playing to learn. We studied learning in an experimental simulated environment where the possibility to win the game was exaggerated as a consequence of desirable safety behaviours (positive learning group) and effectively reduced as a consequence of undesirable (negative learning group) behaviour. The positive learning group significantly improved their mean score on a composite behavioural indicator compared with no significant change amongst control group participants. The results demonstrate that implicit learning embedded in a sports-action game can lead to changes in game-play behaviour. (C) 2008 Elsevier Ltd. All rights reserved.	[Goodman, David] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada; [Ciavarro, Chad; Dobson, Mike] Simon Fraser Univ, Surrey, BC, Canada		Goodman, D (corresponding author), Simon Fraser Univ, Sch Kinesiol, 8888 Univ Blvd, Burnaby, BC V5A 1S6, Canada.	cdc@sfu.ca; mdobson@sfu.ca; goodman@sfu.ca					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Berry D.C., 1993, IMPLICIT LEARNING TH; Bryant AL, 2003, J ADOLESCENT RES, V18, P36, DOI 10.1177/0743558402238276; CIAVARRO C, 2005, ED MEDIA 2005 MONTR; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; De Castell S, 2003, J CURRICULUM STUD, V35, P649, DOI 10.1080/0022027032000145552; DeKeyser R., 1995, STUD SECOND LANG ACQ, V17, P379, DOI [DOI 10.1017/S027226310001425X, 10.1017/S027226310001425X]; DESTREBECQZ A, 2003, ATTENTION IMPLICIT L; DOBSON M, 2005, DIGRA 2005 JUN 16 20; DRYDEN K, 2004, GLOBE MAIL      0327, pA21; Egenfeldt-Nielsen S., 2005, THESIS IT U COPENHAG; *ESA, 2005, ESS FACTS COMP VID G; FRENSCH PA, 1998, HDB IMPLICIT LEARNIN; HADDON L, 1988, SCREEN, V29, P52, DOI 10.1093/screen/29.2.52; HAZELTINE E, 2003, ATTENTION IMPLICIT L; Jimenez L, 2003, ATTENTION IMPLICIT L; Jonassen D. H., 2004, HDB RES ED COMMUNICA, P3; Jonassen DH, 1997, ETR&D-EDUC TECH RES, V45, P65, DOI 10.1007/BF02299613; Lieberman D A, 2001, J Ambul Care Manage, V24, P26; *LUD, 2005, RES CTR; MAUSHAK NJ, 2001, NAT CONV ASS ED COMM; McCrory P, 2005, BRIT J SPORT MED, V39, P116, DOI 10.1136/bjsm.2004.015958; PLEISS MK, 1995, EDUC PSYCHOL, V30, P159, DOI 10.1207/s15326985ep3003_6; Rapp DN, 2006, COMPUT HUM BEHAV, V22, P603, DOI 10.1016/j.chb.2005.12.004; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Rose M, 2005, J COGNITIVE NEUROSCI, V17, P918, DOI 10.1162/0898929054021193; Salen K., 2004, RULES PLAY GAME DESI; Shanks DR, 2005, PSYCHOL RES-PSYCH FO, V69, P369, DOI 10.1007/s00426-004-0211-8; Sheldon JP, 2001, RES Q EXERCISE SPORT, V72, P304, DOI 10.1080/02701367.2001.10608965; Silverman Barry G, 2002, J Healthc Inf Manag, V16, P80; SMITH MD, 1988, CHILDREN SPORT, P301; Squire K., 2003, Educational Technology, V43, P17; STEINKUEHLER C, 2004, 6 INT C LEARN SCI LO; Villa V., 1994, STUDIES 2 LANGUAGE A, V16, P183, DOI DOI 10.1017/S0272263100012870; Vyse S.A., 1997, BELIEVING MAGIC PSYC; Weinstein MD, 1995, SEX ROLES, V33, P831, DOI 10.1007/BF01544782; Williams JN, 2005, STUD SECOND LANG ACQ, V27, P269, DOI 10.1017/S0272263105050138	38	15	15	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0747-5632	1873-7692		COMPUT HUM BEHAV	Comput. Hum. Behav.	SEP	2008	24	6			SI		2862	2872		10.1016/j.chb.2008.04.011			11	Psychology, Multidisciplinary; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	364TQ	WOS:000260358600028					2022-02-06	
J	Davis, RL; Buck, DJ; Saffarian, N; Mohan, S; DeSilva, U; Fernando, SC; Stevens, CW				Davis, Randall L.; Buck, Daniel J.; Saffarian, Neda; Mohan, Shekher; DeSilva, Udaya; Fernando, Samodha C.; Stevens, Craig W.			beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells	JOURNAL OF NEUROIMMUNE PHARMACOLOGY			English	Article						neuroinflammation; opioids; astrocytes; nitric oxide; fentanyl; morphine	TRAUMATIC BRAIN-INJURY; MESSENGER-RNA; ANTAGONIST; MODULATION; MICROGLIA; NEURONS; RATS	The inducible isoform of nitric-oxide synthase (iNOS) is involved in neuropathogenesis associated with infection and disease in the brain. Hence, there is considerable interest in the identification of therapeutic interventions to prevent iNOS-mediated pathology. Astroglia are a major site of iNOS expression during neuropathogenesis. To mimic a key component of neuroinflammation, human A172 astroglial cells were exposed in vitro to a cytokine mixture containing interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta, resulting in significant iNOS expression. Next, we assessed the effects of the mu opioid receptor antagonist, beta-funaltrexamine (beta-FNA), on cytokine induced iNOS expression in human astroglia. beta-FNA dose-dependently inhibited iNOS expression. beta-FNA transcriptionally (or pre-transcriptionally) inhibited cytokine-induced iNOS activation as indicated by a significant decrease in NOS2 messenger RNA expression. Further characterization of the novel, anti-inflammatory actions of beta-FNA may provide insights for pharmacologic strategies to treat or prevent brain pathologies associated with neuroinflammation.	[Davis, Randall L.; Buck, Daniel J.; Saffarian, Neda; Mohan, Shekher; Stevens, Craig W.] Oklahoma State Univ, Ctr Hlth Sci, Dept Pharmacol Physiol, Tulsa, OK 74107 USA; [DeSilva, Udaya; Fernando, Samodha C.] Oklahoma State Univ, Div Agr Sci & Nat Resources, Stillwater, OK 74078 USA		Davis, RL (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Dept Pharmacol Physiol, 1111 W 17th St, Tulsa, OK 74107 USA.	randall.davis@okstate.edu		DeSilva, Udaya/0000-0003-2517-6566	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA 014955] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA 012448, R15 DA012448-04A1] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA014955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R15DA012448] Funding Source: NIH RePORTER		Davis RL, 2007, J NEUROIMMUNOL, V186, P141, DOI 10.1016/j.jneuroim.2007.03.021; Davis RL, 2004, ALCOHOL, V32, P195, DOI 10.1016/j.alcohol.2004.01.006; Davis RL, 2002, ALCOHOL CLIN EXP RES, V26, P1404, DOI 10.1097/01.ALC.0000030841.92766.80; Hettinger AM, 2001, BIOL REPROD, V65, P507, DOI 10.1095/biolreprod65.2.507; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Lee J, 2004, IMMUNOPHARM IMMUNOT, V26, P17, DOI 10.1081/IPH-120029941; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Liu YX, 2002, J PHARMACOL EXP THER, V302, P1212, DOI 10.1124/jpet.102.035956; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Marchetti B, 2005, BRAIN RES REV, V48, P302, DOI 10.1016/j.brainresrev.2004.12.030; Poluektova L, 2005, GLIA, V52, P344, DOI 10.1002/glia.20253; QI JA, 1990, J PHARMACOL EXP THER, V252, P1006; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; Zhao H, 2002, NEUROSCIENCE, V114, P1019, DOI 10.1016/S0306-4522(02)00233-6; Zhao P, 2006, J NEUROPATH EXP NEUR, V65, P945, DOI 10.1097/01.jnen.0000235123.05677.4b	15	15	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1890			J NEUROIMMUNE PHARM	J. Neuroimmune Pharm.	SEP	2008	3	3					150	153		10.1007/s11481-008-9102-x			4	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	337AI	WOS:000258407500002	18278557	Green Accepted, Green Submitted			2022-02-06	
J	Feliciano, CE; De Jesus, O				Feliciano, Caleb E.; De Jesus, Orlando			Conservative management outcomes of traumatic acute subdural hematomas	PUERTO RICO HEALTH SCIENCES JOURNAL			English	Article						acute subdural hematoma; conservative treatment; traumatic brain injury	CRITERIA; SCALE	Background: Traumatic brain injury represents a significant cause of mortality and permanent disability in the adult population. Acute subdural hematoma is one of the conditions most strongly associated with severe brain injury. Knowledge on the natural history of the illness and the outcomes of patients conservatively managed may help the neurosurgeon in the decision-making process. Methods: We present the clinical course and outcomes of a group of 38 patients with traumatic acute subdural hematomas conservatively treated. Outcomes analysis taking into consideration age, Glasgow Coma Scale scores on admission, and radiological findings is provided. Results: Patients less than 65 years old had a favorable or functionally independent outcome in 85% of the cases. Patients with Glasgow Coma Scale scores greater than 8 had a functionally independent outcome in 78%, of the cases. Patients with acute subdural hematomas with thicknesses :510 mm and midline shifts <= 5 rum showed functionally independent outcomes in 82% of the cases. Conclusion: The conservative management of patients with acute subdural hematomas can be a viable alternative in certain cases. Those patients younger than 65 years old, with small acute subdural hematomas and Glasgow Coma Scale scores greater than 8, will have the best functional outcomes.	[Feliciano, Caleb E.; De Jesus, Orlando] Univ Puerto Rico, Dept Surg, Sect Neurol Surg, San Juan, PR 00936 USA		Feliciano, CE (corresponding author), Univ Puerto Rico, Dept Surg, Sect Neurol Surg, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.	cfeliciano@rcm.upr.edu; odejesus@pol.net					Bullock MR, 2006, NEUROSURGERY S, V58, P16; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1974, LANCET, V2, P1; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	16	15	15	0	2	UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS	SAN JUAN	OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA	0738-0658			P R HEALTH SCI J	P. R. Health Sci. J.	SEP	2008	27	3					220	223					4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	349BX	WOS:000259254900006	18782966				2022-02-06	
J	Bledsoe, KA; Kramer, AH				Bledsoe, Kathleen A.; Kramer, Andreas H.			Propylene glycol toxicity complicating use of barbiturate coma	NEUROCRITICAL CARE			English	Article						propylene glycol; barbiturate coma; pentobarbital; phenobarbital; refractory status epilepticus	REFRACTORY STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; LORAZEPAM INFUSION; ETOMIDATE INFUSION; THERAPY; ANESTHESIA; PROPOFOL; PATIENT; EDEMA	Introduction Barbiturate coma is a necessary medical therapy in certain instances, such as the treatment of refractory status epilepticus or severe intracranial hypertension, but its use is often wrought with serious complications. Potential complications include hemodynamic instability, respiratory depression, and immunosuppression with frequent nosocomial infections. High doses of barbiturates may also lead to the accumulation of propylene glycol, the vehicle used in the intravenous formulations of both pentobarbital and phenobarbital, thereby yielding another less-recognized complication of therapy. Results We present a case of propylene glycol toxicity associated with the use of high-dose intravenous pentobarbital and phenobarbital during the treatment of refractory status epilepticus.	[Bledsoe, Kathleen A.] Univ Virginia Hlth Syst, Dept Pharm, Charlottesville, VA 22908 USA; [Kramer, Andreas H.] Univ Calgary, Foothills Med Ctr, Dept Crit Care Med, Calgary, AB T2N 2T9, Canada; [Kramer, Andreas H.] Univ Calgary, Foothills Med Ctr, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada		Bledsoe, KA (corresponding author), Univ Virginia Hlth Syst, Dept Pharm, POB 800674, Charlottesville, VA 22908 USA.	kv9k@virginia.edu					Arroliga AC, 2004, CRIT CARE MED, V32, P1709, DOI 10.1097/01.CCM.0000134831.40466.39; ARULANANTHAM K, 1978, J PEDIATR-US, V93, P515, DOI 10.1016/S0022-3476(78)81183-4; BEDICHEK E, 1991, ARCH INTERN MED, V151, P2297, DOI 10.1001/archinte.151.11.2297; Bratton S L, 2007, J NEUROTRAUMA S1, V24, pS71, DOI DOI 10.1089/NEU.2007.9985; Cairns CJS, 2002, INTENS CARE MED, V28, P1357, DOI 10.1007/s00134-002-1399-y; CHOI SD, 1985, ANESTHESIOLOGY, V62, P442, DOI 10.1097/00000542-198504000-00012; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; DEMEY HE, 1987, CRIT CARE MED, V15, P540, DOI 10.1097/00003246-198705000-00021; EBERHARDT KEW, 1992, INFECTION, V20, P12, DOI 10.1007/BF01704886; ECKSTEIN JW, 1961, ANESTHESIOLOGY, V22, P525, DOI 10.1097/00000542-196107000-00002; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; LEVY ML, 1995, NEUROSURGERY, V37, P363, DOI 10.1227/00006123-199508000-00035; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; LOUIS S, 1967, AM HEART J, V74, P523, DOI 10.1016/0002-8703(67)90011-7; Parker MG, 2002, INTENS CARE MED, V28, P81, DOI 10.1007/s00134-001-1125-1; PARTINEN M, 1981, BRIT MED J, V282, P520, DOI 10.1136/bmj.282.6263.520; Parviainen I, 2002, NEUROLOGY, V59, P1249, DOI 10.1212/01.WNL.0000032253.88378.D7; Ploppa A, 2006, CRIT CARE MED, V34, P478, DOI 10.1097/01.CCM.0000199067.71968.6E; Reves JG, 2005, MILLERS ANESTHESIA, P326; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Tayar J, 2002, NEW ENGL J MED, V346, P1253, DOI 10.1056/NEJM200204183461618; TODD MM, 1985, ANESTH ANALG, V64, P681; VERRESEN L, 1986, CRIT CARE MED, V14, P753, DOI 10.1097/00003246-198608000-00021; Wilson KC, 2000, NEW ENGL J MED, V343, P815, DOI 10.1056/NEJM200009143431115; Wilson KC, 2005, CHEST, V128, P1674, DOI 10.1378/chest.128.3.1674; Yaucher NE, 2003, PHARMACOTHERAPY, V23, P1094, DOI 10.1592/phco.23.10.1094.32762; Yorgin PD, 1997, AM J KIDNEY DIS, V30, P134, DOI 10.1016/S0272-6386(97)90577-1; Zar T, 2007, SEMIN DIALYSIS, V20, P217, DOI 10.1111/j.1525-139X.2007.00280.x	30	15	15	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2008	9	1					122	124		10.1007/s12028-008-9065-z			3	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	340PM	WOS:000258657500019	18270846				2022-02-06	
J	Richmond, TS; Lemaire, J				Richmond, Therese S.; Lemaire, Jean			Years of life lost because of gunshot injury to the brain and spinal cord	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						life expectancy; brain injuries; spinal cord injuries; wounds; gunshot	MORTALITY; SUICIDE; BURDEN; DEATH; FIREARMS; HEALTH; TRENDS; STATES	Objective: A recent study (Lemaire) estimated the life expectancy loss attributable to gun deaths at 103.6 days for the overall U.S. population: 150.7 days for white males and 361.5 days for black males. This study estimates the life expectancy loss attributable to the premature death of individuals who initially survived gun-related traumatic brain injury (TBI) and spinal cord injury (SCI) in the United States. Design: Interpersonal TBI data were drawn from a surveillance system, and self-inflicted TBI data were obtained from the Web-based Injury Statistics and Reporting System. SCI data were obtained from a national database. Multiple decrement analysis was used to calculate the days of life lost to gunshot wounds to the brain and spinal cord, by race and gender, in the United States. Results: On average, across age, gender, and race, life expectancy in the United States is reduced by 3.1 days because of the shorter lifespan for individuals who survive an initial gunshot wound to the brain or spinal cord. Black males bear a disproportionate burden, losing 9.5 days, whereas white males lose 4.6 days. Black and white females lose 1.5 and 1.0 days, respectively. Conclusions: We add these findings to the Lemaire study, resulting in a total of 106.7 days of life expectancy loss from gunshot wounds for the U.S. population, with 37 1.0 days of life lost for black males.	[Richmond, Therese S.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Richmond, Therese S.] Univ Penn, Firearm & Injury Ctr Penn, Philadelphia, PA 19104 USA; [Lemaire, Jean] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA		Richmond, TS (corresponding author), Univ Penn, Sch Nursing, Fagin Hall,418 Curie Blvd, Philadelphia, PA 19104 USA.						BOWERS N.L, 1997, ACTUARIAL MATH; *CDC, 2002, HLTH EXP PERC GROSS; *CENTR INT AG, 2006, FACTB; *CTR INJ PREV CONT, WISQARS; Cukier W. T. Sarkar, 2000, CANADIAN CRIMINAL LA, V6, P99; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Fingerhut L A, 1998, Adv Data, P1; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hyder AA, 2006, HEALTH POLICY, V77, P129, DOI 10.1016/j.healthpol.2005.07.008; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062; Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lemaire J, 2005, J RISK INSUR, V72, P359, DOI 10.1111/j.1539-6975.2005.00128.x; Miller M, 2004, J TRAUMA, V57, P626, DOI 10.1097/01.TA.0000093367.07960.E4; *NAT SPIN CORD INJ, 2004, 2004 ANN STAT REP MO; National Spinal Cord Injury Statistical Center, SPIN CORD INJ FACTS; Perrott GSJ, 2005, MILBANK Q, V83, P569, DOI 10.1111/j.1468-0009.2005.00393.x; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; SHAVELLE RM, 2007, BRAIN INJURY MED PRI; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; *SPIN CORD INF NET, 2004, FACTS FIG GLANC; Stolzenberg L, 2000, SOC FORCES, V78, P1461, DOI 10.2307/3006181; Sutton L, 2005, SOC PSYCH PSYCH EPID, V40, P324, DOI 10.1007/s00127-005-0889-y; Wadman MC, 2003, ANN EMERG MED, V42, P468, DOI 10.1067/S0196-0644(03)00489-X; Yeo JD, 1998, SPINAL CORD, V36, P329, DOI 10.1038/sj.sc.3100628	29	15	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2008	87	8					609	615		10.1097/PHM.0b013e31817fb496			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	333AK	WOS:000258124200001	18645321	Green Submitted			2022-02-06	
J	Roscigno, CI; Van Liew, K				Roscigno, Cecelia I.; Van Liew, Kevin			Pushed to the Margins and Pushing Back: A Case Study of One Adult's Reflections on Social Interactions After a Traumatic Brain Injury Sustained as an Adolescent	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SELF; MIND; NARRATIVES; PEOPLE; LIFE	Traumatic brain injury (TBI) is a worldwide chronic health problem. Current empirical approaches to defining factors that contribute to a meaningful life after TBI have been limited to the biomedical perspective. Such a limited paradigm fails to address how people with TBI find meaning and act on and are acted on by the world in which they live. Between 2005 and 2007 an in-depth qualitative case study was conducted. The primary data source was a man's retrospective journal writings about his life after sustaining a severe TBI. The qualitative perspective of symbolic interactionism framed this case study analysis. Meaning is strongly influenced by the ways in which the social world interacts with the injured person. Despite an accumulation of negative social experiences, a traumatically brain-injured person can also assign positive meanings to the quality of his or her life. This has been ignored or explained away as a defense mechanism in previous investigations. More studies that include unbiased methods able to capture subjective experiences and what they mean to individuals with TBI are needed. This information will lead to more relevant interventions and better outcome instruments for use with this population.	[Roscigno, Cecelia I.] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA			graymtr@u.washington.edu			National Institutes of Nursing [1 F31 NR009599-02]; University of WashingtonUniversity of Washington [6 T73 MC 00041-11-02]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR009599] Funding Source: NIH RePORTER	The first author would like to acknowledge funding and training support from a National Institutes of Nursing Research Individual Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02), the University of Washington Leadership Education in Neurodevelopmental and Related Disabilities traineeship (TG # 6 T73 MC 00041-11-02), and the University of Washington Gatzert Child Welfare Fellowship during this case study. The first author also would like to acknowledge Kevin for his selfless sharing of his personal life so that others could learn. This publication is in honor of him.	Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blumer H., 1969, SYMB INTERACT; Donnelly JP, 2005, BRAIN INJURY, V19, P1077, DOI 10.1080/02699050500110728; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21; Frankl V., 1984, MANS SEARCH MEANING; Glaser B., 1967, DISCOVERY GROUNDED T; Goffman E., 1963, STIGMA NOTES MANAGEM; Hall Edward T., 1973, SILENT LANGUAGE; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; HAUERWAS S, 2006, SEPT 2006 C; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Keagan R, 1982, EVOLVING SELF PROBLE; KEEN J, 1995, BRIT MED J, V311, P444, DOI 10.1136/bmj.311.7002.444; KNAPP ML, 1996, INTERPERSONAL COMMUN, P97; Luck L, 2006, NURS INQ, V13, P103, DOI 10.1111/j.1440-1800.2006.00309.x; Martsolf DS, 1998, J ADV NURS, V27, P294, DOI 10.1046/j.1365-2648.1998.00519.x; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Mead G.H., 1934, MIND SELF SOC STANDP; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; NIETZSCHE F, 1964, COMPLETE WORKS F NIE, V16; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Swanson K M, 1993, Image J Nurs Sch, V25, P352; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Wendell Susan, 1996, REJECTED BODY FEMINI; WHO, 2004, WORLD REP ROAD TRAFF; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; [No title captured]	39	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	AUG	2008	40	4					212	221		10.1097/01376517-200808000-00005			10	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	516XR	WOS:000271577200005	18727337	Green Accepted			2022-02-06	
J	Hallen, M; Carlhed, R; Karlsson, M; Hallgren, T; Bergenheim, M				Hallen, Magnus; Carlhed, Rickard; Karlsson, Mathias; Hallgren, Thomas; Bergenheim, Mikael			A comparison of two different assays for determining S-100B in serum and urine	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						head trauma; methods; protein S-100B; serum analysis; urine analysis	MINOR HEAD-INJURY; TRAUMATIC BRAIN-DAMAGE; PROTEIN MEASUREMENTS; S100B PROTEIN; ELIMINATION; EXPRESSION; S100-BETA; FAMILY	Background: Brain injury after head trauma can be detected by S-100B measurements in serum. Recent preliminary studies indicate that urinary levels of S-100B are also increased after head injury, a finding that is of possible clinical value. The aims of the present study are two-fold: to compare serum measurements of two assays, the Liaison Sangtec (R) 100 system and the Elecsys (R) S100 test, and to investigate to what extent they can detect and measure S-100B in urine. Methods: A total of 191 serum and 174 urine samples from 107 patients (children aged between 1 and 18 years following head trauma) were measured with both assays. The results were compared using correlation analysis and Bland-Altman difference plots. Results: Serum values of the Sangtec (R) system ranged from 0.02 to 2.28 mu g/L, and from 0.005 to 2.13 mu g/L for the Elecsys (R) test. Comparisons showed a clear correlation (correlation coefficient 0.80) but not an agreement between the methods. The Sangtec (R) system could only detect S-100B in 20 out of 174 urine samples (range 0.02-0.06 mu g/L), whereas the Elecsys (R) test could detect S-100B in 171 samples (range 0.005-0.14 mu g/L). No clear relation was observed between the two methods in urine analysis (correlation coefficient 0.60). Conclusion: The Sangtec (R) and Elecsys (R) assays are not interchangeable methods when analyzing S-100B in serum or urine samples after head injury.	[Hallen, Magnus; Karlsson, Mathias; Hallgren, Thomas; Bergenheim, Mikael] Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden; [Carlhed, Rickard] Cent Hosp Karlstad, Dept Lab Med, S-65185 Karlstad, Sweden		Bergenheim, M (corresponding author), Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden.	mikael.bergenheim@liv.se					Banfalvi T, 2003, ONCOLOGY-BASEL, V64, P374, DOI 10.1159/000070296; BAUDIER J, 1984, BIOCHIM BIOPHYS ACTA, V790, P164, DOI 10.1016/0167-4838(84)90220-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2001, CLIN CHEM, V47, P1836; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	23	15	16	0	3	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	JUL	2008	46	7					1025	1029		10.1515/CCLM.2008.190			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	334JS	WOS:000258218700021	18624623				2022-02-06	
J	Hobbs, CE; Oorschot, DE				Hobbs, Catherine E.; Oorschot, Dorothy E.			Neonatal rat hypoxia-ischemia: Long-term rescue of striatal neurons and motor skills by combined antioxidant-hypothermia treatment	BRAIN PATHOLOGY			English	Article						hypoxia-ischemia; motor skills; stereology; striatum	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; RETINAL GANGLION-CELLS; MEDIUM SPINY NEURONS; BUTYL-NITRONE PBN; NEUROTROPHIC FACTOR; RADICAL SCAVENGERS; SELECTIVE HEAD; BASAL GANGLIA; ANIMAL-MODELS	Perinatal hypoxia-ischemia can cause long-term neurological and behavioral disability. Recent multicenter clinical trials suggest that moderate hypothermia, within 6 h of birth, offers significant yet incomplete protection. We investigated the effect of combined treatment with the antioxidant N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN) and moderate hypothermia on long-term neuronal injury and behavioral disability. S-PBN or its diluent was administered 12-hourly to rats from postnatal day (PN) 7 to 10. On PN8, hypoxia-ischemia was induced. Immediately post-hypoxia, additional S-PBN and 6 h of moderate hypothermia or additional diluent and 6 h of normothermia were administered. At 1 week, and at 11 weeks, after hypoxia-ischemia, the absolute number of surviving medium-spiny neurons was measured in the coded right striatum. In a separate experiment, skilled forepaw ability was investigated in coded 9- to 11-week-old rats. Normal, uninjured animals were also tested for motor skills at 9- to 11-weeks-of-age. The combination of S-PBN and moderate hypothermia provided statistically significant short- and long-term protection of the striatal medium-spiny neurons to normal control levels. This combinatorial treatment also preserved fine motor skills to normal control levels. The impressive histological and functional preservation suggests that S-PBN and moderate hypothermia is a safe and attractive combination therapy for perinatal hypoxia-ischemia.	[Hobbs, Catherine E.; Oorschot, Dorothy E.] Univ Otago, Dept Anat & Struct Biol, Otago Sch Med Sci, Dunedin 9054, New Zealand		Oorschot, DE (corresponding author), Univ Otago, Dept Anat & Struct Biol, Otago Sch Med Sci, POB 913, Dunedin 9054, New Zealand.	dorothy.oorschot@stonebow.otago.ac.nz	Oorschot, Dorothy/AAJ-9543-2020	Oorschot, Dorothy/0000-0003-0212-4456			ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Benders MJNL, 2006, ARCH DIS CHILD-FETAL, V91, pF163, DOI 10.1136/adc.2005.086652; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHEN GM, 1990, FREE RADICAL RES COM, V9, P317, DOI 10.3109/10715769009145690; Covey MV, 2007, PEDIATR RES, V62, P646, DOI 10.1203/PDR.0b013e318157d1fe; Covey MV, 2006, EXP NEUROL, V199, P513, DOI 10.1016/j.expneurol.2005.12.026; Dawson DA, 2001, BRAIN RES, V892, P344, DOI 10.1016/S0006-8993(00)03269-8; Dehouck MP, 2002, BRAIN RES, V955, P229, DOI 10.1016/S0006-8993(02)03469-8; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Fricker RA, 1996, BRAIN RES BULL, V41, P409, DOI 10.1016/S0361-9230(96)00083-4; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fukuda H, 2001, BRAIN RES, V910, P187, DOI 10.1016/S0006-8993(01)02659-2; Galvin KA, 1998, PEDIATR RES, V44, P740, DOI 10.1203/00006450-199811000-00017; Galvin KA, 2003, NEUROSCIENCE, V118, P1023, DOI 10.1016/S0306-4522(03)00066-6; GERFEN CR, 1982, J COMP NEUROL, V207, P283, DOI 10.1002/cne.902070308; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GRABOWSKI M, 1993, STROKE, V24, P889, DOI 10.1161/01.STR.24.6.889; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; Hallenbeck JM, 1996, ADV NEUROL, V71, P281; Hamrick SEG, 2003, CURR OPIN NEUROL, V16, P147, DOI 10.1097/00019052-200304000-00005; Hayashi T, 2005, BRAIN RES, V1038, P41, DOI 10.1016/j.brainres.2004.12.048; Hensley K, 1997, INT REV NEUROBIOL, V40, P299; HICKS SP, 1975, AM J ANAT, V143, P1, DOI 10.1002/aja.1001430102; HOBBS CE, 2008, PEDIAT INT IN PRESS; Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x; Jeyasingham RA, 2001, BRAIN RES BULL, V55, P541, DOI 10.1016/S0361-9230(01)00557-3; Klocker N, 1998, J NEUROSCI, V18, P1038; Ko ML, 2000, INVEST OPHTH VIS SCI, V41, P2967; Kohzuki M, 2006, AM J OBSTET GYNECOL, V195, P240, DOI 10.1016/j.ajog.2005.12.036; Kumral A, 2006, BRAIN RES, V1115, P169, DOI 10.1016/j.brainres.2006.07.114; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; Larsen M, 2004, ANAT EMBRYOL, V208, P239, DOI 10.1007/s00429-004-0395-0; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; MacLellan CL, 2006, STROKE, V37, P1266, DOI 10.1161/01.STR.0000217268.81963.78; MacLellan CL, 2006, BEHAV BRAIN RES, V175, P82, DOI 10.1016/j.bbr.2006.08.001; Maples KR, 2004, CNS DRUGS, V18, P1071, DOI 10.2165/00023210-200418150-00003; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; MONTOYA CP, 1990, PROG BRAIN RES, V82, P459; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Nedelcu J, 2000, BRAIN PATHOL, V10, P61; OORSCHOT DE, 1994, PROG NEUROBIOL, V44, P233, DOI 10.1016/0301-0082(94)90040-X; Oorschot DE, 2002, ADV BEHAV BIOL, V52, P421; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; Peterson SL, 2005, NEUROTOXICOLOGY, V26, P969, DOI 10.1016/j.neuro.2005.04.002; PRICE AW, 1981, BRAIN RES, V205, P81, DOI 10.1016/0006-8993(81)90721-6; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rogalska J, 2004, BEHAV BRAIN RES, V154, P321, DOI 10.1016/j.bbr.2004.02.020; Roohey T, 1997, EARLY HUM DEV, V47, P115, DOI 10.1016/S0378-3782(96)01773-2; Rumiris D, 2006, HYPERTENS PREGNANCY, V25, P241, DOI 10.1080/10641950600913016; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; SCHULZ JB, 1995, J CEREBR BLOOD F MET, V15, P948, DOI 10.1038/jcbfm.1995.120; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Toien O, 2001, AM J PHYSIOL-REG I, V281, pR572; Tomimatsu T, 2002, BRAIN RES, V926, P108, DOI 10.1016/S0006-8993(01)03311-X; Tuor UI, 2001, EXP NEUROL, V167, P272, DOI 10.1006/exnr.2000.7565; Volpe J., 2001, NEUROLOGY NEWBORN; Wagner CL, 1999, PEDIATR NEUROL, V21, P429, DOI 10.1016/S0887-8994(99)00020-X; Wemer J, 2006, CURR MED RES OPIN, V22, P1813, DOI 10.1185/030079906X121075; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Wickens J., 1993, THEORY STRIATUM; Yang Y, 2000, EXP NEUROL, V163, P39, DOI 10.1006/exnr.2000.7364	74	15	15	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2008	18	3					443	454		10.1111/j.1750-3639.2008.00146.x			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	308MU	WOS:000256395500015	18371175	Green Published			2022-02-06	
J	Faleiro, RM; Faleiro, LCM; Caetano, E; Gomide, I; Pita, C; Coelho, G; Bras, E; Carvalho, B; Gusmao, SNS				Faleiro, Rodrigo Moreira; Faleiro, Luiz Carlos Mendes; Caetano, Elisa; Gomide, Isabella; Pita, Cristina; Coelho, Gustavo; Bras, Ellen; Carvalho, Bruna; Silva Gusmao, Sebastiao Nataniel			Decompressive craniotomy - Prognostic factors and complications in 89 patients	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						head injury; intracranial hypertension; decompressive craniotomy	SEVERE HEAD-INJURY; MASS LESIONS; CRANIOPLASTY; CRANIECTOMY; MANAGEMENT; REDUCTION; CHILDREN	Decompressive craniotomy (DC) is applied to treat post-traumatic intracranial hypertension (ICH). The purpose of this study is to identify prognostic factors and complications of unilateral DC. Eighty-nine patients submited to unilateral DC were retrospectively analyzed over a period of 30 months. Qui square independent test and Fisher test were used to identify prognostic factors. The majority of patients were male (87%). Traffic accidents had occurred in 47% of the cases. 64% of the patients had suffered severe head injury, while pupillary abnormalities were already present in 34%. Brain swelling plus acute subdural hematoma were the most common tomographic findings (64%). Complications occurred in 34.8% of the patients: subdural effusions in 10 (11.2%), hydrocephalus in 7 (7.9%) and infection in 14 (15.7%). The admittance Glasgow coma scale was a statistically significant predictor of outcome (p=0.0309).	Hosp Pronto Socorro Joao XXIII FHEMIG, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Felicio Rocho & HPS J23, Belo Horizonte, MG, Brazil; FCMMG, Sch Med Sci Minas Gerais, Belo Horizonte, MG, Brazil; [Silva Gusmao, Sebastiao Nataniel] Hosp Clin UFMG, Belo Horizonte, MG, Brazil		Faleiro, RM (corresponding author), Rua Caraca 518-201, BR-30220260 Belo Horizonte, MG, Brazil.	rfaleiro@brfree.com.br					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper P R, 1976, Surg Neurol, V5, P25; DOSS K, 2005, ANNS ORG LIB; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; IWAMA T, 2002, NEUROSURGERY, V52, P501; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT WB, 1960, J NEUROSURG, V17, P598, DOI 10.3171/jns.1960.17.4.0598; MARMAROU A, 1989, INTRACRANIAL PRESSUR, P549; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Missori P, 2003, ACTA NEUROCHIR, V145, P899, DOI 10.1007/s00701-003-0118-y; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; PEREIRA WC, 1977, ARQ NEURO-PSIQUIAT, V35, P99, DOI 10.1590/S0004-282X1977000200002; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SILVA JA, 1976, ARQ NEURO-PSIQUIAT, V34, P232; WHITFIELD P, 1995, STROKE, V26, P1125; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Woolf JI, 1945, INT ABSTR SURG, V81, P1; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	30	15	17	0	2	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2008	66	2B					369	373		10.1590/S0004-282X2008000300017			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	327WV	WOS:000257760100017	18641874	Green Submitted, gold			2022-02-06	
J	McIntosh, SE; Swanson, ER; Barton, ED				McIntosh, Scott E.; Swanson, Eric R.; Barton, Erik D.			Cricothyrotomy in air medical transport	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						air medical transport; airway; cricothyrotomy	PREHOSPITAL SURGICAL CRICOTHYROTOMY; TRAUMATIC BRAIN-INJURY; EMERGENCY; INTUBATION; EXPERIENCE; EFFICACY; PATIENT; SUCCESS; RATES; FIELD	Background: Airway management is an essential skill for air medical transport (AMT) providers. The endpoint of airway maneuvers is a cricothyrotomy which may be live-saving if other measures fail. We reviewed cricothyrotomy cases in our AMT program to evaluate the success rate and the circumstances surrounding the procedure. Methods: This was a retrospective review of cases in which a cricothyrotomy was performed at the University of Utah AirMed night program during the years of 1995 to 2004. Data included incidence, indications, complications, neurologic outcome, and success rates of the procedure. Results: Of the 14,994 transports during the study period, 17 cricothyrotomies were performed. Airway obstruction by blood and/or vomit was the most frequent indication (47%) followed by airway edema/distorted anatomy (24%). The total number of cricothyrotomies decreased during the study period. Seven (41%) patients survived with a reasonable neurologic outcome. The remaining 10 patients died during initial treatment or subsequent hospitalization. Success rate of the procedure in our series was 100%. These results were compared with those of other cricothyrotomy studies. Conclusion: Cricothyrotomy has become less common as an emergency rescue technique. However, AMT personnel have a high success rate when performing the cricothyrotomy procedure. This rate is as high as or higher than other emergency personnel.	[McIntosh, Scott E.; Swanson, Eric R.; Barton, Erik D.] Univ Utah, Hlth Sci Ctr, Div Emergency Med, Salt Lake City, UT 84132 USA		McIntosh, SE (corresponding author), Univ Utah, Hlth Sci Ctr, Div Emergency Med, 30 N Med Dr, Salt Lake City, UT 84132 USA.	scott.mcintosh@hsc.utah.edu					Bair AE, 2003, J EMERG MED, V24, P151, DOI 10.1016/S0736-4679(02)00715-1; Boyle Michael F., 1993, Journal of Emergency Medicine, V11, P41, DOI 10.1016/0736-4679(93)90008-U; Chang RS, 1998, ACAD EMERG MED, V5, P247, DOI 10.1111/j.1553-2712.1998.tb02621.x; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; ERLANDSON M J, 1989, Journal of Emergency Medicine, V7, P115; Eyer SD, 1997, J TRAUMA, V42, P837; Foley LJ, 2000, CRIT CARE CLIN, V16, P429, DOI 10.1016/S0749-0704(05)70121-4; Fortune JB, 1997, J TRAUMA, V42, P832, DOI 10.1097/00005373-199705000-00013; Jacobson LE, 1996, J TRAUMA, V41, P15, DOI 10.1097/00005373-199607000-00004; JENNETT B, 1975, LANCET, V1, P480; Ma OJ, 1998, AM J EMERG MED, V16, P125, DOI 10.1016/S0735-6757(98)90027-4; MCGILL J, 1982, ANN EMERG MED, V11, P361, DOI 10.1016/S0196-0644(82)80362-4; MIKLUS RM, 1989, J TRAUMA, V29, P506, DOI 10.1097/00005373-198904000-00016; NUGENT WL, 1991, ANN EMERG MED, V20, P367, DOI 10.1016/S0196-0644(05)81656-7; Oliver R., 1992, Journal of Trauma, V33, P159, DOI 10.1097/00005373-199207000-00072; Robinson K J, 2001, Air Med J, V20, P27, DOI 10.1067/mmj.2001.120085; Rose W D, 1994, Air Med J, V13, P475, DOI 10.1016/S1067-991X(05)80289-5; Sing RF, 1996, ACAD EMERG MED, V3, P41, DOI 10.1111/j.1553-2712.1996.tb03301.x; SPAITE DW, 1990, ANN EMERG MED, V19, P279, DOI 10.1016/S0196-0644(05)82045-1; Swanson Eric R, 2002, Air Med J, V21, P28, DOI 10.1016/S1067-991X(02)70054-0; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; XEROPOTAMOS NS, 1993, INJURY, V24, P222, DOI 10.1016/0020-1383(93)90172-3	23	15	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2008	64	6					1543	1547		10.1097/TA.0b013e3181271b60			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	313MG	WOS:000256744100023	18545121				2022-02-06	
J	Chang, CH; Liao, JJ; Chuang, CH; Lee, CT				Chang, Chih-Hung; Liao, Jui-Jung; Chuang, Chung-Hua; Lee, Chien-Te			Recurrent hyponatremia after traumatic brain injury	AMERICAN JOURNAL OF THE MEDICAL SCIENCES			English	Article						hyponatremia; head injury; syndrome of inappropriate antidiuretic hormone secretion	ANTIDIURETIC-HORMONE SECRETION; CENTRAL-NERVOUS-SYSTEM; PITUITARY DYSFUNCTION; PREVALENCE; DISEASE; WATER	Dysregulation of the neuroendocrine system is a frequent complication after traumatic brain injury (TBI). Symptoms of these hormonal abnormalities might be subtle and thus easily ignored. Hyponatremia usually indicates underlying disorders that disrupt fluid homeostasis. In most patients with TBI, hyponatremia is a feature of the syndrome of inappropriate antidiuretic hormone (SIADH) secretion due to pituitary dysfunction after head injury. Usually TBI-associated hyponatremia is transient and reversible. We report the case of a 48-year-old man with TBI-associated hyponatremia with delayed recovery and recurrent hyponatremia precipitated by subsequent surgery. In this report, we emphasize the importance of identifying patients with slow recovery of the injured brain, which could complicate with SIADH and acute hyponatremia. Differentiating TBI-associated SIADH from other important causes of hyponatremia such as cerebral salt wasting, and hypocortisonism are also reviewed. Prevention of its recurrence by avoiding further risk is mandatory in managing patients with TBI.	[Chang, Chih-Hung; Chuang, Chung-Hua; Lee, Chien-Te] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Chang Gung Mem Hosp,Div Nephrol,Dept Internal Med, Kaohsiung Hsien 833, Taiwan; [Liao, Jui-Jung] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Chang Gung Mem Hosp,Div Neurosurg,Dept Surg, Kaohsiung Hsien 833, Taiwan		Lee, CT (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Chang Gung Mem Hosp,Div Nephrol,Dept Internal Med, 123,Ta Pei Rd, Kaohsiung Hsien 833, Taiwan.	ctlee33@adm.cgmh.org.tw					Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Cole Chad D, 2004, Neurosurg Focus, V16, pE9; CORT JH, 1954, LANCET, V1, P752; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Kumar PD, 2001, ANN INTERN MED, V135, P932, DOI 10.7326/0003-4819-135-10-200111200-00027; Lee CT, 2000, AM J EMERG MED, V18, P264, DOI 10.1016/S0735-6757(00)90118-9; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Nathan BR, 2007, NEUROCRIT CARE, V6, P72, DOI 10.1385/NCC:6:1:72; Palmer BF, 2000, NEPHROL DIAL TRANSPL, V15, P262, DOI 10.1093/ndt/15.2.262; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rabinstein AA, 2006, CLIN NEUROPHARMACOL, V29, P87, DOI 10.1097/00002826-200603000-00006; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; WELT LG, 1952, ARCH INTERN MED, V90, P355, DOI 10.1001/archinte.1952.00240090076007; Wong LL, 2002, ENDOCRIN METAB CLIN, V31, P121, DOI 10.1016/S0889-8529(01)00007-X	21	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0002-9629			AM J MED SCI	Am. J. Med. Sci.	MAY	2008	335	5					390	393		10.1097/MAJ.0b013e318149e6f1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	306VO	WOS:000256276100012	18480658	Green Submitted			2022-02-06	
J	Kim, E				Kim, Edward			Does traumatic brain injury predispose individuals to develop schizophrenia	CURRENT OPINION IN PSYCHIATRY			English	Article						epidemiology; psychosis; schizophrenia; traumatic brain injury	HEAD-INJURY; MAJOR DEPRESSION; PSYCHOSIS; RISK; DISORDERS	Purpose of review Psychosis following traumatic brain injury has been studied in both prospective and retrospective studies that have been frequently limited by unclear criteria for classifying psychiatric syndromes or case ascertainment bias regarding traumatic brain injury. Schizophrenia is a psychotic disorder commonly attributed to the interaction of genetic vulnerability and environmental events, yet its relationship with traumatic brain injury has not been systematically reviewed. Recent findings The literature is not conclusive and highlights the challenges to observational research in conditions in which case ascertainment is difficult. The evidence supports a risk-modifying effect of traumatic brain injury in individuals who are genetically at risk for schizophrenia, but is less supportive of traumatic brain injury as an independent risk factor for schizophrenia in individuals without such risk. Summary Research in psychotic disorders following traumatic brain injury must distinguish schizophrenia from other psychotic syndromes, and take familial risk factors into consideration.	[Kim, Edward] Bristol Myers Squibb Co, Outcomes Res USA, Plainsboro, NJ 08536 USA; [Kim, Edward] Robert Wood Johnson Med Sch, Dept Psychiat, Plainsboro, NJ USA		Kim, E (corresponding author), Bristol Myers Squibb Co, Outcomes Res USA, 777 Scudders Mill Rd, Plainsboro, NJ 08536 USA.	edward.kim@bms.com					AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Cochrane J, 2000, CAN J PSYCHIAT, V45, P185, DOI 10.1177/070674370004500210; Compton MT, 2007, SCHIZOPHR RES, V94, P64, DOI 10.1016/j.schres.2007.04.002; Corcoran C, 2003, SCHIZOPHRENIA BULL, V29, P671, DOI 10.1093/oxfordjournals.schbul.a007038; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; Folsom DP, 2006, PSYCHIAT RES, V144, P167, DOI 10.1016/j.psychres.2005.12.002; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kraus P, 1999, J HIGH ENERGY PHYS; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9	21	15	18	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0951-7367			CURR OPIN PSYCHIATR	Curr. Opin. Psychiatr.	MAY	2008	21	3					286	289		10.1097/YCO.0b013e3282fbcd21			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	291YK	WOS:000255233200011	18382229				2022-02-06	
J	Wietek, BM; Baron, CH; Erb, M; Hinninghofen, H; Badtke, A; Kaps, HP; Grodd, W; Enck, P				Wietek, B. M.; Baron, C. H.; Erb, M.; Hinninghofen, H.; Badtke, A.; Kaps, H. -P.; Grodd, W.; Enck, P.			Cortical processing of residual ano-rectal sensation in patients with spinal cord injury: an fMRI study	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						anorectum; functional magnetic resonance imaging; spinal cord injury; visceral sensation	DORSAL COLUMN PATHWAY; FUNCTIONAL CLASSIFICATION; INTERNATIONAL STANDARDS; BRAIN ACTIVATION; SELF-STIMULATION; CEREBRAL ACTIVATION; MICTURITION; WOMEN; RESPONSES; CONTRACTION	Eleven paraplegic patients with complete traumatic spinal cord injuries (SCI) [according to American Spinal Injury Association (ASIA) criteria] at different levels (Th3-L3) were investigated during non-painful stimulation of the distal rectum and anal canal, using event related functional magnetic resonance imaging. Although a complete lesion was clinically diagnosed in all, four of them experienced reproducible sensations during anal and/or rectal stimulation. In six patients, individual data analysis revealed significant activation in the right secondary somatosensory cortex SII, the posterior cingular gyrus, the prefrontal cortex, and the left posterior cerebellar lobe during either anal or rectal stimulation or both. A Region of interest analysis using a data mask from healthy controls confirmed that SCI patients demonstrate cortical activation in areas similar to those activated in healthy volunteers, but to a less extensive degree. This supports the notion that the diagnosis of complete spinal cord transsection by ASIA criteria alone may be insufficient for assessment of 'completeness' of cord lesions, and that visceral sensitivity testing may be required in addition.	[Wietek, B. M.] Univ Tubingen, Dept Diagnost Radiol, Expt Sect Radiol, D-72076 Tubingen, Germany; [Baron, C. H.; Badtke, A.; Kaps, H. -P.] Univ Tubingen, BG Trauma Ctr, Dept Paraplegia Orthoped Surg Rehabil, Tubingen, Germany; [Erb, M.; Grodd, W.] Univ Tubingen Hosp, Dept Neuroradiol, Sect Exp MR CNS, Tubingen, Germany; [Hinninghofen, H.; Enck, P.] Univ Tubingen Hosp, Dept Psychosomat Med, Tubingen, Germany		Wietek, BM (corresponding author), Univ Tubingen, Dept Diagnost Radiol, Expt Sect Radiol, D-72076 Tubingen, Germany.	bmwietek@med.uni-tuebingen.de		Erb, Michael/0000-0002-9311-4693			AlChaer ED, 1996, J NEUROPHYSIOL, V76, P2675, DOI 10.1152/jn.1996.76.4.2675; AlChaer ED, 1996, J NEUROPHYSIOL, V76, P2661, DOI 10.1152/jn.1996.76.4.2661; *AM SPIN INJ ASS, 1996, INT STAND NEUR CLASS; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Athwal BS, 2001, BRAIN, V124, P369, DOI 10.1093/brain/124.2.369; Aziz Q, 1998, GASTROENTEROLOGY, V114, P559, DOI 10.1016/S0016-5085(98)70540-2; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Blok BFM, 1998, BRAIN, V121, P2033, DOI 10.1093/brain/121.11.2033; Blok BFM, 1997, BRAIN, V120, P111, DOI 10.1093/brain/120.1.111; Cohen ME, 1998, SPINAL CORD, V36, P554, DOI 10.1038/sj.sc.3100602; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio A., 1994, DESCARTES ERROR EMOT; Derbyshire SWG, 2003, AM J GASTROENTEROL, V98, P12, DOI 10.1111/j.1572-0241.2003.07168.x; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Ersoz M, 2004, SPINAL CORD, V42, P110, DOI 10.1038/sj.sc.3101525; Finnerup NB, 2004, ACTA NEUROL SCAND, V109, P194, DOI 10.1034/j.1600-0404.2003.00219.x; Fukuyama H, 1996, NEUROREPORT, V7, P3009, DOI 10.1097/00001756-199611250-00042; GILDENBERG PL, 1984, J NEUROL NEUROSUR PS, V47, P94, DOI 10.1136/jnnp.47.1.94; Greving I, 1998, NEUROGASTROENT MOTIL, V10, P509; Hobday DI, 2001, BRAIN, V124, P361, DOI 10.1093/brain/124.2.361; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kern MK, 2004, AM J PHYSIOL-GASTR L, V286, pG304, DOI 10.1152/ajpgi.00201.2003; Klose U, 1999, MAGN RESON IMAGING, V17, P471, DOI 10.1016/S0730-725X(98)00173-8; Komisaruk BR, 2004, BRAIN RES, V1024, P77, DOI 10.1016/j.brainres.2004.07.029; Komisaruk BR, 1997, ARCH NEUROL-CHICAGO, V54, P1513, DOI 10.1001/archneur.1997.00550240063014; Lotze M, 2001, NEUROIMAGE, V14, P1027, DOI 10.1006/nimg.2001.0901; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Naliboff BD, 2001, PSYCHOSOM MED, V63, P365, DOI 10.1097/00006842-200105000-00006; Nicotra A, 2006, BRAIN, V129, P718, DOI 10.1093/brain/awh699; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Rapp AM, 2007, BRAIN LANG, V100, P142, DOI 10.1016/j.bandl.2006.04.004; SAKAKIBARA R, 1995, J AUTONOM NERV SYST, V55, P165, DOI 10.1016/0165-1838(95)00039-Z; SHERWOOD AM, 1992, J NEUROL SCI, V110, P90, DOI 10.1016/0022-510X(92)90014-C; Sipski ML, 2001, CLIN AUTON RES, V11, P279, DOI 10.1007/BF02332972; SUN WM, 1995, GASTROENTEROLOGY, V108, P990, DOI 10.1016/0016-5085(95)90194-9; Talairach J., 1988, COPLANAR STEREOTAXIC; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Whipple B, 2002, J SEX MARITAL THER, V28, P79, DOI 10.1080/009262302317251043; WIETEK B, 2002, NEUROGASTROENT MOTIL, V14, P567; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; WYNDAELE JJ, 1991, PARAPLEGIA, V29, P490, DOI 10.1038/sc.1991.67; Zhang H, 2005, NEUROIMAGE, V24, P174, DOI 10.1016/j.neuroimage.2004.08.027	42	15	15	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	MAY	2008	20	5					488	497		10.1111/j.1365-2982.2007.01063.x			10	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Neurosciences & Neurology	288NC	WOS:000254992100009	18298436				2022-02-06	
J	Pascual, JL; Maloney-Wilensky, E; Reilly, PM; Sicoutris, C; Keutmann, MK; Stein, SC; Leroux, PD; Gracias, VH				Pascual, Jose L.; Maloney-Wilensky, Eileen; Reilly, Patrick M.; Sicoutris, Corinna; Keutmann, Michael K.; Stein, Sherman C.; Leroux, Peter D.; Gracias, Vicente H.			Resuscitation of hypotensive head-injured patients: Is hypertonic saline the answer?	AMERICAN SURGEON			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; HEMORRHAGIC-SHOCK; TISSUE OXYGEN; HYPERTENSION; SEVERITY; MANNITOL; MODEL	Hypertonic saline (HTS) may decrease intracranial pressure (ICP) in severe traumatic brain injury (STBI) and effectively resuscitates hypotensive patients. No data exist on institutional standardization of HTS for hypotensive patients with STBI. It remains unclear how HTS affects brain tissue oxygenation (PbtO(2)) in STBI. We hypothesized HTS could be safely standardized in patients with STBI and would lower ICP while improving cerebral perfusion pressure (CPP) and PbtO(2). Under institutional guidelines in a Level I trauma center, 12 hypotensive STBI intensive care unit subjects received HTS. Inclusion criteria included mean arterial pressure (MAP) <= 90 mmHg, Glasgow Coma Scale (GCS) <= 8, ICP <= 20 mmHg, and serum [Na+] < 155 mEq/L. All patients under-went ICP monitoring. Hemodynamics, CPP, ICP, and PbtO(2) data were collected before and hourly for 6 hours after FITS infusion. Guideline criteria compliance was greater than 95 per cent. No major complications occurred. Mean ICP levels dropped by 45 per cent (P < 0.01) and this drop persisted for 6 hours. CPP levels increased by 20 per cent (P < 0.05). PbtO(2) remained persistently elevated for all time points after HTS infusion. Institutional use of HTS in STBI can be safely implemented in a center caring for neurotrauma patients. HTS infusion in hypotensive STBI reduces ICP and raises CPP. Brain tissue oxygenation tends to improve after HTS infusion.	[Pascual, Jose L.; Reilly, Patrick M.; Sicoutris, Corinna; Gracias, Vicente H.] Univ Penn, Sch Med, Div Traumatol & Surg Crit Cate, Dept Surg, Philadelphia, PA 19104 USA; [Maloney-Wilensky, Eileen; Keutmann, Michael K.; Stein, Sherman C.; Leroux, Peter D.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Gracias, VH (corresponding author), Univ Penn, Sch Med, Div Traumatol & Surg Crit Cate, Dept Surg, 3440 Market St, Philadelphia, PA 19104 USA.	graciasv@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; *BRAIN TRAUM FDN, 2003, AM ASS NEUR SURG JOI; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Favre JB, 1996, SCHWEIZ MED WSCHR, V126, P1635; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Hartl R, 1997, ACT NEUR S, V70, P126; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2002, J NEUROSURG ANESTH, V14, P22, DOI 10.1097/00008506-200201000-00005; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Saltarini M, 2002, Eur J Emerg Med, V9, P262, DOI 10.1097/00063110-200209000-00011; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; TEASDALE G, 1974, LANCET, V2, P81; van den Brink WA, 1998, J NEUROTRAUM, V15, P813, DOI 10.1089/neu.1998.15.813; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	26	15	18	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2008	74	3					253	259					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	267OR	WOS:000253519000016	18376694				2022-02-06	
J	Gall, C; Mueller, I; Kaufmann, C; Franke, GH; Sabel, BA				Gall, C.; Mueller, I.; Kaufmann, C.; Franke, G. H.; Sabel, B. A.			Visual field defects after cerebral lesions from the patient's perspective. Health- and vision-related quality of life assessed by SF-36 and NEI-VFQ	NERVENARZT			German	Article						quality of life; perimetry; visual field defect; National Eye Institute - Visual Function Questionnaire; SF-36 Health Survey	FUNCTION QUESTIONNAIRE; DEPRESSION; REHABILITATION; THERAPY; PEOPLE	Background. In patients with visual field defects, measurement of health-related quality of life (hQoL) and vision-related quality of life (vQoL) is an important adjunct to clinical measures such as perimetry. The purpose of this study was to describe hQoL and vQoL of patients with visual field defects after cerebral lesions such as infarction, traumatic brain injury, and tumor. Methods. The National Eye Institute - Visual Function Questionnaire (NEI-VFQ) for vQoL and the SF-36 Health Survey for hQoL were administered to 24 patients about 2 years after occurrence of the visual field defect. Visual fields were measured by standard perimetry and a near-threshold campimetric method. Visual acuity was measured by the Landolt-Ring-Test. Results. The NEI-VFQ scores - but not SF-36 scores - were not only lower than those of a disease-free group but also lower than those of patients with visual impairments not caused by cerebral damage. Rank correlations between the size of the visual field defect and NEI-VFQ subscales were significantly high or modest. With SF-36 scores these correlations were generally low and moderate at best. Conclusion. The NEI-VFQ is a valuable measure of self-reported visual impairment in patients with visual field defects after cerebral lesions. The measurement of unspecific hQoL is not sufficient to reflect the problems of patients with visual field defects.	[Gall, C.; Mueller, I.; Sabel, B. A.] Otto Von Guericke Univ, Fac Med, Inst Med Psychol, D-39120 Magdeburg, Germany; [Kaufmann, C.] Humboldt Univ, Inst Psychol, D-1086 Berlin, Germany; [Franke, G. H.] Studeingang Rehabilitationspsychol, Magdeburg, Germany		Gall, C (corresponding author), Otto Von Guericke Univ, Fac Med, Inst Med Psychol, Leipzig Str 44, D-39120 Magdeburg, Germany.	carolin.gall@med.ovgu.de	Sabel, Bernhard A./E-6579-2013	Franke, Gabriele Helga/0000-0002-2459-0362; Sabel, Bernhard/0000-0002-4472-5543			Brody BL, 2001, OPHTHALMOLOGY, V108, P1893, DOI 10.1016/S0161-6420(01)00754-0; Brody BL, 2001, OPHTHALMOLOGY, V108, P1901; Bullinger M, 1997, PSYCHOTHER PSYCH MED, V47, P76; Bullinger M, 2003, Rehabilitation (Stuttg), V42, P218; BULLINGER M, 1998, SF36 FRAGEBOGEN GESU; Carta A, 1998, CURR EYE RES, V17, P506, DOI 10.1076/ceyr.17.5.506.5191; Cole SR, 2000, INVEST OPHTH VIS SCI, V41, P1017; Deramo VA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1297, DOI 10.1001/archopht.121.9.1297; FRANKE GH, 2002, SCL90R SYMPTOM CHECK; Franke GH., 1998, Z MED PSYCHOL, V7, P178; Gutierrez P, 1997, ARCH OPHTHALMOL-CHIC, V115, P777, DOI 10.1001/archopht.1997.01100150779014; Jampel HD, 2002, J GLAUCOMA, V11, P154, DOI 10.1097/00061198-200204000-00012; Kasten E, 1997, SPATIAL VISION, V10, P499, DOI 10.1163/156856897X00456; Kasten E, 2006, BEHAV BRAIN RES, V175, P18, DOI 10.1016/j.bbr.2006.07.024; KERKHOFF G, 1990, NERVENARZT, V61, P711; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; Klein R, 2001, ARCH OPHTHALMOL-CHIC, V119, P733, DOI 10.1001/archopht.119.5.733; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Miskala PH, 2004, ARCH OPHTHALMOL-CHIC, V122, P758, DOI 10.1001/archopht.122.5.758; Muller I, 2006, NERVENARZT, V77, P694, DOI 10.1007/s00115-006-2054-6; Parrish RK, 1997, ARCH OPHTHALMOL-CHIC, V115, P1447, DOI 10.1001/archopht.1997.01100160617016; Paz SH, 2003, ARCH OPHTHALMOL-CHIC, V121, P1021, DOI 10.1001/archopht.121.7.1021; Rovner BW, 2002, ARCH OPHTHALMOL-CHIC, V120, P1041; SPILKER B, 1998, QUALITY LIFE PHARMAC; Stelmack JA, 2002, INVEST OPHTH VIS SCI, V43, P2859; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Wolffsohn JS, 2000, BRIT J OPHTHALMOL, V84, P1035, DOI 10.1136/bjo.84.9.1035	29	15	15	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-2804	1433-0407		NERVENARZT	Nervenarzt	FEB	2008	79	2					185	+		10.1007/s00115-007-2342-9			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	259LY	WOS:000252942000005	17934709				2022-02-06	
J	Herrmann, B				Herrmann, B.			Non-accidental head injury and shaking baby syndrome. Clinical and pathophysiological aspects	RECHTSMEDIZIN			German	Article						non-accidental head injury; shaken baby syndrome; inflicted traumatic brain injury; subdural hemorrhages; retinal hemorrhages; child abuse	TRAUMATIC BRAIN-INJURY; SHAKEN INFANT SYNDROME; CHILDREN; ABUSE; NEUROPATHOLOGY; HEMORRHAGES; SYMPTOMS; INTERVAL; DAMAGE	Traumatic brain injury, in particular the shaken baby syndrome, leads to significant neurological disability in more than two-thirds of surviving victims and is fatal in 12-27% of cases. It is characterized by a constellation of subdural hematoma and mostly marked retinal hemorrhaging with severe diffuse brain injury, usually without external signs of injuries. Shaken baby syndrome resulting in significant brain damage requires extensive, violent shaking of a child leading to uncontrolled rotation of the head. The resulting subdural and retinal hemorrhages are, however, not important for the prognosis. The combination of diffuse axonal injury and initial traumatic apnea leading to hypoxia, ischemia and intracranial hypertension is assumed to be responsible for the marked brain damage. Clinical symptoms are irritability, feeding problems, somnolence, apathy, cerebral convulsions, vomiting, apnea, coma and death. Shaking injury is a syndromic diagnosis dependant on the total picture of clinical, ophthalmological, radiological and brain imaging features.	Klinikum Kassel, Kinderklin, D-34125 Kassel, Germany		Herrmann, B (corresponding author), Klinikum Kassel, Kinderklin, Monchebergstr 43, D-34125 Kassel, Germany.	herrmann@klinikum-kassel.de					Adams G, 2004, EYE, V18, P795, DOI 10.1038/sj.eye.6701643; Alexander R. C, 2001, CHILD ABUSE MED DIAG, P47; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bays J., 2001, CHILD ABUSE MED DIAG, P177; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; CAFFEY J, 1974, PEDIATRICS, V54, P396; Davies W. H., 2001, J AGGRESS MALTREAT T, V5, P41; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Hartley LM, 2001, PEDIATRICS, V107, P174, DOI 10.1542/peds.107.1.174; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Herrmann B, 2002, MONATSSCHR KINDERH, V150, P1324, DOI 10.1007/s00112-002-0610-0; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C., 2003, INFLICTED CHILDHOOD, P49; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan H, 2003, INFLICTED CHILDHOOD, P3; KOCHANEK PM, 2003, INFLICTED CHILDHOOD, P191; Kuker W, 2006, MONATSSCHR KINDERH, V154, P659, DOI 10.1007/s00112-004-1043-8; LEVIN AV, 2001, CHILD ABUSE MED DIAG, P97; Lloyd B, 1998, BRIT MED J, V317, P1538, DOI 10.1136/bmj.317.7172.1538; Matschke J, 2008, RECHTSMEDIZIN, V18, P36, DOI 10.1007/s00194-007-0488-1; Minns RA, 2005, CLIN DEV MED, P1; NASHELSKY MB, 1995, AM J FOREN MED PATH, V16, P154, DOI 10.1097/00000433-199506000-00016; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; Sane SM, 2000, PEDIATRICS, V105, P1345; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STENGER RD, 2005, PADIATR PRAX, V67, P294; Thomsen H, 1998, MONATSSCHR KINDERH, V146, P875, DOI 10.1007/s001120050339; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130	36	15	15	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	FEB	2008	18	1					9	16		10.1007/s00194-007-0482-7			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	316KH	WOS:000256947800003					2022-02-06	
J	Amantini, A; Amadori, A; Fossi, S				Amantini, A.; Amadori, A.; Fossi, S.			Evoked potentials in the ICU	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			critical care; brain injury acute; trauma; hypoxia-ischaemia; brain; evoked potentials; somatosensory	ANOXIC-ISCHEMIC COMA; SEVERE HEAD-INJURY; SEVERE BRAIN-INJURY; PREDICTION; EEG; PROGNOSIS	The most informative neurophysiological techniques available in the neurosurgical intensive care unit are electroencephalograph and somatosensory evoked potentials. Such tools, which give an evaluation of cerebral function in comatose patients, support clinical evaluation and are complementary to neurolmaging. They serve both diagnostic/prognostic and monitoring purposes. While for the former, discontinuous monitoring is sufficient, for the latter, to obtain increased clinical impact, continuous monitoring is necessary. To perform and interpret these examinations in the neurosurgical intensive care unit, both the technician and the neurophysiologist need specific training in the intensive care field. There is sufficient evidence to show that somatosensory evoked potentials are the best single indicator of early prognosis in traumatic and hypoxic-ischaemic coma compared to the Glasgow Coma Score, computed tomography scan and electroencephalograph. Indeed, somatosensory evoked potentials should always be combined with clinical examination to determine the prognosis of coma. Despite widespread use of somatosensory evoked potentials and their prognostic utility in acute brain injury, few studies exist on continuous somatosensory evoked potential monitoring in the intensive care unit. We carried out a pilot study of continuous electroencephalograph-somatosensory evoked potential monitoring in the neurosurgical intensive care unit (traumatic brain injury and intracranial haemorrhage, Glasgow Coma Score <9, intracranial pressure monitoring). All patients stable from a clinical and computed tomography scan point of view showed no significant somatosensory evoked potential modifications, while in the case of clinical deterioration (2396), somatosensory evoked potentials always showed significant modifications. While somatosensory evoked potentials correlated with short-term outcome, intracranial pressure showed a poor correlation. We believe neurophysiological monitoring is an ideal complement to the other parameters monitored in the neurosurgical intensive care unit. Whereas intracranial pressure is simply a pressure index, electroencephalograph-somatosensory evoked potential monitoring reflects to what extent cerebral parenchyma still remains metabolically active during acute brain injury.	[Amantini, A.; Fossi, S.] Univ Florence, Univ Careggi, Azienda Osped, Dept Neurol & Psychiat Sci,UO Neurophysiopatol, I-50134 Florence, Italy; [Amadori, A.] Univ Florence, Univ Careggi, Azienda Osped, Dept Neurol & Psychiat Sci,Neurointens Care Unit, I-50134 Florence, Italy		Amantini, A (corresponding author), Univ Florence, Dept Neurol & Psychiat Sci, Az Osped Careggi, Vle Morgagni 85, I-50134 Florence, Italy.	amantini@unifi.it					Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Attia J, 1998, CRIT CARE CLIN, V14, P497, DOI 10.1016/S0749-0704(05)70013-0; Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Facco E, 2000, INTENS CARE MED, V26, P998, DOI 10.1007/s001340051294; Facco E, 2002, CLIN NEUROPHYSIOL, V113, P1855, DOI 10.1016/S1388-2457(02)00259-6; Fischer C., 2002, Annales de Readaptation et de Medecine Physique, V45, P448, DOI 10.1016/S0168-6054(02)00295-7; Fossi S, 2006, NEUROPHYSIOL CLIN, V36, P195, DOI 10.1016/j.neucli.2006.09.001; Guerit JM, 1999, NEUROPHYSIOL CLIN, V29, P301, DOI 10.1016/S0987-7053(99)90044-8; GUERIT JM, 1999, ELECTROENCEPHALOGR S, V52, P117; GUERIT JM, 2005, 27 INT C CLIN NEUR S; KONASIEWICZ SJ, 1994, CAN J NEUROL SCI, V21, P219, DOI 10.1017/S0317167100041196; KRAFT GH, 1999, MUSCLE NERVE       S, V8, pS123; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Moulton RJ, 1998, CAN J NEUROL SCI, V25, pS7, DOI 10.1017/S031716710003465X; REGAN D, 1989, SCI MED; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Zandbergen EGJ, 2000, J CLIN NEUROPHYSIOL, V17, P498, DOI 10.1097/00004691-200009000-00008; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8; [No title captured]	24	15	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			196	202		10.1017/S0265021507003183			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	283AY	WOS:000254610100034	18289442				2022-02-06	
J	Guo, YE; Togher, L				Guo, Yiting Emily; Togher, Leanne			The impact of dysarthria on everyday communication after traumatic brain injury: A pilot study	BRAIN INJURY			English	Article						brain injury; dysarthia; communication; discourse analysis	CALL CENTERS; HEAD-INJURY; DISCOURSE; INTELLIGIBILITY; ACCEPTABILITY; PERCEPTIONS; PEOPLE; INTEGRATION; POPULATION; COMPETENCE	Primary objective: To compare the everyday communication of individuals with mild and moderate dysarthria and concomitant cognitive-communication impairments following traumatic brain injury (TBI). Methods and procedures: Five participants with mild dysarthria and five with moderate dysarthria following TBI were recorded during telephone service enquiries with bus timetable call centre operators. Transcripts were analysed using exchange structure analysis derived from systemic functional linguistics. Listener comfort ratings were collected using a novel equal appearing interval scale to measure how comfortable people would feel interacting with the participants. Main outcomes and results: Participants with moderate dysarthria were not necessarily penalized for having poorer intelligibility during bus timetable service encounters. While participants with moderate dysarthria were given poorer listener comfort ratings, this did not affect the way information was exchanged with bus timetable call centre operators. These findings were attributed to the powerful interactional role of TBI participants as customers, the amount of disability awareness training and experience held by call centre operators and the highly structured nature of bus timetable service enquiries. Listener comfort ratings could be predicted with moderate accuracy from intelligibility scores. Conclusions: Service encounters where individuals with TBI are placed in a powerful interactional role of customer may be functional generalization tasks for people with moderate dysartrhia. Training and education of service providers may also impact on the communicative effectiveness of individuals with TBI.	[Guo, Yiting Emily; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Lidcombe, NSW 1825, Australia		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, S Block,POB 170,East St, Lidcombe, NSW 1825, Australia.	l.togher@usyd.edu.au	Guo, Emily/AAU-9784-2021; Togher, Leanne/AAC-7083-2019	Guo, Emily/0000-0002-2434-9392; Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; BERRY M, 1981, STUDIES DISCOURSE AN, P120; Brown J.R., 1975, MOTOR SPEECH DISORDE; COELHO C, 1996, J SPEECH HEAR RES, V39, P5; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Comrie P, 2001, CLIN LINGUIST PHONET, V15, P383, DOI 10.1080/02699200110036380; Dagenais PA, 2006, CLIN LINGUIST PHONET, V20, P141, DOI 10.1080/02699200400026843; Dagenais PA, 1999, J MED SPEECH-LANG PA, V7, P91; DAGENAIS PA, 2002, INVESTIGATIONS CLIN; Deery S, 2002, J MANAGE STUD, V39, P471, DOI 10.1111/1467-6486.00300; Drager K. D. R., 2004, AUGMENTATIVE ALTERNA, V20, P103, DOI [DOI 10.1080/07434610410001699681, 10.1080/07434610410001699681]; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Duffy, 2005, MOTOR SPEECH DISORDE; Enderby P. M., 2000, NEUROGENIC COMMUNICA, P247; ENDERBY PM, 1983, FRENCH DYSARTHRIA AS; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GERRATT BR, 1993, J SPEECH HEAR RES, V36, P14, DOI 10.1044/jshr.3601.14; Halliday M., 2004, INTRO FUNCTIONAL GRA; Holman D, 2002, MOTIV EMOTION, V26, P57, DOI 10.1023/A:1015194108376; Hustad Katherine C., 1998, Seminars in Speech and Language, V19, P291, DOI 10.1055/s-2008-1064051; KAZDIN AE, 1977, SOCIAL INSTRUCTIONAL; Larkins B., 2000, NEUROGENIC COMMUNICA, P206; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; LASS NJ, 1988, J COMMUN DISORD, V21, P385, DOI 10.1016/0021-9924(88)90023-8; Lass Norman J., 1993, Journal of Communication Disorders, V26, P3, DOI 10.1016/0021-9924(93)90012-Y; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; Linden MA, 2005, BRAIN INJURY, V19, P1011, DOI 10.1080/02699050500110314; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; *MIN TRASP, 2005, ACC TRANSP ACT PLAN; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; MURDOCH BE, 1999, COMMUNICATION DISORD; O'Brian S, 2003, J SPEECH LANG HEAR R, V46, P503, DOI 10.1044/1092-4388(2003/041); Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Redpath SJ, 2004, BRAIN INJURY, V18, P861, DOI 10.1080/02699050410001671838; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sewell-Staples W. J., 2003, MANAGERIAL AUDITING, V18, P68; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Southwood M., 1993, J MED SPEECH-LANG PA, V1, P151; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Susca M, 2002, J FLUENCY DISORD, V27, P135, DOI 10.1016/S0094-730X(02)00126-2; Susca M, 2001, J SPEECH LANG HEAR R, V44, P61, DOI 10.1044/1092-4388(2001/006); Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Taylor P, 2002, WORK EMPLOY SOC, V16, P133, DOI 10.1177/09500170222119281; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; TOGHER L, 1998, INTERPERSONAL COMMUN; Ventola E, 2005, FOLIA LINGUIST, V39, P19, DOI 10.1515/flin.2005.39.1-2.19; VENTOLA E, 1987, STRUCTURE SOCIAL INT; Whitehill TL, 2004, J MED SPEECH-LANG PA, V12, P229; World Health Organization, 2001, INT CLASS IMP ACT PA; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Zapf D., 2003, EUROPEAN J WORK ORG, V12, DOI [DOI 10.1080/13594320344000183, 10.1080/13594320344000183]	62	15	17	2	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	1					83	97		10.1080/02699050701824150			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400010	18183512				2022-02-06	
J	Jellish, WS; Zhang, X; Langen, KE; Spector, MS; Scalfani, MT; White, FA				Jellish, Walter S.; Zhang, Xin; Langen, Kenneth E.; Spector, Matthew S.; Scalfani, Michael T.; White, Fletcher A.			Intrathecal magnesium sulfate administration at the time of experimental ischemia improves neurological functioning by reducing acute and delayed loss of motor neurons in the spinal cord	ANESTHESIOLOGY			English	Article							GLUTAMATE TRANSPORTER GLT-1; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; RECEPTOR CHANNELS; HIPPOCAMPAL CA1; AMPA RECEPTOR; BLOOD-FLOW; CEREBRAL-ISCHEMIA; CA2+ PERMEABILITY; TNF-ALPHA	Background: In this study, the authors determined the effect of magnesium sulfate on intrathecal glutamate concentrations, hindlimb motor function, and histopathology after a transient episode of spinal cord ischemia. Methods: Fifty-two New Zealand White rabbits underwent spinal cord ischemia for 30 min. Fifteen minutes before ischemia, animals received intrathecal magnesium sulfate (MgSO4) (3 mg/kg) or placebo (artificial cerebrospinal fluid). Intrathecal microdialysis samples were measured for glutamate using high-performance liquid chromatography. Neurologic function and spinal cord histopathology were assessed throughout the recovery period. Results: Intrathecal glutamate levels in placebo-treated animals were higher after spinal cord ischemia compared with sham- and MgSO4-treated animals. MgSO4-treated animals had increased lower extremity motor function compared with the placebo group (64.7% vs 14.3%, P < 0.01). Histologic examination of placebo-treated animals revealed significant motor neuron cell loss at thoracolumbar levels by Day 7 (P < 0.05), whereas lower lumbar regions displayed significant neuron loss on Day 1. Spinal cords from MgSO4-treated animals exhibited less neuronal loss in lumbar regions. Similar effects were present in the thoracolumbar segments on Day 7. A significant correlation existed between diminished neuronal loss and hind leg movement (Tarlov score) and demonstrates that the neurologic outcome after MgSO4 treatment was related to lower lumbar ventral horn cell survival (r(2) = 0.812, P < 0.001). Conclusions: These results demonstrate that MgSO4 affords significant spinal cord motor neuron protection by diminishing acute neuronal loss at the foci of the ischemic injury (L3-L6) with delayed neuronal degeneration in adjacent spinal cord regions (T7-L2).	[Jellish, Walter S.; Zhang, Xin; Langen, Kenneth E.; Spector, Matthew S.; Scalfani, Michael T.; White, Fletcher A.] Loyola Univ, Med Ctr, Dept Anesthesiol, Maywood, IL 60153 USA; [Jellish, Walter S.; Zhang, Xin; Langen, Kenneth E.; Spector, Matthew S.; Scalfani, Michael T.; White, Fletcher A.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell Biol Neurobiol & Anat, Maywood, IL 60153 USA		Jellish, WS (corresponding author), Loyola Univ, Med Ctr, Dept Anesthesiol, 2160 S 1st Ave,Bldg 103,Room 3114, Maywood, IL 60153 USA.	wjellis@lumc.edu	White, Fletcher/F-3203-2015; White, Fletcher A/F-2895-2012	White, Fletcher/0000-0002-8408-9262; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049136] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS049136, R01 NS049136-02] Funding Source: Medline		Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; BENVENISTE H, 1989, J CEREBR BLOOD F MET, V9, P629, DOI 10.1038/jcbfm.1989.90; BENVENISTE H, 1988, ACTA NEUROL SCAND, V78, P529, DOI 10.1111/j.1600-0404.1988.tb03697.x; Brock MV, 1997, ANN THORAC SURG, V64, P999, DOI 10.1016/S0003-4975(97)00621-8; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHI OZ, 1990, ARCH INT PHARMACOD T, V304, P196; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; DEGIROLAMI U, 1982, J NEUROPATH EXP NEUR, V41, P129, DOI 10.1097/00005072-198203000-00004; Dingledine R, 1999, PHARMACOL REV, V51, P7; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gorter JA, 1997, J NEUROSCI, V17, P6179; Hamann M, 2002, EUR J NEUROSCI, V15, P308, DOI 10.1046/j.0953-816x.2001.01861.x; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Ishikawa T, 1999, CELL MOL NEUROBIOL, V19, P199, DOI 10.1023/A:1005401926320; Jellish WS, 2005, EXP BRAIN RES, V167, P526, DOI 10.1007/s00221-005-0064-4; JOHNSON SH, 1993, STROKE, V24, P1547, DOI 10.1161/01.STR.24.10.1547; Juvonen T, 2002, SCAND CARDIOVASC J, V36, P136, DOI 10.1080/713783301; Kaplan S, 2004, EUR SURG RES, V36, P20, DOI 10.1159/000075070; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kemp PA, 1999, BRIT J PHARMACOL, V126, P621, DOI 10.1038/sj.bjp.0702342; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lang-Lazdunski L, 2000, J VASC SURG, V32, P179, DOI 10.1067/mva.2000.105960; Lang-Lazdunski L, 2001, ANN THORAC SURG, V72, P2180, DOI 10.1016/S0003-4975(01)02919-8; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; MARSALA J, 1991, NEUROSCIENCE, V45, P479, DOI 10.1016/0306-4522(91)90243-H; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P604, DOI 10.1038/jcbfm.1994.75; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; MOORE WM, 1991, ANN SURG, V213, P427, DOI 10.1097/00000658-199105000-00007; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; RAM Z, 1991, STROKE, V22, P922, DOI 10.1161/01.STR.22.7.922; REINHART RA, 1991, J AM COLL CARDIOL, V17, P651, DOI 10.1016/S0735-1097(10)80179-2; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Saeki H, 2004, ANESTH ANALG, V99, P1805, DOI 10.1213/01.ANE.0000138039.04548.3D; Sakurai M, 1997, J THORAC CARDIOV SUR, V113, P159, DOI 10.1016/S0022-5223(97)70411-2; SIMPSON JI, 1994, ANESTHESIOLOGY, V81, P1493, DOI 10.1097/00000542-199412000-00025; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; TEO KK, 1991, BMJ-BRIT MED J, V303, P1499, DOI 10.1136/bmj.303.6816.1499; TORREGROSA G, 1994, J CARDIOVASC PHARM, V23, P1004, DOI 10.1097/00005344-199406000-00020; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; Van der Schyf CJ, 2006, EXPERT OPIN INV DRUG, V15, P873, DOI 10.1517/13543784.15.8.873; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Wakamatsu H, 1999, ANESTH ANALG, V88, P56, DOI 10.1097/00000539-199901000-00011; Weng YC, 2007, EXP NEUROL, V204, P433, DOI 10.1016/j.expneurol.2006.12.003; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002	59	15	20	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	JAN	2008	108	1					78	86		10.1097/01.anes.0000296109.04010.82			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	245AA	WOS:000251905400013	18156885	Bronze			2022-02-06	
J	Mcwilliams, J; Schmitter-Edgecombe, M				Mcwilliams, Jennifer; Schmitter-Edgecombe, Maureen			Semantic memory organization during the early stage of recovery from traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; semantic memory; semantic knowledge; object definition test; semantic organisation; closed-head injury	CLOSED-HEAD-INJURY; ALZHEIMERS TYPE; POSTTRAUMATIC AMNESIA; PRACTICAL SCALE; TEMPORAL-LOBE; KNOWLEDGE; DEMENTIA; DEFICITS; PERFORMANCE; IMPAIRMENT	Primary objective: This study used an object definitions test to examine semantic memory and the organization of semantic knowledge during the early stage of recovery from traumatic brain injury (TBI). Research design: Twenty-four participants with moderate-to-severe TBI and 24 controls described three living and three non-living objects as if they were describing them to someone who had never heard of or seen such things before. Methods and procedures: The verbal definitions were examined at a feature level and for whether they communicated the core concept (i.e. could a blind rater identify the object). Main outcomes and results: Compared to the control group, the TBI group less often provided object definitions that communicated the core concept and included superordinate category information. The TBI group also produced a smaller proportion of physical specific features and the production of fewer physical specific features was associated with lower production of the core concept. Despite these group differences, both groups produced more specific feature information about the objects than general feature information; and more physical specific features for living objects and associative specific features for non-living objects. Conclusions: The findings were interpreted as suggesting a decreased efficiency in ability to access semantic information following moderate-to-severe TBI, which influenced core concept production, despite intact organization of semantic knowledge.	[Mcwilliams, Jennifer; Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 4820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu					Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Bell BD, 2001, NEUROPSYCHOLOGY, V15, P434, DOI 10.1037//0894-4105.15.4.434; Benton AL, 1994, MULTILINGUAL APHASIA; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; COEHLO CA, 1995, BRAIN INJURY, V9, P471; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Constantinidou F, 2004, BRAIN LANG, V89, P216, DOI 10.1016/S0093-934X(03)00399-7; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Devlin JT, 1998, J COGNITIVE NEUROSCI, V10, P77, DOI 10.1162/089892998563798; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Garrard P, 2005, BRAIN LANG, V93, P79, DOI 10.1016/j.bandl.2004.08.003; GERMAN DJ, 1990, NATL COLL ED TEST AD; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; Haut MW, 1991, NEUROPSYCHOLOGY, V5, P81, DOI 10.1037/0894-4105.5.2.81; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Hodges JR, 1996, BRAIN LANG, V54, P302, DOI 10.1006/brln.1996.0077; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; HUX K, 1997, J MED SPEECH-LANG PA, V5, P181; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lee GP, 1997, CLIN NEUROPSYCHOL, V11, P59, DOI 10.1080/13854049708407030; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; Ralph MAL, 1997, NEUROPSYCHOLOGIA, V35, P1251, DOI 10.1016/S0028-3932(97)00052-3; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Smith A., 1991, SYMBOL DIGIT MODALIT; Solso R.L., 2001, COGNITIVE PSYCHOL; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; WARRINGTON EK, 1983, BRAIN, V106, P859, DOI 10.1093/brain/106.4.859; Zachary R., 1991, SHIPLEY I LIVING SCA	47	15	17	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	3					243	253		10.1080/02699050801935252			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	267LW	WOS:000253511500005	18297596				2022-02-06	
J	Robertson, RH; Knight, RG				Robertson, R. Heidi; Knight, Robert G.			Evaluation of social problem solving after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						assertiveness; social skill; role-play; behavioural skills; self-awareness	NEUROPSYCHOLOGICAL ASSESSMENT; SELF-AWARENESS; DYSFUNCTION; DEPRESSION; DEFICITS; OUTPATIENTS; INTEGRATION; VALIDITY; SKILLS	A trial of a procedure for the assessment of social problem-solving skills (the Social Problem-Solving Test; SPST), designed to assess 18 component skills distributed across five domains of functioning, is reported. A group of 48 persons with traumatic brain injury (TBI) observed seven videotaped scenarios involving a complex social interaction between two people. They were first questioned about their interpretation of the event, and how the actors should respond, and then asked to complete a role-play in which they were required to implement a strategy to reach a specified goal. Their performance on each of the components was compared with the results from 20 aged-matched family controls. The TBI participants were most impaired in their ability to perform in a socially skilled manner in the role-play and evaluate this performance, and their orientation towards resolving the problem was characterised by greater anxiety and evaluation of difficulty. The results support the usefulness of procedures designed to identify the specific deficits in social problem solving of persons in post-acute rehabilitation.	[Knight, Robert G.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Robertson, R. Heidi] Casuarina Lodge, Acquired Brain Injury Unit, Brisbane, Qld, Australia		Knight, RG (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.	rknight@psy.otago.ac.nz					Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; CORNELIUS SW, 1987, PSYCHOL AGING, V2, P144, DOI 10.1037/0882-7974.2.2.144; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Frye AA, 2000, COGNITIVE THER RES, V24, P637, DOI 10.1023/A:1005583210589; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Guilford JP, 1978, ALTERNATIVE USES MAN; GUTH M, 1999, HDI PROFESSIONAL SER, V15; Hanes KR, 1996, ARCH CLIN NEUROPSYCH, V11, P185, DOI 10.1016/0887-6177(95)00034-8; Holtzer R, 2000, BRAIN INJURY, V14, P959, DOI 10.1080/02699050050191904; Kant GL, 1997, COGNITIVE THER RES, V21, P73, DOI 10.1023/A:1021820326754; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; MUESER KT, 1992, SCHIZOPHRENIA OVERVI, P182; Nelson H.E., 1982, NATL ADULT READING T; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P1; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Rath JF, 2003, REHABIL PSYCHOL, V48, P137, DOI 10.1037/0090-5550.48.3.137; Rath JF, 2000, J HEAD TRAUMA REHAB, V15, P724, DOI 10.1097/00001199-200002000-00010; SARASON BR, 1985, J PERS SOC PSYCHOL, V49, P469; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; TALLMAN I, 1993, SOC PSYCHOL QUART, V56, P157, DOI 10.2307/2786776; TROWER P, 1978, SOCIAL SKILLS MENTAL; WANG PL, 1986, COGNITIVE COMPETENCY	37	15	15	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2008	18	2					236	250		10.1080/09602010701734438			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	276HD	WOS:000254131000005	18350415				2022-02-06	
J	Salerian, AJ; Saleri, NG; Salerian, JA				Salerian, Alen J.; Saleri, Nansen G.; Salerian, Justin A.			Brain temperature may influence mood: A hypothesis	MEDICAL HYPOTHESES			English	Article							CORE TEMPERATURE; ANTIDEPRESSANTS	Lowering core body and brain temperature has been shown to be beneficial for multiple sclerosis, cardiovascular accidents, traumatic brain injuries and myocardial infarction. Svante Arrhenius' rate taw governs human thermoregulation and all biochemical reactions including complex chemical processes involved in mood disorders. We reviewed the studies on core body and brain temperature's influence on mood, mood disorders and their treatment. Our review suggests the majority of therapeutic strategies against mania are hypothermic white thermogenic strategies are used to combat depressive disorders. We hypothesize that therapeutic manipulation of brain temperature may represent a key mechanism in the treatment of mood disorders possibly because of brain temperature's profound influence on human biology governed by Svante Arrhenius' rate law. We postulate that brain temperature may rise with mania and fall with depression. (c) 2007 Published by Elsevier Ltd.	[Salerian, Alen J.; Saleri, Nansen G.; Salerian, Justin A.] Washington Ctr Psychiat, Washington, DC 20015 USA		Salerian, AJ (corresponding author), Washington Ctr Psychiat, 5225 Wisconsin Ave,Suite 104, Washington, DC 20015 USA.	gsalerian@psychiatrydc.com					BLATTEIS C, 2001, PHYSL PATHOPHYSIOLOG; CHAL V, 1976, BRIT J PHARMACOL, V57, P1487; Chong TW, 2004, SCHIZOPHR RES, V69, P149, DOI 10.1016/S0920-9964(03)00222-6; DULLOO AG, 1987, ANN NUTR METAB, V31, P69, DOI 10.1159/000177253; Duncan N. B., 1995, Journal of Management Information Systems, V12, P37; DUNCAN WC, 1995, NEUROPSYCHOPHARMACOL, V12, P17, DOI 10.1016/0893-133X(94)00055-5; ELKASSEM M, 1983, PHARMACOL BIOCHEM BE, V19, P257, DOI 10.1016/0091-3057(83)90049-7; GLEITER CH, 1989, CONVULSIVE THER, V5, P152; Hasegawa H, 2005, J APPL PHYSIOL, V99, P1397, DOI 10.1152/japplphysiol.00435.2005; HEH CW, 1988, NEUROPSYCHOPHARMACOL, V1, P149, DOI 10.1016/0893-133X(88)90006-1; Kudoh A, 2003, ANESTH ANALG, V97, P275, DOI 10.1213/01.ANE.0000068821.29712.AC; LERER B, 1985, BIOL PSYCHIAT, V20, P20, DOI 10.1016/0006-3223(85)90132-5; Liu YL, 2004, EUR J PHARMACOL, V498, P219, DOI 10.1016/j.ejphar.2004.07.004; MARKS MJ, 1984, PHARMACOL BIOCHEM BE, V21, P953, DOI 10.1016/S0091-3057(84)80079-9; Mendelson JH, 2005, NEUROPSYCHOPHARMACOL, V30, P1751, DOI 10.1038/sj.npp.1300753; Oerther S, 2000, J PHARMACOL EXP THER, V292, P731; OKUMARA A, 2005, BRAIN DEV, V27, P1554; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Salerian AJ, 2006, MED HYPOTHESES, V66, P636, DOI 10.1016/j.mehy.2005.07.021; SOUBRIE P, 1989, PSYCHIAT RES, V27, P149, DOI 10.1016/0165-1781(89)90130-3	20	15	16	1	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses		2008	70	3					497	500		10.1016/j.mehy.2007.06.032			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	268WI	WOS:000253610300007	17951014				2022-02-06	
J	White, H; Cook, D; Venkatesh, B				White, H.; Cook, D.; Venkatesh, B.			The role of hypertonic saline in neurotrauma	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			saline solution hypertonic; intracranial pressure; intracranial; hypertension; mannitol	TRAUMATIC BRAIN-INJURY; ELEVATED INTRACRANIAL-PRESSURE; 7.5-PERCENT SODIUM-CHLORIDE; SEVERE HEAD-INJURY; CEREBRAL EDEMA; 10-PERCENT SALINE; RESUSCITATION; HYPERTENSION; FLUID; INFUSION	Animal and human studies suggest that hypertonic saline is a potential therapeutic agent to assist with the medical treatment of patients with traumatic brain injury. It may have a place as osmotherapy to decrease brain size, predominately of uninjured brain and has several potential advantages over mannitol. Hypertonic saline has clinically desirable physiological effects on cerebral blood flow, intracranial pressure and inflammatory responses in models of neurotrauma. Animal studies support its use, but definitive human trials using mortality end-points in brain trauma are lacking. Hypertonic saline may be considered a therapeutic adjunct to the medical management of traumatic brain injury, awaiting definitive evidence to support routine use.	[Cook, D.; Venkatesh, B.] Univ Queensland, Princess Alexandra Hosp, Dept Intens Care, Brisbane, Qld 4102, Australia; [White, H.] Univ Queensland, Dept Anesthesiol, QE 2 Hosp, Brisbane, Qld 4102, Australia		Venkatesh, B (corresponding author), Univ Queensland, Princess Alexandra Hosp, Dept Intens Care, Brisbane, Qld 4102, Australia.	bala_venkatesh@health.qld.gov.au	Cook, David/D-7318-2013	Venkatesh, Bala/0000-0002-3234-5244			ADAMS RD, 1959, ARCH NEURO PSYCHIATR, V81, P154, DOI 10.1001/archneurpsyc.1959.02340140020004; Bentsen G, 2004, ACTA ANAESTH SCAND, V48, P1089, DOI 10.1111/j.1399-6576.2004.00497.x; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; CROSS JS, 1989, ANN SURG, V209, P684, DOI 10.1097/00000658-198906000-00005; DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; Eilig I, 2001, ANESTH ANALG, V92, P669, DOI 10.1213/00000539-200103000-00023; Einhaus S L, 1996, J Tenn Med Assoc, V89, P81; FENSTERMACHER JD, 1966, AM J PHYSIOL, V211, P341, DOI 10.1152/ajplegacy.1966.211.2.341; Finfer S, 2004, NEW ENGL J MED, V350, P2247; GUNNAR W, 1988, SURGERY, V103, P398; Hartl R, 1997, ZBL CHIR, V122, P181; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Hartl R, 1996, J CEREBR BLOOD F MET, V16, P1108; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 1998, J NEUROSURG ANESTH, V10, P188, DOI 10.1097/00008506-199807000-00010; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Schatzmann C, 1998, ACT NEUR S, V71, P31; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; SHACKFORD SR, 1997, J TRAUMA S, V42, P48; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; [The American Association of Neurological Surgeons The Brain Trauma Foundation], 2000, J NEUROTRAUM, V17, P463; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	44	15	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0265-0215			EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			104	109		10.1017/S0265021507003420			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	283AY	WOS:000254610100018	18289426				2022-02-06	
J	Ziaja, M; Pyka, J; Machowska, A; Maslanka, A; Plonka, PM				Ziaja, Marek; Pyka, Janusz; Machowska, Anna; Maslanka, Anna; Plonka, Przemyslaw M.			Nitric oxide spin-trapping and NADPH-diaphorase activity in mature rat brain after injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; EPR; NADPH-diaphorase; nitric oxide; spin trapping	CEREBRAL-BLOOD-FLOW; ELECTRON-PARAMAGNETIC-RESONANCE; CORTICAL IMPACT INJURY; L-ARGININE; IN-VIVO; SYNTHASE; EPR; EXPRESSION; ISCHEMIA; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) induces inflammatory reactions, and one of the essential mediators of this reaction is nitric oxide (NO). The action of this compound is still under study because no clear consensus has been reached about its exact action in the central nervous system. Further, it is unknown if, in the damaged brain, its neuroprotective activity outweighs its putative neurodegenerative properties. Using ferrous-diethyldithiocarbamate chelate, a lipophilic spin trap for NO detection by electron paramagnetic resonance (EPR) spectroscopy, we followed NO production in injured brain of mature Wistar rats. To relate changes in the amount of NO in the lesioned brain to the activity of NO synthase (NOS), this study also used NADPH-diaphorase staining. Our data show a rapid drop of NO concentration in the damaged brain below control values. This phenomenon persisted over several hours postinjury and varied with brain region. This decrease in NO concentration was accompanied by a simultaneous increase in the number of NADPH-diaphorase-positive cells, perhaps indicative of increased NOS activity. It is therefore assumed that, in the lesioned brain, a very rapid removal of NO occurs via its transformation to other reactive species such as peroxynitrite, which further adversely influence the damaged tissue.	[Ziaja, Marek; Machowska, Anna] Jagiellonian Univ, Inst Zool, Dept Neuroanat, PL-30060 Krakow, Poland; [Pyka, Janusz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Lab Radiospectroscope Studies, Krakow, Poland; [Maslanka, Anna] Jagiellonian Univ, Coll Med, Dept Inorgan & Analyt Chem, Krakow, Poland; [Plonka, Przemyslaw M.] Jagiellonian Univ, Fac Biophys & Biotechnol, Dept Biophys, Lab Radiospectroscopy Canc & Radiobiol, Krakow, Poland		Ziaja, M (corresponding author), Jagiellonian Univ, Inst Zool, Dept Neuroanat, Ingardena 6, PL-30060 Krakow, Poland.	ziajam@poczta.fm	Maslanka, Anna/AAD-8271-2022	Maslanka, Anna/0000-0001-8625-6987; Plonka, Przemyslaw/0000-0002-0261-3439; Pyka, Janusz/0000-0002-7723-5321; Ziaja, Marek/0000-0002-8576-0206			Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; AUGUET M, 1995, JPN J PHARMACOL, V69, P285, DOI 10.1254/jjp.69.285; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Berliner LJ, 2004, ANTIOXID REDOX SIGN, V6, P649, DOI 10.1089/152308604773934413; BUNE AJ, 1995, FEBS LETT, V366, P127, DOI 10.1016/0014-5793(95)00495-U; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cheung RTF, 2003, J PINEAL RES, V34, P153, DOI 10.1034/j.1600-079X.2003.00034.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Del Moral ML, 2004, MICROSC RES TECHNIQ, V64, P304, DOI 10.1002/jemt.20081; Ergenekon E, 1999, BIOL NEONATE, V76, P200, DOI 10.1159/000014159; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gallez B, 2004, NMR BIOMED, V17, P223, DOI 10.1002/nbm.913; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Huang PL, 1999, BRAZ J MED BIOL RES, V32, P1353, DOI 10.1590/S0100-879X1999001100005; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Janeczko K, 1997, BRAIN RES, V770, P237, DOI 10.1016/S0006-8993(97)00873-1; Kozlov AV, 2003, FREE RADICAL BIO MED, V34, P1555, DOI 10.1016/S0891-5849(03)00179-5; KUBRINA LN, 1992, BIOCHIM BIOPHYS ACTA, V1099, P233, DOI 10.1016/0005-2728(92)90032-W; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Plonka PM, 2003, ACTA BIOCHIM POL, V50, P807; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; SCHMIDT HHHW, 1992, J HISTOCHEM CYTOCHEM, V40, P1439, DOI 10.1177/40.10.1382087; Shutenko Z, 1999, BIOCHEM PHARMACOL, V57, P199, DOI 10.1016/S0006-2952(98)00296-2; Sjakste N, 1999, BIOCHEM PHARMACOL, V58, P1955, DOI 10.1016/S0006-2952(99)00281-6; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Suzuki H, 2001, CIRCULATION, V103, pE81; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; TOMINAGA T, 1994, J CEREBR BLOOD F MET, V14, P715, DOI 10.1038/jcbfm.1994.92; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wolf G, 1994, J Neural Transm Suppl, V43, P105; WU GY, 1993, AM J PHYSIOL, V265, pH1965, DOI 10.1152/ajpheart.1993.265.6.H1965; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Zhang YN, 1996, J NEUROSCI METH, V68, P165; Zhou P, 2005, J CEREBR BLOOD F MET, V25, P348, DOI 10.1038/sj.jcbfm.9600036; Ziaja M, 1999, J NEUROSCI RES, V58, P379, DOI 10.1002/(SICI)1097-4547(19991101)58:3<379::AID-JNR3>3.3.CO;2-A; Ziaja M., 2005, CURR TOP BIOPHYS, V29, P73	47	15	15	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2007	24	12					1845	1854		10.1089/neu.2007.0303			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	245BR	WOS:000251910000007	18159996				2022-02-06	
J	Doering, P; Danscher, G; Larsen, A; Bruhn, M; Sondergaard, C; Stoltenberg, M				Doering, P.; Danscher, G.; Larsen, A.; Bruhn, M.; Sondergaard, C.; Stoltenberg, M.			Changes in the vesicular zinc pattern following traumatic brain injury	NEUROSCIENCE			English	Article						AMG; nanocrystals; zinc ions; ZnSeAMG; ZnT3; brain lesion	ACID-INDUCED SEIZURES; NEURONAL CELL-DEATH; I PLUS II; HIPPOCAMPAL-NEURONS; SYNAPTIC ZINC; NITRIC-OXIDE; MOUSE; METALLOTHIONEIN; TRANSLOCATION; ACCUMULATION	The present study aims at evaluating the significance of zinc ions on the development of brain damage in a model of traumatic brain injury (TBI). The zinc ion specific autometallographic technique, the ZnSeAMG method, using silver enhancement of in vivo-captured zinc ions bound in zinc-selenium nanocrystals was applied to follow changes in the vesicular zinc pattern. Balb/c mice, ZnT3 knockout (ZnT3-Ko) mice, a mouse genetically knocked out for the protein ZnT3 responsible for sequestering zinc into synaptic vesicles, and littermates from the genetically un-manipulated mother type mice, wild type (Wt), were used. The Wt and the Balb/c mice exhibited instantaneously a boost in the zinc staining adjacent to the lesion involving all six neocortical layers. Ultra-structural analyses revealed that the in vivo created ZnSe nanocrystals were still confined to the vesicles of the zinc-enriched (ZEN) neurons in the neuropil. No differences between the Balb/c and Wt mice were seen at any time points. In the ZnT3-Ko mice the ZEN terminals stayed void of AMG grains, but a number of neuronal somata around the lesion became loaded with ZnSe nanocrystals. These silver-enhanced ZnSe nanocrystals were confined to the cytoplasm of the somata and their proximal dendrites. No such soma staining was seen in the Wt or Balb/c mice. We speculate that vesicular zinc may not contribute to neuronal damage following TBI. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.	[Doering, P.; Danscher, G.; Larsen, A.; Bruhn, M.; Sondergaard, C.; Stoltenberg, M.] Univ Aarhus, Dept Neurobiol, DK-8000 Aarhus C, Denmark		Doering, P (corresponding author), Univ Aarhus, Dept Neurobiol, DK-8000 Aarhus C, Denmark.	pdj@neuro.au.dk		Larsen, Agnete/0000-0001-8765-8443			Andreasen A, 1997, J NEUROSCI METH, V72, P15, DOI 10.1016/S0165-0270(96)00149-5; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bancila V, 2004, J NEUROCHEM, V90, P1243, DOI 10.1111/j.1471-4159.2004.02587.x; Blasco-Ibanez JM, 2004, NEUROSCI LETT, V355, P101, DOI 10.1016/j.neulet.2003.10.053; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Brown CE, 2004, J COMP NEUROL, V479, P156, DOI 10.1002/cne.20308; Brown CE, 2003, NEUROSCIENCE, V119, P795, DOI 10.1016/S0306-4522(03)00292-6; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Cho IH, 2003, J NEUROSCI RES, V74, P736, DOI 10.1002/jnr.10794; CHOI DW, 1993, P NATL ACAD SCI USA, V90, P9741, DOI 10.1073/pnas.90.21.9741; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Cote A, 2005, J PHYSIOL-LONDON, V566, P821, DOI 10.1113/jphysiol.2005.089458; Danscher G, 2004, J HISTOCHEM CYTOCHEM, V52, P1619, DOI 10.1369/jhc.4A6371.2004; DANSCHER G, 1982, HISTOCHEMISTRY, V76, P281, DOI 10.1007/BF00543951; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Dominguez MI, 2003, NEUROSCIENCE, V116, P791, DOI 10.1016/S0306-4522(02)00731-5; Frederickson CJ, 2005, J ALZHEIMERS DIS, V8, P155; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; HOLM IE, 1988, HISTOCHEMISTRY, V89, P289, DOI 10.1007/BF00493154; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Kitamura Y, 2006, J PHARMACOL SCI, V100, P142, DOI 10.1254/jphs.FP0050805; Knipp M, 2005, BIOCHEMISTRY-US, V44, P3159, DOI 10.1021/bi047636d; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Land PW, 2005, EUR J NEUROSCI, V21, P647, DOI 10.1111/j.1460-9568.2005.03903.x; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Lee JY, 2006, EUR J NEUROSCI, V23, P435, DOI 10.1111/j.1460-9568.2005.04553.x; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; Maret W, 2003, J NUTR, V133, p1460S, DOI 10.1093/jn/133.5.1460S; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Penkowa M, 1999, J COMP NEUROL, V412, P303, DOI 10.1002/(SICI)1096-9861(19990920)412:2<303::AID-CNE9>3.0.CO;2-G; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; PEREZCLAUSELL J, 1986, BRAIN RES, V362, P358, DOI 10.1016/0006-8993(86)90463-4; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; Riba-Bosch A, 2004, NEUROSCIENCE, V125, P803, DOI 10.1016/j.neuroscience.2004.02.017; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sondergaard LG, 2005, HORM METAB RES, V37, P133, DOI 10.1055/s-2005-861290; Sorensen JC, 1998, BRAIN RES, V812, P265, DOI 10.1016/S0006-8993(98)00943-3; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2005, NEUROSCI LETT, V377, P164, DOI 10.1016/j.neulet.2004.11.096; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2000, BRAIN RES REV, V34, P137, DOI 10.1016/S0165-0173(00)00044-8; Takeda A, 2001, BIOMETALS, V14, P343, DOI 10.1023/A:1012982123386; THEORET Y, 1988, BRAIN RES, V449, P341, DOI 10.1016/0006-8993(88)91050-5; Tsuchiya D, 2002, J CEREBR BLOOD F MET, V22, P1231, DOI 10.1097/01.wcb.0000037995.34930.F5; Wall MJ, 2005, CEREBELLUM, V4, P224, DOI 10.1080/14734220500242084; Wang SZ, 2002, CONSERV GENET, V3, P321, DOI 10.1023/A:1019925910992; Wang ZY, 2001, BRAIN RES, V921, P165, DOI 10.1016/S0006-8993(01)03114-6; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Yeiser EC, 1999, NEUROSCI LETT, V277, P75, DOI 10.1016/S0304-3940(99)00825-3	66	15	16	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 30	2007	150	1					93	103		10.1016/j.neuroscience.2007.09.066			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	242AI	WOS:000251696500012	17996379				2022-02-06	
J	Louin, G; Neveux, N; Cynober, L; Plotkine, M; Marchand-Leroux, C; Jafarian-Tehrani, M				Louin, G.; Neveux, N.; Cynober, L.; Plotkine, M.; Marchand-Leroux, C.; Jafarian-Tehrani, M.			Plasma concentrations of arginine and related amino acids following traumatic brain injury: Proline as a promising biomarker of brain damage severity	NITRIC OXIDE-BIOLOGY AND CHEMISTRY			English	Article						nitric oxide; arginine; proline; fluid percussion brain injury; neurological deficit	OXIDE SYNTHASE EXPRESSION; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; NITRIC-OXIDE; NEUROLOGICAL DEFICIT; CEREBROSPINAL-FLUID; METABOLISM; GLUTAMINE; NITRATE; BIOSYNTHESIS	The aim of this study was to find a plasma biomarker, in relation with nitric oxide (NO), as a sign of brain damage severity following traumatic brain injury (TBI). We first investigated the post-traumatic evolution of the plasma concentrations of NO via the level of NO end-products metabolites (nitrite plus nitrate, NOx), that of L-arginine (Arg) and amino acids involved in its metabolism as well as the time course of neurological score in a rat model of lateral fluid percussion brain injury. First, the level of NOx, was increased in plasma at 24 and 48 h post-TBI with a marked increase at 72 h. In contrast, this elevation was neither accompanied by a modification of plasma concentrations of Arg, nor of amino acids involved in NO and Arg metabolism, L-ornithine (Orn), L-glutamate (Glu), and L-glutamine (Gln). Second, TBI induced a fall of plasma L-proline (Pro) concentrations. The time course of post-TBI neurological deficit showed also a decrease of neurological score at 24, 48, and 72 h. Furthermore, there is a weak negative correlation between the neurological score and the plasma level of NOx (r = -0.305; P < 0.05), while a marked positive correlation has been found between the neurological score and the plasma level of Pro (r = 0.563; P < 0.001). In conclusion, the plasma concentrations of Pro could be a promising marker of post-traumatic neurological deficit. (c) 2007 Elsevier Inc. All rights reserved.	Univ Paris 05, UPRES EA 2510, Pharmacol Lab, F-75270 Paris 6, France; Univ Paris 05, UPRES EA 2498, Lab Biol Nutr, F-75270 Paris, France		Jafarian-Tehrani, M (corresponding author), Univ Paris 05, UPRES EA 2510, Pharmacol Lab, 4,Ave Observ, F-75270 Paris 6, France.	mehrnazjafarian@univ-paris5.fr	Cynober, Luc/ABB-2368-2020; MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856			Adibhatla RM, 2002, BRAIN RES, V938, P81, DOI 10.1016/S0006-8993(02)02447-2; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Armengou A, 2003, J CEREBR BLOOD F MET, V23, P978, DOI 10.1097/01.WCB.0000080651.64357.C6; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; BERHOLD HK, 1995, METABOLISM, V44, P466; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; CERRA FB, 1979, ANN SURG, V190, P577, DOI 10.1097/00000658-197911000-00004; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; COUDRAYLUCAS C, 1985, CLIN NUTR, V4, P179, DOI 10.1016/0261-5614(85)90026-3; CYNOBER L, 2004, ENCY BIOL CHEM, P90; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; DEUTSCHMAN CS, 1987, WORLD J SURG, V11, P182, DOI 10.1007/BF01656401; Doumit J, 1999, AMINO ACIDS, V16, P107, DOI 10.1007/BF01321530; FLAKOLL PJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE636, DOI 10.1152/ajpendo.1995.269.4.E636; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hlatky R, 2002, ACT NEUR S, V81, P331; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; JAKSIC T, 1990, AM J CLIN NUTR, V52, P307, DOI 10.1093/ajcn/52.2.307; JAKSIC T, 1991, AM J CLIN NUTR, V54, P408, DOI 10.1093/ajcn/54.2.408; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Luiking YC, 2007, J NUTR, V137, p1662S, DOI 10.1093/jn/137.6.1662S; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Murphy C, 1998, CLIN SCI, V95, P397, DOI 10.1042/CS19980194; Neveux N, 2004, METABOLIC THERAPEUTI, P17; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; PETERSEN SR, 1993, J TRAUMA, V34, P653, DOI 10.1097/00005373-199305000-00007; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Salimuddin, 1999, AM J PHYSIOL-ENDOC M, V277, pE110, DOI 10.1152/ajpendo.1999.277.1.E110; Schmidlin A, 1998, GLIA, V24, P428, DOI 10.1002/(SICI)1098-1136(199812)24:4<428::AID-GLIA8>3.0.CO;2-1; Sharma AC, 1998, NEUROL RES, V20, P632; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wakabayashi Y, 2003, METABOLIC THERAPEUTI, P135; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; WU GY, 1992, BIOCHEM J, V281, P45, DOI 10.1042/bj2810045; YAMANAKA K, 1995, NEUROSCI LETT, V194, P124, DOI 10.1016/0304-3940(95)11715-9; ZHANG P, 2000, PLANT CELL, V12, P1	52	15	15	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1089-8603	1089-8611		NITRIC OXIDE-BIOL CH	Nitric Oxide-Biol. Chem.	SEP	2007	17	2					91	97		10.1016/j.niox.2007.05.006			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	206BB	WOS:000249157800006	17613263				2022-02-06	
J	Seel, RT; Wright, G; Wallace, T; Newman, S; Dennis, L				Seel, Ronald T.; Wright, Greg; Wallace, Tracey; Newman, Sary; Dennis, Leanne			The utility of the FIM plus FAM for assessing traumatic brain injury day program outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						day program; FIM plus FAM; functional outcomes; prognosis; psychometrics; recovery; rehabilitation; traumatic brain injury	FUNCTIONAL ASSESSMENT MEASURE; COGNITIVE REHABILITATION; FIM+FAM; IMPACT	Objective: To evaluate the effectiveness of the FIM+FAM as a primary outcome measure for traumatic brain injury (TBI) comprehensive day programs. Design: Retrospective data analysis. Setting: Single center, TBI comprehensive day program facility. Participants: A demographically and regionally diverse sample of 105 persons with moderate or severe TBI admitted to the Shepherd Pathways comprehensive TBI day rehabilitation program. Main outcome measures: Functional Independence Measure + Functional Assessment Measure (FIM+FAM). Results: Twenty-eight percent or fewer of participants reached ceiling effects on 25 of the 30 FIM+FAM items at day program admission with only 2% of clients rated above ceiling score levels on the FIM+FAM total score. The criteria of Guyatt et al showed that 20 of the 30 FIM+FAM items showed clinically meaningful improvements in 60% or more of clients. On average, clients with TBI improved over 27 points on the FIM+FAM total score. Fifteen of 30 items showed ceiling effects of 33% or less at discharge where only 25% of clients exceeded the FIM+FAM total score ceiling threshold. Discharge FIM+FAM motor scale was a very good predictor of the need for additional single service physical therapy. However, reaching ceiling rating on the FIM+FAM cognitive scale demonstrated poor specificity (0.28) and negative predictive power (0.42) for the need for additional speech/cognitive therapy services. Conclusions: The FIM+FAM demonstrated utility as an outcome measure for TBI comprehensive day program treatment in the current milieu. Future research is required to replicate and extend the current findings.	Shepherd Ctr, Crawford Res Inst, ATT, Atlanta, GA 30309 USA		Seel, RT (corresponding author), Shepherd Ctr, Crawford Res Inst, ATT, 2020 Peachtree Rd, Atlanta, GA 30309 USA.	ron_seel@shepherd.org		Wallace, Tracey/0000-0002-6820-4363			Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; MAYER D, 2004, ESSENTIAL EVIDENCE B, pCH21; Pentland B, 1999, CLIN REHABIL, V13, P498, DOI 10.1191/026921599676188597; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550	23	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2007	22	5					267	277		10.1097/01.HTR.0000290971.56130.c8			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216RA	WOS:000249895500002	17878768				2022-02-06	
J	Golan, JD; Marcoux, J; Golan, E; Schapiro, R; Johnston, KM; Maleki, M; Khetarpal, S; Jacques, L				Golan, Jeff Dror; Marcoux, Judith; Golan, Eyal; Schapiro, Robert; Johnston, Karen M.; Maleki, Mahanuned; Khetarpal, Suneel; Jacques, Line			Traumatic brain injury in intoxicated patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	73rd Annual Meeting of the American-Association-of-Neurological-Surgeons/Congress of Neurological Surgeons Cerebrovascular Section/American-Society-of-Interventional-and-Therapeutic-Neuroradiology	APR 16-21, 2005	New Orleans, LA	Amer Assoc Neurol Surg		traumatic brain injury; alcohol intoxication; intracranial pressure	BLOOD-ALCOHOL LEVEL; GLASGOW COMA SCALE; HEAD-INJURY; SEVERITY; PRESSURE; EXPERIENCE; MANAGEMENT; ABUSE; SCORE	Background. we sought to evaluate the effect alcohol intoxication may have had in nonsurgically treated patients with severe traumatic brain injury. Methods: The Montreal General Hospital Traumatic Brain Injury Registry was used to identify all adult patients with a Glasgow Coma Scale score <= 8 at admission, within a 15-month period. All charts were retrospectively reviewed. Results: Twenty-three patients had toxic blood alcohol levels (BAL >= 21.7 mmol/L), 24 were alcohol negative (BAL < 3 mmol/L), and 10 were alcohol-influenced or had unknown BAL. Patients were more likely to have intracranial pressure monitoring if they had multiple intracranial hemorrhages, sustained multiple injuries, or had a postresuscitative Glasgow Coma Scale score <= 8. Intoxicated patients had a mean delay of 151 minutes more in the insertion time of an intracranial pressure monitoring device, compared with alcohol-negative patients. Conclusions: Alcohol was a confounding factor in the treatment of some of our patients.	McGill Univ, Montreal Neurol Hosp, Dept Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; Univ Toronto, Dept Intens Care Med, Toronto, ON, Canada; Univ Toronto, Div Neurosurg, Univ Ctr, Toronto, ON, Canada; Univ S Florida, Coll Med, Dept Surg, Tampa, FL 33620 USA		Golan, JD (corresponding author), McGill Univ, Montreal Neurol Hosp, Dept Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	jeffgolan@hotmail.com	Golan, Eyal/D-3086-2014	Golan, Eyal/0000-0002-2904-9321			Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Bullock RM, 2000, J NEUROTRAUM, V17, P449; ChathamShowalter PE, 1996, PSYCHOSOMATICS, V37, P285, DOI 10.1016/S0033-3182(96)71567-0; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Fabbri A, 2001, J TRAUMA, V50, P521, DOI 10.1097/00005373-200103000-00018; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; Macewen William, 1879, Glasgow Med J, V11, P1; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Tate PS, 1999, BRAIN INJURY, V13, P767; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604	37	15	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2007	63	2					365	369		10.1097/TA.0b013e31811ec178			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	200AC	WOS:000248735300022	17693837				2022-02-06	
J	Hooper, L; Williams, WH; Wall, SE; Chua, KC				Hooper, Lucy; Williams, W. Huw; Wall, Sarah E.; Chua, Kia-Chong			Caregiver distress, coping and parenting styles in cases of childhood encephalitis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; BEHAVIOR PROBLEMS; HEAD-INJURY; FAMILY ADJUSTMENT; CHILDREN; DISABILITY; MODEL; LONG; PREVALENCE; PREDICTORS	This study presents an exploration of the impact of childhood encephalitis on parental mood, coping and disciplinary strategies. Thirty six parents of children aged between 10 and 17 years were recruited. They were split into groups of recent and remote cases (within or beyond 7 years). Group comparison revealed that neurobehavioural consequences of childhood encephalitis appear to persist over time. Higher levels of behavioural symptoms consistent with dysexecutive disorder were associated with greater parental distress. Parents remain distressed despite reporting proactive profiles of coping. There was an indication that severity of dysexecutive disorder was asscociated with less use of proactive parental management strategies. Support for parents, in particular focused on effective management of dysexecutive problems, is recommended.	Univ Exeter, Ctr Clin Neuropsychol Res, Sch Psychol, Washington Singer Labs, Exeter EX4 4QG, Devon, England; Minist Community Dev Youth & Sports, Psychol Serv Unit, Singapore, Singapore		Hooper, L (corresponding author), Univ Exeter, Ctr Clin Neuropsychol Res, Sch Psychol, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	lucy.hooper@plymouth.ac.uk	; Chua, K/J-6249-2013	Chua, K/0000-0003-2713-5434; williams, huw/0000-0003-0670-2620; Chua, Kia-Chong/0000-0002-6693-6333; Chua, K/0000-0003-2922-3497			Anderson V, 2004, J PEDIATR PSYCHOL, V29, P67, DOI 10.1093/jpepsy/jsh011; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Baker BL, 2005, J INTELL DISABIL RES, V49, P575, DOI 10.1111/j.1365-2788.2005.00691.x; BEAUMONT J, 1996, BLACKWELL DICT PSYCH; Boos J, 2003, VIRAL ENCEPHALITIS H; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CHONG KC, 2004, CAREGIVER DISTRESS P; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Cummings EM, 2005, J CHILD PSYCHOL PSYC, V46, P479, DOI 10.1111/j.1469-7610.2004.00368.x; CUMMINGS EM, 1999, INT NATURE DEPRESSIO; Deeken JF, 2003, J PAIN SYMPTOM MANAG, V26, P922, DOI 10.1016/S0885-3924(03)00327-0; DOWELL E, 2002, CONSEQUENCES ENCEPHA; Elliott TR, 2003, BRIT J HEALTH PSYCH, V8, P149, DOI 10.1348/135910703321649132; FLOYD FJ, 1993, AM J MENT RETARD, V97, P673; Folkman S., 1984, STRESS; Garske GG, 1998, INT J REHABILITATION, V4, P29; Glozman Janna M., 2004, Neuropsychology Review, V14, P183, DOI 10.1007/s11065-004-8158-5; Goldstein G, 2002, HAEMOPHILIA, V8, P461, DOI 10.1046/j.1365-2516.2002.00642.x; Hassall R, 2005, J INTELL DISABIL RES, V49, P405, DOI 10.1111/j.1365-2788.2005.00673.x; Hastings RP, 2004, J CHILD PSYCHOL PSYC, V45, P1338, DOI 10.1111/j.1469-7610.2004.00357.x; Heiman T, 2002, J DEV PHYS DISABIL, V14, P159, DOI 10.1023/A:1015219514621; Jelalian E, 1997, CHILD HEALTH CARE, V26, P169, DOI 10.1207/s15326888chc2603_3; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Laszloffy TA, 2002, FAM RELAT, V51, P206, DOI 10.1111/j.1741-3729.2002.206098.x; Lee S, 2003, FOOD SCI BIOTECHNOL, V12, P425; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Trute B, 2002, J PEDIATR PSYCHOL, V27, P271, DOI 10.1093/jpepsy/27.3.271; Vitaliano PP, 2004, CURR DIR PSYCHOL SCI, V13, P13, DOI 10.1111/j.0963-7214.2004.01301004.x; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1017/S0021963097001741; WILGOSH L, 2004, INT J ADV COUNS, V26, P301, DOI DOI 10.1023/B:ADCO.0000035532.45759.FE; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Woolfson L, 2004, BRIT J HEALTH PSYCH, V9, P1, DOI 10.1348/135910704322778687; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	15	15	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG-OCT	2007	17	4-5					621	637		10.1080/09602010601137054			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	210AV	WOS:000249430000012	17676538				2022-02-06	
J	Buxbaum, LJ; Ferraro, M; Whyte, J; Gershkoff, A; Coslett, HB				Buxbaum, Laurel J.; Ferraro, Mary; Whyte, John; Gershkoff, Arthur; Coslett, H. Branch			Amantadine treatment of hemispatial neglect - A double-blind, placebo-controlled study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						amantadine; neglect treatment; pharmacology of hemispatial neglect; hemispatial neglect treatment; NMDA; glutamate antagonists; Parkinsonian syndromes	TRAUMATIC BRAIN-INJURY; UNILATERAL SPATIAL NEGLECT; DOPAMINE AGONIST THERAPY; PARKINSONS-DISEASE; PRISM ADAPTATION; DAMAGED PATIENTS; VISUAL NEGLECT; METHYLPHENIDATE; APOMORPHINE; DEFICITS	Objective: The resemblance of some aspects of the hemispatial neglect syndrome (hypokinesia, decreased arousal) to aspects of Parkinsonian syndromes, and the success of amantadine in treating disorders of attention, prompted a placebo-controlled, double-blind trial of amantadine, an inhibitor of the N-methyl d-aspartate (NMDA) glutamate receptor that modulates dopamine transmission, in four patients with chronic hemispatial neglect. Design: Patients received placebo or 100 mg of amantadine twice a day in an ABA design. Dependent measures of drug effect included an extensive battery of tests assessing arousal, hemiinattention, hemihypokinesia, personal neglect, disability, anosognosia, family burden, and naturalistic action. Results: There was no evidence of increased adverse effects with the treatment drug compared with placebo. Of the 17 measures used to assess treatment response in the four patients (68 measures total), linear regressions revealed significant positive treatment effects on very few (four) measures (uncorrected for multiple comparisons), and scattered negative responses to treatment were evident on three measures. The vast majority of measures showed no change in response to treatment. Conclusions: Possible reasons for failure of treatment effects in the present study are discussed. Additional study will be required to determine whether there are neglect patients who may benefit from amantadine.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; MossRehab, Philadelphia, PA USA; Univ Penn, Philadelphia, PA 19104 USA		Buxbaum, LJ (corresponding author), Moss Rehabil Res Inst, Korman 213,1200 W Tabor Rd, Philadelphia, PA 19141 USA.			Whyte, John/0000-0002-4381-1474			Adair JC, 1998, BRAIN COGNITION, V37, P351, DOI 10.1006/brcg.1998.1002; ADAIR JC, 1995, J NEUROL NEUROSUR PS, V58, P724, DOI 10.1136/jnnp.58.6.724; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barrett AM, 1999, ARCH PHYS MED REHAB, V80, P600, DOI 10.1016/S0003-9993(99)90205-8; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P759, DOI 10.1016/0028-3932(86)90075-8; BISIACH E, 1990, NEUROLOGY, V40, P1278, DOI 10.1212/WNL.40.8.1278; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Buxbaum LJ, 2001, NEUROPSYCHOLOGIA, V39, P653, DOI 10.1016/S0028-3932(01)00011-2; Cocchini G, 2001, NEUROPSYCHOL REHABIL, V11, P17, DOI 10.1080/09602010042000132; CORWIN JV, 1986, EXP NEUROL, V94, P683, DOI 10.1016/0014-4886(86)90247-5; COSLETT HB, 1990, BRAIN, V113, P475, DOI 10.1093/brain/113.2.475; COSLETT HB, 1978, NEUROLOGY, V28, P229; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Farne A, 2004, J NEUROL NEUROSUR PS, V75, P1401, DOI 10.1136/jnnp.2002.003095; Farne A, 2002, NEUROPSYCHOLOGIA, V40, P718, DOI 10.1016/S0028-3932(01)00186-5; FLEET WS, 1987, NEUROLOGY, V37, P1765, DOI 10.1212/WNL.37.11.1765; FRIEDRICH WN, 1983, AM J MENT DEF, V88, P41; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Geminiani G, 1998, J NEUROL NEUROSUR PS, V65, P344, DOI 10.1136/jnnp.65.3.344; Giacino JT, 2003, J HEAD TRAUMA REHAB, V18, P4, DOI 10.1097/00001199-200301000-00003; Grujic Z, 1998, NEUROLOGY, V51, P1395, DOI 10.1212/WNL.51.5.1395; GUARIGLIA C, 1992, NEUROPSYCHOLOGIA, V30, P1001, DOI 10.1016/0028-3932(92)90051-M; HEILMAN KM, 1979, NEUROPSYCHOLOGIA, V17, P315, DOI 10.1016/0028-3932(79)90077-0; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; HOROWSKI R, 1978, EUR J PHARMACOL, V51, P157, DOI 10.1016/0014-2999(78)90340-0; Hurford P, 1998, ARCH PHYS MED REHAB, V79, P346, DOI 10.1016/S0003-9993(98)90019-3; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; Lange KW, 1997, NEUROSCI BIOBEHAV R, V21, P393, DOI 10.1016/S0149-7634(96)00043-7; Larisch R, 1998, NUCL MED COMMUN, V19, P781, DOI 10.1097/00006231-199808000-00009; LEVY D, 1995, EUR NEUROL, V35, P341, DOI 10.1159/000117157; MARSHALL JF, 1979, EXP NEUROL, V65, P398, DOI 10.1016/0014-4886(79)90107-9; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mehta MA, 2000, J PSYCHOPHARMACOL, V14, P299, DOI 10.1177/026988110001400314; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MIYASHITA N, 1995, NEUROREPORT, V6, P1257, DOI 10.1097/00001756-199506090-00007; Mukand JA, 2001, ARCH PHYS MED REHAB, V82, P1279, DOI 10.1053/apmr.2001.25149; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; Pierce SR, 2002, ARCH PHYS MED REHAB, V83, P256, DOI 10.1053/apmr.2002.27333; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROBERTSON IH, 1993, UNILATERAL NEGLECT C, P00257; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Schneider WN, 1999, BRAIN INJURY, V13, P863; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SMALL M, 1994, EUR NEUROL, V34, P147, DOI 10.1159/000117028; Suen H. K., 1989, ANAL QUANTITATIVE BE; Thomas A, 2004, J NEUROL NEUROSUR PS, V75, P141; Tomassini V, 2004, J NEUROL SCI, V218, P103, DOI 10.1016/j.jns.2003.11.005; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vallar G, 1997, PHILOS T ROY SOC B, V352, P1401, DOI 10.1098/rstb.1997.0126; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WICHMANN T, 1997, MOVEMENT DISORDERS N; WILSON BA, 1989, BEHAV INATTENTION TE; Young LC, 1941, ANN MATH STAT, V12, P293, DOI 10.1214/aoms/1177731711; 1996, GUIDE UNIFORM DATA S; 2003, NATURALISTIC ACTION	58	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL	2007	86	7					527	537		10.1097/PHM.0b013e31806e3392			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	181OE	WOS:000247445200003	17581287				2022-02-06	
J	Radad, K; Gille, G; Jia, XJ; Durany, N; Rausch, WD				Radad, Khaled; Gille, Gabriele; Jia Xiaojing; Durany, Nuria; Rausch, Wolf-Dieter			CDP-choline reduces dopaminergic cell loss induced by MPP+ and glutamate in primary mesencephalic cell culture	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						citicoline; dopaminergic; glutamate; MPP+; neuroprotection; Parkinson's disease	HUMAN NEUROBLASTOMA-CELLS; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; PARKINSONS-DISEASE; CITICOLINE; CYTIDINE; DEATH; RAT; METABOLISM; ACTIVATION	Cytidine-5'-diphosphocholine (citicoline or CDP-choline) is an essential endogenous intermediate in the biosynthesis of phosphatidylcholine. In the present study, primary dopaminergic cultures from mouse mesencephala were treated with citicoline to investigate its neuroprotective potential on the survival of dopaminergic neurons exposed to MPP+ and glutamate. Treatment with citicoline alone significantly increased the survival of dopaminergic neurons compared to controls. MPP+ or glutamate decreased the total number of dopaminergic neurons whereas citicoline afforded significant protection against either toxicity. Moreover, citicoline significantly decreased propidium iodide uptake by cultured cells. The study concludes that citicoline exerts stimulant and neuroprotective actions on cultured dopaminergic neurons.	Tech Univ Dresden, Dept Neurol, D-01307 Dresden, Germany; Vet Med Univ, Inst Med Chem, Vienna, Austria; Univ Int Catalunya, Fac Hlth Sci, Barcelona, Spain; Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; Assiut Univ, Fac Med Vet, Dept Pathol, Assiut 71516, Egypt		Gille, G (corresponding author), Tech Univ Dresden, Dept Neurol, Fetscherstasse 74, D-01307 Dresden, Germany.	Gabriele.Gille@neuro.med.tu-dresden.de		Radad, Khaled/0000-0002-7620-8591			Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Adibhatla RM, 2006, J BIOL CHEM, V281, P6718, DOI 10.1074/jbc.M512112200; Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; Adibhatla RM, 2002, J NEUROCHEM, V80, P12; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; AGNOLI A, 1982, NEUROPSYCHOBIOLOGY, V8, P289, DOI 10.1159/000117914; AGUT J, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1045; Anderson CM, 2000, GLIA, V32, P1; Barrachina M, 2003, J NEUROL SCI, V215, P105, DOI 10.1016/S0022-510X(03)00204-1; Barrachina M, 2002, BRAIN RES, V957, P84, DOI 10.1016/S0006-8993(02)03605-3; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Brana C, 2002, BRAIN RES PROTOC, V10, P109, DOI 10.1016/S1385-299X(02)00201-5; Conant Richard, 2004, Altern Med Rev, V9, P17; Crespo D, 2004, ANN NY ACAD SCI, V1019, P41, DOI 10.1196/annals.1297.009; EBERHARDT R, 1990, CLIN THER, V12, P489; GALLETTI P, 1991, J NEUROL SCI, V103, pS19; Grieb P, 2002, J NEUROSCI RES, V67, P143, DOI 10.1002/jnr.10129; Grieb P, 2001, FOLIA NEUROPATHOL, V39, P141; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; Krupinski J, 2005, NEUROCHEM RES, V30, P1067, DOI 10.1007/s11064-005-7201-0; Krupinski J, 2002, NEUROPHARMACOLOGY, V42, P846, DOI 10.1016/S0028-3908(02)00032-1; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LOPEZ G-COVIELLA I, 1992, Journal of Nutritional Biochemistry, V3, P313; McDaniel MA, 2003, NUTRITION, V19, P957, DOI 10.1016/S0899-9007(03)00024-8; Mehler-Wex C, 2006, J NEURAL TRANSM, V113, P1383, DOI 10.1007/s00702-005-0425-y; Meldrum BS, 1998, PROG BRAIN RES, V116, P441, DOI 10.1016/S0079-6123(08)60454-9; Mir C, 2003, J MOL NEUROSCI, V20, P53, DOI 10.1385/JMN:20:1:53; SAVCI V, 1995, J NEUROCHEM, V64, P378; Secades JJ, 2002, METHODS FIND EXP SB, V24, P1; Teather LA, 2005, LEARN MEMORY, V12, P39, DOI 10.1101/lm.83905; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T	32	15	16	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	JUL	2007	117	7					985	998		10.1080/10623320600934341			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	177NG	WOS:000247159200008	17613109				2022-02-06	
J	Avdibegovic, E; Becirovic, E; Selimbasic, Z; Hasanovic, M; Sinanovic, O				Avdibegovic, Esmina; Becirovic, Elvir; Selimbasic, Zihnet; Hasanovic, Mevludin; Sinanovic, Osman			Cerebral cortical atrophy and silent brain infarcts in psychiatric patients	PSYCHIATRIA DANUBINA			English	Article						silent brain infarct; cerebral cortical atrophy; cognitive dysfunction; mental disorders	STROKE; DEPRESSION; RISK; MORTALITY; PATHOGENESIS; INDIVIDUALS; DEMENTIA; DISORDER; SCAN	Aim To assess the frequency of silent brain infarcts and cerebral cortical atrophy in psychiatric patients with cognitive dysfunction. Methods One hundred and ninety four patients with cognitive dysfunction determined by the use of the Benton Visual Retention Test and Wechsler Memory Scale were analyzed according to age, gender, education, duration of psychiatric treatment, presence of mental disorders, neurological findings, and CT scan of neurocranium. The results were analyzed using descriptive statistics. Results Average age of the group of patients studied was 48 +/- 9.7 years, and average duration of psychiatric treatment was 6 +/- 7.3 years. Regarding mental disorders, patients suffered from posttraumatic stress disorder (PTSD) in comorbidity with depression (21.1%), depressive disorder (14.4%), Complex PTSD (13.9%), PTSD (11.3%), and post-concussion syndrome (7.7%). Cerebral cortical atrophy was determined in 47.4%, silent brain infarct in 3.6%, whereas the combination of cerebral cortical atrophy and silent brain infarct was found in 26.3% of patients. In 22.6% of patients with cognitive dysfunction on the Benton Visual Retention Test and Wechsler Memory Scale CT scan findings were completely normal. Cerebral cortical atrophy was more frequent in patients with PTSD in comorbidity with depression (43%), PTSD (39.0%), Complex PTSD (26%), depression (25%), whereas the silent brain infarct was more frequent in patients with post-concussion syndrome (53.3%) and depression (42.8%). Conclusion Cerebral cortical atrophy and silent brain infarct are frequent findings in computerized tomography of the brain in psychiatric patients with cognitive dysfunction. Cerebral atrophy is frequent in patients with PTSD, whereas in patients with depression, besides cerebral atrophy, silent brain infarct is also frequently present.	[Avdibegovic, Esmina; Becirovic, Elvir; Selimbasic, Zihnet; Hasanovic, Mevludin] Univ Tuzla, Univ Clin Ctr Tuzla, Psychiat Clin, Sch Med, Tuzla 75000, Bosnia & Herceg; [Sinanovic, Osman] Univ Tuzla, Univ Clin Ctr Tuzla, Neurol Clin, Sch Med, Tuzla 75000, Bosnia & Herceg		Avdibegovic, E (corresponding author), Univ Tuzla, Univ Clin Ctr Tuzla, Psychiat Clin, Sch Med, 18th Hrvatske Brigade 49, Tuzla 75000, Bosnia & Herceg.	esmina@bih.net.ba	Avdibegovic, Esmina/P-3415-2019; Hasanovic, Mevludin/AAU-3608-2020	Avdibegovic, Esmina/0000-0002-3486-8903; Hasanovic, Mevludin/0000-0002-5884-0884			Baldwin R, 2005, BRIT J PSYCHIAT, V186, P308, DOI 10.1192/bjp.186.4.308; BENAVENTE W, 2005, CURR CARDIAL REP, V7, P23; Benton AL, 1974, REVISED VISUAL RETEN; Bergeson AG, 2004, CLIN NEUROPSYCHOL, V18, P509, DOI 10.1080/1385404049052414; Caeiro L, 2006, J PSYCHIATR NEUROSCI, V31, P377; Coutts SB, 2005, NEUROLOGY, V65, P513, DOI 10.1212/01.WNL.0000169031.39264.ff; FUJIKAWA T, 1995, STROKE, V26, P946, DOI 10.1161/01.STR.26.6.946; Hedges Dawson W, 2003, Cogn Behav Neurol, V16, P219, DOI 10.1097/00146965-200312000-00003; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Liebetrau M, 2004, STROKE, V35, P1816, DOI 10.1161/01.STR.0000131928.47478.44; Maes M, 2000, ALCOHOL, V20, P117, DOI 10.1016/S0741-8329(99)00066-X; Masuda J, 2001, CURR OPIN NEUROL, V14, P77, DOI 10.1097/00019052-200102000-00012; Medalia Alice, 2004, J Psychiatr Pract, V10, P17, DOI 10.1097/00131746-200401000-00003; Mochizuki H, 2005, CLIN NEUROPHYSIOL, V116, P223, DOI 10.1016/j.clinph.2004.07.007; Pitman RK, 2001, J CLIN PSYCHIAT, V62, P47; Ramasubbu R, 2003, CAN J PSYCHIAT, V48, P250, DOI 10.1177/070674370304800409; Sairenchi T, 2005, HYPERTENS RES, V28, P901, DOI 10.1291/hypres.28.901; Soderlund H, 2004, ACTA NEUROL SCAND, V109, P398, DOI 10.1111/j.1600-0404.2004.00239.x; Terai Satoshi, 2004, Nihon Ronen Igakkai Zasshi, V41, P521; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Van der Kolk B.A., 2001, TRAUMATIC STRESS; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wechsler D, 1975, WECHSLER MEMORY SCAL; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Yatsu Frank M, 2004, Curr Atheroscler Rep, V6, P307, DOI 10.1007/s11883-004-0063-0	27	15	15	0	3	MEDICINSKA NAKLADA	ZAGREB	VLASKA 69, HR-10000 ZAGREB, CROATIA	0353-5053			PSYCHIAT DANUB	Psychiatr. Danub.	JUN	2007	19	1-2					49	55					7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	270GV	WOS:000253710100008	17603416				2022-02-06	
J	Sheftell, FD; Tepper, SJ; Lay, CL; Bigal, ME				Sheftell, F. D.; Tepper, S. J.; Lay, C. L.; Bigal, M. E.			Post-traumatic headache: emphasis on chronic types following mild closed head injury	NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	Seminar Focus on Primary Headaches - Recent Advances in Mechanisms and Management	MAY 24-26, 2007	Stresa, ITALY			post-traumatic headache; whiplash; posttraumatic syndrome	SPREADING DEPRESSION; MINOR HEAD; MIGRAINE; NECK; SYMPTOMS; WHIPLASH	The syndrome known as chronic post-traumatic headache (CPTH) is controversial, particularly when it occurs following mild closed head injury or "whiplash". Problems with the diagnosis include issues related to classification, epidemiology, pathophysiology (psychogenic vs. organic) and treatment. In addition, there are cultural differences that may influence prevalence and diagnosis, as in some countries with little medico-legal recourse the disorder is virtually unknown. In this paper we review some of these controversies clinicians are left to formulate their own understanding based on available evidence and clinical experience. This is perhaps as it should be given that the best practice combines knowledge of the evidence with individual clinical experience.	New England Ctr Headache, Stamford, CT 06902 USA; Yale Univ, Sch Med, New Haven, CT USA; Roosevelt Hosp, Headache Inst, New York, NY USA; Albert Einstein Coll Med, Bronx, NY 10467 USA		Sheftell, FD (corresponding author), New England Ctr Headache, 778 Long Ridge Rd, Stamford, CT 06902 USA.	Ninotores1@aol.com					Alberti A, 2001, HEADACHE, V41, P579, DOI 10.1046/j.1526-4610.2001.041006579.x; BARNAT MR, 1986, HEADACHE, V26, P271, DOI 10.1111/j.1526-4610.1986.hed2606271.x; Bartsch T, 2005, HEADACHE CURRENT, P42; Berry H, 2000, ARCH NEUROL-CHICAGO, V57, P592, DOI 10.1001/archneur.57.4.592; Bogduk N, 2000, ARCH NEUROL-CHICAGO, V57, P590, DOI 10.1001/archneur.57.4.590; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; COUCH JR, 2000, AM HEAD SOC 42 ANN S; EDMEADS J, 1985, HEADACHE, V25, P117, DOI 10.1111/j.1526-4610.1985.hed2502117.x; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hayes JS, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P249; Hines ME, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P375; KELLY R, 1988, HEADACHE PROBLEMS DI, P217; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Malec JF, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P15; MATHEW NT, 2005, HEADACHE, V31, P315; McDonald GJ, 1999, NEUROSURGERY, V45, P61, DOI 10.1097/00006123-199907000-00015; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; PACKARD RC, 2005, CURRENT HEADACHE REP, V4, P19; RASKIN NH, 1988, POSTTRAUMATIC HEADAC; RUFF M, 1994, DIAGNOSTIC STAT MANU; Ruff RM, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P99; Russell MB, 1996, EUR J NEUROL, V3, P424, DOI 10.1111/j.1468-1331.1996.tb00243.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Solomon S, 2005, HEADACHE, V45, P53, DOI 10.1111/j.1526-4610.2005.05011.x; SPEED WG, 1987, PSYCHIAT ASPECTS POS, P211; STRICH S, 1985, LANCET, V2, P443; TAYLOR AR, 1966, LANCET, V2, P178; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; YOUNG WB, 2005, CHRONIC DAILY HEADAC, P185	35	15	17	0	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2007	28			2			S203	S207		10.1007/s10072-007-0777-1			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	175IA	WOS:000247006100026	17508171				2022-02-06	
J	Vungkhanching, M; Heinemann, AW; Langley, MJ; Ridgely, M; Kramer, KM				Vungkhanching, Martha; Heinemann, Allen W.; Langley, Mervin J.; Ridgely, Mary; Kramer, Karen M.			Feasibility of a skills-based substance abuse prevention program following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affect; alcohol; brain injury; drug use; coping skills; employment	HEAD-INJURY; ALCOHOLISM; OUTCOMES; MANAGEMENT; AMNESIA	Objective: To demonstrate the feasibility of a skills-based substance abuse prevention counseling program in a community setting for adults who sustained traumatic brain injury. Participants: Convenience sample of 117 participants (mean age = 35 years) with preinjury history of alcohol or other drug use. Intervention group participants (n = 36) from 3 vocational rehabilitation programs; a no-intervention comparison group (n = 81) from an outpatient rehabilitation service. Intervention: 12 individual counseling sessions featuring skills-based intervention. Main Outcome Measures: Changes in self-reported alcohol and other drug use, coping skillfulness, affect, and employment status from baseline to 9 months postintervention. Results: Significant differences were noted at baseline for the intervention and comparison groups on ethnicity, time postinjury, marital status, and employment (P < .05). At the 9-month follow-up, the intervention group participants achieved a statistically significant decrease in alcohol and drug use (P < .05), increase in coping skillfulness (P < .01), and increased likelihood of maintaining employment (P < .01) relative to the comparison group. Controlling for baseline-adjusted means for the intervention and comparison groups, a statistically significant group difference in adjusted change was noted; the intervention group participants reported lower negative affect at the 9-month follow-up assessment (P < .05). Conclusions: A skills-based intervention provides a promising approach to promoting abstinence from all substances and increasing readiness for employment for adults with traumatic brain injuries in outpatient settings.	Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; Dominican Univ, Grad Sch Social Work, River Forest, IL USA; Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; Clin Psychol Associates, Burlington, WI USA; Employment Psychol Associates, Madison, WI USA; Univ Kansas, Sch Med, Dept Prevent Med & Publ Hlth, Wichita, KS 67214 USA; Univ Kansas, Sch Med, Res Off, Wichita, KS 67214 USA		Heinemann, AW (corresponding author), Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, 345 E Super St, Chicago, IL 60611 USA.	a-heinemann@northwestern.edu	Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326			Blackerby W.F., 1990, J HEAD TRAUMA REHAB, V5, P47; BLOUNT JP, 1996, ALCOHOL DRUG INVENTO; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Hagenaars J.A., 1994, CATEGORICAL LONGITUD; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JONES SL, 1982, ADDICT BEHAV, V7, P285, DOI 10.1016/0306-4603(82)90057-0; JONES SL, 1981, J STUD ALCOHOL, V42, P521, DOI 10.15288/jsa.1981.42.521; LANGLEY M, 1992, NEUROREHABILITATION, V2, P65; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; LANGLEY MJ, 1994, SKILL BASED SUBSTANC; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MILLER WR, 1985, PSYCHOL BULL, V98, P84, DOI 10.1037/0033-2909.98.1.84; Monti P, 2002, TREATING ALCOHOL DEP; Monti PM, 1999, ALCOHOL RES HEALTH, V23, P107; Panting A, 1972, REHABILITATION, V38, P33; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schmidt MF, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P211; Sherer M, 1999, BRAIN INJURY, V13, P973; SISSON RW, 1989, HDB ALCOHOLISM TREAT, P242; SPARADEO F, 1993, STAFF DEV CLIN INTER, P189; WANBERG K, 1987, TREATMENT PREVENTION, P27; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	31	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2007	22	3					167	176		10.1097/01.HTR.0000271117.19652.98			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	174OH	WOS:000246951100003	17510592				2022-02-06	
J	Gilad, GM; Gilad, VH				Gilad, Gad M.; Gilad, Varda H.			Astroglia growth retardation and increased microglia proliferation by lithium and ornithine decarboxylase inhibitor in rat cerebellar cultures: Cytotoxicity by combined lithium and polyamine inhibition	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						alpha-difluoromethylornithine; astrocytes; neuroprotection	BIPOLAR AFFECTIVE-DISORDER; DIBUTYRYL-CYCLIC AMP; PROTEIN-KINASE-C; STRESS-RESPONSE; SIGNAL-TRANSDUCTION; INDUCED DETACHMENT; COMMON MECHANISM; GRANULE NEURONS; BRAIN; ASTROCYTES	Lithium, the most prevalent treatment for manic-depressive illness, might have a neuroprotective effect after brain injury. In culture, lithium can exert neurotoxic effects associated with reduction in polyamine synthe_ sis but neuroprotective effects as cultured neurons mature. Cumulative evidence suggests that lithium may exert some of its effects on neurons indirectly, by initially acting on glial cells. We used rat cerebellar cultures to ascertain the effects of lithium on ornithine decarboxylase (ODC) activity, the enzyme catalyzing the first step in polyamine synthesis, and to compare effects of lithium with those of the ODC inhibitor alpha-difluoromethylornithine (DFMO) on neuron survival and glial growth. Switching cultures from high (25 mM) to low (5 mM) KCl concentrations served as the traumatic neuronal insult. The results indicate the following. 1) Whereas high depolarizing KCl concentration enhances neuron survival, it inhibits astroglial growth. 2) Lithium (LiCl; 15 mM) enhances neuronal survival but inhibits astroglial growth. 3) Lithium treatment leads to reduced ODC activity. 4) DFMO enhances neuron survival but inhibits astroglial growth. 5) Lithium and DFMO lead to transformation of astroglia from epithelioid (flat) to process-bearing morphology and to increased numbers of microglia. 6) Combined lithium plus DFMO treatment is cytolethal to both neurons and glia in culture. In conclusion, lithium treatment results in growth retardation and altered cell morphology of cultured astroglia and increased microglia proliferation, and these effects may be associated with inhibition of polyamine synthesis. This implies that direct effects on astrocytes and microglia may contribute to the effects of lithium on neurons. (c) 2006 Wiley-Liss, Inc.	G&V Gilad Ltd, IL-67639 Tel Aviv, Israel		Gilad, GM (corresponding author), G&V Gilad Ltd, 7 Plugot St, IL-67639 Tel Aviv, Israel.	gm-gilad@zahav.net.il	Gilad, Gad M/E-7193-2010				Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; AVISSAR S, 1988, NATURE, V331, P440, DOI 10.1038/331440a0; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BUEB JL, 1992, BIOCHEM J, V282, P545, DOI 10.1042/bj2820545; Chen Y, 1996, BRAIN RES, V711, P245, DOI 10.1016/0006-8993(95)01199-4; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; CRIGNON S, 1996, EUR J PHARMACOL, V315, P111; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; D'MELLO SR, 1994, EXP CELL RES, V211, P332, DOI 10.1006/excr.1994.1095; EBSTEIN RP, 1980, J PHARMACOL EXP THER, V213, P161; FLAMIGNI F, 1986, J MOL CELL CARDIOL, V18, P3, DOI 10.1016/S0022-2828(86)80977-4; GILAD GM, 1989, INT J DEV NEUROSCI, V7, P133, DOI 10.1016/0736-5748(89)90064-6; GILAD GM, 1987, INT J DEV NEUROSCI, V5, P79, DOI 10.1016/0736-5748(87)90053-0; Gilad GM, 2003, CELL MOL NEUROBIOL, V23, P637, DOI 10.1023/A:1025036532672; GILAD GM, 1981, J HISTOCHEM CYTOCHEM, V29, P687, DOI 10.1177/29.6.6788836; GILAD GM, 1988, BRAIN RES, V458, P249, DOI 10.1016/0006-8993(88)90467-2; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; GILAD GM, 1990, BRAIN RES, V508, P215, DOI 10.1016/0006-8993(90)90399-V; GILAD GM, 1986, INT J DEV NEUROSCI, V4, P195, DOI 10.1016/0736-5748(86)90059-6; Gilad GM, 1999, NEUROSCI LETT, V268, P33, DOI 10.1016/S0304-3940(99)00375-4; GILAD GM, 1992, LIFE SCI, V50, pPL149, DOI 10.1016/0024-3205(92)90289-2; Gilad GM, 1998, INT J DEV NEUROSCI, V16, P271, DOI 10.1016/S0736-5748(98)00033-1; Gilad GM, 1996, J NEUROCHEM, V67, P1992; GILAD GM, 1995, J NEUROSCI RES, V41, P594, DOI 10.1002/jnr.490410505; JOPE RS, 1994, BIOCHEM PHARMACOL, V47, P429, DOI 10.1016/0006-2952(94)90172-4; KANBA S, 1991, NEUROPHARMACOLOGY, V30, P497, DOI 10.1016/0028-3908(91)90012-Z; LACHMAN HM, 1989, LIFE SCI, V45, P1413, DOI 10.1016/0024-3205(89)90031-3; Levine S, 2000, CELL PROLIFERAT, V33, P203, DOI 10.1046/j.1365-2184.2000.00170.x; LI PP, 1993, J NEUROCHEM, V61, P1722, DOI 10.1111/j.1471-4159.1993.tb09809.x; Lubrich B, 2000, NEUROPHARMACOLOGY, V39, P680, DOI 10.1016/S0028-3908(99)00162-8; Lubrich B, 1999, NEUROPSYCHOPHARMACOL, V21, P519, DOI 10.1016/S0893-133X(99)00037-8; Manji HK, 2000, MOL PSYCHIATR, V5, P578, DOI 10.1038/sj.mp.4000811; MANJI HK, 1993, J NEUROCHEM, V61, P2303, DOI 10.1111/j.1471-4159.1993.tb07474.x; MASANA MI, 1992, J NEUROCHEM, V59, P200, DOI 10.1111/j.1471-4159.1992.tb08891.x; MATSUI I, 1980, BIOCHIM BIOPHYS ACTA, V633, P87, DOI 10.1016/0304-4165(80)90040-9; MOONEN G, 1975, CELL TISSUE RES, V163, P365; MORUZZI MS, 1993, MOL CELL BIOCHEM, V124, P1, DOI 10.1007/BF01096375; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; PERIYASAMY S, 1994, J NEUROCHEM, V63, P1319; Queiroz G, 1999, NEUROSCIENCE, V91, P1171, DOI 10.1016/S0306-4522(98)00644-7; RICHARDS JF, 1990, LIFE SCI, V47, P233, DOI 10.1016/0024-3205(90)90325-L; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; SCHUBER F, 1989, BIOCHEM J, V260, P1; SCHUBERT T, 1991, PSYCHOPHARMACOLOGY, V104, P45, DOI 10.1007/BF02244552; SEILER N, 1985, NEUROCHEM RES, V10, P529, DOI 10.1007/BF00964656; Seiler N, 1991, Prog Drug Res, V37, P107; SEILER N, 1984, NEUROCHEM RES, V9, P871, DOI 10.1007/BF00964520; Shao L, 2006, LIFE SCI, V78, P1317, DOI 10.1016/j.lfs.2005.07.007; SINGH SS, 1995, LIFE SCI, V57, P685, DOI 10.1016/0024-3205(95)00320-6; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Sparapani M, 1998, J NEUROCHEM, V71, P1898; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; WALZ W, 1983, PROG NEURO-PSYCHOPH, V7, P697, DOI 10.1016/0278-5846(83)90048-9; Wolfson M, 1998, BRAIN RES, V787, P34, DOI 10.1016/S0006-8993(97)00775-0; Xu JH, 2003, STROKE, V34, P1287, DOI 10.1161/01.STR.0000066308.25088.64; YOUNG LT, 1991, BRAIN RES, V553, P323, DOI 10.1016/0006-8993(91)90843-K; Zamfirescu G, 2000, Rom J Physiol, V37, P81; Zhou R, 2005, J NEUROSCI, V25, P4493, DOI 10.1523/JNEUROSCI.4530-04.2005	61	15	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB 15	2007	85	3					594	601		10.1002/jnr.21152			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	139ZP	WOS:000244472000014	17171700				2022-02-06	
J	Chieregato, A; Tanfani, A; Compagnone, C; Pascarella, R; Targa, L; Fainardi, E				Chieregato, Arturo; Tanfani, Alessandra; Compagnone, Christian; Pascarella, Rosario; Targa, Luigi; Fainardi, Enrico			Cerebral blood flow in traumatic contusions is predominantly reduced after an induced acute elevation of cerebral perfusion pressure	NEUROSURGERY			English	Article						brain ischemia; catecholamines; computed tomography; contusion; intracranial pressure; regional blood flow; xenon; X-ray	FOCAL ISCHEMIA; HEAD-INJURY; BRAIN; DOPAMINE; CT; NOREPINEPHRINE; NORADRENALINE; THRESHOLDS; ACTIVATION; DAMAGE	Objective: To evaluate the response to an acute elevation of cerebral perfusion pressure (CPP) of the regional cerebral blood flow (rCBF) measured in the edematous area of traumatic contusions. Methods: rCBF was measures in the intracontusional low-density area, in the pericontusional healthy-appearing brain tissue surrounding the contusion, in a healthy-appearing area in he contralateral hemisphere, in 16 head-injured patients with 16 traumatic contusions larger than 2 cm at the baseline, and after 20 minutes of nonrepinephrine-induced 20-mmHg elevation of CPP levels. Results: After an induced acute elevation of CPP from baseline values of 65.8 ml/100 g/min (standard deviation, 608) to final values of 88.7 ml/100 g/min (standard deviation, 8.6) to final values of 88.7 ml/100 g/min (standard deviation, 8.9; P <= 0.0001), we found that rCBF mean levels decreased in the intracontusional low-density area (P = 0.0278), and change in rCBF was inversely associated to the baseline values. After grouping contusions according to the rCBF response to induced acute CPP elevation, rCBF mean values recorded at baseline were significantly lower contusional low-density area (P = 0.0435). Conclusion: Our findings suggest that CPP elevation induced by norepinephrine is effective in improving contusional rCBF only in selected cases, which are represented by a subset of contusions with critical perfusion, which can be identified by rCBF measurements. Conversely, in contusions with rCBF higher than critical low values, the CPP elevation could probably induce a temporary breakdown of the blood brain barrier, and the norepinephrine leads to a vasoconstriction with a worsening of regional perfusion.	Maurizio Bufalini Hosp, Intens Care Unit, Cesena, Italy		Chieregato, A (corresponding author), Osped Bufalini, Viale Ghirotti 286, I-47023 Cesena, Italy.	achiere@ausl-cesena.emr.it	Pascarella, Rosario/AAL-2639-2021; Pascarella, Rosario/ABA-7178-2021	Pascarella, Rosario/0000-0002-0512-9298; Compagnone, Christian/0000-0001-9951-5503			BULLOCK R, 1990, ACT NEUR S, V51, P286; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Chieregato A, 2005, ACTA NEUROCHIR SUPPL, V95, P159; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; CHIUEH CC, 1978, BRAIN RES, V145, P291, DOI 10.1016/0006-8993(78)90863-6; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; DARBY JM, 1994, J NEUROSURG, V80, P857, DOI 10.3171/jns.1994.80.5.0857; EDVINSSON L, 2000, CEREBRAL BLOOD FLOW, P191; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; GUR D, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P68; HARDEBO JE, 1977, ACTA PHYSIOL SCAND, V101, P342, DOI 10.1111/j.1748-1716.1977.tb06016.x; Hoelper BM, 2000, ACTA NEUROCHIR SUPPL, V76, P21; Horn P, 2001, AM J NEURORADIOL, V22, P1543; JENNETT B, 1975, LANCET, V1, P480; JING ZA, 1992, J TRAUMA, V33, P83, DOI 10.1097/00005373-199207000-00016; JOHANSSON BB, 1997, PRIMER CEREBROVASCUL, P142; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kawamata T, 2002, ACTA NEUROCHIR SUPPL, V81, P281; Kim DH, 2003, NEUROSURGERY, V53, P1044, DOI 10.1227/01.NEU.0000088567.59324.78; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Latchaw RE, 2003, STROKE, V34, P1084, DOI 10.1161/01.STR.0000064840.99271.9E; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Nellgard BMG, 1999, BRAIN RES, V847, P262, DOI 10.1016/S0006-8993(99)02059-4; Obrist WD, 1998, J CEREBR BLOOD F MET, V18, P1192, DOI 10.1097/00004647-199811000-00005; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pindzola RR, 1998, NEUROSURGERY, V43, P1488; RAPOPORT SI, 1997, PRIMER CEREBROVASCUL, P25; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Stocchetti N, 1998, ACT NEUR S, V71, P162; TEASDALE G, 1974, LANCET, V2, P81; TODA N, 1976, BRIT J PHARMACOL, V58, P121, DOI 10.1111/j.1476-5381.1976.tb07700.x; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; WOLFSON SK, 1990, STROKE, V21, P751, DOI 10.1161/01.STR.21.5.751; YONAS H, 1993, J NEUROSURG, V79, P483, DOI 10.3171/jns.1993.79.4.0483; YONAS H, 1990, J NEUROSURG, V73, P266, DOI 10.3171/jns.1990.73.2.0266	41	15	18	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2007	60	1					115	122		10.1227/01.NEU.0000249194.76527.28			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	125DG	WOS:000243421400022	17228259				2022-02-06	
J	Giles, GM; Mohr, JD				Giles, Gordon Muir; Mohr, James D.			Overview and inter-rater reliability of an incident-based rating scale for aggressive behaviour following traumatic brain injury: The Overt Aggression Scale-Modified for Neurorehabiltation Extended (OAS-MNR-E)	BRAIN INJURY			English	Article						traumatic brain injury; Overt Aggression Scale; incident rating; direct-care staff	HEAD-INJURY; LONG-TERM; AGITATION; DISTURBANCES	Primary objective: The presentation and evaluation of the Overt Aggression Scale-Modified for Neurorehabilitation-Extended ( OAS-MNR-E). Research design: Inter-rater reliability study using data collection procedures mirroring clinical practice. Methods and procedures: Fifteen clinical staff representing five different disciplines received a 30-minute orientation to the study and a 30-minute overview of the OAS-MNR-E. There were 34 patients who engaged in a rateable behaviour and were observed by two raters. There were 199 observed aggressive behaviours during the 6-week study period. Main outcomes and results: All sub-scales of the OAS-MNR-E had high percentage agreement (> 92%) and the kappa statistic was uniformly excellent (> 0.77). Multiple ratings within a sub-scale resulted in lower reliabilities. Incidents with multiple interventions were of longer duration. Interventions were on average more intrusive when used in combination than when used singly. Conclusions: The OAS-MNR-E can be easily incorporated into facility routines and is reliable. The rating tool reported here can provide data that assists in programme design, evaluation and treatment planning.	Samuel Merritt Coll, Oakland, CA 94609 USA; Idylwood Care Ctr, Oakland, CA USA; Crestwood Treatment Ctr, Oakland, CA USA; Mohr Consulting Grp, San Francisco, CA USA		Giles, GM (corresponding author), Samuel Merritt Coll, 450 30th St, Oakland, CA 94609 USA.	ggiles@samuelmerritt.edu					Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Angelino E, 2002, BRAIN INJURY, V16, P269, DOI 10.1080/02699050110103968; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bowers L., 1999, J MENT HEALTH, V8, P339; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; Fleiss J.L., 1981, STAT METHODS RATES P; Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108; GILES GM, 2000, THESIS CALIFORNIA SC; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; KAY SR, 1988, J NERV MENT DIS, V176, P539, DOI 10.1097/00005053-198809000-00007; Levy M, 2005, NEUROREHABILITATION, V20, P279; LION JR, 1981, HOSP COMMUNITY PSYCH, V32, P497; McMillan TM, 2001, BRAIN DAM B, P257; Paxton R, 1997, J MENTAL HLTH, V6, P149, DOI [10.1080/09638239718914, DOI 10.1080/09638239718914]; Robson C., 1993, REAL WORLD RES RESOU; SILVER JM, 1991, J NEUROPSYCHIAT, V3, P22; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Tooth LR, 2004, ARCH PHYS MED REHAB, V85, P1371, DOI 10.1016/j.apmr.2003.12.002; van der Naalt J, 2000, BRAIN INJURY, V14, P781; WILSON J, 1999, REHABILITATION SEVER, P54; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; [No title captured]	28	15	15	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	5					505	511		10.1080/02699050701311729			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000007	17522990				2022-02-06	
J	Lippert-Gruener, M; Maegele, M; Garbe, J; Angelov, DN				Lippert-Gruener, Marcela; Maegele, Marc; Garbe, Janika; Angelov, Doychin N.			Late effects of enriched environment (EE) plus multimodal early onset stimulation (MEOS) after traumatic brain injury in rats: Ongoing improvement of neuromotor function despite sustained volume of the CNS lesion	EXPERIMENTAL NEUROLOGY			English	Article						rat; brain injury; enriched environment; stimulation; lesion volume; neurological recovery	FLUID PERCUSSION INJURY; MOTOR CORTEX; COGNITIVE FUNCTION; MESSENGER-RNA; SPATIAL MEMORY; CEREBRAL EDEMA; DENTATE GYRUS; UP-REGULATION; ADULT-RATS; IN-VITRO	Recently we showed that the combination between MEOS and EE applied to rats for 7-15 days after traumatic brain injury (TBI) was associated with reduced CNS lesion volume and enhanced reversal of neuromotor dysfunction. In a continuation of this work, we tested whether these effects persisted for longer post-operative periods, e.g. 30 days post-injury (dpi). Rats were subjected to lateral fluid percussion (LFP) or to sham injury. After LFP, one third of the animals (injured and sham) was placed under conditions of standard housing (SH), one third was kept in EE-only, and one third received EE+MEOS. Standardized composite neuroscore (NS) for neurological functions and computerized analysis of the vibrissal motor performance were used to assess post-traumatic neuromotor deficits. These were followed by evaluation of the cortical lesion volume (CLV) after immunostaining for neuron-specific enolase, caspase 3 active, and GEAR Finally, the volume of cortical lesion containing regeneration-associated proteins (CLV-RAP) was determined in sections stained for GAP-43, MAP2, and neuronal class III beta-tubulin. We found (i) no differences in the vibrissal motor performance; (ii) EE+MEOS rats performed significantly better than SH rats in NS; (iii) EE-only and EE+ MEOS animals, but not SH rats, showed better recovery at 30 dpi than at 15 dpi; (iv) no differences among all groups in CLV (larger than that at 15 dpi) and CLV-RAP, despite a clear tendency to reduction in the EE-only and EE+MEOS rats. We conclude that EE+MEOS retards, but cannot prevent the increase of lesion volume. This retardation is sufficient for a continuous restoration of neurological functions. (c) 2006 Elsevier Inc. All rights reserved.	Univ Cologne, Inst Anat 1, D-50931 Cologne, Germany; Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; Univ Witten Herdecke, Dept Surg, Merheim Med Ctr, Witten, Germany		Angelov, DN (corresponding author), Univ Cologne, Inst Anat 1, Joseph Stelzmann Str 9, D-50931 Cologne, Germany.	angelov.anatomie@uni-koeln.de					Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 1996, SOMATOSENS MOT RES, V13, P225, DOI 10.3109/08990229609052578; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brook GA, 1998, ACTA NEUROPATHOL, V95, P378, DOI 10.1007/s004010050814; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Czeh B, 1998, HIPPOCAMPUS, V8, P647, DOI 10.1002/(SICI)1098-1063(1998)8:6<647::AID-HIPO7>3.0.CO;2-L; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DORFL J, 1985, J ANAT, V142, P173; Emery DL, 2000, J COMP NEUROL, V424, P521; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Guntinas-Lichius O, 2002, J NEUROSCI, V22, P7121; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ikeda S, 1998, BRAIN RES, V792, P164, DOI 10.1016/S0006-8993(98)00213-3; INGLIS FM, 1995, NEUROSCIENCE, V66, P81, DOI 10.1016/0306-4522(94)00578-S; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; KOMISARU.BR, 1970, J COMP PHYSIOL PSYCH, V70, P482, DOI 10.1037/h0028709; Landgrebe M, 2000, EUR J NEUROSCI, V12, P3729, DOI 10.1046/j.1460-9568.2000.00264.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Laskawi R, 1997, EUR ARCH OTO-RHINO-L, V254, P81, DOI 10.1007/BF01526185; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lippert-Gruner M, 2002, ACT NEUR S, V79, P21; LIPPERTGRUENER ML, 2002, BRAIN INJURY, V14, P585; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Popratiloff AS, 2001, J COMP NEUROL, V433, P364, DOI 10.1002/cne.1145; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; SANES JN, 1990, EXP BRAIN RES, V79, P479; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; SINSON G, 1995, J NEUROCHEM, V65, P2209; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; SULLIVAN H, 1976, J NEUROSURG, V45, P184; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomov TL, 2002, EXP NEUROL, V178, P207, DOI 10.1006/exnr.2002.8040; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WINESKI LE, 1985, J MORPHOL, V183, P199, DOI 10.1002/jmor.1051830208; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; ZILLES K, 1985, CORTEX RAT SEREOTACT	92	15	17	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2007	203	1					82	94		10.1016/j.expneurol.2006.07.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	123NU	WOS:000243303400010	16965773				2022-02-06	
J	Maskell, F; Chiarelli, P; Isles, R				Maskell, Fiona; Chiarelli, Pauline; Isles, Rosemary			Dizziness after traumatic brain injury: Results from an interview study	BRAIN INJURY			English	Article						dizziness; traumatic brain injury; functional impact; symptomatology	HEAD-INJURY; QUANTITATIVE-EVALUATION; POSTURAL INSTABILITY; ATTENTIONAL DEMANDS; VISUAL VERTIGO; HANDICAP; BALANCE; INDIVIDUALS; MOTION; ABNORMALITIES	Background: Dizziness is a commonly reported sequel to traumatic brain injury ( TBI). Objective: To better define the nature of the symptomatology and the impact that dizziness has on the TBI survivor. Setting: A community brain injury rehabilitation programme and a community access programme for TBI survivors. Method: Focus groups with TBI survivors and individual interviews with TBI survivors and some of their carers. Results: The data confirmed that dizziness is difficult for TBI survivors to define and describe and it consists of multiple symptoms. Dizziness also appears to be associated with significant functional difficulties. Additionally, many of the participants of this study reported falling. Carers reported a number of observable signs of dizziness and indicated that they believed they were able to tell when the person they cared for was dizzy. Conclusion: The results provide information which will help in the development of more appropriate outcome measurement tools for dizziness after a TBI.	Univ Newcastle, Discipline Physiotherapy, Sch Hlth Sci, Fac Hlth, Callaghan, NSW 2308, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; Hunter Brain Injury Serv, Newcastle, NSW, Australia		Maskell, F (corresponding author), Univ Newcastle, Discipline Physiotherapy, Sch Hlth Sci, Fac Hlth, Univ Dr, Callaghan, NSW 2308, Australia.	fiona.maskell@hnehealth.nsw.gov.au					Allison L., 1999, NEUROLOGY REPORT, V23, P13, DOI DOI 10.1097/01253086-199923010-00010; Andersson G, 1998, AM J OTOL, V19, P632; Asai M, 1997, ACTA OTO-LARYNGOL, P116; ASBURY JE, 1995, QUAL HEALTH RES, V5, P414, DOI 10.1177/104973239500500402; Benvenuti F, 1999, ARCH PHYS MED REHAB, V80, P278, DOI 10.1016/S0003-9993(99)90138-7; BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Bronstein AM, 2002, BRIT MED BULL, V63, P213, DOI 10.1093/bmb/63.1.213; BRONSTEIN AM, 1990, BRAIN, V113, P767, DOI 10.1093/brain/113.3.767; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; COHEN H, 1992, OTOLARYNG HEAD NECK, V107, P638, DOI 10.1177/019459989210700505; Cohen HS, 2000, ARCH OTOLARYNGOL, V126, P881, DOI 10.1001/archotol.126.7.881; Cohen HS, 2003, J SAFETY RES, V34, P361, DOI 10.1016/j.jsr.2003.09.009; Cohen HS, 2002, J VESTIBUL RES-EQUIL, V12, P47; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Davies RA, 1997, HDB VESTIBULAR REHAB, P30; El-Kahky AM, 2000, ACTA OTO-LARYNGOL, V120, P508, DOI 10.1080/000164800750046018; Emily A, 2000, VESTIBULAR REHABILIT, P52; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; FITZGERALD DC, 1995, ARCH PHYS MED REHAB, V76, P1017, DOI 10.1016/S0003-9993(95)81041-2; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; FOLCHLYON E, 1981, STUD FAMILY PLANN, V12, P443, DOI 10.2307/1965656; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; HALMAGYI GM, 1996, DISORDERS VESTIBULAR, P171; Herdman SJ, 2000, VESTIBULAR REHABILIT, P424; Herdman SJ, 2000, VESTIBULAR REHABILIT, V2nd, P451; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; HOFFER ME, 2003, OTOLOGY NEUROLOGY, V34, P633; Honrubia V, 1996, AM J OTOL, V17, P595; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KIRJAVAINEN S, 1968, ACTA OTO-LARYNGOL, V233, P5; Kisilevski V, 2001, Int Tinnitus J, V7, P118; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Lin SI, 2002, J BIOMED SCI, V9, P428; Longridge NS, 2005, OTOL NEUROTOL, V26, P695, DOI 10.1097/01.mao.0000178152.21634.6d; Mactavish JB, 2000, MENT RETARD, V38, P216, DOI 10.1352/0047-6765(2000)038<0216:ICSFMI>2.0.CO;2; MALLINSON AI, 1996, J MUSCULOSKELET PAIN, V4, P105, DOI DOI 10.1300/J094V04N04_10; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mckiernan D, 2001, CLIN OTOLARYNGOL, V26, P1, DOI 10.1046/j.1365-2273.2001.00410.x; Mendel B, 1997, J ADV NURS, V26, P1134, DOI 10.1111/j.1365-2648.1997.tb00805.x; Morgan D. L., 1988, FOCUS GROUPS QUALITA; *NH MRC, 1999, NAT STAT ETH COND RE; Ocampo S, 1997, OCCUP THER INT, V4, P161; PAGE NGR, 1985, J NEUROL NEUROSUR PS, V48, P729, DOI 10.1136/jnnp.48.8.729; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Peruch P, 2005, COGNITIVE BRAIN RES, V25, P862, DOI 10.1016/j.cogbrainres.2005.09.012; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Ritchie J., 2003, QUALITATIVE RES PRAC; SEALE J, 1998, THERAPY RES PROCESSE; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Whitney SL, 2000, J VESTIBUL RES-EQUIL, V10, P99; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Yardley L, 1998, J NEUROL NEUROSUR PS, V65, P679, DOI 10.1136/jnnp.65.5.679; Yardley L, 2002, NEUROPSYCHOLOGIA, V40, P373, DOI 10.1016/S0028-3932(01)00113-0; Yardley L, 1999, NEUROPSYCHOLOGIA, V37, P1293, DOI 10.1016/S0028-3932(99)00024-X; YARDLEY L, 1992, CLIN OTOLARYNGOL, V17, P231, DOI 10.1111/j.1365-2273.1992.tb01833.x; YARDLEY L, 1994, SOC SCI MED, V39, P573, DOI 10.1016/0277-9536(94)90100-7; Yardley L, 1994, VERTIGO DIZZINESS; Yardley L, 1992, PSYCHOL HEALTH, V6, P85; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924	74	15	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	7					741	752		10.1080/02699050701472109			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400010	17653948				2022-02-06	
J	Spinella, M				Spinella, Marcello			Measuring the executive regulation of emotion with self-rating scales in a nonclinical population	JOURNAL OF GENERAL PSYCHOLOGY			English	Article						emotion; executive; FrSBe; prefrontal; regulation	SYSTEMS BEHAVIOR SCALE; TRAUMATIC BRAIN-INJURY; ANXIETY STRESS SCALES; FRONTAL-LOBE; PSYCHOMETRIC PROPERTIES; POSTSTROKE DEPRESSION; CIRCUITS; DISORDER; NEUROPSYCHIATRY; DYSFUNCTION	Prefrontal systems play an important role in the regulation of emotion as evidenced by clinical neuroimaging studies. Both subjective and objective neuropsychological tests provide functional evidence of executive dysfunction in emotional deregulation. The present authors evaluated these relationships here in a nonclinical community sample using the Frontal Systems Behavior Scale, Profile of Mood States (POMS), and Depression Anxiety Stress Scales (DASS). Positive correlations uniformly emerged between prefrontal system dysfunction and negative emotional states (anger, depression, anxiety, stress, confusion, and fatigue), whereas positive emotion (vigor) showed a modest inverse correlation with prefrontal system dysfunction, even after control for demographic influences. These relationships may result from cognitive strategies for managing emotion mediated by reciprocal connections between prefrontal systems and the limbic system. The findings corroborated those of other methodologies, supporting the Frontal Systems Behavior Scale (FrSBe) as a valid tool to measure prefrontal function in nonclinical populations.	Richard Stockton Coll New Jersey, Div Social & Behav Sci, Pomona, NJ 08240 USA		Spinella, M (corresponding author), Richard Stockton Coll New Jersey, Div Social & Behav Sci, POB 195, Pomona, NJ 08240 USA.						Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Bassarath L, 2001, CAN J PSYCHIAT, V46, P728, DOI 10.1177/070674370104600805; Beblo T, 1999, NEUROPSY NEUROPSY BE, V12, P236; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Cahn-Weiner DA, 2002, NEUROPSY NEUROPSY BE, V15, P79, DOI 10.1097/01.WNN.0000012908.05122.F4; Cecil KM, 2002, BIPOLAR DISORD, V4, P357, DOI 10.1034/j.1399-5618.2002.02235.x; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Helmstaedter C, 2001, EPILEPSY BEHAV, V2, P384, DOI 10.1006/ebeh.2001.0259; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Malizia AL, 1999, J PSYCHOPHARMACOL, V13, P372, DOI 10.1177/026988119901300418; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Menza M, 2000, Curr Psychiatry Rep, V2, P421, DOI 10.1007/s11920-000-0027-1; Moritz S, 2002, ARCH CLIN NEUROPSYCH, V17, P477, DOI 10.1016/S0887-6177(01)00130-5; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Paulsen JS, 2000, J INT NEUROPSYCH SOC, V6, P815, DOI 10.1017/S1355617700677081; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; PORRINO LJ, 1981, J COMP NEUROL, V198, P121, DOI 10.1002/cne.901980111; Rankin KP, 2003, NEUROLOGY, V60, P266, DOI 10.1212/01.WNL.0000041497.07694.D2; REDDON JR, 1985, J PSYCHOPATHOL BEHAV, V7, P243, DOI 10.1007/BF00960756; REEP R, 1984, BRAIN BEHAV EVOLUT, V25, P5, DOI 10.1159/000118849; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; SHIWACH R, 1994, ACTA PSYCHIAT SCAND, V90, P241, DOI 10.1111/j.1600-0447.1994.tb01587.x; Soloff PH, 2000, BIOL PSYCHIAT, V47, P540, DOI 10.1016/S0006-3223(99)00202-4; Spinella M, 2004, INT J NEUROSCI, V114, P83, DOI 10.1080/00207450490249356; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Toren P, 2000, J ANXIETY DISORD, V14, P239, DOI 10.1016/S0887-6185(99)00036-5; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0	47	15	15	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-1309	1940-0888		J GEN PSYCHOL	J. Gen. Psychol.	JAN	2007	134	1					101	111		10.3200/GENP.134.1.101-111			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	129XN	WOS:000243763500007	17283857				2022-02-06	
J	Yilmaz, S; Pekdemir, M				Yilmaz, Serkan; Pekdemir, Murat			An unusual primary blast injury - Traumatic brain injury due to primary blast injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article									Kocaeli Univ, Dept Emergency Med, Sch Med, TR-41380 Kocaeli, Turkey		Yilmaz, S (corresponding author), Kocaeli Univ, Dept Emergency Med, Sch Med, TR-41380 Kocaeli, Turkey.	cmdsercy@yahoo.com; mpekdemir@yahoo.com	Pekdemir, Murat/F-9741-2018; Yilmaz, Serkan/G-2731-2018	Pekdemir, Murat/0000-0002-3917-0192; Yilmaz, Serkan/0000-0003-1496-6976			Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; SINGER P, 2005, CRIT CARE MED, V33, P61; SIRI KK, 2003, NEUROSCI RES, V46, P377	5	15	15	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2007	25	1					97	98		10.1016/j.ajem.2006.04.014			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	121ES	WOS:000243141500023	17157696				2022-02-06	
J	Young, TP; Hoaglin, HM; Burke, DT				Young, Timothy P.; Hoaglin, Heather M.; Burke, David T.			The role of serum testosterone and TBI in the in-patient rehabilitation setting	BRAIN INJURY			English	Article						brain injury; rehabilitation; testosterone; traumatic brain injury; acquired brain injury	TRAUMATIC BRAIN-INJURY; DYSFUNCTION; MEMORY; MEN	Objectives: To explore the relationship between serum testosterone levels, age, length of stay, admission, discharge and changes in functional capacity over time among patients with traumatic brain injury treated in a rehabilitation hospital. Design: This study used a nonrandomized chart review of 54 males, consecutively admitted to a brain injury rehabilitation hospital. Methods: The charts of 54 males consecutively admitted to a brain injury rehabilitation unit between the periods of December 2004 and May 2005 were included in this study. Individuals were included in this study if they were 18 years of age or older, had suffered a traumatic brain injury, undergone admission and discharge, functional independence measure (FIM) testing and had received a serum testosterone level check within one to seven days from admission. Main outcome and results: The main outcome measure of this study was the FIM changes over time, as compared with admission testosterone levels. Low serum testosterone levels on admission to the in-patient rehabilitation unit were associated with longer lengths of stay, lower average admission FIM scores, less improvement in FIM scores, and a lower FIM efficiency. Although not statistically significant, individuals presenting to our unit with low testosterone levels, on average, stayed 26 days longer than did those with normal levels. Age and the presence of multi- trauma did not appear to be factors associated with serum testosterone levels. Changes in discharge cognitive FIM scores between the two groups approached statistical significance (p = 0.06). Conclusion: This pilot study suggests that testosterone levels may be important in the recovery of patients with traumatic brain injury, treated at an in- patient rehabilitation hospital.	Harvard Univ, Sch Med, Dept Phys & Med Rehabil, Sch Spaulding Rehabil Hosp, Boston, MA 02115 USA		Burke, DT (corresponding author), Harvard Univ, Sch Med, Dept Phys & Med Rehabil, Sch Spaulding Rehabil Hosp, 125 Nashua St, Boston, MA 02115 USA.	dburke1@partners.org					Acuff ME, 2004, AM J PHYS MED REHAB, V83, P934, DOI 10.1097/01.PHM.0000143403.63328.C7; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cherrier MM, 2001, NEUROLOGY, V57, P80, DOI 10.1212/WNL.57.1.80; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; FORGER NG, 1992, J NEUROBIOL, V23, P1192, DOI 10.1002/neu.480230910; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gregory CM, 2003, SPINAL CORD, V41, P23, DOI 10.1038/sj.sc.3101370; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; LEE SC, 1994, BRAIN INJURY, V8, P571; Matsumoto A, 1997, BRAIN RES BULL, V44, P539, DOI 10.1016/S0361-9230(97)00240-2; Richard I., 2001, Annales de Readaptation et de Medecine Physique, V44, P19, DOI 10.1016/S0168-6054(00)00059-3	12	15	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	6					645	649		10.1080/02699050701210426			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LU	WOS:000248204100011	17577715				2022-02-06	
J	Brady, SL; Darragh, M; Escobar, NG; O'Neil, K; Pape, TLB; Rao, N				Brady, Susan L.; Darragh, Meghan; Escobar, Nelson G.; O'Neil, Kara; Pape, Theresa L. -B.; Rao, Noel			Persons with disorders of consciousness: Are oral feedings safe/effective?	BRAIN INJURY			English	Article						coma; deglutition; dysphagia; outcomes; rehabilitation	TRAUMATIC BRAIN-INJURY; SWALLOWING DISORDERS; RECOVERY	Primary objective: Evaluate the safety and efficacy of providing oral feedings to persons early in coma recovery following a severe brain injury. Research design: Descriptive, retrospective study. Methods and procedures: Medical chart reviews of all patients admitted to a rehabilitation hospital following severe brain injury. Main outcomes and results: Twenty-five patients met the inclusion criteria, 22 had a tracheostomy, and all were NPO. Subjects were divided into two cohorts. Group 1, n = 10, mean age 43.5 years, received oral feedings early in. coma recovery. Group 2, n = 15, mean age 45.2 years, did not. Group 1, 30% returned to an oral diet of three meals daily at discharge from inpatient rehabilitation as compared to 40% in group 2 (X-2 = 0.260, p = 0.610). Average cost of care for group 1 = US$45759 and group 2 = US$41056 (p = 0.634). Conclusion: Safe therapeutic oral feedings, in accordance with findings from instrumental swallowing examinations, are possible for patients with disordered consciousness. The therapeutic oral feedings do not significantly increase the cost of care, but the effectiveness of oral feedings early in coma recovery requires further investigation.	Marianjoy Rehabil Hosp, Wheaton, IL 60187 USA; Hines VA Hosp, Res Serv, Hines, IL USA		Brady, SL (corresponding author), Marianjoy Rehabil Hosp, 26 W 171 Roosevelt Rd, Wheaton, IL 60187 USA.	sbrady@marianjoy.org		Bender Pape, Theresa/0000-0001-7738-5963			*CDCP NAT CTR INJ, 1998, 1994 NAT HOISP DISCH; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; HEGAN C, 1982, COGNITIVE REHABILITA, P131; *INIDRR NAT I DIS, 2001, TRAUM BRAIN INJ FACT, V7, P9; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; O'Neil-Pirozzi TM, 2003, BRAIN INJURY, V17, P389, DOI 10.1080/0269905031000070251; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SASAKI CT, 2004, DYSPHAGIA, V19, P60; Walker WC, 1996, BRAIN INJURY, V10, P65	15	15	17	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1329	1334		10.1080/02699050601111435			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100002	17378224				2022-02-06	
J	Martin, CD				Martin, Christopher D.			Ernest Hemingway: A psychological autopsy of a suicide	PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES			English	Article								Much has been written about Ernest Hemingway, including discussion of his well-documented mood disorder, alcoholism, and suicide. However, a thorough biopsychosocial approach capable of integrating the various threads of the author's complex psychiatric picture has yet to be applied. Application of such a psychiatric view to the case of Ernest Hemingway in an effort toward better understanding of the author's experience with illness and the tragic outcome is the aim of this investigation. Thus, Hemingway's life is examined through a review and discussion of biographies, psychiatric literature, personal correspondence, photography, and medical records. Significant evidence exists to support the diagnoses of bipolar disorder, alcohol dependence, traumatic brain injury, and probable borderline and narcissistic personality traits. Late in life, Hemingway also developed symptoms of psychosis likely related to his underlying affective illness and superimposed alcoholism and traumatic brain injury. Hemingway utilized a variety of defense mechanisms, including self-medication with alcohol, a lifestyle of aggressive, risk-taking sportsmanship, and writing, in order to cope with the suffering caused by the complex comorbidity of his interrelated psychiatric disorders. Ultimately, Hemingway's defense mechanisms failed, overwhelmed by the burden of his complex comorbid illness, resulting in his suicide. However, despite suffering from multiple psychiatric disorders, Hemingway was able to live a vibrant life until the age of 61 and within that time contribute immortal works of fiction to the literary canon.	Baylor Coll Med, Menninger Clin, COMPAS Unit, Menninger Dept Psychiat & Behav Sci, Houston, TX 77280 USA		Martin, CD (corresponding author), Baylor Coll Med, Menninger Clin, COMPAS Unit, Menninger Dept Psychiat & Behav Sci, POB 809045,2801 Gessner Dr, Houston, TX 77280 USA.	cmartin@menninger.edu					ALLEN J, 1999, HEMINGWAY BIOGRAPHY; Baker C., 1969, ERNEST HEMINGWAY LIF; BURGESS A, 1978, E HEMINGWAY; Hemingway E., 1929, FAREWELL ARMS; Hemingway E., 1964, MOVEABLE FEAST; Hemingway Ernest, 1952, OLD MAN SEA; Hemingway Ernest., 1935, GREEN HILLS AFRICA; Hemingway Ernest, 1981, E HEMINGWAY SELECTED; HOTCHNER AE, 1966, PAPA HEMINGWAY; Jamison K. R., 1993, TOUCHED FIRE MANIC D; LYNN KS, 1987, HEMINGWAY; MARANO HE, 1996, PSYCHOL TODAY   0526; MELLOW JR, 1992, HEMINGWAY LIFE CONSE; MONNIER AJ, 1957, COMMUNICATION   0318; OHARA J, 1950, NY TIMES        0910, P200; REYNOLDS M, 1989, HEMINGWAY PARIS YEAR; REYNOLDS M, 1986, YOUNG HEMINGWAY; REYNOLDS M, 1999, HEMINGWAY FINAL YEAR; SCHOENBERG N, 2001, CHICAGO TRIBUNE 1119; YALOM ID, 1971, ARCH GEN PSYCHIAT, V24, P485	20	15	17	1	11	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012 USA	0033-2747			PSYCHIATRY	Psychiatry-Interpers. Biol. Process.	WIN	2006	69	4					351	361		10.1521/psyc.2006.69.4.351			11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	133XV	WOS:000244048100010	17326729				2022-02-06	
J	Zink, BJ; Stern, SA; McBeth, BD; Wang, X; Mertz, M				Zink, Brian J.; Stern, Susan A.; McBeth, Brian D.; Wang, Xu; Mertz, Michelle			Effects of ethanol on limited resuscitation in a model of traumatic brain injury and hemorrhagic shock	JOURNAL OF NEUROSURGERY			English	Article						brain injury; hemorrhage; shock; ethanol; resuscitation; pig	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURIES; UNCONTROLLED HEMORRHAGE; INTRACRANIAL-PRESSURE; ALCOHOL-INTOXICATION; PERFUSION-PRESSURE; SWINE MODEL; RATS; ISOFLURANE; OUTCOMES	Object. Limited resuscitation following uncontrolled hemorrhagic shock (HS) has been associated with improved outcomes in various animal models, although it has not been previously studied in the setting of traumatic brain injury (TBI) and ethanol intoxication. The aim of the present study was to determine the effects of ethanol intoxication in a model of experimental TBI and HS treated with limited resuscitation. Methods. After induction of anesthesia and the placement of instruments, swine were subjected to a fluid-percussion injury of 3 atm. Simultaneously, hemorrhage was induced from an arterial catheter via a computerized roller pump to a mean arterial blood pressure (MABP) of 50 mm Hg, at which time uncontrolled hemorrhage was induced by the creation of an aortic tear. When the MABP decreased to 30 mm Hg, limited resuscitation to a MABP of 60 mm Hg was begun. After 60 minutes, animals were aggressively resuscitated to baseline MABP levels. Two groups of animals were studied: those receiving tap water by gastrostomy tube and those receiving ethanol (4 g/kg) by gastrostomy tube. Animals were monitored for 180 minutes after TBI. Hemorrhage volumes were significantly greater in ethanol-infused animals (mean +/- standard deviation, 41 +/- 34 mm Hg) compared with tap water-infused animals (17 +/- 18 mm Hg; p = 0.048). Resuscitation requirements were significantly higher and metabolic parameters significantly worse in the ethanol group. Survival time was also significantly decreased in the animals infused with ethanol (81 +/- 60 minutes) compared with those infused with tap water (130 +/- 51 minutes; p = 0.035). Conclusions. Ethanol intoxication led to increased hemorrhage volume and worsened hemodynamic and metabolic profiles in this model of limited resuscitation after TBI and HS. Ethanol-exposed animals had increased resuscitation requirements and decreased survival times.	Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI 48109 USA; Univ Minnesota, Reg Hosp, Dept Emergency Med, St Paul, MN 55455 USA		Zink, BJ (corresponding author), Brown Univ, Sch Med, Dept Emergency Med, 593 Eddy St,Potter 245, Providence, RI 02903 USA.	bzink@lifespan.org			NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA00184] Funding Source: Medline		Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Altura B M, 1984, Alcohol, V1, P325, DOI 10.1016/0741-8329(84)90056-9; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; Ema M, 1998, ALCOHOL, V15, P95, DOI 10.1016/S0741-8329(97)00102-X; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; GABRIEL EJ, 2000, J NEUROTRAUM, V19, P125; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; GROSSLIGHT K, 1985, ANESTHESIOLOGY, V63, P533, DOI 10.1097/00000542-198511000-00011; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HANNON JP, 1981, DOMESTIC SWINE PHYSL; HONKANEN R, 1991, INJURY, V22, P225, DOI 10.1016/0020-1383(91)90047-I; HOVDA DA, 1992, J NEUROTRAUMA S1, V9, P47; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Lacoste L, 2001, AM J CARDIOL, V87, P82, DOI 10.1016/S0002-9149(00)01277-7; Li WY, 2004, NEUROSCI LETT, V354, P221, DOI 10.1016/j.neulet.2003.10.047; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1991, J NEUROSURG S, V75, P59; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MURR R, 1993, ANESTH ANALG, V77, P898; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rubin R, 1999, ALCOHOL CLIN EXP RES, V23, P1114, DOI 10.1111/j.1530-0277.1999.tb04234.x; SCHELLER MS, 1987, ANESTHESIOLOGY, V67, P507, DOI 10.1097/00000542-198710000-00011; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Sinert R, 2005, ACAD EMERG MED, V12, P1141, DOI [10.1111/j.1553-2712.2005.tb01488.x, 10.1197/j.aem.2005.07.016]; STEM SA, 1993, ANN EMERG MED, V22, P155; Stern SA, 2001, SHOCK, V15, P16, DOI 10.1097/00024382-200115010-00003; STERN SA, 1995, ACAD EMERG MED, V2, P89, DOI 10.1111/j.1553-2712.1995.tb03167.x; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; THURMAN DJ, 1999, TRAUMATIC BRAIN  INJ; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zhang QH, 2000, ALCOHOL CLIN EXP RES, V24, P528; ZINK BJ, 1988, ANN EMERG MED, V17, P15, DOI 10.1016/S0196-0644(88)80496-7; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	58	15	15	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	DEC	2006	105	6					884	893		10.3171/jns.2006.105.6.884			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	111DJ	WOS:000242431300014	17405260				2022-02-06	
J	Kirkness, CJ; Burr, RL; Cain, KC; Newell, DW; Mitchell, PH				Kirkness, Catherine J.; Burr, Robert L.; Cain, Kevin C.; Newell, David W.; Mitchell, Pamela H.			Effect of continuous display of cerebral perfusion pressure on outcomes in patients with traumatic brain injury	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							BLOOD-FLOW; SEVERITY SCORE; HEAD-INJURY; DAMAGE; METABOLISM; DISABILITY; ISCHEMIA; INSULTS	BACKGROUND Clinical bedside monitoring systems do not provide prominent displays of data on cerebral perfusion pressure (CPP). Immediate visual feedback would allow more rapid intervention to prevent or minimize suboptimal pressures. OBJECTIVE To evaluate the effect of a highly visible CPP display on immediate and long-term functional outcome inpatients with traumatic brain injury. METHODS A total of 157 patients with traumatic brain injury at a level I trauma center who had invasive arterial blood pressure and intracranial pressure monitoring were randomized to beds with or without an additional, prominent continuous CPP display. Primary end points were scores on the Extended Glasgow Outcome Scale (GOSE) and Functional Status Examination (FSE) 6 months after injury. Secondary end points were GOSE scores at discharge and 3 months after injury and FSE score 3 months after injury. RESULTS Although GOSE and FSE scores at 6 months were better in the group with the highly visible CPP display, the differences were not significant. Slope of recovery for GOSE and FSE over all follow-up time points did not differ significantly between groups. However, the intervention positive effect on odds of survival at hospital discharge was strong and significant. Within a subgroup of more severely injured patients, the intervention group was much less likely than the control group to have CPP deviations. CONCLUSION The Presence of a highly visible display of CPP was associated with significantly better odds of survival and overall condition at discharge.	[Kirkness, Catherine J.; Burr, Robert L.; Cain, Kevin C.; Mitchell, Pamela H.] Univ Washington, Biostat & Off Nursing Res, Seattle, WA 98195 USA; [Newell, David W.] Swedish Med Ctr, Seattle Neurosci Inst, Seattle, WA USA		Kirkness, CJ (corresponding author), Univ Washington, Biostat & Off Nursing Res, 1959 Pacific NE St,Box 357266, Seattle, WA 98195 USA.	kirkness@u.washington.edu			NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR04901] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004901] Funding Source: NIH RePORTER		BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; BULLOCK MR, GUIDELINES MANAGEMEN; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KENNER GIA, 2002, NURSING CARE ACTIVIT; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; LITTLE RJA, 1988, J BUS ECON STAT, V6, P287, DOI 10.2307/1391878; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Rubin D.B., 1987, MULTIPLE IMPUTATION; Schafer JL, 1997, MONOGRAPHS STAT APPL, V72; Schroder ML, 1998, NEUROSURGERY, V42, P1276, DOI 10.1097/00006123-199806000-00042; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	37	15	15	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	NOV	2006	15	6					600	610					11	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	V44BU	WOS:000202979000010	17053267				2022-02-06	
J	Leach, K; Kinsella, G; Jackson, M; Matyas, T				Leach, Kathleen; Kinsella, Glynda; Jackson, Martin; Matyas, Tom			Recovery of components of memory in post-traumatic amnesia	BRAIN INJURY			English	Article						post-traumatic amnesia; Westmead PTA scale; traumatic brain injury; recovery of memory	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; POST-COMA DISTURBANCE; WESTMEAD PTA SCALE; NONLINEAR PREDICTORS; REHABILITATION; DISORIENTATION; ORIENTATION	Primary objective: Post-traumatic amnesia by definition indicates significant impairment of new learning ability, however very few studies have, examined the natural history and resolution of memory and new learning during PTA. Those studies which have, tended to examine orientation separately from the memory processes required to achieve orientation. Analysis of the order of recovery of the items of the Westmead PTA scale was used to examine recovery of memory and new learning capacity. Methods: The results of daily assessment of 34 patients with traumatic brain injury (TBI) on the Westmead PTA scale were analysed for order of recovery. Results: The pattern of rank order of item recovery indicated that Date of Birth recovered consistently first. There was variability in the remaining items, however items reflecting long-term memory tended to recover second and items reflecting simple new learning followed. Recall of all three pictures reflecting complex new learning recovered last. Conclusion: The pattern of recovery of memory and new learning during PTA reflects a number of complex, inter-related variables including; the familiarity with the information, amount of rehearsal both before and since the accident and the number of cues available in the environment.	La Trobe Univ, Fac Sci, Sch Psychol Sci Technol & Engn, Melbourne, Vic, Australia		Leach, K (corresponding author), Cedar Court Rehabil Hosp, 888 Toorak Rd, Camberwell, Vic 3124, Australia.	kathleen.leach@cedarcourt.com.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; DANIEL WF, 1986, ANN NY ACAD SCI, V462, P293, DOI 10.1111/j.1749-6632.1986.tb51264.x; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Everitt BS., 2011, CLUSTER ANAL, V5, DOI [10.1002/9780470977811, DOI 10.1002/9780470977811]; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fleming J, 1999, BRAIN INJURY, V13, P417; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; HASLAM C, 1995, NEUROPSYCHOLOGY, V9, P599, DOI 10.1037/0894-4105.9.4.599; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HORN S, 1991, J CLIN EXP NEUROPSYC, V13, P19; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lunn V, 1949, ACTA PSYCH NEUROL, V24, P33, DOI 10.1111/j.1600-0447.1949.tb04589.x; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MOWBRAY RM, 1959, ACTA PSYCH NEUROL, V34, P330, DOI 10.1111/j.1600-0447.1959.tb07583.x; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; SHORES A, 1986, MED J AUSTRALIA, V144, P569; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Thibault L.E.O.A., 1993, BIOMECHANICS IMPACT, P411; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	34	15	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2006	20	12					1241	1249		10.1080/02699050601049874			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	110DF	WOS:000242357800003	17132547				2022-02-06	
J	Darbin, O; Carre, E; Naritoku, D; Risso, JJ; Lonjon, M; Patrylo, PR				Darbin, Olivier; Carre, Emily; Naritoku, Dean; Risso, Jean Jacque; Lonjon, Michel; Patrylo, Peter R.			Glucose metabolites in the striatum of freely behaving rats following infusion of elevated potassium	BRAIN RESEARCH			English	Article						lactate; pyruvate; microdialysis; depolarization; injury	CORTICAL SPREADING DEPRESSION; CEREBRAL-ARTERY OCCLUSION; GAMMA-AMINOBUTYRIC-ACID; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; EXTRACELLULAR POTASSIUM; ENERGY-METABOLISM; INVIVO RELEASE	The outcome of patients with traumatic brain injury (TBI) can be predicted by the extracellular potassium concentration and the change in energy homeostasis. in this study, the authors investigated the effects of high potassium concentrations on extracellular levels of glucose, pyruvate and lactate in the rat striatum. Applying artificial cerebrospinal fluid (ACSF) enriched with 120 mM potassium by reverse microdialysis leads to an increase in lactate and reduction in glucose and pyruvate. Consequently, the lactate to pyruvate ratio was also increased. These data are discussed in the context of recent studies on lactate/pyruvate conversion and the potential mechanisms whereby high potassium could affect this equilibrium. We conclude that ischemic-like events are unlikely to explain these K+-induced changes. (c) 2006 Elsevier B.V. All rights reserved.	So Illinois Univ, Dept Physiol, Sch Med, Carbondale, IL 62901 USA; Hop Instruct Armees St Anne, IMNSAA, Dept Neurochem, F-83800 Toulon, France; So Illinois Univ, Sch Med, Dept Neurol & Pharmacol, Springfield, IL 62794 USA; CHU Pasteur, UNSA, Serv Neurochirurg, F-06002 Nice 01, France		Darbin, O (corresponding author), So Illinois Univ, Dept Physiol, Sch Med, Carbondale, IL 62901 USA.	olivier@darbin.com		Darbin, Olivier/0000-0003-1461-8517	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 00795] Funding Source: Medline		ADACHI K, 1995, J CEREBR BLOOD F MET, V15, P97, DOI 10.1038/jcbfm.1995.11; AMBERG G, 1989, J PHARMACOL METHOD, V22, P157, DOI 10.1016/0160-5402(89)90012-0; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; BURES J, 1984, AN ACAD BRAS CIENC, V56, P385; Darbin O, 2000, BRAIN RES, V881, P121, DOI 10.1016/S0006-8993(00)02633-0; Darbin O, 2003, EXP NEUROL, V181, P327, DOI 10.1016/S0014-4886(03)00112-2; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; DIETZEL I, 1982, EXP BRAIN RES, V46, P73; Doppenberg EMR, 1999, ACT NEUR S, V75, P31; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; FERNANDEZGALAZ C, 1993, J NEUROCHEM, V60, P1806, DOI 10.1111/j.1471-4159.1993.tb13407.x; GIRAULT JA, 1986, NEUROSCIENCE, V19, P1101, DOI 10.1016/0306-4522(86)90126-0; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Goodman JC, 1999, ACT NEUR S, V75, P35; GRANATA AR, 1983, BRAIN RES, V259, P77, DOI 10.1016/0006-8993(83)91068-5; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hashimoto M, 2000, BRAIN RES, V872, P294, DOI 10.1016/S0006-8993(00)02509-9; Hattori N, 2003, J NUCL MED, V44, P1709; HERTZ E, 1979, IN VITRO CELL DEV B, V15, P429; Hertz L, 1998, METHODS, V16, P293, DOI 10.1006/meth.1998.0686; HERTZ L, 1973, BRAIN RES, V60, P517, DOI 10.1016/0006-8993(73)90814-7; HERTZ L, 1966, J NEUROCHEM, V13, P1373, DOI 10.1111/j.1471-4159.1966.tb04300.x; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kett-White R, 2002, ACT NEUR S, V81, P363; KOnig J.F.R., 1963, RAT BRAIN; LEBOULCH NL, 1991, BRAIN RES, V559, P200, DOI 10.1016/0006-8993(91)90003-E; Lin JY, 2002, LIFE SCI, V71, P803, DOI 10.1016/S0024-3205(02)01738-1; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; Lonjon M, 2001, NEUROSCI LETT, V304, P21, DOI 10.1016/S0304-3940(01)01739-6; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; Mazel T, 2002, PHYSIOL RES, V51, pS85; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; NIELSEN EO, 1989, NEUROCHEM RES, V14, P321, DOI 10.1007/BF01000034; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; NOTO T, 1986, J NEUROCHEM, V46, P1877; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Pellerin L, 1996, DEV NEUROSCI-BASEL, V18, P336, DOI 10.1159/000111426; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PENG L, 1994, BRAIN RES, V663, P168, DOI 10.1016/0006-8993(94)90475-8; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; ROSENTHAL M, 1973, J NEUROPHYSIOL, V36, P739, DOI 10.1152/jn.1973.36.4.739; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; SCHELLER D, 1992, NEUROSCI LETT, V135, P83, DOI 10.1016/0304-3940(92)90141-S; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Selman WR, 2004, BRAIN RES, V999, P167, DOI 10.1016/j.brainres.2003.11.016; Siesjo B K, 1978, Acta Anaesthesiol Scand Suppl, V70, P56; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Taylor DL, 1997, BRAIN RES, V764, P117, DOI 10.1016/S0006-8993(97)00434-4; Ungerstedt U, 1997, Acta Anaesthesiol Scand Suppl, V110, P123; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Yamamoto T, 1999, ACT NEUR S, V75, P17	59	15	15	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 20	2006	1116						127	131		10.1016/j.brainres.2006.06.095			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102EN	WOS:000241793900015	16979147				2022-02-06	
J	Yuan, HB; Huang, Y; Zheng, S; Zuo, Z				Yuan, H. -B.; Huang, Y.; Zheng, S.; Zuo, Z.			Hypothermic preconditioning reduces Purkinje cell death possibly by preventing the over-expression of inducibl nitric oxide synthase in rat cerebellar slices after an in vitro simulated ischemia	NEUROSCIENCE			English	Article						neuroprotection; oxygen-glucose deprivation; heat shock protein; hypothermia; inducible nitric oxide synthase; preconditioning	GLOBAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; MILD HYPOTHERMIA; POSTISCHEMIC HYPOTHERMIA; AMINOGUANIDINE TREATMENT; INFLAMMATORY RESPONSE; GLUCOSE DEPRIVATION; FOCAL ISCHEMIA; NEUROPROTECTION	We showed that hypothermic preconditioning (HPC) increased survival of Purkinje neurons in rat cerebellar slices after oxygen-glucose deprivation (OGD). HPC also reduced the OGD-increased expression of high mobility group I (Y) proteins, a transcription factor that can enhance inducible nitric oxide synthase (iNOS) expression. iNOS is a putatively damaging protein that contributes to ischemic brain injury. Heat shock proteins (HSPs) can be induced by various stimuli to protect cells. We hypothesize that HPC induces neuroprotection by reducing the expression of putatively damaging proteins such as iNOS and/or by increasing the expression of putatively protective proteins such as HSPs. Cerebellar slices were prepared from adult male Sprague-Dawley rats and incubated in circulating artificial cerebrospinal fluid. OGD was for 20 min at 37 degrees C and was followed by a 5-h recovery at 37 degrees C before slices were used for morphological, immunohistochemical and Western analyses. HPC was performed by incubating slices at 33 degrees C for 20 min at 1 h before the OGD. HPC and aminoguanidine, an MOS inhibitor, prevented OGD-induced Purkinje cell death/injury. OGD increased the expression of MOS and nitrosylated proteins. These increases were abolished by aminoguanidine and HPC. Interestingly, the expression of HSP70 was increased by OGD but not by HPC. Our results suggest that an increased MOS expression contributes to the pathophysiology of OGD-induced Purkinje neuronal death in our model. Our results also suggest the involvement of inhibiting the expression of the putatively damaging iNOS proteins in the HPC-induced neuroprotection. HSP70 may not contribute to the HPC-induced neuroprotection. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22908 USA; Natl Yang Ming Univ, Dept Anesthesiol, Vet Gen Hosp, Taipei 112, Taiwan		Zuo, Z (corresponding author), Univ Virginia Hlth Syst, Dept Anesthesiol, 1 Hosp Dr,POB 800710, Charlottesville, VA 22908 USA.	zz3c@virginia.edu	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM065211] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045983] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM065211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045983] Funding Source: NIH RePORTER		ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; BAK IJ, 1980, BRAIN RES, V197, P341, DOI 10.1016/0006-8993(80)91120-8; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BERNTMAN L, 1981, ANESTHESIOLOGY, V55, P495, DOI 10.1097/00000542-198111000-00003; Bickler PE, 2005, ANESTHESIOLOGY, V103, P532, DOI 10.1097/00000542-200509000-00016; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chang CP, 2004, J PHARMACOL SCI, V95, P56, DOI 10.1254/jphs.95.56; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; Danielisova V, 2004, PHYSIOL RES, V53, P533; deVera ME, 1995, BIOCHEM SOC T, V23, P1008, DOI 10.1042/bst0231008; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Holtz ML, 2001, BRAIN RES, V898, P49, DOI 10.1016/S0006-8993(01)02140-0; Irazuzta JE, 1999, BRAIN RES, V847, P143, DOI 10.1016/S0006-8993(99)02120-4; Jiang XH, 2005, SURF REV LETT, V12, P59, DOI 10.1142/S0218625X05006792; KARIBE H, 1994, BRAIN RES, V649, P12, DOI 10.1016/0006-8993(94)91043-X; Kawakami S, 2000, BRAIN RES, V858, P198, DOI 10.1016/S0006-8993(00)01980-6; KELLY S, 2002, CURR MED RES OPIN, V18, P55; Ko HK, 2001, BRAIN RES, V894, P297, DOI 10.1016/S0006-8993(00)03188-7; Li J, 2002, BRAIN RES, V958, P399, DOI 10.1016/S0006-8993(02)03700-9; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Mancuso A, 2000, BRAIN RES, V887, P34, DOI 10.1016/S0006-8993(00)02963-2; Marion DW, 1996, CRIT CARE MED, V24, pS81; Masada T, 2002, ACT NEUR S, V81, P265; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moro MA, 1998, EUR J NEUROSCI, V10, P445, DOI 10.1046/j.1460-9568.1998.00028.x; Moseley PL, 1998, ANN NY ACAD SCI, V856, P206, DOI 10.1111/j.1749-6632.1998.tb08327.x; Nishio S, 2000, J NEUROSURG, V93, P845, DOI 10.3171/jns.2000.93.5.0845; Niwa K, 1999, NEUROSCI LETT, V271, P109, DOI 10.1016/S0304-3940(99)00534-0; NOBACK CR, 1991, HUMAN NERVOUS SYSTEM, P281; Olsson T, 2004, EXP BRAIN RES, V154, P442, DOI 10.1007/s00221-003-1683-2; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; Popovic R, 2000, ANESTHESIOLOGY, V92, P1343, DOI 10.1097/00000542-200005000-00024; Rodrigo J, 2001, BRAIN RES, V909, P20, DOI 10.1016/S0006-8993(01)02613-0; Ruetten H, 1996, BIOCHEM BIOPH RES CO, V225, P525, DOI 10.1006/bbrc.1996.1206; Shirhan M, 2004, LIFE SCI, V76, P661, DOI 10.1016/j.lfs.2004.07.015; Sreedhar AS, 2004, FEBS LETT, V562, P11; Sugimoto K, 2002, NEUROSCI LETT, V331, P25, DOI 10.1016/S0304-3940(02)00834-0; THARION J, 1982, J THORAC CARDIOV SUR, V84, P66; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; WOLFF DJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P290, DOI 10.1006/abbi.1995.1040; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Yuan HB, 2004, ANESTHESIOLOGY, V100, P331, DOI 10.1097/00000542-200402000-00023; Zheng S, 2003, NEUROSCIENCE, V118, P99, DOI 10.1016/S0306-4522(02)00767-4; Zuo ZY, 1997, MOL PHARMACOL, V52, P606, DOI 10.1124/mol.52.4.606	59	15	22	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT 13	2006	142	2					381	389		10.1016/j.neuroscience.2006.06.053			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098NT	WOS:000241530300007	16890370				2022-02-06	
J	Ariza, M; Pueyo, R; Junque, C; Mataro, M; Poca, MA; Mena, MP; Sahuquillo, J				Ariza, Mar; Pueyo, Roser; Junque, Carme; Mataro, Maria; Antonia Poca, Maria; Pau Mena, Maria; Sahuquillo, Juan			Differences in visual vs. verbal memory impairments as a result of focal temporal lobe damage in patients with traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; temporal lesion; memory; laterality	SEVERE HEAD-INJURY; HIGH INTRACRANIAL-PRESSURE; RECOGNITION MEMORY; NEUROPSYCHOLOGICAL DEFICITS; HIPPOCAMPAL ATROPHY; NONVERBAL MEMORY; EPILEPSY; LOBECTOMY; RAT; RESECTION	Primary objective: The aim of the present study was to determine whether the type of lesion in a sample of moderate and severe traumatic brain injury (TBI) was related to material-specific memory impairment. Methods and procedures: Fifty-nine patients with TBI were classified into three groups according to whether the site of the lesion was right temporal, left temporal or diffuse. Six-months post-injury, visual (Warrington's Facial Recognition Memory Test and Rey's Complex Figure Test) and verbal (Rey's Auditory Verbal Learning Test) memories were assessed. Main outcome and results: Visual memory deficits assessed by facial memory were associated with right temporal lobe lesion, whereas verbal memory performance assessed with a list of words was related to left temporal lobe lesion. The group with diffuse injury showed both verbal and visual memory impairment. Conclusions: These results suggest a material-specific memory impairment in moderate and severe TBI after focal temporal lesions and a non-specific memory impairment after diffuse damage.	Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Barcelona, Spain; August Pi & Sunyer Biomed Res Inst, IDIBAPS, Barcelona, Spain; Dept Neurosurg, Barcelona, Spain; Vall Hebron Univ Hosp, Neurotraumatol Res Unit, Barcelona, Spain		Pueyo, R (corresponding author), Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Passeig Vall Hebron 171, Barcelona, Spain.	rpueyo@ub.edu	Mataro, Maria/B-4524-2011; Junque, Carme/B-4400-2011; Ariza, Mar/F-2754-2019; Benito, Roser Pueyo/G-3433-2011; Mena, Mari-Pau/AAC-7966-2020; Poca, Maria A./B-8475-2008; Sahuquillo, Juan/B-3577-2008	Mataro, Maria/0000-0002-9946-2656; Junque, Carme/0000-0002-6381-3063; Benito, Roser Pueyo/0000-0002-8230-8409; Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Ariza, Mar/0000-0003-1020-6945; Mena Jaramillo, Maria de la Paz/0000-0001-9248-5997			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Barr WB, 1997, BRAIN COGNITION, V35, P26, DOI 10.1006/brcg.1997.0925; Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; Baxendale SA, 1997, NEUROPSYCHOLOGIA, V35, P591, DOI 10.1016/S0028-3932(96)00123-6; BENSON DF, 1974, ACTA NEUROL SCAND, V50, P133; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BIGLER ED, 1996, HDB HUMAN BRAIN FUNC, V2; Breier J I, 1996, J Int Neuropsychol Soc, V2, P535; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cahn DA, 1998, J INT NEUROPSYCH SOC, V4, P106, DOI 10.1017/S1355617798001064; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; FORMISANO R, 1991, ACTA NEUROCHIR, V109, P1, DOI 10.1007/BF01405688; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Gleissner U, 1998, J NEUROL NEUROSUR PS, V65, P665, DOI 10.1136/jnnp.65.5.665; Glosser G, 1998, J INT NEUROPSYCH SOC, V4, P502; Helmstaedter C, 1997, BRAIN COGNITION, V35, P110, DOI 10.1006/brcg.1997.0930; HERMANN BP, 1995, J EPILEPSY, V8, P139, DOI 10.1016/0896-6974(95)00022-6; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; JonesGotman M, 1997, NEUROPSYCHOLOGIA, V35, P963, DOI 10.1016/S0028-3932(97)00024-9; JONESGOTMAN M, 1986, NEUROPSYCHOLOGIA, V24, P659, DOI 10.1016/0028-3932(86)90005-9; Kilpatrick C, 1997, SEIZURE, V6, P213, DOI 10.1016/S1059-1311(97)80008-8; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Malina AC, 1998, PERCEPT MOTOR SKILL, V86, P1320, DOI 10.2466/pms.1998.86.3c.1320; MAPOU RL, 1992, HDB HEAD TRAUMA ACUT, P75; Martin RC, 1999, NEUROLOGY, V53, P2052, DOI 10.1212/WNL.53.9.2052; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Miller LA, 1998, NEUROPSYCHOLOGIA, V36, P1247, DOI 10.1016/S0028-3932(97)00139-5; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1958, Res Publ Assoc Res Nerv Ment Dis, V36, P244; MITCHELL DE, 1973, LANCET, V2, P215; Mitrushina MN, 1999, HDB NORMATIVE DATA N; MORRIS RG, 1995, BRIT J CLIN PSYCHOL, V34, P571, DOI 10.1111/j.2044-8260.1995.tb01490.x; Naugle RI., 1994, ASSESSMENT, V1, P373, DOI [10.1177/107319119400100406, DOI 10.1177/107319119400100406]; PHILLIPS NA, 1995, J CLIN EXP NEUROPSYC, V17, P713, DOI 10.1080/01688639508405161; Rey A., 1959, TEST COPIE REPROD ME; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Simons JS, 2001, NEUROPSYCHOLOGY, V15, P101, DOI 10.1037/0894-4105.15.1.101; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Taylor L B, 1969, Clin Neurosurg, V16, P269; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vaz SAM, 2004, SEIZURE-EUR J EPILEP, V13, P446, DOI 10.1016/j.seizure.2003.12.004; VONCRAMON DY, 1988, BRAIN, V111, P1061, DOI 10.1093/brain/111.5.1061; Walton NH, 1999, SEIZURE-EUR J EPILEP, V8, P241, DOI 10.1053/seiz.1999.0291; Warrington E, 1984, RECOGNITION MEMORY T, V1; White JR, 2002, EPILEPSY BEHAV, V3, P383, DOI 10.1016/S1525-5050(02)00051-3	59	15	15	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1053	1059		10.1080/02699050600909862			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100007	17060138				2022-02-06	
J	Bishop, M; Degeneffe, CE; Mast, M				Bishop, Malachy; Degeneffe, Charles Edmund; Mast, Melinda			Family Needs After Traumatic Brain Injury: Implications for Rehabilitation Counselling	AUSTRALIAN JOURNAL OF REHABILITATION COUNSELLING			English	Article								Family involvement in the rehabilitation counselling process is increasingly being recognised as an important component of rehabilitation success. This may be particularly true for persons who have an acquired or traumatic brain injury (TBI). For such individuals the emotional and psychosocial functioning of their family and caregivers has been associated with a variety of functional, psychosocial, and employment outcomes. Addressing the needs of family members is an important component of providing effective rehabilitation counselling services, but one that has received little attention in the rehabilitation counselling literature. This article reviews current research on the frequently identified needs of families and caregivers of persons with TBI, the family and situational variables that have been explored for their relationship to family needs, and the extent to which these needs are met. Clinical and research implications for rehabilitation counsellors are identified.	[Bishop, Malachy] Univ Kentucky, 220 Taylor Educ Bldg, Lexington, KY 40506 USA; [Degeneffe, Charles Edmund] San Diego State Univ, San Diego, CA 92182 USA; [Mast, Melinda] Brain Injury Assoc Kentucky, Louisville, KY USA		Bishop, M (corresponding author), Univ Kentucky, 220 Taylor Educ Bldg, Lexington, KY 40506 USA.	mbishop@uky.edu					Blacher J, 1997, FAM RELAT, V46, P325, DOI 10.2307/585093; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Brain Injury Association of America, TBI INC COMP TRAUM B; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Carson P, 1993, J Neurosci Nurs, V25, P165; CHWALISZ K, 1992, REHABIL PSYCHOL, V37, P189, DOI 10.1037/h0079103; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Cunningham J.M., 1999, CASE MANAGEMENT REHA, P91; Degeneffe C.E., 2002, THESIS; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DeJong G., 1999, REPORT NIH CONSENSUS, P121; Dell Orto A.E., 1994, HED INJURY FAMILY LI; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Engli M, 1993, J Neurosci Nurs, V25, P78; Fortune N., 1999, DEFINITION INCIDENE; Gamble D., 2002, J APPL REHABILITATIO, V33, P41, DOI DOI 10.1891/0047-2220.33.3.41; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; Hallauer D. S., 1989, J APPL REHABILITATIO, V20, P3; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; Kendall E, 2003, J VOCAT REHABIL, V19, P31; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kolakowski-Hayner S, 2001, J HEAD TRAUMA REHAB, V16, P1; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; KOSCIULEK J, 1994, J APPL REHABILITATIO, V25, P61; Kosciulek JF, 1996, J REHABIL, V62, P49; KOSCIULEK JF, 1993, J REHABIL, V59, P40; Kreutzer J. S., 2000, SERVICE OBSTACLES SC; Kreutzer J.S., 1990, COMMUNITY INTEGR TRA, P249; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kreutzer JS, 1989, FAMILY NEEDS QUESTIO; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lees M., 1988, REHABILITATION SEVER, P166; LESKE JS, 1986, HEART LUNG, V15, P189; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Livingston MG., 1990, REHABILITATION ADULT, P225; Los Angeles Caregiver Resource Center, 1996, FACT SHEET COP BEH P; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; Lustig D., 2003, J APPL REHABIL COUS, V34, P30; Man DWK, 2003, BRAIN INJURY, V17, P437, DOI 10.1080/0269905031000070152; Marme M., 1993, J APPL REHABILITATIO, V24, P19; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marwitz J., 2000, FAMILY NEEDS QUESTIO; Marwitz J, 1996, SERVICE OBSTACLES SC; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Michaels C.A., 1992, J APPL REHABILITATIO, V24, P38; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; Moore R.L., 1990, J APPL REHABILITATIO, V21, P3; Moules S, 1999, BRAIN INJURY, V13, P983; National Institutes of Health, 1999, NIH CONS DEV C REH P; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; PRESTON B, 1992, REHABIL COUNS BULL, V35, P230; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; Rosenthal M., 1989, TRAUMATIC BRAIN INJU, P191; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; RUFF RM, 2001, HDB MEASUREMENT EVAL, P233; SACHS PR, 1991, TREATING FAMILIES BR; Schonbrun S. L., 2004, J APPL REHABILITATIO, V35, P14; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Shaw LR, 1997, BRAIN INJURY, V11, P219; SIMPSON GK, 1999, YOU ME ED PROGRAM SE; Stebbins P, 1998, J REHABIL, V64, P15; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wargo L.M., 2001, J HEAD TRAUMA REHAB, V16, P47; WATANABE Y, 1999, JAPANESE J REHABILIT, V36, P180; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	84	15	15	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1323-8922	1838-6059		AUST J REHABIL COUNS	Aust. J. Rehabil. Couns.	SEP	2006	12	2					73	87		10.1375/jrc.12.2.73			15	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V0D5A	WOS:000216128500002					2022-02-06	
J	Piatt, JH				Piatt, Joseph H., Jr.			Detected and overlooked cervical spine injury in comatose victims of trauma: report from the Pennsylvania Trauma Outcomes Study	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal cord injury; traumatic brain injury; coma	GUNSHOT WOUNDS; HEAD-INJURIES; PATIENT; CLEARANCE; RISK	Object. This study was undertaken to determine whether a clinically useful rule could be formulated for identifying the presence of traumatic brain injury (TBI) in patients who are at exceptionally low risk of cervical spine injury. Methods. The Pennsylvania Trauma Outcomes Study database was searched for cases of TBI in which the admission Glasgow Coma Scale (GCS) score was less than or equal to 8. Cases of cervical injury were identified based on diagnostic codes. Associations between cervical injury and various clinical variables were tested using chi-square analysis. The probability of cervical injury was modeled using logistic regression. Decision tree models were constructed. Statistical determinants of overlooked cervical injury were examined. The prevalence of cervical injury among 41,142 cases of TBI was 8%. Mechanism of injury, thoracolumbosacral (TLS) fracture, age, limb fracture, admission GCS score, hypotension, and facial fracture were associated with cervical injury and were incorporated into the following logistic regression model: probability = 1/(1 + exp[4.248 - 0.417 X mechanism -0.264 X age - 0.678 X TLS - 0.299 X limb - 0.218 X GCS - 0.231 X hypotension - 0.157 X facial]). The results of applying this model provided a rule for cervical spine clearance applicable to 28% of the cases with a negative predictive value (NPV) of 97.0%. Decision tree analysis yielded a rule applicable to 24% of the cases with an NPV of 98.2%. The prevalence of overlooked cervical injury in all individuals with severe TBI was 0.3%; the prevalence of overlooked cervical injury in patients with cervical injury was 3.9%. Overlooked cervical injury was less common in patients with associated TLS fractures (odds ratio 0.453, 95% confidence interval 0.245-0.837). Conclusions. This analysis identified no acceptable rule to justify relaxing vigilance in the search for cervical injury in patients with severe TBI. Provider vigilance and consequent rates of overlooked cervical injury can be affected by environmental cues and presumably by other behavioral and organizational factors.	St Christophers Hosp Children, Neurosurg Sect, Philadelphia, PA 19134 USA; Drexel Univ, Coll Med, Dept Pediat, Philadelphia, PA 19104 USA		Piatt, JH (corresponding author), St Christophers Hosp Children, Neurosurg Sect, Erie Ave Front St, Philadelphia, PA 19134 USA.	joseph.piatt@tenethealth.com		Piatt, Joseph/0000-0002-9332-8376			Avellino AM, 2005, CHILD NERV SYST, V21, P122, DOI 10.1007/s00381-004-1058-4; BAYLESS P, 1989, AM J EMERG MED, V7, P139, DOI 10.1016/0735-6757(89)90125-3; Blackmore CC, 1999, RADIOLOGY, V212, P117, DOI 10.1148/radiology.212.1.r99jl08117; Brohi K, 2005, J TRAUMA, V58, P897, DOI 10.1097/01.ta.0000171984.25699.35; Brooks RA, 2001, J TRAUMA, V50, P862; Chiu WC, 2001, J TRAUMA, V50, P457, DOI 10.1097/00005373-200103000-00009; D'Alise MD, 1999, J NEUROSURG, V91, P54, DOI 10.3171/spi.1999.91.1.0054; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Kaups KL, 1998, J TRAUMA, V44, P865, DOI 10.1097/00005373-199805000-00020; KENNEDY FR, 1994, SOUTHERN MED J, V87, P621, DOI 10.1097/00007611-199406000-00008; LAHAM JL, 1994, PEDIATR NEUROSURG, V21, P221, DOI 10.1159/000120839; Lanoix R, 2000, J TRAUMA, V49, P860, DOI 10.1097/00005373-200011000-00011; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; OMALLEY KF, 1988, J TRAUMA, V28, P1476, DOI 10.1097/00005373-198810000-00013; ROSS SE, 1992, INJURY, V23, P317, DOI 10.1016/0020-1383(92)90178-U; Schenarts PJ, 2001, J TRAUMA, V51, P663, DOI 10.1097/00005373-200110000-00007; SOICHER E, 1991, BRIT J SURG, V78, P1013, DOI 10.1002/bjs.1800780837; Widder S, 2004, J TRAUMA, V56, P1179, DOI 10.1097/01.TA.0000130758.71098.78	19	15	17	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	SEP	2006	5	3					210	216		10.3171/spi.2006.5.3.210			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	076CH	WOS:000239934100004	16961081				2022-02-06	
J	Prough, DS; Kramer, GC; Uchida, T; Stephenson, RT; Hellmich, HL; DeWitt, DS				Prough, Donald S.; Kramer, George C.; Uchida, Tatsuo; Stephenson, Rachael T.; Hellmich, Helen L.; DeWitt, Douglas S.			Effects of hypertonic arginine on cerebral blood flow and intracranial pressure after traumatic brain injury combined with hemorrhagic hypotension	SHOCK			English	Article						cerebral blood flow; hemorrhagic hypotension; hypertonic arginine; intracranial pressure; rats; traumatic brain injury	NITRIC-OXIDE SYNTHASE; LACTATED RINGERS SOLUTION; FLUID-PERCUSSION INJURY; CORTICAL IMPACT INJURY; SEVERE HEAD-INJURY; CEREBROVASCULAR REACTIVITY; SALINE RESUSCITATION; SUPEROXIDE-DISMUTASE; CONTROLLED-TRIAL; OXYGEN DELIVERY	Hypertonic saline solutions improve cerebral blood flow (CBF) when used for acute resuscitation from hemorrhagic hypotension accompanying some models of traumatic brain injury (TBI); however, the duration of increased CBF is brief. Because the nitric oxide synthase substrate L-arginine provides prolonged improvement in CBF after TBI, we investigated whether a hypertonic resuscitation fluid containing L-arginine would improve CBF in comparison to hypertonic saline without L-arginine in a model of moderate, paramedian, fluid-percussion TBI followed immediately by hemorrhagic hypotension (mean arterial pressure [MAP] = 60 mm Hg for 45 min). Sprague-Dawley rats were anesthetized with 4.0% isoflurane, intubated and ventilated with 1.5%-2.0% isoflurane in oxygen/air (50:50). After preparation for TBI and measurement of CBF using laser Doppler flowmetry and measurement of intracranial pressure (ICP) using an implanted transducer, rats were subjected to moderate (2.0 atm) TBI, hemorrhaged for 45 min, and randomly assigned to receive an infusion of hypertonic saline (7.5%, 2,400 mOsm total; 6 mL/kg; n = 6) or hypertonic saline with 50, 100, or 300 mg/kg L-arginine (2,400 mOsm; 6 mL/kg; n = 6 in each of the three dose groups) and then monitored for 120 min after the end of infusion. CBF was measured continuously and calculated as a percent of the pre-TBI baseline during the hemorrhage period, after reinfusion of one of the hypertonic arginine solutions, and 30, 60, and 120 min after reinfusion. All four hypertonic solutions initially improved MAP, which, by 120 min after infusion, had decreased nearly to the levels observed during hemorrhage. ICP remained below baseline levels during resuscitation in all groups, although ICP was slightly greater (P = NS) than baseline in the hypertonic saline group. CBF increased similarly in all groups during infusion and then decreased similarly in all groups. At 120 min after infusion, CBF was highest in the group infused with hypertonic saline, but the difference was not significant. We conclude that the improvement of MAP, ICP, and CBF produced by hypertonic saline alone after TBI and hemorrhagic hypotension is not significantly enhanced by the addition Of L-arginine at these doses.	Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA		Prough, DS (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	dsprough@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X			Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beckman JS, 1996, ADV NEUROL, V71, P339; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BECKMAN JS, 1991, J CEREB BLOOD FLO S2, V11, pS629; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; DEWITT D S, 1992, Anesthesiology (Hagerstown), V77, pA689, DOI 10.1097/00000542-199209001-00689; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DeWitt DS, 2001, J CEREBR BLOOD F MET, V21, P253, DOI 10.1097/00004647-200103000-00009; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; DEWITT DS, 1991, ANESTHESIOLOGY, V3, P211; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; *DOHSP COMM FLUID, 1999, STAT SCI TREAT COMB, V1; Elliott SJ, 1998, AM J PHYSIOL-HEART C, V275, pH1585, DOI 10.1152/ajpheart.1998.275.5.H1585; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; FARACI FM, 1991, AM J PHYSIOL, V261, pH1038, DOI 10.1152/ajpheart.1991.261.4.H1038; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HE Z, 1995, BRAIN RES, V699, P208, DOI 10.1016/0006-8993(95)00907-8; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Liu PK, 2002, ANN NY ACAD SCI, V962, P226, DOI 10.1111/j.1749-6632.2002.tb04071.x; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MORIKAWA E, 1992, BRIT J PHARMACOL, V107, P905, DOI 10.1111/j.1476-5381.1992.tb13382.x; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; PELLIGRINO DA, 1993, J NEUROSURG ANESTH, V5, P221; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Prough DS, 1999, J NEUROSURG ANESTH, V11, P102, DOI 10.1097/00008506-199904000-00006; PROUGH DS, 1991, ANESTH ANALG, V73, P736; PROUGH DS, 1985, CRIT CARE MED, V13, P1040, DOI 10.1097/00003246-198512000-00011; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; SZABO C, 1994, CIRC SHOCK, V44, P104; SZABO C, 1992, CIRC SHOCK, V37, P307; TANAKA K, 1991, NEUROSCI LETT, V127, P129, DOI 10.1016/0304-3940(91)90911-C; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WHITLEY JM, 1991, J NEUROSURG ANESTH, V3, P47, DOI 10.1097/00008506-199103000-00008; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	60	15	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2006	26	3					290	295		10.1097/01.shk.0000225405.66693.49			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	076HO	WOS:000239947800010	16912655				2022-02-06	
J	Sundstrom, T; Guez, M; Hildingsson, C; Toolanen, G; Nyberg, L; Riklund, K				Sundstrom, Torbjorn; Guez, Michel; Hildingsson, Christer; Toolanen, Goran; Nyberg, Lars; Riklund, Katrine			Altered cerebral blood flow in chronic neck pain patients but not in whiplash patients: a Tc-99m-HMPAO rCBF study	EUROPEAN SPINE JOURNAL			English	Article						whiplash; chronic neck pain; Tc-99m-HMPAO rCBF-SPECT; brain imaging; regional cerebral blood flow	POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; THALAMIC-STIMULATION; GENDER-DIFFERENCES; NEURAL ACTIVITY; RISK-FACTORS; BRAIN; INJURY; ACTIVATION; RESPONSES	A cross-sectional study to investigate regional cerebral blood flow (rCBF) in patients with chronic whiplash syndrome and chronic neck pain patients without previous history of trauma along with a healthy control group. Chronic neck pain is a common disorder and a history of cervical spine injury including whiplash trauma constitute a risk factor for persistent neck pain. The aetiology of the late whiplash syndrome is unknown with no specific diagnostic criteria based on imaging, physiological, or psychological examination. Earlier studies indicate a parieto-occipital hypoperfusion but it is unclear if the hypoperfusion represents a response to chronic pain. The rCBF was monitored in 45 patients with chronic neck pain: 27 cases with chronic whiplash syndrome and 18 age and gender matched cases with non-traumatic chronic neck pain. The rCBF was estimated with single-photon emission computed tomography (SPECT) using technetium-99m hexamethylpropylene amine oxime (HMPAO). The non-traumatic patients displayed rCBF changes in comparison with the whiplash group and the healthy control group. These changes included rCBF decreases in a right temporal region close to hippocampus, and increased rCBF in left insula. The whiplash group displayed no significant differences in rCBF in comparison with the healthy controls. The present study suggests different pain mechanisms in patients with chronic neck pain of non-traumatic origin compared to those with chronic neck pain due to a whiplash trauma.	Umea Univ, Norrlands Univ Hosp, Dept Radiat Sci, S-90185 Umea, Sweden; Umea Univ, Norrlands Univ Hosp, Dept Surg & Perioperat Sci, S-90185 Umea, Sweden; Umea Univ, Dept Psychol, S-90185 Umea, Sweden		Sundstrom, T (corresponding author), Umea Univ, Norrlands Univ Hosp, Dept Radiat Sci, S-90185 Umea, Sweden.	torbjorn.sundstrom@diagrad.umu.se	Nyberg, Lars/C-2514-2009; Sundstrom, Torbjorn/X-5745-2019; Nyberg, Lars/M-5986-2019	Nyberg, Lars/0000-0002-3367-1746; Sundstrom, Torbjorn/0000-0002-9071-8993; Nyberg, Lars/0000-0002-3367-1746; Riklund, Katrine/0000-0001-5227-8117			ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; BARNSLEY L, 1994, PAIN, V58, P283, DOI 10.1016/0304-3959(94)90123-6; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Cote P, 2000, SPINE, V25, P1109; Croft PR, 2001, PAIN, V93, P317, DOI 10.1016/S0304-3959(01)00334-7; Curatolo M, 2001, CLIN J PAIN, V17, P306, DOI 10.1097/00002508-200112000-00004; Davis KD, 2000, J NEUROSURG, V92, P64, DOI 10.3171/jns.2000.92.1.0064; Derbyshire SWG, 2002, J PAIN, V3, P401, DOI 10.1054/jpai.2002.126788; Derbyshire SWG, 2002, NEUROIMAGE, V16, P158, DOI 10.1006/nimg.2002.1066; Di Piero V, 2001, PSYCHOPHARMACOLOGY, V158, P252; Freitag P, 2001, NEUROREHAB NEURAL RE, V15, P31, DOI 10.1177/154596830101500105; Guez M, 2002, ACTA ORTHOP SCAND, V73, P455, DOI 10.1080/00016470216329; Hsieh JC, 1999, EUR J PAIN, V3, P51, DOI 10.1016/S1090-3801(99)90188-X; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016/0304-3959(95)00015-K; Jones AKP, 1997, ANN RHEUM DIS, V56, P601, DOI 10.1136/ard.56.10.601; Kastrup A, 1999, J CEREBR BLOOD F MET, V19, P1066, DOI 10.1097/00004647-199910000-00002; Kupers RC, 2000, PAIN, V87, P295, DOI 10.1016/S0304-3959(00)00295-5; Kwiatek R, 2000, ARTHRITIS RHEUM-US, V43, P2823, DOI 10.1002/1529-0131(200012)43:12<2823::AID-ANR24>3.0.CO;2-E; Larsson A, 2003, NUCL MED COMMUN, V24, P411, DOI 10.1097/00006231-200304000-00011; Liotti M, 2000, BIOL PSYCHIAT, V48, P30, DOI 10.1016/S0006-3223(00)00874-X; MARSHALL PD, 1995, INJURY, V26, P17, DOI 10.1016/0020-1383(95)90546-A; Nakabeppu Y, 2001, ANN NUCL MED, V15, P459, DOI 10.1007/BF02988354; Newberg AB, 2005, J NEUROIMAGING, V15, P43, DOI 10.1177/1051228404271005; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Otte A, 1998, EUR J NUCL MED, V25, P306; Otte A, 1996, EUR J NUCL MED, V23, P72, DOI 10.1007/BF01736993; OTTE A, 1995, LANCET, V345, P1513, DOI 10.1016/S0140-6736(95)91075-1; Otte A, 1997, J NEUROL NEUROSUR PS, V63, P368, DOI 10.1136/jnnp.63.3.368; Petrovic P, 1999, PAIN, V83, P459, DOI 10.1016/S0304-3959(99)00150-5; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; REIMAN EM, 1984, NATURE, V310, P683, DOI 10.1038/310683a0; Richter M, 2004, J NEUROL NEUROSUR PS, V75, P758, DOI 10.1136/jnnp.2003.026963; Rodriquez AA, 2004, MUSCLE NERVE, V29, P768, DOI 10.1002/mus.20060; SPITZER WO, 1995, SPINE, V20, pS1; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Sugiura M, 2000, NEUROIMAGE, V11, P541, DOI 10.1006/nimg.2000.0564; Viikari-Juntura E, 2001, OCCUP ENVIRON MED, V58, P345, DOI 10.1136/oem.58.5.345; Wik G, 2003, NEUROREPORT, V14, P619, DOI 10.1097/00001756-200303240-00019	41	15	16	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0940-6719			EUR SPINE J	Eur. Spine J.	AUG	2006	15	8					1189	1195		10.1007/s00586-005-0040-5			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	085QM	WOS:000240618600005	16614854	Green Published			2022-02-06	
J	Ardila, A; Surloff, C				Ardila, Alfredo; Surloff, Cheri			Dysexecutive agraphia: A major executive dysfunction sign	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						agraphia; dysexecutive syndrome; executive functions; frontal syndrome	ALZHEIMERS-DISEASE; EVOLUTION; DEMENTIA; LANGUAGE; DAMAGE	Different types of writing disorders associated with brain pathology have been described. Limited mention the writing disturbances associated with prefrontal pathology, however, is found. Clinical observations of patients not only with focal prefrontal pathology but also with other conditions affecting the frontal system ( e. g., traumatic head injury, dementia) confirm the assumption that these patients present an overt decrease in the ability to express ideas in writing. It is proposed that complex aspects of writing, such as planning, narrative coherence, and maintained attention, are significantly disturbed in cases of impairments of executive functions. Frontal lobe patients not only have difficulties in keeping the effort required for writing, but also to organize the ideas in the written texts. The term dysexecutive agraphia is proposed to refer to this writing disorder. Three illustrative cases are presented. It is finally suggested that questions regarding the ability to write should be included in dementia questionnaires and executive functioning testing.	Florida Int Univ, Dept Commun Sci & Disorders, Miami, FL 33199 USA; Mem Reg Hosp, Hollywood, FL USA		Ardila, A (corresponding author), Florida Int Univ, Dept Commun Sci & Disorders, NLS144, Miami, FL 33199 USA.	ardilaa@fiu.edu					ANDERSON SW, 1993, ACTA PSYCHOL, V82, P193, DOI 10.1016/0001-6918(93)90012-G; ANDERSON SW, 1990, BRAIN, V113, P749, DOI 10.1093/brain/113.3.749; ARDILA A, 1993, BRAIN COGNITION, V22, P137, DOI 10.1006/brcg.1993.1029; ARDILA A, 2004, MEDLINK NEUROLOGY; ARDILA A, 2000, MEDLINK NEUROLOGY; Baddeley A.D., 1986, WORKING MEMORY; Benson D. F., 1996, APHASIA CLIN PERSPEC; Benson D. F., 1985, HDB CLIN NEUROLOGY, V45, P457; Benson D.F., 1986, FRONTAL LOBES; Berthier M. L., 1999, TRANSCORTICAL APHASI; Chedru F, 1972, Cortex, V8, P395; Croisile B, 1999, DEMENT GERIATR COGN, V10, P226, DOI 10.1159/000017124; Denckla M B, 1994, FRAMES REFERENCE ASS, P117; DUBOIS J, 1969, NEUROPSYCHOLOGIA, V7, P271, DOI 10.1016/0028-3932(69)90008-6; Exner S., 1881, UNERSUCHUNGEN LOKALI; Forbes KE, 2004, BRAIN RES BULL, V63, P19, DOI 10.1016/j.brainresbull.2003.11.005; GOLDBERG E, 2001, EXECUTIVE BRAIN; Goldstein K., 1948, LANGUAGE LANGUAGE DI; Groves-Wright K, 2004, J COMMUN DISORD, V37, P109, DOI 10.1016/j.jcomdis.2003.08.004; Hecaen H., 1978, HUMAN NEUROPSYCHOLOG; HENDERSON VW, 1992, NEUROLOGY, V42, P776, DOI 10.1212/WNL.42.4.776; Hooper SR, 2002, J LEARN DISABIL-US, V35, P57, DOI 10.1177/002221940203500105; HORNER J, 1988, ARCH NEUROL-CHICAGO, V45, P760; Katanoda K, 2001, HUM BRAIN MAPP, V13, P34, DOI 10.1002/hbm.1023; Krasnegor N.A., 1996, ATTENTION MEMORY EXE, P263; LABARGE E, 1992, ARCH NEUROL-CHICAGO, V49, P1151, DOI 10.1001/archneur.1992.00530350065021; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Luria AR., 1976, BASIC PROBLEMS NEURO; Luria AR, 1969, HDB CLINICAL NEUROLO, P725; Luzzatti C, 2003, NEUROPSYCHOLOGIA, V41, P759, DOI 10.1016/S0028-3932(02)00328-7; Matsuo K, 2003, NEUROSCI LETT, V340, P13, DOI 10.1016/S0304-3940(03)00050-8; NEILS J, 1989, J CLIN EXP NEUROPSYC, V11, P692, DOI 10.1080/01688638908400925; Omura K, 2004, NEUROREPORT, V15, P949, DOI 10.1097/00001756-200404290-00004; PLATEL H, 1993, NEUROPSYCHOLOGIA, V31, P1147, DOI 10.1016/0028-3932(93)90064-7; Roeltgen DP, 2003, CLIN NEUROPSYCHOLOGY, P127; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TOMOEDA CK, 1993, ALZ DIS ASSOC DIS, V7, P223	38	15	16	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	MAY	2006	116	5					653	663		10.1080/00207450600592206			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	041XL	WOS:000237489900010	16644524				2022-02-06	
J	Kennedy, RE; Livingston, L; Marwitz, JH; Gueck, S; Kreutzer, JS; Sander, AM				Kennedy, RE; Livingston, L; Marwitz, JH; Gueck, S; Kreutzer, JS; Sander, AM			Complicated mild traumatic brain injury on the inpatient rehabilitation unit - A multicenter analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional outcome; inpatient rehabilitation; medical complications; mild brain injury; traumatic brain injury	DISABILITY RATING-SCALE; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; DOUBLE-BLIND; MODERATE; CLASSIFICATION; RECOVERY; LENGTH; STAY; RISK	Objective: To determine characteristics of patients with complicated mild traumatic brain injury (CMTBI) on the inpatient rehabilitation unit and to accentuate limits of current classification systems for patients with mild TBI. Design: Multicenter analysis of individuals with a Glasgow Coma Scale (GCS) score of 13 to 15 (lowest score in 24 h) and positive computed tomography findings admitted to inpatient rehabilitation for TBI. Setting: 16 TBI Model System centers funded by the National Institute on Disability and Rehabilitation Research. Participants: 373 adults with CMTBI. Main Outcome Measures: Functional Independence Measure (FIM) and Disability Rating Scale (DRS) scores, length of stay, and medical complications. Results: 16% of the sample experienced serious cranial complications (eg, cerebrospinal fluid leak, intracranial hypertension), with seizures being the most common during the course of inpatient rehabilitation. Most patients demonstrated substantial improvements on functional outcome measures during rehabilitation (mean admission FIM 68.2, discharge FIM 100.6; admission DRS 9.1, discharge DRS 4.8). Age, acute length of stay, and FIM score on rehabilitation admission were significant predictors of rehabilitation length of stay. Factors not predictive of rehabilitation duration were GCS score, ethilicity, gender, incidence of fractures, and incidence of cranial/noncranial complications. Conclusion: Despite favorable GCS scores, some patients with CMTBI suffer a variety of serious cranial and noncranial complications. Such patients appear to benefit from additional brain injury services offered in inpatient rehabilitation. Further study of the unique treatment needs of these patients is warranted.	Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Inst Rehabil & Res, Houston, TX 77030 USA		Kennedy, RE (corresponding author), Virginia Commonwealth Univ, Dept Biostat, Med Coll Virginia Campus,Box 980032, Richmond, VA 23298 USA.	rkennedy@hsc.vcu.edu	Kennedy, Richard/K-1525-2018	Kennedy, Richard/0000-0003-4638-126X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A020516, H133A011403] Funding Source: Medline		ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bontke C. F., 1993, J HEAD TRAUMA REHAB, V8, P34; Centers for Disease Control and Prevention, 2003, MILD TRAUM BRAIN INJ; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN S, 2003, J INT NEUROPSYCH SOC, V9, P172; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALLAHAN DP, 1997, ADV LEARN BEHAV DISA, V11, P27; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; JOHNSON PC, 1994, DERMATOL CLIN, V12, P9, DOI 10.1016/S0733-8635(18)30197-9; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; *KESSL MED REH RES, 2002, TRAUM BRAIN INJ MOD; Kraus J, 2000, HEAD INJURY, P1; Kraus J. F., 1999, REHABILITATION ADULT, P3; Kraus Jess F., 1994, P3; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; LEVIS HS, 1997, J NERV MENT DIS, V167, P675; Merchant RE, 1999, ANN NY ACAD SCI, V890, P42, DOI 10.1111/j.1749-6632.1999.tb07979.x; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; *STAT U NEW YORK, 1997, GUID UN DAT SET MED; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	45	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2006	21	3					260	271		10.1097/00001199-200605000-00006			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	044YL	WOS:000237709600006	16717503				2022-02-06	
J	Revelly, JP; Imperatori, L; Maravic, P; Schaller, MD; Chiolero, R				Revelly, JP; Imperatori, L; Maravic, P; Schaller, MD; Chiolero, R			Are terminally ill patients dying in the ICU suitable for non-heart beating organ donation?	INTENSIVE CARE MEDICINE			English	Article						coma; terminal care; treatment withdrawal; organ donation; non-heart beating organ donor	TRANSPLANTATION	Objective: To evaluate the feasibility of implementing a program of controlled non-heart beating organ donation, in patients undergoing the withdrawal of intensive care treatment. Design and setting: Prospective observational study. Medical and Surgical ICUs in a tertiary university hospital. Patients: Consecutive patients younger than 70 years dying in the ICU after treatment withdrawal for dire neurological prognosis. Measurements and results: We analyzed prospectively collected data from the ICU clinical information system. Seventy-three of 516 ICU deaths (13%) were identified, equally distributed among traumatic, stroke, and anoxic brain injury. The management and the course in these three diagnostic categories were similar. All patients underwent withdrawal of mechanical ventilation and half were extubated. Median time to death was of 4.8 h (IQR 1.4-11.5). In 70% of cases the patient received analgesia and 30% sedation. Such treatment was not related to earlier death. Hypotension was observed in 50% of patients during the 30 min preceding cardiac death. Conclusions: With our current management of terminal patients controlled non-heart beating organ procedure may be difficult due to the duration and variability of the dying process. This observation suggests that we can perform better by evaluating this process more closely.	CHU Vaudois, Surg Intens Care Unit, CH-1011 Lausanne, Switzerland; CHU Vaudois, Transplantat Ctr, CH-1011 Lausanne, Switzerland		Revelly, JP (corresponding author), CHU Vaudois, Surg Intens Care Unit, CH-1011 Lausanne, Switzerland.	jrevelly@chuv.hospvd.ch					Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Bell MDD, 2005, BRIT J ANAESTH, V94, P474, DOI 10.1093/bja/aei048; Bell MDD, 2003, J MED ETHICS, V29, P176, DOI 10.1136/jme.29.3.176; Brook NR, 2004, CLIN TRANSPLANT, V18, P627, DOI 10.1111/j.1399-0012.2004.00287.x; Daar AS, 2004, TRANSPL P, V36, P1885, DOI 10.1016/j.transproceed.2004.08.130; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2965; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; REVELLY JP, 2005, INTENS CARE MED, V31, pS156; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Sudhindran S, 2003, CLIN TRANSPLANT, V17, P93, DOI 10.1034/j.1399-0012.2003.00014.x; Truog RD, 2003, CRIT CARE MED, V31, P2391, DOI 10.1097/01.CCM.0000090869.19410.3C; VALLOTTON M, 2004, CARE PATIENTS END LI	12	15	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAY	2006	32	5					708	712		10.1007/s00134-006-0116-7			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036QQ	WOS:000237090300011	16534569	Green Submitted			2022-02-06	
J	Schmitter-Edgecombe, M				Schmitter-Edgecombe, M			Implications of basic science research for brain injury rehabilitation - A focus on intact learning mechanisms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	Galveston Brain Injury Conference (GBIC)	APR, 2005	Galveston, TX	Moody Fdn		attention; automaticity; automatic processes; cognitive rehabilitation; controlled processes; implicit learning; implicit memory; skill learning; traumatic brain injury	CLOSED-HEAD INJURY; IMPLICIT MEMORY TESTS; DIVIDED ATTENTION; EXPLICIT MEMORY; SEARCH PERFORMANCE; ACQUISITION; ASSOCIATIONS; RETENTION; DEFICITS; 1-YEAR	Within a theoretical framework for rehabilitation that distinguishes between automatic and controlled processes, this article reviews basic science research and addresses the following issues: What cognitive abilities remain relatively intact after severe traumatic brain injury, and how can we incorporate intact skills into rehabilitative techniques? The reviewed research indicates that individuals with severe traumatic brain injury (a) generally perform similar to controls on cognitive tasks (or task components) that require automatic and implicit processes as opposed to consciously controlled processes; (b) can learn through implicit learning mechanisms; and (c) can acquire and use automatic processes in complex, cognitive task performance.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS047690, R01 NS047690-01, R01 NS047690-02, R01 NS47690-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER		ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Anderson SI, 1996, BRAIN INJURY, V10, P115, DOI 10.1080/026990596124601; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Berry D.C., 1993, IMPLICIT LEARNING TH; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1984, CLOSED HEAD INJURY P; *CDCP, INJ FACT BOOK 2001 2; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DUKE IW, 1992, HDB HEAD TRAUMA ACUT, P165; FAHY JF, 1995, J INT NEUROPSYCH SOC, V1, P183; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FINUF P, 1995, REPORTED TRAUMATIC B; FISK AD, 1987, HUMAN FACTORS PSYCHO, P159; GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GREENE RL, 1986, Q J EXP PSYCHOL-A, V38, P663, DOI 10.1080/14640748608401619; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JACOBY LL, 1993, J EXP PSYCHOL GEN, V122, P139, DOI 10.1037/0096-3445.122.2.139; Kapur N, 2004, NEUROPSYCHOL REHABIL, V14, P41, DOI 10.1080/09602010343000138; Kraus Jess F., 1994, P3; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LONG C, 1988, NEUROPSYCHOLOGICAL A; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; Miller E, 1970, Cortex, V6, P121; Mulligan NW, 1996, MEM COGNITION, V24, P453, DOI 10.3758/BF03200934; Mulligan NW, 1997, MEM COGNITION, V25, P11, DOI 10.3758/BF03197281; MUTTER SA, 1994, J CLIN EXP NEUROPSYC, V16, P271, DOI 10.1080/01688639408402638; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PAGE M, 2001, J INT NEUROPSYCH SOC, V7, P413; PAVAWALLA S, 2005, 33 ANN M INT NEUR SO; PERMA RB, 2000, J COGN REHABIL, P16; Riley GA, 2004, NEUROPSYCHOL REHABIL, V14, P257, DOI 10.1080/09602010343000057; Riley GA, 2000, NEUROPSYCHOL REHABIL, V10, P133, DOI 10.1080/096020100389219; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; Schmitter-Edgecombe M, 1999, MEM COGNITION, V27, P512, DOI 10.3758/BF03211545; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; Seger C. A., 1998, HDB IMPLICIT LEARNIN, P295; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Squires EJ, 1997, NEUROPSYCHOLOGIA, V35, P1103, DOI 10.1016/S0028-3932(97)00039-0; SRINIVAS K, 1990, J MEM LANG, V29, P389, DOI 10.1016/0749-596X(90)90063-6; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Vakil E, 1997, J Int Neuropsychol Soc, V3, P327; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; [No title captured]	73	15	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2006	21	2					131	141		10.1097/00001199-200603000-00006			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	031PK	WOS:000236716300005	16569987				2022-02-06	
J	Schaller, C; Kessler, M				Schaller, C; Kessler, M			On the difficulty of neurosurgical end of life decisions	JOURNAL OF MEDICAL ETHICS			English	Article							WITHDRAWAL	Objective: To analyse the process of end of life decisions in a neurosurgical environment. Methods: All 113 neurosurgical patients, who were subject to so called end of life decisions within a one year period were prospectively enrolled in a computerised data bank. Decision pathways according to patient and physician related parameters were assessed. Results: Leading primary diagnoses of the patients were traumatic brain injury and intracranial haemorrhage. Forty-five patients had undergone an emergency neurosurgical operation prior to end of life decision, N = 69 were conservatively treated, which included intracranial pressure recording, or they were not offered neurosurgical care because of futile prognosis. N = 111 died after a median of two ( zero to nine) days. Two, in whom the end of life decisions were revised, survived. Clear decisions to terminate further treatment were made by a senior staff member on call being informed by the senior resident on call (27.4%), difficult decisions on the basis of extensive round discussions (71.7%), and very difficult decision by an interdisciplinary ethical consult (0.9%). Decisions were further substantiated by electrophysiological examinations in N = 59. Conclusion: End of life decisions are to be considered standard situations for neurosurgeons. These decisions may reach a high rate of "positive'' prediction, if substantiated by electrophysiological examinations as well as on the grounds of clinical experience and respect for the assumed will of the patient. The fact that patients may survive following revision of an end of life decision underlines the necessity for repeated reassessment of these decisions. Ethical training for neurosurgeons is to be encouraged.	Univ Bonn, Med Ctr, Dept Neurosurg, D-53127 Bonn, Germany		Schaller, C (corresponding author), Univ Bonn, Med Ctr, Dept Neurosurg, Siegmund Freud Str 25, D-53127 Bonn, Germany.	carlo.schaller@ukb.uni-bonn.de					Agich GJ, 2000, CLEV CLIN J MED, V67, P392; Ashkan K, 2001, BRIT J NEUROSURG, V15, P342; BARLOW P, 1991, SCOT MED J, V36, P109, DOI 10.1177/003693309103600404; Christophis P, 2004, ZBL NEUROCHIR, V65, P25, DOI 10.1055/s-2004-44885; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Fitzpatrick MO, 1999, SCOT MED J, V44, P47, DOI 10.1177/003693309904400206; Kelly PJ, 2003, NEUROSURGERY, V52, P927, DOI 10.1227/01.NEU.0000053179.51319.D0; Levy MM, 2001, CRIT CARE MED, V29, pN56, DOI 10.1097/00003246-200102001-00011; Nyman DJ, 2000, INTENS CARE MED, V26, P1414, DOI 10.1007/s001340000641; Prendergast TJ, 2002, JAMA-J AM MED ASSOC, V288, P2732, DOI 10.1001/jama.288.21.2732; Sittisombut S, 2001, INT J EPIDEMIOL, V30, P896, DOI 10.1093/ije/30.4.896; Tschann JM, 2003, J AM GERIATR SOC, V51, P835, DOI 10.1046/j.1365-2389.2003.51266.x; Vincent JL, 2001, CRIT CARE MED, V29, pN52, DOI 10.1097/00003246-200102001-00010; ZENTNER J, 1994, NEUROL RES, V16, P89	15	15	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	FEB 1	2006	32	2					65	69		10.1136/jme.2005.011767			5	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	007XF	WOS:000235004000002	16446408	Green Published			2022-02-06	
J	Borlongan, CV; Fournier, C; Stahl, CE; Yu, GL; Xu, L; Matsukawa, N; Newman, M; Yasuhara, T; Hara, K; Hess, DC; Sanberg, PR				Borlongan, CV; Fournier, C; Stahl, CE; Yu, GL; Xu, L; Matsukawa, N; Newman, M; Yasuhara, T; Hara, K; Hess, DC; Sanberg, PR			Gene therapy, cell transplantation and stroke	FRONTIERS IN BIOSCIENCE-LANDMARK			English	Article						nervous system; neuron; cancer; tumor; neuroteratocarcinoma cells; NT2N; intracerebral transplantation; treatment; therapeutic; gene therapy; neuroprotection; stroke; review	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; EMBRYONAL CARCINOMA-CELLS; IN-VITRO CHARACTERIZATION; MARROW STROMAL CELLS; HUMAN NEURONAL CELLS; RAT PARKINSON MODEL; HUMAN NT2N NEURONS; HNT NEURONS; TYROSINE-HYDROXYLASE	The use of neuroteratocarcinoma cells for transplantation therapy in stroke has emerged as a strategy for cell replacement therapy that has begun its transition from basic science laboratories to a clinical setting. Procurement logistics and novel neuroprotective functions associated with these cells allow neuroteratocarcinoma cells to serve as efficacious alternatives to using fetal cells as donor cell grafts for stroke therapy, although the optimal transplantation regimen must still be determined. In particular, the limitations of current stroke treatments and management reveal an urgent need to examine the efficacy of experimental treatments, such as neural transplantation, in order to develop better treatment therapies. This chapter will discuss the characteristics of NT2N cells, the role of the host brain microenvironment, the need for more rigorous laboratory research and clinical trials for the intracerebral transplantation of NT2N cells in stroke, the mechanisms underlying the grafts' beneficial effects, and the need for immunosuppression. This chapter will highlight some of the most recent findings regarding NT2N cells.	Med Coll Georgia, Dept Neurol, Augusta, GA 30904 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30904 USA; Med Coll Georgia, Sch Grad Studies, Augusta, GA 30904 USA; Vet Adm Med Ctr, Res & Affiliat Serv Line, Augusta, GA 30912 USA; Dwight D Eisenhower Army Med Ctr, Dept Med, Ft Gordon, GA 30905 USA; Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Surg, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pharmacol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Psychol, Tampa, FL 33612 USA		Borlongan, CV (corresponding author), Med Coll Georgia, Dept Neurol, BI 3080,1120 15th St, Augusta, GA 30904 USA.	cborlongan@mail.mcg.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782			Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; Bjorklund A, 1992, Curr Opin Neurobiol, V2, P683, DOI 10.1016/0959-4388(92)90039-N; Borlongan CV, 2000, EXPERT OPIN INV DRUG, V9, P2319, DOI 10.1517/13543784.9.10.2319; Borlongan CV, 1998, NEUROREPORT, V9, P2837, DOI 10.1097/00001756-199808240-00028; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Borlongan CV, 1998, NEUROREPORT, V9, P3703, DOI 10.1097/00001756-199811160-00025; Borlongan CV, 1999, LANCET, V353, pSL29; Brundin P, 2001, NAT MED, V7, P512, DOI 10.1038/87796; Cao YJ, 2001, GENE THER, V8, P1357, DOI 10.1038/sj.gt.3301536; Carrol JE, 2000, NEUROREPORT, V11, pR1; Chang CF, 2002, NEUROPHARMACOLOGY, V43, P418, DOI 10.1016/S0028-3908(02)00092-8; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chiang YH, 1999, J CEREBR BLOOD F MET, V19, P1329, DOI 10.1097/00004647-199912000-00006; Christie SD, 2004, CAN J NEUROL SCI, V31, P87, DOI 10.1017/S0317167100002882; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Cordelier P, 2003, MOL THER, V7, P801, DOI 10.1016/S1525-0016(03)00093-5; EMERICH DF, 1992, NEUROSCI BIOBEHAV R, V16, P437, DOI 10.1016/S0149-7634(05)80185-X; Faiella A, 2000, HUM MOL GENET, V9, P227, DOI 10.1093/hmg/9.2.227; FAIELLA A, 1994, P NATL ACAD SCI USA, V91, P5335, DOI 10.1073/pnas.91.12.5335; FAULL RLM, 1995, ADV BEHAV BIOL, V43, P173; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED WJ, 1989, BRAIN RES, V485, P349, DOI 10.1016/0006-8993(89)90579-9; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; FREUND TF, 1985, J NEUROSCI, V5, P603; Gortz P, 2004, BRAIN RES, V1018, P18, DOI 10.1016/j.brainres.2004.05.076; HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Hoffer B, 1997, J NEURAL TRANSM-SUPP, P1; Huang DQ, 2004, J MOL NEUROSCI, V24, P323, DOI 10.1385/JMN:24:2:323; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Hurlbert MS, 1999, CELL TRANSPLANT, V8, P143, DOI 10.1177/096368979900800106; Iacovitti L, 1997, NEUROREPORT, V8, P1471, DOI 10.1097/00001756-199704140-00029; Isacson O, 2001, PARKINSONISM RELAT D, V7, P205, DOI 10.1016/S1353-8020(00)00059-6; Johnston RE, 2001, BRAIN RES, V900, P268, DOI 10.1016/S0006-8993(01)02327-7; KAWAJA MD, 1991, J COMP NEUROL, V307, P695, DOI 10.1002/cne.903070414; KLEPPNER SR, 1995, J COMP NEUROL, V357, P618, DOI 10.1002/cne.903570410; Kofler P, 1998, CELL TRANSPLANT, V7, P175, DOI 10.1016/S0963-6897(97)00162-0; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kordower J H, 2000, Prog Brain Res, V127, P333; LEE VMY, 1986, J NEUROSCI, V6, P514; Lee VMY, 2000, PROG BRAIN RES, V128, P299; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Lin S.Z., 1999, SOC NEUR ABSTR, V25, P1344; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; MAHALIK TJ, 1994, EXP NEUROL, V129, P27, DOI 10.1006/exnr.1994.1144; MAHALIK TJ, 1985, J COMP NEUROL, V240, P60, DOI 10.1002/cne.902400105; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Matsuoka T, 1997, BIOCHEM BIOPH RES CO, V237, P719, DOI 10.1006/bbrc.1997.7087; Meltzer CC, 2001, NEUROSURGERY, V49, P586, DOI 10.1097/00006123-200109000-00011; Misiuta IE, 2003, DEV BRAIN RES, V145, P107, DOI 10.1016/S0165-3806(03)00221-9; MIYAZONO M, 1995, LAB INVEST, V73, P273; Miyazono M, 1996, J COMP NEUROL, V376, P603, DOI 10.1002/(SICI)1096-9861(19961223)376:4<603::AID-CNE8>3.0.CO;2-5; Mukhtar M, 2000, HUM GENE THER, V11, P347, DOI 10.1089/10430340050016076; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; NIKKHAH G, 1994, J NEUROSCI, V14, P3449; NIKKHAH G, 1994, BRAIN RES, V633, P133, DOI 10.1016/0006-8993(94)91532-6; NISHINO H, 1990, NEUROSCI RES, pS54, DOI 10.1016/0921-8696(90)90031-W; Nishino H, 2000, Prog Brain Res, V127, P461; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; SAPORTA S, 2002, J NEUROSURG, P9763; Sarnacki PG, 1998, EXP NEUROL, V153, P386; Schinstine M., 1996, Society for Neuroscience Abstracts, V22, P1959; Schmeisser F, 2002, HUM GENE THER, V13, P2113, DOI 10.1089/104303402320987815; SCHUELER SB, 1993, J NEUROSCI, V13, P4496; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tomac AC, 2000, NEUROSCIENCE, V95, P1011; Tornatore C, 1996, CELL TRANSPLANT, V5, P145, DOI 10.1016/0963-6897(95)02041-1; TROJANOWSKI JQ, 1993, EXP NEUROL, V122, P283, DOI 10.1006/exnr.1993.1128; Trojanowski JQ, 1997, EXP NEUROL, V144, P92, DOI 10.1006/exnr.1996.6393; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Willing AE, 2002, EUR J NEUROSCI, V16, P2271, DOI 10.1046/j.1460-9568.2002.02300.x; ZETTERSTROM RH, 1994, NEUROSCIENCE, V62, P899, DOI 10.1016/0306-4522(94)90482-0; Zigova T, 1999, EXP NEUROL, V157, P251, DOI 10.1006/exnr.1999.7054; Zigova T, 2000, DEV BRAIN RES, V122, P87, DOI 10.1016/S0165-3806(00)00055-9; Zivin JA, 2000, NEUROLOGY, V55, P467, DOI 10.1212/WNL.55.4.467	79	15	16	0	1	FRONTIERS IN BIOSCIENCE INC	IRVINE	16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA	1093-9946	1093-4715		FRONT BIOSCI-LANDMRK	Front. Biosci.	JAN 1	2006	11						1090	U46		10.2741/1865			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973MX	WOS:000232528000091	16146799				2022-02-06	
J	Champagne-Lavau, M; Stip, E; Joanette, Y				Champagne-Lavau, Maud; Stip, Emmanuel; Joanette, Yves			Social Cognition Deficit in Schizophrenia: Accounting for Pragmatic Deficits in Communication Abilities?	CURRENT PSYCHIATRY REVIEWS			English	Article						Social cognition; non-literal language; theory of mind; context; executive function; schizophrenia	MIND DEFICIT; EXECUTIVE FUNCTIONS; NEGATIVE SYMPTOMS; THOUGHT-DISORDER; PEOPLE; LANGUAGE; SYMPTOMATOLOGY; COMPREHENSION; CONTEXT; IRONY	Schizophrenic individuals show impairments in language affecting what is referred to as the pragmatic component of language, typically the processing of non-literal language (e.g., irony, metaphor, indirect request). Such non-literal utterances require the ability to process the speaker's utterance beyond its literal meaning in order to allow one to grasp the speaker's intention by reference to the contextual information. This paper gives a selective literature review showing that different cognitive processes-specific to language or not-may underlie the processing of pragmatic aspects of language, and particularly of non-literal language in schizophrenia. Indeed, the fact that many other disorders (e.g., right hemisphere lesion, traumatic brain injury, autism) are characterized by pragmatic impairments may reflect a heterogeneous range of underlying functional deficits that have to be determined. Evidence is reviewed suggesting that cooccurrence of a deficit in non-literal language understanding and a deficit in theory of mind may be accounted for by an impairment in context processing associated with a lack of flexibility.	[Champagne-Lavau, Maud] Hop Sacre Coeur, 6555 Boul Gouin Ouest, Montreal, PQ H4K 1B3, Canada; [Stip, Emmanuel] Hop Louis H Lafontaine, Ctr Rech Fernand Seguin, Montreal, PQ, Canada; [Joanette, Yves] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Champagne-Lavau, Maud; Stip, Emmanuel; Joanette, Yves] Univ Montreal, Fac Med, Montreal, PQ, Canada		Champagne-Lavau, M (corresponding author), Hop Sacre Coeur, 6555 Boul Gouin Ouest, Montreal, PQ H4K 1B3, Canada.	M-Champagne@crhsc.rtss.qc.ca	Champagne-Lavau, Maud/F-9334-2010	Champagne-Lavau, Maud/0000-0003-4659-6957; Joanette, Yves/0000-0001-9212-1827	Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MT15006]	Preparation of this review was made possible with the support of the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research to MC (postdoctoral fellowship), the chair of schizophrenia to ES, and the Canadian Institutes of Health Research (Grant # MT15006) to YJ.	Abu-Akel A, 2003, BRAIN RES REV, V43, P29, DOI 10.1016/S0165-0173(03)00190-5; ANAND A, 1994, J NERV MENT DIS, V182, P488, DOI 10.1097/00005053-199409000-00002; ANDREASEN NC, 1979, ARCH GEN PSYCHIAT, V36, P1325; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P943; Austin JL., 1962, DO THINGS WORDS, V2; Bara BG, 2000, BRAIN COGNITION, V43, P21; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Besche C, 1996, CAN J PSYCHIAT, V41, P587, DOI 10.1177/070674379604100908; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Champagne M, 2003, BRAIN COGNITION, V53, P152, DOI 10.1016/S0278-2626(03)00099-X; CHAPMAN LJ, 1960, J ABNORM SOC PSYCH, V60, P412, DOI 10.1037/h0043371; CLARK HH, 1979, COGNITIVE PSYCHOL, V11, P430, DOI 10.1016/0010-0285(79)90020-3; CLARK HH, 1975, J VERB LEARN VERB BE, V14, P56, DOI 10.1016/S0022-5371(75)80006-5; Colston HL, 2002, METAPHOR SYMBOL, V17, P57, DOI 10.1207/S15327868MS1701_5; Coltheart M, 2001, COGNITIVE NEUROPSYCH, V6, P81, DOI DOI 10.1080/13546800042000061; Corcoran R, 1997, SCHIZOPHR RES, V24, P319, DOI 10.1016/S0920-9964(96)00117-X; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; CUTTING J, 1990, BRAIN LANG, V39, P459, DOI 10.1016/0093-934X(90)90151-6; deBonis M, 1997, PSYCHOPATHOLOGY, V30, P149, DOI 10.1159/000285041; DONE DJ, 1984, BRAIN LANG, V23, P318, DOI 10.1016/0093-934X(84)90071-3; Donohoe G, 2003, NEUROCASE, V9, P97, DOI 10.1076/neur.9.2.97.15075; Doody GA, 1998, PSYCHOL MED, V28, P397, DOI 10.1017/S003329179700648X; Drury VM, 1998, PSYCHOL MED, V28, P1101, DOI 10.1017/S0033291798006850; EALES MJ, 1993, J AUTISM DEV DISORD, V23, P593, DOI 10.1007/BF01046104; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Frith C.D., 1992, COGN NEUROPSYCHOL; Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Frith R C, 1996, Cogn Neuropsychiatry, V1, P305, DOI 10.1080/135468096396460; Frye D, 1996, DEV PSYCHOL, V32, P120, DOI 10.1037/0012-1649.32.1.120; GIBBS R, 1982, TEXT, V2, P9; Gibbs R., 1994, POETICS MIND; GIBBS RW, 1995, PSYCHOL BULL, V118, P133, DOI 10.1037/0033-2909.118.1.133; GIBBS RW, 1986, ACTA PSYCHOL, V62, P41, DOI 10.1016/0001-6918(86)90004-1; Giora R, 2002, J PRAGMATICS, V34, P487, DOI 10.1016/S0378-2166(01)00045-5; GRICE HP, 1969, PHILOS REV, V78, P147, DOI 10.2307/2184179; GRICE HP, 1975, SYNTAX SEMANTICS, V3, P374; Happe F, 2002, MIND LANG, V17, P24, DOI 10.1111/1468-0017.00187; Hardy-Bayle MC, 2002, EVOL PSYCHIATR, V67, P83; Herold R, 2002, PSYCHOL MED, V32, P1125, DOI 10.1017/S0033291702005433; Ivanko SL, 2003, DISCOURSE PROCESS, V35, P241, DOI 10.1207/S15326950DP3503_2; Janssen I, 2003, ACTA PSYCHIAT SCAND, V108, P110, DOI 10.1034/j.1600-0447.2003.00092.x; Kington JM, 2000, J PSYCHIAT RES, V34, P341, DOI 10.1016/S0022-3956(00)00029-7; Kuperberg GR, 2000, PSYCHOL MED, V30, P345, DOI 10.1017/S0033291700001744; Kuperberg GR, 1998, J ABNORM PSYCHOL, V107, P423, DOI 10.1037/0021-843X.107.3.423; Langdon R, 2004, PSYCHIAT RES, V125, P9, DOI 10.1016/j.psychres.2003.10.005; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; Lee KH, 2004, PSYCHOL MED, V34, P391, DOI 10.1017/S0033291703001284; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; Mitchley N.J., 1998, COGNITIVE NEUROPSYCH, V3, P127, DOI [10.1080/135468098396206, DOI 10.1080/135468098396206]; Monetta L, 2004, REEDUCATION ORTHOPHO, V42, P27; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Pantelis C, 1997, BRAIN, V120, P1823, DOI 10.1093/brain/120.10.1823; Perner J, 1999, DEVELOPING THEORIES OF INTENTION, P133; Pickup GJ, 2001, PSYCHOL MED, V31, P207, DOI 10.1017/S0033291701003385; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Roncone R, 2004, NEUROPSYCHOL REHABIL, V14, P421, DOI 10.1080/09602010343000291; Russell J., 1995, BODY SELF, P127; Russell J., 1996, AGENCY ITS ROLE MENT; Russell J., 1997, AUTISM EXECUTIVE DIS, P256; Sarfati Y, 1999, SCHIZOPHR RES, V37, P183, DOI 10.1016/S0920-9964(98)00154-6; Sarfati Y, 1997, SCHIZOPHR RES, V25, P199, DOI 10.1016/S0920-9964(97)00025-X; Sarfati Y, 1999, PSYCHOL MED, V29, P613, DOI 10.1017/S0033291799008326; Sarfati Y, 2000, CAN J PSYCHIAT, V45, P363, DOI 10.1177/070674370004500405; Searle John R., 1969, SPEECH ACTS ESSAY PH; Semkovska M, 2001, ENCEPHALE, V27, P405; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; SPITZER M, 1993, EUR ARCH PSY CLIN N, V243, P57, DOI 10.1007/BF02191566; Sponheim SR, 2003, SCHIZOPHR RES, V65, P117, DOI 10.1016/S0920-9964(02)00525-X; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tenyi T, 2002, PSYCHOPATHOLOGY, V35, P25, DOI 10.1159/000056212; Titone D, 2000, J ABNORM PSYCHOL, V109, P761, DOI 10.1037/0021-843X.109.4.761; Titone D, 2002, J ABNORM PSYCHOL, V111, P313, DOI 10.1037//0021-843X.111.2.313; Velakoulis D, 1996, AUST NZ J PSYCHIAT, V30, P195, DOI 10.3109/00048679609076095; Wilson D., 1986, RELEVANCE COMMUNICAT; Winner Ellen, 1993, METAPHOR THOUGHT, P425, DOI [10.1017/CBO9781139173865.021, DOI 10.1017/CBO9781139173865.021]	81	15	15	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-4005	1875-6441		CURR PSYCHIATRY REV	Curr. Psychiatry Rev.		2006	2	3					309	315		10.2174/157340006778018184			7	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	VA9YO	WOS:000411477400002					2022-02-06	
J	Johnstone, B; Reid-Arndt, S; Franklin, KL; Harper, J				Johnstone, Brick; Reid-Arndt, Stephanie; Franklin, Kelly Lora; Harper, John			Vocational outcomes of state vocational rehabilitation clients with traumatic brain injury: A review of the Missouri Model Brain Injury System Studies	NEUROREHABILITATION			English	Article; Proceedings Paper	1st International Conference on Vocational Outcomes in Traumatic Brain Injury	APR 14-16, 2005	Vancouver, CANADA			traumatic brain injury; state vocational rehabilitation; rehabilitation	COMMUNITY INTEGRATION; GENDER-DIFFERENCES; HEAD-INJURY; EMPLOYMENT; WORK; PREDICTORS; SAMPLE; IMPACT; RETURN	Although there is considerable research on the vocational outcomes of individuals with traumatic brain injuries (TBI), there has been minimal research on the characteristics of persons with TBI who seek services from state vocational rehabilitation services. Such research is deemed critical given the significant number of individuals who request such services, as well as the significant federal and state costs associated with these programs. The current article reviews a series of studies completed collaboratively between the University of Missouri-Columbia and Missouri Division of Vocational Rehabilitation (DVR). Information is reported regarding the typical demographic, injury severity, and neuropsychological characteristics of DVR clients with TBI, as well as the most common DVR services provided to them and their vocational outcomes (i. e., successful, unsuccessful). Studies are reviewed which indicate that the provision of specific DVR services predict successful vocational outcomes, although traditional medical and neuropsychological variables do not. Additional studies are reviewed which examine the impact of gender, race, age, geographic location (i. e., rural vs. urban), and concomitant disabilities on vocational outcomes. Results indicate the importance of considering environmental and social factors when providing vocational rehabilitation services to clients with TBI, and that specific DVR services can lead to successful vocational outcomes regardless of TBI severity. Implications for future clinical services and research are presented.	Univ Missouri, Dept Hlth Psychol, Sch Hlth Profess, Columbia, MO 65212 USA		Johnstone, B (corresponding author), Univ Missouri, Dept Hlth Psychol, Sch Hlth Profess, DC116-88,1 Hosp Dr, Columbia, MO 65212 USA.	johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980008] Funding Source: Medline		Bogan AM, 1997, BRAIN INJURY, V11, P431; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; *BUR CENS, 1995, CURR POP SURV; Burnett DM, 2000, BRAIN INJURY, V14, P713; Cook J. A., 2003, J VOCATIONAL REHABIL, V18, P25; CUMMINGS RW, 1987, EXCEPT CHILDREN, V54, P167, DOI 10.1177/001440298705400210; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HARING KA, 1990, J LEARN DISABIL, V23, P108, DOI 10.1177/002221949002300206; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Johnstone B, 2003, BRAIN INJURY, V17, P95, DOI 10.1080/0269905021000010212; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; JOHNSTONE B, IN PRESS J VOCATIONA; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kaye H. S., 1998, VOCATIONAL REHABILIT; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lewis DR, 2003, J INTELLECT DEV DIS, V28, P24, DOI 10.1080/1366825031000086876; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Mitrushina MN, 1999, HDB NORMATIVE DATA N; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Partridge T M, 1996, Work, V7, P63, DOI 10.3233/WOR-1996-7108; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; ROESSLER RT, 1992, J REHABIL, P17; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; *RUR POL RES I, 1999, METR NONM COUNTR DEF; SCHOOTMAN M, 1999, BRAIN INJURY; SCUCCIMARRA DJ, 1990, J LEARN DISABIL, V23, P213, DOI 10.1177/002221949002300403; Skeel RL, 2003, REHABIL PSYCHOL, V48, P145, DOI 10.1037/0090-5550.48.3.145; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *USDA, RSA PROGR DAT STAT; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Zasler ND, 1997, J HEAD TRAUMA REHAB, V12, P42, DOI 10.1097/00001199-199710000-00005; [No title captured]	45	15	15	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2006	21	4					335	347					13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	145VU	WOS:000244894700008	17361050				2022-02-06	
J	Winkens, I; Van Heugten, CM; Fasotti, L; Duits, AA; Wade, DT				Winkens, Ieke; Van Heugten, Caroline M.; Fasotti, Luciano; Duits, Annelien A.; Wade, Derick T.			Manifestations of mental slowness in the daily life of patients with stroke: a qualitative study	CLINICAL REHABILITATION			English	Article							CLOSED-HEAD INJURY; COGNITIVE IMPAIRMENT; PROCESSING-SPEED; FLEXIBILITY; ATTENTION	Objective: To explore the consequences of mental slowness in the daily life of patients with stroke. Design: In a cross-sectional survey semi-structured interviews were completed. Interviews were transcribed and coded by two independent reviewers. Qualitative analysis was done by means of the 'constant comparison method'. Setting: Three rehabilitation centres in the Netherlands. Participants: A convenience sample of 13 patients with stroke, suffering from mental slowness, was derived from December 2003 to May 2004. Main outcome measures: Interview descriptions of the everyday consequences of mental slowness. Results: Patients experienced many problems in daily life due to mental slowness. These could be divided into two main groups: (1) problems in cognitive functioning; (2) psychological and somatic complaints. In response to these problems, some patients mentioned the use of compensation strategies in order to reduce the demands on their information processing capacity. Conclusions: Mental slowness in cognitive functioning affects a wide range of activities, causing emotional symptoms in many patients and stimulating the spontaneous use of compensation strategies in some patients.	Inst Rehabil Res, IRv, NL-6430 AD Hoensbroek, Netherlands; St Maartensklin Res, Nijmegen, Netherlands; Acad Hosp Maastricht, Dept Med Psychol, Maastricht, Netherlands		Winkens, I (corresponding author), Inst Rehabil Res, IRv, POB 192, NL-6430 AD Hoensbroek, Netherlands.	i.winkens@irv.nl		Wade, Derick/0000-0002-1188-8442			Anderson J. R., 1993, RULES MIND; Anderson JR., 1976, LANGUAGE MEMORY THOU; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Gerritsen MJJ, 2003, J CLIN EXP NEUROPSYC, V25, P1, DOI 10.1076/jcen.25.1.1.13622; Glaser B., 1967, DISCOVERY GROUNDED T; Hochstenbach J, 1998, J CLIN EXP NEUROPSYC, V20, P503, DOI 10.1076/jcen.20.4.503.1471; HOCHSTENBACH J, 1999, THESIS CATHOLIC U NI; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; MUHR T, 1998, ATLAS TI KNOWLEDGE W; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; Rasquin SMC, 2002, J NEUROL SCI, V203, P115, DOI 10.1016/S0022-510X(02)00264-2; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SPIKMAN JM, 1996, J CLIN EXP NEUROPSYC, V37, P467; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; *TRANSM ZORGM CVA, 1996, MOD VERB KWAL ZORG C; VANZOMEREN AH, 1987, NEUROBEHAVIORAL RECO; VANZOMEREN AH, 2003, NIET AANGEBOREN HERS; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Visser-Keizer AC, 2002, J CLIN EXP NEUROPSYC, V24, P1032, DOI 10.1076/jcen.24.8.1032.8383; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	23	15	15	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.		2006	20	9					827	834		10.1177/0269215506070813			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	101IL	WOS:000241734400008	17005506				2022-02-06	
S	Wong, SBC; Chapman, SB; Cook, LG; Anand, R; Gamino, JF; Devous, MD		Moller, AR		Wong, Stephanie B. Chiu; Chapman, Sandra B.; Cook, Lori G.; Anand, Raksha; Gamino, Jacquelyn F.; Devous, Michael D., Sr.			A SPECT study of language and brain reorganization three years after pediatric brain injury	REPROGRAMMING THE BRAIN	PROGRESS IN BRAIN RESEARCH		English	Article; Proceedings Paper	Symposium on Reprogramming the Human Brain	APR 07-08, 2005	Univ Texas Dallas, Richardson, TX		Univ Texas Dallas	children; plasticity; recovery; language; SPECT; functional brain imaging; cognition; brain injury	CLOSED-HEAD INJURY; DEFICIT HYPERACTIVITY DISORDER; TECHNETIUM-99M-HMPAO SPECT; CHILDREN; DISCOURSE; MILD; MRI; ADOLESCENTS; ATTENTION; TOMOGRAPHY	Using single photon emission computed tomography (SPECT), we investigated brain plasticity in children 3 years after sustaining a severe traumatic brain injury (TBI). First, we assessed brain perfusion patterns (i.e., the extent of brain blood flow to regions of the brain) at rest in eight children who suffered severe TBI as compared to perfusion patterns in eight normally developing children. Second, we examined differences in perfusion between children with severe TBI who showed good versus poor recovery in complex discourse skills. Specifically, the children were asked to produce and abstract core meaning for two stories in the form of a lesson. Inconsistent with our predictions, children with severe TBI showed areas of increased perfusion as compared to normally developing controls. Adult studies have shown the reverse pattern with TBI associated with reduced perfusion. With regard to the second aim and consistent with previously identified brain-discourse relations, we found a strong positive association between perfusion in right frontal regions and discourse abstraction abilities, with higher perfusion linked to better discourse outcomes and lower perfusion linked to poorer discourse outcomes. Furthermore, brain-discourse patterns of increased perfusion in left frontal regions were associated with lower discourse abstraction ability. The results are discussed in terms of how brain changes may represent adaptive and maladaptive plasticity. The findings offer direction for future studies of brain plasticity in response to neurocognitive treatments.	Univ Texas, Ctr Brain Hlth, Dallas, TX 75235 USA; Univ Texas, Inst Biomed Sci & Technol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Nucl Med Ctr, Dallas, TX USA		Chapman, SB (corresponding author), Univ Texas, Ctr Brain Hlth, Dallas, TX 75235 USA.	schapman@utdallas.edu					ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Bigler ED, 1996, J LEARN DISABIL-US, V29, P515, DOI 10.1177/002221949602900507; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2005, ALZ DIS ASSOC DIS, V19, P202, DOI 10.1097/01.wad.0000189050.41064.03; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2003, PEDIATR NEUROL, V29, P34, DOI 10.1016/S0887-8994(03)00012-2; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; CHAPMAN SB, 1999, BRAIN DAM B, P235; CHAPMAN SB, 2001, ANN AM ASS ADV SCI M; Christensen J.R., 2001, CHILDREN TRAUMATIC B; Chugani HT, 1996, BRAIN DEV-JPN, V18, P347, DOI 10.1016/0387-7604(96)00032-0; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; CHUGANI HT, 1991, J CEREBR BLOOD F MET, V11, P35, DOI 10.1038/jcbfm.1991.4; COOK LG, 2006, IN PRESS COGNITIVE B; Dapretto M, 2005, NEUROREPORT, V16, P1661, DOI 10.1097/01.wnr.0000183332.28865.11; DELIS DC, 1990, ADV PSYCHOL ASSESS, P101; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Goldstone BP, 2001, READ TEACH, V55, P362; Graham D.I., 1996, NEUROTRAUMA, P43; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Gullion CM, 1996, BIOL PSYCHIAT, V40, P1106, DOI 10.1016/S0006-3223(95)00636-2; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JOHNSON NS, 1983, CHILDRENS LANGUAGE, P314; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; Kilgard MP, 2002, BIOL CYBERN, V87, P333, DOI 10.1007/s00422-002-0352-z; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; Langlois JA, 2001, TRAUMATIC BRAIN INJU; LEVIN HS, 1993, J CLIN EXP NEUROPSYC, V15, P21; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Montes LGA, 2005, SALUD MENT, V28, P1; Moses P, 2002, NEUROIMAGE, V16, P415, DOI 10.1006/nimg.2002.1064; Nichelli P, 1995, NEUROREPORT, V6, P2309, DOI 10.1097/00001756-199511270-00010; POSTMAN WA, 2006, CUNY SENT PROC C NEW; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; Robertson DA, 2000, PSYCHOL SCI, V11, P255, DOI 10.1111/1467-9280.00251; Schulz KP, 2004, AM J PSYCHIAT, V161, P1650, DOI 10.1176/appi.ajp.161.9.1650; STEIN BL, 1992, J READING BEHAV, V24, P217, DOI 10.1080/10862969209547773; Talairach J., 1988, COPLANAR STEREOTAXIC; TURKINGTON TG, 1993, J NUCL MED, V34, P1587; Umile EM, 1998, BRAIN INJURY, V12, P577; Yorkston KM, 1997, ARCH PHYS MED REHAB, V78, P1096, DOI 10.1016/S0003-9993(97)90134-9	60	15	15	12	19	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0079-6123		978-0-444-51602-2	PROG BRAIN RES			2006	157						173	+		10.1016/S0079-6123(06)57011-6			15	Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	BGH62	WOS:000247002900011	17167907				2022-02-06	
J	Kumar, A; Schmidt, EA; Hiler, M; Smielewski, P; Pickard, JD; Czosnyka, M				Kumar, A; Schmidt, EA; Hiler, M; Smielewski, P; Pickard, JD; Czosnyka, M			Asymmetry of critical closing pressure following head injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CEREBRAL-CIRCULATION; TRANSCRANIAL DOPPLER; AUTOREGULATION; HEMODYNAMICS; TONE	Objective: Critical closing pressure (CCP) is the arterial pressure below which the vessels collapse. Hypothetically it is the sum of intracranial pressure (ICP) and vessel wall tension in the cerebral circulation. This study investigated transhemispherical asymmetry of CCP by studying its correlation with radiological findings on computed tomography (CT) scans in head injury patients. Method: ICP, arterial blood pressure, and middle cerebral artery blood flow velocity were recorded daily in 119 ventilated patients. Waveforms were processed to calculate CCP. CT scans were analysed according to a system based on the Marshall classification. Results: Left-right differences in CCP correlated with midline shift on the CT scan (r = 0.48; p < 0.02). Asymmetry of CCP also corresponded with the side of the head lesion (p < 0.007) and the side of the craniotomy where it was performed (p < 0.006). Absolute CCP weakly correlated with brain swelling (r = -0.23; p < 0.03) and arterial pressure (r = 0.21; p < 0.02) but did not correlate with ICP. Cerebral perfusion pressure calculated as the difference between mean arterial pressure and CCP did not correlate with outcome, but ''traditional'' cerebral perfusion pressure (mean arterial pressure minus intracranial pressure) did. Conclusions: Critical closing pressure is disturbed by localised brain lesions. Its asymmetry corresponds to asymmetrical findings on CT scans. CCP seems to describe vascular resistance better than ICP.	Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Sch Clin, Addenbrookes Hosp, Cambridge, England		Czosnyka, M (corresponding author), Addenbrookes Hosp, Acad Neurosurg Unit, Hills Rd,Box 167, Cambridge CB2 2QQ, England.	mc141@medschl.cam.ac.uk		Smielewski, Peter/0000-0001-5096-3938	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Aaslid R, 1992, TRANSCRANIAL DOPPLER, P49; BURTON AC, 1951, AM J PHYSIOL, V164, P319, DOI 10.1152/ajplegacy.1951.164.2.319; Carey BJ, 2001, CLIN SCI, V101, P351, DOI 10.1042/CS20010021; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Gooskens I, 2003, ACTA NEUROCHIR, V145, P527, DOI 10.1007/s00701-003-0045-y; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Schmidt EA, 2003, J NEUROIMAGING, V13, P248, DOI 10.1177/1051228403013003008; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Soehle M, 2004, STROKE, V35, P1393, DOI 10.1161/01.STR.0000128411.07036.a9; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002	15	15	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2005	76	11					1570	1573		10.1136/jnnp.2004.059493			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	974HF	WOS:000232581400025	16227554	Bronze, Green Published			2022-02-06	
J	Gahm, C; Holmin, S; Rudehill, S; Mathiesen, T				Gahm, C; Holmin, S; Rudehill, S; Mathiesen, T			Neuronal degeneration and iNOS expression in experimental brain contusion following treatment with colchicine, dexamethasone, tirilazad mesylate and nimodipine	ACTA NEUROCHIRURGICA			English	Article						brain injury; colchicine; dexamethasone; iNOS; neuronal degeneration; nimodipine; tirilazad mesylate	NITRIC-OXIDE SYNTHASE; EXPERIMENTAL HEAD-INJURY; SMOOTH-MUSCLE-CELLS; SUBARACHNOID HEMORRHAGE; CORTICAL INJURY; RAT; APOPTOSIS; TRAUMA; NEUROPROTECTION; CYTOKINE	Background. The pathophysiological mechanisms of secondary neurological injury after traumatic brain injury are complex. Posttraumatic biochemical reactions include parenchymal inflammation, free radical production, increased intracellular calcium and lipid peroxidation and nitric oxide production. The relative importance of each mechanism is unknown in brain contusions. This study was undertaken to investigate protection by the neuroprotective and/or anti-inflammatory drugs that have different putative mechanisms of action: colchicine, dexamethasone, tirilazad mesylate and nimodipine. Method. A brain contusion was produced using a weight-drop model in rats. The animals were treated with either one of the drugs at previously defined relevant dosage or control. Fluoro-Jade labelling, TUNEL-staining and immunohisto-chemistry were used to study neuronal degeneration, cellular apoptosis and iNOS expression. In addition, the number of surviving neurons after 14 days was determined. Findings. The number of degenerating neurons was significantly reduced in all treatment groups at 24 hours while the total number of apoptotic cells including inflammatory cells and glia was unchanged. iNOS-expression was reduced in all treatment groups at 24 hours but not later. Only colchicine and tirilazad mesylate significantly enhanced neuronal survival at 14 days after injury. Conclusions. The findings underscored that an early neuroprotective effect does not necessarily lead to increased long-term neuronal survival. The absence of a significant long-term effect with nimodipine and dexamethasone agrees with clinical studies. Colchicine with an anti-macrophage/anti-inflammatory activity and the free radical scavenger tirilazad mesylate were effective for amelioration of experimental contusion with moderate energy transfer. Early neuroprotection may to some extent target iNOS via different pathways since all tested drugs affected both iNOS expression and neuronal degeneration.	Karolinska Univ Hosp, Neurosurg Sect, Dept Clin Neurosci, Karolinska Inst, S-17176 Stockholm, Sweden		Gahm, C (corresponding author), Karolinska Univ Hosp, Neurosurg Sect, Dept Clin Neurosci, Karolinska Inst, S-17176 Stockholm, Sweden.	caroline.gahm@karolinska.se	mathiesen, tiit/ABC-3627-2021	Holmin, Staffan/0000-0002-1628-1615; Mathiesen, Tiit/0000-0001-9463-1919			ALDERSON P, 2000, COCHRANE DATABASE SY, V25; Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Cattaruzza M, 2000, BRIT J PHARMACOL, V129, P1155, DOI 10.1038/sj.bjp.0703192; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Conti AC, 1998, J NEUROSCI, V18, P5663; Dimlich R V, 1990, Adv Neurol, V52, P365; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Ganster RW, 2000, NITRIC OXIDE BIOL PA, P129; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1988, EXP NEUROL, V99, P594, DOI 10.1016/0014-4886(88)90176-8; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Haynes LE, 2001, NEUROSCIENCE, V104, P57, DOI 10.1016/S0306-4522(01)00070-7; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hortobagyi T, 2000, PFLUG ARCH EUR J PHY, V441, P409, DOI 10.1007/s004240000441; HUBSCHMANN OR, 1985, J NEUROSURG, V62, P698, DOI 10.3171/jns.1985.62.5.0698; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Kavanagh RJ, 2001, BRIT J ANAESTH, V86, P110, DOI 10.1093/bja/86.1.110; Langham J., 2000, COCHRANE DATABASE SY; LIPTON SA, 2003, NATURE, V12, P626; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MALAWISTA SE, 1968, ARTHRITIS RHEUM-US, V11, P191, DOI 10.1002/art.1780110210; Marczin N, 1996, BRIT J PHARMACOL, V118, P1085, DOI 10.1111/j.1476-5381.1996.tb15510.x; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; MAYER B, 1989, BIOCHEM BIOPH RES CO, V164, P678, DOI 10.1016/0006-291X(89)91513-1; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MINCGOLOMB D, 1994, BRIT J PHARMACOL, V112, P720, DOI 10.1111/j.1476-5381.1994.tb13136.x; Mitchell IJ, 1998, NEUROSCIENCE, V84, P489, DOI 10.1016/S0306-4522(97)00534-4; MOLAD Y, 2002, CURR RHEUMATOL REP, V42, P52; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RINK A, 1995, AM J PATHOL, V147, P1575; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Salahudeen A, 1996, TRANSPLANTATION, V62, P1628, DOI 10.1097/00007890-199612150-00017; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; TEASDALE G, 1990, ACT NEUR S, V51, P315; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; YUI Y, 1991, J BIOL CHEM, V266, P12544; Zhu DY, 1999, LIFE SCI, V65, pPL221	66	15	16	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2005	147	10					1071	1084		10.1007/s00701-005-0590-7			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	966XH	WOS:000232055600018	16044358				2022-02-06	
J	Karabiyikoglu, M; Keep, R; Hua, Y; Xi, GH				Karabiyikoglu, M; Keep, R; Hua, Y; Xi, GH			Acute subdural hematoma: New model delineation and effects of coagulation inhibitors	NEUROSURGERY			English	Article						ischemia; rat; subdural hematoma; thrombin; thrombosis	CEREBRAL-BLOOD-FLOW; PLATELET-ACTIVATING-FACTOR; TRAUMATIC BRAIN-INJURY; ISCHEMIC DAMAGE; INTRACEREBRAL HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; RAT; THROMBIN; NEUROPROTECTION; ARGATROBAN	OBJECTIVE: To develop a highly reproducible rat model and behavioral tests for acute subdural hematoma (ASDH) and to investigate the role of intravascular coagulation and thrombin in the pathogenesis of brain injury in this model. METHODS: A new method was implemented to inject 200 mu l of autologous blood subdurally in rats. Immunohistochemistry was used to investigate intravascular fibrin deposition and thrombin levels in the cortex underlying the ASDH. Effectiveness of systemic heparin, argatroban, or ginkgolide B treatment was determined by histological lesion volume, number of occluded microvessels, and neurological deficits. Neurological deficits were monitored for 7 days after ASDH by use of forelimb placing, forelimb use asymmetry, and corner turn tests. RESULTS: Consistent brain damage and sensorimotor deficits were observed in all animals with ASDH. Histological analysis demonstrated occluded microvessels and enlarged perivascular spaces in the underlying cortex starting 1 hour after hematoma induction. Fibrin and thrombin immunoreactivity were increased in the lesioned cortical parenchyma at 4 and 24 hours. However, no intravascular fibrin deposition was detected. Heparin induced hemorrhagic transformation in the cortical lesion and did not attenuate microvessel occlusion. Argatroban and ginkgolide B did not induce hemorrhage but failed to improve microvessel occlusion, lesion volume, and neurological deficits. CONCLUSION: Intravascular coagulation and thrombin are not the major mediators of brain damage after ASDH. The model and behavioral tests presented in this study can be used to investigate other putative mechanisms of injury and to test future therapeutic interventions in ASDH.	Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA		Karabiyikoglu, M (corresponding author), Univ Michigan, Dept Neurosurg, 5550 Kresge 1, Ann Arbor, MI 48109 USA.	karabiyikoglu@yahoo.com	Karabiyikoglu, Murat/AAB-9443-2021	Keep, Richard/0000-0001-6441-5334	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039866] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-39866] Funding Source: Medline		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Berry CN, 2000, THROMB HAEMOSTASIS, V84, P278; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Daneyemez M, 1999, NEUROSCIENCE, V92, P783, DOI 10.1016/S0306-4522(99)00035-4; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Donovan FM, 1997, J NEUROSCI, V17, P5316; FUJISAWA H, 1994, ACT NEUR S, V60, P193; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HARA T, 1994, HAEMOSTASIS, V24, P351; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Jiang YJ, 2002, J CEREBR BLOOD F MET, V22, P404, DOI 10.1097/00004647-200204000-00004; Karabiyikoglu M, 2004, J CEREBR BLOOD F MET, V24, P159, DOI 10.1097/01.WCB.0000100062.36077.84; Kawai H, 1996, J PHARMACOL EXP THER, V278, P780; KURODA Y, 1992, NEUROSURGERY, V30, P687; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Li SQ, 1999, CLIN EXP PHARMACOL P, V26, P824, DOI 10.1046/j.1440-1681.1999.03146.x; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Maeda T, 1997, ACT NEUR S, V70, P102; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Mary V, 2001, STROKE, V32, P993, DOI 10.1161/01.STR.32.4.993; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Mori M, 1996, J NEUROSCI, V16, P3590; Ninomia T, 2000, J CEREBR BLOOD F MET, V20, P998, DOI 10.1097/00004647-200006000-00012; Nishida K, 1996, J NEUROCHEM, V66, P433; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; RADEN AI, 1992, AM J PHYSIOL, V263, pR909; Riek-Burchardt M, 2002, NEUROSCI LETT, V329, P181, DOI 10.1016/S0304-3940(02)00645-6; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SPINNEWYN B, 1987, PROSTAGLANDINS, V34, P337, DOI 10.1016/0090-6980(87)90079-7; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Uchida K, 2001, EUR J ANAESTH, V18, P295, DOI 10.1046/j.0265-0215.2000.00825.x; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; Zhang ZG, 2001, BRAIN RES, V912, P181, DOI 10.1016/S0006-8993(01)02735-4	44	15	16	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0148-396X			NEUROSURGERY	Neurosurgery	SEP	2005	57	3					565	571		10.1227/01.NEU.0000170435.47739.AE			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	963DB	WOS:000231782400031	16145537				2022-02-06	
J	Pantovic, R; Draganic, P; Erakovic, V; Blagovic, B; Milin, C; Simonic, A				Pantovic, R; Draganic, P; Erakovic, V; Blagovic, B; Milin, C; Simonic, A			Effect of indomethacin on motor activity and spinal cord free fatty acid content after experimental spinal cord injury in rabbits	SPINAL CORD			English	Article						chromatography; free fatty acids; indomethacin; rabbit; spinal cord injury	ARACHIDONIC-ACID; PROSTAGLANDIN SYNTHESIS; LIPID-METABOLISM; BLOOD-FLOW; RAT; INHIBITOR; TRAUMA; EDEMA; DEXAMETHASONE; ACCUMULATION	Study design: Determination of functional and biochemical parameters as well as the effect of specific therapies on these parameters, in the experimental model of neurotrauma in rabbits. Objective: To assess the effect of indomethacin (0.1 - 3.0 mg/kg for 9 days), a potent inhibitor of endogenous prostaglandin synthesis, on the motor activity and on the spinal cord tissue concentration of free palmitic, stearic, oleic, arachidonic and docosahexaenoic acids in an experimental model of a spinal cord injury in rabbits. Setting: Faculty of Medicine, University of Rijeka, Croatia. Methods: The animals were randomly divided into nine experimental groups, four sham and/ or vehicle-treated and five indomethacin-treated ( including one sham-operated and four injured groups). Laminectomy was followed by contusion of the spinal cord, using a modi. cation of the technique of Albin. Motor activity was controlled daily during the course of the next nine postoperation days and scored using Tarlov's system. Spinal cord samples from the impact injury site were taken and frozen in liquid nitrogen. Total lipids were isolated and purified by a modi. cation of the method of Folch. Free fatty acids (FFAs) were separated from the total lipid extract by preparative thin-layer chromatography, converted to the corresponding methyl esters and identified using gas chromatography, using nonadecanoic acid as the internal standard. Results: The concentrations of all analysed free fatty acids were increased in the spinal cord after neurotrauma, in comparison to control tissues. Treatment of injured rabbits with indomethacin resulted in a significant decrease in spinal cord FFAs and exerted a positive effect on neurotrauma-induced motor impairment. Conclusion: These results indicate a mechanism whereby indomethacin protects rabbits from the sequellae of neuronal damage caused by trauma, and suggests that it may be beneficial in the therapy of neurotrauma.	Univ Rijeka, Fac Med, Dept Chem & Biochem, HR-51000 Rijeka, Croatia; PLIVA Res Inst Ltd, Zagreb, Croatia		Pantovic, R (corresponding author), Univ Rijeka, Fac Med, Dept Chem & Biochem, B Branchetta 20, HR-51000 Rijeka, Croatia.		Blagovic, Branka/S-4391-2018	Blagovic, Branka/0000-0001-5075-8256; Erakovic Haber, Vesna/0000-0003-0016-768X			ALBIN MS, 1968, J NEUROSURG, V29, P113, DOI 10.3171/jns.1968.29.2.0113; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Banik NL, 2000, NEUROCHEM RES, V25, P1509, DOI 10.1023/A:1007684311023; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; BINGHAM WG, 1975, J NEUROSURG, V43, P162, DOI 10.3171/jns.1975.43.2.0162; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; DEMEDIUK P, 1989, J NEUROSCI RES, V23, P95, DOI 10.1002/jnr.490230113; DEMEDIUK P, 1985, PROG BRAIN RES, V63, P211; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; FADEN AI, 1987, J NEUROCHEM, V48, P1809, DOI 10.1111/j.1471-4159.1987.tb05740.x; Farooqui AA, 1997, J NEUROCHEM, V69, P889; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; FOLCH J, 1957, J BIOL CHEM, V226, P497; GUTH L, 1994, EXP NEUROL, V126, P76, DOI 10.1006/exnr.1994.1043; Guven MB, 1999, PEDIATR NEUROSURG, V31, P189, DOI 10.1159/000028860; HALT PS, 1992, ARCH NEUROL-CHICAGO, V49, P1178, DOI 10.1001/archneur.1992.00530350096025; Horrocks L A, 1985, Cent Nerv Syst Trauma, V2, P115; HSU CY, 1986, J NEUROL SCI, V74, P289, DOI 10.1016/0022-510X(86)90114-0; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; JONSSON HT, 1976, PROSTAGLANDINS, V11, P51, DOI 10.1016/0090-6980(76)90172-6; MORELAND DB, 1989, SURG NEUROL, V31, P277, DOI 10.1016/0090-3019(89)90052-9; MURPHY EJ, 1994, MOL CHEM NEUROPATHOL, V23, P13, DOI 10.1007/BF02858504; Olby N, 1999, J VET INTERN MED, V13, P399, DOI 10.1892/0891-6640(1999)013&lt;0399:CCITMO&gt;2.3.CO;2; OLSSON Y, 1992, PROG BRAIN RES, V91, P197; Pantovic R, 2002, PERIOD BIOL, V104, P95; Schwab JM, 2000, J NEUROIMMUNOL, V111, P122, DOI 10.1016/S0165-5728(00)00372-6; SHARMA HS, 1995, RESTOR NEUROL NEUROS, V7, P207, DOI 10.3233/RNN-1994-7403; SHARMA HS, 1993, ACTA NEUROPATHOL, V85, P145; SHARMA HS, 2002, MUSCLE NERVE, V11, P583; Shehab D, 2002, J NUCL MED, V43, P346; SIEGAL T, 1988, SPINE, V13, P1171; SIEGAL T, 1990, NEUROSURGERY, V26, P967, DOI 10.1227/00006123-199006000-00008; SIEGAL T, 1988, NEUROSURGERY, V22, P334, DOI 10.1227/00006123-198802000-00010; SIMPSON RK, 1991, J SPINAL DISORD, V4, P420, DOI 10.1097/00002517-199112000-00003; Slavik RS, 1999, NEUROL RES, V21, P491; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Toborek M, 1999, J NEUROCHEM, V73, P684, DOI 10.1046/j.1471-4159.1999.0730684.x; Toborek M, 2000, EXP NEUROL, V161, P609, DOI 10.1006/exnr.1999.7308; VANHEDEMAN LS, 1974, J NEUROSURG, V40, P37; VISER WM, 1974, J NEUROSURG, V40, P77; WINKLER T, 1993, NEUROSCIENCE, V52, P1057, DOI 10.1016/0306-4522(93)90552-Q; Yin K S, 2001, J Spinal Cord Med, V24, P119; YOSHIHARA Y, 1990, BIOCHEM BIOPH RES CO, V170, P484, DOI 10.1016/0006-291X(90)92117-I; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355; Zheng ZH, 1996, NEUROCHEM INT, V28, P551, DOI 10.1016/0197-0186(95)00131-X; ZUPAN G, 1995, CROAT CHEM ACTA, V68, P485	47	15	16	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	SEP	2005	43	9					519	526		10.1038/sj.sc.3101763			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	962GA	WOS:000231717800002	15852057	Bronze			2022-02-06	
J	Caspi, Y; Gil, S; Ben-Ari, IZ; Koren, D; Aaron-Peretz, J; Klein, E				Caspi, Y; Gil, S; Ben-Ari, IZ; Koren, D; Aaron-Peretz, J; Klein, E			Memory of the traumatic event is associated with increased risk for PTSD: A retrospective study of patients with traumatic brain injury	JOURNAL OF LOSS & TRAUMA			English	Article; Proceedings Paper	18th Annual Meeting of the International-Society-for-Traumatic-Stress-Studies	NOV 07-10, 2002	Baltimore, MD	Int Soc Traumat Stress Studies			POSTTRAUMATIC-STRESS-DISORDER; AMNESIA	Studies of the relationship between explicit episodic memory of a traumatic event ( MTE) and posttraumatic stress disorder ( PTSD) are inconclusive. The authors examined whether memory for the details of the traumatic event as reported by patients with mild traumatic brain injury was associated with the development of PTSD. In a retrospective study of 120 participants, MTE was found to be associated with an increased risk of PTSD, particularly for the reexperiencing symptom cluster. Although less frequently, PTSD was nonetheless present even in the absence of explicit memory. Possible explanations for mechanisms that enable this phenomenon are considered.	Rambam Med Ctr, Dept Psychiat, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; Rambam Med Ctr, Neurocognit Clin, IL-31096 Haifa, Israel		Klein, E (corresponding author), Rambam Med Ctr, Dept Psychiat, POB 9602, IL-31096 Haifa, Israel.	e_klein@rambam.health.gov.il		Koren, Danny/0000-0003-0238-766X			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Basso MR, 2000, J PERS INTERPERS LOS, V5, P125, DOI 10.1080/10811440008409748; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard E. B., 1997, CRASH ASSESSMENT TRE; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Elhai JD, 2001, ASSESSMENT, V8, P75, DOI 10.1177/107319110100800107; First M.B., 1994, STRUCTURED CLIN INTE; Foa E. B, 1999, AM J CLIN PSYCHIAT, V60, P5; Freedman SA, 1999, BRIT J PSYCHIAT, V174, P353, DOI 10.1192/bjp.174.4.353; GIL S, IN PRESS AM J PSYCHI; Hyman IE, 1998, CLIN PSYCHOL REV, V18, P933, DOI 10.1016/S0272-7358(98)00041-5; Kaplan CP, 2000, BRAIN INJURY, V14, P251; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KULKA R, 1990, TRAUMA VIETNAM WAR E; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Leskin GA, 1998, CLIN PSYCHOL REV, V18, P983, DOI 10.1016/S0272-7358(98)00039-7; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; MCFARLANE AC, 1989, BRIT J PSYCHIAT, V154, P221, DOI 10.1192/bjp.154.2.221; McFarlane AC, 2000, AUST NZ J PSYCHIAT, V34, P896, DOI 10.1046/j.1440-1614.2000.00826.x; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; PRIGATANO GP, 1987, J CLIN PSYCHOL, V44, P816; Resnick PJ, 1997, PSYCHIAT CLIN N AM, V20, P473, DOI 10.1016/S0193-953X(05)70323-3; Roediger H., 1997, RECOVERED MEMORIES F, P118; ROSENBERG SJ, 1984, J CLIN PSYCHOL, V40, P785, DOI 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4; ROTHBAUM BO, 2000, POSTTRAUMATIC STRESS, P101; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Seedat S, 2001, Curr Psychiatry Rep, V3, P288, DOI 10.1007/s11920-001-0021-2; SHALEV A, 1992, AM J PSYCHIAT, V153, P219; van der Kolk B. A., 2001, TRAUMA COGNITIVE SCI; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; YOUNG A, 2000, PL S STRESS, P51	44	15	15	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1532-5024	1532-5032		J LOSS TRAUMA	J. Loss Trauma	JUL-SEP	2005	10	4					319	335		10.1080/15325020590956756			17	Psychology, Social	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	940PX	WOS:000230157500001					2022-02-06	
J	Portella, G; Cormio, M; Citerio, G; Contant, C; Kiening, K; Enblad, P; Piper, I				Portella, G; Cormio, M; Citerio, G; Contant, C; Kiening, K; Enblad, P; Piper, I			Continuous cerebral compliance monitoring in severe head injury: its relationship with intracranial pressure and cerebral perfusion pressure	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; ICP; compliance; CPP; Spiegelberg	VOLUME INDEX; BLOOD-FLOW; DYNAMICS; CSF	Background. Cerebral compliance expresses the capability to buffer an intracranial volume increase while avoiding a rise in intracranial pressure (ICP). The autoregulatory response to Cerebral Perfusion Pressure (CPP) variation influences cerebral blood volume which is an important determinant of compliance. The direction of compliance change in relation to CPP variation is still under debate. The aim of the study was to investigate the relationship between CPP and compliance in traumatic brain injured (TBI) patients by a new method for continuous monitoring of intracranial compliance as used in neuro-intensive care (NICU). Method. Three European NICU's standardised collection of CPP, compliance and ICP data to a joint database. Data were analyzed using an unpaired student t-test and a multi-level statistical model. Results. For each variable 108,263 minutes of data were recorded from 21 TBI patients ( 19 patients GCS <= 8; 90% male; age 10 - 77 y). The average value for the following parameters were: ICP 15.1 +/- 8.9 mmHg, mmHg, CPP 74.3 +/- 14 mmHg and compliance 0.68 +/- 0.3 ml/mmHg. ICP was >= 20 mmHg in 20% and CPP < 60 mmHg for 10.7% of the time. Compliance was lower (0.51 +/- 0.34 ml/mmHg) at ICP >= 20 than at ICP < 20mmHg (0.73 +/- 0.37 ml/mmHg) (p < 0.0001). Compliance was significantly lower at CPP < 60 than at CPP >= 60mmHg: 0.56 +/- 0.36 and 0.70 +/- 0.37ml/mmHg respectively (p < 0.0001). The CPP compliance relationship was different when ICP was above 20mmHg compared with below 20mmHg. At ICP < 20mmHg compliance rose as CPP rose. At ICP >= 20mmHg, the relation curve was convexly shaped. At low CPP, the compliance was between 0.20 and 0.30 ml/mmHg. As the CPP reach 80 mmHg average compliance was 0.55 ml/mmHg., but compliance fell to 0.40 ml/mmHg when CPP was 100 mmHg. Conclusions. Low CPP levels are confirmed to be detrimental for intracranial compliance. Moreover, when ICP was pathological, indicating unstable intracranial equilibrium, a high CPP level was also associated with a low volume-buffering capacity.	Osped San Gerardo, Dept Intens Care, Monza, MI, Italy; Baylor Coll Med, Houston, TX 77030 USA; Univ Heidelberg, Heidelberg, Germany; Univ Uppsala Hosp, Uppsala, Sweden; So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland		Portella, G (corresponding author), Osped San Gerardo, Dept Intens Care, Monza, MI, Italy.	portella.gina@libero.it		Citerio, Giuseppe/0000-0002-5374-3161			AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Avezaat CJJ, 1984, THESIS ERASMUS U ROT; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, INTRACRANIAL PRESSUR, V8, P529; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P732, DOI 10.1136/jnnp.63.6.732; Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; HERMANN HD, 1993, NEUROSURGERY, V33, P1111; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; KONTOS HA, 1978, AM J PHYSIOL, V234, P371; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1973, THESIS DREXEL U; MARMAROU A, 1993, INTRACRANIAL PRESSUR, pCH10; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Miller J D, 1972, Prog Brain Res, V35, P411; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; Miller JD, 1972, INTRACRANIAL PRESSUR, P270; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1989, INTRACRANIAL PRESSUR, V7, P825; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; PIPER IR, 1990, ACT NEUR S, V51, P387; Raabe A, 1999, ACTA NEUROCHIR, V141, P31, DOI 10.1007/s007010050263; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SPIEGELBERG A, 1996, WORK C INT GROUP INT; TANS JTJ, 1983, J NEUROSURG, V59, P810, DOI 10.3171/jns.1983.59.5.0810; Yau YH, 2000, J NEUROSURG, V93, P1072, DOI 10.3171/jns.2000.93.6.1072	32	15	15	1	3	SPRINGER WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUL	2005	147	7					707	713		10.1007/s00701-005-0537-z			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	938AK	WOS:000229972100004	15900402				2022-02-06	
J	Bakir, A; Temiz, U; Umur, S; Aydin, V; Torun, F				Bakir, A; Temiz, U; Umur, S; Aydin, V; Torun, F			High-velocity gunshot wounds to the head: Analysis of 135 patients	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						high-velocity missile; shrapnel; head injury	PENETRATING CRANIOCEREBRAL INJURIES; GLASGOW-COMA-SCALE; CIVILIAN PRACTICE; SURGICAL-MANAGEMENT; TRAUMATIC ANEURYSMS; LEBANESE CONFLICT; BONE FRAGMENTS; BRAIN; PROGNOSIS; CHILDREN	Head injuries due to high-velocity missiles and shrapnel as a result of military conflicts have become a very important cause of death or severe neurological deficits. Military-type missiles have high velocities and transfer higher amounts of energy to neural tissue, compared to civil-type missiles. This physical phenomenon also causes greater neural tissue destruction. Shrapnel particles derive from blasts and cause less severe injury because of the irregular particle shape and low energy transmission. This study analyzed 135 patients with head trauma, 80 patients (59%) injured by missiles and 55 patients (41%) by shrapnel. Glasgow Coma Scale (GCS) scores at admission were 3 to 7 in 69 patients, 8 to 10 in 29 patients, and 11 to 15 in 37 patients. The most common anatomical localizations were the right frontoparietal region in 42 patients and the left frontoparietal region in 40 patients. one hundred patients (74%) were operated on immediately and 35 patients (26%) were treated conservatively in the intensive care unit. Ten of the 135 patients died (7.4%), seven from missile injury and three from shrapnel injury. In this study, we found that high mortality was associated with low GCS score at admission, presence of multilobar or skull base injuries, and involvement of ventricles. Early and aggressive surgical intervention decreased the mortality.	Mevki Mil Hosp, Dept Neurosurg, Ankara, Turkey; Celal Bayar Univ, Dept Neurosurg, Fac Med, Manisa, Turkey; Adnan Menderes Univ, Fac Med, Dept Neurosurg, Aydin, Turkey; Ankara Univ, Fac Med, Dept Neurosurg, TR-06100 Ankara, Turkey		Bakir, A (corresponding author), Mevki Mil Hosp, Dept Neurosurg, Ankara, Turkey.	abdbak@hotmail.com					Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BRANDT F, 1983, NEUROCHIRURGIA, V26, P164; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BRUNNER FX, 1995, OPERATIVE NEUROSURGI, P27; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Dosoglu M, 1999, NEUROCHIRURGIE, V45, P201; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; GEORGE ED, 1999, MISSILE WOUNDS HEAD, V1, P130; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HUBSCHMANN O, 1979, J TRAUMA, V19, P6, DOI 10.1097/00005373-197901000-00002; JACOBS DG, 1995, AM SURGEON, V61, P647; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1983, ACTA NEUROCHIR, V67, P115, DOI 10.1007/BF01401671; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Nathoo N, 2002, SURG NEUROL, V58, P225, DOI 10.1016/S0090-3019(02)00828-5; ORDOG GJ, 1987, J TRAUMA, V27, P1272; Paret G, 1996, J TRAUMA, V41, P859, DOI 10.1097/00005373-199611000-00017; RISH BL, 1980, J NEUROSURG, V53, P772, DOI 10.3171/jns.1980.53.6.0772; Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949; SABA MI, 1988, OPERATIVE NEUROSURGI, P37; SABA MI, 1995, OPERATIVE NEUROSURGI, P89; Semple PL, 2001, S AFR MED J, V91, P141; SHERMAN WD, 1980, WESTERN J MED, V132, P99; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; Splavski B, 1998, SURG NEUROL, V50, P194, DOI 10.1016/S0090-3019(98)00047-0; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; SUDDABY L, 1987, CAN J NEUROL SCI, V14, P268, DOI 10.1017/S0317167100026597; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007	43	15	16	0	3	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUN	2005	45	6					281	287		10.2176/nmc.45.281			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	936GQ	WOS:000229843900001	15973060	Bronze			2022-02-06	
J	Martz, E				Martz, E			Associations and predictors of posttraumatic stress levels according to person-related, disability-related, and trauma-related variables among individuals with spinal cord injuries	REHABILITATION PSYCHOLOGY			English	Article							VEHICLE ACCIDENT VICTIMS; PSYCHOLOGICAL IMPACT; BRAIN-INJURY; RISK-FACTORS; DISORDER; SURVIVORS; PREVALENCE; SYMPTOMS; PTSD; ADAPTATION	Objective: To examine the associations and predictors of posttraumatic stress among individuals with spinal cord injuries (SCI) in the framework of a Person X Disability X Traumatic Event model. Design: An exploratory study involving analyses of variance, correlations, and a hierarchical multiple regression of a cross-sectional sample. Participants: Three hundred twelve individuals with SCI using a veteran or a civilian SCI clinic. Main Outcome Measures: Purdue Posttraumatic Stress Disorder-Revised scale (PPTSD-R). Results: Four out of all the examined variables had significant regression coefficients: spiritual-religious coping, pain level, severity of SCI, and number of traumatic events. Severity of SCI was a significant predictor, but data suggested that severity of SCI had a curvilinear association with both total posttraumatic stress levels and hyperarousal scores. Conclusion: Treatment of an individual's pain may reduce posttraumatic stress symptoms. Clinicians also can evaluate for previous trauma unrelated to the onset of the SCI and can intervene with the goal of reducing the impact of previous trauma on the individual's present emotional state and reactions to SCI.	Univ Missouri, Rehabil Counceling Program, Educ Sch & Counseling Psychol Dept, Columbia, MO 65202 USA		Martz, E (corresponding author), Univ Missouri, Rehabil Counceling Program, Educ Sch & Counseling Psychol Dept, 4B Hill Hall, Columbia, MO 65202 USA.	martze@missouri.edu					ABENHAIM L, 1992, J CLIN EPIDEMIOL, V45, P103, DOI 10.1016/0895-4356(92)90002-5; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Amir M, 1999, J TRAUMA STRESS, V12, P139, DOI 10.1023/A:1024754618063; Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2; Bernat JA, 1998, J TRAUMA STRESS, V11, P645, DOI 10.1023/A:1024485130934; Blanchard EB, 1997, J TRAUMA STRESS, V10, P215, DOI 10.1002/jts.2490100205; Boyer B, 1998, SCI PSYCHOSOCIAL PRO, V11, P75; Boyer BA, 2000, REHABIL PSYCHOL, V45, P339, DOI 10.1037/0090-5550.45.4.339; BRACKEN MB, 1980, PARAPLEGIA, V18, P74, DOI 10.1038/sc.1980.13; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Butler RW, 1996, J PEDIATR PSYCHOL, V21, P499, DOI 10.1093/jpepsy/21.4.499; CHIBNALL JT, 1990, PSYCHOL, V4, P283, DOI DOI 10.1080/08870449008400397; CORDOVA MJ, 1995, J CONSULT CLIN PSYCH, V63, P981, DOI 10.1037/0022-006X.63.6.981; DELIMAR D, 1995, MIL MED, V160, P635, DOI 10.1093/milmed/160.12.635; Desivilya HS, 1996, J TRAUMA STRESS, V9, P881; Difede J, 1999, J TRAUMA STRESS, V12, P363, DOI 10.1023/A:1024788812393; Fullerton CS, 2001, AM J PSYCHIAT, V158, P1486, DOI 10.1176/appi.ajp.158.9.1486; GREEN BL, 1993, INT HDB TRAUMATIC ST, P135, DOI DOI 10.1007/978-1-4615-2820-3_11; HAGSTROM R, 1995, J TRAUMA STRESS, V8, P391, DOI 10.1007/BF02102965; Harvey MR, 1996, J TRAUMA STRESS, V9, P3, DOI 10.1002/jts.2490090103; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Kennedy P, 2001, SPINAL CORD, V39, P1, DOI 10.1038/sj.sc.3101100; Kennedy P, 2001, SPINAL CORD, V39, P381, DOI 10.1038/sj.sc.3101172; KUTZ I, 1994, ISRAEL J PSYCHIAT, V31, P48; Ladwig KH, 1999, AM J PSYCHIAT, V156, P912, DOI 10.1176/ajp.156.6.912; Lauterbach D., 1996, ASSESSMENT, V3, P17, DOI DOI 10.1177/107319119600300102; Martz E, 2004, J LOSS TRAUMA, V9, P139, DOI 10.1080/15325020490423343; Martz E, 2001, REHABIL COUNS BULL, V44, P217, DOI 10.1177/003435520104400404; Nielsen MS, 2003, REHABIL PSYCHOL, V48, P289, DOI 10.1037/0090-5550.48.4.289; NIELSEN MS, 2003, SCI PSYCHOSOCIAL PRO, V16, P137; Norman E M, 1991, Appl Nurs Res, V4, P171; PENT W, 2000, EFFECTIVE TREATMENT, P224; Perry S W, 1987, J Pain Symptom Manage, V2, P29, DOI 10.1016/S0885-3924(87)80043-X; Post Robert M., 1995, P203; Powers Pauline S., 1994, Journal of Burn Care and Rehabilitation, V15, P147, DOI 10.1097/00004630-199403000-00008; Radnitz CL, 1998, J ABNORM PSYCHOL, V107, P676, DOI 10.1037/0021-843X.107.4.676; Radnitz CL, 2000, J ANXIETY DISORD, V14, P313, DOI 10.1016/S0887-6185(00)00025-6; Radnitz CL, 1998, J TRAUMA STRESS, V11, P505, DOI 10.1023/A:1024404729251; Radnitz CL, 1995, SCI PSYCHOSOCIAL PRO, V8, P145; ROCA RP, 1992, AM J PSYCHIAT, V149, P1234; SCHNURR PP, 1993, J ABNORM PSYCHOL, V102, P288, DOI 10.1037/0021-843X.102.2.288; Schnurr PP, 2002, J CLIN PSYCHOL, V58, P877, DOI 10.1002/jclp.10064; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; SHONTZ FC, 1975, PSYCHOLOGICAL ASPECT; Smith MY, 1999, J TRAUMA STRESS, V12, P485, DOI 10.1023/A:1024719104351; TERR LC, 1991, AM J PSYCHIAT, V148, P10; THOMPSON RN, 1999, THESIS W VIRGINIA U; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; [No title captured]; [No title captured]; [No title captured]	55	15	16	0	6	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2005	50	2					149	157		10.1037/0090-5550.50.2.149			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	931ND	WOS:000229491100008					2022-02-06	
J	Beresford, TP; Arciniegas, D; Clapp, L; Martin, B; Alfers, J				Beresford, TP; Arciniegas, D; Clapp, L; Martin, B; Alfers, J			Reduction of affective lability and alcohol use following traumatic brain injury: A clinical pilot study of anti-convulsant medications	BRAIN INJURY			English	Article							RELAPSE PREVENTION; AFFECTIVE-DISORDER; GABA(A) RECEPTOR; AXIS-I; CARBAMAZEPINE; ASSOCIATION; DIVALPROEX; VALPROATE; RELEASE; GENE	Objective: A large and under-recognized sub-set of patients suffer both traumatic brain injury (TBI) and alcohol dependence (ADep). This group appears to use alcohol to self-treat affective and anxiety lability following TBI, resulting in new ADep or worsened prior ADep. This study hypothesized that treatment of such patients with mood-stabilizing medications would relieve post-TBI emotional dysregulation and facilitate reduction in alcohol use. Design: This study reported retrospective medical record data from outpatients in the Substance Abuse Treatment Programme who were treated for labile mood. Medications followed clinical indication and were given in non-blind fashion. Method: Subjects included 18 patients who (1) complained of debilitating affective lability following TBI, ( 2) described drinking alcohol to ease lability symptoms, (3) met DSM-IV criteria for current ADep and (4) were treated with a mood stabilizing medication. Results: During 6 weeks of treatment, 16 (89%) achieved abstinence from alcohol. All but two (14/16 or 88%) also showed improvement in their affective and anxiety symptoms. Conclusions: These preliminary data are limited by the retrospective collection, clinical impression and non-blinded trial. Nonetheless, the results suggest further investigation of anti-convulsants as potentially useful agents in co-morbid emotional lability and ADep following TBI.	Denver Vet Affairs Med Ctr, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Colorado, Sch Med, Dept Psychiat, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Neurol, Denver, CO USA; Spalding Rehabil Hosp, Brain Injury Rehabil Unit, Aurora, CO USA		Beresford, TP (corresponding author), Denver Vet Affairs Med Ctr, 151,1055 Clermont St, Denver, CO 80220 USA.	thomas.beresford@uchsc.edu	Arciniegas, David/A-3792-2009		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R03AA012095] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA12095] Funding Source: Medline		Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; Brady KT, 2002, DRUG ALCOHOL DEPEN, V67, P323, DOI 10.1016/S0376-8716(02)00105-9; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; ERB DE, 1991, EXP BRAIN RES, V83, P253; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Ichikawa J, 1999, EUR J PHARMACOL, V380, pR1, DOI 10.1016/S0014-2999(99)00517-8; Johnson BA, 2003, LANCET, V361, P1677, DOI 10.1016/S0140-6736(03)13370-3; Kawata Y, 2001, BRIT J PHARMACOL, V133, P557, DOI 10.1038/sj.bjp.0704104; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Longo LP, 2002, J ADDICT DIS, V21, P55, DOI 10.1300/J069v21n02_05; Miller Norman S., 1994, P471; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Oruc L, 1997, NEUROPSYCHOBIOLOGY, V36, P62; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Papadimitriou GN, 1998, AM J MED GENET, V81, P73, DOI 10.1002/(SICI)1096-8628(19980207)81:1<73::AID-AJMG14>3.3.CO;2-#; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; PETTY F, 1995, J AFFECT DISORDERS, V34, P275, DOI 10.1016/0165-0327(95)00025-I; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Schneider U, 2001, ALCOHOL ALCOHOLISM, V36, P219, DOI 10.1093/alcalc/36.3.219; White HS, 1999, EPILEPSIA, V40, pS2, DOI 10.1111/j.1528-1157.1999.tb00913.x	21	15	15	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2005	19	4					309	313		10.1080/02699050410001720121			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	917MN	WOS:000228466400007	15832875				2022-02-06	
J	Wilson, MS; Chen, XB; Ma, XC; Ren, DX; Wagner, AK; Reynolds, IJ; Dixon, CE				Wilson, MS; Chen, XB; Ma, XC; Ren, DX; Wagner, AK; Reynolds, IJ; Dixon, CE			Synaptosomal dopamine uptake in rat striatum following controlled cortical impact.	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; dopamine; transporter; striatum; rat; Western blotting; radioligand binding	TRAUMATIC BRAIN-INJURY; WATER MAZE PERFORMANCE; METHYLPHENIDATE TREATMENT; OXIDATIVE STRESS; FRONTAL-CORTEX; TRANSPORTER; AMANTADINE; DEFICITS; TRIAL; MOTOR	Functional deficits following traumatic brain injury (TBI) are associated with alterations in markers of dopaminergic neurotransmission. To assess the effects of TBI on the expression and functional integrity of dopamine transporters, we measured transporter protein levels and investigated synaptosomal dopamine uptake in the rat striatum. Two or four weeks after lateral controlled cortical impact or sham injury, Western blotting revealed a decrease in transporter protein in the ipsilateral striatum of injured rats relative to shams (P < 0.05). However, no significant difference in synaptosomal uptake (K-m, V-max) was found between injured and sham-injured animals. Our data suggest that striatal dopamine transporters are capable of normal function at 2 weeks and 4 weeks after injury. However, it is unclear whether neurons in the injured striatum can properly regulate the activity of dopamine transporters in vivo. (c) 2005 Wiley-Liss, Inc.	Safar Ctr Resuscitat Res, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA		Dixon, CE (corresponding author), 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu	Reynolds, Ian Jeffery/ABH-3197-2020; Reynolds, Ian/C-4358-2008	Reynolds, Ian/0000-0003-3028-5070	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-33150] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033150] Funding Source: NIH RePORTER		Berman SB, 1996, J NEUROCHEM, V67, P593; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; LANGSTON JW, 1986, CLIN NEUROPHARMACOL, V9, P485, DOI 10.1097/00002826-198612000-00001; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McIntosh TK, 1996, LAB INVEST, V74, P315; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Reith MEA, 1997, EUR J PHARMACOL, V324, P1, DOI 10.1016/S0014-2999(97)00065-4; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	33	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR 1	2005	80	1					85	91		10.1002/jnr.20419			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914CW	WOS:000228203400009	15704194				2022-02-06	
J	Wu, TS; Garmel, GM				Wu, TS; Garmel, GM			Improved neurological function after amantadine treatment in two patients with brain injury	JOURNAL OF EMERGENCY MEDICINE			English	Article						amantadine; brain injury; dopaminergic agonists	RECOVERY	This article presents two cases of functional recovery in patients with brain injury after treatment with Amantadine, a dopaminergic stimulant. Also presented is a review of current data available concerning dopaminergic therapy after traumatic brain injury. (c) 2005 Elsevier Inc.	Stanford Kaiser Emergency Med Residency Program, Stanford, CA USA; Kaiser Permanente Med Ctr, Santa Clara, CA USA		Wu, TS (corresponding author), 701 Welch Rd,Bldg C, Palo Alto, CA 94304 USA.						ALLEN RM, 1983, CLIN NEUROPHARMACOL, V6, pS64; BOTEZ MI, 1989, NEUROLOGY, V39, P749, DOI 10.1212/WNL.39.5.749-b; CHANDLER M, 1988, BRAIN INJURY, V4, P309; CHIERICHETTI SM, 1977, CURR THER RES CLIN E, V22, P158; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; CROSBY NJ, 2003, COCHRANE LIB; Debette S, 2002, J NEUROL, V249, P1678, DOI 10.1007/s00415-002-0903-1; DIXON CE, IN PRESS COMMUNICATI; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Meythaler JM, 2003, J HEAD TRAUMA REHAB, V18, P5, DOI 10.1097/00001199-200301000-00004; ROSENBERG GA, 1985, CAN J NEUROL SCI, V12, P251; STEVENS JR, 1973, ARCH GEN PSYCHIAT, V29, P177; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	17	15	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	APR	2005	28	3					289	292		10.1016/j.jemermed.2004.11.016			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	908LT	WOS:000227789200007	15769570				2022-02-06	
J	Maurer, E; Martin, J; Milewski, P; Dinkel, M				Maurer, E; Martin, J; Milewski, P; Dinkel, M			Remarks on relevant CNS examination and monitoring techniques on the ICU, and the effectiveness of a basic course in imparting the necessary knowledge and skills	ANASTHESIOLOGIE & INTENSIVMEDIZIN			German	Article						neurological diagnosis; intensive care; neurological examination; electroencephalography; evoked potentials	SOMATOSENSORY-EVOKED-POTENTIALS; TRAUMATIC BRAIN-INJURY; OUTCOME PREDICTION; HEAD-INJURY; COMA; PROGNOSIS	Intensive care physicians in operative ICUs are often called upon to deal with neurological and neurotraumatological disorders. For this purpose, they need a basic knowledge of neurological diagnosis and monitoring. Since relevant guidelines are lacking, a curriculum for a two-day course of further training in this area was defined. The current article presents the proposed basic knowledge and invites discussion. After the completion of three such courses, we investigated how effectively the necessary basic knowledge and skills needed for the clinical neurological examination, the EEG, and evoked potentials in the ICU patient can be imparted in such a course. Former course participants were sent a structured questionnaire aimed at determining the state of their knowledge before and after the course, and whether there had been any increase in the use of the three measures. The results showed that it is possible to impart an adequate knowledge of the clinical neurological examination and evoked potentials in a two-day workshop.	Klin Eichert, Abt Anasthesie & Operat Intens Med, Goppingen, Germany; Herz & Gefassklin GmbH, Abt Anasthesie & Operat Intens Med, Bad Neustadt an der Saale, Germany		Maurer, E (corresponding author), Klinikum Eichert, Klin Anasthesiol Operat Intens Med & Schmerzthera, Eicherstr 3, D-73006 Goppingen, Germany.	ekhard.maurer@web.de					Attia J, 1998, CRIT CARE CLIN, V14, P497, DOI 10.1016/S0749-0704(05)70013-0; Banoub M, 2003, ANESTHESIOLOGY, V99, P716, DOI 10.1097/00000542-200309000-00029; BARELLI A, 1991, CRIT CARE MED, V19, P1374, DOI 10.1097/00003246-199111000-00013; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; Engelhardt W, 1997, ANASTH INTENSIVMED, V38, P366; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; KEREN O, 1993, STROKE, V24, P1789, DOI 10.1161/01.STR.24.12.1789; LAWRENCE R, 2003, CRIT CARE MED, V31; Madl C, 1996, ARCH NEUROL-CHICAGO, V53, P512, DOI 10.1001/archneur.1996.00550060054017; Maurer E, 1998, ANASTH INTENSIV NOTF, V33, P430, DOI 10.1055/s-2007-994280; MAURER E, 2002, ZUCKSCHWERDT VERLAG; Meixensberger J., 1998, Intensivmedizin und Notfallmedizin, V35, P72; Moulton RJ, 1998, CAN J NEUROL SCI, V25, pS7, DOI 10.1017/S031716710003465X; MUMENTHALER M, 1988, KLINISCHE UNTERSUCHU; Mumenthaler M, 1990, NEUROLOGIE; Raggueneau JL, 2001, ANN FR ANESTH, V20, P108; RIFFEL B, 1989, ANAESTHESIST, V38, P51; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; RUMPL E, 1996, NOTFALLBEHANDLUNG, V21, P121; RUMPL E, 1998, EEG ANDERUNGEN BEI A; SCHWARZ G, 1994, ANASTH INTENSIVMED, V35, P376; SCHWERDTFEGER K, 1997, ANASTHESIOL INTENSIM, V32, P199; SIMPSON TP, 1999, BRIT J INTESNSI 0701; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; XU S, 1995, CHUNG HUA WAI KO TSA, V33, P238; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8; ZEITLHOFER J, 1989, ANAESTHESIST, V38, P10	32	15	15	0	0	AKTIV DRUCK & VERLAG GMBH	EBELSBACH	AN DER LOHWIESE 36, EBELSBACH, 97500, GERMANY	0170-5334	1439-0256		ANASTH INTENSIVMED	Anasthesiol. Intensivmed.	MAR	2005	46						84	+					6	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	922KS	WOS:000228837400006					2022-02-06	
J	Fountas, KN; Sitkauskas, A; Feltes, CH; Kapsalaki, EZ; Dimopoulos, VG; Kassam, M; Grigorian, AA; Robinson, JS; Ragauskas, A				Fountas, KN; Sitkauskas, A; Feltes, CH; Kapsalaki, EZ; Dimopoulos, VG; Kassam, M; Grigorian, AA; Robinson, JS; Ragauskas, A			Is non-invasive monitoring of intracranial pressure waveform analysis possible? Preliminary results of a comparative study of non-invasive vs. invasive intracranial slow-wave waveform analysis monitoring in patients with traumatic brain injury	MEDICAL SCIENCE MONITOR			English	Article						arterial blood pressure; B waves; cerebral auto-regulation; cerebral perfusion pressure ultrasound	INTRA-CRANICAL PRESSURE; SEVERE HEAD-INJURY; AUTOREGULATION; EXPERIENCE; MANAGEMENT	Background: An increasing body of evidence supports the concept that intracranial pressure (ICP) slow B waves represent the auto-regulatory response of spontaneous fluctuations of cerebral perfusion pressure. A relationship between cerebral auto-regulation and clinical outcome in patients with traumatic brain injury has also been established. The objective of our prospective clinical study was to compare the B slow ICP waves obtained invasively by standard ICP monitoring to those obtained noninvasively using a new ultrasound technology. Material/Methods: In the participating institutions, over a period of six months, thirteen consecutive patients (8 males and 5 females) with severe closed bead injuries (GCS <8) were included in our IRB-approved study. Intracranial pressure and B slow waves, as well as arterial blood pressure and waveforms, were evaluated by standard invasive techniques. Additionally, a new non-invasive ultrasound device, Vittamed (Telematics Scientific Laboratory, Kaunas, Lithuania), was employed for monitoring intracranial blood volume slow waves. Using these modalities, it was possible to compare the changes that occurred with invasive monitoring (Correlation factor RI) and the changes that occurred using noninvasive technology (Correlation factor RN). Results: Bland Altman plot analysis showed positive correlation between the invasively and non-invasively obtained slow intracranial B waves (2sigma=8.9%, p<0.0001) and cerebral auto-regulation indexes (RI and RN) (SD=5%, p<0.0001). Positive RI and RN values were correlated with poor clinical outcome. Conclusions: Ultrasonographic technology (Vittamed) may have significant application in non-invasive continuous cerebrovascular auto-regulation monitoring in patients with severe head injuries.	Mercer Univ, Sch Med, Dept Neurosurg, Med Ctr Cent Georgia, Macon, GA 31207 USA; Kaunas Univ, Dept Neurosurg, Sch Med, Kaunas, Lithuania; Mercer Univ, Sch Med, Dept Neuroradiol, Med Ctr Cent Georgia, Macon, GA 31207 USA; Kaunas Univ Technol, Telemat Sci Lab, Kaunas, Lithuania		Fountas, KN (corresponding author), 840 Pine St,Suite 800, Macon, GA 31201 USA.	knfountasmd@excite.com	Ragauskas, Art/J-7486-2016	Ragauskas, Art/0000-0002-3536-554X			ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; COTTER DJ, 1982, MED INSTRUM, V16, P9; Czosnyka M, 2002, ACT NEUR S, V81, P117; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; CZOSNYKA M, 1993, INTRACRANIAL PRESSUR, V8, P699; FELDMAN Z, 1993, HEAD INJURY, P247; Fountas KN, 2002, CHILD NERV SYST, V18, P211, DOI 10.1007/s00381-002-0573-4; FOUNTAS KN, 2000, NEUROSURGERY, V47, P537; KAISER AM, 1987, DEV MED CHILD NEUROL, V29, P320; Kanter M J, 1991, Neurosurg Clin N Am, V2, P257; KANTER RK, 1985, CRIT CARE MED, V13, P837, DOI 10.1097/00003246-198510000-00012; KURAMOTO S, 1986, Neurological Research, V8, P93; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LYONS MK, 1990, MAYO CLIN PROC, V65, P684, DOI 10.1016/S0025-6196(12)65131-3; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Merwa R, 2004, PHYSIOL MEAS, V25, P347, DOI 10.1088/0967-3334/25/1/038; MILLER JD, 1978, BRIT J HOSP MED, V19, P497; NADVI SS, 1994, BRIT J NEUROSURG, V8, P573, DOI 10.3109/02688699409002950; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Penson RP, 1998, J ROY SOC HEALTH, V118, P289, DOI 10.1177/146642409811800515; Ragauskas A, 2003, MED ENG PHYS, V25, P667, DOI 10.1016/S1350-4533(03)00082-1; Rosner M J, 1976, Clin Neurosurg, V23, P494; RYDER HW, 1953, AMA ARCH NEUROL PSY, V70, P563, DOI 10.1001/archneurpsyc.1953.02320350015003; Sahuquillo J, 2000, ACTA NEUROCHIR SUPPL, V76, P485; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schmidt Bernhard, 2002, Eur J Ultrasound, V16, P37, DOI 10.1016/S0929-8266(02)00044-7; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Sidi A, 1999, J CLIN MONITOR COMP, V15, P185, DOI 10.1023/A:1009993232534; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236	36	15	15	0	2	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	FEB	2005	11	2					CR58	CR63					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	897UA	WOS:000227029700010	15668632				2022-02-06	
J	Travers, C; King, R				Travers, C; King, R			An investigation of organic factors in the neuropsychological functioning of patients with borderline personality disorder	JOURNAL OF PERSONALITY DISORDERS			English	Article							TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDHOOD ABUSE; HIPPOCAMPAL; NEUROBIOLOGY; DYSFUNCTION; AMYGDALA; ADULTS; WOMEN	The hypothesis to be tested in this study was that the cognitive deficits that have been documented in patients with Borderline Personality Disorder (BPD) are largely the consequence of organic insult, either developmental or acquired. Using a cross-sectional design, 80 subjects (males and females) who met the criteria for BPD participated in the study. They completed a battery of neuropsychological tests and a comprehensive interview assessing organic status as well as measures of the potentially confounding factors of current levels of depression and anxiety. It was expected that BPD-patients with a probable history of organic insult would perform significantly worse than would BPD patients without such a history. Analyses of the results provided partial support for the hypothesis. Subjects with both BPD and a history of organic insult were significantly more impaired on several measures including measures of attention than were BPD only subjects. The results suggested that the impaired cognitive performance of persons diagnosed with BPD may, in part, be attributed to organic factors.	Univ Queensland, Betty Byrne Henderson Womens Hlth Res Ctr, St Lucia, Qld 4067, Australia; Univ Queensland, Dept Psychiat, St Lucia, Qld 4067, Australia		Travers, C (corresponding author), Royal Brisbane & Womens Hosp, Betty Byrne Henderson Womens Hlth Res Ctr, Level 6,Ned Hanlon Bldg, Herston, Qld 4029, Australia.	traversc@psychiatry.uq.edu.au	Travers, Catherine/AAD-4938-2019; Travers, Catherine/F-5495-2010; King, Robert/F-5922-2010	Travers, Catherine/0000-0002-7762-2305; 			Abrahams S, 1999, BRAIN COGNITION, V41, P39, DOI 10.1006/brcg.1999.1095; ANDRULONIS PA, 1981, PSYCHIAT CLIN N AM, V4, P47; ANDRULONIS PA, 1982, J NERV MENT DIS, V170, P670, DOI 10.1097/00005053-198211000-00006; ANDRULONIS PA, 1984, BRIT J PSYCHIAT, V144, P358, DOI 10.1192/bjp.144.4.358; Army U. S, 1944, ARM IND TEST BATT MA; Barkley R. A., 1997, ASSESSMENT CHILDHOOD, P71; Bazanis E, 2002, PSYCHOL MED, V32, P1395, DOI 10.1017/S0033291702006657; Beck A. T., 1970, DEPRESSION CAUSES TR; Benton A., 1976, MULTILINGUAL APHASIA; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; Bowden S., 1992, CLIN NEUROPSYCHOL, V6, P43, DOI [10.1080/13854049208404116, DOI 10.1080/13854049208404116]; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corsi P. M., 1972, THESIS MCGILL U MONT; CUMMINGS LB, 1998, THESIS SCH PROFESSIO; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Fastenau PS, 1999, CLIN NEUROPSYCHOL, V13, P30, DOI 10.1076/clin.13.1.30.1976; First M.B., 1994, STRUCTURAL CLIN INTE, Vsecond; First M.B., 1996, STRUCTURED CLIN INTE; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; HERMAN JL, 1989, AM J PSYCHIAT, V146, P490; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; JUDD PH, 1993, J PERS DISORD, V7, P275, DOI 10.1521/pedi.1993.7.4.275; KAPUR N, 1988, MEMORY DISORDERS CLI; KORFINE L, 1998, THESIS HAVARD U; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; O'Leary KM, 2000, PSYCHIAT CLIN N AM, V23, P41, DOI 10.1016/S0193-953X(05)70142-8; OGATA SN, 1990, AM J PSYCHIAT, V147, P1008; OLEARY KM, 1991, AM J PSYCHIAT, V148, P106; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; SILVER AA, 1994, LIT REDEFINITION, P187; Spencer TJ, 2002, J CLIN PSYCHIAT, V63, P3; Spielberger CD., 1983, STATE TRAIT ANXIETY; Spreen O, 1991, COMPENDIUM NEUROPSYC; Sprock J, 2000, J CLIN PSYCHOL, V56, P1587, DOI 10.1002/1097-4679(200012)56:12<1587::AID-9>3.0.CO;2-G; *SPSS INC, 2001, SPSS ADV MOD; *SPSS INC, 2001, SPSS SAMPL POW 2 0; STREETER CC, 1995, J NERV MENT DIS, V183, P577, DOI 10.1097/00005053-199509000-00003; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; SWIRSKYSACCHETT.T, 1993, J CLIN PSYCHOL, V493, P385; Taylor E. M., 1959, APPRAISAL CHILDREN C; TEICHER MH, 1993, J NEUROPSYCH CLIN N, V5, P301; THOMPSON RF, 1976, AM PSYCHOL, V31, P209, DOI 10.1037/0003-066X.31.3.209; Torgersen S, 2000, COMPR PSYCHIAT, V41, P416, DOI 10.1053/comp.2000.16560; VANREEKUM R, 1993, J PSYCHIATR NEUROSCI, V18, P121; vanReekum R, 1996, J PSYCHIATR NEUROSCI, V21, P13; WALSH K, 1978, BRAIN IMPAIRMENT; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y; [No title captured]	59	15	15	0	4	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012 USA	0885-579X			J PERS DISORD	J. Pers. Disord.	FEB	2005	19	1					1	18		10.1521/pedi.19.1.1.62181			18	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	910WQ	WOS:000227963300001	15899717				2022-02-06	
J	Marmor, M; Parnes, N; Aladgem, D; Birshan, V; Sorkine, P; Halpern, P				Marmor, M; Parnes, N; Aladgem, D; Birshan, V; Sorkine, P; Halpern, P			Characteristics of road traffic accidents treated in an urban trauma center	ISRAEL MEDICAL ASSOCIATION JOURNAL			English	Article						road traffic accidents; urban trauma center	MOTOR-VEHICLE ACCIDENTS; EPIDEMIOLOGY; INJURY	Background: Road traffic accidents are the leading cause of accidental injury and death for persons under the age of 35. The medical literature presents surprisingly little information on the general characteristics of such accidents in the urban setting. Objectives: To characterize RTA patients arriving at an urban trauma center. Methods: We prospectively examined the charts of all patients admitted to the Tel Aviv Sourasky Medical Center due to RTA injuries during two periods in 1995. Results: Of the 1,560 patients examined, the male:female ratio was 1:1 and median age was 27 years (47% aged 20-30 years); 51% of the accidents took place between 8 a.m. and 4 p.m. and on working week days; automobiles comprised 47.1% of the vehicles involved, motorized two-wheel vehicles 37.1%, bicycles 3.8%, and pedestrians 12%. The Glasgow Coma Scale was 15 on arrival in 98.7% of the patients. The trunk was the most commonly injured body part (84.7%); whiplash injury to the neck was diagnosed in 343 patients (22%), and brain concussion in 183 (11.7%). Computed tomography studies were performed in 34 patients (2.2%). The vast majority of patients (1,438, 92.2%) was discharged home; 14 (0.9%) were admitted to the intensive care unit, and 2 (0.13%) died during hospitalization. The average time spent in the emergency department in the morning shift was 2.1 hours. Conclusions: We could identify distinguishing factors of this population: equal gender distribution, peak RTA incidence in the young adult working population during working hours, automobile drivers being the most injured subgroup, a disproportionate number of motorcycle and motor scooter involvement, and a relatively extensive amount of time and resources spent treating these injuries despite their generally minor nature.	Tel Aviv Sourasky Med Ctr, Dept Emergency Med, IL-64239 Tel Aviv, Israel; Tel Aviv Sourasky Med Ctr, Dept Orthoped B, IL-64239 Tel Aviv, Israel; Tel Aviv Sourasky Med Ctr, Intens Care Unit, IL-64239 Tel Aviv, Israel		Halpern, P (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Emergency Med, 6 Weizman St, IL-64239 Tel Aviv, Israel.	dr_halperin@tasmc.health.gov.il	Marmor, Michael/L-9014-2015; Marmor, Meir/AAC-8596-2020				Aharonson-Daniel L, 2001, Harefuah, V140, P919; Andrade S M, 2001, Rev Saude Publica, V35, P318, DOI 10.1590/S0034-89102001000300017; Charbotel B, 2001, EUR J EPIDEMIOL, V17, P773, DOI 10.1023/A:1015667114529; Goldberg J, 2002, ANN EMERG MED, V40, P429, DOI 10.1067/mem.2002.128187; HYOT DB, 1997, ESSENTIALS SURG SCI, P271; Jirojwong Sansnee, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P193; Levine N, 1995, ACCIDENT ANAL PREV, V27, P785, DOI 10.1016/0001-4575(95)00038-0; LIDDELL FDK, 1982, J EPIDEMIOL COMMUN H, V36, P140, DOI 10.1136/jech.36.2.140; LINDQVIST KS, 1991, ACCIDENT ANAL PREV, V23, P509, DOI 10.1016/0001-4575(91)90016-X; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; Nofal RH, 1996, J ROY SOC HEALTH, V116, P304, DOI 10.1177/146642409611600508; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; Petridou E, 1997, ACCIDENT ANAL PREV, V29, P687, DOI 10.1016/S0001-4575(97)00038-9; RICHTER ED, 1981, INT J EPIDEMIOL, V10, P145, DOI 10.1093/ije/10.2.145; Simoncic M, 2001, ACCIDENT ANAL PREV, V33, P147, DOI 10.1016/S0001-4575(00)00025-7	15	15	15	0	10	ISRAEL MEDICAL ASSOC JOURNAL	RAMAT GAN	2 TWIN TOWERS, 11TH FL, 35 JABOTINSKY ST, PO BOX 3604, RAMAT GAN 52136, ISRAEL	1565-1088			ISR MED ASSOC J	Isr. Med. Assoc. J.	JAN	2005	7	1					9	12					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886SM	WOS:000226248800003	15658138				2022-02-06	
J	Gastone, P; Fabrizia, C; Homere, M; Francesco, C; Alberto, M; Nicola, D				Gastone, P; Fabrizia, C; Homere, M; Francesco, C; Alberto, M; Nicola, D			Chronic subdural hematoma: Results of a homogeneous series of 159 patients operated on by residents	NEUROLOGY INDIA			English	Article						chronic subdural hematoma; surgical training; head injury	CLOSED-SYSTEM DRAINAGE; SURGICAL-TREATMENT; CRANIOTOMY; RECURRENCE	Aims: A series of cases with chronic subdural hematoma operated upon by residents in neurosurgery is analysed. Materials and Methods: 159 patients treated between 1998 and 2001 were included in the study. Mean age was 76.4 years and male/female ratio was 1.7/1. The patients were classified both on admission and at discharge according to the Markwalder scale. The standard operative procedure consisted of an enlarged single burr-hole, rinsing the subdural space with iso-osmotic saline solution and insertion of a subdural drain. Conclusion: In CSDH, operation by the residents is safe and the results are comparable to those of the major series of the literature as the surgical procedure is standardized.	Univ Florence, Neurosurg Clin, I-50121 Florence, Italy		Gastone, P (corresponding author), Osped CTO, Neurosurg Clin, Largo P Palagi 1, I-50139 Florence, Italy.	dilorenzo@unifi.it	Cacciola, Francesco/AAV-1559-2021	Cacciola, Francesco/0000-0001-6290-9189			Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; HAMILTON MG, 1993, NEUROSURGERY, V33, P67; KOTWICA Z, 1991, British Journal of Neurosurgery, V5, P461, DOI 10.3109/02688699108998474; Lind CRP, 2003, J NEUROSURG, V99, P44, DOI 10.3171/jns.2003.99.1.0044; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; Mellergard P, 1996, ACTA NEUROCHIR, V138, P708, DOI 10.1007/BF01411476; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Nakajima H, 2002, SURG NEUROL, V58, P385, DOI 10.1016/S0090-3019(02)00921-7; Penchet G, 1998, NEUROCHIRURGIE, V44, P247; RICHTER HP, 1984, ACTA NEUROCHIR, V71, P179, DOI 10.1007/BF01401313; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; Suzuki K, 1998, SURG NEUROL, V50, P231, DOI 10.1016/S0090-3019(97)00339-X; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937	14	15	20	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	DEC	2004	52	4					475	477					3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	887RV	WOS:000226324100013	15626837				2022-02-06	
J	Glass, TF; Reeves, B; Sharp, FR				Glass, TF; Reeves, B; Sharp, FR			The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture	NEUROBIOLOGY OF DISEASE			English	Article						excitotoxicity; NMDA; AMPA; glutamate; traumatic brain injury; hypoxia; lschemia; culture; neuronal	TRAUMATIC BRAIN-INJURY; METABOTROPIC GLUTAMATE RECEPTORS; BINDING PROTEIN-PHOSPHORYLATION; SEVERE HEAD-INJURY; STRIATAL NEURONS; NMDA RECEPTORS; CREB SHUTOFF; ISCHEMIA; CHILDREN; DEATH	Traumatic brain injury (TBI) involves alterations in neuronal physiology, often complicated by secondary hypoxic or hypotensive events. Excitotoxicity is an important process induced in both TBI and hypoxic or ischemic insults to the brain. We investigated two hypotheses: (1) excitotoxicity is more prominent following combined mechanical and hypoxic injury than either alone; (2) both AMPA and NNMA receptor activation mediate combined mechanical and hypoxic injury. Media in primary mixed neuronal cultures were replaced with conditioned media containing MK801 (NMDA antagonist) and/or NBQX (AMPA/kainate antagonist). Cultures were then subjected to mechanical injury. Afterward, media were exchanged for hypoxic media containing the antagonist, and plates were placed in hypoxia chambers for 7 h. At 24 h following hypoxia, LDH release, trypan blue uptake, and morphologic changes were assessed. Blockade had no effect after mechanical injury. After hypoxia, MK801 and combined MK801/NBQX decreased LDH and trypan blue to control levels. NBQX alone after hypoxia had less impact. After combined mechanical injury and hypoxia, both MK801 and NBQX partially reduced LDH and trypan blue. Combining the antagonists led to reduction to control values for both endpoints. We conclude that excitotoxic processes are more prominent after combined than isolated injuries in neurons and that increased cell death is mediated by both NMDA and AMPA receptor activation following combined injuries. (C) 2004 Elsevier Inc. All rights reserved.	Childrens Hosp, Med Ctr, Dept Pediat Emergency Med, Cincinnati, OH 45229 USA; Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Neurosci Program, Cincinnati, OH 45267 USA		Glass, TF (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat Emergency Med, Locat C 2008,3333 Burnet Ave, Cincinnati, OH 45229 USA.	todd.glass@cchme.org					Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Boswell WC, 1996, SOUTHERN MED J, V89, P218, DOI 10.1097/00007611-199602000-00012; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chen HM, 2003, J WORLD BUS, V38, P1, DOI 10.1016/S1090-9516(02)00105-0; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Glass TF, 2002, NEUROSCI LETT, V328, P133, DOI 10.1016/S0304-3940(02)00510-4; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Halterman MW, 1999, EXP NEUROL, V159, P65, DOI 10.1006/exnr.1999.7160; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; HOVDA DA, 1990, ACT NEUR S, V51, P331; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Koura SS, 1998, ACT NEUR S, V71, P244; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Mao L, 2002, NEUROSCIENCE, V115, P395, DOI 10.1016/S0306-4522(02)00400-1; Mao LM, 2002, MOL PHARMACOL, V62, P473, DOI 10.1124/mol.62.3.473; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Nucci C, 2000, BIOCHEM BIOPH RES CO, V278, P360, DOI 10.1006/bbrc.2000.3811; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; Schurov IL, 1999, J NEUROENDOCRINOL, V11, P43	31	15	17	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	DEC	2004	17	3					378	384		10.1016/j.nbd.2004.07.017			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	878UD	WOS:000225671600003	15571974				2022-02-06	
J	Yildirim, E; Solaroglu, I; Okutan, O; Ozisik, K; Kaptanoglu, E; Sargon, MF; Sakinci, U				Yildirim, E; Solaroglu, I; Okutan, O; Ozisik, K; Kaptanoglu, E; Sargon, MF; Sakinci, U			Ultrastructural changes in tracheobronchial epithelia following experimental traumatic brain injury in rats: Protective effect of erythropoietin	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article							NEUROGENIC PULMONARY-EDEMA; ACUTE LUNG INJURY; CENTRAL-NERVOUS-SYSTEM; MUCOCILIARY TRANSPORT; NITRIC-OXIDE; RESPIRATORY EPITHELIUM; HEME OXYGENASE-1; IN-VITRO; ANTIOXIDANT; TRANSPLANTATION	Background: We aimed to demonstrate the time dependent ultrastructural changes in tracheobronchial epithelia after traumatic brain injury. And also, protective effect of erythropoietin was demonstrated. Methods: We used 56 Wistar-Albino female rats weighing 170 to 200 g. The rats were allocated into 7 groups. First group was the control. The second underwent craniotomy without trauma. The third, fourth, and fifth groups were respectively 2-, 8-, and 24-hour trauma groups. The sixth and seventh groups were respectively treatment (erythropoietin, 1,000 IU/kg) and vehicle (0,4 ml/rat) groups. Weight-drop method was used for achieving head trauma. Samples were obtained from both trachea and main bronchi. Modified electron microscopic scoring model was used to reveal the ultrastructural changes in both trauma and treatment groups. Results: There was no statistical difference between control and sham groups (p > 0.05). Scores of all trauma groups were significantly different from the controls (p < 0.05). Trauma produced obvious gradual damage on ultrastructure of the tracheobronchial epithelia. Erythropoietin decreased tracheobronchial scores after traumatic brain injury in significant levels. Erythropoietin attenuated ultrastructural scores for each organelle in significant levels (p < 0.05 for each organelle). Conclusions: The data suggested that ultrastructural damage is obvious at 2 hours deteriorating with time. Erythropoietin protects epithelia against damage after traumatic brain injury. Pharmaceutical lung preservation may help gaining efficacious donor lungs in brain death. But, further time dependent experiments are needed to determine the liability of the donor lung after traumatic brain injury. This fact is to be known for achieving higher graft survival rates. Copyright (C) 2004 by the International Society for Heart and Lung Transplantation.	Univ Hacettepe, Ankara Numune Educ & Res Hosp, Dept Thorac Surg, TR-06100 Ankara, Turkey; Univ Hacettepe, Ankara Numune Educ & Res Hosp, Dept Neurosurg, TR-06100 Ankara, Turkey; Univ Hacettepe, Fac Med, Dept Anat, TR-06100 Ankara, Turkey		Yildirim, E (corresponding author), Asagiovecler Mh 79 sk 8-3, TR-06460 Ankara, Turkey.	erseyda@yahoo.com	YILDIRIM, Erkan/AAO-6961-2020; Sargon, Mustafa F./AAZ-5470-2021; Solaroglu, Ihsan/ABF-7606-2020; Solaroglu, Ihsan/ABE-8816-2020	Sargon, Mustafa F./0000-0001-6360-6008; Solaroglu, Ihsan/0000-0002-9472-1735			ALBERTS B, 1994, MOL BIOL CELL, P569; Atkinson JLD, 1997, NEUROSURGERY, V41, P1214, DOI 10.1097/00006123-199711000-00052; BanyMohammed FM, 1996, PEDIATR RES, V40, P381, DOI 10.1203/00006450-199609000-00003; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Berger SP, 2000, KIDNEY INT, V58, P2314, DOI 10.1046/j.1523-1755.2000.00415.x; BODENHAM A, 1989, BRIT MED J, V299, P1009, DOI 10.1136/bmj.299.6706.1009; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; CECKA JM, 1988, DONOR PRESERVATION F, P399; Cerami A, 2001, SEMIN HEMATOL, V38, P33, DOI 10.1053/shem.2001.27484; CORMAN J, 1991, ANN CHIR, V45, P791; DETTBARN CL, 1989, HEART LUNG, V18, P583; Eid Tore, 2002, Clin Breast Cancer, V3 Suppl 3, pS109, DOI 10.3816/CBC.2002.s.021; FRIZZELL RA, 1988, AM REV RESPIR DIS, V138, pS3, DOI 10.1164/ajrccm/138.6_Pt_2.S3; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hall SRR, 2002, ANESTH ANALG, V94, P948; HASANI A, 1994, EUR RESPIR J, V7, P1497, DOI 10.1183/09031936.94.07081497; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; Holt AW, 1999, MED J AUSTRALIA, V170, P479, DOI 10.5694/j.1326-5377.1999.tb127848.x; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kaptanoglu E, 2002, J NEUROSURG ANESTH, V14, P114, DOI 10.1097/00008506-200204000-00005; Kondo CS, 2002, CRIT CARE, V6, P81, DOI 10.1186/cc1458; KONRAD F, 1995, INTENS CARE MED, V21, P482, DOI 10.1007/BF01706201; Marti HH, 1997, KIDNEY INT, V51, P416, DOI 10.1038/ki.1997.55; PEARSON FG, 2002, THORACIC SURG, P215; PEARSON FG, 2002, THORACIC SURG, P9; Pieper GM, 2001, ANTIOXID REDOX SIGN, V3, P81, DOI 10.1089/152308601750100542; Pyeron A M, 2001, J Neurosci Nurs, V33, P203; SAID SI, 1995, NEUROSCIENCE, V65, P943, DOI 10.1016/0306-4522(95)00021-A; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schutz A, 2002, CELLS TISSUES ORGANS, V170, P246, DOI 10.1159/000047928; Schwarz S, 1997, NERVENARZT, V68, P956, DOI 10.1007/s001150050222; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; Taira M, 2002, AM J PHYSIOL-LUNG C, V282, pL556, DOI 10.1152/ajplung.00360.2001; Trout L, 1998, AM J PHYSIOL-LUNG C, V274, pL258, DOI 10.1152/ajplung.1998.274.2.L258; Tsuchihashi S, 2003, SURGERY, V133, P556, DOI 10.1067/msy.2003.124; WAUCHOB TD, 1984, ANAESTHESIA, V39, P529, DOI 10.1111/j.1365-2044.1984.tb07355.x	40	15	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	DEC	2004	23	12					1423	1429		10.1016/j.healun.2003.10.006			7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	884LS	WOS:000226087100015	15607673				2022-02-06	
J	McGrath, J				McGrath, J			Beyond restoration to transformation: positive outcomes in the rehabilitation of acquired brain injury	CLINICAL REHABILITATION			English	Article							SENSE; SELF	Objectives: This paper compares the situation of the person with acquired brain injury to that of the people of Israel in the sixth century BCE (before the current era) during the period of exile in Babylon. Both situations are characterized by traumatic multiple losses, and a struggle to regain a sense of identity: personal, national or spiritual. Evidence from the literature on both brain injury rehabilitation and from the Hebrew Scriptures indicates that models of restoration of function and transformation of suffering have been applied to both situations. The relative strengths and weaknesses of these models are considered, and it is argued that models of transformation of suffering have much to offer, especially in the longer term psychotherapeutic rehabilitation of people with acquired brain injury, when restoration of function has reached its limits.	Rivermead Rehabil Ctr, Oxford OX1 4XD, England; Univ Oxford, Oxford, England		McGrath, J (corresponding author), Wycliffe Hall,54 Banbury Rd, Oxford OX2 6PW, England.	Joanna.McGrath@wycliffe.ox.ac.uk					ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; DIRENFELD G, 1991, COGNIT REHABIL, V9, P20; Folkman S., 1984, STRESS; FRANK RG, 1987, CLIN PSYCHOL REV, V7, P611, DOI 10.1016/0272-7358(87)90009-2; Frankl V.E., 1963, MANS SEARCH MEANING; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; JUNG CG, 1955, INTERPRETATION NATUR; KAY T, 1986, MINOR HEAD INJURY IN; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; MCGRATH J, 1998, THESIS OXFORD BROOKE; MOHL PC, 1982, GEN HOSP PSYCHIAT, V4, P113, DOI 10.1016/0163-8343(82)90040-8; Nadell J., 1991, COGNITIVE REHABILITA, V9, P8; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; PRIGATANO G, 1986, NEUROPSYCHOL REHABIL, P216; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Smith Daniel, 1989, RELIG LANDLESS, P198; STILLWELL J, 1997, NATL TRAUMATIC BRAIN; Whitehouse A. M., 1994, J COGN PSYCHOTHER, V8, P141; [No title captured]	23	15	15	0	3	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.	NOV	2004	18	7					767	775		10.1191/0269215504cr802oa			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	871VM	WOS:000225164700007	15573833				2022-02-06	
J	Greenwood, RJ; Strens, LHA; Watkin, J; Losseff, N; Brown, MM				Greenwood, RJ; Strens, LHA; Watkin, J; Losseff, N; Brown, MM			A study of acute rehabilitation after head injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						acute rehabilitation; head injury; resource use	TRAUMATIC BRAIN-INJURY	In 1999 a report from the Royal College of Surgeons of England drew attention to the fact that, in the UK, there is little structured acute inpatient rehabilitation for patients admitted after traumatic brain injury (TBI). This paper reports the results of a retrospective study of acute inpatient rehabilitation (AR) after TBI, comparing aspects of resource use in 92 patients who received structured unit-based multidisciplinary AR with 97 patients who received usual practice. About 10% of patients admitted via casualty after TBI required AR after neurosurgical consultation or care. These patients remained in AR for a mean of 20.5 days; length of stay in an acute bed was not prolonged compared with patients in usual practice. Sixty per cent of patients discharged home from unit-based care were referred to community-based rehabilitation on discharge compared with no patients discharged home from neurosurgical care. There is an urgent need to discuss and plan at national level the structured secondary provision of acute rehabilitation after acquired brain injury.	Natl Hosp Neurol & Neurosurg, Acute Brain Injury Serv, London WC1N 3BG, England; UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; UCL, Inst Neurol, Dept Headache Brain Injury & Neurorehabil, London, England		Greenwood, RJ (corresponding author), Natl Hosp Neurol & Neurosurg, Acute Brain Injury Serv, Queen Sq, London WC1N 3BG, England.	richard.greenwood@uclh.org	Brown, Martin M/B-3288-2009	Brown, Martin M/0000-0002-3273-1356			COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Edwards MJ, 2003, DISABIL REHABIL, V25, P405, DOI 10.1080/0963828031000062642; *HOUS COMM, 2001, HEAD INJ REH; LIVINGSTON MG, 1986, BRIT MED J, V293, P742, DOI 10.1136/bmj.293.6549.742; MCKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; *ROYAL COLL PHYS, 2002, NAT CLIN GUID STROK; *ROYAL COLL SURG E, 1999, REP WORK PART MAN PA; Royal College of Physicians, 2000, MED REH PEOPL PHYS C; Seeley HM, 2001, EMERG MED J, V18, P358, DOI 10.1136/emj.18.5.358; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Swann IJ, 2001, EMERG MED J, V18, P352, DOI 10.1136/emj.18.5.352; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Turner-Stokes L, 2004, CLIN MED, V4, P61, DOI 10.7861/clinmedicine.4-1-61; TURNERSTOKES L, 2003, REHABILITATION FOLLO	17	15	15	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2004	18	5					462	466		10.1080/02688690400012327			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	881JL	WOS:000225863000002	15799146				2022-02-06	
J	Spikman, JM; Van Der Naalt, J; Van Weerden, TW; Van Zomeren, AH				Spikman, JM; Van Der Naalt, J; Van Weerden, TW; Van Zomeren, AH			Indices of slowness of information processing in head injury patients: Tests for selective attention related to ERP latencies	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						selective attention; event-related potentials; head injury	EVENT-RELATED POTENTIALS; AUDITORY ODDBALL TASK; REACTION-TIME; GO/NOGO TASK; INHIBITION; COMPONENTS; DEFICITS; RECOVERY; PERFORMANCE; AMPLITUDE	We explored the relation between neuropsychological (attention tests involving time constraints) and neurophysiological (N2 and P3 event-related potential (ERP) latencies) indices of slowness of information processing after closed head injury (CHI). A group of 44 CHI patients performed worse than healthy controls on most neuropsychological indices, and had significantly longer ERP latencies. Significant correlations between neuropsychological measures and ERP latencies were found only for the 3 subtasks of the Stroop test. In additional multiple regression analyses P3 latency appeared the best predictor in Stroop Color only. A possible explanation is that stimulus evaluation processes comprise a relatively large part of performance on this subtask. In Stroop Color-Word, response related processes are supposed to play a greater role, reducing the role of the preceding input related processes. The absence of significant correlations between P3 latency and scores on the other attention tests suggests a relatively small role of stimulus evaluation processes in these tasks, implying that these tasks are not sensitive to slowness of these processes. The Stroop test appears to be the only attention test administered in which slowness ill Stimulus evaluation processes requiring selective attention contributes significantly to the delay in final performance on the task.	Rehabil Ctr Friesland, Beetsterzwaag, Netherlands		Spikman, JM (corresponding author), Acad Hosp, Dept Neurol, AZG, Hanzeplein 1, NL-9713 AB Groningen, Netherlands.	J.m.spikman@neuro.azg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418			Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; BROUWER WH, 1985, THESIS STATE U GRONI; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; Campbell K. B., 1995, HDB NEUROPSYCHOLOGY, V10, P269; CAMPBELL KB, 1990, NEW TRENDS ADV TECHN, P202; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; Curry S H, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P283; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Donchin E., 1988, BEHAVIORAL BRAIN SCI, V11, P355, DOI DOI 10.1017/S0140525X00058027; DONCHIN E, 1986, PSYCHOPHYSIOLOGY SYS, P702; Donchin E., 1986, PSYCHOPHYSIOL SYST P, P244; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; Gron G, 1996, J CLIN EXP NEUROPSYC, V18, P406, DOI 10.1080/01688639608408997; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Hillyard Steven A., 1995, P665; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; KOK A, 1990, ACTA PSYCHOL, V74, P203; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; Kok A, 2000, BIOL PSYCHOL, V54, P107, DOI 10.1016/S0301-0511(00)00054-5; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; MCCARTHY G, 1981, SCIENCE, V21, P171; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Plum F., 1987, HDB PHYSL 1 NERVOUS, V5, P519; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; STOCKX LC, 1986, J CLIN EXPT NEUROPSY, V8, P421; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; UNSAL A, 1995, PSYCHOPHYSIOLOGY, V32, P249, DOI 10.1111/j.1469-8986.1995.tb02953.x; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P; VANZOMEREN AH, 1981, THESIS STATE U GRONI; WARREN LR, 1979, INT J NEUROSCI, V9, P217, DOI 10.3109/00207457909147677; [No title captured]	53	15	18	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2004	10	6					851	861		10.1017/S1355617704106061			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	862PB	WOS:000224502000006	15637776	Green Published			2022-02-06	
J	Adekoya, N; Majumder, R				Adekoya, N; Majumder, R			Fatal traumatic brain injury, West Virginia, 1989-1998	PUBLIC HEALTH REPORTS			English	Article							MOTOR-VEHICLE CRASHES; ELDERLY PERSONS; UNITED-STATES; RURAL TRAUMA; RISK; MORTALITY; FALLS; COMMUNITY; FIREARMS; SYSTEM	Objective. The objective of this study was to describe fatal cases of traumatic brain injury (TBI) among West Virginia residents. Methods. The authors analyzed data from the National Center for Health Statistics Multiple Cause of Death tapes for the period 1989-1998. They compared West Virginia's annualized average TBI death rate with the rates of other states and with the rate among U.S. residents for the same period. U.S. Bureau of Census population estimates were used as denominators. Results. A total of 4,416 TBI deaths occurred in West Virginia in 1989-1998, for an annual average death rate of 23.6 per 100,000 population. From 1989 to 1998, TBI death rates declined 5% (p=0.4042). Seventy-five percent (n=3,31 5) of fatalities occurred among men. Adults greater than or equal to65 years of age accounted for the highest percentage of fatal injuries (n= 1,135). The leading external causes of fatal TBI were: firearm-related (39% of reported fatalities), motor vehicles-related (34%), and fall-related (10%). Firearm-related TBI became the leading cause of TBI fatalities in 1991, surpassing motor vehicle-related TBI. Seventy-five percent of firearm-related TBI deaths were suicides (n=1,302). West Virginia's TBI death rate (23.6 per 100,000) was higher than the national rate (20.6 per 100,000). In 23 states, the average TBI death rates over the 10-year period were higher than West Virginia's. Whereas modest declines in TBI death rates occurred for motor vehicle-related and firearm-related causes in West Virginia, a concomitant 38% increase occurred in the fall-related TBI death rate during the decade. Conclusion. Data presented in this report can be used to develop targeted prevention programs in West Virginia.	Ctr Dis Control & Prevent, Epidemiol Program Off, Surveillance Sust Branch, CDC, Atlanta, GA 30341 USA; W Virginia Univ, Rehabil Res & Training Ctr, Morgantown, WV 26506 USA		Adekoya, N (corresponding author), Ctr Dis Control & Prevent, Epidemiol Program Off, Surveillance Sust Branch, CDC, MS-K74,4770 Buford Hwy, Atlanta, GA 30341 USA.	nba7@cdc.gov					BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; BAKER SP, 1992, OVERVIEW INJURY MORT; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BRODSKY H, 1983, SOC SCI MED, V17, P731, DOI 10.1016/0277-9536(83)90261-7; *CDCP NAT CTR INJ, WELC WISQARS TM FAT; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Clark DE, 1999, ACAD EMERG MED, V6, P125, DOI 10.1111/j.1553-2712.1999.tb01050.x; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; Cummings P, 2001, INJURY CONTROL, P64; Derrig RA, 2002, ACCIDENT ANAL PREV, V34, P101, DOI 10.1016/S0001-4575(01)00004-5; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; ESCOBEDO LG, 1992, ACCIDENT ANAL PREV, V24, P643, DOI 10.1016/0001-4575(92)90016-C; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gotsch K. E., 2001, Morbidity and Mortality Weekly Report, V50, P1; Helmkamp, 2000, Ann Epidemiol, V10, P478, DOI 10.1016/S1047-2797(00)00116-2; Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X; Hoyert DL, 2001, PEDIATRICS, V108, P1241, DOI 10.1542/peds.108.6.1241; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Lerner E B, 2000, Air Med J, V19, P134, DOI 10.1016/S1067-991X(00)90003-8; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; *NAT CTR HLTH STAT, 1995, VIT STAT US MORT; Ota FS, 2001, AM J EMERG MED, V19, P204, DOI 10.1053/ajem.2001.22662; *PUBL HLTH SERV US, 2001, NAT STRAT SUIC PREV; RAY WA, 1989, LANCET, V1, P687; Rivara FP, 1999, AM J PREV MED, V16, P1, DOI 10.1016/S0749-3797(98)00111-1; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; Rogers FB, 1997, ARCH SURG-CHICAGO, V132, P376; ROZENFELD S, 2003, PAN AM J PUBLIC HLTH, V13, P369; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46, DOI 10.1111/j.1532-5415.1991.tb05905.x; THAPA PB, 1995, AM J EPIDEMIOL, V142, P202, DOI 10.1093/oxfordjournals.aje.a117619; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Wiebe DJ, 2003, ACCIDENT ANAL PREV, V35, P711, DOI 10.1016/S0001-4575(02)00049-0; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106; World Health Organization, 1977, INT CLASS DIS MAN IN; 1999, MMWR MORB MORTAL WKL, V48, P369	41	15	15	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-3549	1468-2877		PUBLIC HEALTH REP	Public Health Rep.	SEP-OCT	2004	119	5					486	492		10.1016/j.phr.2004.07.006			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	860BC	WOS:000224311200006	15313112	Green Published			2022-02-06	
J	Bhatoe, HS				Bhatoe, HS			Missile injuries of the anterior skull base	SKULL BASE-AN INTERDISCIPLINARY APPROACH			English	Article						brain abscess; gunshot wound; head injury; meningitis; missile injury; orbitocranial injury	GUNSHOT WOUNDS; HEAD WOUNDS; PROGNOSIS	Missile injuries of the anterior skull base usually occur during war or warlike situations. These injuries may be isolated or associated with multiple traumatic injuries. We report 23 such cases managed during military conflicts and peacekeeping operations. All were adult males. Four of these patients sustained bullet injuries; the rest were injured from shrapnel. Eighteen patients had injury to the visual apparatus with permanent blindness. Proptosis was seen In 16, cerebrospinal fluid (CSF) leak from the wound in seven, and CSF orbitorrhea in three patients. Sixteen had irreparable injury to the eye necessitating evisceration/ enucleation, and two had retrobulbar optic nerve injury. Three patients were comatose [Glasgow Coma Scale (GCS) 3/15], and 14 had altered sensorium. Six patients were fully conscious. All were investigated by computed tomography (CT), which revealed injury to the eyeball and skull base, orbital fracture, frontal hematoma, contusion, and pneumocephalus. Seventeen patients underwent emergency surgery, and six patients were initially managed conservatively. Neurosurgical management consisted of making bifrontal flaps, craniotomy/craniectomy, debridement, and repair of the base with fascia lata. Reconstruction of the orbital rim was required in three cases. All were managed postoperatively with cerebral decongestants and antibiotics in antimeningitic dosages. There was one death in the postoperative period; outcome was good in 16 and moderate in four patients. Twelve patients had retained intracranial splinters; three of these developed recurrent suppurative meningitis. Of the six patients initially managed conservatively, three were subsequently operated for CSF rhinorrhea. Gross communition, dural loss, and injury to the frontal scalp often preclude the use of pericranial repair of the skull base. Fascia lata is extremely useful for reconstruction and repair. Anterior cranial fossa injury probably carries a better prognosis; however, there is increased risk of suppurative complications due to breach of air-fined sinuses by the missile and contamination of the intradural compartment, as compared with supratentorial vault injuries not involving the orbit or paranasal sinuses. Three patients who underwent no operative procedure and remain asymptomatic are under follow-up.	Army Hosp R&R, Dept Neurosurg, Delhi 110010, India		Bhatoe, HS (corresponding author), Army Hosp R&R, Dept Neurosurg, Delhi 110010, India.	hsbhatoe@indiatimes.com					Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; Betz P, 1997, FORENSIC SCI INT, V86, P155, DOI 10.1016/S0379-0738(97)02121-X; Bhatoe HS, 2001, NEUROL INDIA, V49, P29; BHATOE HS, 1997, ASIAN ARCH CRITICAL, V46, P63; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Cooper PR, 1993, HEAD INJURY, P355; Dillon J D Jr, 1975, Surg Neurol, V4, P515; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Jankovic S, 1998, MIL MED, V163, P490, DOI 10.1093/milmed/163.7.490; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; LEVY M, 2000, OUTCOME PREDICTION F; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; Splavski B, 1998, SURG NEUROL, V50, P194, DOI 10.1016/S0090-3019(98)00047-0; SWAN KG, 1991, SURG CLIN N AM, V71, P221	16	15	16	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1531-5010			SKULL BASE-INTERD AP	Skull Base-Interdiscip. Appr.	FEB	2004	14	1					1	8		10.1055/s-2004-821351			8	Clinical Neurology; Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology; Surgery	800PM	WOS:000220040200001	16145579	Green Published			2022-02-06	
J	O'Neil-Pirozzi, TM; Kendrick, H; Goldstein, R; Glenn, M				O'Neil-Pirozzi, TM; Kendrick, H; Goldstein, R; Glenn, M			Clinician influences on use of portable electronic memory devices in traumatic brain injury rehabilitation	BRAIN INJURY			English	Article							AIDS; REMEMBER; PEOPLE	Primary objective: To explore the relationship between a group of clinicians' own experience, training and confidence with portable electronic memory devices and their use of the same in traumatic brain injury (TBI) rehabilitation. Research design: Survey study. Methods and procedures: Eighty-one TBI clinicians from various disciplines and work settings completed a survey distributed in person or by mail. Main outcomes and results: Twenty-nine respondents (36%) reported using portable electronic memory devices with patients with TBI. Using regression analysis, respondent device training and confidence teaching patients device use were statistically associated with respondents' use of such devices in TBI rehabilitation. Conclusions: Portable electronic memory device use with persons following TBI may be under-utilized. The importance of ongoing clinician training and of maximizing clinician confidence utilizing these devices in TBI rehabilitation is emphasized. The representativeness of the respondent sample is discussed. Specific training strategies and continued research needs are presented.	Northeastern Univ, CCC SLP, Speech Language Pathol & Audiol Dept, Boston, MA 02115 USA; Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Profess Dev Dept, Boston, MA USA; Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, CCC SLP, Speech Language Pathol & Audiol Dept, 103 Forsyth Bldg, Boston, MA 02115 USA.	toneilpi@lynx.dac.neu.edu					*AM SPEECH LANG HE, 1997, HLTH CAR ISS BRIEF L; Fuhrer MJ, 2001, AM J PHYS MED REHAB, V80, P528, DOI 10.1097/00002060-200107000-00013; GALVIN JC, 2002, ASSIST TECHNOL, P153; Glisky E. L, 1995, HDB MEMORY DISORDERS, P557; GOLPER LAC, 2002, CURR TRENDS HLTH CAR; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; LYNCH WJ, 1995, J HEAD TRAUMA REHAB, V10, P94, DOI 10.1097/00001199-199502000-00011; PETRO SJ, 1991, INT J AGING HUM DEV, V33, P295, DOI 10.2190/0J3N-F3QB-TEDH-CUYX; Scherer Marcia J., 2000, LIVING STATE STUCK A; Scherer MJ, 2002, DISABIL REHABIL, V24, P1, DOI 10.1080/09638280110066262; Sohlberg M., 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; *STAT CORP, 2001, STAT 7 0; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; TEMKIN T, 1999, NEEDS ASSESSMENT RES; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146	23	15	15	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2004	18	2					179	189		10.1080/0269905031000149560			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	751DR	WOS:000187038000006	14660229				2022-02-06	
J	Padosch, SA; Bottiger, BW				Padosch, Stephan A.; Boettiger, Bernd W.			Neuronal apoptosis following cerebral ischaemia: pathophysiology and possible therapeutic implications	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						cerebral ischaemia; neuroprotection; apoptosis; death receptors; erythropoietin; Bcl proteins	TRANSIENT BRAIN ISCHEMIA; INDUCIBLE FACTOR-I; ERYTHROPOIETIN PROTECTS; CARDIAC-ARREST; BCL-XL; NEUROPROTECTION; INJURY; VIVO; INHIBITION; TOLERANCE	Purpose of review Neuronal apoptosis following cerebral ischaemia has become an issue of extraordinary scientific interest in the past decade. Besides necrosis, this highly relevant pathomechanism has been shown to be markedly involved in the pathogenesis of delayed postischaemic neuronal damage. As a result, a variety of possible neuroprotective strategies and therapeutic options subsequent to cerebral ischaemia have emerged. This article provides an overview of the pathophysiologic mechanisms underlying delayed neuronal apoptotic degeneration after cerebral ischaemia. Based on these facts, selected therapeutic implications are discussed in detail. Recent findings Recent findings from experimental studies have demonstrated a new therapeutic neuroprotective potential of pharmaceutical blockade of death-inducing ligands (e.g. Fas/CD95 ligand), enhancement of survival signal transduction with endogenous ligands (e.g. erythropoietin) and therapeutically modulating the balance between intracellular anti-and proapoptotic Bcl proteins with intriguing molecular techniques after cerebral ischaemia. Summary Neuronal apoptosis is highly relevant in the pathophysiology of neurodegenerative disorders, neurotrauma and cerebral ischaemia/reperfusion. Within the past few years, a variety of therapeutic strategies have emerged based on our increasing knowledge of the pathophysiology of apoptosis. Whereas inhibition of single factors in apoptotic cascades (e.g. proteases) has produced rather unsatisfying results, new opportunities have emerged at the molecular level due to advances in molecular medicine. These approaches offer promising opportunities for neuroprotective therapeutic strategies subsequent to cerebral ischaemia. It is tempting to speculate that a combination ('cocktail') of these antiapoptotic interventions might even increase their neuroprotective potential.	[Boettiger, Bernd W.] Heidelberg Univ, Dept Anaesthesiol, D-69120 Heidelberg, Germany; [Padosch, Stephan A.] Univ Bonn, Dept Legal Med, Bonn, Germany		Bottiger, BW (corresponding author), Heidelberg Univ, Dept Anaesthesiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	bernd_boettiger@med.uni-heidelberg.de			'Deutsche Forschungsgemeinschaft' (DFG)German Research Foundation (DFG) [Bo 1686/1-1]	The authors are indebted to Jutta von Bergmann for excellent assistance in graphic design and to Sherryl Sundell for proofreading of the manuscript. This work was supported in part by a grant from 'Deutsche Forschungsgemeinschaft' (DFG) to Bernd W. Bottiger (Bo 1686/1-1).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Asoh S, 2000, J BIOL CHEM, V275, P37240, DOI 10.1074/jbc.M005841200; Asoh S, 2002, P NATL ACAD SCI USA, V99, P17107, DOI 10.1073/pnas.262460299; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Bilsland James, 2002, Curr Opin Investig Drugs, V3, P1745; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Cao GD, 2002, J NEUROSCI, V22, P5423; Cao YJ, 2002, GENE THER, V9, P415, DOI 10.1038/sj.gt.3301676; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Cerami A, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_1.8; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Dietz GPH, 2002, MOL CELL NEUROSCI, V21, P29, DOI 10.1006/mcne.2002.1165; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Fisher JW, 2003, EXP BIOL MED, V228, P1; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hou ST, 2002, INT REV CYTOL, V221, P93; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Jin KL, 2001, J CEREBR BLOOD F MET, V21, P1411, DOI 10.1097/00004647-200112000-00005; Juul S, 2002, ACTA PAEDIATR, V91, P36, DOI 10.1080/080352502320764184; Kilic E, 2002, ANN NEUROL, V52, P617, DOI 10.1002/ana.10356; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Love S, 2000, NEUROREPORT, V11, P2495, DOI 10.1097/00001756-200008030-00030; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Padosch SA, 2003, NEUROSCI LETT, V338, P247, DOI 10.1016/S0304-3940(02)01408-8; Padosch SA, 2001, ANAESTHESIST, V50, P905, DOI 10.1007/s00101-001-0247-8; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Prass K, 2002, J CEREBR BLOOD F MET, V22, P520, DOI 10.1097/00004647-200205000-00003; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Siren AL, 2001, EUR ARCH PSY CLIN N, V251, P179, DOI 10.1007/s004060170038; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Tsai TH, 2002, METHODS, V28, P253, DOI 10.1016/S1046-2023(02)00230-X; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; Vogel P, 2003, ANESTHESIOLOGY, V99, P112, DOI 10.1097/00000542-200307000-00020; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Yoshida M, 2002, ACTA NEUROPATHOL, V104, P267, DOI 10.1007/s00401-002-0554-4; Zhang C, 2002, NEUROBIOL DIS, V10, P289, DOI 10.1006/nbdi.2002.0526; Zhang ZJ, 2001, MOL BRAIN RES, V95, P75, DOI 10.1016/S0169-328X(01)00247-9	46	15	19	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2003	16	5					439	445		10.1097/00001503-200310000-00001			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	V24WJ	WOS:000208440200001	17021494				2022-02-06	
J	Ko, K; Conforti, A				Ko, K; Conforti, A			Training protocol for intracranial pressure monitor placement by nonneurosurgeons: 5-year experience	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						ventricular catheter; ventriculostomy; intracranial pressure; monitoring; brain injury; neurosurgeon; neurosurgery house officer	GUIDE; CARE	Background: This report evaluates a protocol for training nonneurosurgeon medical staff to perform ventricular catheter placement for ICP monitoring in traumatic brain injury and other appropriate patients under the guidance of neurosurgeons. Methods. Eleven neurosurgery house officers were enrolled in the program to be certified for ventricular catheter placement. The training program using the Ghajar Guide is described as well as the preprocedural checklist. The results of these certified house officers were tracked over a 5-year period. Results: Ten house officers successfully completed the certification process for ventricular catheter placement in a total of 106 patients. The majority of ventricular catheters were placed at the bedside. The reported results and the complication rates of catheter-related infections and intracranial hemorrhage are similar to that of neurosurgeons or neurosurgeons in training. Conclusion:. House officers under the guidance of neurosurgeons can be trained to successfully and safely place ventricular catheters for ICP monitoring in patients needing ICP monitoring.	Cornell Univ, Dept Neurol Surg, New York, NY USA; Jamaica Hosp, Med Ctr, Queens, NY USA		Ko, K (corresponding author), Cherokee Stn, POB 20398, New York, NY 10021 USA.	kgyrus@attglobal.net					Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; Bullock RM, 2000, J NEUROTRAUM, V17, P449; GHAJAR JBG, 1985, J NEUROSURG, V63, P985, DOI 10.3171/jns.1985.63.6.0985; HERSDORFFER DC, 2002, J TRAUMA, V52, P1202; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; Picard P, 1997, ANN FR ANESTH, V16, P420, DOI 10.1016/S0750-7658(97)81474-8; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004	9	15	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2003	55	3					480	483		10.1097/01.TA.0000074111.04885.28			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	721DZ	WOS:000185302900018	14501890				2022-02-06	
J	Simpson, G; Winstanley, J; Bertapelle, T				Simpson, G; Winstanley, J; Bertapelle, T			Suicide prevention training after traumatic brain injury - Evaluation of a staff training workshop	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						evaluation; suicide prevention; training; traumatic brain injury	ATTITUDES	Objectives: To evaluate a suicide prevention training workshop for staff working in the field of traumatic brain injury (TBI) and to develop new measures for evaluation of similar training in the future. Design: A prospective controlled pre- and posttest evaluation with a 6-month follow-up. Subjects: Multidisciplinary TBI rehabilitation and disability staff from the state of Victoria attending the workshop (n = 50) and an equivalent control group (n = 28) recruited from New South Wales. Setting: A statewide training workshop was held at a major rehabilitation center in Melbourne. Outcome measures: Three designed measures including an objective knowledge test, a self-assessment inventory of knowledge/skills and an attitudinal inventory. Results: Participants recorded statistically significant increases in their scores comparing the pre- to postworkshop evaluations. Many of these gains were maintained at the 6-month follow-up evaluation. In contrast, the control group had scores equivalent to those of workshop participants on the pretest evaluations but recorded no similar increase at follow-up. Factor analysis found that the knowledge and skills self-assessment inventory had 2 factors, each having good internal reliability. Conclusion: The current workshop has proved effective in increasing staff knowledge and skills in the assessment and management of people with TBI exhibiting suicidal behaviors. Finally, the initial development of a knowledge and skills self-assessment measure shows promise, providing a resource for the ongoing evaluation of suicide prevention training in the TBI field.	Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW 1871, Australia; Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Royal Rehabil Ctr, Sydney, NSW, Australia		Simpson, G (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Sydney, NSW 1871, Australia.	grahame.simpson@swsahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060; Winstanley, Julie/0000-0002-9353-6757			ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1; *AM SOC TRAIN DEV, 1998, NEW BAS TRAIN TRAIN, V2; *AUSTR BUR STAT, 1999, SUIC 1921 1998; *AUSTR BUR STAT, 1997, CAUS DEATH 1996; *AUSTR BUR STAT, 1999, CAUS DEATH 1998; Broad M.L., 1992, TRANSFER TRAINING AC; Cox J F, 1997, Crisis, V18, P178, DOI 10.1027/0227-5910.18.4.178; Crawford MJ, 1998, J ACCID EMERG MED, V15, P18; DAVIS M, 1991, CANADIAN J COUNSELLI, V25, P73; DOMINO G, 1982, J CLIN PSYCHOL, V38, P257, DOI 10.1002/1097-4679(198204)38:2<257::AID-JCLP2270380205>3.0.CO;2-I; INMAN DJ, 1984, DEATH EDUC, V8, P179, DOI 10.1080/07481188408252456; Juhnke G. A., 1994, COUNS EDUC SUPERV, V34, P52; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Mackenzie TB, 1990, SUICIDE LIFE CYCLE R, P205; MCINTOSH JL, 1985, DEATH STUD, V9, P267, DOI 10.1080/07481188508252523; MICHEL K, 1992, BRIT J PSYCHIAT, V160, P757, DOI 10.1192/bjp.160.6.757; Morgan HG, 1996, J ROY SOC MED, V89, P87, DOI 10.1177/014107689608900208; Morriss R, 1999, J AFFECT DISORDERS, V52, P77, DOI 10.1016/S0165-0327(98)00080-9; Mrazek PB, 1994, REDUCING RISKS MENTA; NEIMEYER RA, 1981, J COUNS PSYCHOL, V28, P176, DOI 10.1037/h0077970; NEIMEYER RA, 1994, DEATH STUD, V18, P131, DOI 10.1080/07481189408252648; POTTER LB, 1995, SUICIDE LIFE-THREAT, V25, P82; ROY A, 1986, SUICIDE; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x; SCHNEIDER SG, 1991, J PERS SOC PSYCHOL, V61, P776, DOI 10.1037/0022-3514.61.5.776; Siegal S., 1956, NONPARAMETRIC STAT B; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SIMPSON GK, 2002, MIND BRAIN TBI FUNCT; SIMPSON GK, 2001, SUICIDE PREVENTION T; STENAGER EN, 1992, ARCH NEUROL-CHICAGO, V49, P1296, DOI 10.1001/archneur.1992.00530360098025; STREINER DL, 1993, CAN J PSYCHIAT, V38, P140, DOI 10.1177/070674379303800214; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tierney R J, 1994, Crisis, V15, P69	34	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2003	18	5					445	456		10.1097/00001199-200309000-00006			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	725BF	WOS:000185522200006	12973274				2022-02-06	
J	Macniven, JA; Poz, R; Bainbridge, K; Gracey, F; Wilson, BA				Macniven, JA; Poz, R; Bainbridge, K; Gracey, F; Wilson, BA			Emotional adjustment following cognitive recovery from 'persistent vegetative state': psychological and personal perspectives	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY	Previously, the cognitive recovery of a 26 year old woman, Kate, who developed a severe encephalomyelopathy and was in a 'minimally conscious/persistent vegetative state' for 6 months was reported. After 6 months, Kate began to respond to her environment and, at 2 years post-illness, neuropsychological assessment indicated that Kate was functioning within the normal range on tests of general intellectual functioning, executive functioning and most memory functions (with the exception of visual recognition memory). Although Kate has a severe dysarthria necessitating the use of a communication board and severe physical disabilities that require her to use a wheelchair, she has demonstrated an almost complete cognitive recovery and is among a tiny percentage of minimally conscious patients to do so. This single case report describes the emotional factors central to Kate's rehabilitation. Using a newly developed model of cognitive rehabilitation as a framework, the pivotal role that emotional and psychological factors played in Kate's adjustment to the consequences of her illness and the role of psychotherapeutic intervention in facilitating this adjustment are discussed.	Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Cambridge CB2 2QQ, England; Univ Nottingham Hosp, Queens Med Ctr, Nottingham NG7 2UH, England; W Suffolk Hosp, Bury St Edmunds, Suffolk, England; Sect Cambridge, Cambridge, England; Oliver Zangwill Ctr, Ely, England		Wilson, BA (corresponding author), Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Box 58, Cambridge CB2 2QQ, England.			Gracey, Fergus/0000-0002-1416-7894			BLOWERS GH, 1995, BRIT J CLIN PSYCHOL, V34, P1; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Ekman P., 1976, PICTURES FACIAL AFFE; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Judd D. P., 1999, COUNSELLING PSYCHOL, V14, P4; Kelly G., 1955, PERSONAL CONSTRUCT P; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Meissner WW, 1996, THERAPEUTIC ALLIANCE; NICHOLSON S, 1995, AUSTR NZ J FAMILY TH, V16, P23; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Segal Z. V., 2002, MINDFULNESS BASED CO; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tyerman A, 2001, NEUROREHABILITATION, V16, P59; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 2001, BRAIN INJURY, V15, P1083, DOI 10.1080/02699050110082197	15	15	16	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2003	17	6					525	533		10.1080/0269905031000086254			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	672GG	WOS:000182512400006	12745707				2022-02-06	
J	Doninger, NA; Heinemann, AW; Bode, RK; Sokol, K; Corrigan, JD; Moore, D				Doninger, NA; Heinemann, AW; Bode, RK; Sokol, K; Corrigan, JD; Moore, D			Predicting community integration following traumatic brain injury with health and cognitive status measures	REHABILITATION PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; IMPAIRED AWARENESS; NEUROPSYCHOLOGICAL DEFICITS; INPATIENT REHABILITATION; BEHAVIORAL LIMITATIONS; SURVEY SF-36; QUESTIONNAIRE; TESTS; REPLICATION; DYSFUNCTION	Objective: To examine measurement properties of the Community Integration Questionnaire (CIQ) and the Short-Form Health Survey (SF-36) and assess the contributions of cognitive functioning and health to community integration. Design: Rating scale analyses and regression analysis data on basic cognitive functioning and health collected from 289 individuals with traumatic brain injury. Results: Person reliabilities indicated substantial measurement error. Ceiling effects weakened the model (adjusted R-2 = .143) specifying the contributions of age, gender, cognitive functioning, and health to community integration. Conclusions: Poor measurement properties and definitional problems associated with community integration weakened the results. The extent to which potential familial and environmental characteristics contributing to role fulfillment change across time requires further research.	Northwestern Univ, Inst Rehabil, Sch Med, Evanston, IL 60208 USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Wright State Univ, Dept Community Hlth, Dayton, OH 45435 USA		Doninger, NA (corresponding author), Univ Chicago, Dept Psychiat, 5841 S Maryland Ave,Mail Code 3077, Chicago, IL 60637 USA.	ndoninge@yoda.bsd.uchicago.edu	Corrigan, John D./E-2921-2011; Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326			ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bode R K, 2001, J Appl Meas, V2, P78; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; ENGLEHART C, 1994, CLIN NEUROPSYCHOL, V8, P405; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fayers PM, 1997, QUAL LIFE RES, V6, P393, DOI 10.1023/A:1018491512095; Fisher W., 1992, RASCH MEAS T, V6, P238; Fisher W P Jr, 1997, J Outcome Meas, V1, P329; Fleming J, 1999, BRAIN INJURY, V13, P417; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; GOLDSTEIN FC, 1987, NEUROBEHAVIORAL RECO, P217; Goldstein K., 1939, ORGANISM; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; HALL K, 1996, ARCH PHYSICAL MED RE, V75, pSC10; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; HEILES C, 1993, PROTOSTARS PLANETS, V3, P279; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; HENRICHS WR, 1990, PROFESSIONAL PSYCHOL, V21, P171; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johnson David, 1994, CURRENT WRITING, V6, P73; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LINACRE JM, 1999, WINSTEPS PC COMPATIB; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Millis S R, 1994, Int J Neurosci, V79, P165; *N CAL NEUR GROUP, 1988, MAN NEUR COGN STAT E; Nabors NA, 2000, ANN M INT NEUR SOC D; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; Rasch Georg, 1980, PROBABILISTIC MODELS; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; STARRATT C, 1992, 100 ANN CONV AM PSYC; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1990, J CLIN EXP NEUROPSYC, V12, P34; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; STUSS DT, 1987, FRONTAL LOBES REVIS; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF 3L HLTH SURVEY MA; Weinstein EA, 1955, DENIAL ILLNESS; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 1993, INT CLASS IMP DIS HA; Wright B, 1982, RATING SCALE ANAL RA	66	15	15	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2003	48	2					67	76		10.1037/0090-5550.48.2.67			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	674FV	WOS:000182627500001					2022-02-06	
J	Golden, Z; Golden, CJ				Golden, Z; Golden, CJ			Impact of brain injury severity on personality dysfunction	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						head trauma; Halstead-Reitan; loss of consciousness; MMPI-2; personality		Although the cognitive effects of traumatic brain injury (TBI) have been well investigated, emotional problems are less well understood. The purpose of this study was to explore the relationship of the length of loss of consciousness (LOC) and the severity of cognitive impairment (HRNB) to personality changes after head trauma. The subjects included 320 chronic TBI patients. A multivariate analysis was conducted using HRNB (three levels), as measured by a modified Halstead-Reitan Impairment Index and LOC (four levels), as the independent variables, and 30 scales from the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) as the dependent variables. Multivariate Fs were significant for both HRNB and LOC. Follow-up ANOVAs and t-tests revealed a consistent pattern of findings across both variables. The data indicated that the reported emotional problems increased with the severity, of both LOC and HRNB, except in the most severe groups. The severe subjects when defined by either variable displayed high levels of denial and a lack of awareness of their problems. LOC and HRNB contributed independently to the degree of personality problems, however, LOC was found to be a stronger predictor of personality change than was HRNB at milder levels of severity. The implications of these findings for both treatment and understanding of the mechanisms of head injury are discussed.	Ely High Sch, Pompano Beach, FL USA; Nova SE Univ, Ft Lauderdale, FL 33314 USA		Golden, CJ (corresponding author), Nova SE Univ, Ctr Psychol Studies, 3301 Coll Ave, Ft Lauderdale, FL 33314 USA.						Alyman C. A., 1999, DISS ABSTR INT B, V59, P6482; BLACK FW, 1975, PERCEPT MOTOR SKILL, V40, P87, DOI 10.2466/pms.1975.40.1.87; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Golden C, 2000, NEUROPSYCHOLOGICAL I; Hoffman R. G., 1999, J FORENSIC NEUROPSYC, V1, P3, DOI DOI 10.1300/J151V01N02_02; LANDRY TH, 1997, DISS ABSTR INT B, V57, P5381; Marcelli D, 1977, Ann Med Psychol (Paris), V2, P839; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; YOUNGJOHN JR, 1997, PSYCHOL ASSESSMENT, V9, P77	10	15	15	1	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	MAY	2003	113	5					733	745		10.1080/00207450390200044			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	681XT	WOS:000183061400009	12745630				2022-02-06	
J	Turner, AP; Bombardier, CH; Rimmele, CT				Turner, AP; Bombardier, CH; Rimmele, CT			A typology of alcohol use patterns among persons with recent traumatic brain injury or spinal cord injury: Implications for treatment matching	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						alcoholism; brain injuries; rehabilitation; spinal cord injuries	SUBSTANCE-ABUSE; CHANGE QUESTIONNAIRE; READINESS; VALIDITY	Objective: To describe empirically valid and clinically meaningful types of alcohol use among persons with recent traumatic brain or spinal cord injury. Design: Cross-sectional cohort survey. Setting: Acute inpatient rehabilitation program in a level I trauma center. Participants: A total of 218 (87%) of 250 consecutive initial admissions who met inclusion criteria and completed interviews. Interventions: Not applicable. Main Outcome Measures: Alcohol and drug use questionnaires, alcohol problem questions, admission toxicology results, readiness to change, and treatment preference questions. Results: Participants were on average 37 years old, 84% were men, and 82% were white. Four types were identified by using k-means cluster analysis based on preinjury alcohol consumption, alcohol problems, and alcohol dependence. Cluster groups differed on extrinsic variables such as drug use, readiness to change, and interest in treatment or in attending Alcoholics Anonymous. The 4 types corresponded to those with a history of (1) alcohol abuse; (2) alcohol dependence; (3) alcohol dependence in remission, partial remission, or relapsed; and (4) normal or nondrinkers. Conclusion: More effective care may be possible if clinicians match common patient types to specific interventions such as education, motivational interventions, formal substance abuse treatment, and relapse prevention.	Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Sch Med, Seattle, WA 98104 USA; Univ Washington, Vet Adm Puget Sound Hlth Care Syst, Ctr Excellence Subst Abuse Treatment & Educ, Sch Med, Seattle, WA 98104 USA; Seattle VA Puget Sound Hlth Care Syst, Dept Psychiat & Behav Sci, Seattle, WA USA		Bombardier, CH (corresponding author), Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Sch Med, Box 359740,325 9th Ave, Seattle, WA 98104 USA.	chb@u.washington.edu	Turner, Aaron/A-7902-2009; Bombardier, Charles H./AAZ-3260-2021	Turner, Aaron/0000-0001-6897-8003; Bombardier, Charles H./0000-0003-4758-6283	ODCDC CDC HHS [R49/CCR11714-01] Funding Source: Medline		Allen J, 1997, ADDICTION, V92, P1671; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BABOR TF, 1990, BEHAV ASSESS, V12, P5; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bombardier CH, 1998, ARCH PHYS MED REHAB, V79, P1110, DOI 10.1016/S0003-9993(98)90180-0; Bombardier CH, 1997, REHABIL PSYCHOL, V42, P259; Bombardier CH, 2000, J HEAD TRAUMA REHAB, V15, P696, DOI 10.1097/00001199-200002000-00008; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CONNORS GJ, 1996, ADDICTION S, V91, P5; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DONOVAN DM, 1982, J CONSULT CLIN PSYCH, V50, P241, DOI 10.1037/0022-006X.50.2.241; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FILLMORE KM, 1994, ADDICTION, V89, P1143, DOI 10.1111/j.1360-0443.1994.tb02791.x; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; JELLINEK EM, 1952, Q J STUD ALCOHOL, V13, P673, DOI 10.15288/QJSA.1952.13.673; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; MAISTO SA, 1990, BEHAV ASSESS, V12, P117; Marlatt GA, 1985, RELAPSE PREVENTION M; Meyers R.J., 1995, CLIN GUIDE ALCOHOL T; MEYERS RJ, 1997, SOURCEBOOK PSYCHOL T, P257; Miller WR, 1997, J CLIN PSYCHOL, V53, P263, DOI 10.1002/(SICI)1097-4679(199704)53:3<263::AID-JCLP10>3.0.CO;2-G; MILLER WR, 1984, MANUAL COMPREHENSIVE; Miller WR, 1991, MOTIVATIONAL INTERVI; Minugh PA, 1997, ACAD EMERG MED, V4, P1059, DOI 10.1111/j.1553-2712.1997.tb03680.x; MOREY LC, 1984, J ABNORM PSYCHOL, V93, P408, DOI 10.1037/0021-843X.93.4.408; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117	34	15	16	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2003	84	3					358	364		10.1053/apmr.2003.50107			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	653KL	WOS:000181434300007	12638103				2022-02-06	
J	Zasler, ND; Martelli, MF				Zasler, ND; Martelli, MF			Mild traumatic brain injury: Impairment and disability assessment caveats	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							HEAD-INJURY; CLASSIFICATION	Mild traumatic brain injury (MTBI) accounts for approximately 80% of all brain injuries, and persistent sequelae can impede physical, emotional, social, marital, vocational, and avocational functioning. Evaluation of impairment and disability following MTBI typically can involve such contexts as social security disability application, personal injury litigation, worker's compensation claims, disability insurance policy application, other health care insurance policy coverage issues, and the determination of vocational and occupational competencies and limitations. MTBI is still poorly understood and impairment and disability assessment in MTBI can present a significant diagnostic challenge. There are currently no ideal systems for rating impairment and disability for MTBI residua. As a result, medicolegal examiners and clinicians must necessarily familiarise themselves with the variety of disability and impairment evaluation protocols and understand their limitations. The current paper reviews recommended procedures and potential obstacles and confounding issues.	Concuss Care Ctr, Glen Allen, VA 23060 USA; Virginia Commonwealth Univ Hlth Syst, Glen Allen, VA USA		Zasler, ND (corresponding author), Concuss Care Ctr, 10120 W Broad St,Suites G, Glen Allen, VA 23060 USA.						American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Medical Association, 1993, GUID EV PERM IMP; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1996, Neurology, V47, P592; BINDER LM, 1996, AM J PSYCHIAT, V153, P1; BLAU TH, 1984, PSYCHOL EXPERT WITNE; Brodsky S. L., 1991, TESTIFYING COURT GUI; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Green DR, 2000, NAT IMMUNOL, V1, P15, DOI 10.1038/76868; JOHNSON MT, 2000, EXPERT TESTIMONY FED; KRAUS JF, 1995, EPIDEMIOLOGY BRAIN I; Larrabee GJ, 2000, J CLIN EXP NEUROPSYC, V22, P702, DOI 10.1076/1380-3395(200010)22:5;1-9;FT702; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; LORING DW, 1995, ANN M AM AC NEUR SEA; Martelli M F, 2001, Phys Med Rehabil Clin N Am, V12, P571; Martelli MF, 1999, NEUROREHABILITATION, V13, P45; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; MARTELLI MF, 2000, ATTORNEYS GUIDE ETHI; MARTELLI MF, 1999, GUIDE FUNCTIONAL CAP; MARTELLI MF, IN PRESS PRACTICES B; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; Rohling ML, 2000, ARCH CLIN NEUROPSYCH, V15, P843, DOI 10.1016/S0887-6177(00)80349-2; Sbordone RJ, 2000, ARCH CLIN NEUROPSYCH, V15, P465; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P12; ZASLER ND, 1996, HEAD INJURY POSTCONS; ZASLER ND, 1998, AMA GUIDES NEWSL NOV, P1; ZASLER ND, 1996, MED REHABILITATION T; ZASLER ND, UNPUB PRINCIPLES PRA; ZASLER ND, 2002, STATE ART REV PHYSIC, V16; ZASLER ND, 1997, ARCH PHYS MED REHAB, V78, P12	33	15	15	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR-MAY	2003	13	1-2			SI		31	41		10.1080/09602010			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	665EK	WOS:000182106500003	21854326				2022-02-06	
J	Burger, R; Bendszus, M; Vince, GA; Roosen, K; Marmarou, A				Burger, R; Bendszus, M; Vince, GA; Roosen, K; Marmarou, A			A new reproducible model of an epidural mass lesion in rodents. Part 1: Characterization by neurophysiological monitoring, magnetic resonance imaging, and histopathological analysis	JOURNAL OF NEUROSURGERY			English	Article						trauma; mass lesion; ischemia-reperfusion; laser Doppler flowmetry; partial pressure of oxygen; magnetic resonance imaging; rat	CEREBRAL BLOOD-FLOW; ACUTE SUBDURAL-HEMATOMA; INCREASED INTRACRANIAL-PRESSURE; TRAUMATIC BRAIN INJURY; SYSTEMIC VASCULAR-RESPONSES; LASER-DOPPLER SPECTROSCOPY; SEVERE HEAD-INJURY; TISSUE OXYGEN; COMPUTERIZED-TOMOGRAPHY; HYDROGEN CLEARANCE	Object. The goal of this study was to characterize a new model of an epidural mass lesion in rodents by means of neurophysiological monitoring, magnetic resonance imaging, and histopathological analysis. Methods. Changes in intracranial pressure (ICP), cerebral perfusion pressure (CPP), and laser Doppler flowmetry (LDF) values, intraparenchymal tissue partial oxygen pressure (PtiO(2)), and electroencephalography (EEG) activity were evaluated in the rat during controlled, epidural expansion of a latex balloon up to a maximum ICP of 60 nun Hg. The initial balloon inflation was followed by periods of sustained inflation (30 +/- 1 minute) and reperfusion (180 +/- 5 minutes). Histopathological analysis and magnetic resonance (MR) imaging were performed to characterize the lesion. The time to maximum balloon expansion and the average balloon volume were highly reproducible. Alterations in EEG activity during inflation first appeared when the CPP decreased to 57 mm Hg, the LDF value to 66% of baseline values, and the NO, to 12 mm Hg. During maximum compression, the CPP was reduced to 34 mm Hg, the LDF value to 40% of baseline, and the NO, to 4 to 5 mm Hg. The EEG tracing was isoelectric during prolonged inflation and the values of LDF and NO, decreased due to accompanying hypotonia. After reperfusion, the CPP was significantly decreased (p < 0.05) due to the elevation of lCP. Both the LDF value and EEG activity displayed incomplete restoration, whereas the value of NO, returned to normal. Histological analysis and MR imaging revealed brain swelling with a midline shift and a combined cortical-subcortical ischemic lesion beyond the site of balloon compression. Conclusions. This novel model of an epidural mass lesion in rodents closely resembles the process observed in humans. Evaluation of pathophysiological and morphological changes was feasible by using neurophysiological monitoring and MR imaging.	Univ Regensburg, Dept Neurosurg, D-93053 Regensburg, Germany; Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany; Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA		Burger, R (corresponding author), Univ Regensburg, Dept Neurosurg, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	RBurger@t-online.de		Vince, Giles/0000-0002-0222-8733			Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Bardt TF, 1998, ACT NEUR S, V71, P153; Bendszus M, 2002, J NEUROSURG, V97, P1419, DOI 10.3171/jns.2002.97.6.1419; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Burger R, 1999, J NEUROTRAUM, V16, P1149, DOI 10.1089/neu.1999.16.1149; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; CROCKARD HA, 1976, J NEUROL SCI, V27, P29, DOI 10.1016/0022-510X(76)90232-X; DELAPAZ RL, 1991, AM J NEURORADIOL, V12, P89; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIMAGL U, 1989, J CEREB BLOOD FLOW M, V9, P589; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; EYRE JA, 1988, CLIN PHYS PHYSIOL M, V9, P65, DOI 10.1088/0143-0815/9/1/006; FITCH W, 1977, J NEUROL NEUROSUR PS, V40, P843, DOI 10.1136/jnnp.40.9.843; FITCH W, 1977, J NEUROL NEUROSUR PS, V40, P833, DOI 10.1136/jnnp.40.9.833; FLECKENSTEIN W, 1989, FUNKTIONSANALYSE BIO, V19, P211; FUJISAWA H, 1994, ACT NEUR S, V60, P193; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; GOODMAN SJ, 1972, J NEUROSURG, V37, P514, DOI 10.3171/jns.1972.37.5.0514; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; HEINRICH U, 1985, ADV EXP MED BIOL, V191, P77; HEKMATPANAH J, 1970, J NEUROSURG, V32, P21, DOI 10.3171/jns.1970.32.1.0021; HEKMATPANAH J, 1970, J NEUROSURG, V32, P16, DOI 10.3171/jns.1970.32.1.0016; Herguido MJ, 1999, NEUROSCIENCE, V93, P71, DOI 10.1016/S0306-4522(99)00163-3; HOSSMANN KA, 1973, ARCH NEUROL-CHICAGO, V29, P375, DOI 10.1001/archneur.1973.00490300037004; JAKOBSSON K E, 1990, Neurological Research, V12, P153; JAKOBSSON KE, 1989, INTRACRANIAL PRESSUR, V7, P853; JAMJOOM A, 1992, Acta Neurochirurgica, V115, P86, DOI 10.1007/BF01406363; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; KLINTWOR.GK, 1965, AM J PATHOL, V47, P525; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, NEUROSURGERY, V30, P687; LANGFITT TW, 1964, J NEUROSURG, V21, P989, DOI 10.3171/jns.1964.21.11.0989; LANGFITT TW, 1965, NEUROLOGY, V15, P761, DOI 10.1212/WNL.15.8.761; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P599; LUBBERS DW, 1994, OXYGEN TRANSPORT TIS, V15, P567; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MENDELOW AD, 1986, INTRACRANIAL PRESSUR, V6, P515; Metzger H, 1977, Adv Exp Med Biol, V94, P49; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; NUMOTO M, 1970, J NEUROSURG, V33, P381, DOI 10.3171/jns.1970.33.4.0381; Oliff HS, 1997, J CEREBR BLOOD F MET, V17, P571, DOI 10.1097/00004647-199705000-00012; PARZHUBER A, 1994, UNFALLCHIRURG, V97, P615; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; SCHETTINI A, 1989, J NEUROSURG, V71, P578, DOI 10.3171/jns.1989.71.4.0578; SEYDE WC, 1986, ANESTHESIOLOGY, V64, P480, DOI 10.1097/00000542-198604000-00011; SHALIT MN, 1974, J NEUROSURG, V40, P594, DOI 10.3171/jns.1974.40.5.0594; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V134, P133, DOI 10.1111/j.1748-1716.1988.tb08469.x; SMITH DR, 1977, SURG NEUROL, V7, P233; STERN MD, 1977, AM J PHYSIOL, V232, pH441, DOI 10.1152/ajpheart.1977.232.4.H441; Tsuchida E, 1999, J NEUROTRAUM, V16, P595, DOI 10.1089/neu.1999.16.595; Uranishi R, 1999, J VASC RES, V36, P100, DOI 10.1159/000025631; van den Brink WA, 1998, J NEUROTRAUM, V15, P813, DOI 10.1089/neu.1998.15.813; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; ZIDAN AH, 1978, J NEUROSURG, V49, P61, DOI 10.3171/jns.1978.49.1.0061; ZWETNOW NN, 1986, ACTA NEUROCHIR, V80, P47, DOI 10.1007/BF01809557; Zwienenberg M, 1999, J NEUROTRAUM, V16, P1095, DOI 10.1089/neu.1999.16.1095; [No title captured]	72	15	18	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2002	97	6					1410	1418		10.3171/jns.2002.97.6.1410			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	626YG	WOS:000179901000023	12507141				2022-02-06	
J	Sekiya, T; Yagihashi, A; Asano, K; Suzuki, S				Sekiya, T; Yagihashi, A; Asano, K; Suzuki, S			Nimodipine ameliorates trauma-induced cochlear neuronal death	NEUROLOGICAL RESEARCH			English	Article						calcium channel; cochlear nerve; hearing; nerve degeneration; nimodipine; spiral ganglion cell	SPIRAL GANGLION-CELLS; GUINEA-PIG; CALCIUM CHANNELS; FACIAL-NERVE; RAT; ISCHEMIA; INJURY; BRAIN; METHYLPREDNISOLONE; DAMAGE	Excessive entry of Ca2+ into injured cochlear neurons activates various Ca2+-activated enzymes and subsequent spiral ganglion cell death. Therefore, preventing intracellular calcium overload by using Ca2+ channel antagonists may become an important countermeasure to spiral ganglion cell death. We experimentally investigated whether an L-type Ca2+ channel blocker (nimodipine) can rescue traumatized cochlear neurons from degeneration. A group of rats (n = 6) was pre-operatively treated with nimodipine for one week and compression injury was applied to the cerebellopontine angle portion of the cochlear nerve in a highly quantitative fashion. The rats from the compression with nimodipine treatment groups were post-operatively treated with nimodipine for 10 days and killed for histological examination. The histological analysis of the temporal bones revealed that the spiral ganglion cells in the basal turn of the cochlea where the magnitude of traumatic impact had been the least in our experimental condition were rescued in a statistically significant fashion in the compression with nimodipine treatment group. The results of the present study indicate that nimodipine may become an intra- and post-operative important adjunct to raise the rate of hearing preservation in vestibular schwannoma excision or other cerebellopontine angle surgical interventions.	Hirosaki Univ, Sch Med, Dept Neurosurg, Hirosaki, Aomori 0368216, Japan		Sekiya, T (corresponding author), Hirosaki Univ, Sch Med, Dept Neurosurg, 5 Zaifu Cho, Hirosaki, Aomori 0368216, Japan.	seky@cc.hirosaki-u.ac.jp					Angelov DN, 1996, J NEUROSCI, V16, P1041; Asai Y, 1996, ANN OTO RHINOL LARYN, V105, P472, DOI 10.1177/000348949610500610; BAR PR, 1990, J NEUR TR S, V31, P55; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DINGLEDINE R, 1998, BASIC NEUROCHEMISTRY, P315; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fechter LD, 1995, HEARING RES, V91, P101, DOI 10.1016/0378-5955(95)00176-X; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; HAN DY, 1993, ACTA OTO-LARYNGOL, P26; Hille B., 2001, ION CHANNELS EXCITAB, P95; Hisashi K, 1995, HEARING RES, V91, P196, DOI 10.1016/0378-5955(95)00191-3; Horn J, 2001, STROKE, V32, P2433, DOI 10.1161/hs1001.096009; Kusakari J, 1981, Auris Nasus Larynx, V8, P55; LANGLEY MS, 1989, DRUGS, V37, P669, DOI 10.2165/00003495-198937050-00004; LUITEN PGM, 1994, ANN NY ACAD SCI, V747, P431; Mattson P, 1999, J NEUROSURG, V90, P760, DOI 10.3171/jns.1999.90.4.0760; NYAKAS C, 1994, NEUROSCIENCE, V59, P541, DOI 10.1016/0306-4522(94)90176-7; Ogawa K, 1996, ACTA OTO-LARYNGOL, V116, P253, DOI 10.3109/00016489609137835; Olney JW, 1999, CELL DEATH AND DISEASES OF THE NERVOUS SYSTEM, P197; PERLMAN HB, 1959, LAYNGOSCOPE, V9, P591; PUTNEY JW, 1998, BASIC NEUROCHEMISTRY, P453; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; SCHUURMAN T, 1987, NEUROSCI RES COMMUN, V1, P9; Sekiya T, 2001, HEARING RES, V151, P125, DOI 10.1016/S0378-5955(00)00219-7; Sekiya T, 2001, BRAIN RES, V905, P152, DOI 10.1016/S0006-8993(01)02523-9; Sekiya T, 2000, J NEUROSURG, V93, P90, DOI 10.3171/jns.2000.93.1.0090; Sekiya T, 2000, EXP NEUROL, V161, P490, DOI 10.1006/exnr.1999.7280; Sekiya T, 2000, ACTA OTO-LARYNGOL, V120, P473, DOI 10.1080/000164800750045956; SHIMOZONO M, 1995, NEUROREPORT, V6, P421, DOI 10.1097/00001756-199502000-00004; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Strauss C, 2001, J NEUROSURG, V95, P771, DOI 10.3171/jns.2001.95.5.0771; TETTENBORN D, 1993, DRUG DEV, V2, P473; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VANDERZEE CEEM, 1987, NEUROSCI LETT, V83, P143, DOI 10.1016/0304-3940(87)90231-X; Zornow M H, 1996, New Horiz, V4, P107	36	15	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2002	24	8					775	780		10.1179/016164102101200889			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622PR	WOS:000179655900006	12500700				2022-02-06	
J	de Cleen, M				de Cleen, M			Obliteration of pulp canal space after concussion and subluxation: Endodontic considerations	QUINTESSENCE INTERNATIONAL			English	Article						concussion; dental trauma; pulp space obliteration; root canal treatment; subluxation	TRAUMA; TEETH	Concussion and subluxation injuries to permanent teeth lead to obliteration of the pulp canal space in 3% to 11% of cases, depending on the severity of the injury and the developmental stage of the tooth. Obliteration of the pulp canal space may make root canal treatment necessary because of the development of apical periodontitis or for cosmetic reasons. If carefully executed, root canal treatment in teeth with an obliterated pulp canal space is highly successful and may act as a basis for internal bleaching.			de Cleen, M (corresponding author), Schubertstr 40-1, NL-1077 GV Amsterdam, Netherlands.						ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; ANDREASEN FM, 1987, ENDOD DENT TRAUMATOL, V3, P101; Andreasen JO, 1994, TXB COLOR ATLAS TRAU; BAGHDADY VS, 1981, J DENT RES, V60, P677, DOI 10.1177/00220345810600030201; BARTHEL CR, 1999, ENDODONTIE, V8, P21; Clarkson B H, 1973, J Int Assoc Dent Child, V4, P21; CRONALARSSON G, 1989, ENDOD DENT TRAUMATOL, V5, P176; CVEK M, 1982, ACTA ODONTOL SCAND, V40, P223, DOI 10.3109/00016358209019816; De Cleen M., 1994, ENDODONTIE, V3, P39; EBERLESEDER KA, 1999, ENDODONTIE, V8, P101; Herforth V A, 1976, Dtsch Zahnarztl Z, V31, P938; JACOBSEN I, 1977, SCAND J DENT RES, V85, P588; JARVINEN S, 1979, ACTA ODONTOL SCAND, V37, P47, DOI 10.3109/00016357909004684; PETERS LB, 1992, ENDODONTIE, V1, P57; Robertson A, 1996, J ENDODONT, V22, P557, DOI 10.1016/S0099-2399(96)80018-5; Simon JHS, 1999, ENDOD DENT TRAUMATOL, V15, P145; WEIGER R, 1992, ENDODONTIE, V1, P109	17	15	16	1	7	QUINTESSENCE PUBL CO INC	CAROL STREAM	551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA	0033-6572			QUINTESSENCE INT	Quintessence Int.	OCT	2002	33	9					661	669					9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	611NL	WOS:000179024100004	12666890				2022-02-06	
J	Nassiri, JD; Daniel, JC; Wilckens, J; Land, BC				Nassiri, JD; Daniel, JC; Wilckens, J; Land, BC			The implementation and use of the standardized assessment of concussion at the US Naval Academy	MILITARY MEDICINE			English	Article							SPORTS	The Standardized Assessment of Concussion (SAC), a sideline mental status assessment tool, was used for the U.S. Naval Academy football team. Baseline SAC data were obtained for 298 subjects; the SAC was also used in immediate assessment and subsequent monitoring of 21 concussed players. Analysis of baseline data revealed no significant difference in SAC score based on position on team, position category (offense, defense, or special team), test form used, graduating class year, or history of prior concussion, nor was there any correlation on the basis of age. Among injured players, there was a significant drop in mean SAC total score from baseline to immediately following concussion. Surveys by athletic trainers and physicians who used the SAC indicated that, despite identifying potential limitations, they considered it to be easy and quick to administer and a useful tool in the assessment, monitoring, and management of concussed athletes at U.S. Naval Academy.	USN, Med Clin, Dept Mil Med, Annapolis, MD 21402 USA; USN, Med Clin, Dept Orthoped, Annapolis, MD 21402 USA; Womack Army Med Ctr, Dept Family Practice, Ft Bragg, NC 28310 USA		Daniel, JC (corresponding author), Amer Embassy Jakarta, Unit 8132, NAMRU 2, FPO, AP 96520 USA.						Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; GUSKIEWICZ KM, 2001, NEUROLOGICAL SPORTS, P123; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; MCCREA, 2001, NEUROLOGICAL SPORTS, P109; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M., 2000, STANDARDIZED ASSESSM; OLESNIEWICZ MH, 2001, NEUROLOGICAL SPORTS, P281; Schnirring L, 2001, PHYSICIAN SPORTSMED, V29, P11; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	9	15	15	1	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	OCT	2002	167	10					873	876		10.1093/milmed/167.10.873			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653EB	WOS:000181421300020	12392259				2022-02-06	
J	Shkrum, MJ; McClafferty, KJ; Nowak, ES; German, A				Shkrum, MJ; McClafferty, KJ; Nowak, ES; German, A			Driver and front seat passenger fatalities associated with air bag deployment. Part 1: A Canadian study	JOURNAL OF FORENSIC SCIENCES			English	Article; Proceedings Paper	51st Annual Meeting of the American-Academy-of-Forensic-Sciences	FEB 15-21, 1999	ORLANDO, FL	Amer Acad Forens Sci		forensic science; motor vehicles; air bags; wounds and injuries	RESTRAINT EFFECTIVENESS; INJURY; RUPTURE; TRAUMA; CHILD; REDUCTIONS; COLLISIONS; CRASHES; AIRBAGS; DEATH	Real world motor vehicle collision research of injuries due to deployment of "first-generation" air bags has been conducted by Transport Canada since 1993. Fifty-three fatal crashes (36 frontal impacts; 17 side collisions) involving 48 drivers and 10 right front passengers were reviewed. In the Canadian data, air bag deployment in five of nine low severity frontal crashes (delta-V (Delta/V) < 25 km/h or 15 mph) was linked to five deaths, four of whom were autopsied (four adults with craniocervical (basal skull and C-2 fracture with brainstem avulsion, "closed head injury"-no autopsy) or chest trauma (aortic or pulmonary artery tears), one child with atlanto-occipital dislocation). An occupant who is close ("out-of-position") to the air bag at the time of deployment is at risk for injury In 27 high severity frontal impacts, unusual (e.g., Pulmonary "blast" hemorrhage in one autopsied case) or isolated potentially survivable injuries (e.g. clinically documented ruptured right atrium: probable flail chest observed during the autopsy on a decomposed body) localized to the head, neck or chest in three possibly out-of-position drivers pointed to the deployed air bag as a source of injury In one of 17 side collisions an out-of-position driver sustained a radiographically confirmed C-1-C-2 dislocation in a minimally intruded vehicle.	London Hlth Sci Ctr, Dept Pathol, London, ON N6A 4G5, Canada; Transport Canada, Collis Invest Rd Safety & Motor Vehicle Regulat D, Ottawa, ON, Canada; Univ Western Ontario, Fac Engn Sci, Multidisciplinary Accid Res Team, London, ON N6A 5B9, Canada; Univ Western Ontario, Fac Med, London, ON, Canada		Shkrum, MJ (corresponding author), London Hlth Sci Ctr, Dept Pathol, 375 South St, London, ON N6A 4G5, Canada.						ANTOSIA RE, 1995, ANN EMERG MED, V25, P794, DOI 10.1016/S0196-0644(95)70210-5; AUGENSTEIN JS, 1995, J TRAUMA, V38, P502, DOI 10.1097/00005373-199504000-00007; AUGENSTEIN JS, 1996, P 15 INT TECHN C ENH; AUGENSTEIN JS, 1998, P 1L INT TECHN C ENH; BLACKSIN MF, 1993, J TRAUMA, V35, P840, DOI 10.1097/00005373-199312000-00006; BLOCH B, 1998, P 16 INT TECHN C ENH; Braver ER, 1997, JAMA-J AM MED ASSOC, V278, P1437, DOI 10.1001/jama.278.17.1437; BREED D, 1993, 930650 SAE; Brown DK, 1995, J TRAUMA, V39, P1204, DOI 10.1097/00005373-199512000-00039; Campbell K., 1974, 740565 SAE; Chandler P, 1996, APPL COGNITIVE PSYCH, V10, P151, DOI 10.1002/(SICI)1099-0720(199604)10:2<151::AID-ACP380>3.0.CO;2-U; CHIDESTER AB, 1998, P 16 INT TECHN C ENH; COBEN LE, 1997, 970492 SAE; COLLINS MP, 1989, ANN THORAC SURG, V47, P612, DOI 10.1016/0003-4975(89)90446-3; Cooper G J, 1989, J R Army Med Corps, V135, P58; Cooper JT, 1998, J FORENSIC SCI, V43, P1077; DALMOTAS DJ, 1995, J TRAUMA, V38, P476, DOI 10.1097/00005373-199504000-00002; DALMOTAS DJ, P 16 INT TECHN C ENH; DALMOTAS DJ, 1996, P 40 AAAM C 1996 OCT; DALMOTAS DJ, 1996, P 15 INT TECHN C ENH; deGuzman BJ, 1997, NEW ENGL J MED, V337, P573, DOI 10.1056/NEJM199708213370815; Dunn JA, 1996, ANN THORAC SURG, V62, P577, DOI 10.1016/0003-4975(96)00367-0; EVANS L, 1990, ACCIDENT ANAL PREV, V22, P167, DOI 10.1016/0001-4575(90)90067-U; FRAME P, 1998, 980905 SAE; GERMAN A, 1998, P 16 INT TECHN C ENH; GERMAN A, P CAN SOC MECH ENG C; Giguere JF, 1998, J PEDIATR SURG, V33, P811, DOI 10.1016/S0022-3468(98)90648-0; GRAHAM JD, 1998, PEDIATRICS, P102; Hanna K M, 1997, Tenn Med, V90, P195; HIGHT PV, 1985, 850437 SAE; Hollands CM, 1996, J TRAUMA, V41, P920, DOI 10.1097/00005373-199611000-00033; HORSCH J, 1990, 902324 SAE; HUELKE DF, 1995, J TRAUMA, V38, P482, DOI 10.1097/00005373-199504000-00003; HUELKE DF, 1993, ACCIDENT ANAL PREV, V25, P717, DOI 10.1016/0001-4575(93)90036-V; HUELKE DF, 1995, 950866 SAE; HUELKE DF, 1996, P 15 INT TECHN C ENH; Jolly BT, 1998, ANN EMERG MED, V31, P783, DOI 10.1016/S0196-0644(98)70245-8; Jolly BT, 1998, ANN EMERG MED, V31, P782, DOI 10.1016/S0196-0644(98)70244-6; JUMBELIC MI, 1995, J FORENSIC SCI, V40, P492; KAHANE CJ, 1996, NATL HIGHWAY TRAFFIC; KING AI, 1995, J TRAUMA, V38, P570, DOI 10.1097/00005373-199504000-00017; LANCASTER GI, 1993, NEW ENGL J MED, V328, P358, DOI 10.1056/NEJM199302043280519; Lau I., 1986, 861882 SAE; LAU IV, 1993, ACCIDENT ANAL PREV, V25, P29, DOI 10.1016/0001-4575(93)90094-D; LAU VK, 1981, J TRAUMA, V21, P1022, DOI 10.1097/00005373-198112000-00003; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; LUND AK, 1995, J TRAUMA, V38, P469, DOI 10.1097/00005373-199504000-00001; MALLIARIS AC, 1996, 960659 SAE; MARQUARDT JF, 1977, P 21 AAAM C 1977 SEP; MARSH JC, 1993, 930646 SAE; Martinez R, 1996, ANN EMERG MED, V28, P709; Maxeiner H, 1997, J TRAUMA, V42, P1148, DOI 10.1097/00005373-199706000-00029; McCaffrey M, 1999, J PEDIATR ORTHOPED, V19, P60, DOI 10.1097/00004694-199901000-00014; MCCLAFFERTY KJ, 1997, P CAN MULT ROAD SAF; MELVIN JW, 1993, 933119 SAE; MERTZ HJ, 1985, 851199 SAE; Morgenstern K, 1998, CHEST, V114, P624, DOI 10.1378/chest.114.2.624; MORRIS AP, 1996, P 15 INT TECHN C ENH; Morrison AL, 1998, AM J FOREN MED PATH, V19, P218, DOI 10.1097/00000433-199809000-00003; *NAT HIGHW TRAFF S, 1992, NAT TECHN INF SERV P; *NAT HIGHW TRAFF S, 1996, ANN EMERG MED, V28, P241; *NAT HIGHW TRAFF S, 1982, NAT HIGHW TRAFF SAF; Perez J, 1996, ANN EMERG MED, V28, P722, DOI 10.1016/S0196-0644(96)70099-9; Pillgram-Larsen Johan, 1997, Tidsskrift for den Norske Laegeforening, V117, P2437; Prasad P., 1984, 841656 SAE; Shkrum MJ, 1999, J FORENSIC SCI, V44, P44; Smith DP, 1997, J TRAUMA, V42, P341, DOI 10.1097/00005373-199702000-00032; SMOCK WS, 1995, J TRAUMA, V38, P489, DOI 10.1097/00005373-199504000-00004; STRUBLE DE, 1998, 980648 SAE; Tumbas N.S., 1988, 880072 SAE; VIANO DC, 1995, J TRAUMA, V38, P538, DOI 10.1097/00005373-199504000-00013; VIANO DC, 1988, B NEW YORK ACAD MED, V64, P376; WERNER JV, 1994, 940802 SAE; Wilson JV, 1943, LANCET, V1, P257; ZADOR PL, 1993, AM J PUBLIC HEALTH, V83, P661, DOI 10.2105/AJPH.83.5.661; 1995, AIR BAG INJURIES MOS, P30; 1995, INSURANCE I HIGHWAY, V30, P1; 1998, AIR BAG DEACTIVATION; 1996, INSURANCE I HIGHWAY, V31, P6	79	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2002	47	5					1028	1034					7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Legal Medicine	596UY	WOS:000178185800018	12353540				2022-02-06	
J	Harker, WF; Dawson, DR; Boschen, KA; Stuss, DT				Harker, WF; Dawson, DR; Boschen, KA; Stuss, DT			A comparison of independent living outcomes following traumatic brain injury and spinal cord injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						community integration; independent living; productivity; spinal cord injure; traumatic brain injure	EMPLOYMENT; QUALITY; LIFE; REHABILITATION; DISABILITIES; COMMUNITY; PROFILE; PEOPLE; STATE	This study compares independent living outcomes in persons with traumatic brain injury (TBI) and spinal cord injury (SCI). Both injuries represent life-altering events that are known to have a negative impact on independent living and are predominantly experienced by members of the same demographic group. However, the types of resultant impairments and disabilities experienced by the two populations differ substantially. The TBI participants were recruited consecutively from Canada's largest tertiary care trauma centre and followed prospectively for four years. The SCI participants were recruited via a mailed survey to members of a provincial branch of the Canadian Paraplegic Association. Independent living outcomes were measured using DeJong and Hughes' (1982) classification system of productivity status, the Reintegration to Normal Living Index, and questions on assistance from environmental supports in the form of wheelchair use and paid/unpaid personal assistance. The TBI group was found to be significantly more productive. have higher levels of satisfaction with their current experience of community integration, and use fewer environmental supports than their SCI counterparts (P less than or equal to 0.0001). Methodological and demographic differences between the samples are discussed in relation to the results. The results suggest that various aspects of independent living in these two defined groups (TBI and SCI) although highly related require specific attention and that clinicians and researchers working with TBI and SCI might benefit from further collaborative efforts.	Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada; Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; Toronto Rehabil Inst, Lyndhurst Ctr, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Neurol, Toronto, ON, Canada; Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada		Dawson, DR (corresponding author), Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.		Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121			Boschen K.A, 1997, J DEV DISABIL, V5, P91; Boschen KA, 1998, INT J REHABIL RES, V21, P285, DOI 10.1097/00004356-199809000-00004; BOSCHEN KA, 1999, J REHABILITATION OUT, V3, P1; BOSCHEN KA, 2000, AM J PHYSICAL MED RE, V81, P1618; BOSCHEN KA, IN PRESS CANADIAN J; BOSCHEN KA, 1993, CANADIAN J REHABILIT, V7, P50; BOSCHEN KA, 1995, UNPUB VARIABLES AFFE; BROWN D, 1992, ARCH PHYSICAL MED RE, V73, P788; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Caplan B, 1984, Int Rehabil Med, V6, P58; CASTLE R, 1994, PARAPLEGIA, V32, P182, DOI 10.1038/sc.1994.33; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DAWSON DR, 2001, STABILITY PSYCHOL FA; DAWSON DR, UNPUB RELATIONSHIP A; DEJONG G, 1979, ARCH PHYS MED REHAB, V60, P435; DEJONG G, 1982, ARCH PHYS MED REHAB, V63, P68; DEJONG G, 1984, ARCH PHYS MED REHAB, V65, P66; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Drewes A M, 1989, Int Disabil Stud, V11, P178; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; FRIEDEN L, 1985, AM J OCCUP THER, V39, P734, DOI 10.5014/ajot.39.11.734; FRIEDEN L, 1979, ILRU SOURCE BOOK TEC; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Hamilton BB, 1987, REHABILITATION OUTCO, P137; KENNEDY DW, 1990, PARAPLEGIA, V28, P130, DOI 10.1038/sc.1990.15; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUSE JS, 1991, REHABIL PSYCHOL, V36, P89, DOI 10.1037/0090-5550.36.2.89; Krause JS, 1996, ARCH PHYS MED REHAB, V77, P737; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; MOORE AD, 1995, BRAIN INJURY, V9, P103; NOSEK MA, 1992, REHABIL COUNS BULL, V36, P6; NOSEK MA, 1992, REHABIL COUNS BULL, V36, P21; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; SKINNER HA, 1991, UNPUB MEASURING SOCI; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER BS, 1993, BRAIN INJURY REHABIL; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583	42	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2002	25	2					93	102		10.1097/00004356-200206000-00003			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	557WE	WOS:000175931000003	12021596				2022-02-06	
J	Johnstone, B; Hogg, JR; Schopp, LH; Kapila, C; Edwards, S				Johnstone, B; Hogg, JR; Schopp, LH; Kapila, C; Edwards, S			Neuropsychological deficit profiles in senile dementia of the Alzheimer's type	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Alzheimer's disease; cognitive decline; premorbid intelligence	PREMORBID INTELLIGENCE; DISEASE; PATTERN; IMPAIRMENT; SUBGROUPS; DECLINE	Recent studies using Wide Range Achievement Test - Revised (WRAT-R) Reading scores as estimates of premorbid abilities have demonstrated that distinct neuropsychological deficit profiles may be associated with specific cognitive disorders such as traumatic brain injury [Brain Inj. 9 (1995) 377] and lupus [Appl. Neuropsychol. 7 (2000) 96], and that these deficit scores predict both functional and financial outcomes [J. Head Trauma Rehab. 14 (1999) 220]. Although the main cognitive deficits associated with senile dementia of the Alzheimer's type (SDAT) are well known, the relative degree of impairment in each has yet to be adequately determined. The present study calculated indices of relative decline (Z(Diff)) for 32 patients with probable SDAT by comparing estimates of premorbid functioning to concurrent neuropsychological test scores. The results suggest that intelligence is least declined in SDAT [Wechsler Adult Intelligence Scale - Revised (WAIS-R) FIQ, Z(Diff)= -0.72], followed by attention [Wechsler Memory Scale - Revised (WMS-R) Attention Index, Z(Diff)= -1.14], memory (WMS-R General Memory, Z(Diff)= -2.12; WMS-R Delay Memory, Z(Diff)= -2.33), speed of processing (Trails A, Z(Diff)= -2.85), and cognitive flexibility (Trails B, z(Diff) = -5.33). Clinical and research implications are discussed. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Missouri, Sch Med, Dept Phys Med & Rehabil, Columbia, MO 65212 USA		Johnstone, B (corresponding author), Univ Missouri, Sch Med, Dept Phys Med & Rehabil, DC046-00,1 Hosp Dr, Columbia, MO 65212 USA.			Johnstone, Brick/0000-0001-8845-9649			BECKER JT, 1988, ARCH NEUROL-CHICAGO, V45, P263, DOI 10.1001/archneur.1988.00520270037018; BERG L, 1990, ANN NEUROL, V28, P648, DOI 10.1002/ana.410280508; BOTWINICK J, 1986, ARCH NEUROL-CHICAGO, V43, P1124, DOI 10.1001/archneur.1986.00520110024008; CHRISTENSEN H, 1991, PSYCHOL ASSESSMENT, V3, P147; CHUI HC, 1985, NEUROLOGY, V35, P1544, DOI 10.1212/WNL.35.11.1544; Crowe SF, 2000, ARCH CLIN NEUROPSYCH, V15, P9, DOI 10.1016/S0887-6177(98)00040-7; Fisher NJ, 1996, J CLIN EXP NEUROPSYC, V18, P349, DOI 10.1080/01688639608408993; Ivnik RJ, 2000, NEUROPSYCHOLOGY, V14, P163, DOI 10.1037/0894-4105.14.2.163; JACOBS D, 1994, NEUROLOGY, V44, P1215, DOI 10.1212/WNL.44.7.1215; Jastak J., 1984, WIDE RANGE ACHIEVEME; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; JOHNSTONE B, 1992, PHYSICAL MED REHABIL, P495; KASNIAK AW, 1986, CANADIAN J NEUROLOGI, V13, P420; LORING DW, 1985, NEUROPSYCHOLOGIA, V23, P351, DOI 10.1016/0028-3932(85)90021-1; MASUR DM, 1994, NEUROLOGY, V44, P1427, DOI 10.1212/WNL.44.8.1427; MAYEUX R, 1985, NEUROLOGY, V35, P453, DOI 10.1212/WNL.35.4.453; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MITRUSHINA M, 1993, DEV BRAIN DYSFUNCT, V6, P324; Reitan R, 1986, TRAIL MAKING TEST MA; Schopp LH, 1998, ARCH CLIN NEUROPSYCH, V13, P637, DOI 10.1016/S0887-6177(97)00096-6; Skeel R L, 2000, Appl Neuropsychol, V7, P96, DOI 10.1207/S15324826AN0702_5; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; [No title captured]	27	15	15	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2002	17	3					273	281	PII S0887-6177(01)00112-3	10.1016/S0887-6177(01)00112-3			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	536ZN	WOS:000174731900004	14589727				2022-02-06	
J	Hanke, J				Hanke, J			Anatomical correlations of intrinsic axon repair after partial optic nerve crush in rats	ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER			English	Article						diffuse axonal injury; impaired axoplasmic transport; cytoskeletal change; retinal ganglion cells	RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; NEUROFILAMENT PROTEINS; TAIL DOMAIN; TRANSPORT; PHOSPHORYLATION; MODEL; HEAD; RECOVERY; ACCELERATION	About 15% of retinal ganglion cells survive diffuse axonal injury of the optic nerve in adult rats. Following initial blindness, discrimination of visual stimuli in behavioral tests recovers within three weeks. To investigate the mechanisms promoting this functional recovery the axonal transport and the neurofilaments were studied. Intraocularly applied MiniRuby is transported until the place of crush and accumulated in enlarged axon terminals. Three weeks after lesion the anterograde transport of MiniRuby recovers distal to the place of crush. At the same point in time the retrograde transport of surviving retinal ganglion cells is restored which was visualized by horseradish peroxidase injected into the superior colliculus. The heavy neurofilament was stained immunohistochemically and analyzed statistically up to three weeks after optic nerve crush. The stained filaments in the axon fibers of retinal ganglion cells appear wavelike and/or fragmented up to day 8, but first signs of heavy neurofilament restitution in the fibers of the optic nerve are seen at day 12 after axonal injury. Because these results cannot be explained by longlasting axon regeneration, the present results provide convincing evidence for intrinsic axon repair soon after diffuse axonal injury that correlates in time with recovery of vision.	Otto Von Guericke Univ, Fac Med, Inst Med Psychol, D-39120 Magdeburg, Germany		Hanke, J (corresponding author), Inst Anat, Leipziger Str 44, D-39120 Magdeburg, Germany.	Joachim.Hanke@medizin.uni-magdeburg.de	Sabel, Bernhard A./E-6579-2013				Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; Gennarelli T.A., 1986, MECHANISMS SECONDARY, P15; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRILL RJ, 1999, CNS REGENERATION BAS, P27; HESS DT, 1987, BRAIN RES BULL, V18, P581, DOI 10.1016/0361-9230(87)90124-9; HISANAGA S, 1991, J BIOL CHEM, V266, P21798; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; LASEK RJ, 1993, BRAIN RES, V616, P58, DOI 10.1016/0006-8993(93)90192-P; LORENZ T, 1978, P NATL ACAD SCI USA, V75, P505, DOI 10.1073/pnas.75.1.505; LUDWIN SK, 1992, J NEUROL SCI, V109, P140, DOI 10.1016/0022-510X(92)90160-M; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MAYOR HD, 1961, J BIOPHYS BIOCHEM CY, V9, P909, DOI 10.1083/jcb.9.4.909; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MCKERRACHER L, 1992, J NEUROBIOL, V23, P568, DOI 10.1002/neu.480230510; MIYASAKA H, 1993, J BIOL CHEM, V268, P22695; Nixon RA, 1998, BIOESSAYS, V20, P798, DOI 10.1002/(SICI)1521-1878(199810)20:10<798::AID-BIES5>3.0.CO;2-7; NIXON RA, 1993, BRAIN PATHOL, V3, P29, DOI 10.1111/j.1750-3639.1993.tb00723.x; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raghupathi R, 1998, P W PHARMACOL SOC, V41, P241; Rousseau V, 1999, NEUROREPORT, V10, P3387, DOI 10.1097/00001756-199911080-00024; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sabel BA, 1999, RESTOR NEUROL NEUROS, V15, P177; Sabel BA, 1997, ADV NEUROL, V73, P251; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; Schmitt U, 1996, EXP NEUROL, V139, P17, DOI 10.1006/exnr.1996.0076; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; SMITH RS, 1993, EUR J NEUROSCI, V5, P1127, DOI 10.1111/j.1460-9568.1993.tb00967.x; Terada S, 1996, SCIENCE, V273, P784, DOI 10.1126/science.273.5276.784; TOYOSHIMA I, 1995, NEUROSCI LETT, V189, P69, DOI 10.1016/0304-3940(95)11451-2; Vorwerk CK, 1999, CURR EYE RES, V19, P59, DOI 10.1076/ceyr.19.1.59.5336; WATSON DF, 1991, BRAIN RES, V539, P103, DOI 10.1016/0006-8993(91)90691-N; XIE XY, 1991, J NEUROSCI, V11, P3257	45	15	19	0	1	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0940-9602	1618-0402		ANN ANAT	Ann. Anat.-Anat. Anz.	MAR	2002	184	2					113	123		10.1016/S0940-9602(02)80002-4			11	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	535LH	WOS:000174645600002	11936190				2022-02-06	
J	Hausmann, ON; Hu, WH; Keren-Raifman, T; Witherow, DS; Wang, Q; Levay, K; Frydel, B; Slepak, VZ; Bethea, JR				Hausmann, ON; Hu, WH; Keren-Raifman, T; Witherow, DS; Wang, Q; Levay, K; Frydel, B; Slepak, VZ; Bethea, JR			Spinal cord injury induces expression of RGS7 in microglia/macrophages in rats	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						RGS protein; Gbeta5; CNS; inflammation; TNF-alpha; trauma	PROTEIN BETA-SUBUNIT; GTPASE-ACTIVATING PROTEINS; ALPHA-SUBUNITS; INFLAMMATORY RESPONSE; MESSENGER-RNA; MICE LACKING; G-BETA-5; DOMAIN; BRAIN; REGULATORS	RGS proteins regulate G protein-mediated signalling pathways through direct interaction with the Galpha subunits and facilitation of GTP hydrolysis. An RGS subfamily consisting of RGS 6, 7, 9, and 11 also interacts with the G protein beta subunit Gbeta5 via a characteristic Ggamma-like domain. Thus far, these complexes were found only in neurons, with RGS7 being the most widely distributed in the brain. Here we confirm the expression of RGS7 in spinal neurons and show as a novel finding that following an experimental spinal cord injury in rats, expression of RGS7 is induced in a subpopulation of other cells. Immunofluorescent confocal microscopy using a series of cell specific antibodies identified these RGS7 positive cells as activated microglia and/or invading peripheral macrophages. To rule out interference from the adjacent neurons and confirm the presence of RGS7-Gbeta5 complex in inflammatory cells, we performed immunocytochemistry, RT-PCR, Western blot, and immunoprecipitation using microglial (BV2) and peripheral macrophage (RAW) cell lines. Expression of RGS7 mRNA and protein are nearly undetectable in non-stimulated BV2 and RAW cells, but remarkably increased after stimulation with LPS or TNF-alpha In addition, RGS7-positive cells were also found in the perinodular rim in the rat spleen. Our findings show that RGS7-Gbeta5 complex is expressed in immunocompetent cells such as resident microglia and peripheral macrophages following spinal cord injury. This expression might contribute to the post-traumatic inflammatory responses in the central nervous system.	Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33101 USA; Univ Clin, Dept Neurosurg, Basel, Switzerland		Bethea, JR (corresponding author), Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33101 USA.		Kumar, Rishabh/P-4667-2017	Witherow, D. Scott/0000-0002-7344-1574	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM60019] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37130] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM060019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037130] Funding Source: NIH RePORTER		Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 1998, J NEUROSCI, V18, P3251; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Jones PG, 1998, BBA-MOL CELL RES, V1402, P288, DOI 10.1016/S0167-4889(98)00017-2; Keren-Raifman T, 2001, FEBS LETT, V492, P20, DOI 10.1016/S0014-5793(01)02220-7; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Liang JJ, 2000, J NEUROSCI RES, V60, P58, DOI 10.1002/(SICI)1097-4547(20000401)60:1<58::AID-JNR6>3.0.CO;2-L; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/0968-0004(96)30027-3; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2000, PROG BRAIN RES, V128, P43; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Watanabe T, 1999, J NEUROTRAUM, V16, P255, DOI 10.1089/neu.1999.16.255; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zhang SL, 2000, ACTA MATH SCI, V20, P1	40	15	16	0	1	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2002	15	4					602	612		10.1046/j.1460-9568.2002.01916.x			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HB	WOS:000174693700002	11886441				2022-02-06	
J	Smith, CP; Somogyi, GT; Bird, ET; Chancellor, MB; Boone, TB				Smith, CP; Somogyi, GT; Bird, ET; Chancellor, MB; Boone, TB			Neurogenic bladder model for spinal cord injury: spinal cord microdialysis and chronic urodynamics	BRAIN RESEARCH PROTOCOLS			English	Article						microdialysis; amino acid; spinal cord injury; bladder	EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN INJURY; MICTURITION REFLEX; NMDA RECEPTORS; IMPACT INJURY; RAT; GLUTAMATE; NEUROTOXICITY; ANTAGONIST; ELEVATION	We describe an animal model to study neurotransmitter changes in parallel with urodynamic testing following Spinal Cord Injury (SCI). Urodynamic access was achieved using a subcutaneously placed 7 French dual lumen portacatheter. Spinal cord injury was induced by weight drop technique onto exposed dura at T8. The L6-S1 detrusor nuclei were localized stereotactically and microdialysis probe placement was confirmed through histologic methods. Chronic urodynamics revealed detrusor hyper-reflexia (DH) 14 days following SCI. In vivo microdialysis of spinal cord amino acids was performed using CMA 11 (240 muM) probes in halothane-anesthetized rats at baseline and intervals of 20-30 min following spinal cord injury. Significant increases in the excitatory amino acid glutamate, and the inhibitory amino acids, glycine and taurine, were seen following spinal cord injury. Amino acid levels peaked at approximately 40 min following contusion injury with glycine demonstrating the highest levels of all amino acids measured. This neurogenic rat model provides a useful means of examining the effects of spinal cord injury on bladder function. By utilizing spinal cord microdialysis, one could intervene at the level of the detrusor nuclei to modulate bladder function. (C) 2002 Elsevier Science B.V. All rights reserved.	Baylor Coll Med, Dept Urol, Houston, TX 77030 USA; Vet Affairs Spinal Cord Injury Unit, Houston, TX USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA		Smith, CP (corresponding author), LS Kaufmann Bldg 700,3471 5th Ave, Pittsburgh, PA 15213 USA.						BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BUTCHER SP, 1987, J NEUROCHEM, V48, P722, DOI 10.1111/j.1471-4159.1987.tb05576.x; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; MATSUMOTO G, 1995, NEUROSCI LETT, V183, P58, DOI 10.1016/0304-3940(94)11114-X; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; NOBLE LJ, 1987, EXP NEUROL, V95, P530, DOI 10.1016/0014-4886(87)90162-2; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pikov V, 1998, J NEUROTRAUM, V15, P375, DOI 10.1089/neu.1998.15.375; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; SIMPSON RK, 1993, NEUROCHEM RES, V18, P887, DOI 10.1007/BF00998273; SLUKA KA, 1994, J PHARMACOL EXP THER, V271, P76; STEERS WD, 1991, J COMP NEUROL, V310, P401, DOI 10.1002/cne.903100309; SVED AF, 1993, J NEUROCHEM, V61, P2089, DOI 10.1111/j.1471-4159.1993.tb07446.x; WAHL P, 1989, J NEUROCHEM, V53, P1316, DOI 10.1111/j.1471-4159.1989.tb07430.x; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; YOSHIYAMA M, 1993, J PHARMACOL EXP THER, V265, P844; ZANOTTO L, 1983, NEUROSCI LETT, V35, P79, DOI 10.1016/0304-3940(83)90530-X	23	15	17	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1385-299X			BRAIN RES PROTOC	Brain Res. Protoc.	FEB	2002	9	1					57	64	PII S1385-299X(01)00137-4	10.1016/S1385-299X(01)00137-4			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	536VL	WOS:000174722500008	11852271				2022-02-06	
J	Cihangiroglu, M; Ramsey, RG; Dohrmann, GJ				Cihangiroglu, M; Ramsey, RG; Dohrmann, GJ			Brain injury: Analysis of imaging modalities	NEUROLOGICAL RESEARCH			English	Article						brain injuries; brain CT; brain MR; brain SPECT; brain PET; imaging of brain trauma	MAGNETIC-RESONANCE-SPECTROSCOPY; DIFFUSE AXONAL INJURY; INTERMEDIATE-FIELD MR; COMPUTED-TOMOGRAPHY; HEAD TRAUMA; SUBDURAL HEMATOMAS; CT; CHILDREN; LOCALIZATION; PREDICTORS	Advances in imaging have had a significant impact not only on the diagnosis of but also on the management of patients with brain injury. Various modalities are available to image the brain; however, it is not always clear which imaging modality (CT, MRI, SPECT, PET, etc.) is optimal for a specific aspect of traumatized brain. The purpose of this paper is to analyze the over 20,000 imaging studies clone in brain injury and to compare the results with the experience in the literature. A detailed comparison has been clone relative to CT, MRI, SPECT and PET in traumatic brain injury.	Univ Chicago, Med Ctr, Neurosurg Sect, Chicago, IL 60637 USA; Univ Chicago, Med Ctr, Neuroradiol Sect, Chicago, IL 60637 USA		Dohrmann, GJ (corresponding author), Univ Chicago, Med Ctr, Neurosurg Sect, MC 3026,5841 S Maryland Ave, Chicago, IL 60637 USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1991, NEUROIMAG CLIN N AM, V1, P397; AHMADI J, 1983, AM J NEURORADIOL, V4, P131; Balcer LJ, 1996, AM J OPHTHALMOL, V122, P437, DOI 10.1016/S0002-9394(14)72078-1; BAYKANER K, 1988, SURG NEUROL, V30, P339, DOI 10.1016/0090-3019(88)90195-4; BORZCUK P, 1997, EMERG MED CLIN N AM, V15, P563; BOYKO OB, 1991, AM J NEURORADIOL, V12, P341; CARON MH, 1996, NEUROTRAUMA, P163; COMELIUS RS, 1991, NEUROIMAG CLIN N AM, V1, P433; Diaz-Marchan PG, 1996, NEUROTRAUMA, V1st, P137; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Gean AD, 1994, IMAGING HEAD TRAUMA; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gentry LR, 1991, NEUROIMAG CLIN N AM, V1, P411; Gomori J M, 1988, Radiographics, V8, P427; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HANKINS L, 1996, NEUROTRAUMA, P151; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Holbourn AHS, 1943, LANCET, V2, P438; Howard-Lech VL, 1999, PHYSIOL MEAS, V20, P75, DOI 10.1088/0967-3334/20/1/006; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KLEINMAN PK, 1990, AM J ROENTGENOL, V155, P703, DOI 10.2214/ajr.155.4.2119097; LESOIN F, 1984, NEURORADIOLOGY, V26, P515, DOI 10.1007/BF00342691; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mogbo KI, 1998, RADIOLOGY, V208, P521, DOI 10.1148/radiology.208.2.9680586; Mullan BP, 1996, NEUROSURG CLIN N AM, V7, P617; Newmark J, 1999, MIL MED, V164, P59, DOI 10.1093/milmed/164.1.59; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P199; OZGEN T, 1990, NEURORADIOLOGY, V32, P481; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Petitti N, 1998, ACAD RADIOL, V5, P215, DOI 10.1016/S1076-6332(98)80287-0; PHELPS ME, 1992, CLIN BRAIN IMAGING P, P71; REED D, 1986, AM J NEURORADIOL, V7, P417; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; SEIDENWURM D, 1989, RADIOLOGY, V172, P189, DOI 10.1148/radiology.172.1.2740502; SMITH WP, 1981, AM J ROENTGENOL, V136, P543, DOI 10.2214/ajr.136.3.543; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; Yano Koh, 1997, Neurologia Medico-Chirurgica, V37, P838; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525; ZIMMERMAN RA, 1991, NEUROIMAG CLIN N AM, V1, P443; ZYED A, 1991, AM J NEURORADIOL, V12, P469	56	15	15	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2002	24	1					7	18		10.1179/016164102101199440			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	519WJ	WOS:000173748200003	11783756				2022-02-06	
